0.39018702507019043 ||| Titration and maintenance dose The daily dose is subsequently increased by doubling the dose at intervals of one to three days up to the target maintenance dose of 5 mg twice daily. ||| reduce the dosage by initiating the patient at 90% of the previous total daily dosage, with 40% as basal rate and 50% as boluses divided between the three main meals. ||| 22 Titration et dose d’ entretien La dose quotidienne sera augmentée par la suite en doublant la dose à un à trois jours d’ intervalle jusqu’ à atteindre la dose d’ entretien cible de 5 mg deux fois par jour.
0.47699597477912903 ||| No preclinical safety testing with the vaccine has been conducted. ||| The preclinical safety data satisfy the requirements of the WHO. ||| Aucun test de sécurité préclinique avec le vaccin n’ a été réalisé.
0.03808992728590965 ||| Dynepo 6,000 IU/ 0.3ml Injection Epoetin delta ||| Dynepo 4,000 IU/ 0.4ml Injection Epoetin delta ||| é Dynepo 6000 UI/ 0,3ml Injection
0.4617854654788971 ||| Overall treatment for 16 weeks resulted in lower sustained viral response (65%) than treatment for 24 weeks (76%) (p < 0.0001). ||| No development effects were seen at 3.4-fold human exposure at 400 mg twice daily based on AUC0-24 hr (see section 4.6). ||| La réponse virologique prolongée obtenue avec un traitement de 16 semaines a été plus faible (65%) que celle obtenue avec un traitement de 24 semaines (76%) (p < 0,0001).
0.6874193549156189 ||| 2 4.2 Posology and method of administration ||| 22 Method of administration: for oral administration. ||| 4.2 Posologie et mode d’ administration
0.38327181339263916 ||| BeneFIX should be administered using the pre-filled solvent syringe provided or a single sterile disposable plastic luer lock syringe. ||| The use of specialized DEHP-free solution containers or administration sets is not necessary to prepare or administer Abraxane infusions. ||| BeneFIX doit être administré à l’aide de la seringue de solvant pré-remplie fournie ou d’une seringue stérile en plastique à extrémité luer et à usage unique.
0.3890775442123413 ||| Glass vial (Type 1) closed with a disc (bromobutyl/ polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution. ||| REGRANEX is a clear colourless to straw-coloured non-sterile preserved gel and is filled in multidose tubes containing 15 grams. ||| Flacon en verre (type 1) obturé par un disque (caoutchouc bromobutyl/ polyisoprène) et un opercule de sécurité en plastique contenant 10 ml de solution.
0.17662502825260162 ||| Emulsion for injection. ||| Emulsion for injection ||| Emulsion pour injection.
0.35629159212112427 ||| Sensory neuropathy occurs frequently with Abraxane, although development of severe symptoms is less common. ||| Fainting (syncope) is a common symptom of the illness itself but can also occur during treatment with Ventavis. ||| Toutefois, des symptômes sévères se développent plus rarement.
0.40334010124206543 ||| 19 D-89150 Laichingen Germany ||| 15 D- 06796 Brehna Germany ||| 19 D-89150 Laichingen Allemagne
0.09261412918567657 ||| 17 A course of therapy is defined as three intravenous injections of Pedea given at 24 hour intervals. ||| A course of therapy is defined as three intravenous doses of Pedea given at 24-hour intervals. ||| Une cure de traitement correspond à trois doses de Pedea administrées par voie intraveineuse à 24 heures d’ intervalle.
0.3944922685623169 ||| The objective of the group was to identify European brand leaders in major therapeutic areas for harmonisation referrals under Article 30 of the Community Code. ||| The two scientific committees are responsible for formulating the Agency’s opinion on any question relating to the evaluation of human or veterinary medicinal products. ||| Le groupe avait pour objectif d’ identifier des personnalités éminentes dans les domaines thérapeutiques majeurs pour les saisines liées à l’ harmonisation en vertu de l’ article 30 du code communautaire.
0.25263097882270813 ||| In patients with N-acetylglutamate synthase deficiency, carglumic acid was shown to induce a rapid normalisation of plasma ammonia levels, usually within 24 hours. ||| Carbaglu can help eliminating excess of hyperammonaemia (elevated ammonia level in the blood), due to the lack of a specific liver enzyme N- acetylglutamate synthase. ||| Chez les patients atteints d’ un déficit en N-acétylglutamate synthase, il a été montré que l’ acide carglumique induisait une normalisation rapide de l’ ammoniémie, le plus souvent dans les 24 heures.
0.3309188485145569 ||| Glycine, Disodium phosphate anhydrous, Sodium dihydrogen phosphate monohydrate, ||| Sodium chloride Sodium phosphate dibasic (E339) Potassium phosphate monobasic (E340) ||| Glycine, Phosphate disodique anhydre, Phosphate monosodique monohydraté, Solution d’ albumine humaine.
0.08245012909173965 ||| Then, the usual dose is one 75-mg tablet of Clopidogrel BMS per day to be taken orally with or without food, and at the same time each day. ||| Then, the usual dose is one 75 mg tablet of Plavix per day to be taken orally with or without food, and at the same time each day. ||| Puis, la dose habituelle est de un comprimé de Clopidogrel BMS 75 mg par jour, à prendre par voie orale pendant ou en dehors des repas et tous les jours au même moment de la journée.
0.37873488664627075 ||| In addition, dose-related undesirable effects should be monitored after birth. ||| Clinical response and undesirable effects may also be used as guidance for dose titration. ||| De plus, les effets indésirables dose-dépendants doivent être surveillés après la naissance.
0.2527505159378052 ||| Mains monitoring apparatus (Electric -) ||| Control boxes (Electric -) ||| Appareils de contrôle pour réseaux électriques
0.43194207549095154 ||| The EU remains committed to promote and defend human rights in the region, including through its support to civil society and media. ||| The EU will put all efforts, together with Member States, to help the European tourism ecosystem recover from the crisis. ||| L'UE reste déterminée à promouvoir et à défendre les droits de l'homme dans la région, notamment en soutenant la société civile et les médias.
0.31486132740974426 ||| Insulin Human Winthrop Basal comes in cartridges sealed in disposable pen injectors, OptiSet. ||| Insulin Human Winthrop Rapid in cartridges has been developed for use in the OptiPen series. ||| Insulin Human Winthrop Basal se présente en cartouches scellées dans un stylo injecteur jetable, OptiSet.
0.30096861720085144 ||| Recycled paper pulp ||| Recycled bond paper ||| Pulpe de papier recyclé
0.4942050874233246 ||| Follow your doctor’s instruction carefully on which medicines can be combined. ||| This checklist will remind prescribers how to use the medicine safely. ||| Suivez attentivement les instructions de votre médecin quant aux médicaments qui peuvent être associés.
0.2727832496166229 ||| By this mechanism, efalizumab inhibits the binding of LFA-1 to ICAM-1, which interferes with T lymphocytes adhesion to other cell types. ||| Temsirolimus binds to an intracellular protein (FKBP-12), and the protein-temsirolimus complex binds and inhibits the activity of mTOR that controls cell division. ||| Par ce mécanisme, l'efalizumab inhibe la liaison de LFA-1 à ICAM-1, interférant ainsi avec l'adhésion des lymphocytes T aux autres types de cellules.
0.3253723978996277 ||| Based on the review of the data and the company’ s response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Advexin could not have been approved for the treatment of Li-Fraumeni cancer. ||| The Applicant further described data from the time of the safety cut-off (Jan-08) and considered that the derived information compared favourably to values quoted for Effentora and Actiq, although the reason for patient drop-out was not provided by the sponsor. ||| Sur la base de l’ examen des données et des réponses du laboratoire à la liste de questions du CHMP, au moment du retrait, le CHMP avait des inquiétudes et pensait à ce stade qu’ Advexin ne pouvait pas être approuvé pour le traitement des patients atteints du cancer de Li-Fraumeni.
0.23378980159759521 ||| If enalapril is used in such patients, periodic monitoring of white blood cell counts is advised and patients should be instructed to report any sign of infection. ||| If repeated or severe low blood glucose levels occur, the patient should notify the health care professional and the need to reduce or stop the insulin administration should be considered. ||| Si l’ énalapril est utilisé chez de tels patients, un contrôle périodique du nombre de leucocytes est conseillé et les patients doivent être avertis de signaler tout signe d’ infection.
0.5072720646858215 ||| Articulated transmissions for aircraft ||| Contoured inflated pads for patients ||| Transmissions articulées pour aéronefs
0.2544916272163391 ||| The very common side-effects (reported in at least 1 out of 10 patients) are: • Loss of hair • Abnormal decrease in the number of neutrophils in the blood • Decrease in the number of white blood cells in the blood • Deficiency of red blood cells • Reduction in the number of lymphocytes in the blood • Effect of peripheral nerves (pain, and numbness) • Pain in a joint or joints • Pain in the muscles • Nausea, diarrhoea • Vomiting • Weakness and tiredness ||| Very common side effects • bone, joint and muscle pain • elevations in blood levels of uric acid and certain enzymes • decreases in blood glucose • leukocytosis (an abnormally high number of white blood cells in the blood) • low level of blood platelets (which increases risk of bleeding or bruising) • low level of red blood cells (which can make the skin pale and cause weakness and breathlessness) • headache • nose bleed • enlarged spleen ||| Les effets indésirables les plus fréquemment observés (signalés chez au moins 1 patient sur 10) ont été: • Perte des cheveux • Diminution anormale du nombre de neutrophiles dans le sang • Diminution du nombre de globules blancs dans le sang • Insuffisance de globules rouges • Réduction du nombre de lymphocytes dans le sang • Effet sur les nerfs périphériques (douleur et engourdissement) • Douleurs articulaires • Douleurs musculaires • Nausées, diarrhée 22 • Vomissements • Faiblesse et fatigue
0.21486929059028625 ||| 9 Clinical efficacy The efficacy of tocilizumab in alleviating the signs and symptoms of RA was assessed in five randomised, double-blind, multi-centre studies. ||| The efficacy and safety of Valtropin has been assessed in a randomised, double-blind, parallel, controlled Phase III study in children with growth hormone deficiency. ||| Efficacité clinique L’ efficacité du tocilizumab sur le soulagement des signes et des symptômes de la PR a été évaluée au cours de cinq études multicentriques randomisées en double aveugle.
0.2712138295173645 ||| Trizivir is contraindicated in patients with known hypersensitivity to abacavir, lamivudine or zidovudine, or to any of the excipients. ||| Clinical isolates (n=5) with decreased susceptibility to zidovudine, lamivudine, or nevirapine remain fully susceptible to nelfinavir in vitro. ||| L’ administration de Trizivir est contre-indiquée en cas d’ hypersensibilité connue à l’ abacavir, à la lamivudine, à la zidovudine ou à l'un des excipients.
0.4593779742717743 ||| Rare: disturbed vision, diplopia, chromatopsia. ||| Papilloedema, reduced visual acuity*, myopia* ||| Rare: troubles visuels, diplopie, chromatopsie.
0.46272751688957214 ||| itching, loss of appetite or abdominal pain (uncommon). ||| - fatigue, generalised weakness, unspecified pain. ||| yeux, urines foncées, démangeaisons, perte d’appétit ou douleur abdominale (peu fréquent).
0.35387009382247925 ||| 0.084 ||| 0.19 ||| 0,084
0.24057883024215698 ||| 1 vial of solution for injection ||| Solution for injection 1 vial ||| 1 flacon de solution injectable
3.11860563415034e-13 ||| Fluoxetine (a CYP2D6 inhibitor), single doses of antacid (aluminium, magnesium) or cimetidine have not been found to significantly affect the pharmacokinetics of olanzapine. ||| Fluoxetine (a CYP2D6 inhibitor), single doses of antacid (aluminium, magnesium) or cimetidine have not been found to significantly affect the pharmacokinetics of olanzapine. ||| 21 Avec la fluoxétine (inhibiteur du CYP2D6), des doses uniques d'anti-acides (aluminium, magnésium) ou la cimétidine il n’ a pas été retrouvé d'effet significatif sur les paramètres pharmacocinétiques de l'olanzapine.
0.2011529505252838 ||| A new injection needle must be attached before each use. ||| A new needle should be used for every injection. ||| 549 Une nouvelle aiguille d’injection doit être fixée avant chaque utilisation.
0.08853591978549957 ||| The full EPAR for Synagis can be found here. ||| The full EPAR for Lysodren can be found here. ||| L’ EPAR complet est disponible ici.
0.258815735578537 ||| The scientific conclusions are provided in the Annex II, together with the amended Summary of Product Characteristics in the Annex III. ||| An overall summary of the scientific evaluation is provided in Annex II together with the harmonised summary of product characteristics in Annex III. ||| Les conclusions scientifiques sont présentées en annexe II et le résumé modifié des caractéristiques du produit en annexe III.
0.0 ||| 3. ||| 3. ||| 152 3.
0.3198949694633484 ||| Wash your hands before and after contact with the tablets. ||| Wash your hands before and after applying the ointment. ||| Toute personne touchant Siklos doit bien se laver les mains avant et après contact avec les comprimés.
0.08834721148014069 ||| Very common side effects (occurring in at least 1 in 10 patients) are: ||| Very common side effects (occurring in 1 or more patients out of 10) are: ||| Les effets indésirables très fréquents (observés chez plus d’ 1 patient sur 10):
1.0748285055160522 ||| Rosacea ct ||| Blue Pen Cap ||| Rosacée e C
0.0061246659606695175 ||| 15 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 16 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 15 MENTIONS MINIMALES DE L’ EMBALLAGE PRIMAIRE
0.0 ||| When turning the dose selector be careful not to push the push- button as insulin will come out. ||| When turning the dose selector be careful not to push the push- button as insulin will come out. ||| Lorsque vous tournez le sélecteur de dose, prenez garde à ne pas enfoncer le bouton-poussoir car de l'insuline s'échapperait.
0.0 ||| STATEMENT OF ACTIVE SUBSTANCE(S) ||| STATEMENT OF ACTIVE SUBSTANCE(S) ||| LISTE DES EXCIPIENTS
0.5959740877151489 ||| Frameless picture holders ||| Valanced bed covers ||| Supports sans cadre pour photos
0.10503221303224564 ||| Ciprofloxacin Bayer 200 mg/ 100 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1). ||| Ciprofloxacin Bayer 250 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). ||| Ciprofloxacine Bayer 200 mg/100 ml solution pour perfusion est indiquée dans le traitement des infections suivantes (voir les rubriques 4.4 et 5.1).
0.3259880542755127 ||| 4 One to 3 minutes after the subcutaneous administration of IL-2 has been completed, Ceplene should be administered by slow subcutaneous injection at a rate not to exceed 0.1 ml (0.1 mg histamine dihydrochloride) per minute. ||| The entire, fully diluted ORENCIA solution should be administered over a period of 30 minutes and must be administered with an infusion set and a sterile, non-pyrogenic, low-protein-binding filter (pore size of 0.2 to 1.2 μm). ||| Une à trois minutes après la fin de l’ administration sous-cutanée d’ IL-2, Ceplene doit être administré par injection sous-cutanée lente, à une vitesse ne dépassant pas 0,1 ml (0,1 mg d’ histamine dichlorhydrate) par minute.
0.04069386050105095 ||| If a drop of insulin still does not appear, the device is defective and must not be used. ||| 108 If a drop of insulin still does not appear, the device is defective and must not be used. ||| Si aucune goutte d’ insuline n’ apparaît, le stylo est défectueux et ne doit pas être utilisé.
0.19600550830364227 ||| The vaccine CELVAPAN may be used during lactation. ||| The vaccine INTANZA may be used during breast-feeding. ||| Le vaccin CELVAPAN peut être utilisé pendant l'allaitement.
0.01256553828716278 ||| INFORMATION FOR THE USER Tandemact 30 mg/ 2 mg tablets ||| INFORMATION FOR THE USER Tandemact 30 mg/ 4 mg tablets ||| INFORMATION DE L’ UTILISATEUR Tandemact 30 mg/ 2 mg, comprimés
0.7229400873184204 ||| - barbiturates (for difficult sleeping or epilepsy) ||| • convulsions (fits or seizures); no ||| - barbituriques (pour traiter l’ insomnie ou l’ épilepsie),
0.3184877038002014 ||| In the pooled MEDAL Program, 0.3% of patients on etoricoxib and 2.7% of patients on diclofenac discontinued due to hepatic-related adverse experiences. ||| ALT normalisation (≤ 1 times ULN) occurred in 27% of entecavir-treated and 21% of lamivudine-treated patients at end of dosing. ||| Dans le Programme MEDAL, 0,3% des patients sous étoricoxib et 2,7% des patients sous diclofénac ont arrêté le traitement en raison d'événements indésirables hépatiques.
0.6461293697357178 ||| Risperidonum ||| Tenofovir ||| Risperdal
0.4918771982192993 ||| They are expected to trigger close to €514 billion in additional investment across EU countries and to benefit some 1.4 million small and mid-sized companies. ||| More than 10,000 start-ups and SMEs have applied so far with a total financial request for of over €26 billion. ||| Elles devraient générer près de 514 milliards d'euros d'investissements supplémentaires dans les différents pays de l'UE et bénéficier à environ 1,4 million de petites et moyennes entreprises.
0.2732847332954407 ||| TRISENOX is to be administered intravenously at a dose of 0.15 mg/ kg/ day for 25 doses given 5 days per week, followed by 2 days interruption, repeated for 5 weeks. ||| Initial treatment Dosages should be increased gradually from a starting-dose of 0.264 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days. ||| TRISENOX doit être administré par voie intraveineuse à la dose de 0,15 mg/ kg/ jour, 25 fois, réparties à raison de 5 jours par semaine, suivis par 2 jours d’ interruption, et ce pendant 5 semaines.
0.2941851019859314 ||| If necessary, pregnancy testing should be undertaken (see Section 4.6). ||| If required, diuretic therapy may be resumed (see section 4.4 and section 4.5). ||| Si nécessaire, un test de grossesse devra être effectué (voir section 4.6).
0.16290414333343506 ||| Tel: + 34 91 623 1732 ||| Tel: + 356 21 238131 ||| Tel: + 36 1 328 5100
0.6019901037216187 ||| Losartan selectively blocks the AT1 receptor. ||| Tasmar blocks COMT and slows the breakdown of levodopa. ||| Le losartan inhibe sélectivement les récepteurs AT1.
0.19364531338214874 ||| • 11.06.2001 • 18.07.2001 • 54 days ||| • 23.02.2001 • 23.05.2001 • 90 days ||| 25.05.2001 11.06.2001 18.07.2001 54 jours
0.5025129318237305 ||| - Zonegran 100 mg hard capsules have a white opaque body and a red opaque cap and are printed ||| Each capsule has a white opaque body with a light blue opaque cap. ||| - Les gélules de Zonegran 100 mg ont un corps blanc opaque et une tête rouge opaque et portent
0.2744455933570862 ||| EMEA/CPMP/BWP/1143/00 ||| EMEA/ CPMP/ EWP/197/99 ||| CPMP/QWP/2819/00
0.5262109637260437 ||| Additional measures to support youth employment include employment and start-up incentives in the short term, and capacity building, young entrepreneur networks and inter-company training centres in the medium term. ||| Mitigations being used include recruiting military and sports medics, final-year doctors in training, private sector staff, and re-recruiting retired staff and those who have moved from the medical sector. ||| Parmi les mesures supplémentaires destinées à soutenir l'emploi des jeunes figurent les aides à l'emploi et à la création d'entreprises, à court terme, et le renforcement des capacités, les réseaux de jeunes entrepreneurs et les centres de formation interentreprises, à moyen terme.
0.5998200178146362 ||| Computerised financial services ||| Computerised business promotion ||| Services financiers informatisés
0.03211711347103119 ||| LABEL - BOTTLE OF 180 TABLETS 800 mg WITHOUT OUTER CARTON ||| LABEL - BOTTLE OF 180 TABLETS 800 mg WITH OUTER CARTON ||| ÉTIQUETTE - FLACON DE 180 COMPRIMES 800 mg SANS EMBALLAGE EXTERIEUR
0.00576848816126585 ||| The following instructions explain how to inject Omnitrope 1.3 mg/ ml yourself. ||| The following instructions explain how to inject Omnitrope 3.3 mg/ ml yourself. ||| Les instructions suivantes expliquent comment injecter Omnitrope 1,3 mg/ ml vous- même.
0.43779051303863525 ||| It will finance economic recovery, stronger health systems and the implementation of the Sustainable Development Goals in all countries outside of the EU , as part of the EU global response to fight the pandemic (‘Team Europe'). ||| The Commission will organise a European tourism convention with EU institutions, the industry, regions, cities and other stakeholders to jointly build the future of a sustainable, innovative and resilient European tourism ecosystem - the ‘European Agenda for Tourism 2050'. ||| Il financera la reprise économique, le renforcement des systèmes de santé et la mise en œuvre des objectifs de développement durable dans tous les pays en dehors de l'UE , dans le cadre de la réaction mondiale de l'UE face à la pandémie («équipe d'Europe»).
0.6725869178771973 ||| Hot water boilers for beverage making ||| Fertiliser for soil and potting soil ||| Bouilloires pour la préparation de boissons
0.29101628065109253 ||| Atorvastatin (80 mg daily) did not alter the pharmacokinetics of prasugrel and its inhibition of platelet aggregation. ||| Erythromycin, a CYP 3A4 inhibitor, does not change the pharmacokinetics of risperidone and the active antipsychotic fraction. ||| L'atorvastatine (80 mg par jour) n'a pas modifié la pharmacocinétique du prasugrel et son inhibition de l'agrégation plaquettaire.
0.25127071142196655 ||| Skin and subcutaneous tissue disorders: macular rash, papular rash, pruruitis, urticaria, angioneurotic oedema. ||| Rare: acute renal failure, impaired renal function, vaginal moniliasis, haematuria, crystalluria, interstitial nephritis. ||| 20 Affections de la peau et du tissu sous-cutané: rash maculaire, rash papulaire, prurit, urticaire, œ dème angioneurotique.
0.06712479889392853 ||| If you forget to take a dose, take it as soon as your remember unless it is nearly time for your next dose. ||| If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. ||| Si vous oubliez de prendre une dose, prenez-la dès que vous vous en apercevez à moins qu’il ne soit presque temps de prendre la dose suivante.
0.2733798623085022 ||| All packages except the 150 ml package are supplied with a measuring spoon marked for doses of 2.5 ml and 5 ml. ||| A measuring spoon is provided with each bottle for measuring 2.5 and 5 ml doses of the oral suspension. ||| Toutes les présentations sauf le flacon de 150 ml sont fournies avec une cuillère mesure graduée aux doses 2,5 ml et 5 ml.
8.075853354105877e-13 ||| 12. ||| 12. ||| 368 12.
0.3824377655982971 ||| indications for oral and intravenous formulations in children and adolescents: • Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa. • Complicated urinary tract infections and pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative intent) ||| Staphylococcus intermedius, Streptococcus spp., Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli, etc… The in-vitro activity of gentamicin against pathogens isolated from clinical cases of canine otitis externa in EU field trials between 2004 and 2007 was: ||| suivantes, pour les formulations orales et intraveineuses, chez les enfants et adolescents: • Infections broncho-pulmonaires de la mucoviscidose causées par Pseudomonas aeruginosa • Infections urinaires compliquées et pyélonéphrite • Charbon pulmonaire (prophylaxie post-exposition et traitement curatif)
0.3987528383731842 ||| Hydroxycarbamide is excreted in human milk. ||| Glycerol is added as a humectant. ||| L'hydroxycarbamide est excrété dans le lait humain.
0.34041720628738403 ||| Onset of these reactions occurred within the first 3 months after initiation of treatment with sitagliptin, with some reports occurring after the first dose. ||| In studies specifically designed to measure the onset of action of etoricoxib, the onset of action occurred as early as 24 minutes after dosing. ||| Ces réactions sont apparues dans les 3 premiers mois après l'initiation du traitement par la sitagliptine, certains cas apparaissant après la première prise.
0.2488715648651123 ||| The most abundant metabolite is 8-hydroxy-ibafloxacin, which is also microbiologically active. ||| The major metabolite of tylvalosin is 3-acetyltylosin (3-AT), which is also microbiologically active. ||| Le métabolite le plus important est le 8-hydroxy-ibafloxacine, qui est également microbiologiquement actif.
0.7285876274108887 ||| HSE. ||| rhythm. ||| BRGM.
0.0 ||| 95% CI ||| 95% CI ||| IC à 95%
0.43941229581832886 ||| If such contact occurs, wash thoroughly with soap and water; rinse eyes with plain water. ||| Wash your hands thoroughly with soap and water and dry them with a towel. ||| En cas de contact accidentel, bien laver au savon et à l'eau; rincer les yeux à l'eau courante.
0.507871687412262 ||| The European Commission coordinates the delivery of emergency medical supplies to China through the EU Civil Protection Mechanism. ||| The Commission will accelerate its work on the legislative proposal for a European Unemployment Reinsurance Scheme. ||| La Commission européenne coordonne la livraison de fournitures médicales d'urgence à la Chine par l'intermédiaire du mécanisme de protection civile de l'UE.
0.49495401978492737 ||| In addition, as with all protein medicines, some patients may develop antibodies (proteins that are produced in response to Valtropin). ||| products may sometimes develop antibodies to factor VIII (also known as factor VIII inhibitors), which may prevent the factor VIII product from working properly. ||| De plus, comme avec tous les médicaments à base de protéine, certains patients peuvent développer des anticorps (protéines produites en réponse à Valtropin).
0.3336088955402374 ||| • Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products, as amended (OJ L 214, 24.8.1993, p. ||| Photo “Management The Board will explore a proposal from its chairman to Board” collect and publish information about the safety and effectiveness of medicinal products in accordance with Article 51(c) and (i) of Council Regulation (EEC) No 2309/93. ||| • Règlement (CEE) n° 2309/93 du Conseil du 22 juillet 1993, établissant des procédures communautaires pour l’autorisation et la surveillance des médicaments à usage humain et à usage vétérinaire et instituant une agence européenne pour l’évaluation des médicaments, tel que modifié (JO L 214, 24.8.1993, p.
0.34734010696411133 ||| The dosage of Siklos can be adjusted to body weight by increments of 250 mg by using a quarter of a tablet. ||| Following a single dose of 3 mg of cetrorelix a duration of action of at least 4 days has been evaluated. ||| La dose de Siklos peut être ajustée au poids corporel par palier de 250 mg en utilisant le quart d'un comprimé.
0.44516852498054504 ||| Materials testing and analysing ||| Statistical analysis and reporting ||| Tests et analyses de matériaux
0.6643654108047485 ||| Wardrobes ||| Abdomen ||| Armoires
0.6380200386047363 ||| It is registered in the EU since 1996 through Mutual Recognition Procedure and national procedures. ||| The hospital has run under the jurisdiction and management of the People's Liberation Army after completion. ||| Il est enregistré dans l’ Union européenne depuis 1996 par la procédure de reconnaissance mutuelle et les procédures nationales.
0.31346699595451355 ||| Agrawal et al conducted a double-blind RCT in 353 patients with gastric ulcer and who continued to receive stable doses of NSAIDs. ||| Lai et al studied 123 patients with ulcer complications relating to the use of low dose aspirin and who were infected by H. pylori. ||| Agrawal et al ont mené un essai de contrôle randomisé en double aveugle auprès de 353 patients atteints d’ ulcère gastrique ayant continué à recevoir des doses stables d’ AINS.
0.08035752177238464 ||| Since the introduction into the market, isolated cases of NMS have been reported, especially following abrupt reduction or discontinuation of entacapone and other concomitant dopaminergic medicinal products. ||| Since the introduction of entacapone into the market, isolated cases of NMS have been reported, especially following abrupt reduction or discontinuation of entacapone and other concomitant dopaminergic medicinal products. ||| Depuis la mise sur le marché, des cas isolés de SMN ont été signalés, particulièrement suite à une diminution ou un arrêt brutal de l’ entacapone et d’ autres médicaments dopaminergiques associés.
0.4268672466278076 ||| Chemical cleaning agents for use in industrial processes ||| Storage systems adapted for use in motor vehicles ||| Agents chimiques de nettoyage destinés aux procédés industriels
0.2765854299068451 ||| What Trazec contains ||| What Tracleer contains ||| Que contient Trazec:
0.14107483625411987 ||| Shuttering (Non-metallic -) ||| Shutter doors (Non-metallic -) ||| Coffrages non métalliques
0.0 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial in the outer carton in order to protect from light. ||| Conserver le flacon dans l'emballage extérieur, à l'abri de la lumière.
0.4634920060634613 ||| The majority (67%) of patients were MTX-naïve. ||| A total of 14 patients (50%) experienced a-GVHD. ||| La majorité des patients (67%) étaient naïfs de MTX.
0.6403279304504395 ||| The magnitude of the task requires the mobilisation of citizens globally. ||| European standards are an essential pillar of a fully functioning internal market. ||| L'ampleur de la tâche requiert la mobilisation des citoyens à l'échelle mondiale.
0.45118948817253113 ||| Removable partitions [furniture] of metal ||| Decalcifying preparations [industrial] in powder form ||| Cloisons mobiles en métal [mobilier]
0.25726741552352905 ||| - Chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole ||| - Invasive aspergillosis in patients with disease that is refractory to amphotericin B or ||| - Chromoblastomycose et mycétome chez les patients réfractaires à l’ itraconazole ou chez les
0.4773971438407898 ||| Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder [other than for veterinary use] ||| a food security issue - plants, animals including pollinators and soil organisms play a vital role in our food system; ||| Mélanges de produits chimiques et de micro-organismes accroissant la valeur nutritionnelle des aliments pour animaux autres qu'à usage vétérinaire
0.3489067852497101 ||| renal failure (acute and chronic), acute tubular necrosis, proximal renal tubulopathy including Fanconi syndrome, nephritis, acute interstitial nephritis, nephrogenic diabetes insipidus, increased creatinine, proteinuria ||| Uncommon: renal failure acute, renal failure, oliguria, renal colic, haematuria, proteinuria, urinary retention, urinary frequency, difficulty in micturition, loin pain, urinary incontinence, micturition urgency. ||| Insuffisance rénale (aiguë et chronique), nécrose tubulaire aiguë, tubulopathie rénale proximale, y compris le syndrome de Fanconi, néphrite, néphrite interstitielle aiguë, diabète insipide néphrogénique, hypercréatininémie, protéinurie
0.5206268429756165 ||| These were observed slightly more frequently in patients treated with InductOs for shin bone studies than in patients who did not receive the product. ||| The brain scans were analysed by an expert who did not know whether the patients had received Gliolan or not. ||| Ils ont été observés de façon légèrement plus fréquente chez les patients avec fracture du tibia traités par InductOs que chez ceux non traités par le produit dans les études cliniques.
0.292309045791626 ||| Concomitant administration of lapatinib with capecitabine or trastuzumab did not meaningfully alter the pharmacokinetics of these agents (or the metabolites of capecitabine) or lapatinib. ||| Effects of other medicinal products on the pharmacokinetics of parecoxib (or its active metabolite valdecoxib) Parecoxib is rapidly hydrolysed to the active metabolite valdecoxib. ||| L'administration concomitante du lapatinib avec la capécitabine ou le trastuzumab ne modifie pas significativement la pharmacocinétique de ces médicaments (ou des métabolites de la capécitabine) ou du lapatinib.
0.36609023809432983 ||| In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products. ||| Note for guidance on immune sera of animal origin Points to consider on human somatic cell therapy products (jointly with Efficacy and Safety Working Parties) ||| En cas d’ administration concomitante d’ un traitement antiviral de l’ hépatite B ou C, veuillez consulter le Résumé des Caractéristiques du Produit de ces médicaments.
0.4074960947036743 ||| The median duration of therapy in study B2225 was 6.2 months, with a maximum duration of 24.3 months. ||| The median duration of therapy was 11 months (range 0.03 -31 months). ||| La durée médiane de traitement dans l’ étude B2225 était de 6,2 mois, avec une durée maximale de 24,3 mois.
0.23843131959438324 ||| Patients with a recent history of pulmonary infiltrates or er pneumonia may be at higher risk. ng ||| Patients without a history of sulphonamide allergy may also be at risk for serious skin reactions. ||| Les risques peuvent être majorés chez les patients ayant des antécédents récents d’ infiltration pulmonaire ou de pneumonie. 'e
0.18898966908454895 ||| How is Pelzont used? ||| How is Myocet used? ||| Comment Pelzont est -il utilisé?
0.434846431016922 ||| Accommodation bureau services [apartments] ||| Appointment scheduling services [office functions] ||| Services d'agences de logement [appartements]
0.3503350019454956 ||| Several foods can naturally contain toxins, many of which are not produced by bacteria. ||| These resistant bacteria may spread and cause infections in other people who have not taken any antibiotics. ||| En contraste, divers aliments peuvent contenir naturellement des toxines qui ne sont pas produites par des bactéries et sont présentes naturellement dans les denrées alimentaires, parmi lesquelles :
0.3792777955532074 ||| 19 Ísland Orphan Europe Nordic AB Banérgatan 37 S-11522 Stockholm Svíþjóð Tel: + 46 8 545 80 230 ||| 29 Eesti Polska ESTOBIIN OÜ Udeselja 4-4 11913, Tallinn, Estonia Tel: +372 600 2996 ||| Ísland Orphan Europe Nordic AB Banérgatan 37 S-11522 Stockholm Svíþjóð Tel: + 46 8 545 80 230
0.4182640016078949 ||| As long-term efficacy of SIFROL in the treatment of RLS has not been sufficiently tested, patient´s response should be evaluated after 3 months treatment and the need for treatment continuation should be reconsidered. ||| However, we are at present unsure as to whether the scale of this surveillance provides sufficient data to drive local containment strategies or if reporting infrequently meets the need of our information age. ||| L’ efficacité à long terme de SIFROL dans le traitement du syndrome des jambes sans repos n’ a pas été suffisament évaluée, la réponse du patient doit être déterminée après 3 mois de traitement et la nécessité de la poursuite de ce dernier doit être reconsidérée.
0.661778450012207 ||| Before use (without grey needle shield) ||| After use (needle safety cover down) ||| Avant utilisation (sans capuchon
0.2876807749271393 ||| Moreover, there are no clinical studies in pathogens others than Salmonella employing a daily dose of 2 X 30 mg/ kg body weight. ||| As in adults, there is no evidence of clinically significant medicinal product interactions in paediatric patients receiving up to 60 mg/ kg/ day levetiracetam. ||| De plus, on ne dispose d’ aucune étude clinique sur des agents pathogènes autres que Salmonella employant une dose journalière de 2 X 30 mg/ kg poids corporel.
0.33753594756126404 ||| Patients treated with idursulfase may develop infusion-related reactions (see section 4.8). ||| Revasc may cause allergic reactions including anaphylaxis and shock (see section 4.8). ||| Les patients traités par idursulfase sont susceptibles de développer des réactions associées à la perfusion (voir rubrique 4.8).
0.0449068546295166 ||| 156 9. ||| 146 9. ||| 9.
0.37714019417762756 ||| 10 mg/kg body weight three times a day with a maximum of 400 mg per dose. ||| For children, it is 70 mg per kilogram body weight up to a maximum dose of 5 g. ||| 10 mg/kg 3 fois/jour avec un maximum de 400 mg par dose
0.23504257202148438 ||| Known hypersensitivity to the active substance, to mouse or hamster protein or to any of the excipients. ||| · Hypersensitivity to bovine or human thyroid stimulating hormone or to any of the excipients. ||| Hypersensibilité connue à la substance active, aux protéines de souris ou de hamster ou à l’ un des excipients.
0.4117107391357422 ||| After a loading dose of 400 mg, the concentrations found in the extravascular fluid are equivalent to plasma concentrations. ||| Only a few metabolites were found in plasma, and all were at trace levels (0.2% or less of the plasma radioactivity). ||| Après absorption d'une dose de charge de 400 mg, les concentrations dans le liquide extravasculaire sont équivalentes aux taux plasmatiques.
0.7146643400192261 ||| Strength 60 mg 60 mg 60 mg 60 mg ||| 30 mg 45 mg 60 mg 120 mg 240 mg ||| Dosage 60 mg 60 mg 60 mg 60 mg
0.10922165215015411 ||| EU/ 1/ 06/ 364/ 006 – 2 tablets EU/ 1/ 06/ 364/ 007 – 4 tablets EU/ 1/ 06/ 364/ 008 – 12 tablets EU/ 1/ 06/ 364/ 009 – 40 tablets ||| EU/ 1/ 06/ 364/ 006 (2 tablets) EU/ 1/ 06/ 364/ 007 (4 tablets) EU/ 1/ 06/ 364/ 008 (12 tablets) EU/ 1/ 06/ 364/ 009 (40 tablets) ||| EU/ 1/ 06/ 364/ 006 – 2 comprimés EU/ 1/ 06/ 364/ 007 – 4 comprimés EU/ 1/ 06/ 364/ 008 – 12 comprimés EU/ 1/ 06/ 364/ 009 – 40 comprimés
0.2613973021507263 ||| Study E2100 was an open-label, randomised, active controlled, multicentre clinical trial evaluating Avastin in combination with paclitaxel for locally recurrent or metastatic breast cancer in patients who had not previously received chemotherapy for locally recurrent and metastatic disease. ||| The safety and efficacy of anidulafungin were evaluated in a pivotal Phase 3, randomised, double- blind, multicentre, multinational study of primarily non-neutropenic patients with candidaemia and a limited number of patients with deep tissue Candida infections or with abscess-forming disease. ||| L’ étude E2100 était une étude ouverte, randomisée, contrôlée, multicentrique, évaluant Avastin en association au paclitaxel en première ligne de traitement des patients atteints de cancers du sein métastatique ou en rechute locale.
0.21240222454071045 ||| A very common side effect (likely to occur in more than 1 in 10 patients) is headache. ||| An uncommon side effect (likely to occur in fewer than 1 in 100 patients) is nausea. ||| Un effet indésirable très fréquent (pouvant survenir chez plus d’ un patient sur 10) est le mal de tête.
0.4708232879638672 ||| were 114 out of 207 patients who continued on Humira 40 mg every other week for 60 months. ||| There were 95 subjects from group 2 who continued on 5 mg/ kg every 6 weeks. ||| Il y a eu 114 sur 207 patients qui ont poursuivi par 40 mg de Trudexa toutes les deux semaines pendant 60 mois.
0.4778677523136139 ||| The Marketing Authorisation Holder commits to performing the study and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan. ||| This lead to a split of the pharmacovigilance activities from the Technical Co-ordination Unit to the Human and Veterinary Medicines ||| Le titulaire de l’ autorisation de mise sur le marche s´est engagé à réaliser l’ étude et les activités de pharmacovigilance décrites dans le plan de pharmacovigilance
0.2289741188287735 ||| Please refer to section 3 of the leaflet, “How to use Extavia”, for further details on how to use Extavia. ||| - Be consistent - use Extavia as described in section 3 of the leaflet, “How to use Extavia”. ||| Voir la rubrique 3 « Comment utiliser Extavia » dans la notice pour plus de détails sur le mode d’utilisation d’ Extavia.
0.02013378217816353 ||| Patients receiving CellCept should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression. ||| Patients receiving Myfenax should be instructed to report immediately any evidence of infection, unexpected bruising, bleeding or any other manifestation of bone marrow depression. ||| Les patients traités par CellCept doivent être informés de la nécessité de contacter immédiatement le médecin pour toute infection, toute ecchymose inexpliquée, tout saignement ou tout autre symptôme de myélosuppression.
0.3641780912876129 ||| 100 film-coated tablets ||| 28 or 98 film-coated tablets ||| 100 comprimés pelliculés
3.7256450095141114e-13 ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. ||| Lactose: les patients présentant un problème héréditaire rare d’ intolérance au galactose, une déficience en lactase LAPP ou une malabsorption du glucose et du galactose ne doivent pas prendre ce médicament.
0.2943252623081207 ||| Electric communication apparatus ||| Electric power distribution apparatus ||| Appareils de communication électriques
0.6418353319168091 ||| Arranging of subscriptions for the publications of others ||| Arranging of contracts, for others, for the providing of services ||| Services d'abonnement pour les publications de tiers
0.2879074215888977 ||| Photographic etching of textiles ||| Photographic etching of paper ||| Gravure photographique sur tissus
0.3142850995063782 ||| Aldurazyme treatment should be supervised by a doctor experienced in the management of patients with MPS I or other inherited metabolic diseases. ||| VASOVIST is used to obtain a clearer scan in patients who have suspected or known problems with blood vessels in the abdomen or limbs. ||| Le traitement par Aldurazyme doit être supervisé par un médecin expérimenté dans la prise en charge des patients atteints de MPS I ou d’ autres maladies métaboliques héréditaires.
0.501151978969574 ||| Accordingly, longer infusion times should be considered in children weighing < 20 kg (see section 4.2). ||| Patients were divided into and dosed according to three body- weight groups (see section 4.2) for 12 weeks. ||| De ce fait, des temps de perfusion plus longs devront être envisagés chez les enfants pesant < 20 kg (voir rubrique 4.2).
0.04144759103655815 ||| Treatment should be initiated under the supervision of a physician experienced in the treatment of acromegaly. ||| Treatment should be initiated under the supervision of a physician experienced in the treatment of haemophilia. ||| Le traitement doit être initié sous la surveillance d’ un médecin expérimenté dans le traitement de l’ acromégalie.
0.12124495208263397 ||| 361 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 24 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS (VIAL) ||| 375 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.05040179193019867 ||| ------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only ||| --------------------------------------------------------------------------------------------------------------------------- -- The following information is intended for medical or healthcare professionals only: ||| --------------------------------------------------------------------------------------------------------------------------- Les informations suivantes sont destinées exclusivement aux professionnels de santé.
0.022143207490444183 ||| The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy. ||| 62 The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy. ||| La nature et l'incidence des événements indésirables rapportés chez les patients traités par l'association étaient similaires à ceux du profil des événements indésirables rapportés chez les patients sous monothérapie.
3.576489690342022e-13 ||| Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6 month follow-up after treatment. ||| Furthermore, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6 month follow-up after treatment. ||| En outre, les idées suicidaires ou tentatives de suicides au cours du traitement et lors du suivi de 6 mois après traitement ont été rapportés plus fréquemment chez les enfants et adolescents que chez les adultes (2,4% versus 1%).
0.5344973802566528 ||| The scope of the referral was to agree whether the proposed withdrawal periods of 58 days for cattle and 35 days for pigs were adequately established. ||| This number of days of interpretation is calculated on the basis of number of man-days required to provide interpretation from spoken languages into the interpreted languages. ||| La saisine avait pour objectif de décider si le temps d’ attente proposé, qui était de 58 jours pour les bovins et de 35 jours pour les porcs, avait été fixé de manière appropriée.
0.052238479256629944 ||| Condition monitoring relating to fluids ||| Condition monitoring relating to oils ||| Surveillance concernant l'état des fluides
0.7171057462692261 ||| The Temporary Framework provides for five types of aid which can be granted by Member States: ||| The divergences that previously existed across the SPCs of EU Member States included: ||| L'encadrement temporaire prévoit que cinq types d'aide peuvent être octroyés par les États membres:
0.005959605798125267 ||| 536 Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| 444 Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. ||| 554 Vérifiez votre glycémie et votre cétonurie le plus rapidement possible dès que l'un des symptômes ci-dessus apparaît.
0.3772815465927124 ||| • The solvent for TAXOTERE composition is a 13% w/ w solution of ethanol 95% in water for injections. ||| What solvent vial contains 13% (w/ w) ethanol 95% in water for injections. ||| • La composition du solvant de TAXOTERE est une solution à 13% (m/ m) d'éthanol à 95% dans l'eau pour préparations injectables.
0.5257254838943481 ||| Table 3 ACR Responses in Placebo-Controlled Trials (Percent of Patients) ||| Table 4 ACR Responses in RA Study V (percent of patients) ||| Réponses ACR dans les essais contrôlés contre placebo (pourcentage de patients)
0.002135754097253084 ||| • 1.8.2002 • 7.10.2002 • 11.10.2002 • OJ C 258, 25.10.2002, p. ||| • 1.8.2002 • 7.10.2002 • 10.10.2002 • OJ C 258, 25.10.2002, p. ||| 11.10.2002 JO C 258, 25.10.2002, p.
0.3253710865974426 ||| How to use Apidra 4. ||| How to use Zarzio 4. ||| Comment utiliser Apidra 4.
0.45576757192611694 ||| Pharmacists can have multiple roles in the emergency department, including giving real-time feedback and consultation regarding prescribing practices, and identifying drug interactions. ||| Supporting innovation and research, in particular by providing support to SMEs and by discussing challenges relating to new technologies and therapies with key parties; ||| Les pharmaciens peuvent mener plusieurs actions dans un service des urgences, y compris formuler des commentaires en temps réel (analyse pharmaceutique), proposer des consultations sur les pratiques en matière de prescription et identifier les interactions médicamenteuses.
0.2627057135105133 ||| In some patients with bilateral renal artery stenosis or stenosis of the artery to a solitary kidney, who have been treated with ACE inhibitors, increases in blood urea and serum creatinine, usually reversible 23  EMEA 2005 upon discontinuation of therapy, have been seen. ||| The safety and efficacy of MIRCERA therapy has not been established in patients with haemoglobinopathies, seizures, bleeding or a recent history of bleeding requiring transfusions or with platelet levels greater than 500 x 109/ l. ||| Des augmentations de l’ urée sanguine et de la créatinine sérique, généralement réversibles à l’ arrêt du traitement, ont été observées chez certains patients ayant une sténose bilatérale des artères rénales ou une sténose de l’ artère sur rein unique, traités par des IEC.
0.4811394512653351 ||| 148 (94%) 40 (27%) P=0.01 ||| n = 119 (35%) 194 (65%) ||| 148 (94%) 40 (27%) p=0,01
0.228741854429245 ||| For the purpose of ambulatory use, the product may be removed from the refrigerator for one single period of up to 3 months at a temperature not above 25oC without exceeding the expiry date. ||| Within its shelf-life, for the purpose of transport and/or to facilitate ambulatory use the non- reconstituted product can be kept at or below 25°C for a period up to four weeks before use. ||| Pour une utilisation en ambulatoire, le produit peut être sorti du réfrigérateur pour une durée maximale et unique de 3 mois à une température ne dépassant pas 25°C sans dépasser la date limite d’ utilisation.
0.8029541969299316 ||| Kineret may worsen these conditions; ||| AZARGA may make any of these worse. ||| Kineret peut aggraver ces pathologies;
0.365741491317749 ||| Skin and subcutaneous tissue disorders Common: ecchymosis at the injection site, sweating increased Uncommon: pruritus, rash ||| Eye disorders Common: visual disorder (including visual disturbance, vision blurred, and visual acuity reduced), dry eye Uncommon: conjunctivitis ||| Affections de la peau et du tissu sous-cutané Fréquent: ecchymose au site d’ injection, augmentation de la sudation Peu fréquent: prurit, éruption cutanée
0.6756144165992737 ||| - severe loss of appetite leading to weight loss (anorexia), ||| NO7 Mild or moderate dementia of Alzheimer's type ||| - perte d’appétit sévère entraînant une perte de poids (anorexie),
0.36046063899993896 ||| EU/ 1/ 06/ 368/ 016 (3 pens of 3 ml) EU/ 1/ 06/ 368/ 017 (4 pens of 3 ml) EU/ 1/ 06/ 368/ 018 (5 pens of 3 ml) EU/ 1/ 06/ 368/ 103 (6 pens of 3 ml) EU/ 1/ 06/ 368/ 108 (9 pens of 3 ml) EU/ 1/ 06/ 368/ 019 (10 pens of 3 ml) ||| EU/ 1/ 08/ 458/ 009 14 modified-release tablets EU/ 1/ 08/ 458/ 010 28 modified-release tablets EU/ 1/ 08/ 458/ 011 56 modified-release tablets EU/ 1/ 08/ 458/ 013 168 modified-release tablets EU/ 1/ 08/ 458/ 014 32 x 1modified-release tablets ||| EU/ 1/ 06/ 368/ 016 (3 stylos de 3 ml) EU/ 1/ 06/ 368/ 017 (4 stylos de 3 ml) EU/ 1/ 06/ 368/ 018 (5 stylos de 3 ml) EU/ 1/ 06/ 368/ 103 (6 stylos de 3 ml) EU/ 1/ 06/ 368/ 108 (9 stylos de 3 ml) EU/ 1/ 06/ 368/ 019 (10 stylos de 3 ml)
0.260504812002182 ||| Dogs treated orally with difloxacin (as hydrochloride) at 10 times the recommended dose for 10 days occasionally showed mild adverse reactions such as orange/ yellowing discoloration of the faeces, emesis and hypersalivation. ||| Emesis and/ or activated charcoal (60 to 100 g in adults) and/ or osmotic cathartic may be indicated in patients seen within 4 hours of ingestion with symptoms or following a large overdose. ||| Le traitement des chiens par voie orale avec la difloxacine (sous forme de chlorhydrate) à 10 fois la dose recommandée pendant 10 jours a parfois révélé des effets secondaires légers tels qu’ une décoloration jaune/ orangée des fécès, des vomissements et une hypersalivation.
0.05459985136985779 ||| Cases of recurrence of inhibitors (low titre) have been observed after switching from one recombinant factor VIII product to another in previously treated patients with more than 100 exposure days who have a history of inhibitor development. ||| Cases of recurrent inhibitor (low titre) have been observed after switching from one factor VIII product to another in previously treated patients with more than 100 exposure days who have a history of inhibitor development. ||| Des cas de récurrence d'inhibiteurs (faible titre) ont été observés après le remplacement d'un facteur recombinant VIII par un autre chez des patients précédemment traités pendant plus de 100 jours d'exposition, ayant des antécédents d’ inhibiteurs.
0.22969894111156464 ||| What ONSENAL contains ||| What SOMAVERT contains ||| Que contient Onsenal
0.3099380135536194 ||| 10 SCIENTIFIC CONCLUSIONS ||| 11/ 16 SCIENTIFIC CONCLUSIONS ||| 10 CONCLUSIONS SCIENTIFIQUES
0.45563217997550964 ||| 2.5 [2.1, 2.9] ||| 1.9 [1.4, 2.4] ||| 2,0 [1,7; 2,3]
0.3663553297519684 ||| If you notice either, do not use it. ||| If it is not, do not use. ||| Si ce n’ était pas le cas, n’ utilisez pas la solution
0.04980060085654259 ||| During clinical trials, the following side effects were reported with the use of IDflu. ||| During clinical trials, the following side effects were reported with the use of INTANZA. ||| Au cours des études cliniques, les effets indésirables suivants ont été rapportés avec IDflu.
0.48670291900634766 ||| Infection Neutropenic infection ||| Gastroenteritis Upper respiratory infection ||| Infection Infection neutropénique
0.27107173204421997 ||| Adverse drug reactions reported in the paediatric population (children and adolescents) were, in general, similar to those reported in adults. ||| In general, the adverse events in paediatric patients were similar in frequency and type to those seen in adult patients. ||| Les effets indésirables liés au traitement rapportés dans la population pédiatrique (enfants et adolescents) étaient, en général, similaires à ceux rapportés chez les adultes.
0.569710373878479 ||| Blast furnaces ||| Artificial gutta percha ||| Hauts fourneaux
0.18248958885669708 ||| Each hard capsule contains 150 mg of cysteamine (as mercaptamine bitartrate) For a full list of excipients, see section 6.1. ||| Each tablet contains 500 mg mycophenolate mofetil For a full list of excipients, see section 6.1 ||| Chaque gélule contient 150 mg de cystéamine (sous forme de bitartrate de mercaptamine).
0.21323415637016296 ||| The amount of Filgrastim ratiopharm you need will depend on the condition you are taking Filgrastim ratiopharm for and on your bodyweight. ||| The amount of Biograstim you need will depend on the condition you are taking Biograstim for and on your bodyweight. ||| La dose habituelle est… La quantité de Filgrastim ratiopharm dont vous avez besoin dépendra de la pathologie pour laquelle vous prenez Filgrastim ratiopharm et de votre poids.
0.4527011513710022 ||| [84%-92%]) at 1 year and 75% (95% CI: ||| 8.7– 17.4] and survival at one year was 14% [95% CI: ||| [84%-92%]) à 1 an et de 75% (IC 95%:
0.57096266746521 ||| To give yourself a subcutaneous injection you will need: ||| You should take LYRICA in addition to your current treatment. ||| Pour vous a dministrer une injection sous-cutanée, vous aurez besoin:
0.5387204885482788 ||| България / Eesti/ Latvija/ Lietuva/ Österreich/ România/ Slovenija Wyeth-Lederle Pharma GmbH Tel/ Tãlr: +43 1 89 1140 Факс / Faks/ Fakss/ Faksas/ Fax: +43 1 89 114600 ||| Danmark/ Norge/ Sverige/ Suomi/ Finland/ Ísland Genzyme A/ S, (Danmark/ Tanska/ Danmörk), Tlf/ Puh. / Sími: + 45 32712600 ||| България / Eesti/ Latvija/ Lietuva/ Österreich / România/ Slovenija Wyeth-Lederle Pharma GmbH Tel/ Tãlr: +43 1 89 1140
0.11152377724647522 ||| 7/ 61 ||| 7/ 46 ||| 6/ 57
0.2752210199832916 ||| Tel: + 34 91 623 1732 ||| Τηλ: +30 210 629 4600 ||| Tel: + 36 1 328 5100
0.34303098917007446 ||| A 30 ml adjustable multidose syringe consisting of high density polyethylene (white) and low density polyethylene (white and natural). ||| Each carton contains one high-density polyethylene (HDPE) bottle or three high-density polyethylene (HDPE) bottles closed with child-resistant polypropylene closure. ||| Applicateur multidose ajustable de 30 ml en polyéthylène de haute densité (blanc) et de faible densité (blanc et transparent).
0.30200690031051636 ||| If you are not sure if the medicines you are taking could have this effect, discuss this with your doctor. • if you suffer from a severe heart disease such as heart rhythm disorder, heart failure or heart attack ||| If you have depression, your doctor may still prescribe Avonex for you, but it's important to let your doctor know if you have had depression or any similar problems affecting your moods. ||| Si vous n’ êtes pas sûr que les médicaments que vous prenez puissent avoir cet effet, parlez -en avec votre médecin • Si vous souffrez d’ une maladie cardiaque sévère comme un trouble du rythme cardiaque, d’ une insuffisance cardiaque, ou d’ une attaque cardiaque.
0.24061457812786102 ||| Greece ||| Poland ||| France
0.4017651081085205 ||| Orathecin was given to the patients until their cancer progressed or they could not tolerate the treatment anymore. ||| Treatment with TORISEL should continue until the patient does not benefit any more or has unacceptable side effects. ||| Orathécin a été administré aux patients jusqu’ à la progression de leur cancer ou jusqu’ à ce qu’ ils ne puissent plus tolérer le traitement.
0.010479012504220009 ||| 27 Mutagenicity Olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and in vivo mammalian tests. ||| 97 Mutagenicity Olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and oral in vivo mammalian tests. ||| L’ olanzapine n’ a montré aucun effet mutagène ni clastogène, lors d’ une série complète de tests standard, tels que tests de mutation bactérienne, et tests in vitro et in vivo sur mammifères.
7.286086881400089e-13 ||| Dispose of in accordance with local requirements. ||| Dispose of in accordance with local requirements. ||| À éliminer selon la réglementation locale en vigueur.
0.1396162509918213 ||| Very commonly reported side effects (at least 1 in every 10 patients): pain, swelling and redness or skin damage at site of injection, hair loss, dizziness, changes in appetite, stomach or abdominal pains, diarrhoea, nausea (feeling sick), viral infection, depression, emotional lability, insomnia, anxiety, sore throat and painful swallowing, fatigue, chills/rigors, fever, flu-like reaction, feeling of general discomfort, headaches, weight loss, vomiting, irritability, weakness, mood swings, coughing (sometimes severe), shortness of breath, itching, dry skin, rash, sudden and severe muscle pain, joint pain, musculoskeletal pain, changes in laboratory blood values including decreased white blood cell count. ||| 28 Uncommon side effects (at least 1 in 1,000 and less than 1 in 100 patients): tooth infection, infected skin ulcer, nail fungal infection, skin cancer, low blood platelet count, low blood cell counts, allergic reactions, anxiety, numbness, hives, eye inflammation, dry eye, reduced vision, palpitation, rapid heart rate, low heart rate, low blood pressure, hot flush, mouth sores, increased tendency to bruise, hair loss, dry skin, painful joints, pain in the extremities, flu-like illness, increased weight, infusion-related reactions, depression, absence of menstruation, migraine, kidney infection, psoriasis, difficulty in breathing and throat tightness. ||| Effets indésirables très fréquemment rapportés (au moins 1 patient sur 10): douleur, gonflement et rougeur ou lésions de la peau au point d’ injection, perte de cheveux, étourdissements, changements de l’ appétit, douleurs abdominales ou à l’ estomac, diarrhées, nausées (mal au cœ ur), infection virale, dépression, instabilité émotionnelle, insomnie, anxiété, gorge douloureuse et douleur à la déglutition, fatigue, tremblements/ frissons, fièvre, réaction pseudo- grippale, sensation d’ inconfort général, maux de tête, perte de poids, vomissement, irritabilité, faiblesse, changements d’ humeur, toux (parfois sévère), souffle court, démangeaisons, peau sèche, rash, douleur musculaire brutale et sévère, douleur aux articulations, douleur musculo-squelettique, changements des résultats d’ analyses de sang dont une diminution du nombre de globules blancs.
0.32656341791152954 ||| A medicine labelled with Ytracis should not be used in women who are or may be pregnant. ||| Humalog should not be used in people who may be hypersensitive to any of the ingredients. ||| Un médicament radiomarqué par Ytracis ne doit pas être utilisé chez les patientes enceintes ou susceptibles de l’ être.
0.3567369282245636 ||| 3 bottles of 360 film-coated tablets ||| Cartons of 30 film-coated tablets: ||| 3 flacons de 360 comprimés pelliculés
0.22433651983737946 ||| Emtriva 200 mg hard capsules are available for adults, adolescents and children who weigh at least 33 kg and can swallow hard capsules. ||| Children weighing more than 40 kg and who can swallow capsules may take Tamiflu 75 mg capsules twice daily for 5 days. ||| Emtriva 200 mg gélules est disponible pour les adultes, les adolescents et les enfants pesant au moins 33 kg et pouvant avaler des gélules.
0.22665870189666748 ||| PVC/Aluminium blisters containing 14, 21, 56, 84 or 112 (2 x 56) hard capsules. ||| PVC/Aluminium blisters containing 14, 21, 56 or 84 hard capsules. ||| Plaquettes thermoformées en PVC/Aluminium contenant 14, 21, 56, 84 ou 112 (2 x 56) gélules.
0.1419450044631958 ||| Always take Tandemact exactly as your doctor has told you. ||| Always takeZeffix exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.5419296026229858 ||| Frequencies are defined as: rare ≥ 1/ 10,000, < 1/ 1000 and very rare < 1/ 10,000 including isolated reports. ||| The frequency of all of the events listed below was common (defined as > 1/ 100, < 1/ 10). ||| Les fréquences sont définies comme suit: rare ≥ 1/ 10.000, < 1/ 1000; et très rare < 1/ 10.000 incluant des notifications isolées.
0.8278428912162781 ||| • anaemia (low red blood cell count) ||| • Low absolute neutrophil count (ANC) ||| • anémie (faible nombre de globules rouges)
0.3097582459449768 ||| These reactions were reversible in the majority of patients. ||| No undesirable effects were reported in the majority of individuals. ||| Ces réactions ont été réversibles chez la majorité des patientes.
0.37733131647109985 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "There is a global consensus on the importance of enhancing and accelerating coronavirus related research and the production of relevant products to address the current emergency health crisis. ||| Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: "We are mobilising all means at our disposal to fight this pandemic with testing, treatments and prevention. ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Il existe un consensus au niveau mondial sur l'importance d'intensifier et d'accélérer la recherche liée au coronavirus et la fabrication de produits utiles pour faire face à l'urgence sanitaire actuelle.
0.036998290568590164 ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| 249 Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| 52 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.4536205232143402 ||| The schemes were approved under the State aid Temporary Framework to support the economy in the context of the COVID-19 outbreak adopted by the Commission on 19 March 2020. ||| The European Commission responded to this call by joining forces with global partners to host a pledging event - the Coronavirus Global Response Initiative - as of 4 May 2020. ||| Les régimes ont été autorisés au titre de l' encadrement temporaire des aides d'État visant à soutenir l'économie dans le contexte de la flambée de COVID-19 , adopté par la Commission le 19 mars 2020.
0.4087602496147156 ||| Note for guidance on dry powder inhalers ||| Note for guidance on plasma-derived medicinal products ||| Inhalateurs de poudre sèche
0.4459768533706665 ||| Shaving soap ||| Shaving dishes ||| Savon à barbe
0.23061475157737732 ||| Storage modules [furniture] ||| Sales counters [furniture] ||| Modules de rangement [meubles]
0.2778470516204834 ||| He is currently Director of Licensing at the Veterinary Medicines Directorate in the UK and is a past Chairman of the Veterinary Mutual Recognition Facilitation Group. ||| He is also a member of the UK Broadcasting Standards Commission; Chairman of the Family Fund Trust; and Visiting Fellow of the London School of Economics. ||| Il est actuellement directeur des licences au Veterinary Medicines Directorate au Royaume-Uni et a été président du groupe de facilitation de la reconnaissance mutuelle pour les médicaments vétérinaires.
7.552968667168258e-13 ||| 17. ||| 17. ||| 12 17.
0.2483333945274353 ||| The concomitant use of alpha-blockers and vardenafil may lead to symptomatic hypotension in some patients because both are vasodilators. ||| Rarely, reactions including hypertension and dyskinesia have been reported with the concomitant use of tricyclic antidepressants and levodopa/ carbidopa. ||| L’ administration concomitante d’ alpha-bloquants et de vardénafil peut entraîner, chez certains patients, une hypotension symptomatique car ce sont tous deux des vasodilatateurs.
0.19935175776481628 ||| However, patients at high risk of digoxin toxicity should be monitored for this when etoricoxib and digoxin are administered concomitantly. ||| Caution should be taken if medicinal products associated with hepatotoxicity are administered concomitantly with trabectedin, since the risk of hepatotoxicity may be increased. ||| Cependant, les patients ayant des facteurs de risque favorisant la toxicité de la digoxine seront surveillés pour cette raison lorsque l’ étoricoxib et la digoxine sont administrés de façon concomitante.
0.3602426052093506 ||| Advertising services for the promotion of e-commerce ||| Advertising services for the promotion of beverages ||| Services publicitaires pour la promotion du commerce électronique
0.0 ||| Cartons of 30 film-coated tablets; 3 blister cards of 10 film-coated tablets in PVC/ PVDC/ Aluminium blisters. ||| Cartons of 30 film-coated tablets; 3 blister cards of 10 film-coated tablets in PVC/ PVDC/ Aluminium blisters. ||| 70 Boites de 30 comprimés pelliculés; 3 plaquettes thermoformées de 10 comprimés pelliculés dans des blisters en PVC/ PVDC/ Aluminium.
0.5116525888442993 ||| 15 mg tablet ||| Cream 60 g ||| comprimé à 15 mg
0.10484100133180618 ||| 25 vials ||| 20 vials ||| 25 flacons
0.02593984827399254 ||| While you are being treated with Kivexa, your doctor will monitor you closely for any signs that you may be developing lactic acidosis. ||| While you are being treated with Truvada, your doctor will monitor you closely for any signs that you may be developing lactic acidosis. ||| Votre médecin assurera un suivi régulier des signes liés au risque de développement d’ une acidose lactique, ceci tout au long de votre traitement par Kivexa.
0.42745232582092285 ||| Concrete leveling services ||| Stolen vehicle tracking ||| Services de nivellement de béton
0.4208880662918091 ||| The transient IgM increase usually returned to at least baseline level within 4 months. ||| Plasma concentrations of half the mean Cmax values are reached 25 minutes post-dosing. ||| L’ augmentation transitoire des IgM est en général revenue à un taux basal dans les quatre mois.
0.6716628074645996 ||| Abseamed 1000 IU/ 0.5 ml ||| CRIXIVAN dose Every 8 hours (mg) ||| Abseamed 1 000 UI/ 0,5 ml
0.74147629737854 ||| Storage and Maintenance ||| Storage and Disposal ||| Conservation et Entretien
0.019569486379623413 ||| Efficacy of Silgard in high grade cervical lesions in the modified ITT-population including women regardless of baseline HPV status ||| Efficacy of Gardasil in high grade cervical lesions in the modified ITT-population including women regardless of baseline HPV status ||| Efficacité de Silgard en prévention des lésions de haut grade du col de l'utérus dans la population ITT modifiée quel que soit leur statut HPV initial
0.4272575378417969 ||| Electronic games services, including provision of computer games on-line or by means of a global computer network ||| Provision of education on-line from a computer database or via the internet or extranets ||| Services de jeux électroniques, y compris jeux d'ordinateur fournis en ligne ou par un réseau informatique mondial
0.3619345724582672 ||| Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents. ||| r Glucocorticoids, salicylates, nonsteroidal anti-inflammatory drugs, or analgesics can be continued ||| Ne pas administrer conjointement avec des anti-inflammatoires glucocorticostéroïdes ou non stéroïdiens, ni avec des anticoagulants.
0.28665435314178467 ||| Lansoprazole is not significantly eliminated by haemodialysis. ||| Haemodialysis contributes negligibly to tadalafil elimination. ||| Le lansoprazole n’ est pas éliminé par hémodialyse de façon significative.
0.3161781430244446 ||| • Brief background on Tasigna, its authorised indication and posology • Information on the cardiac risks associated with the use of Tasigna o That Tasigna can cause prolongation of the QT interval and that patients at risk of arrythmia, especially torsade de pointes, should not be prescribed Tasigna. o The need to avoid co-prescription with any other medicines that might prolong the QT interval o Caution in prescribing to patients with a history of or risk factors for coronary heart disease o That Tasigna may cause fluid retention, cardiac failure and pulmonary oedema ||| • Effect of Thelin on bleeding o Interaction with warfarin and vitamin K antagonists leading to an increased INR o Need to decrease established dose of vitamin K antagonist upon starting sitaxentan therapy o Start vitamin K antagonists treatment at a reduced dose if already on sitaxentan sodium o Need for regular monitoring of INR o Be aware of the potential for haemorrhage and investigate as appropriate o Increased risk of epistaxis and gingival bleeding ||| • Résumé des propriétés de Tasigna, son indication thérapeutique autorisée avec le schéma posologique • L’ information sur les risques cardiaques associés à l’ utilisation de Tasigna o Que Tasigna peut entraîner un allongement de l’ intervalle QT et que chez les patients présentant des risques d’ arrythmie, particulièrement des torsades de pointes, Tasigna ne devrait pas être prescrit. o La nécessité d’ éviter une prescription concomittante avec des traitements qui entraînent un allongement de l’ intervalle QT o La prudence requise chez des patients ayant des antécédents ou des facteurs de risques demaladies cardiaques coronariennes o Que Tasigna peut entraîner des oedèmes, une insuffisance cardiaque et un œ dème pulmonaire
0.38910457491874695 ||| The vaccine is given to female pigs before and/ or during pregnancy. ||| The vaccine can be administered to 7-day and older chickens by drinking water. ||| Le vaccin est administré à la truie avant et/ ou pendant la gestation.
0.28716039657592773 ||| The other ingredients are microcrystalline cellulose (E460), lactose anhydrous, medium chain triglycerides, gelatin, croscarmellose sodium, sucrose, colloidal silicon dioxide, magnesium stearate (E572) butylated hydroxytoluene (E321), modified starch (maize), and sodium aluminium silicate (E554). ||| The other ingredients are triacetin, acrylic adhesive solution (containing 2-ethylhexyl acrylate, N- vinyl pyrrolidone and hexamethyleneglycol dimethacrylate polymer domains), clear backing film of polyester/ ethylene vinyl acetate (PET/ EVA), and siliconised polyester release liner (PET). ||| Les autres composants sont la cellulose microcristalline (E460), le lactose anhydre, les triglycérides à chaînes moyennes, la gélatine, la croscarmellose sodique, le saccharose, la silice colloïdale, le stéarate de magnésium (E572), le butylhydroxytoluène (E321), l'amidon modifié (maïs), et le silicate d’aluminium sodique (E554).
0.4258144497871399 ||| In rare instances, thromboembolisms have been associated with menotrophin/ hCG therapy. ||| Patients who required thrombolysis or embolectomy or vena cava filter were excluded. ||| 4 Dans de rares cas, des accidents thromboemboliques ont été associés au traitement par ménotropine/ hCG.
0.5718675851821899 ||| Therefore withdrawal periods for cattle and pigs could not be recommended. ||| Thus it appears that 5 days is acceptable for pigs. ||| Par conséquent, des temps d’ attente pour les bovins et pour les porcs n’ ont pas pu être recommandés.
0.09882800281047821 ||| 32 Effects in non-clinical studies were observed only at exposures sufficiently in excess of the maximum human exposure indicating little relevance to clinical use. ||| Tredaptive Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to human use. ||| Des effets n'ont été observés chez l’ animal qu'à des expositions largement supérieures à l'exposition maximale observée chez l’ homme et ont peu de signification clinique.
0.020938005298376083 ||| 446 PACKAGE LEAFLET: ||| 408 PACKAGE LEAFLET: ||| 452 NOTICE:
0.040917493402957916 ||| One ml solution for injection contains 3333 IU epoetin beta. ||| One ml solution for injection contains 20,000 IU epoetin beta. ||| Un ml de solution injectable contient 3 333 UI d’ epoetin beta.
0.1226055920124054 ||| Insulin Human Winthrop Comb 25 100 IU/ ml suspension for injection in a pre-filled pen. ||| 781 Insulin Human Winthrop Comb 50 suspension for injection in a pre-filled pen. ||| Insulin Human Winthrop Comb 25 100 UI/ ml suspension injectable en stylo prérempli
0.0014416712801903486 ||| Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted 17 with Prometax in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms. ||| Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted 6 with Prometax in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms. ||| Le Tableau 3 liste le nombre et le pourcentage de patients ayant présentés des effets indésirables prédéfinis qui pourraient être le reflet d’ une aggravation des symptômes parkinsoniens dans le cadre de l’ étude clinique spécifique conduite pendant 24 semaines avec Prometax chez les patients atteints de démence associée à la maladie de Parkinson.
0.2584388256072998 ||| In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. ||| Because of possible excretion in human milk and because of the potential for serious adverse reactions in nursing infants, the use of DepoCyte is not recommended in breast-feeding women. ||| Chez la femme enceinte, tout surdosage en calcium et en vitamine D doit être évité car l’hypercalcémie permanente a été associée à des effets négatifs sur le développement du fœtus.
0.37880295515060425 ||| ACE inhibitors are contraindicated in HAE patients due to possible enhancement of bradykinin levels. ||| Cholinesterase inhibitors, including rivastigmine, have been associated with weight loss in these patients. ||| Les inhibiteurs de l’ enzyme de comversion sont contre-indiqués chez les patients souffrant d’ AOH en raison de l’ augmentation possible des taux de bradykinine.
0.006570181809365749 ||| Ciprofloxacin Bayer 200 mg/ 100 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1). ||| Ciprofloxacin Bayer 400 mg/200 mL solution for infusion is indicated for the treatment of the following infections (see sections 4.4 and 5.1). ||| Ciprofloxacine Bayer 200 mg/100 ml solution pour perfusion est indiquée dans le traitement des infections suivantes (voir les rubriques 4.4 et 5.1).
0.0 ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market and for as long as the marketed product remains in use. ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market and for as long as the marketed product remains in use. ||| Le titulaire de l’ AMM doit s’ assurer que le système de pharmacovigilance est en place et opérationnel avant que le produit soit mis sur le marché et pendant toute la durée d’ utilisation du produit.
0.5346325635910034 ||| Roof ridges of metal ||| Cargo slings of rope ||| Faîtes métalliques
0.0031827250495553017 ||| 25 In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5 HT2A than dopamine D2 receptor occupancy. ||| 67 In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5 HT2A than dopamine D2 receptor occupancy. ||| Dans une étude de tomographie par émission de positron (PET) chez le volontaire sain utilisant une dose orale unique (10 mg), l’ olanzapine a entraîné une occupation des récepteurs 5HT2A supérieure à celle des récepteurs D2.
0.04900175333023071 ||| Betaferon should not be used in people who have a history of hypersensitivity (allergy) to natural or recombinant interferon beta, human albumin or any of the other ingredients. ||| Rebif should not be used in people who have a history of hypersensitivity (allergy) to natural or recombinant interferon beta, or any of the other ingredients. ||| Betaferon ne doit pas être utilisé chez des personnes ayant des antécédents d’ hypersensibilité (allergie) à l’ interféron β naturel ou recombinant, à l’ albumine sérique humaine ou à l’ un des excipients.
0.31837576627731323 ||| Starting dose is 60 mg daily (10 ml), increasing to 120 mg (20 ml) daily if required. ||| The initial daily dose should be 100 mg/ kg, up to 250 mg/ kg if necessary. ||| La dose initiale est de 60 mg par jour (10 ml); elle peut, si nécessaire, être portée à 120 mg par jour (20 ml).
0.20739659667015076 ||| Each tablet contains 30 mg of cinacalcet (as hydrochloride) ||| Each tablet contains 500 mg of sodium phenylbutyrate. ||| Chaque comprimé contient 30 mg de cinacalcet (sous forme de chlorhydrate)
0.0 ||| Store in the original package in order to protect from moisture. ||| Store in the original package in order to protect from moisture. ||| A conserver dans l’ emballage extérieur d’ origine à l’ abri de l’ humidité.
0.0 ||| Respiratory, thoracic and mediastinal disorders ||| Respiratory, thoracic and mediastinal disorders ||| Affections respiratoires, thoraciques et médiastinaux
0.06118880584836006 ||| 5 ANNEX III ||| 5 ANNEX II ||| 6 ANNEXE III
0.43951547145843506 ||| At 36 months, analysis of spinal X-rays from 169 alendronate patients and 173 FORSTEO patients showed that 13 patients in the alendronate group (7.7%) had experienced a new vertebral fracture compared with 3 patients in the FORSTEO group (1.7%) (p=0.01). ||| In the STRIDE-2 trial 93 (38%) of the 246 patients were classified at baseline as NYHA functional class II (mean baseline 6 minute walk distance 370 meters) and 144 (59%) as functional class III (mean baseline 6 minute walk distance 322 meters). ||| A 36 mois, l’ analyse de radiographies du rachis portant sur 169 patients sous alendronate et 173 patients sous FORSTEO a montré que 13 patients dans le groupe alendronate (7,7%) avaient eu une nouvelle fracture vertébrale comparés à 3 patients dans le groupe FORSTEO (1,7%) (p=0,01).
0.4907209873199463 ||| Due to reduced travel and closures of heavy industry, there has been a decrease in air pollution and carbon emissions. ||| Biodiversity loss results also in reduced crop yields and fish catches and the loss of potential new sources of medicine. ||| En raison de la diminution des voyages et des fermetures dans l’industrie lourde, il y a eu une diminution de la pollution atmosphérique et des émissions de carbone.
0.31660887598991394 ||| In euglycaemic clamp studies in healthy subjects or in patients with type 1 diabetes, the onset of action of subcutaneous insulin glargine was slower than with human NPH insulin, its effect profile was smooth and peakless, and the duration of its effect was prolonged. ||| The achievement of castrate levels of testosterone is an acceptable surrogate endpoint in hormone sensitive advanced prostate cancer which can be translated into less pain from bone metastases, improvement in urinary flow, and in some cases slowing of tumour progression, although a clear-cut survival benefit has not been demonstrated. ||| Des études de clamp euglycémique menées chez des sujets sains et des patients atteints de diabète de type 1 ont montré que l'effet de l'insuline glargine sous-cutanée apparaissait plus lentement que celui de l'insuline NPH humaine, que cet effet était régulier, sans pics, et que sa durée d'action était prolongée.
0.3319711685180664 ||| Since insulin and pioglitazone are associated with fluid retention, concomitant administration of insulin and Glubrava may increase the risk of oedema. ||| When combination with long-acting insulin is necessary it is only possible to mix Velosulin with isophane or premixed insulin products. ||| L’ insuline et Glubrava étant associées à une rétention hydrique, leur administration concomitante peut augmenter le risque d’œ dème.
0.31202268600463867 ||| Upon repeated administration, the average blood concentration of sirolimus is increased approximately 3-fold. ||| After repeated daily administration for seven days, about 90% inhibition of gastric acid secretion is achieved. ||| En cas d’ administration répétée, la concentration sanguine moyenne du sirolimus augmente d’ un facteur d’ environ 3.
0.47020769119262695 ||| Avoid stress in the birds around the time of vaccination. ||| Administer to dogs within 1-2 hours after feeding. ||| Eviter le stress chez les oiseaux avant, pendant et après la vaccination.
0.34633946418762207 ||| Lesions (erosion/ ulceration) of the oral mucosa and of the skin around the mouth may occasionally be observed in treated animals when administered the recommended treatment dose. ||| For liver metastases, the signal difference between the tumour and surrounding liver tissue is significantly improved during the first 90 seconds after an extracellular ||| Des lésions (érosion ou ulcération) de la muqueuse orale et de la peau autour de la bouche peuvent parfois être observées chez les animaux traités suite à l’ administration de la dose recommandée.
0.20724846422672272 ||| Before administration, visually inspect the solution for particulate matter and discolouration. ||| 5 Visually inspect the diluted product for particles or discolouration prior to administration. ||| Avant administration, inspecter visuellement la solution pour vérifier l'absence de particules ou un changement de couleur.
0.12607342004776 ||| glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid, sodium hydroxide and water for injections ||| zinc chloride, zinc acetate, sodium chloride, methyl parahydroxybenzoate, sodium acetate, sodium lon hydroxide, hydrochloric acid and water for injections ||| glycérol, phénol, métacrésol, acétate de zinc, phosphate disodique dihydraté, chlorure de sodium, acide chlorhydrique, hydroxyde de sodium et eau pour préparations injectables
0.0 ||| Dizziness ||| Dizziness ||| Vertige
0.30917781591415405 ||| Elderly Experience in geriatric patients is limited: in the Phase III trials, 6 patients aged 65 years or older and 53 patients aged 56-64 years received INTELENCE. ||| Elderly patients In clinical studies 24% of patients treated with MIRCERA were ageg 65 to 74 years, while 20% were ageg 75 years and over. ||| Sujets âgés L’ expérience chez les patients âgés est limitée: dans les essais de phase III, 6 patients âgés de 65 ans ou plus et 53 patients âgés de 56 à 64 ans ont reçu INTELENCE.
0.41292840242385864 ||| The vials are for single use only. ||| Each vial is for single use only. ||| Les flacons sont exclusivement à usage unique.
0.09298649430274963 ||| 69 A. ||| 84 A. ||| 74 A.
0.18362782895565033 ||| Single-packs containing 7, 14, 28, 30, 50, 56, 90 or 98 tablets. ||| Each pack contains blisters of 10, 30, 50, 56, 60, 90, 100 or 200 tablets. ||| Boîtes de 7, 14, 28, 30, 50, 56, 90 ou 98 comprimés en conditionnements simples.
0.0 ||| A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances. ||| A higher risk of lipodystrophy has been associated with individual factors such as older age, and with drug related factors such as longer duration of antiretroviral treatment and associated metabolic disturbances. ||| Le risque de lipodystrophie est majoré par des facteurs individuels tels qu’ un âge plus avancé et par des facteurs liés au traitement, tels qu’ une plus longue durée du traitement antirétroviral avec les anomalies métaboliques qui lui sont associées.
0.03646497428417206 ||| Trudexa 40 mg solution for injection in pre-filled syringe with needleguard ||| Humira 40 mg solution for injection in pre-filled syringe with needleguard ||| isé TRUDEXA 40 mg solution injectable en seringue préremplie avec protège-aiguille.
0.2502138018608093 ||| NutropinAq treatment should be started and supervised by a doctor experienced in the management of patients with growth disorders. ||| Treatment with ADVATE will be started by a doctor who is experienced in the care of patients with haemophilia A. ||| Le traitement par NutropinAq doit être instauré et supervisé par un médecin expérimenté dans la prise en charge de patients présentant des troubles de croissance.
0.3228985667228699 ||| Previous treatment failure patients Retreatment of prior treatment failures (relapse and non-responder patients) with peginterferon alfa- 2b in combination with Rebetol In a non-comparative trial, 2,293 patients with moderate to severe fibrosis who failed previous treatment with combination alpha interferon/ribavirin were retreated with peginterferon alfa 2b, 1.5 microgram/kg subcutaneously, once weekly, in combination with weight adjusted Rebetol. ||| However, the pharmacokinetics of clofarabine in adults with relapsed or refractory AML following administration of a single dose of 40 mg/ m2 clofarabine by intravenous infusion over 1 hour were comparable to those described above in patients aged between 2 to 19 years old with relapsed or refractory ALL or AML following administration of 52 mg/ m2 clofarabine by intravenous infusion over 2 hours for 5 consecutive days. ||| Retraitement par peginterféron alfa-2b en association avec Rebetol des patients en situation d’ échec à un précédent traitement (patients rechuteurs et non répondeurs) Dans une étude non-comparative, 2 293 patients avec une fibrose modérée à sévère en échec à un précédent traitement par un interféron alpha en association avec la ribavirine ont été retraités par peginterféron alfa-2b, 1,5 microgramme/ kg par voie sous-cutanée, une fois par semaine, en association avec Rebetol adapté au poids.
0.5005355477333069 ||| Washout procedure ||| 33 Washout procedure ||| Modalité de washout
0.6222301721572876 ||| As part of Team Europe, the EU is also mobilising an emergency support package worth more than €80 million for immediate needs in the Eastern Partnership countries. ||| The first Team Europe packages are already being implemented in the immediate neighbourhood: the Western Balkans, in the East and to the South. ||| Agissant dans le cadre de l'équipe d'Europe («Team Europe»), l'UE est également en train de mobiliser une aide d'urgence de plus de 80 millions d'euros pour répondre à des besoins immédiats dans les pays du partenariat oriental.
0.32955601811408997 ||| Dosage Vimpat must be taken twice a day, once in the morning and once in the evening, at about the same time each day. ||| Corlentor is taken orally, twice daily, i. e. once in the morning and once in the evening during meals. ||| Posologie Vimpat doit être pris deux fois par jour, une fois le matin et une fois le soir, à peu près à la même heure chaque jour.
0.10378022491931915 ||| It must not be used in patients who have severe problems with their kidneys or moderate or severe problems with their liver. ||| Eucreas should not be used in patients who have moderate or severe problems with their kidneys or who have problems with their liver. ||| Il ne doit pas non plus être utilisé chez des patients connaissant des troubles modérés ou aigus des reins ou des troubles du foie.
0.20026403665542603 ||| Blood and lymphatic ||| Blood and lymphatic: ||| Affections hématologiques
1.3155912990947538e-12 ||| nausea, vomiting ||| nausea, vomiting ||| nausée, vomissements
0.36677873134613037 ||| You should always use this special cup to take your Norvir oral solution to make sure you take the right dose. ||| Follow these instructions completely each time you use SoloStar to ensure that you get an accurate dose. ||| Vous devez toujours utiliser ce verre pour être certain d'avoir pris la bonne dose.
4.941845001792122e-13 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Précautions particulières d’ éliumination et manipulation
0.27802979946136475 ||| However, in the presence of an inhibitor the doses required are variable and must be adjusted according to clinical response and monitoring of plasma factor VIII activity. ||| During the course of treatment, appropriate determination of plasma factor VIII levels is advised to guide the dose to be administered and the frequency of repeated injections. ||| Toutefois, en présence d’ un inhibiteur les doses nécessaires sont variables et doivent être ajustées en fonction de la réponse clinique du patient et du dosage de l’ activité plasmatique du facteur VIII.
2.7707100936497087e-13 ||| (ii) State guarantees for loans taken by companies from banks: Member States will be able to provide State guarantees to ensure banks keep providing loans to the customers who need them. ||| (ii) State guarantees for loans taken by companies from banks: Member States will be able to provide State guarantees to ensure banks keep providing loans to the customers who need them. ||| ii) aides sous forme de garanties publiques sur les prêts contractés par des entreprises auprès des banques: les États membres pourront fournir des garanties publiques pour faire en sorte que les banques continuent d'accorder des prêts aux clients qui en ont besoin.
0.36135154962539673 ||| Concomitant treatment with inhibitors of the hepatic CYP 3A4 may result in a decrease of terfenadine metabolism. ||| 17 Long term use of cefuroxime axetil may lead to an excess of pathogens resistant to cefuroxime axetil. ||| Un traitement concomitant par des inhibiteurs du CYP 3A4 hépatique peut se traduire par une diminution du métabolisme de la terfénadine.
0.21244914829730988 ||| Nederland BRISTOL-MYERS SQUIBB BV Tel: + 31 34 857 42 22 ||| 142 Danmark BRISTOL-MYERS SQUIBB Tlf: + 45 45 93 05 06 ||| Tel: + 31 34 857 42 22
0.45026588439941406 ||| Important information for use of OptiSet: • Always attach a new needle before each use. ||| Further injections • Every time you use a Pen you must use a new needle. ||| Informations importantes pour l'utilisation d'OptiSet: • Toujours fixer une aiguille neuve avant chaque utilisation.
0.5513696670532227 ||| Webpage: The EU and the United Kingdom - Forging a new partnership: Guide to the negotiations ||| Questions and answers: Convergence report reviews Member States' progress towards joining the euro area ||| Page web: L'UE et le Royaume-Uni - Forger un nouveau partenariat: Guide des négociations
0.05046933889389038 ||| Use this veterinary medicinal product under strict veterinary monitoring in animals at risk of ulceration of the digestive tract, or if the animal previously displayed intolerance to other NSAIDs. ||| 13 Use this veterinary medicinal product under strict veterinary monitoring in cases at risk of gastrointestinal ulceration, or if the animal previously displayed intolerance to other NSAIDs. ||| Utiliser sous stricte surveillance vétérinaire si l’ animal présente un risque d'ulcération gastro- intestinale ou d’ intolérance connue à d'autres AINS.
0.3401602506637573 ||| Nepafenac is eliminated primarily through biotransformation and the systemic exposure is very low following topical ocular administration. ||| Increased plasma benzodiazepine levels may occur via decreased hepatic metabolism leading to excessive sedation. ||| Le népafénac est éliminé principalement par biotransformation et l’ exposition systémique est très faible après une instillation.
0.15379515290260315 ||| Hold the syringe barrel and gently take the cover from the needle without twisting. ||| Hold the barrel of the syringe with one hand and pull the needle cover straight off. ||| Prenez le corps de la seringue et retirez avec pr écaution le capuchon de
0.3097754120826721 ||| Compensating cylinders for the braking systems of water vehicles ||| Chemical preparations for assisting the starting of internal combustion engines ||| Cylindres de compensation pour systèmes de freinage de véhicules nautiques
0.0 ||| 4. ||| 4. ||| 331 4.
0.07639206200838089 ||| Viraferon is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA uc ||| IntronA is a sterile, stable, formulation of highly purified interferon alfa-2b produced by recombinant DNA techniques. ||| isé Viraferon est une forme stérile, stable d'interféron alfa-2b hautement purifié, obtenu par les techniques de l’ ADN recombinant.
0.49300891160964966 ||| With the skeleton still in place, the cells cannot divide and they eventually die. ||| This means that the HIV cannot enter the cell and then it cannot multiply. ||| Lorsque ce squelette reste en place, les cellules ne peuvent pas se diviser et finissent par mourir.
0.008743304759263992 ||| Slowly withdraw the suspension from the vial in an upright, but slightly angled position as indicated in the picture to ensure that the entire contents are drawn up into the syringe. ||| Slowly withdraw the suspension from the vial in an upright, but slightly angled position as indicated in the picture to ensure that the entire contents are drawn up into the syringe ||| Prélever lentement la suspension du flacon maintenu en position verticale, mais avec une légère inclinaison, comme indiqué sur le schéma afin de s’ assurer que la totalité du contenu de la suspension est prélevé dans la seringue.
0.20036126673221588 ||| 5.1 2.7 ||| 7.1 7.4 ||| 5,1 2,7
0.30545011162757874 ||| Most of the patients received the study medication on top of conventional therapy including platelet inhibitors, lipid lowering agents and beta-blockers. ||| Treatment will include administration of antibiotics, platelet cell transfusions, use of factors which stimulate production of white blood cells and symptomatic treatment of mouth sores. ||| La plupart des patients recevaient le traitement étudié en plus de leur thérapie usuelle incluant des antiagrégants plaquettaires, des hypolipémiants et des bêta- bloquants.
0.45242583751678467 ||| Abstral ||| Capstans ||| Rapinyl
0.04347905516624451 ||| EU/ 1/ 96/ 008/ 005 ||| EU/ 1/ 96/ 004/ 001 ||| EU/ 1/ 96/ 008/ 005 Puregon
0.5030595064163208 ||| Arthrosis, tendon pain ||| Peptic ulcer, pancreatitis ||| Arthrose, tendinites
0.13926416635513306 ||| Invirase is a medicine containing the active substance saquinavir. ||| Renagel is a medicine containing the active substance sevelamer. ||| Invirase est un médicament contenant le principe actif saquinavir.
0.0 ||| The incidence of all adverse events relating to liver and biliary systems was < 1.5% in any treatment group and similar to placebo. ||| The incidence of all adverse events relating to liver and biliary systems was < 1.5% in any treatment group and similar to placebo. ||| L’ incidence de l'ensemble des effets indésirables concernant les systèmes hépatique et biliaire était < 1,5% quelque soit le groupe de traitement et similaire au placebo.
0.42127129435539246 ||| happens after you have been given OLANZAPINE NEOPHARMA tell your doctor. ||| Always take ZYPREXA VELOTAB exactly as your doctor has told you. ||| En cas de survenue de tels effets après avoir reçu OLANZAPINE NEOPHARMA, informer votre médecin.
0.3370930850505829 ||| The pharmacokinetics of atazanavir were evaluated in healthy adult volunteers and in HIV-infected patients; significant differences were observed between the two groups. ||| Similar pharmacokinetic differences between males and females and smokers and nonsmokers were observed in ZYPADHERA clinical trials. ||| La pharmacocinétique d'atazanavir a été évaluée chez des volontaires sains adultes et des patients infectés par le VIH; des différences significatives ont été observées entre les deux groupes.
0.8308001756668091 ||| 6 weeks and older: ||| 60 years and above ||| A partir de 6 semaines et plus:
0.6234957575798035 ||| The system is designed to automate meeting room bookings and scheduling. ||| It also covers purchase, rental and maintenance of plants. ||| Ce système est conçu pour automatiser la planification et la réservation des salles de réunion.
0.007136970292776823 ||| 250 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 100 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 264 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.32011163234710693 ||| If Viread is discontinued in patients with chronic hepatitis B with or without HIV co-infection, these patients should be closely monitored for evidence of exacerbation of hepatitis (see section 4.4). ||| ENGERIX B should not be administered to subjects with known hypersensitivity to any component of the vaccine, or to subjects having shown signs of hypersensitivity after previous ENGERIX B administration. ||| Si Viread est arrêté chez des patients atteints d’ hépatite B chronique avec ou sans co-infection par le VIH, ces patients doivent être étroitement surveillés afin de détecter tout signe d’ exacerbation de l’ hépatite (voir rubrique 4.4).
0.5229660272598267 ||| You should avoid taking SIFROL together with antipsychotic medicines. ||| If you stop using MIRCERA Treatment with MIRCERA is normally long-term. ||| Vous devez éviter de prendre SIFROL simultanément à des antipsychotiques.
0.28387701511383057 ||| In the studies of patients starting treatment for anaemia for the first time, 126 (93%) of the 135 patients receiving MIRCERA in the first study, and 158 (98%) of the 162 receiving it in the second had a clinically significant increase in haemoglobin levels between the start and end of the studies. ||| Following liver transplant, 38% of the patients taking CellCept had rejected their new liver after six months, compared with 48% of those taking azathioprine, but the proportion of patients who had lost their new liver after a year was similar in the two groups, at around 4%. ||| Dans les études portant sur des patients qui commençaient le traitement de l’ anémie pour la première fois, 126 (93%) des 135 patients recevant MIRCERA dans la première étude, et 158 (98%) des 162 patients recevant MIRCERA dans la deuxième étude ont présenté une augmentation du taux d’ hémoglobine significative d’ un point de vue clinique entre le début et la fin des études.
0.2818290591239929 ||| Each film-coated tablet contains 120 mg nateglinide. ||| Each film-coated tablet contains sitagliptin phosphate ||| Chaque comprimé pelliculé contient 120 mg de natéglinide.
0.33530956506729126 ||| Manufacturer Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom. ||| The marketing authorisation holder is Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom. ||| Fabricant Genzyme Ltd., 37 Hollands Road, Haverhill, Suffolk CB9 8PU, Royaume-Uni.
0.6403100490570068 ||| 40 INSTRUCTIONS FOR ADMINISTRATION ||| ADMINISTRATOR’ S INSTRUCTIONS ||| 42 INSTRUCTIONS POUR L’ ADMINISTRATION
0.4003067910671234 ||| Polska sanofi-Aventis Sp. z o. o. ||| Slovenská republika sanofi-aventis Pharma Slovakia s. r. o. ||| Polska sanofi-aventis Sp. z o. o.
0.3079267740249634 ||| Pharmaceutical Form ||| Pharmaceutical advice ||| pharmaceutique
0.5540322065353394 ||| Nederland Astellas Pharma B. V. ||| 23 Ελλάδα Nexus Medicals A. E. ||| Astellas Pharma B.V.
0.4923892617225647 ||| The effects were more pronounced in female rats. ||| Increases were approximately two times more likely in females. ||| Les effets étaient plus marqués chez les rats femelles.
0.44323503971099854 ||| Spine taping machines, other than for office use ||| Curtain drawing devices, other than electrically operated ||| Relieuses à bande pour livres autres que pour le bureau
0.31498420238494873 ||| Your doctor will advise the correct amount of Emtriva oral solution to be taken. ||| Your doctor will advise you about your individualised dose of Omnitrope and treatment schedule. ||| Votre médecin vous conseillera la bonne dose d’Emtriva solution buvable à prendre.
0.5602231025695801 ||| Dusting apparatus, non-electric ||| Valves, non-metallic ||| Dépoussiéreurs non électriques
3.377038503438873e-13 ||| Other interactions: the hyperglycaemic effect of beta-blockers and diazoxide may be enhanced by thiazides. ||| Other interactions: the hyperglycaemic effect of beta-blockers and diazoxide may be enhanced by thiazides. ||| 6 Autres interactions: l'effet hyperglycémiant des bêtabloquants et du diazoxide peut être augmenté par les thiazidiques.
0.3824269771575928 ||| 39 Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214 ||| Κύπρος Δημητριάδης και Παπαέλληνας Λτδ Τηλ: +357 22 690 690 ||| Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214
0.9437613487243652 ||| And about strengthening the EU's geopolitical clout. ||| Europe's moment: Repair and prepare for the next generation ||| Et de renforcer l'influence géopolitique de l'Union européenne.
0.42939645051956177 ||| The mean maximum white blood cell concentration of telithromycin was 83±25 mg/ l. ||| The mean white cell cystine level attained during treatment was 1.7 + 0.2 nmol hemicystine/ mg protein. ||| La moyenne des concentrations maximales de télithromycine dans les globules blancs est de 83±25 mg/ l. tp Métabolisme
0.2922499477863312 ||| Seventy-three percent of non-splenectomised patients receiving romiplostim were able to reduce the dose by more than 25% or discontinue concurrent ITP medical therapies by the end of the study compared to 50% of placebo treated patients (see section 4.5). ||| Two studies looked at Rapamune as maintenance treatment for up to five years in a total of 765 patients who had responded to an initial two- to three-month course of treatment and who were able to stop their dose of ciclosporin. ||| 73% des patients non-splénectomisés ayant reçu du romiplostim ont pu arrêter ou réduire la dose de plus de 25% de leurs traitements concomitants du PTI, par rapport à 50% des patients ayant reçu le placebo (voir rubrique 4.5).
0.26371991634368896 ||| 27 July 2005 ||| 08 July 2005 ||| 27 juillet 2005
0.5182422995567322 ||| Olanzapine Mylan 10 mg film-coated tablets: ||| Paroxetin ‘ Merckle’ 20 mg – Filmtabletten ||| Olanzapine Mylan 10 mg comprimés pelliculés:
0.7321541905403137 ||| - back pain ||| - severe headache ||| - Douleur dorsale
0.0034769619815051556 ||| 125 childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded. ||| 171 childbearing potential and their partners must each use an effective contraceptive during treatment and for 4 months after treatment has been concluded. ||| Les patientes en âge de procréer et leurs partenaires doivent chacun utiliser une contraception efficace pendant toute la durée du traitement et pendant les 4 mois qui suivent son arrêt.
0.23993271589279175 ||| This was a phase III randomised, double-blind, active-controlled clinical trial evaluating Avastin in combination with IFL as first-line treatment for metastatic carcinoma of the colon or rectum. ||| A multicenter, open-label, randomized trial, was conducted to evaluate the safety and efficacy of docetaxel for the treatment of patients with metastatic gastric adenocarcinoma, including ||| Il s’ agissait d’ une étude de phase III, randomisée, en double aveugle, contrôlée, évaluant Avastin en association à une chimiothérapie IFL en traitement de première ligne du cancer colorectal métastatique.
0.27207279205322266 ||| 59 Primary aldosteronism: patients with primary aldosteronism generally will not respond to anti- hypertensive medicinal products acting through inhibition of the renin-angiotensin system. ||| ris Administration of EXUBERA 10 minutes prior to administration of salbutamol did not affect the bronchodilatory response to salbutamol in non-diabetic subjects with mild-moderate asthma. ||| Hyperaldostéronisme primaire: les patients avec hyperaldostéronisme primaire ne répondent généralement pas aux médicaments antihypertenseurs agissant par l'intermédiaire de l'inhibition du système rénine-angiotensine.
0.27370235323905945 ||| - a reduction in the relative risk of total mortality by 23% (p < 0.0001) and cardiovascular mortality by ||| - a decrease in the total number of deaths from a cardiovascular event (RRR 32%; p = 0.03) ||| - une réduction du risque relatif de mortalité totale de 23% (p < 0,0001) et du risque de mortalité
0.15777841210365295 ||| Do not take a double dose to make up for a forgotten dose. ||| You must not be given a double dose to make up for a forgotten dose. ||| N’injectez pas de dose double pour compenser la dose que vous avez oublié d’injecter.
0.18005946278572083 ||| Skin and subcutaneous tissue disorders Common: pruritus Uncommon: ecchymosis ||| Musculoskeletal and connective tissue disorders Uncommon: leg cramps Very rare: myositis ||| Affections de la peau et du tissu sous-cutané Fréquent: prurit Peu fréquent: ecchymose
0.11187353730201721 ||| • Do not breast-feed during treatment with Viread. ||| Do not breast-feed during treatment with Glivec. ||| • N’allaitez pas pendant le traitement par Viread.
0.32122308015823364 ||| How do I prepare my Ratiograstim injection? ||| How do I prepare my Filgrastim ratiopharm injection? ||| Comment préparer l’ injection de Ratiograstim?
0.34616631269454956 ||| In patients with possible hyperglycaemia, nifedipine should be given with caution. ||| In immunocompromised patients, repeat treatment with imiquimod cream is not recommended. ||| Chez les patients présentant une éventuelle hyperglycémie, la nifédipine doit être prescrite avec précaution.
0.39446550607681274 ||| The full effect was seen 24 to 48 hours after the first dose, and was maintained between weekly doses. ||| Following multiple oral administrations, the steady state is reached by the third daily dose. ||| L'effet maximal était observé 24 à 48 h après la première dose et était maintenu entre les injections hebdomadaires.
6.221856255032854e-13 ||| +2.8 kg ||| +2.8 kg ||| +2,8 kg
0.35843926668167114 ||| Bacteriological preparations for use in forestry ||| Bacterial preparations for medical and veterinary use ||| Préparations bactériologiques destinées à la sylviculture
0.4472905397415161 ||| - This anorectic agent should be used with caution in epileptic patients ||| Radiopharmaceutical precursor - Not intended for direct use in patients ||| - Cet anorexigène doit être utilisé avec prudence chez les sujets épileptiques.
0.5878154039382935 ||| Withdraw the syringe and replace the needle guard. ||| Discard the needle and take a new one. ||| Retirer la seringue et remettre en place le capuchon protecteur de l’aiguille.
0.05120685324072838 ||| These studies also established that seroconversion in response to vaccination against measles, mumps, and rubella paralleled protection from these diseases. ||| In these studies seroconversion in response to vaccination against measles, mumps, and rubella paralleled protection from these diseases. ||| Ces études ont également établi que la séroconversion induite par la vaccination contre la rougeole, les oreillons et la rubéole correspondait à la protection conférée contre ces maladies.
0.34378743171691895 ||| Limited data suggests that the abrupt discontinuation of Revatio is not associated with rebound worsening of pulmonary arterial hypertension. ||| Another message claimed that observing Janata curfew will result in the reduction of coronavirus cases by 40%. ||| Des données limitées suggèrent que l’ interruption brutale de Revatio n’ est pas associée à un effet rebond avec aggravation de l’ hypertension artérielle pulmonaire.
0.2568301558494568 ||| ReFacto AF 250 IU powder and solvent for solution for injection Moroctocog alfa ||| ATryn 1750 IU powder for solution for infusion Antithrombin alfa For intravenous use. ||| ReFacto AF 250 UI poudre et solvant pour solution injectable Moroctocog alfa
0.0 ||| This medicinal product has been authorised under “ Exceptional Circumstances”. ||| This medicinal product has been authorised under “ Exceptional Circumstances”. ||| 20 Une autorisation de mise sur le marché « sous circonstances exceptionnelles » a été délivrée à ce médicament.
0.27899032831192017 ||| In addition, EU humanitarian aid will be provided to the World Health Organization's global coronavirus response in partnership with health authorities in Ethiopia, Kenya and Somalia to scale up operational readiness for early detection and response to the pandemic. ||| The EU's 2020 humanitarian funding in the DRC includes recently announced EU humanitarian assistance in reaction to the coronavirus pandemic: €4.5 million is allocated to coronavirus infection prevention and control measures, and access to quality health care, water, sanitation and hygiene. ||| En outre, l'UE apportera son aide humanitaire à l'Organisation mondiale de la santé dans le cadre de la réaction de cette dernière à la crise de COVID-19 au niveau mondial, en partenariat avec les autorités sanitaires en Éthiopie, au Kenya et en Somalie, en vue de renforcer l'état de préparation opérationnelle en matière de détection précoce et de réaction face à la pandémie.
0.25927796959877014 ||| The product should be brought at room temperature (no more than 30 ºC) before use. ||| Keep the product in use at room temperature (below 30°C) for up to 21 days. ||| Le produit doit être amené à température ambiante (ne dépassant pas 30 ºC) avant utilisation.
0.35422390699386597 ||| We will pilot a scheme for collecting convalescent serology from people with confirmed cases and who have had an acute virology sample at the time of their infection. ||| Patients who received at least one dose of study medication and who had a positive culture for Candida species from a normally sterile site before study entry were included in the modified intent- ||| Nous allons mener un projet pilote visant à collecter les résultats sérologiques de patients convalescents dont le cas a été confirmé et auprès desquels un échantillon virologique aigu a été prélevé au moment de leur infection.
0.10594360530376434 ||| Κύπρος BioPartners GmbH Eisenstrasse 3 D-65428 Rüsselsheim Γερμανία Τηλ: + 49(0) 6142 70 8000 ||| România BioPartners GmbH Eisenstrasse 3 D-65428 Rüsselsheim Germania Tel. + 49(0) 6142 70 8000 ||| Κύπρος BioPartners GmbH Eisenstrasse 3 D-65428 Rüsselsheim Γερμανία Τηλ: +49 (0) 6142 70 8000
0.45912593603134155 ||| Biograstim was studied to show that it is comparable to the reference medicine, Neupogen. ||| Based on the mode of action, erlotinib, has the potential to be a teratogen. ||| Biograstim a été étudié pour démontrer sa similitude au médicament de référence, Neupogen.
0.13728030025959015 ||| Where practical, surgical manipulations to the site should be completed prior to implantation of Osigraft. ||| Where practical, surgical manipulations to the site should be completed prior to product implantation. ||| Si possible, accomplir les gestes chirurgicaux sur le site avant l’ implantation d’ Osigraft.
0.49096447229385376 ||| Do not use Helixate NexGen 500 IU if you are allergic (hypersensitive) to octocog alfa, to mouse or hamster protein or to any of the other ingredients of Helixate NexGen 500 IU. ||| The ONLY other solutions that can be administered through the same line are 0.9% Sodium Chloride Injection, Lactated Ringer’ s Injection, Dextrose or Dextrose and Saline mixtures. ||| N'utilisez jamais Helixate NexGen 500 UI si vous êtes allergique (hypersensible) à l’ octocog alfa, aux protéines de hamster ou de souris ou tout autre constituant d'Helixate NexGen 500 UI.
4.791428755493432e-13 ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F- 69007 Lyon, France
0.24104994535446167 ||| 77.0 ||| 67.8 ||| 38,7
0.5018401145935059 ||| Data from extended treatment (more than 12 weeks) have been obtained from 4311 patients in open label uncontrolled studies. ||| However, based on interim data from a long-term follow-up study, 12 (14%) of 84 children had a > 15 percentile ||| Des données de traitement prolongé (au-delà de 12 semaines) ont été recueillies pour 4311 patients à l’ occasion d’ études en ouvert non contrôlées.
0.3035767078399658 ||| Other information about Isentress: ||| Other information about Prevenar: ||| Autres informations relatives à Isentress:
0.28314512968063354 ||| edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections. no ||| is or Excipients: sodium acetate, sorbitol (E420), polysorbate 20, water for injections. ||| monohydraté, édétate disodique, chlorure de sodium, métacrésol, polysorbate 80 et eau pour préparations injectables.
0.5890448093414307 ||| Common Uncommon ||| transient Uncommon ||| Fréquents Peu fréquents
0.3607045114040375 ||| This should be taken into account when prescribing Remeron to this category of patients, particularly with severe hepatic impairment, as patients with severe hepatic impairment have not been investigated (see section 4.4). ||| 9 Experience in patients with decompensated liver disease: placebo controlled studies have been regarded as inappropriate in patients with decompensated liver disease, and have not been undertaken. ||| Ceci doit être pris en compte lorsque Remeron est prescrit à cette catégorie de patients, en particulier chez les patients présentant une insuffisance hépatique sévère, qui n’ ont pas fait l’ objet d’ études spécifiques (voir rubrique 4.4).
0.1109657809138298 ||| Usually, the first symptoms of hyperglycaemia set in gradually, over a period of hours or days. ||| Usually the first symptoms of hyperglycaemia develop gradually over a period of hours or days. ||| En général, les premiers symptômes de l’ hyperglycémie apparaissent progressivement, en quelques heures ou quelques jours.
0.25390875339508057 ||| Trometamol Sodium chloride Hypromellose Hydrochloric acid/ sodium hydroxide (to adjust pH) Purified water ||| Monothioglycerol Propylene glycol Citric acid Hydrochloric acid Sodium hydroxide Water for injections ||| Trométamol Chlorure de sodium Hypromellose Acide chlorhydrique/ hydroxyde de sodium (ajustement du pH) Eau purifiée
0.3185383677482605 ||| Myocardial infarction, congestive heart failure, angina, supraventricular tachycardia, arrhythmia, atrial fibrillation, pericarditis, cardiomyopathy ||| Angina unstable, aortic valve incompetence, coronary artery atherosclerosis, sinus bradycardia, ventricular hypertropy ||| infarctus du myocarde, insuffisance cardiaque congestive, angor, tachycardie supraventriculaire, arythmie, fibrillation auriculaire, péricardite, cardiomyopathie
0.029734808951616287 ||| CARTON OF 1 TRIPLE PACK (3 VIALS/ 3 PFS) AS AN INTERMEDIATE PACK OF A TITRATION PACK OF 4 TRIPLE PACKS – TREATMENT DAYS 13, 15, 17 ||| CARTON OF 1 TRIPLE PACK (3 VIALS/ 3 PFS) AS AN INTERMEDIATE PACK OF A TITRATION PACK OF 4 TRIPLE PACKS – TREATMENT DAYS 1, 3, 5 ||| CONDITIONNEMENT D’UN SET DE 3 INJECTIONS (3 FLACONS/3 SERINGUES PREREMPLIES) COMME CONDITIONNEMENT INTERMEDAIRE D’UN COFFRET D’INITIATION AU TRAITEMENT – JOURS 13, 15 ET 17 DU TRAITEMENT
0.41408097743988037 ||| After reviewing the available data the CHMP concluded that the balance of risks and benefits for Protopic is considered favourable. ||| The Marketing Authorisation Holder was requested to provide all supporting data to justify a positive benefit/ risk ratio for the treated animal. ||| Après examen des informations disponibles, le CHMP est parvenu à la conclusion que le rapport bénéfice/ risque de Protopic est favorable.
0.653427004814148 ||| On 7 March, three new cases were confirmed in Herat province. ||| Two other samples in Pleven and Gabrovo were positive on 8 March. ||| Le 7 mars, trois nouveaux cas ont été confirmés dans la province d'Herat.
0.1288323700428009 ||| 50 TAXOTERE 75 mg/ m² in combination with doxorubicin ||| 15 TAXOTERE 100 mg/ m² in combination with trastuzumab ||| 52 TAXOTERE 75 mg/ m² en association avec la doxorubicine
0.3817482590675354 ||| Put the short needle on the syringe and remove the cover. ||| Remove the paper tab from the capped needle. ||| Fixez la plus petite aiguille sur la seringue et retirez son capuchon.
0.29413095116615295 ||| Hepatotoxicity: ||| Hepatotoxicity ||| Hépatotoxicité:
0.7010062336921692 ||| Efficacy results for study 006 on a subset of 614 patients who had been enrolled for at least 48 weeks are found in Table 2. ||| Data at one year from BM 16549 are represented in Table 1 and cumulative data for the two years from BM 16549 are represented in table 2. ||| Les résultats d’ efficacité de l'étude 006, sur un sous-groupe de 614 patients qui avaient été inclus dans l'étude depuis au moins 48 semaines, sont présentés dans le Tableau 2.
0.3287654519081116 ||| Following rosiglitazone treatment, there were no new safety concerns noted in children compared to adult patients with type 2 diabetes mellitus. ||| In the clinical studies, no toxicities occurred notably more frequently among elderly patients who received Abraxane. ||| Chez l’ enfant diabétique de type 2, aucun nouvel effet indésirable n’ a été mis en évidence par rapport à l’ adulte.
0.2736908495426178 ||| Variations in colour within this range do not affect the potency of the product. ||| Variations of colour within this range do not affect potency. ||| Les variations de couleurs dans cette gamme n’affectent pas l'activité du produit.
0.33204326033592224 ||| Contact your doctor or nurse for a replacement if either the pen or cartridge does not work. • Avoid excessive temperatures. ||| Use the mirror if it helps. • Do not touch your eye or eyelid, surrounding areas or other surfaces with the dropper. ||| Contactez votre médecin ou infirmière afin d’ obtenir une pièce de rechange si le stylo ou la cartouche ne fonctionnent pas • Évitez toute température excessive.
0.6216436624526978 ||| If you stop taking Rapinyl You should only stop taking Rapinyl sublingual tablets on the advice of your doctor. ||| How much Lamictal to take It may take a while to find the best dose of Lamictal for you. ||| Vous ne devez arrêter de prendre les comprimés sublinguaux de Rapinyl que sur les instructions de votre médecin.
0.31057339906692505 ||| Your doctor will advise you for how long you can use Avonex or when to stop. ||| Your doctor will advise you on how long you will need to take the medicine for. ||| Votre médecin vous conseillera sur la durée pendant laquelle vous pourrez prendre Avonex ou le moment de l’ arrêter.
0.2246834635734558 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that TESAVEL’ s benefits are greater than its risks for the treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin and/ or a sulphonylurea, or a PPAR gamma agonist, when diet and exercise plus the other medicines do not provide adequate glycaemic control. ||| If you take any medicines that reduce immunity to infections or have any other type of treatment (such as radiotherapy) that affects the immune system, Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg can still be given but your response to the vaccine may be poor. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de TESAVEL sont supérieurs aux risques qu’ il comporte pour le traitement des patients souffrant de diabète de type 2 en vue d’ améliorer le contrôle de la glycémie, en association avec la metformine et/ ou un sulfamide hypoglycémiant, ou un agoniste des PPAR
0.1338959038257599 ||| 78/ 125 10. ||| 118/ 125 7. ||| 80/ 129 10.
0.35590922832489014 ||| Improvement in bridging fibrosis occurred in 19/ 30 (63%) patients without YMDD variant and 22/ 44 (50%) patients with the variant. ||| A total of 283/ 1351 (21%) of patients had advanced fibrosis or cirrhosis, 85/ 1351 (6%) had cirrhosis. ||| Les patients 19/ 30 (63%) sans variant YMDD et les patients 22/ 44 (50%) avec variant ont eu une amélioration de la fibrose septale.
0.057539235800504684 ||| The Committee recommended that Temodal be given marketing authorisation. ||| The Committee recommended that Dafiro be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Temodal.
0.3782002925872803 ||| Cases of worsening congestive heart failure have also been reported in patients receiving Trudexa. ||| Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping Emtriva. ||| Des cas d'aggravation d'insuffisance cardiaque ont aussi été rapportés chez des patients
0.5950350761413574 ||| This is the time to act on the lessons we have learnt from history and the victories of AIDS activists. ||| We are also thankful for the spirit of solidarity and civic responsibility that European citizens have shown. ||| Il est temps de tirer les leçons de l'Histoire et d'apprendre des victoires remportées par les militants de la lutte contre le sida.
0.4673486649990082 ||| In this case, you should avoid any activities that require mental alertness such as driving a car or using any machine. ||| Avoid buying tickets with a connection in an affected area – even changing planes can make you subject to restrictions. ||| Dans ce cas, vous devriez éviter toute activité requérant votre attention ou votre concentration, telle que conduire un véhicule ou utiliser des machines.
0.000852129072882235 ||| 57 The concomitant use of other central nervous system depressants, including other opioids, sedatives or hypnotics, general anaesthetics, phenothiazines, tranquillisers, skeletal muscle relaxants, sedating antihistamines and alcohol may produce additive depressant effects. ||| 44 The concomitant use of other central nervous system depressants, including other opioids, sedatives or hypnotics, general anaesthetics, phenothiazines, tranquillisers, skeletal muscle relaxants, sedating antihistamines and alcohol may produce additive depressant effects. ||| L'administration concomitante d'Effentora et d'autres dépresseurs du SNC (autres morphiniques, sédatifs ou hypnotiques, anesthésiques généraux, phénothiazines, tranquillisants, myorelaxants, antihistaminiques sédatifs ou alcool) peut potentialiser les effets dépresseurs de chaque produit.
0.13607624173164368 ||| Alopecia, rash Photosensitivity reaction, maculopapular rash, eczema, acne, skin disorder, nail disorder, skin discolouration, pruritus, dry skin, erythema, bruise, sweating increased ||| Alopecia, dry skin, eczema, exfoliative dermatitis, maculopapular rash, nail disorder, Pruritis, seborrhoea, skin discoloration, skin ulcer, face oedema, sweating, skin striae ||| Réaction de photosensibilité, rash maculo-papulaire, eczéma, acné, Fréquent: affections cutanées, problème au niveau de l’ ongle, décoloration de la peau, prurit, peau sèche, érythème, contusion, sudation augmentée Affections musculo- squelettiques et systémiques Arthralgie, myalgie, douleur musculo-squelettique, myalgie Très fréquent:
0.3086598217487335 ||| The sachet containing IONSYS should be opened starting at the pre-cut notch, then by carefully tearing along the top of the sachet. ||| This can be done by pressing the recessed dosing button of the IONSYS, with the IONSYS still in its sealed sachet. ||| Le sachet contenant IONSYS doit être ouvert à partir de l’ encoche pré-découpée, puis en déchirant soigneusement le haut du sachet.
0.0 ||| Chronic renal failure patients ||| Chronic renal failure patients ||| 112 Patients insuffisants rénaux chroniques
0.5531238317489624 ||| Skin and subcutaneous tissue disorders Very common: ||| Coronavirus diseases, a group of closely related syndromes ||| Affections de la peau et du tissus sous-cutané Très fréquentes:
0.13324640691280365 ||| Lawn edge trimmers [hand-operated tools] ||| Lawn rollers [hand-operated tools] ||| Coupe-bordures [outillage manuel]
0.28719738125801086 ||| The dosage of Siklos can be adjusted to body weight by increments of 250 mg by using a quarter of a tablet. ||| The initial dose of Rapinyl used should be 100 micrograms, titrating upwards as necessary through the range of available dosage strengths. ||| La dose de Siklos peut être ajustée au poids corporel par palier de 250 mg en utilisant le quart d'un comprimé.
0.4436652362346649 ||| BATCH NUMBER Batch {number} ||| BATCH NUMBER ng lo Batch {number} no ||| Lot {numéro}
0.67398601770401 ||| - if you have diabetes ||| If you have chronic renal failure ||| - Si vous êtes diabétique.
2.7437850168982036e-13 ||| There was a low frequency (approximately 3%) of myelodysplastic syndromes (MDS) or leukaemia in clinical study patients with SCN treated with filgrastim. ||| There was a low frequency (approximately 3%) of myelodysplastic syndromes (MDS) or leukaemia in clinical study patients with SCN treated with filgrastim. ||| De rares cas (environ 3%) de syndromes myélodysplasiques (SMD) ou de leucémies ont été observés lors des études cliniques chez les patients atteints de neutropénie chronique sévère traités par le filgrastim.
0.06557141244411469 ||| Instructions for use and handling – reconstitution, dilution and administration ||| Instructions for use – reconstitution, dilution and administration ||| Instructions pour l’ utilisation et la manipulation – reconstitution, dilution et administration
0.5552542805671692 ||| If needed, you may cover the injection site with a bandage. ||| The control group received vehicle in order to maintain blinding. ||| Si nécessaire, vous pouvez mettre un pansement.
0.0 ||| 2 years ||| 2 years ||| 2 ans.
0.5087032318115234 ||| EU/ 1/ 99/ 125/ 001 28 orodispersible tablets EU/ 1/ 99/ 125/ 009 35 orodispersible tablets EU/ 1/ 99/ 125/ 005 56 orodispersible tablets EU/ 1/ 99/ 125/ 013 70 orodispersible tablets ||| EU/1/99/107/001 (84 hard capsules) EU/1/99/107/005 (112 hard capsules) EU/1/99/107/002 (140 hard capsules) EU/1/99/107/003 (168 hard capsules) ||| EU/ 1/ 99/ 125/ 001 28 comprimés orodispersibles EU/ 1/ 99/ 125/ 009 35 comprimés orodispersibles EU/ 1/ 99/ 125/ 005 56 comprimés orodispersibles EU/ 1/ 99/ 125/ 013 70 comprimés orodispersibles
0.5542346239089966 ||| Each carton contains 1 bottle of 30 film-coated tablets. ||| Add 30 ml (two tablespoons) of tap water to a glass 2. ||| Chaque emballage contient 1flacon de 30 comprimés pelliculés.
0.5882836580276489 ||| itching, loss of appetite or abdominal pain (uncommon). ||| Pain (burning, pain, soreness) Uncommon: ||| yeux, urines foncées, démangeaisons, perte d’appétit ou douleur abdominale (peu fréquent).
0.21563759446144104 ||| Coaxial cables ||| Coaxial connectors ||| Câbles coaxiaux
0.39455080032348633 ||| Call forwarding services ||| Market reporting services ||| Services de transfert d'appels
0.32167041301727295 ||| After having considered the grounds for this request, the CVMP re-examined the initial opinion, and confirmed the recommendation of the refusal of the marketing authorisation application on 14 September 2006. ||| On 13 September 2006 the CVMP, considered the detailed grounds the re-examination of the opinion and confirmed its previous opinion concluding that the marketing authorisations for Suramox 15% LA should be suspended. ||| Après avoir passé en revue les motifs de cette requête, le CVMP a réexaminé son avis initial et a confirmé la recommandation de refus de l’ autorisation de mise sur le marché, le 14 septembre 2006.
0.39051759243011475 ||| Water distribution installations ||| Water conduits installations ||| Installations de distribution d'eau
0.08215969800949097 ||| What benefit has Privigen shown during the studies? ||| What benefit has Convenia shown during the studies? ||| Quel est le bénéfice démontré par Privigen au cours des études?
0.45536088943481445 ||| There was no increase in blood concentration over time in any patient during the 12 months of treatment. ||| During the one year of treatment, many children did not grow or gain weight as much as expected. ||| Aucun patient n’a présenté d’augmentation de la concentration sanguine au cours du temps durant les 12 mois de traitement.
0.029939640313386917 ||| Appropriate antihypertensive drug must usually replace Aprovel before starting a pregnancy. ||| Appropriate antihypertensive drug must usually replace Karvea before starting a pregnancy. ||| Un autre traitement antihypertenseur approprié devra si possible être mis en place avant le début d’ une grossesse.
0.1294553130865097 ||| HOW TO STORE IRBESARTAN WINTHROP ||| HOW TO TAKE IRBESARTAN WINTHROP ||| COMMENT CONSERVER IRBESARTAN WINTHROP
0.1362507939338684 ||| Injection sites should therefore be alternated within the same region. ||| Injection sites should be rotated within the same region. ||| Les sites d’injection devront être alternés au sein d’une même région.
0.29313790798187256 ||| YENTREVE is indicated for women for the treatment of moderate to severe Stress Urinary Incontinence (SUI), (see section 5.1). ||| ADARTREL is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (see section 5.1). ||| YENTREVE est indiqué chez la femme dans le traitement de l'incontinence urinaire d’ effort modérée à sévère (voir rubrique 5.1).
0.4938957989215851 ||| Coffee grinders ||| Door scrapers ||| Moulins à café
0.3041651248931885 ||| 143 Risk Management plan ||| 27 Risk Management Plan ||| Plan de gestion des risques
0.26228946447372437 ||| Adverse effects not observed in clinical studies but seen in the rat and to a lesser extent in the mouse at exposure levels similar to human exposure levels and with possible relevance for clinical use were liver changes, indicating an adaptive response such as increased weight and centrilobular hypertrophy, fatty infiltration and increased liver enzymes in plasma. ||| Clinical efficacy In clinical trials, where patients suffering from primary insomnia received Circadin 2 mg every evening for 3 weeks, benefits were shown in treated patients compared to placebo in sleep latency (as measured by objective and subjective means) and in subjective quality of sleep and daytime functioning (restorative sleep) with no impairment of vigilance during the day. ||| Les événements indésirables pouvant avoir une pertinence en clinique, bien que n’ ayant pas été observés dans les études cliniques mais rapportés chez le rat et dans une moindre proportion chez la souris à des niveaux d’ exposition identiques à ceux utilisés chez l’ homme, étaient des modifications hépatiques indiquant une réponse d’ adaptation comme augmentation du poids, hypertrophie centrolobulaire, infiltration adipeuse et élévation des enzymes hépatiques dans le plasma.
0.018508177250623703 ||| CPMP/ 2846/ 03 SCIENTIFIC CONCLUSIONS ||| CPMP/ 3257/ 03 SCIENTIFIC CONCLUSIONS |||  EMEA 2003 CPMP/ 2846/ 03 CONCLUSIONS SCIENTIFIQUES
0.3340708315372467 ||| Caution should be used when prescribing fenofibrate with simvastatin, as either agent can cause myopathy when given alone. ||| After this period, Rapamune can be used as maintenance treatment together with corticosteroids, but only if ciclosporin treatment can be stopped. ||| En cas de prescription de fénofibrate et de simvastatine, des précautions doivent être prises, car chacun de ces médicaments séparément, peut entraîner des atteintes musculaires.
0.26867571473121643 ||| If you take more INTELENCE than you should Contact your doctor or pharmacist immediately. ||| If you take more EVISTA than you should Tell your doctor or pharmacist. ||| Si vous avez pris plus d’INTELENCE que vous n’auriez dû Contactez immédiatement votre médecin ou votre pharmacien.
0.31978073716163635 ||| Patients should be followed carefully for any signs of bleeding including occult bleeding, especially during the first weeks of treatment and/ or after invasive cardiac procedures or surgery. ||| Higher infusion rates may be required in conditions with accelerated clearance during major bleedings or extensive tissue damage during surgical interventions. ||| Une recherche soigneuse de tout signe de saignement, y compris de saignement occulte, doit être effectuée notamment pendant les premières semaines de traitement et/ou après gestes cardiaques invasifs ou chirurgie.
0.35199177265167236 ||| Two dosing regimens can be recommended: ||| Two primary immunisation schedules can be recommended: ||| Deux schémas posologiques peuvent être recommandés:
0.11325162649154663 ||| -7.6 ||| -1.0 ||| -7,6
0.7693068981170654 ||| Loratabs ||| TachoSil ||| Loratadin
0.03728439658880234 ||| Hypersensitivity to the active substance or to any of the excipients. ||| - Hypersensitivity to the active substance or to any of the excipients. ||| Hypersensibilité connue à la substance active ou à l’un des excipients de la crème.
0.10357557237148285 ||| - diarrhoea, constipation, nausea, vomiting, abdominal pain ||| Nausea, vomiting, diarrhoea, abdominal pain, mouth ulceration ||| supérieures, sinusite, toux majorée, essoufflement diarrhées, constipation, nausées, vomissements, douleurs abdominales
0.0390644297003746 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Aldurazyme to Genzyme Europe B. V. on 10 June 2003. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Cerezyme to Genzyme Europe B. V. on 17 November 1997. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Aldurazyme à Genzyme Europe B. V., le 10 juin 2003.
0.0 ||| 25 ANNEX II ||| 25 ANNEX II ||| 29 ANNEXE II
0.4271535277366638 ||| There is not enough insulin in the reservoir • you can inject the amount indicated on the injection button from this OptSet and then inject the remaining dose using a new pen, or • you can inject the entire dose using a new pen. ||| This is a procedure that is similar to a Lucentis injection, but with no Lucentis and no needle, in which the syringe is pressed against the surface of the eye but no actual injection is carried out. ||| bouton d'injection est d’injection de cet OptiSet, puis utiliser un nouveau stylo inférieure à la dose pour injecter la dose restante, ou sélectionnée
0.25500524044036865 ||| How is Pelzont used? ||| How is Comtess used? ||| Comment Pelzont est -il utilisé?
0.07347790151834488 ||| Co-administration of ketoconazole (200 mg), a potent CYP3A4 inhibitor, with vardenafil (5 mg) resulted in a 10-fold increase in vardenafil AUC and a 4-fold increase in vardenafil Cmax (see section 4.4). ||| Co-administration of erythromycin (500 mg three times a day), a CYP3A4 inhibitor, with vardenafil (5 mg) resulted in a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax. ||| L'administration concomitante de kétoconazole (200 mg), un puissant inhibiteur du CYP3A4 et de vardénafil (5 mg) a entraîné une augmentation de 10 fois l'AUC et de 4 fois la Cmax du vardénafil (voir rubrique 4.4).
0.35845255851745605 ||| Cardiac Disorders ||| Endocrine Disorders ||| Troubles cardiaques
0.3348781168460846 ||| Tel: +351 21 35 89 4 00 ||| Tel: + 40 21 302 8 208 ||| Tel: +351 21 35 89 400
0.0651378259062767 ||| If you stop taking VIRACEPT Continue to take this medicine until your doctor tells you otherwise. ||| If you stop taking Invirase Continue to take this medicine until your doctor tells you otherwise. ||| Continuez de prendre ce médicament jusqu’à ce que votre médecin vous dise d’arrêter.
0.2198638617992401 ||| 245 Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 23 Lietuva Eli Lilly Holdings Limited atstovybė Tel. + 370 (5) 2649600 ||| 260 Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
0.04916759580373764 ||| For the induction and maintenance of anaesthesia. ||| For induction and maintenance of anaesthesia. ||| Induction et entretien de l’ anesthésie.
0.3844186067581177 ||| Fluvoxamine (100 mg once daily), a potent inhibitor of CYP1A2, decreased the apparent plasma clearance of duloxetine by about 77% and increased AUC0-t 6-fold. ||| Cerivastatin effectively and dose-dependently (0.1-0.8mg/ day) reduces total cholesterol, LDL- cholesterol, triglycerides and increases HDL-cholesterol. ||| La fluvoxamine (100 mg une fois par jour), puissant inhibiteur du CYP1A2, a diminué d'environ 77% la clairance plasmatique apparente de la duloxétine et multiplié par 6 l’ Aire Sous la Courbe (ASC0-t).
0.017298690974712372 ||| Read all of this leaflet carefully including the Instructions for Use of Insuman Rapid, pre-filled pen, SoloStar, before you start using this medicine. ||| Read all of this leaflet carefully including the Instructions for Use of Insuman Basal, pre-filled pen, SoloStar, before you start using this medicine. ||| Veuillez lire attentivement l'intégralité de cette notice, y compris les instructions d’utilisation d’Insuman, stylo prérempli, SoloStar, avant d'utiliser ce médicament.
0.02760353870689869 ||| Truvada is not recommended for use in children below the age of 18 years due to insufficient data on safety and efficacy (see section 5.2). ||| Keppra is not recommended for use in children below 4 years of age due to insufficient data on safety and efficacy (see section 5.2). ||| Truvada ne doit pas être utilisé chez l’ enfant en dessous de 18 ans suite à une insuffisance de données concernant la sécurité et l’ efficacité (voir rubrique 5.2).
1.021796037538325e-12 ||| Not known: ||| Not known: ||| Très rare:
0.04188155010342598 ||| 229 10. ||| 232 10. ||| 250 10.
0.3583855628967285 ||| After reviewing the available data the CHMP concluded that the balance of risks and benefits for Protopic is considered favourable. ||| The CVMP concluded that, based on all available data, there was no concern regarding safety or efficacy for the product. ||| Après examen des informations disponibles, le CHMP est parvenu à la conclusion que le rapport bénéfice/ risque de Protopic est favorable.
0.0 ||| Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy. ||| Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy. ||| Typiquement, la toux est non productive et persistante; elle disparaît après l’ arrêt du traitement.
0.1489933729171753 ||| Not all pack sizes may be available in your country. ||| Some pack sizes may not be marketed in your country. ||| Toutes les tailles de boîte peuvent ne pas être disponibles dans votre pays.
0.08078037947416306 ||| What TRISENOX looks like and contents of the pack ||| What FIRMAGON looks like and contents of the pack ||| Qu’est-ce que TRISENOX et contenu de l’emballage extérieur?
0.2853299677371979 ||| ut ra 3. ||| ho ut 3. ||| au 3.
0.4451681971549988 ||| integration of this functionality directly into iOS and AndroidGoogle and Apple plan to address the take-up and persistent surveillance problems by first distributing the system through operating system updates, and later removing it in the same way once the threat has passed. ||| Instead of using a dedicated app, the system gathered tracking information from a variety of sources including mobile device tracking data and card transaction data, and combined these to generate notices via text messages to potentially-infected individuals. ||| intégration directe de cette fonctionnalité dans iOS et Android. Google et Apple prévoient de régler les problèmes d’adoption de la solution et de persistance de la surveillance en distribuant initialement le système par le biais de mises à jour du système d’exploitation et en le supprimant ultérieurement de la même manière une fois la menace éloignée.
0.24415366351604462 ||| You may need to be given additional medicines to prevent an allergic reaction (e. g. antihistamines and/ or corticosteroids) or antipyretics. ||| Your Doctor might instruct you to take other medications such as antiemetics, antihistamines and/ or paracetamol to decrease the side effects of probenecid. ||| Il se peut que vous ayez besoin de recevoir d’ autres médicaments en prévention d’ une éventuelle réaction allergique (par ex., des anti-histaminiques et/ ou des corticostéroïdes) ou des antipyrétiques.
0.7318685054779053 ||| Rough sawn timber ||| Rhubarb in syrup ||| Bois de sciage brut
0.3200181722640991 ||| In children, thrombocytopenia (< 25x109/ l or requiring platelet transfusion) occurred in 100% of patients. ||| In rats retardation of foetal development, wavy ribs and kidney cavitation occurred (≥ 1 mg/ kg). ||| Chez l’ enfant, une thrombocytopénie (avec plaquettes < 25x109 / lou nécessitant une transfusion plaquettaire) est survenue chez 100% des patients.
0.3643679916858673 ||| On 13 February, the first death in Spain was recorded involving a 69-year-old man who had been in Nepal. ||| On 18 March, a sixth death was registered in the Blida Province, a 62-year-old man died on 17 March. ||| Le 13 février, premier décès en Espagne d'un homme de 69 ans de retour d'un voyage au Népal.
0.27053797245025635 ||| Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), asthenia, agitation or anxiety, nausea and/ or vomiting, tremor and headache are the most commonly reported reactions. ||| Symptoms may vary from CNS depression (sedation, apnoea, diminished mental alertness, cyanosis, coma, cardiovascular collapse) to CNS stimulation (insomnia, hallucination, tremors, convulsions) with possible fatal outcome. ||| rapportées sont les suivantes: sensations vertigineuses, troubles sensoriels (incluant paresthésie), troubles du sommeil (incluant insomnies et rêves intenses), asthénie, agitation ou anxiété, nausées et/ ou vomissement, tremblements et céphalées.
0.3048521876335144 ||| 0.95 (0.81, 1.11) 1.05 (0.93, 1.19) ||| 1.00 (0.88; 1.13) 0.99 (0.88; 1.12) ||| 0,71 (0,61; 0,82) 0,69 (0,61; 078)
0.5561798810958862 ||| Merial Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest France ||| Manufacturer Laboratoire Elaïapharm 2881 Route des Crêtes Z. I. ||| MERIAL Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest France
0.2230580747127533 ||| Co-administration of fosamprenavir with ritonavir in doses greater than 100 mg twice daily has not been clinically evaluated. ||| Ritonavir doses higher than 100 mg twice daily have not been studied with fosamprenavir. ||| Fosamprenavir: la co-administration de fosamprénavir et de ritonavir à des doses supérieures à 100 mg deux fois par jour n’a pas été évaluée cliniquement.
0.2605476975440979 ||| Patients with hepatic impairment AVAGLIM is contraindicated in patients with hepatic impairment (see section 4.3). ||| Subjects with hepatic impairment No study was conducted with Prometax transdermal patches in subjects with hepatic impairment. ||| Insuffisant hépatique AVAGLIM est contre-indiqué chez les patients atteints d’ insuffisance hépatique (voir rubrique 4.3).
0.3373395502567291 ||| Treatment and prevention of swine dysentery ||| Treatment and prevention of Swine Dysentery. ||| Traitement et prévention de la dysenterie porcine
0.3283412754535675 ||| Elimination The elimination of entacapone occurs mainly by non-renal metabolic routes. ||| Distribution Oxybutynin is widely distributed in body tissues following systemic absorption. ||| Elimination L’ élimination de l’ entacapone s’ effectue principalement par voie métabolique non rénale.
0.0 ||| 4.4 Special warnings for each target species ||| 4.4 Special warnings for each target species ||| 4.4 Mises en garde particulières pour chaque espèce cible-
0.2119077444076538 ||| Children and adolescents 3 to 16 years of age with compensated chronic hepatitis C and detectable HCV-RNA (assessed by a central laboratory using a research-based RT-PCR assay) were enrolled in two multicentre trials and received IntronA 3 MIU/m2 3 times a week plus ribavirin 15 mg/kg per day for 1 year followed by 6 months follow-up after-treatment. ||| The efficacy of Forsteo in men and women (N=428) receiving sustained systemic glucocorticoid therapy (equivalent to 5 mg or greater of prednisone for at least 3 months) was demonstrated in the 18- month primary phase of a 36 month, randomised, double-blind, comparator-controlled study (alendronate 10 mg/ day). ||| Des enfants et adolescents âgés de 3 à 16 ans ayant une hépatite C chronique compensée et un ARN- VHC détectable (évalué par un laboratoire central utilisant une méthode RT-PCR non commercialisée) ont été inclus dans deux études multicentriques et ont reçu IntronA 3 MUI/ m2 trois fois par semaine + ribavirine 15 mg/ kg par jour pendant 1 an, puis ont été suivis pendant une période de 6 mois après arrêt du traitement.
0.2860534191131592 ||| Tuition in sports ||| Tuition in animal training ||| Enseignement sportif
0.07007667422294617 ||| 71 9. ||| 61 9. ||| 77 9.
0.32112208008766174 ||| In addition, LYRICA is available in an HDPE bottle containing 200 capsules for the 75, 150 and 300 mg strengths. ||| Ribavirin Teva is available in different pack sizes containing 84, 112, 140 or 168 capsules to be swallowed. ||| LYRICA est également disponible en flacon PEHD contenant 200 gélules pour les dosages à 75, 150 et 300 mg.
0.5037239789962769 ||| EMEA 2004 |||  EMEA 2004 ||| EMEA 2004 CPMP/3258/03
0.38273322582244873 ||| Because alendronate and vitamin D3 are already used separately in authorised medicines in the European Union (EU), the company presented data obtained in earlier studies and from the published literature. ||| Because Stalevo is based on another medicine already authorised in the EU, the company used some of the data from Comtess/ Comtan to support the use of Stalevo. ||| Comme l’ alendronate et la vitamine D3 sont déjà utilisés séparément dans d’ autres médicaments autorisés dans l’ Union européenne (UE), la société a présenté des données obtenues lors d’ études précédentes et provenant de diverses publications.
0.2519838809967041 ||| 10 months. ||| 36 months. ||| 10 mois.
0.1326741874217987 ||| Neulasta should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens. ||| Filgrastim should not be used to increase the dose of cytotoxic chemotherapy beyond established posology regimens (see below). ||| Neulasta ne doit pas être utilisé pour augmenter les doses de chimiothérapie cytotoxique au-delà des schémas posologiques établis.
0.3961377739906311 ||| This process is influenced by several factors (e. g. insulin dosage, injection route and site, thickness of subcutaneous fat, type of diabetes). ||| There is an association between the complete clearance rate and the intensity of local skin reactions (e.g. erythema). ||| Ce processus est influencé par plusieurs facteurs (par exemple la dose d’ insuline, la voie et le site d’ injection, l’ épaisseur du tissu adipeux sous-cutané, le type de diabète).
0.008208648301661015 ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipidaemia (increased fats in the blood) and resistance to insulin. ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipaemia (increased fats in the blood) and resistance to insulin. ||| Les associations d’ antirétroviraux peuvent également entraîner une augmentation de l’ acide lactique et du sucre dans le sang, une hyperlipidémie (augmentation du taux de graisse dans le sang) et une résistance à l’ insuline.
0.30722230672836304 ||| 71 Studies in rats indicated that uptake into brain tissue was limited, distribution into and out of the lymphatic system was rapid, and excretion into the milk of lactating rats was extensive. ||| When the liver capacity of storing copper is exceeded copper is released into the blood and is taken up in extra hepatic sites, such as the brain, resulting in motor disorders and psychiatric manifestations. ||| Les études chez le rat indiquent que la captation dans le tissu cérébral est limitée et la distribution à l'intérieur et à l'extérieur du système lymphatique est rapide; son excrétion dans le lait des rates allaitantes est importante.
0.03952007740736008 ||| 28 Many of the undesirable effects of Aldara cream are due to its local action on your skin. ||| Many of the undesirable effects of Aldara cream are due to its local action on your skin. ||| Un grand nombre des effets indésirables d'Aldara crème sont dus à son action locale sur la peau.
3.074769714013492e-13 ||| In a pre-/ postnatal development study performed in rats sitagliptin showed no adverse effects. ||| In a pre-/ postnatal development study performed in rats sitagliptin showed no adverse effects. ||| Dans une étude de développement pré/ postnatal réalisée chez des rats, la sitagliptine n'a produit aucun effet indésirable.
0.2877044081687927 ||| Lamivudine is metabolised by both infected and uninfected cells to the triphosphate (TP) derivative which is the active form of the parent compound. ||| Panitumumab recognises and binds specifically to a protein known as epidermal growth factor receptor (EGFR), which is found on the surface of some cancer cells. ||| Dans les cellules infectées ou saines, la lamivudine est transformée en un métabolite triphosphate (TP), qui constitue la forme active de la molécule mère.
0.22298821806907654 ||| Pradaxa hard capsules contain the colorant sunset yellow (E110), which may cause allergic reactions. ||| Zonegran 100 mg hard capsules contain a yellow colour called sunset yellow FCF (E110), which may cause allergic reactions. ||| Les gélules de Pradaxa contiennent le colorant jaune orangé (E110), qui peut être à l’ origine de réactions allergiques.
0.8959402441978455 ||| (Days 1-21) Twice daily. ||| Median Time to Event (Days) ||| (jours 1-21) Deux fois
0.17824092507362366 ||| Printed mirrors ||| Printed emblems ||| Miroirs imprimés
0.33855295181274414 ||| The biologic activity of the pegylated isomers is qualitatively similar, but weaker than free interferon alfa-2b. ||| This is predominantly via cytochrome P450 2C8 although other isoforms may be involved to a lesser degree. ||| L’ activité biologique des isomères pégylés est similaire qualitativement, mais plus faible que l’ interféron alfa-2b libre.
0.2198643684387207 ||| Staff Regulations of officials of the European Communities, and in particular Article 14 of Annex VII thereto. ||| Staff Regulations of officials of the European Communities, and in particular Articles 27 to 31 and 33 thereof and Annex III thereto. ||| Statut des fonctionnaires des Communautés européennes, et notamment l'article 14 de son annexe VII.
0.0 ||| 1 pre-filled syringe with needle guard ||| 1 pre-filled syringe with needle guard ||| 1 voorgevulde spuit met naaldbescherming
0.8375407457351685 ||| In rats and dogs, Heinz bodies and/ or Howell-Jolly bodies were found. ||| Of these types, Farmer's Lung and Bird-Breeder's Lung are the most common. ||| Chez le rat et le chien, des corps de Heinz et/ ou de Howell-Jolly ont été observés.
0.08092553913593292 ||| No dosage reduction is required for patients with creatinine clearance > 20 ml/ min. ||| No dose adjustment is necessary for patients with creatinine clearance ≥ 50 ml/ min. ||| Aucune réduction de la posologie n'est nécessaire chez les patients dont la clairance de la créatinine est > 20 ml/ min.
0.48160597681999207 ||| Sustiva must be given in combination with other antiviral medicines. ||| Additional vitamin D supplements may be considered on an individual basis. ||| Sustiva doit être administré en association avec d’ autres médicaments antiviraux.
0.28548702597618103 ||| 10 mg loratadine + 240 mg pseudo- ephedrine sulphate ||| 10 + 240 mg pseudo- epinephrine sulphate ||| loratadine + 240 mg pseudo- ephedrine sulphate
3.645269307760157e-13 ||| The solution should be used immediately after reconstitution. ||| The solution should be used immediately after reconstitution. ||| La solution doit être utilisée immédiatement après reconstitution.
0.3043530583381653 ||| What Aprovel contains The active substance is irbesartan. ||| What Intrinsa contains The active substance is testosterone. ||| Que contient Aprovel La substance active est l'irbésartan.
3.110258361624374e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.3026827573776245 ||| Since insulin and pioglitazone are associated with fluid retention, concomitant administration of insulin and Glubrava may increase the risk of oedema. ||| The administration of Puregon is then discontinued and ovulation can be induced by administering human chorionic gonadotrophin (hCG). ||| L’ insuline et Glubrava étant associées à une rétention hydrique, leur administration concomitante peut augmenter le risque d’œ dème.
0.1720505952835083 ||| A €55 billion top-up of the current cohesion policy programmes between now and 2022 under the new REACT-EU initiative to be allocated based on the severity of the socio-economic impacts of the crisis, including the level of youth unemployment and the relative prosperity of Member States. ||| The top-up for cohesion funding under REACT-EU is additional to the 2014-2020 period and will be allocated based on the severity of the economic and social impacts of the crisis, including the level of youth unemployment and the relative prosperity of Member States. ||| un complément de 55 milliards d'euros pour les programmes actuels de la politique de cohésion entre aujourd'hui et 2022 au titre de la nouvelle initiative REACT-EU qui sera réparti en fonction de la gravité des effets socio-économiques de la crise, notamment le taux de chômage des jeunes et la prospérité relative des États membres;
0.2853352427482605 ||| Following oral administration of ORACEA, mean peak plasma concentrations were 510 ng/ mL after a single dose and 600 ng/ mL at steady state (Day 7). ||| At week 4, the indinavir Cmin was 500 ng/ mL with substantial trough variability (range 5 to 8100 ng/ mL). ||| Après administration orale d’ ORACEA, la moyenne des concentrations plasmatiques maximales était de 510 ng/ mL après dose unique et de 600 ng/ mL à l’ état d’ équilibre (Jour 7).
0.2394954413175583 ||| Temperature scanners for medical use ||| Skin temperature indicators for medical use ||| Scanners de température à usage médical
0.18998408317565918 ||| BEFORE YOU USE INSUMAN COMB 50 ||| BEFORE YOU USE INSUMAN RAPID ||| QUELLES SONT LES INFORMATIONS A CONNAITRE AVANT D'UTILISER INSUMAN COMB 50
0.030515583232045174 ||| 59 In a clinical trial, approximately 1.2% of patients treated with ViraferonPeg or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment. ||| In a clinical trial, approximately 1.2% of patients treated with PegIntron or interferon alfa-2b in combination with ribavirin reported life-threatening psychiatric events during treatment. ||| Dans un essai clinique, approximativement 1,2% des patients traités avec ViraferonPeg ou interféron alfa-2b en association avec ribavirine ont rapporté au cours du traitement des effets psychiatriques affectant le pronostic vital.
0.1322418451309204 ||| Road signs, non-luminous and non-mechanical, not of metal ||| Signalling panels, non-luminous and non-mechanical, not of metal ||| Bornes routières non métalliques, non lumineuses et non mécaniques
0.3158213198184967 ||| What Agopton contains ||| What Faslodex contains ||| Que contient Agopton:
0.28292906284332275 ||| Optaflu has not been studied in the paediatric population and therefore, data on immune response are not available for this age group. ||| Hepatic and Renal impairment Use EMADINE has not been studied in these patients and therefore, its use is not recommended in this population. ||| En conséquence, il n’ existe aucune donnée sur la réponse immunitaire dans cette classe d’ âge.
0.605888843536377 ||| What Aerius oral lyophilisate contains ||| What TAXOTERE concentrate vial contains ||| Que contient Aerius lyophilisat oral
0.49151521921157837 ||| This should be considered when rapid symptomatic relief is needed. ||| This incidence was not statistically significant when adjusted for survival. ||| Cette information est à considérer lorsqu’ un soulagement rapide est nécessaire.
0.4749321937561035 ||| Chemical analysis services for use in design ||| Photosensitive paper for use in medical imagery ||| Services d'analyse chimique destinés à la conception
5.992216271788475e-13 ||| 500 IU ||| 500 IU ||| KOGENATE 500 UI Bayer
0.32216131687164307 ||| Do not take EXJADE ||| Do not take REYATAZ ||| Ne prenez jamais EXJADE
0.22061322629451752 ||| Use in patients with severe renal insufficiency Caution should be exercised when using ivabradine in patients with severe renal insufficiency (creatinine clearance < 15 ml/ min) (see section 4.2). ||| 2 Patients with renal insufficiency For patients with mild renal insufficiency (creatinine clearance [CrCl] ≥ 50 ml/ min), no dosage adjustment for TESAVEL is required. ||| Utilisation chez les patients avec une insuffisance rénale sévère L’ ivabradine doit être utilisée avec précaution chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 15 ml/ min) (voir rubrique 4.2).
0.2990160286426544 ||| Your doctor has determined the exact dose of Firazyr and will tell you how often it should be used. ||| Pegasys dosing Your doctor has determined the exact dose of Pegasys, and will tell you how often to use it. ||| Votre médecin a déterminé la dose exacte de Firazyr et vous indiquera à quelle fréquence vous devez en prendre.
0.4242449998855591 ||| • Place the tablet under your tongue as far back as you can and let it dissolve completely. ||| Push your thumb away from you as far as it will go and you hear a click. ||| • Placez le comprimé sous la langue, aussi loin que possible, et laissez -le se dissoudre complètement.
0.13231834769248962 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Inovelon’ s benefits are greater that its risks for use as adjunctive therapy in the treatment of seizures associated with Lennox- Gastaut syndrome in patients 4 years and older. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Helixate NexGen’ s benefits are greater than its risks for the treatment and prevention of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ||| Le comité des médicaments à usage humain (CHMP) a décidé que les bénéfices d’ Inovelon sont supérieurs aux risques qu’ il comporte en tant que médicament utilisé en association à d’ autres médicaments dans le traitement des crises associées au syndrome de Lennox-Gastaut chez les patients de 4 ans et plus.
0.3454275131225586 ||| The efficacy of Masivet might be reduced in dogs previously treated with chemotherapy and/or radiotherapy. ||| The majority of patients had received rituximab in combination with chemotherapy or as part of a hematopoietic stem cell transplant. ||| L’efficacité de Masivet peut être diminuée chez les chiens précédemment traités par chimiothérapie et/ou radiothérapie.
0.11407873034477234 ||| Check the label to make sure that your Mixtard 30 InnoLet contains the correct type of insulin. ||| Check the label to make sure that your Protaphane NovoLet contains the correct type of insulin. ||| Contrôlez l’ étiquette pour vous assurer que votre Mixtard 30 InnoLet contient le type d’ insuline correct.
0.1387633979320526 ||| 2/ 3 Why has Pegasys been approved? ||| 2/ 3 Why has Sustiva been approved? ||| Pourquoi Pegasys a -t-il été approuvé?
0.267433226108551 ||| Laboratory test findings In the pivotal three-year study with oral ibandronic acid 2.5 mg daily (MF 4411) there was no difference compared with placebo for laboratory abnormalities indicative of hepatic or renal dysfunction, impaired haematologic system, hypocalcaemia or hypophosphataemia. ||| Pharmacodynamic Effects In placebo-controlled clinical trials in patients with severe sepsis, Xigris exerted an antithrombotic effect by limiting thrombin generation and improved sepsis-associated coagulopathy, as shown by a more rapid improvement in markers of coagulation and fibrinolysis. ||| Effets biologiques Dans l’ étude pivot effectuée sur trois ans avec l’ acide ibandronique oral 2,5 mg une fois par jour (MF 4411), aucune différence n’ a été observée par rapport au placebo quant aux bilans biologiques pouvant évoquer une insuffisance hépatique ou rénale, un trouble hématologique, une hypocalcémie ou une hypophosphorémie.
0.08765730261802673 ||| The Merck Sharp & Dohme Netherlands PO Box 581 2003 PC Haarlem The Netherlands ||| Merck Sharp & Dohme PO Box 581 2003 PC Haarlem The Netherlands ||| Merck Sharp & Dohme PO Box 581 2003 PC Haarlem Pays-Bas
0.3114994168281555 ||| The 120 mg film-coated tablets are marked on one side with ‘ 120’. ||| The 750 mg tablets are pale green and are engraved with CVT750 on one side. ||| Les comprimés pelliculés dosés à 120 mg comportent la marque « 120 » sur une face.
0.38110560178756714 ||| If Tasmar is to be prescribed, the patient should be informed about the signs and symptoms which may indicate liver injury, and to contact the physician immediately. ||| Patients should also be advised to inform their partner or caregivers about their treatment, since they may notice symptoms that the patient is not aware of. ||| En cas de prescription de Tasmar, le patient doit être informé sur les signes et les symptômes évocateurs d'une atteinte hépatique et sur le fait de contacter immédiatement son médecin.
0.0 ||| After reconstitution: ||| After reconstitution: ||| 45 Après reconstitution:
0.0 ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| La pioglitazone, principe actif d’ Actos, augmente la sensibilité 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.22654694318771362 ||| Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin. ||| 112 symptom of an anaphylactic shock, manifestations of which may additionally include extreme dizziness, loss of consciousness, and extreme difficulty in breathing. ||| 741 Douleurs d'estomac, respiration rapide et profonde, somnolence, voire perte de connaissance, peuvent traduire un état grave (acidocétose) résultant du manque d'insuline.
0.2896221876144409 ||| Clear, colourless to slightly yellow solution. ||| Clear, colourless to pale yellow solution. pH: ||| Solution limpide, incolore à légèrement jaunâtre.
0.016499944031238556 ||| Herbal preparations containing St John’ s wort (Hypericum perforatum) must not be used while taking APTIVUS due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir (see section 4.5). ||| Herbal preparations containing St John’ s wort (Hypericum perforatum) must not be used while taking Telzir due to the risk of decreased plasma concentrations and reduced clinical effects of amprenavir (see section 4.5). ||| Les préparations phytothérapeutiques à base de millepertuis (Hypericum perforatum) ne doivent pas être utilisées pendant le traitement par APTIVUS, car elles risquent de réduire les concentrations plasmatiques et l'efficacité clinique du tipranavir (voir rubrique 4.5).
0.31210118532180786 ||| Enbrel is supplied as a pre-filled syringe containing a clear, colourless or pale yellow solution for injection. ||| When reconstituted for intravenous infusion, the white to yellowish crystalline powder gives a pale yellow to amber solution. ||| Enbrel est fourni sous forme de seringue pré-remplie pour solution injectable.
0.4912225306034088 ||| TRACTOCILE contains atosiban (INN), a synthetic peptide ([Mpa1, D-Tyr(Et)2, Thr4, Orn8]-oxytocin) which is a competitive antagonist of human oxytocin at receptor level. ||| Alitretinoin (9-cis-retinoic acid), a naturally- occurring endogenous hormone related to vitamin A, binds to and activates all known intracellular retinoid receptor subtypes (RARα, RARβ, RARγ, RXRα, RXRβ, RXRγ). ||| TRACTOCILE contient de l’ atosiban (DCI), peptide de synthèse ([Mpa1, D-Tyr(Et)2, Thr4, Orn8]- ocytocine), qui est un antagoniste compétitif de l'ocytocine au niveau des récepteurs.
0.08675461262464523 ||| The other ingredients are: benzyl alcohol, sodium chloride, polysorbate 20, glacial acetic acid, sodium acetate, and water for injections. ||| − The other ingredients are sodium chloride, phenol, polysorbate 20, sodium citrate, citric acid anhydrous and water for injections. ||| Les autres composants sont: alcool benzylique, chlorure de sodium, polysorbate 20, acide acétique glacial, acétate de sodium et eau pour préparations injectables.
0.22991275787353516 ||| For the full list of all side effects reported with Comtess, see the Package Leaflet. ||| See the Package Leaflet for the list of the medicines that may interact with Sutent. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Comtess, voir la notice.
0.5444992780685425 ||| Minor prolongation in the prothrombin time has been described. ||| A case of cholestatic hepatitis has been reported. ||| Allongement mineur du temps de prothrombine.
0.4286884367465973 ||| Truvada is not recommended for patients who have severe problems with their kidneys or who require haemodialysis (a blood clearance technique). ||| Imiquimod cream may weaken condoms and diaphragms, therefore concurrent use with imiquimod cream is not recommended. ||| Truvada n’ est pas recommandé chez les patients souffrant d’ une insuffisance rénale sévère ou nécessitant une hémodialyse (technique de clairance sanguine).
0.0032323533669114113 ||| What Epivir looks like and the contents of the pack Epivir 150 mg film-coated tablets are supplied in white polyethylene bottles or blister packs containing 60 tablets. ||| What Epivir looks like and the contents of the pack Epivir 300 mg film-coated tablets are supplied in white polyethylene bottles or blister packs containing 30 tablets. ||| A quoi ressemble Epivir et contenu de l’ emballage extérieur Les comprimés pelliculés d’ Epivir 150 mg sont conditionnés par 60 comprimés, dans un flacon blanc en polyéthylène ou sous plaquette thermoformée.
0.00298272049985826 ||| 38 Studies with both hemodialysis and CAPD (chronic ambulatory peritoneal dialysis) indicate that A771726, the primary metabolite of leflunomide, is not dialysable. ||| 24 Studies with both hemodialysis and CAPD (chronic ambulatory peritoneal dialysis) indicate that A771726, the primary metabolite of leflunomide, is not dialysable. ||| Les études réalisées tant chez les patients hémodialysés que chez les patients sous DPCA (dialyse péritonéale continue ambulatoire) montrent que le A 771726, métabolite principal du léflunomide, n’ est pas dialysable.
0.24209095537662506 ||| The full EPAR for Filgrastim Hexal can be found here. ||| The full EPAR for Irbesartan Winthrop is available here. ||| L’ EPAR complet relatif à Filgrastim Hexal est disponible ici.
0.1612425446510315 ||| Abseamed is given by injection under the skin (subcutaneously). ||| Binocrit is given by injection under the skin (subcutaneously). ||| Abseamed est administré par injection sous la peau (par voie sous-cutanée).
0.6897489428520203 ||| Fittings of metal for building ||| Cleaning mitts of fabric ||| Ferrures pour la construction
0.35775884985923767 ||| Insulin Human Winthrop led to a decrease in the level of HbA1c, indicating that blood glucose levels had been controlled to a similar level to that seen with semi-synthetic human insulin. ||| Symptoms of hypoglycaemia (unconfirmed by blood glucose levels) were observed in patients whose baseline HbA1c was close to the therapeutic target (HbA1c < 7.5%). ||| Insulin Human Winthrop a entraîné une diminution du taux de HbA1c, indiquant que les taux de glucose dans le sang avaient été contrôlés à un niveau similaire à celui observé avec de l’ insuline humaine semi-synthétique.
0.15318138897418976 ||| Gastro-intestinal system disorders: ||| - Gastro-intestinal disorders: ||| Troubles du système gastro-intestinal:
0.31799280643463135 ||| A new Recovery and Resilience Facility of €560 billion will offer financial support for investments and reforms, including in relation to the green and digital transitions and the resilience of national economies, linking these to the EU priorities. ||| In this context, the Commission is proposing to reinforce the funds available to support farmers and rural areas as well as the fisheries sector in recovering and delivering the European Green Deal and in particular the new Farm to Fork and Biodiversity strategies. ||| une nouvelle facilité pour la reprise et la résilience d'un montant de 560 milliards d'euros apportera un soutien financier pour les investissements et les réformes, y compris en ce qui concerne les transitions écologique et numérique et la résilience des économies nationales, en les rattachant aux priorités de l'Union.
0.41868218779563904 ||| Blood pressure must be checked before the start of leflunomide treatment and periodically thereafter. ||| The daily dose is then maintained until pre-ovulatory conditions are reached. ||| La pression artérielle doit être contrôlée avant le début du traitement par le léflunomide puis de façon régulière.
0.321785569190979 ||| Hyper- sensitivity ||| Hyper- sensitivity disorder ||| Dysfonction érectile
0.23174995183944702 ||| Sodium iodide ||| Calcium iodide ||| Iodure de sodium
0.30402010679244995 ||| How is Cerepro expected to work? ||| How is DepoCyte expected to work? ||| Comment Cerepro devait -il agir?
0.7082550525665283 ||| Treatment differences (BYETTA minus comparator) were -4.1 kg in the 26-week study and – 5.4 kg in the 52-week study. ||| Alzheimer´s disease assessment scale (ADAS-cog) (p=0.003) and CIBIC-plus (p=0.004) at week 24 (last observation carried forward (LOCF)). ||| Les différences entre le traitement par BYETTA et les traitements comparateurs étaient de -4,1 kg dans l’ étude de 26 semaines et -5,4 kg dans l’ étude de 52 semaines.
0.18164971470832825 ||| Sectional buildings (Non-metallic -) ||| Parts of furniture (Non-metallic -) ||| Constructions modulaires non métalliques
0.5639604330062866 ||| Do not drive or use any tools or machines until you know how Efexor affects you. ||| They must not give you any food or drink as it could choke you. lo ||| Ne conduisez pas, n’ utilisez aucun outil ni aucune machine avant de connaître les effets d’ Efexor sur vous.
3.426492488182997e-13 ||| Significant differences in comparison to the reference product have been identified with regard to the posology section of the SPCs. ||| Significant differences in comparison to the reference product have been identified with regard to the posology section of the SPCs. ||| Des différences considérables en comparaison avec le produit de référence ont été identifiées eu égard à la rubrique relative à la posologie du RCP.
0.13878394663333893 ||| EU Number EU/ 1/ 07/ 417/ 001 ||| EU number EU/ 1/ 05/ 322/ 001 ||| EU/ 1/ 07/ 417/ 001
0.01008821651339531 ||| The Commission therefore concluded that the Hungarian measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| The Commission therefore concluded the Polish measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| La Commission a dès lors conclu que la mesure hongroise était nécessaire, appropriée et proportionnée pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
0.14066700637340546 ||| • 11.10.2001 • 26.10.2001 • 23.1.2002 • 89 days ||| • 02.10.2000 • 15.03.2001 • 23.05.2001 • 70 days ||| 11.10.2001 26.10.2001 23.1.2002 89 jours
0.6539910435676575 ||| The instructions for use of this device should be strictly followed. ||| These documents need to be flexible and easily updated to reflect progress. ||| Les instructions du fabricant doivent être suivies scrupuleusement.
0.0 ||| 10 ||| 10 ||| 10 11
0.6613953709602356 ||| This will prevent infections. ||| This can be serious. ||| Ceci évitera les infections.
0.25462275743484497 ||| 32 Rebif has not yet been investigated in patients with primary progressive multiple sclerosis, and should not be used in such patients. ||| AZARGA has not been studied in patients with narrow-angle glaucoma and its use is not recommended in these patients. ||| Rebif n’ a pas encore été étudié chez les patients atteints de la forme progressive primaire de sclérose en plaques et ne devrait pas être administré à ces patients.
0.6531296968460083 ||| Semi-finished safety glass ||| Pre-cut vegetable salads ||| Verre de sécurité semi-fini
0.13962848484516144 ||| Advisory services relating to energy efficiency ||| Advisory services relating to weight loss ||| Services de conseil en matière d'efficacité énergétique
0.3225078582763672 ||| Efficacy of Neoclarityn syrup has not been investigated in paediatric trials in children less than 12 years of age. ||| Elderly patients The pharmacokinetics of deferasirox have not been studied in elderly patients (aged 65 or older). ||| L’ efficacité de Neoclarityn sirop n’ a pas été étudiée lors d’ études pédiatriques chez l’ enfant de moins de 12 ans.
0.020886536687612534 ||| The presence of food has no relevant influence on AUC and Cmax of Neoclarityn oral lyophilisate while the presence of food prolongs Tmax for desloratadine from 2.5 to 4 hours and Tmax for 3-OH- desloratadine from 4 to 6 hours. ||| The presence of food has no relevant influence on AUC and Cmax of Aerius oral lyophilisate while the presence of food prolongs Tmax for desloratadine from 2.5 to 4 hours and Tmax for 3-OH-desloratadine from 4 to 6 hours. ||| La présence d’ aliments n’ a aucune influence significative sur l’ ASC et le Cmax de Neoclarityn comprimés orodispersibles, mais prolonge le Tmax de la desloratadine de 2,5 à 4 heures et celui de la 3- OH-desloratadine de 4 à 6 heures.
0.2819717228412628 ||| If you use more Fasturtec than you should If it does occur, the doctor will closely monitor the effects on your red blood cells and treat any symptoms that follow. ||| If you need a blood test, tell your doctor that you are taking Activelle, since oestrogen can affect the results of certain laboratory tests. ||| Si vous utilisez plus de Fasturtec que vous n’ auriez dû Si cela se produit, le médecin suivra soigneusement les effets sur vos globules rouges et traitera les symptômes associés.
0.4074819087982178 ||| There are no adequate data from the use of parecoxib sodium in pregnant women or during labour. ||| 44 Lactation There is insufficient/ limited information on the excretion of dasatinib in human or animal breast milk. ||| Il n’ y a pas de données suffisantes sur l’ utilisation du parécoxib sodium chez la femme enceinte ou pendant le travail.
4.154097313531502e-13 ||| Dr Jones joined the EMEA Management Board in 1995 and was elected chairman of the Board in 2001. ||| Dr Jones joined the EMEA Management Board in 1995 and was elected chairman of the Board in 2001. ||| Le Dr Jones a rejoint le conseil d’ administration de l'EMEA en 1995, dont il a été élu président en 2001.
0.29147088527679443 ||| Step 2 ||| Study 2 ||| Etape 2
0.3750835657119751 ||| Motorcycle lights ||| Microphone buttons ||| Feux de motocycle
0.5851404070854187 ||| Orthopedic articles ||| Orthopedic cushions ||| Articles orthopédiques
0.6063023805618286 ||| Non-small cell lung cancer (Tarceva administered as single agent in study BR.21): ||| 5 Immune response against the vaccine strain contained in CELVAPAN (A/ Vietnam/ 1203/ 2004) ||| Cancer bronchique non à petites cellules (Tarceva en monothérapie dans l’ étude BR.21):
0.25782468914985657 ||| Copalia is not recommended for use in patients below 18 years of age. ||| Zypadhera is not recommended for patients over 65 years of age. ||| L’ administration de Copalia n’ est pas recommandée chez les patients âgés de moins de 18 ans.
0.21295785903930664 ||| BATCH NUMBER ||| BATCH NUMBER M ||| NOTICE
0.6000048518180847 ||| Returning to your regular schedule will help you remember when to change your patch. ||| You should bring enough of your factor VIII product for anticipated treatment when travelling. ||| Revenir à votre calendrier habituel vous aidera à vous rappeler quand remplacer votre dispositif transdermique.
0.28016427159309387 ||| 5 ml solvent for NeoRecormon Multidose 100,000 IU (water for injection, benzyl alcohol, benzalkonium chloride) ||| Xeomin100 LD50 units powder for solution for injection Clostridium Botulinum neurotoxin type A (150kD), free of complexing proteins ||| 5 ml Solvant pour NeoRecormon Multidose 100 000 UI (Eau p. p. i., alcool benzylique, chlorure de benzalkonium)
3.3327098134146305e-13 ||| As a result, exceptional interventions by the Member States to compensate for the damages linked to the outbreak are justified. ||| As a result, exceptional interventions by the Member States to compensate for the damages linked to the outbreak are justified. ||| Par conséquent, il est justifié que les États membres prennent des mesures exceptionnelles pour indemniser les dommages liés à la pandémie.
0.34949856996536255 ||| Delete, where applicable, the dose of 2 X 15 mg/ kg body weight per day. ||| Treatment is initiated with 100 mg per kg bodyweight once daily – not exceeding 4 g daily. ||| Supprimer, le cas échéant, la dose de 2 X 15 mg/ kg poids corporel par jour.
0.2771803140640259 ||| Set the tip of the pen on the prepared injection site and press the needle into the skin by pushing the pen downward until the shield is totally depressed. ||| When the cartridge is inserted in the special injection pen and the pen screwed together, the powder and solvent mix to make up the solution for injection. ||| Placez l’ extrémité du stylo sur le point d’ injection préparé et enfoncez l’ aiguille dans la peau en exerçant une pression verticale sur le stylo jusqu’ à ce que le cache soit totalement enfoncé.
0.4013293981552124 ||| Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. ||| These proteins belong to the class of "immunoglobulins", also called antibodies. ||| Aprovel appartient à un groupe de médicaments connus sous le nom d’ antagonistes des récepteurs de l'angiotensine-II.
0.02717675268650055 ||| 38 Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com ||| Ireland Merck Sharp & Dohme Ireland (Human Health) Limited, Tel: +353 (0)1 2998771 medinfo_ireland@merck. com ||| Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com
0.430938720703125 ||| In addition, there would seem to be no reason to mix these vaccines before administration to EU residents and the CHMP does not find any endorsement for mixing in the recommendations of WHO. ||| In today's proposal, there is no longer a limit, as the impact of the coronavirus does not follow the usual cohesion policy categorisation of less and more developed regions. ||| En outre, il ne semble y avoir aucune raison pour que ces vaccins soient mélangés avant leur administration à des résidents de l’ UE et le CHMP n’ a trouvé aucune consigne appuyant le mélange dans les recommandations de l’ OMS.
0.704201340675354 ||| Sildenafil ||| Infliximab ||| Sildénafil
0.24918824434280396 ||| After injecting the liquid, remove the needle while maintaining pressure on the plunger and then let go of your skin. ||| After injecting the liquid, remove the needle and let go of your skin. ||| Lorsque le liquide a été injecté, retirez l’ aiguille tout en maintenant la pression sur le piston et relâchez la peau.
0.44729506969451904 ||| Medical instruments for interstitial thermotherapy of biological tissue ||| Maintenance and repair of horological and chronometric instruments ||| Instruments médicaux pour la thermothérapie interstitielle de tissus biologiques
0.2987072765827179 ||| Adults, children aged three years and older and adolescents: ||| Children age 3 years old or over, and adolescents: ||| Adultes, enfants âgés de trois ans ou plus et adolescents:
0.275384783744812 ||| The major route of elimination of cidofovir was by renal excretion of unchanged drug by a combination of glomerular filtration and tubular secretion. ||| After application of the veterinary medicinal product into the ear canal, absorption of miconazole and gentamicin through the skin is negligible. ||| Le cidofovir est éliminé principalement par voie rénale sous forme inchangée, à la fois par filtration glomérulaire et sécrétion tubulaire.
0.6975798606872559 ||| Do not rub the injection site. ||| The FHA is not detoxified. ||| Ne pas frotter le site de l’injection.
0.04029333218932152 ||| If you have the impression that the effect of Glustin 30 mg tablets is too weak, talk to your doctor. ||| If you have the impression that the effect of Actos 15mg tablets is too weak, talk to your doctor. ||| Informez votre médecin si vous avez l'impression que l'effet de Glustin 30 mg, comprimé est trop faible.
0.3328465521335602 ||| The printing ink contains iron oxide black (E172), hypromellose and propylene glycol. ||| - The printing ink contains also shellac, propylene glycol and iron oxide E172, Brilliant Blue FCF E ||| L’ encre contient du noir d’ oxyde de fer (E172), de l’ hypromellose et du propylèneglycol.
0.3295719623565674 ||| The Coronavirus Response Investment Initiative will seek to mobilise all existing EU budget resources to provide financial support to Member States for their immediate response to the Coronavirus crisis and its long-term impact. ||| To make sure Member States can fully count on EU budget support to address the crisis, the Commission proposes to make Coronavirus related expenditure eligible under structural funds. ||| L'initiative d'investissement en réaction au coronavirus vise à mobiliser toutes les ressources existantes du budget de l'UE afin d'apporter un soutien financier aux États membres pour qu'ils puissent répondre immédiatement à la crise provoquée par le coronavirus et à son incidence à long terme.
0.4097433388233185 ||| Can be used during pregnancy. ||| Can be used during pregnancy in ewes. ||| Le produit peut être utilisé pendant la gestation.
0.26891863346099854 ||| Since all of these patients were pre-treated with alkylating agents, available results provide insufficient data on whether Zevalin contributes to an increased risk of myelodysplasia, or on the extent of risk. ||| Due to high inter-patient variability and limited sampling, the results from that study do not allow firm conclusions to be drawn on the impact of bevacizumab on gemcitabine pharmacokinetics. ||| Tous ces patients ayant reçu précédemment des agents alkylants, les résultats actuellement disponibles ne sont pas suffisants pour déterminer si Zevalin contribue à un risque accru de myélodysplasie ou de tirer des conclusions sur l'importance du risque.
0.08761381357908249 ||| 34 AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| Unless continued ARB therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy. ||| A moins que le traitement avec un ARAII soit considéré comme essentiel, il est recommandé de modifier le traitement antihypertenseur chez les patientes qui envisagent une grossesse pour un médicament ayant un profil de sécurité établi pendant la grossesse.
0.2738536596298218 ||| Based on evidence for a primarily hepatic/ biliary elimination of photoactive substances, severity of phototoxic reactions and duration of the period of photosensitivity in patients with any grade of hepatic impairment may be increased. ||| Hepatic elimination plays a relatively large role (~70%) in the overall clearance of Suboxone and the action of buprenorphine may be prolonged in subjects with impaired hepatic clearance. ||| 6 hépatique/ biliaire des substances photoactives, la sévérité des réactions de phototoxicité et la durée de la période de photosensibilité peuvent être augmentées chez les patients ayant une quelconque altération de la fonction hépatique.
0.3468804955482483 ||| Avaglim doses may need to be adjusted when given with certain other medicines such as gemfibrozil or rifampicin. ||| Your doctor may prescribe a different dose of Viraferon alone or in combination with other medicines (e.g. ribavirin). ||| Il peut s’ avérer nécessaire d’ ajuster les doses d’ Avaglim en cas d’ administration concomitante de certains autres médicaments tels que le gemfibrozil ou la rifampicine.
0.24963757395744324 ||| Due to the hydrochlorothiazide component, Rasilez HCT is contraindicated in patients with severe hepatic impairment (see sections 4.3 and 4.4). ||| Calcichew-D3 mite (and associated names) tablets should be used cautiously in immobilised patients with osteoporosis due to increased risk of hypercalcaemia. ||| En raison de la présence du composant hydrochlorothiazide, Rasilez HCT est contre-indiqué chez les patients présentant une insuffisance hépatique sévère (voir rubriques 4.3 et 4.4).
0.5106770992279053 ||| Storage of documents ||| Design of hotels ||| Stockage de documents
0.6440739631652832 ||| - reduction in red blood cells (anaemia) ||| - Sore (open skin infection) on your skin. ||| - diminution du nombre de globules rouges (anémie)
0.35802626609802246 ||| Insecticidal efficacy duration against new infestations with fleas persists for a minimum of 4 weeks. ||| Lymphocytopenia lasting for several months and immunosuppression with an increased risk of infections are expected. ||| L’ efficacité insecticide contre une nouvelle infestation de puces perdure quatre semaines minimum.
5.215871137775885e-13 ||| Further to a request from the European Commission the CHMP reviewed safety data on non-selective NSAIDs. ||| Further to a request from the European Commission the CHMP reviewed safety data on non-selective NSAIDs. ||| Suite à une demande de la Commission européenne, le comité des médicaments à usage humain (CHMP) a examiné les données de sécurité concernant les AINS non sélectifs.
0.1327851116657257 ||| 58 Member State ||| 43 Member State ||| 58 État membre
0.4066658616065979 ||| Infrared thermometers, not for medical purposes ||| Chemically activated heating pads for medical purposes ||| Thermomètres à infrarouges, non à usage médical
0.3631337881088257 ||| In particular, the maximum aid amount does not exceed €800 000 per company. ||| The maximum amount of support shall however not exceed €5,000 per farmer and €50 000 per SME. ||| Plus particulièrement, le montant maximal de l'aide ne dépasse pas 800 000 euros par entreprise.
0.3930746614933014 ||| 3 4.6 Adverse reactions (frequency and seriousness) ||| Adverse reactions (frequency and seriousness) ||| 3 4.6 Effets indésirables (fréquence et gravité)
0.31999707221984863 ||| Monitoring of liver function There have been rare reports of hepatocellular dysfunction during post-marketing experience with rosiglitazone (see section 4.8). ||| Laboratory-diagnostic tests The Coombs test may be false-positive in rare cases during treatment with ceftriaxone (see section 4.4). ||| Surveillance de la fonction hépatique De rares cas de dysfonctionnement hépatocellulaire ont été rapportés pendant la période de commercialisation (voir rubrique 4.8).
0.13754543662071228 ||| Horses should be monitored for oral lesions during treatment. ||| 16 Horse should be monitored for oral lesions during treatment. ||| Pendant le traitement, l'apparition de lésions orales doit être surveillée.
0.3226914703845978 ||| AUC: ↓ 31% (↓ 8 to ↓ 47) Cmin: ↓ 40% A similar reduction in indinavir exposures was observed when indinavir 1.000 mg q8h was given with efavirenz 600 mg daily. ||| AUC: ↑ 32% (↑ 25 to ↑ 38) Cmax: ↔ Cmin: ↑ 51% (↑ 37 to ↑ 66) Higher tenofovir concentrations could potentiate tenofovir-associated adverse events, including renal disorders. ||| Cmin: ↓ 40% Une baisse similaire de l’ exposition à l’ indinavir a été observée lorsque 1000 mg d’ indinavir ont été administrés toutes les 8 heures avec 600 mg d’ efavirenz par jour.
0.3011516034603119 ||| The Emergency Support Instrument (ESI) allows the EU budget to step in to provide emergency support to allow the Union as a whole to address the human and economic consequences of a crisis such as the ongoing pandemic. ||| Under the EUTF, the EU is working closely with all its partners on the ground to ensure equal access to the healthcare system and strive for disease prevention and health promotion especially among the most vulnerable such as populations on the move. ||| L'instrument d'aide d'urgence (ESI) autorise l'intervention du budget de l'UE afin de fournir une aide d'urgence permettant à l'Union dans son ensemble de faire face aux conséquences humaines et économiques d'une crise telle que la pandémie actuelle.
0.2641567587852478 ||| Combination with metformin In controlled clinical trials with the combination of vildagliptin 100 mg daily + metformin, no withdrawal due to adverse reactions was reported in either the vildagliptin 100 mg daily + metformin or the placebo + metformin treatment groups. ||| Study of sitagliptin in combination with metformin and a sulphonylurea A 24-week placebo-controlled study was designed to evaluate the efficacy and safety of sitagliptin (100 mg once daily) added to glimepiride (alone or in combination with metformin). ||| Association avec la metformine Dans les essais cliniques contrôlés avec 100 mg par jour de vildagliptine en association avec la metformine, aucune sortie d’ essai due à des effets indésirables n’ a été observée dans le groupe traité par 100 mg par jour de vildagliptine en association avec la metformine ni dans le groupe traité par le placebo en association avec la metformine.
0.2582642436027527 ||| Frequencies are defined as: rare ≥ 1/ 10,000, < 1/ 1000 and very rare < 1/ 10,000 including isolated reports. ||| Frequencies are defined as very common (≥ 1/ 10) or common (≥ 1/ 100, < 1/ 10). ||| Les fréquences sont définies comme suit: rare ≥ 1/ 10.000, < 1/ 1000; et très rare < 1/ 10.000 incluant des notifications isolées.
0.009847881272435188 ||| Patients are advised not to drive, operate complex machinery or engage in other potentially hazardous activities until it is known whether this medication affects their ability to perform these activities. ||| Patients are advised not to drive, operate complex machinery or engage in other potentially hazardous activities until it is known whether this medicinal product affects their ability to perform these activities. ||| Il est donc conseillé aux patients de ne pas conduire, de ne pas utiliser de machines complexes ni d’entreprendre d'autres activités potentiellement dangereuses, avant d’avoir évalué l’impact éventuel de ce médicament sur leur capacité à effectuer ces activités.
0.5226349234580994 ||| 5 needles. ||| 10 doses. ||| 5 aiguilles.
0.30712440609931946 ||| By blocking the receptors to which angiotensin II normally attaches, irbesartan stops the hormone having an effect, allowing the blood vessels to widen. ||| Under normal circumstances, growth hormone (GH) binds to its receptor in the liver and other tissues, and stimulates the synthesis/ secretion of IGF-1. ||| En bloquant les récepteurs auxquels l’ angiotensine se lie normalement, l’ irbésartan empêche l'hormone de faire effet, ce qui permet une augmentation du diamètre des vaisseaux sanguins.
5.696664385872185e-13 ||| Pfizer Aps Lautrupvang 8 2750 Ballerup Denmark ||| Pfizer Aps Lautrupvang 8 2750 Ballerup Denmark ||| Pfizer Aps Lautrupvang 8
0.1774107664823532 ||| Pharmacotherapeutic group: other antiglaucoma preparations; ATC code: ||| Pharmacotherapeutic group: antimycotics for systemic use, ATC Code: ||| Classe pharmacothérapeutique: autres préparations antiglaucomateuses; Code ATC:
0.14017263054847717 ||| Withdraw 2.1 ml of water for injections into a sterile syringe. ||| Inject 20 ml of sterile water for injections into the vial. ||| Prélever 2,1 ml d'eau pour préparation injectable dans une seringue stérile.
0.20640145242214203 ||| Abseamed 9000 IU/ 0.9 ml injection ||| Abseamed 10 000 IU/ 1 ml injection ||| Abseamed 9 000 UI/ 0,9 ml, injection
0.0147600332275033 ||| Package containing one or four pre-filled pens of a 60 µg Nespo solution for injection in 0.3 ml (200 µg/ ml). ||| Package containing one or four pre-filled pens of a 10 µg Nespo solution for injection in 0.4 ml (25 µg/ ml). ||| Emballage contenant un ou quatre stylos préremplis de Nespo 60 microgrammes, solution injectable de 0,3 ml (200 µg/ ml). éd
0.2996981143951416 ||| In patients who develop severe diarrhoea during or after use of cefuroxime axetil, the risk of life threatening pseudomembranous colitis should be taken into account. ||| Overdose of sulphonylureas, including glimepiride, can result in severe life-threatening hypoglycaemia lasting 12 to 72 hours, which may recur after apparent recovery. ||| Un risque de colite pseudomembraneuse potentiellement fatale doit être pris en compte en cas de survenue d’ une diarrhée sévère pendant ou au décours d’ un traitement par céfuroxime axétil.
0.4283108115196228 ||| When turning the dose selector be careful not to push the push- button as insulin will come out. ||| A clicking sound can be heard, which will stop when the injection button has been pressed. in completely. ||| Lorsque vous tournez le sélecteur de dose, prenez garde à ne pas enfoncer le bouton-poussoir car de l'insuline s'échapperait.
0.11000289022922516 ||| EMEA budgets 1996 to 1998 ||| EMEA budgets 2001 to 2003 ||| Budgets de l’ EMEA de 1996 à 1998
0.21978899836540222 ||| What is the risk associated with Oprymea? ||| is What is the risk associated with Neupopeg? ||| Quel est le risque associé à l’ utilisation d’ Oprymea?
0.2537829279899597 ||| In an animal model of familial adenomatous polyposis (FAP), treatment with two other thiazolidinediones increased tumour multiplicity in the colon. ||| 23 In an animal model for familial adenomatous polyposis (FAP), treatment with rosiglitazone at 200 times the pharmacologically active dose increased tumour multiplicity in the colon. ||| Dans un modèle animal de polypose adénomateuse familiale, un traitement par deux autres thiazolidinediones a augmenté le nombre de tumeurs du colon.
0.023959331214427948 ||| In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter-regulation. ||| In many patients, the signs and symptoms of neuroglycopenia are preceded by signs of adrenergic counter- regulation. ||| 300 Chez de nombreux patients, les signes et symptômes de neuroglycopénie sont précédés par des signes de réaction adrénergique compensatrice.
0.40393608808517456 ||| In clinical trials, the magnitude of HbA 1c reductions with vildagliptin was greater in patients with higher baseline HbA 1c. ||| In clinical trials with different formulations (H5N3, H9N2 and H5N1) 542 subjects were exposed to thecandidate vaccine. ||| Au cours des essais cliniques, l’ amplitude des diminutions des taux d’ HbA 1c avec la vildagliptine a été supérieure chez les patients présentant un taux initial d’ HbA 1c plus élevé.
0.006586457137018442 ||| Your Mixtard 20 NovoLet is designed to work accurately and safely. ||| Your Mixtard 10 NovoLet is designed to work accurately and safely. ||| Votre Mixtard 20 NovoLet est conçu pour fonctionner avec une grande précision et en toute sécurité.
0.20258554816246033 ||| Valtropin treatment should be supervised by a doctor experienced in the management of patients with growth disorders. ||| Therapy with Zeffix should be initiated by a physician experienced in the management of chronic hepatitis B. ||| Le traitement par Valtropin doit être instauré sous la responsabilité d’ un médecin expert dans la prise en charge des patients présentant des troubles de croissance.
0.019325504079461098 ||| EU/ 2/ 99/ 017/ 002 ||| EU/ 2/ 99/ 017/ 001 ||| EU/ 2/ 99/ 017/ 002 IBRAXION
2.4219461072089166e-13 ||| 30 Children and adolescents Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. ||| 30 Children and adolescents Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. ||| 34 Enfants et adolescents L’ utilisation de l’ olanzapine chez les enfants et les adolescents âgés de moins de 18 ans n’ est pas recommandée du fait du manque de données sur la sécurité d’ emploi et l’ efficacité.
0.002083045430481434 ||| 139 If you accidentally take more REYATAZ capsules than your doctor recommended, contact your HIV doctor at once or contact the nearest hospital for advice. ||| 131 If you accidentally take more REYATAZ capsules than your doctor recommended, contact your HIV doctor at once or contact the nearest hospital for advice. ||| Si vous avez pris accidentellement plus de REYATAZ gélules que votre médecin ne l'avait recommandé, vous devez d'abord le contacter ou vous rendre à l'hôpital le plus proche pour obtenir un avis.
0.0 ||| COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) ||| COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) ||| COMITÉ DES MÉDICAMENTS Á USAGE HUMAIN (CHMP)
0.3844429552555084 ||| Sevoflurane may cause a small increase in intracranial pressure (ICP) under conditions of normocapnia. ||| Bortezomib causes reduction of tumour growth in vivo in many preclinical tumour models, including multiple myeloma. ||| Le sévoflurane est susceptible de causer une légère élévation de la pression intracrânienne (PIC) en normocapnie.
0.22772765159606934 ||| Confirmatory clinical trials in treatment-naïve patients All clinical trials recruited interferon-naïve patients with chronic hepatitis C confirmed by detectable levels of serum HCV RNA, elevated levels of ALT (with the exception of study NR16071) and a liver biopsy consistent with chronic hepatitis. ||| Single clinical event suggestive of multiple sclerosis One controlled clinical trial with Extavia was performed in patients with a single clinical event and Magnetic Resonance Imaging (MRI) features suggestive of multiple sclerosis (at least two clinically silent lesions on the T2-weighted MRI). ||| Résumé des essais cliniques chez les patients naïfs Dans tous les essais cliniques, les patients inclus n’avaient jamais été traités par interféron et présentaient une hépatite chronique C confirmée par des taux sériques d’ARN du VHC détectables, des taux d’ALAT élevés (à l’exception de l’étude NR16071) et une biopsie hépatique compatible avec une hépatite chronique.
0.17381301522254944 ||| 29 Latvija SIA Oriola-Rīga Dzelzavas iela 120 M RĪGA LV-1021 Tel.: + 371 7 802 450 ||| Latvija BAXTER AG Latvijas filiāle Dzelzavas iela 117 Rīga, LV 1021 Tel.: +371 67 784 784 ||| Latvija SIA Oriola-Rīga Dzelzavas iela 120 M RĪGA LV-1021 Tel.: + 371 7 802 450
0.4816880226135254 ||| Gently push the tablet out. ||| Slightly pull back the plunger. ||| Pousser doucement le comprimé.
0.22567486763000488 ||| It is recommended that the dosing interval for tenofovir disoproxil 245 mg (as fumarate) is modified in patients with creatinine clearance < 50 ml/ min or in patients who already have ESRD and require dialysis (see section 4.2). ||| Patients may be started on leflunomide 10 mg or 20 mg depending on the severity (activity) of the disease. • The recommended maintenance dose is 20 mg once daily for patients with psoriatic arthritis (see section 5.1). ||| Il est recommandé de modifier l’ intervalle entre les administrations du ténofovir disoproxil 245 mg (sous forme de fumarate) chez les patients dont la clairance de la créatinine est < 50 ml/ min ou chez les patients qui sont déjà en IRT et nécessitent une dialyse (voir rubrique 4.2).
0.4925677180290222 ||| Contains colouring agent E110; see package leaflet for further information. ||| Contains sunset yellow (E 110) (see leaflet for further information) ||| Contient du colorant E110; consulter la notice pour plus d’ informations.
0.7779804468154907 ||| Motor driven windlasses ||| Electric one wheel scooters ||| Guindeaux à moteur
0.05313841253519058 ||| Eucreas is a medicine containing the active substances vildagliptin and metformin hydrochloride. ||| Icandra is a medicine that contains the active substances vildagliptin and metformin hydrochloride. ||| Eucreas est un médicament contenant les principes actifs vildagliptine et chlorhydrate de metformine.
0.10385299474000931 ||| Karvezide 150 mg/ 12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets. ||| Aprovel 300 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film- coated tablets. ||| Karvezide 150 mg/ 12,5 mg comprimés pelliculés sont fournis en conditionnements de 14, 28, 30, 56, 84, 90 ou 98 comprimés pelliculés présentés en plaquettes thermoformées.
0.3099450469017029 ||| Always use EVRA exactly as described in this leaflet. • If you do not, you may increase your risk of getting pregnant • Check with your doctor or pharmacist if you are not sure • Always keep non-hormonal contraceptives (such as condoms, foam or sponge) as a back-up in case you make a mistake when using the patch. ||| It must not be shared with anyone else. • If the injection is given by another person, special caution must be taken by this person to avoid accidental needle injury and transmission of infection. • Never use OptiSet if it is damaged or if you are not sure that it is working properly. • Always have a spare OptiSet in case your OptiSet is lost or damaged. ||| Utilisez toujours EVRA exactement comme cela est décrit dans cette notice. • Si vous ne respectez pas ces consignes, vous pouvez augmenter votre risque d’ être enceinte • Vérifiez auprès de votre médecin ou de votre pharmacien en cas de doute • Gardez toujours des contraceptifs non hormonaux (comme des préservatifs, de la mousse ou une éponge contraceptives) comme solution de secours en cas d’ erreur d’ utilisation de votre patch.
0.4861264228820801 ||| The NeoRecormon pre-filled syringe is ready for use. ||| Each (pre-filled syringe of) Ibaflin Oral Gel contains: ||| Le NeoRecormon seringue préremplie est prête à l’ emploi.
0.013563450425863266 ||| Ireland GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000 ||| Ireland GlaxoSmithKline (Ireland) Limited Tel: + 353 (0)1 4955000 ||| 42 GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000
0.05811334401369095 ||| The full EPAR for Silgard can be found here. ||| The full EPAR for Norvir can be found here. ||| L’ EPAR complet relatif à Silgard est disponible: ici.
0.3075464963912964 ||| Once withdrawn from vial into the syringe, the suspension should be used immediately. ||| While maintaining pressure on the plunger, remove the syringe from the patient. ||| Une fois transferé du flacon dans la seringue, la suspension doit être utilisée immédiatement.
0.023183468729257584 ||| 385 • lung and bronchial infections in children and adolescents suffering from cystic fibrosis • complicated urinary tract infections, including infections that have reached the kidneys (pyelonephritis) • anthrax inhalation exposure ||| • lung and bronchial infections in children and adolescents suffering from cystic fibrosis • complicated urinary tract infections, including infections that have reached the kidneys (pyelonephritis) • anthrax inhalation exposure ||| • infections des poumons et des bronches chez l’enfant et l’adolescent atteint de mucoviscidose • infections urinaires compliquées, y compris les infections ayant atteint les reins (pyélonéphrite) • exposition à la maladie du charbon
0.3576565086841583 ||| 522 Why does hypoglycaemia occur? ||| Why does hypoglycaemia occur? ||| Pourquoi une hypoglycémie survient?
0.4741223454475403 ||| The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia. ||| By blocking the breakdown of cGMP, Viagra restores erectile function. ||| L’ effet prolongé de l’ insuline glargine en sous-cutané peut retarder la récupération d’ une hypoglycémie.
0.5571704506874084 ||| Sodium benzoate 1.5 mg (equivalent to 0.05 mg per drop) ||| Median (25th, 75th percentile) Cumulative Dose (morphine mg equivalents) ||| (soit 0,05 mg par goutte)
0.4432016611099243 ||| The trials did not include a comparison treatment so the results were judged against historical controls (expected results without treatment based on past studies). ||| It is acknowledge that the recommended dose did not result from a dose-finding study but rather from a confirmatory study (the pivotal trial). ||| Les essais ne comportant pas de traitement comparatif, les résultats ont été analysés par rapport à des témoins historiques (résultats attendus sans traitement, basés sur des études passées).
0.14139045774936676 ||| Do not use Soliris after the expiry date which is stated on the label after “EXP”. ||| Do not use after the expiry date, which stated on the label as “EXP” ||| Ne pas utiliser Soliris après la date de péremption mentionnée sur l’ étiquette après « EXP ».
0.5444140434265137 ||| At a time when violations of privacy rules may affect large numbers of individuals simultaneously in several parts of the world, it is time to step up international cooperation between data protection enforcers. ||| And we have seen how public-private partnerships have managed to make many life-saving vaccines available to the poorest people on earth over the last two decades. ||| Alors que les violations des règles en matière de protection de la vie privée peuvent toucher simultanément un grand nombre de personnes dans plusieurs régions du monde, il est temps d'intensifier la coopération internationale entre les instances chargées de veiller à la protection des données.
0.07378363609313965 ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4. ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur (see section 4.4). ||| Les effets d’un surdosage avec GONAL-f ne sont pas connus, néanmoins, chez la femme, un syndrome d’hyperstimulation ovarienne n’est pas exclu (se reporter à la rubrique 4).
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 6 6.6 Précautions particulières d’ élimination et manipulation
0.06501634418964386 ||| 4 Ulcerative colitis 5 mg/ kg given as an intravenous infusion over a 2 hour period followed by additional 5 mg/ kg infusion doses at 2 and 6 weeks after the first infusion, then every 8 weeks thereafter. ||| Ankylosing spondylitis 5 mg/ kg given as an intravenous infusion over a 2-hour period followed by additional 5 mg/ kg infusion doses at 2 and 6 weeks after the first infusion, then every 6 to 8 weeks. ||| Rectocolite hémorragique 5 mg/ kg administrés en perfusion intraveineuse d’ une durée de 2 heures suivis par des perfusions supplémentaires de 5 mg/ kg aux semaines 2 et 6 après la première perfusion, puis ensuite toutes les 8 semaines.
0.0 ||| In Study III, improvement in physical function was maintained through week 260 (60 months) of open-label treatment. ||| In Study III, improvement in physical function was maintained through week 260 (60 months) of open-label treatment. ||| Dans l'étude III, l'amélioration des capacités fonctionnelles était maintenue jusqu'à la semaine 260 (60 mois) du traitement en ouvert.
0.48060107231140137 ||| Adequate supplements of vitamin D and calcium are also recommended for all patients receiving Aclasta. ||| 77 Because Agenerase capsules contain vitamin E, you should not take additional vitamin E supplements. ||| Il est également recommandé que tous les patients traités par Aclasta reçoivent un supplément approprié de vitamine D et de calcium.
0.2424815446138382 ||| Approximately 75% of the administered dose of meloxicam is eliminated via faeces and the remainder via urine. ||| Approximately 90% of 14 C-labelled dose is excreted through the kidneys while less than 2% is found in the faeces. ||| Près de 75% de la dose administrée se retrouvent dans les fèces, le reste étant excrété par voie urinaire.
0.35557979345321655 ||| 71% 41% ||| 54% 50% 61% ||| 41%
0.4723103642463684 ||| The contribution of renal excretion to total clearance in subjects with normal renal function was 65-85%. ||| A study in normal healthy volunteers provided an estimate of the absolute bioavailability of 59%. ||| La contribution de l’ excrétion rénale à la clairance totale chez un sujet à la fonction rénale normale était de 65% - 85%.
0.17916834354400635 ||| During treatment with olanzapine in combination with lithium or divalproex, an increase of ≥ 7% from baseline body weight occurred in 17.4% of patients during acute treatment (up to 6 weeks). ||| Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of  from baseline body weight in 39.9% of 7% patients. ||| Lors de l'association de l'olanzapine au lithium ou au valproate, une augmentation supérieure ou égale à 7% du poids initial est survenue chez 17,4% des patients pendant la phase aiguë du traitement (jusqu'à 6 semaines).
0.18664351105690002 ||| Other information about Azomyr: ||| Other information about Angiox: ||| Autres informations relatives à Azomyr:
0.24156366288661957 ||| The mean baseline blood pressure was approximately 172/ 113 mmHg in each treatment group and decreases of SeSBP/ SeDBP at five weeks were 30.8/ 24.0 mmHg and 21.1/ 19.3 mmHg for irbesartan/ hydrochlorothiazide and irbesartan, respectively (p < 0.0001). ||| In this population, Rasilez HCT 150 mg/ 12.5 mg to 300 mg/ 25 mg provided dose-dependent systolic/ diastolic blood pressure reduction from 20.6/ 12.4 mmHg to 24.8/ 14.5 mmHg, which were significantly superior to the respective monotherapies. ||| La pression artérielle moyenne avant traitement était approximativement de 172/ 113 mmHg dans chaque groupe de traitement et la diminution de la PAS/ PAD à 5 semaines était de 30,8/ 24,0 mmHg et 21,1/ 19,3 mmHg respectivement dans les groupes irbésartan/ hydrochlorothiazide et irbésartan (p < 0,0001).
0.004832365550100803 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA), http: / /www. emea. europa. eu/. ||| Des informations détaillées concernant ce médicament vétérinaire sont disponibles sur le site Web de l'EMEA (European Medicines Agency) http: / /www. emea. europa. eu/.
0.31330931186676025 ||| Following oral administration, the plasma concentration of unchanged lacosamide increases rapidly and reaches Cmax about 0.5 to 4 hours post-dose. ||| Thereafter, plasma levels declined rapidly to below the 10 pg/ ml assay quantitation limit before 1 hour post-administration. ||| Après une administration orale, la concentration plasmatique du lacosamide sous forme inchangée augmente rapidement et la Cmax est atteinte environ 0,5 à 4 heures après l’ administration.
0.40448081493377686 ||| Concomitant administration of lapatinib with capecitabine or trastuzumab did not meaningfully alter the pharmacokinetics of these agents (or the metabolites of capecitabine) or lapatinib. ||| In a Phase Ib study, there were no significant effects of gemcitabine on the pharmacokinetics of erlotinib nor were there significant effects of erlotinib on the pharmacokinetics of gemcitabine. ||| L'administration concomitante du lapatinib avec la capécitabine ou le trastuzumab ne modifie pas significativement la pharmacocinétique de ces médicaments (ou des métabolites de la capécitabine) ou du lapatinib.
0.25440317392349243 ||| Exfoliative dermatitis, acne, skin nodule, alopecia, dry skin Musculoskeletal, connective tissue and bone disorders ||| Haematuria, kidney calculus, increased creatinine, urinary tract infection, dysuria, urinary retention Reproductive system and breast disorders ||| Sueurs Eruption cutanée, prurit, urticaire Dermatite exfoliative, acné, nodule cutané, alopécie, sécheresse cutanée
0.6671788692474365 ||| - 10 x 5 doses: ||| - 400 units (2x200) ||| 20 10 x 5 doses:
0.0 ||| Frequency ||| Frequency ||| Fréquent:
0.3626537621021271 ||| On 1 June 2006, the representative of the MAH notified the EMEA on his intention to request the reexamination of the CVMP opinion in accordance with Article 36(4)2. ||| The Committee did not support the objection of The Netherlands to the summary of product characteristics agreed by the reference and other concerned Member States (OJ C 49, 22.2.2002, p. ||| Le 1er juin 2006, le représentant du TAMM a informé l’EMEA de son intention de demander le réexamen de l’avis du CVMP conformément à l’article 36, paragraphe 42.
0.0 ||| In addition, an updated RMP should be submitted ||| In addition, an updated RMP should be submitted ||| De plus, un PGR actualisé doit être soumis
0.4751623272895813 ||| No treatment-related malformations were seen in the rat. ||| No serious vaccine-related side effects were reported. ||| Aucune malformation liée au traitement n’a été observée chez le rat. m ica
0.4806680977344513 ||| 97 Pharmacotherapeutic group: gonadotrophins, ATC code: ||| Antihistamines – H1 antagonist, ATC code: ||| Classe pharmacothérapeutique: gonadotrophines, code ATC:
0.3848511576652527 ||| EU State aid rules and more specifically the Rescue Aid and Restructuring Guidelines, which are based on article 107(3)(c) TFEU, enable Member States to help companies cope with liquidity shortages and needing urgent rescue aid. ||| Effective monitoring and management introduced under the directive, combined with other EU environmental legislation such as the Urban Waste Water Treatment Directive (1991), led to a drastic reduction in untreated or partially treated municipal and industrial waste water ending up in bathing water. ||| les règles de l'UE en matière d'aides d'État et, plus précisément, les lignes directrices concernant les aides au sauvetage et à la restructuration, qui sont fondées sur l' article 107, paragraphe 3, point c) , du TFUE, permettent aux États membres d'aider les entreprises à faire face à une pénurie de liquidités et à un besoin urgent d'aide au sauvetage.
0.027436666190624237 ||| 284 PACKAGE LEAFLET: ||| 282 PACKAGE LEAFLET: ||| 290 NOTICE:
0.26870208978652954 ||| It is good clinical practice that vaccination should be preceded by a review of the medical history especially with regard to the contraindications and by a clinical examination. ||| Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events) and a clinical examination. ||| La vaccination doit être précédée d’ une recherche des antécédents médicaux notamment concernant les contre-indications et d’ un examen clinique.
3.533681051763604e-13 ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| 29 prolactinémie chez la rate comprenaient une diminution du poids des ovaires et de l’ utérus, des modifications morphologiques de l’ épithélium vaginal et de la glande mammaire.
0.17348530888557434 ||| 32 Eesti Österreich The Medicines Company UK Ltd Tel.: + 800 843 633 26 või +41 61 564 1320 E-mail: ||| Suomi/Finland The Medicines Company UK Ltd Puh./tel. + 800 8436 3326 tai +41 61 564 1320 S-posti: ||| Eesti The Medicines Company UK Ltd Tel.: + 800 843 633 26 või +41 61 564 1320 E-mail:
0.6038177013397217 ||| As of 18 March, the whole world is defined as a high risk area. ||| In the United States, COPD is estimated to be the third leading cause of death in 2011. ||| Depuis le 18 mars, le monde entier est défini comme une zone à haut risque.
0.19377705454826355 ||| Evoltra 1 mg/ ml concentrate for solution for infusion clofarabine ||| Abraxane 5 mg/ml powder for suspension for infusion Paclitaxel ||| Evoltra 1 mg/ ml, solution à diluer pour perfusion clofarabine
0.5778730511665344 ||| Preserving boxes of metal ||| Toughened glass for building ||| Boîtes à conserves métalliques
0.020830737426877022 ||| As the cardiovascular risks of lumiracoxib may increase with dose and duration of exposure, the shortest duration and the lowest effective daily dose should be used. ||| As the cardiovascular risks of etoricoxib may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. ||| En raison de l’ augmentation possible des risques cardiovasculaires du lumiracoxib avec la dose et la durée de traitement, ce médicament doit être prescrit à la dose minimale journalière efficace pendant la période la plus courte possible.
0.19278484582901 ||| One ml of the reconstituted solution contains 4 mg basiliximab. ||| After reconstitution each ml of the solution contains 20 mg degarelix. ||| Un ml de la solution reconstituée contient 4 mg de basiliximab.
0.21626512706279755 ||| Co-administration of rotigotine (3 mg/ 24 h) did not affect the pharmacodynamics and pharmacokinetics of oral contraceptives (0.03mg ethinylestradiol, 0.15mg levonorgestrel). ||| In an interaction study, celecoxib had no clinically relevant effects on the pharmacokinetics of oral contraceptives (1 mg norethistherone / 35 microg ethinylestradiol). ||| L’ administration concomitante de rotigotine (3 mg/ 24 h) n’ a pas affecté la pharmacodynamique et la pharmacocinétique des contraceptifs oraux (0,03 mg d’ éthinylestradiol, 0,15 mg de lévonorgestrel).
0.392119437456131 ||| Fresh mulberries ||| Fresh cranberries ||| Mûres fraîches
0.40518802404403687 ||| In the event of an overdose, general medical supportive measures should be instituted. ||| Close surveillance with regard to immunological reactions is especially important in such situations. ||| En cas de surdosage, une prise en charge médicale globale doit être mise en place.
0.51011723279953 ||| LeukoScan is not recommended for use in children. ||| Therefore is not recommended for paediatric use. ||| L’ utilisation du LeukoScan n’ est pas recommandée chez l’ enfant.
0.2616403102874756 ||| In controlled clinical trials, at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to placebo. ||| In growing rats, there was no evidence of impaired mineralisation even at doses greater than 5,000 times the dose required for osteoporosis treatment. ||| Lors des essais cliniques contrôlés à la dose recommandée de 5 mg par jour, il n’ y a pas eu d’ augmentation de l’ incidence de la somnolence par comparaison avec le placebo.
0.4388921856880188 ||| (μ g/ 0.5 ml) ||| concentration* (g/ dl) ||| utiliser (μ g/ 0,5ml)
0.4764186441898346 ||| Effentora was more effective than placebo in reducing pain in both studies. ||| Dicural was as effective as or slightly more effective than the comparator antibiotics. ||| Effentora s’ est avéré plus efficace que le placebo pour la réduction de la douleur dans les deux études.
0.23707547783851624 ||| Effect of aprepitant on the pharmacokinetics of other agents CYP3A4 inhibition As a moderate inhibitor of CYP3A4, aprepitant can increase plasma concentrations of orally co-administered medicinal products that are metabolised through CYP3A4. ||| Boosted indinavir (indinavir with ritonavir) may have additive pharmacokinetic effects on substances that share the CYP3A4 pathway as both ritonavir and indinavir inhibit the cytochrome P450 enzyme CYP3A4. ||| Effet de l’ aprépitant sur la pharmacocinétique d’ autres médicaments Inhibition du CYP3A4 En tant qu’ inhibiteur modéré du CYP3A4, l’ aprépitant peut entraîner une élévation des concentrations plasmatiques des médicaments également administrés par voie orale et métabolisés par le CYP3A4.
0.28595927357673645 ||| However, caspofungin has been shown to interact with other medicinal products in pharmacological and clinical studies (see below). ||| In pharmacological studies, calcitonin has been shown to have analgesic activity in animal models. ||| Cependant, dans les études pharmacologiques et cliniques (voir ci-dessous), il a pu être démontré que la caspofungine interfère avec d’ autres médicaments.
0.23970258235931396 ||| The schemes aim at enhancing access to liquidity by those companies which are most severely affected by the economic impact of the coronavirus outbreak, thus ensuring the continuation of their activities. ||| The scheme is designed to support the liquidity of SMEs facing temporary difficulties as a result of the outbreak and, thus, remedy a serious disturbance in the Greek economy. ||| Les régimes visent à améliorer l'accès aux liquidités pour les entreprises qui sont le plus durement touchées par l'impact économique de la pandémie de coronavirus, en assurant ainsi la poursuite de leurs activités.
0.18607312440872192 ||| Natural oils for cosmetic purposes ||| Animal oils for industrial purposes ||| Huiles naturelles à usage cosmétique
0.4956575632095337 ||| The Board however also agreed to the release of information by the Agency during the evaluation phase in exceptional circumstances. ||| Appointment of additional experts by the Committees should take place after proper consultation of the Member States. ||| d’ informations par l’ Agence au cours de la phase d’ évaluation dans certaines circonstances exceptionnelles.
0.3298439681529999 ||| However, cases of life threatening pulmonary oedema have been reported with vasodilators (mainly prostacyclin) when used in those patients. ||| Allergic reactions, including anaphylactoid reactions, may occur very rarely (less than 1 per 10,000 doses of vaccine). ||| Néanmoins, des cas d’œ dème pulmonaire mettant en jeu le pronostic vital du patient ont été rapportés avec des vasodilatateurs (principalement la prostacycline) utilisés dans ces situations.
0.2542133927345276 ||| When NEVANAC was compared with placebo, around 70% of the patients using NEVANAC had no signs of inflammation after two weeks, compared with 17% to 59% of those using placebo. ||| One month after the last dose, 91% of the patients receiving Fendrix had protective levels of antibodies against hepatitis B, compared with 84% of those receiving the comparator. ||| Dans le cadre de la comparaison de NEVANAC à un placebo, environ 70% des patients utilisant NEVANAC n’ ont pas présenté de signes d’ inflammation après deux semaines, contre 17 à 59% des patients utilisant le placebo.
0.34950774908065796 ||| - decreased number of cells in the blood, these include white cells (which may occur with a fever), ||| These include a small increase in the number of certain white blood cells called eosinophils (but without any apparent symptoms) and rash. ||| - diminution du nombre de cellules dans le sang, incluant les globules blancs (qui peut se
0.35443153977394104 ||| These findings were observed across species at plasma concentrations ≤ 4 times the clinical exposure. ||| Across all clinical studies, reports of changes in colour vision were rare (< 0.1%). ||| Ces résultats ont été observé d’ une espèce à l’ autre à des concentrations plasmatiques inférieures ou égales à 4 fois celles utilisées en clinique.
0.27505627274513245 ||| The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| To prevent contamination of the dropper tip and solution, care should be taken not to touch the eyelids, surrounding areas or other surfaces with the dropper tip of the bottle. ||| Examinez les cartouches régulièrement et ne pas les utiliser si la suspension présente des grumeaux ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.559255838394165 ||| 5 x 3 ml Humalog Mix50 100 U/ ml KwikPens 2 x (5 x 3 ml) Humalog Mix50 100 U/ ml KwikPens ||| 300 µg / ml + 5 mg/ ml Eye drops, solution Ocular use 300 µg / ml+ 5 mg/ ml Eye drops, solution Ocular use ||| Emballage multiple de 2 boîtes de 5 stylos de 3 ml Humalog Mix50 100 UI/ ml KwikPen.
0.20871706306934357 ||| S. A. ||| S.A. ||| S.A.
0.3333163857460022 ||| The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease. ||| Though no formal healthy volunteer studies have been conducted to confirm a pharmacokinetic interaction, there is currently no reason to believe that this is likely to be a pharmacodynamic interaction. ||| Le rôle de ces porteurs asymptomatiques dans la transmission n’est pas encore totalement connu, cependant des éléments préliminaires suggèrent qu’ils pourraient contribuer à la propagation de la maladie.
2.9826380081032777e-13 ||| The decrease in cetirizine clearance in these elderly volunteers appeared to be related to their decreased renal function. ||| The decrease in cetirizine clearance in these elderly volunteers appeared to be related to their decreased renal function. ||| 30 diminution de la clairance de la cétirizine retrouvée chez les sujets volontaires âgés semble liée à l'altération de leur fonction rénale.
0.5878134965896606 ||| SAFETY The overall safety profile of paroxetine containing medicinal products was reviewed by the CHMP. ||| ‘EudraWatch’ (pharmacovigilance database) was installed during the year and thoroughly tested. ||| SÉCURITÉ Le profil général de sécurité des médicaments contenant de la paroxétine a été réétudié par le CHMP.
7.329444668378871e-13 ||| 60 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 60 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 65 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.2585621178150177 ||| 199 This leaflet was last approved in ||| This leaflet was last approved on XXXXX ||| 221 La dernière date à laquelle cette notice a été approuvée est
0.06716980785131454 ||| EU/ 2/ 08/ 091/ 009 ||| EU/ 2/ 08/ 089/ 020 ||| EU/ 2/ 08/ 091/ 009 Porcilis PCV
0.37473052740097046 ||| Ventilating apparatus for vehicles ||| Mobile heating apparatus ||| Appareils de ventilation pour véhicules
0.26713746786117554 ||| Due to both the potential risk of neonate hypoglycaemia related to metformin and the lack of human data with vildagliptin, Zomarist should not be used during lactation (see section 4.3). ||| Additionally, patients treated with PegIntron and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia (low number of red blood cells). ||| En raison à la fois du risque potentiel d’ hypoglycémie chez le nouveau-né lié à la metformine et de l’ absence de données chez l’ Homme avec la vildagliptine, Zomarist ne doit pas être utilisé pendant l’ allaitement (voir rubrique 4.3).
0.5750503540039062 ||| More frequent monitoring of hepatic function was recommended in all instances. ||| Several measures are commonly used to quantify mortality. ||| Une surveillance plus fréquente de la fonction hépatique a été recommandée dans tous les cas.
0.08320824801921844 ||| Summary of the EMEA work programme 2006 EMEA/ 62913/ 2006 Annex 4 ||| Summary of the EMEA work programme 2006 EMEA/ 62913/ 2006 Annex 1 EMEA structure ||| Résumé du programme de travail 2006 de l’ EMEA EMEA/ 145689/ 2006 Annexe 4
0.0 ||| Information on the prescription status of this product may be found on the label/ outer package. ||| Information on the prescription status of this product may be found on the label/ outer package. ||| Pour toute information relative à la prescription de ce produit, veuillez consulter l’ étiquetage/ emballage extérieur.
0.2851400375366211 ||| Gastrointestinal disorders: vomiting ||| Gastrointestinal disorders Common: flatulence ||| Affections gastro-intestinales: vomissements
0.4842020273208618 ||| What is antibiotic resistance? ||| What is osteoporosis? ||| Qu'est-ce que la résistance aux antibiotiques?
0.4675403833389282 ||| Participation in the work of the scientific committees and their working parties represents a significant workload for all national competent authorities. ||| However, a large part of the secretarial activities for breakout sessions and working parties are shared with the other sectors of the Unit. ||| La participation aux activités des comités scientifiques et de leurs groupes de travail représente une charge de travail considérable pour toutes les autorités nationales compétentes.
0.28653424978256226 ||| In separate pharmacokinetic interaction studies, co-administration of ritonavir (potent CYP3A4 inhibitor) or saquinavir in combination with a booster dose of ritonavir or rifampicin (potent CYP34A inducer) did not result in clinically significant changes of the pharmacokinetics of enfuvirtide. ||| The long elimination half-lives of both fluoxetine and norfluoxetine should be borne in mind (see'Pharmacokinetic properties') when considering pharmacodynamic or pharmacokinetic drug interactions (e. g. when switching from fluoxetine to other antidepressants). ||| Influence des médicaments associés sur le métabolisme de l'enfuvirtide: dans des études distinctes d'interactions pharmacocinétiques, l'administration concomitante de ritonavir (inhibiteur puissant du CYP3A4) ou de saquinavir en association à de faibles doses de ritonavir et de rifampicine (inducteur puissant du CYP3A4) n'a pas entraîné de modifications cliniquement significatives de la pharmacocinétique de l'enfuvirtide.
0.37882858514785767 ||| Rental of machines for the manufacture of corrugated board ||| Gelatine for the manufacture of printing paper ||| Location de machines de fabrication de carton ondulé
0.637771487236023 ||| How does Ebixa work ||| How Ventavis works: ||| Comment Ebixa agit -il
0.2851265072822571 ||| Total clearance of ibandronic acid is low with average values in the range 84-160 ml/ min. ||| The efficacy of prasugrel was independent of the ASA dose (75 mg to 325 mg once daily). ||| La clairance totale de l’ acide ibandronique est faible, avec des valeurs moyennes comprises entre 84 et 160 ml/ min.
0.6104943752288818 ||| - improved insulin sensitivity (by, e. g., removal of stress factors), ||| Symptomatic treatment, e. g., fluid therapy, should be provided. ||| - amélioration de la sensibilité à l'insuline (par exemple, après élimination des facteurs de stress),
0.385283887386322 ||| Overall no additional risk of accumulation is to be assumed in such patients. ||| This appears to be due to reduction of apparent clearance in these patients. ||| Cependant, il ne semble pas y avoir de risque d'accumulation chez ces patients.
0.01980423554778099 ||| 103 HYPERGLYCAEMIA AND HYPOGLYCAEMIA ||| 125 HYPERGLYCAEMIA AND HYPOGLYCAEMIA ||| 106 HYPERGLYCEMIE ET HYPOGLYCEMIE
0.3718816637992859 ||| Mutagenicity and carcinogenic potential Zoledronic acid was not mutagenic in the mutagenicity tests performed and carcinogenicity testing did not provide any evidence of carcinogenic potential. ||| Carcinogenicity/ mutagenicity/ effects on fertility In view of the genotoxicity results, a carcinogenic potential of deferiprone cannot be excluded (see section 5.3). ||| Mutagénicité et potentiel carcinogène L'acide zolédronique ne s'est pas avéré mutagène dans les tests de mutagénicité et les études de carcinogénèse n'ont mis en évidence aucun élément en faveur d'un potentiel carcinogène.
0.26295626163482666 ||| It contains the active substance doxorubicin hydrochloride. ||| Ammonaps contains the active substance sodium phenylbutyrate. ||| Le principe actif est le chlorhydrate de doxorubicine.
0.5988847017288208 ||| Rzymowskiego 28 02-697 Warszawa ||| Mogilska 80 31-546 Krakow Poland ||| Rzymowskiego 28 02-697 Varsovie
0.3195056617259979 ||| In case of incompatibility an adaptor can be used and removed together with the glass syringe immediately after administration ||| - Before each application, the ulcer should be gently rinsed with saline or water to remove residual ||| En cas d’ incompatibilité, un adaptateur peut être utilisé, et retiré immédiatement après administration, en même temps que la seringue en verre.
0.08908770978450775 ||| In patients with moderate renal impairment at baseline, a dose reduction to 75% for a starting dose of 1250 mg/ m2 is recommended. ||| In patients with moderate renal impairment at baseline, no dose reduction is required for a starting dose of 1000 mg/ m2. ||| 5 recommandé de réduire la posologie à 75% pour une dose initiale de 1250 mg/ m².
0.365421861410141 ||| For children from one to five years of age, the dose is 1.25 mg once a day, taken as 2.5 ml syrup or oral solution. ||| Children aged 12 - 23 months: two doses, each of 0.5 ml, with an interval of at least 2 months between doses. ||| Pour les enfants âgés de un à cinq ans, la dose est de 1,25 mg une fois par jour, à prendre sous la forme de sirop ou de solution buvable (quantité à boire:
0.2665153443813324 ||| Today's Regulation also implements some targeted changes to maximise the capacity of credit institutions to lend and to absorb losses related to the Coronavirus pandemic, while still ensuring their continued resilience. ||| The State of Kuwait also reaffirmed its commitment to support all international efforts aimed at expediting the process of manufacturing the vaccine and ensuring its fair distribution to those in need. ||| Le règlement adopté aujourd'hui met également en œuvre certaines modifications ciblées visant à maximiser la capacité des établissements de crédit à prêter, ainsi qu'à absorber les pertes liées à la pandémie de coronavirus, tout en maintenant leur résilience.
0.43028226494789124 ||| This is a common side effect. ||| This reaction can be serious. ||| C’ est un effet secondaire fréquent.
0.00502188503742218 ||| 34 In view of the above, in some clinical situations blood transfusion should be the preferred treatment for the management of anaemia in patients with cancer. ||| 21 In view of the above, in some clinical situations blood transfusion should be the preferred treatment for the management of anaemia in patients with cancer. ||| Compte tenu des résultats cités ci-dessus, la transfusion sanguine devrait être le traitement de choix dans la gestion de l’ anémie des patients cancéreux lors de certaines situations cliniques.
0.4229990243911743 ||| Blood trough levels of tacrolimus should be monitored during the post-transplantation period. ||| 174 Serum potassium levels should be monitored regularly during Nespo therapy. ||| Les concentrations résiduelles sur sang total de tacrolimus doivent être surveillées en période post- transplantation.
0.3559838533401489 ||| Mechanical musical instruments ||| Mechanical pianos ||| Instruments de musique mécaniques
0.30771583318710327 ||| • Don’t stop taking Viread without your doctor’s advice. ||| • Don’ t stop taking Emtriva without talking to your doctor. ||| • N’arrêtez pas de prendre Viread sans avoir consulté votre médecin.
0.35522133111953735 ||| Cotyloid implants made from artificial materials ||| Dental implants made from artificial materials ||| Implants cotyloïdes en matières synthétiques
0.34180498123168945 ||| Because of its short half-life and rapid clearance, the activity of eptifibatide may be halted readily by discontinuing the infusion. ||| In view of the long half-life of amiodarone the potential for drug interaction may exist for weeks after discontinuation of amiodarone. ||| En raison de sa demi- vie courte et de sa clairance rapide, l’ activité de l’ eptifibatide prend pratiquement fin à l’ arrêt de la perfusion.
0.0 ||| Cough ||| Cough ||| Nausées
0.2851463854312897 ||| 48 As with all potent opioids some patients may experience respiratory depression with Fentanyl- ratiopharm, and patients must be observed for this effect. ||| Cancer patients Cancer patients are more likely to suffer from blood clots if receiving erythropoietin medicines, like Silapo (see section 4). ||| Dépression respiratoire Comme avec tous les opioïdes forts, certains patients peuvent présenter une dépression respiratoire sous traitement par Fentanyl-ratiopharm et les patients doivent être surveillés à la recherche de cet effet.
0.025450389832258224 ||| EU/ 1/ 02/ 219/ 048 112 film-coated tablets. ||| EU/ 1/ 02/ 219/ 038 28 film-coated tablets. ||| EU/ 1/ 02/ 219/ 048 112 comprimés pelliculés.
0.3212374448776245 ||| 79 Although there is elimination of radioactivity in urine after administration of radiolabelled etanercept to patients and volunteers, increased etanercept concentrations were not observed in patients with acute renal or hepatic failure. ||| Use in elderly patients, in hepatic impairment and in renal insufficiency Experience with the use of intranasal calcitonin in the elderly has shown no evidence of reduced tolerability or altered dosage requirements. ||| Bien que l’ on détecte de la radioactivité dans les urines après l’ administration d’ etanercept radiomarqué à des patients et à des volontaires sains, aucune augmentation des concentrations d’ etanercept n’ a été observée chez les patients présentant une insuffisance rénale ou hépatique aiguë.
0.4726375937461853 ||| Patients should always take Rapamune consistently, either with or without food. ||| When administering Prac-tic, the user should not smoke, eat or drink. ||| Les patients doivent toujours prendre Rapamune invariablement, soit en dehors, soit au cours d’ un repas.
0.387868732213974 ||| Further dose adjustments should be done based on the clinical response and the occurrence of undesirable effects. ||| The side effects in this section are given with an estimation of the frequency with which they may occur. ||| Les adaptations de doses doivent être réalisées en fonction de la réponse clinique et La survenue d’ effets indésirables.
0.0014138857368379831 ||| 19 It has been proposed that aripiprazole’ s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5HT1a receptors and antagonism of serotonin 5HT2a receptors. ||| 30 It has been proposed that aripiprazole’ s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5HT1a receptors and antagonism of serotonin 5HT2a receptors. ||| L'efficacité de l'aripiprazole dans la schizophrénie et dans les troubles bipolaires de type I pourrait être due à l'association de son activité agoniste partiel sur le récepteur dopaminergique D2 et sérotoninergique 5-HT1a et de son activité antagoniste sur le récepteur sérotoninergique 5-HT2a.
0.30551889538764954 ||| Patients should be instructed to seek medical attention if signs or symptoms of neurotoxicity develop, or if oral dexamethasone is not well tolerated. ||| Patients treated with Aldurazyme should be closely monitored and all cases of infusion-associated reactions, delayed reactions and possible immunological reactions reported. ||| Le patient doit être averti qu’ en cas d’ apparition de signe ou symptôme de neurotoxicité ou de mauvaise tolérance à la dexaméthasone per os, il doit en informer son médecin.
0.006330873351544142 ||| Stop taking Janumet and see a doctor straight away if you notice any of the following symptoms: • feeling sick (nausea) or being sick (vomiting), abdominal pain, muscular cramps, unexplained weight loss, rapid breathing, and feeling cold or uncomfortable. ||| Stop taking Velmetia and see a doctor straight away if you notice any of the following symptoms: • feeling sick (nausea) or being sick (vomiting), abdominal pain, muscular cramps, unexplained weight loss, rapid breathing, and feeling cold or uncomfortable. ||| Arrêtez de prendre Janumet et consultez immédiatement un médecin si vous ressentez l'un des symptômes suivants: • nausées ou vomissements, douleurs abdominales, crampes musculaires, perte de poids inexpliquée, respiration rapide et sensation de froid ou de malaise.
2.7656029593162157e-13 ||| Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin. ||| Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin. ||| 741 Douleurs d'estomac, respiration rapide et profonde, somnolence, voire perte de connaissance, peuvent traduire un état grave (acidocétose) résultant du manque d'insuline.
0.42255014181137085 ||| Machines for scouring ||| Stoves for heating ||| Machines à récurer
0.32469475269317627 ||| Single leaf screens [furniture] ||| Rearview mirrors [vehicle parts] ||| Paravents à un vantail [mobilier]
0.5131238102912903 ||| Terfenadine AUC ↑, associated with a prolongation of QTc intervals. ||| observed following exposure to toremifene, in the form of QT prolongation. ||| ASC Terfénadine ↑, associé à un allongement de l’ espace QT.
0.4607889652252197 ||| A white to slightly yellowish off-white crystalline powder ||| A dark red to reddish brown lyophilised powder or cake. ||| Poudre cristalline blanche à légèrement jaunâtre-blanc cassé
0.10379582643508911 ||| Other side effects include • Systemic allergic reactions Associated symptoms may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema, shortness of breath, a fall in blood pressure with rapid heart beat and sweating. ||| Such reactions to insulin or to the excipients can cause large-scale skin reactions (rash and itching all over the body); severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating. ||| Les symptômes associés peuvent comprendre des réactions cutanées étendues (rash et démangeaison sur l’ensemble du corps), un gonflement sévère de la peau ou des muqueuses (œdème de Quincke), une gêne respiratoire, une diminution de la pression artérielle avec des battements cardiaques rapides et une transpiration abondante.
0.23993456363677979 ||| The studies in children showed that Ziagen, in combination with other antiviral medicines, reduced viral loads to a similar extent to other combinations after 24 weeks. ||| However, in patients continuing to take Januvia or glipizide, the two medicines had similar levels of effectiveness after a year of treatment. ||| Les études chez l’ enfant ont démontré que Ziagen, en association à d’ autres médicaments antiviraux, conduit à une réduction de la charge virale similaire à celle provoquée par d’ autres associations après 24 semaines.
0.10877197235822678 ||| What benefit has Advate shown during the studies? ||| What benefit has Galvus shown during the studies? ||| Quel est le bénéfice démontré par Advate au cours des études?
0.3705339729785919 ||| Maintenance and repair of office buildings ||| Planning and design of residential communities ||| Entretien et réparation d'immeubles de bureaux
0.20633268356323242 ||| Using glucagon ||| Using glucagon du ||| 190 Utilisation de glucagon
4.834271004339197e-13 ||| The treating physician decides on the duration of treatment. ||| The treating physician decides on the duration of treatment. ||| La durée du traitement est fixée par le médecin traitant.
0.4020307660102844 ||| For patients at risk of hyperuricemia, the use of allopurinol should be considered. ||| Therefore, it is recommended to avoid prolonged exposure to sunlight or UV light during treatment with ciprofloxacin. ||| Pour les patients susceptibles de développer une hyperuricémie, l'utilisation de l'allopurinol doit être envisagée.
0.08111098408699036 ||| WHAT INTRONA IS AND WHAT IT IS USED FOR ||| WHAT PREVENAR IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE INTRONA ET DANS QUEL CAS EST-IL UTILISE
0.37624892592430115 ||| Previous treatment with anthracyclines may increase the risk of QT prolongation. ||| Some azoles have been associated with prolongation of the QTc interval. ||| Tout traitement antérieur à base d’ anthracyclines peut accroître le risque de prolongation de l'intervalle QT.
0.21100550889968872 ||| Regulating modules (Electric -) ||| Control installations (Electric -) ||| Modules électriques de régulation
0.34627261757850647 ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| Hepatitis A is distinguished from other viral causes by its prolonged (2–6 week) incubation period and its ability to spread beyond the stomach and intestines into the liver. ||| Le traitement par Binocrit peut être associé à un risque accru de formation post-opératoire de caillots sanguins (troubles vasculaires/ thrombotiques post-opératoires) si votre taux sanguin d’ hémoglobine (pigment rouge du sang) est trop élevé.
0.3827374279499054 ||| With regards to inhalation, intestinal and cutaneous anthrax, EMEA proposed guidelines in 2002 including the recommended use of ciprofloxacin in a first line treatment. ||| Furthermore, the MAH has proposed to change the Product Information (PI), namely separate administration of pneumococcal and meningococcal conjugate vaccines. ||| En ce qui concerne le charbon pulmonaire, intestinal et cutané, l’ EMEA a proposé des directives en 2002, recommandant notamment l’ usage de la ciprofloxacine en traitement de première intention.
0.4851340651512146 ||| MEDAL Program Gastrointestinal Tolerability Results: ||| MEDAL Program Hepatic Safety Results: ||| Résultats de tolérance gastro-intestinale du Programme MEDAL:
0.47220349311828613 ||| Lubricants for aircraft engines ||| Loaders for agricultural machines ||| Lubrifiants pour moteurs d'avion
0.20055381953716278 ||| NutropinAq treatment should be started and supervised by a doctor experienced in the management of patients with growth disorders. ||| Treatment with RILUTEK should only be started by a specialist doctor with experience in the management of motor neurone diseases. ||| Le traitement par NutropinAq doit être instauré et supervisé par un médecin expérimenté dans la prise en charge de patients présentant des troubles de croissance.
0.25968873500823975 ||| In embryotoxicity and teratogenicity studies in mice, dose-related increases in foetal resorption and teratogenicity were observed. ||| Studies in animals have shown reproductive toxicity, consisting of embryotoxicity and teratogenic effects at maternally toxic doses. ||| Dans les études d'embryotoxicité et de tératogénèse chez la souris, l’ augmentation de la résorption fœ tale et de la tératogénicité qui ont été observées étaient dose-dépendantes.
2.968925019025681e-13 ||| Common reported side effects (experienced in more than 1 in 100 but less than 1 in 10 patients) • Skin and allergic reactions Reactions at the injection site may occur (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation). ||| Common reported side effects (experienced in more than 1 in 100 but less than 1 in 10 patients) • Skin and allergic reactions Reactions at the injection site may occur (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation). ||| 126 Effets indésirables fréquents (rapportés chez plus de 1 patient sur 100 mais moins de 1 patient sur 10) • Réactions cutanées et allergiques Des réactions peuvent survenir au point d’ injection (telles que rougeur, douleur d’ intensité inhabituelle lors de l’ injection, démangeaisons, urticaire, œ dème ou inflammation).
0.5000394582748413 ||| Some of the undesirable effects mentioned under section 4.8 may affect the ability to drive or operate machinery. ||| This affects the ability to drive or use machines (see section 4.7). ||| Certains des effets indésirables mentionnés dans la rubrique 4.8 peuvent modifier l’ aptitude à conduire des véhicules ou à utiliser des machines.
0.45696234703063965 ||| Women receiving Foscan must not breast feed for at least one month following injection. ||| EMADINE should not be used for longer than 4 weeks after first opening. ||| Les femmes recevant Foscan ne doivent pas allaiter pendant au moins un mois après l’ injection.
0.003919585607945919 ||| Each pre-filled syringe contains 0.9 ml solution for injection. ||| Each pre-filled syringe contains 0.6 ml solution for injection. ||| Chaque seringue préremplie contient 0,9 ml de solution injectable.
0.0 ||| The specification of breath analysis parameters like linearity, stability (reference gas precision), and precision of measurement are fundamental for the accuracy of the system. ||| The specification of breath analysis parameters like linearity, stability (reference gas precision), and precision of measurement are fundamental for the accuracy of the system. ||| Les spécifications des paramètres de l’analyse respiratoire telles que la linéarité, la 62 stabilité (précision du gaz de référence) et la précision des mesures sont essentielles pour l’exactitude du système.
0.3886041045188904 ||| The rate of genotypically confirmed telbivudine resistance in the pivotal study at 48 weeks was 2.7%. ||| The average absolute bioavailability of adalimumab estimated from three studies following a single 40 mg rod ||| Dans l’ étude clinique pivot, le taux de résistance génotypiquement confirmé à la telbivudine était de 2,7% à 48 semaines.
0.5115768313407898 ||| Leasing of radio telephones ||| Administration of frequent flyer programs ||| Location de radiotéléphones
0.4318150281906128 ||| Transferring a patient to another type or brand of insulin should be done under strict medical supervision. ||| The patient should be transferred to an environment within which full resuscitation facilities are available. ||| Le transfert d'un patient à un autre type d'insuline ou à une autre marque doit se faire sous strict contrôle médical.
0.37416595220565796 ||| 32 compared with healthy subjects; however there were no changes in Cmax and AUC of rivastigmine in subjects with severe renal impairment. ||| IGFBP-3 is reduced in subjects with severe Primary IGFD, resulting in increased clearance of IGF-1 in these subjects relative to healthy subjects. ||| Par contre, chez l’ insuffisant rénal sévère, aucune modification de la Cmax ou de l’ ASC n’ a été retrouvée.
1.1246259212493896 ||| Kjell STRANDBERG Dr Per SJOBERG ||| Gerhard Josef KOTHMANN ||| Sverige Pr Kjell STRANDBERG Dr Per SJOBERG
0.25306686758995056 ||| 20 single doses, 0.5 ml pre-filled syringes with 2 needles each. ||| 1 dose, 0.5 ml pre-filled syringe with a needle guard and 2 needles. ||| 20 seringues préremplies unidoses de 0,5 ml avec 2 aiguilles chacune.
0.13647273182868958 ||| 29 5. ||| 30 5. ||| 5.
0.3196219205856323 ||| The reconstituted solution is isotonic and may be given as a bolus injection or diluted to a volume of 50 ml or greater with normal saline or dextrose 50 mg/ ml (5%) for infusion. ||| It is available as a powder and solvent, which are made up into a solution for injection (1.3 or 5 mg/ ml), or as a ready-to-use solution in a cartridge (3.3 or 6.7 mg/ ml). ||| La solution reconstituée est isotonique et peut être administrée en injection en bolus ou en perfusion diluée dans un volume de 50 ml ou plus de soluté physiologique ou de glucose à 50 mg/ ml (5%) pour perfusion.
0.204019233584404 ||| Typical non-steroidal anti-inflammatory drugs (NSAIDs) side effects such as lesions and bleedings in the alimentary tract, diarrhoea, urticaria, lethargy, inappetence. ||| Typical adverse reactions of non-steroidal anti-inflammatory drugs (NSAIDs) such as loss of appetite, vomiting, diarrhoea, faecal occult blood and apathy have occasionally been reported. ||| Effets indésirables caractéristiques des AINS, tels que lésions du tractus digestif et saignements, diarrhées, urticaire, léthargie, inappétence peuvent apparaître.
0.9343589544296265 ||| Document reproduction ||| and submission ||| Reproduction de documents
0.3622809648513794 ||| Use of Tarceva in patients with severe hepatic impairment is not recommended (see section 5.2). ||| Beta-blockers can mask the signs and symptoms of hypoglycaemia (see section 4.4). ||| L’ utilisation de Tarceva chez les patients ayant une insuffisance hépatique sévère n’ est pas recommandée (voir rubrique 5.2).
0.3574185371398926 ||| • if you are allergic to emedastine or any of the other ingredients. ||| If you have an intolerance to lactose or any other sugars: ||| • si vous êtes allergique à l’émédastine ou à l’un des autres composants.
6.235915104603473e-13 ||| For instructions for preparation see section 6.6. ||| For instructions for preparation see section 6.6. ||| Pour les instructions de préparation, voir section 6.6.
0.2584500312805176 ||| Co-administration of atazanavir with ritonavir in doses greater than 100 mg once daily has not been clinically evaluated. ||| Ritonavir doses higher than 100 mg twice daily have not been studied with darunavir. ||| Atazanavir: la co-administration d’atazanavir et de ritonavir à des doses supérieures à 100 mg une fois par jour n’a pas été évaluée cliniquement.
0.17511238157749176 ||| L10F/ I, L24I, V32I, L33F, M36I, M46I/ L, I47V, I50V, I54L/ M/ S, A71I/ T/ V, G73S, V82A, I84V, and L90M. ||| L10F/ I/ R/ V, K20M/ R, L24I, M46I/ L, F53L, I54L/ T/ V, L63P, A71I/ L/ T/ V, V82A/ F/ T, I84V and L90M. ||| 41 L10F/ I, L24I, V32I, L33F, M36I, M46I/ L, I47V, I50V, I54L/ M/ S, A71I/ T/ V, G73S, V82A, I84V, et L90M.
0.5802963376045227 ||| Remove the plastic packaging from the vial adapter and discard. ||| Clean the injection area with an alcohol wipe. ici ed ||| Retirer l’emballage plastique de l’adaptateur et le jeter.
1.108196496963501 ||| c) The dose of antibiotic is either too low or too high; ||| ed • Eating more than usual • Less exercise than usual. ||| c) la dose d'antibiotiques est trop faible ou trop élevée;
0.38523995876312256 ||| Starlix 120 mg tablets Nateglinide ||| Parareg 90 mg tablet Cinacalcet ||| Starlix 120 mg, comprimés Natéglinide
0.38691914081573486 ||| Doses are lower if the patient has liver problems. ||| The doses need to be lower in patients who have kidney problems. ||| Les doses sont inférieures si les patients souffrent de troubles hépatiques.
0.3001866936683655 ||| Careful attention should be made to clinical signs/ symptoms, tissue biopsies, and laboratory parameters. ||| Monitoring of cardiac and vital signs is recommended, along with appropriate symptomatic and supportive measures. ||| Une attention particulière doit être apportée aux signes/ symptômes cliniques, aux biopsies tissulaires et aux paramètres biologiques.
0.30660033226013184 ||| Attach the plunger rod to the solvent syringe by inserting the rod into the opening in the syringe stopper and pushing and turning the rod firmly until it is securely seated in the stopper. ||| Remove the transparent protective cover from the short end of the sterile double-ended needle, and insert that end of the needle into the solvent vial at the centre of the stopper. ||| Vissez le piston sur la seringue de solvant en l’insérant dans l’ouverture du bouchon de la seringue et en le poussant et le tournant fermement jusqu’à ce qu’il soit correctement placé sur le bouchon.
0.4069001078605652 ||| Invirase may have a minor influence on the ability to drive and use machines. ||| Thus, the ability to drive or to operate machinery may be impaired. ||| Invirase pourrait avoir une influence mineure sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.2830163836479187 ||| If this medicinal product is used mistakenly during pregnancy or the patient becomes pregnant while taking it, the patient should be informed of the potential hazard to the foetus (see section 5.3). ||| Therefore, the benefit of using CEPROTIN during pregnancy or lactation must be judged against the risk for the mother and baby, and should be used only if clearly needed. ||| Si ce médicament est utilisé par erreur pendant la grossesse, ou si la patiente débute une grossesse alors qu'elle est sous traitement, elle doit être informée des risques potentiels pour le fœ tus (voir rubrique 5.3.).
0.22461988031864166 ||| Tilling machines for agricultural use ||| Tilling implements for agricultural use ||| Machines de labourage à usage agricole
1.1043517589569092 ||| 250 mg 500 mg 750 mg 2 mg/ ml 2 mg/ ml 2 mg/ ml 2 mg/ ml ||| 1 x 10 ml 10 x 10 ml 1 x 15 ml 10 x 15 ml 1 x 20 ml 10 x 20 ml ||| 250 mg 500 mg 750 mg 2 mg/ ml
0.27831539511680603 ||| When first starting treatment with Rebif, dose should be gradually escalated in order to allow tachyphylaxis to develop thus reducing adverse reactions. ||| 105 If stopping treatment, as with other antiepileptic medicines, Keppra should be discontinued gradually to avoid an increase of seizures. ||| Au commencement du traitement par Rebif, la dose devra être augmentée progressivement afin de permettre le développement de la tachyphylaxie et, ainsi, réduire les effets indésirables.
0.11308133602142334 ||| Insuman Rapid is administered subcutaneously. ||| Insuman Basal is administered subcutaneously. ||| Insuman Rapid est administré par voie sous-cutanée.
0.33697742223739624 ||| In the clinical program, there were nine cases of accidental extravasation of Myocet, none of which were associated with severe skin damage, ulceration or necrosis. ||| It is unclear if some or all of these episodes correspond to true somnambulism (a parasomnia occurring during non- REM sleep) or to any other specific medical disorder. ||| Dans les essais cliniques, il s’ est produit neuf cas d’ extravasation accidentelle de Myocet, dont aucun n’ a été associé à une ulcération, une nécrose ou une lésion cutanée sévère.
0.013870928436517715 ||| In the event of elevated ALT and/ or AST during treatment, follow- up should be organised and dose reduction should be considered. ||| In the event of elevated ALT and/ or AST during treatment, follow-up should be organised and dose reduction should be considered. ||| La survenue d’ une élévation des ALAT et/ ou des ASAT en cours de traitement doit faire envisager un suivi et éventuellement une réduction posologique.
0.3247244954109192 ||| Nplate is given once a week as an injection under the skin. ||| Lucentis is given as an injection into the affected eye. ||| Nplate est administré une fois par semaine par injection sous la peau.
0.3738586902618408 ||| - the calculated volume of Busilvex must be removed from the vial. ||| Withdraw the total amount of Soliris from the vial(s) using a sterile syringe. ||| la quantité calculée de Busilvex doit être prélevé du flacon.
0.47280025482177734 ||| is 0.56) and the volume of distribution (Vss) is approximately equal to plasma volume (50 ml/ kg). ||| The pH is between 7 and 8 and osmolality is between 300 and 500 mOsm/ kg. ||| La clairance de la darbepoetin alfa est de 1,9 ml/ h/ kg (DS = 0,56) et le volume de distribution (Vd) est approximativement égal au volume plasmatique (50 ml/ kg).
1.0895111560821533 ||| White, biconvex, round, scored tablets. ||| a) Bovine,ovine, caprine, honey bees ||| Comprimés blancs, biconvexes avec une barre de cassure.
0.2338058352470398 ||| 15/ 23 10. ||| 20/ 21 15. ||| 16/ 25 10.
0.40093928575515747 ||| The frequency of undesirable effects listed in the table below is based on the following convention: ||| The adverse reactions reported below are classified according to frequency of occurrence as follows: ||| La fréquence des effets indésirables énumérés dans le tableau est fondée sur la convention suivante:
0.5308802723884583 ||| Pneumatic controls for machines, motors and engines ||| Fuel economisers for motors and engines ||| Commandes pneumatiques pour machines et moteurs
0.4729996919631958 ||| Abatacept is produced by recombinant DNA technology in Chinese hamster ovary cells. ||| – The active substance is insulin human made by recombinant biotechnology. ||| L'abatacept est produit par la technologie de l'ADN recombinant et est exprimé dans des cellules ovariennes de hamster chinois.
0.28878331184387207 ||| Put the outer needle cap back on the needle, and use it to unscrew the needle from the pen. ||| Now press the ampoule firmly over the neck, and break the ampoule away from the coloured dot. ||| Remettez le capuchon extérieur de l’aiguille sur l’aiguille et utilisez le pour dévisser l’aiguille du stylo.
0.21400345861911774 ||| Therefore such medicinal products or foodstuffs should be taken after a period of 2 to 3 hours following ingestion of doxycycline. ||| For this reason, tetracycline preparations should be administered at least two hours before or four to six hours after oral intake of calcium. ||| C’ est pourquoi de tels produits ou médicaments ne doivent être absorbés que dans un intervalle de 2 à 3 heures suivant l’ ingestion de doxycycline.
0.3188680112361908 ||| Patients should be advised to seek medical advice if they experience joint aches and pain, joint stiffness or difficulty in movement. ||| If you develop swallowing difficulties, speech or breathing disorders, please contact medical emergency services immediately or ask your relatives to do so. ||| 5 est conseillé aux patients de solliciter un avis médical s’ ils éprouvent des douleurs et des arthralgies, une raideur articulaire ou des difficultés pour se mouvoir.
0.6249752044677734 ||| Organisation and management of business incentive and loyalty schemes ||| Investment management of and distribution of variable annuities ||| Organisation et gestion de programmes de stimulation et de fidélisation commerciales
0.016376327723264694 ||| 25 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 14 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 28 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.04188155010342598 ||| 229 10. ||| 232 10. ||| 250 10.
0.0 ||| France Merck Lipha Santé s. a. s. ||| France Merck Lipha Santé s. a. s. ||| France Merck Lipha Santé s.a.s.
0.3894534111022949 ||| As coronaviruses are enveloped viruses, washing your hands with soap kills the virus by disrupting the mostly fat-based viral envelope. ||| In the continuous fight for "ecological space", all resistant bacteria are selected as the antibiotic kills the still-susceptible bacteria around them. ||| Étant donné que les coronavirus sont des virus enveloppés, le lavage des mains au savon tue le virus en désorganisant l’enveloppe virale principalement lipidique.
0.294175922870636 ||| Limited data suggest that icatibant exposure is not influenced by hepatic or renal impairment. ||| 28 The glucodynamic response to insulin lispro is not affected by renal or hepatic function impairment. ||| Des données limitées suggèrent que l’ exposition à l’ icatibant n’ est pas influencée par les troubles hépatiques ou rénaux.
0.34203028678894043 ||| 256 The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Insuman cartridges and as recommended in the information provided by the device manufacturer. ||| Instructions for use and handling Humalog Mix50 cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer. ||| Stylo à insuline Les cartouches doivent être utilisées avec un stylo à insuline tel qu'OptiPen ou avec d’ autres stylos compatibles avec les cartouches Insuman et conformément aux instructions du fabricant du dispositif.
0.3630141019821167 ||| The effect of Lysodren on non-functional adrenal cortical carcinoma is not established. ||| Cytotoxic actions of epoetin alfa on bone marrow cells could not be detected. ||| L’ efficacité de Lysodren sur le carcinome corticosurrénalien non fonctionnel n’ est pas établie.
0.4290049076080322 ||| In elderly patients with dementia, more fatal cases have been reported while taking aripiprazole. ||| However, in Europe ovariohysterectomy is most frequently performed in middle aged and old bitches. ||| Chez des personnes âgées souffrant de démence, des cas de décès ont été rapportés plus fréquemment lors de la prise d'aripiprazole.
1.0196764469146729 ||| Wyeth Pharma GmbH Wienburgstr. ||| KG Leipziger Str. ||| Wyeth Pharma
0.1551552712917328 ||| No dose adjustment is required in patients with hepatic impairment (see section 5.2). ||| No initial dose adjustment is considered necessary in patients with renal impairment (see section 5.2). ||| Insuffisance hépatique: aucune adaptation de la dose n’ est nécessaire chez les patients insuffisants hépatiques (voir rubrique 5.2).
0.7297128438949585 ||| Red pepper powder (Gochutgaru) ||| Chinese white liquor (baiganr) ||| Poudre de piment rouge [Gochutgaru]
0.21115079522132874 ||| Multipack comprising 3 cartons, each containing 30 sachets. ||| Multipack comprising 2 packs, each containing 98 capsules. ||| Conditionnement multiple contenant 3 boîtes, chaque boîte contenant 30 sachets.
5.522726915542508e-13 ||| Always keep the vial in the outer carton when you’ re not using it in order to protect it from light. ||| Always keep the vial in the outer carton when you’ re not using it in order to protect it from light. ||| 91 Conserver toujours le flacon dans l’ emballage extérieur, quand vous ne l’ utilisez pas, afin de le protéger de la lumière.
0.2457611858844757 ||| Patients with a family history of or actual defects in glucose-6-phosphate dehydrogenase activity are prone to haemolytic reactions with quinolones, and so ciprofloxacin should be used with caution in these patients. ||| Since glimepiride belongs to the chemical class of sulphonylurea drugs, caution should be used in patients with G6PD-deficiency and a non-sulphonylurea alternative should be considered. ||| Les patients ayant des antécédents familiaux de déficit en glucose-6-phosphate déshydrogénase ou un déficit de cette enzyme sont sujets à des réactions hémolytiques en cas de traitement par quinolones.
0.24450892210006714 ||| Fluids for use in etching glass ||| Acids for use in etching ||| Fluides destinés à la gravure du verre
0.2334357053041458 ||| Doripenem inactivates multiple essential penicillin-binding proteins (PBPs) resulting in inhibition of cell wall synthesis with subsequent cell death. ||| Mode of action Ertapenem inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). ||| Le doripénème inactive plusieurs protéines liant les pénicillines (PLP), ce qui entraîne une inhibition de la synthèse de la paroi cellulaire aboutissant à la mort de la cellule.
0.12865330278873444 ||| Norge Aventis Pharma Norge AS Tlf: +47 67 10 71 00 ||| Norge Aventis Pharma NorgeAS Tlf: +47 67 10 71 00 ||| Norge sanofi-aventis Norge AS Tlf: +47 67 1 0 71 00
0.3742065727710724 ||| Co-administration of efavirenz with medicinal products that alter gastric pH would not be expected to affect efavirenz absorption. ||| Taking Zyrtec with food and drink Food does not affect noticeabily the absorption of cetirizine. ||| La co-administration de l'éfavirenz avec les médicaments modifiant le pH gastrique ne devrait pas affecter l'absorption de l'éfavirenz.
0.3015093207359314 ||| 12 21 ||| 14 12 ||| 8 12 19 21
0.7301609516143799 ||| 104 This leaflet was last approved in {MM/ YYYY}. ||| EXP {MM/ YYYY} See embossed stamp. ||| La dernière date à laquelle cette notice a été approuvée est {MM/ AAAA}
0.030378682538866997 ||| 150 micrograms/0.5 ml ||| 50 micrograms/0.5 ml ||| 150 microgrammes/ 0,5 ml
0.6244097352027893 ||| Lower doses may be necessary for children with kidney failure aged 10 years or below. ||| Dose to be administered two times a day to children aged 3 to 13 ||| Des doses plus réduites peuvent être nécessaires pour les enfants de 10 ans ou moins atteints d’ insuffisance rénale.
0.2434338927268982 ||| Bulgaria notified to the Commission under the Temporary Framework a State aid scheme with an estimated budget of €150 million (approx. BGN 294 million) to support companies affected by the coronavirus outbreak. ||| Greece notified to the Commission a repayable advances scheme amounting to an estimated €1 billion under the Temporary Framework to support companies affected by the coronavirus outbreak. ||| La Bulgarie a notifié à la Commission, au titre de l' encadrement temporaire , un régime d'aides d'État doté d'un budget prévisionnel de 150 millions d'euros (environ 294 millions de leva) visant à soutenir les entreprises touchées par la pandémie de coronavirus.
0.3349730968475342 ||| The use of ciprofloxacin for specific severe infections other than those mentioned above has not been evaluated in clinical trials and the clinical experience is limited. ||| The following groups of patients with cardiovascular disease were not included in clinical trials and the use of tadalafil is therefore contraindicated: ||| L’utilisation de la ciprofloxacine dans ces infections sévères spécifiques autres que les infections mentionnées plus haut n’a pas été évaluée lors des essais cliniques et l’expérience clinique dans ce domaine est limitée.
0.23705758154392242 ||| As with interferon alfa-2b, patients with a history of congestive heart failure, myocardial infarction and/ or previous or current arrhythmic disorders, receiving PegIntron therapy require close monitoring. ||| Patients receiving other medicinal products inhibiting the renin-angiotensin system (RAS), and/ or those with reduced kidney function and/ or diabetes mellitus are at an increased risk of hyperkalaemia during aliskiren therapy. ||| Comme avec l’ interféron alfa-2b, les patients ayant des antécédents d'insuffisance cardiaque congestive, d'infarctus du myocarde et/ ou ayant souffert ou souffrant de troubles du rythme cardiaque, et recevant un traitement par PegIntron doivent être étroitement surveillés.
0.7627725005149841 ||| Patients with known cardiovascular disease have not been studied. ||| Patients who are not controlled by, ||| Les patientes atteintes de maladie cardio-vasculaire connue n’ ont pas été étudiées.
0.7070223689079285 ||| 0.5 ml for the injections at day 7, 9 and 11 of therapy. ||| 2 for treatment days 7, 9 and 11 Use green triple pack No. ||| 0,5 ml pour les injections des jours 7, 9 et 11 du traitement.
0.21995681524276733 ||| At two years 93.4% (p < 0.001) of patients receiving Bonviva 150 mg once monthly and 78.4%, of patients receiving ibandronic acid 2.5 mg daily had total hip BMD increases above or equal to baseline. ||| Similarly, greater proportions of children treated with the abacavir containing combinations had HIV-1 RNA ≤ 50 copies/ ml at 48 weeks (53%, 42% and 28% respectively, p=0.07). ||| A deux ans, 93,4% des patientes ont été définies comme répondeurs sous Bonviva 150 mg une fois par mois versus 78,4% sous acide ibandronique 2,5 mg une fois par jour (p < 0,001).
0.4991692304611206 ||| Our fiscal rules and our economic governance framework are well equipped to deal with the impact of the pandemic, without endangering fiscal sustainability in the medium term. ||| Today we are further bolstering our defences to fight money laundering and terrorist financing, with a comprehensive and far-reaching Action Plan. ||| Nos règles budgétaires et notre cadre de gouvernance économique sont bien conçus pour faire face aux conséquences de la pandémie, sans mettre en péril la viabilité budgétaire à moyen terme.
1.1271724700927734 ||| Invented name ||| Mean Change from ||| Nom inventé
0.8173021078109741 ||| Each bottle contains 60 tablets. ||| Each pack contains: ||| Chaque flacon contient 60 comprimés.
0.5968843102455139 ||| Wardrobes ||| Asbestos ||| Armoires
0.3935924768447876 ||| Common reported side effects (likely to affect between 1 in 10 and 1 in 100 patients): ||| Common (occurring in 1 in 100 to 1 in 10 patients): • chest pain ||| Effets secondaires fréquents (susceptibles de concerner entre 1 patient sur 10 et 1 patient sur 100):
0.43068718910217285 ||| [51 to 69%]), compared with placebo. ||| [87 to 97%]) for the placebo group. ||| 51 à 69%) par rapport au placebo.
0.42220503091812134 ||| The Commission will also continue to assess EU instruments and their possible shortcomings and, where necessary come forward with legislative proposals by 2022 to further strengthen victims' rights. ||| And beyond that, we will continue to support the region, including with the reforms needed on their EU path, as the recovery will only work effectively if the countries keep delivering on their commitments." ||| Par ailleurs, elle continuera d'évaluer les instruments de l'UE et leurs éventuelles lacunes et, le cas échéant, elle présentera des propositions législatives d'ici 2022 afin de renforcer encore les droits des victimes.
0.33475351333618164 ||| Sheets of reclaimed cellulose for wrapping ||| Extruded polythene sheeting for the construction of cloches ||| Feuilles de cellulose régénérée pour l'emballage
0.599933385848999 ||| Therapeutic Indications (SPC section 4.1) ||| Section I (pharmacokinetic and clinical evaluation) ||| Indications thérapeutiques (section 4.1 du RCP)
0.5410027503967285 ||| Transmission of database information via telecommunications networks ||| Arranging subscriptions to telecommunication services for others ||| Transmission d'informations de bases de données via des réseaux de télécommunications
0.366720974445343 ||| A statistically significant decrease in pain intensity was achieved and clinically important decreases in pain occurred more rapidly in patients treated with Rapinyl compared to placebo. ||| The possible contribution of fluid retention to weight gain should be individually assessed as rapid and excessive weight gain has been reported very rarely as a sign of fluid retention. ||| Une diminution statistiquement significative de l’ intensité des douleurs a été obtenue et des diminutions cliniquement importantes des douleurs sont intervenues plus rapidement chez les patients traités par Rapinyl que chez ceux ayant reçu un placebo.
0.4781114161014557 ||| Cruise operators should take overall responsibility for arranging the repatriation of passengers and crews from their cruise ships, including from non-EU ports. ||| Member States should facilitate the transit of EU and third-country fishermen who are EU residents so that they may return home. ||| Les exploitants de navires de croisière devraient assumer la responsabilité globale de l'organisation du rapatriement des passagers et des équipages se trouvant à bord de leurs navires, y compris à partir de ports de pays tiers.
0.23836082220077515 ||| Also contains: maltitol, preservatives E216, E218. ||| Other ingredients include E216, E218 and maltitol. ||| Autres composants: maltitol, conservateurs E216, E218.
0.32951614260673523 ||| Predictability of sustained virological response in naïve patients Virological response by week 12, defined as a 2-log viral load decrease or undetectable levels of HCV RNA has been shown to be predictive for sustained response (Table 8). ||| Intravenous route Measurement of erythropoietin following multiple dose intravenous administration revealed a half-life of approximately 4 hours in healthy volunteers and a somewhat more prolonged half-life of approximately 5 hours in renal failure patients. ||| Pronostic de réponse virologique prolongée chez les patients naïfs La réponse virologique à la 12ème semaine, définie par une diminution de 2 log de la charge virale ou un niveau indétectable d’ ARN-VHC s’ est avérée être un facteur prédictif de réponse prolongée (Tableau 8).
0.2971773147583008 ||| As with all bisphosphonates, patients taking Zometa may be at risk of osteonecrosis (death of bone tissue) in the jaw. ||| By preventing this clumping, antiplatelet medicinal products reduce the chances of blood clots forming (a process called thrombosis). ||| Comme dans le cas de tous les bisphosphonates, Zometa peut provoquer une ostéonécrose (mort du tissu osseux) au niveau de la mâchoire.
0.7559088468551636 ||| Adverse reactions in these two pivotal studies are summarised in Table 2. ||| These aims equate to four phases; specific actions involved in each of these phases are: ||| Les réactions indésirables de ces deux essais pivots sont résumées dans le tableau 2.
0.26622581481933594 ||| Sixty-three patients received a starting dose of 50 mg of SUTENT orally, once daily for 4 consecutive weeks followed by a 2-week rest period, to comprise a complete cycle of 6 weeks (schedule 4/ 2). ||| Overall, in the two studies taken together, patients taking Volibris at a dose of 5 mg once a day could walk an average of 44.6 m further after 12 weeks of treatment, from a baseline of around 345 m at the start of the study. ||| Soixante-trois patients ont reçu 50 mg de SUTENT par voie orale, à raison d’ une prise par jour pendant 4 semaines consécutives, suivies d’ une fenêtre thérapeutique de 2 semaines, correspondant à un cycle complet de 6 semaines (schéma posologique 4/ 2).
0.3546523451805115 ||| Do not use Yttriga: ||| Do not use Nonafact: ||| N’ utilisez jamais Yttriga
0.03349021449685097 ||| • You must not take Truvada during pregnancy unless specifically discussed with your doctor. ||| • You must not take Viread during pregnancy unless specifically discussed with your doctor. ||| • Vous ne devez pas prendre Truvada pendant une grossesse, sauf si vous en avez spécifiquement discuté avec votre médecin.
0.38894152641296387 ||| The main measure of effectiveness was the time taken before the disease started to get worse or the patient died. ||| This is very important because the amount of virus may start to increase if the medicine is stopped for even a short time. ||| Le principal critère d’ évaluation de l’ efficacité était la durée précédant l’ aggravation de la maladie ou le décès du patient.
0.17849186062812805 ||| Step 2: ||| Step 3: ||| Étape 2:
0.30458343029022217 ||| As each dose may contain undetectable traces of neomycin, streptomycin and polymyxin B, caution should be exercised when the vaccine is administered to subjects with hypersensitivity to these antibiotics. ||| Because the naloxone in the combination tablet precipitated withdrawal in individuals dependent on heroin, methadone, or other full agonists, Suboxone is expected to be less likely to be diverted for intravenous use. ||| Chaque dose pouvant contenir des traces indétectables de néomycine, streptomycine et polymyxine B, il convient d'utiliser ce vaccin avec précaution chez les sujets présentant une hypersensibilité à ces antibiotiques.
0.26874595880508423 ||| As for NSAIDs, the risk of acute renal insufficiency, which is usually reversible, may be increased in some patients with compromised renal function (e. g. dehydrated patients or elderly patients)when ACE inhibitors or angiotensin II receptor antagonists are combined with NSAIDs, including celecoxib. ||| The long-term cardiovascular toxicity in children exposed to celecoxib has not been evaluated and it is unknown if the long-term risk may be similar to that seen in adults exposed to celecoxib or other COX-2 selective and non-selective NSAIDs (see section 4.4; cardiovascular effects.). ||| Comme pour les AINS, le risque d’ insuffisance rénale aiguë, généralement réversible, peut être augmenté chez certains patients ayant une fonction rénale altérée (par exemple: patients déshydratés ou patients âgés) lors de l’ association des IEC ou des antagonistes des récepteurs de l’ angiotensine II avec les AINS, y compris le célécoxib.
0.5785356760025024 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Firmagon to Ferring Pharmaceuticals A/ S on 17 February 2009. ||| Manufacturing Authorisation issued on 21.06.2001 by Agence Nationale du Médicaments Vétérinaire, France. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Firmagon à Ferring Pharmaceuticals A/ S le 17 février 2009.
0.39900314807891846 ||| (v) Short-term export credit insurance: The Framework introduces additional flexibility on how to demonstrate that certain countries are not-marketable risks, thereby enabling short-term export credit insurance to be provided by the State where needed. ||| With respect to aid for coronavirus-related R&D, (i) the aid is considered necessary in order for the company to engage in this R&D activity; and (ii) rules on eligible costs and eligible categories of research eligible are respected. ||| v) aides sous forme d'assurance-crédit à l'exportation à court terme: l'encadrement prévoit également davantage de souplesse quant à la manière de démontrer que les risques ne sont pas cessibles dans certains pays, ce qui permet aux États membres de fournir une assurance-crédit à l'exportation lorsque cela est nécessaire.
0.5410705208778381 ||| BOTTLE LABEL FOR ORAL SUSPENSION ||| REFACTO AF SOLVENT PRE-FILLED SYRINGE LABEL ||| ETIQUETTE FLACON – SUSPENSION BUVABLE
0.13154862821102142 ||| 2 to 15 years old ||| 6 to 14 years old ||| De 2 à 15 ans
0.5923730134963989 ||| C. whereas the global and European spread of COVID-19 has already tragically cost the lives of many thousands of people in Europe and the world, causing irreparable damage and confining over a billion people to their homes; ||| This virus has caused devastation and pain in all corners of the world, locking us away from the touch of the people we love, the joy of the things we usually do and the sights of the places we want to be. ||| C. considérant que la pandémie mondiale et européenne de COVID-19 a déjà eu pour conséquence dramatique la mort de plusieurs milliers de personnes en Europe et dans le monde, qu'elle cause des préjudices irréparables et force au confinement à domicile de plus d'un milliard de personnes;
0.4804303050041199 ||| Characteristics in patients Gender: ||| b) Characteristics in patients: ||| Caractéristiques des patients Sexe:
0.42715001106262207 ||| Under no circumstances should you attempt to inject yourself unless you have been trained to do so. ||| Do not attempt to inject yourself unless you are sure you understand everything fully. ||| Vous ne devez en aucun cas procéder à une auto-injection sans avoir reçu au préalable une formation appropriée.
0.424415647983551 ||| • Clinical Description ||| • Clinical Management ||| • Description clinique
3.3042289065456087e-13 ||| Uncommon Arthralgia, arthritis, myalgia, muscle cramp, musculoskeletal pain ||| Uncommon Arthralgia, arthritis, myalgia, muscle cramp, musculoskeletal pain ||| Peu fréquent Arthralgie, arthrite, myalgies, crampes musculaires, douleurs musculo-squelettiques
0.43883752822875977 ||| Nplate is given once a week as an injection under the skin. ||| Livensa is used as a continuous treatment, as one patch twice a week. ||| Nplate est administré une fois par semaine par injection sous la peau.
0.5846191644668579 ||| As the crisis evolves, many businesses will also need capital to stay afloat. ||| It is severely hitting completely healthy companies because public life has shutdown. ||| À mesure que la crise évoluera, de nombreuses entreprises auront également besoin de fonds propres pour rester à flot.
0.015957964584231377 ||| D Remove the protective tab from a new disposable needle. ||| C Remove the protective tab from a new disposable needle. ||| 129 D Retirez l’ onglet de protection d’ une aiguille neuve à usage unique.
0.33410221338272095 ||| The aim is to ensure that sufficient liquidity remains available to businesses of all types and to preserve the continuity of economic activity during and after the outbreak, while making sure that support for businesses in one Member State does not undermine the European single market. ||| From this year, fish stocks are to be managed in line with the maximum sustainable yield target, namelythe maximum amount of fish that fishers can take out of the sea without compromising the regeneration and future productivity of the stock. ||| Elle entend faire en sorte que toutes les catégories d'entreprise puissent disposer de liquidités suffisantes et préserver la continuité de l'activité économique pendant et après la pandémie, tout en s'assurant que le soutien aux entreprises dans un État membre ne nuira pas au marché unique européen.
0.058096274733543396 ||| 3 Paediatrics The experience in children is limited, therefore no recommendation for treatment of paediatric patients with HYCAMTIN can be given (see sections 5.1 and 5.2). ||| Paediatrics The experience in children is limited, therefore no recommendation for treatment of paediatric patients with HYCAMTIN can be given (see section 5.1). ||| Pédiatrie Les données chez l’ enfant sont limitées, c’ est pourquoi aucune recommandation de traitement par HYCAMTIN dans la population pédiatrique ne peut être apportée (voir rubriques 5.1 et 5.2).
0.20864921808242798 ||| Single doses up to 20 mg/ kg have been administered without toxic effects. ||| Doses of up to 150 mg/ kg/ day have been used with good tolerability. ||| Des doses uniques allant jusqu’ à 20 mg/ kg ont été administrées sans effets toxiques.
0.21959134936332703 ||| 7.5 µg ||| 180 µg ||| 7,5 µg
0.07124636322259903 ||| 24 Pregnancy and breast-feeding You should not use TYSABRI if you are pregnant unless you have discussed this with your doctor. ||| Pregnancy and breast-feeding You should not use ABILIFY if you are pregnant unless you have discussed this with your doctor. ||| Grossesse et allaitement Vous ne devez pas utiliser TYSABRI si vous êtes enceinte, sauf si vous en avez discuté au préalable avec votre médecin.
0.37575626373291016 ||| Important information about some of the ingredients of Tamiflu Before you take Tamiflu, make sure your prescribing doctor knows if you have hereditary fructose intolerance. ||| If you become pregnant while taking Clopidogrel Winthrop, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant. ||| Informations importantes concernant certains composants de Tamiflu Avant de prendre Tamiflu, assurez -vous que votre médecin sait si vous avez une intolérance héréditaire au fructose.
0.38770753145217896 ||| Manufacturer Catalent UK Packaging Ltd Lancaster Way Wingates Industrial Park Westhoughton BL5 3XX United Kingdom ||| Encysive (UK) Limited Regus House Highbridge Industrial Estate Oxford Road Uxbridge UB8 1HR United Kingdom ||| Catalent UK Packaging Ltd (importateur) Lancaster Way Wingates Industrial Park Westhoughton BL5 3XX Royaume-Uni
0.06961396336555481 ||| One pre-filled syringe of 3 ml solution contains 3 mg ibandronic acid (as 3.375 mg ibandronic acid, monosodium salt, monohydrate). ||| One vial with 2 ml concentrate for solution for infusion contains 2 mg ibandronic acid (as 2.25 mg ibandronic acid, monosodium salt, monohydrate). ||| Une seringue pré-remplie contient 3 mg d’ acide ibandronique (sous forme de 3,375 mg d’ ibandronate monosodique monohydraté) dans 3 ml de solution.
0.4848882257938385 ||| Ketek tablets are not recommended for use in children and adolescents less than 12 years old. ||| When Optimark was used in children aged 2 or older they had similar side effects as in adults. ||| Il est déconseillé d’utiliser Ketek chez l’enfant et l’adolescent de moins de 12 ans.
0.02123451977968216 ||| 40 6.4 Special precautions for storage ||| 39 6.4 Special precautions for storage ||| 6.4 Précautions particulières de conservation
0.35898491740226746 ||| Available pharmacokinetic data preclude conclusions regarding the relationship between plasma levels of total/ free doxorubicin and its influence on the efficacy/ safety of Myocet. ||| The results show that Nifedipine Retard demonstrates both a comparable antihypertensive effect and a comparable effect on the above-mentioned composite end-point. ||| Les données pharmacocinétiques disponibles excluent toute conclusion relative à la relation entre les concentrations plasmatiques de la doxorubicine totale/ libre et son influence sur l’ efficacité/ tolérance de Myocet.
0.7035590410232544 ||| 191 9904 ||| Study 0102 ||| 191
0.1220073327422142 ||| Insuman doses might also need to be adjusted when it is given with other medicines that may have an effect on blood glucose levels. ||| Insulin Human Winthrop doses might need to be adjusted when it is given with other medicines that may have an effect on blood glucose levels. ||| Les doses d'Insuman peuvent également nécessiter un ajustement lorsque le produit est administré en association à d’ autres médicaments pouvant avoir un effet sur les niveaux de glucose sanguin.
0.4719083905220032 ||| Reprographic instruments ||| Holographic projectors ||| Instruments de reprographie
0.7682043313980103 ||| Adverse reactions reported with the use of irbesartan alone General disorders and administration site conditions: ||| Discontinued due to adverse reactions/ intercurrent † illness/ labs ||| Peu fréquents: douleur thoracique Troubles généraux et anomalies au site d'administration:
0.2612682580947876 ||| Usually, side effects are observed within the first week after treatment and are temporary in nature. ||| Most side effects were mild or moderate in intensity and happened within the first two weeks of treatment. ||| Généralement, les effets indésirables se manifestent au cours de la première semaine suivant le traitement et sont de nature transitoire.
0.6729072332382202 ||| Conducting of medical examinations ||| Conducting technical project studies ||| Réalisation d'examens médicaux
0.5928835868835449 ||| The therapeutic benefit should regularly (at least every three months) be reassessed. ||| Treatment should be reassessed regularly on a case-by-case basis. ||| Le bénéfice thérapeutique devra être réévalué régulièrement (au moins tous les 3 mois).
0.2510922849178314 ||| Fluoxetine/ Emtricitabine Fluoxetine/ Tenofovir disoproxil fumarate CARDIOVASCULAR AGENTS Calcium Channel Blockers ||| Simvastatin/ Emtricitabine Simvastatin/ Tenofovir disoproxil fumarate HORMONAL CONTRACEPTIVES ||| Fluoxétine/ Emtricitabine Fluoxétine/ Fumarate de ténofovir disoproxil
0.633961021900177 ||| In these cases observation is recommended. ||| This approach is considered acceptable. ||| Dans de tels cas, une période d’ observation est recommandée.
0.7133883237838745 ||| EU/ 1/ 06/ 363/ 006 - 56 film-coated tablets (blisters) EU/ 1/ 06/ 363/ 009 - 60 x 1 film-coated tablets (unit-dose blisters) EU/ 1/ 06/ 363/ 003 - 60 film-coated tablets (bottle) ||| Month 1 __/__/__ 3 film-coated tablets Month 2 __/__/__ 3 film-coated tablets Month 3 __/__/__ 3 film-coated tablets Note down the date you take your tablet Open ||| EU/ 1/ 06/ 363/ 006 - 56 comprimés pelliculés (plaquette thermoformée) EU/ 1/ 06/ 363/ 009 - 60 x 1 comprimés pelliculés (plaquette thermoformée unidose) EU/ 1/ 06/ 363/ 003 - 60 comprimés pelliculés (flacon)
0.2085135281085968 ||| 0.84 ± 0.39 ||| 0.16 ± 0.10 ||| 0,84 ± 0,39
0.2477337270975113 ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| In order to preserve renal blood flow, prolonged episodes of hypotension (mean arterial pressure below 60 mmHg) should be avoided in dogs during sevoflurane anaesthesia. ||| Le traitement par Binocrit peut être associé à un risque accru de formation post-opératoire de caillots sanguins (troubles vasculaires/ thrombotiques post-opératoires) si votre taux sanguin d’ hémoglobine (pigment rouge du sang) est trop élevé.
0.6448239088058472 ||| Please read the package leaflet before use. ||| In correspondence please quote the batch number. ||| Veuillez lire la notice avant utilisation.
0.24243299663066864 ||| Following oral administration, the plasma concentration of unchanged lacosamide increases rapidly and reaches Cmax about 0.5 to 4 hours post-dose. ||| Following oral administration, pioglitazone is rapidly absorbed, and peak plasma concentrations of unchanged pioglitazone are usually achieved 2 hours after administration. ||| Après une administration orale, la concentration plasmatique du lacosamide sous forme inchangée augmente rapidement et la Cmax est atteinte environ 0,5 à 4 heures après l’ administration.
0.49074989557266235 ||| Renal excretion does not contribute to the clearance of telmisartan. ||| Co-administration of lithium and losartan should be undertaken with caution. ||| L’ excrétion rénale n’ intervient pas dans la clairance du telmisartan.
0.6652176380157471 ||| Snow removal services ||| Heartworm prevention ||| Services de déneigement
0.39273834228515625 ||| Weatherproofing coatings [chemical, other than paints] for masonry ||| Winding spools, not of metal, non-mechanical, for flexible hoses ||| Revêtements d'étanchéité chimiques autres que peintures destinés à la maçonnerie
0.40117013454437256 ||| Vericore Ltd., Kinnoull Road Kingsway West Dundee DD2 3XR United Kingdom ||| Almac Pharma Services Limited 20 Seagoe Industrial Estate Craigavon, Co Armagh BT63 5QD United Kingdom ||| Vericore Ltd., Kinnoull Road Kingsway West Dundee DD2 3XR Royaume-Uni
0.09542232751846313 ||| Neulasta is not recommended for use in children, due to a lack of information on its safety and effectiveness in this group. ||| Sprimeo is not recommended for children, due to a lack of information on safety and effectiveness in this group. ||| Neulasta n’ est pas recommandé chez l’ enfant en raison d’ un manque d’ informations concernant la sécurité et l’ efficacité au sein de ce groupe.
0.36017221212387085 ||| Once the vacuum is broken, remove the vial stopper while holding the vial upright to prevent loss of product. ||| The plastic cap must be removed from the vial and the stopper disinfected with alcohol. ||| Une fois que le vide n’ est plus assuré, retirer le bouchon du flacon tout en maintenant le flacon droit afin d’ éviter toute perte de produit.
0.4564431607723236 ||| Vertigo, paraesthesia, tremor, balance disorder, burning sensation, dysgeusia, ageusia ||| grand mal convulsion, syncope, dyskinesia,, dizziness postural, ||| paresthésies, tremblements, trouble de l’ équilibre, sensation de brûlure, dysgueusie, agueusie
0.3293203115463257 ||| Approximately 70% of the administered human dose is excreted in the urine, mainly as conjugates of gemfibrozil and its metabolites. ||| Radiochemical purity of the radiolabelled preparation applies as long as more than 95% of yttrium-90 is incorporated into the monoclonal antibody. ||| Près de 70% de la dose humaine administrée sont excrétés dans l'urine, essentiellement sous forme conjuguée et de métabolites.
0.040788039565086365 ||| ------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only ||| --------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only: ||| --------------------------------------------------------------------------------------------------------------------------- Les informations suivantes sont destinées exclusivement aux professionnels de santé.
0.041993968188762665 ||| Dose titration with rosiglitazone (added to the optimal dose of metformin) may be considered before the patient is switched to AVANDAMET. ||| Dose titration with pioglitazone (added to the optimal dose of metformin) should be considered before the patient is switched to Glubrava. ||| Une adaptation de la dose de rosiglitazone (en association à la dose optimale de metformine) pourra être envisagée avant de passer à AVANDAMET.
0.32991406321525574 ||| Tel: +356 2540 2600 medinfo_mt@merck. com ||| Simi: +354 520 8600 ISmail@merck. com ||| Tel: +356 2397 6000 medinfo_mt@merck.com
0.2679485082626343 ||| - Phenytoin, carbamazepine or phenobarbital, treatments for epilepsy and other conditions ||| - phenytoin or phenobarbital, used to treat epilepsy ||| - La phénytoïne, la carbamazépine ou le phénobarbital, des traitements pour l’ épilepsie et d’ autres
0.29682105779647827 ||| The vaccination schedule should be completed at least 4 weeks before the start of laying. ||| It is recommended that vaccinations are given at least one month before the tick season. ||| Le schéma vaccinal doit être complété au moins 4 semaines avant l’ entrée en ponte.
0.4215071201324463 ||| 1 cartridge containing 2 ml solution for injection ||| Solution for injection, 5 x 3ml cartridges ||| 1 cartouche contenant 2 ml de solution injectable.
0.32658326625823975 ||| Also, you should not be vaccinated with live viral vaccines during treatment and for at least 12 months after you have finished your treatment. ||| If you have not responded to treatment after this period, your treatment may carry on for at least 18 months. ||| En outre, vous ne devez pas être immunisé(e) par des vaccins vivants atténués durant le traitement et pendant les 12 mois qui suivent.
0.7062275409698486 ||| Imitation toilet preparations being toys ||| Miter sanders being hand tools ||| Imitations de produits de toilette [jouets]
0.2206697165966034 ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| If it is almost time for the next dose, leave out the missed dose and continue with the next dose of your regular routine. ||| Cependant, s’ il est l’ heure de la prise suivante, sautez la prise oubliée et ne prenez qu’ une seule dose comme d’ habitude.
0.24382974207401276 ||| SOMAVERT 20 mg powder and solvent for solution for injection. ||| Kepivance 6.25 mg powder for solution for injection. ||| SOMAVERT 20 mg poudre et solvant pour solution injectable
0.2543787956237793 ||| • If you have HIV infection and hepatitis B, it is especially important not to stop your Truvada treatment without talking to your doctor first. ||| 83 If you do become pregnant during the treatment with Revlimid, you must stop the treatment and inform your doctor immediately. ||| • Si vous avez une infection par le VIH et une hépatite B, il est particulièrement important que vous n’arrêtiez pas votre traitement par Truvada sans vous en entretenir auparavant avec votre médecin.
0.22529394924640656 ||| Aldurazyme is used for enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis I (MPS I; α -L-iduronidase deficiency) to treat the non-neurological symptoms of the disease (not connected with the brain or nerves). ||| Erbitux is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic colorectal cancer • in combination with chemotherapy • as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecan. ||| Aldurazyme est indiqué en tant que traitement enzymatique substitutif chez les patients pour lesquels un diagnostic confirmé de mucopolysaccharidose de type I (MPS I, déficit en α -L-iduronidase) a été établi, afin de traiter les symptômes non neurologiques de la maladie (non connectés au cerveau ni aux nerfs).
0.4726507067680359 ||| Investigations Common: weight increased, blood creatinine phosphokinase increased ||| Investigations Blood lactate dehydrogenase increased Blood creatinine increased ||| prise de poids, augmentation de la créatine phosphokinase sanguine
0.258431613445282 ||| VIRAMUNE must not be readministered to patients who have required permanent discontinuation for severe rash, rash accompanied by constitutional symptoms, hypersensitivity reactions, or clinical hepatitis due to nevirapine. ||| Somatropin therapy should be discontinued if evidence of tumour growth develops. • During acute critical illness due to complications following open-heart or abdominal surgery, multiple accidental trauma, or in case of acute respiratory failure. ||| VIRAMUNE ne doit pas être ré-administré aux patients chez qui le traitement a été interrompu définitivement à la suite d’ une éruption cutanée sévère, d’ une éruption cutanée accompagnée de symptômes généraux, de réactions d’ hypersensibilité ou de manifestations cliniques d’ hépatite liées à l’ administration de névirapine.
0.31999266147613525 ||| This means that it is injected through a short injection needle into the fatty tissue just under your skin. ||| The vaccine is given by injection into a muscle in the neck, in the area behind the ear. ||| Cela signifie qu’il est injecté à l’aide d’une aiguille courte dans le tissu graisseux juste sous la peau.
0.36646851897239685 ||| Your doctor may consider reducing the infusion rate of Erbitux to manage these symptoms. ||| Your doctor may consider giving you an alternative medicine or changing the dose of the protease inhibitors. ||| Votre médecin pourra envisager de réduire le débit de la perfusion d’ Erbitux dans le cadre de la prise en charge de ces symptômes.
0.2667706608772278 ||| If this is not possible the doses of SUTENT may need to be reduced to a minimum of 37.5 mg daily, based on careful monitoring of the tolerability. ||| Based on the limits of exposure available from observation in clinical trials, it is recommended not to co-administer to adults more than 1200 IU vitamin E per day. ||| Si cela n’ est pas possible, la dose de SUTENT pourra être diminuée jusqu’ à une dose minimale de 37,5 mg par jour, sous étroite surveillance de la tolérance.
0.2139466404914856 ||| No dosage adjustment is necessary in elderly patients. ||| No dosage adjustment of Stalevo is required for elderly patients. ||| Aucun ajustement posologique n’ est nécessaire chez la personne âgée.
0.005402872804552317 ||| During post-marketing experience the following additional side effects have been reported (frequency not known): hypersensitivity reactions, including anaphylaxis, angioedema, rash, urticaria and exfoliative skin conditions including Stevens-Johnson syndrome (see section 4.4). ||| During post-marketing experience the following additional side effects have been reported (frequency not known): hypersensitivity reactions including anaphylaxis, angioedema, rash, urticaria, and exfoliative skin conditions including Stevens-Johnson syndrome (see section 4.4). ||| Depuis la commercialisation Depuis la commercialisation, les effets indésirables supplémentaires suivants ont été rapportés (fréquence non connue): réactions d'hypersensibilité incluant anaphylaxie, angio-œdème, rash, urticaire et lésions cutanées exfoliatives y compris syndrome de Stevens-Johnson (voir rubrique 4.4).
0.3409254252910614 ||| 1 vial contains 250 mg bivalirudin. ||| One vial contains 500 mg/ 5 ml levetiracetam. ||| 1 flacon contient 250 mg de bivalirudine.
0.0 ||| Nervous system disorders ||| Nervous system disorders ||| épileptique, syncope
2.947053408600131e-13 ||| During its 21 - 24 April 2008 meeting, the CHMP, in the light of the overall submitted data and the scientific discussion within the Committee, was of the opinion that the proposal for the harmonisation of the SPC, Labelling and Package leaflet including the quality aspects was acceptable and that they should be amended. ||| During its 21 - 24 April 2008 meeting, the CHMP, in the light of the overall submitted data and the scientific discussion within the Committee, was of the opinion that the proposal for the harmonisation of the SPC, Labelling and Package leaflet including the quality aspects was acceptable and that they should be amended. ||| Au cours de sa réunion du 21 au 24 avril 2008, le CHMP a été d’ avis que la proposition d’ harmonisation des résumés des caractéristiques du produit, de l’ étiquetage et de la notice était acceptable et qu’ il convenait de les modifier, compte tenu de l’ ensemble des données soumises globalement et de la discussion scientifique tenue au sein du comité.
0.37690985202789307 ||| Strainers for water lines ||| Reagents for testing water ||| Filtres pour conduites d'eau
0.01035425253212452 ||| In a 20-week study, as well as reducing fasting triglycerides, pioglitazone reduced post prandial hypertriglyceridaemia through an effect on both absorbed and hepatically synthesised triglycerides. ||| In a 20-week study, as well as reducing fasting triglycerides, pioglitazone reduced postprandial hypertriglyceridaemia through an effect on both absorbed and hepatically synthesised triglycerides. ||| Dans une étude sur 20 semaines, la pioglitazone a réduit l’ hypertriglycéridémie post-prandiale, ainsi que les triglycérides à jeûn, par un effet sur les triglycérides absorbés et ceux synthétisés par le foie.
0.5117747187614441 ||| Patients may develop antibodies to AVONEX. ||| No patient developed IgE antibodies during any study. ||| Des patients sont susceptibles de développer des anticorps contre AVONEX.
0.030132565647363663 ||| Lietuva Novartis Pharma Services Inc. ||| Latvija Novartis Pharma Services Inc. ||| 45 Lietuva Novartis Pharma Services Inc.
6.650766634468119e-13 ||| The total dose should not exceed 8.7 ml per patient. ||| The total dose should not exceed 8.7 ml per patient. ||| La dose totale ne doit pas dépasser 8,7 ml/ patient.
0.24098926782608032 ||| 20 In pediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks. ||| The safety and efficacy of Aldurazyme was assessed in a randomised, double-blind, placebo controlled, Phase 3 Study of 45 patients, ranging in age from 6 to 43 years. ||| Chez les enfants (de 4 à 16 ans), l’ efficacité du levetiracetam a été établie lors d’ une étude en double aveugle contrôlée versus placebo incluant 198 patients sur 14 semaines de traitement.
0.4003462493419647 ||| Straps of metal ||| Pivots of metal ||| Lanières en métal
0.4204992651939392 ||| Symptoms of hypoglycaemia usually occur suddenly. ||| Signs and symptoms of hypovolemic shock include: ||| Les symptômes de l’hypoglycémie surviennent habituellement de manière soudaine.
0.49921348690986633 ||| - pain or tenderness in chest, muscles or joints. ||| In adults: stiffness of the limbs, joint and muscle pain ||| - Douleurs ou douleur à la pression au niveau de la poitrine, des muscles ou des articulations.
0.0019205020507797599 ||| Do not use Helixate NexGen 250 IU if you notice any particles or the solution is cloudy. ||| Do not use Helixate NexGen 500 IU if you notice any particles or the solution is cloudy. ||| Ne pas utiliser Helixate NexGen 250 UI si vous observez des particules ou si la solution est trouble.
0.2551143765449524 ||| Bimatoprost is eliminated primarily by renal excretion, up to 67% of an intravenous dose administered to healthy volunteers was excreted in the urine, 25% of the dose was excreted via the faeces. ||| Biotransformation and elimination One week following administration of a single oral dose of 1 mg immediate-release 14C-paliperidone, 59% of the dose was excreted unchanged into urine, indicating that paliperidone is not extensively metabolised by the liver. ||| Jusqu’ à 67% d’ une dose administrée en intraveineuse à des volontaires sains est éliminée dans l'urine et 25% est excrétée dans les fèces.
0.4821571409702301 ||| 67.4 ± 36.9 ||| 60.2 43.6 0.0001 ||| 67,4 ± 36,9
0.47798943519592285 ||| Operators should wash their hands after use of the product. ||| Patients will be taught how to use the eye drops by themselves. ||| Les manipulateurs devront se laver les mains après l'utilisation du produit.
0.2606951892375946 ||| Chemicals for use in immuno-assay testing [other than medical or veterinary] ||| Reagents for use with analyzers [other than for medical or veterinary purposes] ||| Produits chimiques pour immunoessais autres qu'à usage médical ou vétérinaire
0.28295475244522095 ||| Some patients have experienced the following side effects while taking TESAVEL in combination with a sulphonylurea and metformin: ||| The following side effects have occurred with the combination of Rebetol and interferon alfa-2b in children and adolescents: ||| Certains patients ont présenté les effets indésirables suivants au cours du traitement par TESAVEL en association à un sulfamide hypoglycémiant et à la metformine:
0.8931509256362915 ||| 5 (1.9) 0 ||| - 0 .3 5 ||| 5 (1,9) 0
0.44414636492729187 ||| The company provided evidence that the levels of the active substances in the blood were the same in people taking Tandemact and people taking the separate tablets. ||| The study in children showed that the medicine produced similar levels of the active substance in the blood in children and adults, with similar side effects and effectiveness. ||| La société a démontré que les taux de principes actifs dans le sang étaient identiques chez les patients traités par Tandemact et chez ceux prenant les comprimés séparés.
0.3891775906085968 ||| 14 In an additional study limited to patients with severe SUI, all responses with duloxetine were achieved within 2 weeks. ||| All patients in the chronic hepatitis C studies had a liver biopsy before inclusion, but in certain cases (i. e. na ||| 14 Dans une étude complémentaire limitée aux patientes atteintes d 'incontinence urinaire d’ effort sévère, toutes les réponses avec la duloxétine ont été obtenues dans les 2 semaines.
0.39762526750564575 ||| CEPROTIN 1000 IU Powder and solvent for solution for injection Human Protein C ||| FORCALTONIN 100 IU solution for injection Recombinant salmon calcitonin ||| CEPROTIN 1000 UI Poudre et solvant pour solution injectable protéine C humaine
0.2827470302581787 ||| Tredaptive 1000 mg/ 20 mg modified-release tablets nicotinic acid/ laropiprant ||| Aerinaze 2.5 mg/ 120 mg modified-release tablets desloratadine/ pseudoephedrine (as sulphate) ||| Tredaptive 1000 mg/ 20 mg, comprimé à libération modifiée acide nicotinique/ laropiprant
0.0 ||| Do not use if the solution contains particles or is not clear. ||| Do not use if the solution contains particles or is not clear. ||| Ne pas l’ utiliser si elle contient des particules ou si elle n’ est pas limpide.
0.700322151184082 ||| Safety and effectiveness in women have not been established because of the paucity of clinical data. ||| data security and anonymity would have to be protected and shown to be protected based on evidence; ||| La sécurité et l’ efficacité chez la femme n’ ont pas été établis en raison de données cliniques succinctes.
0.2831384241580963 ||| In patients with severe renal insufficiency, vitamin D in the form of cholecalciferol is not metabolised normally and other forms of vitamin D should be used (see section 4.3, contraindications). ||| There is no experience in patients with renal insufficiency (serum creatinine ≥ 2 x ULN for age) and clofarabine is predominately excreted via the kidneys (see sections 4.3 and 4.4). ||| Chez les patients présentant une insuffisance rénale grave, la vitamine D sous forme de cholécalciférol n’est pas métabolisée normalement et d’autres formes de la vitamine D3 doivent être utilisées (voir section 4.3., Contre-indications).
0.12524977326393127 ||| Following the administration of a double dose of vaccine, no adverse reactions other than those described under section 4.6 have been observed. ||| Following the administration of a double dose in chickens and ducks, no adverse reactions other than those described in section 6 have been observed. ||| Après administration d’ une double dose par la voie d’ administration recommandée, aucun autre symptôme que ceux décrits dans la rubrique « Effets indésirables (fréquence et gravité) », n’ a été observé.
0.40503767132759094 ||| In general, febuxostat pharmacokinetic parameters estimated by these analyses are consistent with those obtained 23 from healthy subjects, indicating that healthy subjects are representative for pharmacokinetic/ pharmacodynamic assessment in the patient population with gout. ||| Special populations In a population pharmacokinetic analysis of data from phase III studies, no difference in fulvestrant’ s pharmacokinetic profile was detected with regard to age (range 33 to 89 years), weight (40-127 kg) or race. ||| En règle générale, les paramètres pharmacocinétiques du fébuxostat estimés par ces analyses ont été similaires à ceux déterminés chez les sujets sains, indiquant que ces derniers sont représentatifs pour l’ évaluation pharmacocinétique/ pharmacodynamique chez les patients atteints de goutte.
1.023923635482788 ||| Non-electric footwarmers ||| Non-agricultural lime ||| Chauffe-pieds non électriques
0.7199704051017761 ||| The EIB Group is playing a vital role in this investment plan. ||| The company Wish.com has recently joined the initiative. ||| Le Groupe BEI joue un rôle essentiel dans ce plan d'investissement.
0.33691293001174927 ||| The peak plasma concentration of perindoprilat is achieved within 3 to 4 hours. ||| Rosiglitazone plasma concentrations peak at around 1 h after dosing. ||| Le pic de concentration plasmatique du périndoprilate est atteint en 3 à 4 heures.
0.00931163877248764 ||| Viraferon 5 million IU/ ml powder and solvent for solution for injection ||| Viraferon 1 million IU/ ml powder and solvent for solution for injection ||| Viraferon 5 millions d’ UI/ ml poudre et solvant pour solution injectable
0.18303319811820984 ||| Patients with renal or hepatic impairment Gemcitabine should be used with caution in patients with hepatic or renal insufficiency as there is insufficient information from clinical studies to allow for clear dose recommendations for these patient populations (see sections 4.4 and 5.2). ||| There are no data that support specific guidance for dosage adjustment in patients with hepatic impairment, but, due to safety considerations, Siklos is contraindicated in patients with severe hepatic impairment (see section 4.2). ||| Insuffisants rénaux ou insuffisants hépatiques La gemcitabine devra être administrée avec précaution chez les patients atteints d’insuffisance hépatique ou rénale car les données issues des essais cliniques sont insuffisantes pour établir des recommandations claires sur les doses à administrer pour ces populations de patients (voir rubriques 4.4 et 5.2).
1.0136338383232024e-12 ||| INSTRUCTIONS ON USE ||| INSTRUCTIONS ON USE ||| INSTRUCTIONS POUR UTILISATION
0.5031526684761047 ||| In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products in the same syringe. ||| 94 As for any combination of two active substances, side effects associated with each individual component cannot be excluded. ||| En l’ absence d’ études de compatibilité, ce vaccin ne doit pas être mélangé avec d’ autres médicaments dans la même seringue.
0.5030948519706726 ||| A carry-forward from the 1996 budget to 1997 of ECU 1.62 million was approved by the Board at its February meeting. ||| The €4.9 billion comes on top of the €2 billion already pledged by the EIB on 4 May . ||| Un report de 1,62 million d’ écus du budget de 1996 à celui de 1997 a été approuvé par le Conseil d’ administration au cours de sa réunion de février.
0.7544099688529968 ||| Weight at baseline (kg) ||| Weight of dog [kg] ||| initiale (kg) Sujets avec
0.338189959526062 ||| The Commission found that the Swedish aid scheme will compensate damages that are directly linked to the coronavirus outbreak. ||| The measure aims at partly compensating the airline for the damage suffered due to the coronavirus outbreak. ||| La Commission a estimé que le régime d'aides suédois compenserait les dommages directement liés à la pandémie de COVID-19.
0.4276438057422638 ||| Sometimes your doctor will need to reduce the dose or stop Zavesca treatment to stop the tremor. ||| Volibris is a treatment that you will need to keep on taking to control your PAH. ||| Quelquefois, votre médecin aura besoin de diminuer la dose de Zavesca ou d’ arrêter Zavesca pour mettre fin aux tremblements.
0.7296702861785889 ||| In general, to prevent hypoglycaemia you must eat more food and monitor your blood ||| Exercise Like muscles, bones need exercise to stay strong and healthy. ||| En général, pour prévenir une hypoglycémie, vous devez manger davantage de nourriture et contrôler votre taux de sucre
0.278318852186203 ||| In clinical studies 2.1% of patients treated with 600 mg of efavirenz discontinued therapy because of nervous system symptoms. ||| In a study in 130 patients with metastatic breast cancer the safety of Bondronat infused over 1 hour or 15 minutes was compared. ||| Au cours des études cliniques, 2,1% des patients traités par 600 mg d’ éfavirenz ont interrompu leur traitement en raison de symptômes neurologiques.
0.12046974897384644 ||| N05AX13 ||| N03AX16 ||| N05AX13.
0.4976732134819031 ||| The usual dose is one 20 mg tablet to be taken once daily in the Me ||| The usual dose is one drop in the morning in each eye that needs treatment. ||| La dose habituelle est de un comprimé à 20 mg à prendre une fois par jour le matin avant le petit-déjeuner.
0.45713335275650024 ||| Elimination of fondaparinux decreases with weight. ||| There is limited metabolism of emtricitabine. ||| L’ élimination du fondaparinux décroît avec la diminution du poids.
0.0 ||| 25 ANNEX II ||| 25 ANNEX II ||| 29 ANNEXE II
2.9841542648414987e-13 ||| Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636 ||| Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636 ||| 374 Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636
0.42915934324264526 ||| If you stop taking Procoralan: ||| Do not take Procoralan: ||| Si vous arrêtez de prendre Procoralan:
0.408314049243927 ||| The in vitro antiviral activity of tenofovir against HBV was assessed in the HepG2 2.2.15 cell line. ||| The addition of Avastin to IFN alfa-2a significantly increased PFS and objective tumour response rate (Table 11). ||| L’ activité antivirale in vitro du ténofovir vis-à-vis du VHB a été évaluée dans la lignée cellulaire HepG2 2.2.15.
0.26721465587615967 ||| The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. ||| Examinez les cartouches régulièrement et ne pas les utiliser si la suspension présente des grumeaux ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.20344272255897522 ||| The active substance in Onsenal, celecoxib, is a ‘ non-steroidal anti-inflammatory drug’ (NSAID) that belongs to the group ‘ cyclo-oxygenase-2 (COX-2) inhibitors’. ||| Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group of medicines called ‘ cyclo-oxygenase-2 (COX-2) inhibitors’. ||| Le principe actif d’ Onsenal, le célécoxib, est « un anti-inflammatoire non-stéroïdien » (AINS) qui appartient au groupe des « inhibiteurs de la cyclo-oxygénase-2 (COX-2) ».
0.4529510736465454 ||| In the original main study, both Optaflu and the comparator vaccine brought about adequate levels of antibodies for protection against all three flu strains, as defined in criteria laid down by the Committee for Medicinal Products for Human Use (CHMP) for flu vaccines produced in cell culture. ||| Assess responses to lists of questions in relation to provisional MRLs for old substances Develop guidelines as part of preparation for CVMP contribution to VICH Finalise revision of guidelines on safety evaluation of antimicrobial substances regarding the effect on human gut flora ||| Dans l’ étude principale initiale, Optaflu et le vaccin de comparaison ont tous deux généré des niveaux adéquats d’ anticorps permettant une protection contre les trois souches du virus, tel que défini dans les critères établis par le comité des médicaments à usage humain (CHMP) pour les vaccins contre la grippe produits en cultures cellulaires.
0.6740142107009888 ||| Inactivated Feline Leukaemia Virus (61E strain) Adjuvants ||| Cross-reactive Immune Response Against Related H5N1 Strains ||| Virus inactivé de la leucémie féline (souche 61 E) Adjuvants
0.24061129987239838 ||| Mechanical transmissions [other than for land vehicles] ||| Internal combustion motors [other than for land vehicles] ||| Transmissions mécaniques autres que pour véhicules terrestres
0.12887199223041534 ||| 0. 25 ||| 0. 15 ||| 0,25
0.06757283210754395 ||| 26 A. ||| 28 A. ||| 30 A.
0.23332524299621582 ||| Intervet Danmark AS PO Box 66 Literbuen 9 DK-2740 Skovlunde Denmark Tel: +45 (44) 546 900 Fax: +45 (44) 531 955 ||| Intervet Baltic States Vasario 16-osios 9-6A LT-Kauna 3000 Lithuania Tel: +370 373 216 60 Fax: +370 372 012 93 ||| Intervet Danmark AS PO Box 66 Literbuen 9 DK-2740 Skovlunde Danemark Tél.: +45 (44) 546 900 Fax: +45 (44) 531 955
0.3464447259902954 ||| If you forget to give yourself an injection, you should inject the next dose of Trudexa as soon as you remember. ||| If this is a multidose vial, you will only have to remove the cap when preparing the first dose. ||| tor Si vous oubliez de vous faire une injection, vous devrez vous injecter Trudexa dès que vous vous en souviendrez.
0.0 ||| Keppra may impair your ability to drive or operate any tools or machinery, as Keppra may make you feel sleepy. ||| Keppra may impair your ability to drive or operate any tools or machinery, as Keppra may make you feel sleepy. ||| Keppra peut altérer votre capacité à conduire ou à manipuler un outil ou une machine car Keppra peut vous rendre somnolent.
0.36487552523612976 ||| Video entertainment services ||| Television studio services ||| Services de divertissement vidéo
0.205117329955101 ||| You and your partner must each use an effective contraceptive during the time you are taking the treatment and for 7 months after stopping treatment. ||| If you are a male patient, you and your partner must each use an effective contraceptive during the time you are taking Rebetol and for 7 months after stopping treatment. ||| Vous et votre partenaire devez chacun utiliser une méthode de contraception efficace durant toute la durée de votre traitement et pendant les 7 mois suivant son arrêt.
0.4034510850906372 ||| The safety and efficacy have not been studied in patients with renal impairment. ||| Safety and efficacy has not been evaluated in the elderly (see section 5.2). ||| La tolérance et l’ efficacité n’ ont pas été étudiées chez les patients insuffisants rénaux.
0.06506629288196564 ||| 13 6.2 Incompatibilities ||| 9 6.2 Incompatibilities ||| 6.2 Incompatibilités
0.4164493680000305 ||| B cell levels in human neonates following maternal exposure to MabThera have not been studied in clinical trials. ||| Data from clinical trials in MDS on the incidence of blast cell increases and progression to AML. ||| Chez l'Homme, aucune étude clinique n’ a mesuré les taux de lymphocytes B chez le nouveau-né après exposition maternelle au MabThera.
0.6145018339157104 ||| Each dose of 1ml of vaccine contains Bluetongue virus serotype 8 antigen............... ...≥ 7.1 CCID50 ||| Hepatitis B surface antigen 1, 2, 3 1 adjuvanted by AS04C containing: ||| Chaque dose de 1 ml de vaccin contient le Virus Bluetongue inactivé, sérotype 8.......... > 7,1 DICC50*
0.015986062586307526 ||| EU/ 1/ 01/ 178/ 001 ||| EU/ 1/ 01/ 172/ 001 ||| EU/ /1/ 01/ 178/ 001
0.38449591398239136 ||| In the prepartum period, additional monitoring and alternative therapy to REYATAZ should be considered. ||| AVANDAMET dose adjustment within the recommended posology or changes in diabetic treatment should be considered. ||| Dans la période précédant l'accouchement, une surveillance accrue et un traitement alternatif à REYATAZ devraient être envisagés.
0.002540548797696829 ||| Nespo 50 micrograms solution for injection in a pre-filled pen Darbepoetin alfa ||| Nespo 60 micrograms solution for injection in a pre-filled pen Darbepoetin alfa ||| Nespo 50 microgrammes solution injectable en stylo prérempli Darbepoetin alfa
1.0347576141357422 ||| • Wilex AG ||| Lot Wyeth Europa Ltd ||| Wilex AG
0.4734271168708801 ||| Asbestos millboards ||| Toy wheelbarrows ||| Cartons d'amiante
0.05293601378798485 ||| CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT ||| CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT cin ||| CONDITIONS OU RESTRICTIONS RELATIGES A L’ AUTORISATION DE MISE SUR LE MARCHE POUR UNE UTILISATION SURE ET EFFICACE
0.3519866168498993 ||| Dabigatran etexilate 220 mg ||| Aerius 5 mg tablet desloratadine ||| Dabigatra n etexilate 220 mg
0.586799144744873 ||| Eyebrow brushes ||| Eyebrow powder ||| Brosses à sourcils
0.1756037175655365 ||| What is the risk associated with Netvax? ||| What is the risk associated with Competact? ||| Quel est le risque associé à l'utilisation de Netvax?
0.6212307214736938 ||| The distribution will be agreed upon during the implementation of the EU4Health programme. ||| The legal revision of the agreement is now being finalised. ||| La répartition fera l'objet d'un accord lors de la mise en œuvre du programme «L'UE pour la santé».
0.5674678683280945 ||| Check if insulin comes out of the needle tip. ||| Rinse away the liquid that comes out. ||| Vérifiez que l’insuline sort de l’aiguille
0.5342198610305786 ||| Panretin 0.1% gel ||| Ibaflin 3% oral gel ||| Panretin 0,1% gel
0.35506337881088257 ||| After 2– 4 weeks, the dose should be titrated to 500 mg twice daily and, according to the patient’ s response, further titrated to a recommended maximum dose of 750 mg twice daily (see section 5.1). ||| When first starting treatment with Rebif, the dose should be slowly increased to avoid side effects, starting with 8.8 micrograms three times a week for the first two weeks, followed by 22 micrograms three times a week for the next two weeks. ||| Après 2-4 semaines, procéder à une titration de dose vers la posologie 500 mg deux fois par jour et, en fonction de la réponse du patient, envisager une nouvelle titration pour atteindre la dose maximale recommandée de 750 mg deux fois par jour (voir rubrique 5.1).
0.6664751768112183 ||| AZARGA 10 mg/ ml + 5 mg/ ml eye drops, suspension ||| HDPE bottle / can: volume 1000 ml / 5000 ml. ||| AZARGA 10 mg/ ml + 5 mg/ ml, collyre en suspension
0.2765192985534668 ||| Agenerase capsules are contraindicated in patients with severe hepatic impairment when used in combination with ritonavir (see section4.3). ||| Treatment with Ceplene in conjunction with IL-2 should be used with caution in patients with poorly compensated cardiac function. ||| Les capsules d'Agenerase sont contre-indiquées lorsqu'elles sont administrées en association au ritonavir chez les patients ayant une insuffisance hépatique sévère (voir rubrique 4.3).
0.3175286650657654 ||| Animal studies revealed no adverse effects on fertility apart from a slight reduction in implantations and viable foetuses (see section 5.3). ||| No observable teratogenicity was detected in reproductive studies performed in pregnant rats and rabbits (see section 5.3). ||| Les études chez l’ animal n’ ont révélé aucun effet indésirable sur la fécondité, mis à part une légère réduction du nombre d’ implantations et de foetus viables (voir rubrique 5.3).
4.64171832480903e-13 ||| - At the request of the EMEA ||| - At the request of the EMEA ||| - A la demande de l’ EMEA
0.044848427176475525 ||| - If you have any further questions, ask your doctor, nurse or pharmacist. ||| If you have any further questions, ask your doctor, nurse or pharmacist. ||| - Si vous avez d’ autres questions, si vous avez un doute, demandez plus d’ informations à votre
0.5067023038864136 ||| Politician Igor Nikulin made rounds on Russian television and news media, arguing that Wuhan was chosen for the attack because the presence of a BSL-4 virus lab provided a cover story for the Pentagon and CIA about a Chinese bio-experiment leak. ||| "In January 2020, Buzzfeed News reported on an internet meme of a link between the logo of the WIV and ""Umbrella Corporation"", the agency that created the virus responsible for a zombie apocalypse in the Resident Evil franchise." ||| Le politicien Igor Nikulin a fait le tour des plateaux de télévision et des médias russes, arguant que Wuhan avait été choisi pour l'attaque car la présence d'un laboratoire pathogène de classe 4 fournissait au Pentagone et la CIA un prétexte pour dire qu'il s'agissait d'une fuite d'une expérience biologique chinoise.
0.21557247638702393 ||| 61 ||| 63 ||| 66
0.32592910528182983 ||| No clinically significant differences were observed in the pharmacokinetics between young (aged 21-40 years) and elderly (65-75 years). ||| 4 Special patient populations No differences in safety or efficacy were observed between elderly (≥ 65 years) patients and younger patients. ||| Personnes âgées: aucune différence cliniquement significative dans la pharmacocinétique du zonisamide n’ a été observée entre des sujets jeunes (21 à 40 ans) et des sujets âgés (65 à 75 ans).
0.7117737531661987 ||| ELAPRASE ||| SINGULAIR ||| ÉLAPRASE
0.3528451919555664 ||| Immunogenicity Of 339 renal transplant patients treated with basiliximab and tested for anti-idiotype antibodies, 4 (1.2%) developed an anti-idiotype antibody response. ||| Immunogenicity Approximately 5% of ustekinumab-treated patients developed antibodies to ustekinumab, which were generally low-titer. ||| Immunogénicité Parmi les 339 patients transplantés rénaux traités par le basiliximab chez lesquels une recherche d’ anticorps anti-idiotypiques a été effectuée, seul quatre patients (1,2%) ont développé des anticorps anti-idiotypiques.
0.5056851506233215 ||| In order to make it more resilient, we will need to reflect together on the lessons learned and on the new trends that might emerge. ||| In that conversation, we considered what we thought would be an appropriate response to what we’re facing and the best way to keep the organization sustainable during this time. ||| Pour le rendre plus résilient, nous devrons réfléchir ensemble aux enseignements qui auront été tirés et aux nouvelles tendances susceptibles d'émerger.
0.010021025314927101 ||| Peach film-coated tablet of biconvex, oblong shape with the marking ‘ 500’ on the one side and ‘ Xeloda’ on the other side. ||| Light peach film-coated tablet of biconvex, oblong shape with the marking ‘ 150’ on the one side and ‘ Xeloda’ on the other side. ||| Comprimé pelliculé de couleur pêche, biconvexe, oblong avec inscription « 500 » sur une face et « Xeloda » sur l’ autre face.
0.4578908085823059 ||| See the accompanying Pen User Manual for instructions for using the BYETTA Pen. ||| Please see the accompanying BYETTA Package Leaflet. ||| Consultez le manuel d’ utilisation de votre stylo BYETTA.
0.3196837902069092 ||| The pharmacokinetic parameters for Privigen were determined in a clinical study in PID patients (see section 5.1). ||| Data from clinical studies with Silapo are in line with the safety profile of other authorized erythropoietins. ||| Les paramètres pharmacocinétiques de Privigen ont été déterminés lors d’une étude clinique portant sur des patients DIP (voir rubrique 5.1).
0.44203507900238037 ||| Other side effects are uncommon or rare. ||| Serious allergic reactions are uncommon. ||| L’ observation d’ autres effets indésirables est peu fréquente ou rare.
0.0009970823302865028 ||| 108 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| 224 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| Si l'équilibre glycémique n'est pas optimal ou si le patient a tendance à présenter des épisodes hyperglycémiques ou hypoglycémiques, il faut d'abord vérifier le respect par le patient du traitement prescrit, les sites et les techniques d'injection et l'ensemble des autres facteurs susceptibles d'augmenter la tendance à l'hyper- ou l'hypoglycémie, avant d'envisager l'ajustement de la dose d'insuline.
0.2956897020339966 ||| Disorders of the nerves and senses such as convulsions, tremor, dizziness, depression, drowsiness, numbness, muscle spasms, anxiety, changes in thinking or mood. ||| Nervous system and general disorders: depression, difficulty with memory, headache, nervousness, irritability, tiredness, shaking, feeling abnormal, fainting, dizziness, drowsiness, generalised or severe weakness ||| Troubles du système nerveux: convulsions, tremblements, vertiges, dépression, somnolence, engourdissement, spasmes musculaires, anxiété, troubles de la pensée ou de l’ humeur.
0.6727923154830933 ||| Hydrocortisone creams ||| Antibiotics Clarithromycin ||| Crèmes à l'hydrocortisone
0.45701536536216736 ||| It should be discarded according to the time specified in the Patient Information Leaflet, even if it still contains insulin. ||| Thus, an in-line filter must be used as a precautionary measure and is provided in the package. ||| Il doit être jeté après le temps d'utilisation spécifié dans la notice d’utilisation, même s'il contient encore de l'insuline.
1.0198005634398655e-12 ||| Store in a refrigerator ||| Store in a refrigerator ||| A conserver au réfrigérateur
0.001106172800064087 ||| 47 A comparison of serum concentrations of methoxy polyethylene glycol-epoetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| 39 A comparison of serum concentrations of methoxy polyethylene glycol-epoetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| Une comparaison des concentrations sériques du méthoxy polyéthylène glycol-epoetin beta mesurées avant et après hémodialyse chez 41 patients atteints d’ une IRC a montré que l’ hémodialyse n’ avait aucun effet sur les paramètres pharmacocinétiques de ce médicament.
0.14951549470424652 ||| 22 In a clinical trial in patients with diabetes mellitus, vardenafil significantly improved the erectile function domain score, the ability to obtain and maintain an erection long enough for successful intercourse and penile rigidity compared to placebo at vardenafil doses of 10 mg and 20 mg. ||| In a flexible-dose clinical trial in patients with Spinal Cord Injury, vardenafil significantly improved the erectile function domain score, the ability to obtain and maintain an erection long enough for successful intercourse and penile rigidity compared to placebo. ||| Au cours d'une étude clinique chez des patients diabétiques, le vardénafil à la dose de 10 mg et 20 mg a significativement amélioré le score du domaine de la fonction érectile, la capacité à obtenir et à maintenir une érection suffisamment longue pour permettre un rapport sexuel et une rigidité pénienne comparativement au placebo.
0.27786344289779663 ||| - If you have injected too much Insulin Human Winthrop Rapid, your blood sugar level may ||| - If you have injected too much Insuman Rapid, your blood sugar level may become too low ||| - Si vous avez injecté une dose trop importante d’ Insulin Human Winthrop Rapid, votre
3.1328054300033825e-13 ||| From 1975 to 1990 Mrs Mendosa held a number of posts at the European Commission in Luxembourg, including the Conference Service, the Office for Official Publications and the Statistical Office. ||| From 1975 to 1990 Mrs Mendosa held a number of posts at the European Commission in Luxembourg, including the Conference Service, the Office for Official Publications and the Statistical Office. ||| Expérience professionnelle: de 1975 à 1990, Mme Mendosa a occupé plusieurs postes à la Commission européenne à Luxembourg, notamment au service des conférences, l'office des publications et l'office statistique.
0.20459407567977905 ||| alone ||| become ||| seul
0.225428968667984 ||| When administered to rats during organogenesis, sparfloxacin demonstrates a dose-related increase in the incidence of ventricular septal defects (this effect was not observed in primate studies). ||| TP plays a role in platelet function; however, therapeutic doses of laropiprant had no clinically relevant effect on bleeding time and collagen-induced platelet aggregation (see section 4.5). ||| Administrée à des rattes pendant la phase d'organogenèse, la sparfloxacine a donné lieu à une élévation dose dependante de l’ incidence des communications interventriculaires (cet effet n'a pas été retrouvé chez les primates).
0.4336087703704834 ||| Bookbinding apparatus and machines for industrial purposes ||| Aluminium profiles for use with information or display apparatus ||| Appareils et machines pour la reliure à usage industriel
0.34793850779533386 ||| INVANZ is not recommended in children under 3 months of age, as no data are available. ||| - Please note that STAMARIL must not be given to children aged less than 6 months. ||| En raison de l’ absence de donnée, INVANZ est déconseillé chez les enfants âgés de moins de 3 mois.
0.23533889651298523 ||| For more than 2 days (48 hours or more): • If you forget to change your patch for more than 2 days, you may become pregnant • You must start a new four week cycle as soon as you remember by putting on a new patch • You now have a different “Patch Change Day” and a new Day 1 • You must use back-up contraception for the first week of your new cycle. ||| If you need to place the patch on a new area on your body on a day other than your “Patch Change Day” If the patch causes irritation or you become uncomfortable wearing it: • You can take it off and replace it with a new patch in a different place on your body until your next “Patch Change Day” • You may only use one patch at a time. ||| Pendant plus de 2 jours (48 heures ou plus): • Si vous oubliez de changer votre patch pendant plus de 2 jours, vous pouvez tomber enceinte • Vous devez entamer un nouveau cycle de quatre semaines dès l’oubli constaté, en appliquant un nouveau patch • Vous avez désormais un « Jour de Changement de Patch » différent et un nouveau Jour 1 • Vous devez utiliser un mode de contraception supplémentaire pendant la première semaine de votre nouveau cycle.
0.13327738642692566 ||| Tin and its alloys ||| Lead and its alloys ||| Étain et ses alliages
0.5048322677612305 ||| Leashes for bodyboards ||| Jackets for video cassettes ||| Leashs de bodyboards
0.0014014069456607103 ||| Clinical adverse reactions in patients with chronic hepatitis B, treated with telbivudine 600 mg in the pooled 104-week NV-02B-007 (GLOBE) and NV-02B-015 studies* ||| Clinical adverse reactions in patients with chronic hepatitis B, treated with telbivudine 600 mg in the pooled 104-week NV-02B-007 (GLOBE) and NV-02B-015 studies * ||| Tableau 2 Effets indésirables cliniques survenant chez les patients atteints d’ hépatite B chronique traités par telbivudine (600 mg) au cours des études NV-02B- 007 (GLOBE) et NV-02B-015 (analyse combinée à 104 semaines de traitement)*
0.3554743528366089 ||| Persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment. ||| There are reports of compromise in the rate and depth of respiration and of life-threatening respiratory depression, necessitating intubation and ventilation. ||| - Hyperhidrose axillaire primaire sévère persistante, ayant un retentissement sur la vie
0.3157941699028015 ||| Rubber hose for the splicing of cables ||| Downpoles of metal for the ducting of wires ||| Tuyau en caoutchouc pour le raccord de câbles
0.0 ||| If your blood sugar level falls too much you may become unconscious. ||| If your blood sugar level falls too much you may become unconscious. ||| 530 Si votre taux de sucre dans le sang diminue trop, vous risquez de perdre connaissance.
0.22671659290790558 ||| Dosage is individual and determined by the physician in accordance with the needs of the patient. ||| Dosage Dosage is individual and determined by the physician in accordance with the needs of the patient. lP ||| La posologie dépend de chaque individu et est déterminée par le médecin en fonction des besoins du patient. e
0.0 ||| AUC: ↓ 69% (↓ 62 to ↓ 73) Cmax: ↓ 76% (↓ 63 to ↓ 79) Simvastatin acid: ||| AUC: ↓ 69% (↓ 62 to ↓ 73) Cmax: ↓ 76% (↓ 63 to ↓ 79) Simvastatin acid: ||| ASC: ↓ 69% (↓ 62 à ↓ 73) Cmax: ↓ 76% (↓ 63 à ↓ 79) Simvastatine sous forme acide:
0.22207863628864288 ||| There have been no clinical studies to evaluate the interactions of riluzole with other medicinal products. ||| Therefore, no clinical studies have been conducted to investigate interactions of fluticasone furoate on other drugs. ||| Il n'y a pas eu d'études cliniques évaluant les interactions du riluzole avec d'autres médicaments.
0.031175067648291588 ||| Very rare side effects (These can affect less than 1 in every 10,000 patients treated) ||| Very rare side effects (These can affect less than 1 in every 10,000 patients) ||| Effets indésirables très rares (Peuvent affecter moins de 1 patient sur 10.000 traités)
0.27773043513298035 ||| Distribution of gas ||| Extraction of gas ||| Distribution de gaz
0.3499096632003784 ||| Liprolog Mix50 100 U/ ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use ||| Ciprofloxacin Hikma 200 mg/ 100 ml, solution for infusion [To be completed nationally] ciprofloxacin Intravenous use ||| Liprolog Mix50 100 UI/ ml, suspension injectable en cartouche Insuline lispro 50% et insuline lispro protamine en suspension 50% Voie sous-cutanée.
0.13175100088119507 ||| The safe use of Agenerase in pregnancy has not been established. ||| The safe use of CELSENTRI in pregnancy has not been established. ||| La sécurité d'emploi d'Agenerase au cours de la grossesse n'a pas été établie.
0.27802979946136475 ||| However, in the presence of an inhibitor the doses required are variable and must be adjusted according to clinical response and monitoring of plasma factor VIII activity. ||| During the course of treatment, appropriate determination of plasma factor VIII levels is advised to guide the dose to be administered and the frequency of repeated injections. ||| Toutefois, en présence d’ un inhibiteur les doses nécessaires sont variables et doivent être ajustées en fonction de la réponse clinique du patient et du dosage de l’ activité plasmatique du facteur VIII.
3.300245276713354e-13 ||| Dose adjustments are required when voriconazole is co-administered with efavirenz (see sections 4.2 and 4.4). ||| Dose adjustments are required when voriconazole is co-administered with efavirenz (see sections 4.2 and 4.4). ||| Un ajustement des doses est nécessaire lors de la co-administration du voriconazole et de l’ efavirenz (voir rubriques 4.2 et 4.4).
0.4544857144355774 ||| Food may increase the amount of loratadine absorbed, but without clinically significant results. ||| Used patches still contain active substance, which may be harmful to others. ||| L’ ingestion concomitante de nourriture peut augmenter la quantité de loratadine absorbée, mais sans effet cliniquement significatif.
0.0066354600712656975 ||| Do not put Insuman Comb 15 next to the freezer compartment or a freezer pack. ||| Do not put Insuman Comb 50 next to the freezer compartment or a freezer pack. ||| Ne pas mettre Insuman Comb 15 à côté du compartiment congélateur ou d’ une poche de congélation.
0.16595186293125153 ||| Why has TOVIAZ been approved? ||| Why has VFEND been approved? ||| Pourquoi TOVIAZ a -t-il été approuvé?
0.08168499916791916 ||| 32 Rebif has not yet been investigated in patients with primary progressive multiple sclerosis, and should not be used in such patients. ||| Rebif has not yet been investigated in patients with primary progressive multiple sclerosis and should not be used in such patients ||| Rebif n’ a pas encore été étudié chez les patients atteints de la forme progressive primaire de sclérose en plaques et ne devrait pas être administré à ces patients.
0.2811760902404785 ||| In addition, EU humanitarian aid will be provided to the World Health Organization's global coronavirus response in partnership with health authorities in Ethiopia, Kenya and Somalia to scale up operational readiness for early detection and response to the pandemic. ||| The facility will be implemented with the involvement of the European Investment Bank and will encourage investments that support the transition towards a climate-neutral economy by public sector authorities to the benefit of coal- and carbon-intensive regions. ||| En outre, l'UE apportera son aide humanitaire à l'Organisation mondiale de la santé dans le cadre de la réaction de cette dernière à la crise de COVID-19 au niveau mondial, en partenariat avec les autorités sanitaires en Éthiopie, au Kenya et en Somalie, en vue de renforcer l'état de préparation opérationnelle en matière de détection précoce et de réaction face à la pandémie.
0.03275834023952484 ||| 19 Hallucinations are known as an adverse event of treatment with dopamine agonists and levodopa. ||| Hallucinations are known as an adverse event of treatment with dopamine agonists and levodopa. ||| Les hallucinations sont un effet indésirable connu du traitement par les agonistes dopaminergiques et la lévodopa.
0.02666252665221691 ||| After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Zestril the following was considered to be the most suitable harmonised Section 4.2 Posology text: ||| After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Pravachol, the following was considered to be the most suitable harmonised Section 4.1 indications text: ||| Après étude de la documentation fournie par le TAMM et évaluation des pratiques cliniques actuelles dans toute l’ UE à propos de l’ utilisation de Zestril le texte suivant a été considéré comme étant le texte harmonisé le plus approprié pour la rubrique 4.2 Posologie:
0.2731078863143921 ||| The studies measured the effectiveness of the treatment by looking at how the liver damage had evolved after 48 weeks treatment (using a liver biopsy, when a sample of liver tissue is taken and examined under a microscope) as well as measuring other signs of the disease such as the levels of a liver enzyme (ALT) or viral DNA circulating in the blood of the patients. ||| The trials looked at cure and clinical improvement of the infections, after seven to 12 days in the studies of skin and soft-tissue infections, and, in the study of bacteraemia, after a length of time determined by each patient ’ s diagnosis and susceptibility of the bacteria causing their infection to the medicines being used. ||| Ces études évaluaient l’ efficacité du traitement en observant l’ évolution des lésions du foie après 48 semaines de traitement (par biopsie du foie, en prélevant un échantillon de tissu du foie et en l’ examinant au microscope) ainsi que d’ autres signes de la maladie tels que les taux d’ enzyme hépatique (ALT) et l’ ADN viral présents dans le sang des patients.
0.3963426947593689 ||| Gelatin Titanium dioxide (E 171) ||| Yellow iron oxide (E172) ||| Gélatine Dioxyde de titane (E 171)
0.38279229402542114 ||| Do not use Zevalin: ||| Do not take Zeffix: ||| N’utilisez jamais Zevalin:
0.1909307837486267 ||| Respiratory, thoracic and mediastinal disorders Common: dyspnoea ||| Respiratory, thoracic and mediastinal disorders Rare: interstitial lung disease ||| Troubles respiratoires, thoraciques, et médiastinaux Fréquent:
0.2920854091644287 ||| 108 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| If inadequate control of blood phenylalanine levels is observed during treatment with Kuvan, the patient ’ s adherence to the prescribed treatment, and diet, should be reviewed before considering an adjustment of the dose of Kuvan. ||| Si l'équilibre glycémique n'est pas optimal ou si le patient a tendance à présenter des épisodes hyperglycémiques ou hypoglycémiques, il faut d'abord vérifier le respect par le patient du traitement prescrit, les sites et les techniques d'injection et l'ensemble des autres facteurs susceptibles d'augmenter la tendance à l'hyper- ou l'hypoglycémie, avant d'envisager l'ajustement de la dose d'insuline.
0.3623313009738922 ||| Fluoxetine/ Emtricitabine Fluoxetine/ Tenofovir disoproxil fumarate CARDIOVASCULAR AGENTS Calcium Channel Blockers ||| Calcitonins Human coagulation factor VIII Loratadine Sibutramine Gatifloxacin Nimesulide COX-2-Inhibitors: ||| Fluoxétine/ Emtricitabine Fluoxétine/ Fumarate de ténofovir disoproxil
0.3183937668800354 ||| 6 Findings in general toxicology studies were similar to those observed with other glucocorticoids and are associated with exaggerated pharmacological activity. ||| In general, effects observed during these studies were related to the thrombopoietic activity of romiplostim and were similar regardless of study duration. ||| Les résultats des études de toxicologie générale sont similaires à ceux observés avec d’ autres corticoïdes et sont le reflet d’ une amplification des effets pharmacologiques.
0.051704540848731995 ||| If you become pregnant during therapy with Karvea, please inform and see your doctor without delay. ||| If you become pregnant during therapy with Micardis, please inform and see your doctor without delay. ||| Si vous débutez une grossesse pendant le traitement avec Karvea, vous devez informer et consulter votre médecin sans délai.
0.160088449716568 ||| HOW TO STORE PUREGON ||| HOW TO STORE AGOPTON ||| COMMENT CONSERVER PUREGON
0.3057025969028473 ||| The in vitro plasma protein binding of ambrisentan was, on average, 98.8% and independent of concentration over the range of 0.2 – 20 microgram/ ml. ||| specifically bound to antithrombin protein with a dose-dependant plasma concentration binding (98.6% to 97.0% in the concentration range from 0.5 to 2 mg/ l). ||| In vitro, l’ ambrisentan était lié en moyenne à 98,8% aux protéines plasmatiques indépendemment de la concentration dans l'intervalle de 0,2 à 20 microgrammes/ ml.
0.3915899395942688 ||| There are no studies in pregnant women using TRISENOX. ||| Pregnancy There are no studies of cidofovir in pregnant women. ||| Il n'a pas été conduit d'étude avec TRISENOX chez la femme enceinte.
0.4406745731830597 ||| There is no experience in children with CML below 2 years of age (see section 5.1). ||| For children 6-9 years limited clinical data exists (see section 5.1). ||| Il n’ y a pas d’ expérience chez l’ enfant de moins de 2 ans (voir rubrique 5.1).
0.6183669567108154 ||| SonoVue has not been studied in patients aged 18 years or younger and should not be used in this group. ||| Cozaar Comp works equally well in and is equally well tolerated by most older and younger adult patients. ||| SonoVue n’ a pas été évalué chez les patients de moins de 18 ans et le produit ne doit donc pas être utilisé dans cette population.
0.15880444645881653 ||| Film-coated tablet: ||| Film-coated tablets. ||| Comprimé pelliculé:
0.5922828912734985 ||| Patients with known cardiovascular disease have not been studied. ||| Only a few families with this disease are known worldwide. ||| Les patientes atteintes de maladie cardio-vasculaire connue n’ ont pas été étudiées.
0.7179784178733826 ||| How will the guarantee system work? ||| How would the three partnerships work? ||| Comment fonctionnera le système de garanties?
0.0905015841126442 ||| - If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, ||| if any of the side effects gets serious or if you notice any side effects not listed in this leaflet. ||| - Si l’ un des effets indésirables devient sérieux ou si vous remarquez un effet indésirable non
4.0992797806400916e-13 ||| Effects of the injection ||| Effects of the injection ||| Effets de l’injection
0.06547902524471283 ||| Administration of Viani to pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus. ||| Administration of to pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus. ||| L’ utilisation de Viani au cours de la grossesse ne devra être envisagée que si le bénéfice attendu pour la mère l’ emporte sur tout risque éventuel pour le fœ tus.
0.5592905282974243 ||| Apparatus for use in alleviating hearing disorders ||| Adjustment guidelines for treatment-limiting toxicity ||| Appareils destinés au soulagement de troubles de l'audition
0.010469801723957062 ||| The Temporary Framework, as amended on 3 April , 8 May , and 29 June 2020, provides for the following types of aid, which can be granted by Member States: ||| The Temporary Framework, as amended on 3 April , 8 May and 29 June 2020 , provides for the following types of aid, which can be granted by Member States: ||| L'encadrement temporaire, tel que modifié le 3 avril , le 8 mai et le 29 juin 2020, prévoit que les types d'aide ci-dessous peuvent être octroyés par les États membres:
0.30071645975112915 ||| er Very rare (seen in less than 1 in 10,000 people) ||| Rare (seen in more than 1 in 10,000 people) ||| Très rares (observés chez moins d’une personne sur 10 000)
0.4329085648059845 ||| 26 closely related to the plasma concentration of A771726 and to the daily dose of leflunomide. ||| This finding is consistent with the low affinity of tadalafil for PDE6 compared to PDE5. ||| Dans ces études, l’ effet clinique s’ est révélé étroitement lié aux taux plasmatiques d’ A 771726 et à la dose quotidienne de léflunomide.
0.4184665083885193 ||| The aim is to ensure that sufficient liquidity remains available to businesses of all types and to preserve the continuity of economic activity during and after the outbreak, while making sure that support for businesses in one Member State does not undermine the European single market. ||| It is essential to act together to secure production, stocking, availability and rational use of medical protective equipment and medicines in the EU, openly and transparently, rather than taking unilateral measures that restrict the free movement of essential healthcare goods. ||| Elle entend faire en sorte que toutes les catégories d'entreprise puissent disposer de liquidités suffisantes et préserver la continuité de l'activité économique pendant et après la pandémie, tout en s'assurant que le soutien aux entreprises dans un État membre ne nuira pas au marché unique européen.
0.16455453634262085 ||| 26 13. ||| 24 13. ||| 13.
0.19882124662399292 ||| Blades for earth moving machines ||| Buckets for earth moving machines ||| Lames pour machines de terrassement
0.4334762990474701 ||| Alternative forms of contraception should be considered. ||| Apply usual procedures for the handling of animals. ||| D'autres méthodes de contraception doivent être envisagées.
0.1543866991996765 ||| RoActemra is a concentrate that is made up into a solution for infusion (drip into a vein). ||| Docetaxel Winthrop is a concentrate and solvent to be made up into a solution for infusion (drip into a vein). ||| RoActemra est une solution à diluer pour perfusion (goutte-à-goutte dans une veine).
0.5525411367416382 ||| Sweden ||| Sverige ||| Spain
0.05768118426203728 ||| However, if it is almost time for your next dose, do not take the missed dose and continue as usual. ||| However, if it is almost time for your next dose, skip the missed dose and continue as usual. ||| Toutefois, s’il est presque l’heure de prendre la dose suivante, ne prenez pas la dose oubliée et continuez le traitement normalement.
0.28771090507507324 ||| Do not use Fertavid ||| Do not use Insulatard ||| N’ utilisez jamais Fertavid
0.06501161307096481 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial of powder in the outer carton in order to protect from light. ||| Conserver le flacon dans l’ emballage d’ origine, à l’ abri de la lumière.
0.3759867548942566 ||| Trabectedin can have genotoxic effects. ||| Baraclude may have a mild laxative effect. ||| La trabectédine peut avoir des effets génotoxiques.
0.18222253024578094 ||| Stocrin is a medicine that contains the active substance efavirenz. ||| Viagra is a medicine that contains the active substance sildenafil. ||| Stocrin est un médicament contenant le principe actif éfavirenz.
0.0 ||| Infections and infestations ||| Infections and infestations ||| Infections et infestations Affections vasculaires
0.21446827054023743 ||| Insulin Human Winthrop Infusat is a neutral insulin solution (regular insulin). ||| Insulin Human Winthrop Basal is an isophane insulin suspension. ||| Insulin Human Winthrop Infusat est une solution d'insuline neutre (insuline ordinaire).
0.30175596475601196 ||| The concomitant use of aliskiren with ciclosporin, a highly potent P-gp inhibitor, and other potent P- gp inhibitors (quinidine, verapamil), is contraindicated (see section 4.5). ||| Reversible, selective MAO-A inhibitor (moclobemide) Due to the risk of serotonin syndrome, the combination of venlafaxine with a reversible and selective MAOI, such as moclobemide, is not recommended. ||| L’ utilisation concomitante d’ aliskiren avec la ciclosporine, un inhibiteur hautement puissant de la gp- P, ainsi qu’ avec d’ autres inhibiteurs puissants de la gp-P (quinidine, vérapamil), est contre-indiquée (voir rubrique 4.5).
0.2991146445274353 ||| Preparation and administration precautions: paclitaxel is a cytotoxic anticancer drug and, as with other potentially toxic compounds, caution should be exercised in handling Paxene. ||| 4 Depression, suicidal ideation and behaviour Although ARICLAIM is not indicated for the treatment of depression, its active ingredient (duloxetine) also exists as an antidepressant medication. ||| Précautions de préparation et d’ administration: le paclitaxel est un médicament anticancéreux cytotoxique; Paxene doit donc, au même titre que tout composé toxique, être manipulé avec précaution.
0.3714979887008667 ||| • Each ml of STOCRIN oral solution contains 30 mg of the active substance efavirenz. • The other ingredients are: medium chain triglycerides, benzoic acid (E210) and strawberry/mint flavour. ||| However, Ciprofloxacin 2mg/ ml Solution for Infusion has been shown to be compatible with Ringer's solution, 0.9% sodium chloride solution, 5% and 10% glucose solutions, glucose/ saline and fructose 10% solution. ||| Que contient STOCRIN Chaque ml de STOCRIN solution buvable contient 30 mg de principe actif éfavirenz.
0.3195134997367859 ||| The Emergency Support Instrument (ESI) allows the EU budget to step in to provide emergency support to allow the Union as a whole to address the human and economic consequences of a crisis such as the ongoing pandemic. ||| Whilst the new Medical Devices Regulation is key to ensure patient safety and increase transparency on medical devices across the EU, the currently applicable rules will continue to guarantee the protection of public health. ||| L'instrument d'aide d'urgence (ESI) autorise l'intervention du budget de l'UE afin de fournir une aide d'urgence permettant à l'Union dans son ensemble de faire face aux conséquences humaines et économiques d'une crise telle que la pandémie actuelle.
0.02664783038198948 ||| България Ю СИ БИ Търговско представителство Teл.: + 359 (0) 2 962 99 20 ||| 141 България Ю СИ БИ Търговско представителство Teл.: + 359 (0) 2 962 99 20 ||| Te.: + 359 (0) 2 962 99 20
0.3471367061138153 ||| The most common adverse reactions observed at a higher incidence than placebo in patients with Lennox-Gastaut syndrome were somnolence and vomiting. ||| Only constipation and dyspepsia were reported by a higher percentage among those receiving Cholestagel, compared with placebo. ||| Les effets indésirables les plus fréquemment observés à une incidence plus élevée que pour le placebo chez des patients atteints de syndrome de Lennox-Gastaut ont été la somnolence et les vomissements.
0.06695401668548584 ||| If an anaphylactic reaction or other serious allergic reaction occurs, administration of Humira should be discontinued immediately and appropriate therapy initiated. ||| If severe allergic or anaphylactic-type reactions occur, the administration of Replagal should be discontinued immediately and appropriate treatment initiated. ||| En cas de survenue d'une réaction anaphylactique ou d'une autre réaction allergique grave, l'administration d’ Humira doit être immédiatement interrompue et un traitement approprié mis en œ uvre.
0.6098719239234924 ||| 53 improved following discontinuation of therapy. ||| au accumulation was observed with either route of administration. ||| L'état des patients s'est amélioré après l'arrêt du traitement.
0.14279893040657043 ||| Rare pulmonary undesirable effects, in particular interstitial pneumonia, have been reported after G- CSF administration. ||| Rare pulmonary adverse reactions, in particular interstitial pneumonia, have been reported after G-CSF administration (see section 4.8). ||| Après administration de facteurs de croissance de la lignée granulocytaire (G-CSFs), de rares cas d'effets indésirables pulmonaires ont été rapportés, en particulier, des pneumonies interstitielles.
0.4004877507686615 ||| Trocoxil 20 mg chewable tablets for dogs Mavacoxib ||| Metacam 2.5 mg chewable tablets for dogs Bottle: ||| Trocoxil 20 mg comprimés à croquer pour chiens Mavacoxib
0.28622937202453613 ||| Medicinal products added to the insulin suspension may cause degradation of the insulin, e. g. if the medicinal products contain thiols or sulphites. ||| Similar to comparable products or thrombin solutions, the product may be denatured after exposure to solutions containing alcohol, iodine or heavy metals (e. g. antiseptic solutions). ||| Les médicaments ajoutés à la suspension d’ insuline peuvent entraîner une dégradation de l’ insuline, par exemple s’ ils contiennent des thiols ou des sulfites.
0.2547425329685211 ||| Rifampicin: in patients not also taking ciclosporin, concomitant administration of Mycophenolate mofetil and rifampicin resulted in a decrease in MPA exposure (AUC 0-12h) of 18% to 70%. It is recommended to monitor MPA exposure levels and to adjust Mycophenolate mofetil Teva doses accordingly to maintain clinical efficacy when rifampicin is administered concomitantly. ||| Co-administration of increased doses of fosamprenavir 1400 mg twice daily with lopinavir/ ritonavir 533/ 133 mg twice daily to protease inhibitor-experienced patients resulted in a higher incidence of gastrointestinal adverse events and elevations in triglycerides with the combination regimen without increases in virological efficacy, when compared with standard doses of fosamprenavir/ ritonavir. ||| Il est en conséquence recommandé de surveiller les niveaux d’ exposition au MPA et d’ adapter les doses de Mycophénolate mofétil Teva en conséquence afin de maintenir l’ efficacité clinique lorsque la rifampicine est administrée de façon concomitante.
0.26845139265060425 ||| No drug interaction study has been performed for the co-administration of VIRACEPT with benzodiazepines. ||| Non-clinical studies with the combination of alendronate and colecalciferol have not been conducted. ||| Aucune étude d’ interaction médicamenteuse n’ a été réalisée sur la co-administration de VIRACEPT avec les benzodiazepines.
0.11479420214891434 ||| The Committee recommended that Angiox be given marketing authorisation. ||| The Committee recommended that OPATANOL be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Angiox.
0.5737957954406738 ||| Publication of the editorial content of sites accessible via a global computer network ||| Sales promotion for others provided through the distribution and the administration of privileged user cards ||| Publication du contenu éditorial de sites accessibles via un réseau informatique mondial
0.32299184799194336 ||| Effects in the body worsening of asthma, dizziness, ringing in ears, increased prostate antigen. ||| Rare side effects Confusion, acute kidney problems, dry mouth, hair loss, psoriasis, enlargement of breasts in men. ||| Effets généraux: aggravation de l’asthme, étourdissements, bourdonnements d’oreilles, augmentation de l’antigène de la prostate.
0.41603851318359375 ||| Do not use if the eardrum is perforated. ||| - Do not use if the seal on the sachet is broken. ||| Ne pas administrer en cas de perforation de la membrane tympanique.
0.006926565431058407 ||| 19 Should exposure to AIIRAs have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended. ||| 32 Should exposure to AIIRAs have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended. ||| En cas d’ exposition aux ARAII à partir du 2ème trimestre de la grossesse il est recommandé de faire une échographie fœ tale afin de vérifier la fonction rénale et les os de la voute du crâne.
0.7463998198509216 ||| • 5-Aminolevulinic acid hydrochloride ||| Clostridium botulinum type A neurotoxin complex ||| 5-Aminolevulinic acid hydrochloride
0.0 ||| 6.6 Special precautions for disposal ||| 6.6 Special precautions for disposal ||| 6.6 Instructions pour l'utilisation, la manipulation et l' élimination
0.4185393452644348 ||| The main medical purpose of washing hands is to cleanse the hands of pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals which can cause harm or diseases. ||| However, the major cause of antimicrobial resistance in microorganisms from humans remains the use of antimicrobials in human medicine, in the community and in hospitals and other healthcare settings. ||| Le principal objectif médical du lavage des mains est d’éliminer les agents pathogènes (bactéries, virus ou autres microorganismes susceptibles de provoquer des maladies) et les produits chimiques, pouvant être nocifs ou provoquer des maladies.
0.022980056703090668 ||| Pull sheath away from the needle – do not twist sheath as needle may be loosened from Needle- Pro device. ||| Pull sheath away from the needle - do not twist sheath as needle may be loosened from Needle- Pro® device. ||| Retirer le capuchon protecteur de l’ aiguille - ne pas tourner le capuchon protecteur car l’ aiguille pourrait se détacher du dispositif Needle-Pro.
0.023104291409254074 ||| Patients already taking sitagliptin and metformin as separate tablets should switch to Efficib containing the same doses of both active substances. ||| Patients already taking sitagliptin and metformin as separate tablets should switch to Janumet containing the same doses of both active substances. ||| Les patients prenant déjà la sitagliptine et la metformine sous forme de comprimés séparés devraient prendre Efficib contenant les mêmes doses de ces deux principes actifs.
0.43767207860946655 ||| Based on animal studies, the rate of excretion is expected to be low. ||| It was also shown that there was a one-third reduction in annual relapse rate. ||| D’après les études chez l’animal, on peut s’attendre à un taux d’excrétion réduit.
0.022660817950963974 ||| Patients were randomized to receive either ViraferonPeg (100 or 150 µg /week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight). ||| Patients were randomized to receive either pegylated interferon alfa-2b (100 or 150 µg / week based on weight) plus ribavirin (800-1,200 mg/ day based on weight) or Viraferon (3 MIU TIW) plus ribavirin (800-1,200 mg/ day based on weight). ||| Les patients étaient 163 randomisés pour recevoir soit ViraferonPeg (100 ou 150 µg/ semaine, adapté en fonction du poids) en association avec de la ribavirine (800-1 200 mg/ jour, adaptée en fonction du poids) soit de l’ interféron alfa-2b (3 MUI trois fois par semaine) en association avec de la ribavirine (800-1 200 mg/ jour, adaptée en fonction du poids).
0.3444810211658478 ||| Propellers for boats ||| Masts for boats ||| Hélices pour bateaux
0.2708824574947357 ||| No dosage adjustment is necessary for efavirenz. ||| No dosage adjustment of digoxin is recommended. ||| Aucun ajustement posologique n’ est nécessaire pour ces médicaments.
0.24285104870796204 ||| 4 In a long-term randomised (4 to 6 year) monotherapy study in recently diagnosed patients with type 2 diabetes mellitus, an increased incidence of bone fractures was noted after the first year of treatment in female patients taking rosiglitazone (9.3%, 2.7 patients per 100 patient years) vs metformin (5.1%, 1.5 patients per 100 patient years) or glyburide/ glibenclamide (3.5%, 1.3 patients per 100 patient years). ||| Pharmacokinetic analysis revealed that adefovir exposure was comparable among 3 age groups, 2 to 6 years (0.3 mg/ kg), 7 to 11 years (0.25 mg/ kg) and 12 to 17 years (10 mg) and all age groups achieved adefovir exposure in the target range (for efficacy results see section 5.1), which was based on adefovir plasma concentrations in adult patients with chronic hepatitis B with established safety and efficacy profiles. ||| 4 Lors d'une étude à long terme (4 à 6 ans) en monothérapie randomisée chez des patients ayant un diabète de type 2 récemment diagnostiqué, une augmentation de l'incidence des fractures osseuses a été observée après la première année de traitement chez les patients de sexe féminin recevant rosiglitazone (9,3%, 2,7 patients pour 100 patients-année) vs metformine (5,1%, 1,5 patients pour 100 patients-année) ou glyburide/ glibenclamide (3,5%, 1,3 patients pour 100 patients-année).
0.48431330919265747 ||| Passive electronic ciruits ||| Examination fingercots ||| Circuits électroniques passifs
0.531993567943573 ||| The Prime Minister will certainly be looking at ways to recognise Tom's heroic efforts. ||| I am glad that the European Commission can support Gavi in such a crucial endeavour. ||| Plus tard dans la journée, un porte-parole du gouvernement britannique a déclaré que le premier ministre chercherait certainement une façon de reconnaître cet « effort héroïque ».
0.26816922426223755 ||| What Kinzalmono contains ||| What Kinzalkomb contains ||| Que contient Kinzalmono
0.01974918507039547 ||| Osteonecrosis: although the etiology is considered to be multifactorial (including corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index), cases of osteonecrosis have been reported particularly in patients with advanced HIV disease and/ or long term exposure to combination antiretroviral therapy (CART). ||| Osteonecrosis: although the etiology is considered to be multifactorial (including corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index), cases of osteonecrosis have been reported particularly in patients with advanced HIV-disease and/ or long-term exposure to combination antiretroviral therapy (CART). ||| L’ étiologie est considérée comme multifactorielle (incluant l’ utilisation de corticoïdes, la consommation d’ alcool, une immunosuppression sévère, un indice de masse corporelle élevé), cependant des cas d’ ostéonécrose ont été rapportés en particulier chez des patients à un stade avancé de la maladie liée au VIH et/ ou ayant un traitement par association d’ antirétroviraux au long cours.
0.3237622380256653 ||| Nappy pants for incontinents ||| Nappy liners of paper for incontinents ||| Couches-culottes pour incontinents
0.5580728054046631 ||| Inhalati on powder pre-dispensed 30 x 1 perforated unit dose blisters 60 x 1 perforated unit dose blisters ||| 10 vials of suspension (5 dose size) + 10 vials of emulsion (5 dose size) 25 doses: ||| 30 x 1 dose sous plaquette thermoformée prédécoupée tn
0.4957399368286133 ||| 10 ml single use vial. ||| Type I, 5 ml glass vial. ||| Flacon à usage unique 5 ml.
0.2322903275489807 ||| Calcium folinate should only be given by intramuscular or intravenous injection and must not be administered intrathecally. ||| If intravenous administration is impossible, naloxone hydrochloride can also be given intramuscularly or subcutaneously. ||| Le folinate de calcium doit être administré uniquement par voie intramusculaire ou intraveineuse et ne doit pas être administré par voie intrathécale.
3.9228207271077564e-13 ||| - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, ||| - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, ||| - Si l’ un des effets indésirables devient sérieux ou si vous remarquez des effets indésirables non
0.17773041129112244 ||| TAXOTERE should be used in specialised chemotherapy wards and it should only be given under the supervision of a doctor who is qualified in the use of anticancer chemotherapy. ||| Myocet should be used in units specialised in giving cytotoxic chemotherapy (cell-killing cancer treatments) under the supervision of a doctor who is qualified in the use of chemotherapy. ||| Le traitement par TAXOTERE doit être mis en place au sein de services spécialisés dans la chimiothérapie et ne doit être administré que sous la surveillance d’ un médecin dûment formé à l’ utilisation de la chimiothérapie anticancéreuse.
0.32016271352767944 ||| The presence of renal and hepatic impairment should not require a change in dosage. ||| 3 Insulin requirements may be reduced in the presence of renal impairment. ||| La présence d’ une insuffisance rénale ou hépatique ne devrait pas nécessiter d’ ajustement de la posologie.
0.5489603281021118 ||| Creatinine clearance (ml/ min) ||| serum creatinine (μmol/l) ||| Créatinine (ml/ min)
0.2294807732105255 ||| In a study using orally administered 14C-memantine, a mean of 84% of the dose was recovered within 20 days, more than 99% being excreted renally. ||| Pemetrexed is primarily eliminated in the urine, with 70% to 90% of the administered dose being recovered unchanged in urine within the first 24 hours following administration. ||| Dans une étude avec administration par voie orale de 14C-mémantine, 84% de la dose en moyenne a été retrouvée dans les 20 jours, dont plus de 99% par excrétion rénale.
0.5807212591171265 ||| In the main study, 60 (97%) of 62 patients had either complete or partial remission, and 47 (76%) had complete remission. ||| Of this group 1250 enrolled infants had 6 injections, 183 infants had 7 injections, and 27 infants had either 8 or 9 injections. ||| Dans l’ étude principale, sur 62 patients, 60 (97%) ont bénéficié d’ une rémission complète ou partielle, et 47 (76%) d’ une rémission complète.
0.45096009969711304 ||| Congenital disorders: see further details in section 4.6. ||| For information on reconstituting Synagis, see section 6.6. ||| Affections congénitales: voir rubrique 4.6 pour plus d’ information.
0.29684269428253174 ||| The dose may need to be adjusted in patients who have problems with their kidneys or certain side effects. ||| Any disease other than multiple sclerosis that could better explain signs and symptoms of the patient had to be excluded. ||| Il peut être nécessaire d’ ajuster la dose chez des patients ayant des problèmes de reins ou présentant certains effets indésirables.
0.16802799701690674 ||| 111 ||| 114 ||| 124
0.311371386051178 ||| Ventavis is intended for inhalation use by nebulisation (see section 6.6). ||| Zestril may be removed from the general circulation by haemodialysis (see section 4.4). ||| Ventavis est destiné à être administré par voie inhalée à l’ aide d’ un nébuliseur (voir rubrique 6.6).
0.06038467213511467 ||| 125 Č eská republika Novartis s. r. o. ||| Č eská republika Novartis s. r. o. ||| Č eská republika Novartis s. r. o.
0.40551096200942993 ||| Such vaccinations should be postponed for at least 3 months after the last infusion of Privigen. ||| Oral administration of other medicinal products should be avoided within 1 hour before and after administration of DUKORAL. ||| De telles vaccinations doivent être remises à 3 mois au moins après la dernière perfusion de PRIVIGEN.
0.002507106401026249 ||| Toxicological findings also well known from preclinical studies with angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists were: a reduction of red cell parameters (erythrocytes, haemoglobin, haematocrit), changes of renal haemodynamics (increased blood urea nitrogen and creatinine), increased plasma renin activity, hypertrophy/ hyperplasia of the juxtaglomerular cells and gastric mucosal injury. ||| 39 Toxicological findings also well known from preclinical studies with angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists were: a reduction of red cell parameters (erythrocytes, haemoglobin, haematocrit), changes of renal haemodynamics (increased blood urea nitrogen and creatinine), increased plasma renin activity, hypertrophy/ hyperplasia of the juxtaglomerular cells and gastric mucosal injury. ||| Les études précliniques déjà réalisées avec des inhibiteurs de l’ enzyme de conversion et des antagonistes de l’ angiotensine II ont mis en évidence les anomalies toxicologiques suivantes: diminution des paramètres érythrocytaires (érythrocytes, hémoglobine et hématocrite), modifications des paramètres hémodynamiques rénaux (augmentation du taux plasmatique d’ urée et de créatinine), augmentation de l’ activité rénine plasmatique, hypertrophie/ hyperplasie des cellules 44 juxtaglomérulaires et lésions de la muqueuse gastrique.
0.3451308012008667 ||| In very rare cases, hyperthermia and lethargy sometimes associated with lameness has been observed one to three weeks following booster vaccination in adult cats. ||| Neutrophil nadirs occurred at a median of 7 days but this interval may be shorter in heavily pre-treated patients. ||| Dans des cas très rares, de l’ hyperthermie et de la léthargie parfois associées avec des boiteries ont pu être observées une à trois semaines après la vaccination de rappel chez des chats adultes.
0.0 ||| In a clinical study, the concomitant use of erlotinib with ketoconazole (200 mg orally twice daily for 5 days), a potent CYP3A4 inhibitor, resulted in an increase of erlotinib exposure (86% of AUC and 69% of Cmax). ||| In a clinical study, the concomitant use of erlotinib with ketoconazole (200 mg orally twice daily for 5 days), a potent CYP3A4 inhibitor, resulted in an increase of erlotinib exposure (86% of AUC and 69% of Cmax). ||| Dans une étude clinique, l’ utilisation concomitante du kétoconazole (200 mg par voie orale deux fois par jour pendant 5 jours), un inhibiteur puissant du CYP3A4, a entraîné une augmentation de 86% de l’ aire sous la courbe [ASC] et de 69% de la Cmax de l’ erlotinib.
0.267436683177948 ||| Once opened, the vial should be used within 28 days. ||| After dilution, the product should be used immediately within 24 hours. ||| Une fois entamé, le flacon doit être utilisé dans les 28 jours.
0.07550093531608582 ||| Blankets, electric, for medical purposes ||| Belts, electric, for medical purposes ||| Couvertures électriques à usage médical
0.6255345344543457 ||| The COVID-19 crisis has demonstrated how vulnerable the increasing biodiversity loss makes us and how crucial a well-functioning food system is for our society. ||| The Covid-19-crisis has made getting aid to the most vulnerable members of our societies more challenging. ||| La crise provoquée par la pandémie de COVID-19 a mis en évidence notre vulnérabilité due à l'appauvrissement croissant de la biodiversité et démontré l'importance cruciale d'un système alimentaire efficace pour notre société.
0.011429961770772934 |||  311 PARTICULARS TO APPEAR ON THE OUTER PACKAGING |||  327 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 337 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.36186569929122925 ||| How to take Tandemact 4. ||| How to take Comtess 4. ||| Comment prendre Tandemact 4.
0.36181241273880005 ||| - beta-blockers (used to treat high blood pressure), ||| - fibrates (used to lower high levels of blood lipids), ||| - des bêta-bloquants (utilisés pour traiter l’ hypertension),
0.901658296585083 ||| Unfermented preserved must ||| Invented Name Strength ||| Moût conservé non fermenté
0.4145812392234802 ||| It reported that 13 countries had enacted preventive measures including the temporary closure of schools and universities, impacting 290.5 million students around the world. ||| Schools and universities have closed either on a nationwide or local basis in 193 countries, affecting approximately 99.4 percent of the world's student population. ||| L’organisation a déclaré que 13 pays avaient adopté des mesures de prévention, dont la fermeture temporaire des écoles et universités, touchant 290,5 millions d’élèves dans le monde.
0.5944231748580933 ||| *50% cell culture infectious dose **plaque-forming units ||| Distribution Methylnaltrexone undergoes moderate tissue distribution. ||| * dose infectant 50% des cultures cellulaires ** unités formant plages
0.6131922006607056 ||| Reclamation of solvents ||| Availability of medicines ||| Valorisation de solvants
0.08030429482460022 ||| Less common are pain at the place of injection, flushing, low or high blood pressure, dry or teary eyes, redness of skin or skin disorder, psoriasis, hives, nail disorder, feeling unwell, feeling faint, poor coordination, confusion, increased or decreased sensitivity to touch, tense muscles, arthritis, bruising, loss of interest in activities including sex, sexual problem, unusual dreams, shaky hands, vertigo (spinning feeling), increased appetite, heartburn, intestinal gas (flatus), constipation, hemorrhoids, red or bleeding gums, redness or sores in mouth, change in taste, changes in hearing or ringing in ears, thirst, changed behaviour or aggressive behaviour (sometimes directed against others), feeling sleepy, cold sores, fungal or bacterial infections, irritation of prostate gland, increased need to pass urine, ear or respiratory infections, sinusitis, stuffy or runny nose, abnormal hair texture, sensitivity to sunlight, migraine headache, eye pain or infection, blurred vision, puffy face, puffy hands or feet, enlarged liver, problem affecting ovary or vagina, pain in breast, difficulty in speaking and swollen glands. ||| Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of  423 liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis. ||| Les effets moins fréquents sont douleur au point d’ injection, bouffée de chaleur, pression sanguine élevée ou faible, œ il sec ou qui coule, rougeur ou trouble cutané, psoriasis, urticaire, lésion des ongles, sensation de mal-être, sensation de malaise, mauvaise coordination, confusion, sensibilité du toucher augmentée ou diminuée, tension musculaire, arthrite, ecchymoses, perte d’ intérêt pour les activités y compris le sexe, problèmes sexuels, rêves inhabituels, mains qui tremblent, vertige (sensation que ça tourne), augmentation de l’ appétit, brûlures d’ estomac, flatulence (gaz), constipation, hémorroïdes, rougeur ou saignement des gencives, rougeur ou aphtes dans la bouche, changement du goût, changements de l’ audition ou bourdonnement d’ oreille, soif, changement de comportement ou comportement agressif (parfois dirigé contre autrui), sensation de somnolence, boutons de fièvre, infections fongiques ou bactériennes, irritation de la prostate, envie plus fréquente d’ uriner, infections respiratoires ou de l’ oreille, sinusite, nez bouché ou qui coule, texture anormale des cheveux,
0.09535544365644455 ||| Fabrics made from polyester, other than for insulation ||| Fabrics made from silk, other than for insulation ||| Tissus en polyester autres que pour l'isolation
0.0 ||| No interaction studies have been performed. ||| No interaction studies have been performed. ||| Aucune étude d’ interaction n’ a été réalisée.
0.012698776088654995 ||| 200 mg dispersible/ chewable tablets: ||| 100 mg dispersible/ chewable tablets: ||| Comprimés dispersibles ou à croquer à 200 mg:
0.26080387830734253 ||| Flashings (Non-metallic -) for waterproofing buildings ||| Child resistant security closures (Non-metallic -) for containers ||| Solins non métalliques pour imperméabilisation de bâtiments
0.3444078862667084 ||| It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with the product. ||| Since no preservative is present, it is recommended that administration is started as soon as possible and within 3 hours of dilution. ||| Il est par conséquent recommandé de ne pas administrer d’ autre vaccin pendant les 14 jours qui précèdent et qui suivent la vaccination.
0.41760528087615967 ||| For detailed recommendations on the reconstitution and administration of the medicinal product see section 6.6. ||| 2 Method of administration For instructions on reconstitution prior to administration, see section 6.6. ||| Voir les recommandations détaillées sur la reconstitution et l’ administration du médicament dans la rubrique 6.6.
0.4172782599925995 ||| In patients with severe hepatic impairment (Child Pugh C), the dose of Tygacil should be reduced to 25 mg every 12 hours following the 100 mg loading dose. ||| Patients currently on methotrexate therapy (stable for  2 months) could continue at a stable dose of  25 mg/ week methotrexate. ||| Chez les patients avec une insuffisance hépatique sévère (score Child Pugh C), la dose de Tygacil doit être réduite à 25 mg toutes les 12 heures après une dose de charge de 100 mg.
0.33248984813690186 ||| Doxazosin potentiates the blood pressure lowering effect of other antihypertensives. ||| 32 NSAIDs may reduce the effect of diuretics and antihypertensive medicinal products. ||| La doxazosine exacerbe les effets hypotenseurs des autres anti-hypertenseurs.
0.5004202723503113 ||| Dosage adjustments are not required in elderly patients. ||| Overweight patients should continue their energy-restricted diet. ||| Un ajustement de la posologie n’ est pas requis chez les sujets âgés.
0.18892347812652588 ||| Ciprofloxacin should be administered by intravenous infusion. ||| 415 Ciprofloxacin Bayer should be administered by intravenous infusion. ||| La ciprofloxacine doit être administrée en perfusion intraveineuse.
0.17463380098342896 ||| In healthy elderly (65 and over) versus non-elderly subjects administered oral olanzapine, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| Chez le sujet sain âgé (65 ans et plus), par rapport au sujet sain jeune recevant l'olanzapine par voie orale, la demi-vie moyenne d’ élimination de l’ olanzapine est prolongée (51,8 versus 33,8 heures) et la clairance est réduite (17,5 vs 18,2 l/ heure).
0.40979906916618347 ||| One of the principal international forums is ICH and the EMEA will ensure adequate coordination and provision of expertise through its scientific committees. ||| Desktop videoconference services were tested between EMEA and some national authorities, with the aim of becoming fully operational in the near future. ||| L'ICH est l'un des principaux forums internationaux et l'EMEA garantira une coordination adéquate et une fourniture d'expertise par le biais de ses comités scientifiques.
0.4193706512451172 ||| it was not possible to establish a withdrawal period for cattle and pigs based on the data available; ||| It was concluded that the product is well tolerated by horses of different age. ||| il n’était pas possible de fixer un temps d’attente pour les bovins et les porcs en se fondant sur les données disponibles;
0.2826724946498871 ||| If any of these side effects cause you a problem, speak to your doctor. ||| > If any of these affects you, talk to your doctor or nurse. ||| Si vous êtes affecté par l’ un de ces effets indésirables, consultez votre médecin.
0.20462098717689514 ||| In the event of an overdose the patient should be monitored and appropriate supportive treatment should be given, if considered necessary. ||| If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. ||| En cas de surdosage, une surveillance du patient s’ impose et, si besoin, des traitements symptomatiques appropriés seront administrés.
0.26608505845069885 ||| Picture D ||| Picture B ||| Figure D 84 8.
0.5002262592315674 ||| Boxes (packaging -) in collapsible form [wood] ||| cartridge (glass) in a pre- filled pen (OptiSet) ||| Boîtes d'emballage pliables en bois
0.2552638053894043 ||| Due to an increase in the unbound darunavir plasma concentrations, PREZIST A should be used with caution in patients with mild or moderate hepatic impairment (see sections 4.2, 4.3 and 5.2). ||| In patients with pre-existing conduction problems (second degree or higher atrioventricular or complex bundle-branch block), REYATAZ should be used with caution and only if the benefits exceed the risk (see section 5.1). ||| En raison d’une augmentation des concentrations plasmatiques de darunavir libre, PREZISTA doit être utilisé avec prudence chez ces patients ayant une insuffisance hépatique légère ou modérée (voir rubriques 4.2, 4.3 et 5.2).
0.4325277507305145 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Aivlosin are greater than any risks when Aivlosin is mixed into animal feed or drinking water and then used as described in the package leaflet. ||| If you have not been provided probenecid, please contact your pharmacist or the local representative of the Marketing Authorisation Holder of Vistide for information (see also section 3 How to use VISTIDE, Why is the medication given with probenecid). ||| Le comité des médicaments à usage vétérinaire (CVMP) a estimé que les bénéfices d’ Aivlosin sont supérieurs à ses risques quand Aivlosin est mélangé à l'alimentation des animaux ou à l'eau potable, puis utilisé selon la notice.
0.0 ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 20 4.5 Interactions avec d’ autres médicaments et autres formes d’ interactions
0.30717673897743225 ||| Do not add water to bottles of VIRACEPT powder. ||| Do not mix the powder inside the bottles of REYATAZ. ||| Ne pas ajouter d’eau dans les flacons de VIRACEPT poudre.
0.31415829062461853 ||| Epoetin beta is identical in its amino acid and carbohydrate composition to erythropoietin that has been isolated from the urine of anaemic patients. ||| Unlike phenytoin and carbamazepine however, zonisamide acts preferentially on seizures originating in the cortex. ||| La composition en hydrates de carbone et en acides aminés de l'epoetin beta est identique à celle de l'érythropoïétine isolée à partir de l'urine des malades anémiques.
0.036355599761009216 ||| Fewer EVISTA treated women than placebo treated women required surgical intervention for uterine prolapse. ||| Fewer OPTRUMA treated women than placebo treated women required surgical intervention for uterine prolapse. ||| Un nombre plus faible de patientes traitées par EVISTA par comparaison au placebo a eu recours à une intervention chirurgicale pour prolapsus utérin.
0.27040013670921326 ||| As with other blood pressure lowering medicines, the effect of PritorPlus may be reduced when you take NSAIDs (non steroidal anti-inflammatory medicines, e. g. aspirin or ibuprofen). ||| Medicinal products for the treatment of hypersensitivity reactions, e. g. adrenaline, antihistamines and corticosteroids, should be available for immediate use in the event of an allergic reaction during administration of Zevalin. ||| Comme avec d’ autres médicaments diminuant la pression artérielle, l’ effet de PritorPlus peut être réduit en cas de prise simultanée d’ un AINS (médicament anti-inflammatoire non stéroïdien, par exemple aspirine ou ibuprofène).
0.6721150875091553 ||| This is stated on the outer carton and the blister foil. ||| It is printed on the labels and on the carton. ||| Elle est indiquée sur l’ emballage extérieur et la feuille d’ aluminium.
0.1916065216064453 ||| Use in elderly (over 65 years of age) No dose reduction is necessary in elderly patients. ||| Elderly (age 65 years or over) In elderly patients, caution is required when increasing the dosage. ||| Utilisation chez le sujet âgé (âgé de plus de 65 ans) Aucune réduction posologique n’ est nécessaire chez le sujet âgé.
0.40730956196784973 ||| Very Common Uncommon Rare Very ||| Very Common Common Uncommon Rare Very rare ||| Très Fréquent Peu fréquent Rare Très
5.631899026997678e-13 ||| 6. ||| 6. ||| 15 6.
0.5102550983428955 ||| Uncommon: muscular weakness. ||| Uncommon: insomnia, restlessness ||| Peu fréquent: faiblesse musculaire.
0.43318063020706177 ||| OPTISON was more effective than the reference medicine at increasing the ability to see the endocardium of the left ventricle. ||| These will monitor the amount of iron in your body (blood level of ferritin) to see how well EXJADE is working. ||| OPTISON s’ est révélé plus efficace que le médicament de référence pour accroître la visibilité de l’ endocarde du ventricule gauche.
0.2724805772304535 ||| For patients who develop osteonecrosis of the jaw while on bisphosphonate therapy, dental surgery may exacerbate the condition. ||| Hypocalcemia and other disturbances of bone and mineral metabolism should be effectively treated before starting Bondronat therapy for metastatic bone disease. ||| La chirurgie dentaire peut aggraver l’ état des patients développant une ostéonécrose de la mâchoire pendant un traitement par bisphosphonate.
0.21313932538032532 ||| Each ml of Vimpat syrup contains 280 mg sorbitol (E420), 0.2 mg sodium propylparahydroxybenzoate (E217), 2.0 mg sodium methylparahydroxybenzoate (E219), 0.05 mg aspartame (E951) and 1.89 mg sodium. ||| Each dose (24 ml) contains 36 mg methyl parahydroxybenzoate (E218), 3.6 mg propyl parahydroxybenzoate (E216), 1.2 mg Sunset Yellow (E110) and has a sodium content of 254 mg. ||| Chaque ml de Vimpat sirop contient 280 mg de sorbitol (E420), 0,2 mg de parahydroxybenzoate de propyle sodique (E217), 2,0 mg de parahydroxybenzoate de méthyle sodique (E 219), 0,05 mg d’ aspartame (E 951) et 1,89 mg de sodium.
0.09100969135761261 ||| What Ambirix looks like and contents of the pack ||| What Pandemrix looks like and contents of the pack ||| Qu’est-ce-qu’ Ambirix et contenu de l’emballage extérieur
0.05410943552851677 ||| The estimated time to first emesis in the combined analysis is depicted by the Kaplan-Meier plot in Figure 1. ||| 20 The estimated time to first emesis in the study is depicted by the Kaplan-Meier plot in Figure 2. ||| Dans l’analyse combinée, le temps estimé jusqu’au premier vomissement est donné par la courbe de Kaplan-Meier sur la Figure 1.
4.0937305628707676e-13 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000 ||| 210 Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000
0.3735915422439575 ||| TORISEL is a selective inhibitor of mTOR (mammalian target of rapamycin) that blocks tumour cell growth and division. ||| Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. ||| TORISEL est un inhibiteur sélectif de la protéine mTOR (cible de la rapamycine chez les mammifères), qui bloque la croissance et la division des cellules tumorales.
0.4403528571128845 ||| The pouch must not be opened until the patient has been prepared for injection. ||| Treated animals therefore should not be bathed until the solution has dried. ||| L’étui ne doit pas être ouvert avant que le patient n’ait été préparé pour l’injection.
0.7858442068099976 ||| Tuition in law ||| The expiry ||| Cours de droit
0.5165993571281433 ||| Belt sanding machines ||| Electric knitting machines ||| Ponceuses à bande
0.33474093675613403 ||| 5 (0.2) ||| 5 (0.6) 5 ||| 5 (0,2)
0.0 ||| The solution should be inspected visually for particulate matter and discolouration prior to administration. ||| The solution should be inspected visually for particulate matter and discolouration prior to administration. ||| Inspecter visuellement la solution pour vérifier l’ absence de particules ou de décoloration avant emploi.
0.30914801359176636 ||| The support will be given in the form of subsidised loans at favourable interest rates which can be redeemed by 30 September 2021 in an amount not exceeding 75% of the actual damage incurred by the beneficiary companies from 1 March until at the latest 31 August 2020 directly due to the coronavirus outbreak. ||| Sweden decided to complement the existing scheme by providing for compensation of the damage directly linked to the coronavirus outbreak to those airlines which are eligible for a State guarantee under the existing scheme, but which face difficulties in obtaining loans from credit institutions under the conditions prescribed in the approval decision of 11 April 2020. ||| Le soutien sera octroyé sous la forme de prêts bonifiés à taux d'intérêts réduits qui pourront être amortis au 30 septembre 2021 à hauteur d'un montant ne dépassant pas 75 % des dommages réels subis par les sociétés bénéficiaires entre le 1er mars et au plus tard le 31 août 2020 en conséquence directe de la pandémie de coronavirus.
0.6446821689605713 ||| If pemetrexed solutions contact the mucous membranes, flush thoroughly with water. ||| If foam forms, let vial stand to allow foam to dissipate. ||| En cas de contact de la solution de pemetrexed avec les muqueuses, rincer abondamment avec de l’ eau.
0.3321536183357239 ||| In 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/ day was not associated with any distinguishing profile of adverse events. ||| In patients > 75 years undergoing orthopaedic surgery, the estimated plasma clearance was 1.2 to 1.4 times lower than in patients < 65 years. du ||| Chez 44 patients schizophrènes et âgés de plus de 65 ans, des doses de 5 à 20 mg par jour n’ ont pas été associées à un profil d’ effets indésirables particulier.
0.4070645868778229 ||| The wide variation in individual responses implies that the effects of CEPROTIN on coagulation parameters should be checked regularly. ||| Consumer price movements and any possible partitioning of the internal market will be monitored closely to avoid adverse effects. ||| La grande variation des réponses individuelles nécessite que les effets de CEPROTIN sur les paramètres de la coagulation soient vérifiés régulièrement.
0.7878022193908691 ||| Dilution requirements for ECALTA administration ||| ICH-derived CPMP guidelines ||| Dilutions pour l’ administration d’ ECALTA
0.8731028437614441 ||| The first case was a Sonangol employee who flew from Lisbon to Luanda. ||| Chen Qiushi, a Chinese citizen journalist who disappeared in February 2020. ||| Le premier cas était un employé de Sonangol qui a pris l'avion de Lisbonne à Luanda.
0.3718832731246948 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "There is a global consensus on the importance of enhancing and accelerating coronavirus related research and the production of relevant products to address the current emergency health crisis. ||| Trade Commissioner Phil Hogan and Mexican Minister of Economy Graciela Márquez Colín - in a phone call today - agreed on the exact scope of the reciprocal opening of public procurement markets and a high level of predictability and transparency in public procurement processes. ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Il existe un consensus au niveau mondial sur l'importance d'intensifier et d'accélérer la recherche liée au coronavirus et la fabrication de produits utiles pour faire face à l'urgence sanitaire actuelle.
0.0 ||| Oral use ||| Oral use ||| Orale
3.6074431202653967e-13 ||| Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child. ||| Pregnancy If you become pregnant, or are planning to become pregnant, you must contact your doctor to discuss the potential adverse effects and the benefits and risks of your antiretroviral therapy to you and your child. ||| 74 Grossesse Si vous êtes enceinte, ou envisagez une grossesse, vous devez contacter votre médecin afin de discuter avec lui des effets indésirables possibles ainsi que du bénéfice/ risque liés à votre traitement antirétroviral, pour vous et votre enfant.
0.445196270942688 ||| The frequency as reported in clinical trials was 9.4% following multiple injections of 0.25 mg cetrorelix. ||| The second study compared the effectiveness of the 60- and 30-microgram doses in 802 patients. ||| Leur fréquence, observée dans les études cliniques, était de 9,4% après injections multiples de 0,25 mg de cétrorélix.
0.12867562472820282 ||| 36 1. ||| 38 1. ||| 38 1.
0.3308388292789459 ||| If you have used more KOGENATE Bayer 2000 IU than you should, please inform your doctor. ||| If you think you have injected more NeoRecormon than you should, contact your doctor. ||| Si vous avez pris plus de KOGENATE Bayer 2000 UI que vous n'auriez dû, informez votre médecin.
0.4406108260154724 ||| The significance of these data in pregnant women is not known; therefore the use of AMMONAPS is contra-indicated during pregnancy (see section 4.3). ||| However the company challenged this view and proposed a contraindication through out pregnancy, based on data from the ramipril pregnancy register. ||| La signification de ces données pour la femme enceinte n'est pas connue; par conséquent, l'utilisation d’ AMMONAPS est contre-indiquée pendant la grossesse (voir rubrique 4.3).
0.23863361775875092 ||| Repeated subcutaneous administration at dosages of 2 -20 mg/ kg produced no change in the blood profile, with neither bioaccumulation of robenacoxib nor enzyme induction. ||| The parent substance mycophenolate mofetil can be measured systemically during intravenous infusion; however, after oral administration it is below the limit of quantitation (0.4 μ g/ ml). ||| Des injections sous-cutanées répétées de robenacoxib à des doses de 2-20 mg/ kg n’ ont pas entraîné de modifications du profil sanguin, ni de bioaccumulation du robenacoxib, ni d'induction enzymatique.
0.0 ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F- 69007 Lyon, France
0.1381230652332306 ||| XERISTAR should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus. ||| REYATAZ should be used during pregnancy only if the potential benefit justifies the potential risk. ||| XERISTAR ne doit être administré pendant la grossesse que si les bénéfices potentiels justifient les risques fœ taux potentiels.
0.4469301104545593 ||| Please follow these recommendations closely as they will give you the best chance to delay development of a resistance to the medicinal product. ||| This set of recommendations will ease their already stressful mission and it will bring more safety and predictability to their work." ||| Veuillez suivre étroitement ses recommandations car elles vous donneront la meilleure chance de retarder le développement d'une résistance au médicament.
0.47980576753616333 ||| On 27 January, following the developments of COVID-19 outbreak in mainland China, Finland's Ministry for Foreign Affairs advised citizens to avoid unnecessary travel to Hubei province. ||| After Denver withdrew, citing scheduling conflicts, Las Vegas was chosen as the original host on December 12, 2018, coinciding with the Las Vegas Raiders' arrival in the city. ||| Le 27 janvier, à la suite de l'évolution de l'épidémie de Covid-19 en Chine continentale, le ministère finlandais des Affaires étrangères conseille aux citoyens d'éviter les déplacements inutiles dans la province du Hubei.
0.2836204767227173 ||| With hydrochlorothiazide, onset of diuresis occurs in 2 hours, and peak effect occurs at about 4 hours, while the action persists for approximately 6-12 hours. ||| In most patients, after administration of a single oral dose, onset of antihypertensive activity occurs within 2 hours, and the peak reduction of blood pressure is achieved within 4-6 hours. ||| La diurèse commence deux heures après une administration orale d’ hydrochlorothiazide; elle atteint son maximum environ 4 heures après la prise pour se maintenir pendant environ 6 à 12 heures.
0.32126176357269287 ||| (39-06) 59 94 39 45/46 Fax (39-06) 59 94 32 17 E-mail: alimentivet@sanita.it ||| Tel: + 353 91 841788 Fax: + 353 91 842937 e-mail: sales@chanellegroup. ie ||| (39-06) 59 94 39 45/ 46 fax (39-06) 59 94 32 17 e-mail: alimentivet@sanita. it
0.1388646513223648 ||| EU/ 1/ 00/ 163/ 001 EU/ 1/ 00/ 163/ 002 ||| EU/ 1/ 99/ 128/ 030 EU/ 1/ 99/ 128/ 031 ||| EU/ 1/ 00/ 163/ 001
0.5572279691696167 ||| These are insufficient to make dosage recommendations and therefore use in this age group is not recommended. ||| The additionality requirements under this window would also differ from those envisaged for the other windows. ||| Elles sont insuffisantes pour recommander une posologie et en conséquence l'utilisation n'est pas recommandée dans cette tranche d'âge.
0.38094860315322876 ||| After dilution, the concentration of atosiban is 0.75 mg/ ml. ||| In liver transplant, the starting dose is 0.10 to 0.20 mg/ kg. ||| Après dilution selon les instructions en 6.6, la concentration en atosiban est de 0,75 mg/ ml.
0.34401530027389526 ||| If your OptiSet is in cool storage, take it out 1 to 2 hours before you inject to allow it to warm up to room temperature. ||| Throw away the bottle 28 days after first opening it, but don’ t dispose of medicine in your waste water or your household waste. ||| Si votre OptiSet est conservé au frais, sortez le 1 à 2 heures avant votre injection pour lui permettre de se réchauffer à température ambiante.
0.28786924481391907 ||| Certain severe adverse drug reactions may be related to the rate of infusion. ||| 20 Serious allergic reactions may occur following the administration of proteins. ||| Certains effets indésirables graves peuvent être liés au débit de la perfusion.
0.1310809850692749 ||| These side effects may be more severe when TAXOTERE is used with other anticancer medicines. ||| These side effects may be more severe when Docetaxel Winthrop is used with other anticancer medicines. ||| Ces effets indésirables peuvent être accentués lorsque TAXOTERE est utilisé en association avec d’ autres médicaments anticancéreux.
0.3228048086166382 ||| NovoRapid produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. ||| Mixing Levemir with a rapid acting insulin analogue like insulin aspart, results in an action profile with a lower and delayed maximum effect compared to separate injections. ||| NovoRapid possède un délai d’ action plus rapide que l’ insuline humaine soluble, de plus la glycémie se maintient à des valeurs plus basses dans les quatre heures qui suivent le repas.
0.5037239789962769 ||| EMEA 2004 |||  EMEA 2004 ||| EMEA 2004 CPMP/3258/03
0.4250994324684143 ||| The Emergency Support Instrument (ESI) allows the EU budget to step in to provide emergency support to allow the Union as a whole to address the human and economic consequences of a crisis such as the ongoing pandemic. ||| As a long-standing humanitarian donor committed to support the most vulnerable people of Palestine, the EU continues to provide assistance in critical sectors such as health care, education and safe water. ||| L'instrument d'aide d'urgence (ESI) autorise l'intervention du budget de l'UE afin de fournir une aide d'urgence permettant à l'Union dans son ensemble de faire face aux conséquences humaines et économiques d'une crise telle que la pandémie actuelle.
0.0 ||| Additional doses may need to be considered for persons who do not respond or have a sub-optimal response to a course of vaccinations. ||| Additional doses may need to be considered for persons who do not respond or have a sub-optimal response to a course of vaccinations. ||| Des doses supplémentaires peuvent être envisagées chez les sujets ne répondant pas ou répondant moins bien à l’ administration du schéma de vaccination.
0.06321985274553299 ||| This medicinal product has been authorised under “ Exceptional Circumstances”. ||| The medicinal product has been authorised under “ Exceptional Circumstances” ||| 20 Une autorisation de mise sur le marché « sous circonstances exceptionnelles » a été délivrée à ce médicament.
0.22138884663581848 ||| 195 • seeing or hearing things that are not real (hallucinations), confusion, having unusual dreams, difficulty in sleeping • involuntary movements related to Parkinson’s disease (dyskinesia), feeling dizzy when standing up because of a fall in blood pressure, headache • vomiting, diarrhoea, constipation, heartburn, dry mouth • increased or abnormal liver function test results • rash, redness, itching, increased sweating • swelling of legs and feet, feeling weak, weight loss • falling ||| Talk to your doctor for advice on how to minimize the risk of bleeding. • Feeling drowsy and sleepy; headache; dizziness. • shortness of breath, difficult or laboured breathing; cough. • Feeling of an upset stomach (nausea); being sick/ throwing up (vomiting); diarrhoea; constipation • Muscle pain. • Swelling of parts of the body due to accumulation of abnormal amounts of fluid (oedema). • High body temperature (fever); tiredness; feeling weak/ loss of strength. ||| Effets indésirables fréquents (survenant chez 1 à 10 patients sur 100) • voir ou entendre de choses qui n’ existent pas (hallucinations), confusion, rêves anormaux, difficultés d’ endormissement • mouvements involontaires liés à la maladie de Parkinson (dyskinésie), étourdissements lors du passage à la station verticale dus à une chute de la tension artérielle, céphalées • vomissements, diarrhée, constipation, sécheresse de la bouche, brûlures d’ estomac • augmentation ou anomalies des résultats des tests de la fonction hépatique • éruption cutanée, rougeurs, démangeaisons, transpiration accrue • oedème des jambes et des pieds, sensation de faiblesse, perte de poids • chutes
0.1977950632572174 ||| How to take Naglazyme 4. ||| How to store Naglazyme 6. ||| Comment utiliser Naglazyme 4.
0.0 ||| Metabolism and nutritional disorders ||| Metabolism and nutritional disorders ||| 7 Troubles du métabolisme et de la nutrition
5.0013988718740354e-14 ||| Other signs and symptoms of overdose are drowsiness, low body temperature, slow heart rate, decreased muscle tone, deep sedation, loss of muscle co-ordination, constriction of the pupils and convulsions. ||| Other signs and symptoms of overdose are drowsiness, low body temperature, slow heart rate, decreased muscle tone, deep sedation, loss of muscle co-ordination, constriction of the pupils and convulsions. ||| 89 Les autres signes et symptômes de surdosage sont la somnolence, la diminution de la température corporelle, un ralentissement de la fréquence cardiaque, une diminution du tonus musculaire, une sédation profonde, la perte de la coordination musculaire, une constriction des pupilles et des convulsions.
0.3944714069366455 ||| Thermostat controllers ||| Biometric scanners ||| Contrôleurs thermostatiques
0.16399657726287842 ||| 20 mg ||| 25 mg ||| Robenacoxib 20 mg
0.16103586554527283 ||| Testing apparatus not for medical purposes ||| Testing apparatus for medical purposes ||| Appareils pour l'analyse non à usage médical
0.24385210871696472 ||| - Sodium chloride ||| - Sodium citrate ||| - Chlorure de sodium
0.0 ||| Concentrate for solution for infusion ||| Concentrate for solution for infusion ||| Solution à diluer pour Voie intraveineuse perfusion
0.23828306794166565 ||| Expel air from the syringe and needle by holding the syringe vertically and gently pressing the plunger upwards. ||| Remove them by gently tapping the syringe and pushing the plunger to the respective marking on the syringe. ||| Chasser l’ air de la seringue et de l’ aiguille en tenant la seringue à la verticale et en poussant doucement sur le piston.
0.4489070773124695 ||| You will take Temodal alone once daily for the first 5 days. ||| 26 Your doctor will give you Evoltra once every day for 5 days. ||| Vous prendrez Temodal seul une fois par jour pendant les 5 premiers jours.
0.5419716835021973 ||| Ultratard should be protected from excessive heat and sunlight. ||| Avoid exposure to strong sunlight, or artificial UV light such as sunbeds. ||| Ultratard doit être conservé à l'abri de la chaleur excessive et de la lumière. nt
0.0 ||| 98 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 98 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 104 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.0 ||| Pharmaceutical Form ||| Pharmaceutical Form ||| pharmaceutique
0.5426362156867981 ||| Clapperboards ||| Staircases ||| Claquettes
0.3618351221084595 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| To prevent licking, apply topically to the skin restricting the area of application to the cat’ s neck at the base of the skull. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
0.39012646675109863 ||| Take special care with NovoMix 70 ||| 20 Take special care with DuoTrav ||| Faites attention avec NovoMix 70
0.12911921739578247 ||| Sonata 10 mg hard capsules zaleplon ||| Zerene 5 mg hard capsules zaleplon ||| Sonata 10 mg gélules (zaleplon)
0.3095005452632904 ||| Mixtures of chemicals and microorganisms for increasing the nutritional value of animal fodder [other than for veterinary use] ||| Mixtures of bacterial concentrates for addition to silages [other than for medical or veterinary use] ||| Mélanges de produits chimiques et de micro-organismes accroissant la valeur nutritionnelle des aliments pour animaux autres qu'à usage vétérinaire
0.4117656946182251 ||| CLL affects a particular lymphocyte, the B cell, which originates in the bone marrow and develops in the lymph nodes. ||| MS is a disease of the nerves, in which inflammation destroys the protective sheath around the nerves. ||| La LLC affecte un type particulier de lymphocyte, le lymphocyte B, qui est fabriqué dans la moelle osseuse puis se développe dans les ganglions lymphatiques.
0.2659044563770294 ||| To avoid extravasation, a free-flowing intravenous line should be established before starting Visudyne infusion and the line should be monitored. ||| Therefore, the perfusion of the optic nerve head should be verified and elevation of intraocular pressure should be managed appropriately post injection. ||| Afin d'éviter toute extravasation, une voie intraveineuse à écoulement libre doit être posée avant le début de la perfusion, et contrôlée par monitoring.
0.3668091893196106 ||| Cladding panels of metal for roofing ||| Rotating junctions of metal for pipes ||| Panneaux de bardage métalliques pour toitures
0.7009854912757874 ||| We will remember the Suzanne's incredible gesture to leave her ventilator to someone younger than her in Belgium, and the image of Francis who waved goodbye to his brother through a hospital window in Ireland. ||| "A few days ago, this horrible virus hit us very closely, it took away a young life, a young man who worked right here with us in the European Parliament. ||| Nous nous souviendrons du geste incroyable de Suzanne de laisser son respirateur aux plus jeunes en Belgique - et de l'image de Francis faisant ses adieux à son frère à travers une fenêtre d'hôpital en Irlande.
0.2974998354911804 ||| 1.5 mg/ ml ||| 0.5 mg/L ||| Méloxicam 1,5 mg/ ml
0.0963456779718399 ||| • 14.02.2001 ||| • 23.02.2001 ||| 03.01.2001 14.02.2001
0.25464797019958496 ||| Each vial contains 90 mg of ustekinumab in 1 ml. ||| Each ampoule with 1 ml contains 10 micrograms iloprost. ||| Chaque flacon de 1 ml contient 90 mg d’ ustkinumab.
0.4200422167778015 ||| Certain severe adverse drug reactions may be related to the rate of infusion. ||| Local skin reactions can be a sign that the drug is working as intended. ||| Certains effets indésirables graves peuvent être liés au débit de la perfusion.
0.09156014025211334 ||| HOW TO STORE HUMALOG MIX25 ||| HOW TO STORE HUMALOG MIX25 PEN ||| COMMENT CONSERVER HUMALOG MIX25
0.5832419395446777 ||| Careful monitoring of glucose control is essential. ||| Blood glucose monitoring is recommended. ||| Une surveillance soigneuse de l'équilibre glycémique est indispensable.
0.3516294062137604 ||| Your baby ’ s doctor will decide how long your baby should be treated with INOmax. ||| Your baby ’ s doctor will examine your baby closely for all side effects. ||| Le médecin de votre enfant déterminera la durée du traitement par INOmax.
0.3952515423297882 ||| More than one dose must not be administered per vial. ||| The first dose should not be administered less than 24 hours ||| Ne pas utiliser un même flacon pour l’ injection de plusieurs doses.
0.41618722677230835 ||| Usual warning symptoms may disappear in patients with longstanding diabetes. ||| Most side effects occur in patients with chronic renal failure or cancer. ||| Les signes précurseurs habituels peuvent disparaître chez les patients présentant un diabète ancien.
0.5158019065856934 ||| Atripla has not been evaluated in the presence of food. ||| ESAs are not indicated for use in this patient population. ||| Atripla n’ a pas été évalué en présence de nourriture.
0.0 ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| Any unused product or waste material should be disposed of in accordance with local requirements. ||| Les produits non utilisés ou les déchets doivent être détruits conformément aux réglementations locales.
0.4451599717140198 ||| Installations for automated washing of vehicles ||| Provision of testing facilities for firearms ||| Installations de lavage automatisé de véhicules
0.30402326583862305 ||| Imatinib in combination with chemotherapy induction (see Table 5) resulted in a complete haematological response rate of 93% (147 out of 158 evaluable patients) and in a major cytogenetic response rate of 90% (19 out of 21 evaluable patients). ||| In a randomised, placebo-controlled, double-blind study (study 1, see section 5.1) the incidence of treatment-emergent cardiac ischaemia/ infarction events was higher in the Nexavar group (2.9%) compared with the placebo group (0.4%). ||| L’ imatinib en association avec la chimiothérapie d’ induction (voir Tableau 5) a permis d’ obtenir un taux de réponse complète hématologique de 93% (147 sur 158 patients évaluables) et un taux de réponse cytogénique majeure de 90% (19 sur 71 21 patients évaluables).
0.20651131868362427 ||| The most common side effects with Infanrix Hexa (seen in more than 1 in 10 doses of the vaccine) are loss of appetite, fever of 38ºC or more, local swelling, pain and redness at the injection site, fatigue (tiredness), abnormal crying, irritability and restlessness. ||| Allergic-type reactions to Neulasta, including redness and flushing, skin rash, raised areas of the skin that itch and anaphylaxis (weakness, drop in blood pressure, difficulty breathing, swelling of the face), have rarely (likely to occur in fewer than 1 in 1000 patients) been reported. ||| Les effets indésirables les plus couramment observés sous Infanrix Hexa (dans plus d’ une dose sur dix du vaccin) sont les suivants: perte d’ appétit, fièvre supérieure ou égale à 38°, gonflement localisé, douleur et rougeur au site d’ injection, fatigue, cris inhabituels, irritabilité et agitation.
0.08048222213983536 ||| 5 (6) Very common: ||| 5 (5) Very common: ||| 5 (6) Très fréquent:
0.430486261844635 ||| Otherwise, use only according to the risk-benefit assessment and subject the dog to regular clinical evaluations. ||| During treatment periodic check-ups are recommended of a frequency and nature adapted to the individual woman. ||| Au-delà, l’ utilisation ne doit se faire que conformément à l’ évaluation bénéfice/ risque établie par le vétérinaire et le chien doit être soumis à des visites de contrôle.
0.14765819907188416 ||| Patients with hepatic impairment AVAGLIM is contraindicated in patients with hepatic impairment (see section 4.3). ||| Use in patients with hepatic impairment Losartan/ HCTZ is contraindicated in patients with severe hepatic impairment (see section 4.3.). ||| Insuffisant hépatique AVAGLIM est contre-indiqué chez les patients atteints d’ insuffisance hépatique (voir rubrique 4.3).
0.7395542860031128 ||| Neuroleptic Malignant Syndrome (NMS): ||| Psychiatric and Central Nervous System (CNS): ||| Syndrome Malin des Neuroleptiques (SMN):
0.32499879598617554 ||| Interactions In clinical studies, PRILACTONE was co-administered with furosemide and pimobendan without evidence of associated adverse reactions. ||| Bioequivalence studies in healthy volunteers have shown Competact to be bioequivalent to the administration of pioglitazone and metformin given as separate tablets. ||| Interactions médicamenteuses et autres Lors des essais cliniques, PRILACTONE a été administré avec du furosémide et du pimobendane, aucun effet indésirable associé n’ a été mis en évidence.
0.3382970690727234 ||| The effect of pioglitazone (45 mg monotherapy vs. placebo) was studied in a small 18-week trial in type 2 diabetics. ||| 1 Hypercholesterolaemia was reported in up to 5.3% of patients treated with rosiglitazone (monotherapy, dual or triple oral therapy). ||| Les effets de la pioglitazone (45 mg en monothérapie versus placebo) ont été étudiés dans un essai de 18 semaines chez des patients diabétiques de type 2.
0.36093711853027344 ||| 23 Other In patients receiving thiazides, hypersensitivity reactions may occur with or without a history of allergy or bronchial asthma. ||| Allergic contact dermatitis, contact urticaria syndrome or hypersensitivity to alcohol or additives present in alcohol hand rubs rarely occur. ||| Autre Des réactions d'hypersensibilité peuvent survenir chez les patients ayant ou non des antécédents d'allergies ou d'asthme bronchique et traités par diurétiques thiazidiques.
0.42088592052459717 ||| Providing video entertainment via a website ||| Providing business information via a web site ||| Fourniture de divertissements vidéos via un site web
0.31373482942581177 ||| Sanofi Winthrop Industrie 1, rue de la Vierge Ambarès & Lagrave F-335 65 Carbon Blanc cedex France ||| Glaxo Wellcome Production 1, rue de l’ Abbaye F-76960 Notre Dame de Bondeville France ||| Sanofi Winthrop Industrie 1, Rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc cedex France
0.06059502065181732 ||| 3 million IU/0.5 ml ||| 3 million IU/ 0.5ml ||| 3 millions d’ UI/ 0,5 ml
0.6710662245750427 ||| Treatment of narcolepsy with cataplexy in adult patients. ||| • metastatic cancer of the large intestine. ||| Traitement de la narcolepsie chez les patients adultes présentant une cataplexie.
0.14168810844421387 ||| How has Noxafil been studied? ||| How has Fendrix been studied? ||| Quelles études ont été menées avec Noxafil?
0.24540093541145325 ||| Viracept 50 mg/g oral powder Nelfinavir ||| Ziagen 20 mg/ ml oral solution Abacavir ||| Viracept 50 mg/g poudre orale Nelfinavir
0.013645950704813004 ||| 1 pre-filled syringe with 1.2 ml solvent for reconstitution contains sodium chloride solution 5.4 mg/ ml. ||| 1 pre-filled syringe with 1.2 ml solvent for reconstitution contains: sodium chloride solution 5.4 mg/ ml. ||| 1 seringue préremplie de 1,2 ml de solvant pour reconstitution contenant du chlorure de sodium 5,4 mg/ml.
0.29330116510391235 ||| However, polymicrobial intra-abdominal infections have shown to respond to treatment with tigecycline in clinical trials. ||| Studies in vitro and in animal models demonstrate that abatacept modulates T lymphocyte-dependent antibody responses and inflammation. ||| Une efficacité clinique a cependant été observée dans les infections intra-abdominales polymicrobiennes.
0.0 ||| Package size ||| Package size ||| Taille de l' emballage
0.3882409334182739 ||| If you have liver disease you may also be more at risk of getting this condition. ||| If you experience drowsiness this can be made worse if you drink alcohol. ||| Si vous avez une maladie du foie, ceci peut augmenter le risque de développer cet
0.09999266266822815 ||| No dosage adjustment is necessary for patients with creatinine clearance ≥ 30 ml/ min (see section 5.2). ||| Dose reduction in patients with a creatinine clearance of < 50 ml/ min is necessary (see section 4.2). ||| Insuffisance rénale: aucune adaptation de la posologie n’ est nécessaire chez les patients ayant une clairance de la créatinine ≥ 30 ml/ min (voir rubrique 5.2 Propriétés pharmacocinétiques).
0.29788562655448914 ||| Such elevation in white blood cells is transient, typically seen 24 to 48 hours after administration and is consistent with the pharmacodynamic effects of Neulasta. ||| The rate of fatal rhabdomyolysis associated with cerivastatin therapy, however, is 16 to 80 times as high as the rates of any other statin. ||| Une telle élévation de leucocytes est transitoire, spécifiquement observée 24 à 48 heures après l’ administration et conforme aux effets pharmacodynamiques de Neulasta.
0.30334776639938354 ||| In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium. ||| The overall incidence of adverse events reported with telmisartan (41.4%) was usually comparable to placebo (43.9%) in placebo controlled trials. ||| Dans une autre étude clinique à 12 semaines, l’ incidence des symptômes extrapyramidaux était de 26,6% chez les patients traités par aripiprazole et 17,6% chez les patients traités par lithium.
0.28138649463653564 ||| In cases of severe cardiopulmonary depression, discontinue sevoflurane administration, ensure the existence of a patent airway and initiate assisted or controlled ventilation with pure oxygen. ||| If hypotension occurs, the patient should be placed in a supine position and intravenous fluid replacement (intravenous infusion of physiologic saline) should be administered if necessary. ||| En cas de dépression cardio-pulmonaire sévère, il est nécessaire d’ arrêter l’ administration de sévoflurane, de s’ assurer de la fonctionnalité des voies aériennes et de mettre en place une ventilation assistée ou contrôlée avec de l’ oxygène pur.
0.42595309019088745 ||| If you are taking any of these medicines, tell your doctor immediately. ||| If a child swallows some tablets, contact your doctor immediately. ||| 156 Prévenez immédiatement votre médecin si vous prenez l'un de ces médicaments.
0.21750923991203308 ||| 60 tablets ||| 500 tablets ||| 60 comprimés
0.35160118341445923 ||| Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concurrent use of ACE inhibitors. ||| Increases in cholesterol and triglyceride levels have been associated with thiazide diuretic therapy. ||| Lithium Des augmentations réversibles des concentrations sériques de lithium et de la toxicité ont été rapportées lors de l’ administration concomitante d’ IEC.
0.03329291567206383 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged studies in 403 patients). ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 47 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged established osteoarthritis. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées sur OptiMARK?
0.25176259875297546 ||| In a 144-week controlled clinical study that compared tenofovir disoproxil fumarate with stavudine in combination with lamivudine and efavirenz in antiretroviral-naïve patients, small decreases in bone mineral density of the hip and spine were observed in both treatment groups. ||| In in-vitro studies, tipranavir was found to inhibit platelet aggregation when using human platelets (see section 4.4) and thromboxane A2 binding in an in vitro cell model at levels consistent with exposure observed in patients receiving APTIVUS/ ritonavir. ||| Au cours d’ une étude clinique contrôlée de 144 semaines comparant le fumarate de ténofovir disoproxil à la stavudine, en association à la lamivudine et à l’ éfavirenz, chez des patients naïfs de traitement antirétroviral, de légères diminutions de la densité minérale osseuse au niveau de la hanche et du rachis ont été observées dans les deux groupes de traitement.
0.4178025424480438 ||| 21 (4.5) 4 (0.9) ||| 23 (9.5) 13 (9.1) ||| 21 (4,5) 4 (0,9)
0.3227793276309967 ||| Children and adolescents (< 18 years) STELARA is not recommended for use in children below age 18 due to a lack of data on safety and efficacy. ||| Elderly patients (≥ 65 years) No overall differences in efficacy or safety in patients age 65 and older who received STELARA were observed compared to younger patients. ||| Enfants et adolescents (< 18 ans) En l’ absence de données sur la tolérance et l’ efficacité, STELARA ne doit pas être utilisé chez les enfants de moins 18 ans.
0.1512509137392044 ||| ARICLAIM 30 mg is available in packs of 7, 28 and 98 capsules. ||| XERISTAR 30 mg is available in packs of 7 and 28 capsules. ||| ARICLAIM 30 mg est disponible en boîtes de 7, 28 et 98 gélules.
0.04991840571165085 ||| 21 Clinical trials data The glucose lowering effects observed with rosiglitazone are gradual in onset with near maximal reductions in fasting plasma glucose (FPG) evident following approximately 8 weeks of therapy. ||| In clinical trials, the glucose lowering effects observed with rosiglitazone are gradual in onset with near maximal reductions in fasting plasma glucose (FPG) evident following approximately 8 weeks of therapy. ||| Données cliniques L’ abaissement de la glycémie débute progressivement; une diminution maximale de la glycémie a jeun est obtenue après environ 8 semaines de traitement.
0.6454688310623169 ||| Treatment should be discontinued in these patients. ||| should be discontinued indefinitely. ||| L’ arrêt du traitement doit être envisagé chez ces patients.
0.5450304746627808 ||| Peripheral and central neuropathic pain: ||| Diabetic Peripheral Neuropathic Pain: ||| Douleurs neuropathiques périphériques et centrales:
0.3506868779659271 ||| The highest dose tested in the animal carcinogenicity studies resulted in approximately 2 – 3 times the systemic exposure (AUC or Cmax) observed in renal transplant patients as the recommended clinical dose of 2 g/ day and 1.3 – 2 times the systemic exposure (AUC or Cmax) observed in cardiac transplant patients at the recommended clinical dose of 3 g/ day. ||| In newborn rats receiving daily carglumic acid by oral gavage for 18 days as well as in young rats receiving daily carglumic acid for 26 weeks, the No Observed Effect Level (NOEL) was established at 500 mg/ kg/ day and the No Observed Adverse Effect Level (NOAEL) was established at 1000 mg/ kg/ day. ||| La dose la plus forte testée dans les études d'oncogenèse chez l'animal a conduit à une exposition systémique (ASC ou Cmax) 2 à 3 fois supérieure à celle observée chez des transplantés rénaux traités par le mycophénolate mofétil à la dose de 2 g/ jour et 1,3 à 2 fois supérieure à celle relevée chez les transplantés cardiaques traités par le mycophénolate mofétil à la dose clinique recommandée de 3 g/ jour.
0.5116701722145081 ||| so the total number of new applications is placed at 30, contingent on the industry survey currently underway and expected to be completed early in 1997. ||| The studies were still ongoing at the time of the medicine’ s assessment and are scheduled to last for up to five years. ||| Malgré cela, il est prévisible que les demandes concernant des molécules nouvelles augmenteront en 1997 pour atteindre 30, d’après une enquête de l’industrie qui devrait être s’achever au début de l’année 1997.
0.4124318063259125 ||| Vertigo Deafness, hypoacusia, tinnitus, ear pain, ear pruritus ||| Pyrexia Injection site reaction / inflammation, chills, asthenia, ||| vertige surdité, hypo-acousie, acouphènes, douleur auriculaire, prurit auriculaire
0.16647015511989594 ||| Children and adolescents The pharmacokinetic and pharmacodynamic properties of insulin glulisine were investigated in children (7-11 years) and adolescents (12-16 years) with type 1 diabetes mellitus. ||| However, the pharmacokinetic and pharmacodynamic properties of soluble insulin aspart have been investigated in children (6– 12 years) and adolescents (13– 17 years) with type 1 diabetes. ||| Enfants et adolescents Les propriétés pharmacocinétiques et pharmacodynamiques de l’ insuline glulisine ont été étudiées chez les enfants (7-11 ans) et les adolescents (12-16 ans) diabétiques de type 1.
0.3188777267932892 ||| The 84-day survival rate for voriconazole was statistically significantly higher than that for the comparator and a clinically and statistically significant benefit was shown in favour of voriconazole for both time to death and time to discontinuation due to toxicity. ||| At 48 months, there was a statistically significant difference in graft survival in favour of the Rapamune following ciclosporin elimination group compared to the Rapamune with ciclosporin therapy group (including and excluding loss to follow-up). ||| 39 significatif a été observé en faveur du voriconazole à la fois pour le temps de survie et le délai avant arrêt du traitement dû à la toxicité.
0.24201741814613342 ||| Agenerase capsules are contraindicated in patients with severe hepatic impairment when used in combination with ritonavir (see section4.3). ||| In patients with metastatic colorectal cancer, cetuximab is used in combination with chemotherapy or as a single agent (see section 5.1). ||| Les capsules d'Agenerase sont contre-indiquées lorsqu'elles sont administrées en association au ritonavir chez les patients ayant une insuffisance hépatique sévère (voir rubrique 4.3).
0.3903437852859497 ||| Controllers for video game machines ||| Interactive gaming chairs for video games ||| Commandes de machines de jeux vidéo
0.3661022186279297 ||| In animals, only a small amount of unchanged pioglitazone can be detected in either urine or faeces. ||| No unchanged parecoxib is detected in urine and only trace amounts in the faeces. ||| Chez l'animal, seule une faible quantité de pioglitazone inchangée a pu être détectée dans les urines ou les selles.
0.34550315141677856 ||| Decreases in ALT and AST, which are considered to be a result of inhibition of these aminotransferases by vigabatrin, have been observed. ||| Hypersensitivity reactions, as have been reported for other contrast media containing gadolinium, have also been observed after administration of Gadovist. ||| Des baisses de l'ALAT et de l'ASAT, considérées comme le résultat de l'inhibition de ces aminotransférases par le vigabatrin, ont été observées.
1.014000515497937e-12 ||| 5 pre-filled pens ||| 5 pre-filled pens ||| 5 stylos pré- remplis
0.3296704888343811 ||| What Mycophenolate mofetil Teva is and what it is used for 2. ||| 48 What Mycophenolate mofetil Teva looks like and contents of the pack ||| Qu'est -ce que Mycophénolate mofétil Teva et dans quels cas est -il utilisé?
0.2726474702358246 ||| Studies in animals have not shown evidence of selective developmental toxicity or effects on reproductive function and fertility (see section 5.3). ||| Reproductive studies in animals have not shown evidence of teratogenicity and showed no effect on male or female fertility. ||| Des études chez l'animal n'ont pas mis en évidence de toxicité sélective du développement ou d'effets sur la fonction reproductrice et la fertilité (voir rubrique 5.3).
0.46174871921539307 ||| Broadcasting of financial information by radio ||| Providing information about cable television broadcasting ||| Diffusion d'informations financières à la radio
0.40633732080459595 ||| Rebreathers for diving ||| Feathers for bedding ||| Recycleurs pour la plongée
0.4858994781970978 ||| Communicate: During the crisis, the EU has been stepping up its work to inform citizens about the risks and to enhance cooperation with other international actors to tackle disinformation. ||| The European Union is on the side of the victims and today's strategy aims at empowering victims, especially the most vulnerable such as victims of gender-based violence or hate crime. ||| Communiquer: pendant la crise, l'UE a renforcé son travail pour informer les citoyens des risques et améliorer la coopération avec d'autres acteurs internationaux afin de lutter contre la désinformation.
0.596897542476654 ||| On 1 March, the first case in the country and the Caribbean was confirmed. ||| The following day, the government of Rio Grande do Sul declared a public emergency situation. ||| Le 1er mars, le premier cas du pays et des Caraïbes est confirmé.
0.1013769581913948 ||| Solutions for scientific use in the storage of human organs ||| Solutions for scientific use in the preservation of human organs ||| Solutions à usage scientifique pour le stockage d'organes humains
0.556035041809082 ||| The doses are adjusted according to the patient’ s weight (see the Package Leaflet). ||| - The SPC, labelling and package leaflet proposed by the applicant has been assessed based on ||| Les doses sont ajustées en fonction du poids du patient (voir la notice).
0.622492790222168 ||| Flushing, increased sweating, dark sweat, rash, hair loss. ||| fatigue, energy increased feeling abnormal, feeling jittery, chills ||| Bouffées vasomotrices, hyperhidrose, sueur foncée, éruption cutanée, chute des cheveux.
0.24006396532058716 ||| Taking other medicines The activity of ZIMULTI is increased by simultaneous use of some drugs (so-called CYP3A4 inhibitors) such as: − itraconazole (antifungal medicine) − ketoconazole (antifungal medicine) − ritonavir (medicine for the treatment of HIV infections) − telithromycin (antibiotic) ||| 25 Using other medicines If Ciprofloxacin Hikma and one of the following medicines are given at the same time, special care should be taken: • theophylline (used to treat asthma), clozapine (used to treat schizophrenia), tacrine (used to treat symptoms of Alzheimer´s disease), ropinirol (used to treat Parkinson disease) and tizanidine (used to treat muscle spasms). ||| tor Prise d'autres médicaments L’activité de ZIMULTI peut être augmentée lors de l’utilisation simultanée de certains médicaments (appelés inhibiteurs du CYP3A4) comme:
0.19355852901935577 ||| d Quixidar 10 mg/ 0.8 ml solution for injection ||| Fertavid 150 IU/ 0.18 ml solution for injection ||| Quixidar 10 mg/ 0,8 ml solution injectable Fondaparinux sodique
0.6430525779724121 ||| Ethyl carbamate ||| Tetraethyl lead ||| Carbamate d’éthyle
0.3258421719074249 ||| Care must be taken not to administer Bondenza injection via intra-arterial or paravenous administration as this could lead to tissue damage. ||| RELISTOR should be added to induce prompt bowel movements when response to usual laxative therapy has been insufficient. ||| Toutes les précautions doivent être prises afin de ne pas administrer Bondenza IV par voie intra-artérielle ou périveineuse, car cela pourrait entraîner une lésion tissulaire.
0.2967923581600189 ||| Very common side effects (these can affect more than 1 in 10 patients treated) Feeling sick (nausea), dry mouth, and tiredness. ||| Very common (in more than 1 in 10 patients): • injection site reactions (including pain, swelling, redness or itching). ||| Effets indésirables les plus fréquents (pouvant affecter plus de 1 patiente traitée sur 10): • Envie de vomir (nausées), sécheresse de la bouche et fatigue.
0.111203134059906 ||| Important information about some of the ingredients of Soliris This medicinal product contains 5.00 mmol sodium per dose (1 vial). ||| Important information about some of the ingredients of Aldurazyme This medicinal product contains 1.29 mmol sodium per vial. ||| Informations importantes concernant certains composants de Soliris Ce médicament contient 5,00 mmol de sodium par dose (1 flacon).
0.3136051595211029 ||| In addition, infusion site induration and infusion site pain were common adverse reactions in a bioequivalence study in which 66 subjects were dosed with 115 mg of fosaprepitant intravenously. ||| Additionally, in one interaction trial in healthy female volunteers administered a single dose of ethinyl oestradiol followed by APTIVUS co- administered with low dose ritonavir, 33% of subjects developed a rash. ||| Par ailleurs, une induration et une douleur au site de perfusion ont été des effets indésirables fréquents au cours d'une étude de bioéquivalence réalisée chez 66 sujets traités par 115 mg de fosaprépitant administrés par voie intraveineuse.
0.433843731880188 ||| Deoxyribose phosphorothioate (5’- ||| TGF-ß2-specific phosphorothioate ||| Deoxyribose phosphorothioate (5’ -tct- ccc-agc-gtg-cgc-cat-3’)
0.34129732847213745 ||| Give the exceptional and temporary possibility for Member States to request for cohesion policy programmes a co-financing rate of 100% to be applied for the accounting year 2020-2021; ||| This will effectively increase the amount of investment in 2020 and help to front-load the use of the as yet unallocated EUR 28 billion of cohesion policy funding within the 2014-2020 cohesion policy programmes. ||| de donner aux États membres la possibilité exceptionnelle et temporaire de demander, pour les programmes relevant de la politique de cohésion, un taux de cofinancement de 100 % pour l'exercice financier 2020-2021;
0.4997066259384155 ||| I. whereas the Commission has already taken initial action, including a package of measures voted on by Parliament during its plenary session on 26 March 2020; ||| All CPMP opinions were issued by consensus in 1996 and therefore required no further scientific discussion during the Standing Committee phase. ||| I. considérant que la Commission a déjà pris des premières mesures, notamment un train de mesures votées par le Parlement lors de sa session plénière du 26 mars 2020;
0.5702452659606934 ||| Microporous synthetic sheets for the manufacture of protective clothing ||| Clothes drying hangers specially designed for specialty clothing ||| Feuilles synthétiques microporeuses pour la fabrication de vêtements de protection
0.36180830001831055 ||| Hans Bruyninckx, EEA Executive Director, said:"Regular monitoring and assessment of bathing water are essential for ensuring that we maintain the already very high quality across Europe and, where needed, we take effective measures to address water pollution. ||| "Sweden's foreign ministry stated to Agence France-Presse that ""We expect France to promptly cease the requisition of medical equipment and do what it can to ensure that supply chains and the transportation of goods are secured." ||| M. Hans Bruyninckx, directeur exécutif de l'AEE, a déclaré: «Il est essentiel de contrôler et d'évaluer régulièrement les eaux de baignade pour garantir le maintien d'une qualité déjà très élevée dans toute l'Europe et, lorsque cela s'avère nécessaire, nous agissons efficacement pour lutter contre la pollution de l'eau.
0.42439430952072144 ||| 58 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| Adjustments in dosage of the medicinal product, meal patterns, or physical activity may be needed. ||| Un ajustement de la posologie peut également être nécessaire si le patient modifie son activité physique ou son régime alimentaire.
0.12357687950134277 ||| STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS ||| STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) ||| LISTE DU (DES) SUBSTANCE(S) ACTIVE(S) ET AUTRE(S) INGRÉDIENT(S)
0.0796487033367157 ||| Cerezyme is a powder to be made up into a solution for infusion (a drip into a vein). ||| Cyanokit is a powder to be made up into a solution for infusion (drip into a vein). ||| Cerezyme est une poudre à diluer pour perfusion (goutte-à-goutte dans une veine).
0.24760499596595764 ||| The active substance in Baraclude, entecavir, is an antiviral belonging to the class of the nucleoside analogues. ||| The active substance in TAXOTERE, docetaxel, belongs to the group of anticancer medicines known as the taxanes. ||| Le principe actif de Baraclude, l’ entecavir, est un antiviral appartenant à la classe des analogues nucléosidiques.
0.40595492720603943 ||| Headache Somnolence ||| Headache Asthenia ||| Maux de tête Somnolence
0.07081052660942078 ||| Concentrations of amiodarone, flecainide or propafenone may be increased when co-administered with Invirase/ ritonavir. ||| Concentrations of bepridil, systemic lidocaine or quinidine may be increased when co-administered with Invirase/ritonavir. ||| Les concentrations d’ amiodarone, flécaïnide ou propafénone peuvent être augmentées en cas de co-administration avec Invirase/ ritonavir.
0.5532649755477905 ||| 25 provinces are affected by the pandemic in Algeria. ||| As in Réunion, the island is also affected by dengue fever. ||| 25 wilayas sont touchées par la pandémie en Algérie.
0.4641706645488739 ||| Do not add water to bottles of VIRACEPT powder. ||| The tablet form of VIRACEPT must be taken by mouth. ||| Ne pas ajouter d’eau dans les flacons de VIRACEPT poudre.
5.522545311678617e-13 ||| Patients with existence of or history of severe psychiatric conditions: ||| Patients with existence of or history of severe psychiatric conditions: ||| 189 Patients présentant ou ayant des antécédents de troubles psychiatriques sévères:
0.4992356598377228 ||| Side effects at the injection site are most common with the starting dose and less common with the maintenance dose. ||| Yields in excess of this minimum yield appear to correlate with more rapid recovery, those below with slower recovery. ||| Les effets indésirables au point d’ injection surviennent plus fréquemment lors du début du traitement.
0.3063710927963257 ||| Concrete vibrators ||| Concrete conduits ||| Vibrateurs à béton
0.4996267259120941 ||| On 7 March, health authorities announced that 45 people on board had tested positive and that the ship had been placed in quarantine at a dock in Luxor. ||| February 4, the Ministry confirmed that around 30 Brazilians were in Wuhan, and that they would return to the country on 8 February. ||| Le 7 mars 2020, les autorités sanitaires annoncent que 45 personnes à bord ont été testées positives et que le navire a été placé en quarantaine sur un quai à Louxor.
0.4204196333885193 ||| - excess fluid in the body (oedema); swelling of the arms and legs (peripheral oedema) ||| • Blood clots (thrombosis) • Pain around the area injected • Rash and/ or redness of the skin ||| - excès de fluide dans le corps (œ dème), gonflement des bras et des jambes (œ dème périphérique)
3.029304238011399e-13 ||| Although the optimal (minimum) dose for full clinical benefit is unknown, patients must be treated at the recommended dose, with dose reduction for toxicity as described. ||| Although the optimal (minimum) dose for full clinical benefit is unknown, patients must be treated at the recommended dose, with dose reduction for toxicity as described. ||| 166 Bien que la dose optimale (minimale) pour obtenir un bénéfice clinique ne soit pas encore connue, les patients doivent être traités à la dose recommandée, en ajustant les doses en fonction de la tolérance comme décrit ci-dessus.
0.573809027671814 ||| Use immediately or within 3 hours of reconstitution. ||| For immediate and single use following first opening and reconstitution. ||| Utilisation immédiatement ou dans les 3 heures de la reconstitution.
0.21034163236618042 ||| - a significant reduction of the absolute risk of diabetes-related mortality: metformin ||| - a significant reduction of the absolute risk of any diabetes-related complication in the metformin ||| - une réduction significative du risque absolu de mortalité liée au diabète: metformine
0.28162968158721924 ||| As anaesthetic drugs may affect renal perfusion, the use of parenteral fluid therapy during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively. ||| Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolized and thus result in airborne spread. ||| Les produits anesthésiques pouvant affecter la perfusion rénale, un apport liquidien parentéral doit être envisagé pendant l’ opération afin de réduire de potentielles complications rénales lors de l’ utilisation d’ AINS en péri-opératoire.
0.04029899463057518 ||| Ritonavir increases the serum levels of tipranavir as a result of CYP3A inhibition. ||| Ritonavir increases the serum levels of nelfinavir as a result of CYP3A4 inhibition. ||| Le ritonavir augmente les concentrations sériques du tipranavir par inhibition du CYP3A.
0.2082754373550415 ||| Try to take Actos 45mg tablets daily as prescribed. ||| Try to take Glubrava tablets daily as prescribed. ||| Essayez de prendre Actos 45 mg, comprimé tous les jours selon la prescription.
0.08715125173330307 ||| Polyurethane film for use in sealing and insulating buildings ||| Polyurethane film for use in sealing and insulating ||| Films en polyuréthane destinés à l'étanchéité et l'isolation des bâtiments
0.14035849273204803 ||| The marketing authorisation holder is Pfizer Limited. ||| The marketing authorisation holder is Eisai Limited. ||| Le titulaire de l’ autorisation de mise sur le marché est Pfizer Limited.
0.09913663566112518 ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu ||| 43 Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) hhtp://www.emea.europa.eu ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu/
0.43941229581832886 ||| If such contact occurs, wash thoroughly with soap and water; rinse eyes with plain water. ||| Wash your hands thoroughly with soap and water and dry them with a towel. ||| En cas de contact accidentel, bien laver au savon et à l'eau; rincer les yeux à l'eau courante.
0.49332886934280396 ||| Allergy (hypersensitivity) ||| Hypersensitivity (no severe) ||| Allergie (hypersensibilité)
0.4383193552494049 ||| In view of the indication, alendronate should not be used during pregnancy. ||| Thus, drug use is recorded prospectively to pregnancy outcome. ||| Compte tenu de l’ indication, l’ alendronate ne devrait pas être administré pendant la grossesse.
0.4128234386444092 ||| Human thrombin: ||| Human thrombin vial: ||| Thrombine humaine:
0.13628681004047394 ||| Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a person who has received appropriate instruction, or by glucose given intravenously by a medical professional. ||| It is therefore recommended that the diabetic patient constantly carry sugar containing products • Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated by glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a trained person, or glucose given intravenously by a medical professional. ||| Les épisodes hypoglycémiques sévères, accompagnés d’ une perte de connaissance, seront traités par du glucagon (0,5 à 1 mg) administré par voie intramusculaire ou sous-cutanée par une personne spécifiquement formée, ou par du glucose administré par voie intraveineuse par un professionnel de santé.
0.5478120446205139 ||| Filtration control agents for drilling fluids for subterranean wells ||| Drilling rigs for drilling off-shore wells ||| Agents de contrôle de la filtration pour fluides de forage de puits souterrains
0.4221605360507965 ||| It is not known whether bosentan is excreted into human milk. ||| Studies in animals demonstrate that it is excreted into milk. ||| Il n’ existe pas de données sur le passage du bosentan dans le lait maternel.
0.5036225318908691 ||| Method of administration Oral ||| Route of administration Oral use ||| Mode d'administration Voie orale.
0.05182333290576935 ||| Clopidogrel BMS 75 mg film-coated tablets ||| - Clopidogrel BMS 75 mg film-coated tablets ||| Clopidogrel BMS 75 mg comprimés pelliculés
0.8093379139900208 ||| State aid: Commission approves Austrian guarantee schemes ||| Commission approves the Spanish "umbrella" scheme ||| Aides d'État: la Commission autorise des régimes de garantie autrichiens
0.3392048478126526 ||| In these patients, therapy should be started under medical supervision and the patients should be followed closely whenever the dose of and/or diuretic is adjusted. ||| included in the phase 3 trials followed a restrictive diet during the trial prescribed by a dietician and they were advised to increase their physical activity. ||| Chez ces patients, le traitement doit être débuté sous surveillance médicale et les patients doivent être suivis étroitement chaque fois que la dose de et/ ou de diurétique est ajustée.
0.33145081996917725 ||| The company that makes Elaprase will investigate the long-term effects of the medicine, and whether it stimulates the body to produce special proteins called antibodies against the medicine. ||| The company that makes RotaTeq will monitor some of the side effects of RotaTeq once it is on the market, particularly the side effects that affect the digestive system. ||| La société qui fabrique Élaprase va étudier les effets à long terme du médicament et déterminer s’ il stimule la production par l’ organisme de protéines spéciales appelées anticorps contre le médicament.
0.5329657196998596 ||| 156 Aylonos Str Sepolia GR-1044 Greece ||| 5th km Paiania-Markopoulo 194 00 Koropi Greece ||| 156 Aylonos Str Sepolia GR-1044 Grèce
0.353579580783844 ||| Elastomeric sheeting for protecting surfaces in areas used for shot-peening ||| Elastomer waterproof preparations in the nature of paint for preserving asbestos roofs ||| Feuilles élastomères pour la protection des surfaces de zones destinées au grenaillage
0.18015244603157043 ||| 27 4.6 Pregnancy and lactation ||| 293 4.6 Pregnancy and lactation ||| 28 4.6 Grossesse et allaitement
0.29867541790008545 ||| The most common side effects noted during the studies are local swellings and/ or other mild reactions (skin discolouration, small cysts) at the injection site. ||| Most of the common side effects related to alli (for example, wind with or without oily spotting, sudden or more frequent bowel motions and soft stools) are caused by the way it works (see Chapter 1). ||| Les effets secondaires les plus fréquents observés au cours des études étaient des gonflements locaux et/ ou d'autres réactions légères (décoloration de la peau, petits kystes) au point d’ injection.
0.43393826484680176 ||| General disorders and administration site conditions Very common: erythema, * pain/ tenderness, * swelling* Common: haematoma, pruritus, warmth ||| Psychiatric disorders Common: insomnia Uncommon: anxiety, depression, tiredness Very rare: confusion, hallucinations. ||| Troubles généraux et anomalies liés au site d'administration Très fréquent: érythème*, douleur/ sensibilité au toucher, à la pression *, gonflement* Fréquent: hématome, prurit, chaleur
0.9363883137702942 ||| Dr Reinhard Kroker Chairman, Committee for Veterinary Medicinal Products ||| Sabine BROSCH Deputy Head of Sector ||| Préface de M. le Professeur Reinhard Kroker président du Comité des médicaments vétérinaires
0.2603917121887207 ||| 9 Clinical efficacy The efficacy of tocilizumab in alleviating the signs and symptoms of RA was assessed in five randomised, double-blind, multi-centre studies. ||| The clinical safety and efficacy of Lucentis have been assessed in three randomised, double-masked, sham- or active-controlled studies in patients with neovascular AMD. ||| Efficacité clinique L’ efficacité du tocilizumab sur le soulagement des signes et des symptômes de la PR a été évaluée au cours de cinq études multicentriques randomisées en double aveugle.
0.07413892447948456 ||| What benefit has Lysodren shown during the studies? ||| What benefit has Orgalutran shown during the studies? ||| Quel est le bénéfice démontré par Lysodren au cours des études?
0.27666279673576355 ||| Publishing of electronic publications ||| Online publication of electronic newspapers ||| Édition de publications électroniques
0.25088682770729065 ||| 5 ml (2.5 mg) Aerius oral solution once a day. ||| 10 ml (5 mg) Azomyr syrup once a day. ||| 5 ml (2,5 mg) d’ Aerius solution buvable une fois par jour.
0.16865958273410797 ||| Programme carriers (Optical -) ||| Programme carriers (Magnetic -) ||| Supports de programmes optiques
0.1939614862203598 ||| These side effects may occur with certain frequencies, which are defined as follows: very common: affects more than 1 user in 10 common: affects 1 to 10 users in 100 uncommon: affects 1 to 10 users in 1,000 rare: affects 1 to 10 users in 10,000 very rare: affects less than 1 user in 10,000 not known: frequency cannot be estimated from the available data. ||| The side effects are described into the following frequencies very common: affects more than 1 user in 10 common: affects 1 to 10 users in 100 uncommon: affects 1 to 10 users in 1,000 rare: affects 1 to 10 users in 10,000 very rare: affects less than 1 user in 10,000 ||| Ces effets indésirables peuvent se produire à différentes fréquences, qui sont définies de la façon suivante: • très fréquent: touche plus d’1 patient sur 10 • fréquent: touche de 1 à 10 patients sur 100 • peu fréquent: touche de 1 à 10 patients sur 1000 • rare: touche de 1 à 10 patients sur 10 000 • très rare: touche moins de 1 patient sur 10 000 • fréquence indeterminée: qui ne peut être estimée sur la base des données disponibles.
8.075853354105877e-13 ||| 12. ||| 12. ||| 368 12.
0.30246859788894653 ||| Balanced central serotonin and dopamine antagonism may reduce extrapyramidal side effect liability and extend the therapeutic activity to the negative and affective symptoms of schizophrenia. ||| The anti-toxin intestinal antibodies prevent the cholera toxin from binding to the intestinal mucosal surface thereby preventing the toxin-mediated diarrhoeal symptoms. ||| L’ équilibre entre l’ antagonisme sérotoninergique et l’ antagonisme dopaminergique peut diminuer la susceptibilité aux effets extrapyramidaux et élargit l’ effet thérapeutique aux symptômes négatifs et affectifs de la schizophrénie.
0.23278561234474182 ||| It should also not be used in patients who have had recent bleeding, who have severe high blood pressure or severe kidney problems, or a heart infection. ||| It should not be used in those who have high bilirubin levels (a marker of certain liver problems) or who have severe problems with their kidneys. ||| Il convient en outre de ne pas l’ utiliser chez les patients ayant eu une hémorragie récente, souffrant d’ hypertension aiguë ou présentant des troubles graves des reins, ou encore chez les patients présentant une infection cardiaque.
0.17845991253852844 ||| There is no clinical experience with MicardisPlus in patients with hepatic impairment. ||| MicardisPlus is not indicated in patients with severe hepatic impairment. ||| Aucune donnée clinique n’ est disponible concernant l’ utilisation de MicardisPlus chez des patients atteints d’ insuffisance hépatique.
0.02472362108528614 ||| Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination. ||| 3 Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination. ||| Collapsus ou état de choc (épisodes d'hypotonie - hyporéactivité) dans les 48 heures suivant la vaccination.
0.16758224368095398 ||| The recommended dose is 10 microlitre dispersion/ kg by slow bolus intravenous injection, followed by a 10 ml bolus of sodium chloride 9 mg/ ml (0.9%) or glucose 50 mg/ ml (5%) solution for injection. ||| 2 If necessary, a second 10 microlitre dispersion/ kg dose followed by a second 10 ml bolus of sodium chloride 9 mg/ ml (0.9%) or glucose 50 mg/ ml (5%) solution for injection may be administered 5 minutes after the first injection to prolong contrast enhancement. ||| 2 La dose recommandée est de10 microlitres/ kg de suspension par injection intraveineuse lente en bolus, suivie d’ une injection intraveineuse en bolus de 10 ml de solution injectable de chlorure de sodium 9 mg/ ml (0,9%) ou de glucose 50mg/ ml (5%).
0.2992044985294342 ||| * All Patients Treated Population (an intention-to-treat analysis). † Least squares means adjusted for prior antihyperglycaemic therapy status and baseline value. ‡ p < 0.001 compared to placebo or placebo + combination treatment. § HbA1c (%) at week 18. ||| • That Thelin is hepatotoxic o Need for liver function tests prior to and during treatment o Contraindication in patients with pre-existing hepatic impairment (Child-Pugh Class A-C). o Need for close monitoring if liver enzymes measure > 3 × upper limit normal (ULN): > 3 and ≤ 5 x ULN: ||| * Population Tous Patients Traités (analyse en Intention de Traiter) † Moyenne des moindres carrés ajustée en fonction du traitement antihyperglycémiant précédent et de la valeur initiale p < 0,001 comparé au placebo ou au placebo + traitement associé ‡
0.5158451199531555 ||| Member States should report on their actions by 31 May 2020 and make the measures accessible to other Member States and the Commission for peer review. ||| We will introduce our proposal to the Board next week and will update delegates and teams on the next steps as soon as we have confirmation. ||| Les États membres devraient rendre compte des mesures qu'ils ont prises au plus tard le 31 mai 2020 et permettre à la Commission et aux autres États membres d'en prendre connaissance en vue d'un examen réciproque.
0.0 ||| Mode of action ||| Mode of action ||| 104 Mode d' action
0.9213976860046387 ||| - pain in the joints ||| of the blood vessels ||| - douleurs articulaires
0.045204631984233856 ||| EU/ 1/ 99/ 119/ 008 ||| EU/ 1/ 99/ 117/ 001 ||| EU/ 1/ 99/ 119/ 008 NovoRapid 100 U/ ml
0.8268046975135803 ||| 1999 (estimate) ||| areas (dose) ||| 1998 (estimation) 1999 (estimation)
0.4363018274307251 ||| In dogs, prominent U waves on the electrocardiogram have been observed associated with prolonged PR interval and bradycardia. ||| Supraventricular and ventricular premature complexes, sinus pause and 3rd degree AV block may be observed in rare cases. ||| Chez le chien, des ondes U proéminentes ont été observées sur l’ électrocardiogramme associées à un intervalle PR prolongé et à une bradycardie.
0.39365512132644653 ||| These findings are not considered clinically significant. ||| These changes do not have any clinical significance. ||| Ces données ne sont pas considérées comme cliniquement significatives.
0.34078383445739746 ||| In such a common effort to face the coronavirus pandemic, the Commission, CEN and CENELEC have agreed to make a number of harmonised standards for important medical protective equipment like face masks and single-use gloves freely available to those companies that are willing to start producing these items. ||| Further implementation of the orphan-medicines policy, whereby developers of designated orphan medicinal products — often derived from new technologies — enjoy reduced fees or fee waivers for a number of Agency procedures, thus stimulating the development of these products and increasing patients ’ access to them; ||| Dans le cadre de ces efforts communs déployés pour faire face à la pandémie provoquée par le coronavirus, la Commission, le CEN et le CENELEC ont convenu de mettre une série de normes harmonisées relatives à des équipements de protection médicale importants comme des masques et des gants à usage unique gratuitement à la disposition des entreprises souhaitant commencer à produire ces articles.
0.4282073974609375 ||| However, the results were insufficient to support the use of Ibaflin in the treatment of urinary tract infections in cats. ||| These will focus on the safety of Stelara, particularly the risks of developing tuberculosis, other infections and cancers. ||| En revanche, les résultats étaient insuffisants pour justifier l’ utilisation d’ Ibaflin dans le traitement des infections urinaires chez les chats.
2.2524408553603603e-13 ||| You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. ||| You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. ||| Veuillez lire attentivement l’intégralité de cette notice avant de prendre ce médicament. • Gardez cette notice, vous pourriez avoir besoin de la relire. • Si vous avez d'autres questions, si vous avez un doute, demandez plus d’informations à votre médecin ou votre pharmacien. • Ce médicament vous a été personnellement prescrit.
0.47260618209838867 ||| Back pain, myalgia ||| Limb pain Myalgia, back pain ||| Douleur du dos, myalgie
0.22107017040252686 ||| Shovels [hand tools] ||| Taps [hand tools] ||| Pelles [outils]
0.0015779829118400812 ||| Cartridges Before insertion into the pen, Insuman Comb 25 must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents. ||| Cartridges Before insertion into the pen, Insuman Comb 15 must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents. ||| 208 Cartouches Avant son insertion dans le stylo, Insuman Comb 25 doit être conservé à température ambiante pendant 1 à 2 heures, puis remise en suspension pour en vérifier le contenu.
0.3091554343700409 ||| BEFORE YOU TAKE AZOMYR ORAL LYOPHILISATE ||| HOW TO STORE AZOMYR ORODISPERSIBLE TABLET ||| QUELLES SONT LES INFORMATIONS A CONNAITRE AVANT DE PRENDRE AZOMYR LYOPHILISAT ORAL
5.288900285609077e-13 ||| Rare ||| Rare ||| Crise
0.11409488320350647 ||| The containers are closed with butyl rubber stoppers and sealed with aluminium caps. ||| The bottles are closed with a butyl rubber stopper and sealed with an aluminium cap. ||| Les flacons sont fermés par des bouchons en caoutchouc butylé et scellés avec des capsules en aluminium.
0.05830033868551254 ||| • The residual insulin scale on the transparent insulin reservoir shows approximately how much insulin remains in the OptiSet. ||| 536 • The residual insulin scale on the transparent insulin reservoir shows approximately how much insulin remains in the OptiSet. ||| L’ échelle indicatrice de l’ insuline résiduelle figurant sur le réservoir transparent d’ insuline • indique approximativement combien d’ insuline reste dans l’ OptiSet.
0.036289066076278687 ||| This medicine is the same as Karvezide, which is already authorised in the European Union (EU). ||| This medicine is the same as Karvea, which is already authorised in the European Union (EU). ||| Ce médicament est le même que Karvezide, qui est déjà autorisé dans l’ Union européenne (UE).
0.5246893167495728 ||| 44 Instructions for injecting with the Neulasta pre-filled pen (SureClick) ||| Inject into a vial of ZYPREXA Powder for Solution for Injection. ||| Instructions pour l’injection du stylo prérempli de Neulasta (SureClick)
0.07024227827787399 ||| Hb between 10 and 12 g/ dl (6.2-7.5 mmol/ l). ||| Hb between 10 and 12 g/dl (6.2-7.5 mmol/l). ||| (Hb comprise entre 10 et 12 g/ dl (6,2-7,5 mmol/ l).
0.0 ||| 3. ||| 3. ||| 152 3.
0.5715676546096802 ||| Administration of investment funds ||| Management of financial assets ||| Administration de fonds d'investissement
0.0 ||| 6.5 Nature and contents of container ||| 6.5 Nature and contents of container ||| 20 6.5 Nature et contenu de l'emballage extérieur
0.30947622656822205 ||| Bearings for transmission shafts ||| Sheaths for electric cables ||| Paliers pour arbres de transmission
0.40056657791137695 ||| The successful implementation of distributed document review through the network of national competent authorities will be extended to Iceland and Norway in 2000. ||| EMEA interactions with the Japanese authorities will be strengthened in 2002, in particular through the exchange of officials. ||| La mise en œuvre réussie d’un examen de documents réparti par le biais du réseau des autorités nationales compétentes sera étendue à l’Islande et à la Norvège en 2000.
0.15854942798614502 ||| What is Avonex used for? ||| What is Econor used for? ||| Dans quel cas Avonex est -il utilisé?
0.492275595664978 ||| Cardiac failure Dizziness Gait abnormal Seizures ||| Visual disturbance Palpitation Hypertension Nausea ||| Insuffisance cardiaque Sensations vertigineuses Troubles de la marche Convulsions
0.33390265703201294 ||| The studies included very few children aged below four years. ||| Similar results were seen in children aged six years and above. ||| Ces études comprenaient un nombre très faible d’ enfants de moins de quatre ans.
0.2622610330581665 ||| Erbitux is used to treat the following types of cancer: • metastatic cancer of the colon or rectum (lower intestine or large bowel). ‘ Metastatic ’ means that the cancer has spread to other parts of the body. ||| It is used to treat the following diseases: • Chronic myeloid leukaemia (CML), a cancer of the white blood cells in which granulocytes (a type of white blood cell) start growing out of control. ||| Erbitux est utilisé pour le traitement des types de cancer suivants: • cancer métastatique du côlon ou du rectum (partie inférieure de l’ intestin ou gros intestin). « Métastatique » signifie que le cancer s’ est propagé à d’ autres parties du corps.
0.6132383942604065 ||| Somatropin and agonists, ATC code: ||| Others Sucralfate/Antacids: ||| Classe pharmacothérapeutique: somatropine et agonistes, code ATC:
0.24266625940799713 ||| Patients with moderate or severe renal impairment require a dose adjustment of emtricitabine and tenofovir disoproxil fumarate that cannot be achieved with the combination tablet (see sections 4.2 and 5.2). ||| 3 Combination with other antianginal therapies Concomitant use of ivabradine with heart rate reducing calcium channel blockers such as verapamil or diltiazem is not recommended (see section 4.5). ||| Les patients présentant une insuffisance rénale modérée ou sévère ont besoin d’ une adaptation de posologie pour l’ emtricitabine et le fumarate de ténofovir disoproxil qui ne peut être obtenue avec le comprimé de l’ association fixe (voir rubriques 4.2 et 5.2).
0.8847335577011108 ||| Foreword by the Chairman of the Management Board ||| Chairman of the CPMP Vice-chairman of the CPMP ||| Avant-propos du président du conseil d’ administration
0.4518606662750244 ||| For patients with body weight < 50 kg, the recommended dose is 5 mg. ||| Low body weight Clinical experience is limited in patients with body weight < 50 kg. ||| Pour les patients dont le poids est inférieur à 50 kg, la posologie recommandée est de 5 mg.
0.0 ||| < 0.001 ||| < 0.001 ||| 0.001
0.5519447326660156 ||| The guarantees will be channelled through credit institutions. ||| These intermediary funds or vehicles must be established and operate in the EU. ||| Les garanties transiteront par des établissements de crédit.
0.30775758624076843 ||| Anaemia means the production of red blood cells is reduced, and a child may have symptoms of tiredness or breathlessness. ||| blood does not contain enough red blood cells and the symptoms may be fatigue, weakness and shortness of breath. ro ||| L’anémie signifie que la production de globules rouges est diminuée, auquel cas l’enfant peut présenter des symptômes de fatigue ou d’essoufflement.
0.14074474573135376 ||| Woven textiles (Non-metallic -) for stabilising the bottoms of watercourses ||| Woven fabrics (Non-metallic -) for the protection of slopes against erosion ||| Matières textiles tissées (non métalliques) pour la stabilisation des fonds de cours d'eau
0.5996630787849426 ||| The other ingredients are sodium chloride and water for injections. ||| The patients received calcium and vitamin D supplements. ||| Les autres composants sont du chlorure de sodium et de l’eau pour préparations injectables.
0.4133058488368988 ||| For more information: ||| For more information ||| Pour en savoir plus:
0.352899968624115 ||| ACE inhibitors are contraindicated in HAE patients due to possible enhancement of bradykinin levels. ||| Therefore CYP450 mediated drug interactions are unlikely to occur with entecavir. ||| Les inhibiteurs de l’ enzyme de comversion sont contre-indiqués chez les patients souffrant d’ AOH en raison de l’ augmentation possible des taux de bradykinine.
0.4393326938152313 ||| Cured sausages ||| Scented soaps ||| Saucisses séchées
0.09013838320970535 ||| Arranging of displays for educational purposes ||| Arranging of displays for advertising purposes ||| Organisation d'exposés à des fins didactiques
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.2720806896686554 ||| Daronrix may be used during lactation. ||| NEVANAC can be used during lactation. ||| Le vaccin peut être administré durant d'allaitement.
0.38297098875045776 ||| Insurance services ||| Health insurance ||| Services d'assurances
0.29799884557724 ||| 1 pre-filled syringe + ||| 1 single use pre-filled syringe ||| 1 seringue préremplie +
0.2562370300292969 ||| In clinical trials, the proportions of subjects meeting a weight gain criterion of ≥ 7% of body weight were compared, revealing a similar incidence of weight gain for INVEGA 3 mg and 6 mg compared with placebo, and a higher incidence of weight gain for INVEGA 9 mg and 12 mg compared with placebo. ||| In comparative studies a less than 15% reduction in fibrinogen and a less than 25% reduction in plasminogen were observed in subjects treated with the maximum dose of tenecteplase (10,000 U, corresponding to 50 mg), whereas alteplase caused an approximately 50% decrease in fibrinogen and plasminogen levels. ||| Dans les essais cliniques, les pourcentages de patients atteignant le critère de prise de poids > 7% ont été comparés, montrant une incidence comparable de prise de poids pour INVEGAaux doses de 3 mg et 6 mg par rapport au placebo, et une incidence plus élevée de prise de poids pour INVEGA à 9 mg et 12 mg par rapport au placebo.
0.3312404155731201 ||| The safety and efficacy of Atripla have not been studied for the treatment of chronic HBV infection. ||| is or The safety and efficacy of Neupopeg have not been investigated in patients receiving high dose ||| La sécurité d’ emploi et l’ efficacité d’ Atripla n’ ont pas été étudiées dans le traitement de l’ infection chronique à VHB.
0.22281906008720398 ||| The Polish support measure ||| The Bulgarian support measure ||| La mesure de soutien polonaise
0.3259967565536499 ||| If trabectedin is used at the end of pregnancy, potential adverse reactions should be monitored carefully in the newborns. ||| Before starting treatment, the couple's infertility should be assessed as appropriate and putative contraindications for pregnancy evaluated. ||| Si la trabectédine est utilisée en fin de grossesse, les effets indésirables potentiels devront être étroitement surveillés chez le nouveau-né.
0.41270190477371216 ||| The majority of adverse reactions have not usually required cessation of therapy. ||| This reaction was generally associated with lack of proper rotation of injections. ||| La majorité des évènements indésirables n’ a habituellement pas nécessité d’ arrêt de traitement.
0.5038337707519531 ||| B/ Malaysia/ 2506/ 2004 like strain 9 micrograms HA** ||| A/ Wisconsin/ 67/ 2005 (H3N2) like strain ||| B/ Malaysia/ 2506/ 2004 souche analogue 9 microgrammes HA**
0.39236581325531006 ||| Bondenza is not recommended for patients who have severe kidney problems. ||| Treatment cessation for chronic hepatitis B in these patients is not recommended. ||| Bondenza n'est pas recommandé chez les patientes présentant des troubles rénaux sévères.
0.019231226295232773 ||| 176 Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck.com ||| Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck.com ||| 194 Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com
0.543865442276001 ||| Cefuroximaxetil per tablet, equivalent to 125 mg of cefuroxime. ||| Ceftiofur crystalline free acid corresponding to ceftiofur ||| céfuroximaxetil par comprimé, correspondant à 125 mg de céfuroxime.
0.4258865714073181 ||| Computer software to enable the provision of information via communications networks ||| Providing access to a global computer network for the transfer and dissemination of information ||| Logiciels de mise à disposition d'informations par le biais de réseaux de communications
0.5888997316360474 ||| Hb between 10 and 12 g/ dl (6.2-7.5 mmol/ l). ||| 0.12 ml/ kg body weight (equivalent to 0.03 mmol/ kg) ||| (Hb comprise entre 10 et 12 g/ dl (6,2-7,5 mmol/ l).
0.5011570453643799 ||| Any patient developing significant liver function abnormalities during treatment must be monitored closely. ||| Evaluation of patients with heart failure should always include assessment of renal function .” ||| Tout patient développant des anomalies significatives de la fonction hépatique au cours du traitement doit être étroitement suivi.
0.8706299662590027 ||| 3 morning, 4 evening ||| 2 morning, 2 ||| 3 le matin, 4 le soir
0.5653715133666992 ||| 62% / 26% / 8% 4.3 33.0 16 (5%) ||| 44% (23/52) 0.006 38% (12/32) ||| 62% / 26% / 8% 4.3 33,0
0.31503862142562866 ||| INFORMATION FOR THE USER Karvea 75 mg film-coated tablets irbesartan ||| INFORMATION FOR THE USER Agenerase 150 mg soft capsules Amprenavir ||| INFORMATION DE L'UTILISATEUR Karvea 75 mg comprimés pelliculés irbésartan
0.36203545331954956 ||| International Units are determined by comparison of the activity of the recombinant interferon alfa-2b with the activity of the international reference preparation of human leukocyte interferon established by the World Health Organisation. ||| The number of units of antithrombin alfa administered is expressed in International Units (IU), which is related to the current WHO standard for antithrombin concentrate. ||| Les Unités Internationales sont déterminées par comparaison entre l’ activité de l’ interféron alfa-2b recombinant et celle de la préparation de référence internationale d’ interféron leucocytaire humain établie par l’ Organisation Mondiale de la Santé.
0.7994239330291748 ||| The database provides guidance on past regulatory decisions, permitting a consistent approach across therapeutic areas. ||| Any potential proposal will reflect national traditions, whether collective agreements or legal provisions. ||| Elle fournit des orientations sur les anciennes décisions réglementaires, afin de permettre une approche cohérente dans tous les domaines thérapeutiques.
0.6463150978088379 ||| Generalised Anxiety Disorder ||| Anxiety Depression ||| Trouble Anxieux Généralisé
0.2042931318283081 ||| Light blue, capsular-shaped, biconvex tablets debossed with “ Pfizer ” on one side and “ CHX 1.0” on the other side. ||| 10.2 mm, round, normal convex, white film-coated tablets debossed “ OZ 10 ” on one side and “ G” on the other side. ||| Comprimé pelliculé à 1 mg: comprimé bleu clair, biconvexe, en forme de capsule, gravé avec « Pfizer » sur une face et « CHX 1.0 » sur l’ autre face.
0.4130150079727173 ||| The recommended dose of Viagra is 50 mg taken as needed about one hour before sexual activity. ||| < 30 As doses below 150 mg are needed the use of the oral solution is recommended ||| La dose recommandée de Viagra est de 50 mg à prendre le cas échéant, environ une heure avant l’ activité sexuelle.
0.2522304058074951 ||| If you have the impression that the effect of IntronA is too strong or too weak, talk to your doctor or pharmacist. ||| If you think that you have a serious side effect when using EVRA, take off the patch and speak to your doctor or pharmacist immediately. ||| Si vous avez l’impression que l’effet d’IntronA est trop fort ou trop faible, consultez votre médecin ou votre pharmacien.
0.42620906233787537 ||| Currently there is no licensed vaccine for HIV or AIDS. ||| Currently, there is no vaccine or specific antiviral treatment for COVID-19. ||| Il n'existe, à ce jour, aucune vaccination efficace contre le sida.
0.26605865359306335 ||| In 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/ day was not associated with any distinguishing profile of adverse events. ||| No other thrombotic complications from overdose have been reported, not even after treatment of a 6 year old boy with haemophilia A with inhibitors with 8 - 10 times the recommended dose. ||| Chez 44 patients schizophrènes et âgés de plus de 65 ans, des doses de 5 à 20 mg par jour n’ ont pas été associées à un profil d’ effets indésirables particulier.
0.0 ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NOM DU TITULAIRE DE L‘AUTORISATION DE MISE SUR LE MARCHÉ
0.15069471299648285 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| Ensure that the plunger rod is drawn sufficiently back when emptying the vial in order to completely empty the filter needle. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
5.276915514794422e-13 ||| Blister packs, aluminium/ aluminium 10, 20, 28, 30, 50, 56, 98, 100, 300 tablets, 50 x 1 tablets (unit dose), 100 x 1 tablets (unit dose). ||| Blister packs, aluminium/ aluminium 10, 20, 28, 30, 50, 56, 98, 100, 300 tablets, 50 x 1 tablets (unit dose), 100 x 1 tablets (unit dose). ||| Comprimés à 10 mg: emballages sous plaquette thermoformée, aluminium/ aluminium 10, 20, 28, 30, 50, 98, 100, 300 comprimés, 50 x 1 comprimé (dose unitaire),100 x 1 comprimé (dose unitaire).
0.0 ||| Operational matters ||| Operational matters ||| Aspects opérationnels
0.2242075502872467 ||| In vivo, probenecid (500 mg every 6 hours) decreased the bound fraction of ertapenem in plasma at the end of infusion in subjects administered a single 1 g intravenous dose from approximately 91% to approximately 87%. ||| Within 5 to 8 weeks following the 12th and final dose of efalizumab administered at 1.0 mg/ kg/ wk, CD11a levels returned to within a range of ±25% of baseline values. ||| In-vivo, le probénécide (500 mg toutes les 6 heures) a diminué de 91% approximativement à 87% approximativement la fraction de liaison de l’ ertapénème dans le plasma à la fin de la perfusion chez des sujets ayant reçu une dose unique intraveineuse de 1 g.
0.3636486232280731 ||| France Lilly France S. A. S Tél.: +33-(0)1 55 49 34 34 ||| Österreich Eli Lilly Ges.m.b.H Tel: +43 -(0) 1 711 780 ||| France Lilly France S. A. S Tél.: +33-(0)1 55 49 34 34 Ireland Eli Lilly and Company (Ireland) Limited.
0.3508908152580261 ||| Atripla, your doctor may need to adjust your dose of the calcium channel blocker. ||| Patients taking rifampicin (an antibiotic) may need to take a higher dose of Sustiva. ||| Lorsque vous commencez votre traitement par Atripla, votre médecin devra peut-être changer votre dose d’ inhibiteur de canal calcique.
0.37291601300239563 ||| An accompanying improvement in the glomerular filtration rate (GFR) was not observed during the first three months of treatment. ||| Reduction in fasting plasma glucose (FPG) was observed at 3 weeks, the first time point at which FPG was measured. ||| Une amélioration concomitante du taux de filtration glomérulaire (TFG) n'a pas été observée pendant les trois premiers mois de traitement.
7.80007352110812e-13 ||| Ι talia Merck Sharp & Dohme (Italia) S. p. A. ||| Ι talia Merck Sharp & Dohme (Italia) S. p. A. ||| 59 Ι talia Merck Sharp & Dohme (Italia) S. p. A.
0.3075319528579712 ||| It may be suitable for those who are unable to take clarithromycin as part of an eradication therapy, when local resistance rates to metronidazole are low. ||| It can be used as monotherapy only in patients in whom HMG-CoA reductase inhibitors are considered inappropriate or not tolerated. ||| Elle peut être intéressante dans le cadre d’un traitement d’éradication pour les patients ne pouvant pas prendre de clarithromycine, lorsque les taux locaux de résistance au métroni- dazole sont faibles.
0.033512555062770844 ||| PegIntron monotherapy was not studied in HCV/HIV co-infected patients. ||| PegIntron monotherapy was not studied in HCV/ HIV co-infected patients. ||| PegIntron en monothérapie n’ a pas été étudié chez les patients co-infectés VHC-VIH.
1.053586721420288 ||| They must not give you any food or drink. ||| But they have more money, in cash. ||| Elles ne doivent rien vous donner à manger ni à boire.
0.263475626707077 ||| • Keep out of the reach and sight of children. • Do not store above 25°C. ||| Keep out of the reach and sight of children Do not store above 30oC. ||| • Ne pas laisser à la portée des enfants. • A conserver à une température ne dépassant pas 25ºC. • Ne pas congeler.
0.2338070571422577 ||| The full EPAR for Xeloda is available here. ||| The full EPAR for Tadalafil Lilly is available here. ||| L’ EPAR complet de Xeloda est disponible à l’ adresse suivante: ici
0.0 ||| However, the dose given on any one day should not exceed 24 mg. ||| However, the dose given on any one day should not exceed 24 mg. ||| Cependant, la dose administrée par jour ne doit pas dépasser 24 mg.
0.5637296438217163 ||| 36 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 351 ANNEX TO THE PACKAGE LEAFLET ||| 37 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.33218711614608765 ||| Muscular effects Cases of myopathy and myalgia have been reported with telbivudine use several weeks to months after starting therapy (see section 4.8). ||| Adverse reactions reported in at least 5% of patients in any treatment group – study 100554 in hepatocellular carcinoma (see study 3 in section 5.1). ||| Effets musculaires Des cas de myopathie et de myalgie ont été rapportés lors de l’ utilisation de la telbivudine, plusieurs semaines à plusieurs mois après le début du traitement (voir rubrique 4.8).
0.37719133496284485 ||| Please check with your doctor if you receive other medicines to treat your psoriasis. ||| Visit your doctor regularly to keep track of your cholesterol and discuss your goals with your doctor. ||| Si vous utilisez d'autres médicaments pour traiter le psoriasis, consultez votre médecin.
0.018022552132606506 ||| the refrigerator and has reached room temperature (up to 25°C) it must either be used within 7 days or disposed of. ed ||| refrigerator and has reached room temperature (up to 25°C) it must either be used within 7 days or disposed of. ed ||| Lorsque le stylo a été sorti du réfrigérateur et a atteint la température ambiante (jusqu’ à 25°C) il doit être utilisé dans les 7 jours ou jeté. am
0.4104325473308563 ||| Computer software development tools ||| Computer software operating manuals ||| Outils de développement de logiciels
0.3655516803264618 ||| Via Privata Maria Teresa, 11 20123 Milano Italy ||| Via Aurelia, 58 00165 Roma Italy ||| Via Privata Maria Teresa, 11 20123 Milano Italie
0.3435438275337219 ||| If you are taking an oral contraceptive to prevent pregnancy, you should use an additional or different type of contraception since ritonavir may reduce the effectiveness of oral contraceptives. ||| If you are taking the contraceptive pill, it is recommended that you use an alternative method (e.g. a condom) to prevent pregnancy, while you are taking Agenerase. ||| Si vous prenez un contraceptif oral afin d’éviter de tomber enceinte, vous devez utiliser un méthode contraceptive différente ou supplémentaire car le ritonavir peut réduire l’efficacité des contraceptifs oraux.
0.5918647646903992 ||| Tadalafil Lilly tablets are for oral use. ||| Swallow Tamiflu capsules whole with water. ||| Les comprimés de Tadalafil Lilly sont à prendre par voie orale.
0.07440704107284546 ||| EU/ 2/ 97/ 004/ 008 ||| EU/ 1/ 97/ 044/ 007 ||| EU/ 2/ 97/ 004/ 008 Metacam
0.308154821395874 ||| The efficacy of MIRAPEXIN was evaluated in four placebo-controlled clinical trials in approximately 1000 patients with moderate to very severe idiopathic Restless Legs Syndrome. ||| In two 3-week, flexible-dose, placebo-controlled monotherapy trials involving patients with a manic or mixed episode of Bipolar I Disorder, aripiprazole demonstrated superior efficacy to placebo in ||| 34 L’ efficacité de MIRAPEXIN a été évaluée dans quatre essais cliniques contrôlés contre placebo chez environ 1000 patients atteints de syndrome idiopathique des jambes sans repos, d’ intensité modérée à très sévère.
0.735230565071106 ||| Product Name ||| Tradename ||| Nom de fantaisie
0.30760955810546875 ||| Patients who are constipated should be monitored carefully while being treated with Renagel. ||| You should be monitored for signs of infection while being treated with somatropin. ||| Les patients constipés doivent être attentivement suivis pendant le traitement par Renagel.
9.084417246230103e-13 ||| c) 1 Presentation ||| c) 1 Presentation ||| c) 1 Présentation
0.39362093806266785 ||| Binding machines ||| Butter machines ||| Lieuses [machines]
0.08170301467180252 ||| The initial time frame agreed on June 6, 1995 by the CPMP was 90 days, extended to an extra period of 90 days on September 12, 1995. ||| The initial time frame agreed by the CPMP on 19 February 1997 was 90 days, extended by an extra period of 90 days on 14 May 1997. ||| Le délai initial de 90 jours fixé le 6 juin 1995 par le C. S. P. a été prolongé le 12 septembre 1995 pour une nouvelle période de 90 jours.
0.31723713874816895 ||| In chronic hepatitis B or C patients, peginterferon alfa-2a serum concentrations accumulate 2 to 3 fold after 6 to 8 weeks of once weekly dosing compared to single dose values. ||| Interferon beta-1b has been given without serious adverse events compromising vital functions to adult cancer patients at individual doses as high as 5,500 microgram (176 million IU) intravenously three times a week. ||| Chez les patients atteints d’hépatite chronique B ou C, les concentrations sériques de peginterféron alfa-2a révèlent une accumulation d’un facteur 2 à 3 après 6 à 8 semaines de traitement hebdomadaire par comparaison aux valeurs obtenues après administration unique.
0.30614742636680603 ||| The following side effects have been experienced by some patients taking Actos 45mg tablets: ||| In addition, some patients have reported the following side effects while taking Januvia: ||| Certains patients sous Actos 45 mg comprimé ont présenté les effets indésirables suivants:
0.3577289581298828 ||| In such cases, the patient should prolong skin and eye protection from direct sunlight or bright indoor light for a period proportionate with the overdose given. ||| precautions for use”): it is essential to avoid exposure to the sun, bright natural light and UV rays throughout the entire duration of treatment and for 5 days after treatment is stopped. ||| Dans ce cas, le patient doit porter des lunettes de soleil sombres et éviter l’ exposition directe au soleil ainsi qu’ à une lumière intérieure forte pendant une période proportionnelle au surdosage.
0.33736246824264526 ||| Loose covers made of textile materials for furniture ||| Textile piece goods made of plastics materials ||| Housses en matières textiles pour mobilier
0.445835679769516 ||| After 18 months of treatment retinal atrophy was observed. ||| Reversible irritancy of rabbits' eyes was detected. ||| Après 18 mois de traitement une atrophie rétinienne a été observée.
0.4051807224750519 ||| Shake the vial gently to dissolve the powder. ||| Rinse the syringe and plunger with clean water. ||| Agiter le flacon doucement afin de dissoudre la poudre.
0.2799988090991974 ||| Aclasta must not be mixed or given intravenously with any other medicinal products. ||| Palivizumab should not be mixed with any medicinal products or diluents other than water for injections. ||| Aclasta ne doit pas être mélangé ou administré par voie intraveineuse avec d'autres médicaments.
0.4844895005226135 ||| Summary of individual signs/ symptoms characterising local injection site reactions in studies TORO 1 and TORO 2 combined (% of patients) n=663 ||| Assessment of adverse reactions is based on data from three studies in adults (n=1,479) and three paediatric studies (n=169). ||| Résumé des signes/ symptômes caractéristiques des réactions locales au site d'injection dans les études TORO 1 et TORO 2 combinées (% de patients) n = 663
0.37060266733169556 ||| Whilst no overgrowth by opportunistic microorganisms such as yeasts were noted during the clinical studies with ORACEA, therapy with tetracyclines at higher doses may result in overgrowth of non- susceptible microorganisms including fungi. ||| The efficacy of Enbrel versus other systemic therapies in patients with moderate to severe psoriasis (responsive to other systemic therapies) has not been evaluated in studies directly comparing Enbrel with other systemic therapies. ||| Même si aucune colonisation par des micro-organismes opportunistes tels que les levures, n’ a été observée lors des études cliniques avec ORACEA, un traitement par tétracyclines à fortes doses peut entraîner une colonisation par de micro-organismes non sensibles, y compris par des champignons.
0.15834705531597137 ||| Tell your doctor at once if any of these apply to you. ||| Ask your doctor for advice if any of these apply to you. ||| Indiquez à votre médecin si vous prenez un de ces médicaments.
0.297102689743042 ||| TESAVEL has not been studied in patients with severe hepatic insufficiency. ||| Clinical study experience with TESAVEL in patients with moderate or severe renal insufficiency is limited. ||| TESAVEL n'a pas été étudié chez les patients ayant une insuffisance hépatique sévère.
0.15577444434165955 ||| Use in elderly (over 65 years of age) No dose reduction is necessary in elderly patients. ||| Elderly patients (over 65 years) No adjustment of the initial dose is required in elderly patients. ||| Utilisation chez le sujet âgé (âgé de plus de 65 ans) Aucune réduction posologique n’ est nécessaire chez le sujet âgé.
0.0 ||| 4.1 Therapeutic indications ||| 4.1 Therapeutic indications ||| 4.1 Indications thérapeutiques
0.3401077091693878 ||| The use of etoricoxib, as with any drug substance known to inhibit COX-2, is not recommended in women attempting to conceive. ||| [Invented name] works by killing bacteria that cause infections, if they are caused by bacteria that are susceptible to the active ingredient moxifloxacin. ||| L’ utilisation d’ étoricoxib, comme tout médicament connu pour inhiber la COX-2, n’ est pas recommandée chez les femmes envisageant une grossesse.
0.35562947392463684 ||| Side effects reported in children are similar to those seen in adult patients. ||| Sustained virological response rates in children and adolescents were similar to those in adults. ||| Les effets secondaires observés chez les enfants sont similaires à ceux remarqués chez les adultes.
0.23424303531646729 ||| Appropriate measures should be taken and discontinuation of parecoxib therapy should be considered if there is clinical evidence of deterioration in the condition of specific clinical symptoms in these patients (see section 5.1). ||| Patients with signs or symptoms compatible with autoimmune disorders should be evaluated carefully, and the benefit-risk of continued interferon therapy should be reassessed (see also section 4.4 Thyroid changes and 4.8). ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une preuve clinique de détérioration symptomatique de l’ état de ces patients (voir rubrique 5.1 Propriétés pharmacodynamiques).
0.23726683855056763 ||| Tighteners [hand-operated tools] ||| Tillers [hand-operated tools] ||| Tendeurs [outillage manuel]
0.29009878635406494 ||| - if you are having a heart attack; ||| - If you are having a blood test. ||| - si vous venez de subir une attaque cardiaque;
0.5210882425308228 ||| • Brief background on Tasigna, its authorised indication and posology • Information on the cardiac risks associated with the use of Tasigna o That Tasigna can cause prolongation of the QT interval and that patients at risk of arrythmia, especially torsade de pointes, should not be prescribed Tasigna. o The need to avoid co-prescription with any other medicines that might prolong the QT interval o Caution in prescribing to patients with a history of or risk factors for coronary heart disease o That Tasigna may cause fluid retention, cardiac failure and pulmonary oedema ||| "Similarly, various Arab media outlets accused Israel and the United States of creating and spreading COVID-19, avian flu, and SARS. Users on social media offered a variety of theories, including the supposition that Jews had manufactured COVID-19 to precipitate a global stock market collapse and thereby profit via insider trading, while a guest on Turkish television posited a more ambitious scenario in which Jews and Zionists had created COVID-19, avian flu, and Crimean–Congo hemorrhagic fever to ""design the world, seize countries, neuter the world's population""." ||| • Résumé des propriétés de Tasigna, son indication thérapeutique autorisée avec le schéma posologique • L’ information sur les risques cardiaques associés à l’ utilisation de Tasigna o Que Tasigna peut entraîner un allongement de l’ intervalle QT et que chez les patients présentant des risques d’ arrythmie, particulièrement des torsades de pointes, Tasigna ne devrait pas être prescrit. o La nécessité d’ éviter une prescription concomittante avec des traitements qui entraînent un allongement de l’ intervalle QT o La prudence requise chez des patients ayant des antécédents ou des facteurs de risques demaladies cardiaques coronariennes o Que Tasigna peut entraîner des oedèmes, une insuffisance cardiaque et un œ dème pulmonaire
0.35967838764190674 ||| 21 (4.5) 4 (0.9) ||| 4 (0.9) 4 (0.9) ||| 21 (4,5) 4 (0,9)
0.2503843903541565 ||| Do not take Starlix ||| Do not take Kaletra ||| Ne prenez jamais Starlix:
0.08008396625518799 ||| {100 ml, 250 ml bottle} ||| {10 ml, 50 ml bottle} ||| {flacon de 100 ml, 250 ml}
0.5309306383132935 ||| Orthodontic appliances ||| Otological prosthetic appliances ||| Appareils d'orthodontie
0.042096979916095734 ||| 1 bag of 1600 ml. ||| 1 bag of 1000 ml. ||| 1 poche de 1600 ml.
0.6192685961723328 ||| Use only as directed by your doctor. ||| according to your weight by your doctor. ||| Suivre les indications de votre médecin.
0.3408556580543518 ||| However, appropriate clinical advice should be given to patients regarding a possible decrease in blood pressure when they are treated with antihypertensive medicines. ||| When administering medicinal products for which alterations in blood levels could have a clinically significant effect on safety or efficacy, physicians should consider monitoring serum levels or effects. ||| Cependant, des conseils cliniques appropriés doivent être donnés aux patients concernant la possibilité d'une diminution de la pression artérielle en cas de traitement concomitant par des antihypertenseurs.
0.05593245476484299 ||| Containers (Non-metallic -) in the form of bins ||| Containers (Non-metallic -) in the form of kegs ||| Conteneurs non métalliques sous forme de bacs
0.5469352006912231 ||| No other findings, in the above toxicity studies, provide information of significant relevance to clinical use. ||| - The body of published literature and resistance data presented provide adequate justification, both ||| Aucune autre observation n’ est ressortie des études de toxicité susmentionnées qui fournisse une information d’ une pertinence significative à l’ usage clinique.
0.24002741277217865 ||| Tylvalosin tartrate is a macrolide antibiotic that has antibacterial activity against Gram-positive, some Gram-negative organisms and mycoplasma. ||| Ciprofloxacin is a quinolone effective in vitro against a large number of Gram-negative aerobic bacteria as well as against some Gram-positive organisms. ||| Le tartrate de tylvalosine est un antibiotique macrolide dont l’ activité antibactérienne s’ exerce contre les organismes Gram positifs et certains Gram négatifs, ainsi que le mycoplasme.
0.28002017736434937 ||| As pramipexole treatment inhibits secretion of prolactin in humans, inhibition of lactation is expected. ||| Tenofovir is eliminated by renal excretion and the exposure to tenofovir increases in patients with renal dysfunction. ||| Le pramipexole inhibant la sécrétion de prolactine dans l'espèce humaine, il faut s'attendre à une inhibition de la lactation.
3.18024334080777e-13 ||| Pregnancy Travoprost has harmful pharmacological effects on pregnancy and/ or the foetus/ new-born child. ||| Pregnancy Travoprost has harmful pharmacological effects on pregnancy and/ or the foetus/ new-born child. ||| Grossesse Le travoprost a des effets pharmacologiques nocifs sur la grossesse et/ ou le fœ tus/ nouveau né.
0.2968088686466217 ||| In that case infusion sets with minimal priming space should be used (i.e 0.3-0.6 ml), primed with medicinal product solution prior to beginning the actual Busilvex infusion and then flushed with sodium chloride 9 mg/ml (0.9%) solution for injection or glucose (5%) solution for injection. ||| This was demonstrated in a single dose, 3-way crossover bioequivalence study of FDC (fasted) versus 2 x 300 mg abacavir tablets plus 2 x 150 mg lamivudine tablets (fasted) versus FDC administered with a high fat meal, in healthy volunteers (n = 30). ||| Amorcez la perfusion avec la solution reconstituée avant de commencer la perfusion de Busilvex et rincez ensuite avec une solution pour perfusion de chlorure de sodium à 9 mg/ ml (0,9%) ou une solution pour perfusion de glucose à 5%.
0.0020504030399024487 ||| Based on the results of in vitro experiments and the known major metabolic pathways of abacavir, the potential for P450 mediated interactions with other medicinal products involving abacavir are low. ||| Based on the results of in vitro experiments and the known major metabolic pathways of abacavir, the potential for P450 mediated interactions with other medicinal products involving abacavir is low. ||| Sur la base des études in vitro et des principales voies métaboliques connues de l’ abacavir, le risque potentiel d’ interactions médicamenteuses entre l’ abacavir et les médicaments métabolisés par le cytochrome P450 est faible.
0.3693793714046478 ||| Dosing should be delayed in the presence of elevated ciclosporin blood levels. ||| The upper limit of the target haemoglobin concentration should not be exceeded. ||| 36 L’ administration doit être différée en cas de concentrations sanguines élevées de ciclosporine.
0.38224679231643677 ||| A dose of 60 mg/ day is recommended. ||| A dose of 1 ml is advised. ||| Boulimie - Adultes et sujets âgés: une posologie de 60 mg/ jour est recommandée.
0.0 ||| CARTON FOR OPA-ALUMINIUM-PVC/ ALUMINIUM BLISTER ||| CARTON FOR OPA-ALUMINIUM-PVC/ ALUMINIUM BLISTER ||| BOITE POUR PLAQUETTES THERMOFORMEES OPA-ALUMINIUM-PVC/ ALUMINIUM
0.5481358766555786 ||| The recommended duration of treatment is 1 year. ||| Label the solution with a one month expiration date. ||| La durée recommandée de traitement est de 1 an.
0.25318264961242676 ||| 11 Table 3. ||| 13 Table 9. ||| 12 Tableau 3.
0.031296662986278534 ||| Although statistically more common than under placebo, somnolence was mild to moderate in the majority of cases. ||| 34 Although statistically more common than under placebo, somnolence was mild to moderate in the majority of cases. ||| La somnolence était statistiquement plus fréquente que sous placebo, mais d'intensité légère à modérée dans la majorité des cas.
0.37761086225509644 ||| The IEF decreased by 52% in the Yentreve group, compared with a decrease of 33% in the placebo-treated group. ||| The I-QOL questionnaire scores were also improved in the Yentreve group compared with the placebo group. ||| La FEI a baissé de 52% dans le groupe sous Yentreve, contre une baisse de 33% dans le groupe sous placebo.
0.2824949622154236 ||| Magnetic field generators for medical use ||| Magnetic separators for scientific use ||| Générateurs de champs magnétiques à usage médical
0.9193213582038879 ||| Grade 3-4 ||| Month 6 ||| 3/ 4
0.4640706777572632 ||| 86 (19.5%) 81 (18.4%) 67 (15.2%) 26 (5.9%) 10 (2.3%) ||| 26/ 144 77/ 269 (18.1%) (28.6%) 14/ 190 44/ 392 (7.4%) (11.2%) ||| 81 (18.4%) 67 (15.2%) 26 (5.9%) 10 (2.3%) 59 (13.4%)
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 151 4.8 Effets indésirables
0.398379921913147 ||| Accommodation bureau services [apartments] ||| Accommodation reservation services [time share] ||| Services d'agences de logement [appartements]
0.1391245573759079 ||| Powder for solution for infusion. ||| Powder for solution for infusion ||| Poudre pour solution pour perfusion.
0.0 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial in the outer carton in order to protect from light. ||| Conserver le flacon dans l'emballage extérieur, à l'abri de la lumière.
0.18244332075119019 ||| Do not use STELARA • After the expiry date which is stated on the label and the carton after “ EXP”. ||| Do not use after the expiry date which is stated on the carton and bottle label after “ EXP’’ ||| 49 Ne pas utiliser STELARA • Après la date de péremption mentionnée sur l’ étiquette et la boîte après “ EXP”.
0.1789400428533554 ||| 1/ 14 ||| 1/ 44 ||| 2/ 14
0.18790870904922485 ||| HOW TO STORE OPTISON ||| HOW TO STORE STOCRIN ||| COMMENT CONSERVER OPTISON
0.33836978673934937 ||| When administered with H2-antagonists or other drugs that increase gastric pH Bondronat absorption may be slightly increased but no dose adjustment is needed. ||| Dopamine agonists and antagonists acting on the postsynaptic dopamine receptors are not expected to interfere with DaTSCAN imaging and can therefore be continued if desired. ||| Lorsqu’ il est administré avec des antagonistes des récepteurs H2 ou avec d’ autres médicaments qui élèvent le pH gastrique, l’ absorption de Bondronat peut être légèrement augmentée mais ne nécessite pas d’ ajustement posologique.
0.26092755794525146 ||| In patients scheduled for major elective orthopaedic surgery the cause of anaemia should be established and treated, if possible, before the start of epoetin alfa treatment. ||| Also, if medically appropriate, when switching patients from depot antipsychotics, initiate RISPERDAL therapy in place of the next scheduled injection. ||| Chez les patients devant bénéficier d’ une intervention chirurgicale orthopédique majeure programmée, la cause de l'anémie doit être établie et traitée, si possible avant l'instauration du traitement par époétine alfa.
0.776102602481842 ||| Uncommon (0.1-1%) ||| Uncommon (≥ 1/ 1,000 to ||| Peu fréquents (0.1-1%)
0.35096079111099243 ||| In the treatment of cats with FeLV, there was a reduction of clinical signs over 4 months and a reduction in the mortality rate. ||| Patients receiving Extavia showed a reduction in frequency (30%) and severity of clinical relapses, as well as the number of hospitalisations due to disease. ||| Suite au traitement des chats infectés par le FeLV, on a observé une réduction des signes cliniques sur une période de 4 mois et une réduction du taux de mortalité.
0.39698174595832825 ||| Patients with severe renal impairment, including those on hemodialysis, should be closely monitored. ||| - Patients with endocrine (hormonal) disorders are more likely to have problems with their hips. ||| Les patients avec une insuffisance rénale sévère, y compris les patients hémodialysés, doivent être attentivement surveillés.
0.15990731120109558 ||| If this was noticed later than 6 hours of the time it is usually taken, the missed dose should not be taken and the patient should resume the usual dosing schedule. ||| If a patient misses a dose by more than 6 hours of the time it is usually taken, the patient should be told not to take the missed dose and simply resume the usual dosing schedule. ||| Si l’ oubli a été noté plus de 6 heures après l’ horaire de la prise habituelle, la dose oubliée ne doit pas être prise et le patient doit poursuivre le schéma posologique habituel.
0.463972270488739 ||| Abrasive discs for kitchen [cleaning] purposes ||| Mouthwashes [gargles] for medical purposes ||| Disques abrasifs de cuisine à des fins de nettoyage
0.16945528984069824 ||| Don’t put in any more drops until it’s time for your next regular dose. ||| Do not put in any more drops until it is time for your next regular dose. ||| Ne mettez pas d’ autres gouttes jusqu’ à ce que le moment soit venu de prendre la goutte suivante.
0.5776467323303223 ||| In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician. ||| You should be screened for skin type Area in card for physician to record skin type and date of injection. ||| En cas d’ injection accidentelle à l’ homme, consulter un médecin immédiatement et lui montrer la notice ou l’ étiquette.
0.17415158450603485 ||| In healthy elderly (65 and over) versus non-elderly subjects administered oral olanzapine, the mean elimination half-life was prolonged (51.8 versus 33.8 hr) and the clearance was reduced (17.5 versus 18.2 l/ hr). ||| 82 In smoking subjects with mild hepatic dysfunction, mean elimination half-life (39.3 hr) was prolonged and clearance (18.0 l/ hr) was reduced analogous to non-smoking healthy subjects (48.8 hr and 14.1 l/ hr, respectively). ||| Chez le sujet sain âgé (65 ans et plus), par rapport au sujet sain jeune recevant l'olanzapine par voie orale, la demi-vie moyenne d’ élimination de l’ olanzapine est prolongée (51,8 versus 33,8 heures) et la clairance est réduite (17,5 vs 18,2 l/ heure).
0.5043439269065857 ||| Shoulder pads for sports use ||| Leg pads for American football ||| Protège-épaules pour le sport
0.5717958211898804 ||| 1% (2/ 141) ||| 1/ 65(1.5%) ||| 15% (67/439)
0.47416067123413086 ||| All-terrain vehicles ||| Self-loading vehicles ||| Véhicules tout terrain
0.5757121443748474 ||| Vaccination scheme: ||| Basic vaccination: ||| Programme de vaccination.
4.218438749356568e-13 ||| Hepatobiliary disorders: ||| Hepatobiliary disorders: ||| Affections hépato-biliaires:
2.4940786198454634e-13 ||| The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171), iron oxide yellow and red (E 172), all in the tablet coating. ||| The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171), iron oxide yellow and red (E 172), all in the tablet coating. ||| Les autres composants sont cellulose microcristalline, croscarmellose sodique, silice colloïdale anhydre, stéarate de magnésium (tous présents dans le noyau du comprimé) et hypromellose, macrogol 400, dioxyde de titane (E171) et oxyde de fer rouge et jaune (E172) (tous présents dans la pellicule du comprimé).
0.2971569299697876 ||| The clinical significance of these changes in clarithromycin plasma levels is not known. ||| The effects of high fluticasone systemic exposure on ritonavir plasma levels are yet unknown. ||| La signification clinique de ces variations de concentrations plasmatiques de clarithromycine n’ est pas connue.
0.33714401721954346 ||| Paresthesia, neuritis ||| Paresthesia, somnolence ||| Paresthésie, névrite
0.0 ||| STATEMENT OF ACTIVE AND OTHER SUBSTANCES ||| STATEMENT OF ACTIVE AND OTHER SUBSTANCES ||| LISTE DES PRINCIPES ACTIFS ET AUTRES SUBSTANCES
0.06932119280099869 ||| B CONDITIONS OF THE MARKETING AUTHORISATION o ||| B CONDITIONS OF THE MARKETING AUTHORISATION ||| L’ AUTORISATION DE MISE SUR LE MARCHÉ
0.4305260479450226 ||| Findings were only observed in association with maternal toxicity at ≥ 150 mg/kg and included a transient decrease in body weight and reduced motor activity in the F1 generation. ||| With a decrease of 29% of CO² per unit of gross value added between 2009 and 2017, fisheries and aquaculture growth is firmly decoupled from greenhouse gas production. ||| 27 maternelle à des doses ≥ 150 mg/ kg et ont inclus une diminution transitoire du poids et une réduction de l’ activité motrice dans la génération F1.
0.3826495409011841 ||| Irbesartan Hydrochlorothiazide BMS is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide. ||| C09A A04 Perindopril is an inhibitor of the enzyme that converts angiotensin I into angiotensin II (Angiotensin Converting Enzyme ACE). ||| 55 Irbesartan Hydrochlorothiazide BMS est l'association d’ un antagoniste des récepteurs de l'angiotensine-II, l'irbésartan, et d’ un diurétique thiazidique, l'hydrochlorothiazide.
0.3743070065975189 ||| 75 Don't worry if a little Norvir oral solution is left in the measuring cup after you've taken your dose. ||| Do not try to remove this air bubble before making the injection - you may lose some of the medicine if you do. ||| Ne vous inquiétez pas s'il reste un peu de Norvir solution buvable au fond du verre doseur.
0.4841013550758362 ||| Hepato-biliary disorders Very rare: ||| Endocrine disorders rare: hirsutism ||| Troubles hépato-biliaires Très rare:
0.46239015460014343 ||| In addition, the Commission is augmenting the budget firepower through the resources channelled via Next Generation EU. ||| This comes in addition to support already available via the EU Civil Protection Mechanism and deliveries of protective equipment through rescEU. ||| Dans le même temps, la Commission augmente la puissance budgétaire grâce aux ressources mobilisées dans le cadre de Next Generation EU.
0.4354706406593323 ||| It contains no antibacterial preservative. ||| It is also active against gastrointestinal nematodes. ||| Elle ne contient aucun conservateur antibactérien.
0.06335150450468063 ||| Store in a refrigerator (2°C - 8°C). ||| Store in a refrigerator (2°C - 8ºC). ||| Conserver au réfrigérateur (entre +2° C et +8° C).
6.543224078878196e-13 ||| Do not inject directly into a vein. ||| Do not inject directly into a vein. ||| N'injectez pas directement dans une veine.
0.4343894124031067 ||| Humira was studied in 6,593patients in controlled and open label trials for up to 60 months. ||| Among the 41 patients enrolled in the trial 14 patients were treated with Zavesca for more than 3 years. ||| Humira a été étudié chez 6 593 patients dans des essais contrôlés et en ouvert d’ une durée maximale de 60 mois.
4.271461114500885e-13 ||| - A history of severe pre-existing cardiac disease, e. g., uncontrolled congestive heart failure, recent ||| - A history of severe pre-existing cardiac disease, e. g., uncontrolled congestive heart failure, recent ||| n'e infarctus du myocarde récent, désordres arythmiques sévères.
0.657793402671814 ||| This list contained a large number of herbal medicines and homeopathic substances which had not been originally accounted for prior to the Agency taking over responsibility for the setting of MRLs. ||| The use of names or logo of government authorities, official experts or international institutions that have allegedly endorsed them, but with no hyperlinks or references to official documents ||| Cette liste contenait un grand nombre de médicaments à base de plantes et de substances homéopathiques qui n’avait initialement pas été pris en considération avant que l’Agence ne prenne en charge la responsabilité de la fixation des LMR.
0.27353882789611816 ||| Immune system disorder Frequency not known: hypersensitivity reactions, including anaphylactic/ anaphylactoid reactions. ||| Allergy Generalised hypersensitivity reactions (e. g. anaphylactic reaction), or immunological reactions such as vasculitis. ||| Affections du système immunitaire Fréquence indéterminée: réactions d’ hypersensibilité, incluant les réactions anaphylactiques et les réactions anaphylactoïdes.
0.03912089020013809 ||| In insulin infusion pumps If InnoLet is dropped, damaged or crushed there is a risk of leakage of insulin If it hasn’ t been stored correctly or been frozen (see 6 How to store Protaphane) If it’ s not uniformly white and cloudy when it’ s resuspended. ||| In insulin infusion pumps If Penfill or the device containing Penfill is dropped, damaged or crushed there is a risk of leakage of insulin If it hasn’ t been stored correctly or been frozen (see 6 How to store Protaphane) If it’ s not uniformly white and cloudy when it’ s resuspended. ||| dans une pompe à perfusion d’insuline si InnoLet est tombé, a été endommagé ou a été écrasé, car il y a un risque de fuite d’insuline s’il n’a pas été conservé correctement ou s’il a été congelé (voir 6 Comment conserver Protaphane) s’il n’apparaît pas uniformément blanc et opaque après remise en suspension.
0.25029808282852173 ||| The maximum licensed dose of fluticasone propionate delivered by Viani Diskus in children is 100mcg twice daily. ||| The recommended dose of Pegasys in combination with ribavirin is 180 mcg once weekly by subcutaneous administration. ||| Une inhalation de 100 microgrammes de propionate de fluticasone et 50 microgrammes de salmétérol 2 fois par jour.
0.21761693060398102 ||| Rivastigmine oral solution may be swallowed directly from the syringe. ||| Each dose of Exelon oral solution may be swallowed directly from the syringe. ||| Rivastigmine solution buvable peut être avalée directement à partir de la seringue.
0.39501333236694336 ||| 15.1% 4.7% ||| 10.0% 2.2% ||| 15,1% 4,7%
0.07364089787006378 ||| 19/ 48 A. ||| 17/ 48 A. ||| 19/ 49 A.
0.2801486849784851 ||| common ||| known ||| rhinite
0.4574081003665924 ||| Efficacy of Xolair treatment in combination with specific immunotherapy has not been established. ||| Paediatric Use Efficacy and safety of use in children has not been fully established. ||| L’ efficacité du traitement par Xolair administré en association avec une immunothérapie spécifique n’ a pas été établie.
0.369851291179657 ||| Cages for household pets ||| Beverages for cats ||| Cages pour animaux d'intérieur
0.3978845179080963 ||| Epivir contains methyl parahydroxybenzoate and propyl parahydroxybenzoate. ||| Contains methylparahydroxybenzoate (E 218) and propylparahydroxybenzoate (E 216), among other substances. ||| Epivir contient du parahydroxybenzoate de méthyle et du parahydroxybenzoate de propyle.
0.38762086629867554 ||| Treatment of waste ||| Recycling of waste ||| Traitement de déchets
0.2910768389701843 ||| None of the components in the vaccine are infectious. ||| None of the ingredients in the vaccine can cause flu. ||| Aucun des composants contenus dans le vaccin n'est contaminant.
0.40443283319473267 ||| The difference was not statistically significant, however more than half of the patients in the anastrozole alone arm crossed over to a Herceptin containing regimen after progression of disease. ||| The remaining 102 subjects were healthy volunteers who had not been exposed to cyanide at the time of hydroxocobalamin administration. ||| Toutefois plus de la moitié des patientes du groupe anastrozole seul ont reçu un traitement à base de Herceptin après progression de la maladie.
0.19090811908245087 ||| NovoMix 30 Penfill 100 U/ ml Suspension for injection Insulin aspart SC use ||| NovoRapid NovoLet 100 U/ ml Solution for injection Insulin aspart SC use ||| NovoMix 30 Penfill 100 U/ ml Suspension injectable Insuline asparte Voie SC
0.10871490836143494 ||| What is Hycamtin used for? ||| What is Thymanax used for? ||| Dans quel cas Hycamtin est -il utilisé?
0.454030841588974 ||| The first case was reported in Zagreb on 25 February, when a patient who had come from Italy was tested positive. ||| On 13 March, the third case was also confirmed, a person who had had direct contact with the first two cases. ||| La pandémie de Covid-19 en Croatie est identifiée à Zagreb à partir du 25 février 2020 lorsqu'un patient venu d'Italie est testé positif.
0.4156927466392517 ||| Taking/ using other medicines Before starting treatment with Agenerase, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| At present, there is not very much information about MabThera treatment in children and adolescents; if you are under 18 years of age, you or your parent/career should ask your doctor if MabThera is right for you. ||| Avant de débuter votre traitement par Agenerase, veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment un autre médicament, même s’il s’agit d’un médicament obtenu sans ordonnance.
0.3795071244239807 ||| It works by blocking the bacteria's ribosomes, the parts of the cell where proteins are produced, and inhibits the growth of bacteria. ||| When the blood clots, this is due to special cells in the blood, the platelets, sticking together (aggregating). ||| Il agit en bloquant les ribosomes des bactéries, parties de la cellule où sont produites les protéines, et empêche la croissance des bactéries.
5.203756804801618e-13 ||| 37 B. ||| 37 B. ||| 39 B.
0.21752464771270752 ||| However, if you take more Aerius oral solution than you were told to, contact your doctor or pharmacist. ||| If you think that you may have taken too many AZILECT tablets, contact your doctor or pharmacist immediately. ||| Cependant, si vous avez pris plus d’ Aerius solution buvable que vous n’ auriez dû, prévenez votre médecin ou votre pharmacien.
0.834767758846283 ||| Risperdal Consta 50 mg ||| Intradermal 15µg ||| Risperdal Consta 50 mg 50 mg
0.5477521419525146 ||| Vegetable corers [machines] ||| Tropical fruits [fresh] ||| Machines à évider les légumes
0.6329766511917114 ||| Electronic games services, including provision of computer games on-line or by means of a global computer network ||| Health care services offered through a network of health care providers on a contract basis ||| Services de jeux électroniques, y compris jeux d'ordinateur fournis en ligne ou par un réseau informatique mondial
0.39261436462402344 ||| Venlafaxine and ODV are minimally bound at therapeutic concentrations to human plasma proteins (27% and 30%, respectively). ||| 32 pharmacokinetic characteristics of stavudine is low, approximately 15% and 25%, respectively, after oral administration. ||| Aux concentrations thérapeutiques, la venlafaxine et l’ ODV sont à peine liées aux protéines plasmatiques humaines (respectivement 27% et 30%).
0.04435030370950699 ||| Ledervorin Calcium 500 mg/ 50 ml ||| Ledervorin Calcium 100 mg/ 10 ml ||| 500 mg/ 50 ml
0.5129609704017639 ||| 20 mg x 10 vials ||| 50 mg x 1 VIAL ||| 20 mg x 10 flacons
0.27338266372680664 ||| burning, herpes simplex, alcohol intolerance (facial flushing or skin sensitivity after alcohol intake), skin tingling, hyperaesthesia, acne and fungal dermatitis occurred more often in the tacrolimus a ||| Fatigue, Chest pain, Asthenia, Mild and transient injection site events, including pain, swelling, erythema, localised bruising, pruritis and minor bleeding at injection site. ||| Brûlures cutanées, herpès simplex, intolérance à l’ alcool (rougeur du visage ou sensibilité cutanée accrue après consommation de boisson alcoolisée), picotements cutanés, hyperesthésie, acné et dermatite fongique sont apparus plus fréquemment dans le groupe tacrolimus.
0.22720515727996826 ||| The following table presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan. ||| The table below lists the adverse reactions reported during placebo-controlled clinical trials for registration in patients treated with tadalafil on demand and daily dosing. ||| Les effets indésirables suivants ont été rapportés au cours des études cliniques versus placebo dans lesquelles 1965 patients ont reçu de l’ irbésartan.
0.4401697516441345 ||| Therefore, women of child- bearing potential should avoid contact with, or wear disposable gloves when administering, the product. ||| When administering Profender, users should not smoke, eat or drink, and should wash their hands thoroughly after use. ||| En conséquence, les femmes enceintes ou susceptibles de l’ être devront éviter les contacts avec le produit lors de son application ou porter des gants jetables.
0.40886491537094116 ||| An increased incidence of opportunistic infections is expected during, and for 6 months following, therapy with cladribine. ||| This benefit was consistent across age, gender and with or without fibrinolytics, and was observed as early as 24 hours. ||| Une augmentation de l'incidence des infections opportunistes est prévisible pendant le traitement par cladribine et au cours des 6 mois suivants.
0.5596218705177307 ||| Farmers and related bodies can take the following collective actions for example: market withdrawal and free distribution, joint promotion and planning of production. ||| Planning concerning business management, namely, searching for partners for amalgamations and business take-overs as well as for business establishments ||| Les agriculteurs et organismes associés peuvent par exemple prendre les mesures collectives suivantes: retrait du marché et distribution gratuite, actions de promotion conjointes et planification de la production.
0.005390912294387817 ||| 58 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| 51 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| Un ajustement de la posologie peut également être nécessaire si le patient modifie son activité physique ou son régime alimentaire.
0.3737926483154297 ||| Compositions for industrial use in removing scale from boilers ||| Rubber bearings for seismic isolation of buildings ||| Compositions à usage industriel pour détartrer les chaudières
0.385047972202301 ||| Patient reported adverse reactions from 185 patients treated with imiquimod cream in placebo controlled phase III clinical studies for superficial basal cell carcinoma are presented below. ||| Imiquimod cream was evaluated in a photocarcinogenicity bioassay in albino hairless mice exposed to simulated solar ultraviolet radiation (UVR). ||| Les réactions indésirables rapportées par 185 patients traités avec la crème imiquimod pour un carcinome baso-cellulaire superficiel dans des études cliniques en phase III, contrôlées contre placebo, sont présentées ci-après.
1.1378055615740568e-12 ||| Single use only. ||| Single use only. ||| A usage unique exclusivement.
0.44787299633026123 ||| 99 G ||| 110 M ||| G
0.3211303949356079 ||| 0.088 mg pramipexole equivalent to pramipexole dihydrochloride monohydrate 0.125 mg ||| 64 mg fluoxetine (as 72.34 mg fluoxetine hydrochloride) ||| 0,088 mg de pramipexole correspondant à 0,125 mg de dichlorhydrate de pramipexole monohydraté
0.1833898425102234 ||| Optaflu has not been studied in the paediatric population and therefore, data on immune response are not available for this age group. ||| Xeomin has not been studied in the paediatric population and is therefore not recommended in the paediatric age group until further data become available. ||| En conséquence, il n’ existe aucune donnée sur la réponse immunitaire dans cette classe d’ âge.
0.49746495485305786 ||| Reduced risk of Hepatocellular Carcinoma Hepatocellular carcinoma is a serious complication of hepatitis B virus infection. ||| b) Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia (CLL) is the most common form of adult leukaemia. ||| Risque réduit de cancer du foie Le cancer primitif du foie est une complication grave de l'infection par le virus de l'hépatite B.
0.0397019162774086 ||| 72 6.4 Special precautions for storage ||| 80 6.4 Special precautions for storage ||| 6.4 Précautions particulières de conservation
0.4821283519268036 ||| 40 (19) 21 (10) 28 (14) 22 (11) 16 (8) ||| 85 (25) 19 (6) 54 (16) 18 (5) 53 (16) 4 (1) ||| 40 (19) 21 (10) 28 (14) 22 (11) 16 (8) 41 (20)
0.20742593705654144 ||| If not used immediately, it must be stored at 2°C - 8°C in the refrigerator and used within 24 hours. t uc ||| After reconstitution, the product must be kept in a refrigerator (2°C - 8°C) and must be used within 6 hours. ||| Si elle n’est pas utilisée immédiatement, elle doit être conservée entre 2°C et 8°C au réfrigérateur et utilisée dans les 24 heures.
0.5733817219734192 ||| Sixth General Report on the Activities of the European Agency for the Evaluation of Medicinal Products ||| Work programme for the European Agency for the Evaluation of Medicinal Products — 2000–2001 ||| Matthews, Canary Wharf Ltd Sixième Rapport général sur les activités de l’ Agence européenne pour l’ évaluation des médicaments
0.21627968549728394 ||| If you forget to take Imprida If you forget to take this medicine, take it as soon as you remember. ||| If you forget to take Velmetia If you miss a dose, take it as soon as you remember. ||| Si vous oubliez de prendre Imprida Si vous oubliez de prendre ce médicament, prenez -le dès que vous vous en rendez compte.
0.0747741311788559 ||| SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EMEA ||| SCIENTIFIC CONCLUSIONS AND GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET PRESENTED BY THE EMEA ||| CONCLUSIONS SCIENTIFIQUES ET MOTIFS DE LA MODIFICATION DES RÉSUMÉS DES CARACTÉRISTIQUES DU PRODUIT, DE L’ ÉTIQUETAGE ET DE LA NOTICE PRÉSENTÉS PAR L' EMEA
0.11857594549655914 ||| If you forget to take Ciprofloxacin Bayer ||| If you stop taking Ciprofloxacin Bayer ||| Si vous oubliez de prendre Ciprofloxacine Bayer
0.2589864730834961 ||| Enbrel is administered by an injection under the skin (by subcutaneous injection). ||| The vaccine is given as an intramuscular injection (injection into a muscle). ||| Enbrel est administré par une injection sous la peau (par injection en sous-cutanée).
0.41763269901275635 ||| The objective of the group was to identify European brand leaders in major therapeutic areas for harmonisation referrals under Article 30 of the Community Code. ||| Participation in the International Conferences on Harmonisation (ICH) for human and veterinary medicines remained a priority area of activity in 1997. ||| Le groupe avait pour objectif d’ identifier des personnalités éminentes dans les domaines thérapeutiques majeurs pour les saisines liées à l’ harmonisation en vertu de l’ article 30 du code communautaire.
0.6145939826965332 ||| Uncommon: increased lactic dehydrogenase ||| Very common: elevated creatine kinase ||| augmentation de la lactate deshydrogénase
0.31294113397598267 ||| The Member States should also agree with the MAH prior to the launch of the product: • The feasibility of collecting detailed data relating to the indication in order to monitor closely the off-label use within the national territory. • The set-up of national measures to assess the effectiveness of and compliance with the PPP ||| The Commission is therefore taking all necessary steps to that end including by providing guidance for Member States on how to put in place adequate control mechanisms to ensure security of supply, and by launching an accelerated joint procurement procedure for these goods and issuing a recommendation on non CE-marked protective equipment. ||| Les Etats Membres, en accord avec le titulaire de l’ AMM et avant la mise sur le marché du médicament, doivent s’ assurer de: • La faisabilité au niveau national de collecter des données détaillées relatives aux indications afin de surveiller de près son utilisation hors AMM • La mise en place au niveau national de mesures d’ évaluation de l’ efficacité du PPG et de sa conformité.
0.18304823338985443 ||| As with other anti-HIV medicines, patients taking Telzir may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| Since platelets participate in the initiation and/ or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function can result in the reduction of the rate of cardiovascular events such as death, myocardial infarction, or stroke. ||| 2/ 3 Comme d’ autres médicaments anti-VIH, Telzir peut entraîner un risque de lipodystrophie (anomalie de la distribution des graisses dans le corps), d’ ostéonécrose (mort du tissu osseux) ou d’ apparition du syndrome de réactivation immunitaire (symptômes de l’ infection dus à la reconstitution du système immunitaire).
0.6477304697036743 ||| There were no adverse experiences in the majority of overdose reports. ||| Both cases were unremarkable and no sequelae were reported. ||| Il n’ a pas été rapporté d'effet indésirable dans la majorité des cas décrits.
0.516187310218811 ||| Your doctor may want to monitor you for inhibitor development. ||| If you plan to start using a hormonal contraceptive: ||| Votre médecin pourra vouloir rechercher l’apparition d’un inhibiteur.
0.4873840808868408 ||| Boleros ||| Lorries ||| Boléros
0.32358983159065247 ||| Wyeth Europa Ltd Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH United Kingdom ||| Lonza Biologics, plc 228 Bath Road Slough Berkshire SL1 4DX United Kingdom ||| Wyeth Europa Ltd Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH Royaume Uni
0.17207345366477966 ||| Hyperkalaemia Concomitant use with potassium supplements, potassium-sparing diuretics, salt substitutes containing potassium, or other agents that may increase potassium levels (heparin, etc.) is not recommended. ||| Potassium sparing diuretics (e. g. spironolactone, triamterene or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium. ||| Hyperkaliémie L’ administration concomitante de suppléments potassiques, de diurétiques épargneurs de potassium, de substituts du sel contenant du potassium ou d’ autres agents pouvant augmenter les taux de potassium (héparine, etc.) est déconseillée.
0.3323937654495239 ||| Etoricoxib is an oral, selective cyclo-oxygenase-2 (COX-2) inhibitor within the clinical dose range. ||| Tepoxalin is a dual cyclooxygenase / 5-lipoxygenase inhibitor with anti-inflammatory activity. ||| Aux doses thérapeutiques, l’ étoricoxib par voie orale est un inhibiteur sélectif de la cyclo-oxygénase- 2 (COX-2).
0.028310561552643776 ||| Table 3b – Reduced ViraferonPeg Dose for the 1.0 μg/kg Monotherapy Regimen ||| Table 3b – Reduced ViraferonPeg Dose for the 1.0 μ g/ kg Monotherapy Regimen ||| Tableau 3b – Réduction des doses du ViraferonPeg utilisé en monothérapie 1,0 μ g/ kg
0.0 ||| General disorders and administration site conditions ||| General disorders and administration site conditions ||| Troubles généraux et anomalies au site d' administration
0.24377036094665527 ||| In two clinical studies in de novo liver transplant patients the use of sirolimus plus ciclosporin or tacrolimus was associated with an increase in hepatic artery thrombosis, mostly leading to graft loss or death. ||| In patients with a manic or mixed episode of bipolar disorder, olanzapine demonstrated superior efficacy to placebo and valproate semisodium (divalproex) in reduction of manic symptoms over 3 weeks. ||| Dans deux études cliniques chez des transplantés hépatiques de novo, l’ utilisation du sirolimus plus ciclosporine ou tacrolimus a été associée à une augmentation des thromboses de l’ artère hépatique, conduisant le plus souvent à la perte du greffon ou au décès.
0.0 ||| Dose modification for all patients If severe adverse reactions or laboratory abnormalities develop during treatment with PegIntron monotherapy or PegIntron in combination with ribavirin, modify the dosages of each product as appropriate, until the adverse reactions abate. ||| Dose modification for all patients If severe adverse reactions or laboratory abnormalities develop during treatment with PegIntron monotherapy or PegIntron in combination with ribavirin, modify the dosages of each product as appropriate, until the adverse reactions abate. ||| 101 Modification des doses chez tous les patients Si des effets indésirables ou des anomalies sévères des analyses de laboratoire apparaissent pendant le traitement par PegIntron en monothérapie ou en association avec la ribavirine, modifier de manière appropriée les posologies de chaque produit, jusqu’ à ce que les effets indésirables cessent.
0.3921282887458801 ||| • Always use a new needle for each injection to prevent contamination. ||| • Do not use the residual scale to measure your dose of insulin. ||| • Utilisez une aiguille neuve pour chaque injection afin d’ éviter le risque de contamination.
0.06796902418136597 ||| neorecormon 2000 IU ||| neorecormon 6000 IU ||| neorecormon 2000 UI
5.572583410343168e-13 ||| Ear and labyrinth disorders ||| Ear and labyrinth disorders ||| Affections de l’oreille et du labyrinthe
0.4328644871711731 ||| Clip clamps of metal ||| Monorail structures of metal ||| Pinces à clip en métal
0.004683103412389755 ||| Urinary tract infections, increase in certain white blood cells (eosinophilia), allergic reaction (e. g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), slow heart rate (bradycardia), drug rash, eczema (a skin disorder), inflammation of the tendons, ineffectiveness of Pritor and decreased haemoglobin (a blood protein). ||| Urinary tract infections, increase in certain white blood cells (eosinophilia), allergic reaction (e. g. rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), slow heart rate (bradycardia), drug rash, eczema (a skin disorder), inflammation of the tendons, ineffectiveness of Micardis and decreased haemoglobin (a blood protein). ||| Infections urinaires, augmentation de certains globules blancs du sang (éosinophilie), réaction allergique (par exemple éruptions, démangeaisons, difficulté à respirer, sifflement, gonflement du visage et diminution de la pression sanguine), battements du cœ ur lents (bardycardie), éruption d’ origine médicamenteuse, eczéma (une maladie de peau), inflammation des tendons, inefficacité de Pritor et diminution de l’ hémoglobine (une protéine du sang).
0.48263707756996155 ||| The use of Gardasil should be in accordance with official recommendations. ||| The choice of which vaccine to use depends on official recommendations. ||| Gardasil doit être utilisé sur la base des recommandations officielles.
0.31161993741989136 ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4. ||| Exacerbation of anaemia due to ribavirin has been reported when zidovudine is part of the regimen used to treat HIV although the exact mechanism remains to be elucidated. ||| Les effets d’un surdosage avec GONAL-f ne sont pas connus, néanmoins, chez la femme, un syndrome d’hyperstimulation ovarienne n’est pas exclu (se reporter à la rubrique 4).
0.4325307607650757 ||| Individual cases of interstitial lung disorders of unknown causal relationship to cetuximab have been reported. ||| - adult patients with newly-diagnosed gliobl astoma multiforme concomitantly with radiotherapy ||| De rares cas d’ atteinte interstitielle pulmonaire ont été rapportés, sans lien de causalité évident avec le cetuximab.
0.1853140890598297 ||| -24.5 (13.9) ||| -5.9 (13.9) ||| -24,5 (13,9)
0.2174263894557953 ||| In these patients, therapy should be started under medical supervision and the patients should be followed closely whenever the dose of and/or diuretic is adjusted. ||| Careful monitoring of the patient should be performed, when inhaled iloprost therapy is stopped and an alternative treatment should be considered in critically ill patients. ||| Chez ces patients, le traitement doit être débuté sous surveillance médicale et les patients doivent être suivis étroitement chaque fois que la dose de et/ ou de diurétique est ajustée.
0.607376217842102 ||| = 181 8.3 ||| = 288) 2.1 ||| n = 181
0.7054958343505859 ||| Training relating to computer techniques ||| Training guides in electronic format ||| Formation en matière de techniques informatiques
0.35999661684036255 ||| A pharmacodynamic interaction between clopidogrel and heparin is possible, leading to increased risk of bleeding. ||| Combined with hydrochlorothiazide, a significant additional reduction in blood pressure is achieved. ||| Une interaction pharmacodynamique entre le clopidogrel et l’héparine est possible, conduisant à une augmentation du risque de saignement.
0.27246391773223877 ||| 84 Your doctor should decide whether you can take DULOXETINE BOEHRINGER INGELHEIM with other medicines. ||| Care should be taken if you drink alcohol while you are being treated with DULOXETINE BOEHRINGER INGELHEIM. ||| C'est à votre médecin de décider si vous pouvez prendre DULOXETINE BOEHRINGER INGELHEIM avec d'autres médicaments.
0.016002953052520752 ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIAL, IF ANY ||| PRÉCAUTIONS PARTICULIÈRES D’ ÉLIMINATION DES MÉDICAMENTS NON UTILISÉS OU DES DÉCHETS PROVENANT DE CES MÉDICAMENT, le cas échéant
0.5422050356864929 ||| 133 Maintenance ||| 759 Maintenance ||| 138 Entretien
1.0214532613754272 ||| BATCH NUMBER al ||| ANNEX A EU Number ||| NUMERO DU LOT ic
0.0 ||| No interaction studies have been performed. ||| No interaction studies have been performed. ||| Aucune étude d’ interaction n’ a été réalisée.
0.1913846731185913 ||| thrombotic events (especially myocardial infarction) versus naproxen, all available data show an increased risk of CV adverse reactions for Cox-2 inhibitors as a class and agreed that there is an association between duration and dose of intake and the probability of suffering a CV reaction. ||| Although there is no evidence that the incidence of congenital anomalies in offspring of patients taking or another closely related HMG-CoA reductase inhibitor differs from that observed in the general population, maternal treatment with may reduce the foetal levels of mevalonate which is a precursor of cholesterol biosynthesis. ||| augmentation des événements thrombotiques (en particulier de l’ infarctus du myocarde) par rapport au naproxène, toutes les données disponibles montrent un risque accru d’ événements indésirables cardiovasculaires pour la classe des inhibiteurs de la COX-2, et le CHMP a convenu qu’ il existe une relation entre la durée du traitement et la dose administrée, et la probabilité de présenter une réaction cardiovasculaire.
0.012816298753023148 ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| 5 Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu
0.4386565089225769 ||| Serious infections were rarely fatal. ||| Blisters and swelling were reported rarely. ||| Les infections graves ont rarement été fatales.
0.2636859118938446 ||| Double glazing panels (Non-metallic -) ||| V-shaped seals (Non-metallic -) ||| Panneaux de double vitrage non métalliques
0.4711103141307831 ||| Sliding roofs for motor vehicles ||| Fog horns for use on vehicles ||| Toits ouvrants pour véhicules à moteur
0.5630319118499756 ||| The schedule shown in the diagram below will help you to vary the sites appropriately. ||| Check through the window to be sure that the two stoppers are together. ||| Le calendrier illustré sur le schéma ci-dessous vous aidera à alterner les zones de manière adéquate.
0.4447382092475891 ||| Rapid open sharing of data greatly accelerates research and discovery, allowing for an effective response to the coronavirus emergency. ||| Contact tracing is an essential intervention, alongside testing and isolation, in the effort to control the pandemic. ||| Le partage ouvert et rapide des données permet d'accélérer considérablement la recherche et les découvertes et d'apporter une réponse efficace à la crise du coronavirus.
0.09838442504405975 ||| Why has Enbrel been approved? ||| Why has Aprovel been approved? ||| Pourquoi Enbrel a -t-il été approuvé?
0.09054572880268097 ||| - Chemical and physical in-use stability has been demonstrated for 24 hours at 2°C to 8°C. ||| Chemical and physical in-use stability has been demonstrated for 6 hours at a temperature between 2°C to 40°C. ||| - La stabilité physico-chimique de la solution a été démontrée pendant 24 heures entre 2°C et
0.3365499973297119 ||| Lactation Emedastine has been identified in the milk of rats following oral administration. ||| Caspofungin has been shown to cross the placental barrier in animal studies. ||| Allaitement Chez le rat, l’ émédastine a été identifié dans le lait après administration orale.
0.06613627076148987 ||| What benefit has Parareg shown during the studies? ||| What benefit has Protopic shown during the studies? ||| Quel est le bénéfice démontré par Parareg au cours des études?
0.3096923232078552 ||| Air pillows, not for medical purposes ||| Mouth sprays, not for medical use ||| Oreillers à air non à usage médical
7.167771150923263e-13 ||| In this case you should immediately consult your doctor. ||| In this case you should immediately consult your doctor. ||| Dans ce cas, vous devez immédiatement consulter votre médecin.
0.021423175930976868 ||| Actira film-coated tablets contain 400 mg moxifloxacin as hydrochloride. ||| Avalox film-coated tablets contain 400 mg moxifloxacin as hydrochloride. ||| Actira en comprimés pelliculés contient 400 mg de moxifloxacine sous forme d’ hydrochlorure.
0.16264604032039642 ||| Fire retardant panels (Non-metallic -) for use in construction ||| Laminated boards (Non-metallic -) for building use ||| Panneaux ignifuges non métalliques destinés à la construction
0.5347355008125305 ||| It is available as orange- yellow, oblong tablets (25 mg). ||| Hepsera 10 mg tablets are round, white to off-white tablets. ||| Il est disponible en comprimés jaune orangé de forme oblongue (25 mg).
0.17000681161880493 ||| 39 6. ||| 37 6. ||| 6.
0.345485121011734 ||| No clinically relevant complement activation was reported in clinical trials but anaphylactic reactions have been reported during post-marketing surveillance. ||| Medically important adverse reactions reported at an incidence greater than placebo in controlled clinical studies and medically important adverse reactions reported through post- marketing surveillance ||| Bien qu’ il n’ ait pas été observé d’ activation du complément cliniquement significative chez les patients inclus dans les essais cliniques, des réactions anaphylactiques ont été rapportées depuis la commercialisation de Visudyne.
0.2572020888328552 ||| Abseamed contains a hormone called epoetin alfa, which stimulates the production of red blood cells. ||| It works by blocking an enzyme called carbonic anhydrase, which produces bicarbonate ions in the body. ||| Abseamed contient une hormone appelée époétine alfa qui stimule la production des globules rouges.
0.3063109517097473 ||| Genetic testing apparatus for medical purposes ||| Electronic analyzers for medical purposes ||| Appareils de tests génétiques à usage médical
0.3804740309715271 ||| Development of systems for the transmission of data ||| Software for the analysis of business data ||| Développement de systèmes pour la transmission de données
0.3091798424720764 ||| Treatment with higher doses of tetracyclines is associated with emergence of resistant intestinal bacteria, such as enterococci and enterobacteria. ||| Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter. ||| Le traitement par tétracyclines à fortes doses est associé à l'apparition de bactéries intestinales résistantes, tels les entérocoques et les entérobactéries.
0.5092135667800903 ||| 2 Renal and hepatic impairment STELARA has not been studied in these patient populations. ||| Bleeding was a commonly reported event in patients with UA/ NSTEMI and STEMI. ||| 2 Insuffisance rénale et hépatique STELARA n’ a pas été étudié chez ces populations de patients.
3.388255930165951e-13 ||| The consequent increase in dopaminergic stimulation can lead to the dopaminergic side effects observed after treatment with COMT inhibitors. ||| The consequent increase in dopaminergic stimulation can lead to the dopaminergic side effects observed after treatment with COMT inhibitors. ||| L’ augmentation de la stimulation dopaminergique ainsi obtenue est responsable des effets indésirables dopaminergiques observés après l’ instauration du traitement par des inhibiteurs de la COMT.
0.335211843252182 ||| Calcium supplements, antacids and some oral medicinal products containing multivalent cations (such as aluminium, magnesium, iron) are likely to interfere with the absorption of Bonviva. ||| Antibiotics used to treat and prevent bacterial infections in animals belong to the same chemical groups as those used for humans: macrolides, tetracyclines, quinolones, beta-lactams, aminoglycosides. ||| Les suppléments de calcium, les antiacides et certains médicaments administrés par voie orale contenant des cations polyvalents (comme l’ aluminium, le magnésium, le fer) sont susceptibles d’ interférer avec l’ absorption de Bonviva.
0.12204597890377045 ||| Before you inject Neupopeg you must do the following: ||| Before you inject Nespo you must do the following: ||| Avant d’injecter Neupopeg, vous devez suivre les instructions suivantes:
0.6485210657119751 ||| Snow removal services ||| Artificial snow-making services ||| Services de déneigement
0.3549644947052002 ||| For HPV-18, the difference between the vaccine and control groups was not statistically significant for CIN2+ and 12 month persistent infection (TVC-1 cohort). ||| In the CLL first-line study, the overall incidence of grade 3 or 4 cardiac disorders was low (4% R-FC, 3% FC). ||| Pour HPV 18, la différence entre le groupe vaccin et le groupe contrôle n’ était pas statistiquement significative pour les CIN2+ et l’ infection persistante à 12 mois (cohorte TVC-1).
0.39448314905166626 ||| 19 If you administer Luveris to yourself, please carefully read the following instructions: ||| For the administration of Rebif, please read the following instructions carefully: ||| Si vous pratiquez vous -même les injections de Luveris, lisez attentivement les instructions suivantes:
0.4897393584251404 ||| Trizivir should not be taken with stavudine, zalcitabine, injections of ganciclovir or foscarnet. ||| or in combination with doxorubicin, or trastuzumab, or capecitabine. ||| Trizivir ne doit pas être pris en même temps que la stavudine, la zalcitabine, ou le foscarnet et le ganciclovir injectables.
0.20852801203727722 ||| However, when the monovalent hepatitis A and hepatitis B vaccines were administered concomitantly with specific immunoglobulins, no influence on seroconversion was observed although it may result in lower antibody titers. ||| Since zonisamide and its metabolites are excreted renally, it should be discontinued in patients who develop acute renal failure or where a clinically significant sustained increase in serum creatinine is observed. ||| Cependant, quand les vaccins monovalents contre l'hépatite A ou l'hépatite B sont administrés simultanément avec des immunoglobulines spécifiques, aucune influence sur la séroconversion n'a été observée, malgré une baisse des titres d’ anticorps.
0.2962021827697754 ||| Co-administration of fosaprepitant with ergot alkaloid derivatives, which are CYP3A4 substrates, may result in elevated plasma concentrations of these medicinal products. ||| The 4-oxo and 4-hydroxymetabolite epimeric pair are the major metabolites with antiviral activity, but comprise only minute amounts of total plasma radioactivity. ||| La co-administration de fosaprépitant et d’ alcaloïdes dérivés de l’ ergot de seigle, qui sont des substrats du CYP3A4, peut entraîner une élévation des concentrations plasmatiques de ces médicaments.
0.007676151115447283 ||| If inactive (‘ latent’) tuberculosis is diagnosed, treatment for latent tuberculosis must be started with anti-tuberculosis therapy before the initiation of Remicade, and in accordance with local recommendations. ||| If inactive (‘ latent’) tuberculosis is diagnosed, treatment for latent tuberculosis must be started with anti-tuberculosis therapy before the initiation of Enbrel, and in accordance with local recommendations. ||| 7 Si une tuberculose inactive (« latente ») est diagnostiquée, un traitement antituberculeux adapté à une tuberculose latente doit être démarré avec un antituberculeux avant d’ instaurer un traitement par Remicade, en accord avec les recommandations nationales.
0.6824023723602295 ||| - Reduced increase in height or weight, compared to age. ||| Growth rate decrease (height and/ or weight decrease for age) ||| - Retard de croissance (taille et poids) par rapport à l'âge.
0.263551265001297 ||| In patients with an allergic disposition the decision to use Gadovist must be made after particularly careful evaluation of the risk-benefit ratio. ||| It is recommended that Clomicalm be administered to dogs with cardiovascular dysfunction or epilepsy with caution and only after an assessment of the benefit risk ratio. ||| Chez les patients présentant un terrain allergique, l’ utilisation de Gadovist nécessite une évaluation particulièrement prudente du rapport bénéfice/ risque.
0.7069219350814819 ||| Pack size: ||| Batch number: ||| Taille de l’ emballage:
0.026927001774311066 ||| 89 Do not use Fentanyl-ratiopharm after the expiry date which is stated on the package. ||| Do not use Fentanyl-ratiopharm after the expiry date which is stated on the package. ||| Ne pas utiliser Fentanyl-ratiopharm après la date de péremption mentionnée sur l’ emballage.
0.2817349135875702 ||| A placebo controlled study (PRAISE) designed to evaluate patients in NYHA Class III-IV heart failure patients receiving digoxin, diuretics and ACE inhibitors has shown that amlodipine did not lead to an increase in risk of mortality or a combined risk of mortality and morbidity with heart failure. ||| Posology and method of administration The CHMP discussed three areas where there was a divergence: • the use of Diovan with ACE inhibitors and betablockers (triple combination) in chronic heart failure, • how to manage dose increases, • dosage recommendations in patients with renal and hepatic impairment. ||| Une étude placebo controllée (PRAISE) désignée pour évaluer les patients insuffisants cardiaques (chez des patients NYHA Classe III-IV) recevant de la digoxine, des diurétiques, et des IECA a montré que l’ amlodipine ne provoquait pas d’ augmentation du risque de mortalité ou un risque combiné de mortalité et morbidité en cas d’ insuffisance cardiaque.
0.15614643692970276 ||| How is Kentera used? ||| How is Kaletra used? ||| Comment Kentera est -il utilisé?
0.37270456552505493 ||| Insulating oil for transformers ||| Insulating glass for building ||| Huile isolante pour transformateurs
0.4083603024482727 ||| Pharyngitis*, infection viral* Bronchitis, sinusitis, herpes simplex (resistance), rhinitis Bacterial infection Pneumonia§, sepsis ||| Herpes viral infections (herpes simplex dermatitis [eczema herpeticum], herpes simplex [cold sores], Kaposi’ s varicelliform eruption) ||| Effets indésirables Pharyngite*, infection virale* Bronchite, sinusite, herpes simplex (résistance), rhinite Infection bactérienne Pneumonie§, sepsis
0.2290494441986084 ||| PegIntron should be used with caution in patients with moderate to severe renal impairment. ||| • That Volibris should be initiated with caution in patients with severe renal impairment. ||| PegIntron doit être utilisé avec précaution chez les patients avec une insuffisance rénale modérée à sévère.
0.3903162479400635 ||| Actrapid is used in patients who have diabetes. ||| Insuman is used in patients with diabetes who need treatment with insulin. ||| Actrapid est utilisé chez le patient diabétique.
0.23872964084148407 ||| Air filters for household use ||| Lamps for outdoor use ||| Filtres à air à usage domestique
0.5393856167793274 ||| Non-alcoholic fatty liver disease ||| 23 Pulmonary veno-occlusive disease ||| Stéatose hépatique non alcoolique
0.467748761177063 ||| The mechanism of rifabutin and atazanavir interaction is CYP3A4 inhibition ||| Interactions related to amlodipine CYP3A4 inhibitors: ||| Le mécanisme de l’ interaction entre la rifabutine et l’ atazanavir consiste en une inhibition du CYP3A4.
0.2710646092891693 ||| In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not differ between the irbesartan/ hydrochlorothiazide and the placebo groups. ||| The mean serum ferritin levels were not significantly different in the two treatment groups, but mean hepatic iron concentration in deferiprone treated patients seems to increase more than in deferoxamine treated patients. ||| Lors des essais cliniques contrôlés versus placebo menés chez des patients hypertendus, l'incidence globale des événements indésirables n'a pas différé entre le groupe traité par irbésartan/ hydrochlorothiazide et le groupe recevant le placebo.
0.04133005440235138 ||| Other warnings and precautions As observed for angiotensin converting enzyme inhibitors, losartan and the other angiotensin antagonists are apparently less effective in lowering blood pressure in black people than in non-blacks, possibly because of higher prevalence of low-renin states in the black hypertensive population. ||| 3 As observed for angiotensin converting enzyme inhibitors, irbesartan and the other angiotensin antagonists are apparently less effective in lowering blood pressure in black people than in non-blacks, possibly because of higher prevalence of low-renin states in the black hypertensive population (see section 5.1). ||| Autres mises en garde et précautions Comme avec les inhibiteurs de l'enzyme de conversion, le losartan et les autres antagonistes des récepteurs de l'angiotensine semblent être moins efficaces pour diminuer la pression artérielle chez les patients de race noire que chez les patients d'autres races, probablement en raison d'une prévalence plus élevée des concentrations en rénine basse dans la population hypertendue de race noire.
0.2215682864189148 ||| Bone substitutes for surgical use ||| Sponge material for surgical use ||| Substituts osseux à usage chirurgical
0.3388116657733917 ||| If six years after recapitalisation aid to publicly listed companies, or up to seven years for other companies, the exit of the State is in doubt, a restructuring plan for the beneficiary will have to be notified to the Commission. ||| If six years after receiving the recapitalisation aid, the exit of the State is in doubt, a restructuring plan for DLH will be notified to the Commission. ||| Dans le cas où six ans après l'octroi d'aides à la recapitalisation à des sociétés cotées en bourse, ou sept ans après l'octroi de telles aides à d'autres entreprises, la sortie de l'État du capital est incertaine, un plan de restructuration pour le bénéficiaire devra être notifié à la Commission.
0.2051185667514801 ||| The second study showed that Xyrem continued to prevent cataplexy attacks after long-term treatment: there was no change over 2 weeks in the number of attacks in the patients continuing to take Xyrem, compared to an increase of 21.0 in those switching to placebo. ||| The proportion of patients who discontinued treatment due to adverse events was the same in both the Enbrel and placebo treatment groups; in the first active-controlled trial, the dropout rate was significantly higher for methotrexate (10%) than for Enbrel (5%). ||| La seconde étude a montré que Xyrem continuait à empêcher l’ apparition d’ attaques de cataplexie après un traitement au long cours: aucun changement sur 2 semaines dans le nombre d’ attaques n’ a été observé chez les patients poursuivant leur traitement par Xyrem, tandis qu’ on a observé une augmentation de 21,0 chez les patients dont le traitement a été substitué par un placebo.
0.5243850946426392 ||| The impact of the pandemic and its mortality rate are different for men and women. ||| This is the highest number of fatalities in a day due to the virus. ||| L’impact de la pandémie et le taux de mortalité sont différents chez l’homme et chez la femme.
0.31624504923820496 ||| We have also introduced conditions that provide incentives for private investors to participate alongside the State in recapitalisations, thus reducing the need for State aid and the risk of distortions to competition. ||| To avoid the risk of shortages of essential and scarce products and services because of the unprecedented surge in demand due to the pandemic, we need businesses to cooperate and do it in line with European Competition rules. ||| Nous avons introduit des conditions qui incitent les investisseurs privés à participer aux recapitalisations aux côtés de l'État, ce qui réduit la nécessité d'aides d'État et le risque de distorsions de la concurrence.
0.5391653776168823 ||| A total daily dose of 300 mg Zavesca administered in three divided doses was used in the above two studies. ||| The standard doses of NRTIs given every 12 hours were used in each of these studies. ||| Une dose quotidienne totale de 300 mg de Zavesca répartie en trois doses a été utilisée dans les deux études ci-dessus.
0.3307466506958008 ||| This ensures that fleas infesting the animal are killed, no viable flea eggs are produced by these fleas, and larvae (found only in the environment) are also killed. ||| Therefore, it effectively breaks the flea life cycle by killing adults (on the animal), preventing the hatching of eggs (on the animal and in its environment) and by killing larvae (environment only). ||| Ainsi, les puces présentes sur l’ animal sont tuées, leurs œ ufs ne sont pas viables, et les larves (présentes dans l’ environnement) sont tuées.
0.0 ||| 23 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 23 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 24 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.32666370272636414 ||| Peak plasma concentrations occur approximately 2.5 hours after oral administration of lamotrigine. ||| Desloratadine plasma concentrations can be detected within 30 minutes of administration. ||| Le pic plasmatique est atteint environ 2,5 heures après l’ administration orale du produit.
0.36450275778770447 ||| If contractions come back, treatment with Tractocile can be repeated up to three more times during the pregnancy. ||| RotaTeq may be given to infants who were born early provided that the pregnancy had lasted at least 25 weeks. ||| Si les contractions réapparaissent, le traitement par Tractocile peut être renouvelé jusqu’ à trois fois supplémentaires au cours de la grossesse.
0.506041407585144 ||| 41 majority of patients who achieved a CCyR developed the CCyR between months 3 and 10 with a median time to response based on the Kaplan-Meier estimate of 5.6 months. ||| * Any subject with an undetectable HCV-RNA level at the Follow-Up Week 12 visit and missing data at the Follow- Up Week 24 visit was considered a susta ined responder. ||| La majorité des patients qui ont atteint une réponse cytogénétique complète ont développé cette réponse entre 3 et 10 mois avec une estimation selon Kaplan-Meier de la durée médiane de réponse à 5,6 mois.
0.34988152980804443 ||| There are no data from the use of glimepiride in patients on renal dialysis (see section 4.3). ||| No data are available for the treatment with a combination of lamivudine and zidovudine in humans or animals (see also section 5.3). ||| Il n’ y a pas de données concernant l’ utilisation du glimépiride chez les patients en dialyse rénale (voir rubrique 4.3).
0.5686544179916382 ||| At this time the system should be removed. ||| At this point, the stoppers are clean. ||| A ce moment là, le dispositif doit être retiré.
0.41610580682754517 ||| When Tamiflu is used during a flu epidemic, this dose can be given for up to six weeks. ||| To study the safety of Omnitrope, another 51 children have also received the medicine for up to a year. ||| Si Tamiflu est utilisé lors d’ une épidémie de grippe, cette dose peut être prise pendant une période maximale de six semaines.
0.3185924291610718 ||| Severe renal impairment (creatinine clearance < 30 ml/ min) (see section 4.4). ||| Mild renal impairment (creatinine clearance 50-80 ml/ min): ||| 3 Insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) (voir rubrique 4.4).
0.29278212785720825 ||| There was a 3-fold increase in CVAE in patients treated with oral olanzapine compared to patients treated with placebo (1.3% vs. ||| The rate of death in aripiprazole-treated patients was 3.5% compared to 1.7% in the placebo group. ||| Trois fois plus d’ événements indésirables vasculaires cérébraux ont été rapportés dans le groupe de patients traités par olanzapine orale comparativement au groupe de patients traités par placebo (1,3% versus 0,4% respectivement).
0.7330724000930786 ||| There is no known antidote for Telzir. ||| What information is still awaited for Yondelis? ||| Il n’ existe pas d’ antidote connu pour Telzir.
0.29263660311698914 ||| How is EMSELEX used? ||| How is INOmax used? ||| Comment EMSELEX est -il utilisé?
0.065808966755867 ||| Lamivudine and VIRAMUNE can be co-administered without dose adjustments. ||| Stavudine and VIRAMUNE can be co-administered without dose adjustments. ||| La lamivudine et VIRAMUNE peuvent être associés sans ajustement posologique.
0.27018314599990845 ||| Thus no particular interaction is expected as verified through in vivo studies where no inhibition of metabolism of the following active substances was found: tricyclic antidepressant (representing mostly CYP2D6 pathway), warfarin (CYP2C9), theophylline (CYP1A2) or diazepam (CYP3A4 and 2C19). ||| In a study to assess inhibition of a series of P450 isoenzymes (CYP 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4) incubated with 100 µM azacitidine, IC50 values could not be determined, therefore, enzyme inhibition by azacitidine at clinically achievable plasma concentrations is unlikely. ||| 22 suivants n'a été mise en évidence: antidépresseurs tricycliques (représentant principalement la voie du CYP2D6), la warfarine (CYP2C9), la théophylline (CYP1A2), ou le diazépam (CYP3A4 et 2C19).
1.2456236129360088e-12 ||| All patients ||| All patients ||| Tous patients
0.21761737763881683 ||| Pregnancy There are no adequate data from the use of gemcitabine in pregnant women. ||| 39 Pregnancy: there are limited amount of data from the use of efavirenz in pregnant women. ||| Grossesse Il n’existe pas de données suffisantes sur l’utilisation de la gemcitabine chez la femme enceinte.
0.005052658729255199 ||| Each film-coated tablet contains 15 mg of memantine hydrochloride equivalent to 12.46 mg memantine. ||| Each film-coated tablet contains 20 mg of memantine hydrochloride equivalent to 16.62 mg memantine. ||| Chaque comprimé pelliculé contient 15 mg de chlorhydrate de mémantine équivalent à 12,46 mg de mémantine base.
0.3370545208454132 ||| Zevalin should not be administered in the patients mentioned below as safety and efficacy has not been established: ||| The effect on breast-fed infants of the administration of this vaccine has not been assessed; no contraindication has been established. ||| Zevalin ne doit pas être administré chez les patients suivants, car son efficacité et sa tolérance n'ont pas été établies dans ces cas:
0.030644560232758522 ||| Concomitant use of angiotensin II antagonists or diuretics and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function. ||| As with ACE inhibitors, concomitant use of angiotensin II antagonists and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function. ||| Chez les patients présentant une insuffisance rénale préexistante, la co-administration d'antagonistes de l'angiotensine II ou de diurétiques et d’ AINS peut entraîner une aggravation de la fonction rénale, avec possibilité d'insuffisance rénale aiguë, et une augmentation du potassium sérique.
0.07874150574207306 ||| The Committee recommended that Sprycel be given marketing authorisation. ||| The Committee recommended that Mixtard be given marketing authorisation. ||| Il a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Sprycel.
0.0005509944166988134 ||| The non-confidential version of the decision will be made available under the case number SA.56814 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56812 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56814 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.2657965421676636 ||| 7 A comparison of serum concentrations of methoxy polyethylene glycol-epetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| Pretreatment or coadministration of Tarceva did not alter the clearance of the prototypical CYP3A4 substrates, midazolam and erythromycin, but did appear to decrease the oral bioavailability of midazolam by up to 24%. ||| Une comparaison des concentrations sériques du méthoxy polyéthylène glycol-epoetin beta mesurées avant et après hémodialyse chez 41 patients atteints d’ une IRC a montré que l’ hémodialyse n’ avait aucun effet sur les paramètres pharmacocinétiques de ce médicament.
0.3572673499584198 ||| Method of administration Faslodex should be administered by slow intramuscular injection into the buttock. ||| Lucentis must be administered by a qualified ophthalmologist experienced in intravitreal injections. ||| Mode d’ administration Faslodex doit être administré par injection intramusculaire lente dans le muscle fessier.
0.2914464771747589 ||| However, the occurrence of these cytopenias is likely to be related to the stage of the disease being treated and they were more frequent in patients with accelerated phase CML or blast crisis as compared to patients with ||| Patients with advanced stages of ALL or AML may have confounding medical conditions that make causality of adverse events difficult to assess due to the variety of symptoms related to the underlying disease, its progression and the co-administration of numerous medicinal products. ||| Cependant, la survenue de ces cytopénies est vraisemblablement liée au stade de la maladie traitée: elles ont été plus fréquemment retrouvées chez les patients en phase accélérée ou en crise blastique que chez ceux en phase chronique de la LMC.
0.3031052052974701 ||| Furthermore CEPROTIN is used to prevent thrombosis in patients with severe congenital protein C deficiency if one or more of the following conditions are met: • surgery or invasive therapy is imminent • while initiating coumarin (anticoagulant medication, blood thinner) therapy • when coumarin therapy alone is not sufficient • when coumarin therapy is not feasible. ||| Severe hypothyroidism has to be treated prior to start of NutropinAq therapy. • Since somatropin therapy following renal transplantation has not been adequately tested, growth hormone treatment should be terminated after that surgery. • Adrenocorticotrophic Hormone (ACTH) -deficient patients should consult the doctor regularly during growth hormone therapy. ||| De plus, CEPROTIN est utilisé dans la prévention de thrombose chez les patients atteints de déficit congenital sévère en protéine C lorsqu’ une ou plusieurs des conditions suivantes sont présentes: • Lors d'opération chirurgicale ou de traitement invasif imminent, • A l'instauration d’ un traitement par la coumarine (traitement anticoagulant, fluidifiant dusang), • Lorsque le traitement par la coumarine est insuffisant, • Lorsque le traitement par la coumarine est impossible.
0.1626996248960495 ||| 183 Water for injections. ||| 45 Water for injections. ||| Eau pour préparations injectables.
0.43006622791290283 ||| In the presence of anidulafungin, fungal cells have incomplete or defective cell walls, making them fragile or unable to grow. ||| The coronavirus is a relatively large virus, meaning it is not truly airborne: it will settle down in respiratory droplets. ||| Par la présence de l’ anidulafungine, la paroi des cellules fongiques devient incomplète ou défectueuse, ce qui rend les cellules fragiles ou incapables de proliférer.
0.08270732313394547 ||| 32 10. ||| 33 10. ||| 39 10.
0.7983435392379761 ||| The U.S. administration of Donald Trump has referred to the coronavirus as "Chinese virus" or "Wuhan virus" saying that China's "censorship supercharged a virus that has now turned into a global pandemic", which has in turn been criticized by some critics as racism and "distract[ing] from his administration's failure to contain the disease". ||| "Polizeiwissenschaft (German for ""Police science"", though ""Polizei"" may in this case be better translated as ""Public Policy"" or ""Politics"" in a broad sense) was a discipline born in the first third of the 18th century which lasted until the middle of the 19th century." ||| L’administration américaine de Donald Trump a qualifié le coronavirus de « virus chinois » ou « virus de Wuhan », déclarant qu’en Chine « la censure a suralimenté un virus désormais devenu une pandémie mondiale », ce qui a ensuite été taxé de racisme par certains opposants et destiné à « détourner l’attention de l’incapacité de son administration à contenir la maladie ».
0.49793851375579834 ||| Stickers [decalcomanias] ||| Stroboscopic lamps [decorative] ||| Autocollants [décalcomanies]
0.3299482464790344 ||| Very common Common Uncommon Skin and subcutaneous tissue disorders ||| 33 Skin and subcutaneous tissue disorders Uncommon Rare Not known ||| Très fréquent Fréquent Peu fréquent Affections de la peau et du tissu sous-cutané
0.49830642342567444 ||| The effects may result from complement activation. ||| Avonex may interfere with the results. ||| Ces effets pourraient être consécutifs à une activation du complément.
0.005763055756688118 ||| 24/ 34 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 25/ 39 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22/ 35 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.34452277421951294 ||| According to clinical response and tolerability, after a minimum of 2 days the dose may be increased by 200 mg/ day, to the maximum recommended dose of 600 mg/ day. ||| If an FSH dose increase is deemed appropriate, dose adaptation should preferably be after 7-14 day intervals and preferably by 37.5-75 IU increments. ||| En fonction de la réponse clinique et de la tolérance, après un intervalle de temps d’ au moins deux jours, la posologie peut être augmentée de 200 mg/ jour, jusqu’ à la dose maximale recommandée de 600 mg/ jour.
0.5567356944084167 ||| Treatment of patients with hairy cell leukaemia. ||| - Anaemic patients with chronic renal failure ||| Traitement des patients atteints de leucémie à tricholeucocytes.
0.6033034920692444 ||| conjunctival hyperaemia ||| Supraventricular tachycardia ||| hyperémie conjonctivale
0.38778817653656006 ||| So when receiving any other treatment please tell the health professional that you are using DuoTrav. ||| These guidelines apply unless your doctor has given you different instructions on how to use Zyrtec. ||| Si l'on vous prescrit un autre traitement, prévenez votre médecin que vous utilisez DuoTrav.
0.029137592762708664 ||| GONAL-f 37.5 IU (2.8 micrograms) powder and solvent for solution for injection. ||| GONAL-f 75 IU (5.5 micrograms) powder and solvent for solution for injection. ||| GONAL-f 37,5 UI (2,8 microgrammes) poudre et solvant pour solution injectable.
0.32633835077285767 ||| Arranging and conducting of American football training programs ||| Arranging and conducting of day school courses for adults ||| Organisation et conduite de programmes d'entraînement au football américain
0.0371878556907177 ||| Do not use Irbesartan BMS after the expiry date which is stated on the carton and on the blister after EXP. ||| Do not use Irbesartan Winthrop after the expiry date which is stated on the carton and on the blister after EXP. ||| Ne pas utiliser Irbesartan BMS après la date de péremption mentionnée sur la boîte ou sur la plaquette thermoformée.
0.5371867418289185 ||| Parquet wood flooring ||| Hardwood flooring ||| Parquets en bois
0.18235643208026886 ||| Nervous system disorders: ||| - Nervous system disorders ||| Affections du système nerveux:
0.048291437327861786 ||| In hypertensive patients in whom the diuretic is not discontinued, therapy with TRITACE should be initiated with a 1.25 mg dose. ||| In hypertensive patients in whom the diuretic cannot be discontinued, therapy with Zestril should be initiated with a 5 mg dose. ||| Chez les patients hypertendus chez lesquels le diurétique n’ est pas arrêté, le traitement par TRITACE sera débuté à la dose de 1,25 mg.
0.33930134773254395 ||| The most common side effects with Comtess (seen in between 1 and 10 patients in 100) are dyskinesia (uncontrollable movements), nausea (feeling sick) and harmless urine discoloration. ||| Sweet’ s syndrome (plum-coloured, raised, painful lesions on the limbs and sometimes the face and neck with fever) has occurred rarely (likely to occur in fewer than 1 in 1,000 patients) but other factors may play a role. ||| Les effets indésirables les plus courants (observés chez 1 à 10 patients sur 100) sont la dyskinésie (mouvements incontrôlables), les nausées (mal au cœ ur) et une décoloration sans danger des urines.
0.17700408399105072 ||| RILUTEK should also not be given to women who are pregnant or breast-feeding. ||| Ferriprox should not be used in women who are pregnant or breast-feeding. ||| RILUTEK ne doit pas non plus être utilisé chez la femme enceinte ou allaitant.
0.335521399974823 ||| If you use more Fasturtec than you should If it does occur, the doctor will closely monitor the effects on your red blood cells and treat any symptoms that follow. ||| If you do not respond well enough to these medicines, you will be given Remicade to: • reduce the signs and symptoms of your disease. • improve your physical function ||| Si vous utilisez plus de Fasturtec que vous n’ auriez dû Si cela se produit, le médecin suivra soigneusement les effets sur vos globules rouges et traitera les symptômes associés.
0.0 ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| L’ (auto-)injection accidentelle peut provoquer de fortes douleurs et un gonflement, notamment en cas d’ injection dans une articulation ou un doigt de la main, et, dans de rares cas, conduire à la perte de ce doigt si un examen médical n’ est pas effectué rapidement.
0.4941229820251465 ||| The frequency as reported in clinical trials was 8.0%. ||| In these trials the ovulation rate per cycle was 70-75%. ||| Leur fréquence, observée dans une étude clinique, était de 8%.
0.513863205909729 ||| Pump repair and maintenance ||| Quality checking and testing ||| Réparation et entretien de pompes
0.28799697756767273 ||| A study evaluating post-operative absorption of dabigatran etexilate, 1-3 hours following surgery, demonstrated relatively slow absorption compared with that in healthy volunteers, showing a smooth plasma concentration-time profile without high peak plasma concentrations. ||| Plasma total immunoglobulin concentrations, total lymphocytes counts, and white cells generally remained within normal limits following MabThera treatment, with the exception of a transient drop in white cells counts over the first four weeks following therapy. ||| Une étude évaluant l’ absorption postopératoire du dabigatran etexilate 1 à 3 heures après l’ intervention chirurgicale a montré une absorption relativement lente par rapport à celle observée chez des volontaires sains, avec un profil plus régulier des concentrations plasmatiques en fonction du temps, sans pic élevé de concentrations plasmatiques.
0.7176809906959534 ||| 6 FURTHER INFORMATION ||| BACKGROUND INFORMATION ||| INFORMATIONS SUPPLEMENTAIRES
0.26548925042152405 ||| Zevalin should not be used in people who may be hypersensitive (allergic) to ibritumomab, yttrium chloride, mouse proteins or any of the other ingredients. ||| • if you are allergic (hypersensitive) to palifermin‚ any other ingredients of Kepivance, or to Escherichia coli derived proteins. ||| Zevalin ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à l’ ibritumomab, au chlorure d’ yttrium, aux protéines de souris ou à l’ un des autres composants.
0.0889846682548523 ||| 113 8. ||| 106 8. ||| 8.
0.14598459005355835 ||| Contact point Jonna SUNELL-HUET Direct telephone (44-20) 74 18 84 65 E-mail: certificate@emea.eudra.org ||| Contact point Iro MAVROPOULOS Direct telephone (44-20) 74 18 85 82 E-mail: subscriptions@emea.eudra.org ||| Point de contact Jonna SUNELL-HUET Téléphone direct (44-20) 74 18 84 65 E-mail: certificate@emea.eudra.org
0.4075625240802765 ||| Onsenal 400 mg hard capsules Celecoxib ||| Remeron SolTab 30 mg Schmelztabletten ||| Onsenak 400 mg gélules Célécoxib
0.417664498090744 ||| Uncommon side effects • Allergic (hypersensitivity) reaction. ||| - serious allergic (hypersensitivity) reactions, ||| Effets indésirables peu fréquents • Réaction allergique (hypersensibilité).
0.10765045136213303 ||| 232 1. ||| 337 1. ||| 242 1.
0.5014833211898804 ||| information material, toolkit material ||| information material, poster, toolkit material - ||| matériel d'information, matériel de boîte à outils
0.1900877058506012 ||| What is the risk associated with PegIntron? ||| What is the risk associated with NutropinAq? ||| Quel est le risque associé à l’ utilisation de PegIntron?
0.29445722699165344 ||| Antibiotics for use in dentistry ||| Antibiotics for detoxification purposes ||| Antibiotiques à usage dentaire
0.20468148589134216 ||| Taking YENTREVE with food and drink YENTREVE may be taken with or without food. ||| Taking ARICLAIM with food and drink ARICLAIM may be taken with or without food. ||| Aliments et boissons YENTREVE peut être pris pendant ou en dehors des repas.
0.3308020234107971 ||| It may be taken with or without food. ||| It can be taken with food or on an empty stomach. ||| Le médicament peut être pris pendant ou en dehors des repas.
0.432772159576416 ||| Remote controls for projectors ||| Remote controllers for controlling electronic products ||| Télécommandes pour projecteurs
4.813305786929845e-13 ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| Cependant, s’ il est l’ heure de la prise suivante, sautez la prise oubliée et ne prenez qu’ une seule dose comme d’ habitude.
0.5629185438156128 ||| Serious haemorrhage, haemorrhage of operative wound, vasculitis, hypotension ||| Sexual dysfunction Ejaculation disorder Ejaculation delayed Gynaecological haemorrhage ||| Hémorragie grave, hémorragie d’une plaie opératoire, vascularite, hypotension
0.2715432941913605 ||| Caution should be exercised when prescribing nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease. ||| Patients who are positive for viral hepatitis, on concomitant medicinal products (see section 4.5) and/ or have existing liver dysfunction are at risk of accelerated liver injury. ||| Il conviendra d’ être prudent en cas de prescription d’ analogues nucléosidiques à des patients (en particulier des femmes obèses) avec une hépatomégalie, une hépatite ou d’ autres facteurs de risque connus de maladie hépatique.
0.44878992438316345 ||| - if you are suffering from widespread or severe wounds, ulcers or sores on your affected arm or ||| - if you have, or have recently had, any bleeding from your stomach, intestines, bladder or other ||| - si vous souffrez de plaies sévères ou diffuses, ou d’ ulcères sur votre membre atteint.
0.3587263822555542 ||| To prevent interference with the adhesive properties of EVRA, no creams, lotions or powders should be applied to the skin area where the EVRA transdermal patch is to be applied. ||| BEROMUN will be administered to you by the technique of isolated limb perfusion (ILP) which ensures that BEROMUN is kept within the affected arm or leg and does not reach the main part of your body. ||| Afin d’ éviter toute interférence avec les propriétés adhésives d’ EVRA, il convient de ne pas appliquer de crèmes, lotions ou poudres sur la zone cutanée où le dispositif transdermique EVRA doit être mis en place.
0.012826178222894669 ||| NovoMix 30 FlexPen must not be refilled. ||| NovoMix 70 FlexPen must not be refilled. ||| NovoMix 30 FlexPen ne doit pas être reremplie.
0.5943049192428589 ||| 192 Changes at the injection site (Lipodystrophy). ||| Diverticulitis Mild rectal bleeding (see section 4.4) ||| Altérations au site d’ injection (Lipodystrophie).
0.25983837246894836 ||| After subcutaneous dosing, fondaparinux is completely and rapidly absorbed (absolute bioavailability ||| Absorption After subcutaneous administration, omalizumab is absorbed with an average absolute bioavailability of 62%. ||| Absorption Après administration sous-cutanée, le fondaparinux est entièrement et rapidement absorbé (biodisponibilité absolue 100%).
0.21316707134246826 ||| You should stop taking Ranexa and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe: • swollen face, tongue, or throat • difficulty swallowing • hives or difficulty breathing ||| You should see your doctor immediately if you experience symptoms such as swollen face, tongue and/ or pharynx (back of the mouth) and/ or difficulties in breathing (angioedema), or a skin condition whereby the skin can peel off (exfoliative dermatitis). ||| Si vous ressentez les symptômes suivants d'angio-œ dème (maladie rare mais qui peut être sévère), arrêtez de prendre Ranexa et contactez votre médecin immédiatement: • gonflement du visage, de la langue ou de la gorge • difficulté à avaler
0.2410064935684204 ||| 2.5 mg / 12.5mg 5 mg/ 25mg ||| 50 mg/ 12.5 mg/ 200 mg ||| Dosage 2.5 mg / 12.5mg 5 mg/ 25mg
0.0 ||| Parascaris equorum, Pinworms: ||| Parascaris equorum, Pinworms: ||| Parascaris equorum, à des oxyures:
0.003097482956945896 ||| Depending on how your anaemia responds to treatment, the dose may be adjusted approximately every four weeks until your condition is controlled. ||| Depending on how your anaemia responds to treatment, the dose may be adjusted approximately every 4 weeks until your condition is controlled. ||| En fonction de la façon dont votre anémie réagit au traitement, la dose pourra être ajustée environ toutes les 4 semaines jusqu'à ce qu’ un taux satisfaisant d’ hémoglobine soit atteint.
0.0 ||| 7. ||| 7. ||| 209 7.
0.3251535892486572 ||| Road signs, non-luminous and non-mechanical, not of metal ||| Road signs of non-metallic materials [non-mechanical, non-luminous] ||| Bornes routières non métalliques, non lumineuses et non mécaniques
0.2966642379760742 ||| 23.0 (162/704) ||| 23.0 (182/790) ||| 23,0 (162/ 704)
0.35929226875305176 ||| Increasing capacity and adapting healthcare for the needs of COVID-19 patients is described by the WHO as a fundamental outbreak response measure. ||| The COVID-19 pandemic has shown the need to significantly boost the EU's preparedness and capability to respond effectively to major cross border health threats. ||| L’augmentation de la capacité et l’adaptation des soins de santé pour les besoins des patients atteints de la COVID-19 est décrite par l’OMS comme une mesure de réponse fondamentale à l’épidémie.
0.3943871855735779 ||| Table 8 - Efficacy Responses in Placebo-Controlled AS Study – Study VIII Reduction of Signs and Symptoms lP ||| Table 8 - Efficacy Responses in Placebo-Controlled AS Study – Study VIII i dic ||| Tableau 8 – Réponses d'efficacité de l'étude SA contrôlée contre placebo – Etude VIII Réduction des signes et symptômes
0.18827049434185028 ||| Ask your doctor or pharmacist for advice before using any medicine. ||| Ask your doctor or pharmacist for advice before taking any medicine. du ro ||| Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.5600770711898804 ||| A prototype of EudraDoc has been included within the tracking system for a simplified document transfer system. ||| For a new and unused OptiSet, a dose of 8 units is already preset by the manufacturer for the first safety test. ||| Un prototype d’EudraDoc a été inclus dans le système de suivi pour simplifier le système de transfert de documents.
0.37392091751098633 ||| A single daily dose should be initiated at 1 mg/ 24 h. ||| Each subsequent dose (250 mg/ m²) is infused in approximately 1 hour. ||| Le traitement doit débuter à une dose quotidienne unique de 1 mg/ 24 h.
0.4433726966381073 ||| Lopinavir Ritonavir ||| Saquinavir4 Ritonavir ||| Lopinavir Ritonavir - Excipient(s)
0.5142977833747864 ||| - kidney toxicity resulting in temporary functional changes ||| - Growth disturbance associated with chronic renal insufficiency. ||| - effets toxiques sur les reins entraînant des modifications temporaires de la fonction rénale.
0.40636008977890015 ||| Telithromycin, and its principal human metabolites, were negative in tests on genotoxic potential in vitro and in vivo. ||| 82 metabolites, both exhibited significantly less in vivo pharmacological activity than olanzapine in animal studies. ||| Aucun potentiel génotoxique n’ a été observé sur la télithromycine et ses métabolites.
0.4184185266494751 ||| 138 If you switch from another insulin to insulin glulisine, your dosage may have to be adjusted by your doctor. ||| 72 If you have previously developed a factor VIII inhibitor and you switch factor VIII products, you may be at risk of your inhibitor coming back. ||| Si vous passez d’une autre insuline à l’insuline glulisine, il peut être nécessaire que votre médecin ré- évalue votre posologie.
0.5301816463470459 ||| Televisual communication services ||| Multimedia messaging services ||| Services de communications télévisuelles
0.4324193596839905 ||| Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Germany ||| nuclitec GmbH Gieselweg 1 38110 Braunschweig Germany ||| Novartis Pharma GmbH Roonstraße 25 D-90429 Nuremberg Allemagne
0.345625638961792 ||| Administrative processing of purchase orders ||| Processing of electronic check payments ||| Traitement administratif de commandes d'achats
0.1509707272052765 ||| Table 1 ||| Table 1. ||| 22 Tableau 1
0.373119592666626 ||| Solution for injection in a pre-filled syringe. ||| The needle for intramuscular injection is provided. ||| to Solution injectable en seringue préremplie.
0.48550158739089966 ||| Electrical nerve stimulators ||| Radiotherapeutic hormones ||| Neurostimulateurs électriques
0.9076542854309082 ||| Interface cables [electric] ||| DC/AC converters ||| Câbles d'interface électriques
0.44332146644592285 ||| Savory butters ||| Vegetable pastes ||| Beurres salés
0.6266286373138428 ||| Relocation services for businesses ||| Insurance services for thatched properties ||| Services de relogement pour entreprises
0.08288341760635376 ||| Pencil sharpeners, electric or non-electric ||| Pencil sharpening machines, electric or non-electric ||| Taille-crayons, électriques ou non électriques
0.0031698031816631556 ||| 168 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 172 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 178 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDEES
0.31914961338043213 ||| When treating patients who have at least one risk factor for development of congestive heart failure (e. g. prior myocardial infarction or symptomatic coronary artery disease), physicians should start with the lowest available dose and increase the dose gradually. ||| Patients with a high tumour burden or with a high number (≥ 25 x 109/ l) of circulating malignant cells such as patients with CLL, who may be at higher risk of especially severe cytokine release syndrome, should only be treated with extreme caution. ||| Chez des patients présentant au moins un facteur de risque de développer une insuffisance cardiaque, (par ex. antécédent d’ infarctus du myocarde, maladie coronaire symptomatique)les médecins doivent initier la pioglitazone à la plus faible dose disponible et l’ augmenter graduellement.
0.1993832290172577 ||| Risk factors that may predispose this patient population to increased mortality include age > 65 years, dysphagia, sedation, malnutrition and dehydration, pulmonary conditions (e. g., pneumonia, with or without aspiration), or concomitant use of benzodiazepines. ||| Plasma volume expanders, such as Oxyglobin, are contraindicated in dogs predisposed to circulatory overload with conditions such as oliguria or anuria or advanced cardiac disease (i. e., congestive heart failure) or otherwise severely impaired cardiac function. ||| Dans cette population de patients, un âge supérieur à 65 ans, une dysphagie, une sédation, une malnutrition et une déshydratation, une pathologie pulmonaire (telle qu’ une pneumopathie avec ou sans inhalation) ou une utilisation concomitante de benzodiazépines peuvent être des facteurs prédisposant à une augmentation du risque de mortalité.
0.3328760266304016 ||| Again, do NOT touch the needle or let it touch any surface. ||| Again, do not touch the needle or allow it to touch any surface (see Diagram 11). ||| De nouveau, NE touchez PAS l’aiguille et ne la mettez pas en contact avec quelque surface que ce soit.
0.4927384555339813 ||| This would accelerate the development of vaccines and improve access to them across the world for all who need it. ||| Also, improved food accessibility can improve nutrition in communities that need it the most. ||| Cela accélérerait la mise au point de vaccins et améliorerait les possibilités d'accès à ces vaccins dans le monde pour tous ceux qui en ont besoin.
0.07919170707464218 ||| SonoVue should not be used in people who may be hypersensitive (allergic) to sulphur hexafluoride or any of the other ingredients. ||| VASOVIST should not be used in people who may be hypersensitive (allergic) to gadofosveset trisodium or any of the other ingredients. ||| SonoVue ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à l’ hexafluorure de soufre ou à l’ un des autres ingrédients.
0.2542811334133148 ||| Patients with severe renal dysfunction (creatinine clearance 15-29 ml/ minute) should have the starting dose of PegIntron reduced by 50%. ||| In patients with mild to moderate hepatic impairment the posology should not exceed PritorPlus 40 mg/ 12.5 mg once daily. ||| Chez les patients ayant un dysfonctionnement rénal sévère (clairance de la créatinine 15-29 ml/ minute), la dose initiale de PegIntron doit être réduite de 50%.
0.06375406682491302 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that, in accordance with EU requirements, Zarzio has been shown to have a comparable quality, safety and efficacy profile to Neupogen. ||| The Committee for Medicinal products for Human Use (CHMP) considered that, in accordance with EU requirements, Omnitrope has been shown to have a comparable quality, safety and efficacy profile to Genotropin. ||| Le Comité des médicaments à usage humain (CHMP) a considéré que, compte tenu des exigences de l’ Union européenne, Zarzio présentait un profil de qualité, de sécurité et d’ efficacité comparable à celui de Neupogen.
0.49714112281799316 ||| Sharpening machines for tools (Electric -) ||| Positioning tools for setting (Hand operated -) ||| Machines électriques à affûter les outils
0.03974251449108124 ||| - The other ingredients are disodium phosphate anhydrous, sodium dihydrogen phosphate monohydrate, ||| - The other ingredients are glycine, disodium phosphate anhydrous, sodium dihydrogen phosphate ||| - Les autres composants sont phosphate disodique anhydre, phosphate monosodique monohydraté,
0.6240239143371582 ||| For any transition to be sustainable, people need to see concrete and quick dividends, hence our mobilization today. ||| We will frontload it so we can power that investment in those crucial first years of recovery. ||| Pour qu'une transition soit viable, il faut que les citoyens puissent voir des résultats concrets et rapides, d'où notre mobilisation aujourd'hui.
0.2721245288848877 ||| There have been reports of exacerbation of chronic liver dysfunction, including portal hypertension, in patients with underlying hepatitis B or C, cirrhosis and other underlying liver abnormalities. ||| In controlled clinical trials for essential hypertension, hypertensive patients with left ventricular hypertrophy, chronic heart failure as well as for hypertension and type 2 diabetes mellitus with renal disease, the most common adverse event was dizziness. ||| 27 Des cas d’aggravation d’un dysfonctionnement hépatique chronique, incluant une hypertension portale, ont été rapportés chez des patients présentant une hépatite B ou C, une cirrhose ou d’autres anomalies hépatiques sous-jacentes.
0.2557936906814575 ||| Lamivudine has not shown any genotoxic activity in the in vivo studies at doses that gave plasma concentrations up to 40 - 50 times higher than clinical plasma levels. ||| Plasma protein binding studies in vitro indicate that abacavir binds only low to moderately (~ 49%) to human plasma proteins at therapeutic concentrations. ||| La lamivudine n'est pas génotoxique in vivo aux posologies permettant d'obtenir des concentrations plasmatiques 40 à 50 fois supérieures à celles qui peuvent être atteintes chez l'Homme.
0.007365895435214043 ||| Fertavid 100 IU/ 0.5 ml solution for injection follitropin beta ||| Fertavid 75 IU/ 0.5 ml solution for injection follitropin beta ||| Fertavid 100 UI/ 0,5 ml solution injectable follitropine bêta
0.7742915153503418 ||| Stability has been demonstrated for 21 days at room temperature in the CADD-Micro pump. ||| Fixed Very High Capacity broadband networks are available to 44% of EU homes. ||| Dans la pompe CADD-Micro, le produit reste stable pendant 21 jours à température ambiante.
0.5771478414535522 |||  154 Combination therapy with ribavirin: |||  212 Combination therapy: ||| Traitement combiné avec la ribavirine:
0.5463658571243286 ||| There are three vaccination strategies being investigated. ||| Actions that have been demonstrated for human growth hormone include: ||| Trois stratégies de vaccination font l’objet de recherches.
0.35413429141044617 ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 01 dated 30 September 2007 (with effective date 16 May 2008) of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| The Marketing Authorisation Holder shall complete the following programme of studies within the specified time frame, the results of which shall form the basis of the annual reassessment of the benefit/ risk profile: • To ensure the availability of KRAS test kit by 30 November 2007 • To provide a Statistical Analysis Plan describing the analysis of wild-type KRAS subpopulation for 20050181 and 20050203 studies. ||| Plan de Gestion de Risque Le titulaire de l’AMM s’engage à réaliser les études et les activités additionnelles de pharmacovigilance détaillées dans le plan de pharmacovigilance, conformément à la version 01 datée du 30 septembre 2007 (avec date d’effet au 16 mai 2008) du Plan de Gestion de Risque (PGR) presentée dans le Module 1.8.2. du dossier de demande d’Autorisation de Mise sur le Marché, ainsi que toute mise à jour ultérieure du PGR approuvée par le CHMP.
0.5580790042877197 ||| Partial data from Italy found that the number of excess deaths during the pandemic exceeded the official COVID death tally by a factor of 4-5x. ||| Growth projections for the EU and euro area have been revised down by around nine percentage points compared to the Autumn 2019 Economic Forecast . ||| Des données partielles provenant d’Italie révèlent que les chiffres de la surmortalité durant la pandémie sont 4-5 fois supérieurs au décompte officiel des morts de la COVID.
0.30948606133461 ||| The normal safety precautions for cytostatic agents must be observed when preparing and disposing of the infusion solution. ||| The treatment should consist of those general measures employed in the management of overdose with any antidepressant. ||| Les précautions normales de sécurité pour les agents cytotoxiques doivent être observées lors de la préparation et de la pose de la solution pour perfusion.
0.6735867857933044 ||| - depressed level of consciousness (e. g. coma). ||| - Increased sexual desire (e. g. increased libido) ||| - diminution du niveau de conscience (notamnent coma)
0.40278613567352295 ||| Repeated-dose toxicity studies with voriconazole indicated the liver to be the target organ. ||| Systemic safety profile of INTANZA is similar to the comparator vaccine administered intramuscularly. ||| Des études de toxicité à doses répétées de voriconazole ont montré que le foie est l’ organe cible.
0.15318384766578674 ||| 1 vial of 10 ml contains 1000 IU ||| 10 ml 1 vial of 10 ml contains 1000 IU ||| 1 flacon de 10 ml contient 1000 UI.
0.46930617094039917 ||| Among patients with ankylosing spondylitis who received Enbrel, the clinical responses were apparent at the time of the first visit (2 weeks) and were maintained through 6 months of therapy. ||| At the time of a pre-specified interim analysis, the primary endpoint, time to progression, was met and patients in the M+P arm were offered Vc+M+P treatment. ||| Parmi les patients atteints de spondylarthrite ankylosante ayant reçu Enbrel, les réponses cliniques sont apparues dès la première visite (2 semaines) et se sont maintenues au cours des 6 mois de traitement.
0.06967604160308838 ||| Key elements to be included in the educational material ||| Key elements to be included in the educational brochure ||| Principaux éléments du matériel de formation
0.307573139667511 ||| Monitoring of uterine contractions and fetal heart rate during administration of atosiban and in case of persistent uterine contractions should be considered. ||| Patients with risk factors of QTc prolongation or risk factors of torsade de pointes should be monitored with continuous cardiac monitoring (ECG). ||| 3 Une surveillance des contractions utérines et du rythme cardiaque fœ tal doit être envisagée lors de l'administration d’ atosiban et en cas de persistance des contractions utérines.
0.2047281563282013 ||| How to store Oprymea 6. ||| How to store Arixtra 6. ||| Comment conserver Oprymea 6.
0.21872681379318237 ||| Side-effects listed have a rate equal or greater than placebo, and the discontinuation rate due to side effects was 7.1% in patients receiving celecoxib and 6.1% in patients receiving placebo. ||| For tonic-clonic seizures, there was an average reduction in seizure rate of 28.2% in the patients taking placebo, compared with 56.5% in those taking Keppra. ||| Les effets indésirables listés ont une fréquence égale ou supérieure à celle du placebo, et le taux d’ arrêt pour effets indésirables était de 7,1% pour les patients traités par le célécoxib et de 6,1% pour les patients traités par le placebo.
0.25387322902679443 ||| EMEA/CPMP a)Validation b)Opinion c)Active Time d)Clock stop ||| EMEA/CVMP a) Validation b) Opinion c) Active time d) Clockstop ||| EMEA/CPMP a) Validation b) Avis
0.6050096154212952 ||| Escherichia coli Staphylococcus intermedius ||| Organism Staphylococcus spp. ||| Pasteurella spp Mycoplasma spp Staphylococcus intermedius Escherichia coli.
0.6810842752456665 ||| Steinaclox- Medichrom ||| Cisplatin/ Gemcitabine ||| Steinaclox-Medichrom
0.3255385160446167 ||| The dose of Zevalin is calculated to give the appropriate amount of radioactivity for the patient’ s condition, based on the blood cell count. ||| With appropriate adjustment for the rate of absorption from the injection site, the calculated bioavailability is approximately 40%. ||| La dose de Zevalin est calculée pour apporter la quantité appropriée de radioactivité correspondant à l’ état du patient, en fonction de sa numération sanguine.
0.7971246838569641 ||| Prolonged or abnormal crying. ||| - feeling cold or uncomfortable ||| Cris anormaux ou prolongés.
0.45165881514549255 ||| Because doses are titrated for each subject, no additional dose adjustment is necessary based on gender. ||| For most applications one inspection is requested, but more than one per application is no exception. ||| Les doses étant établies pour chaque patient, aucune adaptation posologique supplémentaire n’ est nécessaire en fonction du sexe.
0.4345560669898987 ||| When prescribing Ketek, consideration should be given to official guidance on the appropriate use of antibacterial agents and the local prevalence of resistance (see also sections 4.4 and 5.1). ||| A wording modification was introduced to section on pregnancy and lactation (4.6) in order to add clarity and to put it in line with the guideline on summary of product characteristics. ||| Lors de la prescription de Ketek, il convient de tenir compte des recommandations officielles concernant l’ utilisation appropriée des antibactériens et de la prévalence de la résistance locale aux antibiotiques (voir également chapitres 4.4 et 5.1).
0.3371748626232147 ||| The blood concentrations of cyclosporine A (a CYP3A4 substrate) decreased by approximately 50%. ||| The AUC and Cmax of dehydro-aripiprazole, the active metabolite, decreased by 32% and 47%. ||| Les concentrations plasmatiques de cyclosporine A (un substrat du CYP3A4) étaient diminuées d’ environ 50%.
0.4133463501930237 ||| Sore throat, inflamed sinuses; inflammation of the stomach (gastritis) ||| inflammation of the pharynx, cough, flu-like symptoms ||| Maux de gorge, inflammation des sinus; inflammation de l’ estomac (gastrite).
0.21449610590934753 ||| VISTIDE is supplied as a sterile concentrate for solution for infusion in clear, glass vials containing 375 mg of the active ingredient, anhydrous cidofovir, in 5 ml formulated in Water for Injection at a concentration of 75 mg/ ml. ||| Dynastat is supplied as a sterile, single unit-of-use vial that is packaged with a 2 ml ampoule with a fill volume of 2 ml sodium chloride 9 mg/ ml (0.9%) solution (see below for various pack sizes and configurations) ||| Qu’ est -ce que VISTIDE et contenu de l’ emballage extérieur VISTIDE se présente sous forme d'une solution stérile à diluer pour perfusion, dans des flacons en verre incolore contenant 375 mg de substance active, le cidofovir anhydre, dilué dans 5 ml d'eau pour préparations injectables, à la concentration de 75 mg/ ml.
0.34844154119491577 ||| Cooking tunnels ||| Banking counters ||| Tunnels de cuisson
0.10394404828548431 ||| What Intrinsa is and what it is used for 2. ||| What Zonegran is and what it is used for 2. ||| Qu’ est -ce qu’ Intrinsa et dans quel cas est -il utilisé 2.
0.2474370300769806 ||| 509 patients with advanced breast cancer who had not received prior chemotherapy for metastatic disease were treated with Caelyx (n=254) at a dose of 50 mg/ m2 every 4 weeks, or doxorubicin (n=255) at a dose of 60 mg/ m2 every 3 weeks, in a phase III clinical trial (I97- 328). ||| In a separate trial, 224 patients with genotype 2 or 3 received PegIntron, 1.5 microgram/kg subcutaneously, once weekly, in combination with ribavirin 800 mg –1,400 mg p.o. for 6 months (based on body weight, only three patients weighing > 105 kg, received the 1,400 mg dose) (Table 7). ||| Lors d’ une étude clinique de phase III (I97-328), 509 patients avec un cancer du sein avancé n’ ayant pas reçu de chimiothérapie préalable pour leur maladie métastatique, ont été traités par Caelyx (n=254) à la dose de 50 mg/ m² toutes les 4 semaines ou par doxorubicine (n=255) à la dose de 60 mg/ m² toutes les 3 semaines.
0.26305216550827026 ||| Keep the cartridge in the outer carton. ||| Keep container in the outer carton. ||| Conserver la cartouche dans l’ emballage extérieur.
0.3991687595844269 ||| subcutaneous (injection under the skin) erythropoietin treatment. ||| • Inhalation anthrax (post-exposure prophylaxis and curative treatment) ||| traitement par érythropoïétine par voie sous-cutanée (injection sous la peau).
0.3367890417575836 ||| The review found that limited epidemiological data and spontaneous adverse drug reaction data provided a signal of increased risk of gastrointestinal and skin reactions (including life-threatening bullous reactions) for piroxicam relative to other non-selective NSAIDs. ||| 23 Composite of major VTE (including PE and proximal DVT, whatever symptomatic or asymptomatic detected by routine venography) and VTE-related mortality constituted a secondary end-point and is considered of better clinical relevance. ||| Selon cette évaluation, terminée en juin 2006, des données épidémiologiques limitées et des données sur les effets indésirables déclarés spontanément ont témoigné d’ une augmentation du risque de réactions gastro-intestinales et cutanées (notamment les réactions bulleuses mettant en jeu le pronostic vital) pour le piroxicam par rapport à d'autres AINS non-sélectifs.
0.38744601607322693 ||| Plavix is not intended for use in children or adolescents. ||| ISENTRESS is not for use in children and adolescents. ||| Plavix n'est pas destiné aux enfants ou aux adolescents.
0.12521719932556152 ||| Crohn’ s disease ||| Crohn’ s Disease ||| Maladie de Crohn mé
0.2760258913040161 ||| In reproductive toxicity studies in rats and rabbits no teratogenic effects were observed. ||| No clinically significant differences in nateglinide pharmacokinetics were observed between men and women. ||| Dans des études de toxicité de la reproduction chez le rat et le lapin, aucun effet tératogène n’ a été observé.
0.023013722151517868 ||| Cardiac arrhythmias (primarily supraventricular) usually respond to conventional therapy but may require discontinuation of ViraferonPeg therapy. ||| Cardiac arrhythmias (primarily supraventricular) usually respond to conventional therapy but may require discontinuation of Viraferon therapy. ||| Les arythmies cardiaques (principalement supraventriculaires) répondent habituellement bien au traitement conventionnel mais peuvent nécessiter l'interruption du traitement par ViraferonPeg.
0.39322441816329956 ||| Karvezide may be added to other treatments for hypertension. ||| As for other sealants, TachoSil may cause an allergic reaction. ||| Karvezide peut être associé à d’ autres traitements pour l’ hypertension.
0.10101111978292465 ||| 61/ 72 ||| 62/ 72 ||| 64/ 75
0.12313508242368698 ||| Pharmacotherapeutic group: antiepileptics, ATC code: ||| 29 Pharmacotherapeutic group: other antiepileptics, ATC code: ||| Classe pharmacothérapeutique: antiépileptique, Code ATC:
0.7071659564971924 ||| The list of the product names concerned is given in Annex I. ||| The third column simply represents the sum of the first two. ||| La liste des dénominations concernées figure en annexe I.
0.5838602781295776 ||| - Fluid build up with swollen ankles, legs and/ or hands ||| Wide-brimmed hat: for head, neck, nose and ears. ||| - Rétention d’ eau accompagnée d’ un gonflement des chevilles, des jambes et/ ou des mains
3.3728480620422163e-13 ||| adolescents 3 years of age and older, who have chronic hepatitis C, not previously treated, without liver decompensation, and who are positive for serum HCV-RNA. ||| adolescents 3 years of age and older, who have chronic hepatitis C, not previously treated, without liver decompensation, and who are positive for serum HCV-RNA. ||| de 3 ans et plus et adolescents, atteints d’ hépatite C chronique, non préalablement traités, en l’ absence de décompensation hépatique et ayant un ARN-VHC sérique positif.
0.49284422397613525 ||| Table 8 - Efficacy Responses in Placebo-Controlled AS Study – Study VIII Reduction of Signs and Symptoms lP ||| Summary of Results of Efficacy Analyses as of Dates Studies Were Unblinded — Pooled Studies MM-009 and MM-010 ||| Tableau 8 – Réponses d'efficacité de l'étude SA contrôlée contre placebo – Etude VIII Réduction des signes et symptômes
0.46643540263175964 ||| Critical Evaluation A number of areas of disharmony in the product information for Diovan have been evaluated by the CHMP and a revised PI was adopted. ||| A 1984 review of 18 prospective and 28 retrospective studies suggests that the evidence for each component of the HBMl is strong. ||| Évaluation critique Un certain nombre de points divergents dans les informations du produit Diovan ont été évalués par le CHMP et une notice révisée a été adoptée.
0.06988324224948883 ||| Musculoskeletal and connective tissue disorders ||| Musculoskeletal and connective tissue disorders: ||| Troubles musculo squelettiques, du tissu conjonctif et des os
0.2814214527606964 ||| Luveris is intended for subcutaneous use which means it is given by injection under the skin. ||| Rheumocam is a yellowish opaque oral suspension which is to be given mixed with food. ||| Luveris doit être administré par voie sous-cutanée, c'est-à-dire en injection sous la peau.
0.2852666974067688 ||| High density polyethylene (HDPE) plastic bottle containing 120 tablets, fitted with polypropylene (PP) child resistant closure. ||| White high-density polyethylene (HDPE) bottles with white tamper proof polypropylene (PP) closures containing 30, 60, 100 or 175 tablets. ||| Flacon plastique en polyéthylène haute densité (PEHD) contenant 120 comprimés avec un bouchon sécurité-enfant en polypropylène (PP).
0.42839258909225464 ||| Multicentre Trial N with CR = 34 ||| Multicentre Trial N=40 ||| N avec RC = 34
0.20195256173610687 ||| Interpretation ||| Indication ||| Interprétation
3.926272013673321e-13 ||| The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision. ||| The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision. ||| Le titulaire de cette autorisation de mise sur le marché doit informer la Commission Européenne sur les plans marketing concernant le médicament vétérinaire autorisé par cette décision.
0.1700827181339264 ||| Exjade is a medicine that contains the active substance deferasirox. ||| NovoNorm is a medicine that contains the active substance repaglinide. ||| Exjade est un médicament contenant le principe actif déférasirox.
0.2516728639602661 ||| SIFROL 0.35 mg tablets Pramipexole ||| Oprymea 1.1 mg tablets Pramipexole ||| SIFROL 0,35 mg comprimés Pramipexole
0.3191361129283905 ||| Insert the syringe adapter into the bottle until it is flush with the top of the bottle. ||| Push down on the plunger of the syringe, to empty its entire contents into a second bowl. ||| Insérez l’ adaptateur de seringue dans le flacon de façon à ce qu’ il affleure le sommet de celui -ci.
0.40502363443374634 ||| - Loss of appetite ||| - lack of appetite ||| - Perte d'appétit.
0.730846643447876 ||| BO1 AC04 Prevention of vascular ischaemia ||| Neurofibromatosis type 2 at 22q12 ||| BO1 AC04 Prévention des évenements vasculaires ischémiques
0.24727290868759155 ||| Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) as beta-blockers may mask the signs and symptoms of acute hypoglycemia. ||| Increased intracranial pressure Fentanyl-ratiopharm should be used with caution in patients who may be particularly susceptible to the intracranial effects of CO2 retention such as those with evidence of increased intracranial pressure, impaired consciousness or coma. ||| Les inhibiteurs bêta-adrénergiques doivent être administrés avec prudence chez les patients ayant une tendance à l’ hypoglycémie spontanée ou chez les patients diabétiques (notamment ceux atteints de diabète instable), car les bêta-bloquants peuvent masquer les signes et symptômes d’ hypoglycémie aiguë.
0.2595979869365692 ||| In general, caution should be exercised in the administration and monitoring of APTIVUS in elderly patients reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other therapy. ||| In general, caution must be exercised when prescribing Sebivo to elderly patients in view of the greater frequency of decreased renal function due to concomitant disease or concomitant use of other medicinal products. ||| D'une façon générale, la prudence s'impose lors de l'administration et du suivi d'APTIVUS chez les patients âgés, chez qui la diminution des fonctions hépatique, rénale ou cardiaque, les maladies concomitantes ou les thérapeutiques associées sont plus fréquentes.
0.33472317457199097 ||| - Severe impairment of liver function, hepatic encephalopathy ||| - Chronic hepatitis with decompensated cirrhosis of the liver. ||| - Insuffisance hépatique sévère, encéphalopathie hépatique
0.31033122539520264 ||| Slowly pull the plunger down to the dosage marking on the syringe that matches your dose. ||| Attach the dosing syringe to the bottle by gently pushing the end onto the top the bottle ||| Tirez lentement le piston jusqu’ au repère de la seringue correspondant à votre dose.
0.008869899436831474 ||| 374 HOW TO SELF INJECT VIRAFERON ||| 345 HOW TO SELF INJECT VIRAFERON ||| 377 n'e stp lus au tor isé COMMENT AUTO-INJECTER VIRAFERON
0.20751139521598816 ||| In the absence of compatibility studies, Fabrazyme must not be mixed with other medicinal products in the same infusion. ||| Naglazyme should not be mixed with other medicinal products in the same infusion, except for those mentioned below. ||| En l’ absence d’ études de compatibilité, Fabrazyme ne doit pas être mélangé avec d’ autres médicaments dans la même perfusion.
7.840012276535968e-13 ||| - Do not mix insulin with any other medicines. ||| - Do not mix insulin with any other medicines. ||| - Ne mélanger Insulin Human Winthrop Rapid avec aucun autre médicament.
0.43276768922805786 ||| Mutagenicity: in vitro and in vivo studies with and without metabolic activation have shown that nelfinavir has no mutagenic or genotoxic activity. ||| Deferiprone did not show direct mutagenic properties; however, it did display clastogenic characteristics in in vitro assays and in vivo in animals. ||| Mutagénicité: des études in vitro et in vivo avec et sans activation métabolique ont montré que le nelfinavir est dépourvu d’effets mutagènes ou génotoxiques.
0.24200402200222015 ||| Therefore, men treated with Busilvex are advised not to father a child during and up to 6 months after treatment and to seek advice on cryo-conservation of sperm prior to treatment because of the possibility of irreversible infertility due to therapy with Busilvex. ||| As thalidomide is found in semen, male patients must use condoms during treatment and for 1 week after dose interruption and/ or cessation of treatment when having sexual intercourse with a pregnant woman or with a woman with childbearing potential who is not using effective contraception. ||| Compte tenu de la probable stérilité liée au traitement avec Busilvex, il est conseillé aux hommes traités de ne pas concevoir d’ enfant pendant et jusqu’ à 6 mois après le traitement, et de se renseigner sur la cryoconservation du sperme avant d’ être traités.
0.38153892755508423 ||| Mechanical egg timers ||| Mechanical watches ||| Minuteurs mécaniques
0.3388434648513794 ||| Clinical study results have shown that repaglinide is optimally dosed in relation to main meals (preprandial dosing). ||| In both cases the pharmacokinetic parameters for tenofovir administered with a light meal were unchanged. ||| Les résultats des études cliniques ont montré que le répaglinide avait une efficacité optimale quand il était administré avant chaque repas principal (administration préprandiale).
0.6585911512374878 ||| Via Provinciale Schito 131 I-80058 Torre Annunziata/ NA Italy ||| ra Italia Via fratelli Cervi snc, Centro Direzionale Milano Due ||| Via Provinciale Schito 131 I-80058 Torre Annunziata/ NA Italie
0.030312934890389442 ||| WHAT BENEFIX IS AND WHAT IT IS USED FOR ||| WHAT IS BENEFIX AND WHAT IS IT USED FOR ||| QU’EST-CE QUE BENEFIX ET DANS QUEL CAS EST-IL UTILISE
0.04671208932995796 ||| Treatment with Zerit should be initiated by a doctor who has experience in the treatment of HIV infection. ||| Treatment with Viracept should be initiated by a doctor who has experience in the treatment of HIV infection. ||| Le traitement par Zerit doit être mis en place par un médecin ayant une expérience dans la prise en charge de l’ infection par le VIH.
0.4216201901435852 ||| In such cases medicinal products containing abacavir should be permanently discontinued. ||| ORACEA and certain other medications may not work properly when taken together. ||| Dans ces cas, les médicaments contenant de l'abacavir doivent être définitivement arrêtés.
0.3701797127723694 ||| L-arginine hydrochloride, L-histidine hydrochloride, L-histidine, polysorbate 20, water for injections. ||| L-histidine hydrochloride, L-histidine, polysorbate 20, α ,α -trehalose dehydrate. ||| Contient également: chlorhydrate de L-arginine, chlorhydrate de L-histidine, L-histidine, polysorbate 20, eau pour préparations injectables.
0.3915977478027344 ||| Follow the instructions and recommendations from your doctor regarding the use of NovoRapid in a pump. ||| A user manual is available with the Preotact pen to instruct patients on the correct use of the pen. ||| Suivez les instructions et les recommandations de votre médecin concernant l’ utilisation de NovoRapid dans une pompe.
0.6259500980377197 ||| Involutional osteoporosis in women ||| Postmenopausal osteoporosis: ||| Ostéoporose involutive chez la femme
0.4652267396450043 ||| Rafarm Aebe Korinthou 12 New Psychiko 15451 Greece ||| Remedina Gounari 25 & Areos Kamatero Attiki 13451 Greece ||| Rafarm Aebe Korinthou 12 New Psychiko 15451 Grèce
0.2295951545238495 ||| CRIXIVAN with ritonavir and oral midazolam should not be coadministered (see section 4.3). ||| No dosage adjustment is necessary if methadone is coadministered with REYATAZ and ritonavir. ||| CRIXIVAN ne doit pas être co-administré avec du ritonavir et du midazolam par voie orale (voir rubrique 4.3).
0.11782784759998322 ||| 6 Metabolism and nutrition disorders: ||| • Metabolism and nutrition disorders: ||| Troubles du métabolisme et de la nutrition:
0.0 ||| Store in the original package in order to protect from moisture. ||| Store in the original package in order to protect from moisture. ||| A conserver dans l’ emballage extérieur d’ origine à l’ abri de l’ humidité.
0.40762990713119507 ||| Two additional studies looked at the appropriate duration of the infusion for Vimpat solution and compared its safety with that of placebo infusions in a total of 199 patients. ||| Foxes The distribution of almost four million baits of the product during the field trials over four years have been followed by an intensive surveillance of the vaccination areas. ||| Deux études supplémentaires ont déterminé la durée appropriée de la perfusion de Vimpat solution et comparé sa sécurité d’ emploi à celle des perfusions de placebo chez un total de 199 patients.
0.04672516509890556 ||| For the full list of all side effects reported with Trevaclyn, see the Package Leaflet. ||| For the full list of all side effects reported with Tredaptive, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Trevaclyn, voir la notice.
0.3560747504234314 ||| Panretin gel can be expected to have local therapeutic effects only and it has no role in the prevention or treatment of visceral KS. ||| However, the benefit risk of moxifloxacin may be favourable if other antibiotherapy has failed or cannot be used. ||| Panretin gel n’ aurait que des effets thérapeutiques locaux et il ne joue pas de rôle dans la prévention ou le traitement des lésions viscérales du SK.
0.5038115382194519 ||| If symptoms of overdose appear, treatment is to be symptomatic. ||| If left untreated, however, it can result in broken bones. ||| En cas de survenue de tels symptômes de surdosage, un traitement symptomatique sera entrepris.
0.14274892210960388 ||| Cetrotide is a powder and solvent to be made up in a solution for injection. ||| Betaferon is a powder and solvent, which is made into a solution for injection. ||| Cetrotide se présente sous la forme d’ une poudre et d’ un solvant à mélanger pour obtenir une solution injectable.
0.4547784626483917 ||| TNF and lymphotoxin are pro- inflammatory cytokines that bind to two distinct cell surface receptors: the 55-kilodalton (p55) and 75- kilodalton (p75) tumour necrosis factor receptors (TNFRs). ||| • Baseline values of hepatic aminotransferases (aspartate aminotransferases (AST) and/ or alanine aminotransferases (ALT)) > 3xULN (see sections 4.2 and 4.4). ||| Le TNF et la lymphotoxine sont des cytokines pro-inflammatoires qui lient deux récepteurs distincts à la surface des cellules: les récepteurs du facteur nécrosant des tumeurs (TNFR) de 55-kilodaltons (p55) et de 75-kilodaltons (p75).
5.752186921226254e-13 ||| John’ s wort may persist for at least 2 weeks after cessation of treatment (see section 4.3). ||| John’ s wort may persist for at least 2 weeks after cessation of treatment (see section 4.3). ||| L’ effet inducteur du millepertuis peut persister pendant au moins 2 semaines après l’ arrêt du traitement (voir rubrique 4.3).
0.32760754227638245 ||| If accidental eye exposure occurs, flush the eyes immediately with water and seek medical attention. ||| If the veterinary medicinal product accidentally gets into eyes, flush the eyes thoroughly with water. ||| En cas d'atteinte accidentelle des yeux, les rincer immédiatement et abondamment à l'eau et consulter un médecin.
0.13692161440849304 ||| How is Agenerase used? ||| How is Avandamet used? ||| Comment Agenerase est -il utilisé?
0.0 ||| Children and adolescents Olanzapine is not indicated for the treatment of children and adolescent patients below 18 years. ||| Children and adolescents Olanzapine is not indicated for the treatment of children and adolescent patients below 18 years. ||| 138 L’ olanzapine n’ est pas indiquée chez les enfants et adolescents âgés de moins de 18 ans.
0.2797597348690033 ||| Kinzalmono may increase the blood pressure lowering effect of other medicines used to treat high blood pressure. ||| ABILIFY may increase the effect of medicines used to lower the blood pressure. ||| Kinzalmono peut accentuer l’ effet de diminution de la pression artérielle d’ autres médicaments utilisés pour traiter l’ hypertension artérielle.
0.5098734498023987 ||| 250 mg 500 mg 750 mg 2 mg/ ml 2 mg/ ml 2 mg/ ml 2 mg/ ml ||| 1000 mg 10 g/ 100 ml 5 g/ 100 ml 200 mg/ 100 ml ||| 250 mg 500 mg 750 mg 2 mg/ ml
0.8374650478363037 ||| 6000 units (30 mg) ||| 100 LD50 units ||| Metalyse 6 000 unités (30 mg)
5.600820371723381e-13 ||| Medicines should not be disposed via wastewater or household waste. ||| Medicines should not be disposed via wastewater or household waste. ||| Les médicaments ne doivent pas être jetés au tout à l’égout ou avec les ordures ménagères.
0.2907939553260803 ||| Neurotoxicity, mainly peripheral neuropathy, appeared to be more frequent and severe with a 175 mg/ m2 3 hour infusion (85% neurotoxicity, 15% severe) than with a 135 mg/ m2 24 hour infusion (25% peripheral neuropathy, 3% severe) when paclitaxel was combined with cisplatin. ||| There was less use of morphinic analgesic (p < 0.01), non-morphinic analgesics (p < 0.01), other disease-related medications (p = 0.06) and radiotherapy (p < 0.01) in patients treated with docetaxel at 75 mg/ m² compared to those with BSC. ||| La neurotoxicité, principalement neuropathie périphérique, semble être plus fréquente et sévère avec une perfusion de 175 mg/ m2 sur 3 heures (85% de neurotoxicité, 15% sévère) qu'avec une perfusion de 135 mg/ m2 sur 24 heures (25% de neuropathies périphériques, 3% sévère) de paclitaxel associé à cisplatine.
0.5982222557067871 ||| Retapamulin is for cutaneous use only. ||| Sitagliptin is modestly dialyzable. ||| Rétapamuline est réservée à la voie cutanée uniquement.
0.32915496826171875 ||| Step 2 - The injection site The best site for subcutaneous injection is in the abdomen around the navel (h.) where there is a lot of loose skin and layers of fatty tissue. ||| The best sites for injection are tissues with a layer of fat between skin and muscle: thigh, outer surface of the upper arm (you may need the assistance of another person to use this site), abdomen (except the navel or waistline). ||| 2ème Etape - zone d'injection La zone la plus appropriée pour l'injection sous-cutanée est dans l'abdomen autour du nombril (h.) où il y a une quantité importante de peau et de graisse.
0.26017963886260986 ||| For any information about this medicine, please contact the Marketing Authorisation Holder. ||| For any information about this medicine, please contact the local EXUBERA Customer Care Centre. ||| Pour toute information concernant ce médicament, veuillez contacter le Titulaire de l’autorisation de mise sur le marché.
0.3870309591293335 ||| Serum concentrations should be monitored, however, to determine whether dosage adjustments are necessary, since the elimination rate in these patients may be reduced. ||| As an alternative, in case the oral solution is not available, the dose can be adjusted by increasing the dosage interval, also shown in the table. ||| Les concentrations sanguines devront néanmoins être contrôlées pour déterminer la nécessité éventuelle d’une adaptation posologique, puisque le taux d’élimination peut être réduit chez ces patients.
0.0 ||| - If you have any further questions, ask your doctor or pharmacist. ||| - If you have any further questions, ask your doctor or pharmacist. ||| - Si vous avez d’ autres questions, si vous avez un doute, demandez plus d’ informations à votre
0.34030503034591675 ||| In neonates with PPHN, INOmax can improve oxygenation (as indicated by significant increases in PaO2). ||| Deterioration in oxygenation and elevation in PAP may also occur in neonates with no apparent response to INOmax. ||| Chez les nouveau-nés avec HTAPPN, INOmax améliore l’ oxygénation artérielle (comme en témoignent les augmentations significatives de la PaO2).
0.41439369320869446 ||| If your red blood cell level is stable on a once weekly dosing regimen, your dose may be switched to once every two weeks administration. ||| The combination tablet taken once a day was also as effective as the medicines taken separately twice a day in reducing viral loads over 24 weeks of treatment. ||| Si votre taux de globules rouges est stable avec une injection par semaine, le rythme d’administration peut être espacé à une injection toutes les deux semaines.
0.43053722381591797 ||| PREPARING THE SOMAVERT DOSE FOR INJECTION ||| VIAL WITH POWDER FOR SOLUTION FOR INJECTION ||| PREPARATION DE LA SOLUTION DE SOMAVERT POUR L’INJECTION
0.2341804951429367 ||| 46 6.3 Shelf-life ||| 6.2 Shelf-life ||| 6.3 Durée de conservation
0.24642659723758698 ||| An increased incidence of altered renal microscopic morphology (collecting tubule basophilia) was observed in rats following chronic oral administration of sapropterin dihydrochloride at exposures at or slightly above the maximal recommended human dose. ||| Toxicities observed in dogs at levels similar to human exposure at the maximum recommended dose were liver changes, including bile thrombi, cholestasis and liver enzyme elevations thought to be related to increased bile secretion in this species. ||| 8 Une augmentation de l'incidence des altérations morphologiques microscopiques rénales (basophilie des tubes collecteurs) a été observée chez le rat après administration orale chronique de dichlorhydrate de saproptérine à une dose légèrement supérieure ou égale à la dose maximale recommandée chez l’ homme.
0.4807004928588867 ||| A series of online outreach events during the summer, to gather additional views on digital education and the COVID-19 crisis experience, will complement the process. ||| This coming week we will follow up with additional guidance on Wikimania and other regional and thematic community conferences. ||| Elle sera complétée par une série d'événements d'information organisés en ligne au cours de l'été, qui viseront à recueillir des points de vue supplémentaires sur l'éducation numérique et l'expérience de la crise liée à la COVID-19.
0.33832108974456787 ||| (b) Pull dose knob out (in direction of the arrow) until a “ 0” appears in the dose window. ||| • Put the cap back on the pen, with 0 next to the dosage indicator (picture E) • Check that the push-button is fully down. ||| (b) Tirer la bague de dosage (dans le sens de la flèche) jusqu'à ce que le chiffre "0" apparaisse dans la fenêtre de lecture.
0.2837795615196228 ||| However, because the doses implicated in retinal degeneration were in the lethal dose range, and no comparable effect has been observed in clinical studies, this finding was not considered to have clinical relevance. ||| Because these events were reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency or to establish, for all events, a causal relationship to vaccine exposure. ||| 107 impliquées dans cette dégénerescence appartiennent à un intervalle de doses létales et qu’ aucun effet semblable n’ a été observé lors des études cliniques, ce résultat n’ a pas de signification clinique.
0.3758663237094879 ||| "U.S. Department of State officials, as well as sinologist Dali Yang have said the ""Chinese campaign"" appears intended to deflect attention away from the Chinese government's mishandling of the crisis." ||| "However, Politico Europe reported the French claim as ""unsubstantiated"" and the U.S. Embassy in Paris stated that ""The United States government has not purchased any masks intended for delivery from China to France." ||| Des responsables du Département d'État américain, ainsi que le professeur de sciences politiques de l'Université de Chicago, Dali Yang, une autorité en matière de la politique chinoise, ont déclaré que la campagne chinoise semblait destinée à détourner l'attention de la mauvaise gestion par le gouvernement chinois de la crise,.
0.3250175714492798 ||| Detailed instructions for subcutaneous administration are provided with this leaflet (see How to use the PegIntron pre -filled pen). ||| Please check Section 5 -How to store Lantus- of the reverse (insulin) side of this leaflet for OptiSet storage instructions. ||| Des instructions détaillées pour l’administration sous-cutanée sont fournies avec cette notice (voir Comment utiliser le stylo prérempli PegIntron).
6.335624299497189e-13 ||| QUANTITY OF THE ACTIVE SUBSTANCE(S) ||| QUANTITY OF THE ACTIVE SUBSTANCE(S) ||| QUANTITÉ DU (DES) PRINCIPE(S) ACTIF(S)
0.4031887650489807 ||| Do not use AVONEX ||| Do not use PROCOMVAX: ||| N’ utilisez jamais AVONEX:
0.3843945860862732 ||| Although not reported with Neupro, symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy. ||| When a bone scan is negative, imaging with LeukoScan may rarely show a positive response and this may indicate early osteomyelitis. ||| Bien que cela n’ ait jamais été signalé avec Neupro, des symptômes faisant penser à un syndrome malin des neuroleptiques ont été décrits lors de l’ arrêt brutal de traitement dopaminergique.
0.3554455637931824 ||| Climate change is a global challenge that requires a decisive and confident response from all major economies, which account for some 80% of global greenhouse gas emissions. ||| Like the rest of the world, African countries face immediate healthcare needs and will also bear the economic and social consequences of the global pandemic. ||| Le changement climatique est un défi mondial qui exige une réaction résolue et confiante dans toutes les grandes économies, lesquelles représentent environ 80 % des émissions mondiales de gaz à effet de serre.
0.01675986498594284 ||| • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT ||| • CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SÛRE ET EFFICACE DU MEDICAMENT
0.2212807685136795 ||| In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/ day and serum creatinine ranging from 1.0-3.0 mg/ dl, the long-term effects (mean 2.6 years) of Aprovel on the progression of renal disease and all-cause mortality were examined. ||| In the adolescent population (n=83) (aged from 12 to < 18 years), significantly more patients treated with adefovir dipivoxil achieved the primary efficacy endpoint and obtained significant reductions in serum HBV DNA (23%) compared to placebo-treated patients (0%). ||| Les effets à long terme (en moyenne 2,6 ans) de Aprovel sur la progression de l'atteinte rénale et sur la mortalité toute cause ont été étudiés chez 1.715 patients hypertendus diabétiques de type 2 ayant une protéinurie ≥ 900 mg/ jour et une créatininémie comprise entre 1,0 et 3,0 mg/ dl.
0.7791948318481445 ||| Pharmacokinetics and Drug Metabolism: ||| Common Haematological / Lymphatic ||| Pharmacocinétique et métabolisation du médicament:
0.43576833605766296 ||| The scientific conclusions are provided in the Annex II, together with the amended Summary of Product Characteristics in the Annex III. ||| The scientific conclusions and the grounds for withdrawal of the Marketing Authorisations were set out in Annex to the opinion (Annex C). ||| Les conclusions scientifiques sont présentées en annexe II et le résumé modifié des caractéristiques du produit en annexe III.
0.2857551574707031 ||| 4 One to 3 minutes after the subcutaneous administration of IL-2 has been completed, Ceplene should be administered by slow subcutaneous injection at a rate not to exceed 0.1 ml (0.1 mg histamine dihydrochloride) per minute. ||| The dose of rivastigmine released from the transdermal patch over 24 hours (mg/ 24 h) cannot be directly equated to the amount (mg) of rivastigmine contained in a capsule with respect to plasma concentration produced over 24 hours. ||| Une à trois minutes après la fin de l’ administration sous-cutanée d’ IL-2, Ceplene doit être administré par injection sous-cutanée lente, à une vitesse ne dépassant pas 0,1 ml (0,1 mg d’ histamine dichlorhydrate) par minute.
0.6002797484397888 ||| Potential for rimonabant to affect other medicinal products: ||| Ribavirin has two pathways of metabolism: ||| 4 Effets possibles du rimonabant sur la pharmacocinétique d’autres médicaments:
0.1061718612909317 ||| The use of Myocet should be confined to units specialised in the administration of cytotoxic chemotherapy and should only be administered under the supervision of a physician experienced in the use of chemotherapy. ||| The use of docetaxel should be confined to units specialised in the administration of cytotoxic chemotherapy and it should only be administered under the supervision of a physician qualified in the use of anticancer chemotherapy (see section 6.6). ||| L’ utilisation de Myocet est réservée à des services spécialisés dans l’ administration d’ une chimiothérapie cytotoxique; il ne doit être administré que sous le contrôle d’ un médecin expérimenté dans l’ utilisation de la chimiothérapie.
0.0 ||| A reduction in symptoms of pulmonary arterial hypertension was observed with Tracleer treatment. ||| A reduction in symptoms of pulmonary arterial hypertension was observed with Tracleer treatment. ||| Une réduction des symptômes de l’ hypertension artérielle pulmonaire a été observée chez les patients traités par Tracleer.
0.13615548610687256 ||| Driving and using machines If you feel dizzy or tired after taking Onsenal, do not drive or use machinery until you are feeling normal again. ||| 96 Driving and using machines If the injection makes you feel dizzy or tired, do not drive or use machines until you feel better again. ||| Si vous ressentez un étourdissement ou une fatigue après avoir pris Onsenal, ne conduisez pas etn'utilisez pas de machines avant de vous sentir à nouveau dans un état normal.
0.3077563941478729 ||| Glucosamine is considered to be an simple substance with a high solubility, and therefore, a comparative bioavailability study was not considered necessary for an approval. ||| In the estimation of exposure the information provided indicates that it is not necessary to calculate a plateau concentration for toltrazuril sulfone as this will not be attained in practice. ||| Le glucosamine est considéré comme une substance simple avec une haute solubilité; par conséquent, une étude de biodisponibilité comparative n'a pas été jugée nécessaire pour l'approbation.
0.7505662441253662 ||| Overall, the clinical studies of Rotarix in humans involved over 72,000 infants and took place in various countries worldwide. ||| Artificial intelligence and robotics alone will create almost 60 million new jobs worldwide in the next 5 years. ||| Globalement, l’ utilisation de Rotarix chez les humains a fait l’ objet d’ études cliniques réalisées dans divers pays de la planète sur plus de 72 000 nourrissons.
0.0 ||| Store in the original package in order to protect from light. ||| Store in the original package in order to protect from light. ||| A conserver dans l’ emballage extérieur d’ origine à l'abri de la lumière.
0.3242649435997009 ||| Elimination from the plasma is biphasic with a terminal elimination half-life of about 30-50 hours. ||| A slower terminal elimination phase follows with a dose-independent mean terminal elimination half-life of 2 to 3 h. ||| L’ élimination du plasma est biphasique avec une demi-vie d’ élimination terminale d’ environ 30-50 heures.
0.45938509702682495 ||| Further information er ng If you want more information about this medicine, please contact the local representative of the lo company that is authorised to market Nespo. no ||| If you have any questions about SoloStar or about diabetes, ask your healthc are professional or call the local sanofi-aventis number on the front of this leaflet. ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local de la Compagnie autorisée à commercialiser Nespo.
0.504589319229126 ||| INSTRUCTIONS ON HOW TO STORE AND DISPOSE OF ATRIANCE ||| INSTRUCTIONS FOR SELF-INJECTION OF CEPLENE ||| INSTRUCTIONS SUR LA CONSERVATION ET L'ELIMINATION D' ATRIANCE
0.3029143512248993 ||| Paediatric patients The overall exposure of adolescents (12 to ≤ 17 years) and children (2 to < 12 years) to deferasirox after single and multiple doses was lower than that in adult patients. ||| Clinical trials have been performed in children (61 patients aged 2 to 11) and children and adolescents (481 patients aged 9 to 19 years), comparing insulin lispro to human soluble insulin. ||| Populations particulières de patients Patients pédiatriques L’ exposition totale au déférasirox après l’ administration d’ une dose unique et de doses répétées était plus faible chez les adolescents (12 à 17 ans au plus) et chez les enfants (2 à moins de 12 ans) que chez l’ adulte.
0.36821243166923523 ||| Across a range of doses, higher AUC and Cmax levels have been reported in older subjects compared to younger subjects, reflecting the lower metabolism of melatonin in the elderly. ||| Elderly Older patients have higher blood levels and higher values for the area under the plasma concentration time curve (increased approximately 60%) compared with younger subjects. ||| Pour différentes doses, une ASC plus importante et une Cmax plus élevée ont été rapportées chez des sujets plus âgés, comparé à des sujets plus jeunes, ce qui reflète le métabolisme plus faible de la mélatonine chez les personnes âgées:
0.22066441178321838 ||| Epoetin beta is identical in its amino acid and carbohydrate composition to erythropoietin that has been isolated from the urine of anaemic patients. ||| In laboratory animals, hydrocortisone aceponate is eliminated the same way as hydrocortisone (other name for endogenous cortisol) through urine and faeces. ||| La composition en hydrates de carbone et en acides aminés de l'epoetin beta est identique à celle de l'érythropoïétine isolée à partir de l'urine des malades anémiques.
0.11522641777992249 ||| Epoetin alfa HEXAL 7000 IU/ 0.7 ml injection ||| Epoetin alfa HEXAL 7000 IU/ 0.7 ml ||| Epoetin alfa HEXAL 7 000 UI/ 0,7 ml, injection
0.2651474177837372 ||| Mean pre-therapeutic antibody titers against a panel of antigens (Streptococcus pneumoniae, influenza A, mumps, rubella, varicella) were maintained for at least 6 months after treatment with MabThera. ||| Titers of Ig G antigen specific antibody to mumps, rubella, varicella, tetanus toxoid, influenza and streptococcus pneumococci remained stable over 24 weeks following exposure to MabThera in rheumatoid arthritis patients. ||| 36 Les titres d’ anticorps moyens avant traitement contre un groupe d’ antigènes (Streptococcus pneumoniae, influenza A, les oreillons, la rubéole, la varicelle) ont été maintenus pendant au moins 6 mois après traitement par MabThera.
0.3896833062171936 ||| You should not breast-feed during treatment with Stalevo. ||| Women should not breastfeed while using Thelin. ||| Vous ne devez pas allaiter pendant que vous êtes sous traitement par Stalevo.
0.021992476657032967 ||| 4 A dose of 10 mg ketamine/ kg used concurrently with 40 micrograms dexmedetomidine/ kg may cause tachycardia. ||| A dose of 10 mg ketamine/ kg used concurrently with 40 micrograms dexmedetomidine/ kg may cause tachycardia. ||| L'administration simultanée d'une dose de 10 mg de kétamine/ kg et de 40 microgrammes de dexmédétomidine/ kg peut provoquer des crises de tachycardie.
0.28309598565101624 ||| Concentrate for solution for infusion 5 ml vial ||| Powder for solution for injection 1 vial ||| Solution à diluer pour perfusion Flacon de 5 ml
0.11406966298818588 ||| Relationship between concentration and effect Using a highly specific NK1-receptor tracer, positron emission tomography (PET) studies in healthy young men have shown that aprepitant penetrates into the brain and occupies NK1 receptors in a dose- and plasma- concentration-dependent manner. ||| PET imaging studies, using a highly specific NK1-receptor tracer, in healthy young men after administration of oral aprepitant have shown that aprepitant penetrates into the brain and occupies NK1 receptors in a dose-and plasma-concentration-dependent manner. ||| A l’aide d’un traceur hautement spécifique du récepteur NK1, des études par tomographie par émission de positrons (TEP) menées auprès de jeunes hommes sains ont montré que l’aprépitant pénètre dans le cerveau et se lie aux récepteurs NK1 de façon dose- et concentrations plasmatiques dépendantes.
0.27323800325393677 ||| Very common side effects (These can affect at least 10 in every 100 patients) ||| Very common side effects (These can affect more than 10 in every 100 people taking Hepsera) ||| Effets indésirables très fréquents (Peuvent affecter au moins 10 patients sur 100)
0.19023945927619934 ||| When injected, this small exposure helps the dog’ s immune system to synthesize antibodies against the canine herpes virus and to neutralize it. ||| When injected, this small exposure helps the cat’ s immune system to recognise and attack the viruses and bacterium. ||| Lors de l’ injection, cette faible exposition au virus aide le système immunitaire des chiennes à synthétiser des anticorps contre l’ herpèsvirus canin et à le neutraliser.
0.3388265371322632 ||| • Each ml of STOCRIN oral solution contains 30 mg of the active substance efavirenz. • The other ingredients are: medium chain triglycerides, benzoic acid (E210) and strawberry/mint flavour. ||| KIOVIG contains 10% (100 mg/ml) of human protein of which at least 98% is immunoglobulin G (IgG). – The other ingredients are glycine and water for injections. ||| Que contient STOCRIN Chaque ml de STOCRIN solution buvable contient 30 mg de principe actif éfavirenz.
0.253042072057724 ||| 135 Infections of the bones and joints Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation. ||| Due to the lack of clinical experience in multiple sclerosis patients, the use of Betaferon together with immunomodulators other than corticosteroids or ACTH is not recommended. ||| Infections ostéoarticulaires La ciprofloxacine doit être utilisée en association avec un autre antibiotique en fonction des résultats microbiologiques.
0.0 ||| Spain France The Netherlands United Kingdom ||| Spain France The Netherlands United Kingdom ||| DE/ H/ 0739/ 01/ MR Autriche Allemagne Espagne France Pays-Bas
0.7446126937866211 ||| Merck Sharp & Dohme (Italia) S. p. A. ||| The manufacturer is FAMAR S. A., 7 P. ||| Merck Sharp & Dohme (Italia) S.p.A.
0.04011742025613785 ||| Insulin Human Winthrop Comb 50 40 IU/ml suspension for injection in a vial Insulin human ||| Insulin Human Winthrop Basal 40 IU/ml suspension for injection in a vial Insulin human ||| Insulin Human Winthrop Comb 50 40 UI/ml suspension injectable en flacon Insuline humaine
0.01214650459587574 ||| ● CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| • CONDITIONS OU RESTRICTIONS DE DELIVRANCE ET D’ UTILISATION IMPOSEES AU TITULAIRE DE L'AUTORISATION DE MISE SUR LE MARCHE
0.005606099963188171 ||| 216 Always use Puregon exactly as your doctor has told you. ||| 222 Always use Puregon exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3583763837814331 ||| Treatment with higher doses of tetracyclines is associated with emergence of resistant intestinal bacteria, such as enterococci and enterobacteria. ||| Oxybutynin may lead to suppressed salivary secretions which could result in dental caries, parodontosis or oral candidiasis. ||| Le traitement par tétracyclines à fortes doses est associé à l'apparition de bactéries intestinales résistantes, tels les entérocoques et les entérobactéries.
0.5592834949493408 ||| - inflammation of the mouth or mouth ulcers, ||| - infection, and in particular infection in the blood or bladder, ||| - lésions de la muqueuse buccale (par exemple inflammation de la bouche, aphtes buccaux),
0.41563349962234497 ||| Solvent 2 needles 1 dose (0.5 ml) ||| 10 doses (bottle of 20 ml) ||| 1 flacon: poudre 1 seringue préremplie: solvant 2 aiguilles 1 dose (0,5 ml)
0.3670284152030945 ||| Hyperbaric oxygen chambers for non-medical purposes ||| Elastic compression bandages for surgical purposes ||| Chambres à oxygène hyperbare autres qu'à usage médical
0.5158908367156982 ||| Reporters Without Borders has just published the 2020 edition of the World Press Freedom Index which also takes into account the threat to free and fair journalism from the coronavirus outbreak. ||| Since 2015, the World Health Organization leads the World Antibiotic Awareness Week , a global campaign taking place on the week of the 18 November. ||| Reporters sans frontières vient de publier l'édition 2020 du Classement mondial de la liberté de la presse , qui prend également en compte la menace que représente l'épidémie de coronavirus pour le journalisme libre.
0.28300875425338745 ||| Caution must also be exercised and reduced doses should be considered if ritonavir is used concurrently with atorvastatin, which is metabolised to a lesser extent by CYP3A. ||| Caution should be exercised when Mimpara is administered with individually titrated, narrow therapeutic index medications that are predominantly metabolised by CYP2D6. ||| Lorsque Norvir est administré avec l’ atorvastatine, qui est métabolisée à un degré moindre par le CYP3A, la prudence est également recommandée et des réductions posologiques doivent être envisagées.
0.36798542737960815 ||| In conclusion, the CHMP considers Implanon to be an effective method of contraception with no apparent safety concerns and that the benefit-risk balance of Implanon is positive. ||| They decided that the benefits of Elaprase are greater than its risks in the long-term treatment of patients with Hunter syndrome and recommended that Elaprase be given marketing authorisation. ||| En conclusion, le CHMP considère que l’ Implanon est une méthode de contraception efficace, qui ne suscite aucune inquiétude apparente sur le plan sécuritaire, et dont le ratio bénéfice-risque est positif.
0.00787786953151226 ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 2 (dated 5 July 2006) presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version V03 (dated 19 November 2007) presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Système de pharmacovigilance Le titulaire de l’ AMM doit s’ assurer que le système de pharmacovigilance, comme décrit dans la version 2 (datée du 5 juillet 2006) présentée dans le Module 1.8.1. du dossier de demande d’ Autorisation de Mise sur le Marché, est en place et fonctionne avant et pendant la mise sur le marché du produit.
0.35819458961486816 ||| At haemodialysis or peritoneal dialysis only a modest amount of ciprofloxacin (less than 10%) is eliminated. ||| Up to 30% of the emtricitabine dose and approximately 10% of the tenofovir dose can be removed by haemodialysis. ||| Seul un faible pourcentage de ciprofloxacine (moins de 10%) est extrait par hémodialyse et dialyse péritonéale.
0.27352964878082275 ||| Sorafenib had no effect on the pharmacokinetics of gemcitabine or oxaliplatin. ||| Varenicline did not alter the steady-state pharmacokinetics of bupropion. ||| Le sorafénib n’ a eu aucun effet sur la pharmacocinétique de la gemcitabine ou de l’ oxaliplatine.
0.0 ||| 0.32 (0.25, 0.40) 0.29 (0.24, 0.35) ||| 0.32 (0.25, 0.40) 0.29 (0.24, 0.35) ||| 0,32 (0,25; 0,40) 0,29 (0,24; 0,35)
0.24413473904132843 ||| pimozide or sertindole (used to treat schizophrenia), triazolam or oral (taken by mouth) midazolam (used to treat anxiety or sleep disorders), ergot derivatives (used to treat headaches), astemizole or terfenadine (used to treat allergies or hay fever), the statins simvastatin or lovastatin (used to lower blood cholesterol) or amioradone, bepridil, flecainide, propafenone or quinidine (used to treat heart disorders), and metoprolol (used to treat heart failure). ||| Ketek should also not be used in patients who are taking any of the following medicines: • cisapride (used to relieve certain stomach problems); • ‘ ergot alkaloid derivatives’, such as ergotamine and dihydroergotamine (used to treat migraine headache); • pimozide (used to treat mental illness); • astemizole or terfenadine (commonly used to treat allergy symptoms - these medicines may be available without prescription); • simvastatin, atorvastatin or lovastastin (used to lower cholesterol in the blood). ||| troubles gastriques), du pimozide ou du sertindole (utilisés pour traiter la schizophrénie), du triazolam ou du midazolam administré par voie orale (c'est-à-dire pris par la bouche) (utilisés pour traiter l'anxiété ou les troubles du sommeil), des dérivés de l’ ergot de seigle (utilisés pour traiter les maux de tête), de l’ astémizole ou de la terfénadine (utilisés pour traiter les allergies ou le rhume des foins), des statines telles que la simvastatine ou la lovastatine (utilisées pour diminuer le taux de cholestérol) ou de l’ amiodarone, du bépridil, de la flécaïnide, de la propafénone ou de la quinidine (utilisés pour traiter les troubles cardiaques), et du métoprolol (utilisé pour traiter l’ insuffisance cardiaque).
0.20377853512763977 ||| Driving and using machines Temodal may make you feel tired or sleepy. ||| Driving and using machines Xolair may make you feel dizzy, sleepy or faint. ||| Conduite de véhicules et utilisation de machines Vous pouvez vous sentir fatigué ou somnolent avec Temodal.
0.32866549491882324 ||| From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. ||| The European Democracy Action plan will focus on wider approach to strengthen democracy, counter disinformation and to adapt to evolving threats and manipulations, as well as to support free and independent media.We made great strides in our preparedness to respond to the challenges posed to the elections by the digital environment, including from disinformation and other forms of interference. ||| Entre politiques de renforcement des systèmes de santé et de l’économie mondiale et réponses aux effets du confinement et des restrictions de déplacement, la plateforme numérique inclut un outil Country Policy Tracker visant à aider les pays à apprendre les uns des autres et à faciliter une réponse mondiale coordonnée au défi que pose le coronavirus.
0.4527094066143036 ||| The number of non-EU ADRs has risen sharply in recent years and this is expected to continue in 2002. ||| The EU has seen a substantial decrease in road fatalities in the past, but stagnating figures in recent years. ||| Le nombre d'ADR hors de l'UE a sensiblement augmenté ces dernières années et cette tendance devrait se poursuivre en 2002.
0.4111536741256714 ||| In view of the low exposure in reproductive toxicity studies, the potential developmental toxicity of Telzir has not been fully determined. ||| It should be noted, however, that these studies did not assess genotoxicity, carcinogenic potential, or toxicity to reproduction. ||| Au vu de la faible exposition au fosamprénavir dans les études de toxicité sur la reproduction, il n'a pas été possible de déterminer avec précision une toxicité potentielle de Telzir sur le développement.
0.00788313802331686 ||| Physical, cognitive, or sexual developments in the offspring of mothers receiving methoxy polyethylene glycol-epetin beta during gestation and lactation were not affected. ||| Physical, cognitive, or sexual developments in the offspring of mothers receiving methoxy polyethylene glycol-epoetin beta during gestation and lactation were not affected. ||| Les développements physiques, cognitifs ou sexuels de la descendance de mères recevant du méthoxy polyéthylène glycol-epoetin beta pendant la gestation et l’ allaitement n’ ont pas été altérés.
0.34551090002059937 ||| An in-vivo study showed that voriconazole inhibited the metabolism of efavirenz. ||| Studies in vitro have shown that sildenafil is selective for PDE5. ||| Une étude in vivo a montré que voriconazole inhibe le métabolisme de l’ efavirenz.
0.3350760042667389 ||| In view of the data provided on efficacy and safety, the benefit/ risk of the proposed extended indication “ mild to moderate pelvic inflammatory disease” was therefore considered to be positive by the CHMP as the initially proposed wording was adequately revised to reflect the current knowledge. ||| The LIFE study has been assessed in the past and this has led to the registration of the more extensive indication, i. e. the reduction of the cardiovascular morbidity and mortality (as measured by the combined incidence of CV death, stroke and MI) instead of stroke only. ||| Au vu des informations fournies sur l’ efficacité et la sécurité, le CHMP a considéré que le rapport bénéfice/ risque de l’ indication supplémentaire proposée « maladie inflammatoire du pelvis légère à modérée » est favorable, le texte initialement proposé ayant été révisé de manière adéquate pour refléter l’ état actuel des connaissances.
3.4291769727620713e-13 ||| The treatment required depends on the nature and severity of side-effects (see also “ Take special care with BeneFIX ”). ||| The treatment required depends on the nature and severity of side-effects (see also “ Take special care with BeneFIX ”). ||| Le traitement dépendra de la nature et de la gravité des effets indésirables (voir aussi « Faites attention avec BeneFIX ».
0.008571002632379532 ||| 3 ml of solution (corresponding to 18 MIU) in a vial (type I glass), with a stopper (halobutyl rubber) in a flip- off seal (aluminium) with a bonnet (polypropylene). ||| 1 ml of solution (corresponding to 10 MIU) in a vial (type I glass), with a stopper (halobutyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene). ||| 3 ml de solution (correspondant à 18 MUI) dans un flacon (verre de type I), avec un bouchon (caoutchouc en halobutyle) serti d'une bague d'inviolabilité (aluminium) entourée d’ une protection (polypropylène).
3.9957669334747536e-13 ||| If you accidentally miss a daily dose, just take the next dose as normal. ||| If you accidentally miss a daily dose, just take the next dose as normal. ||| Si vous oubliez de prendre Aprovel Si par inadvertance vous oubliez un jour de prendre votre médicament, prenez la dose suivante comme d'habitude.
0.07619337737560272 ||| Do not take Janumet if any of the above apply to you. ||| Do not take Velmetia if any of the above apply to you. ||| Ne prenez pas Janumet si l’un des points ci-dessus vous concerne.
0.5113698244094849 ||| Composting machines ||| Compostable plates ||| Machines de compostage
0.4042810797691345 ||| The rates of ischemic stroke were 0.14 versus 0.23 per 100 patient years on etoricoxib versus diclofenac respectively. ||| Treatment emergent NRTI resistance was significantly less frequent with fosamprenavir/ritonavir compared to nelfinavir (13% versus 57%; p < 0.001). ||| L’ incidence des accidents ischémiques cérébraux ont été respectivement de 0,14 et 0,23 pour 100 patients-année pour étoricoxib et diclofénac.
0.40213045477867126 ||| Discontinuations due to other specific adverse reactions among patients taking Trevaclyn were infrequent (< 1%). ||| These events were observed predominantly among patients with further risk factors for QTc prolongation. ||| Les arrêts du traitement en raison d’ autres effets indésirables spécifiques ont été rares chez les patients traités par Trevaclyn (moins de 1%).
0.3121964931488037 ||| You may rotate the site for each injection to avoid soreness at any one site. ||| It is better to change the injection site every day to avoid the risk of soreness at any one site. ||| Il peut être nécessaire d’alterner les sites d’injection afin d’éviter toute douleur au site d’injection.
0.015756912529468536 ||| Oral hypoglycaemic agents (OHAs), octreotide, monoamine oxidase inhibitors (MAOIs), non-selective beta-adrenergic blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids and sulphonamides. ||| Oral antidiabetic drugs (OAD), octreotide, monoamine oxidase inhibitors (MAOIs), non-selective beta-adrenergic blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids and sulphonamides. ||| Antidiabétiques oraux (ADO), octréotide, inhibiteurs de la monoamine-oxydase (IMAO), bêtabloquants non sélectifs, inhibiteurs de l’ enzyme de conversion de l’ angiotensine (IEC), salicylés, alcool, stéroïdes anabolisants et sulfamides.
0.2505547106266022 ||| Your doctor may decide to continue to monitor you or the child for the presence of infections after you or the child stop using Enbrel.  Tuberculosis: ||| Tell your doctor if you or the child have a history of congestive heart failure, because Enbrel needs to be used with caution under these circumstances.  Vaccinations: ||| Votre médecin peut décider de continuer à vous suivre ou à suivre l’enfant, pour détecter la présence d’éventuelles infections, après que vous ou l’enfant ayez arrêté de prendre Enbrel. • Tuberculose:
0.4211581349372864 ||| 10 ml (1.4 mg/ ml) 5 vials ||| 1 vial 10 vials 1 mg/ ml ||| 10 ml (1,4 mg/ ml) 5 flacons
0.1503448784351349 ||| The active substance in Tekturna, aliskiren, is a renin inhibitor. ||| The active substance in Prezista, darunavir, is a protease inhibitor. ||| Le principe actif de Tekturna, l’ aliskiren, est un inhibiteur de la rénine.
0.4453202486038208 ||| It was more effective than best supportive care therapy in lung cancer. ||| It was as effective as the standard combination chemotherapy. ||| Il s’ est avéré plus efficace que le meilleur traitement de soutien du cancer du poumon.
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 102 4.9 Surdosage
0.1273840367794037 ||| Pathological gambling, increased libido and hypersexuality have been reported in patients treated with dopamine agonists for Parkinson’ s disease, including pramipexole. ||| Pathologic gambling, increased libido and hypersexuality have been reported in patients treated with dopamine agonists, including rotiogotine. ||| Des cas de jeux pathologiques, de libido accrue et d’ hypersexualité ont été décrits chez des patients atteints de la maladie de Parkinson traités par des agonistes dopaminergiques, y compris le pramipexole.
1.139999270439148 ||| Qualified veterinary surgeon from the University of Hanover. ||| Reports on the Guadeloupe Prefecture website ||| Diplôme de chirurgien vétérinaire de l'université de Hanovre.
0.3257478177547455 ||| Operation of telecommunications satellites ||| Operation of a telecommunications network ||| Transmission par satellites de télécommunications
0.28492364287376404 ||| The first study (136 patients) examined the effects of Xyrem on the number of cataplexy attacks over 4 weeks of treatment. ||| During the assessment of the procedure, concerns were raised over the long-term safety of etoricoxib 90mg in patients with AS. ||| La première étude (136 patients) a étudié les effets de Xyrem sur le nombre d’ attaques de cataplexie sur une période de traitement de 4 semaines.
0.20638155937194824 ||| However, care should be taken when prescribing oseltamivir in subjects when taking co-excreted agents with a narrow therapeutic margin (e. g., chlorpropamide, methotrexate, phenylbutazone). ||| Therefore it is recommended that patients receiving Suboxone should be closely monitored if inducers (e. g. phenobarbital, carbamazepine, phenytoin, rifampicin) are co- administered. ||| Toutefois, une attention particulière est nécessaire quand l'oseltamivir est prescrit simultanément avec des produits ayant la même voie d'élimination mais ayant une faible marge thérapeutique (par ex. chlorpropamide, méthotrexate, phénylbutazone).
0.28255653381347656 ||| In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics You must tell your doctor if you think that you are (or might become) pregnant. ||| 26 as a cold should not be a problem, but your doctor will advise whether you can still be vaccinated with Pandemrix. • if you have problems with your immune system, since your response to the vaccine may then be poor. • if you are having a blood test to look for evidence of infection with certain viruses. ||| Dans ce cas votre médecin peut faire pratiquer des tests sanguins réguliers, en particulier pour mesurer le taux de potassium dans le sang en cas de mauvais fonctionnement des reins si vous devez subir une intervention chirurgicale ou une anesthésie Vous devez informer votre médecin si vous êtes enceinte ou si vous pensez pouvoir être enceinte.
0.4067995548248291 ||| ra No clinical significance of these antibodies has been identified. ||| The precise incidence of antibodies is as yet uncertain. ||| Aucune significativité clinique de ces anticorps n’ a am
3.89545004326336e-13 ||| It is recommended that Xigris be infused with an infusion pump to accurately control the infusion rate. ||| It is recommended that Xigris be infused with an infusion pump to accurately control the infusion rate. ||| Il est recommandé d’ administrer Xigris avec une pompe à perfusion pour contrôler de façon précise le débit de perfusion.
0.39605697989463806 ||| If this happens to you, do not drive or operate any tools or machines until your vision improves. ||| If you are especially sensitive, this might influence your ability to drive or use machines. ||| Dans ce cas, ne conduisez pas et n’ utilisez pas certains outils ou machines jusqu’ à ce que votre vision se soit améliorée.
0.6849488615989685 ||| Tumour lysis syndrome Hyperglycaemia Protein total decreased Anorexia ||| Dizziness Akathisia6 Parkinsonism6 Dyskinesia 6 ||| Syndrome de lyse tumorale Hyperglycémie Réduction du taux de protéines totales Anorexie
0.6049791574478149 ||| 53% 33% 27% 23% 13% 29% ||| 42% 38% 48% 73% ||| 53% 33% 27% 23% 13%
0.06426785886287689 ||| The cartridge in use must not be stored in a refrigerator. ||| The pen in use must not be stored in a refrigerator. ||| Les cartouches en cours d’ utilisation ne doivent pas être conservées au réfrigérateur.
0.38933998346328735 ||| Based on animal studies, the rate of excretion is expected to be low. ||| The effect of food on the rate and extent of absorption was also studied. ||| D’après les études chez l’animal, on peut s’attendre à un taux d’excrétion réduit.
0.25798505544662476 ||| Your blood sugar may get too high (hyperglycaemia). ||| enough insulin, your blood sugar level may become too high (hyperglycaemia). ||| Votre taux de sucre dans le sang peut devenir trop élevé (hyperglycémie).
0.328546404838562 ||| Patients with an impaired liver function have an increased renal excretion of ceftriaxone. ||| In patients with delayed graft function, sirolimus may delay recovery of renal function. ||| L’insuffisance rénale s’accompagne d’une augmentation de l’excrétion biliaire de la ceftriaxone, alors que l’insuffisance hépatique est associée à une augmentation de l’excrétion rénale.
0.003740517655387521 ||| Measles virus1 Enders’ Edmonston strain (live, attenuated)........ not less than 3.00 log10 CCID50* Mumps virus1 Jeryl Lynn™ (Level B) strain (live, attenuated).. not less than 4.30 log10 CCID50* Rubella virus2 Wistar RA 27/ 3 strain (live, attenuated).............. not less than 3.00 log10 CCID50* Varicella virus3 Oka/ Merck strain (live, attenuated)................... not less than 3.99 log10 PFU** ||| Measles virus1 Enders’ Edmonston strain (live, attenuated)........ not less than 3.00 log10 CCID50* Mumps virus1 Jeryl Lynn™ (Level B) strain (live, attenuated)... not less than 4.30 log10 CCID50* Rubella virus2 Wistar RA 27/ 3 strain (live, attenuated)............... not less than 3.00 log10 CCID50* Varicella virus3 Oka/ Merck strain (live, attenuated).................... not less than 3.99 log10 PFU** ||| Virus de la rougeole1 souche Edmonston Enders (vivant, atténué)........ au minimum 3,00 log10 DICC50* Virus des oreillons1 souche Jeryl LynnTM (niveau B) (vivant, atténué). au minimum 4,30 log10 DICC 50 Virus de la rubéole2 souche Wistar RA 27/ 3 (vivant, atténué)............... au minimum 3,00 log10 DICC50 Virus de la varicelle3 souche Oka/ Merck (vivant, atténué).................... au minimum 3,99 log10 UFP**
0.348558247089386 ||| 20 In two clinical studies (study B2222 and an intergroup study S0033) the daily dose of Glivec was escalated to 800 mg in patients progressing at the lower daily doses of 400 mg or 600 mg. ||| As the two major clinical outcome studies, Helsinki Heart Study and the VA- HIT study have been carried out with a 1200 mg daily dose (2x600 mg), the CPMP considered that 1200 mg should be the recommended daily dose. ||| Dans les deux études cliniques (étude B2222 et étude intergroupe S0033), la dose quotidienne de Glivec a été augmentée à 800 mg chez les patients qui progressaient aux plus faibles doses de 400 mg ou 600 mg par jour.
0.4112846851348877 ||| Hand washing is recommended to prevent the spread of the disease. ||| Your doctor can perform a blood test to assess the risk of bleeding. ||| Il est conseillé de se laver les mains pour empêcher la propagation de la maladie.
0.3114697337150574 ||| Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 ||| Deutschland Sanofi-Aventis Deutschland GmbH Tel: +49 (0)180 2 222010 ||| Norge Deutschland sanofi-aventis Norge AS Sanofi-Aventis Deutschland GmbH Tlf: +47 67 10 71 00 Tel: +49 (0)180 2 222010
0.6867555975914001 ||| The mean half-life was 0.75 to 1.5 hours in patients. ||| Median survival was 384 and 373 days. ||| La durée de demi-vie moyenne était de 0,75 à 1,5 heure chez les patients.
0.1299416422843933 ||| If you use more Enbrel than you should ||| If you use more Rebif than you should ||| Si vous avez utilisé plus d’ Enbrel que vous n’ auriez dû
0.6261355876922607 ||| How does the proposal ensure simplification of procedures? ||| How will all the new instruments be financed? ||| Comment la proposition assure-t-elle la simplification des procédures?
0.22290249168872833 ||| ris 2. ||| ris 5. ||| é 2.
0.679656982421875 ||| Zarzio 30 MU/ 0.5 ml solution for injection or infusion in pre-filled syringe Zarzio 48 MU/ 0.5 ml solution for injection or infusion in pre-filled syringe Filgrastim ||| 50/ 100 microgram/ dose inhalation powder, pre-dispensed . 50/250 microgram/dose inhalation powder, pre-dispensed . 50/500 microgram/dose inhalation powder, pre-dispensed. ||| Zarzio 30 MU/ 0,5 ml solution injectable ou pour perfusion en seringue préremplie Zarzio 48 MU/ 0,5 ml solution injectable ou pour perfusion en seringue préremplie Filgrastim
0.3483401834964752 ||| 9 Available in packs of 1 vial containing 5 ml of solution. ||| Vials of 10 ml are available as a pack of 2 vials. ||| Conditionné en boîtes d'un flacon contenant 5 ml de solution.
0.2694564461708069 ||| The other ingredients are: thiomersal, sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, magnesium chloride hexahydrate, calcium chloride dihydrate, sodium citrate, citric acid and water for injections. ||| Excipients: aluminium hydroxide and a buffer solution of disodium phosphate, monopotassium phosphate, sodium carbonate, sodium bicarbonate, trometamol, sucrose, medium 199 (complex blend of amino acids, mineral salts, vitamins and other ingredients) and water for injections. ||| Les autres composants sont: thiomersal, chlorure de sodium, chlorure de potassium, phosphate monopotassique, phosphate disodique dihydraté, chlorure de magnésium hexahydraté, chlorure de calcium dihydraté, citrate de sodium, acide citrique et eau pour préparation injectable.
0.5828365087509155 ||| - feeling anxious, trouble sleeping, ||| - feeling worried, feeling depressed ||| sensations d’anxiété, troubles du sommeil,
0.36294084787368774 ||| 150mg/ ml ||| 150 mg/25 ml ||| Zactran 150mg/ ml
0.3406485617160797 ||| What CYSTAGON contains ||| What GADOVIST contains ||| Que contient CYSTAGON
0.4359065890312195 ||| Headache, syncope Extrapyramidal symptoms ||| Deep vein thrombosis; hematoma ||| Céphalée, syncope Symptômes extrapyramidaux
0.8312321901321411 ||| Tandemact 30 mg/ 2 mg tablets ||| Dicural 15 mg Dicural 50 mg ||| Tandemact 30 mg/ 2 mg, comprimés
0.021853838115930557 ||| 33 6.6 Special precautions for disposal ||| 36 6.6 Special precautions for disposal ||| 6.6 Précautions particulières d’ élimination
0.28515276312828064 ||| Zevalin could affect the ability to drive and to use machines, as dizziness has been reported as a common side effect. ||| LITAK has a major effect on the ability to drive and use machines since it may make you feel drowsy or dizzy. ||| Zevalin pourrait affecter l'aptitude à conduire des véhicules et à utiliser des machines, car des cas de sensations vertigineuses ont été signalés à titre d’ effet indésirable fréquent.
0.35433411598205566 ||| During in vitro studies, cloned human cardiac potassium channel (hERG), was inhibited by 15% at a concentration (30 μ M) of atazanavir corresponding to 30-fold the free drug concentration at Cmax in humans. ||| The mean (standard deviation, SD) dissociation constant (Kd) of binding was 5.1 (3.0) ng/ ml, denoting the concentration at which 50% of binding sites in blood cells were occupied. ||| Des études in vitro ont montré que le canal potassique cardiaque humain cloné (hERG) était inhibé à 15% avec une concentration d’ atazanavir (30 μ M) correspondant à 30 fois la Cmax de la substance libre chez l'homme.
0.32289576530456543 ||| 10 litres ||| 10 bottles ||| 10 Litres
0.02672145515680313 ||| 34 PACKAGE LEAFLET: ||| 31 PACKAGE LEAFLET: ||| 37 NOTICE:
0.298875093460083 ||| Non-textile bags for the transportation of grains in bulk ||| Polythene sacks for the storage of materials in bulk ||| Sacs non en matières textiles pour le transport de graines en vrac
0.27287596464157104 ||| Vials in use should be stored below 30°C. ||| Tygacil should be stored at or below 25°C. ||| Les flacons en cours d’ utilisation doivent être conservés à une température inférieure à 30°C.
0.20640558004379272 ||| It is recommended that individuals who receive the first dose of Gardasil should complete all three doses with Gardasil. ||| It is recommended that infants who receive a first dose of Rotarix complete the 2-dose regimen with Rotarix. ||| Il est recommandé d’ administrer l’ ensemble complet des trois doses de Gardasil aux individus ayant reçu une première dose.
0.40020787715911865 ||| Lay the needle with its protective packaging on the tabletop. ||| Screw the needle straight and tightly onto your FlexPen. ||| Conserver l’aiguille partiellement dans son emballage protecteur et la déposer dans son emballage protecteur sur la table.
0.345551073551178 ||| Multiple sclerosis is linked to nerve (brain or spinal cord) damage. ||| - Muscular atrophy (reduction of muscular tissue) of the ball of the thumb and sensory ||| La sclérose en plaques est liée à une atteinte du système nerveux central (du cerveau ou de la moelle épinière).
0.5221644639968872 ||| Important information about some of the ingredients of Zonegran ||| Important information about some of the ingredients: ||| Informations importantes concernant certains composants de Zonegran:
0.35470452904701233 ||| Cases of cardiomegaly and congestive heart failure have been reported (see section 4.8). ||| Hypersensitivity reactions have been associated with TYSABRI, including serious systemic reactions (see section 4.8). ||| Des cas de cardiomégalie et d’ insuffisance cardiaque congestive ont été rapportés (cf. rubrique 4.8).
0.2177397459745407 ||| Thalidomide has sedative properties thus may enhance the sedation induced by anxiolytics, hypnotics, antipsychotics, H1 anti-histamines, opiate derivatives, barbiturates and alcohol. ||| Substances that may reduce the blood-glucose lowering effect include corticosteroids, danazol, oral contraceptives, thyroid hormones, growth hormone, sympathomimetic agents and thiazides. ||| Le thalidomide possède des propriétés sédatives susceptibles d’ augmenter la sédation due aux anxiolytiques, aux hypnotiques, aux antipsychotiques, aux antihistaminiques H1, aux dérivés d’ opiacés, aux barbituriques et à l’ alcool.
2.99720941425094e-13 ||| It also enables Member States to combine all support measures granted under the Temporary Framework with existing possibilities to grant de minimis to a company of up to € 25,000 over three fiscal years for companies active in the primary agricultural sector, €30,000 over three fiscal years for companies active in the fishery and aquaculture sector and €200,000 over three fiscal years for companies active in all other sectors. ||| It also enables Member States to combine all support measures granted under the Temporary Framework with existing possibilities to grant de minimis to a company of up to € 25,000 over three fiscal years for companies active in the primary agricultural sector, €30,000 over three fiscal years for companies active in the fishery and aquaculture sector and €200,000 over three fiscal years for companies active in all other sectors. ||| Il permet également aux États membres de combiner toutes les mesures de soutien accordées au titre de l'encadrement temporaire avec les possibilités existantes d'octroyer des aides de minimis plafonnées à 25 000 EUR par entreprise sur une période de trois ans pour les entreprises du secteur agricole primaire, à 30 000 EUR sur une période de trois ans pour les entreprises du secteur de la pêche et de l'aquaculture et à 200 000 EUR sur une période de trois ans pour les entreprises de tous les autres secteurs.
0.08344107121229172 ||| 66 10. ||| 67 10. ||| 10.
0.1291104406118393 ||| 2 Children and adolescents Exforge is not recommended for use in patients aged below 18 years due to a lack of data on safety and efficacy. ||| Paediatric patients NEVANAC is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| Enfants et adolescents En raison d’ un manque de données d’ efficacité et de tolérance, Exforge ne doit pas être utilisé chez les patients âgés de moins de 18 ans.
0.4267180562019348 ||| The risk of developing anaemia is higher in the female population. ||| The overall survival rate was about 80% for the disease in newborn babies. ||| Le risque de développer une anémie est plus élevé chez les femmes.
0.2656022608280182 ||| Air filters for mechanical purposes ||| Air mattresses for medical purposes ||| Filtres à air à usage mécanique
0.3949234187602997 ||| This Referral procedure relates to a request for Arbritation concerning a type II variation for a new indication in the “ reduction of risk of cardiovascular events in patients with stable coronary artery disease”. ||| The Applicant implemented a revised a cautionary statement in section 4.4 of the SPC, recommending extra caution during the titration of patients with mouth wounds or mucositis. ||| La présente procédure de saisine est en relation avec une demande d’ arbitrage concernant une modification de type II pour une nouvelle indication « réduction du risque d’ accidents cardiovasculaires chez des patients souffrant d’ une maladie coronaire stable ».
0.1666480451822281 ||| Other information about RILUTEK: ||| Other information about TORISEL: ||| Autres informations relatives à RILUTEK:
0.5265248417854309 ||| Efficacy was demonstrated in controlled trials in patients treated for up to 29 weeks. ||| Surveillance was shortly extended to some hospitals and GP surgeries in Scotland. ||| Son efficacité a été démontrée au cours d’ études contrôlées chez des patients traités jusqu’ à 29 semaines.
0.22434182465076447 ||| Other dermatologicals, ATC code: ||| Other diagnostic agents, ATC-code: ||| Autres médicaments dermatologiques, code ATC:
0.8299575448036194 ||| 12.1 Special precautions for use: ||| • Efficib should be taken: ||| 12.1 Précautions particulières d'emploi
0.21228304505348206 ||| On 26 March, 16 new cases were confirmed thus bringing the total to 96 cases. ||| On 7 April there were 26 confirmed cases, bringing the total to 349. ||| Le 26 mars, 16 nouveaux cas ont été confirmés, ce qui porte le total à 96 cas.
0.25790587067604065 ||| If the reconstituted solution cannot be injected immediately, it must be kept refrigerated until use and used within 24 hours. ||| Once the bottle has been opened, the contents should be kept refrigerated and used within 30 days. ||| Si la solution reconstituée ne peut être injectée immédiatement, elle doit être conservée au réfrigérateur et utilisée dans un délai de 24 heures.
0.23162022233009338 ||| Sodium chloride, L-histidine, polysorbate 80, sodium borate, water for injections. ||| Sodium hydroxide 0.2 M, sodium chloride, D-Sorbitol, purified gelatin of porcine origin. ||| Chlorure de sodium, L-histidine, polysorbate 80, borate de sodium, eau pour préparations injectables.
0.6345038414001465 ||| Human albumin, mannitol ||| Contains ethanol. ||| Excipients: albumine humaine, mannitol
0.0 ||| * reflects patients with 12 week data available ||| * reflects patients with 12 week data available ||| * chez les patients ayant des données disponibles à la 12
0.21396782994270325 ||| Important information about some of the ingredients of Insuman Comb 15 ||| Important information about some of the ingredients of Insuman Rapid ||| Informations importantes concernant certains composants d’Insuman Comb 15
0.19934527575969696 ||| In vitro protein binding of tenofovir to plasma or serum protein was less than 0.7 and 7.2%, respectively, over the tenofovir concentration range 0.01 to 25 µg/ ml. ||| In vitro protein binding In vitro protein binding of cidofovir to plasma or serum protein was 10% or less over the cidofovir concentration range 0.25 to 25 mcg/ ml. ||| La liaison in vitro du ténofovir aux protéines plasmatiques ou sériques a été inférieure à 0,7 et 7,2% respectivement, dans l’ intervalle de concentrations compris entre 0,01 et 25 µg/ ml.
0.37833350896835327 ||| Psychiatric disorders very common: common: ||| ris Psychiatric disorders: very common: irritability ||| Affections psychiatriques Très fréquents: insomnies Fréquents:
0.32711511850357056 ||| Do not use Nespo after the expiry date which is stated on the carton and on the pre-filled pen label ed ||| The concentrate for solution for infusion will not be used after the “use by” date that can be found on the vial label and outer carton. ||| é ris Ne pas utiliser Nespo après la date de péremption indiquée sur l’emballage et l’étiquette après « EXP ».
0.6455554962158203 ||| Tyre analysis services ||| Finger printing analysis ||| Services d'analyse de pneus
0.1693878471851349 ||| 1.5 mg/ ml ||| 25 mg/ ml ||| Méloxicam 1,5 mg/ ml
0.4009120464324951 ||| Enbrel is available as a single use syringe for patients weighing 62.5 kg or more. ||| The contents of one syringe will treat horses weighing up to 600 kg. ||| 184 Enbrel est disponible en seringue à usage unique pour les patients pesant 62,5 kg ou plus.
0.25231441855430603 ||| 100 mg; salmon: ||| 150 mg; blue: ||| 100 mg; saumon:
0.32959264516830444 ||| ed Quintanrix is a vaccine used in children to prevent five infectious diseases: diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B and Haemophilus influenzae type b (a type of bacteria). ||| At higher strengths (5, 7.5 and 10 mg), Arixtra is used to treat VTEs such as deep vein thrombosis (DVT, a blood clot in the leg) or pulmonary embolism (PE, blood clot in the lung). ||| isé Quintanrix est un vaccin utilisé chez l'enfant pour prévenir cinq maladies: la diphtérie, le tétanos, la coqueluche, l'hépatite B, et les infections à Haemophilus influenzae type b (un type de bactérie).
0.5073299407958984 ||| If you have any kind of infection, including long-term or localised infection, or often get infections. ||| Partial, sudden, temporary, or permanent decrease or loss of vision in one or both eyes has been rarely reported. ||| 27 Si vous avez une infection, quelle qu’ elle soit, y compris une infection chronique ou localisée, ou si vous êtes souvent sujet à des infections.
0.3199428915977478 ||| Concomitant administration of pravastatin and cyclosporin leads to an approximately 4-fold increase in pravastatin systemic exposure. ||| Rifampicin reduces plasma levels of raltegravir; the impact on the efficacy of raltegravir is unknown. ||| Ciclosporine: une administration concomitante de pravastatine et de ciclosporine conduit à une augmentation d'un facteur 4 environ de l'exposition systémique à la pravastatine.
0.3916471600532532 ||| And this is why we launched the Coronavirus Response Investment Initiative to help direct EUR 37 billion mitigate the impact of the crisis, to save lives, jobs and businesses. ||| 4) To boost global preparedness, prevention and containment of the virus, new funding worth €232 million will be allocated to different sectors, namely: ||| C'est la raison pour laquelle nous avons créé l'initiative d'investissement en réaction au coronavirus, afin de contribuer directement, à hauteur de 37 milliards d'euros, à atténuer les effets de la crise, à sauver des vies, à préserver l'emploi et les entreprises.
0.012886645272374153 ||| CVMP opinions in 2001 on medicinal products for veterinary use ||| CVMP opinions in 1997 on medicinal products for veterinary use ||| Avis du CVMP en 2001 sur les médicaments à usage vétérinaire
0.3016940653324127 ||| Ventavis is used to treat moderate cases of primary pulmonary hypertension (PPH). ||| Extavia is used to treat adult patients who have multiple sclerosis (MS). ||| Ventavis est indiqué pour le traitement de l’ hypertension artérielle pulmonaire primitive (HPP) modérée.
0.3336307406425476 ||| 83 At the beginning of treatment you will start by using Axura 5 mg film-coated tablets once a day. ||| On Days 2 and 3 following your chemotherapy treatment you will receive one 80 mg capsule of aprepitant each morning. ||| Au début du traitement vous commencerez par prendre les comprimés pelliculés d’Axura à 5 mg une fois par jour.
0.34245070815086365 ||| Patients with increases in AST, ALT and alkaline phosphatase between cycles may necessitate dose reduction (see section 4.2). ||| Alkaline phosphatase, AST and ALT ≤ 5 times upper limit of normal is acceptable if liver has tumour involvement. ||| Les augmentations des taux d’ ASAT, d’ ALAT et de phosphatases alcalines entre les cycles peuvent exiger une réduction de la dose (voir rubrique 4.2).
0.42325979471206665 ||| Viscose sheets, other than for wrapping ||| Glass wool, other than for insulation ||| Feuilles de viscose autres que pour l'emballage
7.34662439390299e-13 ||| 41% ||| 41% ||| 41% 67%
0.14018398523330688 ||| If you see blood in the syringe, pull the needle out and re-insert it in another place. ||| If you see blood in the syringe, pull the needle out and re-insert it in another place after disinfecting the skin. ||| voyez du sang dans la seringue, retirez l'aiguille et introduisez-la ailleurs.
0.17846107482910156 ||| Intrasubject variability of time to peak insulin concentrations was less for inhaled human insulin than for subcutaneous fast-acting human insulin in subjects with type 1 or 2 diabetes. ed ||| The intra-subject variability of glucose lowering activity of inhaled human insulin was generally comparable to that of subcutaneously administered fast-acting human insulin in subjects with type 1 in ||| Chez les patients diabétiques de type 1, une variabilité intraindividuelle de l’ ASC comparable à celle tn
0.0006614724406972528 ||| The non-confidential version of the decision will be made available under the case number SA.57076 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.57066 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.57076 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.2923969030380249 ||| In some patients with bilateral renal artery stenosis or stenosis of the artery to a solitary kidney, who have been treated with ACE inhibitors, increases in blood urea and serum creatinine, usually reversible 23  EMEA 2005 upon discontinuation of therapy, have been seen. ||| Temodal is used first with radiotherapy and then on its own; • adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment. ||| Des augmentations de l’ urée sanguine et de la créatinine sérique, généralement réversibles à l’ arrêt du traitement, ont été observées chez certains patients ayant une sténose bilatérale des artères rénales ou une sténose de l’ artère sur rein unique, traités par des IEC.
0.0022917434107512236 ||| The non-confidential version of the decision will be made available under the case number SA.57185 in the State aid register on the Commission's competition website. ||| The non-confidential version of the decision will be made available under the case number SA.57194 in the State aid register on the Commission's competition website. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.57185 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence .
0.31818142533302307 ||| Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg may be administered in patients insufficiently controlled by Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12.5 mg. ||| Each film-coated tablet of Irbesartan Hydrochlorothiazide BMS 300 mg/ 25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide. ||| Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 25 mg peut être administré chez les patients insuffisamment contrôlés par Irbesartan Hydrochlorothiazide Winthrop 300 mg/ 12,5 mg.
0.11727704852819443 ||| Nervous system disorders Uncommon: ||| 16 Nervous system disorders Uncommon: ||| Affections du système nerveux
0.49894288182258606 ||| M ||| F ||| a
0.4686516523361206 ||| Politician Igor Nikulin made rounds on Russian television and news media, arguing that Wuhan was chosen for the attack because the presence of a BSL-4 virus lab provided a cover story for the Pentagon and CIA about a Chinese bio-experiment leak. ||| According to the BBC, Jordan Sather, a conspiracy theory YouTuber supporting the far-right QAnon conspiracy theory and the anti-vax movement, has falsely claimed the outbreak was a population control scheme created by Pirbright Institute in England and by former Microsoft CEO Bill Gates. ||| Le politicien Igor Nikulin a fait le tour des plateaux de télévision et des médias russes, arguant que Wuhan avait été choisi pour l'attaque car la présence d'un laboratoire pathogène de classe 4 fournissait au Pentagone et la CIA un prétexte pour dire qu'il s'agissait d'une fuite d'une expérience biologique chinoise.
0.5094468593597412 ||| SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE VARIATION OF THE MARKETING AUTHORISATION OF HBVAXPRO PRESENTED BY THE EMEA ||| SCIENTIFIC CONCLUSIONS PRESENTED BY THE EMEA ON THE BASIS OF THE OPINION OF THE CPMP FORMULATED UNDER ARTICLE 12 OF COUNCIL DIRECTIVE 75/ 319/ EEC ||| CONCLUSIONS SCIENTIFIQUES ET MOTIFS DE LA MODIFICATION DE L’ AUTORISATION DE MISE SUR LE MARCHÉ D’ HBVAXPRO PRÉSENTÉS PAR L' EMEA
0.2603312134742737 ||| In both studies, Tasigna had a similar effect in patients who could not tolerate imatinib and those whose disease had stopped responding to it. ||| However, in both studies, patients whose cancer was not affecting squamous cells had longer survival times if they received Alimta than if they received the comparator. ||| Dans les deux études, Tasigna a eu un effet similaire chez les patients présentant une intolérance à l’ imatinib et chez ceux qui ne répondaient plus à ce médicament.
0.0045007457956671715 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| FABRICANT DE LA SUBSTANCE ACTIVE D’ ORIGINE BIOLOGIQUE ET TITULAIRES DE L’ AUTORISATION DE FABRICATION RESPONSABLES DE LA LIBERATION DES LOTS
0.49050652980804443 ||| A pre- and postnatal development study was performed in rats. ||| Peri- and postnatal development has not been studied. ||| Une étude de développement pré et postnatale a été réalisée chez le rat.
0.23220399022102356 ||| The reconstituted solution is isotonic and may be given as a bolus injection or diluted to a volume of 50 ml or greater with normal saline or dextrose 50 mg/ ml (5%) for infusion. ||| The concentrate must be further diluted with 100 ml sterile 0.9% w/ v sodium chloride or 5% w/ v glucose solution and given as a single intravenous infusion in no less than 15 minutes. ||| La solution reconstituée est isotonique et peut être administrée en injection en bolus ou en perfusion diluée dans un volume de 50 ml ou plus de soluté physiologique ou de glucose à 50 mg/ ml (5%) pour perfusion.
0.4541641175746918 ||| Controllers for video game machines ||| Electronic game software for mobile phones ||| Commandes de machines de jeux vidéo
0.0 ||| The benefit-risk balance may be found in module 6 of this EPAR. ||| The benefit-risk balance may be found in module 6 of this EPAR. ||| Le rapport bénéfice/ risque est présenté au module 6 de cet EPAR.
0.20646773278713226 ||| In the pivotal clinical field study, dogs of various breeds, ranging in age from two to seventeen years, were randomly treated with Masivet at a dose of 12.5 mg/ kg or with a placebo. ||| In a comparative clinical trial conducted among subjects aged from 12 years up to and including 15 years of age, 142 received two doses of Ambirix and 147 received the standard three-dose combined vaccine. ||| Dans l’ étude clinique pivot réalisée sur le terrain, des chiens de diverses races, âgés de 2 à 17 ans, ont été randomisés et traités par Masivet à 12,5 mg/ kg ou ont reçu un placebo.
0.28300365805625916 ||| On 25 September 2008, UCB Pharma S. A. officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Lacosamide Pain UCB Pharma, for the treatment of diabetic neuropathic pain in adults. ||| On 26 March 2007, Insmed Europe Ltd officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for IPLEX, for the treatment of patients with primary growth hormone insensitivity and of patients with growth hormone gene deletion who have developed neutralising antibodies to growth hormone. ||| Le 25 septembre 2008, UCB Pharma S. A. a officiellement notifié le comité des médicaments à usage humain (CHMP) de son souhait de retirer sa demande d’ autorisation de mise sur le marché pour Lacosamide Pain UCB Pharma, destiné au traitement de la douleur neuropathique diabétique chez les adultes.
0.36010506749153137 ||| We are all part of this discussion- let us work together and ensure that the new Digital Education Action Plan paves the way for truly inclusive and high quality digital education in Europe." ||| The Digital Education Action Plan will build on these lessons in order to put forward a coherent and well-tailored European vision and set of impactful actions for digital education." ||| Ce débat nous concerne tous, nous allons travailler ensemble et faire en sorte que le nouveau plan d'action en matière d'éducation numérique ouvre la voie à une éducation numérique véritablement inclusive et de haute qualité en Europe.»
0.1335451453924179 ||| Printed mirrors ||| Printed circuits ||| Miroirs imprimés
0.043292801827192307 ||| Like all medicines, ONSENAL can cause side effects, although not everybody gets them. ||| Like all medicines, DUKORAL can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Onsenal est susceptible d’ entraîner des effets indésirables, bien que tout le monde n’ y soit pas sujet.
2.2524408553603603e-13 ||| You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. ||| You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. ||| Veuillez lire attentivement l’intégralité de cette notice avant de prendre ce médicament. • Gardez cette notice, vous pourriez avoir besoin de la relire. • Si vous avez d'autres questions, si vous avez un doute, demandez plus d’informations à votre médecin ou votre pharmacien. • Ce médicament vous a été personnellement prescrit.
0.34941110014915466 ||| Actrapid is used in patients who have diabetes. ||| Monotard is used in patients with diabetes mellitus. ||| Actrapid est utilisé chez le patient diabétique.
0.30738645792007446 ||| Animal studies indicate a potential for reducing intrauterine growth at exposure levels, which are identical or slightly higher than at human exposure (see section 5.3). ||| Animal studies suggest that no effects other than those related directly or indirectly to anti-estrogenic activity were evident with higher doses of fulvestrant (see section 5.3). ||| Les études chez l’ animal indiquent un potentiel de réduction du développement intra-utérin à des niveaux d’ exposition identiques ou légèrement supérieurs à l’ exposition humaine (voir rubrique 5.3).
0.26401084661483765 ||| Adverse effects such as confusion, diarrhoea, dizziness, tiredness, headache, ailing, dilating of pupil, itching, restlessness, sedation, somnolence, stupor, abnormal rapid heart rate, tremors and urinary retention have been reported. ||| generalised weakness, flu like symptoms, malaise, dizziness, numbness, sleepiness (drowsiness), nasal inflammation (rhinitis), upper respiratory tract infection, nausea, oral dryness, skin sores, stiffness, increased muscle tone (hypertonia) ||| Des effets indésirables tels que confusion, diarrhée, vertige, fatigue, céphalée, sensation de malaise, dilatation des pupilles, démangeaison, agitation, sédation, somnolence, stupeur, augmentation anormale du rythme cardiaque, tremblements et rétention urinaire ont été rapportés.
0.18763741850852966 ||| Studies in animals have shown reproductive toxicity at systemic exposure levels (AUC) of duloxetine lower than the maximum clinical exposure (see section 5.3). ||| In animal studies at systemic plasma exposures (AUC) to amprenavir lower than therapeutic exposure in patients treated with Telzir, some developmental toxicity was observed (see section 5.3). ||| Les études chez l 'animal ont montré une toxicité sur la reproduction à des taux systémiques (Aires Sous la Courbe) de duloxétine inférieurs à l’ exposition maximale en clinique (voir rubrique 5.3).
0.5058066844940186 ||| Mint [fresh] ||| Oil cement [putty] ||| Menthe fraîche
0.4203774333000183 ||| Possible side effects following the intravenous administration of Yttrium (90Y)-labelled a medicinal product prepared by radiolabelling with Yttriga, will be dependent on the specific medicinal product being used. ||| For information on contraindications to particular Yttrium (90Y)-labelled medicinal products prepared by radiolabelling with Yttriga refer the Summary of Product Characteristics/ package leaflet of the particular medicinal product to be radiolabelled. ||| Les effets secondaires possibles dus à l'injection intraveineuse d'un médicament marqué à l'yttrium (90Y) préparés par radiomarquage avec de l’ Yttriga, dépendent spécifiquement du médicament utilisé.
0.09572596848011017 ||| CARTON OF    OLANZAPINE TEVA 5 mg ORODISPERSIBLE TABLETS ||| CARTON OF ZYPREXA VELOTAB 15 mg ORODISPERSIBLE TABLETS ||| BOITE DE COMPRIMES ORODISPERSIBLES OLANZAPINE TEVA 5 mg
0.7239735722541809 ||| 28 Ireland Biogen Idec (Ireland) Ltd. ||| Organon (Ireland) Ltd, P. O. ||| Ireland Biogen Idec (Ireland) Ltd.
4.638064021386668e-13 ||| Nespo treatment should be initiated by physicians experienced in the above mentioned indications. du ||| Nespo treatment should be initiated by physicians experienced in the above mentioned indications. du ||| Le traitement par Nespo doit être instauré par des médecins ayant l’ expérience des indications mentionnées ci-dessus. am
0.2334630787372589 ||| Monitoring of platelet counts is recommended in these patients. ||| Monitoring of glucose concentrations is recommended in diabetic patients. ||| La surveillance de la numération plaquettaire est recommandée chez ces patients.
0.12114065140485764 ||| Why has Velcade been approved? ||| Why has Zerene been approved? ||| Pourquoi Velcade a -t-il été approuvé?
0.3473101854324341 ||| Allow the solution to return to room temperature before using. ||| Instruct patients to shake the bottle well before use. ||| Laissez la solution revenir à température ambiante avant utilisation.
0.2871817648410797 ||| In reproduction studies, voriconazole was shown to be teratogenic in rats and embryotoxic in rabbits at systemic exposures equal to those obtained in humans with therapeutic doses. ||| Conventional carcinogenicity rodent studies with low exposures compared to human exposure under therapeutic conditions (factor 0.1 in rats and 1 in mice) did not reveal tumorigenicity of ribavirin. ||| Les études de reproduction ont montré que le voriconazole est tératogène chez le rat et embryotoxique chez le lapin après des expositions systémiques équivalentes à celles obtenues chez l’ homme aux doses thérapeutiques.
0.46092110872268677 ||| - recommended follow up measures to further investigate the safety of celecoxib. ||| precautions should be taken against the risk of haematoma following injection. ||| - a recommandé des mesures de suivi afin d’ examiner plus avant la sécurité d’ emploi du
0.3047787845134735 ||| Prior to adding the reconstituted volume of Fabrazyme required for the patient dose, it is recommended to remove an equal volume of 0.9% sodium chloride intravenous solution, from the infusion bag. ||| It is recommended to administer the diluted solution through an in-line low protein-binding 0.2 µm filter to remove any protein particles which will not lead to any loss of agalsidase beta activity. ||| Avant d’ajouter le volume reconstitué de Fabrazyme nécessaire pour la posologie du patient, il est recommandé de retirer un volume égal de solution pour perfusion de chlorure de sodium à 0,9% de la poche de perfusion.
0.5243968367576599 ||| For section 4.6, the CHMP discussed the wording, moving the mention of galactorrhea to section 4.8 and adopting the following harmonised wording: ||| Finally, « Extrapyramidal symptoms » should be the grouped term in the subparagraph Nervous System Disorders and the single symptoms should be mentioned with an ||| Pour la section 4.6, le CHMP a discuté de la formulation, déplaçant la mention de galactorrhée à la section 4.8 et adoptant la formulation harmonisée suivante:
0.44498902559280396 ||| Practices participating in virology surveillance will opportunistically collect blood samples from patients coming into the practice for a routine blood test. ||| The RCGP RSC practices participating in the annual influenza virology surveillance have started sampling from patients showing symptoms of a LRTI. ||| Les cabinets participant à la surveillance virologique prélèveront de façon opportuniste des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.
0.17625299096107483 ||| Truvada is not recommended for patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis because appropriate dose reductions cannot be achieved with the combination tablet. ||| Dosage in renally impaired patients Monotherapy (Ovarian and Small cell lung carcinoma) Insufficient data are available to make a recommendation for patients with a creatinine clearance < 20 ml/ min. ||| Truvada n’ est pas recommandé chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe.
1.241140604019165 ||| 41.4 (63/152) 31.2, 51.7 ||| ↑ 2.25 ↑ 1.98 ↑ 2.42 diltiazem ||| 41,4 (63/ 152) 31,2; 51,7
0.1233530044555664 ||| Table 4. ||| Table 4 ||| 18 Tableau 4.
0.35313650965690613 ||| Convertible chairs ||| Adjustable beds ||| Chaises convertibles
0.21450525522232056 ||| The likelihood of metabolic interactions with lamivudine is low due to limited metabolism and plasma protein binding, and almost complete renal clearance. ||| The likelihood of metabolic interactions of lamivudine with other medicinal products is low due to the small extent of hepatic metabolism (5-10%) and low plasma protein binding. ||| Le risque d'interactions métaboliques avec la lamivudine est faible en raison d'un métabolisme et d'une liaison aux protéines plasmatiques limités, et de l’ élimination essentiellement rénale de la lamivudine.
5.651978451232109e-13 ||| 3. ||| 3. ||| 152 3.
0.3186880946159363 ||| Optical fibre sensors ||| Optical cables ||| Capteurs à fibres optiques
0.44351592659950256 ||| "During that discussion, Trump repeatedly quizzed the leaders of pharmaceutical companies on the time needed to produce vaccines, stating ""I like the sound of a couple of months better""." ||| "Mayor of Auckland Phil Goff stated that he was ""sickened"" by the reports of Asian-origin people being racially targeted at swimming pools, public transport and restaurants." ||| Au cours de cette discussion, Trump a interrogé à plusieurs reprises les dirigeants des sociétés pharmaceutiques sur le temps nécessaire pour produire des vaccins, déclarant j'aime mieux entendre « quelques mois ».
0.3834927976131439 ||| On initiation of carbamazepine, the dose of INVEGA should be re-evaluated and increased if necessary. ||| In order to obtain the correct dosage the concentration of Methoxasol-T has to be adjusted accordingly. ||| Lors de l’ initiation de la carbamazépine, la posologie d’ INVEGA devra être ré-évaluée et si nécessaire augmentée.
0.18618331849575043 ||| 10/ 18 9. ||| 11/ 20 8. ||| 11/ 20 9.
0.09270751476287842 ||| 82 1. ||| 92 1. ||| 87 1.
0.07801107317209244 ||| The product label includes the correct storage conditions and the expiry date for the batch. ||| The product label includes the appropriate storage conditions and the expiry date for the batch of product. ||| Les conditions de conservation correctes et la date de péremption du lot sont indiquées sur l’étiquette.
0.0 ||| No studies on the effects on the ability to drive and use machines have been performed. ||| No studies on the effects on the ability to drive and use machines have been performed. ||| Aucune étude se rapportant à l’ aptitude à conduire des véhicules et à utiliser des machines n’ a été menée.
0.0 ||| The potential risk for humans is unknown. ||| The potential risk for humans is unknown. ||| Le risque demeure inconnu pour l’ être humain.
0.0 ||| Dementia-related psychosis and/ or behavioural disturbances Olanzapine is not approved for the treatment of dementia-related psychosis and/ or behavioural disturbances and is not recommended for use in this particular group of patients because of an increase in mortality and the risk of cerebrovascular accident. ||| Dementia-related psychosis and/ or behavioural disturbances Olanzapine is not approved for the treatment of dementia-related psychosis and/ or behavioural disturbances and is not recommended for use in this particular group of patients because of an increase in mortality and the risk of cerebrovascular accident. ||| 115 Démence accompagnée de troubles psychotiques et/ ou troubles du comportement L’ olanzapine n’ est pas indiquée dans le traitement de la démence accompagnée de troubles psychotiques et/ ou troubles du comportement et son utilisation chez ce groupe spécifique de patients est déconseillée du fait d’ une augmentation du risque de mortalité et d’ accidents vasculaires cérébraux.
0.349689781665802 ||| For infusion, the contents of the vial(s) should only be added to 100 ml isotonic sodium chloride solution or 100 ml 5% glucose solution. ||| VIRACEPT 50 mg/g oral powder should not be mixed with orange juice, apple juice, apple sauce or other liquids or foods that are acidic due to taste. ||| Pour la perfusion, le contenu de(s) flacon(s) doit être ajouté uniquement à 100 ml de solution isotonique de chlorure de sodium ou 100 ml de solution de glucose à 5%.
0.2914140820503235 ||| Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded. ||| Based on results from animal studies and the mechanism of action of gemcitabine, this substance should not be used during pregnancy unless clearly necessary. ||| Malgré ces mesures, la possibilité de transmettre une infection lors de l’ administration de médicaments préparés à partir de sang ou de plasma humain ne peut pas être totalement exclue.
0.24125400185585022 ||| Thalidomide may also potentially aggravate existing neuropathy and should therefore not be used in patients with clinical signs or symptoms of peripheral neuropathy unless the clinical benefits outweigh the risks. ||| Based on the pharmacokinetic properties of TMZ, it is unlikely that dose reductions are required in patients with severe hepatic impairment or any degree of renal impairment. ||| Il ne doit donc pas être administré à des patients présentant des signes ou des symptômes cliniques de neuropathie périphérique à moins que les bénéfices cliniques ne soient supérieurs aux risques.
0.7202214002609253 ||| Insomnia, hallucinations, confusion, nightmares, agitation ||| Irritability, Nervousness, Restlessness, Insomnia, Abnormal dreams ||| Insomnie, hallucinations, confusion mentale, cauchemars, agitation
0.056027982383966446 ||| 6.8 ||| 8.8 ||| 9,3
0.5334630012512207 ||| - anti-malarial medicines (such as mefloquine or halofantrine) ||| Nondepolarizing skeletal muscle relaxants (e. g. tubocurarine): ||| traitements anti-paludéens (tels que la méfloquine ou l’ halofantrine), érythromycine IV (un antibiotique), pentamidine (un anti-parasitaire),
0.18194405734539032 ||| 518 If you use more Insuman Basal than you should ||| 597 If you use more Insuman Comb 15 than you should ||| Si vous avez utilisé plus d’Insuman Basal que vous n’auriez dû
0.12801069021224976 ||| Insuman Comb 15 must also NOT be mixed with insulins of animal origin or with insulin analogues. ||| Insuman Comb 50 must not be mixed with any other insulin or with insulin analogues. ||| De même, Insuman Comb 15 ne doit PAS être mélangé aux insulines d'origine animale ou à des analogues de l'insuline.
0.2666504383087158 ||| 36 ||| 39 ||| 6.
0.5236798524856567 ||| How to store PegIntron 6. ||| Storing PegIntron 6. ||| Comment conserver PegIntron 6.
0.22639065980911255 ||| Shake before use. ||| Shake well before use. ||| Agiter avant emploi.
0.2029096782207489 ||| 29 August 2006 ||| 28 August 2007 ||| 29 août 2006
0.07556042075157166 ||| (a) 11.7.1997 (b) 16.1.1998 (c) 20.1.1998 (d) OJ C 63, 27.2.1998 ||| (a) 9.1.1998 (b) 14.4.1998 (c) 15.4.1998 (d) OJ C 126, 24.4.1998 ||| a) 11.07.97 b) 16.01.98 c) 20.01.98 d) JO C63, 27.2.1998
0.9792114496231079 ||| 26 Nederland Vigilex B. V. ||| Swensweg 5 P. O. ||| Nederland Vigilex B. V.
0.8671646118164062 ||| Which products does it include? ||| Which countries will most benefit? ||| Quels sont les produits concernés?
0.4956192076206207 ||| Electronic transmission of messages and data ||| Data conversion of electronic information ||| Transmission électronique de message et de données
0.3959280252456665 ||| PVC/ PVDC-aluminium blisters packed in paper cartons. ||| Blisters consisting of PVC/ fluoropolymer foil. ||| Plaquettes thermoformées PVC/ aluminium PVDC dans des boîtes en carton.
0.8242634534835815 ||| Pigs (gilts and sows). ||| Pigs (sows/ gilts) ||| Porcs (cochettes et truies)
0.16789844632148743 ||| Reproductive system and breast disorders Common: ||| Reproductive system and breast disorders Rare: ||| Affections des organes de reproduction et du sein Fréquents
0.24846096336841583 ||| Bondronat 6 mg concentrate for solution for infusion ibandronic acid ||| Visudyne 15 mg powder for solution for infusion verteporfin ||| Bondronat 6 mg solution à diluer pour perfusion acide ibandronique
0.2811239957809448 ||| Human granulocyte colony stimulating factor (G-CSF) is a glycoprotein, which regulates the production and release of neutrophils from the bone marrow. ||| Human G-CSF is a glycoprotein which regulates the production and release of functional neutrophils from the bone marrow. ||| Le Granulocyte-Colony Stimulating Factor humain (facteur de croissance de la lignée granulocytaire, G-CSF) est une glycoprotéine qui régule la production et la libération des polynucléaires neutrophiles
0.3367269039154053 ||| Since tolcapone interferes with the metabolism of catecholamines, interactions with other drugs affecting catecholamine levels are theoretically possible. ||| Revatio may cause a serious increase in the effects of medicines called nitrates and nitric oxide donors such as amyl nitrate (“ poppers”). ||| Médicaments augmentant les taux de catécholamines: étant donné que le tolcapone interfère avec le métabolisme des catécholamines, des interactions avec d'autres médicaments modifiant les taux de catécholamines sont théoriquement possibles.
0.31962820887565613 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| The IONSYS system should be pressed firmly in place with the sticky side down on the skin for at least 15 seconds. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
0.26058483123779297 ||| Children CRIXIVAN can be taken by children 4 years of age and older who are able to swallow hard capsules. ||| NovoMix 30 can be used in children and adolescents aged 10 years and above when premixed insulin is preferred. ||| Utilisation chez l'enfant CRIXIVAN peut être administré chez les enfants âgés de 4 ans et plus qui sont capables d'avaler des gélules.
0.1937200129032135 ||| HOW TO TAKE CIALIS ||| HOW TO TAKE VIAGRA ||| COMMENT PRENDRE CIALIS
0.4605698883533478 ||| In the majority of cases, these complications are observed immediately or within 24 hours after partus. ||| Signs are usually transitory and generally resolved without treatment within 24 hours. ||| Dans la majorité des cas, ces complications apparaissent immédiatement ou dans les 24 heures après l’ accouchement.
0.10061229020357132 ||| What Remicade is and what it is used for 2. ||| What Exforge is and what it is used for 2. ||| Qu'est -ce que Remicade et dans quel cas est -il utilisé 2.
0.07870509475469589 ||| The full EPAR for Silgard can be found here. ||| The full EPAR for Galvus can be found here. ||| L’ EPAR complet relatif à Silgard est disponible: ici.
0.0 ||| medicines, including medicines obtained without a prescription. ||| medicines, including medicines obtained without a prescription. ||| sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.47642141580581665 ||| To that end, the tool seeks to make best use of the existing resources, currently under the EU's cohesion policy. ||| EFSI's success is based not least on its efficient governance structure , which is responsive to constant changes of the markets. ||| À cette fin, cet instrument vise à utiliser au mieux les ressources existantes, actuellement dans le cadre de la politique de cohésion de l'UE.
5.288634113975732e-13 ||| Overall, the safety and efficacy profiles for BID and TID dosing regimens were similar. ||| Overall, the safety and efficacy profiles for BID and TID dosing regimens were similar. ||| Dans l’ ensemble, les profils de sécurité et d’ efficacité ont été similaires pour les schémas posologiques BID et TID.
0.3047492802143097 ||| As each dose may contain undetectable traces of neomycin, streptomycin and polymyxin B, caution should be exercised when the vaccine is administered to subjects with hypersensitivity to these antibiotics. ||| * MRSA are very likely to be resistant to ciprofloxacin and ciprofloxacin should not be used to treat presumed or known MRSA infections unless the organism is known to be susceptible. ||| Chaque dose pouvant contenir des traces indétectables de néomycine, streptomycine et polymyxine B, il convient d'utiliser ce vaccin avec précaution chez les sujets présentant une hypersensibilité à ces antibiotiques.
0.01917777955532074 ||| 44 In addition to medical treatment, good management and hygiene practices should be established on the farm in order to reduce the risk of infection and to control the build up of resistance. ||| In addition to medical treatment, good management and hygiene practices should be established on the farm in order to reduce the risk of infection and to control the build up of resistance. ||| 45 En complément du traitement médicamenteux, de saines pratiques de gestion et d’hygiène doivent être mises en place dans l’exploitation pour réduire le risque d’infection et contrôler l’émergence de la résistance.
0.13385024666786194 ||| There is no known antidote for docetaxel overdose. ||| There is no specific antidote for overdose with nelfinavir. ||| Il n’ existe pas d’ antidote connu en cas de surdosage par le docétaxel.
0.34565794467926025 ||| In the offspring of rats given olanzapine, delays in fetal development and transient decreases in offspring activity levels were seen. ||| In rats, female reproductive function including birth was impaired at toxic dosages and the offspring showed reduced birth weights, viability and growth. ||| Dans les portées de rats ayant reçu de l’ olanzapine, un retard du développement fœ et une diminution transitoire du taux tal d’ activité des petits ont été observés.
0.0599556602537632 ||| 11 ANNEX III ||| 10 ANNEX III ||| 11 A.
0.522816002368927 ||| PSURs The MAH will continue to submit yearly PSURs, unless otherwise specified by the CHMP. ||| The results should be reported to the RMS and the NCAs where bicalutamide 150 mg is authorised. ||| PSURs Le titulaire de l’ autorisation de mise sur le marché devra continuer à soumettre des PSURs annuellement à moins que le CHMP ne l’ ait spécifié autrement.
0.6389928460121155 ||| Pick up the sterile syringe. ||| How to change the transdermal patch ||| Prenez la seringue stérile.
0.4765709638595581 ||| Temperature regulators [thermostatic valves] for central heating radiators ||| Photovoltaic installations for generating electricity [photovoltaic power plants] ||| Régulateurs de température pour radiateurs de chauffage central [robinets thermostatiques]
0.32635343074798584 ||| However, the results were insufficient to support the use of Ibaflin in the treatment of urinary tract infections in cats. ||| There have been 2 clinical studies to evaluate the use of Ceplene in the maintenance of remission in adult AML patients. ||| En revanche, les résultats étaient insuffisants pour justifier l’ utilisation d’ Ibaflin dans le traitement des infections urinaires chez les chats.
0.0029610581696033478 ||| Insulin Human Winthrop Comb 15 cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Insulin Human Winthrop Comb 25 cartridges are not designed to allow any other insulin to be mixed in the cartridge. ||| Les cartouches d’ Insulin Human Winthrop Comb 15 ne sont pas conçues pour permettre de mélanger une autre insuline dans la cartouche.
2.862687029699801e-13 ||| neutropenic patients Ciprofloxacin should be co- administered with appropriate antibacterial agent(s) in accordance to official guidance. ||| neutropenic patients Ciprofloxacin should be co- administered with appropriate antibacterial agent(s) in accordance to official guidance. ||| cuillères-mesure de 5 antibiotique(s) approprié(s) conformément aux recommandations officielles.
0.2656404376029968 ||| Studies in animals have not shown evidence of selective developmental toxicity or effects on reproductive function and fertility (see section 5.3). ||| Reproductive studies in animals have not shown evidence of teratogenicity, and showed no effect on male or female fertility. ||| Des études chez l'animal n'ont pas mis en évidence de toxicité sélective du développement ou d'effets sur la fonction reproductrice et la fertilité (voir rubrique 5.3).
0.5355958938598633 ||| happens after you have been given OLANZAPINE NEOPHARMA tell your doctor. ||| OLANZAPINE NEOPHARMA is not for patients who are under 18 years. ||| En cas de survenue de tels effets après avoir reçu OLANZAPINE NEOPHARMA, informer votre médecin.
0.399787962436676 ||| The pen is designed to deliver its contents of 18 million IU in doses ranging from 1.5 to 6 million IU. ||| The aim is to obtain a platelet count that is below 600 million platelets/ ml, and ideally between 150 and 400 millions/ ml. ||| isé Le stylo est conçu pour délivrer son contenu de 18 millions d’UI en doses allant de 1,5 à 6 millions d’UI.
0.07496266067028046 ||| In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental ingestion, seek medical advice immediately and show the package insert or the label to the physician. ||| En cas d’ingestion accidentelle, demander immédiatement conseil à un médecin et lui montrer la notice du produit ou son étiquetage.
0.0056406473740935326 ||| 13/ 19 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 13/ 20 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 13/ 19 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.30687326192855835 ||| Two of the studies, involving a total of 282 patients, looked at the effectiveness of 2 mg/ kg Bridion in reversing moderate relaxation of the muscles due to rocuronium or vecuronium. ||| Placebo-controlled clinical trials, over 6 and 12 months, have shown that regular use of Viani 50/ 500 micrograms improves lung function and reduces breathlessness and the use of relief medication. ||| Deux de ces études, incluant au total 282 patients, ont porté sur l’ efficacité de 2 mg/ kg de Bridion s’ agissant de l’ inversion d’ une relaxation modérée des muscles induite par le rocuronium ou le vécuronium.
0.1370568871498108 ||| EU Number EU/ 1/ 07/ 397/ 001 ||| EU Number EU/ 1/ 99/ 099/ 001 ||| Numéro UE EU/ 1/ 07/ 397/ 001
0.5805425643920898 ||| Minor prolongation in the prothrombin time has been described. ||| The major route of 14C elimination is renal. ||| Allongement mineur du temps de prothrombine.
0.8578695058822632 ||| Across all three influenza strains, for the comparator intramuscular vaccine GMTs ranged between 34.8 (1/ dil) and 181.0 (1/ dil), seroprotection rates ranged between 48.9% and 87.9%, seroconversion or significant increase rates ranged between 30.0% and 46.9% and GMTRs ranged between 3.04 and 5.35-fold over baseline HI titres. ||| Appearance flat, round, 6 mm diameter, no score flat, oval, 7.86 x 5.63 mm, scores on both sides flat, oval, 10.59 x 7.59 mm, scores on both sides flat, round, 9 mm diameter, scores on both sides flat, round, 11 mm diameter, scores on both sides ||| Parmi les trois souches grippales, les GMT du vaccin comparateur administré par voie intramusculaire étaient compris entre 34,8 (1/ dil) et 181,0 (1/ dil), les taux de séroprotection étaient compris entre 48,9% et 87,9%, les taux de séroconversion ou d'augmentation significative étaient compris entre 30,0% et 46,9% et les RMGT étaient compris entre 3,04 et 5,35 fois le titre mesuré par IH à l'inclusion dans l'étude.
0.3226253092288971 ||| Zarzio 30 MU/ 0.5 ml solution for injection or infusion in pre-filled syringe Zarzio 48 MU/ 0.5 ml solution for injection or infusion in pre-filled syringe Filgrastim ||| REFLUDAN - 50 mg - Powder for solution for injection or infusion - 1 vial REFLUDAN - 50 mg - Powder for solution for injection or infusion - 10 vials ||| Zarzio 30 MU/ 0,5 ml solution injectable ou pour perfusion en seringue préremplie Zarzio 48 MU/ 0,5 ml solution injectable ou pour perfusion en seringue préremplie Filgrastim
0.3352190852165222 ||| The incidence and causes of deaths following dual or triple therapy were similar in basiliximab (2.9%) and placebo groups (2.6%), with the most common cause of deaths in both treatment groups being infections (basiliximab = 1.3%, placebo = 1.4%). ||| There was, however, an increased infant mortality in the stavudine + didanosine (10%) treatment group compared to the stavudine (2%), didanosine (3%) or zidovudine (6%) groups, with a higher incidence of stillbirths in the stavudine + didanosine group. ||| La fréquence et les causes de décès après bi- ou trithérapie étaient identiques dans les groupes basiliximab (2,9%) et placebo (2,6%), les infections représentant la cause la plus fréquente de décès dans les deux groupes (basiliximab = 1,3%, placebo = 1,4%).
0.37954074144363403 ||| The reconstituted solution must be diluted further (see section 6.6). ||| No other solutions should be used for reconstitution (see section 6.2). ||| La solution reconstituée doit être ensuite diluée (cf. section 6.6).
0.39112457633018494 ||| During its September 2005 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Lansoprazol CT-Arzneimittel. ||| A discussion on the efficacy of cerivastatin containing medicinal products took place at CPMP based on the assessment reports of the Rapporteur and co-Rapporteur and the data presented by the MAH. ||| Au cours de sa réunion de septembre 2005, le CHMP, à la lumière des données globales soumises et de la discussion scientifique au sein du comité, a exprimé l’ avis selon lequel le rapport bénéfice/ risque de Lansoprazol CT-Arzneimittel est favorable.
0.28776487708091736 ||| However, since the renal clearance of tipranavir is negligible, a decrease in total body clearance is not expected in patients with renal impairment. ||| In preclinical studies it has been shown that renal clearance is minimal (up to 2% of total clearance), and does not affect the serum half-life. ||| Cependant, la clairance rénale du tipranavir étant négligeable, une diminution de la clairance corporelle totale n’ est pas attendue chez les patients présentant une insuffisance rénale.
0.07997854053974152 ||| Suspension for injection in vial. ||| Suspension for injection in a vial. ||| Suspension injectable en flacon.
0.5407569408416748 ||| • Muscle disorders Not known: unexplained muscle pain, tenderness or weakness (rhabdomyolysis) ||| • Pure red cell aplasia (PRCA) – (anaemia, unusual tiredness, lack of energy) ||| • Affections musculaires Fréquence indéterminée: douleurs musculaires, sensibilité ou faiblesse musculaire inexpliquées (rhabdomyolyse)
0.16758249700069427 ||| België/Belgique/Belgien Rue de Stalle/Stallestraat 73 B-1180 Bruxelles/Brussel/Brüssel Tél/Tel: + 32-(0)2 370 92 11 ||| België/Belgique/Belgien Bayer SA-NV Louizalaan, 143, avenue Louise B–1050 Brussel/Bruxelles/Brüssel Tel/Tél: +32 2 535 66 54 ||| België/Belgique/Belgien Rue de Stalle/Stallestraat 73 B-1180 Bruxelles/Brussel/Brüssel Tél/Tel: + 3 2-(0)2 370 92 11
0.22333881258964539 ||| * In haemodialysis patients or in case of acute renal failure (creatinine clearance below 15 ml/ min or creatinine value above 60 mg/ l [530 μ mol/ l]), infusion of Refludan is to be avoided or stopped. ||| Consideration should also be given to interrupting treatment with tenofovir disoproxil fumarate in patients with creatinine clearance decreased to < 50 ml/ min or decreases in serum phosphate to < 1.0 mg/ dl (0.32 mmol/ l). ||| • Chez les patients hémodialysés ou en cas d'insuffisance rénale aiguë (clairance de la créatinine inférieure à 15 ml/ min ou créatininémie supérieure à 60 mg/ l [530 µmol/ l]), il est nécessaire d'éviter ou d'arrêter la perfusion de Refludan.
0.3039708733558655 ||| 71.9 (± 30.93) ||| 35.7 (± 33.27) ||| 71,9 (± 30,93)
0.04479570686817169 ||| EU/ 1/ 01/ 184/ 046 1 pack EU/ 1/ 01/ 184/ 058 4 pack ||| EU/ 1/ 01/ 184/ 021 1 pack EU/ 1/ 01/ 184/ 022 4 pack ||| ris EU/ 1/ 01/ 184/ 058 Boîte de 4
0.4896979331970215 ||| For the treatment and prevention of flea infestation (Ctenocephalides felis), treatment of biting lice (Trichodectes canis), treatment of ear mite infestation (Otodectes cynotis), sarcoptic mange (caused by Sarcoptes scabiei var. canis), demodicosis (caused by Demodex canis), prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis), treatment of Angiostrongylus vasorum and treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara canis, Ancylostoma caninum and Uncinaria stenocephala, adults of Toxascaris leonina and Trichuris vulpis). ||| Anaerobic micro-organisms Mobiluncus Other micro-organisms Chlamydia trachomatis ($) Chlamydia pneumoniae ($) Mycoplasma hominis ($) Mycoplasma pneumoniae ($) SPECIES FOR WHICH ACQUIRED RESISTANCE MAY BE A PROBLEM Aerobic Gram-positive micro-organisms Enterococcus faecalis ($) Staphylococcus spp. *(2) Aerobic Gram-negative micro-organisms Acinetobacter baumannii+ Burkholderia cepacia +* Campylobacter spp.+* Citrobacter freundii* Enterobacter aerogenes Enterobacter cloacae * Escherichia coli* Klebsiella oxytoca Klebsiella pneumoniae* Morganella morganii* Neisseria gonorrhoeae* Proteus mirabilis* Proteus vulgaris* Providencia spp. ||| Prévention et traitement des infestations par les puces (Ctenocephalides felis), traitement des infestations par les poux broyeurs (Trichodectes canis), traitement de la gale des oreilles (Otodectes cynotis), de la gale sarcoptique (Sarcoptes scabiei var. canis), de la démodécie canine (Demodex canis), prévention de la Dirofilariose (larves L3 et L4 de Dirofilaria immitis), traitement de l’angyostrongylose (Angiostrongylus vasorum), et traitement des infestations par les nématodes gastro-intestinaux (larves L4, adultes immatures et formes adultes de Toxocara canis, Ancylostoma caninum et Uncinaria stenocephala, et formes adultes de Toxascaris leonina et Trichuris vulpis).
1.0002772808074951 ||| Visitors books ||| Delegates from ||| Livres d'or
4.850658720176315e-13 ||| Nervous system disorders: ||| Nervous system disorders: ||| Affections du système nerveux:
0.43774572014808655 ||| Management of overdose should concentrate on supportive therapy, maintaining an adequate airway, oxygenation and ventilation, and management of symptoms. ||| Therefore, respiration must be monitored closely and supported when necessary with supplementary oxygen and/ or assisted ventilation. ||| La prise en charge du surdosage est essentiellement symptomatique, par le maintien de la fonction respiratoire, d'une oxygénation et d'une ventilation, et par la prise en charge des symptômes.
1.009889841079712 ||| 0 0 0 ||| 0 0 0 0 0 ||| 0 0
0.22722256183624268 ||| 5 1 In this placebo-controlled 24-week study of sitagliptin 100 mg once daily in combination with metformin, the incidence of adverse reactions considered as drug-related in patients treated with sitagliptin/ metformin compared to treatment with placebo/ metformin was 9.3% and 10.1%, respectively. ||| Studies of sitagliptin in combination with metformin In a 24-week, placebo-controlled clinical study to evaluate the efficacy and safety of the addition of sitagliptin 100 mg once daily to ongoing metformin, sitagliptin provided significant improvements in glycaemic parameters compared with placebo. ||| 1 Dans cette étude de 24 semaines, versus placebo, menée avec 100 mg de sitagliptine, une fois par jour, en association avec la metformine, l'incidence des effets indésirables considérés comme imputables au médicament a été respectivement de 9,3% et 10,1% chez les patients traités par sitagliptine + metformine et chez les patients traités par placebo + metformine.
0.43039441108703613 ||| - infusion site swelling ||| - infusion site discomfort ||| - œ dème sur le site de perfusion
0.6383081674575806 ||| Swallow the tablet whole with water. ||| Stir and drink the entire mixture. ||| Avaler le comprimé en entier avec de l’ eau.
0.2562786340713501 ||| Subcutaneous use: ||| Subcutaneous use ||| Voie sous-cutanée:
0.22414904832839966 ||| Do not break or crush tablets. ||| Do not crush or break the tablet. ||| Les comprimés ne doivent pas être coupés ou écrasés.
0.0 ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Système de pharmacovigilance Le titulaire de l’ autorisation de mise sur le marché (AMM) doit s’ assurer que le système de pharmacovigilance, tel qu’ il est décrit dans la version 3.0 présentée dans le module 1.8.1. du dossier d’ AMM, est en place et opérationnel avant et pendant la commercialisation du produit.
0.36863791942596436 ||| This complements the tools available to Member States as set out in the Commission's guidelines to ensure a strong EU-wide approach to foreign investment screening in a time of public health crisis and related economic vulnerability. ||| Yesterday, the Commission adopted decisions on harmonised standards which will allow manufacturers to place on the market high performing devices to protect patients, health care professionals and citizens in general. ||| Ces mesures de recapitalisation complètent la panoplie d'instruments à la disposition des États membres figurant dans les orientations de la Commission afin de garantir l'application d'une approche résolue, à l'échelle de l'UE, en matière de filtrage des investissements étrangers, dans le contexte de la crise de santé publique actuelle et de la vulnérabilité économique que celle-ci entraîne.
8.36139317506035e-13 ||| Week 3 (day 15-21): ||| Week 3 (day 15-21): ||| Semaine 3 (Jour 15 à 21):
0.34573954343795776 ||| The disease was principally a British phenomenon; in Germany, for example, sweeps wore tight-fitting protective clothing which prevented the soot from accumulating on the lower surface of the scrotum, whereas boys in the UK were once sent up the chimneys wearing only trousers and shirt, and occasionally naked. ||| Sometime during the late 1760s whilst serving his apprenticeship as a surgeon/apothecary Edward Jenner learned of the story, common in rural areas, that dairy workers would never have the often-fatal or disfiguring disease smallpox, because they had already contracted cowpox, which has a very mild effect in humans. ||| La maladie était principalement un phénomène britannique : en Allemagne, par exemple, les ramoneurs portaient des vêtements de protection appropriés qui empêchaient la suie de s'accumuler à la partie inférieure du scrotum, tandis qu'au Royaume-Uni les garçons descendaient parfois nus dans les cheminées parfois encore chaudes.
0.16315031051635742 ||| For short term travelling, the solution can be kept out of the refrigerator at or below 25°C for a period up to seven days before use. ||| For short term travelling, the non -reconstituted product can be kept out of the refrigerator at or below 25°C for a period up to four weeks before use. ||| Pour des voyages de courte durée et avant utilisation, la solution peut être conservée en dehors du réfrigérateur à une température ne dépassant pas 25°C pendant une période ne dépassant pas 7 jours.
0.21092644333839417 ||| Doses of 25 mg of Enbrel (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered subcutaneously twice a week for 6 months in 138 patients. ||| In a multiple-dose study in HIV-infected patients dosed with 400 mg of atazanavir once daily with a light meal for 12 weeks, atazanavir was detected in the cerebrospinal fluid and semen. ||| Des doses de 25 mg d’ Enbrel (déterminées lors des études de recherche de dose chez les patients atteints de polyarthrite rhumatoïde) ou de placebo ont été administrées par voie sous-cutanée deux fois par semaine pendant 6 mois chez 138 patients.
0.12888839840888977 ||| 12/ 41 ||| 11/ 45 ||| 12/ 43
0.7728571891784668 ||| 1g ||| 1g oral ||| granulés 1g
0.11201804131269455 ||| When an optimal response is obtained, a single injection of 250 micrograms r-hCG or 5 000 IU up to 10 000 IU hCG should be administered 24-48 hours after the last GONAL-f injection. ||| A single injection of 250 micrograms r-hCG or 5 000 IU up to 10 000 IU hCG is administered 24-48 hours after the last GONAL-f injection to induce final follicular maturation. ||| Quand une réponse optimale est obtenue, une injection unique de 250 microgrammes de r-hCG ou de 5.000 à 10.000 UI d’ hCG devra être administrée 24 à 48 heures après la dernière injection de GONAL-f.
0.3540380001068115 ||| Manufacturer Ferring AB Soldattorpsvägen 5 Box 30047 SE - 20061 Limhamn Sweden ||| FERRING AB Soldattorpsvägen 5 SE-20061 Limhamn Sweden ||| Fabricant Ferring AB Soldattorpsvägen 5 Box 30047 S-200 61 Limhamn Suède
0.5529837608337402 ||| Make sure the cap is intact and has not been opened. ||| Check that the cap of the vial is still intact. ||| Vérifier que ce capuchon est intact et n’a pas étécassé.
0.31784355640411377 ||| Before initiation of combination treatment, contraindications for concomitantly used chemotherapeutic agents or radiation therapy must be considered. ||| Special care must be taken to apply appropriate injection technique to avoid inadvertent intravascular or subcutaneous injection (see section 6.6). ||| 19 Avant d’ instaurer un traitement en association, il doit être tenu compte des contre-indications des médicaments chimiothérapeutiques utilisés simultanément ou de la radiothérapie.
0.31246691942214966 ||| QUADRAMET should only be administered by physicians experienced in the use of radiopharmaceuticals and after full oncological evaluation of the patient by qualified physicians. ||| The medicinal product should only be prescribed, and changes in immunosuppressive therapy initiated, by physicians experienced in immunosuppressive therapy and the management of transplant patients. ||| Le QUADRAMET ne doit être administré que par des praticiens spécialistes de médecine nucléaire et après une étude complète du cas clinique par des médecins qualifiés en oncologie.
0.3956846594810486 ||| Packaging bags [sacks] of plastic for bulk transportation ||| Packaging sacks for transporting materials in bulk ||| Sacs d'emballage en matières plastiques pour le transport en vrac
0.32638007402420044 ||| Method of administration Raptiva is for subcutaneous injection. ||| Humalog Mix25 should only be given by subcutaneous injection. ||| Mode d'administration Raptiva s'administre par voie sous-cutanée.
0.03001943789422512 ||| No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. ||| No dosage adjustment is required for patients with mild or moderate hepatic impairment. ||| 13 Aucune adaptation posologique n’ est nécessaire chez les patients atteints d’ insuffisance hépatique légère à modérée.
0.3587532639503479 ||| Very Common (occurring in at least 1 in 10 patients treated) Common (occurring in at least 1 of 100 and less than 1 of 10 patients treated) Uncommon (occurring in at least 1of 1000 and less than 1 of 100 patients treated) Rare (occurring in at least 1 of 10,000 and less than 1 of 1000 patients treated) Not known (cannot be estimated from the available data) ||| (Frequencies are defined as follows: very common (more than 1 out of 10 persons), common (more than 1 out of 100 persons and less than 1 out of 10 persons), uncommon (more than 1 out of 1,000 persons and less than 1 out of 100 persons), rare (more than 1 out of 10,000 persons and less than 1 out of 1,000 persons), very rare (less than 1 out of 10,000 persons including isolated reports) ||| Très fréquent (survenant chez au moins 1/ 10 patients traités) Fréquent (survenant chez au moins 1/ 100 patients traités et chez moins de 1/ 10) Peu fréquent (survenant chez au moins 1/ 1 000 patients traités et chez moins de 1/ 100) Rare (survenant chez au moins 1/ 10 000 patients traités et chez moins de 1/ 1 000) Inconnu (ne pouvant être estimé d’ après les données disponibles)
0.11050039529800415 ||| (13.3, 18.9) ||| (14.1, 17.9) ||| (13,3 – 18,9)
0.2904001772403717 ||| Lesion conspicuity of hypo- and hypervascular lesions may be reduced if imaging is delayed more than 3 minutes due to the diffusion of the contrast agent into the interstitial spaces of both the liver parenchyma and lesion (e. g. metastasis) making the lesion isointense with the normal liver parenchyma. ||| The risk of torsade de pointes is related to the extent of QT prolongation, concomitant administration of QT prolonging medicinal products, a history of torsade de pointes, preexisting QT interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalaemia or hypomagnesaemia. ||| Si l’ acquisition des images est retardée de plus de 3 minutes, la visualisation des lésions hypovasculaires et hypervasculaires peut être diminuée, en raison de la diffusion du produit de contraste vers les espaces interstitiels tant du parenchyme hépatique que de la lésion (métastase, par ex.), mettant la lésion en isosignal avec le parenchyme hépatique sain environnant.
0.2613878846168518 ||| The normal safety precautions for cytostatic agents must be observed when preparing and disposing of the infusion solution. ||| Paxene should only be prepared and administered by personnel appropriately trained in the handling of cytotoxic agents. ||| Les précautions normales de sécurité pour les agents cytotoxiques doivent être observées lors de la préparation et de la pose de la solution pour perfusion.
0.6507942080497742 ||| - kidney failure, blood or crystals in the urine (see Section 2: ||| - Blood in the urine that stains the urine pink or red ||| - insuffisance rénale, présence de sang ou de cristaux dans les urines (voir rubrique 2:
0.3520227074623108 ||| From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. ||| With a view to facilitating safe and secure cross border data flows between them, based on strong convergence of data protection rules ensuring a high level of protection of personal data and privacy, the leaders also welcomedthe significant progress made in the talks on a data adequacy decision. ||| Entre politiques de renforcement des systèmes de santé et de l’économie mondiale et réponses aux effets du confinement et des restrictions de déplacement, la plateforme numérique inclut un outil Country Policy Tracker visant à aider les pays à apprendre les uns des autres et à faciliter une réponse mondiale coordonnée au défi que pose le coronavirus.
0.0 ||| 11. ||| 11. ||| 6.
0.37772488594055176 ||| However, the dose could be increased to 15 mg if well tolerated. ||| The dose should be increased only if the previous lower dose is well tolerated. ||| Cependant, la dose pourrait être augmentée jusque 15 mg si bien tolérée.
0.5134807229042053 ||| Be careful not to push the needle into the skin too slowly, or with great force. ||| To do so, insert the needle deeply at an angle of not less than 45 degrees. ||| Faites attention de ne pas enfoncer l’aiguille dans la peau trop lentement, ou avec trop de force.
0.10677483677864075 ||| Each pre-filled syringe contains 6 mg of pegfilgrastim in 0.6 ml (10 mg/ ml) solution for injection. ||| Each pre-filled syringe contains 48 MIU (480 µg) of filgrastim in 0.8 ml solution for injection or infusion. ||| Chaque seringue préremplie contient 6 mg de pegfilgrastim dans 0,6 ml (10 mg/ ml) de solution injectable.
0.34757494926452637 ||| This medicine contains the sweetener sorbitol (approximately 5 g in each 15 ml dose), which may have a mild laxative effect. ||| One dose (0.5 ml) of the vaccine contains at least 7.5 micrograms of haemagglutinin from the following recommended influenza virus strain: ||| Ce médicament contient un agent édulcorant, le sorbitol (environ 5 g pour chaque dose de 15 ml), qui peut avoir un léger effet laxatif.
0.027227845042943954 ||| JANSSEN-CILAG INTERNATIONAL NV Turnhoutseweg 30 B-2340 Beerse Belgium ||| JANSSEN-CILAG INTERNATIONAL NV Turnhoutseweg, 30 B-2340 Beerse Belgium ||| JANSSEN-CILAG INTERNATIONAL NV Turnhoutseweg 30 B-2340 Beerse Belgique
0.36480090022087097 ||| Therefore, aripiprazole should be used with caution in patients who have a history of seizure disorder or have conditions associated with seizures. ||| Patients with symptoms of bone marrow depression should be treated with caution since further suppression of bone marrow function should be anticipated. ||| Par conséquent, l'aripiprazole doit être utilisé avec prudence chez les patients ayant des antécédents de convulsions ou présentant une pathologie comportant des convulsions associées.
0.06460455805063248 ||| 122 10. ||| 132 10. ||| 10.
0.3631882071495056 ||| If you have not been previously treated with chemotherapy, your first dose of Temodal will be 200 mg/m2 once daily for the first 5 days. ||| If you are already being treated with doxorubicin for your condition, then your first dose of paclitaxel should be given 24 hours after doxorubicin. ||| Si vous n’ avez pas été traité préalablement par chimiothérapie, votre première dose de Temodal sera de 200 mg/ m2 une fois par jour pendant les 5 premiers jours.
0.3254070281982422 ||| Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lansoprazole is initiated or ended. ||| - the risk of rhabdomyolysis is greatly increased when cerivastatin is used concomitantly with ||| Il est recommandé de contrôler les concentrations plasmatiques de tacrolimus lors de l’ instauration ou de l’ arrêt d’ un traitement par le lansoprazole.
0.10733327269554138 ||| 1.09 E+00 6.29 E-02 3.88 E+00 1.29 E-02 8.72 E-01 3.46 E-02 1.16 E+01 ||| 2.17 E+01 1.26 E+00 7.75 E+01 2.58 E-01 1.75 E+01 6.91 E-01 2.33 E+02 ||| 1,09 E+00 6,29 E-02 3,88 E+00 1,29 E-02
0.5201575756072998 ||| BLISTER OF 10 mg FILM-COATED TABLETS ||| CARTON FOR CLINICAL PACK WITH 6 VIALS ||| Plaquette thermoformée de comprimés pelliculés dosés à 10 mg
0.2268298864364624 ||| As with interferon alfa-2b, patients with a history of congestive heart failure, myocardial infarction and/ or previous or current arrhythmic disorders, receiving PegIntron therapy require close monitoring. ||| SPRYCEL is indicated for the treatment of adults with chronic, accelerated or blast phase chronic myeloid leukaemia (CML) with resistance or intolerance to prior therapy including imatinib mesilate. ||| Comme avec l’ interféron alfa-2b, les patients ayant des antécédents d'insuffisance cardiaque congestive, d'infarctus du myocarde et/ ou ayant souffert ou souffrant de troubles du rythme cardiaque, et recevant un traitement par PegIntron doivent être étroitement surveillés.
0.005091280676424503 ||| 131 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 151 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 153 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.20174145698547363 ||| Rare reports of 2nd or 3rd degree atrioventricular block in patients with underlying structural heart disease and pre-existing conduction system abnormalities or in patients receiving drugs known to prolong the PR interval (such as verapamil or atazanavir) have been reported in patients receiving ritonavir. ||| In patients with childhood onset isolated GH deficiency (no evidence of hypothalamic-pituitary disease or cranial irradiation), two dynamic tests should be recommended, except for those having low IGF-I concentrations (SDS < -2) who may be considered for one test. ||| De rares cas de bloc auriculo-ventriculaire de 2ème ou 3ème degré ont été observés, pendant le traitement par le ritonavir, chez des patients présentant une cardiomyopathie sous-jacente ou des anomalies préexistantes du système de conduction ou chez des patients recevant des médicaments connus pour allonger l’intervalle PR (vérapamil ou atazanavir par exemple).
0.11951830238103867 ||| Keep out of the reach and sight of children. lp ||| Keep out of the reach and sight of children lp ||| Tenir hors de la portée et de la vue des enfants. am
0.10560844093561172 ||| Pregnancy Please consult your doctor if you plan to become pregnant. ||| Please consult your doctor if you plan to become pregnant. ||| Grossesse Veuillez consulter votre médecin si vous désirez être enceinte.
4.363555415436149e-13 ||| 21 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 21 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES Etiquette
0.31688904762268066 ||| Caution should be exercised with strong P- glycoprotein inhibitors like verapamil, clarithromycin, and others. ||| Prophylactic antithrombotic medicinal products, such as low molecular weight heparins or warfarin, should be recommended. ||| La prudence est nécessaire avec les inhibiteurs puissants de la P-glycoprotéine tels que le vérapamil, la clarithromycine ou d’autres molécules.
0.2389700561761856 ||| Myalgia (G3/ 4: ||| Asthenia (G3/ 4: ||| Myalgie (G3/ 4:
0.2741900682449341 ||| Ribavirin Teva must not be taken by women who are breast-feeding. ||| Deferiprone must not be used by breast-feeding mothers. ||| Ribavirine Teva est contre-indiqué chez la femme qui allaite.
0.24669384956359863 ||| In two randomised, double-blind, pivotal studies in patients with high risk stage II-IV breast cancer undergoing myelosuppressive chemotherapy consisting of doxorubicin and docetaxel, use of pegfilgrastim, as a single once per cycle dose, reduced the duration of neutropenia and the incidence of febrile neutropenia similarly to that observed with daily administrations of filgrastim (a median of 11 daily administrations). ||| With haemodialysis, use of alternative waste nitrogen excretion pathways (sodium phenylbutyrate, sodium benzoate and sodium phenylacetate), dietary protein restriction, and, in some cases, essential amino acid supplementation, the survival rate in new-borns diagnosed after birth (but within the first month of life) increased to almost 80% with most deaths occurring during an episode of acute hyperammonaemic encephalopathy. ||| Dans deux études pivots randomisées, en double aveugle, chez des patientes atteintes d’ un cancer du sein à haut risque de stade II-IV, traitées par une chimiothérapie myélosuppressive associant doxorubicine et docétaxel, l’ administration de pegfilgrastim, à la posologie d’ une injection unique une fois par cycle, a entraîné la réduction de la durée de la neutropénie et de l’ incidence de la neutropénie fébrile de façon similaire à celle observée après administration quotidienne de filgrastim (avec une durée médiane d’ administration de 11 jours).
0.3420266807079315 ||| Use of efavirenz in combination with saquinavir as the sole protease inhibitor is not recommended. ||| ViraferonPeg is used alone in case of intolerance or contraindication to ribavirin. ||| L'utilisation de l'éfavirenz associé au saquinavir comme seul inhibiteur de protéase n’ est pas recommandée.
0.24448733031749725 ||| 16 15. ||| 17 15. ||| 15.
0.4742888808250427 ||| Tel: +351 210 330 700 farmalerta@tecnifar. pt ||| 0043 (0) 512 / 390 11040 www.alliprogramm.at ||| Tel: +351 210 330 700 farmalerta@tecnifar.pt
2.8734946280056795e-13 ||| Suicide-related behaviours (suicide attempt and suicidal thoughts), and hostility (predominantly aggression, oppositional behaviour and anger) were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo. ||| Suicide-related behaviours (suicide attempt and suicidal thoughts), and hostility (predominantly aggression, oppositional behaviour and anger) were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo. ||| Des comportements de type suicidaire (tentatives de suicide et idées suicidaires) et de type hostile (principalement agressivité, comportement d’ opposition et colère) ont été plus fréquemment observés au cours des études cliniques chez les enfants et adolescents traités par antidépresseurs par rapport à ceux traités par placebo.
0.27780023217201233 ||| In short-term studies (7 days), the incidence of endoscopically observed gastroduodenal ulcers or erosions in healthy young and elderly (≥ 65 years) subjects administered Dynastat (5-21%), although higher than placebo (5-12%), was statistically significantly lower than the incidence observed with NSAIDs (66-90%). ||| Paediatric population Controlled clinical trials with posology comparable to that currently indicated for the use of Rapamune in adults — that is, use in combination with ciclosporin and corticosteroids for 2 to 3 months post-transplantation followed by withdrawal of ciclosporin thereafter— have not been conducted in children or adolescents ( 18 years of age). ||| Dans les études endoscopiques de courte durée (7 jours) chez le volontaire sain jeune et âgé (≥ 65 ans) l'incidence des ulcères gastro-duodénaux ou des érosions après administration de Dynastat (5-21%), bien que supérieure au placebo (5-12%), restait significativement inférieure à l’ incidence observée avec les AINS (66-90%).
0.01086115650832653 ||| 28 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 22 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 29 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.12956243753433228 ||| In both studies, duloxetine 60 mg once daily and 60 mg twice daily significantly reduced pain compared with placebo. ||| In both studies, CYMBALTA 60 mg once daily and 60 mg twice daily significantly reduced pain compared with placebo. ||| Dans les deux études, la duloxétine à 60 mg une fois par jour et 60 mg deux fois par jour a significativement réduit la douleur par rapport au placebo.
0.3152850866317749 ||| As a consequence, before initiating treatment with abacavir, screening for carriage of the HLA- B*5701 allele should be performed in any HIV-infected patient, irrespective of racial origin. ||| In circumstances where exposure to HBV has recently occurred (eg needlestick with contaminated needle) the first dose of ENGERIX B can be administered simultaneously with HBIg which however must be given at a separate injection site. ||| Par conséquent, avant de débuter un traitement contenant de l'abacavir, le dépistage de l'allèle HLA-B*5701 doit être réalisé chez tout patient infecté par le VIH, quelle que soit son origine ethnique.
0.7615642547607422 ||| Česká republika BRI STOL-MYERS SQUIBB SPOL. ||| 150 Eesti Österreich BRISTOL-MYERS SQUIBB GYÓGYSZERKERESKEDELMI KFT. ||| Č eská republika BRISTOL-MYERS SQUIBB SPOL.
0.3525876998901367 ||| Co-administration of lamivudine with food results in a delay of tmax and a lower C max (decreased by 47%). ||| Concomitant intake of a 40 mg dose with a standard breakfast decreased the aprepitant Cmax by 18% but did not affect AUC. ||| 32 L’ administration de lamivudine au cours d’ un repas entraîne un allongement de la valeur du Tmax et une diminution de la valeur de la Cmax (diminuée de 47%).
0.001523882383480668 |||  111 Pulmonary infiltrates, pneumonitis, and pneumonia, occasionally resulting in fatality, have been observed rarely in interferon alpha treated patients, including those treated with IntronA. |||  69 Pulmonary infiltrates, pneumonitis, and pneumonia, occasionally resulting in fatality, have been observed rarely in interferon alpha treated patients, including those treated with IntronA. ||| Des infiltrats pulmonaires, des pneumopathies inflammatoires et des pneumonies, pouvant occasionnellement être fatals, ont été rarement observés chez des patients traités par interféron alpha, y compris ceux traités par IntronA.
0.7438212633132935 ||| Confidence interval (95%) ||| (concentration) size ||| Intervalle de confiance (95%)
0.021939115598797798 ||| EU/ 1/ 06/ 337/ 009 ||| EU/ 1/ 06/ 337/ 006 ||| EU/ 1/ 06/ 337/ 009 M-M-RVAXPRO
0.5440394282341003 ||| Formation of antibodies. ||| Other antidepressants. ||| formation d’ anticorps.
0.0 ||| Vascular Disorders ||| Vascular Disorders ||| Affections vasculaires
0.392985463142395 ||| France also requested CVMP to consider the consequences for the withdrawal period and ecotoxicity assessment in case the therapeutic scheme should be modified and the posology or the frequency of administration increased. ||| The Company informed the Agency that at the time of the withdrawal, all clinical trials in the European Union are closed to enrolment and there is no ongoing compassionate use programmes. ||| La France a également demandé au CVMP d’ envisager les conséquences sur le temps d’ attente et l’ évaluation de l’ écotoxicité d’ une modification éventuelle du régime thérapeutique et d’ une augmentation de la posologie ou de la fréquence d’ administration.
0.1560000777244568 ||| Like all medicines, Ciprofloxacin Kabi can cause side effects, although not everybody gets them. ||| Like all medicines, Helixate NexGen 1000 IU can cause side effects, although not everybody gets them. ||| 49 Comme tous les médicaments, Ciprofloxacine Kabi est susceptible d'avoir des effets indésirables, bien que tous les patients n’ y soient pas sujets.
5.176394794574601e-13 ||| You can set the dose in steps of 2 units, from a minimum of 2 units to a maximum of 40 units. ||| You can set the dose in steps of 2 units, from a minimum of 2 units to a maximum of 40 units. ||| Vous pouvez sélectionner la dose par intervalles de 2 unités, d’ un minimum de 2 unités à un maximum de 40 unités.
0.33211809396743774 ||| Although concomitant administration of CYP3A4 inducers (e. g. rifampicin, phenytoin, phenobarbital, carbamazepine, St John’ s wort) has not been studied, it is expected that concomitant administration of dic ||| It can not be excluded that other inducers, e. g. phenytoin, carbamazepine, phenobarbital, St John’ s wort, may have a similar effect. ||| Bien que l’administration simultanée avec des inducteurs du CYP3A4 (par exemple rifampicine, phénytoïne, phénobarbital, carbamazépine, millepertuis) n’ait pas été étudiée, l’administration concomitante avec des inducteurs puissants du CYP3A4 est susceptible de réduire les concentrations plasmatiques du rimonabant et peut conduire à une diminution de l’efficacité.
0.03126185014843941 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/ ||| Detailed information on this product is available on the web-site of the European Medicines Agency (EMEA) http://www.emea.europa.eu/ ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu/
0.292883038520813 ||| Part of the dose is absorbed systemically where it is extensively metabolised in the liver. ||| It is well absorbed by the oral route since the majority of an oral dose is excreted in urine. ||| Une partie de la dose passe dans la circulation générale et subit un métabolisme hépatique important.
0.1930721253156662 ||| Due to an increased incidence of gastrointestinal and hepatic adverse events, a dose reduction of ketoconazole should be considered when co- administered with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer. ||| Fluticasone propionate given by inhalation at recommended doses has a glucocorticoid anti- inflammatory action within the lungs, resulting in reduced symptoms and exacerbations of asthma, without the adverse effects observed when corticosteroids are administered systemically. ||| Etant donné l’inci dence accrue d’effets indésirables gastro-intestinaux et hépatiques, une réduction de la posologie du kétoconazole doit être envisagée en cas d’utilisation concomitante avec le ritonavir administré à doses théra peutiques ou comme potentialisateur pharmacocinétique.
0.007557200267910957 ||| 24/ 34 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22/ 39 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 22/ 35 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.22798986732959747 ||| 0.4–0.8 g/kg bw ||| 0.4 – 0.8 g/kg ||| 0,4–0,8 g/kg de p. c.
0.06317023932933807 ||| n (%) 1 (0.7) ||| n (%) 1(0.7) ||| n (%) 1 (0,7)
0.4305671453475952 ||| Some patients may get increased levels of liver enzymes in their blood during treatment with Thymanax. ||| Certain patients have experienced these symptoms when taking VIAGRA with alpha-blockers. ||| Certains patients peuvent présenter une élévation des taux sanguins des enzymes du foie pendant le traitement par Thymanax.
0.0 ||| 77 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 77 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 85 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.8898035287857056 ||| - difficulty bre athing ||| - f aster heart beat, ||| - difficultés à respirer
0.43770793080329895 ||| In PIER, the primary efficacy endpoint was mean change in visual acuity at 12 months compared with baseline. ||| A key secondary endpoint was the continuous abstinence (CA) rate for week 13 through week 52. ||| Dans l'étude PIER, le critère principal d'évaluation de l'efficacité était la variation moyenne de l'acuité visuelle à 12 mois par rapport à l'acuité visuelle initiale.
0.2632935047149658 ||| E Pull off the inner needle cap and dispose of it. ||| D Pull off the big outer needle cap and keep it for later. ||| E Retirez la protection interne de l’aiguille et jetez-la.
0.3481253981590271 ||| • Allergic reactions, including anaphylactic reaction, angioedema, skin rash and urticaria. ||| These included: allergic reactions, seizures (fits), and inflammation of the brain (encephalitis). ||| 35 • Réactions allergiques, y compris réactions anaphylactiques, oedème de Quincke, rash cutané et urticaire.
0.23390457034111023 ||| Because ECALTA can affect liver function, patients who show signs of liver problems during treatment should be carefully monitored. ||| Patients who develop any signs or symptoms suggestive of liver injury should have liver function tests performed. ||| Étant donné qu'ECALTA peut affecter la fonction hépatique, les patients présentant des signes de troubles hépatiques pendant le traitement doivent être surveillés attentivement.
0.1450977325439453 ||| 40 10. ||| 50 10. ||| 42 10.
0.2941952049732208 ||| 39 In a randomised open-label study (APV30003) in protease inhibitor experienced patients with virological failure (less than or equal to two PIs) the fosamprenavir with ritonavir (700 / 100 mg twice daily or 1400 / 200 mg once daily) did not demonstrate non-inferiority to lopinavir / ritonavir with regard to viral suppression as measured by the average area under the curve minus baseline (AAUCMB) for plasma HIV-1 RNA over 48 weeks (the primary end point). ||| In the same study, in which the drug potency of ReFacto AF and a full-length recombinant factor VIII (FLrFVIII) comparator, and the FVIII activity measured in patient plasma samples were all determined using the same one-stage clotting assay at a central laboratory, ReFacto AF was shown to be pharmacokinetically equivalent to FLrFVIII in 30 previously treated patients (≥ 12 years) using the standard bioequivalence approach. ||| Dans une étude randomisée en ouvert (APV30003) réalisée chez des patients prétraités par inhibiteurs de protéase et en échec virologique (d'un ou deux IP) l'association fosamprénavir / ritonavir (700 / 100 mg deux fois par jour ou 1400 / 200 mg une fois par jour) n'a pas démontré sa non-infériorité au lopinavir / ritonavir sur la suppression virale de l'ARN VIH-1 mesurée par l'aire moyenne sous la courbe (AAUCMB) au cours des 48 semaines de traitement (critère principal d'évaluation).
0.035769715905189514 ||| EMEA/ H/ C/ 890/ 003 ZYPADHERA 405 mg - 1 vial + 1 vial ||| EMEA/ H/ C/ 890/ 002 ZYPADHERA 300 mg -1 vial + 1 vial ||| EMEA/ H/ C/ 890/ 003 ZYPADHERA 210 mg – 1 flacon + 1 flacon
0.01873505860567093 ||| Press release22 April 2020Brussels ||| Press release27 April 2020Brussels ||| Communiqué de presse22 avril 2020Bruxelles
0.42149239778518677 ||| Therefore, the efficacy of Azomyr orodispersible tablet is expected to be the same as with the Azomyr tablet formulation. ||| The effect of Yttriga depends on the nature of the carrier medicine that is radiolabelled with Yttriga. ||| Par conséquent, l’ efficacité d’ Azomyr comprimés orodispersibles doit être la même que celle de la formulation Azomyr comprimés.
0.00012810324551537633 ||| Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. ||| Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics. ||| Les médicaments susceptibles de provoquer une augmentation de l'effet hypoglycémiant et de la sensibilité à l'hypoglycémie sont, entre autres, les antidiabétiques oraux, les inhibiteurs de l'enzyme de conversion (IEC), le disopyramide, les fibrates, la fluoxétine, les inhibiteurs de la monoamine oxydase (IMAO), la pentoxifylline, le propoxyphène, les salicylés et les antibiotiques de type sulfamides.
0.6295151114463806 ||| Lymphopenia ||| Pharyngitis ||| Lymphopénie.
0.5113253593444824 ||| More frequent monitoring of hepatic function was recommended in all instances. ||| Medical follow-up in a specialised environment is recommended. ||| Une surveillance plus fréquente de la fonction hépatique a été recommandée dans tous les cas.
0.7794321179389954 ||| Portugal sanofi-aventis - Produtos Farmacêuticos, S.A. ||| Slovenija Merck Sharp & Dohme, inovativna zdravila d. o. o. ||| Portugal España sanofi-aventis - Produtos Farmacêuticos, S.A. sanofi-aventis, S.A.
0.290596067905426 ||| Yellow-orange gelatin capsules imprinted in red with “ 0.5 mg” on the light yellow capsule cap and “ 647” on the orange capsule body, containing white powder. ||| Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “ ENA 713 6 mg” on body. ||| Gélules de gélatine jaune - orange portant les inscriptions rouges “ 0.5 mg” sur la coiffe jaune clair de la gélule et “ 647” sur le corps orange de la gélule, contenant une poudre blanche.
0.10769298672676086 ||| Onsior 5 mg tablets for dogs Onsior 10 mg tablets for dogs Onsior 20 mg tablets for dogs Onsior 40 mg tablets for dogs ||| Onsior 5 mg tablets for dogs Onsior 10 mg tablets for dogs Onsior 20 mg tablets for dogs Onsior 40 mg tablets for dogs Robenacoxib ||| Onsior 5 mg comprimés pour chiens Onsior 10 mg comprimés pour chiens Onsior 20 mg comprimés pour chiens Onsior 40 mg comprimés pour chiens
0.4030459523200989 ||| The vaccination schedule should be completed at least 4 weeks before the start of laying. ||| It is recommended to postpone vaccination until after completion of the pregnancy. ||| Le schéma vaccinal doit être complété au moins 4 semaines avant l’ entrée en ponte.
0.3433905243873596 ||| There may also be bleeding, ulcers, swelling, and scarring. ||| Nausea, vomiting, dizziness, and headache can also occur. ||| Il peut aussi survenir des hémorragies, ulcères, un gonflement et des cicatrices.
6.951946071760695e-13 ||| What Kineret is and what it is used for 2. ||| What Kineret is and what it is used for 2. ||| Qu'est -ce que Kineret et dans quel cas est -il utilisé 2.
0.017721280455589294 ||| For paediatric patients who weigh < 47 kg or cannot swallow capsules, see ribavirin oral solution SPC). ||| For paediatric patients who weigh < 47 kg or cannot swallow capsules, see ribavirin oral solution SPC). no ||| Pour les patients de moins de 47 kg ou qui ne peuvent pas avaler de gélules, se reporter au RCP de la ribavirine en solution buvable).
0.05649656057357788 ||| Insulin Human Winthrop Rapid may be mixed with all Sanofi-Aventis human insulins, but NOT with those designed specifically for use in insulin pumps. ||| Insuman Comb 25 may be mixed with all Sanofi-Aventis human insulins, but NOT with those designed specifically for use in insulin pumps. ||| Insulin Human Winthrop Rapid peut être mélangé à toutes les insulines humaines Sanofi-Aventis, mais PAS à celles spécifiquement conçues pour être utilisées dans les pompes à insuline.
0.15845082700252533 ||| HOW TO STORE NOXAFIL ||| HOW TO STORE TYGACIL ||| COMMENT CONSERVER NOXAFIL
0.8903714418411255 ||| Single Market Scoreboard 2020: Member States need to do more ||| Q&A: The Eastern Partnership policy beyond 2020 ||| Tableau d'affichage du marché unique 2020: Les États membres doivent en faire davantage
0.33338403701782227 ||| 14 EXP ||| 37 EXP ||| 14 9.
0.2572634220123291 ||| 2 Method of titration During titration, if adequate analgesia is not obtained within 30 minutes after the start of administration of a single tablet, a second Effentora tablet of the same strength may be used. ||| This titration should follow the course of administering a single sublingual tablet, with administration of a supplemental second sublingual tablet after 15-30 minutes, if inadequate pain relief is obtained. ||| Méthode de titration Durant la titration, si une analgésie satisfaisante n’ est pas obtenue dans les 30 minutes suivant l’ administration d’ un seul comprimé, un deuxième comprimé d’ Effentora du même dosage peut être utilisé.
0.06844548135995865 ||| the CHMP has recommended the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Oracea. ||| The CHMP has recommended the granting of the variation of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III. ||| le CHMP a recommandé l’ octroi des autorisations de mise sur le marché pour lesquelles le résumé des caractéristiques du produit, l'étiquetage et la notice sont définis à l’ annexe III pour Oracea.
0.22722700238227844 ||| These include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from human mast cells/ basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on endothelial cells. ||| Anakinra inhibits responses elicited by IL-1 in vitro, including the induction of nitric oxide and prostaglandin E2 and/ or collagenase production by synovial cells, fibroblasts, and chondrocytes. ||| Celles- ci incluent l'inhibition de la libération de cytokines proinflammatoires telles que IL-4, IL-6, IL-8, et IL-13 par les mastocytes/ basophiles humains, ainsi que l'inhibition de l'expression de la molécule d'adhésion P-sélectine sur les cellules endothéliales.
0.40822574496269226 ||| The use of higher ritonavir doses might alter the safety profile of the combination and therefore is not recommended. ||| However, this is not expected from the low dose of testosterone delivered by the Intrinsa patch. ||| L’utilisation de doses plus élevées de ritonavir pourrait modifier le profil de sécurité de l’association, elle n’est donc pas recommandée.
0.3068443536758423 ||| Puncture the dispensing tip by screwing cap clockwise until it becomes tight. ||| Screw the capped needle clockwise onto the pen until it is tight. ||| Percer le goulot du tube en vissant le bouchon dans le sens des aiguilles d’une montre jusqu’au blocage.
0.22807836532592773 ||| Telephone messaging services ||| Telephone banking services ||| Services de messagerie téléphonique
0.4292716085910797 ||| Opening the financing to learners, businesses and educational organisations will allow as many people and businesses as possible to reap the benefits." ||| We will use the guarantee to help small businesses with liquidity and working capital and enable more people to get the medical care they need. ||| L'ouverture du financement aux apprenants, aux entreprises et aux organismes d'enseignement offrira à un maximum de personnes et d'entreprises la possibilité d'en tirer des avantages.»
0.34578314423561096 ||| Generally, improvement is seen within one week of starting treatment. ||| A clinical response is normally seen within 3-4 days. ||| Habituellement une amélioration est observée au cours de la première semaine de traitement.
0.0 ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| As per the CHMP Guideline on Risk Management Systems for medicinal products for human use, the updated RMP should be submitted at the same time as the next Periodic Safety Update Report (PSUR). ||| Selon la recommandation du CHMP sur les Systèmes de Gestion de Risque pour les médicaments à usage humain, le PGR actualisé devra être soumis en même temps que le prochain Rapport Périodique de Pharmacovigilance (PSUR).
0.22453448176383972 ||| 61 Table 1 shows the categorized incidence of the adverse reactions, which occurred in the clinical trials statistically significantly more frequently during treatment with Remeron than with placebo, added with adverse reactions from spontaneous reporting. ||| The frequency of adverse reactions from spontaneous reporting for which no cases in the randomized placebo-controlled patient trials were observed with mirtazapine has been classified as ‘ not known’. ||| Le tableau 1 présente l’ incidence par catégorie des effets indésirables survenus dans les essais cliniques avec une fréquence statistiquement significativement plus élevée sous Remeron que sous placebo, ainsi que les effets indésirables spontanément rapportés.
0.43480777740478516 ||| The dose titration in these patients should be performed with caution considering co-existing renal impairment. ||| Epoetin alfa should be used with caution in the presence of untreated, inadequately treated ||| L’ augmentation posologique dans cette population de patients doit être effectuée avec précaution en prenant en compte une insuffisance rénale coexistante.
0.040788039565086365 ||| ------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only ||| --------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only: ||| --------------------------------------------------------------------------------------------------------------------------- Les informations suivantes sont destinées exclusivement aux professionnels de santé.
0.28202712535858154 ||| Based on the responses the CPMP considered that although there are no placebo-controlled data, CIU in children between 2 and 12 years is not a different disease entity compared to the disease in adults and that data from adults can be extrapolated to children, as the pharmaco-kinetic data are supportive. ||| Regarding the posology in elderly with schizophrenia, the CHMP considered that the data in elderly patients is limited but suggests that a lower starting dose with a more conservative dose titration than in younger adults is recommended and adopted the following wording: ||| Sur la base des réponses, le CPMP a considéré que bien qu'il n'y ait pas de données contrôlées par placebo, l’ UCI chez les enfants âgés de 2 à 12 ans n’ est pas une entité pathologique différente de la maladie chez les adultes, et que les données des adultes peuvent être extrapolées aux enfants puisque les données pharmacocinétiques appuient cette hypothèse.
0.4415627121925354 ||| The crisis demonstrated the role of free and independent media as an essential service, providing citizens with reliable, fact-checked information, contributing to saving lives.The EU will strengthen its support to independent media and journalists in the EU and around the world.The Commission calls upon Member States to intensify efforts to ensure that journalists can work safely and to make the most of the EU's economic response and recovery package to support media heavily hit by the crisis, while respecting their independence. ||| If we are to end COVID-19 for all, we need our world leaders to commit the billions of dollars needed to equitably deliver testing, treatments and vaccines, Global Goal: Unite for Our Future-The Concert' will bring the centuries-old concept of music as a motivator for change and unity, together with science and data, to honour the problem solvers - including doctors, scientists, lab workers, essential workers and human rights advocates - who are racing to not only create the cure for COVID-19, but also to ensure that it's available for everyone who needs it." ||| Garantir la liberté d'expression et le débat démocratique pluraliste est un élément central de notre réaction à la désinformation.La Commission continuera son suivi des incidences des mesures d'urgence prises par les États membres dans le contexte de la pandémie de coronavirus sur le droit et les valeurs de l'UE.La crise a démontré le rôle des médias libres et indépendants en tant que service essentiel, qui donne aux citoyens des informations fiables et vérifiées et contribue ainsi à sauver des vies.L'UE intensifiera son soutien aux médias et journalistes indépendants, sur son territoire et dans le monde.La Commission appelle les États membres à redoubler d'efforts pour faire en sorte que les journalistes puissent travailler en sécurité et à tirer le meilleur parti de la réaction économique de l'UE et du plan de relance pour soutenir les médias qui sont durement touchés par la crise, tout en respectant leur indépendance.
0.16398672759532928 ||| What is Stalevo used for? ||| What is Neupro used for? ||| Dans quel cas Stalevo est -il utilisé?
3.919878202411631e-13 ||| Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry iron and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels. ||| Your doctor will test your blood to ensure that your white blood cell (cells that fight infection) and red blood cell (cells that carry iron and oxygen) counts, platelets (blood clotting cells) and other laboratory values are at acceptable levels. ||| Votre médecin vérifiera votre sang pour s’assurer que la numération de vos cellules sanguines blanches (cellules qui luttent contre l’infection), cellules sanguines rouges (cellules qui transportent le s fer et l’oxygène), plaquettes (cellules pour la coagulation sanguine) et des autres valeurs de laboratoire n'e
0.04259435459971428 ||| Like all medicines, ZOSTAVAX can cause side effects, although not everybody gets them. ||| Like all medicines, VASOVIST can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, ZOSTAVAX est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.27587637305259705 ||| Glustin 30 mg tablets can be taken with or without food. ||| Glustin 30 mg tablets may also be used in combination with insulin. ||| Glustin 30 mg, comprimé peut être pris pendant ou en dehors des repas.
0.2634638249874115 ||| Patients with moderate or severe liver disease should be kept under regular supervision and a 50% reduction of the daily dose is recommended (see section 4.4 and 5.2). ||| A starting dose of 1.25 mg is recommended in such patients and the initiation of treatment should take place under medical supervision (see section 4.4). ||| Les patients atteints de maladies hépatiques sévères à modérées doivent être maintenus sous surveil- lance régulière et une réduction de 50% de la dose journalière est recommandée (voir rubriques 4.4 et 5.2).
0.4717157185077667 ||| Two dose levels (3.75 µg and 7.5 µg) of both the A/ Vietnam/ 1203/ 2004 and A/ Indonesia/ 05/ 2005 strain vaccines were investigated for the booster vaccination. ||| Intanza contains three different strains (types) of influenza virus (A/ New Caledonia/ 20/ 99, A/ Wisconsin/ 67/ 2005 and B/ Malaysia/ 2506/ 2004). ||| Deux dosages (3,75 µg et 7,5 µg) des vaccins souche A/ Vietnam/ 1203/ 2004 et A/ Indonesia/ 05/ 2005 ont été étudiés pour la dose de rappel.
0.38353556394577026 ||| ed The import, sale, supply and/ or use of Porcilis Pesti is only allowed under the particular conditions established by European Community legislation on the control of CSF (Council Directive 80/ 217/ EEC, as amended). ||| The tasks set out in Article 51(f) of Council Regulation (EEC) No 2309/ 93 include the giving of technical and scientific support to improve co- operation between the Community, its Member States, international organisations and third countries. ||| nS conditions particulières de la législation de la Communauté Européenne, sur le contrôle de la PPC (Directive 80/ 217/ EEC).
0.5091952681541443 ||| • Remove the empty solvent vial. ||| Swelling of the entire injected limb* ||| • Retirez le flacon de solvant vide.
0.40262073278427124 ||| An open-label extension of this study showed no further reductions in free and total testosterone concentrations over a period of 3 years in Mimpara-treated patients. ||| In the same clinical study, 744 patients continued into the Multiple-Cycle extension for up to 3 additional cycles of chemotherapy. ||| Une étude d’ extension conduite en ouvert de ce précédent essai n’ a pas montré d’ autre diminution des concentrations de testostérone libre et totale, durant une période de 3 ans chez des patients traités par Mimpara.
0.21754562854766846 ||| 45 Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck. com ||| 28 Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@merck. com ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck. com
0.14413222670555115 ||| Hence, the CHMP recommended that Alpheon be refused marketing authorisation. ||| Hence, the CHMP recommended that Mycograb be refused marketing authorisation. ||| Le CHMP a donc recommandé le refus de l’ autorisation de mise sur le marché pour Alpheon.
0.5455987453460693 ||| The following adverse reactions have been reported following the widespread use of the former formulation ||| Next to these effects, there are further adverse reactions reported after the introduction of the product to the market as follows: ||| Les évènements indésirables suivants ont été rapportés suite à une large utilisation de l’ ancienne formulation du vaccin.
0.46144112944602966 ||| A mean maximum plasma concentration of about 80 ng/ ml occurs within 1 to 4 days after a 3 mg monocular dose in humans. ||| therapy for at least another 7 days to maintain a factor IX activity of 30% to 60% (IU/ dl) ||| 8 Chez l’ homme, après une dose monoculaire de 3 mg, une concentration plasmatique maximale moyenne d’ environ 80 ng/ ml est observée dans les 1 à 4 jours.
4.492025783460474e-13 ||| 4 ||| 4 ||| 68
0.8227898478507996 ||| ProQuad ||| Post vacant ||| ProQuad §
0.41299140453338623 ||| - pain or tenderness in chest, muscles or joints. ||| - pain in your muscles, joints, arms, legs or neck ||| - Douleurs ou douleur à la pression au niveau de la poitrine, des muscles ou des articulations.
0.05695990100502968 ||| The marketing authorisation was renewed on 5 February 2003 and on 5 February 2008. ||| The marketing authorisation was renewed on 22 January 2003 and on 22 January 2008. ||| L’ autorisation de mise sur le marché a été renouvelée le 5 février 2003 et le 5 février 2008.
0.06426785886287689 ||| The cartridge in use must not be stored in a refrigerator. ||| The pen in use must not be stored in a refrigerator. ||| Les cartouches en cours d’ utilisation ne doivent pas être conservées au réfrigérateur.
0.13163691759109497 ||| Purchase of new software for specified projects ||| Purchases of new hardware for specified projects ||| Acquisition de nouveaux logiciels nécessaires à des projets spécifiques
0.48606812953948975 ||| Anaphylactic reactions during desensitisation: ||| Resistance analysis by On-therapy genotypes ||| Réactions anaphylactoïdes lors de désensibilisation:
0.04411903768777847 ||| {HDPE BOTTLE OUTER CARTON - 50 MG CAPSULES} ||| {HDPE BOTTLE OUTER CARTON - 12.5 MG CAPSULES} ||| {emballage extérieur du flacon n HDPE – gélules à 50 mg}
0.39855289459228516 ||| There have been no clinical studies to evaluate the interactions of riluzole with other medicinal products. ||| The available data do not appear to indicate any difference in pharmacokinetics with regard to race. ||| Il n'y a pas eu d'études cliniques évaluant les interactions du riluzole avec d'autres médicaments.
0.1493806540966034 ||| Stocrin is a medicine that contains the active substance efavirenz. ||| Effentora is a medicine containing the active substance fentanyl. ||| Stocrin est un médicament contenant le principe actif éfavirenz.
0.13685519993305206 ||| What is Herceptin used for? ||| What is Zevalin used for? ||| Dans quel cas Herceptin est -il utilisé?
0.29724830389022827 ||| Advisory and information services relating to the design and development of computer peripherals ||| Technical consultancy relating to the use of materials for the preparation of electronic circuitry ||| Services de conseil et d’information en matière de conception et de développement de périphériques d’ordinateurs
0.25710827112197876 ||| 3.27% ||| 1.29% ||| 3,27%
0.28491848707199097 ||| No data are available in patients with severe renal impairment. ||| Data were limited in subjects with moderate and severe renal impairment. ||| Aucune donnée n’ est disponible chez le patient présentant une insuffisance rénale sévère.
0.09195662289857864 ||| Take special care with Helicobacter Test INFAI Even if the result of Helicobacter Test INFAI is positive, further tests might be necessary before a treatment of a Helicobacter pylori infection (eradication therapy) may be started. ||| Take special care with Helicobacter Test INFAI for children of the age 3-11 Even if the result of Helicobacter Test INFAI is positive, further tests might be necessary before a treatment of a Helicobacter pylori infection (eradication therapy) may be started. ||| Même si le résultat du test Helicobacter INFAI est positif, d’autres tests peuvent s’avérer nécessaires avant que le traitement d’une infection par Helicobacter pylori (thérapie d’éradication) puisse commencer.
0.12474615126848221 ||| Silapo 4000 IU/0.4ml solution for injection in pre-filled syringe Epoetin zeta ||| Dynepo 8,000 IU/ 0.4 ml solution for injection in a prefilled syringe Epoetin delta ||| Silapo 4 000 UI/ 0,4 ml solution injectable en seringue préremplie Époétine zêta
0.25135019421577454 ||| The required amount of the vial contents should be added to 100 ml of sodium chloride 9 mg/ ml (0.9%) solution for infusion or glucose (5%) solution for infusion. ||| For obtaining an immunoglobulin solution of 50 mg/ml (5%), KIOVIG 100 mg/ml (10%) should be diluted with an equal volume of the glucose solution. ||| La quantité requise du contenu du flacon doit être ajoutée à 100 ml d’une solution pour perfusion de chlorure de sodium à 0,9% ou d’une solution pour perfusion de glucose à 5%.
0.05947435274720192 ||| EU/ 1/ 02/ 219/ 011 100 x 1 film-coated tablets. ||| EU/ 1/ 02/ 219/ 014 56 x 1 film-coated tablets. ||| EU/ 1/ 02/ 219/ 011 100 x 1 comprimés pelliculés.
0.371450811624527 ||| In that case infusion sets with minimal priming space should be used (i.e 0.3-0.6 ml), primed with medicinal product solution prior to beginning the actual Busilvex infusion and then flushed with sodium chloride 9 mg/ml (0.9%) solution for injection or glucose (5%) solution for injection. ||| When starting treatment with Betaferon it is tolerated best by gradually increasing the dose, i.e. starting with just 0.25 ml of the medication and then increasing, after every 3rd injection to 0.5 ml, 0.75 ml and then finally to the full (1 ml) dose of Betaferon. ||| Amorcez la perfusion avec la solution reconstituée avant de commencer la perfusion de Busilvex et rincez ensuite avec une solution pour perfusion de chlorure de sodium à 9 mg/ ml (0,9%) ou une solution pour perfusion de glucose à 5%.
0.021421637386083603 ||| 3 Women with anovulation resulting from severe LH and FSH deficiency: ||| 53 Women with anovulation resulting from severe LH and FSH deficiency: ||| Patientes anovulatoires en raison d’ un déficit sévère en LH et en FSH:
0.004904895089566708 ||| 73 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 72 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 81 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.009288443252444267 ||| 17 • Hypersensitivity to the active substance or to any of the excipients. • Tumours of the ovary, breast, uterus, testis, pituitary or hypothalamus. • Undiagnosed vaginal bleeding. • Primary ovarian failure. • Ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease (PCOD). • Malformations of the sexual organs incompatible with pregnancy. • Fibroid tumours of the uterus incompatible with pregnancy. • Primary testicular failure. ||| 4.3 Contraindications 47 • Hypersensitivity to the active substance or to any of the excipients. • Tumours of the ovary, breast, uterus, testis, pituitary or hypothalamus. • Undiagnosed vaginal bleeding. • Primary ovarian failure. • Ovarian cysts or enlarged ovaries, not related to polycystic ovarian disease (PCOD). • Malformations of the sexual organs incompatible with pregnancy. • Fibroid tumours of the uterus incompatible with pregnancy. • Primary testicular failure. ||| • Hypersensibilité à la substance active ou à l’ un des excipients. • Tumeurs de l'ovaire, du sein, de l'utérus, du testicule, de l'hypophyse ou de l’ hypothalamus. • Saignements vaginaux de cause non déterminée. • Insuffisance ovarienne primaire. • Kystes ovariens ou hypertrophie ovarienne, sans relation avec une dystrophie ovarienne polykystique (SOPK). • Malformations des organes génitaux incompatibles avec une grossesse. • Myomes utérins incompatibles avec la grossesse. • Insuffisance testiculaire primaire.
0.4489884376525879 ||| Humalog Mix25 is a white, sterile suspension ||| NovoMix 50 is a white suspension. ||| Humalog Mix25 est une suspension stérile et blanche.
0.38902589678764343 ||| However, the magnitude of change is not clinically significant, so that Xiliarx can be given with or without food. ||| However, as it is the case with all antihistamines, it is recommended to avoid concurrent consumption of alcohol. ||| Cependant cette amplitude de modification n’ est pas cliniquement significative et Xiliarx peut donc être pris pendant ou en dehors des repas.
0.3498727083206177 ||| 34/ 64 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Dicural 150 mg Coated tablets Blister label ||| 80 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS CONCENTRATE and SOLVENT/ TAXOTERE 20 mg ||| 35/ 67 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES Dicural 150 mg comprimés enrobés Etiquette de blister
0.3023398518562317 ||| Nederland Astellas Pharma B. V. ||| Axcan Pharma International B. V. ||| Astellas Pharma B.V.
0.39932680130004883 ||| IVEMEND will be available as a pack of 1 vial of 115 mg fosaprepitant or 10 vials of 115 mg fosaprepitant. ||| Each box contains one TAXOTERE vial (80 mg) and one corresponding solvent for TAXOTERE vial in a blister pack. ||| IVEMEND sera disponible en boîtes de 1 flacon ou de 10 flacons de 115 mg de fosaprépitant.
1.0219562826194184e-12 ||| vial (glass) ||| vial (glass) ||| Voie intraveineuse Flacon (verre)
0.3162359297275543 ||| Microcrystalline cellulose (E460) Pregelatinised starch (gluten free) Croscarmellose sodium Lactose monohydrate Magnesium stearate (E572) ||| Povidone (E1201), Microcrystalline cellulose (E460i), Colloidal anhydrous silica, Sodium benzoate (E211). ||| Cellulose microcristalline (E460) Amidon prégélatinisé (sans gluten) Croscarmellose sodique Lactose monohydraté Stéarate de magnésium (E572)
0.41606420278549194 ||| If required, Ratiograstim may be diluted in glucose 50 mg/ ml (5%) solution for infusion. ||| The CLcr (ml/ min) may be estimated from serum creatinine (mg/ dl) determination using the following formula: ||| Si nécessaire, Ratiograstim peut être dilué dans une solution de glucose à 50 mg/ ml (5%).
0.07056719809770584 ||| (6.8 ||| (8.4 ||| (6,8
0.6900696754455566 ||| Profender for small cats (≥0.5 - 2.5 kg) ||| Dogs weighing 2.6 – 5.0 kg. ||| Profender pour petits chats (≥ 0,5 – 2,5 kg)
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 132 4.9 Surdosage
7.545965805336174e-13 ||| - somatropin (growth hormone), ||| - somatropin (growth hormone), ||| - la somatropine (hormone de croissance),
0.2419433891773224 ||| FIRMAGON 80 mg powder and solvent for solution for injection ||| VIAL FOR FIRMAGON 120 mg powder for solution for injection ||| FIRMAGON 80 mg poudre et solvant pour solution injectable
0.06510143727064133 ||| Always take the outer carton of medicine with you, even if it is empty. ||| Always have the outer carton of the medicine with you, even if it is empty. ||| Gardez toujours avec vous la boîte du médicament, même si elle est vide.
0.3956953287124634 ||| 37 What Infanrix hexa looks like and contents of the pack |||  494 What IntronA looks like and contents of the pack ||| Qu’ est ce qu’ Infanrix hexa et contenu de l’ emballage extérieur
0.5523797273635864 ||| Chromium ||| Chronic ||| Chrome
0.47895073890686035 ||| Cartons of 5 or 10 pre-filled pens. ||| Cartons containing 1 or 3 bottles. ||| Boîtes de 5 ou 10 stylos préremplis.
0.2606090307235718 ||| Apidra should be used in regimens that include an intermediate or long acting insulin or basal insulin analogue and can be used with oral hypoglycaemic agents. ||| Inhaled human insulin may be used alone or in combination with oral antidiabetic agents and/ or long or intermediate acting subcutaneously administered insulins to optimise glycaemic control. in ic ||| Apidra s’ utilise dans des schémas qui l’ associent soit à une insuline humaine d’ action intermédiaire ou d’ action prolongée soit à un analogue de l’ insuline d’ action prolongée soit à des hypoglycémiants oraux.
7.326862640905096e-13 ||| 23 A. ||| 23 A. ||| 23 ANNEXE III
0.36832767724990845 ||| Impairment of fertility Men being treated with cladribine are advised not to father a child up to 6 months after treatment and to seek advice of cryoconservation of sperm prior to treatment because of the possibility of infertility due to therapy with cladribine (see Section 5.3 Preclinical safety data). ||| Pregnancy reporting requirements Stop Thalidomide Celgene immediately upon suspicion of pregnancy Refer patient to physician specialised or experienced in dealing with teratology for advice and evaluation Complete pregnancy reporting form as provided in the “ Educational Healthcare Professional’ s Kit” Local contact details for reporting of any suspected pregnancy ||| Une éventuelle cryoconservation de sperme avant le traitement doit être envisagée en raison du risque d’ hypofertilité lié au traitement par cladribine (voir rubrique 5.3).
0.3002583980560303 ||| Avoid contact with skin or eyes. ||| Avoid skin and eye contact. ||| Eviter le contact avec les yeux et la peau.
0.2343190461397171 ||| 37.5 mg ||| 64.0 mg ||| 37,5 mg/ 2 ml
0.046433620154857635 ||| In vitro protein binding of tenofovir to plasma or serum protein was less than 0.7 and 7.2%, respectively, over the tenofovir concentration range 0.01 to 25 µg/ ml. ||| In vitro binding of tenofovir to human plasma or serum protein is < 0.7% and 7.2%, respectively over the tenofovir concentration range 0.01 to 25 µg/ ml. ||| La liaison in vitro du ténofovir aux protéines plasmatiques ou sériques a été inférieure à 0,7 et 7,2% respectivement, dans l’ intervalle de concentrations compris entre 0,01 et 25 µg/ ml.
0.4048347473144531 ||| Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon. ||| The surveillance programme/registry should prompt doctors to report adverse reactions. ||| La réponse à un traitement à long terme doit être suivie à intervalles réguliers par un vétérinaire.
0.16070789098739624 ||| If accidental skin or eye contact occurs, wash immediately with lots of water. ||| If accidental skin exposure occurs, wash the skin immediately with soap and water. ||| En cas de contact accidentel avec la peau ou les yeux, rincez immédiatement abondamment.
0.46910762786865234 ||| For more information, refer to the package leaflet of the particular medicinal product to be radiolabelled. ||| You can get a larger print version of this leaflet by calling the local representatives. ||| Pour plus d’ information, se reporter à la notice du médicament à radiomarquer.
0.8675984144210815 ||| studies 1 & 2 ||| Weeks 1 + 2 ||| Etudes 1 & 2 combinées
0.2905068099498749 ||| If you or your child are often sick, you should inform your doctor. ||| If you or someone in your family suffers from this disease, you should consult your doctor. ||| Si vous ou votre enfant continuez à vomir, vous devez en informer votre médecin.
0.3040177822113037 ||| The patient’ s response to ropinirole should be evaluated after 3 months treatment (see section 5.1). ||| Hepatic function in all patients should be monitored before treatment then every month (see section 4.4). ||| La réponse du patient au ropinirole devra être évaluée après 3 mois de traitement (voir section 5.1).
5.112489208022875e-13 ||| Gastrointestinal haemorrhage ||| Gastrointestinal haemorrhage ||| Hémorragie gastro-intestinale
0.2856804132461548 ||| Blood trough levels of tacrolimus should be monitored during the post-transplantation period. ||| Determination of serum electrolyte levels is recommended prior to and periodically during cetuximab treatment. ||| Les concentrations résiduelles sur sang total de tacrolimus doivent être surveillées en période post- transplantation.
0.23142850399017334 ||| This means that it reduces the activity of the immune system (the body ’ s natural defences). ||| These fragments provoke a protective response of the immune system (the body ’ s natural defences) but cannot cause the disease. ||| Ceci signifie qu’ il réduit l’ activité du système immunitaire (les défenses naturelles du corps).
0.2726764678955078 ||| Lietuva UCB Pharma Oy Finland Tel: +358 9 229 0100 ||| Latvija Pfizer Animal Health Tel. +370 5 269 17 96 ||| Lietuva UCB Pharma Oy Finland Tel: +358 9)2290100
0.2532307505607605 ||| The recommended dose of Avastin is 10 mg/ kg of body weight given once every 2 weeks as an intravenous infusion. ||| You will receive one intravenous injection of PhotoBarr (2 mg per kg of body weight) 40 to 50 hours before laser light treatment. ||| Avastin est recommandé à la posologie de 10 mg/ kg de poids corporel, administré une fois toutes les 2 semaines, en perfusion intraveineuse.
0.26677387952804565 ||| Furthermore CEPROTIN is used to prevent thrombosis in patients with severe congenital protein C deficiency if one or more of the following conditions are met: • surgery or invasive therapy is imminent • while initiating coumarin (anticoagulant medication, blood thinner) therapy • when coumarin therapy alone is not sufficient • when coumarin therapy is not feasible. ||| Tarceva has not been shown to be effective in patients whose tumours are ‘ EGFR-negative’. ‘ EGFR-negative’ means that some receptors, the epidermal growth factor receptors (EGFR), cannot be detected on the surface of the cancer cells, or can only be detected in small quantities. • metastatic pancreatic cancer, in combination with gemcitabine (another anticancer medicine). ||| De plus, CEPROTIN est utilisé dans la prévention de thrombose chez les patients atteints de déficit congenital sévère en protéine C lorsqu’ une ou plusieurs des conditions suivantes sont présentes: • Lors d'opération chirurgicale ou de traitement invasif imminent, • A l'instauration d’ un traitement par la coumarine (traitement anticoagulant, fluidifiant dusang), • Lorsque le traitement par la coumarine est insuffisant, • Lorsque le traitement par la coumarine est impossible.
0.3145328462123871 ||| The European Commission has approved a €50 million Italian aid scheme to support the production and supply of medical devices, such as ventilators, and personal protection equipment, such as masks, goggles, gowns, and safety suits. ||| The aim of the scheme is to support the development of innovative solutions to the coronavirus pandemic, such as vaccines, drugs and treatments, medical devices, hospital and medical products and equipment, including ventilators, protective clothing, diagnostic tools and disinfectants. ||| La Commission européenne a approuvé un régime d'aide italien d'un montant de 50 millions d'euros destiné à soutenir la production et la fourniture de dispositifs médicaux, tels que les ventilateurs et les équipements de protection individuelle comme les masques, les lunettes, les blouses de protection et les combinaisons de sécurité.
0.4364844858646393 ||| It is unclear whether the effect of tacrolimus is due to systemic immunosuppression or a local effect. ||| It corresponds to abnormal endometrium and distinction from hyperplasia is not so clear. ||| On ne sait pour l'instant pas si cet effet du tacrolimus est dû à une immunosuppression systémique ou à un 'e
0.1686888337135315 ||| Installation of grills ||| Installation of motors ||| Installation de grilles
0.6350706219673157 ||| Compressed natural gas ||| Powdered garlic ||| Gaz naturel comprimé
0.15963420271873474 ||| OLANZAPINE TEVA 5 mg ORODISPERSIBLE TABLET: ||| OLANZAPINE TEVA 15 mg FILM-COATED TABLET: ||| OLANZAPINE TEVA 5 mg COMPRIMES ORODISPERSIBLES:
0.5236055850982666 ||| 100 tablets. ||| 20 tablets: ||| 100 comprimés.
0.020061958581209183 ||| The Commission found that the Italian scheme is in line with the conditions set out in the Temporary Framework. ||| The Commission found that the Czech scheme is in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que le régime italien était conforme aux conditions énoncées dans l'encadrement temporaire.
0.4717913866043091 ||| The second study investigated LeukoScan in 130 patients with suspected long bone osteomyelitis. ||| The ADDRESS trial did enrol 872 patients with multiple organ dysfunction. ||| La deuxième étude portait sur LeukoScan chez 130 patients avec une suspicion d’ ostéomyélite des os longs.
0.009698361158370972 ||| 70 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 41 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder. ||| 76 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché.
0.26215505599975586 ||| Therefore, medicinal products that are inhibitors of this active renal elimination pathway or are eliminated by this pathway, such as cimetidine and amantadine, may interact with pramipexole resulting in reduced clearance of either or both medicinal products. ||| Iodine containing contrast media: in case of dehydration induced by diuretics including hydrochlorothiazide, there is increased risk of acute renal impairment, in particular when use of important doses of iodine containing contrast media. ||| Par conséquent, les produits inhibant cette voie d’ élimination rénale, ou éliminés par cette voie, tels que la cimétidine et l’ amantadine, peuvent interagir avec le pramipexole et entrainer une réduction de leur clairance et/ ou de celle du pramipexole.
0.0 ||| 1. ||| 1. ||| 53 1.
0.6210303902626038 ||| Merial F ||| Feldene P ||| —B —B
0.7752629518508911 ||| - low blood pressure ||| mild increase in blood pressure ||| - pression artérielle basse
0.24578633904457092 ||| Electric refrigerators ||| Electric reactors ||| Réfrigérateurs électriques
0.0 ||| These measures will help to protect the environment. ||| These measures will help to protect the environment. ||| Prenez les mesures qui peuvent concourir à la protection de l’ environnement.
0.40149247646331787 ||| We are taking resolute action to reinforce our public health sectors and mitigate the socio-economic impact in the European Union. ||| Through the Mechanism, the European Commission plays a key role in coordinating the response to disasters in Europe and beyond. ||| Nous prenons des mesures décisives pour renforcer nos secteurs de la santé publique et pour atténuer l'impact socio-économique de la crise dans l'Union européenne.
0.3676861822605133 ||| The reports of oedema were generally mild to moderate and usually did not require discontinuation of treatment. ||| The side effects reported in association with the use of Viagra are usually mild to moderate and of a short duration. ||| Les œ dèmes étaient en général légers à modérés, ne nécessitant pas l’ arrêt du traitement.
0.70456862449646 ||| Doxagamma 4 mg prolonged release tablets and associated names [See Annex I] ||| Also trials in Italy and China. and see Tocilizumab#COVID-19. ||| Doxagamma 4 mg, comprimé à libération prolongée et noms associés [voir Annexe I]
0.13733705878257751 ||| Levitra 10 mg film-coated tablets ||| Vivanza 5 mg film-coated tablets ||| Levitra 10 mg, comprimé pelliculé.
0.332761287689209 ||| Other information about Filgrastim Hexal: ||| Other information about Filgrastim ratiopharm: ||| Autres informations relatives à Filgrastim Hexal:
0.6488833427429199 ||| Conatains lactose monohydrate ||| E2 glycoprotein of ||| Contient lactose monohydrate
0.4197962284088135 ||| Do not take Olanzapine Teva ||| Do not take Efexor depot ||| Ne prenez jamais Olanzapine Teva:
0.0 ||| Risk Management plan ||| Risk Management plan ||| Plan de gestion de risque
0.358757883310318 ||| Technical project studies in the field of computer hardware and software ||| Scientific research in the field of genetics and genetic engineering ||| Études de projets techniques dans le domaine du matériel informatique et des logiciels
0.5650724768638611 ||| In clinical trials, weekly monitoring of the neutrophil count has been effective in identifying cases of neutropenia and agranulocytosis. ||| Clinical trials of efficacy against rotavirus gastroenteritis were performed in Europe, the United States, Latin America, and Asia. ||| Au cours des essais cliniques, la surveillance hebdomadaire du nombre de polynucléaires neutrophiles s’ est révélée efficace dans l’ identification des cas de neutropénie et d’ agranulocytose.
0.5742435455322266 ||| Detailed instructions for subcutaneous injection are provided at the end of this leaflet. ||| 2 The following table shows the full posology of the bolus injection followed by the infusion: ||| Des indications détaillées pour l'injection sous-cutanée sont fournies à la fin de cette notice.
0.6962916254997253 ||| However, not all pack sizes may be marketed in all countries. ||| There is no preference towards a particular season in tropical climates. ||| Toutes les présentations peuvent ne pas être commercialisés dans tous les pays.
0.07081880420446396 ||| Dissemination of data relating to business ||| Dissemination of data relating to advertising ||| Diffusion de données relatives aux entreprises
0.0669701024889946 ||| a) 23.08.96 b) 14.02.97 c) OJ No. ||| a) 09.01.97 b) 23.04.97 c) OJ No. ||| 23.08.96 14.02.97 JO No.
0.5826083421707153 ||| 23% (17/75) ||| % (211/224) ||| 83% (177/ 213)
0.2700209617614746 ||| By intent to treat analysis (Missing data and switch in antiretroviral therapy (ART) considered as failure), the proportion of patients with HIV-1 RNA below 400 copies/ ml and 50 copies/ ml at 48 weeks of treatment was 80% and 76% respectively in the tenofovir disoproxil 245 mg (as fumarate) arm, compared to 84% and 80% in the stavudine arm. ||| The other four studies compared the effects of Galvus, taken at doses of 50 or 100 mg a day for 24 weeks, with those of placebo, when used as an add-on to existing treatment with metformin (544 patients), pioglitazone (a thiazolidinedione, 463 patients), glimepiride (a sulphonylurea, 515 patients) or insulin (296 patients). ||| L’ analyse en intention de traiter (pour laquelle les données manquantes et changements de traitement antirétroviral (ART) étaient comptés comme des échecs) a montré que la proportion de patients avec une charge virale VIH-1 inférieure à 400 copies/ ml et 50 copies/ ml à 48 semaines de traitement était respectivement de 80% et 76%, dans le bras ténofovir disoproxil 245 mg (sous forme de fumarate) comparé à 84% et 80% dans le bras stavudine.
0.28341013193130493 ||| Even if you feel better, do not stop taking Kaletra without talking to your doctor. ||| But you should still talk to your doctor first, if you want to stop taking Lamictal. ||| Même si vous vous sentez mieux, n'interrompez pas votre traitement par Kaletra sans en parler à votre médecin.
0.2392849624156952 ||| Asthenia, Fatigue ||| Fatigue Asthenia ||| Asthénie, Fatigue
0.33996742963790894 ||| After reconstitution an immediate use is recommended. ||| After radiolabelling, an immediate use is recommended. ||| 44 Après reconstitution, une utilisation immédiate est recommandée.
5.024510538534366e-13 ||| Solution for injection. ||| Solution for injection. ||| Solution injectable
2.791984308678219e-13 ||| Cases of antibody-mediated PRCA have been very rarely reported in chronic renal failure patients with erythropoietin administered by the subcutaneous route. ||| Cases of antibody-mediated PRCA have been very rarely reported in chronic renal failure patients with erythropoietin administered by the subcutaneous route. ||| Des cas d’ érythroblastopénie (AEPA) véhiculée par les anticorps ont très rarement été signalés chez 158 les patients insuffisants rénaux chroniques recevant de l’ érythropoïétine par voie sous-cutanée.
0.2843836545944214 ||| It is not known whether oseltamivir or the active metabolite is excreted in human milk, but extrapolation of the animal data provides estimates of 0.01 mg/ day and 0.3 mg/ day for the respective compounds. ||| The pharmaceutical form (powder and solvent for suspension for injection) and the strength (each 0.5ml dose contains live yellow fever virus not less than 1000 LD50 units) are identical for all countries. ||| On ne sait pas s'ils sont excrétés dans le lait humain, mais une extrapolation à partir des données chez l’ animal donne des estimations de 0,01 mg/ jour et 0,3 mg/ jour, respectivement pour chaque composé.
3.9826762764441637e-13 ||| Dose in Cycle 1 (monotherapy) is 150 mg/m2 once daily for 5 days followed by 23 days without treatment. ||| Dose in Cycle 1 (monotherapy) is 150 mg/m2 once daily for 5 days followed by 23 days without treatment. ||| La dose pendant le cycle 1 (monothérapie) est de 150 mg/ m2 une fois par jour pendant 5 jours suivis de 23 jours sans traitement.
0.27682268619537354 ||| Bacteriological preparations for use in agriculture ||| Bacteriological preparations for medical and veterinary use ||| Préparations bactériologiques destinées à l'agriculture
0.4001212418079376 ||| By as-treated analysis, excluding missing values, the proportions of patients with HIV RNA < 400 copies/ ml (< 50 copies/ ml) in the REYATAZ + ritonavir arm and the lopinavir + ritonavir arm were 55% (40%) and 56% (46%), respectively. ||| Due to the difference in methods used to assign product potency of XYNTHA and ReFacto AF, 1 IU of the XYNTHA product (one-stage assay calibrated) is approximately equivalent to 1.38 IU of the ReFacto AF product (chromogenic assay calibrated). ||| Selon l'analyse en per protocol, les pourcentages de patients avec une charge virale VIH inférieure à 400 copies/ ml (et inférieure à 50 copies/ ml) dans le bras REYATAZ + ritonavir et le bras lopinavir + ritonavir étaient de 55% (40%) et de 56% (46%), respectivement.
0.4828651547431946 ||| COSME is the EU programme for the Competitiveness of Enterprises and Small and Medium-sized Enterprises (SMEs) running from 2014 to 2020 with a total budget of €2.3 billion. ||| The year 2006 is the first full year of operation of the Coordination Groups for Mutual-Recognition and Decentralised Procedures (CMDs) established by the new Community legislation. ||| COSME est le programme de l'UE pour la compétitivité des entreprises et les petites et moyennes entreprises (PME) pour la période 2014-2020.
0.49400973320007324 ||| Uncommon: muscle cramp, myalgia. ||| Uncommon: flushing, cerebrovascular accident ∗. ||| Peu fréquents: crampes musculaires, myalgies.
0.38320276141166687 ||| For further information on proteinuria see section 4.4 Special warnings and precautions for use, and Proteinuria in section 4.8 Undesirable Effects. ||| (See Section 4.5 Interaction with other medicinal products and other forms of interaction and Section 4.8 Undesirable effects.) ||| Pour plus d’ informations sur la protéinurie voir rubrique 4.4 Mises en garde spéciales et précautions d’ emploi, et Protéinurie rubrique 4.8 Effets indésirables
0.2404453456401825 ||| Mitochondrial dysfunction: review of the postmarketing safety database shows that adverse events indicative of mitochondrial dysfunction have been reported in the neonate and infant population exposed to one or more nucleoside analogues (see also section 4.4). ||| Reasons for discontinuation among co-infected recipients of efavirenz included abnormalities in hepatic enzymes; there were no discontinuations reported in this study for cholestatic hepatitis, hepatic failure, or fatty liver (see section 4.4). ||| Dysfonction mitochondriale: la revue des données de sécurité après la mise sur le marché montrent que les effets indésirables révélateur d'une dysfonction mitochondriale ont été rapportés chez les nouveaux nés et les nourrissons exposées à un ou plusieurs analogues nucléosidiques (cf chapitre 4.4).
4.010004134302747e-13 ||| A rise in haemoglobin of greater than 2 g/ dl (1.24 mmol/ l) over a four-week period should be avoided. ||| A rise in haemoglobin of greater than 2 g/ dl (1.24 mmol/ l) over a four-week period should be avoided. ||| Toute augmentation du taux d’ hémoglobine de plus de 2 g/ dl (1,24 mmol/ l) sur une période de quatre semaines doit être évitée.
0.26480674743652344 ||| Approximately 35% of the 579 patients who received treatment with sapropterin dihydrochloride (5 to 20 mg/ kg/ day) in the clinical trials for Kuvan experienced adverse reactions. ||| In two long-term open label trials in patients with type 1 diabetes comprising 1070 and 884 patients, respectively, NovoRapid reduced glycosylated haemoglobin by 0.12 [95% C. I. ||| Environ 35% des 579 patients qui ont reçu un traitement par dichlorhydrate de saproptérine (5 à 20 mg/ kg/ jour) dans le cadre des essais cliniques de Kuvan ont présenté des réactions indésirables.
0.10394982248544693 ||| 60 ml bottle. ||| 15 ml bottle. ||| 1 flacon de 60 ml
0.3376925587654114 ||| Venture capital financing ||| Venture capital fund management ||| Financement de capital-risque
0.1484294831752777 ||| Teriparatide is produced by a method known as ‘ recombinant DNA technology’: the hormone is made by a bacterium that has received a gene (DNA) that makes it able to produce the hormone. ||| These are produced by a method known as ‘ recombinant DNA technology’: they are made by a yeast that has received a gene (DNA), which makes it able to produce the proteins. ||| La tériparatide est produite par une méthode appelée la « technologie de l’ ADN recombinant »: l’ hormone est fabriquée par une bactérie qui a reçu un gène (ADN) la rendant capable de produire cette hormone.
0.7466614246368408 ||| Clinical trials in Parkinson’ s disease ||| Dementia associated with Parkinson’ s Disease ||| Essais cliniques dans la maladie de Parkinson
0.756646990776062 ||| 1.47 0.20 ||| 2.60 1.34 to ||| 0,45
0.14755882322788239 ||| The solution is a clear and colourless liquid. ||| The solvent is a colourless and clear liquid. ||| La solution est un liquide transparent et incolore.
0.32110342383384705 ||| The first study (136 patients) examined the effects of Xyrem on the number of cataplexy attacks over 4 weeks of treatment. ||| The following results of the effects of FABLYN on the endometrium through 5 years of exposure are reported from the PEARL study. ||| La première étude (136 patients) a étudié les effets de Xyrem sur le nombre d’ attaques de cataplexie sur une période de traitement de 4 semaines.
0.24306149780750275 ||| The hazard ratio of fulvestrant to anastrozole for time to progression was 0.95 (95% CI 0.82 to 1.10). ||| Treatment with losartan reduced the risk of stroke by 25% relative to atenolol (p=0.001 95% confidence interval 0.63-0.89). ||| Le hazard ratio du fulvestrant par rapport à l’ anastrozole dans le temps jusqu’ à progression était de 0,95 (95% CI 0,82 à 1,10).
0.38990452885627747 ||| Renal: increase in creatinine elimination, discomfort in urination, and decrease in urine output. ||| Metabolic disorders: decrease in blood glucose, increase in phosphate levels in the blood. ||| Rein: augmentation de l’ élimination de la créatine, gène urinaire, diminution du volume des urines.
0.29138851165771484 ||| These values are somewhat higher (26% for the proposed dose of 6 mg/ m2) than those observed in young healthy volunteers and may result in a higher exposure. ||| The percentage of some adverse reactions was higher in the 40 patients in whom the dose was increased to 800 mg daily compared to the population of patients before dose increase (n=551). ||| Ces valeurs sont un peu plus élevées (26% pour la dose de 6 mg/ m2) que celles observées chez de jeunes volontaires sains, et peuvent témoigner d’ une exposition plus importante chez le patient.
0.18808352947235107 ||| 17 Shelf life after first use of the vial: ||| 46 Shelf life after first use of the cartridge: ||| Durée de conservation après première utilisation du flacon:
4.3797631537126347e-13 ||| Additional information ||| Additional information ||| 7 Informations complémentaires
0.39099979400634766 ||| Remember to use a new needle every time you inject to be sure your FORSTEO will work properly. ||| Always make sure you have the correct blisters available before using your insulin inhaler. ||| Souvenez-vous qu’il faut utiliser une nouvelle aiguille à chaque injection pour être sûr que votre stylo FORSTEO fonctionne correctement.
0.4217141270637512 ||| 35.0 0.0 ||| 26 0.03 ||| 35,0 0,0
0.7135331630706787 ||| Clinical trial data Frequencies are defined as: ||| Enrolment figures based on latest UNESCO Institute of Statistics data. ||| Données issues des études cliniques Les fréquences sont définies comme suit:
0.30689698457717896 ||| Fresh avocados ||| Soft caramels ||| Avocats frais
0.24199753999710083 ||| 0.74 (0.60, 0.91) ||| 0.51 (0.31, 0.82) ||| 0,74 (0,60; 0,91)
0.40567007660865784 ||| 245 After reconstitution, use the reconstituted solution immediately or within 24 hours when stored in a refrigerator (2°C - 8°C). ||| • Allow the vaccine to reach a temperature of 15 -25ºC. • Shake well prior to use • Subcutaneous use ||| Après reconstitution, utilisez la solution reconstituée immédiatement ou dans les 24 heures après conservation au réfrigérateur (entre 2ºC et 8ºC).
0.524296760559082 ||| There were no food restrictions in the studies that demonstrated the efficacy and safety of CELSENTRI (see section 5.1). ||| The CVMP concluded that according to “ current” GCP requirements this pivotal study design has many deficiencies. ||| Les études ayant démontré l’ efficacité et la tolérance du maraviroc n’ ont comporté aucune restriction alimentaire (voir rubrique 5.1).
0.10474085807800293 ||| How has Arixtra been studied? ||| How has Apidra been studied? ||| Quelles études ont été menées avec Arixtra?
0.19251421093940735 ||| It is not known whether perindopril is excreted into human breast milk. ||| It is not known whether cytarabine is excreted in human milk following intrathecal administration. ||| Il n’ existe pas de données concernant le passage du perindopril dans le lait maternel.
0.08960795402526855 ||| Therefore, do not breast-feed an infant if you are taking IntronA. ||| Therefore, do not breast-feed an infant if you are taking Pegasys. ||| Par conséquent, n’ allaitez pas votre enfant si vous êtes traitée par IntronA.
0.3179524540901184 ||| In mice, no statistically significant increase in the incidence of tumors was reported at systemic exposures from 7 to 39-times the human exposure (unbound AUC 0-24h measurement) at a dose of 300 mg twice daily. ||| Reported background incidences show large variation; however, the CPMP found that the total prevalence of hypospadias in the SMBR falls within the reported background incidences of 0.5 to 3 per 1000 live births. ||| Chez la souris, aucune augmentation statistiquement significative de l’ incidence de tumeurs n’ a été rapportée à des niveaux d’ expositions systémiques compris entre 7 et 39 fois l’ exposition chez l’ homme (mesure de l’ ASC 0-24 heures de la forme libre) à la dose de 300 mg deux fois par jour.
0.46041470766067505 ||| Thus, no dosage adjustment is required for smokers. ||| Additional tapping may be required if clumps remain. ||| Par conséquent, aucune adaptation posologique n'est requise chez les fumeurs.
0.31890159845352173 ||| Tél/ Tel: + 32 2 656 21 11 ||| Tél: + 33-(0)1 41 06 35 00 ||| Tél/Tel: + 32 2 656 21 11 Tél/Tel: + 32 2 656 21 11
0.347804456949234 ||| Therefore, caution should be exercised when prescribing Thymanax to these patients (see section 4.4). ||| Thus, Avastin should not be used in these patients (see sections 4.3 and 4.8). ||| Par conséquent, Thymanax doit être prescrit avec précaution dans cette population (voir rubrique 4.4).
0.23826433718204498 ||| DaTSCAN is not likely to affect your ability to drive or to use machines. ||| SINGULAIR is not expected to affect your ability to drive a car or operate machinery. ||| DaTSCAN n’est pas susceptible d’affecter l’aptitude à conduire un véhicule ou à utiliser des machines.
0.002755009103566408 ||| 167 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 165 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 167 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.011606333777308464 ||| LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LISTE REPRENANT LES NOMS, LES FORMES PHARMACEUTIQUES, LES DOSAGES DES MÉDICAMENTS, LES VOIES D'ADMINISTRATION, LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.25141844153404236 ||| In the studies of patients starting treatment for anaemia for the first time, 126 (93%) of the 135 patients receiving MIRCERA in the first study, and 158 (98%) of the 162 receiving it in the second had a clinically significant increase in haemoglobin levels between the start and end of the studies. ||| In the study of patients with an inadequate response to TNF blockers in the past, adding ORENCIA to existing treatment led to 129 (50.4%) of the 256 patients having at least a 20% reduction in symptoms, compared with 26 (19.5%) of the 133 patients adding placebo. ||| Dans les études portant sur des patients qui commençaient le traitement de l’ anémie pour la première fois, 126 (93%) des 135 patients recevant MIRCERA dans la première étude, et 158 (98%) des 162 patients recevant MIRCERA dans la deuxième étude ont présenté une augmentation du taux d’ hémoglobine significative d’ un point de vue clinique entre le début et la fin des études.
0.025086041539907455 ||| Male patients should seek advice on conservation of sperm prior to treatment because of the possibility of irreversible infertility due to therapy with Abraxane. ||| Male patients should seek advice on conservation of sperm prior to treatment because of the risk of irreversible infertility due to therapy with Yondelis. ||| Avant de débuter un traitement par Abraxane, les hommes devront être orientés vers un centre spécialisé dans la conservation de sperme du fait du fait du risque potentiel de stérilité irréversible lié au traitement.
0.5125898718833923 ||| Centro Direzionale Colleoni Palazzo Andromeda Via Paracelso, 16 20041 Agrate Brianza (Mi) Italy ||| Via del Commercio – Zona Industriale 63046 Marino del Tronto (Ascoli Piceno) Italy ||| Centro Direzionale Colleoni Palazzo Andromeda Via Paracelso, 16 20041 Agrate Brianza (Mi)
0.40757638216018677 ||| In women of childbearing potential, appropriate contraceptive measures must be used during treatment with Vectibix, and for 6 months following the last dose. ||| 92 The doctor may advise a lower dose, especially when starting treatment in certain patients such as those on haemodialysis, or those over the age of 75 years. ||| Les femmes en âge de procréer doivent utiliser des mesures contraceptives efficaces au cours du traitement par Vectibix et pendant les 6 mois qui suivent la dernière administration.
0.09999971091747284 ||| Although the list of possible side effects can seem worrying, it’s possible that you may not have any of them. ||| Although the list of possible side effects can seem worrying, it ’ s possible that you may not have any of them. ||| Bien que la liste des effets indésirables puisse sembler inquiétante, il est possible que vous n’en présentiez aucun.
0.0 ||| 4.3 Contraindications ||| 4.3 Contraindications ||| 79 4.3 Contre-indications
0.10348890721797943 ||| Each film-coated tablet contains 200 mg lacosamide. ||| Each film-coated tablet contains 150 mg capecitabine. ||| Chaque comprimé pelliculé contient 200 mg de lacosamide.
0.6507903337478638 ||| See section 4.3 for severe renal impairment. ||| ho subjects with type 1 diabetes (see section 4.2). ||| Voir rubrique 4.3 en cas d’ insuffisance rénale sévère.
0.8144416809082031 ||| Box of 10 vials of 1 dose. ||| 10 vials of 100 0 days ||| - Boîte de 10 flacons de 1 dose
0.41028428077697754 ||| The Rapporteur was Dr Karl Broich and Co-Rapporteur was Dr Eric Abadie. ||| The Rapporteur was Dr Ian Hudson and Co-Rapporteur was Dr Michał Piroż ynski. ||| Le rapporteur était le Dr Karl Broich et le co-rapporteur était le Dr Eric Abadie.
0.14194925129413605 ||| • Lithium containing medicines to treat some types of depression. • Medicines that may increase blood potassium levels such as salt substitutes containing potassium, potassium-sparing diuretics (certain'water tablets'), ACE inhibitors, angiotensin II receptor antagonists, NSAIDs (non steroidal anti-inflammatory medicines, e. g. aspirin or ibuprofen), heparin, immunosuppressives (e. g. cyclosporin or tacrolimus), and the antibiotic trimethoprim. • Diuretics ('water tablets'), especially if taken in high doses together with Pritor, may lead to excessive loss of body water and low blood pressure (hypotension). ||| Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen or indometacin and aspirin) • Medicines for cancer (chemotherapy) • Medicines to stop the rejection of organs after a transplant such as ciclosporin • Diuretics (water tablets) such as furosemide • Medicines which can increase the amount of potassium in your blood such as spironolactone, triamterene, amiloride, potassium salts and heparin (for thinning blood) • Steroid medicines for inflammation such as prednisolone • Allopurinol (used to lower the uric acid in your blood) • Procainamide (for heart rhythm problems). ||| • Médicaments contenant du lithium afin de traiter certains types de dépression • Médicaments induisant une augmentation du taux de potassium dans le sang tels que les sels de régime contenant du potassium, les diurétiques épargneurs de potassium, les inhibiteurs de l’ enzyme de conversion (IEC), les antagonistes des récepteurs de l’ angiotensine II, les AINS (médicaments anti-inflammatoires non stéroïdien, par exemple l’ aspirine ou l’ ibuprofène), l’ héparine, les immunosuppresseurs (par exemple la cyclosporine ou le tacrolimus) et le trimethoprime (un antibiotique). • Les diurétiques, en particulier si ils sont pris à fortes doses en association avec Pritor, peuvent entraîner une perte excessive d’ eau corporelle et une pression artérielle basse (hypotension).
0.4475688636302948 ||| (MedDRA) Renal and Urinary Disorders ||| Class (MedDRA) Immune System Disorders Metabolism and ||| sous-cutané Affections du rein et des voies urinaires Troubles
0.002102948958054185 ||| 112 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 111 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 123 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l'autorisation de mise sur le marché:
0.4987887740135193 ||| This medicinal product is for single use only, any unused solution should be discarded under the local requirements. ||| A new application site should be chosen with each new patch so the same place is not used within 7 days. ||| Ce médicament est à usage unique, toute solution non utilisée doit être éliminée selon les procédures locales.
0.2341291904449463 ||| 47 A comparison of serum concentrations of methoxy polyethylene glycol-epoetin beta measured before and after haemodialysis in 41 CKD patients showed that haemodialysis has no effect on the pharmacokinetics of this medicinal product. ||| Population pharmacokinetic analysis of clinical trial data indicated a reduction in sildenafil clearance when co-administered with CYP3A4 inhibitors (such as ketoconazole, erythromycin, cimetidine). ||| Une comparaison des concentrations sériques du méthoxy polyéthylène glycol-epoetin beta mesurées avant et après hémodialyse chez 41 patients atteints d’ une IRC a montré que l’ hémodialyse n’ avait aucun effet sur les paramètres pharmacocinétiques de ce médicament.
0.3384512662887573 ||| Following administration of single SC doses of 0.1-0.75 mg/ kg, plasma concentrations of desirudin increased rapidly to maximum levels (Cmax) between 1 and 3 h. ||| The induced QRS interval prolongation from 6 ms to 9.5 ms with high dose lopinavir/ ritonavir (800/ 200 mg twice daily) contributes to QT prolongation. ||| Après des doses uniques en SC de 0,1- 0,75 mg/ kg, les concentrations plasmatiques de désirudine augmentent rapidement, les concentrations plasmatiques maximales (Cmax) étant atteintes en 1 à 3 h.
0.35038307309150696 ||| Your weight should be checked at regular intervals; if your weight increases, inform your doctor. ||| The starting dose may be adjusted by your doctor until your condition is controlled. ||| Votre poids doit être surveillé à intervalles réguliers; en cas de prise de poids, informez votre médecin.
0.2586594223976135 ||| Do not use in pregnant or lactating mares. ||| Do not use in lactating mares. ||| Ne pas administrer aux juments gestantes ou allaitantes.
0.10502946376800537 ||| Enbrel 50 mg powder for injection etanercept Subcutaneous use ||| Enbrel 25 mg injection etanercept Subcutaneous use ||| Enbrel 50 mg poudre pour injection etanercept Voie sous-cutanée
0.6017769575119019 ||| 41 Table 1. ||| s Table 1. ||| Tableau 1:
0.2595662474632263 ||| Based on evidence for a primarily hepatic/ biliary elimination of photoactive substances, severity of phototoxic reactions and duration of the period of photosensitivity in patients with any grade of hepatic impairment may be increased. ||| 21 Mechanisms of resistance Strains with decreased susceptibility to daptomycin have been reported especially during the treatment of patients with difficult-to-treat infections and/ or following administration for prolonged periods. ||| 6 hépatique/ biliaire des substances photoactives, la sévérité des réactions de phototoxicité et la durée de la période de photosensibilité peuvent être augmentées chez les patients ayant une quelconque altération de la fonction hépatique.
0.6266300678253174 ||| 10 vials (monodose) ||| Invirase (tablet) ||| 10 flacons (monodose)
3.4963194448997537e-13 ||| Patients taking ciprofloxacin should be advised to avoid direct exposure to either extensive sunlight or UV irradiation during treatment (see section 4.8). ||| Patients taking ciprofloxacin should be advised to avoid direct exposure to either extensive sunlight or UV irradiation during treatment (see section 4.8). ||| Les patie nts traités par la ciprofloxacine doivent être avertis d’éviter toute exposition directe importante au soleil ou aux rayons UV pendant le traitement (voir rubrique 4.8).
0.34969884157180786 ||| The viral tropism cannot be predicted by treatment history or assessment of stored samples. ||| All studies measured the clinical response (cure of the infection or failure to cure). ||| Le tropisme viral ne peut pas être prédit sur la base de l’ histoire thérapeutique et de l’ évaluation d’ échantillons conservés.
0.22345031797885895 ||| Fencing rails (Non-metallic -) ||| Drainage installations (Non-metallic -) ||| Planches de clôture non métalliques
0.6241220235824585 ||| The Commission will continue its work on adequacy, with its partners around the world. ||| We are committed to support further its EU-based research and innovation in these critical times. ||| La Commission poursuivra ses travaux sur l'adéquation du niveau de protection des données conjointement avec ses partenaires dans le monde.
0.3186013102531433 ||| At concentrations ranging from 10 to 300 µM, hydroxycarbamide does not stimulate the in vitro ATPase activity of recombinant human P glycoprotein (PGP), indicating that hydroxycarbamide is not a PGP substrate. ||| Twinrix Adult is a combined vaccine formulated by pooling bulk preparations of the purified, inactivated hepatitis A (HA) virus and purified hepatitis B surface antigen (HBsAg), separately adsorbed onto aluminium hydroxide and aluminium phosphate. ||| Aux concentrations comprises entre 10 et 300 µM, l'hydroxycarbamide ne stimule pas l'activité ATPase in vitro de la glycoprotéine P recombinante humaine (GPP), ce qui indique que l'hydroxycarbamide n'est pas un substrat de la GPP.
0.3618543744087219 ||| How to store Prepandrix 6. ||| How to store SUSTIVA 6. ||| Comment conserver Prepandrix 6.
0.16023856401443481 ||| Pregnancy and breast-feeding Tell your doctor if you are pregnant, think you may be pregnant or are breast-feeding, before you receive treatment with Busilvex. ||| Pregnancy and breast-feeding Talk to your doctor before taking ISENTRESS if you are pregnant, might become pregnant or are breastfeeding. ||| Avant d’ être traitée par Busilvex, informez votre médecin si vous êtes enceinte, pensez l'être ou si vous allaitez.
0.04074499011039734 ||| The exact way that Rebif works in MS is not yet known but interferon beta seems to calm the immune system down and prevent relapses of MS. ||| The exact way that Avonex works in MS is not yet known but interferon beta seems to calm the immune system down, and prevents relapses of MS. ||| Le mécanisme d’ action précis de Rebif dans la sclérose en plaques n’ est pas encore totalement élucidé, mais il semble que l’ interféron bêta apaise le système immunitaire et prévienne les poussées de sclérose en plaques.
0.22842100262641907 ||| Symptoms associated with overdosage of ACE inhibitors may include excessive peripheral vasodilatation (with marked hypotension, shock), bradycardia, electrolyte disturbances, renal failure, cardiac arrhythmia, impairment of consciousness including coma, cerebral convulsions, pareses, and paralytic ileus. ||| Non response to epoetin alfa therapy may have the following causes: iron, folate, or vitamin B12 deficiency; aluminium intoxication; intercurrent infections; inflammatory or traumatic episodes; occult blood loss; haemolysis, and bone marrow fibrosis of any origin. ||| Les symptômes associés à un surdosage des IEC peuvent comporter une vasodilatation périphérique excessive (avec hypotension marquée, collapsus), une bradycardie, des troubles électrolytiques, une insuffisance rénale, une arythmie cardiaque, des troubles de la conscience y compris un coma, des convulsions cérébrales, des parésies et un iléus paralytique.
3.088854042335165e-13 ||| In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses. ||| In HIV infected patients at steady state, mean Cmax, mean Cmin, and mean AUC were linear with 200 mg, 400 mg, and 600 mg daily doses. ||| Chez les patients infectés par le VIH, les valeurs moyennes à l'état d’ équilibre de la Cmax, de la Cmin et de l'aire sous la courbe sont linéaires aux doses quotidiennes de 200, 400 et 600 mg.
0.0023301600012928247 ||| 256 The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Insuman cartridges and as recommended in the information provided by the device manufacturer. ||| 141 The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Insuman cartridges and as recommended in the information provided by the device manufacturer. ||| Stylo à insuline Les cartouches doivent être utilisées avec un stylo à insuline tel qu'OptiPen ou avec d’ autres stylos compatibles avec les cartouches Insuman et conformément aux instructions du fabricant du dispositif.
0.03838077932596207 ||| Therefore Agenerase should not be co-administered with orally administered midazolam (see section 4.3), whereas caution should be used with co-administration of Agenerase and parenteral midazolam. ||| Therefore, Norvir should not be co-administered with orally administered midazolam (see section 4.3), whereas caution should be used with co-administration of Norvir and parenteral midazolam. ||| En conséquence, Agenerase ne doit pas être co-administré avec le midazolam administré par voie orale (voir rubrique 4.3), tandis que des précautions doivent être prises en cas de co-administration d’ Agenerase avec le midazolam par voie parentérale.
0.009410088881850243 ||| 69 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 87 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 70 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.42449048161506653 ||| Ensure that cultures are appropriately taken and send to the microbiology laboratory, before starting antibiotics [31,42,70,71]. ||| Reassessing antibiotic treatments in light of clinical conditions at 48-72 hours, or as soon as microbiological results are available, to [31,42,70-72]: ||| Veillez à ce que les prélèvements à visée microbiologique soient correctement réalisés et envoyés au laboratoire de microbiologie avant de commencer les antibiotiques [31,42,70,71].
1.1756248474121094 ||| ut Ramsgate Road Sandwich ||| a) Fort Dodge Laboratories ||| Sandwich Kent tn
0.30937081575393677 ||| If a dog experiences these side effects, treatment should be stopped and general supportive therapy should be given as appropriate for NSAID overdose. ||| If you have stopped treatment due to hypersensitivity reactions it should be permanent and you should not re-start therapy with PROTELOS. ||| Si un chien manifeste ces effets indésirables, le traitement doit être interrompu et une thérapie de soutien général administrée comme cela s’ impose en cas de surdose d’ AINS.
7.880524574913061e-13 ||| SPECIAL STORAGE CONDITIONS ||| SPECIAL STORAGE CONDITIONS ||| PRECAUTIONS PARTICULIERES DE CONSERVATION
0.1494174301624298 ||| • 17.09.2001 • 05.12.2001 ||| • 26.12.2000 • 15.11.2001 ||| 17.09.2001 05.12.2001
0.7333959341049194 ||| Blister pack (21, 84 or 100) and perforated unit dose blister pack (100) for 200 mg hard capsules ||| 14 tablets 30 tablets 42 tablets 56 tablets 90 tablets 100 tablets Starter pack 42 tablets, non-valproate add-on therapy ||| Boîte contenant des plaquettes thermoformées (21, 84 ou 100 gélules) et boîte contenant des plaquettes thermoformées pour délivrance à l'unité (100 gélules) des gélules à 200 mg
0.8154737949371338 ||| The strength of Europe lies in its social and economic balance. ||| Europe is home to a vibrant tourism ecosystem. ||| La force de l'Europe réside dans son équilibre socio-économique.
0.3699401617050171 ||| 3 bottles of 360 film-coated tablets ||| Cartons of 90 film-coated tablets: ||| 3 flacons de 360 comprimés pelliculés
0.3864693343639374 ||| Following dose modifications, the cycle duration should return to 28 days. ||| For the subsequent weekly doses, the recommended infusion period is 60 minutes. ||| Après ces modifications posologiques, la durée du cycle sera ramenée à 28 jours.
0.0 ||| Mode of action ||| Mode of action ||| Mode d' action
0.013212081044912338 ||| ViraferonPeg 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b (conjugation of recombinant interferon alfa-2b with monomethoxy polyethylene glycol) ||| PegIntron 50 micrograms powder and solvent for solution for injection peginterferon alfa-2b (conjugation of recombinant interferon alfa-2b with monomethoxy polyethylene glycol) ||| ViraferonPeg 150 microgrammes poudre et solvant pour solution injectable peginterféron alfa-2b (conjugaison de l’ interféron alfa-2b recombinant avec le monométhoxy polyéthylène glycol)
0.31537240743637085 ||| Hiccups, odynophagia, diarrhoea, dyspepsia, oesophageal ulcer, abdominal pain upper, abdominal pain, haematemesis, oesophageal pain, eructation, melaena (haematocheznia), oesophageal disorder, regurgitation of food, abdominal rigidity, oesophageal spasm, oesophagitis. ||| Dystonia includes dystonia, muscle spasms, hypertonia, torticollis, muscle contractions involuntary, muscle contracture, blepharospasm, oculogyration, tongue paralysis, facial spasm, laryngospasm, myotonia, opisthotonus, oropharyngeal spasm, pleurothotonus, tongue spasm, and trismus. ||| 23 nausées Hoquet, odynophagie, diarrhées, dyspepsie, ulcère de l’œ sophage, douleur dans Fréquents: le haut de l’ abdomen, douleur abdominale, hématémèse, douleur œ sophagienne, éructations, méléna (rectorragie), troubles de l’œ sophage, régurgitation des aliments, raideur abdominale, spasmes œ sophagiens, œ sophagite.
0.057991765439510345 ||| 66 Common: ||| 68 Common: ||| Fréquent:
0.027093861252069473 ||| Betaferon should not be used in patients who are currently suffering from severe depression and/ or have thoughts of suicide. ||| Extavia should not be used in patients who are currently suffering from severe depression and/ or have thoughts of suicide. ||| Betaferon ne doit pas être utilisé chez les patients ayant des troubles dépressifs sévères et/ ou des pensées suicidaires.
0.24941208958625793 ||| Flexible tubes (Non-metallic -) for the conducting of liquid media ||| Trunking (Non-metallic -) for cables carrying telephone signals ||| Tubes flexibles non métalliques pour le transport de liquides
0.0668042004108429 ||| Repair or maintenance of construction machines and apparatus ||| Repair or maintenance of electronic machines and apparatus ||| Réparation ou entretien de machines et d'appareils de construction
0.5597426891326904 ||| Palmitic acid ||| Salicylic acid ||| Acide palmitique
0.24800407886505127 ||| Very common side effects (these can affect more than 1 in 10 patients treated) Feeling sick (nausea), headache, dry mouth, feeling sleepy, fatigue, dizziness and constipation. ||| Very common side effects (affects more than 1 user in 10) include: • nausea, headache, sleepiness/ tiredness, dizziness. ||| 46 Effets indésirables les plus fréquents (pouvant affecter plus de 1 patient traité sur 10): • Envie de vomir (nausées), maux de tête, sècheresse de la bouche, somnolence, fatigue, sensations vertigineuses et constipation.
0.39805367588996887 ||| Concomitant administration of ciprofloxacin and tizanidine (see section 4.5). ||| Concomitant use with spironolactone (see section 4.5) ||| Administration concomitante de ciprofloxacine et de tizanidine (voir rubrique 4.5).
0.12063061445951462 ||| Conditions of the Marketing Authorisation are set out in Annex IV. ||| The conditions of the Marketing Authorisation are listed in Annex IV. ||| Les conditions de l’ autorisation de mise sur le marché figurent à l’ annexe IV.
0.4508060812950134 ||| EU/ 2/ 98/ 006/ 003 Nobilis IB 4-91 ||| l EMEA/ H/ C/ 000482/ II/ 0030/ ||| EU/ 2/ 98/ 006/ 003
0.5975436568260193 ||| 67 ed is or th au ANNEX III er ng LABELLING AND PACKAGE LEAFLET lo no ct du ro lp a in ic ed M ||| ori uth ra ANNEX I ge lon SUMMARY OF PRODUCT CHARACTERISTICS tno uc rod lp nai dic Me ||| 67 é ris to au s u pl ANNEXE III st ÉTIQUETAGE ET NOTICE 'e tn en am ic éd m e C
0.004766102880239487 ||| 2 glucose 50 g/ l (5%) solution for infusion sodium chloride 4.5 mg/ ml (0.45%) and glucose 50 g/ l (5%) solution for injection Ringer-Lactate solution for injection ||| 29 glucose 50 g/ l (5%) solution for infusion sodium chloride 4.5 mg/ ml (0.45%) and glucose 50 g/ l (5%) solution for injection Ringer-Lactate solution for injection ||| une solution de chlorure de sodium à 9 mg/ ml (0,9%) une solution pour perfusion de glucose à 50 g/ l (5%) une solution injectable de chlorure de sodium à 4,5 mg/ ml (0,45%) et de glucose à 50 g/ l (5%) une solution pour injection de Ringer-Lactate.
0.3053147792816162 ||| In rabbits, a treatment related increase in cardiovascular malformations was observed at exposure levels below the clinical exposure at the daily human dose (90 mg). ||| In the 13 week study, female bone marrow and lymphoid changes are reported at the high dose with a weak incidence. ||| Chez le lapin, une augmentation des malformations cardiovasculaires liée au traitement a été observée pour des niveaux d’ exposition inférieurs à l’ exposition clinique à la dose thérapeutique quotidienne chez l’ homme (90 mg).
2.919659414409026e-13 ||| Patients appear to be at highest risk for these reactions early in the course of therapy; the onset of the reaction occurring in the majority of cases within the first month of treatment. ||| Patients appear to be at highest risk for these reactions early in the course of therapy; the onset of the reaction occurring in the majority of cases within the first month of treatment. ||| Le risque de survenue de ces effets semble être le plus élevé en début de traitement, l'apparition de ces effets se situant dans la majorité des cas au cours du premier mois de traitement.
0.25589871406555176 ||| Retail services relating to automobile parts ||| Financial services relating to motor vehicles ||| Services de vente au détail de parties d’automobiles
0.5143253803253174 ||| The antimicrobial activity of Convenia following a single injection lasts for up to 14 days. ||| Corlentor mainly works by reducing the heart rate by a few beats per minute. ||| Après administration unique, l’ activité antimirobienne de Convenia dure pendant 14 jours.
0.28585439920425415 ||| Powder for oral solution ||| Powder for oral suspension ||| Poudre pour solution buvable
0.30320674180984497 ||| Treatment should be maintained in the case of stable disease, i. e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated. ||| On initiation of therapy or increasing of dose the patient should be monitored to minimise the potential for postural effects, e. g. hypotension and syncope. ||| Le traitement doit être maintenu dans le cas d’ une maladie stable, c’ est-à-dire lorsque la réponse tumorale est statique, partielle ou complète, sous réserve que le produit soit suffisamment bien toléré.
0.33707571029663086 ||| Vaccination should be postponed in the case of fever or acute disease. ||| Gastric lavage may be indicated if performed soon after ingestion or in symptomatic patients. ||| La vaccination doit être différée en cas de fièvre ou de maladie aiguë.
0.0 ||| 24 months ||| 24 months ||| 24 mois
0.34838682413101196 ||| After reconstitution of the powder, Nplate solution for injection is administered subcutaneously. ||| Intramuscular and subcutaneous use Reconstitute the powder with the solvent provided immediately prior to use. ||| Après reconstitution, Nplate solution injectable s’ administre par voie sous-cutanée.
0.5413126349449158 ||| No significant differences were detected in overall survival (OS). ||| No significant difference was seen in the STEMI population. ||| Aucune différence significative n’ a été constatée du point de vue de la survie globale.
0.030017536133527756 ||| 4.8 Interactions with other medicinal products and other forms of interaction ||| 4.8 Interaction with other medicinal products and other forms of interaction ||| 4.8 Interactions médicamenteuses et autres formes d’ interaction
0.03998928144574165 ||| 7 This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i. e. essentially “ sodium- free”. ||| 76 This medicinal product contains less than 1 mmol sodium (23 mg) per syringe, i. e. essentially “ sodium-free”. ||| Ce médicament contient moins de 1 mmol de sodium (23 mg) par dose, c'est-à-dire qu’ il est essentiellement « sans sodium ».
0.48518162965774536 ||| - Diarrhoea, vomiting, nausea ||| - nausea, diarrhoea ||| - Diarrhée, vomissements, nausées
0.10631503164768219 ||| The Swedish support measure ||| The Czech support measure ||| La mesure de soutien suédoise
0.0636521577835083 ||| The Committee recommended that Temodal be given marketing authorisation. ||| The Committee recommended that Altargo be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Temodal.
0.34520024061203003 ||| The risk/ benefit should be considered in patients with established hyperlipidemia before initiating an immunosuppressive regimen including Rapamune. ||| The risk/ benefit of further treatment with RISPERDAL CONSTA should be assessed if clinically relevant orthostatic hypotension persists. ||| Le rapport bénéfice/ risque doit être considéré chez les patients présentant une hyperlipidémie établie avant toute initiation d’ un traitement immunosuppresseur incluant Rapamune.
0.5271117687225342 ||| Analysis of resistance in ARV-naïve patients: ||| In vivo resistance (Therapy naïve patients): ||| Analyse de la résistance chez des patients naïfs aux ARV:
0.05145495384931564 ||| Avaglim doses may need to be adjusted when given with certain other medicines such as gemfibrozil or rifampicin. ||| The doses of Avandamet may need to be adjusted when given with certain other medicines such as gemfibrozil or rifampicin. ||| Il peut s’ avérer nécessaire d’ ajuster les doses d’ Avaglim en cas d’ administration concomitante de certains autres médicaments tels que le gemfibrozil ou la rifampicine.
0.20504236221313477 ||| PegIntron should be used with caution in patients with moderate to severe renal impairment. ||| That Volibris should be initiated with caution in patients with severe renal impairment. ||| PegIntron doit être utilisé avec précaution chez les patients avec une insuffisance rénale modérée à sévère.
0.47268012166023254 ||| Bavarian creams ||| Galvanic batteries ||| Crème bavaroise
0.3102330267429352 ||| SOMAVERT is a powder and solvent that are mixed together to make up a solution for injection. ||| The pack contains 1 set of powder and solvent that must be prepared for subcutaneous injection. ||| SOMAVERT se présente sous la forme d’ une poudre et d’ un solvant à mélanger afin de préparer une solution injectable.
0.44958120584487915 ||| − Increased prothrombin and factors VII, VIII, IX and X; decreased anti-thrombin III; decreased protein S; increased norepinephrine (noradrenaline)-induced platelet aggregability. ||| • Vitamin deficiencies, i. e., folic acid or vitamin B12 deficiencies • Haemolysis • Malignant diseases including multiple myeloma and myelodysplastic syndrome • Malnutrition ||| - Augmentation des taux de prothrombine et de facteurs VII, VIII, IX et X; baisse des taux
1.1523640155792236 ||| 1 Other efavirenz resistance mutations included A98G (n=1), K103E (n=1), V179D (n=1), and M230L (n=1). ||| V82 (to A or F), M46 (to I or L), and L10 (to I or R). ||| 1 Les autres mutations de résistance à l’ éfavirenz comprenaient les mutations A98G (n=1), K103E (n=1), V179D (n=1) et M230L (n=1).
0.4887661933898926 ||| Indicator lights for telecommunication apparatus ||| Telephones incorporating intercommunication systems ||| Témoins lumineux pour appareils de télécommunications
0.16638922691345215 ||| 518 If you use more Insuman Basal than you should ||| 738 If you use more Insuman Comb 50 than you should ||| Si vous avez utilisé plus d’Insuman Basal que vous n’auriez dû
0.7516127228736877 ||| Omeprazole (CYP2C19 inhibitor; CYP2C19 and CYP3A4 substrate): ||| Magnesium chloride (MgCl2) Calcium chloride (CaCl2) ||| 10 Oméprazole (inhibiteur du CYP2C19; substrat du CYP2C19 et du CYP3A4):
0.31530261039733887 ||| There have been post-marketing reports of leukopenia, thrombocytopenia or pancytopenia, or aggravation of these cytopenias in patients treated with EXJADE. ||| Immune-mediated haemolytic anaemia In post-marketing surveillance, isolated cases of severe haemolytic anaemia have been reported during treatment with Raptiva. ||| Des cas de leucopénie, thrombopénie ou pancytopénie ou une aggravation des cytopénies ont été rapportés chez des patients traités par EXJADE après sa commercialisation.
4.643605378690241e-13 ||| You may need to read it again. ||| You may need to read it again. ||| - Conservez cette notice, vous pourriez avoir besoin de la relire.
0.2172291874885559 ||| It can also be used as part of treatment for flea allergy dermatitis (skin inflammation) and to help control existing flea infestations, by killing eggs and larvae in the areas to which the animal has access, so breaking the flea life-cycle. ||| The product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access. ||| Il peut également être utilisé dans le cadre du traitement de la dermatite par allergie aux piqûres de puces (inflammation cutanée) et pour aider à maîtriser les infestations par les puces en éliminant les œufs et les larves dans les zones auxquelles l’animal a accès, brisant ainsi le cycle biologique de la puce.
0.39421969652175903 ||| Revatio can cause a serious increase in the effects of these medicines. ||| May modify or increase the effect of other medicines. ||| Revatio peut entraîner une augmentation importante des effets de ces médicaments.
0.006762937642633915 ||| Detailed information on this product is available on the European Medicines Agency (EMEA) website http: / /www. emea. europa. eu ||| Detailed information on this product is available on the European Medicines Agency (EMEA) web site http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne des médicaments (EMEA): http: / /www. emea. europa. eu/.
0.6277921199798584 ||| Design and development of energy management software ||| Construction supervision of civil engineering projects ||| Conception et développement de logiciels de gestion de l'énergie
0.3023834824562073 ||| If Xigris is readministered to patients, caution should be employed. ||| If IONSYS is administered, an antidote for the child should be readily available. ||| Si Xigris est ré-administré aux patients, des précautions doivent être prises.
0.36215072870254517 ||| Age (≥ 12 years) and gender, after adjustment for body weight effects, have no apparent effect on zonisamide exposure in epileptic patients during steady-state dosing. ||| The blood-pressure-lowering effect was sustained during long-term treatment (12 months), and was independent of age, gender, body mass index and ethnicity. ||| L’ âge (12 ans et plus) et le sexe, après ajustement en fonction du poids, n’ ont pas d’ effet apparent sur l’ exposition au zonisamide chez des patients épileptiques pendant l’ administration à l’ état d’ équilibre.
0.4512760639190674 ||| The powder is reconstituted in the water before it is injected by a health professional. ||| It is made up into a solution that is injected directly into the brain during surgery. ||| La poudre est reconstituée dans l’ eau avant son injection par un professionnel de santé.
0.5851486921310425 ||| Birx was confirmed by the Senate by voice vote on April 2, 2014, and was sworn in two days later. ||| On 13 January 2020, Spike Lee was named as the president of the jury. ||| Elle est confirmée par le Sénat et prête serment le 4 avril 2014.
0.32539141178131104 ||| Fendrix should not be given to patients with a severe sudden fever. ||| Infanrix Penta should be postponed in infants with a severe sudden fever. ||| Fendrix ne doit pas être administré aux patients qui présentent soudainement une forte fièvre.
0.10607349127531052 ||| You can clean your Insulatard InnoLet by wiping it with a medicinal swab. ||| You can clean your Actraphane 30 InnoLet by wiping it with a medicinal swab. ||| Vous pouvez nettoyer votre Insulatard InnoLet à l’aide d’une compresse antiseptique.
0.0 ||| Elderly: ||| Elderly: ||| Sujet âgé:
2.5146551507759796e-13 ||| The most frequently observed adverse drug reactions (ADRs) in patients receiving MabThera were infusion-related reactions which occurred in the majority of patients during the first infusion. ||| The most frequently observed adverse drug reactions (ADRs) in patients receiving MabThera were infusion-related reactions which occurred in the majority of patients during the first infusion. ||| 10 Les effets indésirables les plus fréquemment observés chez les patients recevant du MabThera étaient des réactions liées à la perfusion, qui sont survenues lors de la première perfusion chez la plupart des patients.
0.31409507989883423 ||| The active substance in Caelyx, doxorubicin hydrochloride, is a cytotoxic medicine that belongs to the group ‘ anthracyclines’. ||| The active substance in Valdoxan/ Thymanax, agomelatine, is a ‘ melatonergic agonist’ and a ‘ 5-HT2C antagonist’. ||| Le principe actif de Caelyx, le chlorhydrate de doxorubicine, est un médicament cytotoxique appartenant au groupe des « anthracyclines ».
0.6773221492767334 ||| At the end of year 2 (12 months after Preotact was discontinued), there was a 12.1% mean increase in dual energy X-ray absorptiometry (DXA) spine BMD for patients who received alendronate for the second year. ||| On 8 July 1997, Theodore Roosevelt entered the Newport News Shipbuilding yard for a one-year Extended Drydock and Selected Restricted Availability (EDSRA), her first major overhaul since commissioning. ||| A la fin de la deuxième année (12 mois après que Preotact ait été arrêté), une augmentation moyenne de 12% de la DMO du rachis par absorptiométrie biphotonique à rayon X (DXA) a été observée dans le groupe de patientes recevant l’ alendronate la deuxième année.
0.14195527136325836 ||| The Reference Member State was Finland and the Concerned Member States were Austria, Belgium, Denmark, Germany, Italy, Luxembourg, the Netherlands, Portugal, Sweden and United Kingdom. ||| In the MRP Sweden is the Reference Member State and Austria, Belgium, Finland, France, Germany, Italy, Ireland, Luxembourg, Portugal, Spain and the United Kingdom are the Concerned Member States. ||| L'État membre de référence était la Finlande et les États membres concernés étaient l’ Allemagne, l’ Autriche, la Belgique, le Danemark, l’ Italie, le Luxembourg, les Pays-Bas, le Portugal, le Royaume-Uni et la Suède.
0.26089730858802795 ||| However, since it does not contain any antimicrobial preservative or bacteriostatic agent, it is intended for immediate use. ||| Since the medicinal product does not contain any anti-microbial preservative or bacteriostatic agents, aseptic technique must be observed. ||| Cependant, étant donné qu’ il ne contient pas d’ agent conservateur antimicrobien ni d’ agent bactériostatique, il est prévu pour une utilisation immédiate.
0.43555328249931335 ||| These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. ||| These changes are generally not noticed by the patient (no symptoms), are usually reversible and mild, and most often do not require particular treatment. ||| Ils sont dans la plupart des cas transitoires et disparaissent à la suite de l'arrêt du traitement, mais ils peuvent être sévères ou fatals dans de très rares cas.
0.6309894323348999 ||| Do not use in breeding birds and birds in lay. ||| Do not use in small herbivores (including guinea pigs and rabbits). ||| Ne pas utiliser chez les poules en ponte ou en reproduction.
0.3520908057689667 ||| Each bottle contains 60 tablets. ||| Each carton contains 14 vials. ||| Chaque flacon contient 60 comprimés.
7.20524009380219e-13 ||| 18 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 18 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 20 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.0 ||| In the case of overdosage symptomatic treatment should be initiated. ||| In the case of overdosage symptomatic treatment should be initiated. ||| En cas de surdosage, instaurer un traitement symptomatique.
0.13159529864788055 ||| Only solutions which are clear or slightly opalescent, colourless and practically free of visible particles may be injected. ||| Only solutions which are clear, colourless to slightly yellowish and free of visible particles must be injected. ||| Seules les solutions transparentes ou légèrement opalescentes, incolores et pratiquement sans particules visibles à
0.6357816457748413 ||| • Clinical Description ||| 42 Area Clinical ||| • Description clinique
0.327902615070343 ||| No difference in exposure was found with concomitantly treatment with fluvastatin (weak inhibitor of CYP2C9). ||| The significantly lower incidence of this event with celecoxib was maintained with or without acetylsalicylic acid use. ||| Aucune différence en termes d’ exposition n’ a été observée en cas d’ administration concomitante avec la fluvastatine (un inhibiteur faible du CYP2C9).
0.2954040765762329 ||| It should be noted that the decrease in suppression of viral RNA levels was seen more frequently when therapy with indinavir was initiated at doses lower than the recommended oral dose of 2.4 g/ day. ||| Due to the relatively long elimination half-life, repeated administration of the same dose will lead to plasma concentrations of FSH that are approximately 1.5-2.5 times higher than after single dose administration. ||| Il faut souligner que cette diminution de l'efficacité sur la charge virale a été observée plus fréquemment quand le traitement par l'indinavir était initié à des posologies inférieures à la posologie recommandée de 2,4 g/ jour per os.
0.07257262617349625 ||| Which measures are being taken to ensure the safe use of Daronrix? ||| Which measures are being taken to ensure the safe use of Zypadhera? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger de Daronrix?
0.4297264814376831 ||| The prolonged effect of subcutaneous insulin glargine may delay recovery from hypoglycaemia. ||| Renal Impairment Elimination of paliperidone decreased with decreasing renal function. ||| L’ effet prolongé de l’ insuline glargine en sous-cutané peut retarder la récupération d’ une hypoglycémie.
0.10715772211551666 ||| Pack of 1 single dose vial (powder) + 1 pre-filled syringe (solvent)+ 2 unattached needles. ||| Pack of 20 single dose vials (powder) + 20 pre-filled syringes (solvent) + 40 unattached needles. ||| (poudre) + 1 seringue préremplie (solvant) + 2 aiguilles séparées.
0.15417373180389404 ||| What is Karvea used for? ||| What is Velmetia used for? ||| Dans quel cas Karvea est -il utilisé?
0.348791241645813 ||| Around 75% of fentanyl is excreted into the urine, mostly as metabolites, with less than 10% as unchanged active substance. ||| 50% of the insulin is dissolved in water; the other 50% is present as tiny crystals of insulin protamine. ||| Environ 75% du fentanyl sont excrétés dans les urines, essentiellement sous la forme de métabolites, avec moins de 10% sous la forme active inchangée.
0.1626954972743988 ||| After reconstitution Chemical and physical in-use stability has been demonstrated for 3 hours at 25°C. ||| After reconstitution, chemical and physical stability has been demonstrated for 30 hours up to 25ºC. ||| Après reconstitution Une stabilité chimique et physique après reconstitution a été demontrée pendant 3 heures à 25°C.
0.7916247844696045 ||| You will take Temodal alone once daily for the first 5 days. ||| Then, you will have 23 days without Temodal. ||| Vous prendrez Temodal seul une fois par jour pendant les 5 premiers jours.
0.39935940504074097 ||| The Commission is co-financing the delivery of more than 25 tonnes of personal protective equipment to China after the EU Civil Protection Mechanism was activated. ||| During the first half of 1997, the existing ISDN-based network was completely installed in all EU regulatory authorities dealing with human and veterinary medicines. ||| La Commission cofinance la livraison de plus de 25 tonnes d'équipements de protection individuelle à la Chine après le déclenchement du mécanisme de protection civile de l'UE.
0.5859740972518921 ||| ZYPREXA VELOTAB 5 mg orodispersible tablets ZYPREXA VELOTAB 10 mg orodispersible tablets ZYPREXA VELOTAB 15 mg orodispersible tablets ZYPREXA VELOTAB 20 mg orodispersible tablets olanzapine ||| Zalasta 5 mg orodispersible tablets Zalasta 7.5 mg orodispersible tablets Zalasta 10 mg orodispersible tablets Zalasta 15 mg orodispersible tablets Zalasta 20 mg orodispersible tablets Olanzapine ||| ZYPREXA VELOTAB 5 mg, comprimé orodispersible ZYPREXA VELOTAB 10 mg, comprimé orodispersible ZYPREXA VELOTAB 15 mg, comprimé orodispersible ZYPREXA VELOTAB 20 mg, comprimé orodispersible olanzapine
0.3301522731781006 ||| Mechanical egg timers ||| Electrical generator stations ||| Minuteurs mécaniques
0.044129520654678345 ||| Aerius orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| Azomyr orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| Aerius comprimés orodispersibles est aussi utilisé pour soulager les symptômes associés à l'urticaire (atteinte cutanée provoquée par une allergie).
0.2704525589942932 ||| In more than half of the reported cases, treatment with protease inhibitors was continued, or reintroduced if treatment had been discontinued. ||| If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered. ||| Dans plus de la moitié des cas rapportés, le traitement par inhibiteurs de protéase a été poursuivi ou réintroduit en cas d’ arrêt.
0.3686520457267761 ||| It is imperative that any dose re-titration of any analgesic is monitored by a health professional. ||| Serologic status may be evaluated to determine whether or not additional doses of vaccine are needed. ||| Toute nouvelle adaptation de la dose d’ un analgésique, quel qu’ il soit, doit être impérativement effectuée sous surveillance médicale.
0.3299623131752014 ||| In patients (n=39) with recurrence within 180 days after chemoradiotherapy with cisplatin, the median survival in the topotecan plus cisplatin arm was 4.6 months (95% C. I.: ||| In a second study (n=310), which used a weight-adjusted dose (100 microgramsg/ kg), the mean duration of grade 4 neutropenia for the pegfilgrastim group was 1.7 ||| Chez les patientes (n=39) présentant des récurrences dans les 180 jours suivant la chimioradiothérapie avec cisplatine, la survie médiane pour le bras topotécan + cisplatine était de 4,6 mois (IC 95%:
0.26254552602767944 ||| Serum concentrations may be increased when co-administered with ritonavir resulting in the potential for increased incidence of adverse events. ||| Indeed, Kaletra could increase concentrations of the co-administered medicinal products and this may result in an increase of their associated cardiac adverse events. ||| Les concentrations sériques peuvent être augmentées en cas d’administration concomitante avec le ritonavir, ce qui peut entraîner une incidence accrue des effets indésirables.
0.15661320090293884 ||| Adverse events in healthy volunteers ||| • Adverse events in healthy volunteers ||| Evénements indésirables chez des volontaires sains
0.4342660903930664 ||| We need to ensure timely assistance and avoid negative consequences for the populations of conflict affected areas, who already are bearing a heavy burden." ||| The EU has already taken steps to protect those most at risk of detrimental social and employment conditions at this difficult time. ||| Nous devons apporter une aide en temps utile et éviter les conséquences négatives pour les populations des zones touchées par des conflits, qui paient déjà un lourd tribut.»
0.684872031211853 ||| Digestive ||| Anxiety ||| Digestif
0.28842970728874207 ||| Viracept 50 mg/g oral powder Nelfinavir ||| Epivir 10 mg/ ml oral solution Lamivudine ||| Viracept 50 mg/g poudre orale Nelfinavir
0.646815836429596 ||| Mould lacquers ||| Witch hazel ||| Laques de moule
0.2977011799812317 ||| Note: if the product is allowed to stand for more than 5 minutes after activation, it should be resuspended with 10 seconds of hand agitation prior to syringe withdrawal from the vial. ||| Re-priming (approximately 6 sprays until a fine mist is seen) is only necessary if the cap is left off for 5 days or the intranasal device has not been used for 30 days or more. ||| Note: si on laisse reposer le produit plus de 5 minutes après activation, il devra être remis en suspension par une agitation manuelle de 10 secondes, avant d’ être prélevé dans la seringue.
0.20043236017227173 ||| The efficacy and toxicity of a variation of the Zevalin therapeutic regimen employing a reduced activity of [90Y]-Zevalin was further defined in a third study enrolling a total of 30 patients who had mild thrombocytopenia (platelet count 100,000 to 149,000 cells/ mm3). ||| In an ongoing study evaluating the safety and efficacy of conversion from calcineurin inhibitors to sirolimus (target levels of 12 - 20 ng/ mL) in maintenance renal transplant patients, enrollment was stopped in the subset of patients (n=90) with a baseline glomerular filtration rate of less than 40 mL/ min (see section 5.1). ||| L'efficacité et la toxicité d'une variante de ce traitement par Zevalin, se composant de [90Y]-Zevalin à activité réduite, ont ensuite été évaluées au cours d'une troisième étude, portant sur 30 patients atteints de thrombopénie légère (numération plaquettaire comprise entre 100 000 et 149 000/ mm3).
0.12788251042366028 ||| 10 mL twice daily ||| 7.5 mL twice daily ||| 10 ml 2 fois/jour
1.0353217124938965 ||| Volume of distribution: ||| Select a dose of 2. ||| Volume de diffusion:
0.22270716726779938 ||| Method and route of administration ||| Method and route of administration: ||| 41 Mode et voie d’ administration
0.0 ||| Joint CPMP/ CVMP Quality Working Party ||| Joint CPMP/ CVMP Quality Working Party ||| Groupe de travail coinjoint CPMP/CVMP sur la qualité
0.3936416804790497 ||| STOCRIN can reduce or increase the amount of anticonvulsant in your blood. ||| Alcohol can change the ability of Prandin to reduce the blood sugar. ||| STOCRIN peut réduire la quantité de l'anticonvulsivant dans votre sang.
0.34575095772743225 ||| Patients with PWS should be evaluated for upper airway obstruction, sleep apnoea or respiratory infections before initiation of treatment with somatropin. ||| Implants and levonorgestrel-releasing intrauterine systems are associated with an increased risk of infection at the time of insertion and irregular vaginal bleeding. ||| Avant de débuter le traitement par la somatropine chez les patients atteints d’ un syndrome de Prader- Willi, une recherche des signes d’ obstruction des voies aériennes supérieures, d’ apnée du sommeil ou d’ infection respiratoire, devra être effectuée.
0.3458179235458374 ||| 468 • If you have chronic renal failure there is an increased risk of serious problems with your heart or blood vessels (cardiovascular events) if your haemoglobin is kept too high. ||| If you have diabetes, this may make your diabetes worse • Blood test showing a higher amount of uric acid or more fat than usual in your blood • Painful, red, and swollen joints ||| • Si vous souffrez d’ insuffisance rénale chronique, le risque que vous présentiez des problèmes cardiovasculaires graves est augmenté si votre taux d’ hémoglobine est maintenu à un niveau trop élevé.
0.4646536111831665 ||| Selective inhibition of COX-2 by lumiracoxib provides anti-inflammatory and analgesic effects. ||| Ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer ||| L'inhibition sélective de la COX-2 par le lumiracoxib procure des effets anti-inflammatoires et antalgiques.
0.3419775664806366 ||| Like in all patients receiving erythropoietin, blood pressure may rise during treatment with Retacrit. ||| Patients receiving Myocet were less likely to experience heart problems than those receiving standard doxorubicin. ||| Comme pour tous les patients recevant de l’ érythropoïétine, la pression artérielle est susceptible d’ augmenter pendant la durée du traitement par Retacrit.
0.5537824034690857 ||| Apparatus for the diagnosis of neurological diseases ||| Performing diagnosis of diseases ||| Appareils pour le diagnostic de maladies neurologiques
0.4693269729614258 ||| Pipe fittings [junctions] (non-metallic -) ||| Wall lights (fittings for -) [switches] ||| Raccords [jonctions] non-métalliques de tuyaux
0.029178649187088013 ||| In cases where dose increments of 2.5 mg are considered necessary, Olanzapine Teva coated tablets should be used. ||| In cases where dose increments of 2.5 mg are considered necessary, Olanzapine Teva film-coated tablets should be used. ||| Si une progression posologique de 2,5 mg est nécessaire, il convient d’ utiliser Olanzapine Teva, comprimés pelliculés.
0.18474048376083374 ||| Ratiograstim 30 MIU/ 0.5 ml ||| Tevagrastim 30 MIU/ 0.5 ml ||| Ratiograstim 30 MUI/ 0,5 ml
0.3462654948234558 ||| Enzymes [other than for medical use] for labelling proteins ||| Carbon fibers [fibres], other than for textile use ||| Enzymes autres qu'à usage médical pour l'étiquetage des protéines
0.260468989610672 ||| Hungary ||| Norway ||| Grèce
0.2913484573364258 ||| Hydroxycarbamide is excreted in human milk. ||| Urea is one metabolite of hydroxycarbamide. ||| L'hydroxycarbamide est excrété dans le lait humain.
0.24574075639247894 ||| This study is a phase III, randomised, double-blind study of telbivudine 600 mg once daily compared to lamivudine 100 mg once daily for a treatment period of 104 weeks in 332 nucleoside-naïve chronic hepatitis B HBeAg-positive and HBeAg-negative Chinese patients. ||| In a multicentre, double-blind, controlled study (CNA30024), 654 HIV-infected, antiretroviral therapy-naïve patients were randomised to receive either abacavir 300 mg twice daily or zidovudine 300 mg twice daily, both in combination with lamivudine 150 mg twice daily and efavirenz 600 mg once daily. ||| Cette étude est une étude de phase III, randomisée, réalisée en double aveugle et comparant la telbivudine 600 mg une fois par jour à la lamivudine 100 mg une fois par jour sur une période de traitement de 104 semaines chez 332 patients d’ origine chinoise, AgHBe positifs et AgHBe négatifs, atteints d’ hépatite B chronique et n’ ayant jamais été traités par inhibiteurs nucléosidiques.
0.534387469291687 ||| Headache, syncope Extrapyramidal symptoms ||| 242 Peripheral ischaemia, hypotension§ ||| Céphalée, syncope Symptômes extrapyramidaux
0.26903343200683594 ||| In clinical trials, the incidence of hypoglycaemia was common in patients receiving vildagliptin 100 mg daily in combination with metformin (1%) and uncommon in patients receiving placebo + metformin (0.4%). ||| In clinical trials, weight did not change from baseline when vildagliptin 50 mg daily was added to glimepiride (-0.1 kg and -0.4 kg for vildagliptin and placebo, respectively). ||| Dans les essais cliniques, l’ incidence des épisodes d’ hypoglycémie a été de 1% chez les patients recevant 100 mg par jour de vildagliptine en association avec la metformine (fréquents) et de 0,4% chez les patients recevant le placebo en association avec la metformine (peu fréquents).
0.35915499925613403 ||| • Hold the syringe with the solvent vial upside down. ||| Withdraw 4.0 ml of the solution without turning the vial upside down. ||| • Retournez la seringue avec le flacon de solvant.
0.19275715947151184 ||| Peak plasma concentrations occur approximately 2.5 hours after oral administration of lamotrigine. ||| Maximum plasma concentrations of varenicline occur typically within 3-4 hours after oral administration. ||| Le pic plasmatique est atteint environ 2,5 heures après l’ administration orale du produit.
0.468977153301239 ||| The upcoming Farm to Fork strategy will support farmers and ensure sustainability along the agrifood value chain. ||| Making sustainability Europe's trademark will open new business opportunities and diversify sources of income for European farmers and fishers. ||| Par ailleurs, la future stratégie «De la ferme à la fourchette» permettra de soutenir les agriculteurs et de garantir la durabilité tout au long de la chaîne de valeur des produits agroalimentaires.
0.2971823513507843 ||| Viani is indicated for the symptomatic treatment of patients with severe COPD (FEV1 < 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy. ||| 53/ 94 Paradoxical worsening of Restless Legs Syndrome symptoms occurring with earlier onset (augmentation), and reoccurrence of symptoms in the early morning hours (early morning rebound), may be observed during treatment with ropinirole. ||| Viani est indiqué en traitement symptomatique de la BPCO sévère (VEMS < 50% de la valeur théorique) chez les patients présentant des antécédents d’ exacerbations répétées, et des symptômes significatifs malgré un traitement bronchodilatateur continu.
0.30121496319770813 ||| Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycemia or to diabetic patients (especially those with labile diabetes) as beta-blockers may mask the signs and symptoms of acute hypoglycemia. ||| Effentora is a pain-relieving medicine known as an opioid, which is used to treat breakthrough pain in adult patients with cancer who are already taking other opioid pain medicines for their constant (around-the-clock) cancer pain. ||| Les inhibiteurs bêta-adrénergiques doivent être administrés avec prudence chez les patients ayant une tendance à l’ hypoglycémie spontanée ou chez les patients diabétiques (notamment ceux atteints de diabète instable), car les bêta-bloquants peuvent masquer les signes et symptômes d’ hypoglycémie aiguë.
0.8046036958694458 ||| Prandin may not be suitable for you. ||| Sonata will help you to sleep. ||| Prandin peut ne pas vous convenir.
0.44222724437713623 ||| Laboratory studies in puppies have shown evidence of arthropathy after systemic administration of orbifloxacin. ||| Some patients were asymptomatic with pneumonitis detected on computed tomography scan or chest radiograph. ||| Chez les chiots, les études de laboratoires ont montré que l’ administration systémique d’ orbifloxacine provoque de l’ arthropathie.
0.4943723678588867 ||| Further intravenous administration is not contraindicated unless the reactions reoccur or worsen. ||| If the undesirable effect abates, gradual up-titration can be re-instituted. ||| La poursuite de l’ administration par voie intraveineuse n’ est pas contre- indiquée, sauf si les réactions se reproduisent ou s’ aggravent.
0.930435299873352 ||| 6.5 Nature and contents of container a in ||| Wines of protected appellation of origin ||| Nature et contenu de l’ emballage
0.10058002918958664 ||| Each coated tablet contains 5 mg olanzapine. ||| Each film-coated tablet contains 5 mg olanzapine. ||| Chaque comprimé enrobé contient 5 mg d’ olanzapine.
0.22712993621826172 ||| Elimination of etoricoxib occurs almost exclusively through metabolism followed by renal excretion. ||| Elimination of sitagliptin occurs primarily via renal excretion and involves active tubular secretion. ||| L’ étoricoxib est presque exclusivement éliminé sous forme de métabolites par voie rénale.
0.5191932320594788 ||| Desloratadine and Pseudoephedrine: ||| Pseudoephedrine sulphate: ||| Desloratadine et pseudoéphédrine:
0.23156952857971191 ||| 72 During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 5-20 mg/ day. ||| The initial dose of in patients with symptomatic heart failure or asymptomatic left ventricular dysfunction is 2.5 mg, and it should be administered under close medical supervision to determine the initial effect on the blood pressure. ||| 77 Dans toutes les indications, la posologie journalière de l’ olanzapine peut être adaptée en fonction de l’ état clinique du patient entre 5 et 20 mg par jour.
0.1871051788330078 ||| List of excipients: ||| List of excipients ||| Liste des excipients:
0.26065322756767273 ||| If you use more Enbrel than you should ||| If you use more RELISTOR than you should ||| Si vous avez utilisé plus d’ Enbrel que vous n’ auriez dû
0.042936064302921295 ||| Clinical studies of Rapamune did not include a sufficient number of patients > 65 years of age to determine whether they will respond differently than younger patients. ||| Clinical studies with Rapamune oral solution did not include a sufficient number of patients > 65 years of age to determine whether they will respond differently than younger patients. ||| 30 Les études cliniques de Rapamune n’ ont pas inclus un nombre suffisant de patients âgés de plus de 65 ans pour déterminer s’ ils répondent différemment des patients plus jeunes.
0.024402739480137825 ||| For the full list of all side effects reported with Nexavar, see the Package Leaflet. ||| For the full list of all side effects reported with Renagel, see the Package Leaflet. ||| Pour avoir le détail de tous effets indésirables observés lors de l'utilisation de Nexavar, voir la notice.
0.2934437394142151 ||| AUC: ↓ 31% (↓ 8 to ↓ 47) Cmin: ↓ 40% A similar reduction in indinavir exposures was observed when indinavir 1.000 mg q8h was given with efavirenz 600 mg daily. ||| A mean weight loss of 6.5 kg from baseline to one year was shown for ZIMULTI 20 mg versus a mean weight loss of 1.6 kg for placebo (Difference -4.9 kg CI95% -5.3; -4.4, p < 0.001). ||| Cmin: ↓ 40% Une baisse similaire de l’ exposition à l’ indinavir a été observée lorsque 1000 mg d’ indinavir ont été administrés toutes les 8 heures avec 600 mg d’ efavirenz par jour.
0.11673429608345032 ||| The product should be at room or body temperature before use. ||| The product should be brought to room or body temperature before use. ||| Le produit doit être à température ambiante ou à la température du corps avant l’utilisation.
0.1775289624929428 ||| 21 Renal or hepatic impairment The pharmacokinetics of deferasirox have not been studied in patients with renal or hepatic impairment. ||| Renal and hepatic impairment There are no pharmacokinetic or pharmacodynamic data in patients with renal or hepatic impairment (see section 4.4). ||| Insuffisances rénale et hépatique La pharmacocinétique du déférasirox n’ a pas été étudiée chez les patients ayant une insuffisance rénale ou une insuffisance hépatique.
0.47789761424064636 ||| Do not use Zevalin: ||| er Do not use Velosulin ||| N’utilisez jamais Zevalin:
0.02615787833929062 ||| Study SCAB2003 Bipolar I ||| Study SCAB2006 Bipolar I ||| Etude SCAB2003 Bipolaire I
0.38083401322364807 ||| Mixtard 10 Penfill 100 IU/ ml suspension for injection in a cartridge. ||| Fabrazyme 35 mg is supplied in clear Type I glass 20 ml vials. ||| Mixtard 10 Penfill 100 UI/ ml suspension injectable en cartouche
0.5095090270042419 ||| Sealed radioactive substances for medical use ||| Mutual recognition of medicinal products for human use ||| Substances radioactives scellées à usage médical
0.6002905368804932 ||| The backlash included a petition for the WHO Director-General Tedros Adhanom to tender his resignation, signed by 733,000 people as of 6 April. ||| Head of the Georgian National Centre for Disease Control Amiran Gamkrelidze said at a news briefing the following day that there is still no reason to panic. ||| Cette réaction négative a été appuyée par une pétition incitant le directeur général de l’OMS Tedros Adhanom à remettre sa démission, signée par 733 000 personnes au 6 avril.
0.22177477180957794 ||| The following table presents the adverse drug reactions that were reported in placebo-controlled trials in which 1,965 hypertensive patients received irbesartan. ||| In clinical trials adverse events seen on treatment discontinuation occurred in approximately 60% of patients in both the fluoxetine and placebo groups. ||| Les effets indésirables suivants ont été rapportés au cours des études cliniques versus placebo dans lesquelles 1965 patients ont reçu de l’ irbésartan.
0.376844197511673 ||| Manufacturer Roche Diagnostics GmbH Sandhofer Strasse 116 D-68305 Mannheim Germany ||| Marketing Authorisation holder and manufacturer Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria ||| Fabricant Roche Diagnostics GmbH Sandhofer Strasse 116 D-68305 Mannheim Allemagne
0.41034868359565735 ||| Following administration of 0.25 mg digoxin concomitantly with 100 mg of TESAVEL daily for 10 days, the plasma AUC of digoxin was increased on average by 11%, and the plasma Cmax on average by 18%. ||| If renal function declines during maintenance therapy reduce Oprymea daily dose by the same percentage as the decline in creatinine clearance, i. e. if creatinine clearance declines by 30%, then reduce the Oprymea daily dose by 30%. ||| Après administration simultanée de 0,25 mg de digoxine et de 100 mg de TESAVEL par jour pendant 10 jours, l'ASC plasmatique de la digoxine a été augmentée de 11% en moyenne et la Cmax plasmatique de 18% en moyenne.
0.32968199253082275 ||| Enbrel 50 mg is supplied as a white powder and solvent for solution for injection. ||| Zerit 200 mg powder for oral solution is supplied in a bottle containing 200 ml solution. ||| Enbrel 50 mg est fourni sous forme de poudre blanche et de solvant pour solution injectable.
0.4444403350353241 ||| Brakes for aircraft ||| Brakes for industrial machines ||| Freins pour aéronefs
0.2251552939414978 ||| tho Following 52 weeks and 104 weeks of treatment, the percentage of patients without progression (change from baseline in modified total Sharp score ≤ 0.5) was significantly higher with Trudexa/ methotrexate combination therapy (63.8% and 61.2% respectively) compared to methotrexate ||| Six-month seizure freedom was achieved in 73.0% of levetiracetam-treated patients and 72.8% of carbamazepine-CR treated patients; the adjusted absolute difference between treatments was 0.2% (95% CI: -7.8 8.2). ||| A la suite de 52 et 104 semaines de traitement, le pourcentage de patients sans progression (variation du score total de Sharp modifié par rapport à la valeur de base ≤ 0,5) était significativement supérieur avec le traitement par l'association Trudexa/ méthotrexate (respectivement 63,8% et 61,2%) comparativement au méthotrexate en monothérapie (respectivement 37,4% et 33,5%, p < 0,001) et Ce
0.3794682025909424 ||| Allow the pre-filled syringe to reach room temperature before injecting. ||| Apply to the skin immediately after removal from the individually sealed package. ||| Amener la seringue à température ambiante avant l’ injection.
0.43089890480041504 ||| Yeast tablets for consumption by animals ||| Starch derivatives for food human consumption ||| Comprimés de levure pour consommation animale
0.052479714155197144 ||| The European Commission's next economic forecast will be the Spring 2020 Economic Forecast which is scheduled to be published on 7 May 2020. ||| The European Commission's next economic forecast will be the Summer 2020 Interim Economic Forecast which is scheduled to be published in July 2020. ||| Le prochain exercice de prévisions économiques de la Commission européenne sera celui des prévisions économiques du printemps 2020, dont la publication est prévue le 7 mai 2020.
0.353188693523407 ||| Reduction of erythrocytes and neutrophil counts were identified as the effects most likely to be of clinical relevance. ||| The pivotal studies were not designed to assess efficacy of palonosetron in delayed onset nausea and vomiting. ||| 12 Les seuls effets cliniquement pertinents étaient une diminution du nombre de globules rouges et une neutropénie.
0.08459228277206421 ||| WHAT MYFENAX IS AND WHAT IT IS USED FOR ||| WHAT AMMONAPS IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE MYFENAX ET DANS QUEL CAS EST-IL UTILISE?
0.18424096703529358 ||| AUC: ↓ 62% (↓ 45 to ↓ 74) Cmax: ↓ 50% (↓ 28 to ↓ 66) Cmin: ↓ 56% (↓ 16 to ↓ 77) (decrease in saquinavir concentrations: ||| AUC: ↓ 26% (↓ 15 to ↓ 36) Cmax: ↓ 20% (↓ 11 to ↓ 28) Cmin: ↓ 32% (↓ 15 to ↓ 46) (CYP3A4 and CYP2B6 induction) ||| ASC: ↓ 62% (↓ 45 à ↓ 74) Cmax: ↓ 50% (↓ 28 à ↓ 66) Cmin: ↓ 56% (↓ 16 à ↓ 77) (diminution des concentrations de saquinavir: induction du CYP3A4) Efavirenz:
0.4662977457046509 ||| Asbestos felt ||| Asbestos powder ||| Feutre d'amiante
0.8745865821838379 ||| Cozaar Comp 50 mg/ 12.5 mg, Cozaar Comp 100 mg/ 12.5 mg and Cozaar Comp 100 mg/ 25 mg: ||| 5 µg Hib PRP + 12.5 µg TT + 5 µg MenC PSC + 5 µg TT ||| Cozaar Comp 50 mg/ 12,5 mg, Cozaar Comp 100 mg/ 12,5 mg et Cozaar Comp 100 mg/ 25 mg:
0.6005471348762512 ||| Astellas Pharma GmbH Neumarkter Str. ||| ct-Arzneimittel GmbH Lengeder Str. ||| au Astellas Pharma GmbH Neumarkter Str.
0.3282220959663391 ||| ed Each film-coated tablet contains 400 mg of telithromycin. ||| Tasmar is supplied as film coated tablets containing 100 mg tolcapone. ||| Chaque comprimé pelliculé contient 400 mg de télithromycine (D. C. I.).
0.0 ||| 7. ||| 7. ||| 209 7.
0.015617337077856064 ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN lp ||| SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN lP ||| MISE EN GARDE SPECIALE INDIQUANT QUE LE MEDICAMENT DOIT ÊTRE CONSERVE HORS DE PORTEE ET DE VUE DES ENFANTS. ic
0.37982112169265747 ||| There is limited clinical experience with lacosamide overdose in humans. ||| There is limited experience of overdose with saquinavir. ||| L’ expérience clinique de surdosage au lacosamide est limitée.
0.036475859582424164 ||| 158 Methotrexate ||| 138 Methotrexate ||| Méthotrexate
0.14864668250083923 ||| Entertainment services relating to sport ||| Education services relating to fashion ||| Services de divertissement sportif
3.7057742941978833e-13 ||| Your insulin will work more quickly if you inject it around the waist. ||| Your insulin will work more quickly if you inject it around the waist. ||| Votre insuline agira plus rapidement si vous l’injectez au niveau de l’abdomen.
0.17420434951782227 ||| Garden stakes of non-metallic materials ||| Garden sheds of non-metallic materials ||| Piquets de jardin en matériaux non métalliques
0.7079584002494812 ||| • Arixtra • fondaparinux ||| • Invanz • ertapenem ||| Arixtra fondaparinux
0.08829498291015625 ||| What benefit has Neupopeg shown during the studies? ||| What benefit has Macugen shown during the studies? ||| é Quel est le bénéfice démontré par Neupopeg au cours des études?
0.41614824533462524 ||| The following side effects have been reported in clinical studies. ||| These results were confirmed in a field-based study. ||| Les effets indésirables suivants ont été rapportés lors d'études cliniques.
0.41926106810569763 ||| What Januvia contains ||| What Ovitrelle contains ||| Que contient Januvia
0.3706575632095337 ||| The recommended start dose is 5 mg in patients with moderate renal impairment (creatinine clearance < 60 ml/ min). ||| A 15 minute infusion time has not been studied in cancer patients with CLCr < 50 mL/ min. ||| Une dose initiale de 5 mg est recommandée chez les patients > 70 ans (Cf. rubrique 4.4 Mises en garde spéciales et précautions particulières d'emploi).
0.1547040343284607 ||| Blister for Efficib 50 mg/ 850 mg film-coated tablets ||| Blister for Cozaar Comp 100 mg/ 12.5 mg film-coated tablets ||| Plaquette thermoformée pour Efficib 50 mg/ 850 mg, comprimés pelliculés
0.4410986006259918 ||| On 26 March, 16 new cases were confirmed thus bringing the total to 96 cases. ||| On 11 April, a third death was declared; the number of cases increases slightly to 196. ||| Le 26 mars, 16 nouveaux cas ont été confirmés, ce qui porte le total à 96 cas.
0.1705014705657959 ||| Before you use HBVAXPRO 40 micrograms/ ml 3. ||| How to store HBVAXPRO 10 micrograms/ ml 6. ||| Quelles sont les informations à connaître avant d'utiliser HBVAXPRO 40 microgrammes/ml 3.
0.41544032096862793 ||| Intravascular volume depletion: volume and/ or sodium depletion should be corrected prior to administration of Irbesartan BMS. ||| The DTPa-HBV-IPV suspension should be inspected visually for any foreign particulate matter and/ or abnormal physical appearance. ||| Hypovolémie: l'hypovolémie et/ ou la déplétion hydrosodée devront être corrigées préalablement à l'administration de Irbesartan BMS.
0.7011265754699707 ||| Use immediately after reconstitution. ||| Do not use after expiry date ||| Utiliser immédiatement après reconstitution.
0.4103047251701355 ||| At present, there is insufficient clinical experience in these patients to provide dosing recommendations. ||| Some additional data have been obtained from a number of patients in a compassionate use programme. ||| A ce jour, l’ expérience clinique chez ces patients est trop limitée pour permettre des recommandations posologiques spécifiques.
0.5759567022323608 ||| At the same time, it is important that these partnerships develop in a sound manner. ||| At the same time, it is time to look ahead and to focus on protecting livelihoods. ||| Dans le même temps, il importe que ces partenariats se développent de manière rigoureuse.
0.353893518447876 ||| The excretion of tocilizumab in milk has not been studied in animals. ||| The uptake of bexarotene by organs or tissues has not been evaluated. ||| L’ excrétion du tocilizumab dans le lait n’ a pas été étudié chez l’ animal.
0.4325774312019348 ||| The dose may be increased in increments up to 45mg once daily. ||| It is recommended that the rate of administration should not exceed 2 ml/ min. ||| La dose pourra être augmentée progressivement jusqu’ à la dose de 45mg en une seule prise quotidienne.
0.22248448431491852 ||| 33% ||| 6000 ||| 65%
0.21607151627540588 ||| Consultancy relating to the treatment of chemical pollution ||| Consultancy relating to the design of packaging ||| Consultation en matière de traitement de la pollution chimique
0.5253146290779114 ||| In particular, (i) zero-interest loans do not exceed the nominal value of €800,000 per company as foreseen by the Temporary Temporary Framework, and (ii) subsidised loans have a limited size, maturity and interest rates. ||| A summary of vaccine distribution shall be included and provide details of the number of doses of vaccine distributed in: i) EU member states for the reporting period by batch number, ii) EU member states cumulatively and iii) the rest of the world ||| En particulier, i) les prêts à taux zéro ne dépassent pas la valeur nominale de 800 000 euros par entreprise prévue par l'encadrement temporaire, et ii) les prêts bonifiés ont un montant, une durée et des taux d'intérêt limités.
3.245885819239819e-13 ||| In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hrs) and the clearance was reduced (18.9 versus 27.3 l/ hr). ||| In female versus male subjects the mean elimination half life was somewhat prolonged (36.7 versus 32.3 hrs) and the clearance was reduced (18.9 versus 27.3 l/ hr). ||| Chez la femme, par rapport à l’ homme, la demi-vie d’ élimination moyenne est légèrement prolongée (36,7 vs 32,3 heures) et la clairance est réduite (18,9 vs 27,3 l/ heure).
0.1595844328403473 ||| Installations for the roasting of cocoa ||| Installations for the roasting of nuts ||| Installations pour la torréfaction du cacao
0.31389331817626953 ||| The IEF decreased by 52% in the Yentreve group, compared with a decrease of 33% in the placebo-treated group. ||| The percentage of patients reaching HbA1c < 7% was 51% in the rimonabant group and 35% in the placebo group. ||| La FEI a baissé de 52% dans le groupe sous Yentreve, contre une baisse de 33% dans le groupe sous placebo.
0.17278292775154114 ||| Within the pulmonary system, nitric oxide can combine with oxygen and water to produce nitrogen dioxide and nitrite, respectively, which interact with oxyhaemoglobin to produce methaemoglobin and nitrate. ||| At low oxygen saturation, nitric oxide can combine with deoxyhaemoglobin to transiently form nitrosylhaemoglobin, which is converted to nitrogen oxides and methaemoglobin upon exposure to oxygen. ||| Au sein de l’ appareil respiratoire, le monoxyde d'azote peut réagir avec l’ oxygène et l’ eau pour former du dioxyde d'azote et des nitrites, lesquels réagissent avec l’ oxyhémoglobine pour produire de la méthémoglobine et des nitrates.
0.2942265272140503 ||| As human IgG is secreted into human milk, and the potential for harm to the infant is unknown, women should not breast-feed during Osigraft therapy (see Section 5.3). ||| Because the effect on the nursing infant is unknown, it is not recommended to breast-feed your baby while using [Neurontin and associated names]. ||| L’ IgG humaine étant secrétée dans le lait maternel, et la nocivité potentielle en étant inconnue pour le nourrisson, l’ allaitement doit être proscrit pendant le traitement avec Osigraft (voir Section 5.3).
0.6326550841331482 ||| I. whereas the Commission has already taken initial action, including a package of measures voted on by Parliament during its plenary session on 26 March 2020; ||| In January 2001 the Committee’s mandate will change in accordance with its three-year cycle and new members will meet and elect a new chairman and vice-chair. ||| I. considérant que la Commission a déjà pris des premières mesures, notamment un train de mesures votées par le Parlement lors de sa session plénière du 26 mars 2020;
0.48296788334846497 ||| The summary of opinion of the Committee for Orphan Medicinal Products for Exjade is available here. ||| Provision of secretariat for the Committee for Orphan Medicinal Products ||| Le résumé de l’ avis du comité des médicaments orphelins relatif à Exjade est disponible ici.
0.015040170401334763 ||| The CHMP is of the Opinion that the Product Information of HBVAXPRO, should be varied in order to maintain the safe and effective clinical use for the following reasons: ||| The CHMP is of the Opinion that the Product Information of PROCOMVAX, should be varied in order to maintain the safe and effective clinical use for the following reasons: ||| le CHMP estime que les informations relatives au produit d’ HBVAXPRO doivent être modifiées afin de garantir la sûreté et l’ efficacité de l’ utilisation clinique pour les raisons suivantes:
0.29835954308509827 ||| Sodium phosphate ||| Copper phosphate ||| Phosphate de sodium
0.3130751848220825 ||| Your doctor or his/ her assistant will instruct you how to self-inject Valtropin. ||| You will be instructed by your doctor or his/her assistant on the technique of self-injection. ||| Votre médecin ou son assistant(e) vous apprendront comment vous injecter vous -même Valtropin.
0.10418222844600677 ||| Chemical substances for use in the manufacture of perfumes ||| Chemical substances for use in the production of drugs ||| Substances chimiques destinées à la fabrication de parfums
0.30362415313720703 ||| Glazing rollers for use with calendering machines ||| Medical devices for placing and securing catheters ||| Rouleaux satineurs pour calandres [machines]
0.6949746608734131 ||| Nausea Common: ||| Common: nausea. ||| Fréquent:
0.35314905643463135 ||| If you forget to use NEVANAC, use a single dose as soon as you remember. ||| You should take Agenerase capsules as soon as you are able to swallow them. ||| Si vous oubliez d’ utiliser NEVANAC, mettez une dose dès que vous vous en souvenez.
0.4548305869102478 ||| Italy will continue to support cooperative actions, international solidarity and the global response to defeat COVID-19. ||| Japan committed to international cooperation, and to ensure vulnerable and developing nations are prioritized during the pandemic. ||| L'Italie continuera de soutenir des actions de coopération, la solidarité internationale et la réponse mondiale pour vaincre la COVID-19.
0.32179826498031616 ||| If the oral solution is used, the dose is adjusted to the nearest 2.5 ml. ||| The dose is set by turning the selector, which returns to zero during the injection. ||| Si la solution buvable est utilisée, la dose est ajustée à 2,5 ml près.
0.332035630941391 ||| Face shields, other than for medical purposes ||| Radiological contrast agents, other than for medical purposes ||| Écrans faciaux autres qu'à usage médical
0.22023099660873413 ||| Nasal cleaning preparations for medical purposes ||| Nasal sprays for medical purposes ||| Préparations pour le nettoyage du nez à des fins médicales
0.4335421919822693 ||| There have been reports of overdose at doses up to approximately twice the recommended therapeutic dose. ||| These opacities usually occurred only after administration of higher doses than the recommended standard doses. ||| Des cas de surdosage ont été rapportés à des doses allant jusqu’ à environ deux fois la dose thérapeutique recommandée.
0.3220694065093994 ||| In the presence of the above signs, treatment with Cyanokit must not be delayed to obtain a plasma lactate concentration. ||| You should only receive Tasmar if your Parkinson’ s disease is not adequately controlled by the use of other therapies. ||| En présence des signes mentionnés ci-dessus le traitement par Cyanokit ne doit pas attendre la détermination de la concentration plasmatique en lactate.
0.09841810166835785 ||| 30 11. ||| 31 10. ||| 32 11.
0.33870843052864075 ||| 142 ● Clean the rubber top of the vial with a cleansing swab. ||| Clean the rubber closure of each vial such as with an alcohol wipe. ||| • Nettoyez la partie supérieure du bouchon en caoutchouc du flacon avec un tampon désinfectant.
0.11789277195930481 ||| Interface cables [electric] ||| Instrument panels [electric] ||| Câbles d'interface électriques
0.26076579093933105 ||| No dosage adjustment of CoAprovel is necessary in patients with mild to moderate hepatic impairment (see section 4.3). ||| Pre-treatment with dexamethasone (or equivalent) can reduce the incidence and severity of skin reactions (see section 4.2). ||| Un ajustement de la posologie n’ est pas nécessaire chez les patients présentant une insuffisance hépatique légère à modérée (voir rubrique 4.3).
0.42266958951950073 ||| Posaconazole may increase the plasma concentration of ergot alkaloids (ergotamine and dihydroergotamine), which may lead to ergotism. ||| The first pathway results in the formation of nicotinamide adenine dinucleotide (NAD) and nicotinamide. ||| Le posaconazole est susceptible d’ augmenter les concentrations des alcaloïdes de l’ ergot de seigle (ergotamine et dihydroergotamine), pouvant entraîner de l’ ergotisme.
0.37155142426490784 ||| 100 mg; salmon: ||| 0.5 mg; yellow: ||| 100 mg; saumon:
0.4606292247772217 ||| Member States will already be able to update apps to permit information exchange between national, decentralised apps as soon as they are technically ready. ||| In order to improve crisis preparedness across the EU, a European medical capacity will be created, and equipment hosted by one or several Member States. ||| Les États membres seront déjà en mesure de mettre à jour les applications afin de permettre l'échange d'informations entre les applications nationales décentralisées dès qu'elles seront prêtes d'un point de vue technique.
0.08919689804315567 ||| What Rebetol is and what it is used for 2. ||| What Exelon is and what it is used for 2. ||| Qu’ est -ce que Rebetol et dans quel cas est -il utilisé 2.
0.3233489394187927 ||| To continue contacts on good laboratory practice (GLP) inspections with the EMEA scientific committees and GLP inspectors in order to progress the procedures and concept. ||| The development of a strategy on Good Clinical Practice (GCP) inspections has started, together with the development of harmonised Community procedures of GCPs. ||| Poursuivre les contacts sur les inspections des bonnes pratiques de laboratoire (BPL) avec les comités scientifiques de l'EMEA et les inspecteurs BPL pour faire progresser le concept et les procédures.
0.16590842604637146 ||| Fencing rails (Non-metallic -) ||| Fencing materials (Non-metallic -) ||| Planches de clôture non métalliques
0.10140646994113922 ||| Tell your doctor at once if any of these apply to you. ||| Tell your doctor if any of these apply to you. ||| Indiquez à votre médecin si vous prenez un de ces médicaments.
0.18029187619686127 ||| Turnhauseveg 30 B-2340 Beerse Belgium ||| Turnhoutseweg 30 B-2340 Beerse Belgium ||| Turnhauseweg 30 B-2340 Beerse Belgique Portugal
0.5726650953292847 ||| Remote transmission of audio signals by means of telecommunications ||| Electronic communication services for transmission by means of aerials ||| Transmission de signaux audio à distance par le biais de télécommunications
0.0026754620485007763 ||| 118 In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| 127 In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.09397678822278976 ||| In a clinical trial, hyperlipaemia was reported as an adverse event in 27% of patients. ||| In a clinical trial, 26% of patients reported hyperglycaemia as an adverse event. ||| Dans un essai clinique, des évènements indésirables à type d’ hyperlipidémie ont été observés chez 27% des patients.
0.28972315788269043 ||| The tablet must always be taken after an overnight fast, one hour before any food or drink except for water, and with a full glass of plain water. ||| Your Bondronat tablets should be taken after an overnight fast (at least 6 hours) and before the first food or drink of the day. ||| Celui -ci doit toujours être pris à jeun, une heure avant l'absorption de toute nourriture ou boisson sauf de l'eau, et avec un grand verre d'eau plate.
0.7123253345489502 ||| associated mutations Any three NRTI- ||| − Primary PI mutations: ||| liées aux INTI
0.5269219875335693 ||| 7 to 14 days ||| 7 days 5 to 14 days ||| 7 à 14 jours
0.0 ||| 7. ||| 7. ||| 209 7.
0.14744912087917328 ||| L 143 of 27.06.95 7 OJ No. ||| L 290 of 5.12.95 10 OJ No. ||| L 143 du 27.06.95 7 JO N°.
0.06907063722610474 ||| The usual initial dose is one 30mg tablet once-daily. ||| The recommended initial dose is one 30mg tablet once-daily. ||| La posologie initiale habituelle est d’ un comprimé de 30 mg une fois par jour.
0.07303126156330109 ||| Rifampicin: in patients not also taking ciclosporin, concomitant administration of Mycophenolate mofetil and rifampicin resulted in a decrease in MPA exposure (AUC0-12h) of 18% to 70%. ||| Rifampicin: in patients not also taking ciclosporin, concomitant administration of CellCept and rifampicin resulted in a decrease in MPA exposure (AUC0-12h) of 18% to 70%. ||| Rifampicine: chez les patients ne prenant pas également de ciclosporine, l’ administration concomitante de mycophénolate mofétil et de rifampicine a entraîné une diminution de l’ exposition au MPA (ASC0-12h) de 18% à 70%.
0.02502385340631008 ||| 34 PACKAGE LEAFLET: ||| 44 PACKAGE LEAFLET: ||| 37 NOTICE:
0.2098659873008728 ||| Extruded plastics in the form of blocks for use in manufacture ||| Non-woven fabrics in the form of rolls for use in manufacture ||| Matières plastiques extrudées sous forme de blocs destinées à la fabrication
0.5873473882675171 ||| Artificial rice [uncooked] ||| Soya bean paste [condiment] ||| Riz artificiel non cuit
0.34344282746315 ||| Interference with culture test Moxifloxacin therapy may give false negative culture results for Mycobacterium spp. by suppression of mycobacterial growth. ||| Aspergillus infections – efficacy in aspergillosis patients with poor prognosis Voriconazole has in vitro fungicidal activity against Aspergillus spp. ||| Interférence avec les cultures bactériennes Un traitement par moxifloxacine peut entraîner une inhibition de la croissance bactérienne et des cultures faussement négatives pour la recherche de Mycobactérium sp.
0.28378456830978394 ||| In the prevention of invasive fungal infections, the effectiveness of Posaconazole SP has been studied in 600 stem cell transplant patients with fluconazole as a comparator and 602 patients with blood or bone marrow cancer, comparing it to fluconazole or itraconazole. ||| The objective of this trial was to compare the efficacy /safety or lansoprazole 15/30mg to placebo in the prevention of duodenal ulcers in those with a history of duodenal, or gastric ulcer disease in those with a history of gasric ulcers. ||| Dans la prévention d’ infections fongiques invasives, l’ efficacité de Posaconazole SP a été étudiée chez 600 patients ayant subi une greffe de cellules souches, par comparaison avec le fluconazole, et chez 602 patients atteints d’ un cancer du sang ou de la moelle osseuse, par comparaison avec le fluconazole ou l’ itraconazole.
0.21129393577575684 ||| Other information about Fertavid: ||| Other information about Pradaxa: ||| Autres informations relatives à Fertavid:
0.34253281354904175 ||| The Emergency Support Instrument will help fund urgent medical supply needs, such as masks and respirators, the transportation of medical equipment and patients in cross-border regions, the deployment of healthcare workers to contagion hotspots, and the construction of mobile field hospitals. ||| In addition, rural development funds can be used to invest in medical facilities and small-scale infrastructure in rural areas, such as the adaptation of health centres to treat growing numbers of patients or the set-up of mobile health facilities to carry out tests and provide treatments to farmers and rural inhabitants. ||| L' instrument d'aide d'urgence aidera à financer les besoins urgents en matière d'équipements médicaux, tels que les masques et les équipements de protection respiratoire, le transport du matériel médical et des patients dans les régions transfrontalières, le déploiement de professionnels de la santé dans les foyers de contagion et la construction d'hôpitaux de campagne mobiles.
0.3291934132575989 ||| The use of AVANDAMET in combination with a sulphonylurea or insulin may be associated with increased risks of fluid retention and heart failure (see section 4.8). ||| These led to updates of the product information to include class warnings on the risk of CV thrombotic, GI and severe skin reactions with COX-2 selective inhibitors. ||| L’ utilisation d’ AVANDAMET en association avec un sulfamide hypoglycémiant ou de l’ insuline peut être associée à une augmentation du risque de rétention hydrique et d’ insuffisance cardiaque (voir rubrique 4.8).
0.3032436668872833 ||| 0.25 mg ||| 1.25 mg ||| 0,5 mg
0.11237138509750366 ||| • 12.07.2001 • OJ C 209, 27.07.2001, p. ||| • 24.6.2002 • OJ C 178, 26.7.2002, p. ||| 12.07.2001 JO C 209, 27.07.2001, p.
0.3166576027870178 ||| Given this outcome together with published data on the pharmacokinetics of sodium salicylate in calves and significant variation in individual pig concentrations post treatment2, the MAHs should justify that therapeutic concentrations are established and maintained following oral use of the drug through water medication and submit all available data that could substantiate the posology and dosage regimen of sodium salicylate when given orally to calves and pigs, together with a thorough discussion of the these data. ||| differ significantly with regards to the release profile from the originator product with potential for increased incidence of adverse events such as dizziness and hypotension, whether there were significant differences in performance of test batches in the single dose phase of studies 5208 and 1995 and whether the applicant has deviated from CHMP guidelines on the design of the bioequivalence studies, particularly in relation to the effect of food with concern regarding the adequate sensitivity of to detect a difference between products, ||| Au vu de cette observation ainsi que des résultats publiés sur la pharmacocinétique du salicylate de sodium chez les veaux et les variations individuelles significatives des concentrations chez les porcs après le traitement2, les TAMM doivent justifier que les concentrations thérapeutiques sont établies et maintenues
0.32488176226615906 ||| The surface antigen of hepatitis B virus is produced by culture of a recombinant strain of yeast cells (Saccharomyces cerevisiae). ||| The vaccine strain is a recombinant canarypox virus expressing the env and gag genes of FeLV-A. ||| L'antigène de surface du virus de l'hépatite B est produit par culture d'une souche recombinante de cellules de levure (Saccharomyces cerevisiae).
0.03344065696001053 ||| Make sure you get the Liprolog Basal that your doctor has told you to use. ||| Make sure you get the Liprolog Basal Pen that your doctor has told you to use. ||| Assurez-vous que vous avez la forme de Liprolog BASAL prescrite par votre médecin.
0.6203573942184448 ||| 21 March 2007 na ||| tho 1 September 2003 ||| 21 mars 2002 21 mars 2007
0.3315238952636719 ||| Antique furniture ||| Antique style furniture ||| Meubles anciens
0.5042691230773926 ||| Cocoons for silkworm breeding ||| Powders for killing fleas on animals ||| Cocons pour élevage de vers à soie
0.11508800089359283 ||| The full EPAR for Zometa is available here. ||| The full EPAR for PROTELOS is available here. ||| L’ EPAR complet relatif à Zometa est disponible ici.
0.06987768411636353 ||| What benefit has Xolair shown during the studies? ||| What benefit has Xarelto shown during the studies? ||| Quels ont été les avantages de Xolair au cours de ces études?
0.23898093402385712 ||| Clinical experience with epoetins suggest hypertension and thrombosis risk may be reduced by titrating the dose to maintain haemoglobin levels between 10 to 12 g/ dl. ||| At the recommended dosage of 10 - 12 mg/ kg bodyweight lung lesions and weight loss are reduced, but infection with Mycoplasma hyopneumoniae is not eliminated. ||| L’ expérience clinique de l’ époïétine semble indiquer que le risque d’ hypertension et de thrombose peut être réduit par titration de la dose pour maintenir un taux d’ hémoglobine compris entre 10 et 12 g/ dl.
0.3324752151966095 ||| 21 The most commonly reported adverse reactions in patients treated with XERISTAR were nausea, headache, dry mouth, somnolence, fatigue, insomnia, dizziness and constipation. ||| You may find that your cataplexy attacks return if your medicine is stopped and you may experience insomnia, headache, anxiety, dizziness, sleeping problems, sleepiness, hallucination and abnormal thinking. ||| Les événements indésirables les plus fréquemment rapportés chez les patients traités par XERISTAR ont été: nausées, céphalées, sècheresse de la bouche, somnolence, fatigue, insomnie, sensations vertigineuses et constipation.
0.6299972534179688 ||| Paper in sheet form [sensitized] ||| Lot {number} See embossed stamp. ||| Papier sensible sous forme de feuilles
0.036566197872161865 ||| The frequencies are defined as follows: very common (≥ 1/ 10); common (≥ 1/ 100 to < 1/ 10); uncommon (≥ 1/ 1,000 to < 1/ 100); rare (≥ 1/ 10,000 to < 1/ 1,000); very rare (< 1/ 10,000) ||| The frequency categories are defined as follows: very common (≥ 1/ 10); common (≥ 1/ 100, < 1/ 10); uncommon (≥ 1/ 1,000, < 1/ 100), rare (≥ 1/ 10,000, < 1/ 1,000); very rare (< 1/ 10,000). ||| Très fréquent (≥ 1/ 10); fréquent (≥ 1/ 100 à < 1/ 10); peu fréquent (≥ 1/ 1 000 à < 1/ 100); rare (≥ 1/ 10 000 à < 1/ 1 000); très rare (< 1/ 10 000)
0.22975614666938782 ||| Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCV-RNA polymerase chain reaction assay (PCR) (> 30 IU/ ml), a liver biopsy consistent with a histological diagnosis of chronic hepatitis with no other cause for the chronic hepatitis, and abnormal serum ALT. ||| RR-MS, SP-MS and single clinical event suggestive of MS Extavia was effective in all multiple sclerosis studies to reduce disease activity (acute inflammation in the central nervous system and permanent tissue alterations) as measured by magnetic resonance imaging (MRI). ||| Les patients éligibles pour ces études avaient une hépatite C chronique confirmée par un dosage positif « VHC-ARN polymerase chain reaction » (PCR) (> 30 UI/ ml), une biopsie hépatique cohérente avec un diagnostic histologique d’ hépatite chronique sans autre cause d’ hépatite chronique, et des ALT sériques anormales.
0.37148526310920715 ||| The solution also contains potassium sorbate and sorbitol E420. ||| PritorPlus contains milk sugar (lactose) and sorbitol. ||| La solution contient également du sorbate de potassium et du sorbitol E420.
0.017700258642435074 ||| Hepatitis A virus (inactivated)1,2 Hepatitis B surface antigen3,4 1 Produced on human diploid (MRC-5) cells 2 ||| Hepatitis A virus (inactivated)1,2 Hepatitis B surface antigen 3,4 1 Produced on human diploid (MRC-5) cells 2 ||| Virus de l’ hépatite A (inactivé)1,2 Antigène de surface de l’ hépatite B 3,4 1 Produit sur cellules humaines diploïdes (MRC-5) 2
0.04407642036676407 ||| Dispersible tablet ||| Dispersible tablets ||| Comprimé dispersible
0.3891216516494751 ||| Jewellery being articles of precious stones ||| Jewelry cases not of precious metal ||| Bijoux, à savoir articles en pierres précieuses
0.1930387169122696 ||| Electronic instructional and teaching apparatus and instruments ||| Instructional and teaching apparatus and instruments ||| Appareils et instruments électroniques scolaires et d’instruction
0.39433765411376953 ||| Spiked rollers [machines] for use in soil aeration ||| Towels [textile] for use in connection with babies ||| Rouleaux à pointes pour l'aération du sol [machines]
0.7327963709831238 ||| 44%** * ||| 16%*** 38%*** ||| 44 %*** ACR 70
0.3126188814640045 ||| There was no difference seen in median PFS times as more than 50% of patients progressed in both treatment groups before the first scheduled visit. ||| Serum CTX reduction was maintained over the 2 years, with more than half of the patients identified as responders in both treatment groups. ||| Aucune différence de durée médiane de survie sans progression n’ a été observée, plus de 50% des patients ayant progressé avant la première visite programmée dans les deux groupes de traitement.
0.14238056540489197 ||| 1 pre-filled syringe contains 6000 IU Epoetin zeta ||| 1 pre-filled syringe contains 500 IU epoetin beta. ||| 1 seringue préremplie contient 6 000 UI d’ époétine zêta
0.10913873463869095 ||| What is the risk associated with Gliolan? ||| What is the risk associated with Aerius? ||| Quel est le risque associé à l’ utilisation de Gliolan?
0.3403991460800171 ||| Omnipharm Limited, The Spire, Egypt Road, Nottingham NG7 7GD United Kingdom ||| Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom ||| Omnipharm Ltd The Spire Egypt Road Nottingham NG7 7GD Royaume-Uni
0.01153508573770523 ||| Prialt 25 micrograms/ ml, solution for infusion. ||| Prialt 100 micrograms/ ml, solution for infusion. ||| Prialt 25 microgrammes/ ml, solution pour perfusion.
0.41939234733581543 ||| Duloxetine is well absorbed after oral administration with a Cmax occurring 6 hours post dose. ||| By 3 hours after administration plasma concentrations are similar whether telmisartan is taken fasting or with food. ||| La duloxétine est bien absorbée après administration orale, avec une Cmax atteinte 6 heures après l’ administration.
0.31361573934555054 ||| Higher increases in blood pressure and heart rate cannot be excluded in isolated cases. ||| Lowering the blood pressure to a normal level reduces the risk of developing these disorders. ||| Des cas isolés d'augmentation plus importante de la pression artérielle et de la fréquence cardiaque ne peuvent pas être exclus.
0.1152791827917099 ||| 43 Red iron oxide (E172) Yellow iron oxide (E172) Titanium dioxide (E171) Gelatin Black ink containing: shellac, black iron oxide (E172), propylene glycol and potassium hydroxide ||| 11 Capsule shells: gelatin indigo carmine (E132) yellow iron oxide (E172) red iron oxide (E172) titanium dioxide (E171) black iron oxide (E172) potassium hydroxide shellac. ||| Oxyde de fer rouge (E172) Oxyde de fer jaune (E172) Dioxyde de titane (E171) Gélatine L’encre noire contient: vernis, oxyde de fer noir (E172), propylène glycol et hydroxyde de potassium
0.3554303050041199 ||| To ensure that the data of European citizens is protected at all times, in line with EU data protection rules, this guidance accompanies the toolbox as advice for the development of new apps and the subsequent use of data by national health authorities. ||| The EPAR, which is made public once a Decision has been notified by the European Commission, has proven to be a very important tool in providing both health professionals and consumers with the necessary information on centrally-authorised ||| Pour garantir que les données des citoyens européens sont protégées à tout moment, conformément aux règles de l'UE en matière de protection des données, ces orientations accompagnent la boîte à outils en tant que conseils pour le développement de nouvelles applications et l'utilisation ultérieure des données par les autorités sanitaires nationales.
0.11052362620830536 ||| • 27.9.2002 • 14.10.2002 • 13.12.2002 • 61 days ||| • 5.9.2002 • 16.9.2002 • 15.11.2002 • 61 days ||| 27.9.2002 14.10.2002 13.12.2002 61 jours
0.4413001835346222 ||| Pack sizes of 14, 28, 56; 168 modified-release tablets and 32 x 1modified-release tablets in a perforated unit dose blister. ||| The pack sizes 49 x 1, 56 x 1, 98 x 1 and 100 x 1 film-coated tablets are presented in unit dose blister. ||| Boîtes de 14, 28, 56, 168 comprimés à libération modifiée 32 x 1 comprimé à libération modifiée en plaquette thermoformée unidose.
0.37771111726760864 ||| The vaccine helps to reduce the symptoms of the diseases and helps to reduce viral excretion in case of calicivirus infection. ||| Antibiotic resistance severely limits the number of antibiotics available for the treatment of a number of diseases. ||| Le vaccin aide à réduire les symptômes des maladies et également à réduire l’ excrétion virale en cas d’ infection par le calicivirus.
0.7742984294891357 ||| Dosing Recommendations for Combination Therapy for HCV Patients Genotype ||| Confirmed Thrombotic Cardiovascular Serious Adverse Events ||| Recommandations posologiques pour l'association chez les patients infectés par le VHC Génotype
0.4253147840499878 ||| Do not use Insuman Comb 50 after the expiry date which is stated on the carton and on the label of the cartridge. ||| Write the date of expiry of the constituted suspension on the bottle label (the shelf-life of the constituted suspension is 14 days). ||| Ne pas utiliser Insuman Comb 50 après la date de péremption mentionnée sur la boîte et sur l’étiquette de la cartouche.
0.45193856954574585 ||| Caution should be used in prescribing VFEND to patients with hypersensitivity to other azoles (see also section 4.8). ||| Prescribers should consult the section Patients with Renal Impairment (Section 4.2) for recommendations on dosing and administration in this patient group. ||| Il convient d’ être prudent en cas d’ administration de VFEND chez des patients ayant présenté des réactions d’ hypersensibilité à d’ autres azolés (voir aussi rubrique 4.8).
0.4844737946987152 ||| 4 — — 5 ||| — 3 6 — ||| 4 - - 5
0.5249724388122559 ||| The European Parliament is mobilising additional funds to help the EU countries hardest hit by the coronavirus pandemic. ||| The coronavirus pandemic is putting healthcare systems across the EU under unprecedented and increasing pressure. ||| Le Parlement européen mobilise des fonds supplémentaires pour aider les pays de l'Union européenne les plus durement touchés par la pandémie de coronavirus.
0.11610147356987 ||| Dosage adjustment for midazolam should be considered, especially if more than a single dose of midazolam is administered. ||| Dosage adjustment should be considered, especially if more than a single dose of midazolam is administered. ||| Un ajustement de la posologie du midazolam doit être envisagé, particulièrement si plus d'une dose de midazolam est administrée.
0.04743840545415878 ||| I p = 0.0143 P 1.5/R vs. ||| I p = 0.0143 P 1.5/ R vs. ||| I ** p = 0,0143 P 1,5/ R vs.
0.30453500151634216 ||| Therapy should be permanently discontinued in patients who develop arterial thromboembolic events. ||| Bladder catheterisation should be undertaken in patients with urinary obstruction. ||| La survenue d’ un accident thromboembolique impose l’ arrêt définitif du traitement.
0.13648945093154907 ||| Adverse reactions are listed below, by system organ class and absolute frequency. ||| Adverse reactions are listed below, by system organ class and absolute frequency (all reported events). ||| Les effets indésirables sont classés ci-dessous par classe d’ organe et par fréquence absolue.
1.1424253470310175e-12 ||| 6 months 12 months ||| 6 months 12 months ||| 6 mois 12 mois
0.3523941934108734 ||| Periodic monitoring of hepatic function is recommended during treatment. ||| Periodic quantitative monitoring of urinary protein excretion is recommended. ||| Un contrôle périodique de la fonction hépatique est recommandé pendant le traitement.
0.29955318570137024 ||| 15 Adults: intravenous mycophenolate should be administered for the first 4 days following hepatic transplant, with oral Myfenax initiated as soon after this as it can be tolerated. ||| Iron supplementation should be started as soon as possible, even several weeks prior to initiating the autologous predeposit, in order to achieve high iron stores prior to starting Epoetin alfa HEXAL therapy. ||| Adultes: le mycophénolate doit être administré par voie intraveineuse pendant les 4 premiers jours suivant la transplantation hépatique avec un relais du Myfenax par voie orale dès qu'il peut être toléré.
0.17098665237426758 ||| On 13 October 2006, La Jolla Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Riquent, for the treatment of lupus nephritis. ||| On 18 March 2008, Bioenvision Ltd, a wholly owned subsidiary of Genzyme Corporation, officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a change to the marketing authorisation for Evoltra. ||| Le 13 octobre 2006, La Jolla Limited a officiellement informé le Comité des médicaments à usage humain (CHMP) de sa décision de retirer sa demande d’ autorisation de mise sur le marché pour Riquent, dans le traitement de la néphrite lupique.
0.4878474771976471 ||| Consequently the clinical response to each dose of levodopa is enhanced and prolonged. ||| Consequently the incidence of the undesirable effects listed in section 4.8 might be increased. ||| La réponse clinique à chaque dose de lévodopa est donc renforcée et prolongée.
0.19269585609436035 ||| • 12.7.2002 • 10.9.2002 ||| • 5.4.2002 • 17.6.2002 ||| 12.7.2002 10.9.2002
0.4663471281528473 ||| ed is 1. ||| ed ris 2. ||| é ris 1.
0.2776811122894287 ||| The use of Protopic at the same time as other preparations to be used on the skin or while taking oral corticosteroids (e. g. cortisone) or medicines which affect the immune system has not been studied. ||| 46 Taking other medicines It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of ADROVANCE if taken at the same time. ||| L'utilisation de Protopic en même temps que d'autres préparations destinées à l'application sur la peau, ou pendant un traitement par voie orale avec des corticostéroïdes (par exemple, la cortisone) ou des médicaments agissant sur le système immunitaire n'a pas été étudiée.
0.3830623924732208 ||| Any inflammatory symptoms should be evaluated and treatment instituted when necessary (see section 4.8). ||| A dose correction may be needed after six months of treatment (see section 4.4). ||| Tout symptôme inflammatoire doit être évalué et un traitement doit être instauré si nécessaire (voir rubrique 4.8).
0.3374040424823761 ||| The use of pneumococcal conjugate vaccine does not replace the use of 23-valent pneumococcal polysaccharide vaccines in children ≥ 24 months of age with conditions (such as sickle cell disease, asplenia, HIV infection, chronic illness or who are immunocompromised) placing them at higher risk for invasive disease due to Streptococcus pneumoniae. ||| • Pelvic inflammatory disease including cases due to Neisseria gonorrhoeae In the above genital tract infections when thought or known to be due to Neisseria gonorrhoeae it is particularly important to obtain local information on the prevalence of resistance to ciprofloxacin and to confirm susceptibility based on laboratory testing. ||| L’ utilisation d’ un vaccin pneumococcique conjugué ne se substitue pas à celle de vaccins pneumococciques polysaccharidiques 23-valents chez les enfants d’ au moins 24 mois présentant un risque accru de maladie invasive due à Streptococcus pneumoniae (par exemple en cas de drépanocytose, asplénie, infection par le VIH, maladie chronique ou immunosuppression).
0.5148787498474121 ||| Feeding stimulants for animals ||| Hair conditioners for babies ||| Stimulants alimentaires pour animaux
0.4246702790260315 ||| It is available in packs of 2, 7, 10 and 20 pre-filled syringes (not all pack sizes may be marketed). ||| The syringes may be presented in either blistered (1- & 4-pack) or non-blistered packaging (1-pack only). ||| Arixtra est disponible en boîtes de 2, 7, 10 et 20 seringues pré-remplies (certaines présentations peuvent ne pas être commercialisées).
0.0 ||| 2 4.5 Special precautions for use ||| 2 4.5 Special precautions for use ||| 4.5 Précautions particulières d' emploi
0.3787496089935303 ||| Children between 15 days and 12 years old 20-80mg for each kg of body weight once a day, injected into a vein More than 80mg per kg must not be given, even in severe infections-except in meningitis. ||| For children aged 2 to 12 years, the effective dose depends on their body weight — usually, it’ s between 1 mg and 15 mg for each kilogram of the child’ s weight, up to a maximum of 400 mg daily. ||| Enfants âgés de 15 jours à 12 ans 20-80 mg par kg de poids et par jour en une fois, par injection intraveineuse La dose ne doit pas dépasser 80 mg par kg, même en cas d’infections sévères – excepté en cas de méningites.
0.05364883691072464 ||| All patients being treated with Retacrit should receive adequate iron supplementation (e. g. ||| All patients being treated with Silapo should receive adequate iron supplementation (e.g. ||| 141 Tous les patients traités par Retacrit doivent recevoir un apport adéquat en fer (par ex.
0.32633960247039795 ||| For vardenafil as well as M1, protein binding is independent of total drug concentrations. ||| Vitamin D3, along with other forms of vitamin D, is required for calcium absorption and normal bone formation. ||| Pour le vardénafil ainsi que pour M1, la liaison aux protéines est indépendante des concentrations médicamenteuses totales.
0.2952374815940857 ||| No dosage adjustment is necessary for efavirenz. ||| No dosage adjustment is necessary for raltegravir. ||| Aucun ajustement posologique n’ est nécessaire pour ces médicaments.
0.3642108738422394 ||| The pre-filled pen is designed to inject the area under your skin only. ||| The ointment should be applied as a thin layer to affected areas of the skin. ||| Le stylo prérempli n’est conçu que pour procéder à une injection dans la zone située sous la peau.
0.3897823691368103 ||| Arranging of training courses ||| Arranging of conferences ||| Organisation de stages de formation
0.6426001191139221 ||| Flaky pastry containing ham ||| Sloppy joe seasoning mix ||| Pâte feuilletée au jambon
0.5612885355949402 ||| Ensure that the use of applications and platforms does not violate students’ data privacy. ||| Companies are responsible for assessing themselves the legality of their agreements and practices. ||| S’assurer que l’utilisation des applications et plateformes ne compromette pas la confidentialité des données des élèves.
0.5678671598434448 ||| TYSABRI is used to treat multiple sclerosis (MS). ||| ZYPREXA VELOTAB is used to treat schizophrenia. ||| TYSABRI est utilisé pour traiter la sclérose en plaques (SEP).
9.094207591847647e-13 ||| Hypokalaemia ||| Hypokalaemia ||| Arthralgie Hypokaliémie
0.23557743430137634 ||| Sodium chloride Glacial acetic acid Sodium acetate trihydrate Water for injections ||| Sodium chloride Sodium dihydrogen phosphate dihydrate Water for injections ||| Chlorure de sodium Acide acétique glacial Acétate de sodium trihydraté Eau pour préparations injectables
0.5580567121505737 ||| Refurbishment of vehicles ||| Refrigerated vehicles ||| Remise à neuf de véhicules
0.4233177900314331 ||| Rare reports of pancytopenia including aplastic anaemia have been reported with TNF atagonists. ||| As with other alpha interferons, serous retinal detachment has been reported with Pegasys. ||| De rares cas de pancytopénie y compris d'anémie aplasique ont été rapportés avec les anti-TNF.
0.0 ||| Member States can also give, up to the nominal value of €800,000 per company zero-interest loans or guarantees on loans covering 100% of the risk, except in the primary agriculture sector and in the fishery and aquaculture sector, where the limits of €100,000 and €120,000 per company respectively, apply. ||| Member States can also give, up to the nominal value of €800,000 per company zero-interest loans or guarantees on loans covering 100% of the risk, except in the primary agriculture sector and in the fishery and aquaculture sector, where the limits of €100,000 and €120,000 per company respectively, apply. ||| Les États membres peuvent également octroyer, jusqu'à concurrence d'une valeur nominale de 800 000 € par entreprise, des prêts à taux d'intérêt nul ou des garanties sur les prêts couvrant 100 % du risque, sauf dans le secteur agricole primaire et dans le secteur de la pêche et de l'aquaculture, où des limites respectives de 100 000 € et de 120 000 € par entreprise s'appliquent;
0.4476384222507477 ||| The list of the product names concerned is given in Annex I. ||| An example of a medication record is also included (see Annex Part III). ||| La liste des dénominations concernées figure en annexe I.
0.033524610102176666 ||| Intrinsa 300 micrograms/ 24 hours transdermal patch Testosterone Transdermal use ||| Livensa 300 micrograms/ 24 hours transdermal patch Testosterone Transdermal use ||| Intrinsa 300 microgrammes/ 24 heures dispositif transdermique Testostérone Voie transdermique
0.3915344476699829 ||| The CHMP further assessed the need for special mention of hyperprolactinaemia and stimulation of cell growth in breast tumours linked to prolactin. ||| Distribution Following topical ocular administration of TRAVATAN to healthy volunteers, low systemic exposure to active free acid was demonstrated. ||| Le CHMP a analysé de façon plus approfondie la nécessité d’ une mention spéciale sur l’ hyperprolactinémie et la stimulation du développement des cellules pour les tumeurs du sein liées à la prolactine.
0.2035479098558426 ||| Use in children and adolescents ||| Use in children and adolescents: ||| Utilisation chez le sujet âgé
0.16362985968589783 ||| 55 7. ||| 44 7. ||| 7.
0.4667588472366333 ||| An average of only 0.3% of the IV dose was excreted in urine as inhibitors. ||| For use only as a preservative in multidose vaccines at concentration not exceeding 0.02% ||| En moyenne, seuls 0,3% de la dose IV ont été éliminés dans les urines sous forme d’inhibiteurs.
0.5004934668540955 ||| 5 mg tablet ||| 500 mg twice ||| Comprimé à 5 mg
0.024359673261642456 ||| Conversely, due to the irbesartan component of CoAprovel hyperkalaemia might occur, especially in the presence of renal impairment and/ or heart failure, and diabetes mellitus. ||| Conversely, due to the irbesartan component of Karvezide hyperkalaemia might occur, especially in the presence of renal impairment and/ or heart failure, and diabetes mellitus. ||| Inversement, une hyperkaliémie peut survenir du fait de l'irbésartan, composant de CoAprovel, en particulier en présence d’ insuffisance rénale et/ ou d’ insuffisance cardiaque et de diabète sucré.
0.00881342776119709 ||| Light-red, biconvex, ovaloid tablet, imprinted “ IU” on one side and “ NVR” on the other side. ||| Light-red, biconvex, ovaloid tablet, imprinted “ IU ” on one side and “ NVR” on the other side. ||| Comprimé ovale, biconvexe, rouge clair, portant l’ inscription « IU » sur une face et « NVR » sur l’ autre face.
0.2749396860599518 ||| EU/ 1/ 06/ 368/ 016 (3 pens of 3 ml) EU/ 1/ 06/ 368/ 017 (4 pens of 3 ml) EU/ 1/ 06/ 368/ 018 (5 pens of 3 ml) EU/ 1/ 06/ 368/ 103 (6 pens of 3 ml) EU/ 1/ 06/ 368/ 108 (9 pens of 3 ml) EU/ 1/ 06/ 368/ 019 (10 pens of 3 ml) ||| EU/ 1/ 07/ 383/ 007 14 film-coated tablets EU/ 1/ 07/ 383/ 008 28 film-coated tablets EU/ 1/ 07/ 383/ 009 56 film-coated tablets EU/ 1/ 07/ 383/ 010 84 film-coated tablets EU/ 1/ 07/ 383/ 011 98 film-coated tablets EU/ 1/ 07/ 383/ 012 50 x 1 film-coated tablets ||| EU/ 1/ 06/ 368/ 016 (3 stylos de 3 ml) EU/ 1/ 06/ 368/ 017 (4 stylos de 3 ml) EU/ 1/ 06/ 368/ 018 (5 stylos de 3 ml) EU/ 1/ 06/ 368/ 103 (6 stylos de 3 ml) EU/ 1/ 06/ 368/ 108 (9 stylos de 3 ml) EU/ 1/ 06/ 368/ 019 (10 stylos de 3 ml)
0.47820529341697693 ||| Haemophiliac patients ||| Antimycobacterial ||| Patients hémophiles
0.0018897994887083769 ||| Insulin Human Winthrop Comb 25 comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen. ||| Insulin Human Winthrop Comb 50 comes in a cartridge sealed in a plastic container, which is the disposable part of OptiClik, an insulin pen. ||| Insulin Human Winthrop Comb 25 est présenté dans une cartouche scellée dans un contenant en plastique, qui constitue la partie jetable d’OptiClik, un stylo à insuline.
0.27007442712783813 ||| Since NSAIDs and rosiglitazone are associated with fluid retention, concomitant administration may increase the risk of oedema. ||| Drugs known to induce electrolyte imbalance may also precipitate QT prolongation and thus interact with terfenadine. ||| Les AINS et la rosiglitazone pouvant entraîner des rétentions hydriques, leur administration concomitante peut accroître le risque d’œ dème.
0.0 ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE ||| FABRICANT DE LA SUBSTANCE ACTIVE D’ ORIGINE BIOLOGIQUE ET TITULAIRES DE L’ AUTORISATION DE FABRICATION RESPONSABLES DE LA LIBERATION DES LOTS
0.26126396656036377 ||| The first case was reported in Zagreb on 25 February, when a patient who had come from Italy was tested positive. ||| A third case was confirmed on 7 February, with the patient being an Italian man evacuated from Wuhan. ||| La pandémie de Covid-19 en Croatie est identifiée à Zagreb à partir du 25 février 2020 lorsqu'un patient venu d'Italie est testé positif.
0.33155614137649536 ||| Clip clamps of metal ||| Screw caps of metal ||| Pinces à clip en métal
0.31502869725227356 ||| Mechanism of action Tenecteplase is a recombinant fibrin-specific plasminogen activator that is derived from native t-PA by modifications at three sites of the protein structure. ||| Mechanism of action Preotact contains recombinant human parathyroid hormone which is identical to the full-length native 84-amino acid polypeptide. ||| Il dérive du t-PA endogène par des modifications intervenues au niveau de trois sites de sa structure protéique.
0.3844377100467682 ||| If the patient experiences any thromboembolic events, treatment must be discontinued and standard anticoagulation therapy started. ||| If an acute attack occurs, a short-acting inhaled β -agonist should be used. ||| L’ apparition d’ une thrombose veineuse impose l’ interruption du traitement et la mise en place d’ un traitement anticoagulant.
3.7758132124393606e-13 ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| La lettre de la société, notifiant à l’ EMEA le retrait de la demande, est disponible ici.
0.11061051487922668 ||| 150 mg 500 mg ||| 150 mg 150 mg ||| 150 mg
0.0 ||| In most cases you will need a doctor. ||| In most cases you will need a doctor. ||| Dans la plupart des cas vous aurez besoin d'un médecin.
0.13780759274959564 ||| Why has Ytracis been approved? ||| Why has Diacomit been approved? ||| Pourquoi Ytracis a -t-il été approuvé?
0.25485044717788696 ||| Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCV-RNA polymerase chain reaction assay (PCR) (> 30 IU/ ml), a liver biopsy consistent with a histological diagnosis of chronic hepatitis with no other cause for the chronic hepatitis, and abnormal serum ALT. ||| Clinical evidence of inhibition of the late sodium current by ranolazine is provided by a significant shortening of the QTc interval and an improvement in diastolic relaxation in an open-label study of 5 patients with a long QT syndrome (LQT3 having the SCN5A ∆ KPQ gene mutation). ||| Les patients éligibles pour ces études avaient une hépatite C chronique confirmée par un dosage positif « VHC-ARN polymerase chain reaction » (PCR) (> 30 UI/ ml), une biopsie hépatique cohérente avec un diagnostic histologique d’ hépatite chronique sans autre cause d’ hépatite chronique, et des ALT sériques anormales.
0.4548751711845398 ||| Winnie Byanyima, Executive Director of UNAIDS and UN Under-Secretary General: "The time has come for a People's Vaccine: patent-free, free of charge and made available to all people in all countries as a global public good. ||| Usher announced that he will donate his proceeds from his I CRY record, performed for the very first time during the Global Goal: Unite for Our Future concert, to LISC, the Local Initiatives Support Corporation, a core Global Goal: Unite for Our Future campaign partner. ||| Winnie Byanyima, directrice exécutive d'ONUSIDA et secrétaire générale adjointe des Nations unies, a ajouté: «L'heure est venue d'un vaccin populaire: libre de droits, gratuit et accessible à tous, dans tous les pays, en tant que bien public mondial.
0.5633722543716431 ||| The incidence of symptomatic DVT was similar between treatment groups: ||| The adverse event profile remained comparable between treatment groups. ||| L’ incidence des TVP symptomatiques s’ est révélée similaire entre les groupes de traitement:
0.41945698857307434 ||| In this case consult your doctor as your urine needs to be tested. ||| Your doctor will take this into account when treating your diabetes. ||| Dans ce cas, consultez votre médecin pour une analyse d’ urine.
0.09281804412603378 ||| Actraphane Penfill is for single person use only. ||| Actraphane FlexPen is for single person use only. ||| Actraphane Penfill est réservé à l’ utilisation par un seul patient.
0.14823079109191895 ||| Silgard was compared with placebo (a dummy vaccine). ||| Parareg was compared with placebo (a dummy treatment). ||| Silgard a été comparé à un placebo (un vaccin fictif).
0.29905566573143005 ||| Advisory services relating to the corporate structure of businesses ||| Evaluations relating to business management in industrial enterprises ||| Services de conseils en matière de structure sociale des entreprises
0.13944824039936066 ||| Keep the vial in the outer carton in order to protect it from light. ||| Keep the vial(s) in the outer carton in order to protect from light. ||| Conserver le flacon dans son emballage extérieur à l'abri de la lumière.
0.16249501705169678 ||| 250 ||| 180 ||| 217 000
0.25669872760772705 ||| Napkins of cellulose for household purposes ||| Cellulose ethers for industrial purposes ||| Serviettes en cellulose à usage domestique
0.41082262992858887 ||| The peak plasma concentration of perindoprilat is achieved within 3 to 4 hours. ||| Peak concentrations in serum are obtained within 3 (range 2 - 5) hours. ||| Le pic de concentration plasmatique du périndoprilate est atteint en 3 à 4 heures.
0.23133549094200134 ||| disorder ||| insulin ||| sommeil
0.0013167087454348803 ||| 15 In diabetic hypertensive patients with microalbuminuria and normal renal function, orthostatic dizziness and orthostatic hypotension were reported in 0.5% of the patients (i. e., uncommon) but in excess of placebo. ||| 25 In diabetic hypertensive patients with microalbuminuria and normal renal function, orthostatic dizziness and orthostatic hypotension were reported in 0.5% of the patients (i. e., uncommon) but in excess of placebo. ||| Chez les patients hypertendues diabétiques présentant une microalbuminurie et une fonction rénale normale, des vertiges orthostatiques et des hypotensions orthostatiques ont été rapportés chez 0.5% (c’ est à dire, peu fréquemment) des patients, mais en excès par rapport au placebo.
0.254075288772583 ||| BATCH NUMBER al ||| BATCH NUMBER uth ||| NUMERO DU LOT ic
0.3368675708770752 ||| 1000 IU/ 0.5 ml ||| - 10,000 IU in 0.5 ml ||| 1 000 UI / 0,5 ml
0.3026540279388428 ||| Deutschland Takeda Pharma GmbH Tel: + 49 (0) 241 941-0 ||| Romania SC Bayer SRL Tel.: + 40 21528 59 00 ||| 29 Deutschland Takeda Pharma GmbH Tel: + 49 (0) 241 941-0
0.43194955587387085 ||| In carcinogenicity studies, nevirapine induces hepatic tumours in rats and mice. ||| Rabbit enteric coronavirus causes acute gastrointestinal disease and diarrhea in young European rabbits. ||| Les études de carcinogénicité ont montré que la névirapine induisait des tumeurs hépatiques chez le rat et la souris.
0.25803902745246887 ||| Trizivir is contraindicated in patients with known hypersensitivity to abacavir, lamivudine or zidovudine, or to any of the excipients. ||| There are no clinically significant interactions when emtricitabine is co-administered with indinavir, zidovudine, stavudine or famciclovir. ||| L’ administration de Trizivir est contre-indiquée en cas d’ hypersensibilité connue à l’ abacavir, à la lamivudine, à la zidovudine ou à l'un des excipients.
0.6104395985603333 ||| Statins (CYP3A4 substrates): ||| (CYP3A induction) ||| Statines (substrats du CYP3A4):
0.16641762852668762 ||| It is available as tablets (white and round: ||| It is available as capsules (white and yellow: ||| Il est disponible sous la forme de comprimés (blancs et ronds:
0.555038571357727 ||| BOTTLE LABEL FOR ORAL SUSPENSION ||| LABEL (LYOPHILISED POWDER VIAL) ||| ETIQUETTE FLACON – SUSPENSION BUVABLE
0.06280327588319778 ||| What Kivexa looks like and contents of the pack ||| What Ziagen looks like and contents of the pack ||| Qu'est -ce que Kivexa et contenu de l'emballage extérieur
0.2853621244430542 ||| When administered orally at 75 mg/ kg/ day (five times the recommended dose) for a period of 90 days in dogs, ibafloxacin was well tolerated. ||| If the patient misses a dose of Herceptin by more than one week, a re-loading dose of Herceptin should be given (8 mg/ kg over approximately 90 minutes). ||| Administrée par voie orale chez le chien à la dose de 75 mg/ kg/ jour (cinq fois la dose recommandée) pendant 90 jours consécutifs, l’ ibafloxacine a été bien tolérée.
0.4169602692127228 ||| Through 48 weeks of treatment, 64% receiving ISENTRESS 400 mg b. i. d. maintained HIV RNA < 400 copies/ ml and 46% also maintained HIV RNA < 50 copies/ ml. ||| Corneal limbal mononuclear cell infiltrates were noted in 1/ 4 male monkeys treated with 0.5 mg/ ml and in 4/ 4 males and 1/ 4 females treated with1.0 mg/ ml. ||| A 48 semaines de traitement, 64% des patients traités par ISENTRESS 400 mg deux fois par jour ont maintenu une charge virale plasmatique en dessous du seuil de 400 copies/ ml et 46% d'entre eux en dessous du seuil de 50 copies/ ml.
0.20996269583702087 ||| The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated: severe hepatic impairment, recent history of stroke or myocardial infarction, severe hypotension (blood pressure < 90/ 50 mmHg) at initiation. ||| In addition, undesirable effects are reported which are known to occur with controlled ovarian hyperstimulation treatment (e. g. abdominal pain, ovarian hyperstimulation syndrome (OHSS), ectopic pregnancy and miscarriage (see the patient information leaflet of the FSH-containing preparation you are treated with). ||| La sécurité du sildénafil n’ a pas été étudiée dans les sous-groupes de patients suivants et son utilisation est par conséquent contre-indiquée en cas d’ insuffisance hépatique sévère, d’ antécédent récent d’ accident vasculaire cérébral ou d’ infarctus du myocarde, d’ hypotension sévère (pression artérielle < 90/ 50 mmHg) à l’ initiation.
0.0 ||| In female mice, an increased incidence of ovarian tumours in animals given 9 to 242 mg/ kg (0.3 to 32 times the AUC in humans) included benign and malignant tumours of granulosa/ theca cell origin and benign tumours of epithelial cell origin. ||| In female mice, an increased incidence of ovarian tumours in animals given 9 to 242 mg/ kg (0.3 to 32 times the AUC in humans) included benign and malignant tumours of granulosa/ theca cell origin and benign tumours of epithelial cell origin. ||| Chez la souris femelle, il a été observé une augmentation de l’ incidence des tumeurs ovariennes chez les animaux recevant 9 à 242 mg/ kg (0,3 à 32 fois l’ AUC chez l’ homme), incluant
0.2838614881038666 ||| Infrared thermometers, not for medical purposes ||| X-ray tubes not for medical purposes ||| Thermomètres à infrarouges, non à usage médical
0.0 ||| • Insert the needle into your skin. ||| • Insert the needle into your skin. ||| • Insérez l’aiguille dans votre peau.
0.26864656805992126 ||| Neupro may potentiate the dopaminergic adverse reaction of L-dopa and may cause and/ or exacerbate pre-existing dyskinesia, as described with other dopamine agonists. ||| 3 Benzalkonium chloride, which is commonly used as a preservative in ophthalmic products, has been reported to cause punctate keratopathy and/ or toxic ulcerative keratopathy. ||| Neupro est susceptible de potentialiser les effets indésirables dopaminergiques de la L-dopa et peut provoquer et/ ou exacerber une dyskinésie préexistante, comme cela a été décrit pour d’ autres agonistes de la dopamine.
0.4512481987476349 ||| perforatum [St John’ s Wort]) may decrease ivabradine exposure and activity. ||| John’ s wort, rifampicin) might therefore decrease the bioavailability of Riprazo. ||| phénytoïne, Hypericum perforatum (millepertuis)) peuvent diminuer l’ exposition à l’ ivabradine, et son efficacité.
0.29494115710258484 ||| Preparation and administration precautions: paclitaxel is a cytotoxic anticancer drug and, as with other potentially toxic compounds, caution should be exercised in handling Paxene. ||| Depression, suicidal ideation and behaviour Although YENTREVE is not indicated for the treatment of depression, its active ingredient (duloxetine) also exists as an antidepressant medication. ||| Précautions de préparation et d’ administration: le paclitaxel est un médicament anticancéreux cytotoxique; Paxene doit donc, au même titre que tout composé toxique, être manipulé avec précaution.
0.37927907705307007 ||| Do not use if the eardrum is perforated. ||| Do not use the product if the foil pouch is broken. ||| Ne pas administrer en cas de perforation de la membrane tympanique.
0.3652452826499939 ||| The safety of Refludan for use in human pregnancy or lactation has not been established. ||| Sibutramine’ s use in human pregnancy has not been investigated. ||| La tolérance de Refludan chez la femme enceinte ou qui allaite n'a pas été établie.
0.20307886600494385 ||| 39 In a randomised open-label study (APV30003) in protease inhibitor experienced patients with virological failure (less than or equal to two PIs) the fosamprenavir with ritonavir (700 / 100 mg twice daily or 1400 / 200 mg once daily) did not demonstrate non-inferiority to lopinavir / ritonavir with regard to viral suppression as measured by the average area under the curve minus baseline (AAUCMB) for plasma HIV-1 RNA over 48 weeks (the primary end point). ||| In a double-blind study in CHB patients with YMDD variant HBV and compensated liver disease (NUC20904), with a reduced virological and biochemical response to lamivudine (n=95), the addition of adefovir dipivoxil 10 mg once daily to ongoing lamivudine 100mg for 52 weeks resulted in a median decrease in HBV DNA of 4.6 log10 copies/ ml compared to a median increase of 0.3 log10 copies/ ml in those patients receiving lamivudine monotherapy. ||| Dans une étude randomisée en ouvert (APV30003) réalisée chez des patients prétraités par inhibiteurs de protéase et en échec virologique (d'un ou deux IP) l'association fosamprénavir / ritonavir (700 / 100 mg deux fois par jour ou 1400 / 200 mg une fois par jour) n'a pas démontré sa non-infériorité au lopinavir / ritonavir sur la suppression virale de l'ARN VIH-1 mesurée par l'aire moyenne sous la courbe (AAUCMB) au cours des 48 semaines de traitement (critère principal d'évaluation).
0.5215002298355103 ||| Films for wrapping foodstuffs ||| Foodstuffs made from dough ||| Films pour emballer des aliments
0.2554943561553955 ||| Following administration of single SC doses of 0.1-0.75 mg/ kg, plasma concentrations of desirudin increased rapidly to maximum levels (Cmax) between 1 and 3 h. ||| Distribution The apparent steady state volume of distribution (Vss/ F) of febuxostat ranges from 29 to 75 l after oral doses of 10-300 mg. ||| Après des doses uniques en SC de 0,1- 0,75 mg/ kg, les concentrations plasmatiques de désirudine augmentent rapidement, les concentrations plasmatiques maximales (Cmax) étant atteintes en 1 à 3 h.
0.3560907244682312 ||| Severe infusion-related reactions (such as bronchospasm, hypotension) occurred in about 10% of the cases. ||| Cases of abnormalities of the skin including thickening/ inflammation or fibrosis (NSF) have been reported. ||| Des réactions sévères liées à la perfusion (telles que bronchospasme, hypotension) sont survenues dans environ 10% des cas.
0.37790918350219727 ||| If they occur, the dose of levodopa should be decreased. ||| In some cases, your Temodal dose will be reduced or treatment stopped. ||| Dans ce cas, la dose de lévodopa doit être réduite.
0.3910735249519348 ||| Storage of commercial goods ||| Packaging of goods ||| Stockage de produits commerciaux
0.5192166566848755 ||| Cosmetics in the form of milks ||| Colour preparations contained in tubes ||| Cosmétiques sous forme de laits
0.28499358892440796 ||| 398 N-1326 Lysaker Tlf: + 47 67 16 64 50 ||| P-1050-064 Lisboa Tel: +351 21 782 62 30 ||| N-1326 Lysaker Tlf: + 47 67 16 64 50
9.692964746815802e-13 ||| In this leaflet ||| In this leaflet ||| Dans cette notice
0.0945192277431488 ||| What Menitorix looks like and contents of the pack ||| What Cetrotide looks like and contents of the pack ||| Qu’ est -ce que MENITORIX et contenu de l’ emballage extérieur
0.4482252895832062 ||| It is available in packs of 1, 5 or 10 vials. ||| Packs of 1 and 5 vials are available. ||| Il est disponible en boîtes de 1, 5 ou 10 flacons.
0.30591851472854614 ||| Coadministration of voriconazole and sirolimus is contraindicated, since voriconazole is likely to increase plasma concentrations of sirolimus significantly (see section 4.5). ||| In a drug interaction study, carbamazepine plasma concentrations were decreased when carbamazepine was co-administered with efavirenz (see section 4.5). ||| L’ administration concomitante de voriconazole et de sirolimus est contre-indiquée car le voriconazole est susceptible d’ augmenter de manière significative les concentrations plasmatiques de sirolimus (voir rubrique 4.5).
0.3369690775871277 ||| Blood trough levels for Advagraf should be drawn approximately 24 hours post-dosing, just prior to the next dose. ||| Three doses are given on three consecutive days before myeloablative therapy, finishing 24 to 48 hours before the therapy. ||| Les taux sanguins d’ Advagraf doivent donc être déterminés 24 heures environ après l’ administration de la dernière dose, et juste avant la dose suivante.
0.32556790113449097 ||| If your condition is found to be worsening, your doctor will administer Lucentis to your affected eye again. ||| Even if a vaccination against influenza has been given to you Tamiflu may be prescribed by your doctor. ||| Si votre état s'aggrave, votre médecin vous administrera de nouveau Lucentis dans l 'œ il atteint.
0.1085963249206543 ||| 40 Driving and using machines No studies on the effects of Trizivir on the ability to drive and use machines have been performed. ||| Driving and using machines No studies have been performed on the effects of Tyverb on your ability to drive or use machines. ||| Conduite de véhicules et utilisation de machines Aucune étude n’ est disponible concernant les effets de Trizivir sur l’ aptitude à conduire ou à utiliser des machines.
0.39107388257980347 ||| Industrial centrifugal drying machines ||| Electric garbage disposal machines ||| Séchoirs centrifuges industriels [machines]
0.36018869280815125 ||| Ultrasonic sensors ||| Photovoltaic modules ||| Capteurs à ultrasons
0.21328169107437134 ||| What benefit has Cerezyme shown during the studies? ||| What benefit has Ratiograstim shown during the studies? ||| Quel est le bénéfice démontré par Cerezyme au cours des études?
0.340071439743042 ||| Given the importance of tests in the current situation and the rapid development of the pandemic, the Commission is also insisting on pooling resources for the validation of coronavirus tests at EU-level. ||| In addition, the Commission is proposing to extend the scope of the EU Solidarity Fund by also including a public health crisis within its scope, in view of mobilising it if needed for the hardest hit Member States. ||| Compte tenu de l'importance des tests dans la situation actuelle et de l'évolution rapide de la pandémie, la Commission insiste en outre sur la mise en commun des ressources pour la validation des tests liés au coronavirus au niveau de l'Union.
3.5274821258424183e-13 ||| • If you suffer from epilepsy or other neurological conditions such as cerebral ischemia or stroke, you may experience side effects associated with the central nervous system. ||| • If you suffer from epilepsy or other neurological conditions such as cerebral ischemia or stroke, you may experience side effects associated with the central nervous system. ||| 445 • Si vous souffrez d’épilepsie ou d’une autre maladie neurologique de type ischémie cérébrale ou accident vasculaire cérébral, des effets indésirables neurologiques (crises convulsives) pourraient se produire.
0.554930567741394 ||| However, the symptoms for which STELARA was prescribed may come back. ||| The following are reasons why Tadalafil Lilly may also not be suitable for you. ||| Cependant, les symptômes pour lesquels STELARA vous a été prescrit peuvent revenir.
0.2285030484199524 ||| Mirapexin must be given less frequently in patients who have problems with their kidneys. ||| Pramipexole Teva must be given less frequently in patients who have problems with their kidneys. ||| La fréquence d’ administration de Mirapexin doit être réduite chez les patients atteints d’ insuffisance rénale.
0.6223055124282837 ||| Taking Efficib with food and drink Take Efficib with meals to lower your chance of an upset stomach. ||| Taking INTELENCE with food and drink It is important that you take INTELENCE following a meal. ||| 57 Aliments et boissons La prise d'Efficib au cours du repas diminue le risque de troubles gastriques.
0.21303832530975342 ||| • Adults and elderly ||| Adults and elderly: ||| Chez l'adulte et chez le sujet âgé o
0.31414276361465454 ||| Due to the limited clinical experience, Bondenza is not recommended in patients with severe renal impairment (see section 4.2 and section 4.4). ||| Adjustment of the dose is recommended in elderly patients with compromised renal function (see “ Patients with renal impairment ” below). ||| En raison d'une expérience clinique limitée, l’ administration de Bondenza n’ est pas recommandée en cas d’ insuffisance rénale sévère (voir rubrique 4.2 et rubrique 4.4).
0.12888123095035553 ||| 0.67 ml of solution for injection in a pre-filled syringe (Type I glass) with a plunger stopper (bromobutyl rubber) in pack sizes of 1, 7 or 28. ||| 0.75 ml of solution for injection in 3 ml cartridge (Type I glass), with a plunger stopper (halobutyl rubber) and an aluminium crimp cap with a black rubber inlay. ||| 0.67 ml de solution injectable en seringue préremplie (verre de type I) munie d’ un bouchon-piston (caoutchouc bromobutyle) en boîtes de 1, 7 ou 28.
0.3759884238243103 ||| Research and development services in the field of chemistry ||| Consultation services in the field of make-up ||| Services de recherche et de développement dans le domaine de la chimie
0.4642550051212311 ||| Coffee grinders ||| Golf putters ||| Moulins à café
0.7196425199508667 ||| Date of the first authorisation: ||| Date of revision of the text ||| Date de première autorisation:
0.2631832957267761 ||| 41.4 (63/152) 31.2, 51.7 ||| 42.6 (69/162) 32.6, 52.6 ||| 41,4 (63/ 152) 31,2; 51,7
0.41752558946609497 ||| Brokerage ||| Packaging ||| Courtage
0.2876202464103699 ||| Handles of metal for windows ||| Cladding of metal for windows ||| Poignées de fenêtres en métal
0.20226621627807617 ||| • Hypersensitivity to the active substance or to peanut or soya or any of the excipients • Urinary retention • Gastric retention • Uncontrolled narrow angle glaucoma • Myasthenia gravis • Severe hepatic impairment (Child Pugh C) • Concomitant use of potent CYP3A4 inhibitors in subjects with moderate to severe hepatic or renal impairment • Severe ulcerative colitis • Toxic megacolon. ||| 15 • Hypersensitivity to other sulphonamide-derived substances (since hydrochlorothiazide is a sulphonamide-derived medicinal product). • Second and third trimester of pregnancy and lactation (see sections 4.4 and 4.6). • Cholestasis and biliary obstructive disorders. • Severe hepatic impairment. • Severe renal impairment (creatinine clearance < 30 ml/ min). • Refractory hypokalaemia, hypercalcaemia. ||| • Hypersensibilité à la substance active ou aux arachides ou au soja ou à l’ un des excipients • Rétention urinaire • Rétention gastrique • Glaucome à angle fermé non contrôlé • Myasthénie grave • Insuffisance hépatique sévère (Child-Pugh C) • Utilisation concomitante d’ inhibiteurs puissants du CYP3A4 chez les sujets souffrant d’ insuffisance hépatique ou rénale modérée à sévère • Rectocolite hémorragique grave • Mégacôlon toxique
0.4729670286178589 ||| MEPs will focus particularly on the tools being developed and already in use in some member states to counter the spread of the pandemic based on individuals' mobile phone data. ||| In France and Belgium, the decrease was attributed to national action including a yearly, nationwide public campaign on the prudent use of antibiotics; ||| Les députés examineront plus particulièrement les outils en cours de développement et déjà utilisés dans certains États membres pour lutter contre la propagation de la pandémie en se fondant sur les données des téléphones portables personnels.
0.10407130420207977 ||| This patient was able to continue treatment with BeneFIX with no rise in inhibitor or anaphylaxis. ||| This patient was able to continue treatment with BeneFIX with no anamnestic rise in inhibitor or anaphylaxis. ||| Le traitement par BeneFIX a pu être continué chez ce patient sans augmentation du taux d'inhibiteur ou sans allergie généralisée.
0.3472462296485901 ||| The recommended dose of Truvada is one tablet, taken orally, once daily. ||| The recommended dose of INVEGA is 6 mg once daily, administered in the morning. ||| La dose recommandée de Truvada est d’ un comprimé à prendre une fois par jour par voie orale.
0.3988021910190582 ||| Sprimeo 300 mg film-coated tablets ||| Xorimax 250 mg apvalkotā s tabletes ||| Sprimeo 300 mg comprimés pelliculés
0.39476531744003296 ||| Alarms for vehicles ||| Water for batteries ||| Alarmes pour véhicules
0.2685500979423523 ||| Ferriprox 100 mg/ ml oral solution Deferiprone ||| Zeffix 5 mg/ ml oral solution Lamivudine ||| Ferriprox 100 mg/ ml, solution buvable Défériprone
0.23377493023872375 ||| Stiripentol potentiates the efficacy of other anticonvulsants, such as carbamazepine, sodium valproate, phenytoin, phenobarbital and many benzodiazepines, as the result of pharmacokinetic interactions. ||| Corticosteroids, ACTH, amphotericin B, carbenoxolone, large amounts of liquorice, laxatives (in case of a prolonged use), and other kaliuretic or plasma potassium decreasing agents: increased risk of hypokalaemia. ||| En raison d'interactions pharmacocinétiques, le stiripentol potentialise l’ effet d’ autres anti-convulsivants tels que carbamazépine, valproate de sodium, phénytoïne, phénobarbital et de nombreuses benzodiazépines.
0.01066184788942337 ||| 40 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON TEXT Silgard, suspension for injection – pre-filled syringe with a needle guard and no needles, pack of 1, 10, 20 ||| 42 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON TEXT Silgard, suspension for injection – pre-filled syringe with a needle guard and 1 needle, pack of 1, 10, 20 ||| 42 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR TEXTE DE L'ETUI Silgard, suspension injectable – seringue préremplie avec un dispositif de protection de l'aiguille et sans aiguille, boîte de 1, 10, 20
0.4901026487350464 ||| These effects were not considered clinically important. ||| These were therefore considered potential adverse drug reactions. ||| Ces effets n’ ont pas été considérés comme cliniquement pertinents.
0.3733919858932495 ||| 42 Women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with SUTENT. ||| 136 Women of childbearing potential: pregnancy should be avoided in women treated with efavirenz. ||| Il est conseillé aux femmes en âge de procréer d’ éviter d’ être enceintes au cours du traitement par SUTENT.
0.4586203098297119 ||| Fluticasone propionate 50 mcg qid, intranasal (ritonavir 100 mg bid) ||| Lisinopril 10 mg od or nifedipine SR 20 mg bd was given orally. ||| (ritonavir 100 mg deux fois
0.22669261693954468 ||| How has CYSTAGON been studied? ||| How has ACOMPLIA been studied? ||| Quelles études ont été menées avec CYSTAGON?
0.7102546691894531 ||| Storing the Enbrel solution between doses j. ||| Results for endpoint survival using the Cox regression model ||| Conservation de la solution d’Enbrel entre les doses j.
0.13037440180778503 ||| Agents for the treatment of erectile dysfunction should generally not be used in men for whom sexual activity is inadvisable (e. g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure [New York Heart Association III or IV]). ||| Agents for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e. g. patients with severe cardiovascular disorders such as unstable angina or severe cardiac failure). ||| Les médicaments utilisés dans le traitement de la dysfonction érectile ne doivent pas être utilisés chez les hommes pour qui l’ activité sexuelle est déconseillée (par exemple les patients avec des troubles cardiovasculaires sévères tels que l’ angor instable ou l’ insuffisance cardiaque sévère [NYHA III ou IV]).
0.0 ||| 36 1. ||| 36 1. ||| 38 1.
0.27909621596336365 ||| In the fourth study, flushing was seen on fewer days in patients taking Trevaclyn than in those taking nicotinic acid alone. ||| In the second study, patients taking Norvir had greater reductions in viral load and increases in CD4 cell counts than those taking zidovudine alone. ||| Dans la quatrième étude, un rougissement a été observé chez les patients ayant reçu Trevaclyn pendant un nombre de jours inférieur par rapport à ceux ayant reçu de l’ acide nicotinique seul.
0.1420493721961975 ||| Each tablet contains 76.50 mg of lactose monohydrate ||| Each tablet contains 47.82 mg anhydrous lactose. ||| Chaque comprimé contient 76,50 mg de lactose monohydraté.
0.0 ||| • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| CONDITIONS OU RESTRICTIONS DE DeLIVRANCE ET D’ UTILISATION IMPOSeES AU TITULAIRE DE L'AUTORISATION DE MISE SUR LE MARCHe
0.3412001430988312 ||| Individuals who are immune to a disease act as a barrier in the spread of disease, slowing or preventing the transmission of disease to others. ||| Reverse isolation is a way to prevent a patient in a compromised health situation from being contaminated by other people or objects. ||| La vaccination agit comme une sorte de pare-feu, ralentissant ou empêchant la transmission de la maladie au sein d'une population.
3.9405986611805444e-13 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu ||| 128 Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu/.
0.38588541746139526 ||| Lamivudine is predominately cleared unchanged by renal excretion. ||| Similar or higher inhibition of platelet aggregation was observed with prasugrel. ||| Elle est essentiellement éliminée par excrétion rénale sous forme inchangée.
0.2795490026473999 ||| Benzodiazepins When midazolam was coadministered with Levviax, midazolam AUC was increased 2.2-fold after intravenous administration of midazolam and 6.1-fold after oral administration. ||| Furosemide When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by 28% and 49% respectively. ||| Benzodiazépines Lors de l’ administration simultanée du midazolam et de Levviax, l’ ASC du midazolam est augmentée de 2,2 fois après administration intraveineuse et 6,1 fois après administration orale de midazolam.
0.03405974060297012 ||| Patients with inhibitors If you have been informed by your doctor that you have developed factor VIII inhibitors you will possibly be required to use a larger amount of Helixate NexGen than previously to control a bleeding. ||| Patients with inhibitors If you have been informed by your doctor that you have developed factor VIII inhibitors you will possibly be required to use a larger amount of KOGENATE Bayer than previously to control a bleeding. ||| Cas des patients avec inhibiteurs Si votre médecin vous informe que vous avez développé un inhibiteur du facteur VIII, il est possible que vous ayez besoin d'utiliser une plus grande quantité d'Helixate NexGen qu'auparavant afin de contrôler votre saignement.
0.3690260648727417 ||| What Sprimeo contains ||| What Invirase contains ||| Que contient Sprimeo
0.2491559237241745 ||| Tritace is also used to prevent cardiovascular disease in patients who are at cardiovascular risk (such as patients who already have coronary artery disease), and to prevent any further heart attack (acute myocardial infarction [MI]) in patients who have already had one. ||| It should also not be used in patients with diabetic ketoacidosis (high levels of ketones [acids] in the blood), in patients with severe liver problems or in patients also taking gemfibrozil (a medicine used to reduce blood fat levels). ||| Tritace est également utilisé pour la prévention des maladies cardiovasculaires chez les patients présentant un risque cardiovasculaire (comme les patients qui ont déjà une maladie coronarienne) et pour la prévention de toute nouvelle crise cardiaque (infarctus aigu du myocarde [IM]) chez les patients qui en ont déjà eu.
0.2655893564224243 ||| Daily dosing of 1250 mg produces steady state geometric mean (coefficient of variation) Cmax values of 2.43 (76%) µg/ ml and AUC values of 36.2 (79%) µg*hr/ ml. ||| Following a single dose of 600 mg of abacavir, the mean (CV) Cmax is 4.26 µg/ ml (28%) and the mean (CV) AUC∞ is 11.95 µg. h/ ml (21%). ||| Une dose journalière de 1 250 mg entraîne des valeurs de moyennes géométriques (coefficient de variation) de Cmax à l'état d'équilibre de 2,43 (76%) µg/ ml et des valeurs de l’ ASC de 36,2 (79%) µg. hr/ ml.
0.3046172261238098 ||| In the studies involving patients with documented Candida infections, the majority of the patients with invasive Candida infections had serious underlying medical conditions (e. g., haematologic or other malignancy, recent major surgery, HIV) requiring multiple concomitant medications. ||| In the vast majority of cases reported, the patients were predisposed to thrombotic disorders due to pre-existing risk factors such as recent surgery, recent crush injury, arteries narrowed by disease, liver disease and serious blood infection. ||| Dans les études incluant des patients ayant des infections documentées à Candida, la majorité des patients ayant des infections à Candida invasives présentait des pathologies sous- jacentes graves (par exemple: hémopathie ou autre affection maligne, intervention chirurgicale lourde récente, infection par le VIH) nécessitant de nombreux traitements concomitants.
0.37408387660980225 ||| CellCept 500 mg powder for concentrate for solution for infusion is used to prevent your body rejecting a transplanted kidney or liver. ||| When used in lower back fusion surgery InductOs is used in combination with a metal cage which corrects the position of your spine. ||| CellCept 500 mg poudre pour solution à diluer pour perfusion est utilisé pour prévenir le rejet, par votre organisme, du rein ou du foie qui vous a été greffé.
0.5641770362854004 ||| th Date of first authorisation: ||| Date of first suthorisation: ||| Date de première autorisation:
0.3594861626625061 ||| Chemical products for glazing leather ||| Cleaning preparations for leather ||| Produits chimiques pour lustrer le cuir
0.14413726329803467 ||| It is used in combination with at least one other antiviral medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). ||| It is used in combination with other antiviral medicines to treat adults, adolescents and children over three years of age who are infected with human immunodeficiency virus (HIV-1), the virus that causes acquired immune deficiency syndrome (AIDS). ||| Il est indiqué en association avec au moins un autre antirétroviral pour le traitement des patients adultes infectés par le virus de l’ immunodéficience humaine de type 1 (VIH-1), virus responsable du syndrome de l’ immunodéficience acquise (SIDA).
0.0739930123090744 ||| Plavix should not be used in people who may be hypersensitive (allergic) to clopidogrel or any of the other ingredients, who have severe liver disease, or have a disease which may cause bleeding. ||| Clopidogrel BMS should not be used in people who may be hypersensitive (allergic) to clopidogrel or any of the other ingredients, or in patients who have severe liver disease, or have a disease which may cause bleeding. ||| Plavix ne doit pas être administré aux patients présentant une hypersensibilité (allergie) au clopidogrel ou à l’ un des excipients, présentant des troubles hépatiques sévères ou une pathologie susceptible d’ entraîner des hémorragies.
0.3267988860607147 ||| Supports adapted for use with solar heating tubes ||| Filters for use with apparatus heating ||| Supports conçus pour tubes de chauffage solaire
0.340615838766098 ||| It works by preventing the formation of ergosterol, which is an important part of fungal cell walls. ||| The primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. ||| Il empêche la formation d’ ergostérol, qui constitue une partie importante des membranes des cellules fongiques.
0.23654401302337646 ||| Settlement tanks, not of metal ||| Reinforcement rods, not of metal ||| Cuves de décantation non métalliques
0.12990470230579376 ||| < [See Annex I - To be completed nationally] ||| 422 [See Annex I - To be completed nationally] ||| [Voir annexe I - À compléter au niveau national]
0.28180524706840515 ||| The active substance in Talam tablets, the dihydropyridine derivative amlodipine, is a chiral substance, composed of a racemate. ||| The active substance in Prialt, ziconotide, is a copy of a natural substance, omega-conopeptide, extracted from the venom of a type of sea snail. ||| La substance active présente dans Talam comprimés, l'amlodipine, un dérivé dihydropyridinique, est une substance chirale composée d'un racémate.
3.9329591016226684e-13 ||| Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0 ||| Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0 ||| 32 Deutschland Thomas-Dehler-Straße 27 D-81737 München Tel: + 49-(0)89 627 31-0
0.1373484581708908 ||| If unable to activate, discard immediately into an approved sharps collector. ||| If unable to activate the safety needle, discard immediately into an approved sharps collector. ||| Si vous n’ avez pas pu faire fonctionner le dispositif, jetez la seringue immédiatement dans un collecteur d’ aiguilles réglementaire.
0.014570608735084534 ||| Ebixa is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| Axura is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| Ebixa ne doit pas être utilisé chez l’ enfant de moins de 18 ans en raison d’ un manque de données concernant la sécurité et l’ efficacité.
0.14305555820465088 ||| It is supplied in packs of 1, 5, 10 vials of powder with the corresponding number of solvent in pre-filled syringes. ||| It is supplied in packs of 1, 5, 10 ampoules of powder with the corresponding number of solvent ampoules. ||| Il existe en boîte de 1, 5 et 10 flacons de poudre accompagnés du nombre correspondant de seringues préremplies de solvant.
0.6414467692375183 ||| PVC/ PVDC-aluminium blisters packed in paper cartons. ||| Figurines [statuettes] of porcelain, ceramic, earthenware or glass ||| Plaquettes thermoformées PVC/ aluminium PVDC dans des boîtes en carton.
0.19297322630882263 ||| 20 Common (≥ 1/ 100 to < 1/ 10) Uncommon (≥ 1/ 1,000 to < 1/ 100) ||| Uncommon (≥ 1/ 1,000 to < 1/ 100), rare (≥ 1/ 10,000 to < 1/ 1,000) ||| Très fréquent (≥ 1/ 10) Fréquent (≥ 1/ 100 et < 1/ 10) Peu fréquent (≥ 1/ 1 000 et < 1/ 100)
0.06695034354925156 ||| Fungal infection, bacterial infection, pulmonary infection, otitis media, tooth abscess, herpes simplex, urinary tract infection, vaginitis, gastroenteritis ||| Viral infection, pharyngitis Fungal infection, bacterial infection, pulmonary infection, otitis media, tooth abscess, herpes simplex, urinary tract infection, ||| Infection fongique, infection bactérienne, infection pulmonaire, otite Fréquent: moyenne, abcès dentaire, herpes simplex, infection urinaire, vaginite, gastro-entérite Tumeurs bénignes, malignes dic
0.2658475637435913 ||| They decided on that Forcaltonin’ s benefits are greater than its risks for prevention of bone loss due to sudden immobilisation, such as in patients with recent bone fractures caused by osteoporosis (a disease that makes bones fragile), for treatment of Paget’ s disease, and treatment of hypercalcaemia of ol malignancy. ||| The company that makes Velcade will carry out further studies looking in particular at the distribution of Velcade in the body (especially after repeated doses), and at the risk of patients developing amyloidosis (a build-up of a type of protein called amyloid in the body) or of amyloidosis getting worse. ||| que les bénéfices de Forcaltonin sont supérieurs aux risques qu’ il comporte pour la prévention de la perte osseuse liée à une immobilisation soudaine, notamment chez les patients ayant eu récemment des fractures ostéoporotiques (l’ ostéoporose est une maladie qui fragilise les os), pour le traitement de la am
0.0 ||| It is unclear whether the effect of tacrolimus is due to systemic immunosuppression or a local effect. ||| It is unclear whether the effect of tacrolimus is due to systemic immunosuppression or a local effect. ||| On ne sait pour l'instant pas si cet effet du tacrolimus est dû à une immunosuppression systémique ou à un 'e
0.5391557216644287 ||| solution for injection equal to the volume of the reconstituted vials (for 2 vials remove 20 ml, for 3 vials remove 30 ml, for 4 vials remove 40 ml). ||| After lower limb perfusion, 3 to 6 litres should be used, and after upper limb perfusion, 1 to 2 litres. ||| sodium à 9 mg/ ml (0,9%) équivalent au volume total de solution d'ORENCIA reconstituée (pour 2 flacons retirer 20 ml, pour 3 flacons retirer 30 ml, pour 4 flacons retirer 40 ml).
0.6899980306625366 ||| Surgical staple removers ||| Thermally conductive insulators ||| Dégrafeuses chirurgicales
0.3387641906738281 ||| 39 Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214 ||| Ελλάδα MEDA Pharmaceuticals AE Ευρυτανίας 3 GR-15231 Χαλάνδρι -Αττική Τηλ: +30 210 6 77 5690 ||| Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214
0.012677585706114769 ||| Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. • if your child has previously had an allergic reaction to any vaccine against diphtheria, tetanus, pertussis (whooping cough) or hepatitis B diseases. • if your child experienced problems of the nervous system within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease. • if your child has a severe infection with a high temperature (over 38°C). ||| Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. • if your child has previously had an allergic reaction to any vaccine against diphtheria, tetanus, pertussis (whooping cough), hepatitis B or poliomyelitis diseases. • if your child experienced problems of the nervous system within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease. • if your child has a severe infection with a high temperature (over 38°C). ||| Les signes de réaction allergique peuvent prendre la forme d’ une éruption cutanée avec démangeaisons, d'une difficulté respiratoire et d'un gonflement du visage ou de la langue. • si votre enfant a précédemment présenté une réaction allergique à un autre vaccin contre la diphtérie, le tétanos, la coqueluche ou l’ hépatite B. • si votre enfant a présenté des troubles neurologiques dans les 7 jours suivant une précédente vaccination par un vaccin contre la coqueluche. • si votre enfant a une infection sévère avec une forte fièvre (supérieure à 38°C).
0.5295474529266357 ||| Storage of documents ||| Design of restaurants ||| Stockage de documents
0.33484357595443726 ||| CANCIDAS 70 mg powder for concentrate for solution for infusion Caspofungin (as acetate) Intravenous use ||| INFORMATION FOR THE USER LeukoScan (0.31 powder for solution for injection) (sulesomab) ||| CANCIDAS 70 mg poudre pour solution à diluer pour perfusion Caspofungine (acétate) Voie intraveineuse
0.16538308560848236 ||| At the end of this period, the product should not be put back in the refrigerator, but should be used or discarded. ||| At the end of this period of room temperature storage, the product must not be returned to refrigerated storage, but is to be used or discarded. ||| A la fin de cette période, le produit ne doit pas être remis au réfrigérateur mais être utilisé ou éliminé.
0.17754507064819336 ||| In the subset of patients with genotype 1 infection and low viral load (< 600,000 IU/ml) who become HCV-RN A negative at treatment week 4 and remain HCV-RNA negative at week 24, the treatment could either be stopped after this 24 week treatment course or pursued for an additional 24 weeks (i.e. overall 48 weeks treatment duration). ||| Shortening the treatment duration in patients with genotype 1 and high viral load (HVL) (> 800, 000 IU/ ml) at baseline who become HCV RNA negative at week 4 and remain HCV RNA negative at week 24 should be considered with even more caution since the limited data available suggest that this may significantly negatively impact the sustained virologic response. ||| Dans le sous-groupe de patients de génotype 1 avec une faible charge virale (< 600 000 UI/ ml) ayant un taux d’ ARN-VHC indétectable à la 4ème semaine de traitement et restant indétectable à la 24ème semaine, le traitement peut soit être arrêté après ces 24 semaines de traitement soit être poursuivi 24 semaines supplémentaires (soit une durée totale de traitement de 48 semaines).
0.09415661543607712 ||| This applies especially to the medicines listed below taken at the same time with MicardisPlus: ||| This applies especially to the medicines listed below taken at the same time with Kinzalkomb: ||| Cette situation s’applique tout particulièrement aux médicaments ci -dessous si vous prenez l’un d’entre eux en même temps que MicardisPlus:
0.3970246911048889 ||| The facility will include €1.5 billion in grants from the EU budget and up to €10 billion in loans from the European Investment Bank's own sources. ||| The European Central Bank is providing €750 billion to relieve government debt during the crisis, as well as €120 billion in quantitative easing and €20 billion in debt purchases. ||| La facilité sera dotée de 1,5 milliard € provenant du budget de l'UE et de 10 milliards € issus des ressources propres de la Banque européenne d'investissement, sous la forme, respectivement, de subventions et de prêts.
0.20972509682178497 ||| Anxiety, difficulty sleeping Blurred vision, visual disturbance Changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, faint or fainting, dizziness upon standing Dark urine, blood in urine, difficulty urinating Dehydration Difficulty breathing, cough, nose bleed Excessive sweating, itching Feeling swollen or bloated Hot flushes, low blood pressure Increases in a substance called creatinine or increases in urea in your blood, increase in blood platelets or white blood cells, changes in ECG heart tracing Joint swelling, pain in extremity Loss of appetite and/ or weight loss Muscle cramp Ringing in the ears and/ or feeling a spinning sensation Stomach pain or discomfort, indigestion, dry mouth, or wind ||| Anaemia, low numbers of cells called platelets that help the blood to clot, low numbers of some types of white blood cells, enlargement of lymph glands Allergic reaction High blood levels of glucose Disturbances in feeling or moving, tremor, fits Heart rhythm problems including very fast heartbeat (palpitations), abnormal findings on heart tests (like ECGs that show heart rhythm) High or low blood pressure Inflammation of the pancreas Inflammation of liver, liver damage, jaundice (yellow colour of the skin or the eyes) Problems with kidney function, failure of the kidneys Menstrual disorder Blurred vision Hair loss, itching Mouth ulcers 29 Shivering, generally feeling unwell or weak Scattered body pain, including in muscles and joints, back pain Fluid retention, altered medicine levels. ||| Effets secondaires peu fréquents (concernent 1 à 10 utilisateurs sur 1 000): anxiété, troubles du sommeil vision trouble, troubles de la vue changements des sensations (toucher ou goût), tremblements, fatigue ou sensation de lenteur, somnolence ou envie de dormir, être sur le point de s’ évanouir ou perte de connaissance, vertiges au passage en position debout urines de couleur sombre, sang dans les urines, difficultés à uriner déshydratation difficultés à respirer, toux, saignements de nez transpiration excessive, démangeaisons sensation d'être bouffi(e) ou gonflé(e) bouffées de chaleur, baisse de la pression sanguine augmentation d’ une substance appelée créatinine ou augmentation de l'urée dans votre sang, augmentation du nombre de plaquettes sanguines ou de globules blancs, modifications du tracé de l'électrocardiogramme (ECG) gonflement au niveau des articulations, douleurs dans les extrémités perte d’ appétit et/ ou perte de poids crampes musculaires sifflements dans les oreilles et/ ou sensation de tournis douleurs ou gêne à l'estomac, indigestion, sécheresse de la bouche ou flatulences (gaz)
0.334237277507782 ||| An earlier study reported that the R0 of SARS-CoV-2 was as high as 6.47 with a 95% confidence interval (CI) of 5.71-7.23, whereas the R0 of SARS-CoV only ranged from 2 to 4. ||| However, the on-treatment PFS analysis did not confirm the results of the general PFS and OS analysis: the hazard ratio of XELOX versus FOLFOX-4 was 1.24 with 97.5% CI 1.07 - 1.44. ||| Une étude antérieure a rapporté que le R0 du SARS-CoV-2 atteignait 6,47 avec un intervalle de confiance (IC) à 95 % de 5,71-7,23, tandis que le R0 du SARS-CoV n’allait que de 2 à 4.
0.8117783069610596 ||| Network facsimile servers ||| Facsimile transmission ||| Serveurs de télécopie en réseau
0.6601547002792358 ||| Furthermore, work was done to improve version control and minimise duplication of documents. ||| Overall connectivity has improved, as far as both demand and supply are concerned. ||| De plus, des efforts ont été réalisés pour améliorer le contrôle des documents et éviter les duplications.
0.2079603672027588 ||| In clinical trials with Pegasys in HBV, marked transaminase flares have been accompanied by mild changes in other measures of hepatic function and without evidence of hepatic decompensation. ||| In repeated dose toxicity studies in rat signs of hepatotoxicity consisted of increased liver enzymes and degenerative changes of hepatocytes which were accompanied by signs of compensatory regeneration. ||| Lors des essais cliniques dans l’ hépatite chronique B, les élévations prononcées des transaminases se sont accompagnées de légères modifications des autres paramètres de la fonction hépatique, sans survenue d’ une décompensation hépatique.
0.06637324392795563 ||| Like all medicines, ECALTA can cause side effects, although not everybody gets them. ||| Like all medicines, EVRA can cause side effects although not everybody gets them. ||| Comme tous les médicaments, ECALTA peut provoquer des effets indésirables, mais ils ne surviennent pas systématiquement chez tout le monde.
0.22629249095916748 ||| In vivo, probenecid (500 mg every 6 hours) decreased the bound fraction of ertapenem in plasma at the end of infusion in subjects administered a single 1 g intravenous dose from approximately 91% to approximately 87%. ||| 12 Elimination Following administration of an oral [14C]sitagliptin dose to healthy subjects, approximately 100% of the administered radioactivity was eliminated in faeces (13%) or urine (87%) within one week of dosing. ||| In-vivo, le probénécide (500 mg toutes les 6 heures) a diminué de 91% approximativement à 87% approximativement la fraction de liaison de l’ ertapénème dans le plasma à la fin de la perfusion chez des sujets ayant reçu une dose unique intraveineuse de 1 g.
0.40748220682144165 ||| The EMEA is legally responsible under Articles 5 and 27 of Council Regulation (EEC) No 2309/ 93 for the scientific opinions adopted in its name by the CPMP and CVMP, and shall intervene when the responsibility of a national competent authority or that of an individual acting as rapporteur, co- rapporteur, expert or inspector is challenged in proceedings before a national court arising from services performed under the standard contract. ||| National competent authority shall ensure that the [Inspector] Rapporteur and Experts abide by their obligation of confidentiality not to make use of or disclose any fact, information or document acquired in the performance of their duties, to any third party other than members of the Committee for Proprietary Medicinal Products/ Committee for Veterinary Medicinal Products, other national competent authorities, the Agency’ s Executive Director or his representatives. ||| L'EMEA est légalement responsable en vertu des articles 5 et 27 du règlement du Conseil (CEE) n° 2309/ 93 pour les avis scientifiques adoptés en son nom par les comités, et interviendra lorsque la responsabilité d'une autorité compétente nationale ou celle d'un rapporteur, co-rapporteur, expert ou inspecteur sera mise en cause devant une juridiction nationale au titre des services exécutés selon le contrat-type.
0.0 ||| 71 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 71 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 75 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.4019988477230072 ||| Lamivudine and VIRAMUNE can be co-administered without dose adjustments. ||| It is not recommended to co-administer INTELENCE with nelfinavir. ||| La lamivudine et VIRAMUNE peuvent être associés sans ajustement posologique.
0.432834267616272 ||| Around a quarter of the patients in this study also had a reduction in tumour size. ||| In this group of patients a variable response has also been seen with respect to motor function. ||| Près d’ un quart des patients de cette étude ont également présenté une réduction de la taille de la tumeur.
0.36741751432418823 ||| 16.7% ||| 7.6% ||| 16,7%
3.427110483421314e-13 ||| Step 6 - Injecting the solution Depress the plunger slowly and steadily, so the solution is correctly injected and the skin tissues are not damaged. ||| Step 6 - Injecting the solution Depress the plunger slowly and steadily, so the solution is correctly injected and the skin tissues are not damaged. ||| 247 6ème Etape - injection de la solution Pousser doucement et régulièrement le piston, la solution sera alors injectée correctement et la peau ne sera pas lésée.
0.32715725898742676 ||| Turbines, other than for land vehicles ||| Motors, electric, other than for land vehicles ||| Turbines autres que pour véhicules terrestres
0.38519760966300964 ||| This Strategy is therefore similar to an insurance policy, by transferring some of the risks from industry to public authorities in return for assuring Member States of equitable and affordable access to a vaccine, should one become available. ||| Finally, we recall that State aid shall not be granted on the condition of the relocation of production or of another activity of the beneficiary from elsewhere in our Union - because the Single Market is our greatest asset. ||| Cette stratégie est donc analogue à une police d'assurance: elle transfère une partie du risque de l'industrie vers les autorités publiques et, en contrepartie, garantit aux États membres un accès équitable et abordable à un vaccin, si un vaccin est produit.
0.58396315574646 ||| Silver oxides ||| Silver bullion ||| Oxydes d'argent
0.06202521175146103 ||| 16 Hepatic or renal impairment: ||| 55 Hepatic or renal impairment: ||| Insuffisance hépatique ou rénale
0.2521156370639801 ||| Take special care with Targretin ||| Take special care with Firazyr ||| Faites attention avec Targretin
0.37962669134140015 ||| No evidence of photosensitivity was observed in rats following administration of tigecycline. ||| Only minor amounts of reteplase were immunologically detected in the urine. ||| Aucun signe de photosensibilisation n’ a été observé chez le rat après l’ administration de tigécycline.
0.10765649378299713 ||| Parts and fittings for chronometric instruments ||| Parts and fittings for horological instruments ||| Pièces et accessoires d'instruments chronométriques
0.290517121553421 ||| Do not use INCRELEX ||| Do not use RELISTOR ||| N’utilisez jamais INCRELEX
0.2336370199918747 ||| Adverse drug reactions observed in patients using Levemir are mainly dose-dependent and due to the pharmacologic effect of insulin. ||| The manifestations of fentanyl overdosage are an extension of its pharmacologic actions, the most serious effect being respiratory depression. ||| Les effets indésirables observés chez les patients traités par Levemir sont le plus souvent dose- dépendants et sont dus à l’action pharmacologique de l’insuline.
0.5128946900367737 ||| Marketing authorisation holder Norbrook Laboratories Limited Station Works Newry Co. ||| Manufacturer for the batch release Norbrook Laboratories Limited 105 Armagh Road Newry Co. ||| Titulaire de l’ AMM Norbrook Laboratories Limited Station Works Newry Co.
0.3545163869857788 ||| uncommon ||| Uncommon ||| peu fréquents
0.09811286628246307 ||| 54 If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| If the side effects gets serious or you notice any side effects not listed in this leaflet, please tell your doctor. ||| Si un des effets mentionnés s’ aggrave ou si vous remarquez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin..
0.0028677096124738455 ||| 71 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND IMMEDIATE PACKAGING ||| 67 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND IMMEDIATE PACKAGING ||| 71 PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACKAGING
0.2548641264438629 ||| Limited published data for exogenously-administered somatropin suggest absorption and elimination half-lives and time of maximum concentration tmax in Turner patients are similar to those observed in both normal and growth hormone deficient populations. ||| Action potential studies in isolated rabbit heart have shown that toremifene induce cardiac electrophysiological changes which start to develop at concentrations approximately 10 fold compared to the calculated free therapeutic plasma concentration in human. ||| Un petit nombre de données publiées concernant l’ administration exogène de somatropine suggèrent que les demi-vies d’ élimination et d’ absorption et le temps de concentration maximum tmax chez les patientes présentant un syndrome de Turner sont semblables à ceux observés à la fois chez les populations normales et chez les enfants ayant un déficit en hormone de croissance.
0.2220247983932495 ||| Grease boxes [parts of machines] ||| Overload couplings [parts of machines] ||| Boîtes de graissage [machines]
0.0 ||| This is most likely to occur in those patients with more severe degrees of heart failure, as reflected by the use of high doses of loop diuretics, hyponatraemia or functional renal impairment. ||| This is most likely to occur in those patients with more severe degrees of heart failure, as reflected by the use of high doses of loop diuretics, hyponatraemia or functional renal impairment. ||| Ils sont plus fréquents en cas d'insuffisance cardiaque sévère (définie par l'utilisation de fortes doses de diurétiques de l'anse, la présence d'hyponatrémie ou d'insuffisance rénale fonctionnelle).
0.2548694312572479 ||| If you are unsure about this ask your doctor or pharmacist. ||| Please inform your doctor or pharmacist if you are taking: ||| Si vous avez un doute, demandez à votre médecin ou pharmacien.
0.0 ||| 54 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 54 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 58 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2934604287147522 ||| 15 The dose regimen of Mycamine depends on the body weight of the patient as given in the following tables: ||| The actual dosage of Gadovist that is right for you will depend on your body weight and on the region of examination: ||| La posologie de Mycamine dépend du poids du patient comme indiqué dans les tableaux suivants:
0.2857641577720642 ||| България Сервие Медикал ЕООД Тел.: +359 2 921 57 00 ||| България ГлаксоСмитКлайн ЕООД Тел.: + 359 2 953 10 34 ||| 28 България Сервие Медикал ЕООД Тел.: +359 2 921 57 00
0.24497057497501373 ||| What is the risk associated with Pylobactell? ||| What is the risk associated with Twinrix Paediatric? ||| Quel est le risque associé à l'utilisation de Pylobactell?
1.4163546562194824 ||| Gentamicin ||| Bondenza Bondenza ||| Gentamicine
0.162087544798851 ||| As of 10 April 2020, approximately 1.61 million cases of COVID-19 have been reported in 210 countries and territories, resulting in approximately 97,000 deaths. ||| As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths. ||| Au 10 avril 2020, environ 1,61 million de cas de COVID-19 ont été rapportés dans 210 pays et territoires, entraînant environ 97 000 décès.
0.40325307846069336 ||| What Dynepo contains ro ||| What Neoclarityn contains ||| Composition de Dynepo
0.01961793750524521 ||| The use of ViraferonPeg in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up. ||| The use of PegIntron in combination with ribavirin had no observable negative impact on the control of HIV viraemia during therapy or follow-up. ||| 159 d’ impact négatif sur le contrôle de la charge virale VIH pendant le traitement ou la période de suivi.
0.2504339814186096 ||| Pack-sizes of 60 or 180 tablets. ||| Packs of 30, 56 or 100 tablets. ||| Emballages de 60 ou 180 comprimés.
0.2452884018421173 ||| Maintenance dose between 25 and 50 IU/kg 2 times per week into 2 equal doses. ||| Maintenance dose between 17 and 33 IU/ kg 3 times per week by the intravenous route. ||| Dose d’ entretien compris entre 25 et 50 UI/ kg, 2 fois par semaine à raison de 2 injections égales.
0.07222556322813034 ||| 151 4.6 Pregnancy and lactation ||| 100 4.6 Pregnancy and lactation ||| 4.6 Grossesse et allaitement
0.13189515471458435 ||| Fencing rails (Non-metallic -) ||| Drawer sliders (Non-metallic -) ||| Planches de clôture non métalliques
0.7363883256912231 ||| Total mean recovery of radioactivity was 80.9%. ||| The overall response rate was 14.1%. ||| La récupération totale moyenne de la radioactivité était de 80,9%.
0.28185856342315674 ||| In the trial for the prevention of clinical fractures following a recent hip fracture, vitamin D levels were not routinely measured but the majority of patients received a loading dose of vitamin D prior to Aclasta administration (see section 4.2). ||| Your risk of OHSS or multiple pregnancy is reduced if the usual dose of Ovitrelle is used, and you are monitored closely throughout your treatment cycle (e. g. blood tests for estradiol levels and ultrasound). ||| Dans l’ étude RFT, la majorité des patients a reçu une dose de charge en vitamine D avant l’ administration d’ Aclasta bien que le taux de vitamine D n’ ait pas été mesuré de façon systématique (voir rubrique 4.2).
5.62788043164536e-13 ||| 6.2 Incompatibilities ||| 6.2 Incompatibilities ||| 6.2
0.11078762263059616 ||| DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION ||| DOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION ||| POSOLOGIE POUR CHAQUE ESPÈCE, VOIE(S) ET MODE D’ADMINISTRATION
0.31993186473846436 ||| Based on a retrospective analysis of plasma levels in patients who received lamotrigine both with and without gabapentin, gabapentin does not appear to change the apparent clearance of lamotrigine. ||| An HIV isolate obtained from a patient receiving saquinavir therapy showed decreased susceptibility to saquinavir (7- fold) but did not demonstrate a concordant decrease in susceptibility to nelfinavir. ||| 61 Sur la base d’ analyse rétrospective des taux plasmatiques de patients ayant reçu de la lamotrigine à la fois avec et sans gabapentine, la gabapentine n’ a pas semblé modifier la clairance apparente de la lamotrigine.
0.6091694831848145 ||| Hypotension, hypertension, vasodilatation ||| Hypertension, hypertension aggravate d ||| - hypertrophie cutanée, rash, acné, alopécie
0.3079434633255005 ||| EU/ 1/ 99/ 125/ 001 28 orodispersible tablets EU/ 1/ 99/ 125/ 009 35 orodispersible tablets EU/ 1/ 99/ 125/ 005 56 orodispersible tablets EU/ 1/ 99/ 125/ 013 70 orodispersible tablets ||| e EU/ 1/ 02/ 207/ 012- 2 pre-filled syringes EU/ 1/ 02/ 207/ 013 - 7 pre-filled syringes EU/ 1/ 02/ 207/ 014 - 10 pre-filled syringes EU/ 1/ 02/ 207/ 019 - 20 pre-filled syringe 13. ||| EU/ 1/ 99/ 125/ 001 28 comprimés orodispersibles EU/ 1/ 99/ 125/ 009 35 comprimés orodispersibles EU/ 1/ 99/ 125/ 005 56 comprimés orodispersibles EU/ 1/ 99/ 125/ 013 70 comprimés orodispersibles
0.2824931740760803 ||| Step 2: ||| STEP 1: ||| Étape 2:
0.0 ||| Name and address of the manufacturer of the biological active substance ||| Name and address of the manufacturer of the biological active substance ||| Nom et adresse du fabricant du(es) principe(s) actif(s) d'origine biologique
0.4527508616447449 ||| Reticulocyte count increase ≥ 40,000/ µl or Hb increase ≥ 1 g/ dl ||| Resume MabCampath at 10 mg when ANC ≥ 500/μ L and platelet count ≥ 50,000/μ L. ||| Augmentation des réticulocytes ≥ 40 000/ µl ou augmentation Hb ≥ 1 g/ dl
0.3000212013721466 ||| In controlled clinical trials, at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to placebo. ||| In clinical studies, > 90% of patients responded at these doses, achieving reversal of neutropenia in a median of 2 days. ||| Lors des essais cliniques contrôlés à la dose recommandée de 5 mg par jour, il n’ y a pas eu d’ augmentation de l’ incidence de la somnolence par comparaison avec le placebo.
0.2945009469985962 ||| * Your doctor may decide that you can take rifabutin and/or voriconazole with a booster (lower dose) of Norvir but a full dose of Norvir must not be taken together with these two medicines. ||| There are some medications that must not be taken with Invirase/ritonavir (see section "Do not take Invirase") or that require dosage reduction of that medicine or Invirase or ritonavir. ||| * Votre médecin pourra déterminer que vous pouvez prendre la rifabutine et/ou le voriconazole avec une dose de potentialisation pharmacocinétique (dose plus faible) de Norvir, mais Norvir à dose maximale ne doit pas être pris avec ces deux médicaments.
0.3790108859539032 ||| Arranging and conducting horseback expeditions ||| Organising and conducting fishing tournaments ||| Organisation et encadrement de promenades à cheval
0.1466892659664154 ||| Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids. ||| Previcox must not be administered with corticosteroids or other NSAIDs. ||| Ne pas administrer Metacam conjointement avec d'autres AINS ou des glucocorticoïdes.
0.0 ||| Number of patients ||| Number of patients ||| Nombre de patientes
0.9395312666893005 ||| Effect on fertility: ||| Economic impact: jobs and growth ||| Effet sur la fécondité:
0.0007225802401080728 ||| In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products. ||| In case of concomitant antiviral therapy for hepatitis B or C, please also refer to the relevant Summary of Product Characteristics for these medicinal products. ||| En cas d’ administration concomitante d’ un traitement antiviral de l’ hépatite B ou C, veuillez consulter le Résumé des Caractéristiques du Produit de ces médicaments.
0.37476271390914917 ||| The plasma protein binding is 97%. ||| The plasma protein binding of paliperidone is 74%. ||| La liaison aux protéines plas- matiques est de 97%.
0.23766940832138062 ||| Contains lactose monohydrate. ||| Also contains lactose monohydrate. ||| Contient du lactose.
0.5309285521507263 ||| Marketing services in the field of travel ||| Import-export agencies in the field of energy ||| Marketing dans le domaine des voyages
0.0 ||| No studies on the effects on the ability to drive and use machines have been performed. ||| No studies on the effects on the ability to drive and use machines have been performed. ||| 55 Les effets sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ ont pas été étudiés.
0.21451804041862488 ||| 327 6. ||| 620 3. ||| 6.
0.294086754322052 ||| The product may not be returned to refrigerated storage after storage at room temperature. ||| The product may not be returned to refrigerated storage again. ||| Le produit ne doit pas être remis au réfrigérateur après avoir été conservé à température ambiante.
0.3555030822753906 ||| - Tell your doctor if you ever had a heart attack or a heart problem, severe liver diseases ||| Tell your doctor if you have had problems with your liver before, including hepatitis B or C. ||| - Prévenez votre médecin si vous avez déjà eu une crise cardiaque ou un problème cardiaque; des
0.10733270645141602 ||| Insulin Human Winthrop Comb 15 100 IU/ ml suspension for injection in a vial ||| Insulin Human Winthrop Rapid 100 IU/ ml solution for injection in a vial ||| Insulin Human Winthrop Comb 15 100 UI/ ml suspension injectable en flacon
0.29057008028030396 ||| 1 tablet contains 95 mg of mavacoxib. ||| d ise Each tablet contains 20 mg of rimonabant. ||| 1 comprimé contient 95mg de mavacoxib.
0.5452696084976196 ||| On 30 January, a man from Siegsdorf who worked for the same company tested positive. ||| In the following days, he used a vlog to report on the pandemic in Wuhan. ||| Le 30 janvier, un homme de Siegsdorf de la même compagnie est testé positif.
0.49196353554725647 ||| Both the liver and the kidney have been shown to be important protein catabolising organs for growth hormone. ||| It is used to make clearer diagnostic images of the brain, spine and of the liver, in adults and children. ||| Le foie aussi bien que les reins sont des organes importants pour le catabolisme des protéines et donc pour l’ hormone de croissance.
0.3009568154811859 ||| Adverse effects of ibandronic acid in reproductive toxicity studies in the rat were those expected for this class of drugs (bisphosphonates). ||| Use with ribavirin Significant teratogenic and/ or embryocidal effects have been demonstrated in all animal species exposed to ribavirin. ||| Les effets indésirables de l’ acide ibandronique dans les études de reproduction chez le rat ont été ceux attendus avec la classe des bisphosphonates.
0.507981538772583 ||| It is only used in calves and young cattle. ||| It is used for dogs and cats. ||| Il n’ est utilisé que chez les veaux et les jeunes bovins.
0.39685946702957153 ||| Remove any air in the infusion set tubing by drawing back on the syringe. ||| Remove the airspace within the infusion bag to minimize the air/ liquid interface. ||| Retirez tout l’air éventuellement présent dans la tubulure du nécessaire à perfusion en tirant sur le piston de la seringue.
0.40175652503967285 ||| ADENURIC film-coated tablets are pale yellow to yellow in colour and capsule shaped. ||| The capsules are semi– translucent white and coded CRIXIVAN™ 200 mg in blue. ||| Les comprimés pelliculés d’ ADENURIC sont de couleur jaune pâle à jaune, en forme de gélule.
0.0 ||| It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist. ||| It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or your pharmacist. ||| Ne le donnez jamais à quelqu’ un d’ autre, même en cas de symptômes identiques, cela pourrait lui être nocif. – Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin, à votre infirmière d’ éducation ou à votre pharmacien.
2.615232791609856e-13 ||| The required weekly dose of Dynepo is lower when Dynepo is administered subcutaneously compared no ||| The required weekly dose of Dynepo is lower when Dynepo is administered subcutaneously compared no ||| La dose hebdomadaire requise administrée en sous-cutané est inférieure à celle administrée en tn
0.10930618643760681 ||| Actrapid Penfill is for single person use only. ||| Insulatard Penfill is for single person use only. ||| Actrapid Penfill est réservé à l’ utilisation par un seul patient.
0.28079456090927124 ||| Your blood sugar may get too high (hyperglycaemia). ||| - you have hyperglycaemia (high blood sugar levels). ||| Votre taux de sucre dans le sang peut devenir trop élevé (hyperglycémie).
0.15734440088272095 ||| What is the risk associated with Clomicalm? ||| What is the risk associated with Orgalutran? ||| Quel est le risque associé à l'utilisation de Clomicalm?
0.3702695369720459 ||| Rental of photographic processing equipment ||| Rental of software for inventory management ||| Location d'équipements de traitement photographique
0.1994899958372116 ||| Store in the original blister package in order to protect from moisture. ||| Blisters Store in original package in order to protect from moisture. ||| À conserver dans la plaquette thermoformée d’ origine à l'abri de l’ humidité.
0.42939937114715576 ||| - tightening of the gullet (oesophagus), difficulty in swallowing that may cause pain ||| - runny nose, cough, hoarseness due to infection of the upper respiratory tract ||| - rétrécissement de l'œsophage, difficulté à avaler pouvant provoquer une douleur, constipation,
0.5650583505630493 ||| 60 mg nifedipine ||| 10 mg olanzapine per vial ||| 60 mg de nifédipine
0.3831411600112915 ||| Production of the primary metabolite, ucb L057, is not supported by liver cytochrome P450 isoforms. ||| OPTISON consists of perflutren-containing microspheres of heat treated human albumin, suspended in human albumin solution, 1%. ||| La production du métabolite principal, l'ucb L057, est indépendante des isoformes du cytochrome P450
9.768453407277278e-13 ||| Ísland Vistor hf. ||| Ísland Vistor hf. ||| 83 Ísland Vistor hf.
0.055059999227523804 ||| Among patients with ankylosing spondylitis who received Enbrel, the clinical responses were apparent at the time of the first visit (2 weeks) and were maintained through 6 months of therapy. ||| Among patients with psoriatic arthritis who received Enbrel, the clinical responses were apparent at the time of the first visit (4 weeks) and were maintained through 6 months of therapy. ||| Parmi les patients atteints de spondylarthrite ankylosante ayant reçu Enbrel, les réponses cliniques sont apparues dès la première visite (2 semaines) et se sont maintenues au cours des 6 mois de traitement.
0.3832329511642456 ||| Absorption and distribution of 13CO2 is faster than the urease reaction. ||| Unchanged carbidopa accounts for 30% of the total urinary excretion. ||| L'absorption et la distribution du 13CO2 sont plus rapides que l’ action de l'uréase.
0.982086718082428 ||| 0.5 ml; Solvent: ||| 1.4 cm, cut line: ||| Solution à diluer:
0.43765610456466675 ||| 2.25 1.125 0.56 1.35 0.68 0.34 0.9 0.45 0.225 ||| 8.75 5.20 4.31 3.1 5.7 2.02 0.53 0.54 0.24 ||| 2,25 1,125 0,56 1,35 0,68 0,34 0,9 0,45 0,225
0.7467303276062012 ||| NNRTIs/ Efavirenz ||| UA/ NSTEMI ||| INNTIs/ Efavirenz Antibiotiques
0.511040210723877 ||| If you miss a dose, take it as soon as you remember. ||| Take your capsules as soon as you remember. ||| Si vous avez sauté une prise, prenez -la dès que vous vous en rendez compte.
0.26341718435287476 ||| As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/ or tongue have been reported in patients taking irbesartan. ||| In patients with Paget’ s disease: symptoms due to low blood calcium, such as muscle spasms, or numbness, or a tingling sensation especially in the area around the mouth. ||| Comme avec des médicaments similaires, de rares cas de réactions allergiques cutanées (éruption, urticaire), ainsi qu’ un gonflement de la face, des lèvres et/ ou de la langue ont été rapportés chez des patients prenant de l'irbésartan.
0.3740506172180176 ||| The effect of Enbrel on radiographic progression was maintained in patients who continued on treatment during the second year. ||| The incidence of peripheral neuropathy increases early in the treatment and has been observed to peak during cycle 5. ||| 199 l’ aggravation radiographique était maintenu chez les patients qui continuaient le traitement au cours de la deuxième année.
0.4592590928077698 ||| Common: nephrolithiasis in adults; dysuria. ||| Common: infection, nasopharyngitis ||| Fréquent: lithiases des voies urinaires chez l’ adulte, dysurie.
0.345068097114563 ||| The overall frequency of discontinuations in sildenafil/ epoprostenol treated patients due to adverse events was 5.2% compared to 10.7% in the placebo/ epoprostenol treated patients. ||| These events led to the discontinuation of rivastigmine in some cases (e. g. discontinuations due to tremor 1.7% on rivastigmine vs 0% on placebo). ||| La fréquence globale d’ interruptions du traitement chez les patients traités par sildénafil/ époprosténol à cause d’ effets indésirables était de 5,2% contre 10,7% chez les patients traités par placebo / époprosténol.
0.0025597026105970144 ||| 129 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 131 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 140 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.606357216835022 ||| Desloratadine and Pseudoephedrine: ||| Cholestyramine and colestipol resins: ||| Desloratadine et pseudoéphédrine:
0.10519954562187195 ||| Some side effects are common. ||| Some side effects are very common. ||| Certains effets indésirables sont fréquents.
0.26986458897590637 ||| Tartar for pharmaceutical purposes ||| Bark for nutraceutical purposes ||| Tartre à usage pharmaceutique
0.24797648191452026 ||| Co-administration of fosamprenavir with ritonavir in doses greater than 100 mg twice daily has not been clinically evaluated. ||| Pegaptanib sodium has not been adequately studied in patients with creatinine clearance below 20 ml/ min. ||| Fosamprenavir: la co-administration de fosamprénavir et de ritonavir à des doses supérieures à 100 mg deux fois par jour n’a pas été évaluée cliniquement.
0.543571949005127 ||| 3/ 20 Mode of administration: ||| 45/ 50 Method of administration ||| Mode d’ administration:
0.29957371950149536 ||| On 28 February, Azerbaijan confirmed the first case from a Russian national, who was travelling from Iran. ||| On 8 March, three more cases were confirmed from Dominican tourists that came from a trip to Italy. ||| Le 28 février, l'Azerbaïdjan a confirmé le premier cas d'un ressortissant russe, qui voyageait d'Iran.
0.3993934094905853 ||| 5 ml solvent for NeoRecormon Multidose 100,000 IU (water for injection, benzyl alcohol, benzalkonium chloride) ||| Article 30 Referral for Calcichew D3 mite (and related names) Chewable tablets (Calcium 500 mg plus cholecalciferol 5 µg) ||| 5 ml Solvant pour NeoRecormon Multidose 100 000 UI (Eau p. p. i., alcool benzylique, chlorure de benzalkonium)
0.0 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| 57 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché:
0.32945716381073 ||| Keep the needle tip in the liquid, and slowly pull the plunger back all the way to withdraw the solution into the syringe. ||| To keep the needle tip within the liquid, you may have to slowly back it out of the stopper as you draw out the liquid. ||| Laissez la pointe de l’ aiguille dans le liquide et tirez lentement sur le piston pour aspirer la solution dans la seringue.
0.3041694164276123 ||| Screening machines ||| Joining machines ||| Trieuses [machines]
0.5204986929893494 ||| Castrating apparatus [for veterinary purposes] ||| Apparatus for fermentation [laboratory apparatus] ||| Instruments de castration à usage vétérinaire
0.2633572816848755 ||| Available tacrolimus is generally rapidly absorbed. ||| Montelukast is rapidly absorbed following oral administration. ||| Le tacrolimus disponible est généralement rapidement absorbé.
0.14440152049064636 ||| Do not use Rapinyl after the expiry date which is stated on the carton after EXP. ||| Do not use PritorPlus after the expiry date which is stated on the carton after “ EXP”. ||| Ne pas utiliser Rapinyl après la date de péremption mentionnée sur l’ étui en carton, après « EXP ».
0.09262659400701523 ||| Because the elimination of adalimumab may take up to five months, monitoring should be continued throughout this period. t uc ||| Because the elimination of adalimumab may take up to five months, monitoring should be continued throughout this period. ||| La durée d'élimination de l'adalimumab pouvant aller jusqu'à cinq mois, la surveillance devra être poursuivie pendant toute cette période. dic
0.34901201725006104 ||| If after administration of cefuroxime axetil sensitivity reactions occur, the use should be discontinued immediately and an appropriate treatment should be established. ||| If a re- administration of the diuretic is deemed necessary, it is recommended to protect exposed areas to the sun or to artificial UVA. ||| En cas de réaction d’ hypersensibilité après prise de céfuroxime axétil, aucune autre administration ne doit avoir lieu et un traitement adéquat doit être instauré.
0.732094943523407 ||| Capsule shell: ||| Swollen joints. ||| Enveloppe de la capsule:
0.19467982649803162 ||| The safety and efficacy of Vectibix have not been studied in patients with renal or hepatic impairment. ||| There are no data on the safety and efficacy of Rotarix in infants with gastrointestinal illnesses or growth retardation. ||| La tolérance et l’ efficacité de Vectibix n’ ont pas été étudiées chez les patients atteints d’ insuffisance rénale ou hépatique.
0.23506414890289307 ||| Given the frequency of gastrointestinal adverse reactions to treatment with Diacomit and valproate (anorexia, loss of appetite, nausea, vomiting), the growth rate of children under this combination of treatment should be carefully monitored. ||| There is increased risk of lactic acidosis in acute alcohol intoxication (particularly in the case of fasting, malnutrition or hepatic insufficiency) due to the metformin active substance of Glubrava (see section 4.4). ||| En raison de la fréquence des effets indésirables digestifs (anorexie, diminution de l’ appétit, nausées, vomissements) lors d’ un traitement par Diacomit et valproate de sodium, le taux de croissance des enfants recevant cette association doit être surveillé étroitement.
0.45925936102867126 ||| - If you have severe medical conditions that leave you very weak. ||| - what you should do in emergency situations when you feel unwell or become ill. ||| - si vous avez un mauvais état de santé qui vous affaiblit.
0.14559555053710938 ||| 36 B. ||| 16 B. ||| 42 B.
0.42402172088623047 ||| Once prepared, the suspension should be drunk within two hours. ||| Itching will usually disappear within one day after the patch has been removed. ||| La suspension doit être bue dans les deux heures suivant sa préparation.
6.890729306596732e-13 ||| Uncommon Uncommon Uncommon ||| Uncommon Uncommon Uncommon ||| Peu fréquent Peu fréquente Peu fréquente
0.029214464128017426 ||| BOTTLE LABEL AND OUTER CARTON TEXT ||| OUTER CARTON AND BOTTLE LABEL TEXT ||| TEXTE DE L'ETIQUETTE DU FLACON ET DE LA BOITE EN CARTON
0.09797936677932739 ||| What benefit has Rebif shown during the studies? ||| What benefit has Fertavid shown during the studies? ||| Quel est le bénéfice démontré par Rebif au cours des études?
0.3890698552131653 ||| Filgrastim should be discontinued and appropriate treatment given in these cases. ||| Dose reduction and regular monitoring of the patient is required in such cases. ||| Dans de telles circonstances, le filgrastim doit être arrêté et un traitement approprié doit être instauré.
0.7363001108169556 ||| To achieve this, we must keep people in employment and businesses running. ||| If we want a healthy society, we need healthy ecosystems. ||| Pour y parvenir, nous devons veiller à ce que les travailleurs gardent leur emploi et à ce que les entreprises poursuivent leurs activités.
7.564341947957631e-13 ||| Psychiatric disorders ||| Psychiatric disorders ||| dépression, nervosité
3.4564262259631495e-13 ||| Severe and life-threatening skin reactions, including Stevens-Johnson syndrome, were reported in less than 1% of patients included in the clinical development programme. ||| Severe and life-threatening skin reactions, including Stevens-Johnson syndrome, were reported in less than 1% of patients included in the clinical development programme. ||| Des réactions cutanées sévères et mettant en jeu le pronostic vital, dont le syndrome de Stevens-Johnson, ont été rapportées 5 chez moins de 1% des patients inclus dans le programme de développement clinique.
0.14471805095672607 ||| Serious and sometimes life-threatening infusion reactions, which are characterised by allergic-like or anaphylactoid-like reactions, with symptoms including asthma, flushing, urticarial rash, chest pain, fever, hypertension, tachycardia, pruritus, sweating, shortness of breath, facial oedema, chills, back pain, tightness in the chest and throat and/ or hypotension may occur within minutes of starting the infusion of Caelyx. ||| Periodontal (affecting gums) and dental disorders, altered mental status, loss of consciousness, acute hypersensitivity reactions including urticaria (hives), angioedema (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing), bronchoconstriction and anaphylaxis (a severe, whole -body allergic reaction) have been reported, but their frequency is unknown. ||| Des réactions sérieuses et affectant parfois le pronostic vital liées à la perfusion, caractérisées par des réactions de type allergique ou anaphylactique, avec des symptômes tels que asthme, bouffée de chaleur, rash avec urticaire, douleur thoracique, fièvre, hypertension, tachycardie, prurit, sueurs, souffle court, œ dème de la face, frissons, douleur dorsale, oppression thoracique et de la gorge et/ ou hypotension peuvant survenir dans les minutes qui suivent le début de la perfusion de Caelyx.
0.33965227007865906 ||| If your doctor has recommended that you take Agenerase capsules together with low doses of ritonavir, used to boost its activity, then please make sure that you carefully read the ritonavir Package Leaflet before starting therapy. ||| Therefore, when co- prescribing probenecid with cidofovir, it is important for prescribers to consult the current probenecid SmPC (or an appropriate drug reference source) for full information on the safety profile and other features of that product. ||| Si votre médecin vous a recommandé de prendre Agenerase capsules molles avec de faibles doses de ritonavir pour optimiser son efficacité, lisez alors attentivement la notice de ritonavir avant de commencer le traitement.
0.15704670548439026 ||| 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with plunger stopper (siliconized FluroTec- coated bromobutyl elastomer or non-coated chlorobutyl elastomer) and tip cap (bromobutyl) without needle guard (safety) device without needle or with one or two needle(s) - pack size of 1, 10 or 20. ||| Lyophilisate (100,000 IU) for solution for injection in a vial (type 1 glass) with a stopper (teflonised rubber) and 5 ml of solvent in an ampoule (type 1 glass), with one reconstitution and withdrawal device with one needle (21G2) and one disposable syringe (polypropylene and polyethylene) (5 ml). ||| 0,5 ml de suspension injectable en seringue préremplie (verre de type I) munie d'un bouchon-piston (élastomère bromobutyl recouvert de FluoroTec siliconé ou élastomère chlorobutyl) et d'un capuchon (bromobutyl) sans dispositif de protection de l'aiguille, sans aiguille ou avec une ou deux aiguille(s) – boîtes de 1, 10 ou 20.
0.2171478271484375 ||| Tel: +356 2540 2600 medinfo_mt@merck. com ||| Tel: +371 7364 224 msd_lv@merck.com ||| Tel: +356 2397 6000 medinfo_mt@merck.com
0.2840039134025574 ||| Co-administration of fosaprepitant with ergot alkaloid derivatives, which are CYP3A4 substrates, may result in elevated plasma concentrations of these medicinal products. ||| The pharmacokinetics of theophylline, a CYP1A2 39 substrate, were not significantly affected by co-administration with duloxetine (60 mg twice daily). ||| La co-administration de fosaprépitant et d’ alcaloïdes dérivés de l’ ergot de seigle, qui sont des substrats du CYP3A4, peut entraîner une élévation des concentrations plasmatiques de ces médicaments.
0.4033469557762146 ||| Ventavis is provided in colourless ampoules (type I glass), containing either 1 ml or 2 ml nebuliser solution. ||| Cardboard box with either 1 or 12 colourless glass injection vial(s) each containing 20, 50 or 100 ml. ||| Ventavis est fourni dans des ampoules incolores (verre de type I) contenant soit 1 ml soit 2 ml de solution pour inhalation par nébuliseur.
0.3787686824798584 ||| This means that IntronA is injected with a short needle into the fatty tissue just under the skin. ||| On contact with fluid such as blood, the coating on the sponge that contains the active substances dissolves. ||| Cela signifie qu’IntronA est injecté à l’aide d’une aiguille courte dans le tissu graisseux juste sous la peau.
0.7904232740402222 ||| Phoenix slapped Orton, who in turn performed an RKO on her. ||| Also during this time, Otis started a romance with Mandy Rose. ||| Phoenix a giflé Orton qui, à son tour, a exécuté un RKO sur elle.
0.3867735266685486 ||| The periocular skin, eyelid and ocular surface should be disinfected and adequate anaesthesia and a broad-spectrum topical microbicide should be administered prior to the injection. ||| If the clinical situation warrants, a patent airway should be established and maintained, possibly with an oropharyngeal airway or endotracheal tube and oxygen should be administered and respiration assisted or controlled, as appropriate. ||| La peau autour de l 'œ il, la paupière et la surface oculaire doivent être désinfectées et une anesthésie appropriée ainsi qu’ un antibactérien local à large spectre doivent être administrés avant l'injection.
0.42535465955734253 ||| The dose should be adjusted on the basis of laboratory assessment for each individual case. ||| 2 The dosage and administration schedule should be individualised for each patient. ||| La posologie doit être adaptée en fonction des résultats des dosages pour chaque patient.
0.5080821514129639 ||| Wall-mounted spouts for baths ||| Disposable microtome blades ||| Becs muraux pour baignoires
0.06234453618526459 ||| RISPERDAL CONSTA and associated names (see Annex I) 50 mg powder and solvent for prolonged- release suspension for intramuscular injection ||| RISPERDAL CONSTA and associated names (see Annex I) 25 mg powder for prolonged-release suspension for intramuscular injection ||| RISPERDAL CONSTA et dénominations associées (Voir Annexe I) 50 mg poudre et solvant pour suspension injectable intramusculaire à libération prolongée
0.6775330901145935 ||| Like all medicines, XERISTAR can cause side effects, although not everybody gets them. ||| However, not all audiological results from people with NIHL match this typical notch. ||| Comme tous les médicaments, XERISTAR est susceptible d’ avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.19428998231887817 ||| 163 The vials that are being used or about to be used are not to be kept in a refrigerator. ||| The Penfill that is being used or about to be used is not to be kept in a refrigerator. ||| Les flacons en cours d’ utilisation ou sur le point d’ être utilisés ne sont pas à conserver au réfrigérateur.
0.2884558439254761 ||| 5 Table 1 ||| 20 Table 1 ||| Tableau 1
0.19670118391513824 ||| Vegetable corers [machines] ||| Belt sanders [machines] ||| Machines à évider les légumes
0.3314822316169739 ||| Do not take Januvia ||| Do not take Valdoxan ||| Ne prenez jamais Januvia
0.45712170004844666 ||| Amlodipine reduces renal vascular resistance and increases renal plasma flow. ||| Hypertension Irbesartan lowers blood pressure with minimal change in heart rate. ||| L'amlodipine réduit la résistance vasculaire rénale et augmente le débit plasmatique rénal.
0.335358202457428 ||| Although the exact antiviral mode of action of recombinant interferon alfa-2b is unknown, it appears to alter the host cell metabolism. ||| Although Compound A is a dose-dependent nephrotoxin in rats, the mechanism of this renal toxicity is unknown. ||| Bien que le mode d’ action antiviral exact de l’ interféron alfa-2b recombinant ne soit pas connu, il semble modifier le métabolisme de la cellule hôte.
0.36095094680786133 ||| Printing ink Shellac Potassium hydroxide Black iron oxide (E 172) ||| (tablet coating) macrogol and synthetic red iron oxide (E172) ||| 9 Encre d’imprimerie Gomme laque Hydroxyde de potassium Oxyde de fer noir (E 172)
0.12275378406047821 ||| In reproductive toxicity studies, no teratogenic effects were observed. ||| In animal reproductive studies, no teratogenic effect was observed. ||| L’ études des fonctions de reproduction n’ ont révélé aucun effet tératogène chez l’ animal.
0.31211674213409424 ||| It is supplied in a dual-chamber cartridge which contains 1.61 mg parathyroid hormone as powder and 1.13 ml of solvent ||| Each 5 ml of Kaletra oral solution contains 400 mg of lopinavir co-formulated with 100 mg of ritonavir as a pharmacokinetic enhancer. ||| Il est présenté en cartouche double chambre qui contient 1,61 mg d’ hormone parathyroïde sous forme de poudre et 1,13 ml de solvant.
0.6899113655090332 ||| Individual and group psychology services ||| 5.2 Personnel and support services ||| Services de psychologie individuels ou collectifs
0.3047119975090027 ||| • The Trudexa syringe should NEVER be reused. |||  The syringe and needle should NEVER be re-used. ||| • Les seringues de Trudexa ne doivent JAMAIS être réutilisées.
0.006057341583073139 ||| MARKETING AUTHORISATION NUMBER(S) EU/ 1/ 07/ 431/ 009 EU/ 1/ 07/ 431/ 010 ||| MARKETING AUTHORISATION NUMBER(S) EU/ 1/ 07/ 431/ 003 EU/ 1/ 07/ 431/ 004 ||| EU/ 1/ 07/ 431/ 009 EU/ 1/ 07/ 431/ 010
0.03157242760062218 ||| Skin and subcutaneous tissue disorders Common: dermatitis (2.3% vs. ||| 4 Skin and subcutaneous tissue disorders Common: dermatitis (2.3% vs. ||| Affections de la peau et du tissus sous-cutané Fréquent: dermatite (2,3% vs.
0.5856507420539856 ||| The usual starting dose is 150 IU/kg. ||| 0.278mg/ kg) than the recommended treatment dose. ||| La dose d’ attaque habituelle est de 150 UI/kg.
0.08344599604606628 ||| ed {DD/ MM/ YYYY} ||| {DD/ MM/ YYYY} ||| {JJ/ MM/ AAAA} e
0.34784621000289917 ||| Since Tasmar should be used only in combination with levodopa/ benserazide and levodopa/ carbidopa, the prescribing information for these levodopa preparations is also applicable to their concomitant use with Tasmar. ||| This means when it is taken together with levodopa (as levodopa/ benserazide or levodopa/ carbidopa) you should have an improvement in your symptoms of Parkinson’ s disease. ||| Etant donné que Tasmar doit être utilisé uniquement en association avec la lévodopa/ bensérazide ou la lévodopa/ carbidopa, les informations concernant la prescription de ces spécialités à base de lévodopa s'appliquent également lors de leur utilisation concomitante avec Tasmar.
0.38602399826049805 ||| Manufacturer Glaxo Wellcome GmbH & Co. ||| Manufacturer Boehringer Ingelheim Pharma GmbH & Co. ||| Fabricant Glaxo Wellcome GmbH & Co.
0.325952410697937 ||| The pharmacokinetics of drotrecogin alfa (activated) have not been studied in patients with severe sepsis and pre-existing end stage renal disease and chronic hepatic disease. ||| Myozyme is indicated for long-term enzyme replacement therapy (ERT) in patients with a confirmed diagnosis of Pompe disease (acid α -glucosidase deficiency). ||| La pharmacocinétique de la drotrécogine alfa (activée) n’ a pas été étudiée chez des patients présentant un sepsis sévère et ayant une maladie rénale terminale préexistante ou une hépatopathie chronique.
0.2660548686981201 ||| MabCampath is used for the treatment of B-cell chronic lymphocytic leukaemia (B-CLL) in cases where fludarabine combination chemotherapy is not appropriate for you. ||| Pharmacokinetics were characterised in MabCampath-naive patients with B-cell chronic lymphocytic leukaemia (B-CLL) who had failed previous therapy with purine analogues. ||| MabCampath est utilisé dans le traitement de votre Leucémie Lymphoïde Chronique à cellules B (LLC-B) si une polychimiothérapie comportant de la fludarabine n’est pas appropriée.
0.5492455959320068 ||| Step 1 - Preparing the syringe Sterile disposable syringes and needles should be used for administration of Fertavid. ||| Distribution Ceftriaxone distributes well in various compartments and also passes the placental barrier. ||| 132 1ère Etape - préparation de la seringue Des seringues et des aiguilles jetables et stériles doivent être utilisées pour l’ administration de Fertavid.
0.14370191097259521 ||| ed 1 ml solution contains 100 IU (3.5 mg) of insulin human (rDNA). ||| 1 ml solution contains 100 U (3.5 mg) of insulin aspart (r-DNA), ||| 1 ml de solution contient 100 UI (3,5 mg) d’ insuline humaine (ADNr),
0.0663960874080658 ||| If you have further questions on the use of this product ask your doctor or pharmacist. ||| If you have any further questionson the use of this product ask a doctor or pharmacist. ||| Si vous avez d’autres questions sur l’utilisation de ce médicament, demandez plus d’informations à votre médecin ou à votre pharmacien.
0.04668489843606949 ||| The clinical data available suggest that those patients whose initial haemoglobin is very low ( 6.8 g/dl or > 4.25 mmol/l). ||| The clinical data available suggest that those patients whose initial haemoglobin is very low ( 8 g/dl or> 5 mmol/l). ||| Les données cliniques disponibles suggèrent que les patients dont le taux d’ hémoglobine est très faible ( 6,8 g/ dl ou > 4,25 mmol/ l).
0.5199635028839111 ||| This leads to less bone loss in osteoporosis and less disease activity in Paget’ s disease. ||| - Pathological gambling, increased libido and hypersexuality have been reported in Parkinson’ s ||| Cela aboutit à une réduction de la perte osseuse en cas d’ ostéoporose et de l’ activité pathologique en cas de maladie de Paget.
3.5515871927432885e-13 ||| Store in a refrigerator Do not freeze Store in the original package in order to protect from light ||| Store in a refrigerator Do not freeze Store in the original package in order to protect from light ||| A conserver au réfrigérateur Ne pas congeler A conserver dans l’ emballage extérieur d'origine à l’ abri de la lumière.
0.08923091739416122 ||| Slovenia: ||| Slovakia: ||| Slovénie:
0.5892215967178345 ||| Pressurised inhalation suspension ||| inhalation, suspension ||| Suspension pour inhalation en flacon
0.10447762161493301 ||| What benefit has Rebif shown during the studies? ||| What benefit has Abilify shown during the studies? ||| Quel est le bénéfice démontré par Rebif au cours des études?
0.45156624913215637 ||| Partially used vials should be discarded. ||| Empty cartridges must not be refilled. ||| Les flacons partiellement utilisés doivent être jetés.
0.2855169475078583 ||| As with interferon alfa-2b, patients with a history of congestive heart failure, myocardial infarction and/ or previous or current arrhythmic disorders, receiving PegIntron therapy require close monitoring. ||| For the treatment of adult patients with acute coronary syndromes (unstable angina/ non-ST segment elevation myocardial infarction (UA/ NSTEMI)) planned for urgent or early intervention. ||| Comme avec l’ interféron alfa-2b, les patients ayant des antécédents d'insuffisance cardiaque congestive, d'infarctus du myocarde et/ ou ayant souffert ou souffrant de troubles du rythme cardiaque, et recevant un traitement par PegIntron doivent être étroitement surveillés.
0.45604702830314636 ||| Synthetic thickeners for foodstuffs ||| Plug-in diffusers for mosquito repellents ||| Épaississants synthétiques pour aliments
0.5302585959434509 ||| Nervous system: ||| Renal function: ||| Système nerveux:
0.31772100925445557 ||| 7 7 ||| 8 7 ||| 7
0.1652105748653412 ||| EPAR summary for the public ||| ris EPAR summary for the public ||| Résumé de l’ EPAR pour le grand public
0.17081692814826965 ||| Absorption: abacavir is rapidly and well absorbed following oral administration. ||| Absorption Lacosamide is rapidly and completely absorbed after oral administration. ||| L’ abacavir est rapidement et bien absorbé après administration orale.
0.0837337076663971 ||| 24 pre-filled syringes 48 alcohol swabs ||| 4 pre-filled syringes 8 alcohol swabs ||| 24 seringues pré-remplies 48 tampons alcoolisés
0.5610019564628601 ||| This study measured survival rates. ||| The three studies demonstrated similar survival rates. ||| Cette étude a mesuré les taux de survie.
0.2776528596878052 ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com ||| Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@msd. dk ||| Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com
3.5244214231094917e-13 ||| The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration. ||| The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration. ||| 102 Les propriétés pharmacocinétiques de la darbepoetin alfa ont fait l'objet d'études cliniques chez des patients insuffisants rénaux chroniques après administration intraveineuse et sous-cutanée.
0.30400049686431885 ||| The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only. ||| They are designed to protect from airborne particles like dust but effectiveness against a specific biological agent is not guaranteed for off-label uses. ||| Le nébulisateur doit être exempt de sédiments, corrosion et de traces de désinfectant, et idéalement, devrait être réservé pour la vaccination.
0.49715834856033325 ||| Sutent is given in six-week cycles, with 50 mg a day for four weeks, followed by two weeks off treatment. ||| The injections were on different days, with a delay of between 2 and 10 days between the two medicines. ||| Sutent est administré par cycles de six semaines, à raison d’ une prise quotidienne de 50 mg pendant quatre semaines consécutives, suivis d’ une fenêtre thérapeutique de 2 semaines.
0.569209098815918 ||| Notebook paper ||| Aluminium windows ||| Papier à cahiers
0.299506276845932 ||| The cumulative rates of genotypically confirmed telbivudine resistance by week 104 were 25.1% (115/ 458) for HBeAg-positive patients and 10.8% (24/ 222) for HBeAg-negative patients. ||| In all women with a uterus at baseline, histologically benign endometrial polyps were reported in 34 of 2,302 (1.5%) FABLYN-treated women versus 18 of 2,309 (0.8%) placebo-treated women. ||| Les taux cumulés de résistance génotypique confirmée à la telbivudine à la semaine 104 étaient de 25,1% (115/ 458) chez les patients AgHBe positifs et 10,8% (24/ 222) chez les patients AgHBe négatifs.
0.2709530293941498 ||| In separate pharmacokinetic interaction studies, co-administration of ritonavir (potent CYP3A4 inhibitor) or saquinavir in combination with a booster dose of ritonavir or rifampicin (potent CYP34A inducer) did not result in clinically significant changes of the pharmacokinetics of enfuvirtide. ||| A pharmacokinetic interaction study between ropinirole (at a dose of 2 mg, three times a day) and theophylline, a substrate of CYP1A2, revealed no change in the pharmacokinetics of either ropinirole or theophylline. ||| Influence des médicaments associés sur le métabolisme de l'enfuvirtide: dans des études distinctes d'interactions pharmacocinétiques, l'administration concomitante de ritonavir (inhibiteur puissant du CYP3A4) ou de saquinavir en association à de faibles doses de ritonavir et de rifampicine (inducteur puissant du CYP3A4) n'a pas entraîné de modifications cliniquement significatives de la pharmacocinétique de l'enfuvirtide.
0.23422878980636597 ||| In patients with impaired renal function, adjustment of the ceftriaxone dose is not necessary if the hepatic function is normal. ||| There is no specific experience to guide the adjustment to tenecteplase dose in patients with hepatic and severe renal insufficiency. ||| En cas de troubles de la fonction rénale, il n’est pas nécessaire d’adapter la posologie de la ceftriaxone si la fonction hépatique est normale.
6.065303966538982e-13 ||| OSSEOR is meant for use only in postmenopausal women. ||| OSSEOR is meant for use only in postmenopausal women. ||| Allaitement En raison de son indication, OSSEOR ne doit être utilisé que chez la femme après la ménopause.
6.261253993576632e-13 ||| These measures should help to protect the environment. ||| These measures should help to protect the environment. ||| Ces mesures contribuent à protéger l’environnement.
0.01686708815395832 ||| What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 150 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2872 engraved on the other side. ||| What Irbesartan Winthrop looks like and contents of the pack Irbesartan Winthrop 150 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2772 engraved on the other side. ||| Qu’ est -ce que Irbesartan Winthrop et contenu de l'emballage extérieur Les comprimés pelliculés de Irbesartan Winthrop 150 mg sont blancs à blancs cassés, biconvexes, de forme ovale, avec un coeur gravé d'un côté et le numéro 2872 gravé sur l'autre côté.
2.3789911013372134e-13 ||| If on repeated measurements IGF-I levels exceed +2 SD compared to references for age and pubertal status, the IGF-I / IGFBP-3 ratio could be taken into account to consider dose adjustment. ||| If on repeated measurements IGF-I levels exceed +2 SD compared to references for age and pubertal status, the IGF-I / IGFBP-3 ratio could be taken into account to consider dose adjustment. ||| 15 d'IGF-l sont supérieurs à + 2 DS comparés aux valeurs standard pour l'âge et le stade pubertaire, le ratio IGF-l/ IGFBP-3 devra être pris en considération pour l'ajustement de la dose.
0.09211691468954086 ||| Substances for controlling the growth of aquatic weeds ||| Substances for controlling the growth of aquatic plants ||| Substances destinées à contrôler la croissance d'algues aquatiques
6.918786290416312e-13 ||| 31 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 31 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 31 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.3459722101688385 ||| Because renal elimination of valdecoxib is not important to its disposition, no changes in valdecoxib clearance were found even in patients with severe renal impairment or in patients undergoing dialysis (see section 4.2). ||| Because immunoglobulins, in common with many medicinal products, can be excreted in human milk, a decision should be made whether to discontinue breast-feeding or to discontinue Enbrel while breast-feeding. ||| L’ élimination du valdécoxib au niveau rénal n’ étant pas importante pour son devenir, aucun changement de la clairance du valdécoxib n’ a été observé même chez des patients présentant une insuffisance rénale sévère ou chez des patients sous dialyse (voir. rubrique 4.2 Posologie et mode d’ administration).
0.19989027082920074 ||| The CHMP has recommended the granting of the Marketing Authorisation(s) for which the Summaries of Product Characteristics, labelling and package leaflet are set out in Annex III for Nifedipinr Pharmamatch Retard 30/ 60 mg and associated names (see Annex I). ||| the CHMP has recommended the granting of the Marketing Authorisation(s) and the amendment of the Summary of Product Characteristics, labelling and package leaflet which are set out in Annex III for Fentanyl-ratiopharm 25/ 50/ 75/ 100 µg/ h TTS and associated names (see Annex I). ||| le CHMP a recommandé l’ octroi des autorisations de mise sur le marché pour lesquelles les résumés des caractéristiques du produit, de l’ étiquetage et de la notice sont présentés à l’ annexe III pour Pharmamatch Retard 30/ 60 mg et les dénominations associées (voir annexe I).
0.00032964415731839836 ||| 209 increase, the dose should be temporarily withheld until the haemoglobin begins to decrease, at which point therapy should be reinitiated at approximately 25% lower than the previous dose. ||| 208 increase, the dose should be temporarily withheld until the haemoglobin begins to decrease, at which point therapy should be reinitiated at approximately 25% lower than the previous dose. ||| Le traitement sera alors repris à une dose de 25% inférieure à la dose précédente.
0.3676225543022156 ||| There are no data available to indicate whether the administration of 23-valent pneumococcal polysaccharide vaccine to unprimed children or to children primed with Prevenar might result in hyporesponsiveness to further doses of Prevenar. ||| With careful rechallenge Fabrazyme has been re-administered to all 6 patients who tested positive for IgE antibodies or had a positive skin test to Fabrazyme in a clinical trial. ||| Il n’ y a pas de données disponibles indiquant si l’ administration du vaccin pneumococcique polysaccharidique 23-valent à des enfants ayant ou non reçu une primovaccination par Prevenar pourrait entraîner une diminution de la réponse immunitaire lors de l’ administration ultérieure de doses de Prevenar.
0.4404059052467346 ||| Care must be taken to ensure that no area of tissue receives more than the specified light dose. ||| 24 hours Only a sufficient amount of medicated drinking water should be prepared to cover the daily requirements. ||| Il faut s’ assurer qu’ aucune zone tissulaire ne reçoit plus que la dose de lumière spécifiée.
0.5262855291366577 ||| Puregon 300 IU/ 0.36 ml solution for injection contains: sucrose sodium citrate L-methionine polysorbate 20 benzyl alcohol water for injections. ||| 100g gel contains: heparin sodium 50 000 IU levomenthol 0.5 g hydroxyethyl salicylate 5.0 g ||| Puregon 300UI/ 0,36 ml solution injectable contient: du saccharose du citrate de sodium de la L-méthionine du polysorbate 20 de l’ alcool benzylique de l’ eau pour préparations injectables.
0.4739915728569031 ||| Data processing equipment and accessories (electrical and mechanical) ||| Rental of computer software, data processing equipment and computer peripheral devices ||| Équipement et accessoires (électriques et mécaniques) de traitement des données
0.3519216775894165 ||| E216 and methyl parahydroxybenzoate: ||| Methyl parahydroxybenzoate (0.125%) ||| E216 et parahydroxybenzoate de méthyle:
0.7551934719085693 ||| On 10 March, the traditional festivities related to Novruz holiday in Baku and Azerbaijan's regions in March have been canceled. ||| Saturday 9 May is Europe Day, which this year marks the 70th anniversary of the Schuman declaration. ||| Le 10 mars, les festivités traditionnelles liées aux vacances de Norouz à Bakou et dans les régions d'Azerbaïdjan en mars ont été annulées.
0.3220958709716797 ||| Renal and hepatic impairment: ||| Dosage in hepatic impairment: ||| Insuffisance rénale et hépatique:
0.18170994520187378 ||| The diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis (DTPa-HBV-IPV) suspension should be inspected visually for any foreign particulate matter and/ or variation of physical aspect. ||| The diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis (DTPa-HBV-IPV) component is a white, slightly milky liquid presented in a pre-filled syringe (0.5 ml). ||| La suspension diphtérique, tétanique, pertussique acellulaire, hépatite B, poliomyélitique inactivé (DTCa-HepB-P) doit être inspectée visuellement pour mettre en évidence la présence de toute particule étrangère et/ ou altération de l'aspect physique.
0.3073098063468933 ||| Advisory services relating to the repair of environmental control systems ||| Professional consultancy relating to energy efficiency in buildings ||| Services de conseils liés à la réparation de systèmes de contrôle environnemental
0.09841804206371307 ||| 30 11. ||| 31 10. ||| 32 11.
0.4243736267089844 ||| Thus, many women actually experience a benefit with the bleeding pattern although the lack of predictability may remain a problem for some. ||| 4/ 7 Considering safety, the product seems not to create a considerable risk to young and healthy animals. ||| Bon nombre de femmes trouvent un avantage dans ce profil des saignements, bien que l’ absence de prévisibilité puisse rester un problème pour certaines.
0.30576515197753906 ||| In the treatment population discontinuations of therapy due to any clinical adverse event occurred in 12.8% of 2,557 EVISTA treated patients and 11.1% of 2,576 placebo treated patients. ||| The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlled portion of pivotal studies was 4.5% for patients taking Humira and 4.5% for control treated patients. ||| Dans les essais de traitement, les arrêts thérapeutiques dus à un évènement indésirable ont concerné 12,8% des 2557 patientes traitées par EVISTA et 11,1% des 2576 patientes sous placebo.
0.6604586243629456 ||| This dose should be continued for three weeks. ||| This might be every 6 to 12 months. ||| Cette posologie doit être poursuivie pendant trois semaines.
0.39106518030166626 ||| Closures of metal for containers ||| Deodorizing preparations for carpets ||| Fermetures de récipients métalliques
0.0 ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| 97 Retacrit doit également être utilisé avec prudence en présence d’ épilepsie et d’ insuffisance hépatique chronique.
0.04010094702243805 ||| The total tissue concentration 24 h after dose in epithelial lining fluid, alveolar macrophages, bronchial mucosa, tonsils and sinus tissue were 0.84±0.65 mg/ l, 162±96 mg/ l, 0.78±0.39 mg/ kg, 0.72±0.29 mg/ kg and 1.58±1.68 mg/ kg, respectively. ||| The maximum total tissue concentration in epithelial lining fluid, alveolar macrophages, bronchial mucosa, tonsils and sinus tissue were 14.9±11.4 mg/ l, 318.1±231 mg/ l, 3.88±1.87 mg/ kg, 3.95±0.53 mg/ kg and 6.96±1.58 mg/ kg, respectively. ||| Les concentrations tissulaires totales, 24 h après la prise sont respectivement dans le film épithélial alvéolaire, les macrophages alvéolaires, la muqueuse bronchique, les amygdales, et les sinus de 0,84±0,65 mg/ l, 162±96 mg/ l, 0,78±0,39 mg/ kg, 0,72±0,29 mg/ kg, et 1,58±1,68 mg/ kg.
0.09027223289012909 ||| Do not rub the injection site. ||| Do not massage the injection site. ||| Ne pas frotter le site de l’injection.
0.21013301610946655 ||| Norge sanofi-aventis Norge AS Tlf: +47 67 10 71 00 ||| Danmark sanofi-aventis Denmark A/S Tlf: +45 45 16 70 00 ||| Norge Deutschland sanofi-aventis Norge AS Sanofi-Aventis Deutschland GmbH Tlf: +47 67 10 71 00 Tel: +49 (0)180 2 222010
4.546553563321287e-13 ||| Insulin detemir is distributed more slowly to peripheral target tissues compared to NPH insulin. ||| Insulin detemir is distributed more slowly to peripheral target tissues compared to NPH insulin. ||| L’insuline détémir se distribue plus lentement que l’insuline NPH dans les tissus cibles périphériques.
0.006561162881553173 ||| 4 avoided; guidance for appropriate dose adjustment for when haemoglobin values exceeding 12 g/ dl (7.5 mmol/ l) are observed are described below. ||| 49 avoided; guidance for appropriate dose adjustment for when haemoglobin values exceeding 12 g/ dl (7.5 mmol/ l) are observed are described below. ||| Tout taux d’ hémoglobine durablement supérieur à 12 g/ dl (7,5 mmol/ l) doit être évité; les recommandations de conduite à tenir en cas de taux d’ hémoglobine supérieur à 12 g/ dl (7,5 mmol/ l) sont décrites ci-dessous.
0.3244258761405945 ||| Glazing beads of metal ||| Cable thimbles of metal ||| Parcloses métalliques
0.3742259740829468 ||| Platelet counts and haemoglobin level should also be monitored at regular intervals in cancer patients. ||| Vital signs, serum electrolytes and creatinine concentrations should be monitored continuously. ||| Le taux de plaquettes et le niveau d’ hémoglobine doivent être également surveillés à intervalles réguliers chez les patients atteints de cancer.
0.316225528717041 ||| Audio speakers for automobiles ||| Headlights for automobiles ||| Haut-parleurs pour voitures
0.4861021339893341 ||| Aerators [machines] ||| Condensers [capacitors] ||| Aérateurs [machines]
0.43084609508514404 ||| Aprovel 300 mg film-coated tablets irbesartan ||| Irbesartan Krka 150 mg film-coated tablets Irbesartan ||| Aprovel 300 mg comprimés pelliculés irbésartan
0.3557814955711365 ||| Treatment of all genotypes of the disease should be initiated as early as possible to increase overall survival and avoid complications such as liver failure, liver cancer and renal disease. ||| The incidence of lactic acidosis can and should be reduced by also assessing other associated risk factors such as poorly controlled diabetes, ketosis, ||| Le traitement de tous les génotypes de la maladie doit être instauré dès que possible pour prolonger la survie et éviter les complications telles qu’ une insuffisance hépatique, uncancer du foie ou une maladie rénale.
0.0 ||| CELSENTRI 300 mg twice daily. and ethinylestradiol can be co- administered without dose adjustment. ||| CELSENTRI 300 mg twice daily. and ethinylestradiol can be co- administered without dose adjustment. ||| CELSENTRI 300 mg deux fois par jour et l’ éthinylestradiol peuvent être co-administrés sans adaptation posologique.
0.39786314964294434 ||| Do not use after the expiry date stated on the label. ||| Your doctor will note the expiry date on the pack. ||| 28 jours Ne pas utiliser après la date de péremption mentionnée sur l’ étiquette.
0.3712288737297058 ||| * Human interleukin-1 receptor antagonist (r-metHuIL-1ra) produced in Escherichia coli cells by recombinant DNA technology. ||| 15 Darifenacin is a selective muscarinic M3 receptor antagonist (M3 SRA) in vitro. ||| * Antagoniste du récepteur de l’ interleukine-1 humaine (r-metHuIL-1ra) produit sur des cellules d’ Escherichia coli par la technique de l’ ADN recombinant.
0.23814170062541962 ||| Paroxetine 40 mg ||| Paroxetine CF 20 mg ||| 40 mg
0.32305216789245605 ||| Active substances that may have their plasma concentrations altered by dasatinib Concomitant use of dasatinib and a CYP3A4 substrate may increase exposure to the CYP3A4 substrate. ||| Concomitant use of dasatinib and a CYP3A4 substrate may increase exposure to the CYP3A4 substrate. ||| Substances actives dont les concentrations plasmatiques sont susceptibles d’ être modifiées par dasatinib L'utilisation concomitante du dasatinib et d'un substrat du CYP3A4 peut augmenter l'exposition au substrat du CYP3A4.
0.058239784091711044 ||| Do not use Velmetia after the expiry date which is stated on the blister and the carton. ||| Do not use RILUTEK after the expiry date which is stated on the carton and the blister. ||| Ne pas utiliser Velmetia après la date de péremption mentionnée sur la plaquette thermoformée et la boîte.
0.032080333679914474 ||| For the full list of all side effects reported with Tandemact, see the Package Leaflet. ||| For the full list of all side effects reported with Angiox, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Tandemact, voir la notice.
0.06129423901438713 ||| Sun louvres of glass for buildings ||| Sun louvres of metal for buildings ||| Persiennes en verre pour bâtiments
0.19108416140079498 ||| 2 Those patients switching from 2000 mg or more of prolonged-release nicotinic acid can initiate Pelzont at the 2000 mg/ 40 mg dose. ||| Therefore, patients switching from immediate-release nicotinic acid to Tredaptive should be initiated at the 1000 mg/ 20 mg dose. ||| Chez les patients ayant reçu précédemment 2000 mg ou plus d’ un traitement par l'acide nicotinique à libération prolongée, le traitement par Pelzont peut être instauré à la dose de 2000 mg/ 40 mg.
0.004562654532492161 ||| 33 Pemetrexed was not mutagenic in either the in vitro chromosome aberration test in Chinese hamster ovary cells, or the Ames test. ||| 16 Pemetrexed was not mutagenic in either the in vitro chromosome aberration test in Chinese hamster ovary cells, or the Ames test. ||| Le pemetrexed n'a pas montré de potentiel mutagène que ce soit dans le test d'induction d'aberrations chromosomiques in vitro sur cellules d'ovaire de hamster chinois (CHO) ou dans le test d'Ames.
0.5391162633895874 ||| Escalation and maintenance doses should be adjusted according to clinical response (see section 5.2). ||| The choice of positive control products and the dosing regiment applied were discussed: ||| Les augmentations posologiques et les posologies d’ entretien doivent être ajustées en fonction de la réponse clinique (voir rubrique 5.2).
0.3529563546180725 ||| Mean dominant serum half-life, which is of relevance for the serum concentrations under multiple- dose conditions, is about 5 to 8 hours. ||| Its elimination half-life in humans, at an approximate urinary pH of 6, ranges from 5 to 8 hours. ||| En cas d'administrations répétées, la demi-vie d'élimination est de 5 à 8 heures.
1.0850012294866263e-12 ||| Invented name ||| Invented name ||| Nom inventé
0.2898048162460327 ||| If Seretide therapy has to be withdrawn due to overdose of the beta agonist component of the drug, provision of appropriate replacement steroid therapy should be considered. ||| Trevaclyn is normally given together with a statin (the standard medicine used to reduce cholesterol) when the effectiveness of a statin taken alone is inadequate. ||| Si le traitement par Seretide doit être interrompu en raison d’ une exposition excessive aux bêta-2 mimétiques, il sera remplacé par un corticoïde seul.
0.2179221510887146 ||| In all three studies, the main measure of effectiveness was the proportion of patients who had responded to treatment after six weeks. ||| The main measure of effectiveness was the number of patients who ‘ responded ’ after at least five weeks of treatment. ||| Dans les trois études, la principale mesure d’ efficacité était la proportion des patientes qui avaient répondu au traitement au bout de six semaines.
0.11948063224554062 ||| What benefit has Temodal shown during the studies? ||| What benefit has Exjade shown during the studies? ||| Quel est le bénéfice démontré par Temodal au cours des études?
0.5910261869430542 ||| IV/ SC lp ||| ed IV/ SC ||| IV/ SC en
3.223814444563988e-13 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu /
0.33613646030426025 ||| OPA/ Aluminium/ PVC-Aluminium polyester blisters in cartons of 28, 30, 35, 50, 56 or 70 orodispersible tablets per carton. ||| - PVDC/ PE/ PVC/ AL child-resistant blisters with 10, 20, 100 or 500 tablets packed in cardboard ||| Boîte de 28, 30, 35, 50, 56 ou 70 comprimés orodispersibles.
0.28856006264686584 ||| Kepivance has been studied in 212 patients receiving high-dose cytotoxic therapy for a blood cancer (mostly non-Hodgkin’ s lymphoma). ||| Safety and efficacy of MabThera have not been established in combination with other chemotherapies in diffuse large B cell non- Hodgkin’ s lymphoma. ||| Kepivance a été étudié chez 212 patients atteints d’ un cancer du sang (lymphome non Hodgkinien principalement) et recevant un traitement cytotoxique à haute dose.
0.29088252782821655 ||| Treatment may be resumed once hypertension is appropriately controlled. ||| If renal failure occurs, treatment should be discontinued. ||| Le traitement peut être repris dès que l’ hypertension est correctement contrôlée.
0.4238029718399048 ||| 67 ed is or th au ANNEX III er ng LABELLING AND PACKAGE LEAFLET lo no ct du ro lp a in ic ed M ||| ed is or th au er ANNEX Ing SUMMARY OF PRODUCT CHARACTERISTICS lo no ct du ro lp a in ic ed M ||| 67 é ris to au s u pl ANNEXE III st ÉTIQUETAGE ET NOTICE 'e tn en am ic éd m e C
3.109382597319549e-13 ||| RESPONSES OF PATIENTS WITH PSORIASIS IN STUDIES 2, 3 AND 4 ------------------Study 2--------------- ---------------Study 3------------- ---------------Study 4------------- ||| RESPONSES OF PATIENTS WITH PSORIASIS IN STUDIES 2, 3 AND 4 ------------------Study 2--------------- ---------------Study 3------------- ---------------Study 4------------- ||| REPONSES DES PATIENTS ATTEINTS DE PSORIASIS DANS LES ETUDES 2,3 ET 4
0.03687439113855362 ||| We are working in close contact and cooperation with Poland, as with all Member States, to ensure that national support measures can be put in place as quickly and effectively as possible, in line with EU rules." ||| We are working in close contact and cooperation with Poland, as we continue working with all Member States to ensure that national support measures can be put in place as quickly and effectively as possible, in line with EU rules." ||| Nous travaillons en étroite coopération avec la Pologne, ainsi qu'avec l'ensemble des États membres, pour faire en sorte que des mesures nationales de soutien puissent être mises en place aussi rapidement et efficacement que possible, dans le respect des règles de l'UE.»
0.4357369542121887 ||| Reprographic instruments ||| Typographic presses ||| Instruments de reprographie
0.0 ||| 8. ||| 8. ||| 14 8.
0.2628209590911865 ||| The proton pump inhibitors, omeprazole, lansoprazole and pantoprazole are all mainly metabolized by the cytochrome P450 isoform CYP2C19. ||| Atorvastatin is metabolized by cytochrome P450 3A4 to ortho- and parahydroxylated derivatives and various beta-oxidation products. ||| Les inhibiteurs de pompe à protons, l’ omeprazole, le lansoprazole et le pantoprazole sont tous en majeure partie métabolisés par le cytochrome P450 isoforme CYP2C19.
0.0 ||| Non-steroidal anti-inflammatory drugs: when angiotensin II antagonists are administered simultaneously with non-steroidal anti- inflammatory drugs (i. e. selective COX-2 inhibitors, acetylsalicylic acid (> 3 g/ day) and non-selective NSAIDs), attenuation of the antihypertensive effect may occur. ||| Non-steroidal anti-inflammatory drugs: when angiotensin II antagonists are administered simultaneously with non-steroidal anti- inflammatory drugs (i. e. selective COX-2 inhibitors, acetylsalicylic acid (> 3 g/ day) and non-selective NSAIDs), attenuation of the antihypertensive effect may occur. ||| 65 Anti-inflammatoires non stéroïdiens: lorsque les antagonistes de l'angiotensine II sont administrés simultanément avec des anti-inflammatoires non stéroïdiens (c'est à dire les inhibiteurs sélectifs de la cyclo-oxygénase de type 2 (COX-2), l'acide acétylsalicylique (> 3 g/ jour) et les anti-inflammatoires non stéroïdiens non sélectifs), une atténuation de l'effet anti-hypertenseur peut se produire.
0.2062622457742691 ||| 59 (13.4%) ||| 144 (26.5%) ||| 81 (18.4%)
0.06098993867635727 ||| 250-500 mg every 24 h ||| 200-400 mg every 24 h ||| 250-500 mg toutes les 24 h
0.3663524389266968 ||| Common effects: vomiting, mouth ulceration, swallowing difficult. ||| - stomach ache, dry mouth, increased saliva, being sick (vomiting), ||| Effets fréquents: vomissements, ulcération buccale, troubles de la déglutition.
0.021296804770827293 ||| It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with the product. ||| It is therefore recommended that no other vaccines should be administered concurrently within 14 days before or after vaccination with the product. ||| Il est par conséquent recommandé de ne pas administrer d’ autre vaccin pendant les 14 jours qui précèdent et qui suivent la vaccination.
0.018957408145070076 ||| Octreotide/ laneotide may both decrease and increase insulin requirement. no ||| Octreotide/ laneotide may both decrease and increase insulin requirement. t ||| L’ octréotide/ le lanréotide peuvent réduire ou accroître les besoins en insuline. mé
0.6248955726623535 ||| Mouth ulceration, constipation, Vomiting ||| Vomiting and constipation Not known: ||| Ulcération buccale, constipation, vomissement
0.05853549391031265 ||| The full EPAR for Zometa is available here. ||| The full EPAR for Stalevo is available here. ||| L’ EPAR complet relatif à Zometa est disponible ici.
0.0 ||| MM/ YYYY ||| MM/ YYYY ||| MM/AAAA
6.870096939254333e-13 ||| 10. ||| 10. ||| 7.
0.653379499912262 ||| President David Sassoli opens the extraordinary April plenary session in Brussels.© European Parliament ||| At the opening of the session, European Parliament President David Sassoli said: ||| Le Président David Sassoli ouvre la session plénière extraordinaire d'avril à Bruxelles.
0.6817978024482727 ||| Flebogammadif is supplied as 0.5 g/ 10 ml, 2.5 g/ 50 ml, 5 g/ 100 ml, 10 g/ 200 ml and 20 g/ 400 ml vials. ||| ProStrakan Ltd submitted applications for Rapinyl and associated names, 50µg, 100µg, 200µg, 300µg, 400µg, 600µg, 800µg, sublingual tablets. ||| Flebogammadif est fourni en flacons de 0,5 g/ 10 ml, 2,5 g/ 50 ml, 5 g/ 100 ml, 10 g/ 200 ml et 20 g/ 400 ml.
0.4628894329071045 ||| In addition, a prevention indication for HCTZ alone, based on the LIFE data is not considered approvable. ||| The clinical relevance of this increase is unknown therefore, PREZISTA should be used with caution. ||| En outre, une indication de prévention pour l’ hydrochlorothiazide seul, basée sur les données de l’ étude LIFE, n’ est pas considérée comme acceptable.
0.23804882168769836 ||| Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn. ||| From reproductive toxicity studies performed with other somatropin products there is no evidence of an increased risk of adverse reactions for the embryo or foetus. ||| Les données sur un grand nombre de grossesses exposées n'indiquent pas d'effet indésirable de l'insuline lispro sur la grossesse ou sur la santé du fœ tus/ nouveau-né.
0.42861056327819824 ||| Business consultancy services relating to the marketing of fund raising campaigns ||| Banking services relating to the acceptance of fixed interval installment payments ||| Services de conseil aux entreprises en matière de marketing de campagnes de collecte de fonds
0.06584513932466507 ||| 116 1. ||| 113 1. ||| 122 1.
0.0 ||| Leukapheresis should not be performed in donors who are anticoagulated or who have known defects in haemostasis. ||| Leukapheresis should not be performed in donors who are anticoagulated or who have known defects in haemostasis. ||| La cytaphérèse ne doit pas être effectuée chez les donneurs sous traitement anticoagulant ou reconnus comme présentant des anomalies de l'hémostase.
0.38170212507247925 ||| It is supplied in cartons containing a white polyethylene bottle, with a child resistant cap. ||| The Administration syringes made of polypropylene with a stainless steel pre-fixed needle are also provided. ||| Elle est présentée dans une boîte contenant un flacon en polyéthylène blanc, avec fermeture de sécurité.
0.06929659843444824 ||| 54/ 61 ||| 52/ 61 ||| 58/ 65
0.25450223684310913 ||| If you stop taking ADENURIC Do not stop taking ADENURIC without the advice of your doctor even if you feel better. ||| If you stop taking XERISTAR Do not stop taking your capsules without the advice of your doctor even if you feel better. ||| Si vous arrêtez de prendre ADENURIC N’ arrêtez pas de prendre ADENURIC sans l'avis de votre médecin, même si vous vous sentez mieux.
0.023912634700536728 ||| After an initial 10 mg daily dose, a reduction of the daily dose to 7.5 mg may be considered, based on pharmacokinetic modelling (see section 4.2). no ||| After an initial 10 mg daily dose, a reduction of the daily dose to 7.5 mg may be considered, based on pharmacokinetic modelling (see section 4.2). ||| Après une posologie initiale de 10 mg une fois par jour, une diminution de la posologie quotidienne à 7,5 mg peut être envisagée sur la base e
0.05831192433834076 ||| WHAT MIRCERA IS AND WHAT IT IS USED FOR ||| WHAT HEPSERA IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE MIRCERA ET DANS QUEL CAS EST-IL UTILISE
0.0742311030626297 ||| Preclinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeated dose toxicity, toxicity to reproduction or genotoxicity. ||| Non-clinical data with insulin aspart reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction. ||| Les données précliniques issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, toxicité sur les fonctions de reproduction ou génotoxicité, n’ont pas révélé de risque particulier pour l’homme.
0.6090230941772461 ||| 1 ||| 0 ||| 1 6
0.0 ||| Read the package leaflet before use. ||| Read the package leaflet before use. ||| Lire la notice avant emploi.
0.2807723879814148 ||| If during treatment, patients deteriorate in any of the organ system functions described above, appropriate measures should be taken and discontinuation of parecoxib sodium therapy should be considered. ||| Patients must be observed carefully for symptoms and signs of bleeding during treatment particularly if bivalirudin is combined with another anticoagulant (see section 4.5). ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une quelconque détérioration fonctionnelle d’ un des organes sus mentionnés au cours du traitement.
0.31205832958221436 ||| Do not allow treated animals to bathe in water courses until at least two hours after treatment administration. ||| Dogs should not be allowed to swim in surface waters for 4 days after treatment. ||| Empêcher l'animal de se baigner dans tous les endroits où il peut y avoir de l'eau dans les 2 heures suivant l'administration du médicament.
0.3561827540397644 ||| After the Commission Decision, the Member State competent authorities will update Annex III as required. ||| After the CD, the Member State competent authorities will update the product information as required. ||| Après la décision de la Commission, cette Annexe III fera, si nécessaire, l’ objet de mises à jour par les autorités compétentes de l’ état-membre.
0.08214212954044342 ||| Mugs, not of precious metal ||| Cups, not of precious metal ||| Mugs non en métaux précieux
0.4348719120025635 ||| Politician Igor Nikulin made rounds on Russian television and news media, arguing that Wuhan was chosen for the attack because the presence of a BSL-4 virus lab provided a cover story for the Pentagon and CIA about a Chinese bio-experiment leak. ||| On 19 March, Eduardo Bolsonaro, son of President Jair Bolsonaro, set off a diplomatic dispute with China, Brazil's largest trading partner, when he retweeted a message blaming the Chinese Communist Party for the virus. ||| Le politicien Igor Nikulin a fait le tour des plateaux de télévision et des médias russes, arguant que Wuhan avait été choisi pour l'attaque car la présence d'un laboratoire pathogène de classe 4 fournissait au Pentagone et la CIA un prétexte pour dire qu'il s'agissait d'une fuite d'une expérience biologique chinoise.
0.192779541015625 ||| The blood level of this medicine can be increased or reduced. • caffeine (used as a stimulant), pentoxifylline (used to treat circulatory disorders in the limbs) and mexiletine (used to treat irregular heart beat). ||| It should be used with caution if the patient is taking other medicines, including warfarin (a medicine used to thin the blood), ketoconazole (to treat fungal infections), antibiotics (erythromycin, clarithromycin) or St. ||| Le taux de ce médicament dans le sang peut augmenter ou diminuer. • caféine (utilisée comme stimulant), pentoxifylline (pour le traitement des troubles de la circulation dans les membres inférieurs) et mexilétine (pour le traitement de l’ arythmie).
0.3055807948112488 ||| Sodium nitrate ||| Calcium nitrate ||| Nitrate de sodium
0.604693591594696 ||| Elimination of fondaparinux decreases with weight. ||| INTELENCE is expected to increase nelfinavir plasma concentrations. ||| L’ élimination du fondaparinux décroît avec la diminution du poids.
0.2641761302947998 ||| Gait disturbance ||| Gait disturbance* ||| Douleur thoracique
0.19201703369617462 ||| METHOD OF ADMINISTRATION a ||| METHOD OF ADMINISTRATION ct ||| MODE D’ ADMINISTRATION am
0.5458269715309143 ||| The mean systemic clearance of lamivudine is approximately 0.32 l/ h/ kg, with predominantly renal clearance (> 70%) via ||| The total body clearance is 5.04 ± 2.5 l/ h, independent of dose, and unaffected by gender, age, race, and body weight. ||| La clairance systémique moyenne de la lamivudine est d’ environ 0,32 l/ h/ kg, avec une élimination essentiellement rénale (> 70%) par le système de transport cationique.
0.04464900493621826 ||| For the full list of all side effects reported with AZILECT, see the Package Leaflet. ||| For the full list of all side effects reported with ZOSTAVAX, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous AZILECT, veuillez vous reporter à la notice.
0.19271749258041382 ||| If the 60-minute infusion is well tolerated, all subsequent infusions may be administered over 30-minutes. ||| If the first infusion is well tolerated, the second infusion may be administered over 60 minutes. ||| Si la perfusion administrée en 60 minutes est bien tolérée, toutes les perfusions ultérieures pourront être administrées en 30 minutes.
0.005115085281431675 ||| Each buccal tablet contains 100 micrograms fentanyl (as citrate). ||| Each buccal tablet contains 400 micrograms fentanyl (as citrate). ||| Chaque comprimé contient 100 microgrammes de fentanyl (sous forme de citrate).
0.8004733324050903 ||| Action is needed on several levels. ||| It also covers technical assistance. ||| Il convient d'agir à plusieurs niveaux.
0.31351238489151 ||| Gaskets for industrial use ||| Gas mixers for laboratory use ||| Joints à usage industriel
0.4698306620121002 ||| -1- ||| -A ||| 1
0.12687507271766663 ||| EMEND 125 mg hard capsule EMEND 80 mg hard capsules Aprepitant ||| EMEND 125 mg hard capsules EMEND 80 mg hard capsules aprepitant ||| EMEND 125 mg gélule EMEND 80 mg gélules Aprépitant
0.4338563084602356 ||| If no photosensitivity reaction (erythema, oedema, blistering) occurs within 24 hours, the patient can gradually resume normal outdoor activities, initially continuing to exercise caution and gradually allowing increased exposure. ||| ADARTREL can cause excessive daytime somnolence (excessive drowsiness) and very rarely sudden sleep onset episodes where patients fall asleep suddenly without apparently feeling sleepy. ||| Si aucune réaction de photosensibilité (érythème, œ dème, formation de cloques) ne se produit dans les 24 heures, le patient peut progressivement reprendre ses activités extérieures normales, en continuant à prendre des précautions au départ puis en augmentant progressivement l’ exposition.
0.3854658603668213 ||| The 2.5 mg strength is also used to treat patients with unstable angina (a type of chest pain that changes in severity) or who are having a myocardial infarction (heart attack): • without ‘ ST segment elevation’ (an abnormal reading on the electrocardiogram or ECG) in patients who are not going to undergo urgent angioplasty (within two hours): angioplasty or ‘ percutaneous coronary intervention ’ (PCI) is an operation to unblock the heart ’ s blood vessels, • with ‘ ST segment elevation’ in patients who are receiving thrombolytic medicines (‘ clot busters’) or who are not about to receive any other treatment to restore blood flow to the heart. ||| The following inclusion criteria were considered for the treatment: patients older than 50 years of age, presence of CNV secondary to AMD, presence of classic lesion components in the CNV (defined as a well-demarcated area of the fluorescence on angiography), CNV located subfoveally (involved the geometric centre of the foveal avascular zone), area of classic plus occult CNV ≥ 50% of the total lesion surface, greatest linear dimension of the entire lesion ≤ 9 Macular Photocoagulation Study (MPS) disc area, and a best-corrected visual acuity between 34 and 73 letters (i. e. approximately 20/ 40 and 20/ 200) in the treated eye. ||| Le dosage à 2,5 mg est également utilisé pour traiter les patients qui souffrent d'angine instable (un type de douleur thoracique dont la sévérité varie) ou ayant un infarctus du myocarde (attaque cardiaque): • sans "élévation du segment ST" (séquence anormale sur l'électrocardiogramme ou ECG) chez les patients qui ne vont pas subir une angioplastie urgente (dans les deux heures): l'angioplastie, ou "intervention coronarienne transcutanée" est une opération destinée à désobstruer les vaisseaux sanguins du cœ ur, • avec "élévation du segment ST" chez les patients auxquels sont administrés des thrombolytiques (‘ dissolveurs de caillots’) ou qui ne sont pas sur le point de recevoir un quelconque autre traitement visant à rétablir le flux sanguin vers le cœ ur.
0.21918073296546936 ||| Providing temporary use of online, non-downloadable computer software for language translation ||| Providing temporary use of on-line non-downloadable software for the transmission of data ||| Mise à disposition temporaire en ligne de logiciels non téléchargeables pour la traduction de langues
0.09200428426265717 ||| 4/ 64 6.2 Incompatibilities ||| 3/ 17 6.2 Incompatibilities ||| 6.2 Incompatibilités
0.12016630917787552 ||| The recommended dose of Adenuric is 80 mg once a day. ||| The maximum dose of Ranexa is 750 mg twice a day. ||| La dose recommandée d’ Adenuric est de 80 mg une fois par jour.
0.46973732113838196 ||| 58 The orodispersible tablets may be used as an alternative to ABILIFY tablets for patients who have difficulty to swallow ABILIFY tablets (see also section 5.2). ||| After the first dose of Suboxone, it is possible that you may have some opiate withdrawal symptoms, see section 4 ‘ POSSIBLE SIDE EFFECTS’. ||| 63 Les comprimés orodispersibles peuvent être utilisés comme une alternative aux comprimés chez les patients ayant des difficultés à avaler les comprimés d'ABILIFY (cf rubrique 5.2).
0.0 ||| Cmax occurred three to 12 hours after the lower dose and six to no ||| Cmax occurred three to 12 hours after the lower dose and six to no ||| La Cmax a été observée trois à 12 heures après administration de
0.8399140238761902 ||| - poor kidney function ||| - severe nausea ||| - altération de la fonction rénale
0.1462964415550232 ||| - The active substance is lansoprazol. ||| - The active substance is riluzole. ||| La substance active est:
0.41574618220329285 ||| Health authorities will continue to operate manual contact tracing, especially for elderly and disabled persons. ||| Some school districts may offer alternative child care options, prioritising the children of first responders and healthcare workers. ||| Les autorités sanitaires poursuivront le traçage manuel des contacts, en ce qui concerne en particulier les personnes âgées et les personnes handicapées.
0.5276100635528564 ||| Production of musical recordings ||| Artistic management of musical shows ||| Production d'enregistrements musicaux
0.27658402919769287 ||| 12 In the placebo-controlled phase, Extavia delayed the progression from the first clinical event to clinically definite multiple sclerosis (CDMS) in a statistically significant and clinically meaningful manner, corresponding to a risk reduction of 47% (Hazard Ratio = 0.53, 95% confidence interval (0.39, 0.73), p < 0.0001). ||| 25 3 In a retrospective analysis of data from 42 pooled short-term clinical studies, the overall incidence of events typically associated with cardiac ischaemia was higher for rosiglitazone containing regimens, 1.99% versus combined active and placebo comparators, 1.51% [Hazard ratio 1.31 (95% confidence interval 1.01 - 1.70)]. ||| Lors de la phase versus placebo, Extavia a permis de retarder, de façon statistiquement significative et cliniquement confirmée, l’ évolution vers une sclérose en plaques cliniquement définie; ceci correspond à une réduction du risque de 47% (rapport de risques instantanés = 0,53, intervalle de confiance 95% (0,39, 0,73), p < 0,0001).
0.5174124240875244 ||| Several frameworks for building contact tracing apps have been developed. ||| Remote working measures were instituted in several Chinese regions. ||| Plusieurs infrastructures ont été mises au point pour la conception d’applications de traçage des contacts.
0.06396569311618805 ||| As with all other angiotensin II receptor antagonists, telmisartan may be less effective in lowering the blood pressure in black patients. ||| As with all other angiotensin II receptor antagonists, Pritor may be less effective in lowering the blood pressure in black patients. ||| Comme tous les antagonistes des récepteurs de l’ angiotensine II, le telmisartan peut moins efficacement réduire la pression artérielle chez les patients de race noire.
0.3192107677459717 ||| The metabolism in horses has not been investigated. ||| The use of LITAK in children has not been investigated. ||| Le métabolisme chez les chevaux n’ a pas été étudié.
0.27445757389068604 ||| In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. ||| In children whose mother took nucleoside and nucleotide analogues during pregnancy, the benefit from the reduced chance of being infected with HIV is greater than the risk of suffering from side effects. ||| Chez la femme enceinte, tout surdosage en calcium et en vitamine D doit être évité car l’hypercalcémie permanente a été associée à des effets négatifs sur le développement du fœtus.
0.4255790710449219 ||| Additives (Chemical -) for plasticizing concrete ||| Wires (Electric -) of metal alloys ||| Additifs chimiques pour plastifiant pour béton
0.4040411114692688 ||| Fluorescence-guided resection in these patients has been found to impose a higher risk of critical neurological deficits. ||| It should be noted however, that pregnancy itself also carries an increased risk of thrombo-embolic events. ||| On a rapporté que la résection chirurgicale guidée par fluorescence chez ces patients comporte un risque supérieur de déficits neurologiques graves.
0.0 ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| AUTRE(S) MISE(S) EN GARDE SPECIALE (S), SI NECESSAIRE
0.3406464457511902 ||| Before using Avonex, doctors need to exclude other causes for the symptoms. ||| Before using Doribax, doctors should consider official guidance on the use of antibiotics. ||| Avant d’ utiliser Avonex, le médecin doit écarter toute autre cause possible des symptômes.
0.38149064779281616 ||| 183 SUSTIVA 600 mg film-coated tablets are also supplied in packs containing 30 x 1 or 90 (3 x 30 x 1) tablets in aluminium/PVC perforated unit dose blisters. ||| • A kit containing 90 x 1 PVC/ Aluminium perforated unit dose blisters (3 pouches), 1 insulin inhaler, 1 spare chamber and 6 spare Insulin Release Units (IRU) uc ||| Les comprimés pelliculés SUSTIVA 600 mg sont également présentés en boîtes contenant 30 x 1 ou 90 (3 x 30 x 1) comprimés sous plaquettes thermoformées d'aluminium/ PVC pour délivrance à l'unité.
0.07348844408988953 ||| Use in children and adolescents under 18 years of age ARICLAIM should normally not be used for children and adolescents under 18 years. ||| Use in children and adolescents under 18 years of age YENTREVE should not be used for children and adolescents under the age of 18 years. ||| Utilisation chez l’ enfant et l’ adolescent de moins de 18 ans ARICLAIM ne doit habituellement pas être utilisé chez les enfants et adolescents de moins de 18 ans.
0.4910528063774109 ||| As of early April 2020, 103 candidate therapeutics were in preclinical or a stage of Phase I-IV development, with trial results for 29 drug candidates expected during April. ||| In Italy on 17 March 2020, Takis Biotech, an Italian biotech company announced they will have pre-clinical testing results in April 2020 and their final vaccine candidate could begin human testing by fall. ||| Début avril 2020, 103 candidats thérapeutiques étaient en développement préclinique ou en cours d’étude de phases I-IV, les résultats d’essais concernant 29 candidats médicaments étant attendus dans le courant du mois d’avril.
3.961234552180004e-13 ||| Pure Red Cell Aplasia caused by anti-erythropoietin antibodies has been reported in association with ESAs. ||| Pure Red Cell Aplasia caused by anti-erythropoietin antibodies has been reported in association with ESAs. ||| 112 Des cas d'érythroblastopénie dus à des anticorps anti-érythropoïétine ont été rapportés lors de traitement par des ASE.
0.3042517304420471 ||| Shelf-life after first opening the immediate packaging: ||| Shelf-life after first opening the immediate packaging: - Use immediately ||| 2 ans Durée de conservation après première ouverture du conditionnement primaire:
0.019349388778209686 ||| Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Animal studies do not indicate direct harmful effects with respect to pregnancy, embryonal / foetal development, parturition or postnatal development (see section 5.3). ||| Les études chez l’ animal n’ ont pas montré d’ effets délétères directs ou indirects sur la gestation, le développement embryonnaire ou fœ tal, la parturition ou le développement post-natal (voir rubrique 5.3).
0.5190094709396362 ||| Privigen must not be used ||| Levemir must not be used ||| N’utilisez jamais Privigen
0.4007771909236908 ||| Safe use during pregnancy has not been established. ||| The effect on human pregnancy is not known. ||| Il n’ est pas démontré que son emploi soit sûr pendant la grossesse.
0.6437494158744812 ||| Bullous eruption ||| Wound complication ||| Eruption bulleuse
0.4579811990261078 ||| Certain severe adverse reactions may be related to the rate of infusion. ||| The observed undesirable effects were generally of a mild severity. ||| Certains effets indésirables graves peuvent être liés au débit de la perfusion.
1.0404887199401855 ||| Garlic puree ||| mg PO none ||| Purée d'ail
0.39188623428344727 ||| Allow the pre-filled syringe to reach room temperature before injecting. ||| Read all instructions thoroughly before using the pre-filled syringe. ||| Amener la seringue à température ambiante avant l’ injection.
0.3052876591682434 ||| Therefore, the risk/benefit of the combined use of Rebetol and interferon alfa-2b should be assessed in young children prior to the initiation of therapy. ||| Portugal requested that a full assessment of the risk-benefit of cerivastatin be carried out because of concerns regarding a possible increased risk of rhabdomyolysis. ||| Ainsi, le rapport bénéfice/ risque de l’ utilisation combinée de Rebetol et d’ interféron alfa-2b chez les jeunes enfants doit être évalué avant l’ initiation du traitement.
0.5118739604949951 ||| MRCVS, studied for MSc at the Veterinary School of the University of Edinburgh. ||| VAS was first recognized at the University of Pennsylvania School of Veterinary Medicine in 1991. ||| MRCVS, il a suivi une maîtrise en sciences à la faculté vétérinaire de l’université d’Edimbourg.
0.23985335230827332 ||| Subcutaneous route Following subcutaneous injection, serum levels of erythropoietin are much lower than the levels achieved following intravenous injection, the levels increase slowly and reach a peak between 12 and 18 hours postdose. ||| Absorption Following oral administration of lisinopril, peak serum concentrations occur within about 7 hours, although there was a trend to a small delay in time taken to reach peak serum concentrations in acute myocardial infarction patients. ||| 118 Voie sous-cutanée Après injection sous-cutanée, les taux sériques d'érythropoïétine sont largement inférieurs aux taux obtenus après injection intraveineuse; les taux augmentent lentement pour atteindre leur valeur maximale entre 12 et 18 heures après administration.
0.2350841462612152 ||| Co-administration of potent CYP3A4 inhibitors (e. g. ketoconazole, itraconazole, ritonavir) with sildenafil for pulmonary arterial hypertension is contraindicated (see section 4.3). ||| Pioglitazone should be used with caution during concomitant administration of cytochrome P450 2C8 inhibitors (e. g. gemfibrozil) or inducers (e. g. rifampicin). ||| L’ administration concomitante d’ inhibiteurs puissants du CYP3A4 (par ex. kétoconazole, itraconazole, ritonavir) avec du sildénafil pour le traitement d’ une hypertension artérielle pulmonaire est contre-indiquée (voir rubrique 4.3).
0.0 ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| AUTRE(S) MISE EN GARDE(S) SPECIALE(S), SI NECESSAIRE
0.26723939180374146 ||| Patients treated with RoActemra should be given the Patient Alert Card. ||| Patients treated with Trudexa should be given the special alert card. ||| La Carte de Surveillance du Patient devra être remise aux patients traités par RoActemra.
4.966572942841085e-13 ||| ge ||| ge ||| tor B.
0.511642336845398 ||| Caution must be exercised when prescribing to elderly patients. ||| Patients should be advised not to swallow the desiccant. ||| La prescription de Kuvan chez les personnes âgées doit être effectuée avec précaution.
0.08293579518795013 ||| The most commonly reported reactions are listed in section 4.8. ||| The most commonly 38 reported reactions are listed in section 4.8. ||| Les réactions les plus fréquemment rapportées sont listées en rubrique 4.8.
1.07047438621521 ||| Dry mouth ||| when yellow ||| Sécheresse buccale
0.4263257682323456 ||| Reactions at an individual injection site usually last for equal to or less than 7 days. ||| It is recommended to strip fish after injection at intervals of approximately 50-100 degree days. ||| Les réactions à un site d'injection donné durent en général au plus 7 jours.
0.5954589247703552 ||| Rain gauges ||| Reference gauges ||| Pluviomètres
0.2850106954574585 ||| 50 pre-filled syringes 50 x 1 dose (0.5 ml) ||| 3 ml (3.5 mg/ ml) 5 pre-filled pens ||| 50 seringues préremplies 50 x 1 dose (0,5 ml)
0.3305947184562683 ||| Mains monitoring apparatus (Electric -) ||| Mains testers (Electric -) ||| Appareils de contrôle pour réseaux électriques
0.39075618982315063 ||| Anti-shock pads [parts of machines] ||| Anti-corrosive coatings [paints] ||| Patins antichoc [pièces de machines]
0.46385037899017334 ||| Repair of facsimile machines ||| Lubrication grease for vehicles ||| Réparation de télécopieurs
0.3775244951248169 ||| It is recommended that Rapamune be taken consistently either with or without food. ||| STOCRIN is recommended to be taken on an empty stomach preferably at bedtime. ||| Il est recommandé de prendre Rapamune soit toujours avec, soit toujours sans nourriture.
0.0 ||| NAME OF THE MEDICINAL PRODUCT ||| NAME OF THE MEDICINAL PRODUCT ||| DÉNOMINATION DU MÉDICAMENT N
0.08846808969974518 ||| What benefit has Xolair shown during the studies? ||| What benefit has Yondelis shown during the studies? ||| Quels ont été les avantages de Xolair au cours de ces études?
0.36152684688568115 ||| Careful monitoring of glucose control is essential. ||| Close blood glucose monitoring is therefore recommended. ||| Une surveillance soigneuse de l'équilibre glycémique est indispensable.
0.32740962505340576 ||| Azarga is an eye drop suspension that contains two active substances, brinzolamide and timolol. ||| Vildagliptin, a member of the islet enhancer class, is a potent and selective DPP-4 inhibitor. ||| Azarga est un collyre en suspension contenant deux principes actifs, le brinzolamide et le timolol.
0.38164108991622925 ||| Remove the white end cap by pulling straight up. ||| Hold your pen with the needle pointing straight up. ||| Oter le capuchon blanc en tirant vers le haut.
0.2809489369392395 ||| Symptoms may not be seen for 6 weeks to 6 months after infection. ||| Symptoms may not be present for up to 24 hours after ingestion. ||| Les symptômes peuvent apparaître entre 6 semaines à 6 mois après l’ infection.
0.548919141292572 ||| The first step, electronic management of product information throughout the product life cycle will become operational. ||| One example is the design and implementation of the new information technology platform which was successfully completed without interruption ||| La première étape, en l’occurrence la gestion électronique des informations sur les produits pendant toute la durée du cycle de vie du produit, deviendra opérationnelle.
4.635429410107528e-13 ||| 2.5 mg / 12.5mg 5 mg/ 25mg ||| 2.5 mg / 12.5mg 5 mg/ 25mg ||| Dosage 2.5 mg / 12.5mg 5 mg/ 25mg
0.3824423551559448 ||| After this, the patient’ s vision should be checked every month and another injection given if the vision has become worse. ||| Once an effective dose has been established during titration, patients should continue to take this dose as a single tablet of that given strength. ||| Après quoi, la vision du patient doit être contrôlée chaque mois et une autre injection doit être administrée si la vision s’ est détériorée.
0.4634580612182617 ||| Therefore the Commission proposes to use a range of instruments to support investment and reforms in the Member States, focusing on where the crisis impact and resilience needs are greatest: ||| The Recovery and Resilience Facility will be accessible toall Member States but support will be concentrated on the parts of the Union most affected and where resilience needs are the greatest. ||| La Commission propose par conséquent de recourir à un ensemble d'instruments pour soutenir les investissements et les réformes dans les États membres, en mettant l'accent là où les répercussions de la crise se font le plus sentir et où les besoins en termes de résilience sont les plus pressants:
0.48395097255706787 ||| Push syringes for medical use ||| Ligating clip applicators for medical use ||| Pousses-seringues à usage médical
0.6820474863052368 ||| or • plan to get pregnant. ||| • think you may be pregnant; or ||| s u • envisagez d’être enceinte.
0.30348044633865356 ||| You may tend to get side effects most frequently when you start taking your medicine or increase to a higher dose. ||| The side effects are generally mild and may become less after you have taken the medicine for a short time. ||| Il se peut que vous constatiez des effets indésirables, plus fréquemment en début de traitement ou à l’ occasion d’ une augmentation de la dose.
4.507231718929583e-13 ||| Finally, the CPMP considered that all presentations may be useful to treat the patients in the approved indications. ||| Finally, the CPMP considered that all presentations may be useful to treat the patients in the approved indications. ||| Enfin, le CPMP a considéré que toutes les présentations pouvaient être utiles pour le traitement des patients dans les indications autorisées.
0.029043007642030716 ||| 282 4.4 Special warnings and precautions for use ||| 293 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.449049711227417 ||| - if you are taking ciclosporin (a medicine used in transplantation to prevent organ rejection or for ||| - if you have been treated with a medicine of the type called anthracyclines (frequently used in ||| - si vous prenez de la ciclosporine (un médicament utilisé en cas de greffe d’ organe pour prévenir
0.15692830085754395 ||| Provision of entertainment services through the media of audio tapes ||| Provision of entertainment services through the media of video-films ||| Services de divertissement par le biais de bandes audio
0.41624292731285095 ||| A desiccant unit containing black activated carbon and silica gel granules is included in the bottle. ||| The silica gel desiccant is contained in a separate sachet and should not be swallowed. ||| Le flacon contient également un agent dessiccant composé de charbon noir activé et de granules de gel de silice.
0.31058573722839355 ||| Ventavis is used to treat moderate cases of primary pulmonary hypertension (PPH). ||| Volibris is used to treat pulmonary arterial hypertension (PAH). ||| Ventavis est indiqué pour le traitement de l’ hypertension artérielle pulmonaire primitive (HPP) modérée.
0.3084149956703186 ||| 27 Hypersensitivity reactions against ceftriaxone are more likely in patients with any other type of hypersensitivity reaction or asthma bronchiale. ||| Hypoglycaemia Patients receiving AVANDAMET in combination with a sulphonylurea or insulin may be at risk for dose-related hypoglycaemia. ||| 26 Les réactions d’ hypersensibilité vis-à-vis de la ceftriaxone sont plus probables chez les patients ayant d’autres types de réactions d’hypersensibilité ou un asthme.
0.45279330015182495 ||| When these stools were tested for the presence of live vaccine strain, only 17% were positive. ||| In the Netherlands, about 3% may have antibodies, as assessed from blood donors. ||| Quand la présence de souche vaccinale vivante a été recherchée dans les selles, seules 17% des selles étaient positives.
0.21844187378883362 ||| There is no evidence that enfuviritide may alter the patient’ s ability to drive and use machines, however, the adverse event profile of enfuvirtide should be taken into account. ||| There is no evidence that INTELENCE may alter the patient’ s ability to drive and operate machines, however, the adverse drug reaction profile should be taken into account. ||| Il n’ y a pas de preuve que l’ enfuvirtide puisse altérer la capacité à conduire les véhicules ou à utiliser des machines, toutefois il convient de tenir compte du profil d'effets indésirables du produit.
0.2814512848854065 ||| In the 14-week toxicity study etoricoxib caused gastrointestinal ulcers at exposures greater than those seen in man at the therapeutic dose. ||| An additional 476 patients received ertapenem as a single 1 g dose prior to surgery in a clinical study for the prophylaxis of surgical site infections following colorectal surgery. ||| Dans une étude de toxicité de 14 semaines, l’ étoricoxib a provoqué des ulcères gastro-intestinaux pour des expositions supérieures à celles observées chez l’ homme à la dose thérapeutique.
5.11864639216042e-13 ||| Latvija GlaxoSmithKline Latvia SIA Tel: +371-67312687 ||| Latvija GlaxoSmithKline Latvia SIA Tel: +371-67312687 ||| 65 Latvija GlaxoSmithKline Latvia SIA Tel: +371-67312687
0.4405440390110016 ||| Similar effects were observed in sedated pigs. ||| Studies in pregnant mares were also performed. ||| Des effets similaires sont apparus chez le porc sous traitement sédatif.
0.34429827332496643 ||| 21 For treatment of overdose (accidental ingestion) in the opioid-naive person, intravenous access should be obtained and naloxone or other opioid antagonists should be employed as clinically indicated. ||| It can be used in patients undergoing haemodialysis (using a blood filtration machine) or peritoneal dialysis (where fluid is pumped into the abdomen and an internal body membrane filters the blood). ||| Le traitement du surdosage chez une personne qui n'a jamais reçu de traitement morphinique (ingestion accidentelle), nécessite de mettre en place une voie d'abord veineuse et administrer de la naloxone ou un autre antagoniste des morphiniques, selon l'état clinique.
0.32798635959625244 ||| In whole human blood in vitro, the protein binding of manganese is approximately 27% but binding of fodipir to protein is negligible. ||| The volume of distribution of dabigtran of 60 – 70 L exceeded the volume of total body water indicating moderate tissue distribution of dabigatran. ||| In vitro, dans le sang humain total, la fixation du manganèse aux protéines est approximativement de 27% tandis que la fixation du fodipir aux protéines est négligeable.
0.3752293288707733 ||| It is recommended that cats living in, or travelling to, areas endemic for heartworm are treated monthly with the product to protect them from heartworm disease. ||| Clomicalm is used as an aid in the treatment of dogs that have behavioural problems when separated from their owners, their normal home, or other dogs. ||| Il est recommandé que les chats vivants ou voyageant dans des zones endémiques pour la Dirofilariose soient traités tous les mois afin de les protéger contre la Dirofilariose.
0.1683294177055359 ||| Efficib is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. ||| Efficib is also indicated in combination with a sulphonylurea (i. e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea. ||| • chez les patients insuffisamment contrôlés par la metformine seule à la dose maximale tolérée ou chez les patients déjà traités par l’ association sitagliptine/ metformine.
0.2561491131782532 ||| Very Common: side effects which may occur in more than 1 of 10 patients. ||| Very common side effects These are likely to affect more than 1 in 10 patients: ||| Très fréquents: effets indésirables pouvant apparaître chez plus d’ 1 patient sur 10.
0.2923614978790283 ||| Other side effects seen in rare cases were dysgeusia (taste disturbances), nausea, reactions at the injection site, pyrexia (fever), allergic or anaphylactic (severe allergic) reactions, abnormal blood pressure, dizziness, pruritus (itching) and rash. ||| General disorders and administration site conditions Very common: pain and redness at the injection site, fatigue Common: swelling at the injection site, injection site reactions (such as haematoma, pruritus and bruising), malaise Uncommon: fever (≥ 37.5°C) Rare: influenza like illness, chills ||| D'autres effets indésirables ont été observés dans de rares cas, comme la dysgeusie (troubles du goût), les nausées, des réactions au lieu d'injection, la pyrexie (fièvre), des réactions allergiques ou anaphylactiques (allergie aiguë), une tension sanguine anormale, des vertiges, le prurit (démangeaisons) et des éruptions cutanées.
0.46638086438179016 ||| These patients should not be rechallenged with nimesulide. ||| In these patients VIRAMUNE must not be restarted. ||| Pour ces patients, l’ administration de nimésulide sera à proscrire.
0.41586488485336304 ||| Commissioner Breton acknowledged that tourism was the first sector hit by the coronavirus and it is likely to be the slowest to recover from the crisis. ||| In fact, the only way to end the dramatic situation the world is facing since the outbreak of the COVID-19 pandemic would be a safe and effective vaccine. ||| Le commissaire Breton a reconnu que le tourisme avait été le premier secteur touché par la crise liée au coronavirus et qu'il serait probablement celui qui mettrait le plus de temps à s'en remettre.
0.32918015122413635 ||| The safety and efficacy of aripiprazole solution for injection has not been evaluated in patients with alcohol or medicinal product intoxication (either with prescribed or illicit medicinal products). ||| as monotherapy – in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance ||| La tolérance et l'efficacité de l'aripiprazole solution injectable n'ont pas été étudiées chez les patients alcoolodépendants ou pharmacodépendants (que ce soient des médicaments prescrits ou illicites).
2.4219217126600356e-13 ||| Progression free survival (PFS) and overall response rate were similar between treatment arms: median PFS was 4.8 months for ALIMTA plus cisplatin versus 5.1 months for gemcitabine plus cisplatin (adjusted hazard ratio 1.04; 95% CI 0.94-1.15), and overall response rate was 30.6% (95% CI 27.3- 33.9) for ALIMTA plus cisplatin versus 28.2% (95% CI 25.0-31.4) for gemcitabine plus cisplatin. ||| Progression free survival (PFS) and overall response rate were similar between treatment arms: median PFS was 4.8 months for ALIMTA plus cisplatin versus 5.1 months for gemcitabine plus cisplatin (adjusted hazard ratio 1.04; 95% CI 0.94-1.15), and overall response rate was 30.6% (95% CI 27.3- 33.9) for ALIMTA plus cisplatin versus 28.2% (95% CI 25.0-31.4) for gemcitabine plus cisplatin. ||| La survie sans progression (SSP) et le taux de réponse globale étaient similaires entre les bras de traitement: la médiane de la SSP était de 4,8 mois pour ALIMTA plus cisplatine versus 5,1 mois pour gemcitabine plus cisplatine (risque relatif ajusté 1,04; 95% IC 0,94 - 1,15), et le taux de réponse globale était de 30,6% (95% IC 27.3 - 33.9) pour ALIMTA plus cisplatine versus 28,2% (95% IC 25.0 - 31.4) pour gemcitabine plus ciplatine.
8.572449390967241e-13 ||| Store in the original package ||| Store in the original package ||| Conserver dans l’ emballage d’ origine
0.2922389507293701 ||| 19 ||| 18 ||| 140
0.5272365212440491 ||| ↑ 2.4 fold ||| ↑ 4-fold ||| Amprénavir x 2,4
0.47780168056488037 ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. eu. int/ ||| ge Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu. lon no ct du ro lp ina dic Me ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. eu. int/
0.3423941433429718 ||| The scheme will be open to micro companies (excluding self-employed workers) and small and medium-sized enterprises (SMEs) facing economic difficulties and liquidity shortages due to the coronavirus outbreak. ||| Together with the other Italian scheme to support self-employed workers, SMEs and mid-caps affected in the context of the coronavirus outbreak, the scheme will help companies cover their immediate working capital and investment needs in these difficult times. ||| Le régime sera ouvert aux microentreprises (à l'exception des travailleurs indépendants) ainsi qu'aux petites et moyennes entreprises (PME) confrontées à des difficultés économiques et à des pénuries de liquidités dues à la pandémie.
0.0 ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LISTE REPRENANT LES NOMS, LA FORME PHARMACEUTIQUE, LES DOSAGES DES MÉDICAMENTS, LA VOIE D'ADMINISTRATION, LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.44442668557167053 ||| In the four placebo-controlled studies the hazard ratios for overall survival ranged between 1.25 and 2.47 in favour of controls. ||| One randomised controlled trial and epidemiological studies found a two- to threefold higher risk for users compared with non-users. ||| Dans les quatre études contrôlées versus placebo, le risque relatif pour la survie globale était compris entre 1,25 et 2,47 en faveur du groupe contrôle.
0.514148473739624 ||| Of the 36 subjects, 12 (33%) had a history of hypoglycaemia prior to beginning treatment. ||| Of those who did not tolerate other treatments, 70% responded to Cancidas (7 out of 10). ||| Parmi ces 36 patients, 12 (33%) avaient des antécédents d’ hypoglycémie antérieurs au traitement.
0.5220515727996826 ||| Overall, serum levels in paediatric patients with Crohn's disease (53 patients aged 6 to 17 years old; 8 patients aged 6 to 10 years old) were similar to those in adult Crohn's disease patients. ||| 10 mg film-coated tablets in approximately 4000 adult patients 15 years of age and older 5 mg chewable tablets in approximately 1750 paediatric patients 6 to 14 years of age, and 4 mg chewable tablets in 851 paediatric patients 2 to 5 years of age. ||| Dans l’ ensemble, les taux sériques chez les enfants atteints de maladie de Crohn (53 patients âgés de 6 à 17 ans; 8 patients âgés de 6 à 10 ans) étaient similaires à ceux des adultes atteints de maladie de Crohn.
0.40382087230682373 ||| (d) Hold the pen with needle pointing up and tap the clear cartridge holder gently with your finger so any air bubbles collect near the top. ||| Mixing is best done by gently tilting the cartridge or pen (with the cartridge in it) back and forth at least 10 times. ||| (d) Tenir le stylo verticalement, l'aiguille dirigée vers le haut, et donner de petites tapes sur le côté du stylo pour que toutes les bulles présentes remontent à la surface.
0.3067706227302551 ||| The in vitro results showed that CYP3A4 was the major human P450 enzyme catalysing the biotransformation of imatinib. ||| Ketoprofen has been shown to inhibit the intravenously injected E. coli endotoxin induced tromboxane B2 production in the bovine. ||| Les tests in vitro montrent que le CYP3A4 est le principal enzyme du cytochrome P450 humain catalysant la biotransformation de l’ imatinib.
0.23551416397094727 ||| Before you use Preotact 3. ||| Before you use Erbitux 3. ||| Quelles sont les informations à connaître avant d'utiliser Preotact 3.
0.044408105313777924 ||| Lactation It is not known whether aliskiren is excreted in human milk. ||| Lactation It is not known whether losartan is excreted in human milk. ||| Chez l’ homme, on ignore si l’ aliskiren est excrété dans le lait maternel.
0.7446776628494263 ||| Carcinoid tumour: ||| Cellulose acetate ||| Tumeur carcinoïde:
0.8155514001846313 ||| Natural stone ||| Garden lighting ||| Pierre naturelle
0.1281362771987915 ||| The recommended dose of Copalia is one tablet per day. ||| The recommended dose of Exforge is one tablet per day. ||| La dose recommandée de Copalia est d'un comprimé par jour.
0.2230304330587387 ||| When stopping treatment with YENTREVE the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8). ||| In order to improve the tolerability of nervous system undesirable effects, bedtime dosing is recommended during the first two to four weeks of therapy and in patients who continue to experience these symptoms (see section 4.8). ||| Lors de l’ arrêt du traitement par YENTREVE, la dose doit être progressivement diminuée sur une durée d’ au moins une à deux semaines, afin de limiter le risque de réactions de sevrage (voir rubriques 4.4 et 4.8).
0.3479370176792145 ||| Yellow-orange gelatin capsules imprinted in red with “ 0.5 mg” on the light yellow capsule cap and “ 647” on the orange capsule body, containing white powder. ||| Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “ EXELON 1,5 mg ” on body. ||| Gélules de gélatine jaune - orange portant les inscriptions rouges “ 0.5 mg” sur la coiffe jaune clair de la gélule et “ 647” sur le corps orange de la gélule, contenant une poudre blanche.
0.3606211543083191 ||| Other less common adverse events (between 1 and 10 patients out of 100 treated) reported in association with interferon beta include diarrhoea, loss of appetite, vomiting, sleeping difficulty, dizziness, nervousness, itching, rash, nettle-rash, hair loss, dilatation of the blood vessels and palpitation, irregularities and/or changes in menstrual flow and serious reactions of the skin and mucous membranes. ||| Reported bleeding events include: anaemia or drop in the haemoglobin value without obvious source of bleeding, bruising, bleeding from puncture sites, nose bleeding, blood in urine, gastrointestinal bleeding, vaginal bleeding, rectal bleeding, pulmonary haemorrhage, bleeding into chest space and around the heart following surgery, bleeding into the brain. ||| D’autres effets indésirables moins fréquents (de 1 à 10 pour cent des patients traités), associés à l’interféron bêta, ont été rapportés: diarrhée, perte d’appétit, vomissement, hépatite, trouble du sommeil, vertige, nervosité, démangeaisons, éruption cutanée, urticaire, chute de cheveux, dilatation des vaisseaux sanguins et palpitations, règles anormalement abondantes et qui se prolongent au delà de leur durée habituelle, saignements abondants en dehors des règles et réactions sévères de la peau et des muqueuses.
0.003821125254034996 ||| 163 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 158 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 183 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.39047473669052124 ||| Fellow of the Institute of Chartered Accountants in Ireland. ||| Elected Fellow of the Royal College of Physicians in 1995. ||| Associé de l’ Institut des experts comptables d’ Irlande.
0.5355761647224426 ||| - In the population not using low-dose aspirin, the incidence of POBs was 14/ 6950 patients ||| A small number (total of 98) of Caucasian patients were treated with telbivudine. ||| - Dans la population ne prenant pas d’ aspirine à faible dose, l’ incidence des POH a été de 14 cas
0.02094108611345291 ||| - the Summaries of Products Characteristic, labelling and package leaflet proposed by the Marketing ||| - The Summaries of Products Characteristic, labelling and package leaflet proposed by the Marketing ||| - les résumés des caractéristiques du produit, l’ étiquetage et la notice proposés par les titulaires
0.564236044883728 ||| The Agency will progress its work on IP telephony, web-streaming, video-streaming and other audiovisual-meetings systems, to support the Agency’ s objectives in the area of meetings- management. ||| The operational and technical aspects of the Agency’ s work are set out in chapter 2 on human medicines, chapter 3 on veterinary medicines and finally chapter 4 looking at technical co- ordination activities. ||| L’ Agence fera avancer ses travaux dans les domaines de la téléphonie IP (protocole Internet), des retransmissions sur Internet, des transmissions vidéo et d’ autres systèmes de téléréunions audiovisuelles pour atteindre plus facilement ses objectifs dans le domaine de la gestion des réunions.
0.06322382390499115 ||| Do not use Rebetol after the expiry date which is stated on the label. ||| Do not use Optimark after the expiry date which is stated on the label. ||| Ne pas utiliser Rebetol après la date de péremption mentionnée sur l’ étiquette.
0.040486838668584824 ||| Insuman Comb 25 100 IU/ ml ||| Insuman Comb 15 40 IU/ ml ||| Insuman Comb 25 100 UI/ ml
0.15288150310516357 ||| After reconstitution with 20 ml of sodium chloride 9 mg/ ml (0.9%) solution for injection, each vial contains 25 mg/ ml of pemetrexed. ||| After reconstitution with 7.2 ml water for injections, each vial of Fabrazyme contains 5 mg/ ml (35 mg/ 7 ml) of agalsidase beta. ||| Après reconstitution avec 20 ml de chlorure de sodium à 9 mg/ ml (0,9%) pour préparations injectables, chaque flacon contient 25 mg/ ml de pemetrexed.
0.07207240164279938 ||| What benefit has Kaletra shown during the studies? ||| What benefit has Reconcile shown during the studies? ||| Quel est le bénéfice démontré par Kaletra au cours des études?
0.28441911935806274 ||| a) Ciba-Geigy b) CH ||| (a) Ciba-Geigy (b) F ||| b) desirudin
0.8223426342010498 ||| Write your doctor ’ s details below: ||| please tell your baby ’ s doctor. ||| Veuillez indiquer ci-dessous les coordonnées de votre médecin:
0.3396504521369934 ||| The coronavirus outbreak has given rise to a general supply shock resulting from the disruption of supply chains and a demand surge caused mainly by a steep rise in demand for certain products and services, notably in the health sector. ||| Consumer prices are expected to fall significantly this year due to the drop in demand and the steep fall in oil prices, which together should more than offset isolated price increases caused by pandemic-related supply disruptions. ||| La pandémie de coronavirus a provoqué un choc général sur l'offre résultant de la perturbation des chaînes d'approvisionnement et d'une augmentation de la demande due principalement à une forte hausse de la demande de certains produits et services, en particulier dans le secteur de la santé.
0.0 ||| Psychiatric disorders ||| Psychiatric disorders ||| dépression, nervosité
0.42349541187286377 ||| The 3 ml cartridges are sealed in a disposable pen injector. ||| The Hib component is a white powder presented in a glass vial. ||| Les cartouches de 3 ml sont scellées dans un stylo injecteur jetable.
0.5145201086997986 ||| The product label includes the correct storage conditions and the expiry date for the batch. ||| The full 80 doses and 24 hours of use are still available after the functionality test. ||| Les conditions de conservation correctes et la date de péremption du lot sont indiquées sur l’étiquette.
0.4030851721763611 ||| one hand, pick up the open ampoule, insert the needle and draw up all of the solvent. ||| Unscrew the needle all the way by giving the large needle cover 3 to 5 complete turns. ||| Avec la seringue dans une main, saisissez l’ ampoule de solvant que vous aurez ouverte, introduisez -y l’ aiguille et aspirez tout le solvant contenu dans l’ ampoule.
0.38888630270957947 ||| Method of administration Faslodex should be administered by slow intramuscular injection into the buttock. ||| Following topical application of tacrolimus ointment, tacrolimus is selectively delivered to the skin ||| Mode d’ administration Faslodex doit être administré par injection intramusculaire lente dans le muscle fessier.
0.37558144330978394 ||| Hiring of furniture for conferences ||| Installation of stands for exhibitions ||| Location de mobilier pour conférence
0.547726571559906 ||| Coffee grinders ||| Audio expanders ||| Moulins à café
0.21451105177402496 ||| 17 May 2005 ||| 9 June 2005 ||| 17 mai 2005
0.3301633596420288 ||| 5 ml ||| 3 ml ||| 5 ml voie intramusculaire
0.23714812099933624 ||| Other information about ReFacto AF: ||| Other information about OptiMARK: ||| Autres informations relatives à ReFacto AF:
0.34083908796310425 ||| For women taking Thalidomide Celgene Before starting the treatment, you should ask your doctor if you are able to become pregnant, even if you think this is unlikely. ||| If more Bridion is given to you than recommended As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Bridion. ||| Avant de débuter le traitement, vous devez vérifier avec votre médecin si vous êtes susceptible de devenir enceinte, même si cela vous semble improbable.
3.409871126777708e-13 ||| In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2. ||| In patients with chronic renal failure, maintenance haemoglobin concentration should not exceed the upper limit of the target haemoglobin concentration recommended in section 4.2. ||| Chez les patients en insuffisance rénale chronique, le taux d’ hémoglobine à la dose d’ entretien ne doit pas dépasser la limite supérieure du taux d’ hémoglobine cible recommandée dans la rubrique 4.2.
0.5017224550247192 ||| If this happens to you, do not drive or operate any tools or machines until your vision improves. ||| If possible, patients should use less frequent applications, or the lower strength as their condition improves. ||| Dans ce cas, ne conduisez pas et n’ utilisez pas certains outils ou machines jusqu’ à ce que votre vision se soit améliorée.
0.09351770579814911 ||| ProMeris Duo 799.5 mg + 799.5 mg Spot-on for large dogs {25.1 – 40.0 kg} ||| ProMeris Duo 999 mg + 999 mg Spot-on for extra large dogs {40.1 – 50.0 kg} ||| ProMeris Duo 799,5 mg + 799,5 mg Spot -on pour chiens de grande taille {25,1 – 40,0 kg}
0.010440483689308167 ||| The MAH must ensure that the system of pharmacovigilance, as described in version 2 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| The MAH must ensure that the system of pharmacovigilance, as described in Version 1.1 presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market. ||| Le titulaire de l’ Autorisation de Mise sur le Marché (AMM) doit s’ assurer que le système de pharmacovigilance, tel que décrit dans la version 2 présentée dans le Module 1.8.1. de la demande d’ AMM, soit mis en place et fonctionnel avant et pendant la commercialisation du produit.
0.545019268989563 ||| Intelence has been given ‘ Conditional Approval’. ||| This medicine has been given “ conditional approval”. ||| Une « autorisation conditionnelle » a été délivrée pour Intelence.
0.5111287832260132 ||| No specific information is available on the treatment of overdose with Irbesartan Winthrop. ||| Although no data are available on the immune response to the Bacille-Calmette- rod ||| Aucune information spécifique n’ est disponible sur le traitement en cas de surdosage par l'irbésartan.
0.32903265953063965 ||| Based on data collected from secondary contacts in households where there was an index case with typical pertussis, the protective efficacy of the vaccine was 88.7%. ||| Based on a limited number of patients, interindividual variability calculated as the coefficient of variation (CV%), was estimated to be approximately 30% for the main pharmacokinetic parameters. ||| D’ après les données recueillies à partir de sujets exposés dans l'entourage d'un cas index de coqueluche typique, l'efficacité protectrice du vaccin a été de 88,7%.
0.20902051031589508 ||| When necessary Humalog can be given soon after meals. ||| When necessary NovoRapid can be given soon after a meal. ||| Quand cela est nécessaire, Humalog peut être administré juste après les repas.
0.020741788670420647 ||| If a patient receiving Trudexa shows prolonged/ atypical symptoms/ signs of infections or general deterioration, prevalent opportunistic conditions must be considered. ||| If a patient receiving Trudexa shows prolonged/ atypical symptoms/ signs of infections or general deterioration, prevalent opportunistic conditions must be considered. no ||| ou de détérioration générale, des conditions d'infection opportuniste prévalente doivent être envisagées.
0.0 ||| Κύπρος Boehringer Ingelheim Ellas A. E. ||| Κύπρος Boehringer Ingelheim Ellas A. E. ||| Κύπρος Boehringer Ingelheim Ellas A.E.
0.40251636505126953 ||| Efficacy has not been studied in other models of neuropathic pain. ||| There are no studies concerning interactions with agents influencing hepatic metabolism. ||| L’efficacité n’a pas été étudiée dans d’autres modèles de douleur neuropathique.
0.18917638063430786 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Zerit to BRISTOL-MYERS SQUIBB PHARMA EEIG on 8 May 1996. ||| The European Commission granted a marketing authorisation valid throughout the EU for HBVAXPRO to SANOFI PASTEUR MSD SNC on 27 April 2001. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l'Union européenne pour Zerit à BRISTOL-MYERS SQUIBB PHARMA EEIG, le 8 mai 1996.
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 179 4.8 Effets indésirables
0.32699382305145264 ||| Women should be advised to use effective means of contraception to avoid becoming pregnant during therapy with Paxene and to inform the treating physician immediately should this occur. ||| If not established on effective contraception, the patient must be referred to an appropriately trained health care professional for contraceptive advice in order that contraception can be initiated. ||| Les femmes sous traitement par Paxene doivent utiliser des moyens de contraception efficaces afin d’ éviter toute grossesse pendant la durée du traitement et doivent informer immédiatement leur médecin traitant si cela se produit.
0.3034997582435608 ||| Do not use Helixate NexGen 500 IU if you are allergic (hypersensitive) to octocog alfa, to mouse or hamster protein or to any of the other ingredients of Helixate NexGen 500 IU. ||| Irbesartan Hydrochlorothiazide Winthrop should not be used in people who may be hypersensitive (allergic) to irbesartan, hydrochlorothiazide, sulfonamides, or any of the other ingredients. ||| N'utilisez jamais Helixate NexGen 500 UI si vous êtes allergique (hypersensible) à l’ octocog alfa, aux protéines de hamster ou de souris ou tout autre constituant d'Helixate NexGen 500 UI.
1.0108123105895261e-12 ||| Convulsion ||| Convulsion ||| Vomissements, Nausées
0.36593541502952576 ||| In the patient stratum with baseline calculated GFR > 40 mL/ min, renal function was not improved overall. ||| In a clinical study in PID patients, the maximum infusion rate was 7.2 ml/kg bw/hr. ||| Dans le groupe de patients ayant un TFG calculé > 40 ml/ min, la fonction rénale n’ a généralement pas été améliorée.
0.42354005575180054 ||| Elderly (≥ 65 years) An increase in Cmax (26%) and AUC (29%) was observed in elderly subjects (24 subjects ≥ 65 years of age) relative to younger subjects (24 subjects 18 - 45 years of age). ||| At the 20mg dose, elderly (≥ 65 years old) patients had higher frequencies of headaches (16.2% versus 11.8%) and dizziness (3.7% versus 0.7%) than younger patients (< 65 years old). ||| Personnes âgées (≥ 65 ans) Une augmentation de la Cmax (26%) et de l’ ASC (29%) a été observée chez les sujets âgés (24 sujets ≥ 65 ans) par rapport aux sujets plus jeunes (24 sujets âgés de 18 à 45 ans).
0.2635240852832794 ||| What NovoMix 30 looks like and contents of the pack The suspension for injection comes as a white suspension in packs of 5 or 10 cartridges of 3 ml (not all packs may be marketed). ||| au The suspension for injection comes as a white, cloudy suspension in packs of 1 or 5 vials of 10 ml (not all packs may be marketed). ||| 82 Qu’ est ce que NovoMix 30 et contenu de l’ emballage extérieur La suspension injectable est une suspension blanche présentée en boîtes de 5 ou 10 cartouches de 3 ml (toutes les boîtes peuvent ne pas être commercialisées).
0.24223381280899048 ||| Biliary hyperplasia was observed in cynomolgus monkeys given efavirenz for ≥ 1 year at a dose resulting in mean AUC values approximately 2-fold greater than those in humans given the recommended dose. ||| Dasatinib was considered to be non-phototoxic in vivo after a single oral administration to female hairless mice at exposures up to 3-fold the human exposure following administration of the recommended therapeutic dose (based on AUC). ||| Une hyperplasie biliaire a été observée chez des singes cynomolgus ayant reçu, sur des périodes ≥ à un an, une dose d’ éfavirenz conduisant à des valeurs moyennes d’ ASC environ 2 fois supérieures à celles observées chez l’ homme ayant reçu la dose recommandée.
0.22130148112773895 ||| If you notice any symptoms such as loss of appetite, jaundice (yellowing of the skin), dark urine, itching, or tenderness of the stomach, Ciprofloxacin Bayer must be stopped immediately. ||| If you experience clinical symptoms suggesting an injury of the liver, such as loss of appetite, feeling sick (nausea), vomiting, yellow skin (jaundice), abdominal pain you should inform your doctor. ||| Si vous remarquez le moindre symptôme de type perte d’appétit, ictère (jaunisse), urines foncées, démangeaisons ou sensibilité de l’estomac à la palpation, le traitement par Ciprofloxacine Bayer doit être arrêté; informez alors immédiatement votre médecin.
0.24100032448768616 ||| The starting dose may be adjusted by your doctor depending on how your anaemia responds to treatment; you will usually receive Retacrit until 1 month after the end of chemotherapy. ||| As nausea and vomiting may occur in the days following your chemotherapy, it is important that you take EMEND for 2 consecutive days as prescribed by your doctor. ||| La dose d’attaque peut être ajustée par votre médecin selon la manière dont votre anémie réagit au traitement; vous recevrez généralement Retacrit jusqu’à 1 mois après la fin de la chimiothérapie.
0.44518211483955383 ||| Peak plasma concentrations are reached, using recommended doses, within 6-12 hours. ||| A treatment cycle should not exceed 7 consecutive doses (6.5 months). ||| Avec les doses recommandées, les pics plasmatiques sont atteints dans les 6 à 12 heures.
0.46071505546569824 ||| Acute HP is characterized by poorly formed noncaseating interstitial granulomas and mononuclear cell infiltration in a peribronchial distribution with prominent giant cells. ||| Bilateral multilobar ground-glass opacities with a peripheral, asymmetric and posterior distribution are common in early infection. ||| La PHS aiguë se caractérise par la formation de granulomes non-caséeux et une infiltration interstitielle de cellules mononucléaires à distribution péribronchique avec une prédominance de cellules géantes.
0.2728949189186096 ||| OUTER CARTON - BOTTLE OF 180 TABLETS 800 mg ||| OUTER CARTON AND BOTTLE LABEL (180 TABLETS) ||| EMBALLAGE EXTERIEUR - FLACON DE 180 COMPRIMES 800 mg
0.30661657452583313 ||| Due to the unknown risks to the foetus associated with the potential development of neutralizing antibodies to OP-1 protein, Osigraft should not be used during pregnancy unless the potential benefit justifies the potential risks to the foetus (see section 4.4 & section 5.3). ||| Thus, contraindicating the use of nifedipine in women of childbearing potential, which amounts to contraindicating it from the beginning of the first trimester of pregnancy, should result in a loss of chance in this target population since nifedipine cannot be considered as a teratogenic product. ||| En raison des risques inconnus associés à l’ éventuel développement d’ une neutralisation des anticorps de la protéine OP-1 chez le fœ tus, Osigraft ne doit pas être utilisé pendant la grossesse à moins que le bénéfice potentiel ne justifie les risques potentiels pour le fœ tus (voir section 4.4 et section 5.3).
0.39714163541793823 ||| The duration of the treatment should not exceed 48 hours. ||| The recommended dose and treatment time must not be exceeded. ||| La durée du traitement ne doit pas dépasser 48 heures.
0.3404753804206848 ||| 710 C. ||| 307 d. ||| C.
0.05462225526571274 ||| 7 Skin and subcutaneous tissue disorders ||| Skin and subcutaneous tissue disorders 6 ||| Affections de la peau et du tissu sous-cutané
0.15109941363334656 ||| 10/ 125 EU/ 2/ 97/ 004/ 005 100 ml EU/ 2/ 97/ 004/ 029 180 ml ||| EU/ 2/ 97/ 004/ 006 10ml EU/ 2/ 97/ 004/ 011 20ml ||| 10/ 129 EU/ 2/ 97/ 004/ 004 32 ml EU/ 2/ 97/ 004/ 005 100 ml EU/ 2/ 97/ 004/ 029 180 ml
0.39593079686164856 ||| This may cause severe allergic reactions in patients sensitive to latex. ||| Some breast development or acne may occur due to treatment with hCG. ||| Cela peut provoquer des réactions allergiques graves chez les patients sensibles au latex.
0.3062411844730377 ||| 132 Predictability of sustained virological response – Naïve patients Virological reponse by week 12, defined as a 2-log viral load decrease or undetectable levels of HCV- RNA has been shown to be predictive for sustained response (Table 8). ||| 6 In a specific sexual dysfunction comparative study with remitted depressed patients, there was a numerical trend (not statistically significant) towards less sexual emergent dysfunction than venlafaxine for Sex Effects Scale (SEXFX) drive arousal or orgasm scores on Valdoxan. ||| Pronostic de réponse virologique prolongée – Patients naïfs La réponse virologique à la 12ème semaine, définie par une diminution de 2 log de la charge virale ou un niveau indétectable d’ ARN-VHC s’ est avérée être un facteur prédictif de réponse prolongée (Tableau 8).
0.0 ||| 50 mg ||| 50 mg ||| Dosage 50 mg
0.07563866674900055 ||| Do not put Insuman Rapid next to the freezer compartment or a freezer pack. ||| Do not put Apidra next to the freezer compartment or a freezer pack. ||| Ne pas mettre Insuman Rapid à côté du compartiment congélateur ou d’ une poche de congélation.
0.21917596459388733 ||| Similarly administration of fosamprenavir with ritonavir may modify the pharmacokinetics of other active substances that share this metabolic pathway. ||| Similarly, amprenavir might also modify the pharmacokinetics of other medicinal products that share this metabolic pathway. ||| De la même façon, l’ administration de fosamprénavir avec le ritonavir peut également modifier les paramètres pharmacocinétiques d’ autres substances actives qui suivent cette même voie métabolique.
0.2413851022720337 ||| Evoltra is used to treat children with acute lymphoblastic leukaemia (ALL), which is a cancer of the lymphocytes (a type of white blood cell). ||| Vistide is used to treat cytomegalovirus (CMV) retinitis, a viral infection of the retina (the light- sensitive surface at the back of the eye). ||| Evoltra est utilisé pour le traitement des enfants souffrant de leucémie aiguë lymphoblastique (LAL,) un cancer des lymphocytes (un type de globules blancs).
0.09969936311244965 ||| Allogeneic bone marrow transplantation ||| Allogeneic bone marrow transplantation. ||| Allogreffe de moelle osseuse
0.31251463294029236 ||| The present results of Raptiva versus placebo over 12 weeks of treatment with different populations indicate a PASI 75 response to Raptiva in 22% to 39% of patients (see Table 2). ||| In this group, over 3 years of treatment, OSSEOR reduced the risk of hip fracture by 36% relative to the placebo group (table 2). ||| Les résultats disponibles sur 12 semaines de traitement dans différentes populations indiquent un taux de réponse PASI 75 de Raptiva versus placebo chez 22% à 39% des patients (voir tableau 2).
0.6336231231689453 ||| These side effects are common or very common, that is they may affect from 1 to more than 10 in every 100 patients: • Rapid weight gain. ||| 1) you get a skin rash OR 2) you get one or more symptoms from at least TWO of the following groups ||| Ces effets indésirables sont fréquents ou très fréquents, c'est-à-dire qu’ ils peuvent concerner un à dix patients sur 100: • Prise rapide de poids.
0.5315614342689514 ||| Blending machines for chemical processing ||| Printing and bookbinding machines ||| Machines de mélange pour traitements chimiques
0.4648088812828064 ||| If a package is opened or damaged, do not use this medical device. ||| DO NOT USE your Pen if any part appears broken or damaged. ||| Si la boîte est ouverte ou endommagée, n’ utiliser pas son contenu.
0.28610172867774963 ||| (see sections 4.2 and 4.3) the potential risks and benefits of anagrelide therapy in a patient with impairment of renal function should be assessed before treatment is commenced. ||| The expected benefit of treatment should be weighed against the safety findings observed for paediatric subjects in the clinical trials (see sections 4.4, 4.8 and 5.1). i dic ||| (cf rubriques 4.2 et 4.3) Les risques et bénéfices potentiels du traitement par anagrélide chez un patient insuffisant rénal doivent être évalués avant d’ entamer le traitement.
0.019140981137752533 ||| Read the package leaflet before use. rod ||| Read the package leaflet before use. ro ||| Lire la notice avant utilisation. dic
0.2952278256416321 ||| Raloxifene is metabolised primarily in the liver. ||| Riluzole is eliminated mainly in the urine. ||| Le raloxifène est principalement métabolisé par le foie.
0.34236958622932434 ||| TAXOTERE was originally authorised under ‘ Exceptional Circumstances’, because, for scientific reasons, limited information was available at the time of approval. ||| Zevalin was originally authorised under ‘ Exceptional Circumstances ’ because it had not been possible to obtain complete information about Zevalin. ||| TAXOTERE a été autorisé initialement dans des « circonstances exceptionnelles » dans la mesure où, pour des raisons scientifiques, les informations disponibles étaient limitées au moment de l'approbation.
0.3860173225402832 ||| The MAH must agree the details of a controlled distribution system with the National Competent Authorities and must implement such programme nationally to ensure that, prior to prescribing, all doctors who intend to prescribe Thelin are provided with a physician information pack containing the following: • Product information • Physician information about Thelin ||| The Marketing Authorisation Holder (MAH) shall ensure, at launch, all physicians who are expected to prescribe/ use Lucentis are provided with a physician information pack containing the following: • Physician information • Intravitreal injection procedure video • Intravitreal injection procedure pictogram • Patient information pack ||| Le titulaire de l'autorisation de mise sur le marché doit approuver les détails du système de distribution contrôlée auprès des autorités nationales compétentes et doit mettre en œ uvre ce programme à l'échelle nationale afin de s'assurer qu'avant de prescrire du Thelin, les médecins reçoivent un ensemble d’ informations médicales comprenant les éléments suivants:
0.4874785542488098 ||| Propellers for boats ||| Detergents for automobiles ||| Hélices pour bateaux
0.5458956956863403 ||| The oral clearance of both venlafaxine and ODV was reduced. ||| Total cholesterol, LDL cholesterol and apolipoprotein B were significantly reduced. ||| La clairance aussi bien de la venlafaxine que de l’ ODV est réduite.
0.09799190610647202 ||| If you take less Humalog BASAL than you need, a high blood sugar may occur. ||| If you take less Humalog than you need, a high blood sugar may occur. ||| Si vous arrêtez d’utiliser Humalog BASAL Si vous prenez moins d’Humalog BASAL que vous n’auriez dû, une augmentation du taux de sucre dans le sang peut survenir.
0.0 ||| Solution for injection in a pre-filled syringe. ||| Solution for injection in a pre-filled syringe. ||| to Solution injectable en seringue préremplie.
0.3867870271205902 ||| Olanzapine Mylan 5 mg film-coated tablets Olanzapine ||| Olanzapine Neopharma 10 mg coated tablets olanzapine ||| OLANZAPINE MYLAN 5 mg, comprimés pelliculés Olanzapine
0.0 ||| These three main classes are themselves not homogeneous and may contain several different molecular species of interferon. ||| These three main classes are themselves not homogeneous and may contain several different molecular species of interferon. ||| Ces trois classes principales ne sont pas elles- n'e mêmes homogènes et peuvent regrouper plusieurs espèces moléculaires différentes d'interféron.
0.2833910584449768 ||| Ovarian hyperstimulation syndrome has been observed in approximately 4% of the patients in clinical trials; most of these cases were mild or moderate in nature. ||| Complaints of injection site reactions and skin reactions are reported relatively more frequently in patients of 18 years of age or less than in adult patients. ||| Un syndrome d’ hyperstimulation ovarienne a été observé chez environ 4% des patientes au cours des études cliniques; la plupart de ces cas étaient d’ intensité légère à modérée.
0.16705256700515747 ||| Always use TRAVATAN exactly as your doctor has told you. ||| Always inject SOMAVERT exactly as your doctor has told you. ||| Utilisez toujours TRAVATAN comme indiqué par votre médecin.
0.4877365827560425 ||| Five of these NNRTI-resistant isolates were found to have K103N or a valine-to- isoleucine substitution at position 108 (V108I) in RT. ||| Both arms used an Optimised Background Regimen (OBR) consisting of at least 2 antiretrovirals (NRTIs with or without NNRTIs). ||| Cinq de ces isolats résistants aux INNTI ont présenté la mutation K103N ou la substitution valine à isoleucine au codon 108 (V108I) de la transcriptase inverse.
0.25621291995048523 ||| Use in adults (16 years of age and above) Protopy is available in two strengths, Protopy 0.03% and Protopy 0.1% ointment. ||| Adults (16 years of age and older) Two strengths of Protopic (Protopic 0.03% and Protopic 0.1% ointment) are available for adult patients. ||| Utilisation chez l'adulte (16 ans et plus) Protopy est disponible dans deux dosages, Protopy 0,03% et Protopy 0,1% pommade.
0.03716875612735748 ||| Diabetes is a disease in which the body does not produce enough insulin to control the blood sugar. ||| Diabetes is a disease in which the body does not produce enough insulin to control the level of blood sugar. ||| Le diabète est une maladie caractérisée par le fait que le corps ne produit pas suffisamment d’ insuline pour lui permettre de contrôler la glycémie.
0.018285682424902916 ||| Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription. ||| Utilisation d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou à votre pharmacien.
0.4667035937309265 ||| They are produced and secreted by cells in response to viral infections or various synthetic ||| They are also responsible for infections and isolated from food-producing animals and sometimes isolated from foods. ||| Ils sont produits et sécrétés par les cellules en réponse à des dic
0.6323612332344055 ||| Treatment of major depressive episodes. ||| The importance of the refeeding syndrome. ||| Traitement des épisodes dépressifs majeurs.
0.7100502848625183 ||| Keep LYRICA out of the reach and sight of children. ||| SPECIAL STORAGE PRECAUTIONS 19 Keep out of the reach and sight of children. ||| Tenir LYRIC A hors de la portée et de la vue des enfants.
0.4606989920139313 ||| In children efficacy and safety of Optisulin have only been demonstrated when given in the evening. ||| Click Injection is considered successful whether or not the presence of a wheal is observed. ||| Chez l’ enfant, l’ efficacité et la sécurité n’ ont été démontrées que lorsqu’ Optisulin est administré le soir.
0.3183354437351227 ||| Patients with antiviral resistant HBV infection Available evidence does not support the use of telbivudine monotherapy in patients with established lamivudine-resistant hepatitis B virus infection. ||| Patients with lamivudine-resistant HBV are at higher risk of developing subsequent entecavir resistance than patients without lamivudine resistance. ||| Patients porteurs d’ un VHB résistant aux antiviraux Les données disponibles ne sont pas en faveur d’ un traitement par telbivudine en monothérapie chez des patients porteurs d’ un virus de l’ hépatite B avec une résistance confirmée à la lamivudine.
0.2420167326927185 ||| Heavy jackets ||| Down jackets ||| Grosses vestes
0.15354111790657043 ||| 198 ||| 192 ||| 208
0.44763290882110596 ||| 2 - Use an alcohol swab to clean the skin at the injection site. ||| 1 Check the liquid in the syringe It should be clear and colourless. ||| 98 2 – Utilisez un tampon alcoolisé pour nettoyer la peau à l’endroit choisi pour l’injection.
0.0018199085025116801 ||| Non-clinical data reveal no special hazard to humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| Les données de sécurité non cliniques issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, génotoxicité, cancérogénèse, et des fonctions de reproduction n'ont pas révélé de risque particulier pour l'homme.
0.22115066647529602 ||| Installation of apparatus for heating ||| Installation of drying apparatus ||| Installation d'appareils de chauffage
0.12115291506052017 ||| WHAT CYANOKIT IS AND WHAT IT IS USED FOR ||| WHAT LIPROLOG PEN IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE CYANOKIT ET DANS QUEL CAS EST-IL UTILISE
0.16869232058525085 ||| Docetaxel should be administered with caution in patients concomitantly receiving potent CYP3A4 inhibitors (e. g. protease inhibitors like ritonavir, azole antifungals like ketoconazole or itraconazole). ||| Caution should be exercised when prescribing Valdoxan with moderate CYP1A2 inhibitors (e. g. propranolol, grepafloxacine, enoxacine) which may result in increased exposure of agomelatine. ||| Le docétaxel doit être administré avec prudence chez les patients recevant simultanément des inhibiteurs puissants du CYP3A4 (par exemple, les inhibiteurs de protéase tel que le ritonavir, les antifongiques azolés tels que le kétoconazole ou l’ itraconazole).
0.2914140224456787 ||| After deep muscle relaxation, recovery took an average of around 3.0 minutes with 4 mg/ kg Bridion, compared with around 49.5 minutes for neostigmine. ||| The average length of time for which patients had severe oral mucositis was significantly less with Kepivance (3.7 days) than with placebo (10.4 days). ||| Après une relaxation musculaire profonde, la récupération prenait en moyenne 3,0 minutes environ avec 4 mg/ kg de Bridion, contre environ 49,5 minutes pour la néostigmine.
1.0961089134216309 ||| 1 tablet SIFROL ||| I FUM and SO ||| 2 comprimés de SIFROL
0.055234722793102264 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Kineret on 8 March 2002. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Keppra on 29 September 2000. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Kineret, le 8 mars 2002.
0.4289340376853943 ||| 3 Dosing adjustment for adult patients with impaired renal function ||| • Efficacy in adult patients with pulmonary hypertension ||| 3 Adaptation posologique chez l’ adulte ayant une insuffisance rénale
0.055345192551612854 ||| What Silgard is and what it is used for 2. ||| What Telzir is and what it is used for 2. ||| Qu'est-ce que Silgard et dans quel cas est-il utilisé 2.
0.6415761709213257 ||| Thermoelectric apparatus for heating beverages ||| Beverage preparation machines, electromechanical ||| Appareils thermoélectriques pour chauffer les boissons
0.0989876389503479 ||| 7 Mild hypersensitivity reactions may develop into serious reactions with dyspnoea, fall in blood pressure and sometimes shock. ||| In very rare cases mild hypersensivity reactions may develop into serious reactions with dyspnoea, fall in blood pressure and sometimes shock. ||| 7 Des réactions d'hypersensibilité d’ intensité légère pouvant évoluer vers une réaction grave avec dyspnée, chute tensionnelle et parfois choc.
0.3399560749530792 ||| - No dose adjustment required. ||| No dosage adjustment is necessary. ||| - Aucune adaptation posologique n’ est requise.
0.03241875022649765 ||| Like all medicines, Karvezide can cause side effects, although not everybody gets them. ||| Like all medicines, Valtropin can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Karvezide est susceptible de provoquer des effets indésirables, bien que tout le monde n'y soit pas sujet.
0.9000540971755981 ||| 3 years For blisters: ||| Ducks At one day old: ||| 3 ans Plaquettes thermoformées:
0.371479332447052 ||| An increased incidence of mammary adenocarcinomas and haemangiosarcomas was observed with a no-effect dose of 500 mg/kg (59-fold human exposure) and 100 mg/kg (16-fold human exposure), respectively. ||| Single dose toxicology studies have been conducted in cynomolgus monkeys (maximum dose 30 mg/ kg), rabbits (maximum dose 50 mg/ kg) and rats (maximum dose 840 mg/ kg). ||| Une incidence accrue d’ adénocarcinomes mammaires et d’ hémangiosarcomes a été observée, avec une dose sans effet de 500 mg/ kg (59 fois l’ exposition humaine) et de 100 mg/ kg (16 fois l’ exposition humaine) respectivement.
0.515510082244873 ||| If you use drops in both eyes, repeat the steps for your other eye. ||| For every click you feel when you turn the cap, you set 2 units more. ||| Si vous devez traiter les deux yeux, recommencez ces étapes pour l’ autre œ il.
1.1391200482879782e-12 ||| EXP {MM/ YYYY} ||| EXP {MM/ YYYY} ||| 48 EXP {MM/AAAA}
3.8798844237235286e-13 ||| Difference between the recipient species and human Protein C will inevitably result in an immune response with antibody formation. ||| Difference between the recipient species and human Protein C will inevitably result in an immune response with antibody formation. ||| L‘ administration de protéine C exogène résultera immanquablement au développement d’ anticorps.
0.38260573148727417 ||| Remove the plastic packaging from the vial adapter and discard. ||| Peel off the paper cover on the vial adapter plastic housing. ||| Retirer l’emballage plastique de l’adaptateur et le jeter.
0.0 ||| [See Annex I - To be completed nationally] ||| [See Annex I - To be completed nationally] ||| [Voir Annexe I - A compléter selon le pays]
0.41683024168014526 ||| If you have forgotten to change the patch at your usual time, change it as soon as you remember: remove the old patch and use a new one. ||| If this seal has been punctured or is not visible when you first open the package, DO NOT USE and return the product to your pharmacy. ||| Si vous avez oublié de remplacer le dispositif transdermique à l’ heure habituelle, changez le dès que vous constatez l’ oubli en retirant l’ ancien dispositif transdermique et en en appliquant un nouveau.
0.31669291853904724 ||| Protopic is used for the treatment of moderate to severe atopic dermatitis (eczema, an itchy red rash of the skin- atopic means that is linked to an allergy) in adults who do not respond well or do not tolerate usual treatments. ||| Visudyne is used for two diseases where this occur, the wet form of age-related macular degeneration (AMD) and pathological myopia, a rare type of short-sightedness where the eyeball continues to grow, becoming longer than it should be. ||| Protopic est indiqué pour le traitement de la dermatite atopique modérée à sévère (eczéma, une éruption cutanée rouge qui démange; le terme « atopique » indique un lien avec une allergie) chez les adultes répondant insuffisamment ou ne tolérant pas les traitements classiques.
0.3985035717487335 ||| Benefit/Risk considerations Based on the documentation submitted by the MAH and the scientific discussion within the Committee, the CPMP considered that the benefit/risk ratio of Zestril is favourable for use relating to treatment-resistant schizophrenic patients and psychotic disorders occurring during the course of Parkinson’s disease in cases where standard treatment has failed. ||| The need to update some particular aspects of bioequivalence testing and pharmacokinetic aspects of modified released formulations including transdermal patches has been recognised and a joint ad hoc group of experts of the Efficacy Working Party and Quality Working Party has been convened to deal with these issues under the chairmanship of Professor J. ||| Rapport bénéfice/ris que D’après la documentation fournie par le TAMM et en se fondant sur la discussion scientifique tenue au sein du comité, le CPMP a considéré que le rapport bénéfice/risque de Zestril est favorable pour une utilisation relative aux patients souffrant de schizophrénies résistantes au traitement et de troubles psychotiques survenant au cours de l’évolution de la maladie de Parkinson en cas d’échec de la stratégie thérapeutique habituelle
0.22945451736450195 ||| Treatment with PROTELOS should be discontinued in case of serious allergic reaction. ||| The use of certain vaccinations should be avoided during treatment with TORISEL. ||| Le traitement par PROTELOS doit être interrompu en cas de réaction allergique sérieuse.
0.6454180479049683 ||| Get medical care right away if you think serotonin syndrome is happening to you. ||| do you have any blood pressure problem as far as you know? ||| Contactez immédiatement un service médical d’ urgences si vous pensez présenter un syndrome sérotoninergique.
0.24859115481376648 ||| In peri and post natal studies in rats, dystocia, increased foetal deaths in utero, and toxicity to post natal development (pup body weight and development land marks) were observed at systemic exposure levels up to 11 times higher than the expected clinical exposure. ||| In rabbits, reductions in gravid uterine weights and number of live foetuses were due to increases in the number of resorptions, increases in post-implantation loss and complete litter loss in 4 of 6 pregnant females at plasma exposure levels 3-fold higher than is observed in clinic. ||| Dans des études péri et postnatales chez le rat, une dystocie, des morts fœ tales accrues in utero et une toxicité lors du développement postnatal (poids des petits et points de repère) de la croissance ont été observés à des niveaux d’ exposition systémique jusqu’ à 11 fois supérieurs à l’ exposition clinique attendue.
0.13838359713554382 ||| NA-SALICYLAAT, 100%, powder for solution for oral administration ||| NA-Salicylaat, 100%, powder for solution for oral administration ||| NA-SALICYLAAT, 100%, poudre pour solution pour administration orale
0.3469979763031006 ||| Treatment of osteoporosis in men at increased risk of fracture. ||| Enbrel treatment may increase mortality in patients with established sepsis. ||| Traitement de l’ ostéoporose chez l’ homme présentant des risques accrus de fractures.
0.3704323172569275 ||| For the remainder of the day after injection, patients should be advised to be vigilant for signs and symptoms of overdose secondary to post injection adverse reactions, be able to obtain assistance if needed and should not drive or operate machinery (see section 4.7). ||| The individual is obligated to protect others by preventing further spread of disease, respect the instructions from public health authorities and sequester themselves in their homes and not attend public gatherings, and act as a first responder (if a healthcare professional) by providing services to protect and restore public health. ||| Le reste de la journée après l’ injection, il faut conseiller au patient d’ être attentif à tout signe ou symptôme d’ un surdosage secondaire à un effet indésirable post-injection, afin d’ avoir la possibilité d’ obtenir de l’ aide si besoin.
0.08047081530094147 ||| Authorised for 2002 ||| Authorised for 2003 ||| Autorisés pour 2002
0.09446780383586884 ||| 6 Renal and urinary disorders ||| 19 Renal and urinary disorders ||| Affections du rein et des voies urinaires
0.147955060005188 ||| Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg should be used in accordance with official guidance. ||| Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals 3.75 µg is a vaccine for use in adults from 18 to 60 years old. ||| Vaccin grippal prépandémique (H5N1) (virion fragmenté, inactivé, avec adjuvant) GlaxoSmithKline Biologicals 3,75 µg doit être utilisé selon les recommandations officielles.
0.28438571095466614 ||| In healthy male volunteers and postmenopausal women, intravenous ranitidine caused an increase in ibandronic acid bioavailability of about 20% (which is within the normal variability of the bioavailability of ibandronic acid), probably as a result of reduced gastric acidity. ||| Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil, resulting in approximately 90% higher plasma concentrations of sildenafil and the active N-desmethyl metabolite compared to those seen in healthy younger volunteers (18-45 years). ||| Chez des volontaires sains de sexe masculin et chez des femmes ménopausées, la ranitidine administrée par voie intraveineuse a augmenté la biodisponibilité de l’ acide ibandronique d’ environ 20% (ce qui est dans les limites de variabilité normale de la biodisponibilité de l’ acide ibandronique), probablement du fait d’ une réduction de l’ acidité gastrique.
0.5803713202476501 ||| These signs disappear without further treatment. ||| These effects should however decrease over time. ||| Les signes disparaissent sans aucun traitement.
0.3969873785972595 ||| The chemotherapy should be given after MabThera infusion. ||| Fasturtec is given at the start of chemotherapy. ||| La chimiothérapie doit être administrée après la perfusion de MabThera.
0.24335074424743652 ||| Due to the potential for such interactions especially related to the inducing effect of bosentan on CYP450 (see section 4.5), which could affect the efficacy of antiretroviral therapy, these patients should be monitored carefully regarding control of their HIV infection. ||| Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. ||| En raison de la possibilité d’ interactions entre ces médicaments en particulier liées à l’ effet inducteur du bosentan sur le CYP450 (voir rubrique 4.5), susceptibles d’ affecter l’ efficacité du traitement antirétroviral, ces patients doivent être surveillés attentivement en ce qui concerne le contrôle de leur infection par le VIH.
0.22248908877372742 ||| The first infusion will be given to you over 90 minutes. ||| Later infusions may be given to you over 30 minutes. ||| La durée de la première perfusion sera de 90 minutes.
0.3943255543708801 ||| Following the approval of the Luxembourg measure adopted on 24 March 2020 , Luxembourg notified to the Commission an additional support measure under the Temporary Framework in the form of guarantees on loans. ||| The MRP procedure was finalised on Day 221 of the procedure on 09.05.2006 with approval of the proposed indication and inclusion of the liver and kidney imaging studies’ results under Section 5.1. ||| Après que la mesure luxembourgeoise adoptée le 24 mars 2020 a été autorisée, le Luxembourg a notifié à la Commission une mesure de soutien supplémentaire, sous la forme de garanties sur des prêts, au titre de l'encadrement temporaire.
0.07921986281871796 ||| OUTER CARTON - BOTTLE OF 180 TABLETS 800 mg ||| OUTER CARTON - 3 BOTTLES OF 360 TABLETS 400 mg ||| EMBALLAGE EXTERIEUR - FLACON DE 180 COMPRIMES 800 mg
0.04300886392593384 ||| The decision whether to continue the patient on therapy with pioglitazone should be guided by clinical judgement pending laboratory evaluations. ||| The decision whether to continue the patient on therapy with Thymanax should be guided by clinical judgement pending laboratory evaluations. ||| Dans l'attente des résultats, la décision de maintenir le patient sous pioglitazone reposera sur l'interprétation clinique.
0.7925163507461548 ||| This plan should address the following: ||| For the conditions listed above: ||| Ce plan doit couvrir les aspects suivants:
0.2596200704574585 ||| Technical advisory services relating to data processing ||| Consultancy and advisory services relating to personnel placement ||| Services de conseils techniques relatifs au traitement de données
0.47110065817832947 ||| Rental of packing machines ||| Valuation of farm assets ||| Location de machines d'emballage
0.08912985026836395 ||| What benefit has Xeloda shown during the studies? ||| What benefit has Tractocile shown during the studies? ||| Quel est le bénéfice démontré par Xeloda au cours des études?
0.41824084520339966 ||| Based on data collected from secondary contacts in households where there was an index case with typical pertussis, the protective efficacy of the vaccine was 88.7%. ||| Despite this relative flattening of the curve of detected patients, 9 travelers assigned to confinement violated the prefectural decree by leaving their hotel. ||| D’ après les données recueillies à partir de sujets exposés dans l'entourage d'un cas index de coqueluche typique, l'efficacité protectrice du vaccin a été de 88,7%.
0.5005010962486267 ||| Pandemrix should under no circumstances be administered intravascularly. ||| Neither subcutaneous nor intradermal administration has been studied. ||| Pandemrix ne doit en aucun cas être administré par voie intravasculaire.
0.287524938583374 ||| Steady-state levels are reached after about 6 monthly injections, with the major part of the accumulation achieved after 3-4 doses. ||| Early plasma levels fall quickly, reaching 10% of the peak values within 3 and 8 hours after intravenous or oral administration, respectively. ||| Les concentrations à l’ équilibre sont atteintes après environ 6 injections mensuelles avec la majeure partie de l’ accumulation obtenue après 3-4 administrations.
0.3992878794670105 ||| Surfactants for use in coating floor surfaces ||| Lubricating oils for the cutting of metal pieces ||| Agents surfactifs pour le revêtement des sols
0.05261937528848648 ||| Eesti Österreich Roche Eesti OÜ Tel: + 372 - 6 177 380 ||| Eesti Österreich Roche Eesti OÜ Tel: + 372 - 6 112 401 ||| Eesti Roche Eesti OÜ Tel: + 372 - 6 177 380
0.33358439803123474 ||| Pregabalin has been studied in 3 controlled clinical studies of 12 week duration with either twice a day dosing (BID) or three times a day (TID) dosing. ||| Once daily dosing (300 mg once a day): a clinical study has demonstrated the non inferiority between Epivir once a day and Epivir twice a day containing regimens. ||| La prégabaline a été étudiée dans le cadre de 3 études cliniques contrôlées d’une durée de 12 semaines à la posologie de deux (BID) ou trois prises par jour (TID).
0.4437761902809143 ||| Enzymes for scientific purposes ||| Enzymes for technical use ||| Enzymes à usage scientifique
0.3708881139755249 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement. ||| 51 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.3651164174079895 ||| The injection site should be varied with each dose to avoid discomfort. ||| Changing the injection site with each injection may help to prevent such skin changes. ||| Le site d’ injection doit être différent pour chaque dose, afin d’ éviter toute gène.
0.21324002742767334 ||| Plant espaliers of non-metallic materials ||| Compost bins of non-metallic materials ||| Espaliers pour plantes en matériaux non métalliques
0.8262276649475098 ||| Hearing impairment/loss, tinnitus ||| - Skyrocketing youth unemployment, ||| Trouble/ perte d’ audition, acouphène
0.2614651322364807 ||| If this is not possible, close monitoring of toxicities are required and dose reductions of trabectedin should be considered. ||| In the absence of such studies, caution should be exercised as increased levels of indinavir may occur. ||| Si cela est impossible, les effets toxiques devront être étroitement surveillés et une réduction de la dose de trabectédine devra être envisagée.
0.016607321798801422 ||| According to criteria laid down by the Committee for Medicinal Products for Human Use (CHMP), a prepandemic vaccine needs to bring about protective levels of antibodies in at least 70% of people for it to be considered suitable. ||| According to criteria laid down by the Committee for Medicinal Products for Human Use (CHMP), a mock-up vaccine needs to bring about protective levels of antibodies in at least 70% of people for it to be considered suitable. ||| Selon les critères définis par le comité des médicaments à usage humain (CHMP), un vaccin prépandémique doit induire des taux d’ anticorps protecteurs chez au moins 70% des personnes pour pouvoir être considéré comme approprié.
0.5196565985679626 ||| Upper Arm ||| Outer carton ||| Haut du bras
0.3585717976093292 ||| Evidence of efficacy for the once weekly dosing regimen in this patient population has been based on data from the study in patients with ankylosing spondylitis. ||| The following vaccine-related injection-site and systemic adverse reactions were reported at a significantly greater incidence in the vaccine group versus the placebo group in the Adverse Event Monitoring Substudy. ||| Les preuves de l’ efficacité du schéma posologique de une fois par semaine dans cette population de patients reposent sur des données provenant d’ une étude chez des patients atteints de spondylarthrite ankylosante.
0.4706520736217499 ||| - This anorectic agent should be used with caution in epileptic patients. ||| Do not use in animals with impaired haematopoietic systems. ||| Cet anorexigène doit être utilisé avec prudence chez les sujets épileptiques.
0.12624770402908325 ||| SP Europe 73, rue de Stalle B-1180 Bruxelles Belgium ||| 73, rue de Stalle B-1180 Bruxelles Belgium ||| SP Europe 73, rue de Stalle
0.22951127588748932 ||| Appropriate measures should be taken and discontinuation of parecoxib therapy should be considered if there is clinical evidence of deterioration in the condition of specific clinical symptoms in these patients (see section 5.1). ||| In view of the potential for development of heart failure in these patients, rosiglitazone should therefore not be initiated in patients having an acute coronary event and it should be discontinued during the acute phase (see section 4.3). ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une preuve clinique de détérioration symptomatique de l’ état de ces patients (voir rubrique 5.1 Propriétés pharmacodynamiques).
0.30465036630630493 ||| It is also used in cats to treat urinary tract infections caused by certain specific bacteria. ||| Zometa can be used to prevent bone complications in patients with advanced cancer that is affecting the bone. ||| Il est également utilisé chez le chat pour traiter les infections urinaires provoquées par certaines bactéries.
0.09260500967502594 ||| 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 200 film-coated tablets ||| 14 film-coated tablets 28 film-coated tablets 56 film-coated tablets 84 film-coated tablets 98 film-coated tablets 50 x 1 film-coated tablets ||| 20 comprimés pelliculés 30 comprimés pelliculés 50 comprimés pelliculés 60 comprimés pelliculés 100 comprimés pelliculés 200 comprimés pelliculés
0.3111439645290375 ||| Do not try and become pregnant/ father a child until your doctor advises you it is safe to do so. ||| Do not restart breast-feeding until the doctor tells you it is safe to do so. ||| N'envisagez pas de grossesse ni de paternité tant que votre médecin ne vous aura pas précisé qu'il était possible de le faire en toute sécurité.
0.36702868342399597 ||| In all three studies, the patients also took two reverse transcriptase inhibitors (another type of antiviral medicine). ||| • You have taken H2 antagonists or antacids (relieves indigestion) on the same day of the test. ||| Au cours de ces trois études, les patients ont également reçu deux inhibiteurs de la transcriptase inverse (un autre type de médicament antiviral).
0.17914722859859467 |||  Rare (may occur in less than 1 in 1,000 patients): serious allergic reactions (including severe localized swelling of the skin and wheezing); combined low platelet, red, and white blood cell count; nervous system disorders (with signs and symptoms similar to those of multiple sclerosis or inflammation of the nerves of the eyes or spinal cord); tuberculosis; worsening congestive heart failure; seizures; lupus or lupus-like syndrome (symptoms may include persistent rash, fever, joint pain, and tiredness); inflammation of the blood vessels; low red blood cell count, low white blood cell count, low neutrophil (a type of white blood cell) count; elevated liver blood tests; skin rash which may lead to severe blistering and peeling of the skin.. ||| Dynastat must not be used in patients with:  a history of serious allergic reactions to medicines, especially skin reactions;  stomach ulcers or bleeding in the stomach or gut;  allergic-type reactions such as asthma, cold-like symptoms, polyps in the nose, swelling of the face or hives after taking aspirin or NSAIDs, including other COX-2 inhibitors;  severe liver disease;  inflammatory bowel disease;  heart failure (an inability of the heart to pump enough blood around the body), heart disease, peripheral artery disease (obstruction of the arteries in the arms or legs), or cerebrovascular disease (problems affecting the blood vessels in the brain). ||| Réactions allergiques graves (y compris gonflement localisé important de la peau et respiration sifflante); baisse de l’ensemble des globules rouges, globules blancs et plaquettes; troubles du système nerveux (avec des signes et symptômes similaires à ceux de la sclérose en plaques ou d’une inflammation des nerfs des yeux ou de la moelle épinière); tuberculose; aggravation d’une insuffisance cardiaque congestive; lupus ou syndrome de type lupus (symptômes pouvant inclure des éruptions persistantes de la peau, fièvre, douleurs des articulations, et fatigue); inflammation des vaisseaux sanguins; baisse des globules rouges, des globules blancs, des neutrophiles (= un type de globule blanc); tests sanguins hépatiques élevés; éruption cutanée qui peut conduire à des cloques importantes et à un décollement cutané sévère.
0.1221151351928711 ||| If you have the impression that the effect of Glustin 30 mg tablets is too weak, talk to your doctor. ||| If you have the impression that the effect of Tandemact is too weak, talk to your doctor. ||| Informez votre médecin si vous avez l'impression que l'effet de Glustin 30 mg, comprimé est trop faible.
0.33777427673339844 ||| 20.3 ||| 8.3 ||| 20,3
0.6460473537445068 ||| Physical rehabilitation ||| Vocational retraining ||| Rééducation physique
3.635427191488877e-13 ||| The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication may be continued at the same dose for another 4 weeks. ||| The ulcer usually heals within 4 weeks, but in patients not fully healed within this time, the medication may be continued at the same dose for another 4 weeks. ||| L’ulcère cicatrise habi- tuellement en 4 semaines, mais chez des patients dont la cicatrisation n’est pas complète après ce dé- lai, le traitement peut-être poursuivi pendant 4 semaines supplémentaires à la même posologie.
0.10839307308197021 ||| Do not use Cetrotide after the expiry date which is stated on the vial after EXP. ||| Do not use GONAL-f after the expiry date which is stated on the ampoule after EXP. ||| Ne pas utiliser Cetrotide après la date de péremption mentionnée sur le flacon après EXP.
0.39732837677001953 ||| Antithrombotic agent – direct thrombin inhibitor, ATC Code: ||| Immunosupressants, Interleukin inhibitors; ATC code: ||| Agent antithrombotique – inhibiteur direct de la thrombine, code ATC:
0.4572349488735199 ||| Because FMD rarely infects humans, but spreads rapidly among animals, it is a much greater threat to the agriculture industry than to human health. ||| Mesothelioma occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age. ||| Du fait que la fièvre aphteuse n’infecte l’homme que rarement, mais se diffuse rapidement parmi les animaux, elle constitue une menace beaucoup plus évidente pour l’économie agricole que pour la santé humaine.
0.7748088240623474 ||| - if you have thyroid disease that is not well controlled. ||| - your insulin pen does not work properly, ||| - si vous avez une maladie de la thyroïde non adéquatement contrôlée.
0.3601042628288269 ||| If you forget to use Betaferon: ||| If you forget to use BYETTA: ||| Si vous oubliez d’utiliser Betaferon:
0.0011008440051227808 ||| 28 The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| 8 The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.5621603727340698 ||| In Study I, tocilizumab was administered intravenously every four weeks as monotherapy. ||| methotrexate monotherapy and Trudexa monotherapy at week 52, which was maintained through week 104. ||| 10 Dans l’ étude I, le tocilizumab a été administré par voie intraveineuse toutes les quatre semaines en monothérapie.
0.277151882648468 ||| State aid: Commission approves €2 billion Slovenian guarantee and rent relief schemes to support companies affected by coronavirus outbreak ||| State aid: Commission approves €75.5 million Estonian schemes in the form of direct grants and payment advantages to support companies in coronavirus outbreak ||| Aides d'État: la Commission autorise des régimes slovènes de garanties et d'abattement de loyers pour un montant de 2 milliards d'euros en faveur des entreprises touchées par la pandémie de coronavirus
0.22376596927642822 ||| - Check for air bubbles in the syringe. ||| 50 Examine the solution in the syringe for air bubbles. ||| - Recherchez les bulles d’ air dans la seringue.
5.955529038675911e-13 ||| Boehringer Ingelheim Comm. V. ||| Boehringer Ingelheim Comm. V. ||| Boehringer Ingelheim Comm.V.
0.07083848118782043 ||| Therefore, for patients with a body surface area ≤ 0.38 m2, the partial contents of a single vial will be required to produce the recommended daily dosage of clofarabine. ||| However, for patients with a body surface area > 0.38 m2, the contents of between 1 to 7 vials will be required to produce the recommended daily dosage of clofarabine. ||| Par conséquent, pour les patients ayant une surface corporelle ≤ 0,38 m2, le contenu partiel d’ un seul flacon sera suffisant pour obtenir la posologie quotidienne recommandée de clofarabine.
0.5436791181564331 ||| Granulated sugar ||| Clarified butter ||| Sucre semoule
0.2072640359401703 ||| a) 12.06.96 b) 18.09.96 c) 97 days d) 0 ||| a) 12.12.95 b) 24.04.96 c) 102 days ||| a) 12.06.96 b) 18.09.96 c) 97 Jours d) 0
0.434660941362381 ||| - if you have a history of any kidney problems. ||| - have a history of any kind of allergy. ||| - si vous avez des antécédents de maladie des reins.
0.45833292603492737 ||| More than one dose must not be administered per vial. ||| REGRANEX should not be used for more than 20 weeks. ||| Ne pas utiliser un même flacon pour l’ injection de plusieurs doses.
2.2313899859793818e-13 ||| In serious, but rare cases, an ovarian hyperstimulation syndrome with clearly enlarged ovaries, can go hand in hand with possible accumulation of fluid in the abdomen or thorax as well as more serious thromboembolic complications. ||| In serious, but rare cases, an ovarian hyperstimulation syndrome with clearly enlarged ovaries, can go hand in hand with possible accumulation of fluid in the abdomen or thorax as well as more serious thromboembolic complications. ||| Dans les cas sévères mais rares, le syndrome d’ hyperstimulation ovarienne avec augmentation de volume des ovaires peut s’ accompagner d’ une accumulation éventuelle de liquide dans l’ abdomen ou le thorax ainsi que de complications de thrombose plus sérieuses.
0.3200494647026062 ||| Keep the injection button pressed in and slowly count to 10 before you withdraw the needle from the skin. ||| Wait 5 seconds after the button is pushed, then withdraw the pen from the skin. ||| Conservez le bouton d’ injection enfoncé et comptez lentement jusqu’ à 10 avant de retirer l’ aiguille de votre peau.
0.03484883904457092 ||| 66 There is no specific antidote for olanzapine. ||| 24 There is no specific antidote for olanzapine. ||| 71 Il n’ y a pas d’ antidote spécifique de l’ olanzapine.
0.08970329910516739 ||| 1.74 ||| 1.73 ||| 0,39
0.46138185262680054 ||| The absorption of Zestril tablets is not affected by food. ||| Oral absorption by the child is however unlikely. no ||| La prise d’ aliments ne modifie pas l’ absorption des comprimés de Zestril.
0.27138662338256836 ||| The active substance in Abilify, aripiprazole, is an antipsychotic medicine. ||| Inovelon contains rufinamide, which is an antiepileptic medicine. ||| Le principe actif d’ Abilify est l’ aripiprazole, un médicament de la famille des neuroleptiques.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.19493785500526428 ||| Plavix should be given as a single daily dose of 75 mg (one tablet) with or without food. ||| Januvia is taken at a dose of 100 mg once a day, with or without food. ||| Plavix doit être administré à raison d’ une dose quotidienne unique de 75 mg (un comprimé) pendant ou en dehors des repas.
0.10442459583282471 ||| Monotard vials are for use with insulin syringes with the corresponding unit scale. t ||| lon The vials are for use with insulin syringes with a corresponding unit scale. ||| Les flacons de Monotard doivent être utilisés avec des seringues à insuline portant une graduation adéquate.
0.3198305368423462 ||| For children from one to five years of age, the dose is 1.25 mg once a day, taken as 2.5 ml syrup or oral solution. ||| Children 1 through 5 years of age: take 2.5 ml (½ of a 5 ml spoonful) of oral solution once a day. ||| Pour les enfants âgés de un à cinq ans, la dose est de 1,25 mg une fois par jour, à prendre sous la forme de sirop ou de solution buvable (quantité à boire:
0.2913866639137268 ||| It is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the general principles set out in the Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April and 8 May 2020. ||| The measures were approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 , and directly based on Article 107(3)(b) of the Treaty on the Functioning of the European Union (TFEU), respectively. ||| Elle est en effet nécessaire, appropriée et proportionnée pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux principes généraux énoncés dans l'encadrement temporaire adopté par la Commission le 19 mars 2020, tel que modifié le 3 avril et le 8 mai 2020.
0.5477613806724548 ||| Plastic coated paper [sensitized] ||| Battery fluid [acidulated water] ||| Papier plastifié [sensibilisé]
0.22514218091964722 ||| Patients with rare hereditary problems of fructose intolerance should not take this medicine. ||| Patients with rare hereditary problems of fructose intolerance should not take Kinzalmono. ||| Les patients ayant une intolérance héréditaire au fructose ne doivent pas prendre ce médicament.
0.5215753316879272 ||| Mechanical egg timers ||| Dental cements ||| Minuteurs mécaniques
0.22927066683769226 ||| The medicine is used to help in the diagnosis of: • movement disorders such as those seen in Parkinson’ s disease and other related diseases, where a loss of striatal nerve cells in the brain leads to tremor (shaking), gait disturbance and stiffness of muscles. ||| In horses, Quadrisol 100 mg/ ml oral gel is used to relieve pain and reduce inflammation due to problems with and injury to the muscles, bones and joints and also injuries to other non-bony areas of the body(so called soft tissue lesions) including the trauma caused by surgery. ||| Le médicament est utilisé dans le diagnostic: • des troubles de coordination tels que ceux observés dans la maladie de Parkinson et d’ autres maladies liées, dans lesquelles une disparition des cellules nerveuses du striatum entraîne des tremblements, des troubles de la démarche et une raideur musculaire.
0.20231571793556213 ||| Advisory services relating to the installation of generators ||| Technical advice relating to operation of computers ||| Services de conseils liés à l'installation de générateurs
0.23310506343841553 ||| Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine. ||| PROCOMVAX suspension for injection Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant) Vaccine ||| Vaccin Haemophilus influenzae type b (conjugué à la protéine de méningocoque) et hépatite B (recombinant).
0.31787657737731934 ||| The data supporting this application, as interpreted according with the CHMP guidance, did not support authorization of regular daily doses in excess of 160 µg in the treatment populations, and this was considered to be of serious public health concern. ||| Therefore, the CHMP considered that the size of the safety database was already satisfactory before provision of the additional clinical study data and that the new information submitted brings the total to well above the minimum suggested in the CHMP guideline. ||| Les données qui corroborent cette demande, interprétées sur la base des recommandations du CHMP, n’ étaient pas favorables à l’ autorisation de doses régulières de plus de 160 µg/ jour dans le traitement des populations et il a été considéré qu’ il s’ agissait d’ un problème de santé publique majeur.
0.05473973974585533 ||| The scientific conclusions are provided in Annex II, together with the Summary of Product Characteristics in Annex III. ||| The scientific conclusions are provided in Annex II and the amended Summary of Product Characteristics in Annex III. ||| Les conclusions scientifiques sont fournies en Annexe II et le résumé des caractéristiques du produit en Annexe III.
0.27790945768356323 ||| APTIVUS therapy should be discontinued in patients experiencing ASAT or ALAT elevations greater than 10X ULN, or developing signs or symptoms of clinical hepatitis during therapy. ||| If patients develop non-haematologic toxicities ≥ Grade 3 (excluding neurotoxicity), ALIMTA should be withheld until resolution to less than or equal to the patient’ s pre-therapy value. ||| 4 Le traitement par APTIVUS devra être arrêté chez les patients présentant une élévation des taux d’ ASAT ou d’ ALAT supérieure à 10 fois la valeur normale, ou développant des signes ou symptômes d’ hépatite clinique au cours du traitement.
0.3785758912563324 ||| Due to the limited clinical experience, Bondenza is not recommended in patients with severe renal impairment (see section 4.2 and section 4.4). ||| From post marketing experience it appears that serotonin syndrome occurs very rarely in patients treated with Remeron alone (see section 4.8). ||| En raison d'une expérience clinique limitée, l’ administration de Bondenza n’ est pas recommandée en cas d’ insuffisance rénale sévère (voir rubrique 4.2 et rubrique 4.4).
0.3668280839920044 ||| Febril neutropenia, thrombocytopenia, anaemia, leukopenia ||| Pancytopenia, anaemia (grade 3-4), leukopenia ||| Neutropénie fébrile, thrombocytopénie, anémie, leucopénie
0.0 ||| Zyrtec Slovak Republic: ||| Zyrtec Slovak Republic: ||| Zyrtec Roumanie:
0.6252392530441284 ||| Undesirable effect Spleen disorder ||| Influenza-like illness Rigors ||| Effets indésirables Troubles spléniques
0.004401875659823418 ||| You should also tell your doctor: if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Irbesartan Hydrochlorothiazide BMS) if you are to undergo any surgery or receive anaesthetics ||| You should also tell your doctor: if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Irbesartan Hydrochlorothiazide Winthrop) if you are to undergo any surgery or receive anaesthetics ||| Vous devrez également prévenir votre médecin: si vous suivez un régime hyposodé (peu riche en sel) si vous avez des signes, tels que soif anormale, bouche sèche, faiblesse générale, somnolence, douleurs musculaires ou crampes, nausées, vomissements ou battements du coeur anormalement rapides qui pourraient indiquer un effet excessif de l'hydrochlorothiazide (contenu dans Irbesartan Hydrochlorothiazide BMS) si vous devez subir une intervention chirurgicale ou une anesthésie
0.5147718787193298 ||| - Cardboard box with 1 and 10 vials of 25 doses. ||| - in a vial (10 ml) for 20 doses in a pack of 50 ||| - Boîte cartonnée contenant 1 et 10 flacons de 25 doses
0.13123014569282532 ||| Luveris is provided as a powder and solvent for solution for injection. ||| Fasturtec is provided as a powder and solvent for concentrate for solution for infusion. ||| Luveris est présenté sous forme de poudre et solvant pour solution injectable.
0.29013311862945557 ||| Skin and subcutaneous tissue disorders Common: ecchymosis at the injection site, sweating increased Uncommon: pruritus, rash ||| Very rare: pulmonary oedema in case of shock (anaphylactic; life-threatening), itching rash, serum sickness-like symptoms. ||| Affections de la peau et du tissu sous-cutané Fréquent: ecchymose au site d’ injection, augmentation de la sudation Peu fréquent: prurit, éruption cutanée
1.0131769180297852 ||| Chrysanthemum tea (Gukhwacha) ||| Simethicone (dimethicone) ||| Thé au chrysanthème (Gukhwacha)
0.23352409899234772 ||| No effect other than those already mentioned in section “ Adverse reactions” have been observed after the administration of several doses, except hyperthermia that may exceptionally last 5 days. ||| No undesirable effects other than those observed and mentioned in the “ Adverse reactions” section have been observed after the administration of several doses. ||| Aucun effet en dehors de ceux déjà décrits dans la section « Effets Indésirables » n’ a été observé après l’ administration de plusieurs doses, sauf une hyperthermie qui peut exceptionnellement persister 5 jours.
0.16581836342811584 ||| Diagram 9. ||| Diagram 6. ||| 263 Schéma 9.
0.23761427402496338 ||| In this clinical study, the immunogenicity of the monovalent aluminium-adjuvanted whole virus vaccine (A/ H5N1) with a haemagglutinin content of 27µg HA per dose in adults aged 18-60 years (N=49) was also evaluated following a 0, 21 day schedule. ||| Aripiprazole doses ranging from 0.5 to 30 mg administered once a day to healthy subjects for 2 weeks produced a dose-dependent reduction in the binding of 11C-raclopride, a D2/ D3 receptor ligand, to the caudate and putamen detected by positron emission tomography. ||| Dans cette étude clinique, l’ immunogénicité d’ un vaccin à virion entier, monovalent, avec de l’ aluminium (adjuvant)(A/ H5N1) contenant 27 µg d’ hémagglutinine (HA) par dose, a été également évaluée chez les adultes âgés de 18 à 60 ans (N=49) avec le schéma d’ administration 0, 21 jours.
0.021405968815088272 ||| EU/ 1/ 08/ 469/ 016 30 tablets: ||| EU/ 1/ 08/ 469/ 018 90 tablets: ||| EU/ 1/ 08/ 469/ 016 30 Comprimés:
0.0 ||| Vaccines work by ‘ teaching’ the immune system (the body’ s natural defences) how to defend itself against a disease. ||| Vaccines work by ‘ teaching’ the immune system (the body’ s natural defences) how to defend itself against a disease. ||| Les vaccins agissent en « apprenant » au système immunitaire (les défenses naturelles du corps) à se défendre contre une maladie.
0.32874804735183716 ||| Crixivan must be used in combination with other antiviral medicines. ||| Herceptin can also be given weekly when used in combination with other anticancer medicines. ||| Crixivan doit être administré en association avec d’ autres médicaments antiviraux.
0.2666351795196533 ||| Sitagliptin is a potent and highly selective inhibitor of the enzyme DPP-4 and does not inhibit the closely-related enzymes DPP-8 or DPP-9 at therapeutic concentrations. ||| Pelzont should be used in patients in combination with HMG-CoA reductase inhibitors (statins), when the cholesterol lowering effect of HMG-CoA reductase inhibitor monotherapy is inadequate. ||| La sitagliptine est un inhibiteur puissant et hautement sélectif de l'enzyme DPP-4 et n'inhibe pas les enzymes étroitement apparentées DPP-8 ou DPP-9 aux concentrations thérapeutiques.
0.1307755708694458 ||| Gum, raw or semi-worked ||| Rubber, raw or semi-worked ||| Gomme brute ou mi-ouvrée
0.37089961767196655 ||| The first 20 mg dose should be given within 2 hours prior to transplantation surgery. ||| A booster vaccination is given 2 weeks prior to each subsequent farrowing. ||| La première dose de 20 mg doit être administrée dans les 2 heures qui précèdent la transplantation.
0.6574636697769165 ||| Aromatic hydrocarbons ||| Hydrochloric Acid5 ||| Hydrocarbures aromatiques
0.0 ||| However, accumulation of brinzolamide is unlikely as renal elimination is the major route. ||| However, accumulation of brinzolamide is unlikely as renal elimination is the major route. ||| Cependant, l’élimination rénale étant la voie principale, l’accumulation de brinzolamide est improbable.
0.30450043082237244 ||| Put the green needle on the syringe contained in the package and remove the needle cover. ||| Use an alcohol swab to wipe the rubber seal on the end of the pen. ||| (5) Fixer le dispositif sur le flacon jusqu'à blocage du système (6) Mettre l'aiguille verte sur la seringue contenue dans la boîte et ôter le fourreau de l'aiguille.
0.4833248555660248 ||| 76.2* ||| 63 76* ||| 76,2*
0.41821011900901794 ||| Display frames of metal [furniture] ||| Clips of silver [jewellery] ||| Cadres d'affichage en métal [mobilier]
0.29757922887802124 ||| The amount of Starlix that you need may change if you take other medicines as these may cause your blood sugar levels to go up or down. ||| − If you are taking medicines called nitrates, as the combination may cause a potentially dangerous decrease in your blood pressure. ||| Vos besoins en Starlix peuvent changer si vous prenez d'autres médicaments, ce qui peut conduire à une augmentation ou une diminution de votre quantité de sucre dans le sang.
0.2945195734500885 ||| Therefore, clofarabine should be used with caution in patients with mild to moderate renal insufficiency (see sections 4.2 and 4.3). ||| However, these limited data indicate that clofarabine may accumulate in patients with decreased creatinine clearance (see sections 4.2 and 5.2). ||| Par conséquent, une attention particulière sera portée lors de l’ utilisation de la clofarabine chez des patients atteints d’ insuffisance rénale légère à modérée (voir rubriques 4.2 et 4.3).
0.6441490650177002 ||| - shaking, ||| - weakness, ||| - tremblements,
0.2155720293521881 ||| 65 Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48 ||| Deutschland Lilly Deutschland GmbH Tel. + 49 -(0) 6172 273 2222 ||| Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48
0.3289850950241089 ||| Efexor and associated names (see Annex I) 25 mg tablets Efexor and associated names (see Annex I) 37.5 mg tablets Efexor and associated names (see Annex I) 50 mg tablets Efexor and associated names (see Annex I) 75 mg tablets ||| Efexor depot and associated names (see Annex I) 37.5 mg hard prolonged-release capsules Efexor depot and associated names (see Annex I) 75 mg hard prolonged-release capsules Efexor depot and associated names (see Annex I) 150 mg hard prolonged-release capsules ||| Efexor et noms associés (voir Annexe I) 25 mg comprimés Efexor et noms associés (voir Annexe I) 37.5 mg comprimés Efexor et noms associés (voir Annexe I) 50 mg comprimés Efexor et noms associés (voir Annexe I) 75 mg comprimés
0.01881033182144165 ||| 189 PACKAGE LEAFLET: ||| 184 PACKAGE LEAFLET: ||| 197 NOTICE:
0.3210870027542114 ||| [84%-92%]) at 1 year and 75% (95% CI: ||| [87%-100%]) and 74% (95% CI: ||| [84%-92%]) à 1 an et de 75% (IC 95%:
0.37184661626815796 ||| The treatment of acute pulmonary infections in children and adolescents with cystic fibrosis will take 10-14 days. ||| Adjuvant treatment in patients with stage III colon cancer is recommended for a total of 6 months. ||| Le traitement des infections pulmonaires aiguës chez les enfants et adolescents atteints de mucoviscidose dure entre 10 et 14 jours.
0.3893333673477173 ||| In case of allergy to trimethoprim or sulfonamides, special care should be taken when handling this product or the medicated solution. ||| Strictly follow your doctor’ s instructions on when and how to use Stalevo, other levodopa medicines and other antiparkinson medicines. ||| En cas d'allergie au triméthoprime ou aux sulfamidés, on prendra des précautions particulières pour manipuler le médicament vétérinaire ou la solution médicamenteuse.
0.11416912078857422 ||| Neulasta treatment should be initiated and supervised by a doctor who has experience in the treatment of cancer or blood disorders. ||| Evoltra treatment should be started and supervised by a doctor who has experience in the management of patients with acute leukaemia. ||| Le traitement par Neulasta doit être instauré et suivi par un médecin expérimenté dans le traitement du cancer ou des troubles sanguins.
0.42869341373443604 ||| Heat resistant fabrics [other than for insulation] ||| Respiratory masks, other than for artificial respiration ||| Tissus résistants à la chaleur autres que pour l'isolation
0.32218533754348755 ||| The intake of food reduces the bioavailability of lansoprazole: it is recommended to take lansoprazole before the meal. ||| In order to optimise the absorption of tenofovir, it is recommended that Truvada should be taken with food. ||| La prise concomitante de nourriture diminue la biodisponibilité du lansoprazole: il est donc recommandé de prendre le médicament avant les repas.
0.3256794214248657 ||| Some symptoms need immediate medical attention You should stop taking Icandra and see your doctor immediately if you experience the following side effects: ||| Tell your doctor straight away if you notice any of the following serious side effects – you may need urgent medical treatment: ||| Certains symptômes nécessitent une prise en charge médicale immédiate Vous devez arrêter de prendre Icandra et aller voir votre médecin immédiatement si vous présentez les effets indésirables suivants:
0.30070143938064575 ||| Replace the needle guard and place the syringe in a horizontal position until ready for use. ● Allow the solution to reach room temperature before injection or warm the syringe between your palms. ● Visually inspect the solution prior to administration: do not use if it is discoloured or if particles are present. ||| On reconstitution a clear, colourless solution is usually obtained within less than 3 minutes. – Do not use solutions which are cloudy or contain particles. – The reconstituted solution is to be used immediately. – The preparation should be warmed to room temperature before administration. ||| Replacez le capuchon protecteur de l’aiguille et laissez la seringue à l’horizontale jusqu’à l’emploi. • Laissez la solution atteindre la température ambiante avant l'injection ou réchauffer la seringue entre les paumes de vos mains.
0.38074326515197754 ||| In the Zometa-treated group, statistically significant improvement in pain scores (using the Brief Pain Inventory, BPI) was seen at 4 weeks and at every subsequent time point during the study, when compared to placebo (Figure 1). ||| A statistically significant decrease in fatigue as measured by functional assessment of chronic illness therapy (FACIT) scores was seen in all three studies in which it was assessed (Studies I, III, IV). t uc ||| Dans le groupe Zometa, une amélioration statistiquement significative du score de douleur (utilisation de la « Brief Pain Inventory » (BPI)) a été observée à 4 semaines et à tous les moment ultérieurs de l’ étude, en comparaison au placebo (figure 1).
0.42834991216659546 ||| For subcutaneous use only. ||| For intravenous use. ||| Pour usage sous-cutané uniquement.
0.3585415482521057 ||| 200 mg/ day ||| 6 mg/ hour ||| 200 mg/ jour
0.0559544563293457 ||| Insulin Human Winthrop Comb 25 must also NOT be mixed with insulins of animal origin or with insulin analogues. ||| Insulin Human Winthrop Basal must also NOT be mixed with insulins of animal origin or with insulin analogues. ||| De même, Insulin Human Winthrop Comb 25 ne doit PAS être mélangé aux insulines d'origine animale ou à des analogues de l'insuline.
0.6388782262802124 ||| ** either SRH area ≥ 25 mm2 if baseline sample negative or 50% increase in SRH area if baseline sample > 4 mm² *** geometric mean increase ||| N ≥ 90% improvement ≥ 75% improvement ≥ 50% improvement PGA of cleared (0) or minimal (1) PGA of cleared (0), minimal (1), or mild (2) All nails cleared c ||| surface SRH ≥ 25 mm² (si l'échantillon de référence est négatif) ou hausse de 50% dans la surface SRH ** si l'échantillon de référence > 4 mm² *** hausse des moyennes géométriques
0.44688016176223755 ||| The pharmacokinetics of Viraferon and ribavirin (dose-normalized) are similar in adults and children or adolescents. t ||| Gender and race (Caucasian, Black and Oriental) did not significantly influence the pharmacokinetic parameters of micafungin. ||| au Viraferon et ribavirine (dose normalisée) sont similaires chez les adultes et les enfants ou adolescents.
0.5003725290298462 ||| Numerical counters ||| Periodicals ||| Compteurs numériques
0.2797257602214813 ||| Hose systems for peritoneal dialysis ||| Adults receiving peritoneal dialysis ||| Tubes pour machines de dialyse péritonéale
0.5285648703575134 ||| Do not add any water to the solvent. ||| The solution does not contain any preservative. ||| N’ajoutez pas d’eau dans le flacon de solvant.
0.02078750729560852 ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. ||| The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch ||| La notice du médicament vétérinaire doit comporter le nom et l'adresse du fabricant responsable de la libération du lot concerné.
0.0 ||| May be harmful for people with phenylketonuria. ||| May be harmful for people with phenylketonuria. ||| Peut être dangereux pour les sujets atteints de phénylcétonurie.
0.01854671537876129 ||| ZYPREXA 5 mg coated tablets Olanzapine ||| ZYPREXA 2.5 mg coated tablets Olanzapine ||| ZYPREXA 5 mg comprimés enrobés Olanzapine
0.3554014265537262 ||| In our efforts to mitigate the economic impacts of the COVID-19 pandemic, the Commission has today published guidelines to ensure EU passenger rights are applied in a coherent manner across the EU. ||| It is the Commission's response to the global call for action launched by the World Health Organization with governments and partners on 24 April 2020, for access to coronavirus vaccines everywhere, for everyone who needs them. ||| Dans le cadre de nos efforts destinés à atténuer les répercussions économiques de la pandémie de COVID-19, la Commission a publié aujourd'hui des orientations ayant pour objet de garantir l'application cohérente des droits des passagers de l'UE dans l'ensemble de l'Union.
0.21420054137706757 ||| Dynepo 5,000 IU/ 0.5 ml solution for injection in a pre-filled syringe. ||| Neulasta is a solution for injection in a pre-filled pen (6 mg/0.6 ml). ||| Dynepo 5000 UI/ 0,5 ml, solution injectable en seringue préremplie.
0.5183357000350952 ||| No dose adjustment is needed based on gender. ||| No marked changes were observed on an individual level. ||| Aucune adaptation de la dose en fonction du sexe n’ est nécessaire.
0.39404183626174927 ||| All differences between Lucentis 0.5 mg and the two control groups were statistically significant and clinically meaningful, with p-values ranging from 0.009 to < 0.0001. ||| The corresponding negative predictive value and positive predictive value for NeoSpect in association with chest X-ray were 96-98% and 61- 78% respectively. ||| Toutes les différences entre les groupes Lucentis 0,5 mg et les deux groupes contrôles ont été statistiquement significatives et cliniquement pertinentes, avec des valeurs de p comprises entre 0,009 et < 0,0001.
0.5156298875808716 ||| The safety and efficacy of vardenafil was maintained in long term studies. ||| More than 99% of efficacy and safety data were generated in Caucasians. ||| La tolérance et l’ efficacité du vardénafil se maintenaient dans les études à long terme.
0.4043833613395691 ||| Lawn mowing attachments for vehicles ||| Toothed wheels for land vehicles ||| Accessoires de coupe du gazon pour véhicules
0.4859646260738373 ||| Manganese nitrate ||| Iron nitrate ||| Nitrate de manganèse
0.3733021914958954 ||| Amino acids for industrial purposes ||| Alcohol for industrial purposes ||| Acides aminés à usage industriel
0.10532905906438828 ||| In-use pens Pre-filled pens in-use or carried as a spare may be stored for a maximum of 4 weeks not above 25°C away from direct heat (for example next to a heating unit) or direct light (direct sunlight or next to a lamp). ||| Opened vials Once in-use, the vial may be stored for a maximum of 4 weeks not above 25°C in the outer carton away from direct heat (for example next to a heating unit) or direct light (direct sunlight or next to a lamp). ||| Stylos en cours d’utilisation Les stylos préremplis en cours d’utilisation ou emportés en réserve peuvent être conservés jusqu’à 4 semaines maximum, à une température ne dépassant pas 25°C, éloignés d’une source de chaleur directe (comme un appareil de chauffage) ou d’une source lumineuse directe (comme la lumière solaire ou près d’une lampe).
0.3154027462005615 ||| Patients treated with idursulfase may develop infusion-related reactions (see section 4.8). ||| Refludan may cause allergic reactions including anaphylaxis and shock (see section 4.8). ||| Les patients traités par idursulfase sont susceptibles de développer des réactions associées à la perfusion (voir rubrique 4.8).
0.30204933881759644 ||| The systemic clearance was approximately 0.22 ml/ h/ kg. ||| The initial infusion rate is 0.3 ml/kg bw/hr. ||| 13 clairance systémique était d'environ 0,22 ml/ h/ kg.
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Si votre médecin vous a dit que vous aviez une intolérance à certains sucres, contactez -le avant de prendre ce médicament.
0.49380895495414734 ||| Apidra can be injected in the abdominal wall, the thigh or upper arm or by continuous infusion in the abdominal wall. ||| - you change the area of skin where you inject insulin (for example from the thigh to the upper ||| Apidra peut être injecté dans la paroi abdominale, dans la cuisse, dans la partie supérieure du bras ou par perfusion continue dans la paroi abdominale.
0.9185521602630615 ||| Stir well and drink immediately. ||| 200 ml) and drunk immediately. ||| Remuez et buvez immédiatement.
0.017085682600736618 ||| 2/ 34 Special precautions to be taken by the person administering the veterinary medicinal product product to animals ||| 2/ 34 Special precautions to be taken by the person administering the veterinary medicinal product to animals ||| Précautions particulières à prendre par la personne qui administre le médicament vétérinaire aux animaux
0.2867240309715271 ||| There was a 3-fold increase in CVAE in patients treated with oral olanzapine compared to patients treated with placebo (1.3% vs. ||| Comparing the rate of patients with adverse reactions per 100 patient weeks, the rate was higher for placebo than Circadin (8.21 – placebo vs. ||| Trois fois plus d’ événements indésirables vasculaires cérébraux ont été rapportés dans le groupe de patients traités par olanzapine orale comparativement au groupe de patients traités par placebo (1,3% versus 0,4% respectivement).
3.086926059821943e-13 ||| Similar changes were seen in metformin (haemoglobin 3 - 4% and haematocrit 3.6 – 4.1% relative reductions) treated patients in comparative controlled trials with pioglitazone. ||| Similar changes were seen in metformin (haemoglobin 3 - 4% and haematocrit 3.6 – 4.1% relative reductions) treated patients in comparative controlled trials with pioglitazone. ||| Lors d’ essais cliniques contrôlés et comparatifs avec la pioglitazone, des changements similaires ont été observés avec la metformine (diminution de l’ hémoglobine 3-4% et de l’ hématocrite 3,6-4,1%).
0.006331421434879303 ||| 33 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 36 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 38 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTERIEUR
0.20035502314567566 ||| 2 (2.5%) 0 (0%) ||| 0 (0%) 1 (0.2%) ||| 2 (2,5%) 0 (0%)
0.0 ||| 3 years. ||| 3 years. ||| 3 ans.
0.003907888196408749 ||| 203 Sertraline, a medicine used to treat depression, as your doctor may need to change your dose of sertraline. ||| 194 Sertraline, a medicine used to treat depression, as your doctor may need to change your dose of sertraline. ||| La sertraline, un médicament utilisé pour traiter la dépression, étant donné que votre médecin devra peut-être changer votre dose de sertraline.
0.37336161732673645 ||| General disorders and administration site conditions Very common: erythema, * pain/ tenderness, * swelling* Common: haematoma, pruritus, warmth ||| General disorders and administration site conditions Very common: fatigue, pain Common: fever, injection site swelling, redness ||| Troubles généraux et anomalies liés au site d'administration Très fréquent: érythème*, douleur/ sensibilité au toucher, à la pression *, gonflement* Fréquent: hématome, prurit, chaleur
0.06266775727272034 ||| When reconstituted, InductOs contains 1.5 mg/ml dibotermin alfa. ||| After reconstitution, InductOs contains 1.5 mg/ ml dibotermin alfa. ||| Soit, après reconstitution, InductOs contient 1,5 mg/ml de dibotermine alpha.
0.2622911334037781 ||| MabCampath is a concentrate for solution for infusion that comes in a glass ampoule. ||| ALIMTA is a powder for concentrate for solution for infusion in a vial. ||| MabCampath est une solution à diluer pour perfusion, contenue dans une ampoule en verre.
0.2627522647380829 ||| 20 Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC, Cmax and t½ (1.6-fold, 1.4-fold and 1.2-fold respectively) with no statistically significant effects on the blood glucose levels. ||| Multiple-dose ketoconazole administration significantly affected the rate and extent of absorption and sirolimus exposure from Rapamune oral solution as reflected by increases in sirolimus Cmax, tmax, and AUC of 4.4-fold, 1.4-fold, and 10.9-fold, respectively. ||| L’ administration concomitante de triméthoprime (160 mg deux fois par jour), un inhibiteur modéré du CYP2C8, et de répaglinide (dose unique de 0,25 mg) a entraîné une augmentation de l’ ASC, de la Cmax et du t1/ 2 du répaglinide (respectivement de 1,6 fois, 1,4 fois et 1,2 fois) sans effets statistiquement significatifs sur la glycémie.
0.22053739428520203 ||| Data on a large number of exposed pregnancies do not indicate any adverse effect of insulin lispro on pregnancy or on the health of the foetus/ newborn. ||| Data on a limited number of exposed pregnancies indicate no adverse effects of amlodipine and other calcium receptor antagonists on the health of the foetus. ||| Les données sur un grand nombre de grossesses exposées n'indiquent pas d'effet indésirable de l'insuline lispro sur la grossesse ou sur la santé du fœ tus/ nouveau-né.
0.08396944403648376 ||| AZOPT eye drops are used to treat high pressure in the eye. ||| DuoTrav eye drops are used to treat high pressure in the eye. ||| AZOPT collyre est utilisé pour traiter une pression élevée à l’intérieur de l’œil.
0.3795543909072876 ||| Therefore, the dose of simvastatin should not exceed 10 mg daily in patients receiving concomitant medication with cyclosporine. ||| However, digoxin concentrations increased approximately 20% following administration of digoxin with 80 mg atorvastatin daily. ||| Par conséquent, la posologie de simvastatine ne doit pas dépasser 10 mg/jour chez les patients dont le traitement comporte de la cicloporine.
0.39724966883659363 ||| Wax strips for removing body hair ||| Powder for forming sculpted finger nail tips ||| Bandes de cire pour l'épilation
0.39503973722457886 ||| If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet. ||| Eating a balanced diet Your doctor can advise you about your diet or whether you should take any dietary supplements. ||| Si vous allaitez votre enfant, vous devrez peut -être modifier vos doses d'insuline et votre régime alimentaire.
0.04100174084305763 ||| It must not be used if it remains clear or if, for example, clumps, flakes, particles or anything similar are in the suspension or on the sides or bottom of the vial. ||| It must not be used if it remains clear or if, for example, clumps, flakes, particles or anything similar are in the suspension or on the sides or bottom of the cartridge in the pen. ||| Elle ne doit pas être utilisée si elle reste claire ou si, par exemple, elle contient des agrégats, des particules ou des flocons dans la suspension, ou sur les parois ou le fond du flacon.
0.27846139669418335 ||| Based on the pharmacological mechanism of action of efalizumab, the use of Raptiva is not expected to affect patient’ s ability to drive and use machines. ||| Given the mechanism of action of efalizumab, its effects on the immune system may be potentiated by systemic immunosuppressives commonly used for the treatment of psoriasis (see section 4.4). ||| D'après le mécanisme d'action pharmacologique de l'efalizumab, l'utilisation de Raptiva ne devrait pas influencer l'aptitude du patient à conduire un véhicule, ni à utiliser une machine.
0.2867126166820526 ||| A neonatal abstinence syndrome has been reported among newborns of women who have received buprenorphine during pregnancy. ||| Ectopic pregnancy (embryo implanted outside the womb) may occur especially in women with a history of prior tubal disease. ||| Un syndrome de sevrage néonatal a été rapporté chez les nouveaux-nés de femmes qui ont reçu de la buprénorphine pendant la grossesse.
0.4133918285369873 ||| Dressers ||| Tractors ||| Bahuts
0.008613388985395432 ||| INFORMATION FOR THE USER Irbesartan BMS 150 mg tablets irbesartan ||| INFORMATION FOR THE USER Irbesartan BMS 300 mg tablets irbesartan ||| INFORMATION DE L'UTILISATEUR Irbesartan BMS 150 mg comprimés irbésartan
0.03325062617659569 ||| The effects of Tyverb were first tested in experimental models before being studied in humans. ||| The effects of Byetta were first tested in experimental models before being studied in humans. ||| Les effets de Tyverb ont d’ abord été testés sur des modèles expérimentaux avant d’ être étudiés chez les humains.
5.897506875213177e-13 ||| Some of these lesions may be seen on unenhanced, non-contrast MRI. ||| Some of these lesions may be seen on unenhanced, non-contrast MRI. ||| Certaines de ces lésions peuvent être visibles sur l’IRM sans injection de produit de contraste.
3.7256450095141114e-13 ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. ||| Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. ||| Lactose: les patients présentant un problème héréditaire rare d’ intolérance au galactose, une déficience en lactase LAPP ou une malabsorption du glucose et du galactose ne doivent pas prendre ce médicament.
0.37946566939353943 ||| AZARGA is a liquid (white to off-white uniform suspension) supplied in a pack containing one 5 ml plastic bottle with a screw cap or in a pack containing three 5 ml bottles. ||| Flexicam is presented as a pale green oral suspension (1.5mg/ ml) for dogs (to be given mixed with food) and a yellow solution for injection (5mg/ ml) for dogs and cats. ||| AZARGA est un liquide (suspension uniforme blanche à blanchâtre) fourni dans une boîte contenant un flacon en plastique de 5 ml avec un bouchon à vis ou dans une boîte contenant trois flacons de 5 ml.
0.153373122215271 ||| 50 TAXOTERE 75 mg/ m² in combination with doxorubicin ||| 16 TAXOTERE 75 mg/ m² in combination with capecitabine ||| 52 TAXOTERE 75 mg/ m² en association avec la doxorubicine
0.3445252776145935 ||| Patients already taking metformin, with or without a sulphonylurea, should take Velmetia containing the same dose of metformin. ||| Januvia can be used with metformin, and with both metformin and a sulphonylurea, in type 2 diabetes patients. ||| Les patients prenant déjà la metformine, avec ou sans sulphonylurée, devraient prendrait Velmetia contenant la même dose de metformine.
0.2198401689529419 ||| If you could get pregnant while receiving Atripla, you need to use a reliable form of barrier contraception (for example, a condom) with other methods of contraception including oral (pill) or other hormonal contraceptives (for example, implants, injection). ||| Hormonal contraceptives (such as the Pill) can affect the way Lamictal works Your doctor may recommend that you use a particular type of hormonal contraceptive, or another method of contraception, such as condoms, a cap or a coil. ||| Si vous êtes en âge de procréer pendant le traitement par Atripla, vous devez utiliser une méthode de contraception mécanique fiable (par exemple, un préservatif) qui devra toujours être ajoutée aux autres méthodes contraceptives, y compris les contraceptifs oraux (pilule) ou d’ autres contraceptifs hormonaux (par exemple, implants, injection).
0.36413708329200745 ||| No treatment-related malformations were seen in the rat. ||| No hypersensitivity reactions were reported in these patients. ||| Aucune malformation liée au traitement n’a été observée chez le rat. m ica
0.5709779262542725 ||| In the open-label extension of Studies I, II, and III durable and sustained ACR 20, 50, and 70 responses have been observed through 48, 24, and 18 months, respectively, of abatacept treatment. ||| The median duration of follow-up for these studies was 4.0, 3.0, 3.0, and 3.0 years for Protocol 005, Protocol 007, Protocol 013, and Protocol 015, respectively. ||| Dans la phase d'extension en ouvert des études I, II et III, les réponses ACR 20, 50 et 70 ont été durables et se sont maintenues sur des périodes de 48, 24 et 18 mois, respectivement, chez les patients traités par abatacept.
0.31025660037994385 ||| Monitoring of their renal function and plasma potassium levels is recommended before initiation and during treatment with combined therapy (see 4.3). ||| Monitoring of the serum levels of other medicinal products taken during the 1-week eradication therapy is therefore recommended. ||| Une surveillance de leur fonction rénale et du taux de potassium plasmatique est recommandée avant l’ initiation ou pendant le traitement avec la thérapie combinée (voir rubrique « Contre-indications »).
1.0267893075942993 ||| Adoption placement ||| Localised oedema ||| Services d'adoption
0.24623288214206696 ||| Storage conditions of the unopened product: • Store in a refrigerator (2 °C to 8 °C). • Do not freeze. • Keep the pre-filled syringe in the carton in order to protect from light. ||| Store in a refrigerator (2°C – 8°C) Do not freeze Keep the cartridges in the outer carton in order to protect from light ° During use: do not refrigerate or store above 30°C Use within 4 weeks ||| Conditions de conservation du produit avant ouverture: • A conserver au réfrigérateur (entre 2°C et 8°C). • Ne pas congeler. • Conserver la seringue préremplie dans l’ emballage à l’ abri de la lumière.
0.7471963167190552 ||| The approved measures are: ||| The plan comprises: ||| Les mesures approuvées sont :
1.9049906509020775e-13 ||| Don’ t use this to set or check your dose; it may not be accurate • You can’ t set a dose higher than the number of units left in the cartridge • You can use the insulin level indicator to estimate how much is left, but you can’ t use it to set or select your dose. ||| Don’ t use this to set or check your dose; it may not be accurate • You can’ t set a dose higher than the number of units left in the cartridge • You can use the insulin level indicator to estimate how much is left, but you can’ t use it to set or select your dose. ||| Ne vous fiez pas à ce déclic pour sélectionner ou vérifier votre dose, qui pourrait alors ne pas être précise • Vous ne pouvez pas sélectionner une dose supérieure au nombre d’ unités restant dans la cartouche • Vous pouvez utiliser l’ indicateur de niveau d’ insuline pour estimer la quantité d’ insuline restante, mais pas pour sélectionner ou contrôler votre dose.
0.02928253263235092 ||| 80 4.8 Undesirable effects ||| 90 4.8 Undesirable effects ||| 4.8 Effets indésirables
0.11706481128931046 ||| (1.4) ||| (1.2) ||| (1,4)
0.19089749455451965 ||| Phenytoin levels should be monitored when co-administering with lopinavir/ ritonavir. ||| Phenytoin concentrations should be monitored during co-administration with nelfinavir. ||| Les concentrations de phénytoïne doivent être surveillées en cas d'association avec le lopinavir/ ritonavir.
0.4722364842891693 ||| The Commission concluded that the recapitalisation measure will contribute to manage the economic impact of the coronavirus outbreak in Finland. ||| They recognised that COVID-19 reconstruction measures can provide an opportunity to accelerate the transition towards climate neutrality. ||| La Commission est parvenue à la conclusion que la mesure de recapitalisation aidera à gérer l'incidence économique de la pandémie de coronavirus en Finlande.
0.4060785174369812 ||| Therefore, you should continue to use contraceptive measures, as above, for 12 weeks after you stop taking STOCRIN. ||| Therefore, you should employ an alternative, effective and safe contraceptive method if you are taking APTIVUS. ||| C’ est pourquoi vous devez continuer à utiliser des mesures contraceptives, telles que celles citées ci-dessus, pendant 12 semaines après avoir arrêté de prendre STOCRIN.
0.20453433692455292 ||| 1% ||| 2% ||| 1% 0%
0.07117035239934921 ||| How has Sonata been studied? ||| How has Comtan been studied? ||| Quelles études ont été menées sur Sonata?
0.2954493761062622 ||| SINGULAIR as prophylaxis of asthma for 2 to 5 year old patients in whom the predominant component is exercise-induced bronchoconstriction. ||| Risperdal Consta and associated names is an anti-psychotic, indicated for the maintenance treatment of schizophrenia in patients currently stabilised with oral antipsychotics. ||| SINGULAIR utilisé en traitement préventif de l'asthme induit par l'effort chez l'enfant de 2 à 5 ans:
0.3977854251861572 ||| 28 skin together and insert the needle at a 45° to 90° angle using a dart-like motion. ||| With the other hand, insert the needle at an angle of 90 degrees into the skin’ s surface (f). ||| Pincez fermement la peau entre deux doigts et enfoncez l’ aiguille d'un coup sec (avec un angle de 45 à 90 degrés, comme si vous enfonciez une fléchette).
0.3969697952270508 ||| If a package is opened or damaged, do not use this medical device. ||| Do not use Tasmar if you notice that the tablets are damaged. ||| Si la boîte est ouverte ou endommagée, n’ utiliser pas son contenu.
0.327562540769577 ||| Caution is also needed by patients taking APTIVUS at the same time as other medicines. ||| Fasturtec will be administered at the same time as other medicines that may also cause side effects. ||| Des précautions doivent être également prises lorsqu’ APTIVUS est pris de façon concomitante avec d’ autres médicaments.
0.3038812279701233 ||| A commonly used dose starts with 75-150 IU (0.12-0.24 ml) of GONAL-f together with 75 IU of lutropin alfa. ||| The usual dose starts with 75 IU (1 vial) of Luveris together with 75 IU or 150 IU of FSH. ||| La dose usuelle de départ est de 75 à 150 UI (0,12 à 0,24 ml) de GONAL-f avec 75 UI de lutropine alfa.
0.03931612893939018 ||| On the basis of this immunogenicity bridging, the efficacy of Silgard in 9- to 15-year-old girls is inferred. ||| On the basis of this immunogenicity bridging, the efficacy of Gardasil in 9- to 15-year-old girls is inferred. ||| 24 L'efficacité de Silgard chez les filles âgées de 9 à 15 ans a été déduite de ces données d'immunogénicité.
0.4545349180698395 ||| Your doctor will advise you to stop taking Avandamet before the X-ray and for 48 hours after it. ||| Your doctor will tell you to take LYRICA either twice or three times a day. ||| Votre médecin vous conseillera d'arrêter de prendre Avandamet avant la radiographie et pendant 48 heures après la radiographie.
0.6174941062927246 ||| - Tabulated summary of adverse reactions (clinical trials): ||| b) Tabular Listing of adverse events: ||| - Résumé tabulé des effets indésirables (essais cliniques):
0.6473473906517029 ||| Patients in the control arm received RT only. ||| Patients were treated twice daily with . ||| Les patients dans le bras contrôle ont reçu seulement de la RT.
0.41629838943481445 ||| It should also be noted that female patients may have a higher risk of liver injury. ||| In addition, there is a possibility of an increased risk of suicidal behaviour in young adults. ||| Il faut également noter que les femmes semblent avoir un risque plus élevé d’ atteinte hépatique.
0.20414698123931885 ||| The Commission's assessment concluded that the State guarantee in favour of Air France is in line with the conditions under the Temporary Framework : (i) the guarantee premium is in line conditions under the Temporary Framework, increasing over time to encourage early reimbursement, (ii) the guarantee will be granted before 31 December this year, (iii) the loan backed by the guarantee cannot exceed € 4 billion and below the limits of the Temporary Framework, (iv) the maximum duration of the guarantee is 6 years and will not cover more than 90% of loan backed by such a guarantee, and (v) Air France was not in difficulty on or before 31 December 2019. ||| In particular, (i) the trade credit insurers have committed to the Netherlands to maintain their current level of protection in spite of the economic difficulties faced by companies due to the coronavirus outbreak; (ii) the guarantee is limited to only cover trade credit originated until the end of this year; (iii) the scheme is open to all credit insurers in the Netherlands; (iv) the guarantee mechanism ensures risk sharing between the insurers and the State, up to a volume of €1 billion, and provides an additional safety-net to cover up to €12 billion in total if required, and (v) the guarantee fee provides a sufficient remuneration for the Dutch State. ||| L'appréciation de la Commission a montré que la garantie d'État en faveur d'Air France était conforme aux conditions énoncées dans l' encadrement temporaire : i) la prime de garantie est conforme aux conditions de l'encadrement temporaire, étant donné qu'elle augmente au fil du temps pour encourager un remboursement rapide; ii) la garantie sera accordée au plus tard le 31 décembre de cette année; iii) le montant du prêt garanti ne peut dépasser 4 milliards d'euros et est inférieur aux limites prévues dans l'encadrement temporaire; iv) la durée maximale de la garantie est de 6 ans et couvrira au maximum 90 % du montant du prêt garanti, et v) Air France n'était pas en difficulté au 31 décembre 2019.
0.0 ||| 7. ||| 7. ||| 209 7.
0.5555083751678467 ||| Special care before injection ||| For single dose injection ||| 606 Précautions particulières avant l’injection
0.39344727993011475 ||| Because ECALTA can affect liver function, patients who show signs of liver problems during treatment should be carefully monitored. ||| If you have a history of liver disease or chronic hepatitis B infection your doctor may conduct blood tests to monitor your liver function. ||| Étant donné qu'ECALTA peut affecter la fonction hépatique, les patients présentant des signes de troubles hépatiques pendant le traitement doivent être surveillés attentivement.
0.5433169603347778 ||| Our goal is to contain the outbreak at a global level". ||| It is the most important tool to implement our long-term goals. ||| Notre objectif est de contenir l'épidémie au niveau mondial.
0.3416784405708313 ||| Abseamed is given by injection under the skin (subcutaneously). ||| Do not give by injection under the skin (subcutaneously). ||| Abseamed est administré par injection sous la peau (par voie sous-cutanée).
0.14828673005104065 ||| Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Animal reproduction studies have not revealed any differences between insulin glulisine and human insulin regarding pregnancy, embryonal/ foetal development, parturition or postnatal development (see section 5.3). ||| Les études chez l’ animal n’ ont pas montré d’ effets délétères directs ou indirects sur la gestation, le développement embryonnaire ou fœ tal, la parturition ou le développement post-natal (voir rubrique 5.3).
0.2007184773683548 ||| Sorafenib had no effect on the pharmacokinetics of gemcitabine or oxaliplatin. ||| Lamivudine has no effect on the pharmacokinetics of trimethoprim or sulfamethoxazole. ||| Le sorafénib n’ a eu aucun effet sur la pharmacocinétique de la gemcitabine ou de l’ oxaliplatine.
0.40989601612091064 ||| In the aftermath of the crisis, many Europeans will need to retrain in a new skill or improve their existing skills to adapt to the changed labour market. ||| The EU is stepping up to protect jobs , but the specificity of the cultural sector makes it harder for its workers to qualify for support. ||| Dans le prolongement de la crise, de nombreux Européens devront se reconvertir ou renforcer leurs compétences existantes pour s'adapter au nouveau marché du travail.
0.4405398964881897 ||| Vomiting Abdominal pain Hypophenylalaninemia ||| Nasopharyngitis Sinusitis Fungal infection ||| Vomissement Douleur abdominale Hypophénylalaninémie
0.06698659807443619 ||| s These undesirable effects have also been reported with Viraferon alone. ||| s ori These undesirable effects have also been reported with Viraferon alone. ||| Ces effets indésirables ont également été rapportés avec Viraferon seul. mé
0.48283785581588745 ||| Currently there is only evidence of the efficacy of the vaccine against challenge with B. canis. ||| As with any vaccine, Silgard may not fully protect 100% of those who get the vaccine. ||| Actuellement, seule l’ efficacité du vaccin contre B. canis est démontrée, par épreuve virulente.
0.4366506338119507 ||| There may be a rise in the level of platelets (cells that help blood clotting) during treatment with this medicine. ||| Although these usually hurt, breaks in the bones of the spine may go unnoticed until they cause height loss. ||| Il existe un risque de hausse du taux de plaquettes (cellules qui contribuent à la coagulation) pendant le traitement avec ce médicament.
0.38635894656181335 ||| In the short-term studies, Thymanax was seen to be more effective than placebo in the two studies where no active comparator was used. ||| In short-term trials (under 24 weeks), fluoxetine was shown to be significantly more effective than placebo. ||| Dans les études à court terme, Thymanax s’ est avéré plus efficace que le placebo dans les deux études menées sans utilisation de médicament de comparaison.
0.17986857891082764 ||| The final concentration should not exceed 10 mg/ ml. ||| The maximum infusion rate must not exceed 10 mg/ min. ||| La concentration finale de doit pas dépasser 10 mg/ ml.
0.24786636233329773 ||| Although, the majority of them could be managed by dose reduction, close monitoring of haematological parameters should be undertaken in this population of patients (see section 4.2 and below “Laboratory tests” and section 4.8). ||| In study AI455-094 (see also section 4.6), the safety follow-up period was restricted to only six months, which may be insufficient to capture long-term data on neurological adverse events and mitochondrial toxicity. ||| Bien que la majorité d’ entre eux peuvent être contrôlés par des réductions de dose, un suivi attentif des paramètres hématologiques doit être mis en place dans cette population de patients (voir rubrique 4.2 sous « tests de laboratoire » et rubrique 4.8).
0.4526967704296112 ||| België/Belgique/Belgien Novartis Pharma N.V. ||| 76 Belgique/België/Belgien Merck Sharp & Dohme B.V. ||| 53 België/ Belgique/ Belgien Novartis Pharma N. V.
0.27910831570625305 ||| Adverse reactions of moderate or greater severity with at least possible relationship to treatment regimen (based on investigator attribution) reported in clinical trials of efavirenz at the recommended dose in combination therapy (n = 1,008) are listed below. ||| In controlled clinical trials investigating desirudin 15 mg twice daily and a standard dose of unfractionated heparin, the nature of the hip surgery operation and the mode of action of the two drugs studied account for most of the adverse experiences reported. ||| Les effets indésirables d'intensité modérée à grave étant possiblement liés au traitement (d'après le jugment de l'investigateur) et rapportés au cours des essais cliniques évaluant une association antirétrovirale comprenant de l'éfavirenz à la posologie recommandée (n = 1 008) sont listés ci- dessous.
0.32171177864074707 ||| However, Cerenia tablets should not be administered wrapped or encapsulated in food as this may delay dissolution of the tablet and consequently the onset of efficacy. ||| If the insulin inhaler is inadvertently exposed to extremely moist conditions during use this usually leads to a subsequent decreased the insulin dose delivered from the inhaler. ||| Les comprimés de Cerenia ne doivent pas être administrés enrobés dans la nourriture car cela peut retarder la dissolution du comprimé et donc le début de son effet.
0.55323326587677 ||| 27 België/ Belgique/ Belgien sanofi-aventis Belgium Tél/ Tel: +32 (0)2 710 54 00 ||| Tél/ Tel: +32 (0) 2 735 45 34 (België / Belgique) ||| 28 België/Belgique /Belgien sanofi-aventis Belgium Tél/Tel: +32 (0)2 710 54 00
0.0 ||| Detailed information on this medicine is available on the European Medicine’ s Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Detailed information on this medicine is available on the European Medicine’ s Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA): http: / /www. emea. europa. eu
0.2628939151763916 ||| Caution must be exercised in the management and treatment of patients with compromised airways by limitation or careful monitoring of antihistamine and other sedative medication use. ||| General Repaglinide should only be prescribed if poor blood glucose control and symptoms of diabetes persist despite adequate attempts at dieting, exercise and weight reduction. ||| La prudence s’ impose lors de la prise en charge et du traitement des patients ayant des troubles respiratoires: l’ utilisation d’ anti-histaminiques ou d’ autres sédatifs doit être limitée ou étroitement surveillée.
0.10336676985025406 ||| Pioglitazone dose adjustment within the recommended Posology or changes I diabetic treatment should be considered (see section 4.5). ||| Pioglitazone dose adjustment within the recommended posology or changes in diabetic treatment should be considered (see section 4.5). ||| Une adaptation de la dose de pioglitazone au sein de l'intervalle posologique recommandé ou des modifications du traitement antidiabétique doivent être envisagées (voir paragraphe 4.5).
0.013436739332973957 ||| EU/ 1/ 96/ 008/ 027 ||| EU/ 1/ 96/ 008/ 026 ||| EU/ 1/ 96/ 008/ 027 Puregon
0.14790382981300354 ||| 405 11. ||| 407 11. ||| 11.
0.18171638250350952 ||| No studies on the effects on the ability to drive and to use machines have been performed. ||| Studies to determine the effect of Crestor on the ability to drive and use machines have not been conducted. ||| Aucune étude des effets de Herceptin sur l’ aptitude à conduire des véhicules et à utiliser des machines n'a été conduite.
0.5541203022003174 ||| Do not refill NovoMix 30 Penfill cartridges. ||| Your NutropinAq Pen works without shields. ||| Ne reremplissez pas les cartouches NovoMix 30 Penfill.
0.3266943693161011 ||| This appropriation is intended to cover expenditure on the Agency's obligations in respect of entertainment and representation. ||| This appropriation is intended to cover the procurement of program packages and software necessary for the normal operation of the Agency. ||| Ce crédit est destiné à couvrir les dépenses afférentes aux obligations incombant à l'Agence en matière de réception et de représentation.
0.41503727436065674 ||| If LVEF has not improved, or declined further, discontinuation of Herceptin should be strongly considered, unless the benefits for the individual patient are deemed to outweigh the risks. ||| We let them know that we understood that our request for cancellations and other restrictions could make it impossible to complete their agreed-upon grant activities and that no one would be penalized for having to delay or modify those goals. ||| Si la FEVG n’ est pas améliorée, ou qu’ elle s’ est détériorée, l’ arrêt du traitement par Herceptin doit être fortement envisagé, à moins que le bénéfice individuel attendu
0.19862954318523407 ||| The use of the product is not recommended in infants and toddlers aged less than 2 years. ||| The use of the product is not recommended in children aged less than 2 years. ||| L’ utilisation de ce médicament n’ est pas recommandée chez l’ enfant de moins de 2 ans.
0.3972837030887604 ||| The proposal is for financial control to be replaced by an internal audit function within each of the EU decentralised bodies, including the EMEA. ||| As a consequence the links between the European Commission Directorate-General for Financial control and each of the EU decentralised bodies will have to be reconsidered during 2000. ||| La proposition consiste à remplacer le contrôle financier par une fonction d’audit interne au sein de chacun des organismes communautaires décentralisés, notamment de l’EMEA.
8.918284947340149e-13 ||| Efficacy Working Party ||| Efficacy Working Party ||| Groupe de travail “ efficacité”
0.4851601719856262 ||| Extruded aluminium sections ||| Simulated wood sections ||| Profilés en aluminium extrudé
0.24322953820228577 ||| Betaferon should not be used in people who have a history of hypersensitivity (allergy) to natural or recombinant interferon beta, human albumin or any of the other ingredients. ||| Do not use in case of hypersensitivity to any of the ingredients of the veterinary medicinal product, to corticosteroids, to other azole antifungal agents and to other fluoroquinolones. ||| Betaferon ne doit pas être utilisé chez des personnes ayant des antécédents d’ hypersensibilité (allergie) à l’ interféron β naturel ou recombinant, à l’ albumine sérique humaine ou à l’ un des excipients.
0.7950764894485474 ||| 12 - Examine the solution carefully. ||| F) Quick review of the process ||| 12 – Examinez attentivement la solution.
0.2301018238067627 ||| Paediatric patients Vimpat is not recommended for use in children and adolescents below the age of 16 as there is no data on safety and efficacy in these age groups. ||| The safety and efficacy of MabCampath has not been established in children (below 17 years of age) or in patients who have kidney or liver disorders. ||| Utilisation chez l’ enfant Vimpat n’ est pas recommandé chez l’ enfant et l’ adolescent âgé de moins de 16 ans, car aucune donnée de tolérance et d’ efficacité n’ est disponible dans ces tranches d’ âge.
0.3677447438240051 ||| Appropriate measures should be taken and discontinuation of parecoxib therapy should be considered if there is clinical evidence of deterioration in the condition of specific clinical symptoms in these patients (see section 5.1). ||| f) Presenting data in a way that supports prudent antibiotic use, for example by selectively reporting to physicians a limited number of antimicrobial susceptibility results; ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une preuve clinique de détérioration symptomatique de l’ état de ces patients (voir rubrique 5.1 Propriétés pharmacodynamiques).
0.107098288834095 ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Ovitrelle to Serono Europe Limited on 2 February 2001. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for GONAL-f to Serono Europe Limited on 20 October 1995. ||| La Commission européenne a délivré une autorisation de mise sur le marché valable dans toute l’ Union européenne à Serono Europe Limited pour Ovitrelle, le 2 février 2001.
0.4081576466560364 ||| Connect the plunger rod by screwing it clockwise into the syringe. ||| Remove the capped needle by turning it anticlockwise. ||| Fixer le piston en le vissant sur la seringue dans le sens des aiguilles d'une montre.
0.27157506346702576 ||| The active substance in Irbesartan Winthrop, irbesartan, is an ‘ angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II. ||| Losartan is an orally active angiotensin II (Ang- II) receptor antagonist acting on the AT1 receptor subtype, thus blocking the effect of Ang-II in the renin angiotensin system (RAS) cascade. ||| Le principe actif d’ Irbesartan BMS, l’ irbésartan, est un « antagoniste des récepteurs de l'angiotensine- II », ce qui signifie qu’ il bloque l’ action dans le corps d’ une hormone appelée angiotensine-II.
0.0 ||| Intramuscular use. ||| Intramuscular use. ||| Voie intramusculaire.
0.20106294751167297 ||| After oral administration of therapeutic doses, doxazosin in Cardoreg 4 mg prolonged release tablets and associated names is well absorbed with peak blood levels gradually reached at 6 to 8 hours after dosing. ||| Patients treated with immediate release doxazosin tablets against hypertension can be transferred to Cardoreg 4 mg prolonged release tablets and associated names and the dose titrated upwards as needed, while maintaining effect and tolerability. ||| Après administration orale de doses thérapeutiques, la doxazosine contenue dans Cardoreg 4 mg comprimés à libération prolongée et dénominations associées est bien absorbée, avec des pics sanguins atteints progressivement 6 à 8 heures après administration.
0.23156289756298065 ||| Significant effects were also obtained in patients with less disseminated and less active disease at the time of the first event, the risk in two years for progression to CDMS in patients with monofocal onset was 47% for placebo and 24% for Extavia, without gadolinium (Gd-) enhancement 41% and 20%, with less than 9 T2 lesions 39% and 18%. ||| In addition, in monotherapy studies of up to 24 weeks in duration of sitagliptin 100 mg once daily alone compared to placebo, adverse reactions considered as drug-related reported in patients treated with sitagliptin in excess (> 0.2% and difference > 1 patient) of that in patients receiving placebo are headache, hypoglycaemia, constipation, and dizziness. ||| Des effets significatifs ont été obtenus chez les patients présentant une forme moins disséminée et moins active de la maladie au moment du premier événement, correspondant à un risque d’ évolution en SEP cliniquement définie en 2 ans chez les patients présentant un début monofocal de 47% pour le groupe placebo et de 24% pour le groupe Extavia, sans rehaussement gadolinium (Gd) 41% et 20%, avec moins de 9 lésions en T2 39% et 18%.
0.2106260061264038 ||| After intravenous administration of 0.5 mg, total, renal, and non-renal clearances decreased by 67%, 77% and 50%, respectively, in subjects with severe renal failure but there was no reduction in tolerability associated with the increase in exposure. ||| After intravenous administration of 0.5 mg, total, renal, and non-renal clearances decreased by 67%, 77% and 50%, respectively, in subjects with severe renal impairment. ||| 13 la clairance totale, de la clairance rénale et de la clairance non rénale ont été respectivement réduites de 67%, 77% et 50% chez les insuffisants rénaux sévères, mais cette augmentation de l’ exposition ne s’ est pas accompagnée d’ une réduction de la tolérance.
0.09115198254585266 ||| If you have any further questions on the use of thismedicine, ask your doctor or pharmacist. ||| If you have any further questions on the use of NovoNorm, ask your doctor or pharmacist. ||| Si vous avez d’ autres questions sur l’ utilisation de ce médicament, demandez plus d’ informations à votre médecin ou à votre pharmacien.
0.020882749930024147 ||| If you get any of these signs, eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest. ||| If you get any of these signs: eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest. ||| Si vous ressentez l 'de ces signes, avalez des comprimés de glucose ou un produit riche en sucre un (bonbons, biscuits, jus de fruits) puis reposez -vous.
0.3520522713661194 ||| ● Hold the barrel of the syringe with one hand and gently press the coloured needle protection device down on a flat surface until it covers the needle. ||| The release liner is two overlapped siliconised polyester strips that are peeled off and discarded by the patient prior to applying the patch. ||| • Prenez le corps de la seringue avec une main et faites remonter doucement le système de protection coloré en l’appuyant sur une surface plane jusqu’à ce qu’il recouvre l’aiguille.
0.40999966859817505 ||| During the treatment with Revlimid you have an increased risk of developing blood clots in the veins. ||| B lymphocytes are involved in the cause of some of the symptoms you may have. ||| Pendant le traitement par Revlimid, le risque de formation de caillots sanguins dans les veines est augmenté.
0.6863229274749756 ||| Of these, 1,110 were monitored for both serious and non-serious adverse experiences. ||| None of these were considered serious, and all resolved without sequelae. ||| L’ apparition d’ effets indésirables graves et non graves a été surveillée chez 1110 de ces nourrissons.
0.1978912055492401 ||| If someone else is injecting for you, they can also use the back of your arms. ||| If someone else is injecting you, they can also use the back of your arms (see picture 4). ||| Si quelqu’un d’autre pratique l’injection, il peut également la faire sur la partie arrière de vos bras.
0.050857700407505035 ||| If you use more Neupopeg than you should contact your doctor, nurse or pharmacist. ||| If you use more Neulasta than you should contact your doctor, nurse or pharmacist. ||| Si vous avez pris plus de Neupopeg que nécessaire, contactez votre médecin, l’infirmière ou le pharmacien.
0.010548991151154041 ||| If you forget to use Fluticasone furoate GSK • If you miss a dose take it when you remember. • If it is nearly the time for your next dose, wait until then. ||| If you forget to use Fluticasone furoate GSK • If you miss a dose, take it when you remember. • If it is nearly the time for your next dose, wait until then. ||| 22 Si vous oubliez d’ utiliser Fluticasone furoate GSK • Si vous oubliez de prendre une dose, prenez -la lorsque vous vous en souvenez. • Si le moment de votre dose suivante est proche, attendez jusque -là.
0.3224169909954071 ||| The 3 ml cartridges are sealed in a disposable pen injector. ||| The syringes are provided either with or without a blister wrapping. ||| Les cartouches de 3 ml sont scellées dans un stylo injecteur jetable.
0.35204121470451355 ||| Some patients have experienced stomach discomfort when starting the combination of sitagliptin and metformin together. ||| Change from baseline in body weight was similar for patients treated with sitagliptin relative to placebo. ||| Certains patients ont présenté une gêne abdominale au début du traitement par l'association sitagliptine/metformine.
0.5302584171295166 ||| Nervous system: ||| Renal function: ||| Système nerveux:
0.06697101891040802 ||| Use a new needle for each injection. ||| Always use a new needle for each injection. ||| 117 Utilisez une aiguille neuve pour chaque injection.
0.04235421121120453 ||| Retinoids: retinoid compounds are eliminated via alcohol dehydrogenase. ||| 24 Retinoids: retinoid compounds are eliminated via alcohol dehydrogenase. ||| Les rétinoïdes sont éliminés par l'alcool-déshydrogénase.
0.33043134212493896 ||| Karaoke services ||| Theatre services ||| Services de karaoké
0.0 ||| Chickens ||| Chickens ||| Voie
0.4873465299606323 ||| Taking other medicines Please tell your doctor if you are taking or have recently taken: ||| - if you are taking or have recently taken anticoagulant medication (see “Taking other ||| Prise d’ autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez en à votre médecin:
0.01604459434747696 ||| With a view to ensuring legal certainty, the Commission will assess before that date if it needs to be extended. ||| With a view to ensuring legal certainty, the Commission will assess before those dates if it needs to be extended. ||| Afin de garantir la sécurité juridique, la Commission évaluera avant cette date s'il est nécessaire de la prolonger.
0.41001179814338684 ||| Your body's response to treatment will be tested at regular intervals and your doctor will decide whether your treatment needs to be continued and which dose should be used. uc ||| Information will be provided to health care professionals and will ensure that the vaccine will be correctly used in the different age and risk categories. ||| Votre réaction au traitement est évaluée à intervalles réguliers, afin que votre médecin puisse décider si le traitement doit continuer et déterminer la dose à utiliser. en
0.8468998670578003 ||| Now turn over for information on how to use your FlexPen. ||| Will I need an internet connection to use my app? ||| Consultez le dos de cette notice pour savoir comment utiliser votre FlexPen.
0.04162637144327164 ||| 109 A. ||| 104 A. ||| 116 A.
2.2480595943813464e-13 ||| As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/ or tongue have been reported in patients taking irbesartan. ||| As with similar medicines, rare cases of allergic skin reactions (rash, urticaria), as well as localised swelling of the face, lips and/ or tongue have been reported in patients taking irbesartan. ||| Comme avec des médicaments similaires, de rares cas de réactions allergiques cutanées (éruption, urticaire), ainsi qu’ un gonflement de la face, des lèvres et/ ou de la langue ont été rapportés chez des patients prenant de l'irbésartan.
0.5436421632766724 ||| - Fainting ||| - vomiting ||| - Evanouissement,
0.37501874566078186 ||| If your levels of the red blood pigment (haemoglobin) are too high you should not receive Binocrit, since you have an increased risk of blood clotting after the surgery. ||| • Hyperglycaemia (high blood sugars) means there is too much sugar in the blood If your blood sugar level is too high, this tells you that you could have needed more insulin than you injected. ||| Vous ne devez pas recevoir de Binocrit si vous avez un taux d'hémoglobine (pigment donnant sa couleur rouge au sang) trop élevé car vous présenteriez alors un risque accru de thromboses post- opératoires.
0.26934555172920227 ||| Since insulin and pioglitazone are associated with fluid retention, concomitant administration of insulin and Glubrava may increase the risk of oedema. ||| 8 Lamivudine may inhibit the intracellular phosphorylation of zalcitabine when the two medicinal products are used concurrently. ||| L’ insuline et Glubrava étant associées à une rétention hydrique, leur administration concomitante peut augmenter le risque d’œ dème.
0.2292162925004959 ||| Renal impairment No dosage adjustment of Exforge is required for patients with mild to moderate renal impairment (GFR > 30 ml/ min/ 1.73 m2). ||| 2 Dosage in patients with impaired renal function In patients with mild renal impairment (i. e. creatinine clearance (CrCl) is 51-79 ml/ min), no dosage adjustment is necessary. ||| Altération de la fonction rénale Aucun ajustement posologique d'Exforge n'est nécessaire lors d'une altération faible à modérée de la fonction rénale (DFG > 30 ml/ min/ 1,73 m²).
0.21717140078544617 ||| What is Osigraft used for? ||| What is Yttriga used for? ||| Dans quel cas Osigraft est -il utilisé?
0.007268602028489113 ||| If you take more Pelzont than you should • In the event of an overdose, the following adverse events were reported: flushing, headache, pruritus (itching), nausea, dizziness, vomiting, diarrhoea, abdominal pain/ discomfort, and back pain. • If you take more than you should, talk to a doctor or pharmacist straight away. ||| If you take more Tredaptive than you should • In the event of an overdose, the following adverse events were reported: flushing, headache, pruritus (itching), nausea, dizziness, vomiting, diarrhoea, abdominal pain/ discomfort, and back pain. • If you take more than you should, talk to a doctor or pharmacist straight away. ||| Si vous avez pris plus de Pelzont que vous n’ auriez dû • En cas de surdosage, les effets indésirables suivants ont été rapportés: bouffées vasomotrices, maux de tête, prurit (démangeaisons), nausées, étourdissements, vomissements, diarrhée, douleurs ou troubles abdominaux, et douleurs au niveau du dos. • Si vous avez pris plus de comprimés que vous n’ auriez dû, consultez immédiatement un médecin ou un pharmacien.
0.4449503421783447 ||| The prescriber should inform the patient accordingly and discuss or consider the need for dose tapering. ||| The woman should also be instructed to carefully read the package leaflet and to adhere to the advice given. ||| Le prescripteur doit informer le patient en conséquence et discuter ou envisager la nécessité d’ un arrêt progressif.
0.02114541083574295 ||| 5 (1.1%) ||| 5 (1.2%) ||| Grade 3 n (%)
0.09742274135351181 ||| BATCH NUMBER al ||| BATCH NUMBER Lot ||| NUMERO DU LOT ic
0.27098602056503296 ||| Rebif should be administered with caution to patients with a history of seizures, to those receiving treatment with anti-epileptics, particularly if their epilepsy is not adequately controlled with anti-epileptics (see sections 4.5 and 4.8). ||| Lamictal treats epilepsy by blocking the signals in the brain that trigger epileptic seizures (fits). • For adults and children aged 13 years and over, Lamictal can be used on its own or with other medicines, to treat epilepsy. ||| Rebif doit être administré avec prudence chez les patients ayant des antécédents d’ épisodes comitiaux et ceux traités par anti-épileptiques, en particulier lorsque leur épilepsie n’ est pas contrôlée par un traitement de façon satisfaisante (voir rubriques 4.5 et 4.8).
0.557427704334259 ||| Protective coatings in the form of sprays for use on concrete [paints] ||| Snack bars containing a mixture of grains, nuts and dried fruit [confectionery] ||| Revêtements de protection sous forme de spray pour béton [peintures]
0.3626396954059601 ||| It is important to follow the instructions from the doctor/ nurse so that your child completes the course of injections. ||| Advise patients why it is important that they comply with the treatment when they are prescribed antibiotics by a doctor. ||| Il est important de suivre les instructions données par le médecin/ l’ infirmière afin que votre enfant achève la série d’ injections.
0.3500344753265381 ||| Novo Nordisk A/ S Novo Allé, DK-2880 Bagsværd, Denmark ||| The marketing authorisation holder Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark ||| Novo Nordisk A/ S Novo Allé, DK 2880 Bagsvaerd, Danemark
0.330983430147171 ||| No tissue distribution data are available in humans. ||| Limited data are available for overdosage in humans. ||| Aucune donnée de distribution tissulaire n’ est disponible chez l’ homme.
0.0 ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| 84 Si vous avez d’autres questions sur l’utilisation de ce médicament, demandez plus d’informations à votre médecin ou à votre pharmacien.
0.3771193027496338 ||| Renal excretion of the glucuronide (and possibly zidovudine itself) is reduced in the presence of probenecid. ||| Protein binding is slight (binding of perindoprilat to angiotensin converting enzyme is less than 30%), but is concentration-dependent. ||| L'excrétion rénale du dérivé glucuronoconjugué (et peut-être de la zidovudine) est réduite en présence de probénécide.
0.3388975262641907 ||| This includes for instance joint procurement of medical equipment, exempting the region from the EU's export authorisation scheme for personal protective equipment, ensuring the fast flow of essential goods across land borders through "green lanes", and the EU supply of testing material to ensure the correct functioning of coronavirus tests in the Western Balkans. ||| In addition to MFA, the EU supports the Neighbourhood and Western Balkans through several other instruments, including humanitarian aid, budget support, thematic programmes, technical assistance, blending facilities and guarantees from the European Fund for Sustainable Development to support investment in sectors most affected by the coronavirus pandemic. ||| Peuvent ainsi être mentionnées la passation conjointe de marchés portant sur du matériel médical, l'exemption de la région du régime d'autorisations d'exportation des équipements de protection individuelle de l'UE, les «voies réservées» permettant de garantir le passage rapide des marchandises essentielles aux frontières terrestres et la fourniture par l'UE de matériel de dépistage afin de garantir le bon fonctionnement des tests de dépistage du coronavirus dans les Balkans occidentaux.
0.08095980435609818 ||| If you forget to take Neoclarityn If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. ||| If you forget to take Aerius orodispersible tablet If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. ||| Si vous oubliez de prendre Neoclarityn Si vous oubliez de prendre votre dose à temps, prenez -la dès que possible, puis continuez votre traitement normalement.
0.9900295734405518 ||| European institutions ||| United kingdom ||| Institutions européennes
9.37918904868329e-13 ||| However you can still continue to take Telzir. ||| However you can still continue to take Telzir. ||| Si vous avez une éruption cutanée Vous pouvez malgré tout continuer à prendre Telzir.
0.37668025493621826 ||| Therefore, antiplatelet therapies should not be discontinued (see section 5.1). ||| Alternative contraceptive measures should therefore also be considered (see section 4.5). ||| Par conséquent, les traitements anti-agrégant plaquettaires ne devront pas être arrêtés (voir rubrique 5.1 « Propriétés pharmacodynamiques »).
0.5099738836288452 ||| Leukocytoclastic vasculitis ||| cutaneous vasculitis anaphylaxis ||| Vascularite leukocytoclasique
0.33413273096084595 ||| Conclusion on LoQ In conclusion, the CHMP noted that no new data was provided by the Applicant during the procedure but disagreed with the Applicant point of view that further clinical efficacy and safety data are not needed, indeed the justification relies entirely on a bridging strategy that assumes that the bioavailability obtained with Rapinyl is twice higher than that obtained with Actiq at the same molar dose. ||| The CHMP considered that the therapeutic indication “ septicaemia due to Gram negative bacteria” could not be accepted as the Applicant/ MAH did not provide reassurance on the fact that ciprofloxacin could be viewed as an adequate option in this severe situation with regards its level of activity and the available therapeutic alternatives. ||| 11 Conclusion concernant la liste de questions En conclusion, le CHMP a constaté qu’ aucune nouvelle donnée n’ a été apportée par le demandeur au cours de la procédure, mais il n’ était pas de l’ avis du demandeur selon lequel d’ autres données cliniques d’ efficacité et de sécurité n’ étaient pas nécessaires; la justification repose en effet entièrement sur une stratégie d’ étude d’ un médicament comparable, qui suppose que la biodisponibilité obtenue avec Rapinyl est deux fois plus élevée que celle obtenue avec Actiq à la même dose molaire.
0.6814444661140442 ||| Shelf-life after first opening of the tube: ||| After first opening the foil overwrap: ||| Durée de conservation après première ouverture du tube:
0.941008448600769 ||| Ottomans ||| CARTON ||| Ottomanes
0.3857719898223877 ||| What Olanzapine Neopharma contains ||| What Posaconazole SP contains ||| Que contient Olanzapine Neopharma
0.46437329053878784 ||| Linseed oil for use as a lubricant ||| Moleskin for use as a medical bandage ||| Huile de lin utilisée comme lubrifiant
0.02678801491856575 ||| After reconstitution it is recommended to promptly dilute the vials (see below). ||| After reconstitution, it is recommended to promptly dilute the vials (see below). ||| Après reconstitution, il est recommandé de diluer rapidement les flacons (voir ci-dessous).
0.5986517667770386 ||| Very commonly reported side effect in patients taking CIALIS were headache and indigestion. ||| Two patients (0.7%) experienced Serious Adverse Events potentially related to study drug. ||| Les effets indésirables les plus fréquemment rapportés chez les patients prenant CIALIS étaient les maux de tête et les indigestions.
0.30408066511154175 ||| The most common adverse reactions observed at a higher incidence than placebo in patients with Lennox-Gastaut syndrome were somnolence and vomiting. ||| The most frequently reported adverse reactions occurring in the Phase 3 studies at the recommended dose regardless of the incidence compared to OBT alone were diarrhoea, nausea and headache. ||| Les effets indésirables les plus fréquemment observés à une incidence plus élevée que pour le placebo chez des patients atteints de syndrome de Lennox-Gastaut ont été la somnolence et les vomissements.
0.17490437626838684 ||| Crushed oats ||| Processed oats ||| Avoine écachée
0.33446574211120605 ||| Flexible containers of plastics for the storage of liquids ||| Metal containers for the storage and transportation of goods ||| Récipients souples en plastique pour le stockage de liquides
0.48070037364959717 ||| A Phase I-II trial conducts preliminary safety and immunogenicity testing, is typically randomized, placebo-controlled, and at multiple sites, while determining more precise, effective doses. ||| A cumulative overview of all events reported during the period, stratified according to type of reporter (patient or health care professional), seriousness, expectedness, and whether spontaneous or solicited. ||| Un essai de phase I-II mène des tests préliminaires de sécurité et d’immunogénicité, est habituellement randomisé, contrôlé contre placébo et réalisé dans plusieurs centres tout, en déterminant des doses efficaces plus précises.
0.0 ||| Lactic acidosis and worsening liver function are side effects associated with Highly Active Anti-Retroviral Therapy (HAART), an HIV treatment. ||| Lactic acidosis and worsening liver function are side effects associated with Highly Active Anti-Retroviral Therapy (HAART), an HIV treatment. ||| L’acidose lactique et la détérioration de la fonction hépatique sont des effets indésirables associés à un Traitement Anti-Rétroviral Hautement Actif (HAART), un des traitements du VIH.
0.33184969425201416 ||| The key will be particularly beneficial to the countries most affected by the crisis, notably those with low per capita income and high unemployment. ||| This is particularly important in low and middle income countries, such as Ghana, where health interventions have come under increased scrutiny because of the cost. ||| La clé sera particulièrement bénéfique pour les pays les plus touchés par la crise, notamment ceux caractérisés par un faible revenu par habitant et un chômage élevé.
0.0746777281165123 ||| What benefit has Paxene shown during the studies? ||| What benefit has Prometax shown during the studies? ||| Quels ont été les bénéfices démontrés par Paxene au cours des études?
0.21117892861366272 ||| In a specific interaction study, where sildenafil (100 mg) was co-administered with amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood pressure of 8 mmHg. ||| In the study of patients undergoing peritoneal dialysis, the patients receiving Renagel had similar falls in phosphate to those receiving calcium acetate (0.52 and 0.58 mmol/ l, respectively). ||| Dans une étude d'interaction spécifique où le sildénafil (100 mg) a été administré avec l'amlodipine chez des patients hypertendus, on a observé une diminution supplémentaire de la pression artérielle systolique de 8 mmHg en position couchée.
0.4292123317718506 ||| Apnea Hiccup Hypoventilation Dyspnea Lung disorder Cough increased Rhinitis ||| Dyskinesia Poor quality sleep Nervousness Myoclonus Disturbance in attention Dysgeusia ||| Apnée Hoquet Hypoventilation Dyspnée Trouble pulmonaire Toux augmentée Rhinite
0.45809710025787354 ||| 3 (1.2) 5 (1.9) ||| 1 (0.6) 1 (0.6) ||| 3 (1,2)
0.245110884308815 ||| Before you use Liprolog Mix50 3. ||| How to use Liprolog Mix50 4. ||| Quelles sont les informations à connaître avant d'utiliser Liprolog Mix50 3.
2.492402443286801e-13 ||| Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. ||| Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. ||| Les conditionnements vides et tout reliquat de produit doivent être éliminés suivant les pratiques en vigueur régies par la réglementation sur les déchets.
0.34967708587646484 ||| Installations for automated washing of vehicles ||| Repair of suspension systems for vehicles ||| Installations de lavage automatisé de véhicules
0.26872655749320984 ||| The recommended initial dose of Ranexa is 375 mg twice daily. ||| The maximum recommended dose is 8 mg doxazosin once daily. ||| Chez l’ adulte: la posologie initiale recommandée de Ranexa est de 375 mg deux fois par jour.
0.23352178931236267 ||| How to use Humalog Pen 4. ||| How to use Osigraft 4. ||| Comment utiliser Humalog Pen 4.
0.0 ||| 61 PACKAGE LEAFLET: ||| 61 PACKAGE LEAFLET: ||| 63 NOTICE:
0.4328623116016388 ||| Box 99, 24101 Salo. ||| Box 20, 5340 BH Oss, ||| 99, 24101 Salo.
0.1572759598493576 ||| Capsule shell Gelatine Sodium laurilsulfate Titanium dioxide (E171) Silicon dioxide (E551) ||| Capsule shell Gelatin Indigo carmine (E132) Titanium dioxide (E171) Sodium laurilsulfate Sorbitan monolaurate ||| Gélatine Laurylsulfate sodique Dioxyde de titane (E171) Dioxyde de silicium (E551)
0.21924366056919098 ||| Do not use Vasovist if you notice severe discolouration, the occurrence of particulate matter or a defective container. ||| Do not use Myocet if you notice that it shows evidence of discoloration, precipitation or any other particulate matter. ||| Ne pas utiliser Vasovist si vous remarquez une coloration anormale ou la présence de particules ou si l’ emballage est défectueux.
0.2384328693151474 ||| The possibility of interactions with other medicinal products administered concurrently with Trizivir should be considered, particularly when the main route of elimination is active renal secretion especially via the cationic transport system e. g. trimethoprim. ||| Therefore, close monitoring of glycaemic control, dose adjustment within the recommended posology and changes in diabetic treatment should be considered when cationic medicinal products that are eliminated by renal tubular secretion are co-administered (see section 4.4). ||| Interactions avec la lamivudine Des interactions potentielles avec d’ autres médicaments co-administrés avec Trizivir doivent être envisagées, en particulier avec les médicaments à élimination essentiellement rénale par sécrétion tubulaire active, via le système de transport cationique (ex.: triméthoprime).
0.25962918996810913 ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, hyperlipidaemia (increased fats in the blood) and resistance to insulin. ||| Non-steroidal anti-inflammatory drugs have been reported to reduce the clearance of lithium, resulting in elevated plasma levels and lithium toxicity. ||| Les associations d’ antirétroviraux peuvent également entraîner une augmentation de l’ acide lactique et du sucre dans le sang, une hyperlipidémie (augmentation du taux de graisse dans le sang) et une résistance à l’ insuline.
0.323456346988678 ||| 70 Common (affects 1 to 10 users in 100): • Headache, sleepiness, constipation, dizziness and high blood pressure Uncommon (affects 1 to 10 users in 1,000): • Tiredness, fungal infections, confusion, hallucinations, vomiting, abnormal gait, heart failure and venous blood clotting (thrombosis/ thromboembolism) Very Rare (affects less than 1 user in 10,000): • Seizures Not known (frequency cannot be estimated from the available data): • Inflammation of the pancreas and psychotic reactions ||| The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10) common (affects 1 to 10 users in 100) uncommon (affects 1 to 10 users in 1,000) rare (affects 1 to 10 users in 10,000) very rare (affects less than 1 user in 10,000) not known (frequency cannot be estimated from the available data) 24 Uncommon side effects (reported by less than 1 in a 100 but more than 1 in a 1,000 people) include: diarrhoea, stomach pain, stomach cramps, gurgling stomach, bloated stomach, stomach gas and general stomach discomfort, headache ||| Fréquent (affectant 1 à 10 personnes sur 100): • Mal de tête, somnolence, constipation, vertiges et élévation de la tension artérielle Peu fréquent (affectant de 1 à 10 personnes sur 1 000): • Fatigue, mycoses, confusion, hallucinations, vomissements, troubles de la marche, insuffisance cardiaque et formation de caillot sanguin veineux (thrombose/thromboembolisme) Très rare (affectant moins de 1 personne sur 10 000): • Convulsions Fréquence indéterminée (la fréquence ne peut être estimée à partir des données disponibles): • Inflammation du pancréas et réactions psychotiques
0.21210817992687225 ||| It is thought that olanzapine’ s beneficial effect is due to it blocking receptors for the neurotransmitters 5-hydroxytrypamine (also called serotonin) and dopamine. ||| Paliperidone acts mainly by blocking the receptors for the neurotransmitters dopamine and 5-hydroxytryptamine (also called serotonin), which are involved in schizophrenia. ||| On pense que l’ effet bénéfique de l’ olanzapine est dû au fait qu’ il bloque les récepteurs des neurotransmetteurs 5-hydroxytrypamine (également appelée sérotonine) et dopamine.
0.0588584840297699 ||| The management of such patients should be directed by physicians with experience in the care of patients with haemophilia (see section 4.4). ||| Management of such patients should be directed by physicians with experience in the care of patients with haemophilia, see also 4.4. ||| La prise en charge de tels patients doit être effectuée par des médecins spécialisés dans le traitement de l'hémophilie (voir rubrique 4.4.)
0.3360655903816223 ||| If you experience any of these side effects, talk to your doctor as soon as you can. ||| If you take too many capsules, contact a doctor as soon as possible. ||| Si vous présentez l'un de ces effets indésirables, contactez votre médecin dès que possible.
0.34349527955055237 ||| Rifampicin/ Tenofovir disoproxil fumarate (600 q. d. / 300 q. d.) ||| 12 Antibiotics Clarithromycin/ Efavirenz (500 b. i. d. / 400 q. d.) ||| 14 Rifampicine/ Fumarate de ténofovir disoproxil (600 q. d. / 300 q. d.)
0.4511750340461731 ||| The Marketing Authorisation Holder provided the following information: • An updated Environmental Risk Assessment • The complete information submitted to the Reference Member State and the CMD(v) in respect to environmental risk assessment. ||| If formation of neutralising antibodies is suspected, contact the local representative of the Marketing Authorisation Holder (see section 6 of the Package Leaflet) for antibody testing. ||| Le titulaire de l’ autorisation de mise sur le marché a fourni les informations suivantes: • Évaluation actualisée du risque pour l’ environnement • Informations complètes fournies à l’ État membre de référence et au CMD(v) sur l’ évaluation du risque pour l’ environnement.
0.41620299220085144 ||| FURTHER HELPFUL INFORMATION ||| FURTHER INFORMATION lP ||| AUTRES INFORMATIONS UTILES
0.26774516701698303 ||| Store in a refrigerator Keep the container in the outer carton, in order to protect from light ||| Do not store above 25 °C Keep the vial in the outer carton in order to protect from light ||| A conserver au réfrigérateur Conserver le conditionnement primaire dans son emballage extérieur, à l'abri de la lumière
0.36142146587371826 ||| Angiotensin II binds to the AT1 receptor found in many tissues (e. g. vascular smooth muscle, adrenal gland, kidneys and the heart) ||| The ciprofloxacin concentration in blister fluid, lymph, nasal secretion, peritoneal fluid, saliva and fatty tissue is approximately half of the serum concentration. ||| L'angiotensine II se lie aux récepteurs AT1 présents dans de nombreux tissus (muscle lisse vasculaire, glande surrénale, reins et cœ ur par exemple) et exerce plusieurs actions biologiques importantes, notamment la vasoconstriction et la libération d’ aldostérone.
0.157333642244339 ||| How does Helixate NexGen work? ||| How is Helixate NexGen used? ||| Comment Helixate NexGen agit -il?
0.35701391100883484 ||| A double-blind, placebo controlled study by Walker et al, 2005 studying the effect of 20 mg doxycycline bid did not show any statistically significant differences between the active group and the placebo group in terms of emergence of doxycycline- or multidrug-resistant bacteria in faecal or vaginal samples. ||| Nicotinic acid-related adverse reactions The following nicotinic acid-related adverse reactions have been seen in clinical trials or post-marketing experience with other nicotinic acid medicinal products at unknown frequency or in clinical trials with Trevaclyn (or the nicotinic acid component of Trevaclyn) in < 1% of the patients treated: ||| Une étude contrôlée par placebo, en double-aveugle, menée par Walker et al, 2005, examinant l'effet de la doxycycline à 20 mg n'a pas montré de différences statistiques significatives entre le groupe actif et le groupe témoin en termes d'émergence de bactéries résistant à la doxycycline ou à résistance croisée dans les échantillons fécaux ou vaginaux.
0.06587275862693787 ||| Gastrointestinal disorders Very common: ||| Gastrointestinal disorders Very Common: ||| Troubles gastro-intestinaux Très fréquent:
0.41724318265914917 ||| Plavix should be given as a single daily dose of 75 mg (one tablet) with or without food. ||| The dose is 2 mg mavacoxib per kg body weight given immediately before or with the dog’ s main meal. ||| Plavix doit être administré à raison d’ une dose quotidienne unique de 75 mg (un comprimé) pendant ou en dehors des repas.
0.47758734226226807 ||| In order to avoid any cross contamination, the same syringe should not be used for different animals. ||| EU countries will now be allowed to retain it to cover any Coronavirus-related costs. ||| Afin d’ éviter toute contamination croisée, le même applicateur ne doit pas être utilisé pour différents animaux.
0.6553851366043091 |||  When the needle is completely inserted into the skin, release the skin that you are holding. ||| Liquid is always emptying out of the eye, and more liquid is always being produced. ||| • Lorsque l’aiguille est complètement insérée dans la peau, relachez la peau que vous tenez.
0.4064425826072693 ||| • 5 ICH-CPMP guidelines are scheduled to be adopted or released for consultation ||| Some ICH guidelines will have to be consolidated with pre-existing CPMP guidelines. ||| 5 lignes directrices ICH-CPMP devraient également être adoptées ou diffusées pour consultation.
0.2246743142604828 ||| HOW TO STORE KINZALKOMB ||| HOW TO TAKE KINZALKOMB ||| COMMENT CONSERVER KINZALKOMB
0.11975656449794769 ||| Renal and urinary disorders: ||| - Renal and urinary disorders: ||| Fréquent: difficulté pour uriner.
0.17071998119354248 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Zometa’ s benefits are greater than its risks for the prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced malignancies involving bone, and for the treatment of tumour-induced hypercalcaemia. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Hepsera’ s benefits are greater than its risks for the treatment of chronic hepatitis B in adults with compensated liver disease with evidence of active viral replication, persistently elevated serum ALT levels and histological evidence of active liver inflammation and fibrosis, and in adults with decompensated liver disease. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Zometa sont supérieurs à ses risques pour la prévention des complications osseuses (fractures pathologiques, compression médullaire, irradiation ou chirurgie osseuse ou hypercalcémie induite par des tumeurs) chez des patients atteints de pathologie maligne à un stade avancé avec atteinte osseuse et pour le traitement de l’ hypercalcémie induite par des tumeurs.
0.2701871693134308 ||| No clinical studies have been conducted in patients > 75 years of age or in patients with hepatic insufficiency (see section 4.4). ||| Safety and efficacy have been assessed in studies of patients ≤ 21 years old at initial diagnosis (see section 5.1). ||| Aucune étude clinique n’ a été réalisée chez les patients de plus de 75 ans ou chez les patients souffrant d’ une insuffisance hépatique (voir rubrique 4.4).
0.4215731620788574 ||| 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 200 film-coated tablets ||| (2 film-coated tablets) (4 film-coated tablets) (8 film-coated tablets) (12 film-coated tablets) ||| 20 comprimés pelliculés 30 comprimés pelliculés 50 comprimés pelliculés 60 comprimés pelliculés 100 comprimés pelliculés 200 comprimés pelliculés
0.47518378496170044 ||| Continued and uninterrupted maritime services are of key strategic importance for trade to and from the whole EU, with 75% of goods arriving to the EU by sea, and 30% of intra EU trade going on vessels. ||| For the Mediterranean and Black Seas, vigorous conservation efforts must continue, and in the Atlantic sea basins, some stocks continue to be overfished or remain outside safe biological limits. ||| Des services maritimes continus et ininterrompus sont d'une importance stratégique majeure pour le commerce à destination et en provenance de l'UE, 75 % des marchandises arrivant dans l'UE par la mer et 30 % des échanges intra-UE se faisant sur des navires.
0.5164351463317871 ||| There is little experience with EXUBERA in patients older than 75 years. ||| No clinical experience is yet available for patients younger than 18. ||| au L’ expérience chez les sujets âgés de plus de 75 ans avec EXUBERA est limitée.
0.3105112612247467 ||| 166 Dose reduction for patients who use 0.5 μg/kg PegIntron monotherapy must be accomplished by reducing the prescribed volume by one-half. ||| Dose reduction of PegIntron may be accomplished by either reducing the prescribed volume by one- half or by utilizing a lower dose strength as shown in Table 2b. ||| Pour les patients recevant 0,5 μ g/ kg de PegIntron en monothérapie, la réduction de dose doit être effectuée en réduisant de moitié le volume prescrit.
1.054782748222351 ||| Gastric pH: ||| Direct sunlight: ||| pH gastrique:
0.2804212272167206 ||| If you do miss a dose, take the next dose as soon as possible, but do not take a double dose to make up for a forgotten dose. ||| If you miss two or more doses, contact your doctor • Do not take a double dose (two doses at the same time) to make up for a forgotten dose ||| En cas d’ oubli, prenez la prochaine dose le plus rapidement possible, mais ne prenez pas de dose double pour compenser la dose que vous avez oubliée de prendre.
0.34761446714401245 ||| In the fourth study, flushing was seen on fewer days in patients taking Trevaclyn than in those taking nicotinic acid alone. ||| Neupro was less effective than ropinirole: a 20% improvement was seen in 68% of the subjects receiving ropinirole. ||| Dans la quatrième étude, un rougissement a été observé chez les patients ayant reçu Trevaclyn pendant un nombre de jours inférieur par rapport à ceux ayant reçu de l’ acide nicotinique seul.
0.5233103632926941 ||| Powder: ||| Powder:: ||| Solvant:
0.4580092430114746 ||| There were increased liver weights and dose-related thyroid follicular cell hypertrophy in rats. ||| Increases in liver weight, plasma ALT (dog only) and fat tissue were also observed. ||| Une augmentation de la masse du foie et une hypertrophie des cellules folliculaires thyroïdiennes proportionnelle à la dose ont été observées chez le rat.
5.953185400154812e-14 ||| Hypoglycaemic coma and hypoglycaemic unconsciousness As with other hypoglycaemic agents, hypoglycaemic reactions have been observed after administration of repaglinide. ||| Hypoglycaemic coma and hypoglycaemic unconsciousness As with other hypoglycaemic agents, hypoglycaemic reactions have been observed after administration of repaglinide. ||| Coma hypoglycémique et perte de connaissance hypoglycémique Comme pour les autres antidiabétiques, des réactions d’ hypoglycémie ont été observées après l’ administration de répaglinide.
0.34697097539901733 ||| The following dose regimen is recommended for titration, although in all cases the physician should take into account the clinical need of the patient, age and concomitant illness. ||| The choice of start dose should take into account the individual patient’ s cholesterol level and future cardiovascular risk as well as the potential risk for adverse reactions (see below). ||| Le médecin doit toutefois toujours prendre en compte les besoins cliniques du patient, son âge et ses maladies concomitantes.
0.39683330059051514 ||| Your doctor will evaluate which cholesterol lowering regimen is best for your specific situation. ||| A scan will give your doctor information about any changes in this area of your brain. ||| de troubles du tissu musculaire peut augmenter.Votre médecin évaluera quel traitement abaissant le cholestérol est le plus adapté à votre situation.
0.28726375102996826 ||| Didanosine enteric-coated 400 mg SD (Indinavir 800 mg SD) ||| Saquinavir 800 mg SD (soft gel capsule formulation) (Indinavir 800 mg TID) ||| Didanosine 400 mg gélule gastrorésistante, en dose unique (Indinavir 800 mg, en dose unique)
0.3984246551990509 ||| The scheme, which will be open to SMEs active in the agriculture, forestry, fishery and aquaculture sectors, aims at enabling those companies to have access to the financial means they need to cover their immediate working capital and investment needs and maintain their activities. ||| The scheme will enable companies active in the primary agricultural production sector to stabilise their cash flow and pay for supplied goods, raw materials (such as seeds, planting materials, plant protection products, mineral fertilisers) and services. ||| Le régime, qui sera accessible aux PME des secteurs de l'agriculture, de la sylviculture, de la pêche et de l'aquaculture, vise à permettre à ces entreprises d'accéder aux moyens financiers dont elles ont besoin pour couvrir leurs besoins immédiats en fonds de roulement et en investissements et poursuivre leurs activités.
3.998210454120993e-13 ||| These studies have shown a consistent unexplained statistically significant excess mortality in patients who have anaemia ic ||| These studies have shown a consistent unexplained statistically significant excess mortality in patients who have anaemia ic ||| Ces études ont montré une surmortalité inexpliquée et constante, statistiquement significative, chez les patients atteints d’ anémie tn
0.5412552952766418 ||| Liquid paraffin: ||| Paraffin liquid ||| Paraffine liquide:
0.3080708682537079 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that TESAVEL’ s benefits are greater than its risks for the treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin and/ or a sulphonylurea, or a PPAR gamma agonist, when diet and exercise plus the other medicines do not provide adequate glycaemic control. ||| RoActemra, in combination with methotrexate (MTX), is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (DMARDs) or tumour necrosis factor (TNF) antagonists. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de TESAVEL sont supérieurs aux risques qu’ il comporte pour le traitement des patients souffrant de diabète de type 2 en vue d’ améliorer le contrôle de la glycémie, en association avec la metformine et/ ou un sulfamide hypoglycémiant, ou un agoniste des PPAR
0.24675780534744263 ||| INVEGA 9 mg prolonged-release tablets ||| Emselex 7.5 mg prolonged-release tablets ||| INVEGA 9 mg comprimés à libération prolongée palipéridone
0.2953408658504486 ||| Doxazosin, as other medicinal products metabolised by the liver, should be administered with caution in patients with signs of minor to moderate hepatic impairment (see section 5.2). ||| Paliperidone is excreted in the breast milk to such an extent that effects on the breast-fed infant are likely if therapeutic doses are administered to breast-feeding women. ||| 9/ 24 La doxazosine, comme les autres produits médicamenteux métabolisés par le foie, doit être administrée avec précaution chez les patients présentant des signes d’ insuffisance hépatique mineure à modérée (voir la rubrique 5.2).
0.06461596488952637 ||| 8/ 17 A. ||| 8/ 18 A. ||| 8/ 18 A.
0.829037070274353 ||| STATEMENT OF ACTIVE SUBSTANCE(S) ||| LIST OF EXCIPIENTS ||| LISTE DES EXCIPIENTS
0.5243756175041199 ||| For a full list of excipients see section 6.1. ||| For the characteristics of NMS see section 4. ||| Pour tous les excipients, voir rubrique 6.1.
0.19033733010292053 ||| Other information about Tractocile: ||| Other information about Easotic: ||| Autres informations relatives à Tractocile:
0.12454041093587875 ||| For first occurrence: ||| For second occurrence: ||| Pour la première survenue:
0.2517375946044922 ||| Ensuring the quality, safety and efficacy of vaccines. ||| demonstrate the quality, safety and efficacy of medicinal products. ||| Garantir la qualité, l'innocuité et l'efficacité des vaccins.
0.015664346516132355 ||| Eye disorders Uncommon - Refraction disorders Refraction anomalies may occur upon initiation of insulin therapy. ||| Eye disorders Uncommon - Refraction disorder Refraction anomalies may occur upon initiation of insulin therapy. ||| Affections oculaires Peu fréquent - anomalies de la réfraction Des anomalies de la réfraction peuvent survenir au début de l'insulinothérapie.
0.2659003734588623 ||| In epilepsy, three studies involved 1,328 patients, and the measure of the effectiveness of Lyrica was based on the difference in the monthly number of seizures before and during treatment. ||| Studies were also carried out in nearly 1,400 adult patients with type 1 or type 2 diabetes to measure the effectiveness of Lantus injected at any time during the day, compared with an evening injection. ||| L’ efficacité de Lyrica a été mesurée en étudiant la différence entre le nombre de crises mensuelles avant et après traitement.
0.37055492401123047 ||| Treatment and prevention of swine enzootic pneumonia. ||| Treatment and prevention of Swine Enzootic Pneumonia. ||| Traitement et prévention de la pneumonie enzootique du porc.
0.1640135496854782 ||| Because ritonavir is highly protein bound it is unlikely that it will be significantly removed by haemodialysis or peritoneal dialysis. ||| As darunavir and ritonavir are highly bound to plasma proteins, it is unlikely that they will be significantly removed by haemodialysis or peritoneal dialysis. ||| Le ritonavir étant fortement lié aux protéines, il est improbable qu'il soit éliminé en quantité significative par hémodialyse ou dialyse péritonéale.
0.08376889675855637 ||| WHAT BEROMUN IS AND WHAT IT IS USED FOR ||| WHAT BYETTA IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE BEROMUN ET DANS QUEL CAS EST-IL UTILISÉ
0.015920365229249 ||| Each tablet contains 80 mg telmisartan. ||| Each tablet contains 40 mg telmisartan. ||| Chaque comprimé contient 80 mg de telmisartan.
0.02428572252392769 ||| Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom ||| Abbott Laboratories Limited Queenborough Kent ME11 5EL United Kingdom ||| Queenborough Kent ME11 5EL United Kingdom
0.4432131052017212 ||| Enalapril administration once daily lowered trough blood pressure in a dose-dependent manner. ||| Procoralan mainly works by reducing the heart rate by a few beats per minute. ||| L'administration d'énalapril une fois par jour a diminué la valeur de la pression artérielle à la vallée de manière dose-dépendante.
0.32461434602737427 ||| Commissioner for Health and Food Safety, Stella Kyriakides, said: "We know how much European citizens are looking forward to summer and to travel. ||| Stella Kyriakides, Commissioner for Health and Food safety said, "We must move forward and make the EU's food system a driving force for sustainability. ||| Stella Kyriakides, commissaire chargée de la santé et de la sécurité alimentaire: «Nous savons combien les citoyens européens attendent avec impatience l'été et les voyages.
0.674206018447876 ||| 30 days for opened bottle. ||| Open both bottles. ||| 30 jours après l’ ouverture du flacon.
0.24939224123954773 ||| 26 Clinically relevant CTC toxicities that were reported in ≥ 1% and < 5% (common) of the patients that were randomly assigned to pemetrexed include: infection without neutropenia, febrile neutropenia, allergic reaction/ hypersensitivity, increased creatinine, motor neuropathy, sensory neuropathy, erythema multiforme, and abdominal pain. ||| Severe hepatotoxicity, cardiac toxicity including QTc interval prolongation, severe skin reactions, Clostridium difficile associated colitis, tendon and muscular toxicity (including rhabdomyolysis) are important identified risks of the treatment with moxifloxacin which are already described in the product information (PI) and under close monitoring. ||| Les toxicités cliniquement significatives d’ après les Critères Communs de Toxicité rapportées chez ≥ 1% et ≤ 5% (fréquemment) des patients inclus dans le bras recevant du pemetrexed ont inclus infection sans neutropénie, neutropénie fébrile, réaction allergique/ hypersensibilité, augmentation de la créatinine, neuropathie motrice, neuropathie sensitive, érythème multiforme et douleur abdominale.
0.8359566330909729 ||| Malta, Denmark and Luxembourg lead on VHCNs with coverage of at least 90% of homes. ||| Transport for London (TfL) services were reduced in stages. ||| Malte, le Danemark et le Luxembourg sont à la pointe pour les réseaux VHCN, avec une couverture d'au moins 90 % des foyers.
0.27870601415634155 ||| Today, the Commission issued new practical advice on how to implement its Guidelines for border management, in order to keep freight moving across the EU during the current pandemic. ||| Today, the Commission adopted guidance on the implementation of relevant EU rules on asylum and return procedures and on resettlement in the context of the coronavirus pandemic, which it will present to Member States. ||| Afin de garantir la continuité du transport de marchandises sur tout le territoire de l'UE durant la pandémie actuelle, la Commission a publié aujourd'hui de nouvelles orientations pratiques sur la mise en œuvre de ses lignes directrices relatives aux mesures de gestion des frontières.
0.1361706554889679 ||| - If you are allergic (hypersensitive) to ibandronic acid, or to any of the other ingredients of ||| - if you are allergic (hypersensitive) to the active ingredient, ropinirole, or any of the other ||| - Si vous êtes allergique (hypersensible) à l’ acide ibandronique ou à tout autre composant de
0.0 ||| System Organ ||| System Organ ||| systèmes
0.8429954648017883 ||| This will help protect the environment. ||| Our Union must also be healthy and sustainable. ||| Ces mesures permettront de protéger l’ environnement.
0.8438435196876526 ||| - For application to vertebral (spine) fractures. ||| Other allografts (lung, pancreas and intestines) ||| - pour application à des fractures vertébrales (de la colonne).
0.09711660444736481 ||| Azomyr should not be used in people who may be hypersensitive (allergic) to desloratadine, loratadine or any of the other ingredients. ||| Evra should not be used by women who may be hypersensitive (allergic) to norelgestromin, ethinyl estradiol or any of the other ingredients. ||| Azomyr ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à la desloratadine, à la loratadine ou à l’ un de ses autres composants.
0.8647693395614624 ||| Regional Infection Control Networks ||| Disease Control and Detection ||| Réseaux régionaux de contrôle des infections
0.16871759295463562 ||| In the main study, Fabrazyme was compared with placebo (a dummy treatment) in 58 patients. ||| In the PROWESS study, Xigris was compared to placebo (dummy treatment) in 1,690 patients. ||| Dans l'étude principale, Fabrazyme a été comparé à un placebo (traitement fictif) chez 58 patients.
0.0921240895986557 ||| Bows for musical instruments ||| Bridges for musical instruments ||| Archets pour instruments de musique
0.0 ||| The cytotoxicity of MTIC is thought to be due primarily to alkylation at the O6 position of guanine with additional alkylation also occurring at the N7 position. ||| The cytotoxicity of MTIC is thought to be due primarily to alkylation at the O6 position of guanine with additional alkylation also occurring at the N7 position. ||| La cytotoxicité du MTIC est vraisemblablement due principalement à une alkylation de la guanine en position O6 et à une alkylation supplémentaire en position N7.
0.23255030810832977 ||| What is Kineret? ||| What is Rasilez? ||| Qu’ est -ce que Kineret?
0.29117923974990845 ||| There was a low frequency (approximately 3%) of myelodysplastic syndromes (MDS) or leukaemia in clinical study patients with SCN treated with filgrastim. ||| The rates of confirmed lower GI clinical events (small or large bowel perforation, obstruction, or hemorrhage, (POBs)) were not significantly different between etoricoxib and diclofenac. ||| De rares cas (environ 3%) de syndromes myélodysplasiques (SMD) ou de leucémies ont été observés lors des études cliniques chez les patients atteints de neutropénie chronique sévère traités par le filgrastim.
0.4141964316368103 ||| Patient management should include laboratory evaluation of hepatic function (particularly liver function tests and bilirubin). ||| Cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring for possible arrhythmias. ||| 49 hépatique (en particulier tests de la fonction hépatique et de la bilirubine).
0.14691272377967834 ||| Caution is needed when administrating this vaccine to persons with a known hypersensitivity (other than anaphylactic reaction) to the active substance, to any of the excipients and to eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB). ||| Focetria should not be given to patients who have had an anaphylactic reaction (severe allergic reaction) to any of the components of the vaccine, or to any substances found at trace levels in the vaccine, such as eggs, chicken protein, kanamycin or neomycin sulphate (two antibiotics), formaldehyde, cetyltrimethylammonium bromide (CTAB) and polysorbate 80. ||| L’ administration de ce vaccin doit se faire avec précaution chez les sujets ayant des antécédents d’ hypersensibilité (autre qu’ une réaction anaphylactique) à la substance active, à l’ un des excipients ou aux œ ufs, aux protéines de poulet, à la kanamycine et au sulfate de néomycine, au formaldéhyde et au bromure de cétyltriméthylammonium (CTAB).
0.58160799741745 ||| Natural stone ||| Platinum jewelry ||| Pierre naturelle
0.07873447239398956 ||| 130 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS SOLVENT PRE-FILLED SYRINGE ||| 46 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS PRE-FILLED ORAL APPLICATOR ||| 137 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES ETIQUETTE DE LA SERINGUE PREREMPLIE DE SOLVANT
0.5460636615753174 ||| Swags [curtains] ||| Tacks [nails] ||| Festons [rideaux]
0.7317509055137634 ||| Sleeping agent Zolpidem ||| That Volibris is teratogenic ||| Somnifères Zolpidem
0.1892509162425995 ||| Each 20 ml vial contains 180 mg of sodium chloride. ||| Each 70 mg vial contains 50.0 mg of sucrose. ||| Chaque flacon de 20 ml contient 180 mg de chlorure de sodium.
0.8258790969848633 ||| France sanofi-aventis france Tél: ||| Relyo Hellas ΕΠΕ Pan. ||| 81 France sanofi-aventis france Tél:
0.5057225227355957 ||| - difficulty breathing, decrease in level of oxygen, choking, swelling of the airways, fluid in ||| - feeling thirsty and producing darker or less urine than normal, decreased or loss of appetite, ||| - difficulté à respirer, baisse de l’oxygénation, suffocation, congestion des voies respiratoires,
0.004097402095794678 ||| ADARTREL 1 mg film-coated tablets Ropinirole (as hydrochloride) ||| ADARTREL 2 mg film-coated tablets Ropinirole (as hydrochloride) ||| ADARTREL 1 mg, comprimés pelliculés Ropinirole (sous forme de chlorhydrate)
0.4512068033218384 ||| The temperature should then be increased to > 39°C (but not exceeding 40°C) in two different sites of measurement in the tumour area. ||| (Please note that whilst the control settings on the water bath and heat block are set to different levels the temperature of the vial contents are in the same range (55-60°C)). ||| La température doit alors être augmentée pour atteindre 39°C (sans excéder 40°C), en deux sites différents de mesure de la température au niveau de la tumeur.
3.351069421952957e-13 ||| The benefit- risk balance may be found in module 6 of this EPAR. ||| The benefit- risk balance may be found in module 6 of this EPAR. ||| Le rapport bénéfice/ risque est présenté au module 6 de cet EPAR.
0.4593503773212433 ||| Cefovecin exhibits in vitro activity against Staphylococcus intermedius and Pasteurella multocida which are associated with canine and feline skin infections. ||| Menitorix will only confer protection against Haemophilus influenzae type b and Neisseria meningitidis group C. ||| La céfovécine a une activité in vitro contre Staphylococcus intermedius et Pasteurella multocida qui sont associées aux infections de la peau chez les chiens et les chats.
0.20365074276924133 ||| Severe hypoglycaemic reactions with coma, seizure or other neurological symptoms should be treated with intravenous glucose. ||| More severe hypoglycaemia with seizure, loss of consciousness or coma should be treated with IV glucose. ||| En cas de réactions hypoglycémiques sévères, avec coma, crises comitiales ou autres troubles neurologiques, on administrera du glucose par voie intraveineuse.
0.3562822639942169 ||| As requested by the CHMP, the MAH agreed to submit the follow-up measures as listed below: ||| The MAH further agreed to the proposed wording by the CHMP as follows: ||| Sur demande du CHMP, le titulaire de l’ Autorisation de Mise sur le Marché a accepté d’ exécuter les mesures de suivi énumérées ci-dessous:.
0.4766775667667389 ||| These patients should be closely monitored for possible adverse reactions and to ensure efficacy is maintained. ||| there would have to be safeguards against abuse and the rights of citizens to respond to abuses; ||| Ces patients doivent être étroitement surveillés à la recherche des effets indésirables éventuels et afin de s’ assurer du maintien de l’ efficacité du traitement.
0.23186467587947845 ||| Trabectedin does not induce or inhibit major cytochrome P450 enzymes. ||| Strontium ranelate does not inhibit cytochrome P450 enzymes. ||| La trabectédine ne provoque ni induction ni inhibition des iso-enzymes majeures du système du cytochrome P450.
0.293680340051651 ||| IARs may occur at any time during the infusion of Myozyme or generally up to 2 hours after, and are more likely with higher infusion rates. ||| Most side effects with Aclasta tend to occur within the first three days after infusion, becoming less common with repeated infusions. ||| Les RAP peuvent survenir à tout moment pendant la perfusion de Myozyme ou généralement jusqu’ à 2 heures après, et sont plus probables aux débits de perfusion les plus élevés.
0.2559966444969177 ||| Pack sizes of 14, 28, 56; 168 modified-release tablets and 32 x 1modified-release tablets in a perforated unit dose blister. ||| Aluminium/ Aluminium blister with push-through lidding in pack sizes of 14, 28, 56, 168 modified-release tablets and 32 x 1 modified-release tablets in perforated unit dose blister. ||| Boîtes de 14, 28, 56, 168 comprimés à libération modifiée 32 x 1 comprimé à libération modifiée en plaquette thermoformée unidose.
0.4174325168132782 ||| Blood trough levels for Advagraf should be drawn approximately 24 hours post-dosing, just prior to the next dose. ||| During the 8 week double-blind period, patients took modafinil at their established dose or placebo equivalent. ||| Les taux sanguins d’ Advagraf doivent donc être déterminés 24 heures environ après l’ administration de la dernière dose, et juste avant la dose suivante.
0.009594079107046127 ||| The Commission therefore concluded that the measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| The Commission concluded that the measure is necessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| La Commission a dès lors conclu que la mesure était nécessaire, appropriée et proportionnée pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
0.3606143593788147 ||| In a population of patients with refractory SCLC (those not responding to first line therapy), the response rate to topotecan was 4.0%. ||| About half of this 6% (3% of the total patients given BYETTA in the controlled studies), had no apparent glycaemic response to BYETTA. ||| Dans une population de patients réfractaires (ceux ne répondant pas à la première ligne de traitement), le taux de réponse au topotécan était de 4,0%.
0.4982081949710846 ||| Blast furnaces ||| Stain repellents ||| Hauts fourneaux
0.5185872912406921 ||| HMG-CoA REDUCTASE INHIBITIORS Lovastatin, simvastatin ||| DULOXETINE BOEHRINGER INGELHEIM 20 mg hard gastro-resistant capsules Duloxetine ||| INHIBITEURS DE L 'HMG-CoA REDUCTASE Lovastatine, simvastatine
0.0 ||| 6.5 Nature and composition of immediate packaging ||| 6.5 Nature and composition of immediate packaging ||| 4/ 19 6.5 Nature et contenu du conditionnement primaire
0.3961084187030792 ||| Radiator surrounds of non-metallic materials ||| Anti-neoplastic preparations of microbial origin ||| Entourages de radiateur en matériaux non métalliques
0.0 ||| 1. ||| 1. ||| 53 1.
0.32429468631744385 ||| In kidney failure, the kidney does not produce enough of the natural hormone erythropoietin which can often cause anaemia. ||| Administration during childbirth is not recommended because fentanyl crosses the placenta and the foetal respiratory centre is sensitive to opiates. ||| L’insuffisance rénale entraîne souvent une anémie, les reins ne produisant pas assez d’érythropoïétine, l’hormone naturelle.
0.05510540306568146 ||| Each capsule contains 40 mg duloxetine (as hydrochloride). ||| Each capsule contains 20 mg of duloxetine (as hydrochloride). ||| Chaque gélule contient 40 mg de duloxétine (sous forme de chlorhydrate).
0.45766928791999817 ||| The following table can be used to guide dosing in bleeding episodes and surgery: ||| The following changes in the bacterial count after drying the hands were observed: ||| Le tableau ci-dessous fournit des indications concernant le dosage en cas d’ hémorragie et d’ intervention chirurgicale:
0.5518413782119751 ||| Maculopapular and erythematous rashes, skin photosensitivity, urticaria Very rare: ||| - itchy rash (urticaria); itching; skin flushing (erythema) ||| Éruptions maculopapuleuse et érythémateuses, photosensibilité cutanée, urticaire
0.501928448677063 ||| While you are being treated with Kivexa, your doctor will monitor you closely for any signs that you may be developing lactic acidosis. ||| You have already been diagnosed has being infected with Helicobacter pylori and have been taking medication aimed to clear up the infection. ||| Votre médecin assurera un suivi régulier des signes liés au risque de développement d’ une acidose lactique, ceci tout au long de votre traitement par Kivexa.
0.001638581044971943 ||| 108 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| 103 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez en à votre médecin ou à votre pharmacien.
0.15665987133979797 ||| 94 Adult patients on peritoneal dialysis The treatment is divided into two stages: ||| Adult patients on haemodialysis The treatment is divided into two stages: ||| Patients adultes sous dialyse péritonéale Le traitement se divise en deux phases:
0.21880735456943512 ||| Clinical studies have demonstrated the efficacy and safety of Ranexa in the treatment of patients with chronic angina, either alone or when the benefit from other antianginal medicinal products was sub-optimal. ||| In a parallel group study designed to assess the efficacy and safety of riluzole in patients at a late stage of the disease, survival time and motor function under riluzole did not differ significantly from that of placebo. ||| 8 Efficacité clinique: les études cliniques ont montré l’ efficacité et la sécurité de Ranexa dans le traitement des patients atteints d’ angor chronique lorsque le produit était utilisé en monothérapie ou lorsque le bénéfice des autres antiangoreux était sous-optimal.
0.33661168813705444 ||| If this happens to you, tell your doctor. ||| Tell your doctor immediately if this occurs. ||| Consultez votre médecin si cela vous arrive.
0.061195794492959976 ||| Enbrel can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. ||| Trudexa can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate. rod ||| Enbrel peut être donné en monothérapie en cas d’ intolérance au méthotrexate ou lorsque la poursuite du traitement avec le méthotrexate est inadaptée.
0.0 ||| 6. ||| 6. ||| 15 6.
0.2734917998313904 ||| Eesti Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86 ||| Eesti filiaal Pärnu mnt 105 EE - 11312 Tallinn Tel: +372 665 2400 ||| 101 Eesti Österreich Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86
0.25116345286369324 ||| * In haemodialysis patients or in case of acute renal failure (creatinine clearance below 15 ml/ min or creatinine value above 60 mg/ l [530 μ mol/ l]), infusion of Refludan is to be avoided or stopped. ||| Treatment of patients with chemotherapy induced anaemia Retacrit should be administered by the subcutaneous route to patients with anaemia (e. g. haemoglobin concentration ≤ 10 g/ dl (6.2 mmol/ l). ||| • Chez les patients hémodialysés ou en cas d'insuffisance rénale aiguë (clairance de la créatinine inférieure à 15 ml/ min ou créatininémie supérieure à 60 mg/ l [530 µmol/ l]), il est nécessaire d'éviter ou d'arrêter la perfusion de Refludan.
0.0038416055031120777 ||| You can clean the exterior of your Mixtard 50 NovoLet by wiping it with a medicinal swab. ||| You can clean the exterior of your Mixtard 40 NovoLet by wiping it with a medicinal swab. ||| Vous pouvez nettoyer l'extérieur de votre Mixtard 50 NovoLet à l’ aide d’ une compresse antiseptique.
0.518474817276001 ||| Dressers ||| Marker ||| Bahuts
0.5418558120727539 ||| Contrast agents for use in molecular imaging ||| Devices for analyzing genome information ||| Agents de contraste destinés à l'imagerie moléculaire
0.0 ||| Medicinal product subject to medical prescription. ||| Medicinal product subject to medical prescription. ||| CONDITIONS DE PRESCRIPTION ET DE DELIVRANCE Médicament soumis à prescription médicale
0.29388782382011414 ||| Lesser amounts are distributed to adipose and muscle tissue and stored as vitamin D3 at ||| Lesser amounts are distributed to adipose and muscle tissue and stored as vitamin D3 at these sites for later release into the circulation. ||| Des quantités plus petites sont distribuées dans les tissus adipeux et musculaire et y sont stockées sous forme de vitamine D3 qui sera libérée ultérieurement dans la circulation.
0.0 ||| If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you. ||| If you are in a clinical trial and need more information about your treatment, contact the doctor who is giving it to you. ||| Si vous participez actuellement à un essai clinique et si vous souhaitez des informations complémentaires concernant votre traitement, veuillez contacter le médecin qui vous le prescrit.
0.2839829921722412 ||| Slowly pull the plunger back to draw solution into the syringe. • With the needle still inserted in the vial, check the syringe for air bubbles. ||| Preparing the dose of MIRCERA ● Remove the protective cap from the vial (1). ● Clean the rubber top of the vial with a cleansing alcohol swab. ||| Tirez doucement le piston pour aspirer la solution dans la seringue. • L’aiguille toujours insérée dans le flacon, vérifiez l’absence de bulles d’air.
0.4162105619907379 ||| Pam 90 mg Zometa Pam Zome ||| Zometa Pam 90 mg Zometa Pam Zometa ||| Pam Zometa Pam Zomet
0.21447089314460754 ||| Each pre-filled syringe contains 6 mg of pegfilgrastim in 0.6 ml of solution. ||| 1 prefilled syringe with 20 ml of the solution contains 12094 mg gadobutrol. ||| Chaque seringue préremplie contient 6 mg de pegfilgrastim dans 0,6 ml de solution.
0.008307182230055332 ||| EMEA/ CHMP/ 123439/ 2006/ EN ||| EMEA/ CHMP/ 123448/ 2006/ EN ||| EMEA/ CHMP/ 123439/ 2006/ FR
0.3833707571029663 ||| In clinical studies, patients with creatinine clearance of ≥ 45 ml/ min required no dose adjustments other than those recommended for all patients. ||| Under certain circumstances (e. g. presence of a low titre inhibitor) doses larger than those calculated using the formula may be necessary. ||| Dans les études cliniques, des ajustements de doses autres que celles préconisées pour l'ensemble des patients n’ ont pas été nécessaires chez les patients dont la clairance de la créatinine était ≥ 45 ml/ min.
0.760796308517456 ||| Article 2 2 1 — Total ||| Article 3 0 0 — Total ||| Total de l'article 2 2 1
0.10318750143051147 ||| 13 6.3 Shelf life ||| 23 6.3 Shelf life ||| 6.3 Durée de conservation
0.0914740115404129 ||| Always take Karvezide exactly as your doctor has told you. ||| Always take Janumet exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.17272131145000458 ||| In patients with mild or moderate renal impairment (creatinine clearance ≥ 30– 80 ml/ min) compared to those with normal renal function (creatinine clearance > 80 ml/ min), the most commonly reported events and their placebo-corrected frequencies included: constipation (8% versus 4%), dizziness (7% versus 5%), and nausea (4% versus 2%). ||| Of the most commonly reported, the following events occurred more often with Ranexa (placebo-corrected frequencies) in elderly (≥ 75 years of age) than younger patients (< 75 years of age): constipation (8% versus 5%), nausea (6% versus 3%), hypotension (5% versus 1%), and vomiting (4% versus 1%). ||| Chez les insuffisants rénaux légers ou modérés (clairance de la créatinine ≥ 30-80 ml/ min) par rapport aux patients dont la fonction rénale était normale (clairance de la créatinine > 80 ml/ min), les événements les plus fréquemment rapportés et leurs fréquences corrigées par les valeurs sous placebo étaient les suivantes: constipation (8% vs 4%), vertiges (7% vs 5%) et nausées (4% vs 2%).
0.41519060730934143 ||| Common • Febrile neutropaenia Very rare • Thrombocytosis ||| Frequency grouping Very Common • Haematuria • Mild proteinuria ||| Fréquent • Neutropénie fébrile Très rare • Thrombocytémie
0.4599820375442505 ||| - Sodium chloride ||| - Sodium saccharinate ||| - Chlorure de sodium
0.3425847887992859 ||| The incidence and severity of teratogenic effects increased with escalation of the dose. ||| The magnitude of QT prolongation may increase with increasing concentrations of the drug. ||| L’ incidence et la sévérité de ces effets tératogènes ont augmenté avec la dose.
0.3251742720603943 ||| Ciprofloxacin is present in plasma largely in a non- ionised form and has a large steady state distribution volume of 2-3 L/kg body weight. ||| Palivizumab serum concentrations of approximately 30 μ g/ ml have been shown to produce a 99% reduction in pulmonary RSV replication in the cotton rat model. ||| Le volume de distribution à l’équilibre est important, de l’ordre de 2– 3 l/kg de masse corporelle.
0.022333195433020592 ||| 2000 IU octocog alfa (400 IU/ ml after reconstitution). ||| 500 IU octocog alfa (200 IU/ ml after reconstitution). ||| 2000 UI d’ octocog alfa (400 UI/ ml après reconstitution).
0.38723087310791016 ||| The impact of Gardasil on rates of Definitive Cervical Therapy Procedures regardless of causal HPV types was evaluated in 18,150 subjects enrolled in Protocol 007, Protocols 013 and 015. ||| Table 4 lists ADRs associated with the use of Xeloda monotherapy based on a pooled analysis of safety data from three major studies including over 1900 patients (studies M66001, SO14695, and SO14796). ||| 9 L'impact de Gardasil sur les taux de conisation quel que soit les types d'HPV en cause a été évaluée dans les protocoles 007, 013 et 015, incluant 18 150 sujets.
0.1934555172920227 ||| Allow the solution to return to room temperature before using. ||| Allow the refrigerated solution to reach room temperature before administration. ||| Laissez la solution revenir à température ambiante avant utilisation.
0.48605433106422424 ||| Patients with high blood pressure and type 2 diabetes Treatment usually starts with 50 mg losartan (one tablet Cozaar 50 mg) once a day. ||| 14 the RESIST-1 and RESIST-2 Phase III pivotal trials, have been treated with 500 mg/ 200 mg twice daily for at least 48 weeks. ||| Patients hypertendus diabétiques de type 2 La dose habituelle d'initiation est 50 mg de losartan une fois par jour (1 comprimé de Cozaar 50 mg).
3.9371576745356185e-13 ||| Ask your pharmacist how to dispose of medicines no longer required. ||| Ask your pharmacist how to dispose of medicines no longer required. ||| Demandez à votre pharmacien ce qu'il faut faire des médicaments dont vous n'avez plus l'utilité.
0.37895917892456055 ||| Improvement in fatigue, as measured by the Functional Assessment of Cancer Therapy-fatigue (FACT-fatigue) scale, was also observed. ct ||| Relief of the symptoms of GAD as reflected by the Hamilton Anxiety Rating Scale (HAM-A) was observed by Week 1. ||| Une amélioration de la fatigue, mesurée par l’ échelle d’ évaluation fonctionnelle de la fatigue liée à la chimiothérapie anticancéreuse (FACT-fatigue), a également été observée. am
0.5398874282836914 ||| Will part of the money be loans and will the private sector contribute? ||| How will the transfer between cohesion policy funds work, and what are the conditions? ||| Une partie des fonds sera-t-elle constituée par des prêts et le secteur privé contribuera-t-il?
0.17699621617794037 ||| Bathroom installations for water supply purposes ||| Bathroom installations for sanitary purposes ||| Installations de distribution d'eau pour salles de bains
0.329556941986084 ||| Due to the wide therapeutic index of loratadine no clinically relevant interactions are expected and none were observed in the conducted clinical trials (see 5.2). ||| Since no formal dose-response studies have been conducted, Phase III data were analyzed to investigate the existence of a dose– efficacy relationship. ||| En raison de la marge thérapeutique large de la loratadine, aucune interaction cliniquement significative n’ est à attendre et aucune n’ a été observée au cours des essais cliniques réalisés (voir section 5.2).
0.02955237217247486 ||| Retacrit 5000 IU/ 0.5ml solution for injection in pre-filled syringe ||| Retacrit 20000 IU/ 0.5ml solution for injection in pre-filled syringe ||| Retacrit 5 000 UI/ 0,5 ml solution injectable en seringue préremplie
0.41075077652931213 ||| The pronounced increase in mutual recognition procedures requires support to facilitate the smooth running of the Mutual Recognition Facilitation Group (MRFG) and to support to the evaluation of herbal medicinal products, in particular to prevent ||| The efficiency and level of control of the systems for co-ordinating inspections and producing ‘export certificates’ should improve significantly following the introduction of the Agency’s application tracking system (ATS) and quality management system (QMS). ||| Activités spécifiques à la mutuelle doit être favorisée pour faciliter le bon fonctionnement demande des institutions du groupe de facilitation de la reconnaissance mutuelle (MRFG) communautaires et des États et soutenir l’évaluation des médicaments à base de plantes, en membres particulier pour empêcher les arbitrages de routine dans la procédure de reconnaissance mutuelle.
0.566496729850769 ||| Film-coated tablets 200 mg: ||| Gemzar 200 mg contains: ||| Comprimé pelliculé 200 mg:
0.1664602905511856 ||| Slovenija Abbott Laboratories d.o.o. ||| Slovenija Abbott Laboratories d. o. o. ||| Abbott Laboratories d.o.o.
0.4396163821220398 ||| When you start taking insulin, water retention may cause swelling around your ankles and other joints. ||| While women may experience leakage of fluid or milk from the breast, men may develop breast swelling. ||| Lorsque vous commensez votre traitement à l’ insuline, la rétention d’ eau peut provoquer un gonflement de vos chevilles et des autres articulations.
0.46289780735969543 ||| The major circulating metabolite of doxorubicin, doxorubicinol, is formed via aldo-keto-reductase. ||| Valdecoxib, but not parecoxib, is extensively partitioned into erythrocytes. ||| Le principal métabolite de la doxorubicine en circulation, le doxorubicinol, est formé par une aldo-céto réductase.
0.3002484440803528 ||| Straps of metal ||| Pitons of metal ||| Lanières en métal
0.3303655982017517 ||| It is strongly recommended to avoid the use of AZOPT when breast-feeding. ||| It is preferable not to use this product during pregnancy and breast-feeding. ||| Il est fortement recommandé d’ éviter d’ utiliser AZOPT pendant l’ allaitement.
0.05485779792070389 ||| In Study 1 (see section 5.1), decrease in absolute neutrophil count levels below 500 cells/mm3 was observed in 4% (8/194) of patients and decrease in platelets below 50,000/mm3 was observed in 4% (8/194) of patients receiving ViraferonPeg in combination with ribavirin. ||| In Study 1 3 (see section 5.1), decrease in absolute neutrophil count levels below 500 cells/ mm was observed in 3 4% (8/ 194) of patients and decrease in platelets below 50,000/ mm was observed in 4% (8/ 194) of patients receiving Ribavirin in combination with peginterferon alfa-2b. ||| Dans l’ Etude 1 (voir rubrique 5.1), il a été observé des diminutions des taux absolus de neutrophiles en dessous de 500 cellules/ mm3 chez 4% des patients (8/ 194) et des plaquettes en dessous de 50 000/ mm3 chez 4% des patients (8/ 194) recevant ViraferonPeg en association avec la ribavirine.
0.3789200186729431 ||| Take off the outer needle cap and keep it to remove the used needle after injection. ||| Remove the needle after each injection and store InnoLet without the needle attached. ||| Retirez le capuchon extérieur de l’ aiguille et conservez le pour enlever l’ aiguille usagée après l’ injection.
0.6558681726455688 ||| What benefit has DEXDOMITOR shown during the studies? ||| What EU-funded research is ongoing on COVID-19? ||| Quel est le bénéfice démontré par DEXDOMITOR au cours des études?
3.499819791613623e-13 ||| Store in the original package in order to protect from light and moisture. ||| Store in the original package in order to protect from light and moisture. ||| Conserver dans l’ emballage d’ origine à l’ abri de la lumière et de l’ humidité.
0.04287280887365341 ||| Studies have been carried out to prove that Meloxivet is ‘ bioequivalent ’ to the reference veterinary medicine: this means that Meloxivet is equivalent to Metacam 1.5 mg/ ml suspension in the way it is absorbed and used by the body. ||| Studies have been carried out to prove that Loxicom is ‘ bioequivalent ’ to the reference veterinary medicine which means that Loxicom is equivalent to Metacam 1.5 mg/ ml suspension in the way it is absorbed and used by the body. ||| Des études ont été menées pour démontrer que Meloxivet est « bioéquivalent » au médicament vétérinaire de référence: cela signifie que Meloxivet est absorbé et utilisé par l’ organisme de la même façon que Metacam 1,5 mg/ ml suspension orale.
0.2553257644176483 ||| PegIntron 50 micrograms powder for injection SC ||| AVONEX 30 micrograms powder for injection ||| PegIntron 50 microgrammes poudre pour solution injectable S. C.
0.5632163286209106 ||| or What is the risk associated with Advasure? ||| 87 Are there any interactions with an influenza vaccination? ||| to Quels sont les risques associés à Advasure?
0.005652900785207748 ||| Hard capsule White, marked “Pfizer” on the cap and “PGN 50” on the body with black ink. ||| Hard capsule White, marked “Pfizer” on the cap and “PGN 150” on the body with black ink. ||| Gélule Blanche, portant en noir les mentions « Pfizer » sur la partie supérieure et « PGN 50 » sur la partie inférieure.
0.41059768199920654 ||| Experience with long term treatment in adults and in patients with PWS is limited. ||| The experience of OPTISON in severely ill patients is limited. ||| L'expérience d'un traitement au long cours par l'hormone de croissance chez l'adulte et les patients présentant un syndrome de Prader-Willi est limitée.
0.3921630084514618 ||| Try to use Avonex at the same time on the same day each week. ||| It is best to take tablets at the same time each day. ||| Essayez si possible, de prendre Avonex à la même heure et le même jour chaque semaine.
0.21903711557388306 ||| The maximum dose should not exceed 200 IU/ kg 3 times per week. ||| The dosage should not normally exceed 200 IU per kilogram, three times a week. ||| La dose maximale ne doit pas excéder 200 UI/ kg 3 fois par semaine.
0.19876724481582642 ||| Always use Fluticasone furoate GSK exactly as your doctor has told you. ||| Always use Fentanyl-ratiopharm exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.5386224985122681 ||| Crystal [glassware] ||| Lamp black [pigment] ||| Cristaux [verrerie]
0.6595737338066101 ||| 15 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE ||| KEEP THE VIAL IN AN UPRIGHT POSITION. ||| 15 INFORMATIONS APPARENTES SUR L’ EMBALLAGE EXTERIEURE
0.0020754500292241573 ||| Mixtard 50 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA) ||| Mixtard 30 Penfill 100 IU/ ml suspension for injection in a cartridge Insulin human (rDNA) ||| Mixtard 50 Penfill 100 UI/ ml suspension injectable en cartouche Insuline humaine, (ADNr)
0.3035767674446106 ||| The accumulation of bosentan in hepatocytes leading to cytolysis with potentially severe damage of the liver, or an immunological mechanism, are not excluded. ||| 31 This may be due to blood clots in the artery leading to your lungs (called ‘pulmonary embolism’), which is a common side effect. ||| Un mécanisme immuno- allergique ou la possibilité d’ une accumulation du bosentan dans les hépatocytes entraînant une cytolyse et un risque potentiel d’ atteinte hépatique sévère ne peuvent être écartés.
0.4573684334754944 ||| 15 1. ||| 1 16 ||| 17 1.
0.5208228826522827 ||| In total, the EU will support with €800 million our Western Balkan partners and Turkey to address the coronavirus. ||| The €250 million Latvian racapitalisation measure will help airBaltic weather the crisis. ||| Au total, le soutien fourni par l'UE à ses partenaires dans les Balkans occidentaux et à la Turquie pour lutter contre le coronavirus se montera à 800 millions d'euros.
0.16220787167549133 ||| Actrapid is used in patients who have diabetes. ||| Actraphane is used in patients with diabetes. ||| Actrapid est utilisé chez le patient diabétique.
0.26857030391693115 ||| Dosing of APTIVUS, co-administered with low dose ritonavir, with antacids should be separated by at least a two hours time interval. ||| Based on these results, PREZISTA co-administered with 100 mg ritonavir can be co-administered with proton pump inhibitors without dose adjustments. ||| La co-administration d’ APTIVUS, associé au ritonavir à faible dose, avec les antiacides doit être séparée par un intervalle d’ au moins deux heures.
0.29557371139526367 ||| As dosage adjustment of Combivir is not possible separate preparations of zidovudine and lamivudine should be used. ||| Insufficient data are available to make a dosing recommendation for saquinavir/ ritonavir when dosed with Atripla. ||| Dans ce cas, et sachant qu’ une adaptation posologique de Combivir n’ est pas possible, l’ administration séparée de la lamivudine et de la zidovudine est recommandée.
0.5599491596221924 ||| OptiSet is damaged, use a new OptiSet. ||| • Difference is more than 2 units OptiSet is damaged, use a new OptiSet. ||| OptiSet est endommagé, utilisez un nouvel OptiSet.
0.39312848448753357 ||| Women of child-bearing potential must use adequate contraception during treatment with Zonegran and for one month after discontinuation (see section 4.6). ||| Use in elderly patients Elderly should be observed carefully and the dose reduced if necessary (see sections 4.4 and 5.2). ||| Les femmes en âge de procréer doivent utiliser une méthode contraceptive adéquate pendant le traitement par Zonegran et pendant le mois suivant l’ arrêt du traitement (voir rubrique 4.6).
0.5148971080780029 ||| Hycamtin helps to destroy tumours. ||| Maropitant is effective against vomiting. ||| Hycamtin aide à détruire les tumeurs.
0.30813050270080566 ||| Treatment with Tracleer led to a significant increase in cardiac index associated with a significant reduction in pulmonary artery pressure, pulmonary vascular resistance and mean right atrial pressure. ||| A renal function study in healthy volunteers demonstrated a reduction in creatinine clearance with no change in glomerular filtration rate consistent with inhibition of renal tubular secretion of creatinine. ||| Le traitement par Tracleer a entraîné une amélioration significative de l’ index cardiaque associée à une réduction significative de la pression artérielle pulmonaire, des résistances vasculaires pulmonaires et de la pression moyenne de l’ oreillette droite.
0.1334131956100464 ||| One pen contains 18 million IU of interferon alfa-2b in 1.2 ml of solution. ||| - One ml of solution contains 10 million IU of interferon alfa-2b ||| Un stylo contient 18 millions d’ UI d’ interféron alfa-2b dans 1,2 ml de solution.
0.41214126348495483 ||| 11-15, Clă direa S-Park, Corp A2, Etaj 5 013714 Bucureş ti Tel: +40 21 207 18 00 ||| Bucureşti-Ploieşti 1A Corp B, etaj 3, sector 1 013681 Bucureşti Tel: +40 21 529 30 00 ||| 11-15, Clă direa S-Park, Corp A2, Etaj 5 013714 Bucuresti Tel: +40 21 207 18 00
0.33156779408454895 ||| Trudexa is also available as a vial or a pre-filled pen. ||| Aranesp is supplied ready for use in a pre-filled syringe. ||| Trudexa est aussi disponible en flacon ou en stylo prérempli.
0.2506581246852875 ||| Doxazosin potentiates the blood pressure lowering effect of other antihypertensives. ||| Beta-blockers may increase the hypoglycaemic effect of antidiabetic agents. ||| La doxazosine exacerbe les effets hypotenseurs des autres anti-hypertenseurs.
0.04188155010342598 ||| 229 10. ||| 232 10. ||| 250 10.
0.22083473205566406 ||| In addition, patients should be alerted to the risk of hypoglycaemia when Janumet is used in combination with other sulfonylurea agents. ||| In multiple myeloma patients, the risk of renal dysfunction may be increased when intravenous bisphosphonates are used in combination with thalidomide. ||| Les patients doivent de plus être avertis du risque d’ hypoglycémie lorsque Janumet est administré en association avec des sulfamides hypoglycémiants.
0.44824209809303284 ||| By targeting the reproduction number (R) (the average number of secondary cases each case generates) and aiming to reduce the R to below 1, the policy seeks to reduce case numbers to low levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) to eliminate human-to-human transmission. ||| The number varies by region.Other measures include the case fatality rate (CFR), which reflects the percent of diagnosed individuals who die from a disease, and the infection fatality rate (IFR), which reflects the percent of infected individuals (diagnosed and undiagnosed) who die from a disease. ||| En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R en dessous de 1, la politique vise à atteindre de faibles niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.
0.5818512439727783 ||| Pumpkin porridge (Hobak-juk) ||| Fried tofu pieces (abura-age) ||| Porridge de potiron [Hobak-juk]
0.466447651386261 ||| He/ she will determine whether to stop using Raptiva or continue treatment with closer observation. ||| Such information will allow her/ him to decide whether a dose reduction is needed. ||| Celui -ci décidera d'arrêter Raptiva ou de poursuivre le traitement moyennant une surveillance plus étroite.
0.5644288063049316 ||| - The pre-filled syringe is broken. ||| Once a syringe has been removed from the ic ||| - La seringue pré remplie est cassée.
0.34524354338645935 ||| Continue to take TESAVEL as long as your doctor prescribes it so you can continue to help control your blood sugar. ||| Treatment will continue for as long as you need immunosuppression to prevent you rejecting your transplanted organ. ||| Continuez à prendre TESAVEL aussi longtemps que votre médecin vous l’a prescrit de manière à pouvoir maintenir le contrôle de votre taux de sucre dans le sang.
0.36434754729270935 ||| The final opinion was converted into a Decision by the European Commission on 21 February 2006. ||| The Council objected to the list presented by the Commission on 13 February 2019. ||| L’ avis définitif est devenu décision de la Commission européenne en date du 21 février 2006.
0.1928994059562683 ||| What is the risk associated with Osigraft? ||| What is the risk associated with Abseamed? ||| Quel est le risque associé à Osigraft?
0.37140512466430664 ||| 203 Sertraline, a medicine used to treat depression, as your doctor may need to change your dose of sertraline. ||| Your doctor has prescribed Januvia to help lower your blood sugar, which is too high because of your type 2 diabetes. ||| La sertraline, un médicament utilisé pour traiter la dépression, étant donné que votre médecin devra peut-être changer votre dose de sertraline.
0.3076024651527405 ||| What ONSENAL contains ||| What OSSEOR contains ||| Que contient Onsenal
0.3129580616950989 ||| Patients may be at an increased risk of folliculitis, acne and herpes viral infections. ||| Lactic acidosis has a high mortality and may be associated with pancreatitis, liver failure, or renal failure. ||| us Les patients traités peuvent présenter un risque accru de folliculite, d'acné et d'infections à herpès virus.
0.5347025990486145 ||| 36.4% 29.8% ||| 25.8% 23.0% ||| 36,4% 29,8%
0.25833815336227417 ||| It is not known whether alendronate is excreted into human breast milk. ||| It is not known if ADENURIC may pass into human breast milk. ||| Il n’ y a pas de données sur le passage de l’ alendronate dans le lait maternel.
0.8485924005508423 ||| Training in dog handling ||| Use during lactation ||| Formation en dressage canin
0.061249736696481705 ||| 104 10. ||| 114 10. ||| 10.
0.019816096872091293 ||| 262 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 341 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 283 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMÉES OU LES FILMS THERMOSOUDÉS
0.5862810611724854 ||| Treatment with Inovelon should be initiated by a paediatrician (a doctor specialised in treating children) or a neurologist (a doctor who treats brain disorders). ||| Many begin as nurses, some as medical technologists (particularly in clinical microbiology), and some as physicians (typically infectious disease specialists). ||| Le traitement par Inovelon doit être mis en place par un pédiatre (médecin spécialisé dans le traitement des enfants) ou un neurologue (médecin qui traite les troubles cérébraux).
0.3035411238670349 ||| How to store Insuman Comb 25 6. ||| How to store Insuman Rapid 6. ||| Comment conserver Insuman Comb 25 6.
0.22601400315761566 ||| Health Care Professional information The PAC should include the following information for the healthcare professional information regarding Ranexa: • To refer to the Ranexa SPC prior to prescribing any medications to the patient, as there are potential drug interactions which should be taken into consideration. • Ranexa is contraindicated in patients taking: • Potent CYP3A4 inhibitors (e. g. itraconazole, ketoconazole, voriconazol, posaconazol, HIV protease inhibitors, clarithromycin, telithromycin, nefazodone) • Class Ia (e. g. quinidine) or Class III (e. g. dofetilide, sotalol) antiarrhythmics other than amiodarone ||| As with other antipsychotics, caution is advised when prescribing risperidone with medicinal products known to prolong the QT interval, e. g., class Ia antiarrhythmics (e. g., quinidine, dysopiramide, procainamide), class III antiarrhythmics (e. g., amiodarone, sotalol), tricyclic antidepressant (i. e., amitriptyline), tetracyclic antidepressants (i. e., maprotiline), some antihistaminics, other antipsychotics, some antimalarials (i. e., chinice and mefloquine), and with medicines causing electrolyte imbalance (hypokalaemia, hypomagnesiaemia), bradycardia, or those which inhibit the hepatic metabolism of risperidone. ||| La carte d’ alerte médicale de Ranexa devra contenir les informations destinées aux professionnels de santé suivantes: • Consulter le RCP de Ranexa avant toute prescription du médicament: des interactions médicamenteuses potentielles sont en effet à prendre en compte. • Ranexa est contre-indiqué chez les patients sous: • inhibiteurs puissants du CYP3A4 (ex. itraconazole, kétoconazole, voriconazole, posaconazole, inhibiteurs de la protéase du VIH, clarithromycine, télithromycine, néfazodone) • antiarythmiques de Classe Ia (ex. quinidine) ou de Classe III (ex. dofétilide, sotalol) autres que l’ amiodarone
0.2571282684803009 ||| Superior efficacy has been demonstrated with the combination of pegylated interferon with ribavirin (sustained response rate of 61% achieved in a study performed in naïve patients with a ribavirin dose > 10.6 mg/kg, p < 0.01). ||| Limited data suggest that co-administration of Zavesca and Cerezyme in patients with type 1 Gaucher disease may result in decreased exposure to miglustat (approximate reductions of 22% in Cmax and 14% in AUC were observed in a small parallel-group study). ||| L’ association d’ interféron pégylé et de ribavirine a montré une efficacité supérieure (taux de réponse prolongée de 61% chez les patients naïfs avec une dose de ribavirine > 10,6 mg/ kg, p < 0,01).
0.31478142738342285 ||| Musculoskeletal and connective tissue disorders Uncommon: ||| Immune system disorders Uncommon: hypersensitivity reactions ||| Troubles des tissus conjonctifs et musculo-squelettiques Peu fréquents:
0.36273103952407837 ||| 31 Rifampicin: co-administration of Kaletra with rifampicin is not recommended. ||| Amprenavir: see recommendations described for Kaletra tablets co-administration with efavirenz. ||| Rifampicine: la co-administration de Kaletra avec la rifampicine n’ est pas recommandée.
0.6233811974525452 ||| What is Imprida? ||| What is Ariclaim? ||| Qu’ est -ce qu’ Imprida?
0.5647693276405334 ||| Polyethylene/ ethyl vinyl acetate (PET/ EVA), clear ||| PVC/ PVdC/ PE/ Al Polyethylene (PEHD) ||| Polyester / éthylène vinyle acétate (PET/ EVA), transparent
0.30917465686798096 ||| Before initiation of growth hormone therapy, you should be observed for breathing problems during the night using a special monitor. ||| For the prophylaxis of shock, patients should always be maximally hydrated prior to, during and after the perfusion procedure. ||| Avant le début du traitement, vous devez être suivi spécifiquement pour la recherche de problèmes respiratoires pendant la nuit.
0.3297971487045288 ||| One pack of 20 multidose vials (type I glass) of 5 ml suspension (10 x 0.5 ml doses) with a stopper (bromobutyl rubber) ||| 500 IU: one vial (glass type I) of powder + one vial (glass type I) of 5 ml solvent with stoppers (bromobutyl). ||| Une boîte de 20 flacons multidose (verre de type I) contenant 5 ml de suspension (10 doses de 0,5 ml) avec un bouchon (caoutchouc bromobutyle).
0.16784220933914185 ||| Skin and subcutaneous tissue disorders Uncommon: ||| Skin, subcutaneous and soft tissue disorders Uncommon ||| Affections de la peau et du tissu sous-cutané
0.427584707736969 ||| In case they do not implement those commitments within the agreed period, the Commission will proceed with a listing. ||| Where this is not possible, the EMEA is called on to prepare a binding arbitration. ||| Si à l'issue de cette période, ils n'ont pas mis en œuvre leurs engagements, la Commission procédera à leur inscription sur la liste.
0.034972283989191055 ||| This medicine is the same as Karvezide, which is already authorised in the European Union (EU). ||| This medicine is the same as Plavix, which is already authorised in the European Union (EU). ||| Ce médicament est le même que Karvezide, qui est déjà autorisé dans l’ Union européenne (UE).
0.08956493437290192 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology and genotoxicity. ||| 23 Non-clinical data reveal no special hazard for humans based on conventional studies of cardiovascular safety pharmacology. ||| Les données non cliniques issues des études conventionnelles de pharmacologie de sécurité et de génotoxicité n’ont pas révélé de risque particulier pour l’homme.
1.0341746807098389 ||| Visit (weeks) ||| (2nd time) ||| Visite (semaines) en
0.08216012269258499 ||| ed This leaflet was last approved in {MM/ YYYY} ||| 20 This leaflet was last approved on {MM/ YYYY} ||| isé La dernière date à laquelle cette notice a été approuvée est MM/AAAA
0.0 ||| 23 10. ||| 23 10. ||| 24 10.
0.21053606271743774 ||| GONAL-f may be co-reconstituted with lutropin alfa and co-administered as a single injection. ||| Pergoveris may be mixed with follitropin alfa and co-administered as a single injection. ||| On peut reconstituer GONAL-f avec la lutropine alfa et administrer les deux produits en une seule injection.
0.028769083321094513 ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4. ||| 38 The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4.4. ||| Les effets d’un surdosage avec GONAL-f ne sont pas connus, néanmoins, chez la femme, un syndrome d’hyperstimulation ovarienne n’est pas exclu (se reporter à la rubrique 4).
0.2712651789188385 ||| After immediate-release venlafaxine administration, the peak plasma concentrations of venlafaxine and ODV occur in 2 and 3 hours, respectively. ||| After intravenous administration to healthy subjects, the total plasma and renal clearances of vildagliptin are 41 and 13 l/ h, respectively. ||| Après administration de venlafaxine à libération immédiate, les concentrations plasmatiques maximales de venlafaxine et d’ ODV sont atteintes respectivement en 2 et 3 heures.
0.7298943996429443 ||| Laminated paper ||| Aerated water ||| Papier contrecollé
0.396848201751709 ||| 2 0 < 1 < 1 ||| < 1 0 < 1 0 < 1 ||| 0 < 1 < 1
0.3559949994087219 ||| This might be attributed to high rates of metronidazole resistence. ||| This effect may be due to induction of bupropion metabolism. ||| Cette différence pourrait être due aux taux plus élevés de résistance au métronidazole.
0.3887034058570862 ||| Both procedures need some adjustment, in particular there is a need to apply the resources in an efficient way both for European and national obligations. ||| In addition, strong measures to protect the budget against fraud and irregularities are in place and the Commission will strengthen them further. ||| Ces deux procédures ont besoin d’ ajustements, en particulier pour une utilisation des ressources efficace tant pour les applications européennes que pour les applications nationales.
0.2702747583389282 ||| Rasilez HCT is indicated in patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone. ||| Kinzalmono has been studied in 1,647 patients who were treated with telmisartan either alone or in combination with hydrochlorothiazide. ||| Rasilez HCT est indiqué chez les patients dont la pression artérielle n’ est pas suffisamment contrôlée par l’ aliskiren ou l’ hydrochlorothiazide en monothérapie.
0.3175237774848938 ||| Available pharmacokinetic data preclude conclusions regarding the relationship between plasma levels of total/ free doxorubicin and its influence on the efficacy/ safety of Myocet. ||| The CHMP endorsed the current list of products which interact or may interact with Tritazide, including additional text reinforcing lithium toxicity. ||| Les données pharmacocinétiques disponibles excluent toute conclusion relative à la relation entre les concentrations plasmatiques de la doxorubicine totale/ libre et son influence sur l’ efficacité/ tolérance de Myocet.
0.4422156512737274 ||| FeLV recombinant canarypox virus (vCP97)................................................................  10 7.2 CCID 50 1 1: cell culture infective dose 50% For a full list of excipients, see section 6.1. ||| Canine herpesvirus (F205 strain) antigens............................................. .0.3 to 1.75 µg* *expressed in µg of gB glycoproteins Light paraffin oil ||| Virus canarypox recombiné FeLV (vCP97)..........................................................  10 7,2 DICC 50 1 1: dose infectieuse culture cellulaire 50%
0.002351939445361495 ||| 14 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes) ||| 12 x (1 vial + 1 pre-filled syringe + 1 vial adapter with needle + 2 alcohol wipes) ||| 14 x (1 flacon +1 seringue pré-remplie + 1 adaptateur pour flacon avec aiguille + 2 tampons alcoolisés)
0.4532342851161957 ||| Fitted furniture ||| Wooden furniture ||| Meubles encastrables
0.029355205595493317 ||| 34 PACKAGE LEAFLET: ||| 29 PACKAGE LEAFLET: ||| 37 NOTICE:
0.5385169386863708 ||| Bleomycin Teva 15 U (USP)/ vial ||| Cefovecin MIC (µg/ ml) No. of ||| 15 U (USP)/ flacon
0.5373353958129883 ||| Elderly Based on a population pharmacokinetic analysis, there are no special instructions for use in the elderly. ||| The pharmacokinetic variability observed in the elderly is within the range for the non- elderly. ||| Au vu des données de pharmacocinétique de population, aucune précaution particulière n'est à prendre chez le sujet âgé.
0.041264135390520096 ||| Retacrit 20000 IU/ 0.5ml solution for injection in pre-filled syringe Epoetin zeta ||| Retacrit 30000 IU/ 0.75ml solution for injection in pre-filled syringe Epoetin zeta ||| Retacrit 20 000 UI/ 0,5 ml solution injectable en seringue préremplie Époétine zêta
0.0 ||| To be taken into consideration by patients on a controlled sodium diet. ||| To be taken into consideration by patients on a controlled sodium diet. ||| A prendre en compte chez les patients effectuant un régime sans sel.
0.7702810764312744 ||| blood count. ||| wrapping. ||| numération globulaire basse.
0.059750527143478394 ||| DATE OF REVISION OF THE TEXT lo ||| DATE OF REVISION OF THE TEXT ici ||| DATE DE MISE A JOUR DU TEXTE
0.011333098635077477 ||| 248 After reconstitution, use the reconstituted solution immediately or within 24 hours when stored in a refrigerator (2°C - 8°C). ||| 239 After reconstitution, use the reconstituted solution immediately or within 24 hours when stored in a refrigerator (2°C - 8°C). ||| Après reconstitution, utilisez la solution reconstituée immédiatement ou dans les 24 heures après conservation au réfrigérateur (entre 2ºC et 8ºC).
0.3014688491821289 ||| Plant espaliers of non-metallic materials ||| Non-electric candelabras of precious metal ||| Espaliers pour plantes en matériaux non métalliques
0.35986989736557007 ||| How to store KOGENATE Bayer 1000 IU 6. ||| What KOGENATE Bayer 500 IU contains ||| Comment conserver KOGENATE Bayer 1000 UI 6.
0.4285193383693695 ||| Reference standards [chemicals] for use in industry ||| Polymers for use as reference standards in industry ||| Étalons de référence [produits chimiques] à usage industriel
0.4056701958179474 ||| Chemical preparations for use in the repair of tyres ||| Chemical products for insertion into vehicle tyres to repair them ||| Préparations chimiques destinées à la réparation des pneus
0.08616110682487488 ||| One vial contains 22.5 microgram of protein (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| This strength corresponds to 83.3 microgram of protein / ml (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| Un flacon contient 22,5 microgrammes de protéine (la bio-activité spécifique in vivo est environ égale à 10 000 UI de FSH/ mg de protéine).
0.2861132025718689 ||| From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. ||| During the debate, Internal Market Committee MEPs are likely to address the role of digital technologies in tackling the COVID-19 crisis, the new EU industrial strategy, and how to ensure that state aid measures to support the economy do not lead to a fragmentation of the EU Internal Market. ||| Entre politiques de renforcement des systèmes de santé et de l’économie mondiale et réponses aux effets du confinement et des restrictions de déplacement, la plateforme numérique inclut un outil Country Policy Tracker visant à aider les pays à apprendre les uns des autres et à faciliter une réponse mondiale coordonnée au défi que pose le coronavirus.
0.48318198323249817 ||| - Carbamazepine Phenobarbital Phenytoin (saquinavir/ ritonavir) ||| phenytoin carbamazepine phenobarbitone primidone rifampicin lopinavir/ ritonavir ||| Anticonvulsivants - Carbamazepine Phénobarbital Phénytoïne (saquinavir/ ritonavir)
0.07419806718826294 ||| Noxafil can be used to prevent invasive fungal infections in patients whose immune system is weakened. ||| Posaconazole SP can be used to prevent invasive fungal infections in patients whose immune system is weakened. ||| Noxafil peut être utilisé en prévention d’ infections fongiques invasives chez les patients dont le système immunitaire est affaibli.
0.6352466344833374 ||| 75.9 (47.7; 90.2) 79.9 (48.3; 93.8) 66.2 (< 0.0; 94.0) ||| 164/ 335 (49.0) 183/ 322 (56.8) 49/ 161 (30.4) 61/ 144 (42.4) 137/ 870 (15.7) 122/ 849 (14.4) ||| 75,9 (47,7; 90,2) 79,9 (48,3; 93,8) 66,2 (< 0,0; 94,0)
0.42727693915367126 ||| Other information about Thalidomide Celgene: ||| Take special care with Thalidomide Celgene: ||| Autres informations relatives à Thalidomide Celgene:
0.02867039665579796 ||| EU/ 2/ 05/ 054/ 011 ||| EU/ 2/ 05/ 054/ 008 ||| d’ emodepside EU/ 2/ 05/ 054/ 011
0.010099423117935658 ||| 25 In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5 HT2A than dopamine D2 receptor occupancy. ||| 137 In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5HT2A than dopamine D2 receptor occupancy. ||| Dans une étude de tomographie par émission de positron (PET) chez le volontaire sain utilisant une dose orale unique (10 mg), l’ olanzapine a entraîné une occupation des récepteurs 5HT2A supérieure à celle des récepteurs D2.
0.2893156111240387 ||| Ireland GlaxoSmithKline (Ireland) Limited Tel: + 353 (0)1 4 955000 ||| United Kingdom GlaxoSmithKline UK Tel: + 44 (0)808 100 9997 ||| Ireland GlaxoSmithKline (Ireland) Limited Tel: + 353 (0)1 4955000
0.24725869297981262 ||| Sugammadex should not be used for reversal of neuromuscular blockade induced by steroidal neuromuscular blocking agents other than rocuronium or vecuronium, since there are no efficacy and safety data for these situations. ||| Caution should be used when Zonegran is prescribed with other medicinal products that predispose patients to heat related disorders; these include carbonic anhydrase inhibitors and medicinal products with anticholinergic activity. ||| 5 Le sugammadex ne doit pas être utilisé pour une décurarisation après un bloc neuromusculaire induit par des curares stéroïdiens autres que le rocuronium ou le vécuronium car il n’ existe pas de données d’ efficacité et de sécurité dans ces situations.
0.015776850283145905 ||| Abacavir and Zidovudine: ||| Zidovudine and Abacavir: ||| Abacavir et Zidovudine:
0.08365805447101593 ||| The Committee for Medicinal products for Human Use (CHMP) decided that ADROVANCE’ s benefits are greater than its risks for the treatment of osteoporosis in postmenopausal women at risk of vitamin D insufficiency. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that INCRELEX’ s benefits are greater than its risks for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency. ||| Le Comité des médicaments à usage humain (CHMP) a décidé que les bénéfices d’ ADROVANCE sont supérieurs aux risques qu’ il comporte dans le traitement de l’ ostéoporose chez les femmes ménopausées présentant un risque de carence en vitamine D.
0.6752195358276367 ||| 13/ 45 ||| 14, 20 ||| 13/ 46
0.42645952105522156 ||| We are working around the clock with Member States to enable them to take swift, effective and targeted action to support the European economy at this difficult time, while preserving the Single Market. ||| At this time of extraordinary hardship and uncertainty, the Union needs more than ever to show that it is ready and willing to act decisively and chart a path to a better tomorrow. ||| Nous travaillons sans relâche avec les États membres afin de leur permettre de prendre des mesures rapides, efficaces et ciblées pour soutenir l'économie européenne en ces temps difficiles, tout en préservant le marché unique.
0.47171273827552795 ||| Regarding the Victims' Rights Directive, the Commission has currently 21 infringements open for incomplete transposition of the Directive. ||| In parallel, we continue to verify that Member States have fully and correctly transposed the 4th Anti-Money Laundering Directive. ||| En ce qui concerne la directive relative aux droits des victimes, la Commission mène actuellement 21 procédures d'infraction pour transposition incomplète de la directive.
0.09731771796941757 ||| Platform staging (Non-metallic -) for use with scaffolding ||| Platform steps (Non-metallic -) for use with scaffolding ||| Plates-formes non métalliques pour échafaudages
0.754319429397583 ||| The caseload of SOLVIT , an informal problem-solving tool, increased by 4% overall. ||| The Fit for Future Platform succeeds the REFIT platform, building on its experiences. ||| Le nombre de dossiers traités par l'outil informel de résolution de problèmes SOLVIT a augmenté de 4 % au total;
0.24853265285491943 ||| The company provided evidence that the levels of the active substances in the blood were the same in people taking Tandemact and people taking the separate tablets. ||| An additional study in 27 patients was used to show that Exelon capsules and oral solution produced similar levels of the active substance in the blood. ||| La société a démontré que les taux de principes actifs dans le sang étaient identiques chez les patients traités par Tandemact et chez ceux prenant les comprimés séparés.
0.020660951733589172 ||| 50 Ελλάδα Novartis (Hellas) A. E. B. E. ||| 126 Ελλάδα Novartis (Hellas) A. E. B. E. ||| Ελλάδα Novartis (Hellas) A. E. B. E.
0.34092289209365845 ||| Two additional studies looked at the appropriate duration of the infusion for Vimpat solution and compared its safety with that of placebo infusions in a total of 199 patients. ||| In the field, the studies of Purevax RCP looked at the basic vaccination schedule (2 injections 3-4 weeks apart) and at the booster vaccination (only one injection). ||| Deux études supplémentaires ont déterminé la durée appropriée de la perfusion de Vimpat solution et comparé sa sécurité d’ emploi à celle des perfusions de placebo chez un total de 199 patients.
0.10257990658283234 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Viread to Gilead Sciences International Limited on 5 February 2002. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Efient to Eli Lilly Nederland BV on 25 February 2009. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Viread à Gilead Sciences International Limited le 5 février 2002.
0.34102916717529297 ||| Design of sculptures ||| Design of curtains ||| Conception de sculptures
0.22337959706783295 ||| Each tablet contains 2 mg sirolimus. ||| Each vial contains 25 mg sucrose. ||| Chaque comprimé contient 2 mg de sirolimus.
0.5555081963539124 ||| Iontophoretic transdermal system (ITS). ||| Hypersensitivity to dacarbazine (DTIC). ||| Dispositif transdermique iontophorétique (DTI).
0.8971577882766724 ||| Factor IX level required (%) or (IU/ dl) ||| Response rate (%) (95% CI) Stable disease (%) ||| IX nécessaire (%) ou (UI/ dl)
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 42 5.3 Données de sécurité précliniques
0.2782328128814697 ||| The dose of Rebetol is based on the patient’ s body weight, and ranges from 3 to 6 capsules a day in patients weighing more than 47 kg. ||| For younger patients (3 months to 12 years), it is given twice a day, and the dosage is based on the weight of the patient (15 mg/ kg bodyweight). ||| La posologie de Rebetol dépend du poids corporel du patient, et est comprise entre 3 et 6 gélules par jour chez les patients de plus de 47 kg.
0.0159233957529068 ||| Each tablet contains 40 mg spironolactone. ||| Each tablet contains 80 mg spironolactone. ||| Chaque comprimé contient 40 mg de spironolactone
0.3276825547218323 ||| The test must not be used in patients with documented or suspected gastric infection or atrophic gastritis, which might interfere with the urea breath test (see section 4.2). ||| In summary the MAH has deleted the indication for intravesical use and for 5-FU- refractory pancreatic cancer while the indication in ovarian cancer has been justified. ||| Le test ne doit pas être effectué chez les patients ayant eu ou soupçonnés d'avoir une infection gastrique ou gastrite atrophique qui pourrait interférer avec le test respiratoire à l'urée.
0.4217150807380676 ||| patients with evaluable baseline histology (baseline Knodell Necroinflammatory Score ≥ 2) b a primary endpoint c Roche Cobas Amplicor PCR assay (LLOQ = 300 copies/ ml) ||| A Hazard ratio of less than 1 favors docetaxel + cisplatin + 5-FU *Cox model (adjustment for Primary tumor site, T and N clinical stages and PSWHO) **Logrank test *** Chi-square test ||| patients avec une histologie évaluable à la baseline (Score Necroinflammatoire de Knodell ≥ 2 à la baseline) b critère primaire c Roche Cobas Amplicor PCR assay (LLOQ = 300 copies/ ml)
0.8860309720039368 ||| In vivo studies: ||| In the female: ||| Études in vivo:
0.4570966362953186 ||| Insurance underwriting and appraisals and assessment for insurance purposes ||| Financial valuation, adjustment and settlement services relating to insurance claims ||| Souscription d'assurances et estimations et évaluations dans le cadre d'assurances
0.350261926651001 ||| In patients with moderately impaired hepatic function, the dose should be restricted to 15 mg daily. ||| In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose. ||| Chez les patients présentant une insuffisance hépatique modérée, la posologie ne devrait pas excéder 15 mg par jour.
0.4345470666885376 ||| Retapamulin is predominantly bacteriostatic against S. aureus and S. pyogenes. ||| Moxidectin is active against larval stages (L3, L4) of Dirofilaria immitis. ||| Rétapamuline est principalement bactériostatique contre S. aureus et S. pyogenes.
0.3693535327911377 ||| Before you use NEVANAC 3. ||| Before you use KIOVIG 3. ||| Quelles sont les informations à connaître avant d'utiliser NEVANAC 3.
0.37339070439338684 ||| Use in children and adolescents under 18 years of age No clinical trials have been conducted with duloxetine in paediatric populations. ||| In 16 member states, treatment with cetirizine is also recommended in infants and toddlers aged 1 to 2 years. ||| Utilisation chez l’ enfant et l’ adolescent de moins de 18 ans Aucune étude clinique n’ a été réalisée en pédiatrie avec la duloxétine.
0.2658298909664154 ||| Doses of 25 mg of Enbrel (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered subcutaneously twice a week for 6 months in 138 patients. ||| Electrocardiograms were obtained from 528 duloxetine-treated and 205 placebo-treated patients with diabetic neuropathic pain in clinical trials lasting up to 13-weeks. ||| Des doses de 25 mg d’ Enbrel (déterminées lors des études de recherche de dose chez les patients atteints de polyarthrite rhumatoïde) ou de placebo ont été administrées par voie sous-cutanée deux fois par semaine pendant 6 mois chez 138 patients.
0.31877756118774414 ||| Distribution of prospectuses for advertising purposes ||| Publication of printed matter for advertising purposes ||| Distribution de prospectus à buts publicitaires
0.7131063938140869 ||| Do not use Silgard if: ||| Do not use after: ||| N’utilisez jamais Silgard si
0.5591048002243042 ||| Notice to applicants for marketing authorisations for veterinary medicinal products in the European Union catalogue n˚ CO-78-93-443-EN-C, also available in ES, DE, FR, IT ||| EMEA/ MB/ 049/ 01-EN-Final Work progamme for 2002 A subscription service is available for all EMEA public documents, distributing documents electronically or in paper form. ||| Avis aux demandeurs d’autorisation de mise sur le marché de médicaments à usage vétérinaire dans l’Union Européenne catalogue nº CO-78-93-443-FR-C, disponible également en EN, ES, DE, IT
0.4095369875431061 ||| The fraction of sitagliptin reversibly bound to plasma proteins is low (38%). ||| Plasma concentrations of atorvastatin and its active metabolites are markedly increased (approx. ||| La fraction de la sitagliptine qui se lie de manière réversible aux protéines plasmatiques est faible (38%).
0.3742288053035736 ||| The acid metabolite is a potent, active cyclooxygenase inhibitor and prolongs the activity of the parent compound. ||| Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. ||| Le métabolite acide est un inhibiteur puissant et actif de la cyclo-oxygénase et il prolonge l’ activité du composé parental.
0.43992483615875244 ||| In these patients serum calcium levels should be followed and renal function should be monitored. ||| More frequent concentration monitoring of these medicinal products is recommended until blood levels have been stabilised. ||| Dans ces cas, il est nécessaire de surveiller fréquemment les taux de calcium sérique et la fonction rénale.
0.3650701642036438 ||| Patients with severe renal dysfunction (creatinine clearance 15-29 ml/ minute) should have the starting dose of PegIntron reduced by 50%. ||| Grade 3 and 4 hypertension (requiring oral anti-hypertensive medication) in patients receiving Avastin ranged from 3.0% to 17.9%. ||| Chez les patients ayant un dysfonctionnement rénal sévère (clairance de la créatinine 15-29 ml/ minute), la dose initiale de PegIntron doit être réduite de 50%.
0.5047292113304138 ||| The capsules should not be broken or chewed. ||| It must not be chewed, broken, or crushed. ||| Les gélules ne doivent être ni brisées ni mâchées.
4.812095817305351e-13 ||| Name and address of the manufacturer(s) responsible for batch release ||| Name and address of the manufacturer(s) responsible for batch release ||| Nom et adresse du(des) fabricant(s) responsable(s) de la libération des lots:
0.3810041546821594 ||| Because alendronate and vitamin D3 are already used separately in authorised medicines in the European Union (EU), the company presented data obtained in earlier studies and from the published literature. ||| Because zidovudine has been available in the European Union (EU) since the mid-1980s, and lamivudine has been approved in the EU since 1996 as Epivir, the company presented information obtained in earlier studies of the two substances taken together. ||| Comme l’ alendronate et la vitamine D3 sont déjà utilisés séparément dans d’ autres médicaments autorisés dans l’ Union européenne (UE), la société a présenté des données obtenues lors d’ études précédentes et provenant de diverses publications.
0.28787192702293396 ||| Agenerase capsules are contraindicated in patients with severe hepatic impairment when used in combination with ritonavir (see section4.3). ||| Aripiprazole and other antipsychotic drugs should be used cautiously in patients at risk for aspiration pneumonia. ||| Les capsules d'Agenerase sont contre-indiquées lorsqu'elles sont administrées en association au ritonavir chez les patients ayant une insuffisance hépatique sévère (voir rubrique 4.3).
0.4414074122905731 ||| Cases of Pneumocystis carinii pneumonia have been reported in patients not receiving antimicrobial prophylaxis. ||| Trudexa has been studied both in rheumatoid arthritis and psoriatic arthritis patients taking Trudexa as uc ||| 5 Des cas de pneumonie à Pneumocystis carinii ont été rapportés chez des patients ne bénéficiant pas de prophylaxie antibiotique.
0.24409344792366028 ||| A study in elderly patients has shown that diltiazem inhibits the metabolism of amlodipine, probably via CYP3A4 (plasma concentration increases by approximately 50% and the effect of amlodipine is increased). ||| In patients with type 2 diabetes on maximum doses of sulphonyl urea agents, studies have shown that the addition of insulin lispro significantly reduces HbA1c compared to sulphonyl urea alone. ||| Une étude chez des patients âgés a montré que le diltiazem inhibe le métabolisme de l’ amlodipine, probablement via le CYP3A4 (la concentration plasmatique augmente d’ environ 50% et l’ effet de l’ amlodipine est accru).
0.3109704256057739 ||| If this is not done when the dosage knob is first pushed in, NutropinAq will be wasted or the cartridge may crack. ||| If the Pegasys dose is reduced or withheld, therapy can be restored once the flare is subsiding (see section 4.4). ||| Si cela n’ a pas été fait lorsque le bouton de dosage est enfoncé pour la première fois, NutropinAq sera gaspillée ou la cartouche pourrait se fendre.
3.0508598035036694e-13 ||| Rare: abdominal pain upper, abnormal faeces, constipation, flatulence, nausea, salivation increase, stomatitis, teething. ||| Rare: abdominal pain upper, abnormal faeces, constipation, flatulence, nausea, salivation increase, stomatitis, teething. ||| Rare: douleur de l'abdomen supérieur, fèces anormales, constipation, flatulences, nausée, hypersialorrhée, stomatite, trouble de la poussée dentaire.
0.19331780076026917 ||| Zomarist has not been studied in patients older than 75 years. ||| Truvada has not been studied in patients over 65 years of age. ||| Zomarist n’ a pas été étudié chez les patients de plus de 75 ans.
0.4020754396915436 ||| Abatacept is produced by recombinant DNA technology in Chinese hamster ovary cells. ||| BeneFIX is a coagulation factor IX product that is produced by recombinant technology. ||| L'abatacept est produit par la technologie de l'ADN recombinant et est exprimé dans des cellules ovariennes de hamster chinois.
0.5267632007598877 ||| ADROVANCE reduces the risk of vertebral and hip fractures. ||| order to minimise the potential risk of thromboembolic events. ||| ADROVANCE réduit le risque de fractures vertébrales et de la hanche.
0.6765182614326477 ||| Who is in charge of the funds raised? ||| What is the timespan to spend the money? ||| Qui a la responsabilité des fonds levés?
0.30028682947158813 ||| Merck Sharp & Dohme Chaussee de Waterloo 1135 B – 1180 Bruxelles Belgium ||| Merck Sharp & Dohme BV - Chaussée de Waterloo 1135 - B-1180 Brussels Belgium ||| Chaussee de Waterloo 1135 B - 1180 Bruxelles Belgium Merck, Sharp & Dohme Ltd
0.23399218916893005 ||| Based on studies of phenylacetylglutamine excretion in patients with urea cycle disorders it is possible to estimate that, for each gram of sodium phenylbutyrate administered, between 0.12 and 0.15 g of phenylacetylglutamine nitrogen are produced. ||| Effects of hormonal contraceptives on lamotrigine efficacy The use of an ethinyloestradiol/ levonorgestrel (30 µg/ 150 µg) combination increases the clearance of lamotrigine by approximately two-fold resulting in decreased lamotrigine levels (see section 4.5). ||| D’ après les mesures de l’ excrétion de la phénylacétylglutamine chez des patients atteints de désordres du cycle de l'urée, il est possible d'estimer que pour chaque gramme de phénylbutyrate de sodium administré, entre 0,12 et 0,15 g d'azote sont éliminés sous la forme de phénylacétylglutamine.
0.027262460440397263 ||| Like all medicines, Zeffix can cause side effects, although not everybody gets them. ||| Like all medicines, Prometax can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Zeffix est susceptible de provoquer des effets indésirables, bien que tous les patients n’y soient pas sujets.
0.5690237283706665 ||| - with growth disturbance due to insufficient secretion of growth hormone (GH). ||| • significant lack of response to drugs used to treat anaemia; or du ||| - avec un retard de croissance lié à un déficit de production d’ hormone de croissance.
0.06957383453845978 ||| Very common (≥ 1/ 10); common (≥ 1/ 100, < 1/ 10); uncommon (≥ 1/ 1,000, < 1/ 100); rare (≥ 1/ 10,000, < 1/ 1,000); very rare (< 1/ 10,000). ||| Very common (≥ 1/ 10), Common (≥ 1/ 100, < 1/ 10), Uncommon (≥ 1/ 1000, < 1/ 100), Rare (≥ 1/ 10,000, < 1/ 1000), Very rare (< 1/ 10,000) ||| Très fréquent (≥ 1/ 10); fréquent (≥ 1/ 100, < 1/ 10); peu fréquent (≥ 1/ 1 000, < 1/ 100); rare (≥ 1/ 10 000, < 1/ 1 000); très rare (< 1/ 10 000).
0.25367915630340576 ||| • Replace the big outer needle cap and unscrew the needle. ||| Grip the outer needle cap and unscrew the needle by turning counterclockwise. ||| • Replacez le grand capuchon externe de l’aiguille et dévissez l’aiguille.
0.378939688205719 ||| - You have previously experienced a heart attack, stroke or have a condition known as peripheral ||| - if you have difficulty in swallowing, or have a major stomach or intestinal disorder ||| - vous avez déjà eu une crise cardiaque, un accident vasculaire cérébral ou vous avez une artériopathie
0.3898303210735321 ||| Hence, no dose adjustment is required in these patients. ||| Therefore, no special precautions or dose adjustments are required in these patients. ||| Par conséquent, il n’ est pas nécessaire d’ ajuster la posologie chez ces patients.
0.35494673252105713 ||| Heart attack, bleeding gums, weight gain, heart muscle disease, loss of coordination, difficulty in speaking, dry skin, migraine, visual disturbances or double vision, ringing in the ears, increased need to pass water at night, pain, ‘ flu-like’ symptoms. ||| Loss of appetite, feeling thirsty, increased weight Feeling of panic, difficulty thinking, mood swings Tremor, difficulty with coordination, difficulty with speech, less sensitive to touch, increased muscle tension, restlessness, ||| Crise cardiaque, saignement des gencives, prise de poids, maladie du muscle cardiaque, perte de coordination, difficulté d’ élocution, peau sèche, migraine, troubles visuels ou vision double, sifflement dans les oreilles, augmentation du besoin d’ uriner pendant la nuit, douleur, symptômes pseudogrippaux.
0.9499172568321228 ||| 0.3%) Arthralgia (G3/ 4: ||| Dilitazem AUC0-24hr: ||| Arthralgie (G3/ 4:
0.3308357000350952 ||| This is not likely to be relevant for humans given recommended nasal doses which results in minimal systemic exposure (see section 5.2). ||| This does not need emergency action as adrenal function is recovered in a few days, as verified by plasma cortisol measurements. ||| La signification clinique de ces observations pour l’ homme n’ est pas établie compte tenu des faibles taux plasmatiques avec le produit administré par voie nasale (voir rubrique 5.2).
0.595274806022644 ||| Isothermic cabinets ||| Dermatologicals ||| Armoires isothermes
0.0 ||| After reconst. immediate use recommended. ||| After reconst. immediate use recommended. ||| 64 Après reconstitution, une utilisation immédiate est recommandée.
0.4290030598640442 ||| Zoledronic acid is eliminated by renal excretion. ||| This leads to insulin release through exocytosis. ||| L'acide zolédronique est éliminé par excrétion rénale.
0.7348763942718506 ||| 10 ml 32 ml 100 ml. ||| 10 ml 10 ml 10 ml 10 ml ||| 10 ml 32 ml 100 ml
0.19929322600364685 ||| SOMAVERT 10 mg powder and solvent for solution for injection Pegvisomant ||| METALYSE 10,000 units powder and solvent for solution for injection Tenecteplase ||| SOMAVERT 10 mg poudre et solvant pour solution injectable Pegvisomant
0.10304620116949081 ||| In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental ingestion, seek medical advice immediately and show this package insert or the label to the physician. ||| En cas d’ingestion accidentelle, demander immédiatement conseil à un médecin et lui montrer la notice du produit ou son étiquetage.
0.27607977390289307 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Nobivac Bb exceed the risks of its use. ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that Revatio provides an alternative treatment option for PAH. ||| Le comité des médicaments à usage vétérinaire (CVMP) a conclu que les bénéfices de Nobivac Bb sont supérieurs aux risques associés à son utilisation.
0.4194762706756592 ||| Kitchen units ||| Industrial trucks ||| Blocs-cuisines
0.3175447881221771 ||| 1 mg; peach: ||| 5 mg; beige: ||| 1 mg; couleur pêche:
0.24060901999473572 ||| Frequencies of adverse drug reactions from clinical trials that are considered related to Actrapid, are listed below. ||| Frequencies of adverse drug reactions from clinical trials, which by an overall judgement are considered related to insulin aspart are listed below. ||| Les fréquences des effets indésirables issus des études cliniques, et considérés comme imputables à Actrapid, sont répertoriées ci-dessous.
0.4098665714263916 ||| 28 Osteonecrosis of the jaw has been reported in patients treated by bisphosphonates. ||| Grade 3-4 dyspnoea reported as trabectedin related occurred in 2% of the patients. ||| Une ostéonécrose de la mâchoire a été rapportée chez des patients traités par bisphosphonates.
0.24218514561653137 ||| 235 I. ||| 66 I. ||| I.
0.0022658237721771 ||| 379 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON ||| 384 PARTICULARS TO APPEAR ON THE OUTER PACKAGING UNBLISTERED PRE-FILLED SYRINGE CARTON ||| 410 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR SERINGUE PREREMPLIE NON CONDITIONNEE SOUS PLAQUETTE THERMOFORMEE
0.23626209795475006 ||| If you develop a new infection, or are about to have any major surgery, your doctor may wish to monitor your treatment with Enbrel.  Infections/ diabetes: ||| If you have a chronic hepatitis B infection, you should not stop your treatment with Epivir without instructions from your doctor, as you may have a recurrence of your hepatitis. ||| Si vous développez une n ouve lle infection, ou devez subir une intervention chirurgicale importante ou si vous développez une nouvelle infection par Enbrel.
0.3450847268104553 ||| Compared with biphasic human insulin, NovoMix 30 may have a more pronounced glucose lowering effect up to 6 hours after injection. ||| Due to more sustained basal insulin supply with Optisulin, less nocturnal but more early morning hypoglycaemia can be expected. ||| 29 celui de l 'insuline humaine biphasique jusqu' 6 heures après l '
0.29495832324028015 ||| Lamotrigine has a slight inhibitory effect on dihydrofolic acid reductase, hence there is a possibility of interference with folate metabolism during long-term therapy (see section 4.6). ||| Do not use bacteriostatic sodium chloride solution for injection as a diluent for pertechnetate, because it might adversely affect the radiochemical purity and, hence, the biological distribution of the tracer. ||| La lamotrigine est un faible inhibiteur de la dihydrofolate réductase et pourrait donc interférer avec le métabolisme des folates lors d’ un traitement à long terme (voir rubrique 4.6).
0.024104395881295204 ||| The Commission therefore concluded that the Austrian measures arenecessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| The Commission therefore concluded that the Italian measure isnecessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| La Commission est par conséquent parvenue à la conclusion que les mesures autrichiennes étaient nécessaires, appropriées et proportionnées pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
5.675708384181299e-13 ||| This medicinal product is authorised in the Member States of the EEA under the following names: ||| This medicinal product is authorised in the Member States of the EEA under the following names: ||| Ce médicament est autorisé dans les États membres de l’ Espace Economique Européen sous les noms suivants:
0.4066089391708374 ||| - joint pain (arthralgia) ||| - fungal infection (mobilises) ||| - douleurs articulaires (arthralgies)
0.42337173223495483 ||| For vildagliptin studies in animals have shown reproductive toxicity at high doses. ||| Inducers of metabolism Clinically the following substances have been shown to decrease tacrolimus blood levels: ||| Pour la vildagliptine, des études effectuées chez l'animal ont mis en évidence une toxicité sur la reproduction à doses élevées.
0.0 ||| 10/ 17 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 10/ 17 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 10/ 18 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.5438478589057922 ||| Each Lamictal 25 mg dispersible/ chewable tablet contains 25 mg lamotrigine. ||| Remeron 15 mg orodispersible tablets contain 15 mg mirtazapine per orodispersible tablet. ||| Chaque comprimé dispersible ou à croquer de Lamictal 25 mg contient 25 mg de lamotrigine.
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 102 4.9 Surdosage
0.4910944700241089 ||| Accidental use of the drug by a pregnant woman should not produce any harmful effects on the foetus. ||| However due to potential harmful effects for the newborn, breast-feeding is ||| L'utilisation accidentelle lors de la grossesse ne devrait pas affecter le fœ tus.
0.4747477173805237 ||| Each film-coated tablet contains 30, 60, 90 or 120 mg of etoricoxib. ||| ∗ STOCRIN 50 mg, 200 mg and 600 mg film-coated tablets are available. ||| Chaque comprimé pelliculé contient 30, 60, 90 ou 120 mg d’ étoricoxib.
0.24191385507583618 ||| The patients should be instructed to discontinue alendronate and seek medical attention if they develop symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain or new/ worsened heartburn. ||| If signs of systemic toxicity appear for example fever, cardiac arrhythmias, shock/ hypotension, adult respiratory distress syndrome (ARDS), general supportive measures should be employed and the patient immediately transferred to an Intensive Care Unit for monitoring. ||| Les patients doivent être informés d’ arrêter l’ alendronate et de consulter un médecin s’ ils présentent des symptômes
0.5104926824569702 ||| All of the patients were over 50 years of age and had not been treated for wet AMD before. ||| About half of the patients were under the age of 16, and 56 were less than six years old. ||| Tous les patients avaient plus de 50 ans et n’ avaient pas suivi de traitement préalable pour une forme humide de DMLA.
4.900071776288428e-13 ||| A small volume is lost during preparation of PegIntron for injection when the dose is measured and injected. ||| A small volume is lost during preparation of PegIntron for injection when the dose is measured and injected. ||| 121 la préparation de PegIntron solution injectable lorsque la dose est mesurée puis injectée.
0.4348796606063843 ||| Hepatic failure, cholangitis, fatty liver ||| Fanconi syndrome, proximal renal tubulopathy. ||| insuffisance hépatique, cholangite, stéatose hépatique
0.3184087574481964 ||| A large overdose of metformin (or co-existing risks of lactic acidosis) may lead to lactic acidosis which is a medical emergency and must be treated in hospital. ||| AMMONAPS does not completely prevent the occurrence of an acute excess of ammonia in the blood and is not appropriate for treating such a condition, which is a medical emergency. ||| 9 Un surdosage important de metformine (ou l'existence de risques concomitants d’ acidose lactique) peut provoquer une acidose lactique, qui constitue une urgence médicale et doit être traitée en milieu hospitalier.
0.3098694682121277 ||| Before administration, visually inspect the solution for particulate matter and discolouration. ||| Inspect the parenteral solution visually for particles prior to administration. ||| Avant administration, inspecter visuellement la solution pour vérifier l'absence de particules ou un changement de couleur.
0.4993650019168854 ||| The ceilings of the multiannual financial framework are defined in constant 2018 prices and the Commission is making its proposals on that basis. ||| In parallel and for transparency, the Commission published its proposals in both 2018 and current prices. ||| Les plafonds du cadre financier pluriannuel sont définis en prix constants de 2018 et la Commission soumet ses propositions sur cette base.
0.5277637839317322 ||| BOTTLE LABEL ||| EVOHALER LABEL ||| ETIQUETAGE DU FLACON
0.4358603358268738 ||| Portable charging cases for electronic cigarettes and vaporizers ||| Rental of cash dispensers or automated-teller machines ||| Boîtiers portables de charge pour cigarettes et vaporisateurs électroniques
0.19055697321891785 ||| UAB Johnson & Johnson Š eimyniš kių g.1A LT-09312 Vilnius Lithuania ||| UAB Johnson & Johnson, Š eimyniš kių g.1A, LT-09312 Vilnius, Lithuania ||| UAB Johnson & Johnson, Š eimyniš kių g.1A, LT- 09312 Vilnius, Lituanie
0.6565216183662415 ||| Peppermint sweets ||| Aloe vera plants ||| Bonbons à la menthe
0.06896768510341644 ||| What benefit has Valtropin shown during the studies? ||| What benefit has Protaphane shown during the studies? ||| Quels ont été les bénéfices démontrés par Valtropin au cours des études?
0.41349226236343384 ||| Hold the syringe slightly tilted with the vial facing downwards. ||| Fold the bottom gel-containing housing in half with the sticky side facing in. ||| Tenez la seringue légèrement inclinée avec le flacon tourné vers le bas.
0.40702515840530396 ||| Mexiletine Simultaneous administration of ciprofloxacin and mexiletine can lead to increased plasma concentrations of mexiletine. ||| Digoxin Coadminitration of lansoprazole and digoxin may lead to increased digoxin plasma levels. ||| Mexilétine L’ administration simultanée de ciprofloxacine et de mexilétine peut provoquer une augmentation des concentrations plasmatiques de mexilétine.
0.5025426745414734 ||| Each pen contains 3 ml of solution for injection, equivalent to 300 IU insulin. ||| For use in insulin pumps, which are suitable for insulins containing 100 IU/ ml. ||| Chaque stylo contient 3 ml de solution injectable, correspondant à 300 UI d'insuline.
0.22874963283538818 ||| Aldurazyme treatment should be supervised by a doctor experienced in the management of patients with MPS I or other inherited metabolic diseases. ||| Therapy should be initiated by a physician experienced in the treatment of patients with haematological malignancies and malignant sarcomas, as appropriate. ||| Le traitement par Aldurazyme doit être supervisé par un médecin expérimenté dans la prise en charge des patients atteints de MPS I ou d’ autres maladies métaboliques héréditaires.
0.047193534672260284 ||| EU/ 1/ 01/ 178/ 001 ||| EU/ 1/ 01/ 195/ 018 ||| EU/ /1/ 01/ 178/ 001
0.4982621669769287 ||| If your blood sugar level falls too much you may become unconscious. ||| 85 Your blood sugar level may either rise or fall if you take: ||| 530 Si votre taux de sucre dans le sang diminue trop, vous risquez de perdre connaissance.
3.0607124907461314e-13 ||| Data obtained with intravenous fentanyl in patients with renal failure suggest that the volume of distribution of fentanyl may be changed by dialysis. ||| Data obtained with intravenous fentanyl in patients with renal failure suggest that the volume of distribution of fentanyl may be changed by dialysis. ||| 49 avec le fentanyl intraveineux chez des patients souffrant d’ insuffisance rénale suggèrent que le volume de distribution du fentanyl peut être modifié par la dialyse.
0.1690247654914856 ||| 0.5 ml of suspension in a pre-filled syringe (type I glass) with a plunger stopper (rubber butyl) with or without needles in pack sizes of 1 and 10. ||| 0.5 ml suspension for injection in vial (Type I glass) with a grey butyl rubber stopper - pack size of 1 and 10 vials without syringe/ needles. ||| 0,5 ml de suspension en seringue préremplie (verre de type I) avec un bouchon piston (caoutchouc butyle) avec ou sans aiguilles en boîtes de 1 et de 10.
0.7256146669387817 ||| Dosage: ||| 30 Dosage ||| Dose:
0.11887030303478241 ||| What Irbesartan Hydrochlorothiazide Winthrop contains ||| What is Irbesartan Hydrochlorothiazide Winthrop? ||| Que contient Irbesartan Hydrochlorothiazide Winthrop
0.3917025923728943 ||| BENCHMRK 1 and 2 Pooled Parameter Percent HIV-RNA < 400 copies/ ml (95% CI) ||| HIV RNA < 50 copies/ ml,% c All patients Baseline Characteristics HIV RNA ||| Paramètre Pourcentage de patients avec ARN-VIH < 400 copies/ ml (IC à 95%)
0.1483011245727539 ||| Always take GONAL-f exactly as your doctor has told you. ||| Always take CYMBALTA exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.2855460047721863 ||| Concurrent administration of potentially nephrotoxic drugs should be avoided as there might be an increased risk of renal toxicity. ||| If serious adverse reactions occur, such as neurotoxicity, treatment with mitotane may need to be transiently interrupted. ||| Eviter l’ administration simultanée avec des produits ayant un potentiel néphrotoxique en raison d’ un risque accru de toxicité rénale.
0.658981442451477 ||| (351-21) 798 71 02 Fax (351-21) 798 71 20 E-mail: rsantos.ivo@infarmed.pt nternet: http://www.infarmed.pt ||| For matters relating to pharmacovigilance for medicinal products for veterinary use Barbara FREISCHEM Direct telephone (44-20) 74 18 85 81 E-mail: barbara.freischem@emea.eu.int ||| (351-21) 798 71 02 Fax (351-21) 798 71 20 e-mail: rsantos. ivo@infarmed. pt internet: http: / /www. infarmed. pt
0.1887667030096054 ||| EU/ 2/ 97/ 003/ 010 – 10 tablets EU/ 2/ 97/ 003/ 011 – 20 tablets EU/ 2/ 97/ 003/ 012 – 100 tablets ||| EU/ 2/ 04/ 045/ 001 10 tablets EU/ 2/ 04/ 045/ 002 30 tablets EU/ 2/ 04/ 045/ 005 180 tablets ||| EU/ 2/ 97/ 003/ 010 – 10 comprimés EU/ 2/ 97/ 003/ 011 – 20 comprimés EU/ 2/ 97/ 003/ 012 – 100 comprimés
0.0830395445227623 ||| - This medicine has been prescribed for you. ||| - This medicine has been prescribed for you personally. ||| - Ce médicament vous a été prescrit personnellement.
0.26304322481155396 ||| 331 8. ||| 364 15. ||| 335 8.
0.11550004780292511 ||| It may be taken with or without food. ||| It can be taken with or without liquid. ||| Le médicament peut être pris pendant ou en dehors des repas.
0.2097334861755371 ||| Pandemrix should under no circumstances be administered intravascularly. ||| ENGERIX B should under no circumstances be administered intravenously. ||| Pandemrix ne doit en aucun cas être administré par voie intravasculaire.
0.2605726718902588 ||| If you forget to take Revatio, take a dose as soon as you remember, then continue to take your tablets at the usual times. ||| • If you do miss a dose of Hepsera, take it as soon as you can, and then take your next scheduled dose at its regular time. ||| Si vous oubliez de prendre Revatio, prenez-le dès que vous le remarquez, puis continuez à prendre vos comprimés aux horaires habituels.
0.3250579833984375 ||| The pharmacokinetics of etoricoxib are similar between men and women. ||| -Gender The pharmacokinetics of telithromycin are similar between males and females. ||| Sexe: les paramètres pharmacocinétiques de l’ étoricoxib sont comparables entre hommes et femmes.
0.010769114829599857 ||| 304 Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300 ||| 350 Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300 ||| Ελλάδα Αγίου Δημητρίου 63 GR-174 55 Άλιμος Tηλ.: + 30-210 98 97 300
0.28292396664619446 ||| Adjunctive therapy in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy. ||| Duloxetine normalised pain thresholds in several preclinical models of neuropathic and inflammatory pain and attenuated pain behaviour in a model of persistent pain. ||| 48 En association dans le traitement des crises généralisées tonico-cloniques primaires de l’ adulte et de l’ adolescent à partir de 12 ans présentant une épilepsie généralisée idiopathique.
0.34834176301956177 ||| Cimetidine Due to inhibition of the CYP3A4 system, cimetidine increases the plasma concentration of nifedipine, and therefore the antihypertensive effect of nifedipine may be potentiated. ||| ASA did not modify the clopidogrel-mediated inhibition of ADP-induced platelet aggregation, but clopidogrel potentiated the effect of ASA on collagen-induced platelet aggregation. ||| 8/ 46 Cimétidine En raison de l’ inhibition du système CYP3A4, la cimétidine accroît la concentration plasmatique de nifédipine, et par conséquent l’ effet antihypertenseur de la nifédipine peut être potentialisé.
0.43070608377456665 ||| EMADINE 0.5 mg/ml Eye Drops, solution in multidose container. ||| CARTONS FOR (Invented name)® 20 mg per 5 ml oral liquid ||| EMADINE 0,5 mg/ ml Collyre en solution en récipient multidose.
0.1504707634449005 ||| Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| 5.3 Preclinical safety data Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Les données non-cliniques issues des études conventionnelles de pharmacologie de sécurité, de toxicité en administration répétée et de génotoxicité n’ ont pas révélé de risque particulier pour l’ homme.
0.16149939596652985 ||| Caution is needed when administrating this vaccine to persons with a known hypersensitivity (other than anaphylactic reaction) to the active substance, to any of the excipients and to eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB). ||| • if you have had any allergic reaction other than a sudden life-threatening allergic reaction to any ingredient contained in the vaccine, to thiomersal, to egg and, chicken protein, ovalbumin, formaldehyde, gentamicin sulphate (antibiotic) or to sodium deoxycholate. ||| L’ administration de ce vaccin doit se faire avec précaution chez les sujets ayant des antécédents d’ hypersensibilité (autre qu’ une réaction anaphylactique) à la substance active, à l’ un des excipients ou aux œ ufs, aux protéines de poulet, à la kanamycine et au sulfate de néomycine, au formaldéhyde et au bromure de cétyltriméthylammonium (CTAB).
0.24804982542991638 ||| Antidiabetic agents Epidemiological studies have suggested that concomitant administration of ACE inhibitors and antidiabetic medicines (insulins, oral hypoglycaemic agents) may cause an increased blood-glucose lowering effect with risk of hypoglycaemia. ||| Anticoagulant therapy Anticoagulant therapy should be monitored closely in patients receiving warfarin or similar agents, since bile acid sequestrants have been shown to reduce absorption of vitamin K and therefore interfere with warfarin's anticoagulant effect. ||| Antidiabétiques Des études épidémiologiques ont suggéré que l’ utilisation concomitante d’ IEC et d’ antidiabétiques (insuline, hypoglycémiants oraux) peut provoquer une majoration de l’ effet hypoglycémiant avec un risque d’ hypoglycémie.
0.3663952946662903 ||| Overdose of the drug may result in the prolongation of the period during which the patient remains photosensitive. ||| During the first 21 days of treatment, the quantity of food the animal receives may remain unchanged. ||| Les patients exposés à un surdosage de Visudyne peuvent présenter une photosensibilité cutanée prolongée.
0.2005368322134018 ||| • if you have experienced any health problems after previous administration of a vaccine. • if you have a poor immune system due to illness or drug treatment. • if you have a bleeding problem or bruise easily. ||| • if you have/ your child has experienced any health problems after previous administration of a vaccine. • if you have/ your child has a bleeding problem or bruise/ bruises easily. ||| • si vous avez déjà présenté des problèmes de santé après l’ administration d’ un vaccin. • si vous avez une diminution des défenses de l'organisme (déficit immunitaire) liée à une maladie ou à la prise d’ un médicament. • si vous avez des problèmes hémorragiques ou si vous vous faites des hématomes facilement.
0.19817179441452026 ||| Concomitant use of angiotensin II antagonists or diuretics and NSAIDs may lead to an increased risk of worsening of renal function, including possible acute renal failure, and an increase in serum potassium, especially in patients with poor pre-existing renal function. ||| The use of Rapamune in combination with calcineurin inhibitors and corticosteroids was associated with an increased risk of deterioration of renal function, serum lipid abnormalities (including but not limited to increased serum triglycerides and total cholesterol), and urinary tract infections (see section 4.8). ||| Chez les patients présentant une insuffisance rénale préexistante, la co-administration d'antagonistes de l'angiotensine II ou de diurétiques et d’ AINS peut entraîner une aggravation de la fonction rénale, avec possibilité d'insuffisance rénale aiguë, et une augmentation du potassium sérique.
0.4111402630805969 ||| Special populations: ||| Special populations Pregnancy: ||| Populations spécifiques:
0.20276987552642822 ||| 41.4 (63/152) 31.2, 51.7 ||| 30.2 (256/848) 26.1, 34.2 ||| 41,4 (63/ 152) 31,2; 51,7
0.2717394530773163 ||| Depending upon the findings, the medicinal product may be discontinued cautiously so as to prevent withdrawal symptoms and to prevent a return to illicit drug use. ||| Early discontinuation of failing therapies is recommended in order to limit the accumulation of multiple mutations, which may be detrimental to a subsequent rescue regimen. ||| En fonction des résultats obtenus, le traitement pourra être interrompu avec prudence afin de prévenir l’ apparition de symptômes de manque et d’ éviter le retour à l’ utilisation de drogue illicite.
0.32902657985687256 ||| The active substance in Clopidogrel BMS, clopidogrel, is an inhibitor of platelet aggregation. ||| Venlafaxine and its active metabolite, O-desmethylvenlafaxine, are excreted in breast milk. ||| Le principe actif de Clopidogrel BMS, le clopidogrel, est un inhibiteur de l’ agrégation plaquettaire.
0.0 ||| Renal impairment ||| Renal impairment ||| Diarrhée
0.3486874997615814 ||| INFORMATION FOR THE USER Tandemact 30 mg/ 2 mg tablets ||| INFORMATION FOR THE USER Pritor 20 mg tablets Telmisartan ||| INFORMATION DE L’ UTILISATEUR Tandemact 30 mg/ 2 mg, comprimés
0.3337158262729645 ||| If STOCRIN is coadministered with rifampicin, an increase in the dose of STOCRIN to 800 mg/ day may be considered (see section 4.5). ||| Therefore, the benefit-risk profile of Lansoprazol HEXAL 15 mg, 30 mg in the proposed indications can be considered favourable. ||| Si STOCRIN est co-administré avec la rifampicine, une augmentation de la dose de STOCRIN à 800 mg/ jour peut être envisagée (voir rubrique 4.5).
0.3422830104827881 ||| A limited increase in total lopinavir concentrations of approximately 30% has been observed which is not expected to be of clinical relevance (see section 4.2). ||| Based on field trial data, it is evident that the implant may not be retained in a proportion (1.2%) of treated bitches. ||| Une augmentation limitée d’ environ 30% des concentrations totales en lopinavir a été observée, cependant aucun retentissement clinique n’ est attendu (voir rubrique 4.2).
0.36597782373428345 ||| Adjusted Odds Ratios for myopathy with the last statin (with or without gemfibrozil) compared to non-concurrent cerivastatin were not significant. ||| For docetaxel/ carboplatin combination, neither equivalent nor non-inferior efficacy could be proven compared to the reference treatment combination VCis. ||| Les Odds Ratios ajustés pour la myopathie associée à la dernière statine (avec ou sans gemfibrozil) par comparaison à la cérivastatine non simultanée n’étaient pas significatifs.
0.47310084104537964 ||| Patients may develop antibodies to AVONEX. ||| STOCRIN may interact with other medicines. ||| Des patients sont susceptibles de développer des anticorps contre AVONEX.
0.7810792326927185 ||| Hepatocellular changes should be monitored frequently if this combination is prescribed. ||| Would standard cohesion policy rules apply or would you rather activate emergency clauses? ||| - Les modifications hépato- cellulaires doivent être surveillées fréquemment si cette association est prescrite.
0.1364259570837021 ||| 102 6. ||| 120 6. ||| 107 6.
0.6091099977493286 ||| Esplanade Heysel, B 22 B-1020 Bruxelles Belgium ||| 30-36, avenue Gustave Eiffel – BP 27166 uc ||| Esplanade Heysel, B 22 B-1020 Bruxelles Belgique
0.08622151613235474 ||| 153 10. ||| 136 10. ||| 10.
0.04285027086734772 ||| An appropriate antihypertensive medication must usually replace Dafiro before starting a pregnancy. ||| An appropriate antihypertensive medication must usually replace Imprida before starting a pregnancy. ||| Un traitement antihypertenseur approprié devra le plus souvent remplacer Dafiro avant le début d’ une grossesse.
0.0 ||| Requests for general information packs should be sent to ||| Requests for general information packs should be sent to ||| Pour des demandes d’information générales, Point de contact adressez-vous à l’adresse ci-contre
0.41714897751808167 ||| Not known ||| Not applicable ||| Fréquence inconnue
0.3557647466659546 ||| The influence of food has not been investigated because this medicinal product is generally given on empty stomach prior to induction of anaesthesia. ||| The anti-inflammatory effect in tissues has been documented to continue even after the plasma concentration has decreased. ||| L’ influence de la prise d’ aliments n’ a pas fait l’ objet de recherches, car ce produit est généralement administré chez un patient dont l’ estomac est vide avant anesthésie.
0.20528393983840942 ||| ALIMTA 100 mg powder for concentrate for solution for infusion ||| MabThera 500 mg concentrate for solution for infusion ||| ALIMTA 100 mg poudre pour solution à diluer pour perfusion
0.29610803723335266 ||| Feathers [clothing accessories] ||| Birds' feathers [clothing accessories] ||| Plumes [accessoires d'habillement]
0.00495684752240777 ||| EU/ 1/ 97/ 030/ 086 (3 cartridges of 3 ml) EU/ 1/ 97/ 030/ 057 (4 cartridges of 3 ml) EU/ 1/ 97/ 030/ 035 (5 cartridges of 3 ml) EU/ 1/ 97/ 030/ 091(6 cartridges of 3 ml) EU/ 1/ 97/ 030/ 096 (9 cartridges of 3 ml) EU/ 1/ 97/ 030/ 058 (10 cartridges of 3 ml) ||| EU/ 1/ 97/ 030/ 088 (3 cartridges of 3 ml) EU/ 1/ 97/ 030/ 061 (4 cartridges of 3 ml) EU/ 1/ 97/ 030/ 045 (5 cartridges of 3 ml) EU/ 1/ 97/ 030/ 093 (6 cartridges of 3 ml) EU/ 1/ 97/ 030/ 098 (9 cartridges of 3 ml) EU/ 1/ 97/ 030/ 062 (10 cartridges of 3 ml) ||| EU/ 1/ 97/ 030/ 086 (3 cartouches de 3 ml) EU/ 1/ 97/ 030/ 057 (4 cartouches de 3 ml) EU/ 1/ 97/ 030/ 035 (5 cartouches de 3 ml) EU/ 1/ 97/ 030/ 091 (6 cartouches de 3 ml) EU/ 1/ 97/ 030/ 096 (9 cartouches de 3 ml) EU/ 1/ 97/ 030/ 058 (10 cartouches de 3 ml)
0.04953378438949585 ||| For the full list of all side effects reported with Nexavar, see the Package Leaflet. ||| For the full list of side effects reported with Fendrix, see the Package Leaflet. ||| Pour avoir le détail de tous effets indésirables observés lors de l'utilisation de Nexavar, voir la notice.
0.1921156942844391 ||| Darifenacin AUC24 and Cmax from 30 mg once daily dosing in subjects who are extensive metabolisers were 95% and 128% higher when erythromycin (moderate CYP3A4 inhibitor) was co-administered with darifenacin than when darifenacin was taken alone. ||| Concomitant administration of sunitinib malate with the potent CYP3A4 inhibitor, ketoconazole, resulted in a 49% and 51% increase of the complex [sunitinib + primary metabolite] Cmax and AUC0-∞ values, respectively, after a single dose of sunitinib malate in healthy volunteers. ||| L’ ASC24 et la Cmax de 30 mg de darifénacine une fois par jour chez des sujets métaboliseurs rapides étaient de 95% et 128% plus élevées lorsque l’ érythromycine (inhibiteurs modérés du CYP3A4) était co-administrée à la darifénacine que lorsque la darifénacine était prise seule.
0.13903355598449707 ||| 21 Docetaxel Winthrop 75 mg/ m² in combination with cisplatin and 5-fluorouracil for Head and Neck cancer ||| 57 TAXOTERE 75 mg/ m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer ||| 22 Docétaxel Winthrop 75 mg/ m² en association avec le cisplatine et le 5-fluorouracile dans les cancers des voies aéro-digestives supérieures
0.0 ||| Store in the original package in order to protect from light. ||| Store in the original package in order to protect from light. ||| A conserver dans l'emballage extérieur d’ origine, à l'abri de la lumière.
0.30309754610061646 ||| Remove the needle from the syringe. ||| Withdraw all the solvent into the syringe. ||| Retirez l’aiguille de la seringue.
0.13638687133789062 ||| • With the other hand, hold syringe at 45-degree angle to skin, with the grooved side up. • With one quick, short motion, push needle all the way into skin • Release the skin with the first hand • Push plunger to inject solution – it can take from 2 to 5 seconds to empty the syringe • When the syringe is empty, remove the needle from skin, being careful to keep it at the same angle as when it was inserted • Hold the syringe in one hand and with the other hand slide the outer protective shield over the exposed needle until it locks in place • Using your thumb or a piece of gauze, apply pressure over the injection site for 10 seconds. ||| • With the other hand, hold syringe at 45-degree angle to skin, with the grooved side up. • With one quick, short motion, push needle all the way into skin • Release the skin with the first hand • Push plunger to inject solution – it can take from 2 to 5 seconds to empty the syringe • When the syringe is empty, remove the needle from skin, being careful to keep it at the same angle as when it was inserted • Using your thumb or a piece of gauze, apply pressure over the injection site for 10 seconds. ||| • Avec l’autre main, tenez la seringue à 45° par rapport à la peau (la rainure étant orientée vers le haut) • D’un mouvement rapide, poussez toute l’aiguille dans la peau • Relâchez la peau • Poussez le piston pour injecter la solution – cela peut prendre 2 à 5 secondes pour vider la seringue • Quand la seringue est vide, retirez l’aiguille de la peau, en respectant le même angle d’inclinaison qu’au moment de l’introduction • Comprimez le site d’injection pendant 10 secondes à l’aide du pouce ou d’une compresse.
0.27057570219039917 ||| If you feel depressed, please contact your doctor immediately. ||| If you feel dizzy or lightheaded, contact your doctor immediately. ||| Si vous vous sentez déprimé, consultez immédiatement votre médecin.
0.4211587905883789 ||| Cultures, other than for medical or veterinary use ||| Construction vehicles, other than for transportation purposes ||| Culture autre qu'à usage médical ou vétérinaire
0.33262234926223755 ||| Bridion was compared with neostigmine (another medicine used to stop the effect of muscle relaxants) given after rocuronium or vecuronium in the first study and after cis-atracurium (another muscle relaxant) in the second. ||| Four of these studies compared Epivir in combination with zidovudine (another antiviral medicine) to either Epivir or zidovudine alone, or to the combination of Epivir and zalcitabine (another antiviral medicine). ||| Bridion a été comparé à la néostigmine (un autre médicament utilisé pour arrêter l’ effet des relaxants musculaires) administrée après le rocuronium ou le vécuronium dans la première étude et après le cis-atracurium (un autre relaxant musculaire) dans la seconde.
0.24894919991493225 ||| Elderly Experience in geriatric patients is limited: in the Phase III trials, 6 patients aged 65 years or older and 53 patients aged 56-64 years received INTELENCE. ||| Elderly patients In clinical studies 24% of patients treated with MIRCERA were aged 65 to 74 years, while 20% were aged 75 years and over. ||| Sujets âgés L’ expérience chez les patients âgés est limitée: dans les essais de phase III, 6 patients âgés de 65 ans ou plus et 53 patients âgés de 56 à 64 ans ont reçu INTELENCE.
0.2918626070022583 ||| Do not use Ovitrelle if you notice any visible signs of deterioration. ||| Do not use Ribavirin Teva if you notice any change in the appearance of the capsules. ||| Ne pas utiliser pas Ovitrelle si vous remarquez des signes de dégradation.
0.08736375719308853 ||| What is the risk associated with Nexavar? ||| What is the risk associated with Refludan? ||| Quel est le risque associé à l'utilisation de Nexavar?
0.6376911997795105 ||| In 1994, Bradley sued Chiron, seeking to invalidate the patent, have himself included as a coinventor, and receive damages and royalty income. ||| Orton interrupted and said that he attacked Edge so that he would remain at home and continue being a husband and a father to their children. ||| En 1994, Bradley a poursuivi Chiron, pour faire invalider le brevet, se considérant lui-même comme co-inventeur, et demandant à recevoir des dommages et intérêts et des royalties.
0.4606306254863739 ||| A higher rate of fractures was observed in women taking pioglitazone (2.6%) versus comparator (1.7%). ||| Few patients (1.1%; 0.4% serious) discontinued treatment due to a hepatic event. ||| Un taux plus élevé de fractures a été observé chez les femmes traitées par la pioglitazone (2,6%) par rapport à celles traitées par un comparateur (1,7%).
0.412876695394516 ||| Completion of the modifications to floor 3 facilities will increase the capacity for EMEA meetings and support for mutual recognition procedures. ||| The exercise permitted a clearer view in preparation of the EMEA contribution to the fee reform proposals. ||| L’achèvement des modifications des installations du 3e étage augmentera la capacité de réunion de l’EMEA et le soutien des procédures de reconnaissance mutuelle.
0.26277270913124084 ||| Therapy with Tandemact should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5 X upper limit of normal) or with any other evidence of liver disease. ||| Muscle damage must be considered in any patient presenting with diffuse myalgia, muscle tenderness and/ or marked increase in muscle CPK levels (> 5x ULN); under these conditions treatment must be discontinued. ||| Un traitement par Tandemact ne doit pas être instauré chez les patients ayant des enzymes hépatiques élevées (ALAT > 2,5 X la limite supérieure de la normale) ou présentant tout autre signe évocateur d’ une pathologie hépatique.
0.21549642086029053 ||| The cumulative rate of cardiac end-points (cardiac death and non-fatal myocardial infarction) during a 5 year follow-up was 27.3/ 1000 in the gemfibrozil group (56 subjects) and 41.4/ 1000 in the placebo group (84 subjects) showing a relative risk reduction of 34.0% (95% confidence interval 8.2 to 52.6, p < 0.02) and an absolute risk reduction of 1.4% in the gemfibrozil group compared to placebo. ||| In a 26-week, olanzapine-controlled, double-blind, multi-national study of schizophrenia which included 314 patients and where the primary end-point was weight gain, significantly less patients had at least 7% weight gain over baseline (i. e. a gain of at least 5.6 kg for a mean baseline weight of ~80.5 kg) on aripiprazole (N= 18, or 13% of evaluable patients), compared to olanzapine (N= 45, or 33% of evaluable patients). ||| Les taux cumulés des critères d’ efficacité cardiaque (décès cardiaque et infarctus du myocarde non mortel) pendant une période de suivi de 5 ans étaient de 27,3/ 1 000 dans le groupe gemfibrozil (56 sujets) et de 41,4/ 1 000 dans le groupe placebo (84 sujets), ce qui indique une baisse du risque relatif de 34,0% (intervalle de confiance à 95% compris entre 8,2 et 52,6, p < 0,02), ainsi qu’ une baisse du risque absolu de 1,4% dans le groupe gemfibrozil par rapport au groupe placebo.
0.4084118604660034 ||| These medicinal products are contraindicated for use with Invirase/ritonavir (see section 4.3). ||| Nelarabine however, is known to be genotoxic to mammalian cells (see section 5.3). ||| Ces médicaments sont contre-indiqués avec Invirase/ritonavir (voir rubrique 4.3).
0.722131609916687 ||| 1 mg corresponds to 18.2 EAU*. ||| AUC of M8 metabolite* ↑ 86% ||| 1 mg correspond à 18,2 UAE*
0.7545082569122314 ||| LABELLING lon ge ra uth ori sed PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| LABELLING AND PACKAGE LEAFLET t no uc rod lp nai dic Me ||| ETIQUETAGE tp lus au tor isé MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.03269658982753754 ||| 12 The pH may have been adjusted with sodium hydroxide and/ or hydrochloric acid. ||| The pH may have been adjusted with sodium hydroxide and/ or hydrochloric acid. ||| Le pH peut avoir été ajusté au moyen d'hydroxyde de sodium et/ ou d'acide chlorhydrique.
0.35403934121131897 ||| Slovenija MERCK d. o. o. ||| 109 България MERCK d.o.o. ||| Slovenija Ireland MERCK d. o. o.
0.32448750734329224 ||| Take special care with Zevalin: ||| 32 Take special care with Herceptin ||| Faites attention avec Zevalin:
0.2913253903388977 ||| 12 Delayed ovarian atrophy or degeneration and uterine mucosal apoptosis were observed in female mice at the only dose used of 225 mg/ m2/ day clofarabine. ||| The rates for confirmed upper gastrointestinal perforations, ulcerations and bleeds were the same for etoricoxib and diclofenac (1.11 events per 100 patient years.) ||| Une atrophie retard de l’ ovaire ou une dégénérescence et apoptose de la muqueuse utérine ont été observées chez la souris femelle à la dose uniquement utilisée de 225 mg/ m2/ jour de clofarabine.
0.9546135663986206 ||| 2.5 - 6.25 2.5 – 6.25 2.5 - 4 ||| 12 - 60 12 - 24 12 - 19.2 ||| 2,5 – 6,25 2,5 – 6,25 2,5 - 4
0.2667105197906494 ||| At the request of the MAH the evaluation procedure was suspended on 15 March 2006 in order to allow for the MAH to prepare for the provision of oral explanations. ||| Ahead of the first call, an administrative agreement will need to be signed with the European Investment Bank in order to set out the implementation arrangements of the facility. ||| À la demande du TAMM, la procédure d’ évaluation a été suspendue le 15 mars 2006 afin de permettre au TAMM de se préparer à fournir des explications orales.
0.4293319582939148 ||| If a dose is missed, treatment should be continued with the next dose as planned. ||| If a dose is forgotten, the following dose must not be increased. ||| Si une instillation est oubliée, le traitement doit être poursuivi avec l'instillation suivante.
0.21325533092021942 ||| Given the frequency of gastrointestinal adverse reactions to treatment with Diacomit and valproate (anorexia, loss of appetite, nausea, vomiting), the growth rate of children under this combination of treatment should be carefully monitored. ||| A greater frequency of pulmonary embolism, infections (predominantly of dermatologic origin), diarrhoea, and dehydration was also observed in the treatment arms using Vectibix in combination with bevacizumab and chemotherapy. ||| En raison de la fréquence des effets indésirables digestifs (anorexie, diminution de l’ appétit, nausées, vomissements) lors d’ un traitement par Diacomit et valproate de sodium, le taux de croissance des enfants recevant cette association doit être surveillé étroitement.
0.5543991923332214 ||| [To be completed nationally - Statement and phone number to be inserted based on national requirement for information on a toxicological service.] ||| Where the product is authorised in more than one Member State, to detail differences that exist between dossiers with respect to the information as requested. ||| [À compléter au niveau national - Informations et numéro de téléphone à insérer selon les exigences nationales pour les informations sur un Centre Anti-Poison.]
0.3927479386329651 ||| HOW TO TAKE THYMANAX ||| HOW TO TAKE POSACONAZOLE SP ||| COMMENT PRENDRE THYMANAX
0.06900224834680557 ||| However, nicotinic acid a component of Tredaptive does pass into breast milk. ||| However, nicotinic acid a component of Pelzont does pass into breast milk. ||| Mais l’ acide nicotinique, l’ un des composants de Tredaptive, passe dans le lait maternel.
0.35138797760009766 ||| There are no adequate data from the use of sirolimus in pregnant women. ||| There are insufficient data to provide information on inhibitor incidence in PUPs. ||| Il n’ existe pas de données suffisamment pertinentes concernant l’ utilisation de sirolimus chez la femme enceinte.
0.328262060880661 ||| Shoulder pads for sports use ||| Throat protectors for sports use ||| Protège-épaules pour le sport
0.14172646403312683 ||| ris 11. ||| ed 11. ||| au 11.
3.144840616219058e-13 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu. ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu. ||| 100 Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence Européenne du médicament (EMEA) http: / /www. emea. europa. eu.
0.4223202168941498 ||| colloidal anhydrous silica and magnesium stearate. ||| silica colloidal anhydrous. ||| K25, silice colloïdale anhydre et stéarate de magnesium.
0.021557234227657318 ||| 6 SUMMARY OF PRODUCT CHARACTERISTICS ||| 7 SUMMARY OF PRODUCT CHARACTERISTICS ||| 6 RESUME DES CARACTERISTIQUES DU PRODUIT
0.5019588470458984 ||| Children's adventure playground services ||| Children's ride-on toy vehicles ||| Services d'aires de jeux [parcours] pour enfants
0.4456799030303955 ||| the product should be discontinued until the infection has cleared. ||| This reaction was shown to be reversible when the medicinal product was discontinued. ||| REGRANEX, arrêter le traitement par REGRANEX jusqu'à ce que l'infection ait disparu.
0.3954838514328003 ||| Olives stuffed with red peppers and almonds ||| Olives stuffed with red peppers ||| Olives fourrées au piment rouge et aux amandes
0.40920817852020264 ||| Universal precautions refer to the practice, in medicine, of avoiding contact with patients' bodily fluids, by means of the wearing of nonporous articles such as medical gloves, goggles, and face shields. ||| To protect the health of guests as well as workers, it is essential to follow infectionprevention measures, such as physical distancing and hygiene, respiratory etiquette and use of facemasks as well as cleaning and disinfection. ||| Les précautions universelles désignent la pratique, en médecine, consistant à éviter tout contact avec les fluides corporels des patients, par le port d'articles non poreux tels que des gants médicaux, des lunettes de protection et des écrans faciaux.
0.5159342288970947 ||| In Cremona, the number of patients entries was three times the usual while services were running with 50% of their staff. ||| Among the patients who completed the studies, 476 were treated for longer, up to 5 years. ||| À Crémone, le nombre d'entrées de patients était trois fois plus élevé que d'habitude alors que les services fonctionnaient avec 50 % de leur personnel.
0.3224307894706726 ||| Tell your doctor immediately if you notice that your symptoms of the attack get worse after you received Firazyr. ||| If you notice such reactions during the infusion of Privigen, please tell your doctor immediately. ||| Si vous remarquez que les symptômes de la crise empirent après l’ administration de Firazyr, informez -en immédiatement votre médecin.
0.25933021306991577 ||| Pregnancy and breast-feeding Do not take Myfenax if you are breast feeding. ||| ed Pregnancy and breast-feeding You must not use this medicine if you are breast-feeding. ||| Grossesse et allaitement Ne prenez pas Myfenax si vous allaitez.
0.24490496516227722 ||| Enbrel is used in patients who have not responded to or cannot receive other treatments for this disease. ||| Sprycel is used when patients cannot tolerate, or when their disease is not responding to other treatments. ||| Enbrel est utilisé chez les patients n’ ayant pas répondu à d’ autres traitements pour cette maladie ou qui ne peuvent pas les suivre.
0.21470490097999573 ||| The pharmacokinetics of vardenafil in patients with severely impaired hepatic function (Child-Pugh C) has not been studied (see section 4.3). ||| The pharmacokinetics of abacavir have been studied in patients with mild hepatic impairment (Child-Pugh score 5-6) receiving a single 600 mg dose. ||| Les caractéristiques pharmacocinétiques du vardénafil n'ont pas été étudiées chez les insuffisants hépatiques sévères (C dans la classification de Child-Pugh) (voir rubrique 4.3).
0.4460907578468323 ||| Grass ||| Race ||| Herbe
0.3348880112171173 ||| Caution should be exercised in considering treatment of patients with increased risk for malignancy due to heavy smoking. ||| Overdose associated with bleeding complications should lead to treatment discontinuation and search for the primary cause. ||| Des précautions doivent être prises chez les patients présentant un risque accru de tumeurs du fait d’ un tabagisme important.
0.5329450964927673 ||| Bonbons made of sugar ||| Bouquets of fresh flowers ||| Bonbons en sucre
4.438009204923987e-13 ||| In some cases, a prior increase in body weight has been reported which may be a predisposing factor. ||| In some cases, a prior increase in body weight has been reported which may be a predisposing factor. ||| 52 Dans certains cas, une prise de poids antérieure, qui pourrait être un facteur prédisposant a été rapportée.
0.22723114490509033 ||| 34 The occurrence of anaemia (haemoglobin < 10 g/ dl) has been observed in up to 15% of chronic hepatitis C patients in clinical trials on the combined treatment of Pegasys with ribavirin. ||| Plasma concentrations of 9-cis-retinoic acid were evaluated during clinical studies in patients with cutaneous lesions of AIDS-related KS after repeated multiple-daily dose application of Panretin gel for up to 60 weeks. ||| La survenue d’une anémie (hémoglobine < 10 g/dl) a été observée à un pourcentage pouvant aller jusqu'à 15% des patients atteints d’hépatite chronique C et traités par Pegasys associé à la ribavirine dans les études cliniques.
0.251210480928421 ||| Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles. ||| 19 The anti-tumour activity of topotecan involves the inhibition of topoisomerase-I, an enzyme intimately involved in DNA replication as it relieves the torsional strain introduced ahead of the moving replication fork. ||| L'amprénavir se lie au site actif de la protéase du VIH-1 et prévient ainsi la transformation des précurseurs polyprotéiniques gag et gag-pol viraux, conduisant à la formation de particules virales immatures non- infectieuses.
0.2191590666770935 ||| Apart from breathing difficulties, Herceptin can cause fever, chills, flu-like symptoms, swelling of the face and lips, rash, wheezing, heart rhythm disturbances and blood pressure changes. ||| Uncommonly some patients experience changes at the application site (discharge, inflammation, swelling, scabbing, skin breakdown, blisters, dermatitis) or irritability, feeling sick, dry mouth, flu-like symptoms and tiredness. ||| Mis à part les difficultés respiratoires, Herceptin peut provoquer: fièvre, frissons, symptômes pseudo- grippaux, œdème de la face et des lèvres, éruptions cutanées, respiration sifflante, troubles du rythme cardiaque et modification de la pression artérielle.
0.24248719215393066 ||| In controlled clinical studies, the incidence of clinically important elevations in serum transaminases (ALT and/ or AST ≥ 3 X ULN, consecutive) was 1.0% for patients treated with Trevaclyn with or without a statin. ||| There were transient increases in liver ALT and AST of less than or equal to 3-fold the upper limit of normal (ULN) when CANCIDAS and cyclosporin were co-administered, that resolved with discontinuation of the medicinal products. ||| Dans les études cliniques contrôlées, l’ incidence d’ élévations cliniquement importantes des transaminases sériques (ALAT) et/ ou (ASAT) ≥ 3 x LSN consécutivement) a été de 1,0% chez les patients traités par Trevaclyn avec ou sans statine.
0.271743506193161 ||| REYATAZ/ ritonavir should not be used in combination with medicinal products that are substrates of CYP3A4 and have a narrow therapeutic index. ||| Similarly, saquinavir might also modify the pharmacokinetics of other medicinal products that are substrates for CYP3A4 or P-gp. ||| REYATAZ/ ritonavir ne doit pas être utilisé en association avec les medicaments substrats du CYP3A4 qui possèdent un index thérapeutique étroit.
0.2456429898738861 ||| CellCept 500 mg tablets mycophenolate mofetil ||| Myfenax 250mg hard capsules Mycophenolate mofetil ||| CellCept 500 mg, comprimés mycophénolate mofétil
0.337943434715271 ||| The starting dose for adults is one 375 mg tablet twice a day. ||| Your doctor has recommended a lower dose of one 20 mg tablet daily. ||| La dose de départ chez l'adulte est d’ un comprimé de 375 mg deux fois par jour.
0.82004714012146 ||| The mean duration of follow-up was nearly two years. ||| Median duration of response (months) ||| La durée moyenne du suivi a été de près de deux ans.
0.2737664580345154 ||| Each ml contains 75 mg cidofovir anhydrous. ||| Each capsule contains 250 mg mycophenolate mofetil. ||| Chaque ml contient 75 mg de cidofovir anhydre.
0.3932109475135803 ||| • allergic (hypersensitive) to the active substance, to other quinolone drugs or to any of the other ingredients of Ciprofloxacin Bayer (see section 6) • taking tizanidine (see Section 2: ||| • Hypersensitivity to 5-aminolevulinic acid hydrochloride or porphyrins. • Acute or chronic types of porphyria. • Pregnancy (see sections 4.6 and 5.3) ||| • vous êtes allergique (hypersensible) à la substance active, aux autres quinolones ou à l’un des autres composants contenus dans Ciprofloxacine Bayer (voir rubrique 6); • vous prenez de la tizanidine (voir rubrique 2:
0.04333962872624397 ||| This medicine is the same as Karvezide, which is already authorised in the European Union (EU). ||| This medicine is the same as Puregon, which is already authorised in the European Union (EU). ||| Ce médicament est le même que Karvezide, qui est déjà autorisé dans l’ Union européenne (UE).
0.5009442567825317 ||| Inhibitors have been observed in previously treated patients receiving factor VIII products, including ReFacto AF. ||| Although patient outcome was not affected, an interaction between NSAIDs and InductOs cannot be excluded. ||| Des inhibiteurs ont été observés chez les patients préalablement traités recevant des facteurs VIII, incluant ReFacto AF.
0.47247859835624695 ||| You will also take iron supplements before and during Abseamed treatment to increase the effectiveness of Abseamed. ||| Thus, the benefit/ risk balance of therapy with MabThera should be carefully considered before administering subsequent courses of Mabthera. ||| Vous prendrez également un complément de fer avant et pendant le traitement par Abseamed afin d’ augmenter l’ efficacité d’ Abseamed.
0.3874800503253937 ||| Cefuroximaxetil per tablet, equivalent to 125 mg of cefuroxime. ||| Cefuroximaxetil 125 contains 150.36 mg of ||| céfuroximaxetil par comprimé, correspondant à 125 mg de céfuroxime.
0.211400106549263 ||| Snow removal apparatus [machines] ||| Ground drilling apparatus [machines] ||| Appareils de déneigement [machines]
0.346962571144104 ||| You will have to inject Ceplene and IL-2 twice a day by subcutaneous injection (in the layer of tissue just under the skin), according to the directions provided by your doctor. ||| Silgard can be given with Hepatitis B vaccine at a separate injection site (another part of your body, e. g. the other arm or leg) at the same visit. ||| Vous devrez vous injecter Ceplene et l’ IL-2 deux fois par jour par voie sous-cutanée (dans la couche de tissus juste sous la peau), conformément aux directives données par votre médecin.
0.08819934725761414 ||| The marketing authorisation was renewed on 22 September 2003 and on 22 September 2008. ||| The marketing authorisation was renewed on 14 August 2002 and 14 August 2007. ||| L’ autorisation de mise sur le marché a été renouvelée le 22 septembre 2003 et le 22 septembre 2008.
0.37925589084625244 ||| 74 Patients had serum samples tested for autoantibodies at multiple time points in rheumatoid arthritis Studies I− V. ||| The pivotal study with 295 patients involved un-instrumented postero-lateral lumbar spine fusion in 208 patients treated with Opgenra.. ||| Des recherches d'auto-anticorps répétées ont été effectuées sur des échantillons de sérum des patients des essais I-V dans la polyarthrite rhumatoïde.
0.15716010332107544 ||| Slovenia: ||| Netherlands: ||| Slovénie:
0.26836657524108887 ||| 55 287 220 100.00% ||| 78 081 000 100.00% ||| 287 220
0.4751206636428833 ||| Magnetic filters ||| Electric coffee filters ||| Filtres magnétiques
0.2762388586997986 ||| Pigs ||| Dogs ||| porcins
0.43281257152557373 ||| 19 The table below displays the adverse reactions reported in ≥ 1% of patients according to the standard MedDRA system organ class. ||| The proportion of patients with a favorable clinical response assessment at posttreatment visit in the clinical MITT population is shown below: ||| Le tableau ci-dessous indique les réactions indésirables signalées chez au moins 1% des patients.
0.13717027008533478 ||| 0.5 mg ||| 1.5 mg ||| 2,0 mg
0.3109563887119293 ||| Brownish or greyish red, elongated-ellipse shaped, unscored film-coated tablets marked with ‘ LCE 150’ on one side. ||| Tyverb film-coated tablets are oval, biconvex, yellow film-coated, with ‘GS XJG’ marked on one side. ||| Comprimés pelliculés brun-rouge ou gris-rouge, oblongs, de forme ellipsoïdale, non sécables, portant la mention "LCE 150" gravée sur une face.
0.10731802135705948 ||| 0.5 ||| 0.1 ||| 1
0.0 ||| 5. ||| 5. ||| 19 5.
0.3046236038208008 ||| Several adverse events were reported more commonly in 69 juvenile idiopathic arthritis patients receiving 3 months of Enbrel compared to the 349 adult rheumatoid arthritis patients. ||| In general, the adverse events in paediatric patients with juvenile idiopathic arthritis were similar in frequency and type to those seen in adult patients. ||| 167 indésirables ont été rapportés plus fréquemment chez les 69 patients atteints d'arthrite juvénile idiopathique ayant reçu Enbrel pendant 3 mois en comparaison aux 349 patients adultes atteints de polyarthrite rhumatoïde.
0.03969816863536835 ||| 401 Once in-use, vials may be kept for up to 4 weeks. ||| 379 Once in-use, vials may be kept for up to 4 weeks. ||| 404 Une fois utilisés, les flacons peuvent être conservés jusqu'à 4 semaines.
0.28340303897857666 ||| In six HIV-infected children from 2 to 13 years of age, zidovudine plasma pharmacokinetics were evaluated while subjects were receiving 120 mg/ m2 zidovudine three times daily and again after switching to 180 mg/ m2 twice daily. ||| Among patients in the infliximab 5 mg/ kg group who crossed over because of loss of fistula response after week 22, 57% (12/ 21) responded to re-treatment with infliximab 10 mg/ kg every 8 weeks. ||| Chez 6 enfants infectés par le VIH, âgés de 2 à 13 ans, les paramètres pharmacocinétiques plasmatiques de la zidovudine ont été évalués alors que les patients recevaient une dose de zidovudine de 120 mg/ m2 trois fois par jour, puis de nouveau, après passage à une posologie de 180 mg/ m2 deux fois par jour.
0.02302199974656105 ||| Like all medicines, Fuzeon can cause side effects, although not everybody gets them. ||| Like all medicines, Dafiro can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Fuzeon est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.008883330039680004 ||| Adults and adolescents (12 years of age and over): one dose of Azomyr oral lyophilisate placed in the mouth once a day for the relief of symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria (see section 5.1). ||| Adults and adolescents (12 years of age and over): one dose of Neoclarityn oral lyophilisate placed in the mouth once a day for the relief of symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria (see section 5.1). ||| Adultes et adolescents (12 ans et plus): une dose d’ Azomyr lyophilisat oral une fois par jour à laisser fondre dans la bouche pour le soulagement des symptômes associés à la rhinite allergique (incluant les rhinites allergiques intermittente et persistante) et à l’ urticaire (voir rubrique 5.1).
0.19409272074699402 ||| Do not use after the expiry date which is stated on the carton after {abbreviation used for expiry date [To be completed nationally]}. ||| Do not use [Neurontin and associated names] after the expiry date which is stated on the carton after [to be completed nationally]. ||| Ne pas utiliser après la date de péremption mentionnée sur la boîte après {abréviation utilisée pour la date de péremption [A compléter au niveau national]}.
0.3183855712413788 ||| If the patient is experiencing fatigue, caution is advised when driving a car or operating machinery. ||| Those who may already have the infection have been advised to wear a surgical mask in public. ||| Si le patient ressent de la fatigue, la précaution est recommandée lors de la conduite des véhicules et l’ utilisation des machines.
0.005896974354982376 ||| 55 1 tablet of Cefuroximaxetil 250 twice a day for 5-10 days. ||| 48 1 tablet of Cefuroximaxetil 250 twice a day for 5-10 days. ||| 1 comprimé de Cefuroximaxetil 250 deux fois par jour pendant 5 à 10 jours.
0.009504619985818863 ||| 49 MINIMUM PARTICULARS TO APPEAR ON BLISTERS ||| 44 MINIMUM PARTICULARS TO APPEAR ON BLISTERS ||| 49 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES
0.20828646421432495 ||| Why has Azopt been approved? ||| Why has Comtess been approved? ||| Pourquoi Azopt a -t-il été approuvé?
0.023918017745018005 ||| From 1971 to 1974, Mr O’Malley completed articles in Dublin. ||| From 1971 to 1974, Mr O’ Malley completed articles in Dublin. ||| O’ Malley a rédigé des articles à Dublin.
0.5231664776802063 ||| The daily dose should not be divided. ||| It must not be used to set the dose. ||| La dose quotidienne ne doit pas être divisée.
0.3773013949394226 ||| How has ProteqFlu been studied? ||| Why has ProteqFlu-Te been approved? ||| Quelles études ont été menées sur ProteqFlu?
0.4223557412624359 ||| Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. ||| The foil protects the powder for inhalation from the effects of the atmosphere. ||| Un shampoing ou un bain dans l’ eau directement après l’ application du produit sur la peau peut réduire l’ efficacité du produit.
0.18845978379249573 ||| Faslodex contains the active substance fulvestrant, which belongs to the group of estrogen blockers. ||| Busilvex contains the substance busulfan, which belongs to a group of medicines called alkylating agents. ||| Faslodex contient la substance active fulvestrant, qui appartient à la classe des anti-estrogènes.
0.43759262561798096 ||| In most of the cases, these side effects are mild and do not last very long. ||| While these changes have tended to improve with time, in some patients they may be permanent. ||| Dans la plupart des cas, ces effets secondaires sont faibles et ne durent pas très longtemps.
0.3321571350097656 ||| No specific symptoms or signs have been identified following acute overdose with abacavir or lamivudine, apart from those listed as undesirable effects. ||| Rare cases of moderate increases in AST and/ or ALT have been reported where a causal relationship to raloxifene can not be excluded. ||| A l'exception des effets indésirables préalablement mentionnés, aucun symptôme ou signe spécifique n’ a été identifié suite à un surdosage aigu à l'abacavir ou à la lamivudine.
0.4844238758087158 ||| The starting dose is 4 mg/ day rosiglitazone plus 4 mg/ day glimepiride (given as one tablet AVAGLIM 4 mg/ 4 mg). ||| kg) or 10 mg (body weight > 100 kg) SC once daily was compared to enoxaparin sodium 1 mg/ kg SC twice daily. ||| La dose initiale est 4 mg/ jour de rosiglitazone plus 4 mg/ jour de glimépiride (administré en un seul comprimé d’ AVAGLIM 4 mg/ 4 mg).
0.2667370140552521 ||| Hazard ratio estimate is based on a Cox proportional-hazard model adjusted for stratification factors: beta2-microglobulin, albumin, and region. ||| Kaplan-Meier estimate. b Hazard ratio estimate is based on a Cox proportional-hazard model adjusted for stratification factors: β 2-microglobulin, albumin, and region. ||| facteurs de stratification: β 2-microglobuline, albumine et région géographique.
0.13364407420158386 ||| For breast, non-small cell lung, gastric, and head and neck cancers, premedication consisting of an oral corticosteroid, such as dexamethasone 16 mg per day (e. g. ||| For breast and non-small cell lung cancers, premedication consisting of an oral corticosteroid, such as dexamethasone 16 mg per day (e. g. ||| Dans les cancers du sein, du poumon non à petites cellules, gastrique et des voies aéro-digestives supérieures, et sauf contre-indication, une prémédication par un corticoïde oral peut être utilisée, tel que la dexaméthasone à raison de 16 mg par jour (par exemple:
0.49321308732032776 ||| As from the beginning of 1998, all new medicines will have to be evaluated under the new European system, except where a medicine is only to be marketed in a single Member State. ||| If one Member State's app is to work in another Member State, some encrypteddata will be shared with the server processing data collected by the app in that other Member State. ||| A partir du début de l’ année 1998, les nouveaux médicaments devront être évalués selon le nouveau système européen, à l’ exception de ceux destinés à n’ être commercialisés que dans un seul État membre.
0.40378186106681824 ||| Antiseptic sprays in aerosol form for use on the skin ||| Non-slip resin sprays for use by athletes ||| Sprays antiseptiques sous forme d'aérosols pour la peau
0.2670642137527466 ||| The use of Thyrogen should be supervised by a doctor with expertise in thyroid cancer. ||| Orgalutran should only be prescribed by a specialist experienced in the treatment of infertility. ||| L’ utilisation de Thyrogen doit être supervisée par un médecin expérimenté dans la prise en charge du cancer de la thyroïde.
0.35426515340805054 ||| 49 Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214 ||| 24 Κύπρος Akis Panayiotou & Son Ltd Γιάννου Κρανιδιώτη 4 CY-225 78, Λευκωσία Τηλ: +357-22677038 ||| Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214
1.1346706994125322e-12 ||| General Disorders and Administration Site Conditions ||| General Disorders and Administration Site Conditions ||| Troubles généraux et anomalies au site d’ administration
0.08756425976753235 ||| Each tablet contains 25 mg of agomelatine. ||| Each tablet contains 10 mg of simvastatin. ||| Chaque comprimé contient 25 mg d'agomélatine.
0.18015342950820923 ||| How is Cervarix used? ||| How is Myfenax used? ||| Comment Cervarix est -il utilisé?
0.1742037534713745 ||| Comtan 200 mg [folding box only] ||| comtess 200 mg [folding box only] ||| Comtan 200 mg [uniquement pour la boîte]
0.5735687017440796 ||| Lawn mowing attachments for vehicles ||| Bubble making wand and solution sets ||| Accessoires de coupe du gazon pour véhicules
0.2974073886871338 ||| Over long term treatment up to 3 years, a small and gradual decrease in mean platelet counts within the normal range was observed. ||| The slowing in the progression to clinical proteinuria was evident as early as three months and continued over the 2 year period. ||| Lors du traitement au long cours jusqu’ à 3 ans a été observée une légère baisse progressive des numérations plaquettaires moyennes à l’ intérieur des limites de la normale.
8.959347478319779e-13 ||| • Clinical trials ||| • Clinical trials ||| • Essais cliniques:
0.7827198505401611 ||| Information for diabetics: ||| For all patients: ||| Information pour les diabétiques:
0.4366515874862671 ||| Following a decision by the European Commission in July arrangements have been made for the Commission’ s delegation in London to legalise certificates. ||| Following the CHMP’ s opinion, it usually takes around two months for the European Commission to grant a licence. ||| Suite à une décision de la Commission européenne de juillet 1997, des dispositions ont été prises pour que la délégation de la Commission à Londres légalise les certificats.
1.6632463932037354 ||| 3.8% (1/ 26) 0% (0/ 25) 25% (1/ 4) 9.1% (2/ 22) (0/ 5) (0/ 5) ||| 1 3 5 7 9 11 13 (one pocket) 2 4 6 8 10 12 14 (no pocket) 15 17 19 21 23 25 27 (one pocket) 16 18 20 22 24 26 28 (one pocket) ||| 3,8% (1/26) 0% (0/25) 25% (1/4) 9,1% (2/22) (0/5) (0/5)
0.24025599658489227 ||| Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted 17 with Prometax in patients with dementia associated with Parkinson’ s disease with pre-defined adverse events that may reflect worsening of parkinsonian symptoms. ||| The proposed indication is based on the results from the RENAAL study, where the effect of losartan was investigated on a composite primary endpoint of renal endpoints and mortality in patients with Type II diabetes mellitus with proteinuria. ||| Le Tableau 3 liste le nombre et le pourcentage de patients ayant présentés des effets indésirables prédéfinis qui pourraient être le reflet d’ une aggravation des symptômes parkinsoniens dans le cadre de l’ étude clinique spécifique conduite pendant 24 semaines avec Prometax chez les patients atteints de démence associée à la maladie de Parkinson.
0.031839367002248764 ||| Each pre-filled syringe contains 30 micrograms of darbepoetin alfa in 0.3 ml (100 µg/ ml). ||| Each pre-filled syringe contains 500 micrograms of darbepoetin alfa in 1 ml (500 µg/ ml). ||| Chaque seringue préremplie contient 30 microgrammes de darbepoetin alfa dans 0,3 ml (100 µg/ ml).
0.573300838470459 ||| These PSURs will address cumulative data on hepatic reactions and NMS. ||| 7 Frequency of adverse drug reactions (ADRs) in clinical studies with KIOVIG ||| Ces PSUR contiendront les données cumulées sur les réactions hépatiques et le SMN.
0.2814980149269104 ||| Cytochrome P450 2C9 activity is reduced in individuals with genetic polymorphisms that lead to reduced enzyme activity, such as those homozygous for the CYP2C9*3 polymorphism. ||| CYP2C19 is subject to genetic polymorphism and 2-6% of the population, called poor metabolisers (PMs), are homozygote for a mutant CYP2C19 allele and therefore lacks a functional CYP2C19 enzyme. ||| L’ activité du cytochrome P450 CYP2C9 est réduite chez les personnes présentant un polymorphisme génétique ayant pour effet de réduire l’ activité enzymatique, à l’ instar des variantes homozygotes du polymorphisme CYP2C9*3.
0.10117117315530777 ||| In addition, an updated RMP should be submitted When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached At the request of the EMEA ||| • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| Par ailleurs, un PGR actualisé doit être soumis: lorsque de nouvelles informations reçues sont susceptibles d’avoir des conséquences sur le profil de sécurité d’emploi actuel du produit, le plan de pharmacovigilance ou les activités de minimisation des risques; dans les 60 jours qui suivent une échéance importante (en terme de pharmacovigilance ou de minimisation des risques); sur demande de l’EMEA.
0.24770838022232056 ||| New or worse cases of macular oedema have occurred on rare occasions in people taking Avandia and similar medicines. ||| • There have been very rare cases of certain kinds of cancer in patients taking Humira or other TNF blockers. ||| Des cas de survenue ou d’ aggravation d 'œ dème maculaire ont été signalés en de rares occasions chez les personnes prenant Avandia et d’ autres médicaments similaires.
0.28670066595077515 ||| In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics You must tell your doctor if you think that you are (or might become) pregnant. ||| Pregnancy and breast-feeding You must tell your doctor if you think that you are (or might become) pregnant You should not take TRITACE in the first 12 weeks of pregnancy, and you must not take them at all after the 13th week as their use during pregnancy may possibly be harmful to the baby. ||| Dans ce cas votre médecin peut faire pratiquer des tests sanguins réguliers, en particulier pour mesurer le taux de potassium dans le sang en cas de mauvais fonctionnement des reins si vous devez subir une intervention chirurgicale ou une anesthésie Vous devez informer votre médecin si vous êtes enceinte ou si vous pensez pouvoir être enceinte.
0.24560025334358215 ||| You can use FORSTEO for up to 28 days after the first injection, as long as the pen is stored in a refrigerator (2°C to 8°C). ||| To achieve this, the vial should be kept at room temperature (25 ± 3 °C) for at least five minutes before connecting the syringe and reconstituting the vaccine. ||| Vous pouvez utiliser FORSTEO dans un délai de 28 jours après la première injection, tant que le stylo est conservé au réfrigérateur (entre 2°C et 8°C).
0.34765470027923584 ||| A higher proportion of patients receiving the original rituximab/ MTX treatment also had no erosive progression over 56 weeks (Table 8). ||| Similarly, no differences were noted between the groups in the pivotal study with Bonviva 3 mg injection every 3 months (BM 16550). ||| Le pourcentage de patients sans progression radiographique après 56 semaines a été également significativement plus élevé dans le groupe de patients traités à l’ origine par rituximab/ MTX (Tableau8).
0.5352501273155212 ||| ra Gender - No gender differences were observed after adjustment for body weight. ||| Gender/Race No dose adjustment is necessary based on gender or race (see section 5.2). ||| Sexe - Après ajustement au poids corporel, aucune différence liée au sexe n’ a été mise en évidence. en
0.44800400733947754 ||| After a median follow-up of 32 weeks, the tritherapy with the three nucleosides ZDV/ 3TC/ ABC was shown to be virologically inferior to the two other arms regardless of baseline viral load ( 100 000 copies/ml) with 26% of subjects on the ZDV/3TC/ABC arm, 16% on the ZDV/3TC/EFV arm and 13% on the 4 drug arm categorised as having virological failure (HIV RNA > 200 copies/ml). ||| The study contained two parts: an initial unblinded 2-arm part (Part I) in which patients were randomised to two different treatment groups (XELOX and FOLFOX-4) and a subsequent 2 x 2 factorial 4-arm part (Part II) in which patients were randomised to four treatment groups (XELOX + placebo, FOLFOX-4 + placebo, XELOX + Avastin, FOLFOX-4 + Avastin). ||| 26% des sujets du bras ZDV/ 3TC/ ABC, 16% des sujets du bras ZDV/ 3TC/ EFV et 13% des sujets du bras ZDV/ 3TC/ ABC/ EFV se sont avérés en échec virologique (ARN - HIV > 200 copies/ ml).
3.5430252481871705e-13 ||| (vii) Support for the construction and upscaling of testing facilities to develop and test products (including vaccines, ventilators and protective clothing) useful to tackle the coronavirus outbreak, up to first industrial deployment. ||| (vii) Support for the construction and upscaling of testing facilities to develop and test products (including vaccines, ventilators and protective clothing) useful to tackle the coronavirus outbreak, up to first industrial deployment. ||| vii) soutien à la construction et au développement d'installations d'essai pour la mise au point et le test de nouveaux produits (dont les vaccins, respirateurs et vêtements de protection) utiles pour faire face à la flambée de coronavirus, jusqu'au premier déploiement industriel.
0.11266190558671951 ||| EMEA/ CPMP/ 0539/ 04 ||| EMEA/ CPMP/ 4260/ 03 |||  EMEA 2004 EMEA/ CPMP/ 0539/ 04
0.43194979429244995 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €110 million Lithuanian scheme we approved today will enable public guarantees on loans to support Lithuania's economy during the coronavirus outbreak. ||| The mayor of Belo Horizonte, Alexandre Kalil (PSD), asked General Altair José Polsin, commander of the 4th Army Region, for the temporary assignment of 51 professionals from the army garrison to assist in the demands of fighting the coronavirus. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime lituanien d'un montant de 110 millions d'euros que nous avons autorisé aujourd'hui permettra l'octroi de garanties publiques sur des prêts destinés à soutenir l'économie lituanienne durant la pandémie de coronavirus.
0.3162318468093872 ||| In the population pharmacokinetic analysis, a 1.2-fold increase in ranolazine exposure was estimated in subjects with moderate impairment (creatinine clearance 40 ml/ min). ||| A population pharmacokinetic analysis in 591 patients receiving single agent Tarceva shows a mean apparent clearance of 4.47 l/hour with a median half-life of 36.2 hours. ||| Au cours d’ une analyse pharmacocinétique de population, on a estimé que l'exposition à la ranolazine augmentait selon un facteur de 1,2 chez les sujets atteints d'insuffisance rénale modérée (clairance de la créatinine de 40 ml/ min).
0.3237883448600769 ||| No recommendation on dosage reduction is possible in patients with mild hepatic impairment due to the substantial variability of abacavir exposure. ||| It is advisable not to exceed the recommended dosage in view of the potential risks of acromegaly, hyperglycaemia, and glucosuria. ||| Aucune recommandation de réduction de la posologie n’ est possible chez les patients ayant une insuffisance hépatique légère en raison de la grande variabilité de l’ imprégnation plasmatique en abacavir.
0.8741613626480103 ||| 8/ 17 A. ||| EN 8/ 8 ||| 8/ 18 A.
0.04142487794160843 ||| 90 This leaflet was last approved in {MM/ YYYY}. ||| 85 This leaflet was last approved in {MM/YYYY}. ||| La dernière date à laquelle cette notice a été approuvée est {MM/ AAAA}
0.04454002529382706 ||| In these situations the treatment should be carefully supervised, and the clinical benefit of Axura reassessed by your doctor on a regular basis. ||| In these situations the treatment should be carefully supervised, and the clinical benefit of Ebixa reassessed by your doctor on a regular basis. ||| 69 Dans ces situations, le traitement doit se faire sous étroite surveillance et le bénéfice clinique d’Axura doit être régulièrement réévalué par votre médecin.
0.21151970326900482 ||| The use of cefuroxime axetil is not recommended in patients with severe intestinal tract disorders accompanied by vomiting and diarrhoea, since in these situations a sufficient absorption can not be guaranteed. ||| The concomitant use of bronchodilators such as salbutamol may increase the absorption of EXUBERA and may therefore increase the risk of hypoglycaemia when used to relieve acute respiratory symptoms (see section 4.5). ||| 27 L’ administration du céfuroxime axétil n’ est pas recommandée chez les patients présentant des troubles intestinaux sévères accompagnés de vomissements et de diarrhée, car l’ absorption peut ne pas être suffisante dans ces situations.
0.23815931379795074 ||| In a clinical study, the concomitant use of erlotinib and rifampicin (600 mg orally once daily for 7 days), a potent CYP3A4 inducer, resulted in a 69% decrease in the median erlotinib AUC. ||| During continuous treatment with methylprednisolone, the AUC of methylprednisolone may decrease at later time points within 2 weeks following initiation of dosing with EMEND, due to the inducing effect of aprepitant on CYP3A4. ||| Dans une étude clinique, l’utilisation concomitante d’erlotinib et de rifampicine (600 mg par voie orale une fois par jour pendant 7 jours), inducteur puissant du CYP3A4, a conduit à une diminution de 69% de la médiane de l’ASC de l’erlotinib.
0.3849107623100281 ||| Novo Nordisk A/ S Hallas Allé DK-4400 Kalundborg Denmark ||| Lundbeck A/S Ottiliavej 9 DK-2500 Valby Denmark. ||| Novo Nordisk A/ S Hallas Allé DK-4400 Kalundborg Danemark
0.6096978187561035 ||| 3 Adults (≥ 18 years) ||| 11 Infants aged 2 - 6 months: ||| Chez les adultes (≥ 18 ans)
0.1252446174621582 ||| The safety and efficacy of nelfinavir has not been established in patients with significant underlying liver disorders. ||| The safety and efficacy of stavudine has not been established in patients with significant underlying liver ||| La tolérance et l'efficacité du nelfinavir n'ont pas été établies chez les patients présentant des troubles sous-jacents significatifs de la fonction hépatique.
0.36102500557899475 ||| Therefore 70 mg twice daily remains the recommended dose schedule in imatinib-resistant or intolerant patients with advanced phase CML and Ph+ALL. ||| Pharmacokinetic profile of insulin glulisine and regular human insulin in type 1 diabetes mellitus patients after a dose of 0.15 U/ kg. ||| Donc, 70 mg deux fois par jour reste le schéma de dose recommandé chez les patients résistants ou intolérants à l'imatinib dans les phases avancées de la LMC et la LAL Ph+
7.045296420912783e-13 ||| 32 ||| 32 ||| 76 32
0.0 ||| Read the package leaflet before use. ||| Read the package leaflet before use. ||| Lire la notice avant emploi.
0.24639442563056946 ||| In patients insufficiently controlled with 150 mg once daily, the dose of Irbesartan Winthrop can be increased to 300 mg, or other anti-hypertensive agents can be added. ||| An increase in cholesterol and triglyceride levels has been associated with thiazide diuretic therapy; however, at the 12.5 mg dose contained in PritorPlus, minimal or no effects were reported. ||| Chez les patients insuffisamment contrôlés à la dose de 150 mg une fois par jour, la posologie peut être augmentée à 300 mg ou un autre agent antihypertenseur peut être ajouté.
0.026409802958369255 ||| 25 In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5 HT2A than dopamine D2 receptor occupancy. ||| In a single oral dose (10 mg) Positron Emission tomography (PET) study in healthy volunteers, olanzapine produced a higher 5-HT2A than dopamine D2 receptor occupancy. ||| Dans une étude de tomographie par émission de positron (PET) chez le volontaire sain utilisant une dose orale unique (10 mg), l’ olanzapine a entraîné une occupation des récepteurs 5HT2A supérieure à celle des récepteurs D2.
0.07163868844509125 ||| What benefit has TOVIAZ shown during the studies? ||| What benefit has TESAVEL shown during the studies? ||| Quel est le bénéfice démontré par TOVIAZ au cours des études?
0.32956719398498535 ||| The dose is 0.1 mg firocoxib per kg bodyweight, given once a day. ||| Administer 0.1 mg firocoxib per kg bodyweight, once daily. ||| La dose à administrer est de 0,1 mg de firocoxib/ kg de poids corporel, une fois par jour.
0.5034615397453308 ||| If there is bleeding, cover with an adhesive bandage. ||| - if you have a thickening of the womb lining, ||| En cas de saignement, couvrez-le avec un pansement adhésif.
0.45168429613113403 ||| 12.0 ||| 1 dose ||| 12,0
0.6239199638366699 ||| Hypothyroidism Thyroid Disorder Hyperthyroidism ||| Parathyroid carcinoma and Primary Hyperparathyroidism ||| Hypothyroïdie Trouble thyroïdien Hyperthyroïdie
0.02091352827847004 ||| 32 6.6 Special precautions for disposal and other handling ||| 28 6.6 Special precautions for disposal and other handling ||| 35 6.6 Précautions particulières d’ élimination et de manipulation
0.21483998000621796 ||| 154 oral contraceptives ("the Pill") any medicines used to treat diseases related to the acid in the stomach (e. g. antacids, H2- blockers and proton pump inhibitors) medicines to lower blood pressure, to slow heart rate, or to correct heart rhythm simvastatin, lovastatin, and atorvastatin (used to lower blood cholesterol) nevirapine and efavirenz (used to treat HIV) cyclosporin, tacrolimus, and sirolimus (medicines to decrease the effects of body's immune system) certain antibiotics (rifabutin, clarithromycin) ketoconazole, itraconazole, and voriconazole (antifungals) warfarin (anticoagulant, used to reduce the blood clots) irinotecan (used to treat cancer) sedative agents (e. g. midazolam administered by injection) buprenorphine (used to treat opioid addiction and pain). ||| Medicinal products which should not be given with Invirase/ritonavir include: • terfenadine, astemizole, pimozide, cisapride, amiodarone, propafenone and flecainide (potential for life threatening cardiac arrhythmia) • midazolam administered orally (for caution on parenterally administered midazolam, see section 4.5), triazolam (potential for prolonged or increased sedation, respiratory depression) • simvastatin, lovastatin (increased risk of myopathy including rhabdomyolysis) • ergot alkaloids (e.g. ergotamine, dihydroergotamine, ergonovine, and methylergonovine) (potential for acute ergot toxicity) • rifampicin (risk of severe hepatocellular toxicity) (see sections 4.4, 4.5, and 4.8). ||| Il est particulièrement important de signaler les médicaments suivants: autres médicaments traitant l'infection par le VIH sildénafil (utilisé par les hommes pour traiter l'impuissance (troubles de l'érection)) contraception orale ("la pilule") médicaments utilisés pour traiter les maladies liées à l'acidité gastrique (c'est-à-dire antiacides, antagonistes des récepteurs H2 et inhibiteurs de la pompe à protons) médicaments réduisant la pression artérielle, la fréquence cardiaque ou corrigeant le rythme cardiaque simvastatine, lovastatine, et atorvastatine (utilisées pour réduire le cholestérol sanguin) névirapine et éfavirenz (utilisés pour traiter le VIH) ciclosporine, tacrolimus et sirolimus (médicaments immunosuppresseurs) certains antibiotiques (rifabutine, clarithromycine) kétoconazole, itraconazole et voriconazole (antifongiques) warfarine (anticoagulant utilisé pour réduire la coagulation sanguine) irinotecan (utilisé dans le traitement du cancer) les sédatifs (par exemple le midazolam administré par voie intraveineuse) buprénorphine (utilisée pour traiter la dépendance aux opioïdes et la douleur).
0.14431798458099365 ||| Advisory services relating to the repair of environmental control systems ||| Advisory services relating to the installation of building automation equipment ||| Services de conseils liés à la réparation de systèmes de contrôle environnemental
0.408000648021698 ||| Following the video-conference between EU Transport Ministers on 18 March, the Commission set up a network of national contact points and a platform to provide information on national transport measures taken by Member States in response to the coronavirus. ||| Together with Members of the Economic and Social Committee, Members of the European Parliament were able to visit the EMEA on 28 May 1996 to discuss its achieve- ments and some of the difficulties faced by the EMEA. ||| À la suite de la vidéoconférence qui s'est tenue le 18 mars entre les ministres des transports de l'UE, la Commission a mis en place un réseau de points de contact nationaux et une plateforme pour fournir des informations sur les mesures nationales prises par les États membres en matière de transport en réponse à l'épidémie de coronavirus.
0.32532477378845215 ||| When reconstituted, the volume of the suspension is 175 ml, providing a usable volume of 160 – 165 ml. ||| The reconstituted volume allows accurate withdrawal of 5.0 ml (equal to 200 units) from each vial. ||| Après reconstitution, le volume de la suspension est de 175 ml, correspondant à un volume utile de 160-165 ml.
0.24812275171279907 ||| If CRIXIVAN with ritonavir is coadministered with parenteral midazolam, it should be done in an intensive care unit with close clinical monitoring in case of respiratory depression and/ or prolonged sedation. ||| In severe cases or if the patient is unable to take oral suspension (e. g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible. ||| Si CRIXIVAN associé au ritonavir est co- administré avec du midazolam par voie parentérale, cela doit être réalisé dans une unité de soins intensifs avec une surveillance clinique étroite en cas de dépression respiratoire et/ ou de sédation prolongée.
0.2383234202861786 ||| The CHMP noted that an active pharmacovigilance system is in place in Italy since 1975 guaranteeing a strict control of the adverse events linked to medicinal products and that the Italian pharmacovigilance database does not contain a single suspected adverse reaction signal related to UMAN BIG, which is consistent with the statement of the Applicant of the safety of UMAN BIG. ||| • The CHMP identified that the decreased immunogeniticy of the HepB component released by the MAH seems to be due to variability in the production process for this component and that following extensive review of the manufacturing process the MAH has identified the current adjuvantation process as a potential root cause for decreased immunogenicity of the HepB vaccine component. ||| Le CHMP a constaté qu’ un système actif de pharmacovigilance est en place en Italie depuis 1975, garantissant un contrôle strict des événements indésirables liés aux médicaments et que la base de données de pharmacovigilance italienne ne contient aucun signal de réaction indésirable suspectée liée à UMAN BIG, ce qui est en accord avec la déclaration du demandeur relative à la sécurité de UMAN BIG.
0.5223674774169922 ||| The possibility of pharmacological overdose is therefore remote. ||| The mode of administration of Livensa makes overdose unlikely. ||| Un surdosage pharmacologique est donc improbable.
0.040254488587379456 ||| The symptoms should go away quickly (within 2-3 days of the injection) and they do not usually come back after the second injection. ||| The symptoms should go away quickly (within 2 -3 days of the injection) and they do not usually come back after the second injection. ||| Les symptômes devraient disparaître rapidement (dans les 2 ou 3 jours suivant l'injection) et habituellement ils ne reviennent pas après la deuxième injection.
4.904529473520602e-13 ||| Only solutions which are clear or slightly opalescent, colourless and practically free of visible particles may be injected. ||| Only solutions which are clear or slightly opalescent, colourless and practically free of visible particles may be injected. ||| Seules les solutions transparentes ou légèrement opalescentes, incolores et pratiquement sans particules visibles à
0.3443533480167389 ||| The CHMP expressed concerns that there is evidence of unpredictable variability in Hepatitis B antibody response following vaccination with Hexavac. ||| The CHMP was concerned that there was not enough evidence to show that the injection of Advexin into Li-Fraumeni tumours led to benefits for patients. ||| Le CHMP s’ interroge sur le fait qu’ il existe une variabilité prouvée de la réponse en anticorps contre l’ hépatite B non prévisible après vaccination par Hexavac.
0.39098283648490906 ||| c) 216 Days d) 307 Days ||| c) 208 days d) 235 days ||| c) 216 Jours d) 307 Jours
0.39094799757003784 ||| Overall treatment for 16 weeks resulted in lower sustained viral response (65%) than treatment for 24 weeks (76%) (p < 0.0001). ||| 40 response was also higher in the patients treated at 600 mg (33%) as compared to the patients treated at 400 mg (16%, p=0.0220). ||| La réponse virologique prolongée obtenue avec un traitement de 16 semaines a été plus faible (65%) que celle obtenue avec un traitement de 24 semaines (76%) (p < 0,0001).
0.4565684199333191 ||| Profender for small cats (≥0.5 - 2.5 kg) ||| Advocate for medium dogs (> 4-10 kg) ||| Profender pour petits chats (≥ 0,5 – 2,5 kg)
0.38078397512435913 ||| The changes observed at the low dose of the 13 week studies can be classified as minimal and fully reversible. ||| No undesirable effects have been observed after the administration of twice the recommended dosage. ||| Les modifications observées avec la dose faible dans les études sur 13 semaines peuvent être considérées comme minimes et parfaitement réversibles.
0.5183719396591187 ||| Chemical preparations for treating phylloxera ||| Co2 insufflators for urological diagnosis ||| Produits chimiques pour le traitement du phylloxéra
0.10544148832559586 ||| It is possible in some cases to withdraw concomitant immunosuppressive therapy, leading to -based dual- therapy. ||| It is possible in some cases to withdraw concomitant immunosuppressive therapy, leading to Advagraf monotherapy. ||| Il est possible dans certains cas d’ arrêter les autres traitements immunosuppresseurs concomitants et d’ utiliser ainsi un protocole de bithérapie basé sur .
0.3374887704849243 ||| Ziconotide may cause confusion, somnolence and other neurological adverse reactions, therefore patients must be advised not to drive or operate machines if affected. ||| Abraxane may cause side effects such as tiredness (very common) and dizziness (common) that may affect the ability to drive and use machinery. ||| Le ziconotide pouvant provoquer une confusion, une somnolence et d'autres réactions indésirables neurologiques, les patients doivent être avertis de ne pas conduire de véhicules ni d'utiliser des machines s’ ils présentent ces effets.
0.22115087509155273 ||| If Seretide therapy has to be withdrawn due to overdose of the beta agonist component of the drug, provision of appropriate replacement steroid therapy should be considered. ||| When paroxetine is to be co-administered with a known drug metabolising enzyme inhibitor, consideration should be given to using paroxetine doses at the lower end of the range. ||| Si le traitement par Seretide doit être interrompu en raison d’ une exposition excessive aux bêta-2 mimétiques, il sera remplacé par un corticoïde seul.
0.30891937017440796 ||| Advisory services relating to product testing ||| Advisory services relating to the law ||| Services de conseils concernant les tests de produits
0.25937801599502563 ||| Reduced plasma concentrations of atazanavir may be the consequence of increased gastric pH if antacids, including buffered medicinal products, are administered with REYATAZ/ ritonavir. ||| The anticoagulant effect of desirudin is poorly reversible. aPTT levels can, however, be reduced by intravenous administration of DDAVP (desmopressin). ||| La co-administration des antiacides, y compris les médicaments tamponnés avec REYATAZ / ritonavir, peut entraîner une baisse des concentrations plasmatiques d'atazanavir, suite à l’ augmentation du pH gastrique induite par ces médicaments.
0.3705836236476898 ||| Fungal infection, bacterial infection, pulmonary infection, otitis media, tooth abscess, herpes simplex, urinary tract infection, vaginitis, gastroenteritis ||| Septic shock*, sepsis, bacteraemia, pneumonia, herpes zoster, herpes simplex, implant infection, oral candidiasis ||| Infection fongique, infection bactérienne, infection pulmonaire, otite Fréquent: moyenne, abcès dentaire, herpes simplex, infection urinaire, vaginite, gastro-entérite Tumeurs bénignes, malignes dic
0.4317287504673004 ||| Heads of agencies for medicines for veterinary use ||| Unit for the veterinary medicines and inspections ||| Responsables des agences pour les médicaments à usage vétérinaire
0.24327600002288818 ||| Powder and solvent for suspension for injection ||| Powder and suspension for suspension for injection t ||| Poudre et solvant pour suspension injectable
0.496532142162323 ||| Preparing the injection: ||| Setting up for an injection Step 2: ||| Préparation de l’injection:
0.3289707899093628 ||| How is Aranesp used? ||| How is Abseamed used? ||| Comment Aranesp est -il utilisé?
0.0 ||| • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON THE MARKETING AUTHORISATION HOLDER ||| CONDITIONS OU RESTRICTIONS DE DeLIVRANCE ET D’ UTILISATION IMPOSeES AU TITULAIRE DE L'AUTORISATION DE MISE SUR LE MARCHe
0.3555598258972168 ||| Multiple organ dysfunction syndrome (MODS) is altered organ function in an acutely ill patient requiring medical intervention to achieve homeostasis. ||| Ovarian hyperstimulation syndrome (OHSS) can become a serious medical event characterised by large ovarian cysts which are prone to rupture. ||| Le syndrome de défaillance multiviscérale (SDMV), anciennement connu sous le nom de défaillance multiviscérale (DMV) ou défaillance multisystémique, est un état dans lequel un ou plusieurs organes se détériorent rapidement, nécessitant une intervention médicale pour rétablir l'homéostasie.
0.4435800313949585 ||| Loading dose of 200 mg (5 ml) once a day on the first day, then 100 mg (2.5 ml) once a day for 13 days. ||| 300 mg/ day in week 6, if necessary increasing to usual target dose of 400 mg/ day in week 7, to ||| Dose de charge de 200 mg (5 ml) une fois par jour le premier jour, puis 100 mg (2,5 ml) une fois par jour pendant 13 jours.
0.5224921107292175 ||| insomnia anxiety symptoms, confusion and disorientation, depression, depressed mood, mood disorders and disturbances, nightmare, hallucination, mental disorders ||| common: somnolence uncommon: agitation rare: aggression, confusion, depression, hallucination, insomnia very rare: tic ||| signes d’ anxiété, confusion et désorientation, dépression, humeur dépressive, troubles de l’ humeur, cauchemars, hallucinations, troubles mentaux
0.8056371212005615 ||| CORTICOSTEROIDS ||| CYTOTOXIC. ||| CORTICOSTEROÏDES
0.39195120334625244 ||| In addition, the Commission has made available up to €8 billion in financing for 100,000 small businesses hit by the crisis, with the European Investment Fund. ||| Overall, there has been a 42% increase in staff and 49% in budget for all national data protection authorities taken together in the EU between 2016 and 2019. ||| En outre, la Commission et le Fonds européen d'investissement ont mis à disposition jusqu'à 8 milliards d'euros pour financer 100 000 petites entreprises touchées par la crise..
0.3634909391403198 ||| Humoral or cellular (primary or acquired) immunodeficiency, including hypogammaglobulinemia and dysgammaglobulinemia and AIDS, or symptomatic HIV infection or a CDC Class 2 or higher or an age-specific CD4+ T-lymphocyte percentage < 25% (see section 4.4). ||| • Evidence of liver disease or increased liver enzymes • Severe dyskinesia • A previous history of Neuroleptic Malignant Syndrome Symptom Complex (NMS) and / or non- traumatic Rhabdomyolysis or Hyperthermia. • Hypersensitivity to tolcapone or any of its other ingredients. • Phaeochromocytoma. ||| Déficit de l'immunité humorale ou cellulaire (primaire ou acquise) incluant l’ hypogammaglobulinémie et la dysgammaglobulinémie et le SIDA ou toute autre infection symptomatique due au VIH ou de stade CDC classe 2 ou plus, ou avec un taux de lymphocytes T CD4+ < 25% (voir rubrique 4.4).
0.4460460841655731 ||| • Do not store your pen with the pen needle attached. ||| Do not push injection button without a needle attached. ||| • Ne pas conserver votre stylo avec l’aiguille fixée dessus.
0.3631502389907837 ||| This document sets out a programme for 2002 that will make demands on the staff of the EMEA and also colleagues in the national agencies with whom we work. ||| The EMEA will work closely with national authorities, who I anticipate will take responsibility for relating the data to national circumstances and making it available at the national level. ||| Ce document définit un programme pour 2002 qui exigera beaucoup du personnel de l'EMEA, mais également des collègues des agences nationales avec qui nous travaillons.
0.0 ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable ||| LA MENTION « USAGE VÉTÉRINAIRE » ET CONDITIONS OU RESTRICTIONS DE DÉLIVRANCE ET D’ UTILISATION, le cas échéant
2.5912524079588217e-13 ||| * The confidence intervals were calculated with no adjustment for age category (< 55 years, ≥ 55 years) and investigator group, which were included in the primary analysis of odds ratios and logistic models. † One patient in the Aprepitant Regimen only had data in the acute phase and was excluded from the overall and delayed phase analyses. ||| * The confidence intervals were calculated with no adjustment for age category (< 55 years, ≥ 55 years) and investigator group, which were included in the primary analysis of odds ratios and logistic models. † One patient in the Aprepitant Regimen only had data in the acute phase and was excluded from the overall and delayed phase analyses. ||| * Les intervalles de confiance ont été calculés sans ajustement en fonction de la tranche d’âge (< 55 ans, ≥ 55 ans) et du groupe d’investigateur, lesquels avaient été pris en compte dans l’analyse primaire du risque relatif et des modèles logistiques. † Un patient dans le schéma thérapeutique aprépitant avait seulement des données dans la phase aiguë et a été exclu de l'analyse globale et de la phase retardée.
0.1562412977218628 ||| 6.6 Nature and contents of container ||| 6.4 Nature and contents of container ||| 6.7 Nature et contenu de l’ emballage extérieur
0.29452770948410034 ||| In renal insufficiency with a reduced creatinine clearance of < 10 ml/ min the daily dose of ceftriaxone should not exceed 2 g in adult patients. ||| Sildenafil (50 mg) did not potentiate the hypotensive effects of alcohol in healthy volunteers with mean maximum blood alcohol levels of 80 mg/ dl. ||| Dans l’insuffisance rénale avec diminution de la clairance de la créatinine < 10 ml/min, la dose journalière de ceftriaxone ne doit pas dépasser 2 g chez l’adulte.
0.27325934171676636 ||| There have been case reports of dependence after illicit use of GHB at frequent repeated doses (18 to 250 g/ day) in excess of the therapeutic dose range. ||| Incidents of pre-travel vomiting, usually within two hours post-dosing were commonly reported after administration of the 8 mg/kg dose. ||| Il y a eu des cas rapportés de dépendance après utilisation illicite de GHB à doses répétées et fréquentes (18 à 250 g / jour) supérieures aux doses thérapeutiques.
0.34780508279800415 ||| Onsenal is used in addition to surgery (to remove the polyps) and endoscopic monitoring (to check if polyps are developing, using an endoscope, a thin tube that allows a doctor to look inside the gut). ||| Another study, ESPRIT, compared INTEGRILIN with a placebo in 2,000 patients who were having PTCA to remove a blood clot from the coronary arteries and insert a stent (a short tube that remains in the artery to stop it closing). ||| Onsenal est utilisé en complément de la chirurgie (destinée à éliminer les polypes) et d’ une surveillance endoscopique (destinée à vérifier, à l’ aide d’ un endoscope, tube fin qui permet à un médecin d’ examiner l’ intérieur de l’ intestin, si des polypes sont en train de se développer).
0.20021921396255493 ||| The safety and efficacy of nelfinavir has not been established in patients with significant underlying liver disorders. ||| Safety and efficacy have not yet been established in patients with a neurogenic cause for detrusor overactivity. ||| La tolérance et l'efficacité du nelfinavir n'ont pas été établies chez les patients présentant des troubles sous-jacents significatifs de la fonction hépatique.
0.35836243629455566 ||| Blood cell counts normally return to normal within two weeks of stopping Siklos treatment. ||| Median time to blood platelet and granulocyte nadirs were around 60 days after start of treatment. ||| Généralement, la numération redevient normale deux semaines après l’ arrêt du traitement par Siklos.
0.023945873603224754 ||| A subset had recurrence of symptoms when rechallenged with the same medicinal product or another bisphosphonate. ||| A subset had recurrence of symptoms when rechallenged with the same drug or another bisphosphonate. ||| Chez certaines d’ entre elles, une réapparition de ces symptômes a été observée à la reprise du traitement par FOSAVANCE ou par un autre bisphosphonate.
0.1604938805103302 ||| Manufacturer Merckle Biotec GmbH Dornierstraße 10 D-89079 Ulm Germany ||| Merckle Biotec GmbH Dornierstraße 10 DE-89079 Ulm Germany ||| Fabricant Merckle Biotec GmbH Dornierstraße 10 D-89079 Ulm Allemagne
0.4512121081352234 ||| Aseptic technique is required for its preparation. ||| Appropriate aseptic techniques must be used. ||| Sa préparation doit se faire selon une technique aseptique.
0.26001811027526855 ||| If you accidentally take more than the prescribed dose of CELSENTRI, contact your doctor or the nearest hospital right away. ||| Call your doctor or pharmacist immediately if you take more than the amount of Efexor prescribed by your doctor. ||| Si vous avez pris accidentellement une dose de CELSENTRI plus importante que la dose prescrite, contactez immédiatement votre médecin ou l’hôpital le plus proche.
0.21490949392318726 ||| Chemical and physical in-use stability of the diluted solution for infusion has been demonstrated for 24 hours at 2°C to 8°C. ||| After reconstitution with sterile water for injections the reconstituted solution is physically and chemically stable for 48 hours at 2°C – 8°C. ||| La stabilité physico-chimique de la solution diluée pour perfusion a été démontrée pendant 24 heures entre 2°C et 8°C.
0.137393519282341 ||| Tél/ Tel: + 32 2 656 21 11 ||| Tél/ Tel: +32 27 73 33 11 ||| Tél/Tel: + 32 2 656 21 11 Tél/Tel: + 32 2 656 21 11
3.798249895484683e-14 ||| In studies performed in rats and rabbits no clinically relevant evidence of harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development was observed. ||| In studies performed in rats and rabbits no clinically relevant evidence of harmful effects with respect to pregnancy, embryonal/ foetal development, parturition or postnatal development was observed. ||| 247 Dans les études effectuées chez le rat et chez le lapin, aucun effet délétère cliniquement significatif sur la gestation, le développement embryo-foetal, la mise bas ou le développement postnatal n’ a pu être observé.
0.5833405256271362 ||| Betting services ||| Shipping services ||| Services de paris
0.5458450317382812 ||| On 13 October 2006, La Jolla Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Riquent, for the treatment of lupus nephritis. ||| "Another televangelist, Kenneth Copeland, claimed on Victory Channel during a programme called ""Standing Against Coronavirus"", that he can cure television viewers of COVID-19 directly from the TV studio." ||| Le 13 octobre 2006, La Jolla Limited a officiellement informé le Comité des médicaments à usage humain (CHMP) de sa décision de retirer sa demande d’ autorisation de mise sur le marché pour Riquent, dans le traitement de la néphrite lupique.
0.37754687666893005 ||| Exelon oral solution should be used within 1 month of opening the bottle. ||| EXP Use the oral solution within one month after first opening the bottle. ||| Le flacon d’ Exelon solution buvable doit être utilisé dans le mois suivant son ouverture.
0.29446732997894287 ||| 0.23 ml solution in a vial (type I glass) with a stopper (chlorobutyl rubber), with 1 filter needle, 1 injection needle and 1 syringe (polypropylene). ||| Sterile lyophilised cake in 1 ml vial (type I glass) and 1 ml of solvent (saline 0.45%) in 1 ml ampoule (type I glass). ||| Solution de 0,23 ml dans un flacon (en verre de type I) muni d'un bouchon (en caoutchouc chlorobutyl), avec 1 aiguille-filtre, 1 aiguille pour injection et 1 seringue (en polypropylène).
0.28972411155700684 ||| Rapilysin is used in patients who have had a heart attack (suspected acute myocardial infarction) to help dissolve the blood clots (thrombolysis) that have caused the heart attack. ||| Radiation pneumonitis (scarring of the air sacs of the lung associated with radiation therapy) may occur in patients who are also treated with radiation either before, during or after their ALIMTA therapy. ||| Rapilysin est utilisé chez les patients ayant subi une crise cardiaque (suspicion d’ infarctus aigu du myocarde) pour contribuer à la dissolution des caillots sanguins (thrombolyse) à l’ origine de la crise cardiaque.
0.33658379316329956 ||| Non-metallic sealing compounds for joints ||| Non-metallic minerals for building or construction ||| Produits d'étanchéité non métalliques pour joints
0.0 ||| România Novartis Pharma Services Inc. ||| România Novartis Pharma Services Inc. ||| Novartis Pharma Services Inc.
0.0013379869051277637 ||| 209 GONAL-f should not be administered as a mixture with other medicinal products in the same injection, except for lutropin alfa. ||| 191 GONAL-f should not be administered as a mixture with other medicinal products in the same injection, except for lutropin alfa. ||| GONAL-f ne doit pas être mélangé dans la même seringue à d’ autres médicaments, à l’ exception de la lutropine alfa.
0.5694141387939453 ||| Belt sanding machines ||| Curtain fitting services ||| Ponceuses à bande
0.13555186986923218 ||| 18 million IU/ 3ml ||| 18 million IU/3 ml ||| 18 millions UI/ 3 ml
0.3435048460960388 ||| Although significant systemic exposure to free cytarabine is not expected following intrathecal treatment, some effects on bone marrow function cannot be excluded. ||| No studies are available on possible effects of high dose nicotinic acid on fertility or on postnatal development after in utero exposure. ||| Bien qu'une exposition systémique significative à la cytarabine libre ne soit pas attendue après une administration intrathécale, certains effets sur la moelle osseuse ne peuvent pas être exclus.
0.15448376536369324 ||| Manipulators [machines] for industrial use ||| Vibrators [machines] for industrial use ||| Manipulateurs à usage industriel [machines]
0.29070237278938293 ||| If you stop using RoActemra You should not stop using RoActemra without discussing with your doctor first. ||| If you stop taking Oprymea Do not stop taking Oprymea without first talking to your doctor. ||| Si vous arrêtez d’utiliser RoActemra Vous ne devez pas interrompre votre traitement par RoActemra sans en avoir préalablement discuté avec votre médecin.
0.05778162181377411 ||| By lowering the blood pressure, the risk of damage caused by high blood pressure, such as having a stroke, is reduced. ||| By lowering blood pressure, the risk caused by high blood pressure, such as having a stroke, is reduced. ||| En diminuant la pression artérielle, les risques de dommages causés par une pression artérielle élevée, comme un accident vasculaire cérébral, sont réduits.
0.4226786494255066 ||| Calcium fluoride ||| Calcium oxides ||| Fluorure de calcium
3.232587808543741e-13 ||| They both work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| They both work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| Ils agissent tous deux de façon similaire en bloquant l’ activité de la transcriptase inverse, une enzyme synthétisée par le VIH lui permettant d’ infecter les cellules et de produire davantage de virus.
0.4526044726371765 ||| This support will focus on the initial review and maintenance of marketing authorisations through the centralised procedure. ||| The report should provide information on the measures taken to assure and assess the effectiveness of the risk management programme. ||| Ce soutien se concentrera sur la révision initiale et le maintien des autorisations de mise sur le marché par la procédure centralisée.
0.5538429617881775 ||| If the combination is nevertheless considered necessary, a monitoring of the plasma levels of these protease inhibitors is strongly encouraged. ||| The first two are the most used methods of sterilizations mainly because of their accessibility and availability. ||| Néanmoins, si l’ association est considérée comme nécessaire, un suivi des taux plasmatiques de ces inhibiteurs de protéase est fortement recommandé.
0.5630378127098083 ||| Meteor Centre Office Park Sokolovskà 100/ 94 a ||| Hadovka Office Park Evropská 2590/ 33d ||| Meteor Centre Office Park éd
0.4313087463378906 ||| For active immunisation of chickens against avian influenza type A, subtype H5. ||| The vaccine stimulates active immunity against Avian Influenza virus type A, subtype H7N1. ||| Immunisation active des poules contre l’ influenza aviaire de type A, sous-type H5.
0.005333674605935812 ||| 24 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 23 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 23 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.08247750997543335 ||| o EU/ 1/ 01/ 184/ 064 ||| o EU/ 1/ 01/ 184/ 040 ||| 'e (verre) (SureClick) EU/ 1/ 01/ 184/ 064
0.11908157169818878 ||| Financial consultancy relating to credit services ||| Consultancy services relating to personal finance ||| Services de conseil en matière de services de crédit
0.35430389642715454 ||| Contact your doctor immediately if you have any of the following: ||| Tell your doctor if you notice the following: ||| Informez immédiatement votre médecin si vous avez un des effets indésirables suivants:
0.0572337880730629 ||| EU/ 1/ 97/ 047/ 001 ||| EU/ 1/ 98/ 067/ 002 ||| EU/ 1/ 97/ 047/ 007
0.3563195466995239 ||| Tél/ Tel: + 32 2 656 21 11 ||| 29 Тел.: + 359 2 953 10 34 ||| Tél/Tel: + 32 2 656 21 11 Tél/Tel: + 32 2 656 21 11
0.09564069658517838 ||| Ziconotide should not be used during pregnancy unless clearly necessary. ||| Porfimer sodium should not be used during pregnancy unless clearly necessary. ||| Le ziconotide ne doit pas être utilisé pendant la grossesse sauf en cas de nécessité absolue.
0.25232648849487305 ||| When these medications are administered to or withdrawn from a patient receiving repaglinide, the patient should be observed closely for changes in glycaemic control. ||| Patients should be closely monitored for a decrease in platelet count and medically managed to avoid bleeding upon discontinuation of treatment with romiplostim. ||| En cas d’ administration ou de suppression de ces médicaments chez un patient prenant du répaglinide, on surveillera le patient avec soin afin de détecter toute modification du contrôle glycémique.
0.024782694876194 ||| EU/ 1/ 06/ 337/ 013 ||| EU/ 1/ 06/ 337/ 012 ||| EU/ 1/ 06/ 337/ 013 M-M-RVAXPRO 40 aiguilles
0.4088093042373657 ||| Information from clinical trials has shown an increased risk of suicidal ||| These findings dramatically increase the risk of virus spreading. ||| Les études cliniques ont montré que le risque de comportement
0.6567581295967102 ||| Twenty-five patients (aged 13 to 69 years) participated in the pharmacokinetic assessment (see table below). ||| Fifty-six (90%) of the subjects were prepubertal at baseline. ||| Vingt-cinq patients (âgés de 13 à 69 ans) ont participé à l’évaluation pharmacocinétique (voir tableau plus bas).
0.37068867683410645 ||| - if you have a history of pancreatitis, have uncontrolled lipid (blood fats) elevations (high blood ||| - if you have a muscle disorder called myopathy (repeated or unexplained muscle aches or pains) ||| - si vous avez des antécédents de pancréatite, d’ augmentations incontrôlées en lipides dans le sang
0.5056054592132568 ||| Provision of aircraft financing ||| Supervision of weight reduction programmes ||| Fourniture de financement d'aéronefs
0.16587045788764954 ||| Not all pack sizes and container types may be marketed. ||| Not all pack sizes or presentations may be marketed. ||| Toutes les présentations et tous les types de conditionnement peuvent ne pas être commercialisés.
0.3682883083820343 ||| The data from the Long Term Extension Study 301 concerning efficacy and safety are in support for both long-term efficacy and safety for patients, receiving palliative treatment of advanced prostate cancer with histrelin implant for two or more years. ||| Although data from a one-year open label study offer some evidence for longer-term efficacy, no conclusive efficacy data for treatments longer than 12 weeks duration are available from placebo- controlled studies. ||| 4 de l’ étude 301 relatives à l’ efficacité et à l’ innocuité démontrent l’ efficacité et l’ innocuité à long terme chez les patients qui reçoivent un traitement palliatif, pour un cancer évolué de la prostate, consistant en un implant d’ histréline depuis au moins deux ans.
6.621638458902124e-13 ||| Taking other medicines ||| Taking other medicines ||| Utilisation d’ autres médicaments
0.2881609797477722 ||| Calcium supplements, antacids and some oral medicinal products containing multivalent cations (such as aluminium, magnesium, iron) are likely to interfere with the absorption of Bonviva. ||| Other NSAIDs, diuretics, anticoagulants and substances with high plasma protein binding may compete for binding leading to potentially toxic effects. ||| Les suppléments de calcium, les antiacides et certains médicaments administrés par voie orale contenant des cations polyvalents (comme l’ aluminium, le magnésium, le fer) sont susceptibles d’ interférer avec l’ absorption de Bonviva.
0.2960244417190552 ||| Saw blades for use with power tools ||| Abrasive bits for use with machines ||| Lames de scies pour outils électriques
0.2230008989572525 ||| 5.4 mg/ml butylhydroxyanisole (E320; as antioxidant) ||| Benzyl alcohol 1 mg/ ml butylhydroxytoluene (E321: as antioxidant) ||| 5,4 mg/ml butylhydroxyanisole (E320; comme anti-oxydant)
0.2035154551267624 ||| Take special care with Actos 15mg tablets: ||| Take special care with Glustin 45 mg tablets: ||| Prendre des précautions particulières avec Actos 15 mg, comprimé:
0.037584371864795685 ||| When administered subcutaneously care should be taken when injecting Humalog Mix25 to ensure that a blood vessel has not been entered. ||| When administered subcutaneously care should be taken when injecting Liprolog to ensure that a blood vessel has not been entered. ||| Lors de l'injection sous-cutanée d'Humalog Mix25, s'assurer que l'aiguille n'a pas pénétré dans un vaisseau sanguin.
0.5401926040649414 ||| Patients who maintained ≥ PASI 75 response at Week 33 and were originally randomised to active therapy in Period A, were re-randomised in period C to receive 40 mg Humira every other week or placebo for an additional 19 weeks. ||| PSURs The Marketing Authorisation Holder will submit 6 monthly PSURs for one year after the Commission Decision on the extension application for alli 60 mg hard capsules then yearly for 2 years and every three years thereafter. ||| Les patients dont la réponse restait ≥ PASI 75 à la semaine 33 et qui avaient été initialement randomisés pour recevoir le traitement actif pendant la période A, ont à nouveau été randomisés pendant la période C pour recevoir 40 mg d’ Humira une semaine sur deux
0.6517324447631836 ||| Antitumour activity was demonstrated primarily in patients with neuroblastoma. ||| His family in Nuremberg was also ill with respiratory symptoms. ||| L'activité antitumorale a été démontrée principalement chez les patients ayant un neuroblastome.
0.2569115161895752 ||| In the 14-week toxicity study etoricoxib caused gastrointestinal ulcers at exposures greater than those seen in man at the therapeutic dose. ||| Dose-dependent increases in the incidence of lymphomas were observed at all doses in a 39 week monkey oral toxicity study. ||| Dans une étude de toxicité de 14 semaines, l’ étoricoxib a provoqué des ulcères gastro-intestinaux pour des expositions supérieures à celles observées chez l’ homme à la dose thérapeutique.
0.02051260694861412 ||| Pregnancy and breast-feeding Do not take Doxastad 4 mg prolonged release tablets and associated names if you are pregnant or breast-feeding. ||| Pregnancy and breast-feeding Do not take Doxagamma 4 mg prolonged release tablets and associated names if you are pregnant or breast-feeding. ||| Grossesse et allaitement Ne prenez pas de Doxastad 4 mg, comprimés à libération prolongée, et dénominations associées si vous êtes enceinte ou si vous allaitez.
0.28976327180862427 ||| DaTSCAN is not likely to affect your ability to drive or to use machines. ||| Pioglitazone will not affect your ability to drive or operate machinery. ||| DaTSCAN n’est pas susceptible d’affecter l’aptitude à conduire un véhicule ou à utiliser des machines.
0.023976560682058334 ||| Dyskinesia In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of SIFROL. ||| Dyskinesia In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of MIRAPEXIN. ||| Dyskinésies A un stade avancé de la maladie de Parkinson, en association à la lévodopa, des dyskinésies peuvent apparaître lors de la phase initiale de traitement par SIFROL.
0.18135617673397064 ||| - The active substance is rivastigmine. ||| - The active substance is tipranavir. ||| - La substance active est la rivastigmine.
0.296762615442276 ||| No specific interaction studies have been conducted with Prometax transdermal patches. ||| No formal interaction studies with lansoprazole and NSAIDs have been performed. ||| Aucune étude d’ interaction particulière n’ a été réalisée avec les dispositifs transdermiques de Prometax.
0.35672974586486816 ||| Myocet should be administered by intravenous infusion over a period of 1 hour. ||| Luveris should be given as a course of daily injections simultaneously with FSH. ||| 31 Myocet doit être administré par perfusion intraveineuse d’ 1 heure.
0.3973015248775482 ||| Application of rendering to tunnels ||| Preparations for marking roads ||| Application d'enduits pour tunnels
2.380015401339669e-13 ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions. ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions. ||| S’ il n’ est pas utilisé immédiatement, les conditions de durée de conservation avant utilisation sont sous la responsabilité de l’ utilisateur et ne devraient normalement pas dépasser 24 heures entre 2 et 8°C, sous réserve que la reconstitution ait été effectuée dans des conditions d’ asepsie contrôlées et validées.
0.25214701890945435 ||| Therefore you should limit your exposure to sunlight and ultra violet (UV) light by wearing appropriate protective clothing and using a sunscreen with a high protection factor. ||| As general advice to minimise the risk for skin cancer, exposure to sunlight and UV light should be limited by wearing protective clothing and using a sunscreen with a high protection factor. ||| Vous devez donc limiter vos expositions au soleil et aux rayonnements ultra-violets (UV) en portant des vêtements qui vous protègeront et en utilisant, une crème solaire à indice de protection élevé.
0.2415751963853836 ||| In a large outcome study (MERLIN-TIMI 36) in 6,560 patients with UA/ NSTEMI ACS, there was no difference between Ranexa and placebo in the risk of all-cause mortality (relative risk ranolazine: placebo 0.99), sudden cardiac death (relative risk ranolazine: placebo 0.87), or the frequency of symptomatic documented arrhythmias (3.0% versus 3.1%). ||| Although bleeding was increased with prasugrel, an analysis of the composite endpoint of death from any cause, nonfatal myocardial infarction, nonfatal stroke, and non-CABG-related TIMI major haemorrhage favoured Efient compared to clopidogrel (Hazard ratio, 0.87; 95% CI, 0.79 to 0.95; p=0.004). ||| Au cours d’ une vaste étude de mortalité (MERLIN-TIMI 36) portant sur 6 560 patients atteints d'un SCA avec angor instable/ infarctus du myocarde sans sus-décalage ST (UA/ NSTEMI), aucune différence n’ a été observée entre Ranexa et le placebo ni dans le risque de mortalité toutes causes confondues (risque relatif ranolazine: placebo 0,99), ni dans la mort subite cardiaque (risque relatif ranolazine: placebo 0,87), ni dans la fréquence des arythmies symptomatiques documentées (3,0% contre 3,1%).
0.4030466079711914 ||| When using disinfectant wipes, follow the instructions on the packaging. ||| The instructions for using the insulin pen are provided with your insulin pen. ||| Lors de l’utilisation de lingettes désinfectantes, suivez les instructions indiquées sur l’emballage.
0.453406423330307 ||| The pre-filled syringe is ready for use. ||| The implant is supplied in a pre-loaded implanter. ||| La seringue préremplie est prête à l’ emploi.
3.8679834075266983e-13 ||| NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ||| NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ||| DENOMINATION DU MEDICAMENT ET VOIE(S) D’ ADMINISTRATION tn
0.3141269087791443 ||| - The active substance is insulin glulisine. ||| - The active substance is insulin human. ||| − La substance active est l’ insuline glulisine.
0.33262738585472107 ||| Concrete bonding compounds ||| Concrete retaining walls ||| Composés pour lier le béton
0.33733686804771423 ||| Melatonin Receptor Agonists, ATC code: ||| Bone Morphogenetic Proteins, ATC code: ||| Classe pharmacothérapeutique: agonistes des récepteurs de la mélatonine, Code ATC:
0.0 ||| Intravenous use ||| Intravenous use ||| voie intraveineuse
0.0444486141204834 ||| Patients with rare hereditary problems of fructose intolerance should not take this medicine. ||| Patients with rare hereditary problems of fructose intolerance should not use this medicinal product. ||| Les patients ayant une intolérance héréditaire au fructose ne doivent pas prendre ce médicament.
4.163708765790586e-13 ||| The amount indicated on the injection button is higher than the dose selected. ||| The amount indicated on the injection button is higher than the dose selected. ||| La quantité indiquée sur le bouton d'injection est supérieure à la dose sélectionnée
0.4291917681694031 ||| Congenital neutropenia The recommended starting dose is 1.2 MU/ kg/ day (12 μ g/ kg/ day) as a single dose or in divided doses. ||| In rabbits, the NOAEL was 0.1 U/ kg/ day for maternal effects and 0.3 U/ kg/ day for foetal effects. ||| Neutropénie congénitale La dose initiale recommandée est de 1,2 MU/ kg/ jour (12 µg/ kg/ jour) en dose unique ou en doses fractionnées.
0.3165070414543152 ||| 113 Patients developing Factor VIII inhibitors If your plasma Factor VIII fails to reach expected levels with ADVATE, or if bleeding is not adequately controlled, it could be due to the development of Factor VIII inhibitors. ||| Patients with PKU have defective versions of the enzyme, and patients with BH4 deficiency have low levels of BH4, a ‘ cofactor ’ that this enzyme needs to work properly. ||| Patients développant des inhibiteurs dufacteur VIII Si votre taux plasmatique de facteur VIII n'atteint pas le niveau prévu, ou si le saignement n'est pas contrôlé de façon adéquate, la présence d’ un inhibiteur du facteur VIII doit être suspectée.
0.3063463866710663 ||| In study 1, the Enbrel-treated group had a significantly higher proportion of patients with a PASI 75 response at week 12 (30%) compared to the placebo-treated group (2%) (p < 0.0001). ||| In ST-elevation myocardial infarction, fewer patients on Iscover had events than patients on placebo (262 against 377 in the CLARITY study, and 2,121 against 2,310 in the COMMIT study). ||| Dans l’ étude 1, le groupe traité par Enbrel avait une proportion significativement plus élevée de patients présentant une réponse PASI 75 à la semaine 12 (30%) comparativement au groupe traité par placebo (2%) (p < 0,0001).
0.031597115099430084 ||| Parenteral drug products should be inspected visually for particulate matter and discoloration before administration. ||| Parenteral medicinal products should be inspected visually for particulate matter and discoloration prior to administration. ||| Les substances médicamenteuses à usage parentéral doivent être visuellement vérifiées avant administration pour déceler la présence éventuelle de particules ou d'un changement de coloration.
0.19443736970424652 ||| The serum elimination half-life of filgrastim is approximately 3.5 hours, with a clearance rate of approximately 0.6 ml/ min/ kg. ||| The clearance of rotigotine after transdermal administration is approximately 10 l/ min and its elimination half-life is 5 to 7 hours. ||| 15 heures avec une clairance moyenne de 0,6 ml/ min/ kg.
2.940814367198563e-13 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity. ||| Les données précliniques des études conventionnelles de pharmacologie de sécurité, de toxicologie après administration répétée et de génotoxicité n’ ont révélé aucun risque particulier pour l’ homme.
0.5998334288597107 ||| Fixed combination medicinal products ||| Permanent press treatment of clothing ||| Associations fixe de médicaments
0.48105335235595703 ||| Spot-on use. ||| In-feed use. ||| Utilisation en spot -on.
5.558547329018171e-13 ||| Key elements to be included in the educational material ||| Key elements to be included in the educational material ||| Principaux éléments du matériel de formation
5.982020434558422e-13 ||| Batch: ||| Batch: ||| Lot:
0.34161487221717834 ||| This will help Spanish businesses cover their immediate working capital and investment needs in these difficult times. ||| In particular, it will help businesses to cover their immediate working capital or investment needs. ||| Ces aides permettront aux entreprises de couvrir leurs besoins immédiats en fonds de roulement et en investissements en ces temps difficiles.
0.09110806882381439 ||| The same applies to patients with altered hepatic function. ||| The same applies to patients with altered renal or hepatic function. ||| Il en est de même chez les patients présentant une insuffisance hépatique.
0.2883390784263611 ||| The adhesive side of the patch should be applied to a clean, dry area of skin on the lower abdomen below the waist. ||| The sticky adhesive side is stuck to the skin after removal of the clear, plastic, protective covering. ||| Appliquer la face adhésive du dispositif transdermique sur une zone de peau propre et sèche, sur la partie inférieure de l’ abdomen, sous la taille.
0.2628363370895386 ||| Because arsenic trioxide can affect the heart, patients receiving TRISENOX should be closely monitored, and should have electrocardiograms before and during treatment. ||| If neuromuscular blockade is reversed, while anaesthesia is continued, additional doses of anaesthetic and/ or opioid should be given as clinically indicated. ||| Etant donné que le trioxyde d'arsenic peut affecter le cœ ur, il importe que les patients recevant TRISENOX fassent l'objet d'un suivi, et soient soumis à des électrocardiogrammes avant et pendant le traitement.
0.3488312363624573 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| Patients must be instructed to add the water for injections and then gently tap the vial with their fingertip until the powder begins to dissolve. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
0.4579795300960541 ||| The main measures of effectiveness were the number of eggs that could be harvested and the ongoing pregnancy rate. ||| The long-time experience showed that no harmful effects on the course of the pregnancy or the newborn are to be expected. ||| Les principales mesures d’ efficacité étaient le nombre d’ ovules pouvant être prélevés et le taux de grossesses en cours.
0.6912437677383423 ||| The first injection (2ml) can be given from an age of 3 days, second injection (2 ml) 2-3 weeks later. ||| First injection: at chosen date Second injection: ideally 2 months after first injection Third injection: ideally 6 months after first injection ||| La première injection (2 ml) peut être réalisée à partir de l’ âge de 3 jours, suivie d’ une seconde injection (2 ml) 2-3 semaines plus tard.
0.29306691884994507 ||| In addition, EU humanitarian aid will be provided to the World Health Organization's global coronavirus response in partnership with health authorities in Ethiopia, Kenya and Somalia to scale up operational readiness for early detection and response to the pandemic. ||| The EU Humanitarian Air Bridge operations form part of the EU's global response to the coronavirus pandemic in support of partner countries, which follows a Team Europe approach, combining resources from the EU, its Member States and financial institutions. ||| En outre, l'UE apportera son aide humanitaire à l'Organisation mondiale de la santé dans le cadre de la réaction de cette dernière à la crise de COVID-19 au niveau mondial, en partenariat avec les autorités sanitaires en Éthiopie, au Kenya et en Somalie, en vue de renforcer l'état de préparation opérationnelle en matière de détection précoce et de réaction face à la pandémie.
0.31701773405075073 ||| Eosinophilia, anaemia, thrombocytopenia ||| Thrombocytopenia, leucopenia, eosinophilia ||| Eosinophilie, anémie, thrombocytopénie
0.626294732093811 ||| The database provides guidance on past regulatory decisions, permitting a consistent approach across therapeutic areas. ||| The meetings cover a wide range of quality topics for veterinary and human medicinal products. ||| Elle fournit des orientations sur les anciennes décisions réglementaires, afin de permettre une approche cohérente dans tous les domaines thérapeutiques.
0.008856994099915028 ||| 48 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 45 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 51 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.12148339301347733 ||| - if you experience symptoms like irregular heart beat, swelling such as of the ankles or legs, ||| − if you experience symptoms like irregular heart beat, swelling such as of the ankles or legs, or shortness of breath. ||| - si vous présentez des symptômes tels qu’une irrégularité du rythme cardiaque, un
0.5158809423446655 ||| Anticoagulation in adult patients with HIT type II and thromboembolic disease: ||| Individuals with current thrombocytopenia may develop more severe thrombocytopenia following vaccination. ||| Inhibition de la coagulation chez des patients adultes atteints d'une TIH de type II et de maladie thrombo-embolique:
0.321108341217041 ||| The CHMP recommended the granting of the variation of the Marketing Authorisations for which the summaries of product characteristics, labelling and package leaflets are set out in Annex III and under the conditions set out in Annex IV. ||| In addition, other amendments to the Summary of Product Characteristics, labelling and package leaflet not in relation with the outcome of the referral procedure were included in accordance with the Guideline on SPC, excipient guideline and the latest Quality Review of Documents templates. ||| Le CHMP a par conséquent recommandé l’ octroi de la modification des autorisations de mise sur le marché pour lesquelles le résumé des caractéristiques du produit, l’ étiquetage et la notice sont définis à l’ annexe III et dans les conditions définies à l’ annexe IV.
0.20501300692558289 ||| 5 microgram (200 IU) ||| 150 IU (11 micrograms) ||| 5 microgrammes (200 UI)
0.41743385791778564 ||| Azopt was also more effective than placebo when used as an add-on to timolol. ||| Actos on its own was shown to be as effective as metformin and gliclazide. ||| Azopt utilisé en association avec le timolol s’ est également avéré plus efficace que le placebo.
0.3156776428222656 ||| Keep the syringe in the outer carton. ||| Keep the pre-filled syringe in the outer carton. ||| Garder les seringues dans l’ emballage extérieur.
0.5243464708328247 ||| Psoriatic arthritis and ankylosing spondylitis ||| Complicated cystitis, Uncomplicated pyelonephritis ||| 90 Rhumatisme psoriasique et spondylarthrite ankylosante
0.284664511680603 ||| Irbesartan is an ‘ angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II. ||| Tenecteplase is a plasminogen activator, this means that it triggers the transformation of a substance (plasminogen) into plasmin. ||| L'irbésartan, est un « antagoniste des récepteurs de l'angiotensine-II », ce qui signifie qu'il bloque l'action d'une hormone dans l'organisme appelée angiotensine-II.
0.3089880347251892 ||| They may be extremely tired, and have dark urine, pale faces, yellowish skin and/ or eyes (jaundice), and other symptoms possibly requiring hospitalisation. ||| faces, yellowish skin and/ or eyes (jaundice), and other signs of the disease possibly requiring hospitalisation. ||| Ils peuvent être extrêmement fatigués, avoir les urines foncées, le visage pâle, la peau et/ ou les yeux jaunâtres (jaunisse) ainsi que d’ autres symptômes pouvant nécessiter une hospitalisation.
0.0 ||| Using other medicines ||| Using other medicines ||| 234 Utilisation d'autres médicaments
0.8600351214408875 ||| J05AH02 Treatment of influenza and post- exposure prophylaxis of ||| Mechanism of Action Nevirapine is a NNRTI of HIV-1. ||| J05AH02 Treatment of influenza and post-exposure
0.3259936273097992 ||| Tell your pharmacist if you notice any change in the appearance of Aerius orodispersible tablet. ||| Tell your doctor immediately, if any of the following occurs during treatment with Ciprofloxacin Bayer. ||| Prévenez votre pharmacien si vous constatez un changement de l’ aspect d’ Aerius comprimés orodispersibles.
0.3599648177623749 ||| In some rare cases, especially if you are taking other m edicines that suppress the immune system, reactivation of HBV can be life-threatening. ||| Seretide does not work in controlling sudden attacks of breathlessness and wheezing where you would need to use your fast acting ‘ rescue’ medication. ||| Dans de rares cas, particulièrement si vous prenez d’autres médicaments qui diminuent le système immunitaire, une réactivation du virus de l’hépatite B peut être extrêmement grave.
0.5933195352554321 ||| One additional patient died after study end and another one after withdrawal from the study. ||| Two patients died and did not enter into the extension study. ||| Un patient de plus est décédé à l’ issue de l’ étude et un autre, après son retrait de l’ étude.
0.3095712661743164 ||| As a result of the action of both active substances, blood glucose levels are reduced and this helps to control type 2 diabetes. ||| By controlling the level of blood glucose, the symptoms and complications of diabetes are reduced. ||| L’ action de ces deux principes actifs permet de réduire le taux de glucose dans le sang et de mieux contrôler le diabète de type 2.
0.15289705991744995 ||| What Arixtra is and what it is used for 2. ||| What Pradaxa is and what it is used for 2. ||| Qu'est -ce qu'Arixtra et dans quel cas est -il utilisé 2.
0.28813353180885315 ||| When stopping treatment with YENTREVE the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8). ||| When stopping treatment with (Invented name)® the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see section 4.4 Special warnings and precautions for use and section 4.8 Undesirable Effects). ||| Lors de l’ arrêt du traitement par YENTREVE, la dose doit être progressivement diminuée sur une durée d’ au moins une à deux semaines, afin de limiter le risque de réactions de sevrage (voir rubriques 4.4 et 4.8).
0.03244294226169586 ||| In cases where a more rapid response is required your doctor may prescribe a dose of 160 mg at week 0 (as 4 injections in one day or 2 injections per day for two consecutive days), 80 mg (2 injections) at week 2, and thereafter as 40 mg (1 injection) every other lon week. ||| In cases where a more rapid response is required your doctor may prescribe a dose of 160 mg at Week 0 (as 4 injections in one day or 2 injections per day for two consecutive days), 80 mg (2 injections) at Week 2, and thereafter as 40 mg (1 injection) every other week. ||| S'il est nécessaire d'obtenir une réponse plus rapide, votre médecin pourra vous prescrire une dose de 160 mg à la semaine 0 (sous forme de 4 injections le même jour ou de 2 injections par jour pendant deux jours de suite), 80 mg (2 injections) à la semaine 2, puis 40 mg (1 injection) une semaine sur dic
0.1650163233280182 ||| 83.1 [< 0.0;99.7] ||| 87.3* [< 0.0; 99.7] ||| 83,1 [< 0,0; 99,7]
0.6707614660263062 ||| Alerzid ||| Lethargy ||| Lorasol
0.5943773984909058 ||| Cocoa powder ||| Coconut milk ||| Cacao en poudre
0.12737847864627838 ||| Carton – Pramipexole Teva 0.35 mg Tablets ||| Blister – Pramipexole Teva 0.18 mg tablets ||| Boîte – Pramipexole Teva 0,35 mg, comprimé
0.22970698773860931 ||| Metabolism and nutritional disorders General ||| Allergic reaction Metabolism and nutrition disorders ||| Troubles du métabolisme et de la nutrition
0.07714095711708069 ||| If you take more ZYPREXA VELOTAB than you should Patients who have taken more ZYPREXA VELOTAB than they should, have experienced the following symptoms: rapid beating of the heart, agitation/ aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness. ||| If you are given more ZYPREXA than you think you should be Patients who have been given more ZYPREXA than they should, have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness. ||| Les patients ayant pris plus de ZYPREXA VELOTAB qu’ ils n’ auraient dû ont présenté les symptômes suivants: accélération du rythme cardiaque, agitation/ agressivité, problèmes d’ élocution, mouvements anormaux (particulièrement du visage et de la langue), diminution du niveau de conscience.
0.26077717542648315 ||| Zubrin should not be used in people. ||| Aivlosin should not be used in people. ||| Zubrin ne doit pas être utilisé chez l’ homme.
0.052450478076934814 ||| In the interest of the patients, it is recommended that, whenever possible, every time that KOGENATE Bayer is administered to them, the name and the batch number of the product is registered. ||| In the interest of the patients, it is recommended that, whenever possible, every time that Helixate NexGen is administered to them, the name and the batch number of the product is registered. ||| Dans l’ intérêt des patients, il est recommandé, lorque cela est possible, qu’ à chaque administration de KOGENATE Bayer, le nom et le numéro de lot du produit soit enregistré.
0.4426865875720978 ||| Glass vial (Type 1) closed with a disc (bromobutyl/ polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution. ||| It may also be caused by electroplated surfaces or metal-rich anti-corrosion paint, such as cadmium passivated steel or zinc chromate primer on aluminium aircraft parts. ||| Flacon en verre (type 1) obturé par un disque (caoutchouc bromobutyl/ polyisoprène) et un opercule de sécurité en plastique contenant 10 ml de solution.
0.010352482087910175 ||| 189 PACKAGE LEAFLET: ||| 198 PACKAGE LEAFLET: ||| 197 NOTICE:
6.343353576784838e-13 ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NAME OF THE MARKETING AUTHORISATION HOLDER ||| NOM DU TITULAIRE DE L‘AUTORISATION DE MISE SUR LE MARCHÉ
0.04837728664278984 ||| Six tubes each containing 1.0 ml (120 mg selamectin). ||| Six tubes each containing 0.5 ml (60 mg selamectin). ||| 6 tubes contenant 1,0 ml de solution (120 mg de selamectine).
0.25468921661376953 ||| 1) Using a sterile syringe, slowly inject 7.2 ml of sterile water for injections in the vial containing the lyophilised Herceptin, directing the stream into the lyophilised cake. ||| To prepare the solution for infusion or injection, add 5 ml water for injections from the accompanying ampoule to the vial containing the Simulect powder, using aseptic technique. ||| Injecter lentement 7,2 ml d’ eau pour préparations injectables stérile dans le flacon de Herceptin lyophilisé, en dirigeant le jet directement sur le lyophilisat.
0.0022827100474387407 ||| 194 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 197 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 215 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.298859179019928 ||| Capsule-shaped, red film-coated tablet with “ 577 ” debossed on one side. ||| Prolonged-release tablet Light orange oval-shaped tablet engraved with CVT500 on one side. ||| Comprimé pelliculé en forme de gélule, de couleur rose portant l’ inscription « 515 » sur une face.
0.3916626572608948 ||| Mosquito repellants for application to the skin ||| Pumice stones for use on the body ||| Répulsifs anti-moustiques à appliquer sur la peau
0.20372630655765533 ||| What Insulin Human Winthrop Rapid looks like and contents of the pack Insulin Human Winthrop Rapid is a clear, colourless solution for injection, with no solid particles visible, and of a water-like consistency. ||| What Insuman Rapid looks like and contents of the pack Insuman Rapid is a clear, colourless solution for injection, with no solid particles visible, and of a water- like consistency. ||| Qu’ est -ce que Insulin Human Winthrop Rapid et contenu de l’ emballage extérieur Insulin Human Winthrop Rapid est une solution injectable claire, incolore, sans particules solides visibles et qui a la consistance de l’ eau.
0.28515827655792236 ||| Of the nine applications received in 1996 it is expected that eight of these will be the subject of CVMP opinions in 1997, all of which should be processed within the 210 day limit laid down in Council Regulation (EEC) No 2309/93. ||| The average time the CVMP required to undertake the assessment, resulting in an opinion recommending an MRL or adopting a list of questions, was 108 days of the 120 day legislative time frame laid down in Council Regulation (EEC) No 2377/ 90. ||| Huit des neuf demandes reçues en 1996 devraient faire l’objet d’un avis du CVMP en 1997, et elles devraient toutes être traitées dans la limite des 210 jours prévue par le Règlement No 2309/93 (CEE) du Conseil.
0.5918208360671997 ||| Some side effects can be serious: ||| If any of these side effects cause ||| 82 Certains effets indésirables peuvent être graves:
0.0 ||| • Convulsions. ||| • Convulsions. ||| 230 • Convulsions.
0.4031079411506653 ||| Ceftriaxone Tyrol Pharma 1g can be administered by the intramuscular route. ||| Fluticasone furoate nasal spray is for administration by the intranasal route only. ||| Ceftriaxone Tyrol Pharma 1g peut être administré par voie intramusculaire.
1.6116063594818115 ||| France Laboratoires Alcon + 33 (0)1 47 10 47 10 ||| 0 800 25 50 75 / +33 1 55 00 44 44 ||| Slovenija France Laboratoires Alcon + 33 (0)1 47 10 47 10
0.351578950881958 ||| In these studies, the incidence of other types of arthritis-related adverse events were similar between the Raptiva and placebo groups. ||| In addition, the incidences of specific tumours in Raptiva patients were in line with those observed in control psoriasis populations. ||| Dans ces études, l'incidence des autres types d'événements indésirables liés à l'arthrite était comparable pour les deux groupes, Raptiva et placebo.
0.23679202795028687 ||| ♦ Rare (these may occur with up to 1 in 1,000 doses of the vaccine): • Severe stabbing or throbbing pain along one or more nerves • Fits • Low blood platelet count which can result in bleeding or bruising • Allergic reactions leading to a dangerous decrease of blood pressure, which, if untreated, may lead to collapse, coma and death ||| Uncommon effects These could affect less than 1 in every 100 people Worsening of high blood pressure Ulcers in the digestive system The heart may beat more slowly Blood tests may show abnormal liver function You may bruise easily (or have a low blood platelet count) Surgical wounds may become infected There is a risk of stroke. > If any of these affects you, talk to your doctor or nurse. ||| ♦ Rare (pouvant survenir jusqu’ à 1 dose de vaccin sur 1 000) • Douleurs sévères pulsatiles ou lancinantes sur le trajet d’ un ou plusieurs nerfs • Convulsions • Taux anormalement bas des plaquettes, pouvant entraîner des saignements ou des bleus • Réactions allergiques pouvant conduire à une baisse sévère de la pression artérielle qui, si elle n’ est pas traitée, peut conduire à un choc, coma et mort.
0.543019711971283 ||| The EMEA continued to receive information visits from national authorities of a number of non-EU countries. ||| This involved representatives from 31 EU Member States, accession candidate countries and European institutions. ||| L’ EMEA a continué à recevoir des visites d’ information d’ autorités nationales de plusieurs pays tiers.
0.45413273572921753 ||| Tasigna should not be used during pregnancy unless clearly necessary. ||| Effentora should be immediately discontinued if no longer required. ||| Tasigna ne doit pas être utilisé pendant la grossesse à moins d'une nécessité absolue.
0.4805438220500946 ||| Excretion of lithium may be reduced by ACE inhibitors and therefore lithium toxicity may be increased. ||| Potassium and magnesium excretion are increased, uric acid excretion is decreased. ||| L’ excrétion du lithium pourrait être réduite par les IEC, et par conséquent la toxicité du lithium augmentée.
0.43416666984558105 ||| Cartons of 56 film-coated tablets; 4 blister cards of 14 film-coated tablets in PVC/ PVDC/ Aluminium blisters. ||| MULTIPACKS ONLY Carton of 168 film-coated tablets containing 3 Cartons of 56 film-coated tablets (with Blue box) ||| 56 Boites de 56 comprimés pelliculés; 4 plaquettes thermoformées de 14 comprimés pelliculés dans des blisters en PVC/ PVDC/ Aluminium.
0.4648541808128357 ||| 17-21, Băneasa Center, et. ||| 17-21, Băneasa Center, et.8, sector 1 ||| Băneasa Center, et.
0.7949299812316895 ||| Date opened: ||| Date opened ||| Date d'ouverture:
0.3783213496208191 ||| Rental of mini computers ||| Hiring of dental instruments ||| Location de mini-ordinateurs
0.24963122606277466 ||| In phase III studies, at end of study 90%, 95%, 98% and 60% of subjects who received Silgard in the per-protocol immunogenicity population were anti-HPV 6, anti-HPV 11, anti-HPV 16 and anti HPV 18 seropositive, respectively. ||| In the clinical studies, 99.9%, 99.8%, 99.8%, and 99.6% of individuals who received Silgard became anti-HPV 6, anti-HPV 11, anti-HPV 16, and anti-HPV 18-seropositive respectively, by 1 month Postdose 3 across all age groups tested. ||| A la fin des études cliniques de phase III, respectivement 90%, 95%, 98% et 60% des sujets ayant reçu Silgard, dans la population d'immunogénicité per protocole, étaient séropositifs aux anti-HPV 6, 11, 16 et 18.
0.15682664513587952 ||| au 6.1 List of excipients ||| tho 6.1 List of excipients ||| 6.1 Liste des excipients dic
0.13827276229858398 ||| Do not use Kineret after the expiry date which is stated on the label and carton after EXP. ||| - Do not use this medicine after the expiry date which is stated on the label and carton after ||| Ne pas utiliser Kineret après la date de péremption mentionnée sur l’ étiquette de la seringue et sur la boîte après {EXP}.
0.11191245168447495 ||| The oral suspension must be shaken well before use. ||| The suspension needs to be shaken well before use. ||| La suspension buvable doit être bien agitée avant utilisation.
0.0 ||| In first time users, the combination treatment is continued for 3 to 6 months, and sometimes for one year depending on your physicians judgement. ||| In first time users, the combination treatment is continued for 3 to 6 months, and sometimes for one year depending on your physicians judgement. ||| Chez les patients n’ayant jamais été traités, le traitement combiné est administré pendant 3 à 6 mois, et quelquefois pendant un an selon l’avis de votre médecin.
0.5566368103027344 ||| Myocardial infarction (see section 4.4), Tachycardia, Palpitations, ||| Cerebrovascular accident (see section 4.4), Raynaud’ s phenomenon ||| Infarctus du myocarde (voir rubrique 4.4), tachycardie, palpitations
0.18942806124687195 ||| HOW TO USE OVITRELLE ||| HOW TO USE YONDELIS ||| COMMENT UTILISER OVITRELLE
0.4922621548175812 ||| Cough Dysphonia Nasal dryness Dyspnoea exertional Nasal congestion Pleural effusion ||| Stridor Throat tightness Pulmonary infiltration Pleural effusion Breath sounds decreased Respiratory disorder ||| Toux Dysphonie Sécheresse nasale Dyspnée d’ effort Congestion nasale
0.0 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| 57 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ autorisation de mise sur le marché:
0.23361632227897644 ||| Disorders of the lungs such as pneumonia, bronchitis, shortness of breath, cough, fluid on the lungs/ chest cavity, sinus problems. ||| Symptoms of active psoriatic arthritis include inflammation of joints, swelling, difficulty moving, pain and patches of red, scaly skin (skin lesions). ||| Troubles pulmonaires: pneumonie, bronchite, essoufflement, toux, épanchement pleural (présence de liquide au niveau de la membrane entourant le poumon), sinusite.
0.222399041056633 ||| Paxene 6 mg/ ml concentrate for solution for infusion. ||| Concentrate for solution for infusion, 6 mg/ml ||| Paxene 6 mg/ ml solution à diluer pour perfusion.
0.10448555648326874 ||| Betaferon treatment should be started by a doctor who has experience in the treatment of MS. ||| Treatment with Stocrin should be started by a doctor who has experience in the management of HIV infection. ||| Le traitement par Betaferon doit être instauré par un médecin ayant l’ expérience du traitement de la sclérose en plaques.
5.413693581965418e-13 ||| 18 1. ||| 18 1. ||| 1.
0.025585584342479706 ||| 25 Keep out of the reach and sight of children. ||| 29 Keep out of the reach and sight of children. ||| Tenir hors de la portée et de la vue des enfants.
0.28013038635253906 ||| In case anti-erythropoietin antibody- mediated PRCA is diagnosed, therapy with NeoRecormon must be discontinued and patients should not be switched to another erythropoietic protein (see section 4.4). ||| These antibodies have been shown to cross-react with all erythropoietic proteins, and patients suspected or confirmed to have neutralising antibodies to erythropoietin should not be switched to darbepoetin alfa (see section 4.8). ||| Si un cas d’ érythroblastopénie est diagnostiqué, le traitement par NeoRecormon doit être interrompu et un traitement par une autre érythropoïétine recombinante ne doit pas être instauré (voir rubrique 4.4).
0.34003669023513794 ||| 44 In addition to medical treatment, good management and hygiene practices should be established on the farm in order to reduce the risk of infection and to control the build up of resistance. ||| These projects will help develop better monitoring systems in order to effectively prevent and control the spread of the virus, as well as contribute to the assessment of social dynamics. ||| 45 En complément du traitement médicamenteux, de saines pratiques de gestion et d’hygiène doivent être mises en place dans l’exploitation pour réduire le risque d’infection et contrôler l’émergence de la résistance.
0.17323565483093262 ||| Urinary tract infection, vaginal candidiasis, vaginal infection, vulvovaginitis Arthritis infective, bronchitis, cellulitis, cervicitis, diverticulitis, fungal infection, furuncle, genital candidiasis, herpes simplex ophthalmic, impetigo, labyrinthitis, pyelonephritis, pyometra ||| Sepsis, gastrointestinal candidiasis, urinary tract infection, herpes simplex, herpes zoster Pneumonia, influenza, respiratory tract infection, respiratory moniliasis, gastrointestinal infection, candidiasis, gastroenteritis, infection, bronchitis, pharyngitis, sinusitis, fungal skin infection, skin candida, vaginal candidiasis, rhinitis ||| Infections et infestations Candidose vaginale, infection des voies urinaires, infection vaginale, Peu fréquent: vulvovaginite Arthrite infectieuse, bronchite, candidose génitale, cellulite, cervicite, Rare: diverticulite, furoncle, herpès ophtalmique, impétigo, infection fongique, labyrinthite, pyélonéphrite, pyométrie Tumeurs bénignes, malignes, et non précisées (incluant kystes et polypes) Fibrome, fibromyome utérin Peu fréquent:
0.3829413056373596 ||| No accumulation is observed for cetirizine following daily doses of 10 mg for 10 days. ||| The median dose of thalidomide was 217 mg and > 40% of patients received 9 cycles. ||| Il n’ est pas observé d’ accumulation après administration de doses journalières de 10 mg de cétirizine pendant 10 jours.
0.28434130549430847 ||| In animals as well as in humans, the antagonistic hormonal effects of cetrorelix were fully reversible after termination of treatment. ||| Rabbits were shown to be especially sensitive to intravenous administration of tacrolimus, reversible cardiotoxic effects being observed. ed ||| Chez l'animal comme chez l'homme, les effets hormonaux antagonistes du cétrorélix sont complètement réversibles à l’ arrêt du traitement.
0.38677430152893066 ||| If you are taking any of these medicines, your doctor may need to check the level of anticonvulsant medicine in your blood to ensure that it is not affected while taking Atripla. ||| Your doctor will increase the dose of MabCampath slowly to reduce the possibility of you having side effects and to allow your body to tolerate MabCampath better. ||| Si vous prenez l’ un de ces médicaments, votre médecin devra peut-être mesurer la concentration du médicament anticonvulsivant dans votre sang pour s’ assurer que celle -ci
0.34312957525253296 ||| Leflunomide therapy is started with a loading dose of 100 mg once daily for 3 days. • The recommended maintenance dose for rheumatoid arthritis is leflunomide 10 mg to 20 mg once daily. ||| When efavirenz is co-administered with voriconazole, the voriconazole maintenance dose must be increased to 400 mg twice daily and the efavirenz dose must be reduced by 50%, i. e., to 300 mg once daily. ||| 2 La dose d'entretien recommandée est de 10 à 20 mg de léflunomide une fois par jour pour la polyarthrite rhumatoïde.
0.6468531489372253 ||| String materials for sporting racquets ||| Paddles for use in paddle ball games ||| Matériaux de cordage pour raquettes de sport
0.861160159111023 ||| - No dose adjustment required. ||| - Limited exposure due to limited marketing. ||| - Aucune adaptation posologique n’ est requise.
0.016623836010694504 ||| In clinical studies, serum free IgE levels were reduced in a dose-dependent manner within one hour following the first dose and maintained between doses. ||| 8 In clinical studies, serum free IgE levels were reduced in a dose-dependent manner within one hour following the first dose and maintained between doses. ||| Lors des études cliniques, une diminution dose-dépendante des taux d’ IgE sériques circulantes a été observée dans un délai d’ une heure après l’ administration de la première dose et ils se sont maintenus au même niveau entre les doses.
0.31115221977233887 ||| After an initial 10 mg daily dose, a reduction of the daily dose to 7.5 mg may be considered, based on pharmacokinetic modelling (see section 4.2). no ||| During dose escalation in three pivotal studies, efficacy was observed starting at a daily dose of 1.1 mg of base (1.5 mg of salt). ||| Après une posologie initiale de 10 mg une fois par jour, une diminution de la posologie quotidienne à 7,5 mg peut être envisagée sur la base e
0.2745727300643921 ||| 21 The most commonly reported adverse reactions in patients treated with XERISTAR were nausea, headache, dry mouth, somnolence, fatigue, insomnia, dizziness and constipation. ||| The most common adverse reactions of any severity grade were nausea, fatigue, vomiting, anorexia, neutropenia, and increases in AST/ ALT. ||| Les événements indésirables les plus fréquemment rapportés chez les patients traités par XERISTAR ont été: nausées, céphalées, sècheresse de la bouche, somnolence, fatigue, insomnie, sensations vertigineuses et constipation.
0.3623546361923218 ||| In the event of an overdose the patient should be monitored and appropriate supportive treatment should be given, if considered necessary. ||| A course of action should be planned in advance with necessary drugs and equipment available for immediate treatment, in case a serious reaction should occur. ||| En cas de surdosage, une surveillance du patient s’ impose et, si besoin, des traitements symptomatiques appropriés seront administrés.
0.61482834815979 ||| Novartis Pharma N. V. Medialaan 40 B-1800 Vilvoorde Belgium ||| Amgen Manufacturing Limited P. O Box 4060 Road 31 km. ||| Novartis Pharma N. V. Medialaan 40 B-1800 Vilvoorde Belgique
0.1998780071735382 ||| How is Yentreve used? ||| How is Yttriga used? ||| Comment Yentreve est -il utilisé?
0.007951279170811176 ||| TMZ was administered as salvage therapy in the follow-up phase in 161 patients of the 282 (57%) in the RT alone arm, and 62 patients of the 277 (22%) in the TMZ + RT arm. ||| 26 TMZ was administered as salvage therapy in the follow-up phase in 161 patients of the 282 (57%) in the RT alone arm, and 62 patients of the 277 (22%) in the TMZ + RT arm. ||| Le TMZ a été administré comme traitement d’ entretien dans la phase de suivi chez 161 des 282 patients (57%) dans le bras radiothérapie seule, et 62 des 277 patients (22%) dans le bras TMZ + RT.
0.3193112313747406 ||| Gas ovens ||| Glass stoppers ||| Fours à gaz
0.5487020015716553 ||| They generally occurred early in treatment (within 3 months) and most patients experienced only one episode. ||| They were mostly mild, generally lasting for up to 72 hours and resolved spontaneously. ||| Ils sont généralement survenus au début du traitement (au cours des trois premiers mois) et la majorité des patients n’ en a présenté qu’ un seul épisode.
0.15731710195541382 ||| Protaphane is a long-acting insulin. ||| Apidra is a short-acting insulin. ||| Protaphane est une insuline d’ action prolongée.
0.3358299732208252 ||| If you take more suspension than prescribed (or if someone else takes your suspension) you must seek medical advice or go to the nearest hospital casualty department immediately. ||| If you take more Rapamune than you should If you have taken more medicine than you were told contact a doctor or go to the nearest hospital emergency department straight away. ||| Si vous prenez plus de suspension que la quantité prescrite (ou si quelqu’ un prend votre suspension), vous devez consulter un médecin immédiatement ou vous rendre au service des urgences de l’ hôpital le plus proche.
0.02363969013094902 ||| - if you are intolerant to lactose because each hard capsule contains 37.4 mg lactose (anhydrous). ||| - if you are intolerant to lactose because each hard capsule contains 149.6 mg lactose (anhydrous). ||| 104 • si vous avez du diabète, • si vous êtes hémophile, • si vous avez une intolérance au lactose car chaque gélule contient 37,4 mg de lactose (anhydre).
0.5052390098571777 ||| To that end, the tool seeks to make best use of the existing resources, currently under the EU's cohesion policy. ||| Moreover, the company's liquidity needs over the six next months are based on reasonable assumptions. ||| À cette fin, cet instrument vise à utiliser au mieux les ressources existantes, actuellement dans le cadre de la politique de cohésion de l'UE.
3.578651589473958e-13 ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si l'un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.09507369995117188 ||| Any person intending to import, sell, supply and/ or use the veterinary medicinal product must consult the relevant Member State’ s Competent Authority on the current vaccination policies prior to the import, sale, supply and/ or use ||| Any person intending to import, sell, supply and/ or use Circovac must consult the relevant Member State’ s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use ||| Toute personne souhaitant importer, vendre, délivrer et/ ou utiliser ce médicament vétérinaire doit au préalable consulter les autorités compétentes de l’ Etat membre concernant les politiques actuelles de vaccination.
0.3748277723789215 ||| Printed advertising boards of cardboard ||| Signboards of paper or cardboard ||| Supports publicitaires imprimés en carton
0.4664013385772705 ||| The strategy calls for the elimination of pollution from nitrogen and phosphorus flows from fertilisers by 2030. ||| With the clean energy transition, the EU will decrease its dependence on fossil fuels and fossil fuel imports. ||| La stratégie vise à éliminer d'ici à 2030 la pollution par les flux d'azote et de phosphore liés aux fertilisants.
0.34730264544487 ||| Pipetting instruments for surgical use ||| Balloons for use in arthroscopy ||| Instruments de pipetage à usage chirurgical
0.054993435740470886 ||| During their November 2007 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Menitorix, that the objections raised by Greece, Poland and Spain should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended. ||| During the June 2006 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/ risk ratio is favourable for Doxastad 4 mg prolonged release tablets and associated names, that the objections raised should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended. ||| Lors de sa réunion de novembre 2007, le CHMP, prenant en compte l’ ensemble des données soumises et la discussion scientifique au sein même du comité, a considéré que le rapport bénéfice/ risque est favorable pour Menitorix, que les objections soulevées par la Grèce, l’ Espagne et la Pologne et ne doivent pas faire entrave à l’ octroi d’ une autorisation de mise sur le marché et que le résumé des caractéristiques du produit, l’ étiquetage et la notice de l’ État membre de référence doivent être modifiés.
0.16246597468852997 ||| How to use Liprolog Mix50 KwikPen 4. ||| How to use Liprolog Mix50 Pen 4. ||| Comment utiliser Liprolog Mix50 KwikPen 4.
0.767702579498291 ||| ACR 20 ||| ASAS 50 Me ||| ACR 20 dic
0.6869670152664185 ||| thrombosis, cardiac tamponade, myocardial rupture ||| Adenotonsillectomy*, adenoidectomy, ear tube insertion ||| péricardique, thrombose veineuse, tamponade, rupture myocardique
0.4210436940193176 ||| From 1982 to 1986, Dr Bénéfice was a researcher at the University of Montpellier, France. ||| From 1973, Dr de Neef taught medical physiology at the University of Surinam, South America. ||| Expérience professionnelle: de 1982 à 1986, Mme Bénéfice a travaillé en tant que chercheur à l’ université de Montpellier en France.
0.009833787567913532 ||| Viraferon must be used cautiously in patients with debilitating medical conditions, such as those with a history of pulmonary disease (e. g., chronic obstructive pulmonary disease) or diabetes mellitus prone to ketoacidosis. ||| IntronA must be used cautiously in patients with debilitating medical conditions, such as those with a history of pulmonary disease (e.g., chronic obstructive pulmonary disease) or diabetes mellitus prone to ketoacidosis. ||| Viraferon doit être utilisé avec précaution chez des patients en mauvais état général, tels que ceux e
0.3321818709373474 ||| Caution should be exercised with co-administration of venlafaxine and imipramine. ||| Increase in dosage of probenecid or sulfinpyrazone may be necessary. ||| L’ administration concomitante de venlafaxine et d’ imipramine doit être faite avec prudence.
0.4649653136730194 ||| Personal banking services ||| Boarding house services ||| Services bancaires personnels
0.6110918521881104 ||| You should get a replacement when the counter shows the number 020. ||| For a pack containing a single bottle, write only one date. ||| Vous devez envisager le renouvellement de votre médicament lorsque le compteur affiche le nombre 020.
0.13426512479782104 ||| Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands ||| Intervet International BV Wim de Korverstraat 35 NL-5831 AN Boxmeer The Netherlands ||| Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer PAYS BAS.
0.41361886262893677 ||| On 23 February 2020, at least three citizens of Herat who had recently returned from Qom were suspected of COVID-19 infection. ||| On 30 March, it was announced that tarento and comedian Ken Shimura had died at the age of 70 from complications of a COVID-19 infection. ||| Le 23 février 2020, au moins trois citoyens d' Herat récemment rentrés de Qom étaient soupçonnés d'infection au COVID-19.
0.2191562056541443 ||| Cases of antibody-mediated PRCA have been very rarely reported in chronic renal failure patients with erythropoietin administered by the subcutaneous route. ||| Adequate hydration must be maintained in patients undergoing ViraferonPeg therapy since hypotension related to fluid depletion has been seen in some patients treated with alpha interferons. ||| Des cas d’ érythroblastopénie (AEPA) véhiculée par les anticorps ont très rarement été signalés chez 158 les patients insuffisants rénaux chroniques recevant de l’ érythropoïétine par voie sous-cutanée.
0.0 ||| Table 2: ||| Table 2: ||| 63 Tableau 2:
0.5560750365257263 ||| Agency services for the reservation of temporary accommodation ||| Seat reservations for various forms of transport ||| Services d'agences de réservation d'hébergement temporaire
0.029987480491399765 ||| You should tell your doctor if you are taking fluvoxamine (an antidepressant) or ciprofloxacin (an antibiotic), as it may be necessary to change your OLANZAPINE NEOPHARMA dose. ||| You should tell your doctor if you are taking fluvoxamine (an antidepressant), or ciprofloxacin (an antibiotic), as it may be necessary to change your ZYPREXA VELOTAB dose. ||| Vous devez informer votre médecin si vous prenez de la fluvoxamine (un antidépresseur) ou de la ciprofloxacine (un antibiotique), car il peut être nécessaire de modifier votre dose de OLANZAPINE NEOPHARMA.
0.2997468113899231 ||| Like in all patients receiving erythropoietin, blood pressure may rise during treatment with Retacrit. ||| Conversely, in patients receiving replacement therapy with thyroxin mild hyperthyroidism may occur. ||| Comme pour tous les patients recevant de l’ érythropoïétine, la pression artérielle est susceptible d’ augmenter pendant la durée du traitement par Retacrit.
0.09077486395835876 ||| Food intake Meals with a high fat content have been shown to reduce the absorption of Sprimeo substantially. ||| Food intake Meals with a high fat content have been shown to reduce the absorption of Enviage substantially. ||| Prise de nourriture Il a été montré que les repas à haute teneur en graisse réduisent de façon substantielle l’ absorption de Sprimeo.
0.0 ||| th Sodium phosphate monobasic Sodium phosphate dibasic ||| th Sodium phosphate monobasic Sodium phosphate dibasic ||| Phosphate monosodique anhydre Phosphate disodique anhydre
0.010532497428357601 ||| 744 PACKAGE LEAFLET: ||| 734 PACKAGE LEAFLET: ||| 785 NOTICE:
0.3774915933609009 ||| Bioavailability was negligible whether alendronate was administered with, or up to two hours after, a standardised breakfast. ||| Bioavailability decreased to an estimated 0.46% and 0.39% when alendronate was given an hour or half an hour before a standardised breakfast. ||| La biodisponibilité a été quasi-nulle lorsque l'alendronate a été administré au cours d'un petit déjeuner normal ou dans les deux heures qui ont suivi.
0.3898860216140747 ||| The relevance of these tumour findings in rodents in terms of human risk is unknown. ||| Furthermore, no clinically significant renal abnormalities were noted in clinical trials. ||| La signification de ces données tumorales chez les rongeurs en terme de risque pour l’ espèce humaine est inconnue.
0.7140418887138367 ||| How was the €7.5 billion fundraising target set? ||| Is the €55 billion "fresh money"? ||| Comment l'objectif de 7,5 milliards d'euros pour la levée de fonds a-t-il été fixé?
0.5608813166618347 ||| Headache, parathesia ||| headache, tremor ||| Céphalée, paresthésie
0.39613789319992065 ||| The European Commission has approved a €30 million Luxembourg aid scheme to support coronavirus related research and development (R D) and investments in the production of products relevant to the coronavirus outbreak. ||| The European Investment Fund (EIF) and European Commission are launching a new pilot guarantee facility to improve access to finance for individuals and organisations looking to invest in skills and education. ||| La Commission européenne a autorisé un régime d'aides luxembourgeois visant à soutenir la recherche et le développement (R D) portant sur le coronavirus et les investissements dans la fabrication de produits utiles à la lutte contre la pandémie de COVID-19.
0.3340335488319397 ||| Dosage in patients with impaired kidney function If you have impaired kidney function, your doctor will decide upon a dose that suits your condition. ||| Dosage adjustment If you are older than 65 years your doctor may prescribe you a dose based on your kidney function and severity of disease. ||| Posologie pour les patients présentant une insuffisance rénale Si vous présentez une insuffisance rénale, votre médecin décidera de la dose adaptée à votre état.
0.2625223994255066 ||| Known hypersensitivity to the active substance, to mouse or hamster protein or to any of the excipients. ||| Hypersensitivity to the active substance, aprepitant, or to polysorbate 80 or any of the other excipients. ||| Hypersensibilité connue à la substance active, aux protéines de souris ou de hamster ou à l’ un des excipients.
0.6946556568145752 ||| Fever ≥ 38○ C and ANC < 1,000/ mm3 ||| Stop Glivec until ANC ≥ 1.5 x 109/ l and ||| Fièvre ≥ 38○ C et Taux de PNN < 1.000/ mm3
0.45795080065727234 ||| This enzyme normally helps to break down ammonia. ||| This enzyme helps the body control levels of glucocerebroside. ||| Le rôle de cette enzyme est, en principe, de contribuer à l’ élimination de l’ ammoniaque.
0.24335767328739166 ||| Cardboard boxes ||| Cardboard labels ||| Boîtes en carton
0.37411272525787354 ||| During the ‘ induction’ phase, Vistide is given as a one-hour infusion of 5 mg per kilogram body weight once a week for the first two weeks. ||| Apply sufficient Aldara cream to cover the treatment area and 1 cm (about ½ an inch) around the treatment area each day for 5 consecutive days each week for 6 weeks. ||| Durant la phase « d’ induction », Vistide est administré par perfusion d’ une heure, à raison de 5 mg par kilogramme de poids corporel, une fois par semaine pendant les deux premières semaines.
0.320762038230896 ||| If the reconstituted solution cannot be injected immediately, it must be kept refrigerated until use and used within 24 hours. ||| The Vidaza suspension should be prepared immediately before use and the reconstituted suspension should be administered within 45 minutes. ||| Si la solution reconstituée ne peut être injectée immédiatement, elle doit être conservée au réfrigérateur et utilisée dans un délai de 24 heures.
0.12111368775367737 ||| How has Imprida been studied? ||| How has Ventavis been studied? ||| Quelles études ont été menées sur Imprida?
0.14787894487380981 ||| The most common side effects with Arava (seen in between 1 and 10 patients in 100) are leucopenia (low white blood cell counts), mild allergic reactions, anorexia (loss of appetite), weight loss, headache, dizziness, paraesthesia (abnormal skin sensations), mild increase in blood pressure, diarrhoea, nausea (feeling sick), vomiting, inflammation of the mouth such as mouth ulcers, abdominal (tummy) pain, increased liver enzyme levels, hair loss, eczema, dry skin, rash, pruritus pruritus (itching), tenosynovitis (inflammation of the sheath surrounding a tendon) and asthenia (weakness). ||| Inflammation of the lung (bronchitis); feeling sad (depression); difficulty falling asleep (insomnia); impaired vision; difficulty breathing; abdominal pain, constipation, bloating (dyspepsia), feeling sick; abnormal liver function; rapid swelling of the skin and mucosa (angioedema), redness of the skin (erythema); allergic reactions such as itching or rash; increased sweating, hives (urticaria); joint pain (arthralgia) and pain in extremities, muscle cramps; flu-like-illness; pain; increased levels of uric acid, low levels of sodium, increased levels of creatinine, hepatic enzymes or creatine phosphokinase in the blood. ||| Les effets indésirables les plus fréquents d’ Arava (observés chez 1 à 10 patients sur 100) sont: leucopénie (faible nombre de globules blancs), réactions allergiques modérées, anorexie (perte d’ appétit), perte de poids, maux de tête, vertiges, paresthésie (sensations anormales au niveau de la peau), augmentation modérée de la pression artérielle, diarrhée, nausées (sensation de malaise), vomissements, inflammations de la bouche telles que des ulcères de la bouche, douleurs abdominales (mal au ventre), augmentation des taux d’ enzymes hépatiques, perte de cheveux, eczéma, peau sèche, éruptions cutanées, prurit (démangeaisons), ténosynovite (inflammation de la gaine entourant un tendon) et asthénie (faiblesse).
0.35605865716934204 ||| 7 (1.6%) 7 (1.6%) 4 (0.9%) 15 (3.4%) ||| 1 (0.2%) 6 (1.1%) 4 (0.7%) 0 (0%) ||| 7 (1.6%) 7 (1.6%) 4 (0.9%)
0.03526170551776886 ||| 143 5.2 Pharmacokinetic properties ||| 161 5.2 Pharmacokinetic properties ||| 5.2 Propriétés pharmacocinétiques
0.012958981096744537 ||| If you have been told by your doctor that you have an intolerance to some sugars (e. g. lactose), contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars (e. g. lactose), contact your doctor before taking this medicinal product. ||| Si votre docteur vous a déjà dit que vous présentiez une intolérance à certains sucres (par exemple le lactose), vous devez contacter votre médecin avant de prendre ce médicament.
0.48931416869163513 ||| Rebetol oral solution is used in combination with interferon alfa-2b for injection. ||| s Viraferon has been classified as recombinant interferon alfa-2b. ||| Rebetol solution buvable est utilisé en association avec l’ interféron alfa-2b, solution injectable.
0.013971325941383839 ||| Children and adolescents 3 to 16 years of age with compensated chronic hepatitis C and detectable HCV-RNA (assessed by a central laboratory using a research-based RT-PCR assay) were enrolled in two multicentre trials and received IntronA 3 MIU/m2 3 times a week plus ribavirin 15 mg/kg per day for 1 year followed by 6 months follow-up after-treatment. ||| Children and adolescents 3 to 16 years of age with compensated chronic hepatitis C and detectable HCV- RNA (assessed by a central laboratory using a research-based RT-PCR assay) were enrolled in two multicentre trials and received Viraferon 3 MIU/ m2 3 times a week plus ribavirin 15 mg/ kg per day for 1 year followed by 6 months follow-up after-treatment. ||| Des enfants et adolescents âgés de 3 à 16 ans ayant une hépatite C chronique compensée et un ARN- VHC détectable (évalué par un laboratoire central utilisant une méthode RT-PCR non commercialisée) ont été inclus dans deux études multicentriques et ont reçu IntronA 3 MUI/ m2 trois fois par semaine + ribavirine 15 mg/ kg par jour pendant 1 an, puis ont été suivis pendant une période de 6 mois après arrêt du traitement.
0.1396244466304779 ||| Suspension for injection 25 syringes 25 x 1 dose 1 dose (1 ml) ||| Suspension for injection 10 syringes 20 needles 10 x 1 dose 1 dose (0.5 ml) ||| Suspension injectable 25 seringues 25 x 1 dose 1 dose (1 ml)
0.193786159157753 ||| The full EPAR for Emend is available here. ||| The full EPAR for Pritor is available here. ||| L’ EPAR complet relatif à Emend est disponible ici.
0.03259320184588432 ||| Keep the container tightly closed in order to protect from moisture. ||| Keep the bottle tightly closed in order to protect from moisture. ||| Conserver le conditionnement primaire soigneusement fermé pour tenir à l’ abri de l’ humidité.
0.37855374813079834 ||| Driving and using machines You might experience dizziness or sleepiness which could affect your ability to drive or operate machinery. ||| Driving and using machines The amount of alcohol in this product may impair your ability to drive or use machines for a few hours after injection. ||| Conduite de véhicules et utilisation de machines Des sensations vertigineuses et une somnolence peuvent survenir et affecter votre capacité à conduire ou utiliser des machines.
0.2580317258834839 ||| LeukoScan is contraindicated in pregnancy. ||| MabCampath is contraindicated during pregnancy. ||| LeukoScan est contre-indiqué pendant la grossesse.
0.10037066042423248 ||| EU/ 1/ 00/ 132/ 046 ||| EU/ 1/ 00/ 132/ 029 ||| 5/ 6 EU/ 1/ 00/ 132/ 046
0.43013662099838257 ||| The oral clearance of both venlafaxine and ODV was reduced. ||| The free fraction of fentanyl increases with acidosis. ||| La clairance aussi bien de la venlafaxine que de l’ ODV est réduite.
0.32240110635757446 ||| Ultrasonic diagnostic instruments for medical use ||| Surgical apparatus and instruments for medical use ||| Instruments de diagnostic à ultrasons à usage médical
0.19510036706924438 ||| It may also increase the levels of a 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| The study went on to look at the number 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.7685627937316895 ||| Vertigo positional ||| Percent Predicted ||| Vertige positionnel
0.02661137282848358 ||| 2 Intramuscular administration is not recommended as it has not been studied. ||| 13 Intramuscular administration is not recommended as it has not been studied. ||| En l’ absence d’ étude, l’ administration par voie intramusculaire n’ est pas recommandée.
0.5117692947387695 ||| Towards the end of the year the reprographics service was relocated but kept in the immediate vicinity of the main meetings. ||| This same year, the premises were relocated to a former supermarket in Mulhouse, with a capacity of 600 seats. ||| Le service de reprographie a été déménagé à la fin de l’année, mais il reste cependant à proximité immédiate des principales salles de réunion.
0.053233496844768524 ||| Please read all of this leaflet carefully before you start taking this medicine.  Keep this leaflet. ||| Read all of this leaflet carefully before you start taking this medicine.  Keep this leaflet. ||| Veuillez lire attentivement l’intégralité de cette notice avant de prendre ce médicament.
0.44519713521003723 ||| Power transmissions for aircraft ||| Cables for electrical signal transmission ||| Transmissions de puissance pour aéronefs
0.2793121337890625 ||| The data supporting this application, as interpreted according with the CHMP guidance, did not support authorization of regular daily doses in excess of 160 µg in the treatment populations, and this was considered to be of serious public health concern. ||| The CHMP was of the opinion that the MAH proposal was acceptable, but considered that interactions and conditions relevant for all cytotoxics are expected for gemcitabine and that adequate warning should therefore be provided in section 4.4 and 4.5. ||| Les données qui corroborent cette demande, interprétées sur la base des recommandations du CHMP, n’ étaient pas favorables à l’ autorisation de doses régulières de plus de 160 µg/ jour dans le traitement des populations et il a été considéré qu’ il s’ agissait d’ un problème de santé publique majeur.
0.004736652597784996 ||| 19 Renal impairment In an oral single dose (200 mg) study in subjects with normal renal function and mild (creatinine clearance 41-60 ml/ min) to severe (creatinine clearance < 20 ml/ min) renal impairment, the pharmacokinetics of voriconazole were not significantly affected by renal impairment. ||| Renal impairment In an oral single dose (200 mg) study in subjects with normal renal function and mild (creatinine clearance 41-60 ml/ min) to severe (creatinine clearance < 20 ml/ min) renal impairment, the pharmacokinetics of voriconazole were not significantly affected by renal impairment. ||| Insuffisance rénale Dans une étude utilisant une dose orale unique (200 mg) chez des sujets ayant une fonction rénale normale et une insuffisance rénale légère (clairance de la créatinine 41 à 60 ml/ mn) à sévère (clairance de la créatinine < 20 ml/ mn), la pharmacocinétique du voriconazole n’ a pas été significativement modifiée par l’ insuffisance rénale.
0.20326058566570282 ||| Blister Pack of 11 x 0.5 mg varenicline film-coated tablets, Heat Sealed Card ||| Blister Pack of 14 x 1 mg and 28 x 1 mg varenicline film-coated tablets, Heat Sealed Card ||| Plaquette thermoformée de 11 comprimés pelliculés à 0,5 mg de varénicline, étui thermoscellé
0.2590334415435791 ||| 1) Description of post injection syndrome – Education about the 2 intramuscular formulations of olanzapine, including packaging differences – Description of reconstitution and proper administration technique – Recommendation for a 3-hour on-site observation period post injection – Recommendation that prior to giving the injection, the HCP should determine that the patient will not travel alone to their destination – Recommendation for informing patients that for the remainder of the day of the injection, they should not drive or operate machinery, should be vigilant for signs and symptoms of a post injection syndrome event, and should be able to obtain assistance if needed – Description of the most common symptoms reported with olanzapine overdose that represent the clinical manifestation in post injection syndrome events – Recommendation for appropriate monitoring until the event resolves if an event should occur 2) Recommendations for monitoring of patients for glucose, lipids, and weight. – Promote awareness of appropriate metabolic monitoring by distributing utilized published antipsychotic guidelines. ||| In respect of the benefit/ risk balance for target species poultry, the CVMP concludes that: • notwithstanding the fact that a definitive clinical field study using the recommended dosage of the product has not been provided, taking into account the pre-clinical studies, the artificial infection model, the history of use and the other pertinent information provided, the various risk management steps now set out in the proposed SPC and noting the fact that the indications for use are restricted, the benefit / risk balance is positive; • the availability of an authorised veterinary medicinal product containing active substances other than fluoroquinolones might be regarded an indirect benefit and not directly relevant to the scope of this referral procedure (as efficacy must be shown for each product independently); • the conditions of use as proposed in the SPC preclude use in laying birds and restrict use of the product based on culture and sensitivity testing of micro-organisms from diseased farms. ||| • Education à propos des 2 formulations intramusculaires d’ olanzapine, incluant les différences de conditionnement • Description de la technique de reconstitution et d’ administration appropriée • Recommandation pour une surveillance sur site 3 heures après l’ injection • Recommandation pour que, avant d’ administrer l’ injection, le professionnel de santé s’ assure que le patient ne se rendra pas seul vers sa destination après l’ injection • Recommandation d’ informer les patients que pour le reste de la journée de l’ injection, ils ne doivent pas conduire ou utiliser de machines, qu’ ils doivent rester vigilants pour détecter les signes ou symptômes d’ un événement lié au syndrome post-injection et doivent pouvoir obtenir une assistance si nécessaire • Description des effets les plus fréquemment rapportés avec un surdosage en olanzapine qui correspond à la manifestion clinique d’ un événement lié au syndrome post-injection • Recommandation pour une surveillance appropriée jusqu’ à la disparition des événements si un événement se produit
0.10662204027175903 ||| Rubber hose for the splicing of cables ||| Rubber hose for the termination of cables ||| Tuyau en caoutchouc pour le raccord de câbles
0.4748115539550781 ||| During 1997, the strategy for providing appropriate information technology facilities for the EMEA was formally defined and adopted. ||| In 1987, the practice of universal precautions was adjusted by a set of rules known as body substance isolation. ||| En 1997, la stratégie pour la fourniture d’installations informatiques appropriées à l’EMEA a été formellement définie et adoptée.
4.2390369643305337e-13 ||| When medicines are made from human blood or plasma, certain measures are put in place to prevent infections being passed on to patients. ||| When medicines are made from human blood or plasma, certain measures are put in place to prevent infections being passed on to patients. ||| Lorsque des médicaments sont fabriqués à partir de sang ou de plasma humain, certaines mesures sont mises en place afin de prévenir la transmission des infections chez les patients.
0.11620085686445236 ||| International Non-Proprietary Name (INN): cetirizine ||| International Non-Proprietary Name (INN): mirtazapine ||| Dénomination commune internationale (DCI): cétirizine
0.5071419477462769 ||| It is important to treat these problems as soon as possible. ||| It is very important for you to keep all of these appointments. ||| Il est important de traiter ces troubles dans les plus brefs délais.
0.1997038722038269 ||| Each film-coated tablet contains 1 mg of ropinirole (as hydrochloride). ||| Each gram of cream contains 115 mg eflornithine (as hydrochloride monohydrate). ||| Chaque comprimé pelliculé contient 1 mg de ropinirole (sous forme de chlorhydrate).
0.5516383647918701 ||| In particular, newborns, infants, and pregnant women should not be subjected to Ventavis. ||| Use is not recommended in newborns, infants, children and adolescents. ||| Les nourrissons, les jeunes enfants et les femmes enceintes en particulier ne doivent pas être exposés à Ventavis.
0.038537751883268356 ||| 3000 IU/ 0.3 ml ||| 1000 IU/ 0.3 ml ||| 3 000 UI /
4.1380028743820407e-13 ||| The extent to which these outcomes might apply to the administration of recombinant human erythropoietin to patients with cancer, treated with ||| The extent to which these outcomes might apply to the administration of recombinant human erythropoietin to patients with cancer, treated with ||| Les conséquences de ces résultats, quant à l’ administration d’ érythropoïétine humaine recombinante chez les patients atteints de cancer, traités par chimiothérapie, afin d’ atteindre des taux cibles m
0.0 ||| Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy. ||| Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy. ||| Typiquement, la toux est non productive et persistante; elle disparaît après l’ arrêt du traitement.
0.07606452703475952 ||| Uncommon: flu-like symptoms, red spots under the skin, appearance of a swollen face or muscle weakness, low potassium level in the blood, weight gain, mood swings, hallucination and memory impairment, partial paralysis, impaired coordination, difficulty swallowing, impaired sensations, partial loss of vision, dry or painful eyes, deafness, infection of the middle ear, ringing in the ears, earache, palpitations (when you can feel your heart beat), blood clot in the lung, high blood pressure, pneumonia, inflammation of your sinuses, bronchitis, a cold or the flu, swollen stomach, difficulty controlling your bowel movements, haemorrhoids, peeling skin, increased skin sensitivity to sunlight, change in skin colour, increased sweating, muscle damage, back pain, difficulty in urinating, vaginal bleeding, sexual impotence, absent or heavy menstrual periods, vaginal irritation, breast pain, hot flushes, shivering, discolouration of your tongue, change in your sense of smell, thirst, tooth disorder. ||| Common: oral infections, wound infection, reduced number of blood cells (neutropenia, thrombocytopenia, lymphopenia, leukopenia), increased sugar in the blood, loss of weight, change in mental status or alertness, anxiety/depression, sleepiness, difficulty speaking, impaired balance, dizziness, confusion, forgetfulness, difficulty concentrating, inability to fall asleep or stay asleep, tingling sensation, bruising, shaking, abnormal or blurry vision, double vision, hearing impairment, shortness of breath, cough, blood clot in the legs, fluid retention, swollen legs, diarrhoea, stomach or abdominal pain, heartburn, upset stomach, difficulty swallowing, dry mouth, skin irritation or redness, dry skin, itching, muscle weakness, painful joints, muscle aches and pains, frequent urination, difficulty with holding your urine, allergic reaction, fever, radiation injury, face swelling, pain, abnormal taste, abnormal liver function tests. ||| Peu fréquent: symptômes pseudo-grippaux, taches rouges sous la peau, aspect de visage gonflé ou de faiblesse musculaire, faible taux de potassium dans le sang, prise de poids, troubles de l’humeur, hallucinations et troubles de la mémoire, paralysie partielle, coordination altérée, difficulté à avaler, sensations altérées, perte partielle de la vision, yeux secs ou douloureux, surdité, infection de l’oreille moyenne, impression de bourdonnements dans les oreilles, mal d’oreille, palpitations (quand vous sentez votre cœur battre), caillot de sang dans le poumon, hypertension, pneumonie, inflammation de vos sinus, bronchite, un rhume ou la grippe, estomac gonflé, difficulté à contrôler votre transit intestinal, hémorroïdes, peau qui pèle, sensibilité accrue de la peau au soleil, modification de la couleur de la peau, transpiration accrue, troubles musculaires, douleur dorsale, difficulté à uriner, saignement vaginal, impuissance sexuelle, menstruations absentes ou abondantes, irritation vaginale, douleur mammaire, bouffées de chaleur, frissons, décoloration de votre langue, modification de votre odorat, soif, troubles dentaires.
0.5595473051071167 ||| 16 medicinal products with Stalevo should be carefully observed for loss of therapeutic response. ||| standard inhalation technique should be employed to ensure both optimal and consistent drug delivery. uc ||| Les patients prenant ces médicaments et Stalevo doivent être surveillés étroitement à la recherche d'une disparition de la réponse thérapeutique.
0.8778613805770874 ||| When compared separately to ibuprofen and naproxen, the HR were 0.56 [95% CI 0.20-1.54] p=0.2603 and 1.42 [95% CI 0.70-2.90] p=0.3368, respectively. ||| Inactivated FPV (RP 9.50 - 12.25); FCV (RP 1.65 – 2.15); FVR (RP 1.60 – 2.10); Chlam (RP 2.00 – 2.30); FeLV (RP 1.45 – 2.0) ||| Comparé séparément à l’ ibuprofène et au naproxène, le HR a été respectivement de 0,56 [IC 95% 0,20-1,54] p = 0,2603 et de 1,42 [IC 95% 0,70-2,90] p = 0,3368.
0.5558626651763916 ||| Where practical, surgical manipulations to the site should be completed prior to implantation of Osigraft. ||| Steele and Stallman's finished implementation included facilities for extending and documenting the new macro set. ||| Si possible, accomplir les gestes chirurgicaux sur le site avant l’ implantation d’ Osigraft.
0.6808476448059082 ||| making available tools for assessment of performance, such as reference materials and common methods for the comparison of devices; ||| 2. making medicines, medical devices and other crisis relevant products, available and affordable and supporting innovation; ||| la mise à disposition d'outils d'évaluation des performances, tels que les matériaux de référence et des méthodes communes de comparaison des dispositifs;
0.38882553577423096 ||| If necessary, repeat this procedure until the calculated volume has been infused. ||| This is why the vaccine suspension should only be prepared as and when required. ||| Si nécessaire, répéter cette opération jusqu'à ce que le volume calculé soit perfusé.
0.3164618909358978 ||| After adjusting for differences in creatinine clearance and body weight, elderly subjects had a 12.5% higher AUC than young subjects. The population pharmacokinetic analysis covering patients in the age range 16-75 years did not identify age as significantly influencing entecavir pharmacokinetics. ||| Age: pharmacokinetic differences have been identified between younger and elderly females (≥ 65 years) (AUC increases by about 25% and half-life is about 25% longer in the elderly), although the magnitude of these changes is not sufficient to justify adjustments to the dose. ||| Une étude pharmacocinétique de population sur des patients de 16 à 75 ans n'a pas identifié l'âge comme un facteur ayant une influence significative sur la pharmacocinétique de l'entecavir.
0.4606662392616272 ||| 25 Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritā nija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan. com ||| Luxembourg/ Luxemburg Orphan Europe SARL Immeuble « Le Wilson » F-92058 Paris La Défense France/ Frankreich Tél/ Tel: +33 1 47 73 64 58 Magyarország Orphan Europe GmbH Max-Planck Str. ||| Latvija Allergan Ltd 1st Floor Marlow International The Parkway Marlow Bucks, SL7 1YL-UK Lielbritānija Tel: + 44 (0) 1628 494026 E-mail: uk_medinfo@allergan.com
0.2186175137758255 ||| What Cubicin looks like and contents of the pack Cubicin is supplied as a pale yellow to light brown powder in a glass vial. ||| What Fabrazyme looks like and contents of the pack Fabrazyme is supplied as a white to off-white powder. ||| Qu’ est -ce que Cubicin et contenu de l’ emballage extérieur Cubicin est fourni sous forme de poudre jaune pâle à brun clair, dans un flacon en verre.
0.3051438629627228 ||| Dexmedetomidine also induces a number of other α 2-adrenoceptor mediated effects, which include piloerection, depression of motor and secretory functions of the gastrointestinal tract, diuresis and hyperglycaemia. ||| IL-6 is involved in diverse physiological processes such as T-cell activation, induction of immunoglobulin secretion, induction of hepatic acute phase protein synthesis and stimulation of haemopoiesis. ||| La dexmédétomidine induit également un certain nombre d'autres effets associés aux récepteurs α 2-adrénergiques notamment: pilo-érection, dépression des fonctions motrices et sécrétoires du tractus gastro-intestinal, diurèse et hyperglycémie.
0.5157900452613831 ||| Omnitrope is intended for subcutaneous use. ||| This medicinal product is for multidose use. ||| Omnitrope doit être utilisé par voie sous-cutanée.
0.43051284551620483 ||| The use of Gardasil should be in accordance with official recommendations. ||| The advisability of driving should be considered in these circumstances. ||| Gardasil doit être utilisé sur la base des recommandations officielles.
0.23292969167232513 ||| Discontinuation of CELSENTRI should be considered in any patient with signs or symptoms of acute hepatitis, in particular if drug-related hypersensitivity is suspected or with increased liver transaminases combined with rash or other systemic symptoms of potential hypersensitivity (e. g. pruritic rash, eosinophila or elevated IgE). ||| Hypersensitivity reactions with rapid onset, including life-threatening reactions have occurred after restarting Ziagen in patients who had only one of the key symptoms of hypersensitivity (skin rash, fever, gastrointestinal, respiratory or constitutional symptoms such as lethargy and malaise) prior to stopping Ziagen. ||| L’ arrêt du traitement par CELSENTRI devra être envisagé chez tout patient présentant les signes ou symptômes d’ une hépatite aigue, en particulier si une hypersensibilité liée au médicament est suspectée ou en cas d’ augmentation des transaminases hépatiques associée à un rash ou à d’ autres symptômes systémiques d’ une hypersensibilité potentielle (par ex éruption prurigineuse, éosinophilie ou élévation des IgE).
0.5744799375534058 ||| LeukoScan is not recommended for use in children. ||| This product is not effective against adult D. immitis. ||| L’ utilisation du LeukoScan n’ est pas recommandée chez l’ enfant.
0.2718421518802643 ||| When disinfecting the neck of the ampoule with an antiseptic, to avoid any interaction with the Pedea solution, the ampoule must be completely dry before it is opened. ||| If Myocet leaks from the infusion site into the skin and surrounding tissues, the infusion must be stopped immediately and ice applied to the affected area for 30 minutes. ||| Si le col de l’ ampoule est désinfecté avec un antiseptique, afin d’ éviter toute interaction avec la solution de Pedea, l’ ampoule doit être complètement sèche avant ouverture.
0.04535157233476639 |||  194 Children and adolescents: |||  89 Children and adolescents: ||| Enfants et adolescents:
0.21321430802345276 ||| Providing information relating to life insurance brokerage ||| Providing information relating to bicycle rental services ||| Mise à disposition d'informations en matière de courtage d'assurance-vie
0.2752976417541504 ||| 85 When weak inhibitors of CYP3A4 (e. g., diltiazem or escitalopram) or CYP2D6 are used concomitantly with ABILIFY, modest increases in aripiprazole concentrations might be expected. ||| Phenytoin Studies have shown that the dosage of phenytoin (CYP2C19 and CYP2C9 substrate) may have to be reduced when administered concomitantly with lansoprazole. ||| Lors de l’ utilisation concomitante d’ inhibiteurs faibles du CYP3A4 (par exemple, le diltiazem ou l’ escitalopram) ou du CYP2D6 avec ABILIFY, des augmentations modérées des concentrations de l’ aripiprazole peuvent être attendues.
3.4921859241171527e-13 ||| Following single oral dose administration (20 mg/ kg) to epileptic children (6 to 12 years), the half-life of levetiracetam was 6.0 hours. ||| Following single oral dose administration (20 mg/ kg) to epileptic children (6 to 12 years), the half-life of levetiracetam was 6.0 hours. ||| Après administration d’ une dose orale unique (20 mg/ kg) à des enfants épileptiques (âgés de 6 à 12 ans), la demi-vie du lévétiracétam a été de 6,0 heures.
4.357280324312346e-13 ||| The list of the product names concerned is given in Annex I. ||| The list of the product names concerned is given in Annex I. ||| La liste des dénominations concernées figure en annexe I.
0.021992729976773262 ||| EU/ 1/ 01/ 184/ 009 1 pack EU/ 1/ 01/ 184/ 010 4 pack ||| EU/ 1/ 01/ 185/ 009 1 pack EU/ 1/ 01/ 185/ 010 4 pack ||| EU/ 1/ 01/ 184/ 009 (1 seringue sous plaquette thermoformée) EU/ 1/ 01/ 184/ 010 (4 seringues sous plaquette thermoformée)
0.3243083655834198 ||| Biochemical preparations other than for medical use ||| Rheology modifying compositions, other than for medical use ||| Produits biochimiques autres qu'à usage médical
0.16559478640556335 ||| How is Revlimid used? ||| How is Avaglim used? ||| Comment Revlimid est -il utilisé?
0.5503257513046265 ||| For children from 2 years through 5 years of age, a single dose immunisation schedule was used. ||| In both groups, the infants were vaccinated at two, four, and 12 to 15 months of age. ||| Chez les enfants de 2 à 5 ans, un schéma vaccinal avec une seule dose a été utilisé.
0.0 ||| This medicinal product does not require any special storage conditions. ||| This medicinal product does not require any special storage conditions. ||| PRÉCAUTIONS PARTICULIÈRES DE CONSERVATION 59 Ce médicament ne nécessite pas de précautions particulières de conservation.
0.029175162315368652 ||| 32 Incidence of undesirable effects considered related to treatment with Aranesp from controlled clinical studies are: ||| Incidence of undesirable effects considered related to treatment with Aranesp from controlled clinical studies are: ||| L'incidence des effets indésirables considérés comme étant reliés au traitement par Aranesp dans les études cliniques contrôlées est:
0.4312531054019928 ||| Consistent with its known effects on the nitric oxide/ cGMP pathway (see section 5.1), sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors or nitrates in any form is therefore contraindicated (see section 4.3). ||| Overall, the in vitro characterisation of phenotypic cross-resistance between lopinavir and other protease inhibitors suggest that decreased susceptibility to lopinavir correlated closely with decreased susceptibility to ritonavir and indinavir, but did not correlate closely with decreased susceptibility to amprenavir, saquinavir, and nelfinavir. ||| Compte tenu de la connaissance de son mode d’ action au niveau de la voie monoxyde d’ azote / GMPc (voir rubrique 5.1), il a été mis en évidence une potentialisation des effets hypotenseurs des dérivés nitrés par le sildénafil; son administration concomitante avec des donneurs de monoxyde d’ azote ou avec des dérivés nitrés sous quelque forme que ce soit est donc contre-indiquée (voir rubrique 4.3).
0.22639065980911255 ||| Shake before use. ||| Shake well before use. ||| Agiter avant emploi.
0.005285029299557209 ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 4.7 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Risk Management Plan The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 0005 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation Application and any subsequent updates of the RMP agreed by the CHMP. ||| Plan de gestion de risque Le titulaire de l’AMM s’engage à réaliser les études et les activités de pharmacovigilance supplémentaires détaillées dans le plan de pharmacovigilance, acceptées dans la version 4.7 du plan de gestion de risque (PGR) présentée dans le module 1.8.2 du dossier d’AMM et dans toute actualisation du PGR acceptée par le CHMP.
0.28015539050102234 ||| Treatment with Trudexa must be discontinued in patients who develop new or worsening symptoms of congestive heart failure. ||| Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue Icandra. ||| Le traitement par Trudexa doit être arrêté chez les patients présentant de nouveaux symptômes ou une aggravation de leurs symptômes d'insuffisance cardiaque congestive.
0.33935490250587463 ||| European Agency for the Evaluation of Medicinal Products 7 Westferry Circus Canary Wharf UK – London E14 4HB Annex 4 Profiles of EMEA personalities ||| 2000 The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf, London E14 4HB, United Kingdom Tel: ||| Agence européenne pour l’évaluation des médicaments 7 Westferry Circus Canary Wharf Royaume-Uni - Londres E14 4HB Annexe 4 Profil des personnalités de l’EMEA
0.2601165473461151 ||| The risk of these rare events may be higher with postoperative use of indwelling epidural catheters or the concomitant use of other medicinal products affecting haemostasis. ||| Meningitis due to the entrance of organisms along the catheter track or inadvertent contamination of the infusion system is a known complication of intrathecal medicinal product administration, especially with external systems. ||| Le risque de ces événements rares peut être augmenté par l’utilisation postopératoire prolongée de cathéters périduraux ou par l’administration concomitante d’autres médicaments agissant sur l’hémostase.
0.5340461134910583 ||| • Replace the big outer needle cap and unscrew the needle. ||| If more than one sponge is used the sponges should overlap. ||| • Replacez le grand capuchon externe de l’aiguille et dévissez l’aiguille.
0.7385375499725342 ||| The frequencies are defined as: uncommon (1/ 1,000 to < 1/ 100). ||| 25 Very common ≥ 10%; Common is normally defined as ≥ 1% and < 10%. ||| Les fréquences sont définies comme suit: peu fréquent (1/ 1 000 à < 1/ 100).
0.34987908601760864 ||| Neutropenia ||| Neutropaenia ||| Neutropénie
0.24514617025852203 ||| Administration of group insurance ||| Administration of insurance claims ||| Administration d'assurances collectives
0.2755265235900879 ||| Serious cardiovascular events, including myocardial infarction and cerebrovascular events have been uncommonly reported during clinical studies with pemetrexed, usually when given in combination with another cytotoxic agent. ||| Arthropathy events, which ranged from mild pain in one or more joints to severe arthritis with effusion and significant disability, have also been reported in patients treated with deferiprone. ||| 5 Des effets cardiovasculaires graves, y compris des infarctus du myocarde, et des effets cérébrovasculaires ont été peu fréquemment rapportés pendant les études cliniques avec le pemetrexed, habituellement lorsque celui -ci est administré en association avec un autre agent cytotoxique.
0.017825957387685776 ||| Periodic visual examinations during Viraferon therapy are recommended particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension. ||| Periodic visual examinations during IntronA therapy are recommended particularly in patients with disorders that may be associated with retinopathy, such as diabetes mellitus or hypertension. ||| Des examens ophtalmologiques périodiques 45 pendant le traitement par Viraferon sont recommandés, particulièrement chez les patients ayant des pathologies pouvant être associées à des rétinopathies telles que le diabète ou l'hypertension.
0.37853318452835083 ||| Improvement in muscle tone occurred within two weeks with the peak effect generally seen within four to six weeks. ||| Reduction of IOP in man starts within approximately 2 hours after administration and maximum effect is reached after 12 hours. ||| L’ amélioration clinique du tonus musculaire s’ observe généralement au cours des deux semaines qui suivent le traitement, avec un effet maximum généralement observé après quatre à six semaines.
0.4326317310333252 ||| Natural fertilizers ||| Liquid explosives ||| Fertilisants naturels
0.253559410572052 ||| If tests are normal at baseline, routine testing is not needed but should be performed if clinical findings of thyroid dysfunction appear (see section 4.8). ||| Prolonged bleeding time has been reported in patients treated with mitotane and this should be taken into account when surgery is considered (see section 4.8). ||| S’ ils sont normaux avant instauration du traitement, des contrôles de routine ne sont pas nécessaires mais devront être pratiqués en cas de symptômes de dysfonctionnement thyroïdien (voir rubrique 4.8).
0.39460843801498413 ||| If you take more Ketek than you should If you accidentally take one tablet too many, nothing is likely to happen. ||| If you take more Revatio than you should You should not take more tablets than your doctor tells you to. ||| Si vous avez pris plus de Ketek que vous n’auriez dû En cas de prise accidentelle d’un comprimé supplémentaire, il est probable qu’aucun effet secondaire ne survienne.
0.09796973317861557 ||| 12 4.3 Contraindications ||| 22 4.3 Contraindications ||| 13 4.3 Contre-indications
0.025193916633725166 ||| 54 6.5 Nature and contents of container ||| 48 6.5 Nature and contents of container ||| 6.5 Nature et contenu de l'emballage extérieur
0.3237594664096832 ||| The efficacy and safety of Levemir were demonstrated in children and adolescents aged 6 to 17 years in studies up to 6 months (see section 5.1). ||| Tolerability of the maximum dose of 20 mg may be lower in elderly patients (≥ 65 years old) (see sections 4.2 and 4.8). ||| L’ efficacité et la tolérance de Levemir o nt été dém ontrées lors d’études d’une durée allant jusqu’à 6 mois chez les enfants et les adolescents de 6 à 17 ans (voir rubrique 5.1).
0.21432703733444214 ||| b) c) ||| c) d) ||| c) 180 jours
0.30708035826683044 ||| The bioavailability of tulathromycin after subcutaneous administration in cattle was approximately 90%. ||| The absolute bioavailability of 100 micrograms of parathyroid hormone after subcutaneous administration in the abdomen is 55%. ||| La biodisponibilité de la tulathromycine après administration sous-cutanée chez les bovins est approximativement de 90%.
0.001015031710267067 ||| To avoid injection of air and ensure proper dosing: • Hold Actraphane 40 NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| To avoid injection of air and ensure proper dosing: • Hold Actraphane 50 NovoLet with the needle pointing upwards • Tap the cartridge gently with your finger a few times. ||| Pour éviter toute injection d’ air et garantir un dosage correct: • Maintenez Actraphane 40 NovoLet en position verticale, aiguille pointée vers le haut • Tapotez doucement la cartouche avec votre doigt plusieurs fois.
0.42655712366104126 ||| - if you are allergic (hypersensitive) to nateglinide or any of the other ingredients of Trazec. ||| including doxycycline or minocycline, or to any of the other ingredients of ORACEA (see section 6.) ||| - si vous êtes allergique (hypersensible) au natéglinide ou à l’ un des autres composants contenus
0.45335763692855835 ||| Vacuum measuring instruments ||| Mould releasing oils ||| Instruments de mesure à vide
0.29929500818252563 ||| A variable but limited decrease in red blood cell-related parameters was observed, together with increases in activated partial thromboplastin time. ||| A marked change in glycaemic control may cause temporary visual impairment, due to temporary alteration in the turgidity and refractive index of the lens. ||| Une diminution variable mais limitée des paramètres liés aux globules rouges a été observée ainsi qu’une augmentation du tempsde thromboplastine partielle activée.
0.01860516518354416 ||| If traces of the transdermal patch remain on the skin after its removal, these can be cleaned off using copious amounts of soap and water. ||| 25 If traces of the transdermal patch remain on the skin after its removal, these can be cleaned off using copious amounts of soap and water. ||| S’ il reste des traces du dispositif transdermique sur la peau après le retrait, on peut les éliminer en utilisant beaucoup de savon et d’ eau.
0.0018090895609930158 ||| There is not enough insulin in the reservoir • you can inject the amount indicated on the injection button from this OptSet and then inject the remaining dose using a new pen, or • you can inject the entire dose using a new pen. ||| There is not enough insulin in the reservoir • you can inject the amount indicated on the injection button from this OptiSet and then inject the remaining dose using a new pen, or • you can inject the entire dose using a new pen. ||| bouton d'injection est d’injection de cet OptiSet, puis utiliser un nouveau stylo inférieure à la dose pour injecter la dose restante, ou sélectionnée
0.13529472053050995 ||| 41 This leaflet was last approved in MM/YYYY ||| This leaflet was last approved on MM/ YYYY ||| La dernière date à laquelle cette notice a été approuvée est
0.4250198304653168 ||| Anti-cancer preparations of plant origin ||| Antiparasitic preparations from plant sources ||| Produits contre le cancer d’origine végétale
0.44540002942085266 ||| Heavy jackets ||| Champagne buckets ||| Grosses vestes
0.5763640999794006 ||| 9 Presentations ||| 17 Investigations ||| c) 9 Présentations
0.38067513704299927 ||| Care should be taken if you drink alcohol while you are being treated with XERISTAR. ||| Wash your hands after applying Protopic unless your hands are also being treated. ||| Vous devez être très prudent en cas de prise d'alcool pendant votre traitement par XERISTAR.
0.22117486596107483 ||| Polska KRKA Polska Sp.z.o.o ||| Polska MSD Polska Sp.z o.o. ||| KRKA Polska Sp.z.o.o
0.6828020811080933 ||| On 26 February, Georgia confirmed its first COVID-19 case. ||| The CVMP adopted its opinion at its September 2001 meeting. ||| Le 26 février, la Géorgie a confirmé son premier cas de COVID-19.
0.003828035667538643 ||| 114 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| 42 In patients with chronic renal failure and clinical evidence of ischaemic heart disease or congestive heart failure, the target haemoglobin should be determined individually. ||| pl Chez les patients insuffisants rénaux chroniques présentant des manifestations cliniques d'ischémie myocardique ou d'insuffisance cardiaque congestive, le taux d'hémoglobine à atteindre doit être st déterminé individuellement.
0.33006471395492554 ||| Extra vigilance is warranted in patients with chronic hepatitis B or hepatitis C co-infection, as these patients have an increased risk of hepatotoxicity. ||| Such situations may result in severe hypoglycaemia (and possibly loss of consciousness) prior to the patient's awareness of hypoglycaemia. ||| Une vigilance particulière est recommandée chez les patients présentant une co-infection chronique par l’ hépatite B ou C en raison du risque accru d’ hépatotoxicité.
0.13921603560447693 ||| VIAL TEXT Fertavid 200 IU/ 0.5 ml ||| VIAL TEXT Puregon 100 IU/ 0.5 ml ||| TEXTE DU FLACON Fertavid 200 UI/ 0,5 ml
0.07781004905700684 ||| The marketing authorisation was renewed on 5 February 2003 and on 5 February 2008. ||| The marketing authorisation was renewed on 12 March 2004 and on 12 March 2009. ||| L’ autorisation de mise sur le marché a été renouvelée le 5 février 2003 et le 5 février 2008.
0.007041858974844217 ||| 98 Following transfer from an animal insulin to human insulin, dosage reduction may be required in particular in patients who ||| 77 Following transfer from an animal insulin to human insulin, dosage reduction may be required in particular in patients who ||| 99 Après passage d'une insuline animale à une insuline humaine, une réduction de la posologie peut être nécessaire, en particulier chez les patients:
0.3244580626487732 ||| Pharyngitis Rhinitis, sinusitis, epistaxis, nasal irritation, rhinorrhea, dry throat, hyposmia ||| Uncommon: intracranial haemorrhage, migraine, tremor, hypoaesthesia, hyperaesthesia. ||| Rhinite, sinusite, épistaxis, irritation nasale, Peu fréquents: rhinorrhée, sécheresse de la gorge, hyposmie Affections gastro-intestinales Anorexie, constipation Fréquents:
0.702400803565979 ||| • Conduct of bioequivalence studies in animals (ditto, p. ||| Investigations Injury, poisoning *Cross refer to Section 4.4. ||| 31) • Conduite d’études de bioéquivalence sur des animaux (idem, p.
0.439192533493042 ||| Patients with Hunter syndrome do not produce an enzyme called iduronate-2-sulfatase. ||| Other conditions with stimulation of the renin-angiotensin-aldosterone system: ||| Les patients atteints du syndrome de Hunter ne produisent pas l’ enzyme iduronate-2-sulfatase.
0.27489352226257324 ||| Eesti UCB Pharma Oy Finland Tel: +358-(9) 2290 100 ||| Eesti Pfizer Animal Health Tel: +370 5 269 17 96 ||| 132 Eesti Österreich UCB Pharma Oy Finland Tel: +358-(9) 2290 100
0.25003987550735474 ||| If someone is accidentally injected with this product, they must seek immediate medical advice even if only a very small amount is injected. ||| If someone is accidentally injected with even a very small amount of this product, they must seek medical advice immediately and the Package Leaflet should be shown to the doctor. ||| Toute personne subissant une injection accidentelle de ce produit doit immédiatement demander un avis médical, même si la quantité injectée est très faible.
0.23840337991714478 ||| Since telbivudine is eliminated primarily by renal excretion, co-administration of Sebivo with substances that affect renal function (such as aminoglycosides, loop diuretics, platinum compounds, vancomycin, amphotericin B) may affect plasma concentrations of telbivudine and/ or the co- administered substance. ||| Because fluoxetine’ s metabolism (like tricyclic antidepressants and other selective serotonin antidepressants) involves the hepatic cytochrome CYP2D6 isoenzyme system, concomitant therapy with drugs also metabolised by this enzyme system may lead to drug interactions. ||| La telbivudine étant essentiellement éliminée par excrétion rénale, une coadministration de Sebivo avec des médicaments altérant la fonction rénale (tels que les aminoglycosides, les diurétiques de l’ anse, les dérivés du platine, la vancomycine, l’ amphotéricine B) peut modifier les concentrations plasmatiques de la telbivudine et/ ou des médicaments coadministrés.
0.17519935965538025 ||| 20/ 61 ||| 30/ 61 ||| 22/ 65
0.39551591873168945 ||| These may be symptoms of a serious allergic reaction (hypersensitivity), which may become life threatening. ||| Thereby, increasing the risk of serious haematologic abnormalities, or other serious adverse effects from these agents. ||| Il peut s’agir des symptômes liés à une réaction allergique grave (hypersensibilité), pouvant mettre votre vie en péril.
0.2625506520271301 ||| The extent to which these outcomes might apply to the administration of recombinant human erythropoietin to patients with cancer, treated with chemotherapy to achieve haemoglobin concentrations less than 13 g/ dl, is unclear because few patients with these characteristics were included in the data reviewed. ||| Although not all effects of ketoprofen are covered by thromboxane activity (ketoprofen also has lipooxygenase activity), thromboxane activity is a sensitive parameter, not only for evaluating inflammation in this experimental model, but also for allowing extrapolation to the field condition up to a certain point. ||| Toutefois, il n’ est actuellement pas possible d’ établir l’ importance de ce risque en cas d’ administration d’ érythropoïétine humaine recombinante chez les patients cancéreux sous chimiothérapie pour atteindre des taux d’ hémoglobine inférieurs à 13 g/ dl, en raison du trop faible nombre de patients ayant ces caractéristiques dans les données analysées.
0.01570311188697815 ||| 50 IU/kg 3 times per week by the intravenous route. ||| 50 IU/ kg 3 times per week by the intravenous route. ||| 50 UI/ kg 3 fois par semaine, par voie intraveineuse.
0.6070589423179626 ||| Tulathromycin may cause sensitisation by skin contact. ||| Resistant E. coli may then spread between people. ||| La tulathromycine peut provoquer des irritations cutanées.
0.4967249035835266 ||| The use of Galvus in children and adolescents is not recommended. ||| Kuvan can be used in adults and children. ||| L'utilisation de Galvus chez l'enfant et les adolescents n’ est pas recommandée.
0.31307971477508545 ||| If acidosis of either form occurs, Velmetia must be stopped immediately and other appropriate corrective measures initiated. ||| If mild or moderate acute infusion reactions occur, medical attention must be sought immediately and appropriate actions instituted. ||| En cas de survenue d’ une forme quelconque d’ acidose, Velmetia doit être arrêté immédiatement et d’ autres mesures correctives appropriées doivent être mises en place.
0.6151090860366821 ||| Removal ||| Sweating ||| Retrait
0.42871910333633423 ||| Antitumour activity was demonstrated primarily in patients with neuroblastoma. ||| Nervous system undesirable effects occur in approximately 40% of patients. ||| L'activité antitumorale a été démontrée principalement chez les patients ayant un neuroblastome.
0.6491209268569946 ||| In some cases manifestations of toxicity have occurred. ||| As a result the metastases may become bigger. ||| Dans certains cas, des signes de toxicité sont apparus.
0.019471637904644012 ||| 10 ml solution in a vial (type 1 colourless glass) with a flanged cap (aluminium), (type 1, laminate of polyisoprene and bromobutyl rubber) a stopper and a tear-off cap (polypropylene). ||| 10 ml solution in a vial (type 1 colourless glass) with a flanged cap (aluminium), a stopper (type 1, laminate of polyisoprene and bromobutyl rubber) and a tear-off cap (polypropylene). ||| Solution en flacon de 10 ml (en verre incolore de type 1), avec un sertissage (en aluminium), un bouchon (en caoutchouc laminé polyisoprène et bromobutyl (type 1)) et un opercule détachable (en polypropylène).
0.6767765283584595 ||| On 26 May 2005, the CHMP agreed on the need to convene an Ad Hoc Expert Group Meeting on Hepatitis short and long-term protection afforded by recombinant Hepatitis B vaccines. ||| CVW-8 and Theodore Roosevelt participated in Joint Task Force Exercise 08-4 Operation Brimstone off the coast of North Carolina between 21 and 31 July 2008. ||| Le 26 mai 2005, le CHMP a jugé nécessaire de réunir un groupe d’ experts ad hoc sur la protection à court terme et long terme contre l’ hépatite conférée par les vaccins recombinants contre l’ hépatite B.
0.3893035650253296 ||| In human volunteers, a dose-dependent decrease in prolactin was observed. ||| However, an increased rate of fused sternebrae was observed. ||| Chez les volontaires, on a noté une diminution dose-dépendante de la sécrétion de prolactine.
0.23471632599830627 ||| More than 97% of meloxicam is bound to plasma proteins. ||| Approximately 62% of palonosetron is bound to plasma proteins. ||| La liaison du méloxicam aux protéines plasmatiques est d’ environ 97%.
0.2922053337097168 ||| Please tell your doctor or pharmacist if you are now or have recently taken: • rifampicin (a medicine used to treat some infections such as tuberculosis) • medicines used to treat stomach ulcer or heartburn (e. g., omeprazole, cimetidine, ranitidine) • any other medicines with or without a prescription. ||| Taking other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, particularly medicines that may cause skin problems when the skin comes under strong light (for example some types of medicines called antibiotics), but also medicines obtained without prescription (for example hypericin or Saint John’ s wort extracts). ||| Informez votre médecin ou votre pharmacien si vous prenez ou avez pris récemment: • de la rifampicine (un médicament utilisé dans le traitement de certaines infections comme la tuberculose) • des médicaments utilisés dans le traitement des ulcères gastriques ou des brûlures d'estomac (tels que: oméprazole, cimétidine, ranitidine) • tout autre médicament obtenu avec ou sans ordonnance.
0.0 ||| (iv) Safeguards for banks that channel State aid to the real economy: Some Member States plan to build on banks' existing lending capacities, and use them as a channel for support to businesses - in particular to small and medium-sized companies. ||| (iv) Safeguards for banks that channel State aid to the real economy: Some Member States plan to build on banks' existing lending capacities, and use them as a channel for support to businesses - in particular to small and medium-sized companies. ||| aides sous forme de garanties pour les banques qui acheminent les aides d'État vers l'économie réelle: certains États membres envisagent de s'appuyer sur les capacités de prêt existantes des banques et de les utiliser pour acheminer le soutien vers les entreprises, en particulier les petites et moyennes entreprises.
0.23043431341648102 ||| Rapilysin contains the active substance reteplase. ||| Metalyse contains the active substance tenecteplase. ||| Le principe actif de Rapilysin est le retéplase.
0.0 ||| THE WORDS "FOR ANIMAL TREATMENT ONLY" ||| THE WORDS "FOR ANIMAL TREATMENT ONLY" ||| LA MENTION « À USAGE VÉTÉRINAIRE »
0.09386485069990158 ||| Any person intending to import, sell, supply and/ or use the veterinary medicinal product must consult the relevant Member State’ s Competent Authority on the current vaccination policies prior to the import, sale, supply and/ or use ||| Any person intending to import, sell, supply and/ or use Porcilis AR-T DF must consult the relevant Member State’ s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use. ||| Toute personne souhaitant importer, vendre, délivrer et/ ou utiliser ce médicament vétérinaire doit au préalable consulter les autorités compétentes de l’ Etat membre concernant les politiques actuelles de vaccination.
3.295998456803728e-13 ||| If two different insulins have to be drawn into one single injection syringe, it is recommended that the shorter-acting insulin be drawn first to prevent contamination of the vial by the longer-acting preparation. ||| If two different insulins have to be drawn into one single injection syringe, it is recommended that the shorter-acting insulin be drawn first to prevent contamination of the vial by the longer-acting preparation. ||| Si deux insulines différentes doivent être aspirées dans la même seringue d’ injection, il est recommandé d'aspirer d'abord l'insuline à durée d'action plus courte afin d'éviter la contamination du flacon par la préparation à durée d'action plus longue.
0.3385334014892578 ||| Generally, delayed type reactions such as contact dermatitis may occur, but rarely immediate reactions with bronchospasm may occur. ||| Typically, these lesions are mild and resolve without treatment, but oral lesions may be associated with salivation and labial and tongue oedema. ||| Généralement, des réactions de type retardé telles que des dermatites de contact peuvent survenir, mais rarement des réactions de type immédiat avec bronchospasme peuvent apparaître.
0.6328636407852173 ||| Rotation measuring sensors ||| Laser scanning densitometers ||| Capteurs de mesure de rotation
0.11179495602846146 ||| [84; 96.3] ||| [84;96.3] ||| [84; 96,3]
0.10513517260551453 ||| Serum electrolytes should be monitored in chronic renal failure patients. ||| 46 electrolytes should be monitored in chronic renal failure patients. ||| L’ ionogramme sanguin doit être contrôlé chez les insuffisants rénaux chroniques.
0.07178446650505066 ||| Store at 2°C – 8°C (in a refrigerator), protected from light. ||| Store and transport at 2°C – 8°C (in a refrigerator), protected from light. ||| A conserver entre +2ºC et +8ºC (au réfrigérateur), à l’ abri de la lumière.
0.34817272424697876 ||| Injection into an IV line delivering glucose 50 g/ l (5%) in Ringer-Lactate solution for injection, or other IV fluids not listed in 6.6, is not recommended as this may cause precipitation from solution. ||| IV line solution compatibility After reconstitution with acceptable solvents, Dynastat may only be injected IV or IM, or into IV lines delivering: sodium chloride 9 mg/ ml (0.9%) solution ||| L’ injection dans les tubulures de perfusion délivrant du glucose à 50 g/ l (5%) dans une solution de Ringer-Lactate pour injection, ou d’ autres solutions IV non listées en 6.6, n’ est pas recommandée du fait d’ une précipitation possible de la solution.
0.14564330875873566 ||| ed If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| d If you hav e any further questions about how to use this product, ask your doctor or pharmacist. ||| Si vous avez d’autres questions sur l’utilisation de ce médicament, demandez plus d’informations à votre médecin ou à votre pharmacien. tn en
0.19366787374019623 ||| Each prolonged-release tablet contains 12 mg of paliperidone. ||| Each prolonged-release tablet contains 750 mg ranolazine. ||| Chaque comprimé à libération prolongée contient 12 mg de palipéridone.
0.39900967478752136 ||| Owing to the greater sensitivity of this population, a lower starting dose should be considered when clinical factors warrant (see section 4.4). ||| Even though the recovery times in elderly tend to be slower, the same dose recommendation as for adults should be followed (see section 4.4). ||| En raison d'une sensibilité plus grande de cette population, une dose initiale plus faible doit être envisagée lorsque des raisons cliniques le justifient (voir rubrique 4.4).
0.23394708335399628 ||| For the same reason, concomitant administration of both a potent CYP3A4 inhibitor (such as ketoconazole, itraconazole and ritonavir) and a CYP2C9 inhibitor (such as voriconazole) with Tracleer is not recommended (see section 4.4). ||| Co-administration of sirolimus with strong inhibitors of CYP3A4 (such as ketoconazole, voriconazole, itraconazole, telithromycin or clarithromycin) or inducers of CYP3A4 (such as rifampin, rifabutin) is not recommended (see section 4.5). ||| Pour ces mêmes raisons, l’ administration concomitante d’ un inhibiteur puissant du CYP3A4 (tel que le kétoconazole, l’ itraconazole et le ritonavir) et d’ un inhibiteur du CYP2C9 (tel que le voriconazole) au cours d’ un traitement par Tracleer n’ est pas recommandée (voir rubrique 4.4).
0.12357687950134277 ||| STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS ||| STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) ||| LISTE DU (DES) SUBSTANCE(S) ACTIVE(S) ET AUTRE(S) INGRÉDIENT(S)
0.059369172900915146 ||| What benefit has Privigen shown during the studies? ||| What benefit has Circovac shown during the studies? ||| Quel est le bénéfice démontré par Privigen au cours des études?
0.3757314085960388 ||| If you receive Erbitux in combination with other anticancer medicines, these medicines must be administered at least 1 hour after the end of the Erbitux infusion. ||| When Rotarix is given to your child for the first dose, it is recommended that your child also receives Rotarix (and not another rotavirus vaccine) for the second dose. ||| Si vous prenez Erbitux en association avec d’ autres médicaments anticancéreux, ces médicaments doivent être administrés au moins une heure après la fin de la perfusion d’ Erbitux.
0.3179666996002197 ||| Metacam 0.5 mg/ ml oral suspension for dogs ||| 47/ 125 Metacam 15 mg/ ml oral suspension for horses ||| Metacam 0,5 mg/ ml suspension orale pour chiens
0.3862743377685547 ||| These side effects will depend on the medicine being used, and they will be described in the Package Leaflet of the medicine labelled with Yttriga. ||| The following Adverse Reactions listed in the Table below have been accumulated in clinical studies with Axura and since its introduction in the market. ||| Ces effets dépendent du médicament utilisé et sont décrits dans la notice du médicament radiomarqué par Yttriga.
0.32064926624298096 ||| In 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/ day was not associated with any distinguishing profile of adverse events. ||| A comparison of results show that a 1 g once daily dose of ertapenem achieves a pharmacokinetic profile in patients 13 to 17 years of age comparable to that of adults. ||| Chez 44 patients schizophrènes et âgés de plus de 65 ans, des doses de 5 à 20 mg par jour n’ ont pas été associées à un profil d’ effets indésirables particulier.
0.313411682844162 ||| The incidence and severity of teratogenic effects increased with escalation of the dose. ||| The incidence of these symptoms decreased markedly with subsequent doses of Aclasta. ||| L’ incidence et la sévérité de ces effets tératogènes ont augmenté avec la dose.
0.026507684960961342 ||| 97 Lietuva Novartis Pharma Services Inc. ||| 139 Lietuva Novartis Pharma Services Inc. ||| Lietuva Novartis Pharma Services Inc.
0.021010015159845352 ||| 251 In patients with severe hepatic impairment, insulin requirements may be diminished due to reduced capacity for gluconeogenesis and reduced insulin metabolism. ||| In patients with severe hepatic impairment, insulin requirements may be diminished due to reduced capacity for gluconeogenesis and reduced insulin metabolism. ||| En cas d'insuffisance hépatique sévère, les besoins en insuline peuvent être diminués en raison d'une réduction de la capacité de néoglycogenèse et d'une réduction du métabolisme de l'insuline.
0.24261540174484253 ||| Erbitux is used to treat the following types of cancer: • metastatic cancer of the colon or rectum (lower intestine or large bowel). ‘ Metastatic ’ means that the cancer has spread to other parts of the body. ||| Xeloda is used with or without other anticancer medicines in patients who have had surgery for ‘ stage III’ or ‘ Dukes’ stage C’ colon cancer; • metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body). ||| Erbitux est utilisé pour le traitement des types de cancer suivants: • cancer métastatique du côlon ou du rectum (partie inférieure de l’ intestin ou gros intestin). « Métastatique » signifie que le cancer s’ est propagé à d’ autres parties du corps.
0.32644158601760864 ||| Care must be taken to ensure that no area of tissue receives more than the specified light dose. ||| Particular caution should be paid to ensure that it is not injected into a blood vessel. ||| Il faut s’ assurer qu’ aucune zone tissulaire ne reçoit plus que la dose de lumière spécifiée.
0.36603251099586487 ||| Patients with severe dyspnoea at rest due to complications of advanced malignancy or requiring supplementary oxygen therapy. ||| Treatment of advanced idiopathic Parkinson’s disease with severe motor fluctuations and not responding to oral treatment ||| Patients présentant une dyspnée de repos sévère en rapport avec des complications liées au stade avancé de la maladie ou oxygénodépendants.
0.36599022150039673 ||| Abdominal pain/ discomfort Oily spotting from the rectum Flatus with discharge Faecal urgency Fatty/ oily stool Flatulence Liquid stools Oily evacuation Increased defecation ||| Headache Dizziness Numbness and tingling Problems with sense of taste Nausea (feeling sick) Widening of blood vessels Injection site pain Injection site reaction ||| Douleur/ gêne abdominale Trace de graisse au niveau anal Gaz avec suintement Selles impérieuses Selles grasses/ huileuses Flatulence Selles liquides Emissions de graisse Selles abondantes
0.0 ||| Keep the vial in the outer carton in order to protect from light. ||| Keep the vial in the outer carton in order to protect from light. ||| Conserver le flacon dans l'emballage extérieur, à l'abri de la lumière.
0.02550632134079933 ||| 103 6.6 Special precautions for disposal and other handling ||| 70 6.6 Special precautions for disposal and other handling ||| 6.6 Précautions particulières d’ élimination et manipulation
0.5644701719284058 ||| It releases pressure on the whole aviation industry and in particular on smaller airlines. ||| Finnair does not hold a significant market power on the relevant markets on which it operates. ||| Elle diminuera, en effet, la pression exercée sur l'ensemble de ce secteur et, en particulier, sur les compagnies aériennes de taille plus modeste.
0.10984015464782715 ||| Luveris is provided as a powder and solvent for solution for injection. ||| Luveris is a powder and solvent for solution for injection. ||| Luveris est présenté sous forme de poudre et solvant pour solution injectable.
0.16099384427070618 ||| Please ask the doctor for advice before stopping the treatment. ||| Please ask your doctor for advice before stopping treatment. ||| Demandez l’avis de votre médecin avant de mettre fin au traitement.
0.35723626613616943 ||| Women of childbearing potential have to use effective contraception during treatment. ||| Young men and women must use effective contraception during and after treatment. ||| Les femmes en âge de procréer doivent utiliser une contraception efficace pendant le traitement.
0.4651631712913513 ||| If you notice any symptoms of infection, please tell your doctor at once. ||| If you do not see any benefit after using it f or 4 months contact your doctor. ||| Si vous remarquez des symptômes d’ infection, veuillez en informer votre médecin immédiatement.
0.0 ||| 7. ||| 7. ||| 209 7.
0.4569483995437622 ||| Do not use Aldara cream for more than 16 weeks in the treatment of each episode of warts. ||| need to stop taking Efficib for a couple of days before and after the procedure ||| N’utilisez pas Aldara crème plus de 16 semaines pour le traitement de chaque épisode de verrues.
0.022563468664884567 ||| MIRAPEXIN is indicated for treatment of the signs and symptoms of idiopathic Parkinson’ s disease, alone (without levodopa) or in combination with levodopa, i. e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “ on off” fluctuations). ||| Pramipexole Teva is indicated for treatment of the signs and symptoms of idiopathic Parkinson's disease, alone (without levodopa) or in combination with levodopa, i. e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or “ on off ” fluctuations). ||| MIRAPEXIN est indiqué pour le traitement des symptômes et signes de la maladie de Parkinson idiopathique, en monothérapie (sans lévodopa) ou en association à la lévodopa, quand lorsqu’ au cours de l’ évolution de la maladie, au stade avancé, l’ effet de la lévodopa s’ épuise ou devient inconstant et que des fluctuations de l’ effet thérapeutique apparaissent (fluctuations de type fin de dose ou effets "on-off").
0.3440110683441162 ||| Dose adjustments of sildenafil may be required when co-administered with CYP3A4 inducers (see section 4.5). ||| A dose-adjustment may be necessary for drugs metabolised by CYP2D6 and that are individually dose titrated. ||| Des ajustements de la posologie du sildénafil peuvent être nécessaires lors de l’ administration concomitante avec des inducteurs du CYP3A4 (voir rubrique 4.5).
0.5478124022483826 ||| The Member states competent Authorities will continue to keep the product under regular review. ||| The marketing Authorisation holder will continue to submit periodic safety update reports on a 2- year cycle. ||| Les autorités compétentes des États-membres doivent continuer à mener des examens réguliers sur ce produit.
3.5290439190718836e-13 ||| Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively. ||| Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively. ||| Le diabète de type 2 est une maladie dans laquelle le pancréas ne fabrique pas assez d’ insuline pour contrôler le niveau de glucose dans le sang ou lorsque le corps est incapable d’ utiliser l’ insuline de manière efficace.
0.21503551304340363 ||| Rental of apparatus and installations in the field of medical technology ||| Testing of apparatus in the field of electrical engineering for certification purposes ||| Location d'appareils et d'installations dans le domaine de la technologie médicale
0.003922974690794945 ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8°C, unless reconstitution has taken place in controlled and validated aseptic conditions. ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 °C, unless reconstitution has taken place in controlled and validated aseptic conditions. ||| S’ il n’ est pas utilisé immédiatement, les conditions de durée de conservation avant utilisation sont sous la responsabilité de l’ utilisateur et ne devraient normalement pas dépasser 24 heures entre 2 et 8°C, sous réserve que la reconstitution ait été effectuée dans des conditions d’ asepsie contrôlées et validées.
0.017038431018590927 ||| How to store {PRODUCT NAME} 20 mg 6. ||| How to store {PRODUCT NAME} 40 mg 6. ||| Comment conserver {NOM DU PRODUIT} 20 mg 6.
0.15565037727355957 ||| Retacrit has no or negligible influence on the ability to drive and use machines. ||| Tekturna has negligible influence on the ability to drive and use machines. ||| Retacrit n’ a aucun effet ou qu’ un effet négligeable sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.13339652121067047 ||| How is Coaprovel used? ||| How is Aprovel used? ||| Comment Coaprovel est -il utilisé?
0.8774468898773193 ||| The CPMP having considered: ||| The CVMP has also requested scientific ||| Le CPMP ayant pris connaissance des éléments suivants:
0.2790381908416748 ||| If you have or had any medical problems or any allergies or if you are not sure as to whether you can use piroxicam tell your doctor before using this medicine. ||| If you currently have or have previously had problems with your kidneys, talk to your doctor or hospital pharmacist as you may not be able to receive ALIMTA. ||| Si vous présentez ou avez présenté des problèmes médicaux ou des allergies, ou si vous n’ êtes pas sûr de pouvoir prendre du piroxicam, veuillez en informer votre médecin avant d’ utiliser ce médicament.
0.47235798835754395 ||| Depending on your response, your doctor may increase the dose to 40 mg every week. ||| If necessary, your doctor or nurse may give you another injection at least 4 weeks later. ||| En fonction de votre réponse au traitement, votre médecin pourra augmenter la dose à 40 mg par dic
0.22613686323165894 ||| Why has ReFacto AF been approved? ||| Why has RoActemra been approved? ||| Pourquoi ReFacto AF a -t-il été approuvé?
0.8475531339645386 ||| Oral topotecan ||| Caustic alkali ||| topotécan
0.2715526223182678 ||| 1 vial contains 250 mg bivalirudin. ||| After dilution 1 ml contains 5 mg bivalirudin. ||| 1 flacon contient 250 mg de bivalirudine.
0.4154547452926636 ||| There should be an interval of at least 1 month between doses. ||| Dosage increases can be made at intervals of 2 weeks or more. ||| Un intervalle d'au moins 1 mois doit être respecté entre chaque dose.
0.011793764308094978 ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, unless dilution has taken place in controlled and validated aseptic conditions. ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 °C to 8 °C, unless dilution has taken place in controlled and validated aseptic conditions. ||| S'il n'est pas utilisé immédiatement, la durée et les conditions de conservation du produit sont sous la seule responsabilité de l'utilisateur; la durée de conservation ne doit normalement pas dépasser 24 heures à une température comprise entre 2°C et 8°C, à moins que la reconstitution ait été effectuée sous conditions aseptiques validées et contrôlées.
0.22876465320587158 ||| When an optimal response is obtained, a single injection of 250 micrograms r-hCG or 5 000 IU up to 10 000 IU hCG should be administered 24-48 hours after the last GONAL-f and lutropin alfa injections. ||| Then a single injection of a medicine used to induce final follicular maturation and containing 250 micrograms r-hCG or 5000 IU up to 10 000 IU human chorionic gonadotrophin (hCG) is administered 24-48 hours after the last GONAL-f injection. ||| Quand une réponse optimale est obtenue, une injection unique de 250 microgrammes de r-hCG ou de 5.000 à 10.000 UI d’ hCG devra être administrée 24 à 48 heures après les dernières injections de GONAL-f et de lutropine alfa.
0.8879656791687012 ||| 70x1 tablets ||| 2 x 5 pens ||| 70x1 comprimés 84 comprimés
0.21007505059242249 ||| The company also presented the results of a study looking at the effects of Retacrit injected subcutaneously in 261 cancer patients taking chemotherapy. ||| Three further studies from the published scientific literature looked at the effects of adding MabThera to other types of chemotherapy in a total of 1,347 patients. ||| La société a également présenté les résultats d’ une étude recherchant les effets de Retacrit injecté par voie sous-cutanée chez 261 patients atteints de cancer traités par chimiothérapie.
0.22620932757854462 ||| Polyethylene bottle containing 15 or 30 ml with a polyethylene dropper, a tamper proof child resistant closure and a polypropylene measuring syringe. ||| Pre-filled oral syringes made of polypropylene, with a polyethylene cap, a rubber rod tip, and a polypropylene plunger rod. ||| Flacon de polyéthylène avec bouchon de sécurité enfant, de contenance de 15 ou 30 ml et muni d'un compte-goutte en polyéthylène et d'une seringue-doseuse en polypropylène.
0.2676059603691101 ||| The results of the 48 week analysis of the South African study BI 1100.1368 confirmed that the 4/ 7 mg/ kg and 150 mg/ m2 nevirapine dose groups were well tolerated and effective in treating antiretroviral naïve paediatric patients. ||| APV20002 is a 48 week, Phase II, open label study designed to evaluate the pharmacokinetics, safety, tolerability and antiviral activity of fosamprenavir with and without ritonavir in paediatric subjects 4 weeks to < 2 years of age. ||| Les résultats de l’ analyse à 48 semaines de l’ étude BI 1100.1368 conduite en Afrique du Sud ont confirmé que les doses de névirapine de 4/ 7 mg/ kg et de 150 mg/ m2 étaient bien tolérées et efficaces pour le traitement de la population pédiatrique naïve de traitement antirétroviral.
0.0 ||| 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use ||| 3 4.4 Mises en garde spéciales et précautions d’ emploi
0.4016774892807007 ||| Since NSAIDs and rosiglitazone are associated with fluid retention, concomitant administration may increase the risk of oedema. ||| This is often referred to as MLSB resistance as it affects macrolides, lincosamides and streptogramins. ||| Les AINS et la rosiglitazone pouvant entraîner des rétentions hydriques, leur administration concomitante peut accroître le risque d’œ dème.
2.818915348541673e-13 ||| If skin or eye symptoms persist, or the product is accidentally swallowed, seek medical attention and show the package insert to the physician. ||| If skin or eye symptoms persist, or the product is accidentally swallowed, seek medical attention and show the package insert to the physician. ||| Si une irritation oculaire ou cutanée persiste, ou en cas d’ingestion accidentelle du produit, prenez immédiatement conseil auprès de votre médecin et montrez lui la notice.
0.1490139365196228 ||| They both work in similar ways by blocking the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| All three active substances block the activity of reverse transcriptase, an enzyme produced by HIV that allows it to infect cells and make more viruses. ||| Ils agissent tous deux de façon similaire en bloquant l’ activité de la transcriptase inverse, une enzyme synthétisée par le VIH lui permettant d’ infecter les cellules et de produire davantage de virus.
0.08485937118530273 ||| Paediatric population - Fondaparinux is not recommended for use in children below 17 years of age due to a lack of data on safety and efficacy ||| Paediatric population Januvia is not recommended for use in children below 18 years of age due to a lack of data on its safety and efficacy. ||| Pédiatrie - L’ utilisation du fondaparinux n’ est pas recommandée chez l’ enfant de moins de 17 ans, étant donné l’ insuffisance des données de tolérance et d’ efficacité.
0.3388814330101013 ||| In our efforts to mitigate the economic impacts of the COVID-19 pandemic, the Commission has today published guidelines to ensure EU passenger rights are applied in a coherent manner across the EU. ||| The EU commended the Republic of Korea's proactive and innovative steps to prevent and tackle COVID-19 in a transparent, open and democratic way. ||| Dans le cadre de nos efforts destinés à atténuer les répercussions économiques de la pandémie de COVID-19, la Commission a publié aujourd'hui des orientations ayant pour objet de garantir l'application cohérente des droits des passagers de l'UE dans l'ensemble de l'Union.
0.2595539689064026 ||| The European Commission has approved a Polish recapitalisation scheme of up to €1.65 billion (PLN 7.5 billion) to support large enterprises and certain larger small and medium-sized enterprises (SMEs) in the context of the coronavirus outbreak. ||| The European Commission has approved a €100 million Italian State aid scheme to support small and medium-sized enterprises (SMEs) in the agricultural, forestry, fishery and aquaculture sectors in the context of the coronavirus outbreak. ||| La Commission européenne a autorisé un régime polonais de recapitalisation d'un montant maximal de 1,65 milliard d'euros (7,5 milliards de PLN) au soutien de grandes entreprises et de certaines grandes PME, dans le contexte de la pandémie de COVID-19.
0.254759818315506 ||| Anaphylactoid reactions have been reported in patients dialysed with high flux membranes, and treated concomitantly with an ACE inhibitor. ||| Humira is indicated for the treatment of adults with severe active ankylosing spondylitis who have had an inadequate response to conventional therapy. ||| Des réactions anaphylactoïdes ont été rapportées chez les patients dialysés avec des membranes de haute perméabilité, et traités concomitamment par un IEC.
0.46581530570983887 ||| FORSTEO has not been studied in patients with active urolithiasis. ||| Anaphylaxis has been reported during administration of CANCIDAS. ||| FORSTEO n'a pas été étudié chez les patients ayant une lithiase urinaire évolutive.
0.35597527027130127 ||| If both plasma concentrations are below 0.02 mg/ l, and after a waiting period of at least 3 months, the risk of foetal toxicity is very low. ||| Treatment discontinuation should also be considered if the muscular symptoms are severe and cause daily discomfort, even if the CK increase remains ≤ 5 x ULN. ||| Si dans les deux dosages, les concentrations plasmatiques sont inférieures à 0,02 mg/ l, et après une période d’ attente d’ au moins 3 mois, le risque de toxicité fœ tale est très faible.
0.31964415311813354 ||| Many patients had confounding medical conditions, some of which required therapy with agents that have been associated with the development of diabetes mellitus or hyperglycaemia. ||| This is particularly important in those who have reduced or absent awareness of the warning symptoms of hypoglycaemia or have frequent episodes of hypoglycaemia. ||| De nombreux patients présentaient des pathologies associées, dont certaines ont nécessité un traitement pouvant entraîner la survenue d’ un diabète ou d’ une hyperglycémie.
0.3761846423149109 ||| Do not use Yttriga: ||| Do not use Kentera: ||| N’ utilisez jamais Yttriga
4.492025783460474e-13 ||| 4 ||| 4 ||| 68
0.41582316160202026 ||| Janssen-Cilag AB Box 7073 192 07 Sollentuna Sverige ||| Novartis Sverige AB Box 1150 183 11 Täby Sweden ||| Janssen-Cilag AB, Box 7073 192 07 Sollentuna Suède
0.341233491897583 ||| A Phase IV randomised, multicentre, double-blind study was conducted to compare the efficacy of NeuroBloc (10,000 U) to Botulinum Toxin Type A (150 U) in patients with cervical dystonia who have never previously received a botulinum toxin product. ||| In September 2004, the Marketing Authorisation Holder (MAH) of rofecoxib (a selective Cox-2- inhibitor) informed the EMEA that new clinical trial (APPROVe) data for rofecoxib have revealed a risk of thrombotic cardiovascular (CV) events. ||| Une étude multicentrique de Phase IV, randomisé, en double aveugle, a été conduite afin de comparer l’ efficacité de NeuroBloc (10 000 U) par rapport à la Toxine Botulique de type A (150 U) chez les patients atteints de dystonie cervicale n’ ayant jamais reçu de produit à base de toxine botulique.
0.09333209693431854 ||| 16 Nervous system disorders ||| 18 Nervous system disorders ||| Affections du système nerveux
0.27453526854515076 ||| Children between 15 days and 12 years old 20-80mg for each kg of body weight once a day, injected into a vein More than 80mg per kg must not be given, even in severe infections-except in meningitis. ||| Adults and adolescents of 12 years of age and older (greater than 50 kg body weight): the recommended dose of Agenerase capsules is 600 mg twice daily with ritonavir, 100 mg twice daily, in combination with other antiretroviral agents. ||| Enfants âgés de 15 jours à 12 ans 20-80 mg par kg de poids et par jour en une fois, par injection intraveineuse La dose ne doit pas dépasser 80 mg par kg, même en cas d’infections sévères – excepté en cas de méningites.
0.20613911747932434 ||| * produced in Chinese Hamster Ovary cells (CHO) by recombinant DNA technology ||| * Human Osteogenic protein produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology ||| * produite sur une lignée de cellules d’ Ovaire de Hamster Chinois par la technique de l’ ADN recombinante
0.22253316640853882 ||| In 865 patients with leukaemia treated with dasatinib in Phase II clinical trials, the mean changes from baseline in QTc interval using Fridericia's method (QTcF) were 4 - 6 msec; the upper 95% confidence intervals for all mean changes from baseline were < 7 msec (see section 4.8). ||| By intent-to-treat analysis of both dose groups combined (n=57), where patients with missing values are considered virologic failures, the proportion of patients with HIV RNA < 400 copies/ ml at 48 weeks was 65% and the mean increase from baseline CD4 cell count was 94 cells/ mm3. ||| Chez 865 patients atteints de leucémie traités par dasatinib dans les études cliniques de Phase II, les variations moyennes de l'intervalle QTc par rapport à la valeur initiale (utilisant la méthode de Fredericia QTcF), étaient de 4 à 6 msec; la valeur maximale de la limite supérieure des intervalles de confiance à 95% des variations moyennes était < 7 msec.
0.6391772031784058 ||| 40 Danmark Serono Nordic Strandvejen 102 B, 4, th. ||| Eurovet Animal Health Handelsweg 25 P. O. ||| Danmark Serono Nordic Strandvejen 102 B, 4, th.
0.1392819732427597 ||| The most common side effect with MicardisPlus (seen in between 1 and 10 patients in 100) is dizziness. ||| The most common side effect with Efficib (seen in between 1 and 10 patients in 100) is nausea (feeling sick). ||| Les effets indésirables les plus couramment observés sous MicardisPlus (chez 1 à 10 patients sur 100) sont les vertiges.
0.0 ||| 120 ||| 120 ||| 8 530
1.189948320388794 ||| Sleeping agent Zolpidem ||| Meloxicam Meloxicam ||| Somnifères Zolpidem
0.2434648871421814 ||| State aid: Commission approves Belgian €250 million subordinated loan scheme to support start-ups, scale-ups and SMEs affected by the coronavirus outbreak ||| State aid: Commission approves Polish recapitalisation scheme to enable up to €1.65 billion of capital support to SMEs and large enterprises affected by the coronavirus outbreak ||| Aides d'État: la Commission autorise un régime belge de prêts subordonnés de 250 millions d'€ destiné à soutenir les jeunes entreprises, les entreprises en expansion et les PME touchées par la flambée de coronavirus
0.1311490833759308 ||| The full EPAR for RILUTEK is available here. ||| The full EPAR for TAXOTERE is available here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
0.2574959397315979 ||| In pups of mice treated with an antibody analogue of efalizumab, a decrease in T-cell dependent immunity was observed up to at least 11 weeks of age. ||| In male rats dosed for 2 years with varenicline, there was a dose-related increase in the incidence of hibernoma (tumour of the brown fat). ||| Chez des souriceaux traités avec un anticorps analogue de l'efalizumab, une baisse de l'immunité dépendante des cellules T a été observée jusqu'à un âge d'au moins 11 semaines.
0.5556425452232361 ||| I have been told that restaurants, arcades, salons, shops, supermarkets are being closed. ||| Also businesses other than food stores and pharmacies are closed, and public transport has been reduced or stopped. ||| fermeture de l'intégralité des magasins et centres commerciaux à l'exception de ceux relevant d'activités essentielles telles que les marchés, supermarchés, banques, etc ;
0.2536109685897827 ||| Snack food products made from maize flour ||| Snack food products made from cereal starch ||| En-cas à base de farine de maïs
0.21121253073215485 ||| Set the tip of the pen on the prepared injection site and press the needle into the skin by pushing the pen downward until the shield is totally depressed. ||| Place the tip of the pipette on the skin and gently squeeze the pipette to expel a portion of its contents directly onto the skin. ||| Placez l’ extrémité du stylo sur le point d’ injection préparé et enfoncez l’ aiguille dans la peau en exerçant une pression verticale sur le stylo jusqu’ à ce que le cache soit totalement enfoncé.
0.4165724515914917 ||| The pharmacokinetics of aprepitant is non-linear across the clinical dose range. ||| Mirtazapine displays linear pharmacokinetics within the recommended dose range. ||| La pharmacocinétique de l'aprépitant est non linéaire sur l'éventail des doses cliniques.
0.09924974292516708 ||| However, if you take more Aerius oral solution than you were told to, contact your doctor or pharmacist. ||| However, if you take more Aerius than you were told to, contact your doctor or pharmacist. ||| Cependant, si vous avez pris plus d’ Aerius solution buvable que vous n’ auriez dû, prévenez votre médecin ou votre pharmacien.
0.008420849218964577 ||| 35 Medicines should not be disposed of via wastewater or household waste. ||| 34 Medicines should not be disposed of via wastewater or household waste. ||| Les médicaments ne doivent pas être jetés au tout à l’ égout ou avec les ordures ménagères.
0.0 ||| Patients should be advised that current antiretroviral therapy does not cure HIV and has not been proven to prevent the transmission of HIV to others through blood or sexual contact. ||| Patients should be advised that current antiretroviral therapy does not cure HIV and has not been proven to prevent the transmission of HIV to others through blood or sexual contact. ||| Les patients devront être informés que les traitements antirétroviraux actuellement disponibles ne guérissent pas l'infection par le VIH et n’ ont pas démontré leur capacité à prévenir le risque de transmission du VIH à d’ autres personnes par voies sanguine ou sexuelle.
0.00451230350881815 ||| The hard capsules have an opaque white body, an opaque green cap, and are imprinted with black ink. ||| The hard capsules have an opaque white body, an opaque yellow cap, and are imprinted with black ink. ||| Les gélules ont un corps opaque blanc, une coiffe opaque verte, et sont marquées avec une encre noire.
0.27932173013687134 ||| Study V ||| Study I ||| Étude V
0.5518468022346497 ||| Prime Minister Matovič suggested these be dumped into the Danube.Ateş Kara of the Turkish Health Ministry said the test kits Turkey purchased from China had a "high error rate" and did not "put them into use."The UK purchased 3.5 million test kits from China but in early April 2020 announced these were not usable. ||| "He then said ""However, a dealer from Germany came there first, paid more for the shipment, and bought it."" Ukraine lawmaker Andriy Motovylovets also stated that ""Our consuls who go to factories find their colleagues from other countries (Russia, USA, France, Germany, Italy, etc) who are trying to obtain our orders." ||| Le premier ministre Matovič a suggéré de les jeter dans le Danube. Ateş Kara du Ministère de la Santé turc a déclaré que les kits de test que la Turquie a achetés à la Chine avaient un « taux d’erreur élevé » et qu’elle ne les a pas « utilisés ». Le Royaume-Uni a acheté 3,5 millions de kits de test à la Chine, mais a annoncé début avril 2020 qu’ils étaient inutilisables.
0.9449174404144287 ||| 30 mg 15 mg 30 mg ||| 25 ml 25 ml 25 ml 25 ml ||| 15 mg 30 mg
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 179 4.8 Effets indésirables
0.3627369701862335 ||| Some materials (allergens) like pollens, house dust or animal fur may cause allergic reactions resulting in itching, redness as well as swelling of the surface of your eye. ||| Furthermore, foodborne illness can be caused by pesticides or medicines in food and natural toxic substances such as poisonous mushrooms or reef fish. ||| Certaines substances (allergènes) comme les pollens, la poussière de maison ou les poils d'animaux peuvent être à l'origine de réactions allergiques pouvant entraîner des démangeaisons, des rougeurs et des gonflements de la surface de votre œ il.
0.18362390995025635 ||| HOW TO USE CYANOKIT ||| HOW TO USE DYNASTAT ||| COMMENT UTILISER CYANOKIT
0.163070410490036 ||| Like all medicines, Alendronate HEXAL can have side effects, although not everybody gets them. ||| Like all medicines, KOGENATE Bayer 250 IU can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Alendronat HEXAL est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.4005115330219269 ||| Transient elevation above pretreatment levels of erythrocyte COMT activity was observed after withdrawal of tolcapone. ||| Presence of occult CNV lesions (fluorescence not well demarcated on the angiogram) was allowed. ||| 9 Une augmentation transitoire de l'activité érythrocytaire de la COMT, supérieure au niveau mesuré avant traitement, a été observée après l'arrêt du tolcapone.
0.4442833662033081 ||| If you are being treated for TIH, you will normally only be given one infusion of Zometa. ||| If you do not respond to glucagon treatment, you will have to be treated lp ||| Si vous êtes traité(e) pour des métastases osseuses, Zometa vous sera administré en perfusion toutes les 3 à 4 semaines.
0.4017411768436432 ||| Considering the margins of exposure in relation to the expected exposure in the human use, these findings do not change the benefit-risk of Tamiflu in its adopted therapeutic indications. ||| The CPMP considered that possible biases that have been identified in the SMBR, including misclassifications, would bias the risk estimate towards 1 or not affect it. ||| Toutefois, au regard de l'amplitude de l'exposition chez ces rongeurs par rapport à l'exposition attendue en usage clinique, ces données ne modifient pas le rapport bénéfice/ risque de Tamiflu dans les indications approuvées.
0.04373485594987869 ||| Do not use Fasturtec after the expiry date which is stated on the carton. ||| Do not use Tracleer after the expiry date which is stated on the carton. ||| Ne pas utiliser Fasturtec après la date de péremption mentionnée sur la boîte.
0.19368520379066467 ||| Treatment with Trudexa must be discontinued in patients who develop new or worsening symptoms of congestive heart failure. ||| Caution should be exercised when treating patients with clinically significant cardiovascular disease or pre-existing congestive heart failure with Avastin. ||| Le traitement par Trudexa doit être arrêté chez les patients présentant de nouveaux symptômes ou une aggravation de leurs symptômes d'insuffisance cardiaque congestive.
0.34339404106140137 ||| A single oral dose of 30 mg reduces basal secretion by about 70%, and the patients' symptoms are consequently relieved starting from the very first dose. ||| This risk increases with the duration of intake of HRT, but returns to normal within a few (at most five) years of having stopped HRT. ||| Une dose orale unique de 30 mg réduit la sécrétion basale d’ environ 70%; les symptômes des patients sont donc améliorés dès la première dose.
0.3402021527290344 ||| Silgard is available in packs of 1, 10 or 20 pre-filled syringes. ||| Supplied in cartons containing 1 or 5 pre-filled syringes. ||| Silgard est disponible en boîtes de 1, 10 ou 20 seringues préremplies.
0.4059857726097107 ||| The proportion of subjects achieving clinical remission at week 10 was 58.9% (66/ 112). ||| In this subgroup, there was a 92% (89/97) sustained virological response rate. ||| La proportion de sujets ayant atteint une rémission clinique à la semaine 10 était de 58,9% (66/ 112).
0.854681134223938 ||| A total of 2,122 patients received Starlix in all trials combined. ||| CNBC reported there were at least 118,381 cases worldwide. ||| Au total, Starlix été administré à 2122 patients, toutes études confondues.
0.1673082709312439 ||| In the event of overdose, the patient should be closely monitored and the treatment should be symptomatic and supportive. ||| In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. ||| En cas de surdosage, une surveillance étroite du patient, ainsi qu’ un traitement symptomatique et des mesures thérapeutiques adaptées sont recommandés.
0.09548090398311615 ||| Desensitisation Patients receiving ACE inhibitors during desensitisation treatment (e.g. hymenoptera venom) have sustained anaphylactoid reactions. ||| Patients receiving ACE inhibitors during desensitisation treatment (e. g. hymenoptera venom) have experienced anaphylactoid reactions. ||| Désensibilisation Les patients traités par IEC au cours d'une désensibilisation (ex: venin d'hyménoptère) présentent des réactions anaphylactoïdes prolongées.
0.012083174660801888 ||| Clopidogrel Winthrop is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). ||| Clopidogrel BMS is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). ||| Clopidogrel Winthrop est utilisé pour éviter la formation de caillots sanguins (thrombus) dans les vaisseaux sanguins (artères) devenus rigides.
0.387660950422287 ||| Pegasys is a medicine that contains the active substance peginterferon alfa-2a. ||| What is Viraferon? lon Viraferon is a medicine containing the active substance interferon alfa-2b. ||| Pegasys est un médicament qui contient la substance active peginterféron alfa-2a.
0.036252424120903015 ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTE OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LISTE REPRENANT LES NOMS, LA FORME PHARMACEUTIQUE, LES DOSAGES DES MÉDICAMENTS, LA VOIE D'ADMINISTRATION, LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.32528889179229736 ||| The prevention of clinical signs of porcine colonic spirochaetosis (colitis) when the disease has been diagnosed in the herd. ||| One death (colon carcinoma), assessed as unrelated to study treatment (Botox), was reported during the Phase II cervical dystonia study. ||| Traitement des signes cliniques de l’ entéropathie proliférative porcine (iléite) Prévention des signes cliniques de la spirochétose du côlon (colite) du porc après diagnostic de la maladie dans l’ élevage.
0.4200633764266968 ||| 97.10 -1.41 ||| 11.9 -1.94 ||| 97,10 -1,41
0.4448760151863098 ||| Humalog Mix50 100 U/ml KwikPen, suspension for injection (insulin lispro) ||| Viani Mite Dosier-Aerosol FCKW-frei 25 µg/ 50 µg Druckgasinhalation, Suspension ||| Humalog Mix50 100 UI/ml KwikPen, suspension injectable (insuline lispro)
3.0966662610890094e-13 ||| Any patient complaining of ocular symptoms, including loss of visual acuity or visual field must have a prompt and complete eye examination. ||| Any patient complaining of ocular symptoms, including loss of visual acuity or visual field must have a prompt and complete eye examination. ||| 201 d'acuité visuelle ou de champ visuel doit faire l'objet rapidement d'un examen ophtalmologique complet.
0.372913658618927 ||| Both salmeterol and fluticasone propionate are excreted into breast milk in rats. ||| Lamivudine and zidovudine are well absorbed from the gastrointestinal tract. ||| Chez le rat, le salmétérol et le propionate de fluticasone sont éliminés dans le lait.
0.22904305160045624 ||| Each coated tablet contains 15 mg olanzapine ||| Each hard capsule contains 25 mg zonisamide ||| Chaque comprimé enrobé contient 15 mg d’ olanzapine
0.5426762104034424 ||| On 31 January and 3 February respectively, both his children tested positive for SARS-CoV-2. ||| As of 26 April, 18,670 people had tested positive for Covid-19 in Sweden. ||| Le 31 janvier et le 3 février respectivement, ses deux enfants sont testés positifs au SARS-CoV-2.
1.134718418121338 ||| Fort Dodge Santé ||| Mamede do Coronado Portugal ||| Fort Dodge Santé Animale, S. A.
0.44043511152267456 ||| The recommended dose is one implant per dog, irrespective of the size of the dog. ||| 84 The dose given will vary depending on the size of the child. ||| La posologie recommandée est d’ un implant par chien, quelque soit la taille du chien.
0.20581552386283875 ||| If you take more Xiliarx than you should If you take too many Xiliarx tablets, or if someone else has taken your medicine, talk to your doctor straight away. ||| If you use more STELARA than you should If you have used or been given too much STELARA, talk to a doctor or pharmacist straight away. ||| Si vous avez pris plus de Xiliarx que vous n’ auriez dû Si vous avez pris trop de comprimés de Xiliarx, ou si une autre personne a pris votre médicament, prévenez immédiatement votre médecin.
0.48822975158691406 ||| 22 Detailed information on dosage recommendations is provided in the following table: ||| A detailed description of the preparation is given below: ||| 24 Des informations détaillées sur les recommandations posologiques figurent dans le tableau suivant:
0.1659814417362213 ||| 52% (48%) 15% (15%) 7% (8%) 49% (35%) 46% (19%) 23% (11%) 15% (3%) ||| 61% (40%) 40% (13%) 31% (25%) 5% (4%) 7% (7%) 63% (58%) ||| 59% (41%) 52% (48%) 15% (15%) 7% (8%) 49% (35%) 46% (19%) 23% (11%) 15% (3%)
0.3764452040195465 ||| Distribution The average binding of doripenem to plasma proteins was approximately 8.1% and is independent of plasma concentrations. ||| Amfenac was the major metabolite in plasma, representing approximately 13% of total plasma radioactivity. ||| Distribution Le taux moyen de fixation du doripénème aux protéines plasmatiques est de 8,1% environ, et est indépendant de la concentration plasmatique.
0.37685829401016235 ||| PRCA means that the body has stopped or reduced the production of red blood cells which causes severe anaemia. ||| With this condition, parts of the bone tissue die because of reduced blood supply to the bone. ||| 499 production de globules rouges par votre organisme se traduisant par une anémie sévère.
0.2795841693878174 ||| ORENCIA is used in patients who have not had a sufficient response to other medicines for rheumatoid arthritis including at least one ‘ tumour necrosis factor (TNF) blocker’, or who cannot be given these medicines. ||| Patients who do not have enough blood platelets (immune thrombocytopenic purpura (ITP)) and ● who are at high risk of bleeding, ● will have a surgery in the near future. ||| ORENCIA est utilisé chez les patients n’ ayant pas montré de réponse satisfaisante à d’ autres traitements contre la polyarthrite rhumatoïde, dont au moins un « inhibiteur du TNF (facteur de nécrose tumorale) », ou chez les patients qui ne sont pas en mesure de recevoir de tels traitements.
0.28489401936531067 ||| Therefore, therapy with entecavir should not be used for HIV/ HBV co-infected patients who are not receiving HAART. ||| Reductions in HIV RNA have been reported in HIV/ HBV co-infected patients receiving entecavir monotherapy without HAART. ||| En conséquence, le traitement par l’ entecavir ne doit pas être utilisé chez les patients co-infectés VIH/ VHB ne recevant pas de traitement antirétroviral hautement actif (HAART).
0.0 ||| Please read all of this leaflet carefully before you start taking this medicine.  Keep this leaflet. ||| Please read all of this leaflet carefully before you start taking this medicine.  Keep this leaflet. ||| Veuillez lire attentivement l’intégralité de cette notice avant de prendre ce médicament.
0.47125566005706787 ||| In order to identify the first ZYPADHERA dose for all patients the scheme in Table 1 should be considered. ||| The administration of INVEGA should be standardised in relation to food intake (see section 5.2). ||| Se référer au schéma posologique du Tableau 1 pour connaître la première dose de ZYPADHERA pour tous les patients.
0.324748694896698 ||| In 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/ day was not associated with any distinguishing profile of adverse events. ||| The immunogenicity induced by three doses of Cervarix has been evaluated in 5,303 female subjects from 10 to 55 years of age. ||| Chez 44 patients schizophrènes et âgés de plus de 65 ans, des doses de 5 à 20 mg par jour n’ ont pas été associées à un profil d’ effets indésirables particulier.
0.4613618850708008 ||| Amino acrylic polymers for use in manufacture ||| Neopentylglycol for use in the manufacture ||| Polymères aminoacryliques destinés à la fabrication
0.07426922768354416 ||| Studies in animals have shown reproductive toxicity (see section 5.3). ||| Studies in mice have shown reproductive toxicity (see section 5.3). ||| Des études menées chez l’ animal ont mis en évidence une toxicité sur la reproduction (voir rubrique 5.3).
0.2656613886356354 ||| - the scope of the referral was the harmonisation of the Summaries of Products Characteristics, ||| - the scope of the referral was to agree on a summary of Products Characteristics in view of the ||| la saisine était destinée à l’ harmonisation des résumés des caractéristiques du produit,
0.829209566116333 ||| Concomitant use is not recommended. ||| To be taken into account with concomitant use ||| L'administration concomitante de ces substances n'est pas recommandée.
0.0 ||| It is recommended that the date of the first use be noted on the label. ||| It is recommended that the date of the first use be noted on the label. ||| Il est recommandé d'inscrire la date de première ouverture du flacon sur l’ étiquette.
0.2683647871017456 ||| The active substance in KOGENATE Bayer, octocog alfa, is a blood coagulation factor protein. ||| The active substance in SOMAVERT, pegvisomant is known as a growth hormone receptor antagonist. ||| La substance active de KOGENATE Bayer, l’ octocog alfa, est une protéine qui est un facteur de coagulation du sang.
0.3378300666809082 ||| For more detailed dose recommendations, including those for children, see the Package Leaflet of the anti-HIV medicines Norvir is given in combination with. ||| For symptoms and suitable measures please refer to the Patient Information Leaflet of the gonadotropin-containing medicine prescribed for you. ||| Pour des informations posologiques plus détaillées, notamment les doses recommandées chez l’enfant, se reporter à la notice des autres médicaments anti-VIH avec lesquels Norvir est administré.
0.15720310807228088 ||| 240 soft capsules ||| 200 hard capsules ||| 240 capsules molles
0.30298054218292236 ||| Although the available in vitro data suggest a low potential for promotion of tumour growth, the use of InductOs is contraindicated in patients with an active malignancy or in patients undergoing treatment for a malignancy (see also section 4.3). ||| Despite this, your doctor may prescribe (Invented name)® for patients under 18 for moderate to severe major depressive episode in combination with psychological therapy because he/ she decides that this is in their best interests. ||| Bien que les données in vitro disponibles suggèrent un faible potentiel pour la promotion de croissance tumorale, l’utilisation d’InductOs est contre-indiquée chez les patients présentant une malignité active ou des patients subissant un traitement pour une tumeur maligne (voir aussi rubrique 4.3).
0.3027421832084656 ||| 30 Metabolism Gemcitabine is rapidly metabolised by cytidine deaminase in the liver, kidney, blood and other tissues. ||| Mycophenolate mofetil Teva is used to prevent the body from rejecting a transplanted kidney, heart or liver. ||| Métabolisme La gemcitabine est rapidement métabolisée par la cytidine déaminase dans le foie, les reins, le sang et les autres tissus.
0.6684401035308838 ||| 220 Technical equipment and installations ||| Total operational and expertise costs ||| 220 Matériel et installations techniques
0.4443516433238983 ||| Polysaccharides for use as food for human consumption ||| Biscuits for human consumption made from cereals ||| Polysaccharides pour l'alimentation humaine
0.2851265072822571 ||| Total clearance of ibandronic acid is low with average values in the range 84-160 ml/ min. ||| The efficacy of prasugrel was independent of the ASA dose (75 mg to 325 mg once daily). ||| La clairance totale de l’ acide ibandronique est faible, avec des valeurs moyennes comprises entre 84 et 160 ml/ min.
8.537344550925419e-13 ||| 18.12.96 a) ||| 18.12.96 a) ||| a) 18.12.96
0.1460791677236557 ||| Each capsule contains 40 mg duloxetine (as hydrochloride). ||| Each capsule contains 30 or 60 mg of duloxetine (as hydrochloride). ||| Chaque gélule contient 40 mg de duloxétine (sous forme de chlorhydrate).
0.019773179665207863 ||| For the full list of all side effects reported with Zometa, see the Package Leaflet. ||| For the full list of all side effects reported with Humira, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Zometa, voir la notice.
0.595333993434906 ||| 25, The Courtyard, Kilcarbery Business Park Clondalkin, Dublin 22 Ireland ||| Bayer Limited Ciproxin The Atrium, Ciproxin Blackthorn Road, ||| 25, The Courtyard Kilcarbery Business Park Clondalkin, Dublin 22 Irlande
9.029958313207243e-13 ||| Don't transfer it to any other container. ||| Don't transfer it to any other container. ||| Ne pas transférer la solution dans un autre récipient.
0.42727383971214294 ||| Data available from three uncontrolled B-CLL studies are summarised in the following table: ||| The findings are summarised in three Eurosurveillance articles: ||| Les données obtenues durant trois études non contrôlées relatives à la leucémie lymphoïde chronique à cellules B (LLC-B) sont résumées dans le tableau qui suit:
9.047870417298876e-13 ||| SP Europe 73, rue de Stalle ||| SP Europe 73, rue de Stalle ||| SP Europe 73, rue de Stalle Ce
0.8067115545272827 ||| 465 M ed ic in alp ro du ct ||| ori uth ra ge lon ANNEX I ||| 496 C e m éd ic am en
0.2531040906906128 ||| Condition monitoring relating to lubricants ||| Condition monitoring relating to greases ||| Surveillance concernant l'état des lubrifiants
0.2496122121810913 ||| Rapilysin is used in patients who have had a heart attack (suspected acute myocardial infarction) to help dissolve the blood clots (thrombolysis) that have caused the heart attack. ||| Fasturtec is used to treat and prevent acute (sudden) hyperuricaemia (increased levels of uric acid in the blood), in order to prevent kidney failure. ||| Rapilysin est utilisé chez les patients ayant subi une crise cardiaque (suspicion d’ infarctus aigu du myocarde) pour contribuer à la dissolution des caillots sanguins (thrombolyse) à l’ origine de la crise cardiaque.
0.2626713514328003 ||| When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells. ||| For both GLP-1 and GIP, stimulation of insulin release is enhanced as glucose rises above normal concentrations. ||| Lorsque la glycémie est normale ou élevée, le GLP 1 et le GIP augmentent la synthèse et la libération d'insuline par les cellules bêta du pancréas.
0.15476524829864502 ||| 123 of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| En raison des variabilités individuelles, la recherche de la dose thérapeutique optimale doit être effectuée pour chaque patient.
0.3336884677410126 ||| Maintenance treatment of adult patients with schizophrenia sufficiently stabilised during acute treatment with oral olanzapine. ||| The dosage recommendations in paediatric patients are the same as those in adults receiving myelosuppressive cytotoxic chemotherapy. ||| Traitement de maintien de la schizophrénie chez les patients adultes suffisamment stabilisés par olanzapine orale lors de la phase initiale du traitement.
0.31496989727020264 ||| ORENCIA is used in patients who have not had a sufficient response to other medicines for rheumatoid arthritis including at least one ‘ tumour necrosis factor (TNF) blocker’, or who cannot be given these medicines. ||| In adults, Ribavirin Teva can be used in ‘ naïve’ patients (who have not been treated before) or in patients in whom previous treatment including any type of interferon alfa, with or without ribavirin, did not work. ||| ORENCIA est utilisé chez les patients n’ ayant pas montré de réponse satisfaisante à d’ autres traitements contre la polyarthrite rhumatoïde, dont au moins un « inhibiteur du TNF (facteur de nécrose tumorale) », ou chez les patients qui ne sont pas en mesure de recevoir de tels traitements.
0.20272625982761383 ||| Packs of 30 x 1 film-coated tablets in aluminium perforated unit dose blisters. ||| 100 x 1 hard capsules in PVC/Aluminium perforated unit dose blisters. ||| Boîtes de 30 x 1 gélules en plaquettes thermoformées unidoses (aluminium).
0.40588733553886414 ||| Glossing cloths [not abrasive] ||| Synthetic padding bandages [supportive] ||| Chiffons à lustrer non abrasifs
0.2528919279575348 ||| Clinical Studies ||| Clinical Experience ||| Etudes cliniques
0.3902055025100708 ||| Kidney stones have been reported, as well as associated pain and kidney swelling. ||| Breast enlargement, as well as cysts in the ovaries, have been observed. ||| Des calculs rénaux ont été signalés, ainsi que les douleurs et hypertrophies rénales associées.
0.28031444549560547 ||| Tipranavir is a substrate, an inducer and an inhibitor of cytochrome P450 CYP3A. ||| Aprepitant (125 mg/ 80 mg) is a substrate, a moderate inhibitor, and an inducer of CYP3A4. ||| Le tipranavir est un substrat, inducteur et inhibiteur de l'iso-enzyme CYP3A du système du cytochrome P450.
0.8799319863319397 ||| Disposal: see package insert ||| Optional separate additional insert: ed ||| Elimination: consulter la notice.
0.2189299762248993 ||| 6/ 72 ||| 3/ 72 ||| 6/ 75
0.38133442401885986 ||| Intramuscular administration should be avoided. ||| Immunisation should be postponed. ||| L’administration intramusculaire doit être évitée.
0.39219748973846436 ||| Saddle covers for motorcycles ||| Saucer lights with snuffers ||| Housses de selle pour motocycles
0.20142754912376404 ||| The powder must be dissolved before use. ||| The tablet must be taken when dissolved. ||| La poudre doit être dissoute avant usage.
0.33400076627731323 ||| Atripla is not recommended for patients with moderate or severe renal impairment (creatinine clearance (CrCl) < 50 ml/ min). ||| Patients with severe hepatic impairment (bilirubin > 5 x ULN or ASL/ ALT > 10 x ULN) should not be treated with Abraxane. ||| Atripla n’ est pas recommandé chez les patients présentant une insuffisance rénale modérée ou sévère (clairance de la créatinine (ClCr) < 50 ml/ min).
0.06324613094329834 ||| You must use it only if it looks like water. ||| But you must use it only if it looks like water. ||| Vous devez l’utiliser uniquement si elle a l’apparence de l’eau.
2.6033580673157086e-13 ||| paediatric and adult patients in the area under the curve from time 0 to infinity (AUC[0-∞]) was observed; however, this difference was less than the 2-fold range in AUC(0- ∞) observed for the ro ||| paediatric and adult patients in the area under the curve from time 0 to infinity (AUC[0-∞]) was observed; however, this difference was less than the 2-fold range in AUC(0- ∞) observed for the ro ||| 0 à l’ infini (AUC[0-∞]) entre l’ enfant et l’ adulte; toutefois, cette différence était moins de deux fois inférieure à l’ AUC (0-∞) observée chez l’ enfant.
0.39816343784332275 ||| The studies examined death, amputations, and new thromboembolic (clotting) complications. ||| The incidence in clinical trials of thrombotic/ thromboembolic complications. ||| Les études se sont penchées sur les décès, les amputations et les nouvelles complications thromboemboliques (coagulation).
0.6249165534973145 ||| Insert the needle into the pinched skin at an angle of approximately 45°. dic Me ||| ● Pierce the skin at a 45-degree angle. ||| Insérez l’aiguille dans le pli de la peau selon un angle d’environ 45°.
0.29843199253082275 ||| Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. ||| The dose levels, duration of treatment and total cumulative dose in these patients generally far exceeded those recommended for the treatment of acne. ||| Les taux de rémission à long terme et de rechute sont plus étroitement associés à la dose totale administrée qu’ à la durée du traitement ou à la dose quotidienne.
0.28586819767951965 ||| Xyrem should not be used in people who may be hypersensitive (allergic) to sodium oxybate or any of the other ingredients. ||| • If you know that you are allergic (hypersensitive) to sulesomab or any protein which comes from a mouse, tell your doctor. ||| Xyrem ne doit pas être utilisé chez les personnes susceptibles d’ être hypersensibles (allergiques) à l’ oxybate de sodium ou à l’ un des autres composants contenus dans Xyrem.
0.062442194670438766 ||| Like all medicines, Actraphane can cause side effects, although not everybody gets them. ||| Like all medicines, Actrapid can cause side effects although not everybody gets them. ||| Comme tous les médicaments, Actraphane peut provoquer des effets indésirables mais ils ne surviennent pas systématiquement chez tout le monde.
0.40031003952026367 ||| Variations in lamotrigine levels of this order may be associated with adverse effects. ||| Administration of other azoles has been associated with increases in digoxin levels. ||| Ce type de variations des taux de lamotrigine peut être associé à des effets indésirables.
0.35859984159469604 ||| The effect of non-depolarising skeletal muscle relaxants may be potentiated by hydrochlorothiazide. ||| Early administration of activated charcoal may delay the absorption of sibutramine. ||| L’ hydrochlorothiazide peut potentialiser l’ effet des relaxants non dépolarisants des muscles squelettiques.
0.17080768942832947 ||| Why has Fendrix been approved? ||| Why has Ibraxion been approved? ||| Pourquoi Fendrix a -t-il été approuvé?
0.019242659211158752 ||| 49 MINIMUM PARTICULARS TO APPEAR ON BLISTERS ||| 85 MINIMUM PARTICULARS TO APPEAR ON BLISTERS ||| 49 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES
0.6858433485031128 ||| *Pearson chi-square test or Exact test ** Duration of best response *** log-rank test stratified by Rai group (Stage I-II vs III-IV) **** by 4-colour flow ||| Abbreviations: # subj: number subjects; SC: seroconversion; SN: sero-neutralisation; No sAE: no serious AE; (*) tested in 322 subjects ||| *** test log-rank stratifié par la classification Rai (Stade I-II vs III-IV) **** par flux à 4 couleurs
0.5072610378265381 ||| The Council is now invited to endorse this in order to provide clarity to Member States. ||| Therefore the CHMP remained of the opinion that this indication should be withdrawn. ||| Le Conseil est à présent invité à approuver cette conclusion afin de clarifier la situation pour les États membres.
0.6612347364425659 ||| horses ||| Hoes ||| cheval
0.008288739249110222 ||| 90 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 99 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 105 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.4362679719924927 ||| This process is influenced by several factors (e. g. insulin dosage, injection route and site, thickness of subcutaneous fat, type of diabetes). ||| The occurrence of such reactions depends, as for every diabetes therapy, on individual factors, such as dietary habits, dosage, exercise and stress (see section 4.4). ||| Ce processus est influencé par plusieurs facteurs (par exemple la dose d’ insuline, la voie et le site d’ injection, l’ épaisseur du tissu adipeux sous-cutané, le type de diabète).
0.24745678901672363 ||| Treatment should only be given to patients with moderate anaemia (Hb 10 - 13 g/ dl [6.21 - 8.07 mmol/ l], no iron deficiency) if blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). ||| If dose reduction is chosen for patients who experience severe neutropenia (neutrophil count < 0.5 x 109/ l) for 7 days or more, or severe neutropenia associated with fever or infection, or who have had treatment delayed due to neutropenia, the dose should be reduced by 0.4 mg/ m2/ day to 36 1.9 mg/ m2/ day (or subsequently down to 1.5 mg/ m2/ day if necessary). ||| Le traitement ne doit être administré qu’ à des malades présentant une anémie modérée (Hb 10 – 13 g/ dl soit 6,21 – 8,07 mmol/ l et sans carence martiale), s’ il n’ existe pas ou peu de méthodes de récupération du sang lorsqu’ une intervention chirurgicale programmée importante nécessite de grandes quantités de sang (4 unités de sang ou plus chez les femmes et 5 unités de sang ou plus chez les hommes).
0.20289736986160278 ||| Danmark Baxter A/S Gydevang 43 DK-3450 Allerød Tlf: +45 48 16 64 00 ||| 20 Danmark GE Healthcare A/ S Huginsvej 8 DK-3400 Hillerød Tlf: + 45 70 22 22 03 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerød Tlf: +45 48 16 64 00
0.6719577312469482 ||| Garlic puree ||| Manganese alum ||| Purée d'ail
0.23839277029037476 ||| High density polyethylene (HDPE) bottles closed with a child-resistant polypropylene closure. ||| Amber-coloured polyethylene terephthalate (PET) bottle with a child-resistant closure. ||| Flacons en polyéthylène haute densité fermés par des bouchons sécurisés en polypropylène.
0.00574105978012085 ||| Silapo 4000 IU/0.4ml solution for injection in pre-filled syringe Epoetin zeta ||| Silapo 6000 IU/0.6ml solution for injection in pre-filled syringe Epoetin zeta ||| Silapo 4 000 UI/ 0,4 ml solution injectable en seringue préremplie Époétine zêta
0.30420374870300293 ||| Developmental toxicity, including teratogenicity, was observed in rats and rabbits at dose levels of 150 mg/ kg and higher administered daily throughout organogenesis. ||| Mild, oestrogenic effects such as swollen vulva, swollen teats and/ or attractivity for males have been observed at the high dose of 2 mg. ||| Une toxicité sur le développement du fœ tus, incluant une tératogénicité, a été observée chez le rat et le lapin aux doses de 150 mg/ kg et plus administrées quotidiennement tout au long de l’ organogenèse.
0.21831044554710388 ||| Do not use Fuzeon if you notice any particles in the powder or the solution once the water for injection has been added. ||| Also do not use the water for injections if you see any particles in the vial or if the water is cloudy. ||| N’utilisez pas Fuzeon si vous remarquez des amas dans la poudre ou dans la solution après avoir ajouté l'eau pour préparations injectables.
0.13203075528144836 ||| Inhibition of CYP3A4 by both CRIXIVAN and ritonavir could result in elevated plasma concentrations of these medicines, potentially causing serious or life-threatening reactions. ||| Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of theseactive substances, potentially causing serious or life-threatening reactions. ||| L'inhibition du CYP3A4, à la fois par CRIXIVAN et ritonavir, pourrait entraîner une augmentation des concentrations plasmatiques de ces médicaments, et potentiellement provoquer un risque de réactions graves ou mettre en jeu le pronostic vital.
3.144840616219058e-13 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu. ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu. ||| 100 Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence Européenne du médicament (EMEA) http: / /www. emea. europa. eu.
0.5187387466430664 ||| Partial recovery of vision was observed in some patients. ||| All patients had a history of heavy smoking. ||| Une récupération partielle de la vision a été observée chez certains patients.
0.30112800002098083 ||| Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. ||| The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products can not be fully excluded. ||| Malgré cela la possibilité d’une transmission d’agents infectieux ne peut pas être totalement exclue lors de l’administration de médicaments préparés à partir de sang ou de plasma humain.
0.5672574043273926 ||| Woven timber blinds [furniture] ||| Kimchi [fermented vegetable dish] ||| Stores en bois tissé [mobilier]
0.2512349784374237 ||| Humalog Mix25 is a white, sterile suspension ||| Humalog Mix25 is a premixed suspension. ||| Humalog Mix25 est une suspension stérile et blanche.
0.470193088054657 ||| Table 1 summarises response rates based on the best response assessments for studies MM-009 and MM-010. ||| Final results of studies EN3267-005 and 3267-007, including detailed exposure of patients and full safety analysis. ||| Le tableau 1 récapitule les taux de réponse basée sur l’ évaluation de la meilleure réponse pour les études MM-009 et MM-010.
0.32880091667175293 ||| metacresol mannitol glacial acetic acid sodium acetate trihydrate water for injections ||| Zinc chloride m-cresol glycerol hydrochloric acid sodium hydroxide water for injections. ||| Métacrésol Mannitol Acide acétique glacial Acétate de sodium trihydraté Eau pour préparations injectables
0.13273043930530548 ||| Gastrointestinal disorders Very common: nausea Common: diarrhoea, abdominal pain, vomiting Uncommon: pancreatitis ||| 13 Common: gastrointestinal symptoms, diarrhoea, nausea Uncommon: vomiting, abdominal pain* ||| Affections gastro-intestinales Très fréquent: nausées Fréquent: diarrhée, douleur abdominale, vomissements Peu fréquent: pancréatite
0.923566460609436 ||| Waiting period ||| or Study Day ||| Période d’ attente
0.9159771203994751 ||| Initial Phase (hrs) ||| Median time (range) Imatinib ||| Phase initiale (h)
0.11241968721151352 ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES ||| LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTES OF ADMINISTRATION, APPLICANTS IN THE MEMBER STATES ||| LISTE REPRENANT LES NOMS, LA FORME PHARMACEUTIQUE, LES DOSAGES DES MÉDICAMENTS, LA VOIE D'ADMINISTRATION, LES TITULAIRES DE L'AUTORISATION DE MISE SUR LE MARCHÉ DANS LES ÉTATS MEMBRES
0.23041462898254395 ||| At week 14, 282 patients were assessed for clinical response and randomised to receive either placebo or 5 mg/ kg infliximab every 8 weeks through week 46. ||| At the end of this period, 656 patients were randomised to receive fondaparinux 2.5 mg once daily or placebo for an additional 21 +/ - 2 days. ||| A la semaine 14, la réponse clinique a été évaluée chez 282 patients qui ont été randomisés pour recevoir soit du placebo, soit 5 mg/ kg d’ infliximab toutes les 8 semaines jusqu’ à la semaine 46.
0.0 ||| This may require separate administration of hepatitis B vaccine and should follow official recommendations. ||| This may require separate administration of hepatitis B vaccine and should follow official recommendations. ||| Ceci peut nécessiter une administration séparée d’ un vaccin contre l'hépatite B; les recommandations officielles doivent être appliquées.
0.20803141593933105 ||| Research and development services in the field of chemistry ||| Research and development services in the field of immunology ||| Services de recherche et de développement dans le domaine de la chimie
0.05569213628768921 ||| 96 The patient should be informed on the injection technique by his health care professional. ||| The patient should be informed on the injection technique by his health care professional. ||| Le patient doit être éduqué sur les techniques d'injection par son professionnel de santé.
0.3051285147666931 ||| Dating agency services ||| Advertising agency services ||| Agences de rencontres
0.08328117430210114 ||| 5 x 3 ml Liprolog Basal 100 U/ ml KwikPens 2 x (5 x 3 ml) Liprolog Basal 100 U/ ml KwikPens ||| 5 x 3 ml Liprolog Basal 100 U/ ml Pens 2 x (5 x 3 ml) Liprolog Basal 100 U/ ml Pens ||| L'emballage contient 5 stylos de 3 ml Liprolog BASAL 100 UI/ ml KwikPen.
0.0 ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| Système de pharmacovigilance Le titulaire de l’ autorisation de mise sur le marché (AMM) doit s’ assurer que le système de pharmacovigilance, tel qu’ il est décrit dans la version 3.0 présentée dans le module 1.8.1. du dossier d’ AMM, est en place et opérationnel avant et pendant la commercialisation du produit.
0.535134494304657 ||| Fire hose nozzles ||| Spectacle nose pads ||| Lances à incendie
0.40956151485443115 ||| Once the needle is removed from the skin, check to make sure the black injection button is all the way in. ||| A clicking sound can be heard, which will stop when the injection button has been pressed in completely. ||| Une fois que l’aiguille est retirée de la peau, assurez- vous que le bouton d’injection noir est complètement enfoncé.
0.40334010124206543 ||| 19 D-89150 Laichingen Germany ||| 15 D- 06796 Brehna Germany ||| 19 D-89150 Laichingen Allemagne
0.27688151597976685 ||| The combination of rifampicin and CRIXIVAN with concomitant low-dose ritonavir is contraindicated (see section 4.3). ||| Coadministration of voriconazole with carbamazepine and phenobarbital is contraindicated (see section 4.3). ||| L'utilisation concomitante de rifampicine et de CRIXIVAN, en association avec une faible dose de ritonavir, est contre- indiquée (voir rubrique 4.3).
0.3560229539871216 ||| INTELENCE has not been studied in patients with severe hepatic impairment (Child-Pugh Class C) and its use is therefore not recommended in this group of patients (see sections 4.2 and 5.2). ||| In most clinical trials of Avastin, patients with pre-existing CHF of NYHA (New York Heart Association (NYHA) II-IV were excluded, therefore, no information is available on the risk of CHF in this population. ||| INTELENCE n’ a pas été étudié chez les patients présentant une insuffisance hépatique sévère (Child-Pugh classe C) et par conséquent son utilisation chez ce groupe de patients n’ est pas recommandée (voir rubriques 4.2 et 5.2).
0.32234448194503784 ||| Efalizumab is a monoclonal antibody. ||| Amlodipine is a calcium channel blocker. ||| L'efalizumab est un anticorps monoclonal.
0.10367649048566818 ||| If you take less Humalog BASAL than you need, a high blood sugar may occur. ||| If you take less Liprolog than you need, a high blood sugar may occur. ||| Si vous arrêtez d’utiliser Humalog BASAL Si vous prenez moins d’Humalog BASAL que vous n’auriez dû, une augmentation du taux de sucre dans le sang peut survenir.
0.3430379033088684 ||| The development of isolated low-titre anti-growth hormone antibodies was observed in 16.9% of patients treated with SOMAVERT. ||| The use of oral anticoagulants, non-study antiplatelet medicinal products and chronic NSAIDs was not allowed in TRITON. ||| Le développement d’ anticorps isolés anti-hormone de croissance à une faible concentration a été observé chez 16,9% des patients traités par SOMAVERT.
0.7958941459655762 ||| Electronic medical instruments ||| Veterinary Medicines ||| Instruments médicaux électroniques
0.022020410746335983 ||| 54 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| 412 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist. ||| Si vous remarquez des effets indisérables non mentionnés dans cette notice, ou si vous ressentez un des effets mentionnés comme étant sérieux, veuillez en informer votre médecin ou votre pharmacien.
0.5066894292831421 ||| 20 exposure levels were lower than those with the recommended clinical dose in humans. ||| Adverse reactions reported are consistent with those seen after the recommended dosing. ||| Les niveaux d’exposition étaient plus bas que ceux observés à la dose recommandée chez l’homme.
0.18345952033996582 ||| What is Ferriprox used for? ||| What is Trizivir used for? ||| Dans quel cas Ferriprox est -il utilisé?
0.5571025609970093 ||| Very common side effects. ||| Rare side effects. ||| Effets indésirables très fréquents.
0.26652050018310547 ||| Animal studies are insufficient with respect to effects on pregnancy and embryofoetal development (see section 5.3). ||| Animal data are inconclusive but suggest possible deleterious effects on embryonal/ foetal development (see section 5.3). ||| Les études animales ne sont pas concluantes pour ce qui est des effets délétères sur la gestation et le développement embryonnaire (voir rubrique 5.3.).
0.3856625556945801 ||| Sodium chloride, L-histidine, polysorbate 80, sodium borate and water for injections. ||| dipalmitoylphosphatidylglycerol, sodium chloride and water for injections. ||| 54 Chlorure de sodium, L-histidine, polysorbate 80, borate de sodium et eau pour préparations injectables.
0.0 ||| Pulmonary oedema as a result of aortic or mitral stenosis, heart failure at high output, right sided heart failure as a result of pulmonary embolism or pericardiac effusion and left sided ventricular heart insufficiency with low filling pressure. ||| Pulmonary oedema as a result of aortic or mitral stenosis, heart failure at high output, right sided heart failure as a result of pulmonary embolism or pericardiac effusion and left sided ventricular heart insufficiency with low filling pressure. ||| La doxazosine doit être administrée avec prudence chez les patients présentant l’ une des cardiopathies aiguës suivantes: œ dème pulmonaire à la suite d’ une sténose mitrale ou aortique, insuffisance cardiaque à débit élevé, insuffisance cardiaque droite causée par une embolie pulmonaire ou un épanchement péricardique et insuffisance ventriculaire gauche avec pression de remplissage faible.
0.036325059831142426 ||| Do not use Menitorix after the expiry date which is stated on the carton. ||| Do not use Circadin after the expiry date which is stated on the carton. ||| Ne pas utiliser Menitorix après la date de péremption mentionnée sur la boîte.
0.32897496223449707 ||| Patients who experience bortezomib-related neuropathic pain and/ or peripheral neuropathy are to be managed as presented in Table 1 (see section 4.4). ||| For VELCADE-related neuropathic pain and/ or peripheral neuropathy, hold and/ or modify VELCADE as outlined in Table 1. ||| Les patients qui présentent une douleur neurologique et/ ou une neuropathie périphérique liée au bortézomib doivent être pris en charge selon le tableau 1 (voir rubrique 4.4).
0.6689048409461975 ||| Ultrasonic probes, other than for medical use ||| Medical services, namely, in vitro fertilization ||| Sondes à ultrasons, autres qu'à usage médical
0.03467809408903122 ||| More patients had no circulating viral RNA after 24 weeks of treatment with ViraferonPeg than with interferon alfa-2b: ||| More patients had no circulating viral RNA after 24 weeks of treatment with PegIntron than with interferon alfa-2b: ||| Après 24 semaines de traitement, les patients ne présentant pas d’ ARN viral dans le sang étaient plus nombreux parmi ceux traités par ViraferonPeg que parmi ceux traités par interféron alfa-2b:
0.21174278855323792 ||| The pharmacokinetic interaction of Trevaclyn with statins has been studied only with simvastatin (see section 4.4). ||| Similarly, co-administration with tadalafil did not affect the pharmacokinetics of ambrisentan (see section 4.5). ||| Les interactions pharmacocinétiques de Trevaclyn avec les statines n’ ont été étudiées qu’ avec la simvastatine (voir rubrique 4.4).
0.31240764260292053 ||| Musculoskeletal and connective tissue disorders Frequency unknown: musculoskeletal pain including muscle spasm, myalgia, bone pain, arthralgia and pain in extremity. ||| Musculoskeleta, connective tissue and bone disorders Very rare (< 1/ 10,000) Arthralgia, arthritis, myalgia, pain in extremity ||| Affections musculo-squelettiques et systémiques Fréquence inconnue: douleurs musculo-squelettiques incluant spasmes musculaires, myalgies, douleurs osseuses, arthralgies et douleurs des extrémités.
0.11057144403457642 ||| Wash your hands with soap and warm water. ||| Wash your hands thoroughly with soap and water. ||| Lavez vous les mains avec du savon et de l’eau chaude.
0.39148637652397156 ||| The syringe should be well shaken in order to obtain a homogeneous turbid white suspension. ||| Before administration, the vaccine should be well shaken to obtain a slightly opaque, white suspension. ||| La seringue doit être bien agitée afin d'obtenir une suspension trouble blanche homogène.
0.29814600944519043 ||| The dose may need to be adjusted in patients who have problems with their kidneys or certain side effects. ||| Caution is needed when it is given to patients with kidney problems and the dose may need to be reduced. ||| Il peut être nécessaire d’ ajuster la dose chez des patients ayant des problèmes de reins ou présentant certains effets indésirables.
0.0735417902469635 ||| What Rebetol is and what it is used for 2. ||| What Prometax is and what it is used for 2. ||| Qu’ est -ce que Rebetol et dans quel cas est -il utilisé 2.
0.2618074417114258 ||| In a study in patients with type 1 diabetes mellitus after subcutaneous administration of 0.15 U/ kg, for insulin glulisine the Tmax was 55 minutes and Cmax was 82 ± 1.3 U/ ml compared to a Tmax of 82 minutes and a Cmax of 46 ± 1.3 U/ ml for regular human insulin. ||| 10 The mean AUC in 77 infants, children and adolescents receiving 6 mg/ kg emtricitabine once daily as oral solution or 200 mg emtricitabine as hard capsules once daily was similar to the mean AUC of 10.0 µg·h/ ml in 20 adults receiving 200 mg hard capsules once daily. ||| Dans une étude chez des patients diabétiques de type 1 après administration sous-cutanée de 0,15 U/ kg, pour l’ insuline glulisine le Tmax était de 55 minutes et la Cmax de 82 ± 1,3 μ U/ ml versus un Tmax de 82 minutes et une Cmax de 46 ± 1,3 μ U/ ml pour l’ insuline rapide humaine.
0.33469873666763306 ||| Pipetting instruments for surgical use ||| Gaseous mixtures for welding purposes ||| Instruments de pipetage à usage chirurgical
0.04947110265493393 ||| WHAT REMERON IS AND WHAT IT IS USED FOR ||| WHAT GEMZAR IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE REMERON ET DANS QUEL CAS EST-IL UTILISE
0.3526419997215271 ||| It also encourages EU countries to set up mechanisms for recovering compensation payments from the offender. ||| The Commission welcomes the measures taken by Member States to provide guarantees designed to support companies. ||| Elle encourage également les pays de l'UE à mettre en place des mécanismes permettant d'obtenir une indemnisation de la part de l'auteur de l'infraction.
0.36247068643569946 ||| The other study included 150 patients who took Sifrol for six months, and compared the effects of remaining on Sifrol or switching to placebo. ||| Xyrem also reduced excessive daytime sleepiness, in patients who continued to take modafinil, as well as in those who took Xyrem alone. ||| L’ autre étude, incluant 150 patients traités par Sifrol pendant six mois, a comparé les effets de la poursuite du traitement par Sifrol à ceux du passage au placebo.
0.5439926385879517 ||| Profender for small cats (≥0.5 - 2.5 kg) ||| Advocate for small dogs (≤ 4 kg) ||| Profender pour petits chats (≥ 0,5 – 2,5 kg)
0.14759774506092072 ||| - The other ingredients are: metacresol, sodium dihydrogen phosphate dihydrate, glycerol, sodium ||| - The other ingredients are: protamine sulphate, metacresol, phenol, zinc chloride, sodium ||| - Les autres composants sont: métacrésol, phosphate monosodique dihydrogéné dihydraté,
0.5239202976226807 ||| If you suffer from dizziness, do not drive or operate machines, which require your full concentration. ||| Do not wear very thin clothing because it will not protect you from strong light. ||| Si vous ressentez des étourdissements, ne conduisez pas de véhicules et n’ utilisez pas de machines, car ces actions nécessitent votre pleine concentration.
1.1044343709945679 ||| Lipostat 5/ 28 ||| 9/ 17 Ma rke tin gA ||| 5/ 30
0.13039328157901764 ||| In all studies, the main measure of effectiveness was the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled, before and at the end of the study. ||| The studies lasted between four months and two years and measured the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled. ||| Dans toutes les études, la principale mesure d’ efficacité était le niveau d’ une substance sanguine, l’ hémoglobine glycosylée (HbA1c), qui donne une indication de l’ efficacité du contrôle de la glycémie avant et à la fin de l’ étude.
0.467537522315979 ||| EMEA also made progress in improving transparency with the early publication of information on opinions adopted by our scientific committees. ||| Tables showing the Agency’s activities will be regularly published, together with European Public Assessment Reports detailing the scientific review carried out by the EMEA. ||| L’ Agence a également amélioré la transparence de ses opérations par une publication plus précoce des avis de ses comités scientifiques.
0.49706578254699707 ||| - In view of the available data, the CHMP considered that the benefit/ risk balance for Arcoxia ||| - The Committee, as a consequence, considered the benefit/ risk balance of medicinal products ||| - À la lumière des données disponibles, le CHMP a considéré que le rapport bénéfice/ risque pour
0.24327798187732697 ||| Lithuania notified to the Commission under the Temporary Framework a fund with a target size of up to €1 billion to provide liquidity and capital support to medium-sized and large enterprises in Lithuania affected by the coronavirus outbreak. ||| The Netherlands notified to the Commission under the Temporary Framework a guarantee scheme for working capital and investment loans granted by banks, to help Dutch companies meet their liquidity needs in the context of the coronavirus outbreak. ||| La Lituanie a notifié à la Commission, au titre de l' encadrement temporaire , la mise en place d'un fonds d'une taille cible pouvant aller jusqu'à 1 milliard d'euros destiné à fournir des liquidités et un soutien en capital aux moyennes et grandes entreprises en Lituanie touchées par la pandémie de coronavirus.
0.14308209717273712 ||| What is Viraferon used for? ||| What is Trevaclyn used for? ||| Dans quel cas Viraferon est -il utilisé? tn
0.5042496919631958 ||| Some 1,400 operations have been approved under the European Fund for Strategic Investments (EFSI), using a budget guarantee from the European Union and own resources from the EIB Group. ||| EU collective ODA consists of the total ODA spending of EU Member States and the ODA of EU institutions not attributed to individual Member States (notably own resources of the European Investment Bank). ||| Quelque 1 400 opérations ont été approuvées au titre du Fonds européen pour les investissements stratégiques (EFSI), grâce à une garantie budgétaire de l'Union européenne et à des ressources propres du Groupe BEI.
0.023488828912377357 ||| No pharmacokinetic interactions were noted between ViraferonPeg and ribavirin in a multiple-dose pharmacokinetic study. ||| No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study. ||| 154 Aucune interaction pharmacocinétique n’ a été notée entre ViraferonPeg et la ribavirine lors d’ une étude pharmacocinétique en dose multiple.
0.2693455219268799 ||| Skin and subcutaneous tissue disorders Common: pruritus Uncommon: ecchymosis ||| Infections and infestations: common: otitis media, pharyngitis uncommon: pneumonia ||| Affections de la peau et du tissu sous-cutané Fréquent: prurit Peu fréquent: ecchymose
0.4401465058326721 ||| When Tamiflu is used during a flu epidemic, this dose can be given for up to six weeks. ||| It may take up to 6 months for Herceptin to be removed from the body. ||| Si Tamiflu est utilisé lors d’ une épidémie de grippe, cette dose peut être prise pendant une période maximale de six semaines.
0.29995089769363403 ||| Atripla, your doctor may need to adjust your dose of the calcium channel blocker. ||| happens, your doctor may need to change the dose of your antiparkinson medicine ||| Lorsque vous commencez votre traitement par Atripla, votre médecin devra peut-être changer votre dose d’ inhibiteur de canal calcique.
0.48120617866516113 ||| Time to clinical cure was considered the primary end point. ||| The most significant prognostic factor is initial surgical treatment. ||| La durée jusqu’ à la guérison clinique était considérée comme le critère d'évaluation principal.
0.1714264452457428 ||| Metabolism and nutrition disorders Blood glucose decreased (< 55 mg/ dl) × Psychiatric disorders ||| Metabolism and nutrition disorders Blood glucose decreased (< 55 mg/ dl) × ||| Troubles du métabolisme et de la nutrition Baisse de la glycémie (< 55 mg/ dL) × Affections psychiatriques
0.021675018593668938 ||| The effects of Tarceva were first tested in experimental models before being studied in humans. ||| The effects of Pradaxa were first tested in experimental models before being studied in humans. ||| Les effets de Tarceva ont d’abord été testés sur des modèles expérimentaux avant d’être étudiés chez les humains.
0.43134254217147827 ||| When vardenafil is taken with a high fat meal (containing 57% fat), the rate of absorption is reduced, with an increase in the median tmax of 1 hour and a mean reduction in Cmax of 20%. ||| If renal function declines during maintenance therapy, reduce SIFROL daily dose by the same percentage as the decline in creatinine clearance, i. e. if creatinine clearance declines by 30%, then reduce the SIFROL daily dose by 30%. ||| Lorsque le vardénafil est pris avec un repas riche en graisse (contenant 57% de matières grasses), la vitesse d'absorption est diminuée, avec un allongement médian du Tmax de 1 heure et une baisse moyenne de la Cmax de 20%.
0.0 ||| You may hear a second click as the red button pops back up. ||| You may hear a second click as the red button pops back up. ||| Il se peut que vous entendiez un second clic lorsque le bouton rouge remonte
0.37344563007354736 ||| ENGERIX B should be injected intramuscularly in the deltoid region in adults and children or in the anterolateral thigh in neonates, infants and young children. ||| HBVAXPRO is usually given as an injection into the muscle of the thigh in babies and infants, and of the shoulder in children, adolescents and adults. ||| Ce vaccin doit être injecté par voie intramusculaire dans la région deltoïdienne chez les adultes et les enfants, ou dans la région antérolatérale de la cuisse chez les nouveau-nés, les nourrissons et les jeunes enfants.
0.21878018975257874 ||| Chemical preparations for sanitary purposes ||| Biological preparations for veterinary purposes ||| Produits chimiques pour l'hygiène à usage médical
0.45546191930770874 ||| The absolute bioavailability is reduced approximately 16% in patients with heart failure. ||| The risk of daytime hypoglycaemia was not significantly increased. ||| La biodisponibilité absolue est réduite d'environ 16% en cas d'insuffisance cardiaque.
0.31139427423477173 ||| On top of these market measures, the Commission proposed to allow Member States to use rural development funds to compensate farmers and small agri-food businesses with amounts of up to €5,000 and €50,000, respectively. ||| Direct grants, selective tax advantages and advance payments: Member States will be able to set up schemes to grant up to €800,000 to a company to address its urgent liquidity needs. ||| En plus de ces mesures de marché, la Commission a proposé d'autoriser les États membres à utiliser les fonds destinés au développement rural pour indemniser les agriculteurs et les petites entreprises agroalimentaires, à concurrence de 5 000 EUR pour les premiers et de 50 000 EUR pour les secondes.
0.0 ||| Mirtazapine ||| Mirtazapine ||| Mirtazapine Mirtazon
0.3013520836830139 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Comtan’ s benefits are greater than its risks as an adjunct to standard preparations of levodopa/ benserazide or levodopa/ carbidopa for use in patients with Parkinson’ s disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations. ||| Thus, the present application for Oracea (doxycycline 40 mg tablets) is not for a New Chemical Entity but aims to develop a formulation designed for once a day oral administration that could provide steady state doxycycline plasma concentrations at the anti-inflammatory level but not at the antimicrobial level. ||| Le comité des médicaments à usage humain (CHMP) a estimé que le rapport bénéfice-risque de Comtan était favorable comme adjuvant aux traitements standard par lévodopa/ bensérazide ou lévodopa/ carbidopa chez des patients atteints de la maladie de Parkinson et de fluctuations motrices de fin de dose qui ne peuvent être stabilisées avec ces associations.
0.17419296503067017 ||| 1.32 ||| 1.26 ||| 1,32
0.39542973041534424 ||| Glazing rollers for use with calendering machines ||| Tape readers for use with embroidery machines ||| Rouleaux satineurs pour calandres [machines]
0.4214141368865967 ||| Study 2 evaluated 652 patients with chronic plaque psoriasis using the same inclusion criteria as study 1 with the addition of a minimum psoriasis area and severity index (PASI) of 10 at screening. ||| All patients treated suffered from a major depressive disorder, the severity of which was assessed using a standard rating scale (the Hamilton Rating Scale for Depression, HAM-D). ||| 176 L’ étude 2 a évalué 652 patients atteints de psoriasis chronique en plaques avec les mêmes critères d’ inclusion que dans l’ étude 1 et un PASI ≥ 10 au moment du screening.
0.036490585654973984 ||| Like all medicines, Starlix can cause side effects, although not everybody gets them. ||| Like all medicines, Zerit can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Starlix est susceptible d’ avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.5347608923912048 ||| Hiccups, Pharyngolaryngeal pain, Dysphonia ||| constipation,, Hepato-biliary disorders ||| Hoquet, Douleur pharyngo-laryngée, Dysphonie
0.21420615911483765 ||| The effect of other H2 receptor antagonists (e. g. famotidine, ranitidine) and proton pump inhibitors (e. g. omeprazole) that may suppress gastric acidity for several hours on plasma levels of posaconazole has not been studied but a reduction in bioavailability may occur so that co- administration should be avoided if possible. ||| Administration of IntronA in combination with other chemotherapeutic agents (e.g., Ara-C, cyclophosphamide, doxorubicin, teniposide) may lead to increased risk of toxicity (severity and duration), which may be life-threatening or fatal as a result of the concomitantly administered medicinal product. ||| L’ effet d’ autres antagonistes des récepteurs H2 (e. g. famotidine, ranitidine) et inhibiteurs de la pompe à proton (e. g. oméprazole) pouvant supprimer l’ acidité gastrique pendant plusieurs heures n’ a pas été étudié sur les concentrations plasmatiques de posaconazole, mais une diminution de la biodisponibilité peut survenir d’ où la nécessité d’ éviter si possible l’ administration concomitante.
0.7085586190223694 ||| Gemcitabine/ cisplatin (N = 830) ||| Nadir Platelet Count (cells/μ l) ||| cisplatine (N = 830)
4.0161754130685345e-13 ||| Leave the patch on your skin for 24 hours, then remove it and apply a new one. ||| Leave the patch on your skin for 24 hours, then remove it and apply a new one. ||| Laissez le dispositif transdermique sur votre peau pendant 24 heures puis enlevez -le et appliquez -en un
0.22001904249191284 ||| Stapling guns (Electric -) for stationery use ||| Stapling guns (Hand-operated -) for surgical use ||| Pistolets agrafeurs électriques pour la papeterie
0.38669174909591675 ||| Cardiac dysfunction is a known complication of severe iron overload. ||| Severe sepsis is defined as sepsis associated with acute organ dysfunction. ||| Un dysfonctionnement de la fonction cardiaque est l’ une des complications connues de la surcharge en fer.
0.4963095188140869 ||| Levetiracetam is excreted in human breast milk. ||| In rats porfimer sodium passed into breast milk. ||| 31 Le lévétiracétam est excrété dans le lait maternel.
0.09365523606538773 ||| If Enbrel has no effect on your condition after 12 weeks, your doctor may tell you to stop taking this medicine. ||| If Enbrel has no effect on the child’ s condition after 12 weeks, your doctor may tell you to stop using this medicine. ||| Si Enbrel n’ a pas d’ effet après 12 semaines, votre médecin peut vous dire d’ arrêter le traitement.
0.37136396765708923 ||| Anti-fouling paints ||| Floating anti-pollution barriers ||| Peintures antifouling
0.22790470719337463 ||| Glaxo Group Ltd Berkeley Avenue Greenford Middlesex UB6 0NN United Kingdom ||| Glaxo Group Ltd Greenf ord Road Greenford Middlesex UB6 0NN United Kingdom ||| Glaxo Group Ltd Berkeley Avenue Greenford Middlesex UB6 0NN Royaume Uni
0.3110090494155884 ||| Supports adapted for use with solar heating tubes ||| Control units for amplifiers for use in vehicles ||| Supports conçus pour tubes de chauffage solaire
0.7073190212249756 ||| Folding multimeters ||| Letterpress printing ||| Multimètres pliants
0.08772111684083939 ||| Unused solution should be discarded. ||| Any unused solution must be discarded. ||| Toute solution non utilisée doit être jetée.
0.3485325574874878 ||| The main measure of effectiveness was the change in the level of HIV in the blood (viral load), after 4 or 24 weeks of treatment. ||| The main measure of effectiveness was the change in symptoms, including body temperature, breathing and recovery over a period of between two weeks and two months. ||| La principale mesure d’ efficacité était l’ évolution de la quantité de VIH dans le sang (charge virale) après 4 ou 24 semaines de traitement.
0.3256441056728363 ||| Once dissolved, the product should be used immediately (at least within 3 hours). ||| If it cannot be used immediately, the solution may be refrigerated for up to 24 hours. ||| Le produit doit être utilisé immédiatement et, en toute occurrence, dans les trois heures suivant la dissolution.
0.0 ||| This leaflet was last approved on {date} ||| This leaflet was last approved on {date} ||| La dernière date à laquelle cette notice a été approuvée est {date}
0.4362156391143799 ||| We need to ensure timely assistance and avoid negative consequences for the populations of conflict affected areas, who already are bearing a heavy burden." ||| These companies are typically the most affected in a crisis, and it is essential to support them with adequate liquidity so they can survive the crisis. ||| Nous devons apporter une aide en temps utile et éviter les conséquences négatives pour les populations des zones touchées par des conflits, qui paient déjà un lourd tribut.»
0.19187568128108978 ||| Uncommon side effects (affects 1 to 10 users in 1000) are: • increased heart rate, • low blood pressure, • shortness of breath, • heartburn (painful or burning sensation just below the breast bone), • haemorrhoids (piles), • accidental loss or leakage of urine, • increased need to pass water, • weight increase. ||| Common (experienced in less than 1 in 10 but more than 1 in 100 patients): • oral candidiasis • dehydration • dizziness • hearing impaired • decrease in blood pressure; irregular or rapid heart beat • heart failure • oesophagitis • dry mouth • difficulty or painful swallowing • haemorrhage • raised liver enzymes (hence the need for regular blood tests). ||| Les effets indésirables peu fréquents (observés chez au moins 1 patient sur 1000 et moins d’1 patient sur 100) sont: • accélération du rythme cardiaque, • tension artérielle basse, • acceleration de la respiration, • brûlures d’estomac (sensation de douleur ou de brûlure juste en-dessous du sternum), • hémorroïdes, • pertes d’urine accidentelles ou • fuites urinaires, • besoin accru d’uriner, • prise de poids.
0.41877591609954834 ||| Shaver sockets (Electric -) ||| Moulding powders (Foundry -) ||| Prises pour rasoirs électriques
0.13283930718898773 ||| The content of the syringe should be inspected visually both before and after shaking for any foreign particulate matter and/or abnormal physical appearance prior to administration. ||| 7 The vaccine should be visually inspected both before and after re-suspension for any foreign particulate matter and/ or change in physical appearance. ||| Avant administration, le contenu de la seringue doit être inspecté visuellement, avant et après agitation, pour détecter la présence de toute particule étrangère éventuelle et/ou toute altération de l’aspect physique.
0.43234187364578247 ||| België /Belgique / Belgien Pfizer S.A./ N.V. ||| België/ Belgique/ Belgien Luxembourg/ Luxemburg Wyeth Pharmaceuticals S. A. / N. V. ||| België / Belgique / Belgien Pfizer S. A. / N. V.
0.1141122579574585 ||| What is the risk associated with Mycamine? ||| What is the risk associated with Hycamtin? ||| Quel est le risque associé à l'utilisation de Mycamine?
5.742757072831062e-13 ||| A minor infection such as a cold should not be a problem, but talk to your doctor first. ||| A minor infection such as a cold should not be a problem, but talk to your doctor first. ||| Une infection sans gravité tel qu’ un rhume ne devrait pas être un problème, mais informez -en d’ abord votre médecin.
0.012336096726357937 ||| In the body, factor VIII is one of the substances (factors) involved in blood coagulation (clotting). ||| In the body, Factor IX is one of the substances (factors) involved in blood coagulation (clotting). ||| Dans le corps, le facteur VIII est l’ une des substances (facteurs) impliquées dans le processus de coagulation du sang.
0.3105109930038452 ||| Care must be taken when prescribing Prometax transdermal patches: • to patients with sick sinus syndrome or conduction defects (sino-atrial block, atrio-ventricular block) (see section 4.8) • to patients with active gastric or duodenal ulcers or patients predisposed to these conditions because rivastigmine may cause increased gastric secretions (see section 4.8) • to patients predisposed to urinary obstruction and seizures because cholinomimetics may induce or exacerbate these diseases. • to patients with a history of asthma or obstructive pulmonary disease. ||| Purevax RCP FeLV is used to vaccinate cats from the age of 8 weeks against the following diseases: • feline viral rhinotracheitis (a flu-like illness caused by a herpesvirus), • feline calicivirosis (a flu-like illness with inflammation of the mouth caused by a calicivirus), • feline panleucopenia (a serious illness causing bloody diarrhoea caused by a parvovirus), • feline leukaemia (an illness affecting the immune system caused by a retrovirus). ||| Les dipositifs transdermiques de Prometax seront prescrits avec prudence: • chez les patients présentant une maladie du nœ ud sinusal ou des troubles de la conduction cardiaque (bloc sino-auriculaire, bloc atrio-ventriculaire) (voir rubrique 4.8), • chez les patients présentant un ulcère gastrique ou duodénal en poussée, ou chez les patients qui y sont prédisposés, la rivastigmine étant susceptible d'augmenter la sécrétion gastrique (voir rubrique 4.8), • chez les patients prédisposés à une rétention urinaire et des convulsions car les cholinomimétiques peuvent induire ou aggraver de telles maladies, • chez les patients présentant des antécédents d’ asthme ou de bronchopneumopathie obstructive.
0.253325492143631 ||| The active substance of ProMeris, metaflumizone, interferes with the neural activity of the fleas and consequently leads to the death of these parasites. ||| Because iloprost is extensively metabolised by the liver, the plasma levels of the active substance are influenced by changes in hepatic function. ||| Le principe actif de ProMeris, la métaflumizone, agit sur l’ activité neurale des puces et provoque par conséquent la mort de ces parasites.
0.58498215675354 ||| Keep turning the cap until 6 is opposite the dosage indicator. ||| Oral dosing cup for measuring out the dose. ||| Faites encore tourner le capuchon jusqu’ à ce que le 6 se trouve en face de l’ indicateur de dose.
0.08964963257312775 ||| Patients should receive calcium or vitamin D supplements if they are not getting enough from their diet. ||| Patients should also take calcium supplements if they are not getting enough calcium from their diet. ||| Les patientes doivent prendre des suppléments en calcium ou en vitamine D si leurs apports alimentaires sont insuffisants.
0.36923661828041077 ||| When ritonavir is co-administered an increase in clarithromycin concentrations may occur. ||| When testosterone is given concomitantly with anticoagulants, the anticoagulant effect may increase. ||| La co-administration de ritonavir peut majorer l'augmentation des concentrations de la clarithromycine.
0.10222702473402023 ||| Myfenax may cause spontaneous abortions or damage, including problems with development of the ears, to your unborn baby. ||| This is because CellCept may cause spontaneous abortions or damage, including problems with development of the ears, to your unborn baby. ||| Ceci est dû au risque d’avortement spontané ou de lésions, incluant des problèmes de développement des oreilles, que Myfenax peut provoquer chez le fœtus.
0.5019241571426392 ||| Mosquito repellants for application to the skin ||| Instructions for injecting Binocrit under the skin ||| Répulsifs anti-moustiques à appliquer sur la peau
3.8892679224758475e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. ||| Si l’ un des effets indésirables devient sérieux ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin ou votre pharmacien.
0.32051002979278564 ||| France Novartis Pharma S. A. S. ||| Italia Novartis Farma S.p.A. ||| Novartis Pharma S. A. S.
0.10984227061271667 ||| 2 4.3 Contraindications ||| 3 4.3 Contraindications ||| 2 4.3 Contre-indications
0.002557455562055111 ||| 62 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 61 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 68 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMTS PRIMAIRES
0.5681967735290527 ||| Because this condition is slowly progressive, early detection and treatment is critical to achieve the best outcomes. ||| This disorder will persist during the entire life time of the patient and therefore the need for this treatment is lifelong. ||| En raison de la lente progression de cette affection, une détection et un traitement précoces s’ avèrent primordiaux pour obtenir les meilleurs résultats.
0.47942787408828735 ||| Therefore 70 mg twice daily remains the recommended dose schedule in imatinib-resistant or intolerant patients with advanced phase CML and Ph+ALL. ||| Treatment goal should be insulin-like growth factor (IGF-I) concentrations within 2 SDS from the age corrected mean of healthy adults. ||| Donc, 70 mg deux fois par jour reste le schéma de dose recommandé chez les patients résistants ou intolérants à l'imatinib dans les phases avancées de la LMC et la LAL Ph+
0.0 ||| In case of surgery or anaesthesia, you should tell your doctor that you are taking Kinzalmono. ||| In case of surgery or anaesthesia, you should tell your doctor that you are taking Kinzalmono. ||| En cas d’ opération chirurgicale ou d’ anesthésie, vous devez informer votre médecin que vous prenez Kinzalmono.
0.3978162109851837 ||| The rate and extent of absorption is unaffected by food intake, and thus Levviax tablets can be given without regard to food. ||| Consequently, the time-action profile of an insulin preparation is determined solely by its absorption characteristics. ic ed ||| L’ absorption reste inchangée lors de la prise simultanée d’ aliments; par conséquent, les comprimés de Levviax peuvent être pris indifféremment pendant ou en dehors des repas.
0.21834087371826172 ||| PSURs The PSUR cycle of Fertavid will correspond to the one attributed to the cross-referred product, Puregon, until otherwise specified. ||| The PSUR cycle of Docetaxel Winthrop is aligned with the cross-referred product, TAXOTERE, until otherwise specified. ||| PSURs La périodicité des PSURs de Fertavid correspondra à celle attribuée au produit de référence, Puregon, jusqu’ à ce qu’ il en soit décidé autrement.
0.5378941297531128 ||| Growing media, fertilizers and chemicals for use in agriculture, horticulture and forestry ||| Conveyors for agricultural and horticultural machinery and parts and fittings therefor ||| Milieux de culture, engrais et produits chimiques destinés à l’agriculture, l’horticulture et la sylviculture
0.515312135219574 ||| On 3 January 2008 the European Commission referred the matter to the Committee for Medicinal Products for Human Use (CHMP) in order to harmonise the marketing authorisations for Tritace in the EU and the EEA. ||| In this regard, they welcomed the "G20 Actions to Support World Trade and Investment in Response to COVID-19" endorsed by the G20 Trade and Investment Ministers. ||| Le 3 janvier 2008, la Commission européenne a transmis une saisine au comité des médicaments à usage humain (CHMP) visant à l’ harmonisation des autorisations de mise sur le marché pour Tritace dans l’ UE et dans l’ EEE.
0.40240421891212463 ||| Agenerase oral solution is contraindicated in patients with hepatic impairment or failure (see section 4.3) (see Summary of Product Characteristics of Agenerase Capsules for prescribing information) ||| The summaries of opinion of the Committee for Orphan Medicinal Products for Nexavar are available here (hepatocellular carcinoma) and here (renal cell carcinoma). ||| Agenerase solution buvable est contre-indiqué chez les patients ayant une insuffisance ou une défaillance hépatique (voir rubrique 4.3) (voir Résumé des Caractéristiques d’ Agenerase capsules molles).
0.2823599576950073 ||| Glitter for cosmetic purposes ||| Glue for industrial purposes ||| Paillettes à usage cosmétique
0.2155766636133194 ||| Page 15/ 30 ||| Page 28/ 30 ||| Page 17/ 34
0.038016702979803085 ||| 108 Prevention of anaemia of prematurity: ||| 168 Prevention of anaemia of prematurity: ||| Prévention de l'anémie du nouveau-né prématuré:
0.1440020203590393 ||| 13/ 22 ||| 11/ 22 ||| 13/ 23
0.22932493686676025 ||| HOW TO STORE STALEVO ||| HOW TO STORE ZALASTA ||| COMMENT CONSERVER STALEVO
0.3017047345638275 ||| MicardisPlus 80 mg/ 12.5 mg tablets are red and white, oval-shaped, two-layer tablets engraved with the company logo and the code'H8 '. ||| Tarceva 150 mg is supplied as a white to yellowish, round, film-coated tablet with ‘Tarceva 150’ and logo printed in brown on one side and is available in pack sizes of 30 tablets. ||| Les comprimé de MicardisPlus 80 mg/12,5 mg sont ovales rouge et blanc à deux couches portant le logo du laboratoire et le code ‘H8’.
0.1792733371257782 ||| Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Germany ||| Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany ||| Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Allemagne
0.4609755873680115 ||| No effects were detected in the post-natal development of rat pups. ||| About 12% of women in the clinical trials were postmenopausal. ||| Aucun effet n’ a été constaté dans le développement post-natal des rats nouveau-nés.
0.1763271689414978 ||| Suomi/ Finland sanofi-aventis Oy Puh/ Tel: +358 (0) 201 200 300 ||| Suomi/Finland sanofi-aventis Oy Puh/Tel: +358 (0) 201 200 300 ||| Suomi/Finland sanofi-aventis Oy Puh/Tel: +358 (0) 201 200 300
0.28178948163986206 ||| 4 In a long-term randomised (4 to 6 year) monotherapy study in recently diagnosed patients with type 2 diabetes mellitus, an increased incidence of bone fractures was noted after the first year of treatment in female patients taking rosiglitazone (9.3%, 2.7 patients per 100 patient years) vs metformin (5.1%, 1.5 patients per 100 patient years) or glyburide/ glibenclamide (3.5%, 1.3 patients per 100 patient years). ||| These studies include ACTG 240, where 105 paediatric patients ages 3 months to 6 years received Zerit 2 mg/ kg/ day for a median of 6.4 months; a controlled clinical trial where 185 newborns received Zerit 2 mg/ kg/ day either alone or in combination with didanosine from birth through 6 weeks of age; and a clinical trial where 8 newborns received Zerit 2 mg/ kg/ day in combination with didanosine and nelfinavir from birth through 4 weeks of age. ||| 4 Lors d'une étude à long terme (4 à 6 ans) en monothérapie randomisée chez des patients ayant un diabète de type 2 récemment diagnostiqué, une augmentation de l'incidence des fractures osseuses a été observée après la première année de traitement chez les patients de sexe féminin recevant rosiglitazone (9,3%, 2,7 patients pour 100 patients-année) vs metformine (5,1%, 1,5 patients pour 100 patients-année) ou glyburide/ glibenclamide (3,5%, 1,3 patients pour 100 patients-année).
0.36628830432891846 ||| In the main study, Fabrazyme was compared with placebo (a dummy treatment) in 58 patients. ||| 30 In the main dose-finding study, MARISA, ranolazine was used as monotherapy. ||| Dans l'étude principale, Fabrazyme a été comparé à un placebo (traitement fictif) chez 58 patients.
0.1537139117717743 ||| 19 In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population. ||| 41 In controlled clinical trials in adults, insulin glulisine did not show differences in safety and efficacy in subgroup analyses based on race and gender. ||| Dans les études cliniques, les analyses de sous-groupes (selon l'âge et le sexe) ne montrent aucune différence, en terme de tolérance ou d'efficacité, entre l'ensemble de la population étudiée et les différents sous-groupes de patients traités par l’ insuline glargine.
0.25575345754623413 ||| 324 5. ||| 429 5. ||| 5.
0.3852623999118805 ||| Anorexia Hyperglycaemia, weight decreased Hypokalemia, alkaline phosphatase increased, weight increased ||| Blood urea increased, Serum creatinine increased, Hyperkalaemia, Hepatic enzymes increased ||| Anorexie Hyperglycémie, perte de poids Hypokaliémie, augmentation des phosphatases alcalines, prise de poids
0.0 ||| 8000 IU/ 0.8 ml ||| 8000 IU/ 0.8 ml ||| 8 000 UI / 0,8 ml
0.4389445185661316 ||| Interactive telecommunications services ||| Interactive teletext services ||| Services de télécommunications interactives
1.1152310371398926 ||| p. m. deleted ||| (eds.). ||| p. m. supprimé
0.30605313181877136 ||| More extensive haemarthrosis, muscle bleeding or haematoma ||| Early haemarthrosis, muscle bleeding or oral bleeding ||| Hémarthrose plus importante, hémorragie musculaire ou hématome
0.47251513600349426 ||| Power-operated sprayers for insecticides ||| Naturally derived antimicrobials for dermatological use ||| Pulvérisateurs électriques pour insecticides
6.245930422171808e-13 ||| STATEMENT OF ACTIVE SUBSTANCE ||| STATEMENT OF ACTIVE SUBSTANCE ||| LISTE DU (DES) PRINCIPE(S) ACTIFS
0.328989714384079 ||| Filgrastim Hexal can also be used in people who are about to donate blood stem cells for transplant, to help release these cells from the bone marrow. ||| Due to the strong affinity of collagen to blood, TachoSil may also stick to surgical instruments or gloves covered with blood. ||| Filgrastim Hexal peut également être utilisé chez les personnes qui sont sur le point de donner des cellules souches de sang en vue d’ une transplantation, pour aider la moelle osseuse à produire ces cellules.
0.044905051589012146 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Stocrin to Merck Sharp & Dohme Limited on 28 May 1999. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Silgard to Merck Sharp & Dohme Ltd. on 20 September 2006. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Stocrin à Merck Sharp & Dohme Limited, le 28 mai 1999.
0.31775110960006714 ||| Absorption In a study performed in 8 patients with adrenal carcinoma treated with 2 to 3 g daily of mitotane, a highly significant correlation was found between plasma mitotane concentration and the total mitotane dose. ||| A significant correlation between saliva and plasma concentrations has been shown in adults and children (ratio of saliva/ plasma concentrations ranged from 1 to 1.7 for oral tablet formulation and after 4 hours post-dose for oral solution formulation). ||| Absorption Au cours d’ une étude chez 8 patients atteints de carcinome corticosurrénalien traités par 2 à 3 g de mitotane par jour, il a été observé une corrélation hautement significative entre la concentration plasmatique de mitotane et la dose totale de mitotane.
0.2093052864074707 ||| - if you develop symptoms associated with a cold or other respiratory infection, such as fever, cough, or any ||| - If you develop symptoms associated w ith a cold or other respiratory infection, such as fever, cough, ||| - si vous développez des symptômes comme ceux du rhume ou d’une autre affection respiratoire,
0.3016684651374817 ||| Early symptoms of low blood sugar are: shaking, sweating, faintness nervousness, palpitations hunger. ||| nasal congestion, or any allergic reaction such as an itchy skin rash, swelling, breathing difficulties or wheezing ||| Les premiers symptômes d’ une baisse de sucre dans le sang sont les suivants: • tremblements, transpiration, malaise • nervosité, palpitations • sensation de faim.
0.32810717821121216 ||| Previous preclinical safety studies performed with co-administration of telmisartan and hydrochlorothiazide in normotensive rats and dogs, in doses producing exposure comparable to that in the clinical therapeutic range, caused no additional findings not already observed with administration of either substance alone. ||| Another LHRH agonist could be used, but this is superfluous considering the meta-analysis presented by Applicant, orchidectomy is not acceptable when reversible methods are available, DES is obsolete and non-steroidal anti-androgens may have inferior efficacy when used as monotherapy. ||| Au cours des études précliniques précédemment réalisées avec l’ association telmisartan – hydrochlorothiazide chez le rat et le chien normotendus, des doses produisant une exposition comparable à celle observée dans la fourchette des doses thérapeutiques n’ ont pas montré d’ effets autres que ceux déjà observés avec les principes actifs pris individuellement.
0.40244558453559875 ||| However, you still need to take Agopton carefully to get the best results from it. ||| Therefore you should not stop using Rebif but continue to use it regularly to achieve the desired result. ||| Cependant, vous devez toujours prendre Agopton avec précaution afin d’en obtenir les meilleurs résultats.
0.5135253071784973 ||| Cryopreservation services ||| Pharmacovigilance system ||| Services de cryoconservation
0.04838062822818756 ||| 76 KRKA, d. d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenia ka ||| KRKA, d. d., Novo mesto, Š marješ ka cesta 6, 8501 Novo mesto, Slovenia ||| KRKA, d. d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenie ka
0.35647842288017273 ||| In clinical trials, weekly monitoring of the neutrophil count has been effective in identifying cases of neutropenia and agranulocytosis. ||| In some patients treated with INCRELEX, an ultrasound examination of the heart (echocardiogram) showed an increased size of the heart muscle. ||| Au cours des essais cliniques, la surveillance hebdomadaire du nombre de polynucléaires neutrophiles s’ est révélée efficace dans l’ identification des cas de neutropénie et d’ agranulocytose.
0.2365192472934723 ||| - if you are allergic (hypersensitive) to agomelatine or any of the other ingredients of Thymanax (see ||| - if you are allergic (hypersensitive) to shellfish, since glucosamine is manufactured from ||| - si vous êtes allergique (hypersensible) à l’ agomélatine ou à l’ un des autres composants de
0.3018941581249237 ||| This is not considered to be of significance to patient safety and therefore no dosage adjustments are necessary. ||| This decrease can be considered unlikely to be of clinical significance, thus requiring no dose reduction. ||| Cette augmentation n’ est pas significative en terme de tolérance et ne nécessite donc pas d’ ajustement posologique.
0.541590690612793 ||| Concomitant immunoglobulin administration may result in lower antibody titres. ||| Vaccinations Immunosuppressants may affect responses to vaccination. ||| L’ administration concomitante d’ immunoglobulines peut induire des titres en anticorps plus faibles.
0.17362257838249207 ||| Professional services relating to architectural design ||| Consultation services relating to architectural planning ||| Services professionnels en matière de conception architecturale
0.33088165521621704 ||| Check that the solution is clear, colourless and free of particles. ||| It is a clear, colourless solution with no particles visible. ||| Vérifier que la solution est limpide, incolore, et exempte de particules.
0.3240407705307007 ||| Irbesartan Hydrochlorothiazide BMS 300 mg/ 25 mg film-coated tablets. ||| AMMONAPS 940 mg/ g granules. sodium phenylbutyrate ||| Irbesartan Hydrochlorothiazide BMS 300 mg/ 25 mg comprimés pelliculés.
0.027980752289295197 ||| SAFETY The overall safety profile of paroxetine containing medicinal products was reviewed by the CHMP. ||| SAFETY The overall safety profile of loratadine containing medicinal products was reviewed by the CPMP. ||| SÉCURITÉ Le profil général de sécurité des médicaments contenant de la paroxétine a été réétudié par le CHMP.
0.32481324672698975 ||| When the patient undergoes a percutaneous coronary intervention, then the treatment can be continued for up to 20-24 hours after surgery, to a maximum of 96 hours. ||| Patients were to be treated until up to 72 hours after resolution of neutropaenia, with a maximum duration of 28 days. ||| Si une intervention coronarienne percutanée (ICP) est réalisée pendant le traitement par INTEGRILIN, la perfusion devrait être poursuivie pendant 20-24 heures après l'ICP en respectant une durée maximale de traitement de 96 heures.
2.688740885752744e-13 ||| - acute or chronic disease which may cause tissue hypoxia such as: ||| - acute or chronic disease which may cause tissue hypoxia such as: ||| - une maladie aiguë ou chronique pouvant entraîner une hypoxie tissulaire, telle que:
0.2879241704940796 ||| After the powder has dissolved (which usually occurs immediately), gently draw the solution back into the syringe. ||| Slowly (over a few seconds) inject the solution by gently depressing the plunger until the syringe is empty. ||| Une fois la poudre dissoute (ce qui habituellement se produit immédiatement), aspirez doucement la solution obtenue dans la seringue.
0.41103196144104004 ||| Computerised financial analysis ||| Computerised business research ||| Analyses financières informatisées
0.3179066479206085 ||| Each film-coated tablet contains 71.34 mg lactose. ||| 15 This product contains aspartame 1.75 mg per dose. ||| Chaque comprimé pelliculé contient 71,34 mg de lactose..
0.13630053400993347 ||| The combination of rifampicin and CRIXIVAN with concomitant low-dose ritonavir is contraindicated (see section 4.3). ||| Combination of rifampicin with PREZISTA with concomitant low dose ritonavir is contraindicated (see section 4.5). ||| L'utilisation concomitante de rifampicine et de CRIXIVAN, en association avec une faible dose de ritonavir, est contre- indiquée (voir rubrique 4.3).
0.012723144143819809 ||| With prolonged treatment for more than 2 years, regular reassessment is recommended to confirm that continuation of the selected therapy remains appropriate for the patient. ||| With prolonged treatment for more than 2 years, regular reassessment is recommended to confirm that continuing the selected therapy remains appropriate for the patient. ||| En cas de traitement prolongé d’ une durée supérieure à 2 ans, il est recommandé de vérifier régulièrement que la poursuite du traitement choisi reste appropriée pour le patient.
0.07329174876213074 ||| 5.8 ||| 5.9 ||| 5,8
0.36238759756088257 ||| 303 Adherence of the patient to the dosage and dietary regimen, correct insulin administration and awareness of hypoglycaemia symptoms are essential to reduce the risk of hypoglycaemia. ||| You should contact your doctor about the advisability of driving if you have: • frequent episodes of hypoglycaemia • reduced or absent warning signs of hypoglycaemia ||| Pour réduire le risque d'hypoglycémie, il faut absolument que le patient respecte les consignes posologiques et diététiques, administre correctement l'insuline et connaisse les symptômes de l'hypoglycémie.
0.9165083765983582 ||| Absorption is not influenced by food intake. ||| Alleviating the impact on the most deprived ||| L'absorption n'est pas influencée par la prise alimentaire.
0.7330200672149658 ||| The Monogram Trofile assay was used in the clinical studies of CELSENTRI. ||| Esri Portugal - Evolution of COVID-19 in Portugal with graphs and data ||| Le test de tropisme Trofile de Monogram a été utilisé au cours des essais cliniques CELSENTRI.
0.12944439053535461 ||| Read all of this leaflet carefully before you start using this medicine. ||| Read all of this leaflet before you start using this medicine: ||| Veuillez lire attentivement l'intégralité de cette notice avant d’utiliser ce médicament.
0.2780434489250183 ||| Prolongations in PR interval with lacosamide have been observed in clinical studies. ||| Impairments of sperm parameters have been observed among some patients treated with Rapamune. ||| Des allongements de l’ espace PR ont été observés au cours des études cliniques avec le lacosamide.
0.33540213108062744 ||| Such elevation in white blood cells is transient, typically seen 24 to 48 hours after administration and is consistent with the pharmacodynamic effects of Neulasta. ||| Multiples of MAC are used as a guide for surgical levels of anaesthesia, which are typically 1.3 to 1.5 times the MAC value. ||| Une telle élévation de leucocytes est transitoire, spécifiquement observée 24 à 48 heures après l’ administration et conforme aux effets pharmacodynamiques de Neulasta.
0.09560239315032959 ||| 11/ 39 A. ||| 14/ 34 A. ||| 11/ 43 A.
0.43050867319107056 ||| Leashes for bodyboards ||| Fabrics for bookbinding ||| Leashs de bodyboards
0.1389382779598236 ||| Advisory services relating to energy efficiency ||| Advisory services relating to money management ||| Services de conseil en matière d'efficacité énergétique
0.23829388618469238 ||| Consultancy services relating to hydrogeology ||| Consultancy services relating to geographical planning ||| Services de conseil en hydrogéologie
0.7069219350814819 ||| Pack size: ||| Batch number: ||| Taille de l’ emballage:
0.38665226101875305 ||| Method of administration ||| Organisation of training ||| Méthode d' administration
0.0 ||| 80-100 (pre- and post-operative) ||| 80-100 (pre- and post-operative) ||| Majeure 80-100 (pré et post-opératoire)
0.4806545078754425 ||| Horses should be monitored for oral lesions during treatment. ||| Treatment should be stopped if seizures occur. ||| Pendant le traitement, l'apparition de lésions orales doit être surveillée.
0.38204026222229004 ||| Dependence Use of benzodiazepines and benzodiazepine-like agents may lead to physical and psychic dependence. ||| Nephrotoxicity Dose-dependent nephrotoxicity is the major dose-limiting toxicity related to administration of cidofovir. ||| 3 Dépendance L'utilisation des benzodiazépines et des produits similaires aux benzodiazépines peut entraîner une dépendance physique et psychique.
0.3676910400390625 ||| Immunisation should be carried out by intramuscular injection. ||| The injection must be given intra-muscularly. ||| Administrer par voie intramusculaire.
0.29924365878105164 ||| Restrictions on free movement and internal border controls will need to be lifted gradually before we can remove restrictions at the external borders and guarantee access to the EU for non-EU residents for non-essential travel." ||| To help limit the transmission of the virus in Europe and beyond, the EU has closed its external borders to non-essential travel, while ensuring essential goods keep moving across the EU through the introduction of green lanes. ||| Nous devrons progressivement mettre fin aux restrictions de la libre circulation et aux contrôles aux frontières intérieures, avant de pouvoir lever les restrictions à l'entrée appliquées aux frontières extérieures et garantir l'accès à l'UE aux ressortissants de pays tiers.»
0.26931697130203247 ||| If you experience any of these symptoms, call your doctor immediately. ||| If at any time you have these thoughts, immediately contact your doctor. ||| Si vous présentez l’ un de ces symptômes, contactez immédiatement votre médecin.
0.3116024136543274 ||| In pregnant women, overdoses of calcium and vitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus. ||| The effect of nevirapine in HIV-positive adults is expected to be similar to that in paediatric patients and lopinavir concentrations may be decreased. ||| Chez la femme enceinte, tout surdosage en calcium et en vitamine D doit être évité car l’hypercalcémie permanente a été associée à des effets négatifs sur le développement du fœtus.
0.3172517418861389 ||| Patients of advanced age have an increased risk of bleeding complications with anticoagulation. ||| Research has shown an increased risk of birth defects in children of women taking anti-epileptic medicines. ||| Les patients d’ un âge avancé présentent un risque accru de complications hémorragiques avec les anticoagulants.
0.09556303918361664 ||| Preparation of reports relating to design ||| Preparation of reports relating to industrial design ||| Préparation de rapports concernant la conception
0.22639338672161102 ||| 25 April 2008 ||| 23 July 2008 ||| 25 avril 2008
0.13841818273067474 ||| Nervous system disorders Blood and the lymphatic system disorders ||| Blood and lymphatic system disorders Nervous system disorders ||| Affections du système nerveux Affections hématologiques et du système lymphatique
3.3346063540648507e-13 ||| If the co- administration of atazanavir with an NNRTI is required, an increase in the dose of both ||| If the co- administration of atazanavir with an NNRTI is required, an increase in the dose of both ||| administration de l'atazanavir avec les INNTIs est nécessaire, une augmentation à la fois de la dose d’ atazanavir et de ritonavir respectivement à 400 mg et à
0.28747791051864624 ||| Patients with concomitant acute pulmonary infections, COPD and severe asthma should be carefully monitored. ||| Patients who have severe diarrhoea or vomiting should be monitored closely for breakthrough fungal infections. ||| La nébulisation chez les patients présentant une infection pulmonaire aiguë, une BPCO ou un asthme sévère devra être réalisée sous surveillance.
0.0 ||| STATEMENT OF ACTIVE AND OTHER SUBSTANCES ||| STATEMENT OF ACTIVE AND OTHER SUBSTANCES ||| LISTE DES PRINCIPES ACTIFS ET AUTRES SUBSTANCES
0.31735384464263916 ||| Lift the plastic flip-top and remove the crimp from the vial. ||| Remove flip-top from the vial and wipe the top with a 70% alcohol swab. ||| Soulever l’ opercule plastique rabattable et retirer le sertissage du flacon.
0.43575042486190796 ||| Onsenal is used to reduce the number of gastrointestinal polyps in patients with Familial Adenomatous Polyposis (FAP). ||| Among the opportunistic infections are BK virus associated nephropathy and JC virus associated progressive multifocal leukoencephalopathy (PML). ||| Onsenal est utilisé pour réduire le nombre de polypes gastro-intestinaux chez les patients présentant une Polypose Adénomateuse Familiale (PAF).
0.2731933295726776 ||| The syrup contains aspartame (E951), a source of phenylalanine, which may be harmful for people with phenylketonuria. ||| Azagly-nafarelin is a peptide that is primarily degraded by peptidases and not by cytochrome P-450 enzymes. ||| Le sirop contient de l’ aspartame (E 951), source de phénylalanine, qui peut s’ avérer nocif chez les personnes souffrant de phénylcétonurie.
0.3246561884880066 ||| diarrhoea, abdominal pain, stomatitis and mouth ulceration, nausea ||| Nausea, diarrhoea, dyspeptic signs and symptoms ||| isé Oedème pulmonaire, œ dème pharyngé, Rare épanchement pleural, pleurésie.
0.14631298184394836 ||| 22.5% ||| 22.2% ||| 22,5%
0.17424455285072327 ||| 151 ||| 153 ||| 158
0.6793798208236694 ||| Ataxia Paresthesia Vertigo Sleepiness ||| Dizziness, Paresthesia, Dysgeusia ||| Paresthésie Vertiges Somnolence
0.49602529406547546 ||| 38 Pharmacokinetic parameter estimates for ReFacto in previously treated patients with haemophilia A ||| Data to support dose titration in rheumatoid arthritis come from ATTRACT, ASPIRE and the START study. ||| Estimation des paramètres pharmacocinétiques de ReFacto chez des patients préalablement traités atteints d’ hémophilie A
0.5692026615142822 ||| After 18 months of treatment retinal atrophy was observed. ||| One treatment prevents future flea infestation for 4 weeks. ||| Après 18 mois de traitement une atrophie rétinienne a été observée.
0.2709627151489258 ||| Co-administration of nifedipine with 100 mg acetylsalicylic acid does not alter the effect of acetylsalicylic acid on platelet aggregation or bleeding time. ||| Salicylates In case of high dosages of salicylates hydrochlorothiazide may enhance the toxic effect of the salicylates on the central nervous system. ||| La co-administration de nifédipine avec 100 mg d’ acide acétylsalicylique n’ altère pas l’ effet de l’ acide acétylsalicylique sur l’ agrégation plaquettaire ou le temps de saignement.
0.0 ||| See leaflet for further information. ||| See leaflet for further information. ||| Consulter la notice pour plus d'information.
0.35983842611312866 ||| EU State aid rules and more specifically the Rescue Aid and Restructuring Guidelines, which are based on article 107(3)(c) TFEU, enable Member States to help companies cope with liquidity shortages and needing urgent rescue aid. ||| State aid rules based on Article 107(3)(c) TFEU enable Member States to help companies cope with liquidity shortages and needing urgent rescue aid. ||| les règles de l'UE en matière d'aides d'État et, plus précisément, les lignes directrices concernant les aides au sauvetage et à la restructuration, qui sont fondées sur l' article 107, paragraphe 3, point c) , du TFUE, permettent aux États membres d'aider les entreprises à faire face à une pénurie de liquidités et à un besoin urgent d'aide au sauvetage.
0.12275640666484833 ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| If any serious effects or other effects not mentioned in this leaflet are noticed, please ensure the veterinary surgeon is informed. ||| Si vous constatez d’ autres effets indésirables, veuillez en informer votre vétérinaire.
0.42069923877716064 ||| For example, companies may need to coordinate on production stock management and potentially distribution so that not all undertakings focus on one or a few medicines, while others remain in under-production. ||| Delivering on this complex undertaking requires running clinical trials in parallel with investing in production capacity to be able to produce millions, or even billions, of doses of a successful vaccine. ||| Des entreprises pourraient ainsi devoir se coordonner pour la production, la gestion des stocks et, éventuellement, la distribution afin que toutes les entreprises ne concentrent pas leur activité sur un ou quelques médicaments tandis que d'autres restent en situation de sous-production.
0.1740996092557907 ||| The dose may need to be adjusted in patients who have problems with their kidneys or certain side effects. ||| The dose needs to be lowered for patients who have problems with their kidneys, using the oral solution. ||| Il peut être nécessaire d’ ajuster la dose chez des patients ayant des problèmes de reins ou présentant certains effets indésirables.
0.0 ||| PHARMACEUTICAL FORM AND CONTENTS ||| PHARMACEUTICAL FORM AND CONTENTS ||| FORME PHARMACEUTIQUE ET CONTENU
0.17834585905075073 ||| What is AVAMYS used for? ||| How is AVAMYS used? ||| Dans quel cas AVAMYS est -il utilisé?
0.24621626734733582 ||| Decreases in bone resorption as judged by a reduction in urinary hydroxyproline and deoxypyridinoline are observed following calcitoinin treatment in both normal volunteers and patients with bone-related disorders, including Paget’ s disease and osteoporosis. ||| The indication was reworded to state ciprofloxacin's utility in Gram negative bacterial infections of the lower respiratory track causing exacerbations of chronic obstructive pulmonary disease, bronchopulmonary infections in cystic fibrosis or in bronchiectasis and pneumonia. ||| Une diminution de la résorption osseuse, mise en évidence par une réduction de l'hydroxyproline et de la désoxypyridinoline urinaires, a été observée après un traitement par la calcitonine chez des volontaires sains et chez des patients atteints de troubles d'origine osseuse, y compris la maladie de Paget et l'ostéoporose.
0.352221816778183 ||| Critical Evaluation A number of areas of disharmony in the product information for Diovan have been evaluated by the CHMP and a revised PI was adopted. ||| However, as the Codex Committee has not yet reached a conclusion, the revision of the CVMP guideline on injection site residues was deferred. ||| Évaluation critique Un certain nombre de points divergents dans les informations du produit Diovan ont été évalués par le CHMP et une notice révisée a été adoptée.
0.00959082506597042 ||| 32 Incidence of undesirable effects considered related to treatment with Nespo from controlled clinical studies are: ||| 20 Incidence of undesirable effects considered related to treatment with Nespo from controlled clinical studies are: ||| L'incidence des effets indésirables considérés comme étant reliés au traitement par Nespo dans les études cliniques contrôlées est:
0.0 ||| Vasculitis ||| Vasculitis ||| Vascularite
0.3494671583175659 ||| Maintenance and servicing of fire alarm systems ||| Maintenance and updating of software for communication systems ||| Entretien et révision de systèmes d'alarme incendie
0.33295097947120667 ||| Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. ||| Renal effects Renal prostaglandins may play a compensatory role in the maintenance of renal perfusion. ||| Le gluconate de calcium administré par voie intraveineuse peut être utile pour inverser les effets du blocage des canaux calciques.
0.6923446655273438 ||| Adoption placement ||| Immersion probes ||| Services d'adoption
0.5994235873222351 ||| Hypersensitivity, anaphylactic reaction ||| Photosensitivity reaction, photodermatosis ||| Hypersensibilité, réactions anaphylactique
0.6249083876609802 ||| Electronic musical apparatus and instruments ||| Mechanical, electric and electronic musical instruments ||| Équipements et instruments de musique électroniques
0.1089518591761589 ||| On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day as described above. ||| On the basis of the clinical studies, the recommended dose for patients over the age of 65 years is 20 mg per day (20 mg once a day) as described above. ||| Personnes âgées: sur la base des études cliniques, la dose recommandée pour les patients de plus de 65 ans est de 20 mg par jour, comme décrit ci-dessus.
0.17440888285636902 ||| EXULETT is a powder that is made up into a solution for infusion (drip into a vein). ||| ORENCIA is a vial containing a powder to be made up into a solution for infusion. ||| EXULETT est une poudre destinée à être reconstituée en une solution pour perfusion (goutte-à-goutte dans une veine).
0.3138989806175232 ||| Hepatic impairment ||| Hepatic impaired patients ||| Insuffisant hépatique
0.5898889899253845 ||| Pick up the sterile syringe. ||| Leave the syringe to warm up ||| Prenez la seringue stérile.
0.45157361030578613 ||| Authorisation Holders have been assessed based on the documentation submitted and the scientific discussion within the Committee, ||| Annual reports will be submitted as part of annual reassessment of the Marketing Authorisation issued under exceptional circumstances. ||| d'autorisations de mise sur le marché ont été évalués en s’ appuyant sur la documentation fournie et sur la discussion scientifique au sein du Comité,
0.2946208119392395 ||| They are available in packs of 10, 5x2, 14, 20 and 100 tablets. ||| Packs of 3, 4, 5, 6, 9 and 10 cartridges of 3 ml are available. ||| Levviax est disponible en boîtes de 10, 5 x 2,14, 20 et 100 comprimés.
0.33543574810028076 ||| More patients had no circulating viral RNA after 24 weeks of treatment with ViraferonPeg than with interferon alfa-2b: ||| Nevirapine had no antiviral activity in vitro against isolates from group O HIV-1 and HIV-2. ||| Après 24 semaines de traitement, les patients ne présentant pas d’ ARN viral dans le sang étaient plus nombreux parmi ceux traités par ViraferonPeg que parmi ceux traités par interféron alfa-2b:
0.449582576751709 ||| Hypoxia Haemoptysis Bronchospasm Coughing ||| Headache Shunt thrombosis Thrombocytosis ||| Hypoxie Hémoptysie Bronchospasme Toux
0.05750412493944168 ||| If you forget to take Epivir If you forget to take a dose of Epivir, take it as soon as you remember and then continue as before. ||| If you forget to take Telzir If you forget to take a dose of Telzir, take it as soon as you remember and then continue your treatment as before. ||| Si vous oubliez de prendre Epivir Prenez la dose oubliée dès que possible, puis poursuivez votre traitement selon la prescription de votre médecin.
0.1353125274181366 ||| 18 Do not store above 30°C. ||| 119 Do not store above 30 °C. ||| A conserver à une température ne dépassant pas 30°C.
0.2002040296792984 ||| 26.65 mg of lactose monohydrate per tablet. ||| 103.95 mg lactose monohydrate per tablet ||| 26,65 mg de lactose monohydraté par comprimé.
0.44874781370162964 ||| The application should cover the best support work processes and also document archiving in order to allow for cost effective access to any document at any time. ||| 40 Electronic access to application dossiers and their maintenance is a key priority and the ATS will facilitate this aspect of effective document management. ||| Le programme devra utiliser les meilleures méthodes de travail et d’archivage des documents pour permettre un accès permanent à tous les documents de la manière la moins onéreuse.
0.12147171795368195 ||| Hepatobiliary disorders Asymptomatic elevations of serum transaminases, in most cases mild and transient, occurred very commonly in patients treated with Extavia during clinical trials. ||| Asymptomatic elevations of serum transaminases, in most cases mild and transient, occurred very commonly in patients treated with Betaferon during clinical trials. ||| Affections hépatobiliaires Une élévation asymptomatique des transaminases sériques, dans la plupart des cas légère et transitoire, s’ est produite très fréquemment chez les patients traités par Extavia au cours des essais cliniques.
0.31015557050704956 ||| 1.230 ml ||| 5.33 ml ||| 1,230 ml
0.6237403154373169 ||| Since no freezing studies have been performed the SPC must contain the note: ||| No PSURs were submitted as the product is not yet marketed. ||| Comme aucune étude de congélation n’ a été réalisée, le RCP doit porter la mention:
0.2624058127403259 ||| Co-administration may result in competitive inhibition of the metabolism of these active substances thus increasing their plasma levels and leading to serious and / or life-threatening adverse reactions such as cardiac arrhythmia (e. g. amiodarone, astemizole, bepridil, cisapride, pimozide, quinidine, terfenadine) or peripheral vasospasm or ischaemia (e. g. ergotamine, dihydroergotamine). ||| This phenomenon is called serotonin syndrome and may occur in rare cases in connection with the simultaneous use of a selective serotonin reuptake inhibitor [SSRI] together with certain antimigraine drugs (such as sumatriptan, dihydroergotamine), or along with certain opioids (such as pentazocine, pethidine, fentanyl, dextromethorphan), or in the case of simultaneous use of two SSRIs. ||| Leur administration concomitante peut entraîner une inhibition compétitive du métabolisme de ces substances actives, induisant ainsi une augmentation de leur concentration plasmatique et un risque de survenue d'effets indésirables graves et/ ou pouvant mettre en jeu le pronostic vital comme: arythmie cardiaque (ex: amiodarone, astémizole, bépridil, cisapride, pimozide, quinidine, terfénadine) ou vasoconstriction périphérique ou ischémie (ex: ergotamine, dihydroergotamine).
0.5706456899642944 ||| Applications are made to the Member States selected by the applicant and the procedure operates by mutual recognition of national marketing authorisations. ||| The facility will be accessible to all Member States, initially based on national envelopes, through calls for proposals that meet the following criteria: ||| auprès des États membres choisis par le demandeur et la procédure fonctionne par reconnaissance mutuelle des autorisations nationales de mise sur le marché.
0.2908022105693817 ||| Single doses up to 4.5 mg/ kg have been administered intravenously in clinical studies without dose-limiting toxicity. ||| Approximately dose-linear pharmacokinetics were observed in healthy volunteers after single dose administration up to 250 micrograms/ kg. ||| Des doses uniques allant jusqu’ à 4,5 mg/ kg ont été administrées par voie intraveineuse au cours des études cliniques sans qu’ une dose limite toxique n’ ait été observée.
0.40515995025634766 ||| Escalation and maintenance doses should be adjusted according to clinical response (see section 5.2). ||| Estimates were calculated by hazard ratios 2) Last tumour response as assessed by the investigator. ||| Les augmentations posologiques et les posologies d’ entretien doivent être ajustées en fonction de la réponse clinique (voir rubrique 5.2).
4.685567797473034e-13 ||| musculoskeletal pain* ||| musculoskeletal pain* ||| hypotension orthostatique*
0.6546236276626587 ||| Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12.5 mg ||| Alcohol (12%w/w) Castor Oil Polyoxyl 35 ||| Irbesartan Hydrochlorothiazide Winthrop 150 mg/ 12,5 mg
0.18790128827095032 ||| 28 film-coated tablets 84 film-coated tablets ||| 1 film-coated tablet 3 film-coated tablets ||| 84 comprimés pelliculés.
0.30237823724746704 ||| In addition, tigecycline did not show NADPH-dependency in the inhibition of CYP2C9, CYP2C19, CYP2D6 and CYP3A, suggesting the absence of mechanism-based inhibition of these CYP enzymes. ||| Stiripentol is an inhibitor of the enzymes CYP2C19, CYP3A4 and CYP2D6 and may markedly increase the plasma concentrations of drugs metabolised by these enzymes and increase the risk of adverse effects (See, section 4.5.). ||| De plus, l’ inhibition des cytochromes CYP2C9, CYP2C19, CYP2D6 et CYP3A ne dépend pas de la NADPH, ce qui suggère l’ absence d’ inhibition compétitive de ces enzymes.
0.12262587994337082 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Mirapexin on 23 February 1998. ||| The European Commission granted a marketing authorisation valid throughout the European Union for DEXDOMITOR on 30 August 2002. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Mirapexin le 23 février 1998.
0.079200878739357 ||| WHAT PROTELOS IS AND WHAT IT IS USED FOR ||| WHAT APIDRA IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE PROTELOS ET DANS QUEL CAS EST-IL UTILISE
0.39798295497894287 ||| Dialysis clearance of perindoprilat is equal to 70 ml/ min. ||| with creatinine clearance < 50 ml/minute and/or on haemodialysis. ||| La clairance de dialyse du périndoprilate est de 70 ml/ min.
0.17259547114372253 ||| However, patients should be informed that dizziness has been reported during treatment with emtricitabine. ||| However, patients should be informed that dizziness and blurred vision have been reported during treatment with indinavir. ||| Les patients doivent toutefois être informés que des vertiges ont été rapportés au cours du traitement par l’ emtricitabine.
0.39345431327819824 ||| After vaccination, painful swelling or hardened nodules occur commonly at the site of vaccination. ||| Attention should be paid to sudden stabbing migraine-like headaches as a possible warning signal. ||| Après la vaccination, un œ dème douloureux ou des nodules indurés apparaissent fréquemment au point d’ injection de la vaccination.
0.3915642499923706 ||| In Phase 3 clinical studies, infection-related serious adverse events were more frequently reported for subjects treated with tigecycline (6.7%) vs comparators (4.6%). ||| In clinical trials, sixty seven percent (67%) of the patients experienced at least one infusion-associated reaction (See section 4.8). ||| Dans les études cliniques de phase 3, les événements indésirables graves liés aux infections ont été plus fréquents chez les patients traités par la tigécycline (6,7%) que chez les patients recevant les médicaments de comparaison (4,6%).
0.3596073389053345 ||| If severe polycythaemia occurs, conventional methods (phlebotomy) may be indicated to decrease the haemoglobin level. a in ic ||| The dermal toxicity typically begins as erythema; with continued application of Panretin gel erythema may increase and oedema may develop. ||| Si une polyglobulie survient, les méthodes conventionnelles (phlébotomie) peuvent être indiquées pour diminuer le taux d’ hémoglobine. m
0.3674769103527069 ||| In case of concomitant antiviral therapy for hepatitis B or C, please refer also to the relevant Summary of Product Characteristics for these medicinal products. ||| Further advice for the veterinary surgeon - see section 4.8 of the Summary of Product Characteristics for further information on interactions with other medicinal products. ||| En cas d’ administration concomitante d’ un traitement antiviral de l’ hépatite B ou C, veuillez consulter le Résumé des Caractéristiques du Produit de ces médicaments.
0.3515819013118744 ||| In a 20-week study, as well as reducing fasting triglycerides, pioglitazone reduced post prandial hypertriglyceridaemia through an effect on both absorbed and hepatically synthesised triglycerides. ||| Efient showed superior efficacy compared to clopidogrel in reducing the primary composite outcome events as well as the pre-specified secondary outcome events, including stent thrombosis (see Table 3). ||| Dans une étude sur 20 semaines, la pioglitazone a réduit l’ hypertriglycéridémie post-prandiale, ainsi que les triglycérides à jeûn, par un effet sur les triglycérides absorbés et ceux synthétisés par le foie.
0.603325366973877 ||| Forwarding of letters ||| Duplicating of films ||| Acheminement de lettres
0.33333826065063477 ||| In rabbits, a treatment related increase in cardiovascular malformations was observed at exposure levels below the clinical exposure at the daily human dose (90 mg). ||| A tendency was observed in infantile patients treated with a higher dose (40 mg/ kg) to experience more symptoms when developing IARs. ||| Chez le lapin, une augmentation des malformations cardiovasculaires liée au traitement a été observée pour des niveaux d’ exposition inférieurs à l’ exposition clinique à la dose thérapeutique quotidienne chez l’ homme (90 mg).
0.26991426944732666 ||| The Marketing Authorisation Holders presented oral explanations to the CVMP on 18 June 2008. ||| Oral explanations were presented on 10 October 2007 by the Marketing Authorisation Holder to the Committee. ||| Ces derniers ont présenté des explications orales au CVMP le 18 juin 2008.
0.15652485191822052 ||| Myfenax is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. ||| CellCept 1 g/ 5 ml powder for oral suspension is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. ||| Myfenax est indiqué en association à la ciclosporine et aux corticoïdes pour la prévention des rejets aigüs d’ organe chez les patients ayant bénéficiés d’ une allogreffe rénale, cardiaque ou hépatique.
0.41944265365600586 ||| Bases adapted for the mounting of lamps ||| Compounds for patching cracks in vehicles ||| Supports conçus pour le montage de lampes
0.24951207637786865 ||| Patients allergic to tetracycline antibiotics may also be allergic to Tygacil. ||| Patients hypersensitive to tetracycline class antibiotics may be hypersensitive to tigecycline. ||| Les patients allergiques à la tétracycline sont également susceptibles d’ être allergiques à Tygacil.
0.5174622535705566 ||| The dose should be adjusted on the basis of laboratory assessment for each individual case. ||| This can be by a reception or clinician staff, depending on individual practice protocol. ||| La posologie doit être adaptée en fonction des résultats des dosages pour chaque patient.
0.2530800700187683 ||| Yondelis 1 mg powder for concentrate for solution for infusion Trabectedin ||| Enbrel 25 mg powder for solution for injection Etanercept ||| Yondelis 1 mg, poudre pour solution à diluer pour perfusion Trabectédine
0.17420326173305511 ||| Sign boards [mechanical] ||| Metal signboards [mechanical] ||| Panneaux [mécaniques]
0.636406660079956 ||| under the curve) *CI – Confidence Interval ||| K-M median (95% Confidence Interval) ||| (aire sous la courbe)
0.46475496888160706 ||| This reconstituted solution may be stored for up to 24 hours at or below 25°C. ||| The reconstituted final solution is stable for 24 hours at 25°C. ||| Cette solution reconstituée peut être conservée jusqu’ à 24 heures à une température ne dépassant pas 25°C.
0.2146032750606537 ||| Boots for sports ||| Rings for sports ||| Chaussures de sport
0.005226415582001209 ||| 22 3 Observed for fasting normal levels at baseline (< 5.17 mmol/ l) which increased to high (≥ 6.2 mmol/ l). ||| 78 3 Observed for fasting normal levels at baseline (< 5.17 mmol/ l) which increased to high (≥ 6.2 mmol/ l). ||| 3 Observée pour des taux à jeun normaux au début du traitement (< 5.17mmol/ l) qui sont devenus élevés (≥ 6.2mmol/ l).
0.012475540861487389 ||| 10/ 17 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 11/ 20 PARTICULARS TO APPEAR ON THE OUTER PACKAGE ||| 10/ 18 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.4267841577529907 ||| 12 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR SINGLE BOTTLE 2.5 ml + CARTON FOR 3x2.5 ml BOTTLES ||| 200 MG/ 50 MG TABLETS - INNER CARTON OF 40 FILM-COATED TABLETS (5 FOIL BLISTERS OF 8 FILM-COATED TABLETS) ||| 12 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR ETUI POUR FLACON UNIQUE 2,5 ml + ETUI CONTENANT 3 FLACONS DE 2,5 ml
0.2742937207221985 ||| Tadalafil Lilly belongs to a group of medicines called phosphodiesterase type 5 inhibitors. ||| Hydrochlorothiazide belongs to a group of medicines called thiazide diuretics. ||| Tadalafil Lilly appartient à un groupe de médicaments appelés inhibiteurs de la phosphodiestérase de type 5.
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Si votre médecin vous a dit que vous aviez une intolérance à certains sucres, contactez -le avant de prendre ce médicament.
0.20016631484031677 ||| ori ||| EXP ||| tor
0.30442526936531067 ||| Ventavis brings down blood pressure and may cause dizziness or light-headedness in some people. ||| Fast improvement in blood glucose control may cause disturbed sensation (numbness, weakness or pain) in legs or arms. ||| Ventavis fait baisser la pression artérielle dans l’ organisme et peut provoquer des sensations vertigineuses ou de malaises chez certains sujets.
0.4125968813896179 ||| Spinal / Epidural anaesthesia In patients receiving fondaparinux for treatment of VTE rather than prophylaxis, spinal/ epidural anaesthesia in case of surgical procedures should not be used. ||| au Psoriatic arthritis clinical trials: elevations in ALT were more common in psoriatic arthritis patients (Studies VI-VII) compared with patients in rheumatoid arthritis clinical studies. ||| 48 Rachianesthésie/ Anesthésie péridurale Chez les patients recevant le fondaparinux à titre curatif pour le traitement d’ évènements thrombo- emboliques veineux, à la différence du traitement préventif, les anesthésies péridurales ou les rachianesthésies ne doivent pas être utilisées lors d’ actes chirurgicaux.
0.2596683204174042 ||| In addition benzalkonium chloride may cause eye irritation and is known to discolour soft contact lenses. ||| Benzalkonium chloride may be absorbed by soft contact lenses and is known to discolour soft contact lenses. ||| De plus le chlorure de benzalkonium peut conduire à une irritation oculaire et est connu pour teinter les lentilles de contact souples.
0.3494718670845032 ||| International Baccalaureate exams have also been cancelled.School closures impact not only students, teachers, and families, but have far-reaching economic and societal consequences. ||| As of 29 March, nearly 90% of the world's learners were impacted by closures.Even when school closures are temporary, it carries high social and economic costs. ||| Les épreuves du baccalauréat international ont également été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de lourdes conséquences économiques et sociales.
0.09915421903133392 ||| The vaccine is to be administered aseptically by intramuscular injection closely behind the ear of the ||| is The vaccine is to be administered aseptically by intramuscular injection closely behind the ear. ||| s La vaccination est effectuée dans des conditions aseptiques par injection intramusculaire
0.3998827636241913 ||| If you have pain, redness, swelling or sores in your mouth (very common). ||| - if you experience a cough, fever and difficulty breathing. ||| Si vous avez une douleur, une rougeur, un gonflement ou des plaies au niveau de la bouche (très fréquent).
0.7439868450164795 ||| Five minutes after administration, the baseline values had been reached again. ||| Overall, reports were more common after IV administration. ||| Un retour aux valeurs initiales est observé cinq minutes après l’ administration du produit.
0.5974744558334351 ||| Key objectives for technical co-ordination..................................................... ||| Chapter 2 Key objectives for administration.......................................... ..15 ||| Objectifs clés pour la coordination technique...................................................
0.45226889848709106 ||| It was considered that a decision will be taken according to the responses given on quality and clinical concerns. ||| In assessing the application, the expert shall perform the tasks falling within his discipline and describe objectively the results obtained. ||| Il a été décidé qu’ une décision serait prise en fonction des réponses apportées aux questions relatives à la qualité et aux inquiétudes cliniques.
0.4019278883934021 ||| The administration of a non-steroidal anti-inflammatory drugs may reduce the antihypertensive effect of ACE inhibitors. ||| The use of two local beta-adrenergic blocking agents or two local carbonic anhydrase inhibitors is not recommended. ||| L’ administration d’ AINS peut réduire l’ effet anti-hypertenseur des IEC.
0.9658684730529785 ||| Difference ||| Facilities ||| Différence min
0.37361061573028564 ||| Neupopeg contains the active substance pegfilgrastim. ||| Fosamprenavir contains a sulphonamide moiety. ||| Neupopeg contient comme substance active pegfilgrastim.
0.5333674550056458 ||| No cases of overdose were reported in pre-marketing clinical trials. ||| These have been identified either from clinical studies or post marketing surveillance. ||| Aucun cas de surdosage n'a été rapporté dans les essais cliniques menés avant la commercialisation.
0.26545387506484985 ||| Where symptoms have occurred, they have included nausea, vomiting and diarrhoea, hypertension or hallucinations. ||| - immediately, if you have severe or persistent diarrhoea, nausea, loss of appetite, or vomiting ||| Lorsque des symptômes ont été observés il s’ agissait de: nausées, vomissements et diarrhée, hypertension ou hallucinations.
0.28945961594581604 ||| Trizivir tablets are available in opaque PVC/ Aclar blister packs containing 60 tablets or child-resistant HDPE bottles containing 60 tablets. ||| EVISTA tablets are packed either in PVC/ PE/ PCTFE blisters or in high density polyethylene bottles. ||| Trizivir est disponible en plaquettes thermoformées opaques PVC / Aclar contenant 60 comprimés, ou en flacon en polyéthylène de haute densité (HDPE) avec fermeture de sécurité contenant 60 comprimés.
0.8364128470420837 ||| Tritace Mite 1.25 mg tabletta Tritace 2.5 mg tabletta, Tritace 5 mg tabletta, Tritace 10 mg tabletta Ramipril Prevent 1.25 mg tabletta, Ramipril Prevent 2.5 mg tabletta, Ramipril Prevent 5 mg tabletta, Ramipril Prevent 10 mg tabletta Ramiwin 1.25 mg tabletta, Ramiwin 2.5 mg tabletta, Ramiwin 5 mg tabletta, Ramiwin 10 mg tabletta ||| NeoRecormon 500 IU NeoRecormon 1,000 IU NeoRecormon 2,000 IU NeoRecormon 3,000 IU NeoRecormon 4,000 IU NeoRecormon 5,000 IU NeoRecormon 6,000 IU NeoRecormon 10,000 IU NeoRecormon 20,000 IU NeoRecormon 30,000 IU Solution for injection in pre -filled syringe Epoetin beta ||| Tritace Mite 1,25 mg tabletta Tritace 2,5 mg tabletta, Tritace 5 mg tabletta, Tritace 10 mg tabletta Ramipril Prevent 1,25 mg tabletta, Ramipril Prevent 2,5 mg tabletta, Ramipril Prevent 5 mg tabletta, Ramipril Prevent 10 mg tabletta Ramiwin 1,25 mg tabletta, Ramiwin 2,5 mg tabletta, Ramiwin 5 mg tabletta, Ramiwin 10 mg tabletta
0.3356126546859741 ||| Clinical studies of Rapamune did not include a sufficient number of patients > 65 years of age to determine whether they will respond differently than younger patients. ||| However, it was not possible to determine if AVAMYS worked in children below the age of six years, because there were too few children below this age included the studies. ||| 30 Les études cliniques de Rapamune n’ ont pas inclus un nombre suffisant de patients âgés de plus de 65 ans pour déterminer s’ ils répondent différemment des patients plus jeunes.
0.7941633462905884 ||| b) ||| b) USA ||| b) c)
0.5156883001327515 ||| Wave-set lotions ||| Push-on accumulators ||| Lotions frisantes
0.19836610555648804 ||| Screening machines ||| Printing machines ||| Trieuses [machines]
0.5024812817573547 ||| Dasatinib was clastogenic in vitro to dividing Chinese Hamster Ovary (CHO) cells. ||| Diovan contains valsartan, an orally Angiotensin II Receptor Antagonist (AIIRA). ||| Dasatinib a montré un pouvoir clastogène in vitro sur des cellules d’ Ovaire de Hamster Chinois (OHC) en division.
0.8718950748443604 ||| Patient examination gowns ||| Bottom housing assembly: ||| Blouses d'examen pour patients
0.18058805167675018 ||| 2/ 34 Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. ||| Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of renal toxicity. ||| Éviter l’ emploi chez l’ animal déshydraté, hypovolémique ou hypotendu, en raison des risques potentiels de toxicité rénale accrue.
0.0 ||| 9. ||| 9. ||| 137 9.
0.12788820266723633 ||| The Commission therefore concluded that the Austrian measures arenecessary, appropriate and proportionate to remedy a serious disturbance in the economy of a Member State, in line with Article 107(3)(b) TFEU and the conditions set out in the Temporary Framework. ||| The Commission concluded that the measure isnecessary, appropriate and proportionate to remedy a serious disturbance in the economy of Latvia, in line with Article 107(3)(b) of the Treaty on the Functioning of the European Union (TFEU) and the conditions set out in the Temporary Framework. ||| La Commission est par conséquent parvenue à la conclusion que les mesures autrichiennes étaient nécessaires, appropriées et proportionnées pour remédier à une perturbation grave de l'économie d'un État membre, conformément à l'article 107, paragraphe 3, point b), du TFUE et aux conditions énoncées dans l'encadrement temporaire.
0.44786953926086426 ||| "U.S. Department of State officials, as well as sinologist Dali Yang have said the ""Chinese campaign"" appears intended to deflect attention away from the Chinese government's mishandling of the crisis." ||| "An ""intentional disinformation campaign"" by China was discussed among the Group of Seven (G7), and the Chinese efforts were condemned by the U.S. Department of State, which criticized Chinese authorities for spreading ""dangerous and ridiculous"" conspiracy claims." ||| Des responsables du Département d'État américain, ainsi que le professeur de sciences politiques de l'Université de Chicago, Dali Yang, une autorité en matière de la politique chinoise, ont déclaré que la campagne chinoise semblait destinée à détourner l'attention de la mauvaise gestion par le gouvernement chinois de la crise,.
0.3388527035713196 ||| If you have particular difficulty swallowing, you can use the tip of a spoon to crush the tablet. ||| If you are very thin, you should only use the thigh or outer surface of the arm for injection. ||| Si vous avez des difficultés particulières à avaler, vous pouvez écraser le comprimé au moyen d’une cuillère.
0.6154156923294067 ||| In order to ensure optimum response to Binocrit adequate iron stores should be ensured. ||| Saint Vincent and Grenadines called for a fair and effective allocation of resources and vaccines. ||| Pour obtenir une réponse optimale au traitement par Binocrit, il faut s’ assurer que des réserves suffisantes en fer sont disponibles.
0.2799135148525238 ||| Structures made of non-metallic materials ||| Archways made from non-metallic materials ||| Structures en matériaux non métalliques
0.36946097016334534 ||| Patients tended to tolerate consolidation and maintenance treatment with less toxicity than in induction. ||| Re- treatment may be associated with lower or inadequate response to Raptiva than in the earlier treatment periods. ||| Les patients avaient tendance à mieux tolérer le traitement de consolidation et d'entretien que le traitement d'induction.
0.6381551027297974 ||| Metabolism and elimination ||| immune reconstitution syndrome ||| Métabolisme et élimination
0.5042707920074463 ||| Trudexa 40 mg solution for injection. ||| Ibaflin 7.5% oral gel for dogs. ||| Trudexa 40 mg, solution injectable.
0.41337111592292786 ||| For patients who are unable to swallow the capsules or tablets, Sustiva can be given using the oral solution. ||| ● As with all injectable medicines, it is important to inspect the solution for particles. ||| Chez les patients ne pouvant avaler les gélules ou les comprimés, Sustiva peut être administré en utilisant la solution buvable.
0.7073936462402344 ||| Sitagliptin with Metformin1 ||| PegIntron plus ribavirin: ||| sitagliptine +metformine 1
0.01925349235534668 ||| Ask your pharmacist how to dispose of medicines that you no longer need. ||| Ask your pharmacist how to dispose of medicines you no longer need. ||| Demandez à votre pharmacien ce qu’ il faut faire des médicaments inutilisés.
0.25646448135375977 ||| Wheat germ for animal consumption ||| Yeast for animal consumption ||| Germes de blé pour l'alimentation animale
0.3705546259880066 ||| Diarrhoea, vomiting, nausea, abdominal pain Mouth ulceration, stomatitis ulcerative, stomatitis, right upper ||| Oedema, pitting oedema, facial oedema, oedema peripheral, fatigue, flushing, asthenia, hot flush ||| Ulcération de la bouche, stomatite ulcéreuse, stomatite, douleur dans Fréquent: la partie supérieure droite de l'abdomen, dyspepsie, glossite, reflux
0.25867265462875366 ||| Report immediately to your doctor any symptoms of infection such as: fever, sore throat or flu-like symptoms. ||| If you or the child develop symptoms of an infection such as fever, chills or cough, notify your doctor immediately. ||| En cas d’ apparition de symptômes infectieux (fièvre, angine ou symptômes de type grippal), contactez immédiatement votre médecin.
0.027208523824810982 ||| For the full list of all side effects reported with Trevaclyn, see the Package Leaflet. ||| For the full list of all side effects reported with Lysodren, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Trevaclyn, voir la notice.
0.3782896399497986 ||| Deep fryers, electric ||| Juice extractors, electric ||| Friteuses électriques
0.014460924081504345 ||| Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of YENTREVE in this age group have not yet been demonstrated. ||| Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of CYMBALTA in this age group have not yet been demonstrated. ||| Vous devez également savoir que la sécurité à long terme concernant la croissance, la maturation et le développement cognitif et comportemental de YENTREVE n’ a pas encore été établie dans cette tranche d’ âge.
0.2783149480819702 ||| The pharmacokinetics of drotrecogin alfa (activated) have not been studied in patients with severe sepsis and pre-existing end stage renal disease and chronic hepatic disease. ||| The pharmacokinetic characteristics of aripiprazole and dehydro-aripiprazole were found to be similar in patients with severe renal disease compared to young healthy subjects. ||| La pharmacocinétique de la drotrécogine alfa (activée) n’ a pas été étudiée chez des patients présentant un sepsis sévère et ayant une maladie rénale terminale préexistante ou une hépatopathie chronique.
0.413435161113739 ||| You should immediately stop taking piroxicam and tell your doctor if you have stomach pain, or any sign of bleeding in the stomach or intestines, such as passing black or bloodstained bowel movements, or vomiting blood. ||| The CDC recommends that people wash hands often with soap and water for at least twenty seconds, especially after going to the toilet or when hands are visibly dirty; before eating; and after blowing one's nose, coughing, or sneezing. ||| Vous devez immédiatement arrêter de prendre du piroxicam et informer votre médecin si vous avez des douleurs à l’ estomac, ou tout signe d’ hémorragie gastro-intestinale, (rejet de sang par la bouche, présence de sang dans les selles ou coloration des selles en noir).
0.14550620317459106 ||| Do not use Rapinyl after the expiry date which is stated on the carton after EXP. ||| Do not use Advagraf after the expiry date which is stated on the carton after “ Exp”. ||| Ne pas utiliser Rapinyl après la date de péremption mentionnée sur l’ étui en carton, après « EXP ».
0.04465882480144501 ||| Prialt is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| Micardis is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| Prialt ne doit pas être utilisé chez l’ enfant en dessous de 18 ans suite à un manque de données concernant la sécurité et l’ efficacité.
0.03729172423481941 ||| RISPERDAL CONSTA and associated names (see Annex I) 50 mg powder and solvent for prolonged- release suspension for intramuscular injection ||| RISPERDAL CONSTA and associated names (see Annex I) 37.5 mg powder and solvent for prolonged-release suspension for intramuscular injection ||| RISPERDAL CONSTA et dénominations associées (Voir Annexe I) 50 mg poudre et solvant pour suspension injectable intramusculaire à libération prolongée
0.30848538875579834 ||| No clinically relevant differences in the pharmacokinetics of insulin detemir are expected between healthy subjects and subjects with renal or hepatic impairment, based on the studies performed. ||| 2 Kentera should be used with caution in elderly patients, who may be more sensitive to the effects of centrally acting anticholinergics and exhibit differences in pharmacokinetics.. ||| D’après les études conduites, aucune différence cliniquement significative de la pharmacocinétique de l’insuline détémir n’est attendue entre les sujets sains et les sujets atteints de troubles rénaux ou hépatiques.
0.34652209281921387 ||| Excretion of cidofovir-related material into milk of lactating animals was not examined. ||| Blood must be collected into pre-chilled tubes containing heparin anticoagulant. ||| L’ excrétion de métabolite dans le lait des animaux allaitant n’ a pas été étudiée.
0.3749401569366455 ||| Care must be taken not to introduce pathogens into the teat in order to reduce the risk of E. coli infections. ||| To minimize the possibility of agglutination, it is important to limit the amount of blood entering the tubing. ||| Prendre garde à ne pas introduire de germes pathogènes dans le trayon de façon à réduire le risque d'infections par E. coli.
0.36291009187698364 ||| Teratology studies have been conducted in rats and rabbits at doses of up to 1500 mg/ kg/ day and 500 mg/ kg/ day, respectively. ||| Rats, dogs and monkeys tolerated daily doses of 2, 2.5 and 8 mg/ kg/ d respectively without harmful effects. ||| Des études de tératogenèse ont été conduites chez le rat et le lapin à des doses allant respectivement jusqu'à 1500 mg/ kg/ j et 500 mg/ kg/ j.
0.45189404487609863 ||| However it was questioned that this might not be compatible with clinical practice. ||| It is not known whether the effect will be different in multiple myeloma patients. ||| Cependant, il s’ est posé la question de savoir si cela ne pouvait pas être compatible avec la pratique clinique.
0.534838855266571 ||| Special populations HIV/ HBV co-infected patients receiving concomitant HAART: study 038 included 67 HBeAg positive and 1 HBeAg negative patients co-infected with HIV. ||| Although 96% genetic homolog was found between SARS-CoV-2 and two bat SARS-like CoVs, we still cannot conclude that SARS-CoV-2 is from bats. ||| Populations spéciales Patients co-infectés par le VIH et le VHB recevant simultanément un traitement HAART: l'étude 038 a inclus 67 patients AgHBe positifs et 1 patient AgHBe négatif, co-infectés par le VIH.
0.4430726170539856 ||| Watches made of precious metals ||| Trophies coated with precious metals ||| Montres en métaux précieux
0.37528371810913086 ||| The Commission is also discussing other alternatives with industry, such as textile companies reconverting to produce protective equipment. ||| This is why we launched several joint procurements with Member States for testing kits, ventilators and protective equipment. ||| La Commission examine également d'autres solutions avec l'industrie, telles celle consistant à reconvertir des entreprises textiles dans la fabrication d'équipements de protection.
0.3933817446231842 ||| Fever and chills that do not respond to antibacterial therapy are the most common symptoms of this type of infection. ||| Antibiotic-resistant bacteria are a danger to us all because they cause infections that are difficult to treat. ||| De la fièvre et des frissons ne répondant pas à un traitement antibactérien constituent les symptômes les plus courants de ce type d'infection.
0.6544190645217896 ||| Evangelistic services ||| Interim services ||| Services évangélistiques
0.20692022144794464 ||| The starting dose for adults is one 375 mg tablet twice a day. ||| The usual dose in adults is one tablet twice a day. ||| La dose de départ chez l'adulte est d’ un comprimé de 375 mg deux fois par jour.
0.7000712156295776 ||| Active substance: adenovirus-mediated Herpes simplex virus-thymidine kinase gene ||| Genus Betacoronavirus; type species: Murine coronavirus ||| Principe actif: gène de la thymidine kinase du virus Herpes simplex médié par adénovirus
0.7228199243545532 ||| Withdraw the syringe and replace the needle guard. ||| Inserting the needle Remove needle cover. ||| Retirer la seringue et remettre en place le capuchon protecteur de l’aiguille.
0.34317347407341003 ||| It is hypothesised that this enhanced transendothelial transport is mediated by the gp-60 albumin receptor, and that there is accumulation of paclitaxel in the area of tumour due to the albumin-binding protein SPARC (secreted protein acidic rich in cysteine). ||| PROCOMVAX contains small amounts of: • a protein purified from Hib, attached to a carrier (a protein purified from the outer membrane of the bacterium Neisseria meningitidis); • surface antigen (proteins from the surface) of the hepatitis B virus. ||| L’ hypothèse est que ce transport transendothélial facilité est médié par le récepteur de l’ albumine gp60, et qu’ il y a accumulation de paclitaxel dans la zone tumorale grâce à l’ albumin- binding protein, SPARC (secreted protein acidic and rich in cysteine).
0.7067524194717407 ||| Halogen luminaires ||| Vinyl curtains ||| Luminaires halogènes
0.4512074291706085 ||| MRI is an imaging method that relies on the tiny magnetic fields produced by water molecules in the body. ||| SonoVue is a contrast agent that reflects ultrasound waves differently from the tissues of the body and improves the picture from the scan. ||| L’ IRM est une méthode d’ imagerie reposant sur la production par les molécules d’ eau de l’ organisme de minuscules champs magnétiques.
0.3014279901981354 ||| In the event of overdose, general supportive measures should be instituted, including close monitoring of respiratory and cardiac status of the patient. ||| Patients should be closely monitored in the initial phase of the treatment due to the risk of postural adverse events. ||| En cas de surdosage, une prise en charge globale doit être instituée, comprenant une surveillance étroite de l’ état respiratoire et cardiaque du patient.
0.43779969215393066 ||| A/ Wisconsin/ 67/ 2005 (H3N2) like strain (A/ Wisconsin/ 67/ 2005 (NYMC X-161)) 9 micrograms HA** ||| A/ Wisconsin/ 67/ 2005 (H3N2) like strain (NYMC X-161) 15 micrograms HA** ||| A/ Wisconsin/ 67/ 2005 (H3N2) souche analogue (A/ Wisconsin/ 67/ 2005 (NYMC X-161)) 9 microgrammes HA**
0.5094108581542969 ||| In case they do not implement those commitments within the agreed period, the Commission will proceed with a listing. ||| If necessary, the Commission will propose measures to complement this framework by 2022. ||| Si à l'issue de cette période, ils n'ont pas mis en œuvre leurs engagements, la Commission procédera à leur inscription sur la liste.
0.02310555800795555 ||| 243 PACKAGE LEAFLET: ||| 270 PACKAGE LEAFLET: ||| 261 NOTICE:
0.49402153491973877 ||| When approving a scheme, the Commission will request the separate notification of aid to a company above the threshold of €250 million for individual assessment. ||| This support will also come from Horizon 2020, in the form of an EU guarantee of a currently assessed EIB loan of an identical amount. ||| Lorsqu'elle autorisera un régime, la Commission exigera que toute aide à une entreprise d'un montant supérieur au seuil de 250 millions d'euros fixé pour une évaluation individuelle fasse l'objet d'une notification séparée.
0.3023686408996582 ||| DepoCyte is supplied in individual cartons each containing one single-dose Type I glass vial containing 50 mg (in 5 ml), closed with a fluororesin faced butyl rubber stopper and sealed with an aluminium flip-off seal. ||| After radiolabelling the antibody and diluting a 10 µl sample with 1.5 ml saline, immediately determine the radiochemical purity by Instant Thin Layer Chromatography on silica gel impregnated glass fiber strips, 1 × 9 cm using acetone as the solvent. ||| DepoCyte est fourni dans des boîtes individuelles contenant chacune un flacon en verre de type I d'une dose unique, contenant 50 mg (dans 5 ml), muni d'un bouchon en caoutchouc de butyle à face en fluororésine, serti par une capsule flip-off en aluminium.
0.14001238346099854 ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse reactions. ||| Patients with chronic hepatitis B or C and treated with antiretroviral agents are at increased risk for severe and potentially fatal liver adverse events and may require blood tests for control of liver function. ||| Les patients atteints d’ une hépatite chronique B ou C et traités par association d’ antirétroviraux présentent un risque accru de développer des effets indésirables hépatiques sévères et potentiellement fatals.
0.7391366958618164 ||| Sterilisation autoclaves for medical use ||| Pharmacovigilance Plan or risk minimisation activities, ||| Autoclaves de stérilisation à usage médical
1.1073203985689783e-12 ||| Product invented name ||| Product invented name ||| Nom de fantaisie
0.019367516040802002 ||| Apply the 5 ml pipette to 2-3 spots down the backline of large dogs so as to prevent run-off. ||| Apply the 5 ml pipette to 2-3 spots down the backline of large dogs in order to prevent run-off. ||| Appliquer les pipettes de 5 ml en deux à trois points sur la ligne du dos des grands chiens afin d’ éviter tout écoulement.
0.38762933015823364 ||| Chemical preparations for sanitary purposes ||| Preparation of psychological profiles for medical purposes ||| Produits chimiques pour l'hygiène à usage médical
0.31574907898902893 ||| Effentora was more effective than placebo in reducing pain in both studies. ||| Levitra was significantly more effective than placebo for all measures in all studies. ||| Effentora s’ est avéré plus efficace que le placebo pour la réduction de la douleur dans les deux études.
0.7848219275474548 ||| How to take 4. ||| How much to take ||| Comment prendre 4.
0.3583604693412781 ||| Adverse reactions are listed below, by system organ class and frequency. ||| Adverse reactions more common in the vaccine group are listed below per system organ class and frequency. ||| Les effets indésirables sont repris ci-dessous, classés selon les systèmes d’organes et la fréquence.
0.45339277386665344 ||| - reduction in red blood cells (anaemia), increase in white blood cells (leucocytosis), alteration of the ||| - myelosuppressive medicines (decrease production of red, white, or coagulating blood cells) and ||| - diminution du nombre de globules rouges (anémie), augmentation du nombre de globules blancs
1.8410758486318846e-13 ||| Tell your doctor if you are taking theophylline or aminophylline for asthma, and about all other medication you are taking, or have taken recently, even those not prescribed, as the dose of some medications may have to be adjusted while you are treated with IntronA. ||| Tell your doctor if you are taking theophylline or aminophylline for asthma, and about all other medication you are taking, or have taken recently, even those not prescribed, as the dose of some medications may have to be adjusted while you are treated with IntronA. ||| 416 Veuillez dire à votre médecin si vous prenez de la théophylline ou de l’aminophylline pour l’asthme, et si vous prenez ou avez pris récemment tout autre médicament, même s’il s’agit d’un médicament obtenu sans ordonnance, car la dose de certains médicaments peut nécessiter un ajustement pendant votre traitement par IntronA.
0.17545634508132935 ||| Oral hypoglycaemic agents (OHAs), octreotide, monoamine oxidase inhibitors (MAOIs), non-selective beta-adrenergic blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids and sulphonamides. ||| Oral hypoglycaemic agents (OHA), monoamine oxidase inhibitors (MAOI), non-selective beta- blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates and alcohol. ||| Antidiabétiques oraux (ADO), octréotide, inhibiteurs de la monoamine-oxydase (IMAO), bêtabloquants non sélectifs, inhibiteurs de l’ enzyme de conversion de l’ angiotensine (IEC), salicylés, alcool, stéroïdes anabolisants et sulfamides.
0.5708403587341309 ||| Scarves ||| Fever ||| Foulards
0.04257701337337494 ||| The Commission found that the Austrian schemes are in line with the conditions set out in the Temporary Framework. ||| The Commission found that the two Slovenian schemes are in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que les régimes autrichiens étaient conformes aux conditions énoncées dans l'encadrement temporaire.
0.2880481481552124 ||| Clinical supervision is recommended if switching between the stiripentol capsule and powder for oral suspension in sachet formulations. ||| Use aseptic technique during the reconstitution and any further dilution of gemcitabine for intravenous infusion administration. ||| Une surveillance clinique est recommandée en cas de remplacement de la forme gélule par la forme poudre pour suspension buvable.
0.0 ||| Medicines should not be disposed of via wastewater or household waste. ||| Medicines should not be disposed of via wastewater or household waste. ||| 329 Les médicaments ne doivent pas être jetés au tout à l’égout ou avec les ordures ménagères.
0.18524271249771118 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Enbrel to Wyeth Europa Ltd on 3 February 2000. ||| The European Commission granted a marketing authorisation valid throughout the EU for Fertavid to SP Europe on xx March/ April 2009. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Enbrel à Wyeth Europa Ltd, le 3 février 2000.
0.0019370181253179908 ||| 155 Since the treatment experience is limited in patients on peritoneal dialysis, regular haemoglobin monitoring and strict adherence to dose adjustment guidance is recommended in these patients. ||| 75 Since the treatment experience is limited in patients on peritoneal dialysis, regular haemoglobin monitoring and strict adherence to dose adjustment guidance is recommended in these patients. ||| Dans la mesure où l’ expérience du traitement est limitée chez les patients en dialyse péritonéale, la surveillance régulière de l’ hémoglobine et l’ adhésion stricte à l’ ajustement de dose est recommandée chez ces patients.
0.03568083047866821 ||| What Karvezide looks like and contents of the pack Karvezide 150 mg/ 12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side. ||| What CoAprovel looks like and contents of the pack CoAprovel 300 mg/ 12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side. ||| A quoi ressemble Karvezide et contenu de l'emballage extérieur Les comprimés pelliculés de Karvezide 150 mg/ 12,5 mg sont pêche, biconvexes, de forme ovale, avec un coeur gravé d'un coté et le numéro 2875 gravé sur l'autre coté.
0.1696859747171402 ||| 14/ 17 8. ||| 17/ 28 9. ||| 15/ 18 7.
0.06390375643968582 ||| Which measures are being taken to ensure the safe use of Daronrix? ||| Which measures are being taken to ensure the safe use of Atripla? ||| Quelles sont les mesures prises pour garantir une utilisation sans danger de Daronrix?
0.368230938911438 ||| Exacerbation of hepatitis has primarily been detected by serum ALT elevations, in addition to the re-emergence of HBV DNA. ||| Excessive decreases in blood pressure or respiratory depression may be corrected by decreasing or discontinuing the inspired concentration of sevoflurane. ||| L’ exacerbation de l’ hépatite a été principalement mise en évidence par une élévation des taux d’ ALAT sériques associée à une ré-émergence de l’ ADN du VHB.
0.0 ||| 165 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 165 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 187 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.23330946266651154 ||| In the case of an acute thrombotic event these should be performed every 6 hours until your condition is stabilised, thereafter twice a day and always immediately before the next injection. ||| For patients with advanced symptomatic HIV disease, it is generally recommended that blood tests are performed at least every two weeks for the first three months of therapy and at least monthly thereafter. ||| Dans le cas d’ une thrombose aiguë, ce dosage doit être réalisé toutes les 6 heures jusqu’ à ce que le taux se soit stabilisé, puis deux fois par jour et toujours immédiatement avant l'injection suivante.
0.41918209195137024 ||| Pioglitazone may be initiated at 15mg or 30mg once daily. ||| Erbitux must not be infused more rapidly than 10 mg/ min. ||| Le traitement par la pioglitazone peut être initié à la dose de 15mg ou 30mg en une seule prise quotidienne.
0.23761944472789764 ||| Metabolism and nutrition disorders Very common: ||| Metabolism and nutrition disorders Very common: appetite lost ||| 91 Troubles du métabolisme et de la nutrition Très fréquent:
0.5558176040649414 ||| Based on its pharmacodynamic properties, Karvezide is unlikely to affect this ability. ||| Yarvitan also has a slight appetite decreasing effect due to its mode of action. ||| En se basant sur ses propriétés pharmacodynamiques, il est peu probable que l'irbésartan affecte cette aptitude.
0.3471429944038391 ||| A broadened scope through the addition of a fifth window - the strategic European investment window - in order to cater for the future needs of the European economy and to promote and secure EU strategic autonomy in key sectors. ||| Common and coordinated approach: The Commission proposes a coordination mechanism whereby it would support Member States and Schengen Associated States at technical level and facilitate the preparation of a list of countries for which travel restrictions could be lifted. ||| Un élargissement du champ d'application, par l'adjonction d'un cinquième volet - celui des investissements européens stratégiques - dans la perspective de pourvoir aux besoins futurs de l'économie européenne et de promouvoir et d'assurer l'autonomie stratégique de l'Union dans des secteurs essentiels.
0.4549262523651123 ||| On 5 March, five new cases were confirmed: three in Uusimaa, one in Pirkanmaa and one in Tavastia Proper. ||| 3 new cases were in Samara Oblast for the first time, with the first cases in Kirov Oblast and Komi Republic. ||| Le 5 mars, cinq nouveaux cas ont été confirmés : trois à Uusimaa, un à Pirkanmaa et un à Kanta-Häme.
0.43597105145454407 ||| The impact of long- term treatment with Trudexa on the development of autoimmune diseases is unknown. ||| Surveillance data show that antimicrobial resistance is a growing public health problem in European hospitals and communities. ||| L'impact d'un traitement à long terme par Trudexa sur le développement de maladies auto-immunes est inconnu.
0.29346054792404175 ||| However, significant liver toxicity has not been observed in patients treated in clinical studies, either during administration of Agenerase or after discontinuation. ||| No studies have been conducted that include patients with a history of malignancy or in whom treatment with Humira is continued following development of malignancy. ||| Toutefois, aucune hépatotoxicité significative n'a été observée chez les patients traités lors des essais cliniques, que ce soit lors de l'administration d’ Agenerase ou après son arrêt.
0.08810369670391083 ||| Hepatobiliary disorders Skin and subcutaneous tissue disorders ||| Hepato-biliary disorders Skin and subcutaneous tissue disorders ||| Affections de la peau et du tissu sous-cutané
0.5198242664337158 ||| Designing and developing webpages on the internet ||| Publication of electronic books and periodicals on the Internet ||| Conception et développement de pages Web sur Internet
0.008197261020541191 ||| EU/ 1/ 96/ 022/ 010 - ZYPREXA - 10 mg - coated tablets - 56 tablets, per box. ||| EU/ 1/ 96/ 022/ 008 - ZYPREXA - 10 mg - coated tablets - 7 tablets, per box. ||| ZYPREXA - 10 mg - comprimés enrobés - 56 comprimés par boîte.
0.23475763201713562 ||| The Commission concluded that the recapitalisation measure will contribute to manage the economic impact of the coronavirus outbreak in Finland. ||| The Commission concluded that the Danish guarantee schemes for exporting SMEs will contribute to managing the economic impact of the coronavirus outbreak in Denmark. ||| La Commission est parvenue à la conclusion que la mesure de recapitalisation aidera à gérer l'incidence économique de la pandémie de coronavirus en Finlande.
0.38744688034057617 ||| Flower vases of precious metal ||| Jewel cases of precious metal ||| Vases à fleurs en métaux précieux
0.41135475039482117 ||| Allen Pharmazeutika Pharma GmbH, Albert-Schweitzer-Gasse 6 A-1140 Wien Austria ||| • Pfizer Manufacturing Deutschland GmbH, Heinrich-Mack-Strasse 35, 89257 Illertissen, Germany ||| Allen Pharmazeutika Pharma GmbH, Albert-Schweitzer-Gasse 6, A-1140 Wien, Autriche
0.22611452639102936 ||| Reactions (redness, swelling, inflammation, itching and bruising) at the injection site may occur. ||| Occasionally there is swelling, pain, pruritus (itching) or hair loss at the injection site. ||| Des réactions (rougeur, gonflement, inflammation, démangeaison et ecchymose) peuvent survenir au site d’injection.
0.02847270295023918 ||| Exelon 4.5 mg hard capsules ||| Exelon 3.0 mg hard capsules ||| Exelon 4,5 mg gélule
0.06261683255434036 ||| For the full description of the side effects reported with Metalyse, please see the Package Leaflet. ||| For the full description of the side effects reported with Actraphane, please see the Package Leaflet. ||| Pour une description complète des effets secondaires observés avec Métalyse, veuillez vous reporter à la notice.
0.6280362606048584 ||| ↓ 49% ||| -9.4% ||| ↓
6.763610938681497e-13 ||| 500 IU ||| 500 IU ||| KOGENATE 500 UI Bayer
4.455203838227978e-13 ||| 12 Not all pack sizes may be marketed. ||| 12 Not all pack sizes may be marketed. ||| Certaines tailles de conditionnement peuvent ne pas être commercialisées
0.07049576193094254 ||| J05AX09 ||| J05AX07 ||| JO5AX09
0.09526620805263519 ||| Do not use Levitra after the expiry date which is stated on the carton. ||| Do not use this medicine after the expiry date which is stated on the carton. ||| Ne pas utiliser Levitra après la date de péremption mentionnée sur la boîte.
0.11785788834095001 ||| Clinical studies ||| Clinical research ||| Études cliniques
0.3988521695137024 ||| There is no linear relationship between doses and plasma levels. ||| There is no direct correlation between plasma concentration and efficacy. ||| Il n’ y a pas de progression linéaire entre la dose et les taux plasmatiques.
0.5037472248077393 ||| Elixirs for relieving chills ||| Coatings for preserving against rust ||| Élixirs pour soulager les frissons
0.8964059948921204 ||| MRL status Annex II for Salmonidae1 ||| Ascending – Dose Schedule of OPRYMEA Week ||| Statut LMR Annexe II pour les salmonidés 1
0.3388928472995758 ||| 43 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON OF MULTIPACKS (5x1 SINGLE PACK) (INCLUDING BLUE BOX) ||| 69 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING (INCLUDING 1 HARD CAPSULE 125 MG AND 2 HARD CAPUSULES 80 MG) ||| CONDITIONNEMENT DE 5 PRESENTATIONS UNITAIRES (5 X 1 PRESENTATION UNITAIRE) (INCLUANT LE CADRE BLEU « BLUE BOX »)
0.04296349734067917 ||| 1200 IU (87 µg)/ vial ||| 600 IU (44 µg)/ vial ||| 1.200 UI (87 µg)/ flacon.
2.9609832381122247e-13 ||| If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si vous ressentez un des effets mentionnés comme graves ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.45744213461875916 ||| As for the coronavirus, it is too soon to evaluate the extent of its negative economic impact." ||| This is acceptable because of the current political and epidemiological situation in Europe with regard to avian influenza. ||| En ce qui concerne le coronavirus, il est trop tôt pour prendre la mesure de ses conséquences économiques négatives.»
0.3266504406929016 ||| Tel: + 386 (0)1 563 48 11 ||| Tel: + 43-(0) 1 711 780 ||| Tel: +386 (0)1563 48 11
0.43360739946365356 ||| The Commission - in consultation with the European Centre for Disease Prevention and Control - has adopted Guidelines today on different coronavirus tests and their performance; ||| Additional resources are foreseen for the European Centre for Disease Prevention and Control , which provides rapid risk assessments and epidemiological updates on the outbreak. ||| o l'accroissement des capacités de dépistage et l'harmonisation des méthodes; La Commission, en concertation avec le Centre européen de prévention et de contrôle des maladies, a adopté aujourd'hui des lignes directrices sur les différentes méthodes de dépistage et les résultats obtenus;
0.2854381799697876 ||| The efficacy of ECALTA in neutropenic patients with candidaemia and in patients with deep tissue Candida infections or intra-abdominal abscess and peritonitis has not been established. ||| Renal artery stenosis No data are available on the use of Enviage in patients with unilateral or bilateral renal artery stenosis, or stenosis to a solitary kidney. ||| L’ efficacité d’ ECALTA chez les patients neutropéniques avec une candidémie et chez les patients avec des candidoses profondes ou un abcès intra-abdominal ou une péritonite n’ a pas été établie.
0.4593108892440796 ||| Public health concerns require the establishment of efficient communication lines with the European Commission and the competent authorities of the Member States. ||| This is because control of avian influenza is the responsibility of national veterinary authorities in consultation with the European Commission. ||| Les nécessités de santé publique impliquent la création de voies de communication efficaces avec la Commission européenne et les autorités compétentes des États membres.
0.4858997166156769 ||| Other ingredients: ||| Other medicinal products: ||| Autres composants:
0.37899070978164673 ||| The vial contents should be inspected for particulate matter and discolouration prior to administration. ||| The testicular changes were not fully recoverable during the off-dose periods evaluated. ||| Avant l’administration, il convient d’inspecter le contenu du flacon pour s’assurer qu’aucune particule ni décoloration n’est présente.
0.0 ||| A higher proportion of patients receiving the original rituximab/ MTX treatment also had no erosive progression over 56 weeks (Table 8). ||| A higher proportion of patients receiving the original rituximab/ MTX treatment also had no erosive progression over 56 weeks (Table 8). ||| Le pourcentage de patients sans progression radiographique après 56 semaines a été également significativement plus élevé dans le groupe de patients traités à l’ origine par rituximab/ MTX (Tableau8).
0.5283890962600708 ||| Fish hooks ||| Baby bottoms ||| Hameçons
0.07949607074260712 ||| 84 10. ||| 82 10. ||| 92 10.
0.4230160117149353 ||| These results confirm those observed after a minimum of 6 months follow-up which showed HGD ablation in 72% of patients in the PhotoBarr PDT + OM group compared to 31% in the OM only group. ||| The results observed in a population of 211 newly diagnosed Ph+ ALL patients in four uncontrolled clinical studies (AAU02, ADE04, AJP01 and AUS01) are consistent with the results described above. ||| Ces résultats confirment ceux observés après un suivi d’ une durée minimale de 6 mois ayant mis en évidence une ablation de la DHG chez 72% des patients dans le groupe PDT avec PhotoBarr + OM par rapport à 31% dans le groupe OM seul.
0.42147088050842285 ||| Chemical products for glazing leather ||| Oils for tanning leather ||| Produits chimiques pour lustrer le cuir
0.11132153868675232 ||| What benefit has Valtropin shown during the studies? ||| What benefit has Ammonaps shown during the studies? ||| Quels ont été les bénéfices démontrés par Valtropin au cours des études?
0.3551478683948517 ||| Repaglinide is detected in the milk of experimental animals. ||| Busulfan was shown to cause sterility in rodents. ||| Le répaglinide a été détecté dans le lait des animaux d’ expérience.
0.308240681886673 ||| Ecchymosis, bullous eruption, exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema ||| pruritus, rash, alopecias, acne, sweating increased dermatitis, photosensitivity toxic epidermal necrolysis (Lyell’ s syndrome) Stevens Johnson syndrome ||| Ecchymose, éruption bulleuse, dermatite exfoliative, érythème multiforme, syndrome de Stevens-Johnson, nécrolyse épidermique toxique, angio-œ dème
0.39986470341682434 ||| In patients with normal renal function and no other complicating factors, neutropenia occurs rarely. ||| Binding was not notably affected by varying degrees of renal impairment. ||| Chez des patients ayant une fonction rénale normale et sans autre facteur de complication, la neutropénie survient rarement.
0.22395209968090057 ||| Feeders [parts of machines] ||| Lubricators [parts of machines] ||| Entraîneurs [parties de machines]
0.2689685821533203 ||| In vitro studies suggest glucuronidation as a metabolic pathway, and that cytochrome P450 3A4 is the major cytochrome P450 isozyme responsible for formation of the oxidative metabolites. ||| Glimepiride increases the activity of glycosyl-phosphatidylinositol-specific phospholipase C, which may be associated with drug-induced lipogenesis and glycogenesis in isolated fat and muscle cells. ||| Des études in vitro semblent indiquer que la glucuroconjugaison est la voie métabolique principale et que le cytochrome P450 3A4 est le principal isozyme cytochrome P450 responsable de la formation des métabolites oxydatifs.
0.4399540424346924 ||| Elimination of etoricoxib occurs almost exclusively through metabolism followed by renal excretion. ||| Protein metabolism Linear growth is facilitated in part by growth hormone-stimulated protein synthesis. ||| L’ étoricoxib est presque exclusivement éliminé sous forme de métabolites par voie rénale.
0.038894060999155045 ||| 10 6.4 Special precautions for storage ||| 15 6.4 Special precautions for storage ||| 6.4 Précautions particulières de conservation
0.011805279180407524 ||| 99 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom ||| BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom ||| BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH Royaume-Uni
0.3361567258834839 ||| Before using, carefully peel open the blister and remove the dose of orodispersible tablet without crushing it. ||| Stop pulling back the plunger when blood enters the tubing and inject BeneFIX intravenously over several minutes. ||| Avant utilisation, ouvrir la plaquette thermoformée avec précaution et retirer la dose de comprimés orodispersibles sans l’ écraser.
0.808068037033081 ||| 1 1 1 ||| 2 2 1 ||| 5 3 1
0.279139906167984 ||| Taking these data into consideration, rufinamide should not be used during pregnancy unless clearly necessary and in women of childbearing age not using contraceptive measures. ||| Pregnancy Due to possible teratogenicity, Thelin must not be initiated in women of child-bearing potential unless they practise reliable contraception. ||| En prenant en considération ces données, le rufinamide ne doit pas être administré pendant la grossesse ainsi que chez les femmes en âge de procréer n’ utilisant pas de moyen de contraception à moins d'une nécessité absolue.
0.1363292783498764 ||| How has Myfenax been studied? ||| How has Zyprexa been studied? ||| Quelles études ont été menées avec Mifenax?
0.38073796033859253 ||| Advisory services relating to electronic data processing ||| Satellite broadcasting services relating to sporting events ||| Services de conseils concernant le traitement électronique de données
0.2733186185359955 ||| Temoporfin is bound to plasma lipoproteins and high density proteins such as albumin in the blood. ||| Daclizumab binds to an antigen found on the surface of specific white blood cells called T lymphocytes. ||| Elle se lie aux lipoprotéines plasmatiques et aux protéines de haute densité du sang, telles que l'albumine.
0.3704424500465393 ||| Zyrtec 10 mg/ ml -Tropfen Belgium: ||| Zyrtec 10 mg -Filmtabletten Belgium: ||| Zyrtec 10 mg - Filmtabletten Belgique:
0.4492264688014984 ||| Educational services provided for teachers of children ||| Providing courses of instruction for young people ||| Services d'enseignement pour instituteurs
0.14581520855426788 ||| Kaletra 100 mg/ 25 mg film-coated tablets lopinavir/ ritonavir ||| KALETRA 200 mg/50 mg film-coated tablets lopinavir/ritonavir ||| Kaletra 100 mg/ 25 mg, comprimé pelliculé lopinavir/ ritonavir
5.986009214350996e-13 ||| Patients should be monitored carefully for dose-related adverse reactions, especially nervous system symptoms. ||| Patients should be monitored carefully for dose-related adverse reactions, especially nervous system symptoms. ||| 86 dépendants, notamment ceux affectant le système nerveux, doivent être surveillés attentivement.
0.2546079754829407 ||| As cardiac adverse events have been reported uncommonly with imatinib, a careful assessment of the benefit/ risk of imatinib therapy should be considered in the HES/ CEL population before treatment initiation. ||| Re-introduction of treatment with Thelin should only be considered if the potential benefits of treatment with Thelin outweigh the potential risks and when liver aminotransferase levels are within pre-treatment values. ||| Comme des effets indésirables cardiaques ont été observés peu fréquemment avec l’ imatinib, une évaluation du rapport bénéfices/ risques du traitement par l’ imatinib devra être envisagé chez les patients attteints de SHE/ LCE avant l’ instauration du traitement.
0.44201552867889404 ||| Quinolone antibacterials (ATC code: ||| Leukotriene receptor antagonist ATC-code: ||| Groupe pharmacothérapeutique: antibactériens quinolones (code ATC:
0.03879312425851822 ||| Storing of operating parameters and of results under security access to avoid later manipulation ||| Storing of operating parameters and of results under security access to avoid later manipulation 13 ||| Stockage des paramètres opératoires et des résultats avec accès protégé pour éviter des manipulations ultérieures
0.27221763134002686 ||| Omnipharm Limited, The Spire, Egypt Road, Nottingham NG7 7GD United Kingdom ||| Neolab Limited 57 High Street Odiham, Hampshire RG29 1LF United Kingdom ||| Omnipharm Ltd The Spire Egypt Road Nottingham NG7 7GD Royaume-Uni
0.0030711530707776546 ||| 181 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 184 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 191 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.00793992355465889 ||| 95 Your doctor will normally advise you to stop taking CoAprovel as soon as you know you are pregnant. ||| 116 Your doctor will normally advise you to stop taking CoAprovel as soon as you know you are pregnant. ||| Votre médecin vous demandera d’ arrêter CoAprovel dès que vous savez que vous êtes enceinte.
0.8164966106414795 ||| There will be two Steering Committee meetings in 2002 in Brussels and in Washington, DC. ||| It was originally to be held at The Forum in Inglewood, California. ||| Deux réunions du comité directeur seront organisées en 2002, à Bruxelles et à Washington, DC.
0.22231146693229675 ||| Providing information relating to the rental of potted plants ||| Providing information relating to the spreading of fertilizers ||| Mise à disposition d'informations en matière de location de plantes en pot
0.545710563659668 ||| Blade sharpening [stropping] machines ||| Treating [forging] of metal ||| Machines pour le repassage des lames
0.38794809579849243 ||| Beef tallow for industrial purposes ||| Tapioca flour for industrial purposes ||| Suif de bœuf à usage industriel
0.4150843024253845 ||| NSF is a disease involving thickening of the skin and connective tissues. ||| Osteoporosis is a thinning and weakening of the bones. ||| La FSN est une maladie entraînant un épaississement de la peau et du tissu conjonctif, en particulier sous-cutané.
0.0 ||| Table 11. ||| Table 11. ||| Tableau 11:
0.2690190374851227 ||| Installation of apparatus for heating ||| Gas operated apparatus for heating ||| Installation d'appareils de chauffage
0.20183853805065155 ||| The main measure of effectiveness was based on the change in the questionnaire score before the study began and after six months of treatment. ||| The main measure of effectiveness was the improvement in symptoms between the start and end of the study, measured using two standard scales. ||| La principale mesure de l’ efficacité était basée sur l’ évolution du score obtenu au questionnaire avant le début de l’ étude et après six mois de traitement par ce médicament.
0.2802063822746277 ||| Soliris administration should be interrupted in all patients experiencing severe infusion reactions and appropriate medical therapy administered. ||| The administration of Twinrix Adult should be postponed in subjects suffering from acute severe febrile illness. ||| L’ administration de Soliris doit être interrompue chez tous les patients présentant des réactions sévères à la perfusion; ceux -ci doivent alors recevoir un traitement médical approprié.
0.09841592609882355 ||| Insulin Human Winthrop Comb 25 must also NOT be mixed with insulins of animal origin or with insulin analogues. ||| Insulin Human Winthrop Comb 25 must not be mixed with any other insulin or with insulin analogues. ||| De même, Insulin Human Winthrop Comb 25 ne doit PAS être mélangé aux insulines d'origine animale ou à des analogues de l'insuline.
0.335785448551178 ||| Furthermore, Bondenza 150 mg once monthly was proven superior to ibandronic acid 2.5 mg daily for increases in lumbar spine BMD in a prospectively planned analysis at one year, p=0.002, and at two years, p < 0.001. ||| (relative risk reduction RRR was 31%; p = 0.0001 with an absolute risk of 7.9% in the placebo group, and 5.5% in pravastatin treated patients); the effects on these cumulative cardiovascular events rates being evident as early as 6 months of treatment; ||| De plus, dans une analyse prévue de façon prospective, l'augmentation de la DMO lombaire sous Bondenza 150 mg une fois par mois a été significativement supérieure à celle observée sous acide ibandronique 2,5 mg une fois par jour à un an (p=0,002) et à deux ans (p < 0,001).
0.27986353635787964 ||| It is used in combination with dexamethasone (an anti-inflammatory medicine) to treat adult patients with multiple myeloma whose disease has been treated at least once in the past. ||| Paliperidone is an active breakdown product (metabolite) of risperidone, another antipsychotic medicine that has been used in the treatment of schizophrenia since the 1990s. ||| Il est indiqué, en association avec la dexaméthasone (anti-inflammatoire), pour le traitement du myélome multiple chez les patients adultes ayant déjà reçu au moins un traitement antérieur.
0.2603353261947632 ||| Each bottle contains 60 tablets. ||| Each carton contains 1 bottle. ||| Chaque flacon contient 60 comprimés.
0.0 ||| Concomitant use of boosted saquinavir and tipranavir, co-administered with low dose ritonavir in a dual-boosted regimen, results in a significant decrease in saquinavir plasma concentrations (see section 4.5). ||| Concomitant use of boosted saquinavir and tipranavir, co-administered with low dose ritonavir in a dual-boosted regimen, results in a significant decrease in saquinavir plasma concentrations (see section 4.5). ||| Interaction avec le tipranavir: l’ administration concomitante de saquinavir boosté et de tipranavir co- administré avec des faibles doses de ritonavir dans un protocole de “ double boost” a entraîné une décroissance significative des concentrations plasmatiques de saquinavir (voir rubrique 4.5).
0.29088646173477173 ||| Lesions (erosion/ ulceration) of the oral mucosa and of the skin around the mouth may occasionally be observed in treated animals when administered the recommended treatment dose. ||| Clinical symptoms (dizziness and nausea) following doses of 1200 mg/ day were mainly related to the central nervous system and the gastrointestinal system and resolved with dose adjustments. ||| Des lésions (érosion ou ulcération) de la muqueuse orale et de la peau autour de la bouche peuvent parfois être observées chez les animaux traités suite à l’ administration de la dose recommandée.
0.34306600689888 ||| Following the amendment, State insurers will in principle be able to step in and provide insurance for short-term export-credit risk for all countries, without the need for the Member State in question to demonstrate that the respective country is temporarily "non marketable." ||| Importantly, the EFSI also enables the EIB to approve a greater number of projects than would be possible without the EU budget guarantee's backing, as well as to reach out to new clients: three out of four receiving EFSI backing are new to the bank. ||| À la suite de cette modification, les organismes publics d'assurance seront en principe en mesure d'intervenir pour couvrir des risques associés à des crédits à l'exportation à court terme pour tous les pays, sans que l'État membre concerné ne doive démontrer que le pays en question est temporairement un pays à «risques non cessibles».
0.3297920823097229 ||| 50 mg vildagliptin and 1,000 mg metformin hydrochloride). ||| 6 mg norelgestromin and 600 micrograms ethinyl estradiol ||| 50 mg de vildagliptine et 1 000 mg de chlorhydrate de metformine).
0.48801952600479126 ||| Pharmacodynamic properties ||| Pharmacological data ||| 5.1 Propriétés pharmacodynamiques
0.0013064055237919092 ||| 64 Baraclude belongs to a class of medicines that can cause lactic acidosis (excess of lactic acid in your blood) and enlargement of the liver. ||| 59 Baraclude belongs to a class of medicines that can cause lactic acidosis (excess of lactic acid in your blood) and enlargement of the liver. ||| Baraclude appartient à une classe de médicaments qui peut causer une acidose lactique (excès d’ acide lactique dans votre sang) et une augmentation de la taille du foie.
0.6301140785217285 ||| conjugated to tetanus toxoid as a carrier 1 ||| conjugated to tetanus toxoid as carrier protein 1 ||| conjugué à l'anatoxine tétanique 1
0.42732858657836914 ||| It should allow more statistical information to be generated which can be made available in the published monthly MRFG report and will also improve the monitoring of the procedure. ||| The review has resulted in an increase in the scope of information to be collected and maintained by the Agency, which will impact on the development of this database. ||| Ce système devrait permettre de générer davantage de statistiques qui pourraient être publiées dans le rapport mensuel du MRFG et apportera une amélioration au contrôle de la procédure.
0.014601536095142365 ||| EU/ 1/ 02/ 219/ 002 50 film-coated tablets. ||| EU/ 1/ 02/ 218/ 003 100 film-coated tablets. ||| EU/ 1/ 02/ 219/ 002 50 comprimés pelliculés.
0.27563148736953735 ||| Other information about Prepandrix: ||| Other information about CellCept: ||| Autres informations relatives à Prepandrix:
0.18490146100521088 ||| HOW TO USE SILAPO ||| HOW TO USE TYSABRI ||| COMMENT UTILISER SILAPO
0.11028124392032623 ||| 15 ml TYSABRI in a vial (type I glass) with a stopper (bromobutyl rubber) and a seal (aluminium) with a flip-off cap. ||| 50 ml of solution in a vial (Type I glass) with a stopper (teflon-coated bromobutyl rubber) and a seal (aluminium). ||| 15 ml de TYSABRI dans un flacon (verre type I) muni d’ un bouchon de caoutchouc (bromobutyle) serti avec une bague (aluminium) surmonté d’ une capsule protectrice plastique.
0.4072955250740051 ||| 282 4.4 Special warnings and precautions for use ||| 2 4.5 Special precaution(s) for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.39431843161582947 ||| Before using OptiSet, the Instructions for Use included in the Package Leaflet must be read carefully. ||| OptiSet has to be used as recommended in these Instructions for Use (see section 6.6). ||| Les Instructions d’ Utilisation mentionnées dans la notice doivent être lues avec attention avant toute utilisation d’ OptiSet.
0.40507519245147705 ||| The rate of genotypically confirmed telbivudine resistance in the pivotal study at 48 weeks was 2.7%. ||| The linear clearance was estimated as a parameter in the population pharmacokinetic analysis and was 12.5 ml/ h. ||| Dans l’ étude clinique pivot, le taux de résistance génotypiquement confirmé à la telbivudine était de 2,7% à 48 semaines.
0.3130298852920532 ||| Discontinuation of Humira therapy should be considered in patients with confirmed significant haematologic abnormalities. ||| MIRCERA is indicated to treat only the symptomatic anaemia caused by chronic kidney disease. ||| L'arrêt du traitement par Humira devra être envisagé pour les patients chez qui des anomalies sanguines significatives seront confirmées.
0.0 ||| Suspension for injection ||| Suspension for injection ||| Suspension inje ctable
0.5614417791366577 ||| This amounts to about EUR 8 billion from the EU budget, which member states will be able to use to supplement EUR 29 billion of structural funding across the EU. ||| The economic performance of the EU fleet continued to be very good, with a net profit of around €1.4 billion and an average net profit margin of 18% in 2018. ||| Cela représente environ 8 milliards d'euros sur le budget de l'UE, que les États membres pourront utiliser pour compléter 29 milliards d'euros de fonds structurels à travers l'UE.
0.030875444412231445 ||| What Karvea looks like and contents of the pack Karvea 75 mg film-coated tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2871 engraved on the other side. ||| What Aprovel looks like and contents of the pack Aprovel 150 mg tablets are white to off-white, biconvex, and oval-shaped with a heart debossed on one side and the number 2772 engraved on the other side. ||| Qu’ est -ce que Karvea et contenu de l'emballage extérieur Les comprimés pelliculés de Karvea 75 mg sont blancs à blancs cassés, biconvexes, de forme ovale, avec un coeur gravé d'un côté et le numéro 2871 gravé sur l'autre côté.
0.6792799234390259 ||| 4%; Grade III/ IV 8% vs. ||| Grades III/ IV** n=318 ||| 4%; grade III/ IV 8% vs.
0.3745066523551941 ||| Clopidogrel and the main circulating metabolite bind reversibly in vitro to human plasma proteins (98% and 94% respectively). ||| Entacapone is almost completely metabolized prior to excretion via urine (10 to 20%) and bile/ feces (80 to 90%). ||| In vitro, le clopidogrel et son principal métabolite circulant se lient de façon réversible aux protéines plasmatiques humaines (taux de liaison respectifs de 98% et de 94%).
0.49509117007255554 ||| Race Population pharmacokinetic analysis of etravirine in HIV infected patients indicated no apparent difference in the exposure to etravirine between Caucasian, Hispanic and Black subjects. ||| Characteristics in patient populations Age, Race/ Ethnicity, Gender The population pharmacokinetics of Xolair were analysed to evaluate the effects of demographic characteristics. ||| Race L’analyse des données de pharmacocinétique populationnelle de l’étravirine chez des patients infectés par le VIH n’a montré aucune différence en termes d’exposition à l’étravirine entre les sujets caucasiens, hispaniques et noirs.
0.25297850370407104 ||| Pharmacotherapeutic group: antiparathyroid hormone, ATC code: ||| Pharmacotherapeutic group: protein-tyrosine kinase inhibitor, ATC code: ||| Classe pharmacothérapeutique: hormone antiparathyroïdienne, code ATC:
0.35290467739105225 ||| The optimum daily dosage must be determined by careful titration of levodopa in each patient. ||| The results of these tests allow your doctor to choose the correct dose of Fertavid from day to day. ||| La dose quotidienne optimale doit être déterminée par ajustement prudent de la lévodopa chez chaque patient.
0.34026265144348145 ||| Impotence, sterility, azoospermia, and testicular atrophy have been reported in male patients. ||| However, transient, orthostatic hypotension or dizziness was observed in some patients. ||| Des cas d’ impuissance, de stérilité masculine, d’ azoospermie et d’ atrophie testiculaire ont été rapportés.
0.05069846659898758 ||| 23 5.3 Preclinical safety data ||| 20 5.3 Preclinical safety data ||| 5.3 Données de sécurité préclinique
0.03251521289348602 ||| Insulin Human Winthrop Basal comes in cartridges sealed in disposable pen injectors, OptiSet. ||| Insulin Human Winthrop Comb 15 comes in cartridges sealed in disposable pen injectors, OptiSet. ||| Insulin Human Winthrop Basal se présente en cartouches scellées dans un stylo injecteur jetable, OptiSet.
0.013490469194948673 ||| During the marketing of Azomyr, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| 89 During the marketing of Azomyr, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) and rash have been reported very rarely. ||| Depuis la commercialisation d'Azomyr, des cas de réactions allergiques sévères (avec gêne respiratoire, sifflements bronchiques, démangeaisons, plaques d'urticaire et gonflements) et d’ éruption cutanée ont été
0.7108656167984009 ||| Sleeping agent Zolpidem ||| Helicob acter Test INFAI ||| Somnifères Zolpidem
0.3156059682369232 ||| (0.83-1.72) ||| (0.80-1.34) ||| (0,83-1,72)
0.24080058932304382 ||| If you are a nursing mother, you must stop breast-feeding if you are to be given Remicade. ||| If you are a woman of child-bearing age, you should avoid becoming pregnant while you are taking Pradaxa. ||| Si vous allaitez, vous devez arrêter l’ allaitement si vous devez être traitée par Remicade.
0.0 ||| Pancreatitis ||| Pancreatitis ||| Pancréatites
0.35159093141555786 ||| Care must be taken to avoid application of the gel to normal skin surrounding the lesions. ||| Do not use in dogs during the period of growth as articular cartilage may be affected. ||| L’ application du gel sur la peau saine autour des lésions devrait être évitée.
0.3492633104324341 ||| Gabapentin is indicated for the treatment of peripheral neuropathic pain such as painful diabetic neuropathy and post-herpetic neuralgia in adults. ||| Prozac is currently approved for the treatment of major depressive episodes, obsessive-compulsive disorder and bulimia nervosa, in adults. ||| La gabapentine est indiquée dans le traitement des douleurs neuropathiques périphériques telles que les neuropathies diabétiques douloureuses et les névralgies post-zostériennes chez l’ adulte.
0.6129802465438843 ||| - one 75 mg capsule or ||| - a 1 ml syringe; ||| - une gélule de 75 mg ou
0.16220355033874512 ||| Always use TRAVATAN exactly as your doctor has told you. ||| Always take ACOMPLIA exactly as your doctor has told you. ||| Utilisez toujours TRAVATAN comme indiqué par votre médecin.
0.2117493450641632 ||| Common: abdominal pain, stomatitis, dyspepsia, loose stools, abdominal pain upper, flatulence, abdominal distension, hiccups, mouth ulceration, pharyngolaryngeal pain, dry mouth. ||| Dyspnoea, cough, hoarseness, pharyngolaryngeal pain, throat irritation, respiratory tract congestion, sinus congestion, post nasal drip, rhinorrhoea, snoring ||| supérieur, flatulences, distension abdominale, hoquet, ulcération buccale, douleur pharyngo-laryngée, sécheresse buccale.
0.6495686769485474 ||| 29 inspections were carried out in response to these requests of which 4 inspections were in the EU and 25 in third countries (mainly in the USA). ||| Numerous external organisations and delegations were invited to take part in a further 32 meetings over 37 days, bringing the total to 205 meetings and 329 meeting days. ||| 4 dans l’Union européenne et 25 dans des pays tiers (la plupart aux États-Unis).
0.1993715763092041 ||| Your doctor will discuss with you the possible risks and benefits of having Twinrix Adult during pregnancy. ||| Your doctor will discuss the possible risks and potential benefits of using IONSYS while you are pregnant. ||| Votre médecin discutera avec vous des risques et bénéfices possibles de recevoir Twinrix Adulte durant votre grossesse.
0.1990596354007721 ||| Beta-adrenergic blocking agents should be administered with caution in patients subject to spontaneous hypoglycaemia or to patients with labile insulin-dependent diabetes as beta-adrenergic blocking agents may mask the signs and symptoms of acute hypoglycaemia. ||| Anaphylactic reactions While taking beta adrenergic blocking agents, patients with a history of atopy or a history of severe anaphylactic reaction to a variety of allergens may be unresponsive to the usual doses of adrenaline used to treat anaphylactic reactions. ||| Les bêta-bloquants doivent être administrés avec prudence chez les patients sujets aux hypoglycémies spontanées ou chez les patients présentant notamment un diabète insulino-dépendant instable, car les bêta-bloquants sont susceptibles de masquer les signes et les symptômes d'une hypoglycémie aiguë.
0.40575408935546875 ||| Increased plasma concentrations of ergot derivatives leading to acute ergot toxicity, including vasospasm and ischaemia. ||| Diarrhoea related to oral topotecan can occur at the same time as drug-related neutropenia and its sequelae. ||| Augmentation des concentrations plasmatiques des dérivés de l'ergot de seigle entraînant un ergotisme aigu, notamment vasospasme et accident ischémique.
0.5140367746353149 ||| Similar results were seen in the study of children and adolescents. ||| A limited number of women were included in the studies. ||| L’ étude sur les enfants et les adolescents a conduit à des résultats similaires.
0.25407546758651733 ||| Serum concentrations may be increased when co-administered with ritonavir resulting in the potential for increased incidence of adverse events. ||| The absorption of atazanavir may be reduced in situations where gastric pH is increased irrespective of cause. ||| Les concentrations sériques peuvent être augmentées en cas d’administration concomitante avec le ritonavir, ce qui peut entraîner une incidence accrue des effets indésirables.
0.11839647591114044 ||| The Marketing Authorisation Holder provided written explanations on 12 September 2007. ||| The Marketing Authorisation Holder provided supplementary information on 26 September 2007. ||| Le titulaire de l’ autorisation de mise sur le marché a fourni des explications écrites le 12 septembre 2007.
0.2508850693702698 ||| Patients with hepatic impairment Based on pharmacokinetic data with docetaxel at 100 mg/ m² as single agent, patients who have both elevations of transaminase (ALT and/ or AST) greater than 1.5 times the upper limit of the normal range (ULN) and alkaline phosphatase greater than 2.5 times the ULN, the recommended dose of docetaxel is 75 mg/ m2 (see sections 4.4 and 5.2). ||| Daily treatment at doses of 20 and 30 mg/ kg for one year in frequently transfused adult and paediatric patients with beta-thalassaemia led to reductions in indicators of total body iron; liver iron concentration was reduced by about -0.4 and -8.9 mg Fe/ g liver (biopsy dry weight (dw)) on average, respectively, and serum ferritin was reduced by about -36 and -926 µg/ l on average, respectively. ||| D’ après les données pharmacocinétiques relatives au docétaxel à 100 mg/ m2 administré en monothérapie, la dose de docétaxel recommandée chez les patients ayant des transaminases (ALAT et/ ou ASAT) supérieures à 1,5 fois la LSN ainsi que des phosphatases alcalines supérieures à 2,5 fois la LSN, est de 75 mg/ m2 (cf. paragraphes 4.4 et 5.2).
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.502338171005249 ||| Nitric oxide is a compound produced by many cells of the body. ||| The solution contains special proteins, isolated from human blood plasma. ||| Le monoxyde d'azote est un composé produit par de nombreuses cellules de l’ organisme.
0.25577980279922485 ||| OPTISON should only be administered by doctors experienced in the field of diagnostic ultrasound imaging. ||| SonoVue should only be used by doctors who have experience in diagnostic ultrasound imaging. ||| OPTISON ne devra être administré que par des médecins expérimentés dans les techniques d’ imagerie échographique.
0.4069240987300873 ||| Solutions should be used within 4 hours of their removal from the refrigerator. ||| This redness should disappear within several hours after removal of the patch. ||| Les solutions doivent être utilisées dans les 4 heures après avoir été sorties du réfrigérateur.
0.03784050792455673 ||| Pharmaceutical preparations for the treatment of diseases of the endocrine system ||| Pharmaceutical preparations for the prevention of diseases of the endocrine system ||| Produits pharmaceutiques pour le traitement des maladies du système endocrinien
0.06750895082950592 ||| Pregnancy There are no adequate data on the use of duloxetine in pregnant women. ||| Pregnancy There are no data on the use of duloxetine in pregnant women. ||| Grossesse Il n'existe pas de données suffisantes sur l'utilisation de la duloxétine chez la femme enceinte.
0.004084213171154261 ||| If any of the side effects gets serious, or if you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist. ||| 60 Si vous remarquez des effets indésirables non mentionnés dans cette notice, ou si vous ressentez qu’ un des effets mentionnés s’ aggrave, veuillez en informer votre médecin ou pharmacien.
0.5503140091896057 ||| The dosage of solution is: ||| The minimum distribution rate is: ||| Le dosage de la solution est:
0.8466760516166687 ||| Transdermal use Read the package leaflet before use. ||| labelling, package leaflet and Module 3. ||| Voie transdermique Lire la notice avant utilisation.
0.08915144205093384 ||| What Carbaglu is and what it is used for 2. ||| What Glubrava is and what it is used for 2. ||| Qu’ est -ce que Carbaglu et dans quel cas est -il utilisé 2.
0.3948534429073334 ||| Aid will be granted in the form of direct grants to enhance and accelerate research and the production of products directly relevant to coronavirus. ||| This article is intended to receive revenue from the issue of certificates, the authorisation of parallel distributions and other similar administrative charges. ||| Les aides seront accordées sous la forme de subventions directes en vue d'intensifier et d'accélérer la recherche et la fabrication de produits ayant une utilité directe pour la lutte contre le coronavirus.
0.5525820255279541 ||| Conducting of exhibitions for recreation purposes ||| Arranging for students to participate in recreational activities ||| Organisation d'expositions à des fins récréatives
0.20134186744689941 ||| Brackets of (Non-metallic -) used for fixing plaques ||| Brackets of (Non-metallic -) for hanging window draperies ||| Supports non métalliques utilisés pour la fixation de plaques
0.32413941621780396 ||| In these studies, no evidence of altered pharmacokinetics of micafungin was observed. ||| Tolcapone was shown not to be genotoxic in a complete series of mutagenicity studies. ||| Dans ces études, aucun signe de modification de la pharmacocinétique de la micafungine n’ a été observé.
0.12699738144874573 ||| • 13.2.2001 • 13.3.2002 ||| • 13.2.2001 • 12.6.2002 ||| 13.2.2001 13.3.2002
0.029289573431015015 ||| Eesti GlaxoSmithKline Eesti OÜ Tel: +372 667 6900 estonia@gsk. com ||| 76 Eesti GlaxoSmithKline Eesti OÜ Tel: + 372 6676 900 estonia@gsk. com ||| Eesti Österreich GlaxoSmithKline Eesti OÜ Tel: +372 667 6900 estonia@gsk.com
0.4671490788459778 ||| Combivir should not be taken with some other medicines. ||| Agenerase may interact with certain other medicines. ||| Combivir ne doit pas être associé à certains médicaments.
0.3296833634376526 ||| At steady-state (day 8) peak plasma concentrations were higher (37.25 ± 13.25 ng/ ml, but almost 100 times lower than those measured following repeated oral administration. ||| The average time to reach peak methaemoglobin was 10 ± 9 (SD) hours (median, 8 hours) in these 13 patients; but one patient did not exceed 7% until 40 hours. ||| À l’ état d’ équilibre (jour 8), les concentrations plasmatiques maximales ont été plus élevées (37,25 ± 13,25 ng/ ml), mais près de 100 fois inférieures à celles mesurées après des administrations orales réitérées.
0.728251576423645 ||| Maintenance and repair of lifts ||| 11 Reconstitution and administration of the product: ||| Entretien et réparation d'ascenseurs
0.0061050895601511 ||| 39 Sodium dihydrogen phosphate monohydrate, Human albumin solution. ||| 59 Sodium dihydrogen phosphate monohydrate, Human albumin solution. ||| Phosphate disodique anhydre, Phosphate monosodique monohydraté, Solution d’ albumine humaine. dic
0.0 ||| For further details on handling, see section 6.6. ||| For further details on handling, see section 6.6. ||| Pour plus de détails sur la manipulation, voir rubrique 6.6.
0.282950758934021 ||| The possibility that Gadovist may cause torsade de pointes arrhythmias in an individual patient cannot be excluded (see section 5.3 Preclinical safety data). ||| ra In rare cases severe hypersensitivity reactions following administration of Zenapax have been reported (see section 4.4). ge Paediatric patients: ||| La possibilité que Gadovist puisse provoquer des arythmies et des torsades de pointe chez certains patients ne peut pas être exclue (voir. rubrique 5.3 Données de sécurité précliniques).
0.31185388565063477 ||| The difference was not statistically significant, however more than half of the patients in the anastrozole alone arm crossed over to a Herceptin containing regimen after progression of disease. ||| One out of 75 dogs treated with the product during clinical trials mated and tied with a bitch on heat within six months of implantation, but this did not result in pregnancy. ||| Toutefois plus de la moitié des patientes du groupe anastrozole seul ont reçu un traitement à base de Herceptin après progression de la maladie.
0.6665313839912415 ||| Azithromycin ||| Difloxacin ||| Azithromycine
0.21085131168365479 ||| Patients who develop fatigue, somnolence or confusion during treatment with ViraferonPeg are cautioned to avoid driving or operating machinery. ||| However, patients who experience dizziness, vertigo or somnolence while taking etoricoxib should refrain from driving or operating machinery. ||| Les patients qui développent fatigue, somnolence ou obnubilation pendant le traitement par ViraferonPeg doivent être avertis afin d’ éviter de conduire des véhicules ou d’ utiliser des machines.
0.46788936853408813 ||| Fireproofing of clothing ||| Cleaning of furnishings ||| Ignifugation d'étoffes
0.41083064675331116 ||| Caution must be observed in patients who have received other anthracyclines. ||| Adverse reactions which may be reported in association with fibrin sealants are described below. ||| Des précautions doivent être prises chez les patients ayant déjà reçu d'autres anthracyclines.
0.7453224062919617 ||| Eye disorders: ||| Treatment of women: ||| 11 Affections oculaires:
0.3668227791786194 ||| Packs of 30 x 1 film-coated tablets in aluminium perforated unit dose blisters. ||| Outer carton - treatment initiation pack containing 4 cartons of 14 film-coated tablets ||| Boîtes de 30 x 1 gélules en plaquettes thermoformées unidoses (aluminium).
0.3560142517089844 ||| Twenty-five percent of patients with APL treated with TRISENOX have experienced symptoms similar to a syndrome called the retinoic-acid-acute promyelocytic leukaemia (RA-APL) or APL differentiation syndrome, characterised by fever, dyspnoea, weight gain, pulmonary infiltrates and pleural or pericardial effusions, with or without leukocytosis. ||| TRISENOX is indicated for induction of remission and consolidation in adult patients with relapsed/ refractory acute promyelocytic leukaemia (APL), characterised by the presence of the t(15; 17) translocation and/ or the presence of the Pro-Myelocytic Leukaemia/ Retinoic-Acid-Receptor- alpha (PML/ RAR-alpha) gene. ||| Vingt-cinq pour cent des patients atteints de LPA et traités par TRISENOX ont présenté des symptômes analogues à ceux d'un syndrome appelé syndrome de l'acide rétinoïque-LPA (RA-APL) ou syndrome de différenciation LPA, caractérisé par une fièvre, une dyspnée, une prise de poids, des infiltrats pulmonaires et des épanchements pleuraux ou péricardiques, avec ou sans hyperleucocytose.
0.06877784430980682 ||| 228 Side effects reported uncommonly (in less than 1 patient in 100) ||| is Side effects reported uncommonly (in less than 1 patient in 100) ||| (chez moins de 1 patient sur 100)
0.3881913721561432 ||| Partially used vials should be discarded. ||| Opened sachets should not be stored. ||| Les flacons partiellement utilisés doivent être jetés.
0.24265220761299133 ||| Non-clinical data reveal no special hazard to humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| In non-clinical safety pharmacology, general toxicity, genotoxicity and carcinogenicity studies no clinically relevant effects have been observed, except those related to the pharmacological effect of the active substance. ||| Les données de sécurité non cliniques issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, génotoxicité, cancérogénèse, et des fonctions de reproduction n'ont pas révélé de risque particulier pour l'homme.
0.2116253674030304 ||| Roderveldlaan 1 2600 Berchem, ||| Roderveldlaan 1 2600 Berchem, Belgium ||| Janssen Cilag NV Roderveldlaan 1 2600 Berchem, Belgique
0.542667806148529 ||| Barrister services ||| Sanatorium services ||| Services d'avocats
0.6701743006706238 ||| Product development for vehicle construction and for vehicle body construction ||| Building construction supervision services for building projects ||| Développement de produits, en particulier pour la construction de véhicules et de carrosseries
0.27531111240386963 ||| cardiac arrest, cardiac failure, arrhythmia, atrioventricular block, bradycardia, palpitations ||| macular oedema, iritis, conjunctivitis, eyelid ptosis, corneal disorder ||| arrêt cardiaque, insuffisance cardiaque, arythmie, bloc auriculoventriculaire, bradycardie, palpitations
0.01641213521361351 ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. eu. int/ ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. eu. int/ ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. eu. int/
0.5904275178909302 ||| Differential gear mechanisms for machines ||| Adapters for connection between media devices ||| Mécanismes de différentiel pour machines
0.7643731832504272 ||| Patients with recurrent or progressive malignant glioma ||| Neoplasms benign and malignant (including ||| Patients adultes atteints d’ un gliome malin en progression ou récidive
0.2974310517311096 ||| Your doctor or nurse will tell you how much Dynepo you need and how frequently it should be injected. ||| Your doctor will work out how much Xolair you need, and how often you will be given it. ||| Votre médecin ou votre infirmier(ère) vous dira quelle est la dose de Dynepo dont vous avez besoin et la fréquence à laquelle vous devrez vous l’ injecter.
0.27585548162460327 ||| Women of childbearing potential are strongly recommended to use adequate contraception to prevent pregnancy and continue its use for at least five months after the last Trudexa treatment. ||| Should a treated dog mate with a bitch between six weeks and six months after treatment, appropriate measures should be taken to rule out the risk of pregnancy. ||| tor conseillées d'utiliser une méthode de contraception appropriée et la poursuivre pendant cinq mois au moins après la dernière administration de Trudexa.
0.49202990531921387 ||| th 3. ||| or 3. ||| to au 3.
0.04108861833810806 ||| Treatment with Agenerase has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer. ||| 51 Treatment with Ziagen has not been shown to reduce the risk of passing HIV infection on to others by sexual contact or by blood transfer. ||| Il n'a pas été démontré qu'un traitement par Agenerase réduisait le risque de transmission de l'infection par le VIH à d'autres personnes par les rapports sexuels ou les transfusions sanguines.
0.27649521827697754 ||| The plasma elimination half-life of zinc in healthy subjects is around 1 hour after a dose of 45 mg. ||| A 15 minute infusion time has not been studied in cancer patients with a creatinine clearance of < 50ml/ min. ||| La demi-vie d’ élimination plasmatique du zinc chez les sujets sains est d’ environ 1 heure après une dose de 45 mg.
0.3310542404651642 ||| Neutropenia, thrombocytopenia, anaemia Pancytopenia, febrile neutropenia Thrombocythaemia, lymphopenia, bone marrow depression, eosinophilia, lymphadenopathy ||| Bone marrow depression, Agranulocytosis, Leucopenia, Neutropenia, Thrombocytopenia, Haemolytic anaemia Anaemia, Lymphadenopathies ||| et du système lymphatique Neutropénie, thrombopénie, anémie Pancytopénie, neutropénie fébrile Thrombocythémie, lymphopénie, aplasie médullaire, eosinophilie, lymphadénopathie
0.0009524549823254347 ||| The non-confidential version of the decision will be made available under the case number SA.57409 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.57429 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.57409 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.3625049591064453 ||| If you are being treated for Kaposi’ sarcoma, Caelyx will be administered at a dose of 20 mg per square metre of your body surface area (based on your height and weight). ||| A dose of either 3 mg (if the affected limb is your arm) or 4 mg (if the affected limb is your leg) of BEROMUN will be administered by ILP for an initial period of 30 minutes. ||| Si vous êtes traité pour un sarcome de Kaposi, Caelyx sera administré à la dose de 20 mg par mètre carré de votre surface corporelle (basée sur votre taille et votre poids).
0.303122341632843 ||| After oral administration, fosamprenavir is rapidly and almost completely hydrolysed to amprenavir and inorganic phosphate prior to reaching the systemic circulation. ||| After oral administration, dabigatran etexilate is rapidly and completely converted to dabigatran, which is the active form in plasma. ||| Après administration orale, le fosamprénavir est rapidement et presque totalement hydrolysé en amprénavir et phosphate inorganique avant d’ atteindre la circulation systémique.
0.009558790363371372 ||| HEXAVAC - single dose pre-filled syringe without needle - Pack of 10 ||| HEXAVAC - single dose pre-filled syringe without needle - Pack of 50 ||| HEXAVAC - Seringue préremplie unidose sans aiguille - boite de 10 seringues
0.4143507480621338 ||| Banners of paper ||| Blocks of concrete ||| Bannières en papier
0.09955285489559174 ||| What Silgard looks like and contents of the pack ||| What Thyrogen looks like and contents of the pack ||| 70 Qu'est ce que Silgard et contenu de l’emballage extérieur
0.26945412158966064 ||| Problems associated with the stomach including: stomach pain, constipation, indigestion, loose stools (diarrhoea), loss or change in appetite, weight loss. ||| Mild systemic allergic reactions (e. g. mild forms of erythema, rash, facial swelling, urticaria, oedema, difficulty breathing). ||| Maux d’ estomac, constipation, indigestion, selles molles (diarrhée), perte ou modification de l’ appétit, perte de poids.
0.19120022654533386 ||| 8.6 6.5 ||| 3.9 6.1 ||| 8,6 6,5
0.33678340911865234 ||| Skin and subcutaneous tissue disorders Common: pruritus Uncommon: ecchymosis ||| Ear and labyrinth disorders Common: tinnitus Uncommon: vertigo ||| Affections de la peau et du tissu sous-cutané Fréquent: prurit Peu fréquent: ecchymose
0.0 ||| Clearance: ||| Clearance: ||| 25 Clairance:
0.022546477615833282 ||| Do not use Insuman Rapid after the expiry date which is stated on the carton and on the label of the cartridge. ||| Do not use Insuman Rapid after the expiry date which is stated on the carton and on the label of the pen. ||| Ne pas utiliser Insuman Rapid après la date de péremption mentionnée sur la boîte et sur l’ étiquette de la cartouche.
0.09017005562782288 ||| What Fareston is and what it is used for 2. ||| What Rasilez is and what it is used for 2. ||| Qu'est -ce que Fareston et dans quel cas est -il utilisé?
0.5451804995536804 ||| Risk reductions for all-cause mortality (8%; p = 0.128) and cardiovascular mortality (10%; p = 0.073) were observed. ||| AUC: ↔ Cmax: ↓ 24% (↓ 18 to ↓ 30) These changes are not considered clinically significant. ||| Une réduction de la mortalité toutes causes de 8% (p = 0,128) et de la mortalité cardiovasculaire de 10% (p = 0,073) ont été observées.
0.5790866613388062 ||| Ottomans ||| Methane ||| Ottomanes
0.3276522159576416 ||| Repair or maintenance of industrial furnaces ||| Repair of household and kitchen appliances ||| Réparation ou entretien de fours industriels
0.521894097328186 ||| Interferon alfa-2b ||| Interferon alfa- ||| Interféron alfa-2b 3 MUI
0.04943568632006645 ||| every 3 – 4 weeks to obtain IgG trough level of at least 4 – 6 g/l ||| every 3 - 4 weeks to obtain IgG trough level of at least 4 - 6 g/ l ||| toutes les 3 à 4 semaines afin d’obtenir un taux résiduel d’IgG d’au moins 4 à 6 g/l au minimum
0.33958837389945984 ||| Nobilis OR inac emulsion for injection for chickens ||| Vial A Pandemrix suspension for emulsion for injection ||| Nobilis OR inac, émulsion injectable pour poulets.
7.224399030392181e-13 ||| Rue de l'Institut 89 B-1330 Rixensart, Belgium ||| Rue de l'Institut 89 B-1330 Rixensart, Belgium ||| Rue de l'Institut, 89 1330 Rixensart, Belgique Téléphone: +32 (0)2 656 8111 dic
0.1121961921453476 ||| Purevax RCP FeLV is a lyophilisate (freeze-dried pellet) and solvent that are made up into a suspension for injection. ||| Equilis StrepE is available as a lyophilisate (freeze-dried pellet) which is made up into a suspension for injection. ||| Purevax RCP FeLV se présente sous la forme de lyophilisat et de solvant pour suspension injectable.
0.18670669198036194 ||| Estate management services relating to transactions in real property ||| Financial services relating to real estate property and buildings ||| Services de gestion des transactions immobilières en matière de propriété
0.4287664294242859 ||| The three complementary studies were conducted similarly to the pivotal study but in one of the complementary studies animals were younger and weighing much less (53 to 59 kg) than the ones used in the other studies were used but they did all receive at least the maximum injection volume (5 ml). ||| Of these 11 patients, 4 patients escalated up to 800 mg daily, 2 of whom regained a cytogenetic response (1 partial and 1 complete, the latter also achieving a molecular response), while of the 7 patients who did not escalate the dose, only one regained a complete cytogenetic response. ||| Les trois études complémentaires ont été menées dans des conditions similaires à celles de l’ étude pivot, mais dans l’ une d’ entre elles les animaux étaient plus jeunes et pesaient beaucoup moins (53 à 59 kg) que ceux utilisés dans les autres études; ils ont cependant tous reçu au moins le volume maximal d’ injection (5 ml).
0.3977620303630829 ||| BLISTER OF 10 mg FILM-COATED TABLETS ||| SINGULAIR 4 MG CHEWABLE TABLETS ||| Plaquette thermoformée de comprimés pelliculés dosés à 10 mg
0.38962140679359436 ||| Manufacturer ||| Manufacturers ||| 58 Fabricant
0.31421709060668945 ||| Care must be taken to eliminate the possibility of a hypersensitivity reaction if any of these symptoms occur. ||| There is also the potential during any pandemic to monitor the effectiveness of any transmission control measures. ||| Des précautions doivent être prises pour éliminer une possible réaction d’ hypersensibilité si l’ un de ces symptômes est observé.
0.08002138137817383 ||| 9/ 19 ANNEX III ||| 7/ 18 ANNEX III ||| 9/ 19 ANNEXE III
0.30081987380981445 ||| Electricity indicators ||| Electricity conduits ||| Indicateurs d'électricité
0.0842360109090805 ||| Do not use in pregnant or lactating mares. ||| Do not use in pregnant or lactating bitches. ||| Ne pas administrer aux juments gestantes ou allaitantes.
0.6825758218765259 ||| - you get mouth sores, ||| - you inject too much insulin, ||| - vous avez des ulcérations de la bouche,
0.06621599197387695 ||| Insulin preparations which have been frozen must not be used. ||| 49 Insulin preparations which have been frozen must not be used. ||| Les préparations d 'insuline qui ont été congelées ne doivent pas être utilisées.
0.36300191283226013 ||| If you need more information about your animal’ s medical condition or treatment, contact your veterinarian. ||| If your child may be or is pregnant, please ask your child’ s doctor for advice. ||| Pour plus d’ informations sur l’ affection ou le traitement de votre animal, veuillez contacter votre vétérinaire.
0.14480869472026825 ||| Table 9: ||| Table 8: ||| Tableau 9:
0.524348795413971 ||| Kiosks [non-metallic structures] ||| Terpenes [essential oils] ||| Kiosques [structures non métalliques]
0.45716169476509094 ||| Drying agents for paints and putties ||| Insulated lids for plates and dishes ||| Siccatifs pour peintures et mastics
0.319993793964386 ||| 60 film-coated tablets ||| film-coated tablet ||| 60 comprimés pelliculés
0.39473602175712585 ||| Risk reductions for all-cause mortality (8%; p = 0.128) and cardiovascular mortality (10%; p = 0.073) were observed. ||| height (mean percentile decrease of growth velocity of 9%) and weight (mean percentile decrease of 13%) percentile were observed during treatment (see section 4.4). ||| Une réduction de la mortalité toutes causes de 8% (p = 0,128) et de la mortalité cardiovasculaire de 10% (p = 0,073) ont été observées.
0.0035113231278955936 ||| 16 Dosage in paediatric patients (12 months to 17 years) In paediatric patients (12 months to 17 years of age), dosing should be based on the patient’ s body surface area (see Instructions for Use in Paediatric Patients, Mosteller 2 Formula). ||| 2 Dosage in paediatric patients (12 months to 17 years) In paediatric patients (12 months to 17 years of age), dosing should be based on the patient’ s body surface area (see Instructions for Use in Paediatric Patients, Mosteller 1 Formula). ||| Posologie chez les patients pédiatriques (12 mois à 17 ans) Chez les patients pédiatriques (de 12 mois à 17 ans), la posologie doit être établie en fonction de la surface corporelle du patient (voir Instructions pour utilisation chez les patients pédiatriques, formule de Mosteller1).
0.001293455483391881 ||| 45 Cytochrome P450 Ciprofloxacin inhibits CYP1A2 and thus may cause increased serum concentration of concomitantly administered substances metabolised by this enzyme (e. g. theophylline, clozapine, ropinirole, tizanidine). ||| 157 Cytochrome P450 Ciprofloxacin inhibits CYP1A2 and thus may cause increased serum concentration of concomitantly administered substances metabolised by this enzyme (e. g. theophylline, clozapine, ropinirole, tizanidine). ||| Cytochrome P450 La ciprofloxacine inhibe le CYP1A2 et peut donc augmenter la concentration sérique des substances administrées concomitamment et métabolisées par cette enzyme (par ex. théophylline, clozapine, ropinirole, tizanidine).
0.0564185231924057 ||| The marketing authorisation was renewed on 22 September 2003 and on 22 September 2008. ||| The marketing authorisation was renewed on 27 September 2001 and on 27 September 2006. ||| L’ autorisation de mise sur le marché a été renouvelée le 22 septembre 2003 et le 22 septembre 2008.
0.47156718373298645 ||| Apparatus for veterinary purposes ||| Greases for medical or veterinary purposes ||| Appareils à usage vétérinaire
0.007144286762923002 ||| Each buccal tablet contains 100 micrograms fentanyl (as citrate). ||| Each buccal tablet contains 800 micrograms fentanyl (as citrate). ||| Chaque comprimé contient 100 microgrammes de fentanyl (sous forme de citrate).
0.3488108813762665 ||| Before you use Mycamine 3. ||| Before you use Fuzeon 3. ||| Quelles sont les informations à connaître avant d'utiliser Mycamine 3.
0.27712517976760864 ||| Population based analysis demonstrates that age across the range tested (21 – 75 years) does not significantly alter the pharmacokinetics of Caelyx. ||| Based on a population pharmacokinetic analysis in patients 19-78 years of age, clearance of TMZ is not affected by age. ||| L’ analyse de population démontre que l’ âge sur l’ intervalle testé (21 – 75 ans) n’ altère pas significativement les paramètres pharmacocinétiques de Caelyx.
0.16555353999137878 ||| Each ml contains 75 mg cidofovir anhydrous. ||| Each tablet contains 500 mg sodium phenylbutyrate. ||| Chaque ml contient 75 mg de cidofovir anhydre.
0.27183258533477783 ||| Beef tallow for industrial purposes ||| Gelatin beads for industrial use ||| Suif de bœuf à usage industriel
3.5416634902585287e-13 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist ||| Si l’un des effets indésirables devient sérieux ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez en à votre médecin ou votre pharmacien.
0.2532356083393097 ||| Prior to adding the reconstituted volume of Fabrazyme required for the patient dose, it is recommended to remove an equal volume of 0.9% sodium chloride intravenous solution, from the infusion bag. ||| Therefore, each vial contains an excess amount of solvent and ViraferonPeg powder to ensure delivery of the labelled dose in 0.5 ml of ViraferonPeg, solution for injection. ||| Avant d’ajouter le volume reconstitué de Fabrazyme nécessaire pour la posologie du patient, il est recommandé de retirer un volume égal de solution pour perfusion de chlorure de sodium à 0,9% de la poche de perfusion.
0.5773167610168457 ||| For the full list of all side effects reported with MabCampath, see the Package Leaflet. ||| We have developed training material to support this coding (Multimedia Appendix 4). ||| Pour avoir le détail de tous les effets indésirables observés sous MabCampath, voir la notice.
0.27866968512535095 ||| In a clinical study of healthy adults a 4000 IU daily dose of vitamin D3 for up to five months was not associated with hypercalciuria or hypercalcaemia. ||| In particular, liver fibrosis was observed in dogs after administration of hydroxocobalamin for 4 weeks at 300 mg/ kg. ||| Dans une étude clinique, chez des adultes sains, une dose journalière de 4 000 UI de vitamine D3 pendant 5 mois n’ a pas entraîné d’ hypercalcémie ou d’ hypercalciurie.
0.44643914699554443 ||| In the following conditions, the risk of Metalyse therapy may be increased and should be weighed against the anticipated benefits: ||| However the Committee agreed that such a combination should still not be recommended until there is more evidence to support its positive benefit-risk balance. ||| Les risques liés à l'utilisation de Métalyse peuvent être accrus dans les situations suivantes et nécessitent une évaluation approfondie du rapport bénéfice risque:
0.0907001942396164 ||| Haemorrhage Fondaparinux should be used with caution in patients who have an increased risk of haemorrhage, such as those with congenital or acquired bleeding disorders (e. g. platelet count < 50,000/ mm3), active ulcerative gastrointestinal disease and recent intracranial haemorrhage or shortly after brain, spinal or ophthalmic surgery and in special patient groups as outlined below. ||| Fondaparinux should be used with caution in patients who have an increased risk of haemorrhage, such as those with congenital or acquired bleeding disorders (e. g. platelet count < 50,000/ mm3), active ulcerative gastrointestinal disease and recent intracranial haemorrhage or shortly after brain, spinal or ici ||| 14 troubles acquis ou congénitaux de la coagulation (par exemple, numération plaquettaire < 50 000/ mm3), maladie ulcéreuse gastro-intestinale en poussée, hémorragie intracrânienne récente ou dans les suites récentes d'une intervention chirurgicale cérébrale, rachidienne ou ophtalmique, et dans les populations particulières mentionnées ci-dessous.
0.6130825281143188 ||| The EMEA continued to receive information visits from national authorities of a number of non-EU countries. ||| The PERF has been realised with significant contribution from experts from both national competent authorities and the EMEA. ||| L’ EMEA a continué à recevoir des visites d’ information d’ autorités nationales de plusieurs pays tiers.
0.0 ||| In non-clinical safety studies, high doses of irbesartan (≥ 250 mg/ kg/ day in rats and ≥ 100 mg/ kg/ day in macaques) caused a reduction of red blood cell parameters (erythrocytes, haemoglobin, haematocrit). ||| In non-clinical safety studies, high doses of irbesartan (≥ 250 mg/ kg/ day in rats and ≥ 100 mg/ kg/ day in macaques) caused a reduction of red blood cell parameters (erythrocytes, haemoglobin, haematocrit). ||| 21 (≥ 250 mg/ kg/ jour chez le rat et ≥ 100 mg / kg/ jour chez le macaque) ont causé des réductions sur la lignée rouge sanguine (érythrocytes, hémoglobine, hématocrite).
0.16615304350852966 ||| Children (3 months to 12 years of age): ||| Children and adolescents (3 months to 17 years of age): ||| Enfants (3 mois à 12 ans):
0.189984530210495 ||| HOW TO TAKE ADENURIC ||| HOW TO TAKE ARICLAIM ||| COMMENT PRENDRE ADENURIC
0.1596391648054123 ||| 181 Do not use GONAL-f ||| Do not use GONAL-f ||| N’ utilisez jamais GONAL-f
0.2643551230430603 ||| In these patients, tolerability to combination therapy and the presence of additional clinical or prognostic factors such as degree of fibrosis should be taken into account when considering deviations from standard 24 weeks treatment duration. ||| Furthermore, there is no data available on length of time between treatment courses necessary to assure that recurrence of therapy is driven by congestive symptoms and not related to any dependency phenomena. ||| Chez ces patients, la tolérance de la bithérapie et la présence de facteurs cliniques ou pronostiques supplémentaires, comme le degré de fibrose, doivent être pris en compte lorsqu’ une modification de la durée standard du traitement de 24 semaines est envisagée.
0.598639726638794 ||| very rare: abnormal elimination of urine ||| - Insufficient function of your transplanted organ ||| Très rare: difficulté à uriner
0.5284425616264343 ||| Pre-packaged dinners consisting primarily of seafood ||| Stages for musical performances composed of primarily non-metal materials ||| Plats préemballés essentiellement à base de fruits de mer
0.30462586879730225 ||| Sorafenib had no effect on the pharmacokinetics of gemcitabine or oxaliplatin. ||| Varenicline did not alter the steady-state pharmacokinetics of digoxin. ||| Le sorafénib n’ a eu aucun effet sur la pharmacocinétique de la gemcitabine ou de l’ oxaliplatine.
0.19290518760681152 ||| • Replace the big outer needle cap and unscrew the needle. ||| • Replace the big outer needle cap and unscrew the needle (picture 4). ||| • Replacez le grand capuchon externe de l’aiguille et dévissez l’aiguille.
0.030163776129484177 ||| 9/ 34 ANNEX II ||| 9/ 42 ANNEX II ||| 9/ 38 ANNEXE II
0.09596433490514755 ||| • 210 days • 224 days ||| • 192 days • 127 days ||| 210 jours 224 jours
0.5992242097854614 ||| Further discrepancies also exist between Member States regarding sections 4.2 Method of administration, 4.5 Interactions with other Medicinal Products and other forms of Interaction, 4.6 Pregnancy and lactation and 6.2 Incompatibilities ||| The guidance was developed in two phases, phase one (2005) developed the three key Active Design objects of - improving Accessibility, enhancing Amenity and increasing Awareness (The 3 A's). ||| D’ autres divergences entre les Etats membres concernent les rubriques 4.2 Posologie et Mode d’ administration, 4.5 Interactions avec d’ autres médicaments et autres formes d’ interaction, 4.6 Grossesse et Allaitement et 6.2 Incompatibilités.
0.2611563503742218 ||| If you stop taking VIRAMUNE Taking all doses at the appropriate times greatly increase the effectiveness of your medicinal product combination regimen and reduce the development of viral resistance. ||| Prescriptions for venlafaxine should be written for the smallest quantity of the medicinal product consistent with good patient management in order to reduce the risk of overdose. ||| Une prise régulière peut fortement augmenter l'efficacité de l'association des antiviraux que vous recevez et réduire l'apparition de résistances virales.
0.2948581874370575 ||| Results of long term follow-up in Sweden demonstrate that acellular pertussis vaccines are efficacious in infants when administered according to the 3 and 5 months primary vaccination schedule, with a booster dose administered at approximately 12 months. ||| The duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep. ||| Les résultats de suivi à long terme en Suède démontrent que les vaccins coquelucheux acellulaires sont efficaces chez les jeunes enfants, lorsqu’ ils sont administrés selon le schéma de primovaccination à 3 et 5 mois, avec une dose de rappel à l’ âge de 12 mois environ.
0.19477331638336182 ||| Bags made of textile for the storage of tents ||| Bags of textile material for use with trees ||| Sacs en matières textiles pour le rangement de tentes
0.8793883919715881 ||| You may require medical attention. ||| You may need additional factor VIII to control ||| Vous pourriez nécessiter des soins médicaux.
0.5789047479629517 ||| We have committed to a new push for European democracy and we must all play our part to deliver." ||| We will have to learn lessons and have to decide what type of European Union we want for the future. ||| Nous sommes résolus à donner une nouvelle impulsion en faveur de la démocratie européenne et nous devons tous jouer notre rôle dans cette entreprise.»
0.10989644378423691 ||| 168 tablets ||| 196 tablets ||| 168 comprimés
0.2522186040878296 ||| It is therefore recommended that mothers taking lamivudine do not breast feed their infants. ||| It is therefore recommended that mothers being treated with REYATAZ not breast-feed their infants. ||| Il est donc recommandé que les femmes traitées par la lamivudine n’ allaitent pas leur enfant.
0.29178521037101746 ||| The dose may be increased to 100 mg once daily based on blood pressure response from one month after initiation of therapy onwards. ||| The dose may later be increased to 300 mg (two tablets a day) once daily depending on blood pressure response. ||| En fonction de la réponse tensionnelle, la dose pourra être augmentée à 100 mg une fois par jour, un mois après le début du traitement.
0.08442036807537079 ||| What SOMAVERT is and what it is used for 2. ||| What AVONEX is and what it is used for 2. ||| Qu’ est -ce que SOMAVERT et dans quel cas est -il utilisé 2.
0.2299266755580902 ||| Tel: + 39 - 055 42571 ||| Tel.: + 36 1 465 2100 ||| Tel: + 39- 055 42571
0.010901398956775665 ||| Although fluoxetine has been shown not to affect psychomotor performance in healthy volunteers, any psychoactive drug may impair judgment or skills. ||| Although fluoxetine has been shown not to affect psychomotor performance in healthy volunteers, any psychoactive drug may impair judgement or skills. ||| Bien qu’ il ait été démontré que la fluoxétine n’ affecte pas les performances psychomotrices chez des volontaires sains, tout médicament psycho-actif peut entraîner une diminution de l’ attention et des capacités de réaction.
0.7013723850250244 ||| Therefore water intake should be monitored, especially in broilers. ||| Second, a greater direct electrification of end-use sectors. ||| On surveillera donc l'absorption d'eau, surtout chez les poulets.
0.08436885476112366 ||| Channelled strips (Non-metallic -) for securing writing boards to walls ||| Channelled strips (Non-metallic -) for securing flipcharts to walls ||| Bandes cannelées non métalliques pour la fixation murale de panneaux
0.6589540243148804 ||| "The urine may be dark, often described as ""tea-colored"", due to the presence of myoglobin." ||| "Among laypersons, the term ""accidental injury"" is often used." ||| L'urine peut être sombre, souvent décrite comme « de couleur thé », en raison de la présence de myoglobine.
0.8133955001831055 ||| Administer the dose as per standard protocol. ||| Check window to confirm delivery of full dose ||| Administrer la dose selon le protocole standard.
0.3126765191555023 ||| Following oral administration, the plasma concentration of unchanged lacosamide increases rapidly and reaches Cmax about 0.5 to 4 hours post-dose. ||| Following topical administration selamectin is absorbed from the skin reaching maximum plasma concentrations approximately 1 and 3 days after administration in cats and dogs respectively. ||| Après une administration orale, la concentration plasmatique du lacosamide sous forme inchangée augmente rapidement et la Cmax est atteinte environ 0,5 à 4 heures après l’ administration.
0.3131386935710907 ||| In the prevention of VTEs, the recommended dose of Arixtra is 2.5 mg once a day by subcutaneous injection (under the skin). ||| When in pain, the patient uses a button on the IONSYS system to start the delivery of a dose of fentanyl (40 micrograms). ||| Dans la prévention des ETV, la dose recommandée d’ Arixtra est de 2,5 mg, une fois par jour, administrée par injection sous-cutanée (sous la peau).
0.9532896280288696 ||| EU/ 2/ 98/ 006/ 003 Nobilis IB 4-91 ||| N= N= N= 393 205 204 ACR 20 ||| EU/ 2/ 98/ 006/ 003
0.2782084345817566 ||| There is also no clinical data available which demonstrates withdrawal symptoms in patients treated with transdermal fentanyl after injection of buprenorphine. ||| There were no clinically relevant changes in pain scores from baseline in either the methylnaltrexone bromide or placebo-treated patients. ||| Il n’ existe pas non plus de données cliniques disponibles démontrant l’ existence de symptômes de sevrage chez les patients traités par fentanyl par voie transdermique après l’ injection de buprénorphine.
0.6536659002304077 ||| System organ class ||| MedDRA system organ class ||| Classes de systèmes d’ organes
0.636123776435852 ||| 4%; Grade III/ IV 8% vs. ||| 31%) and Grade 4 AEs (34% vs. ||| 4%; grade III/ IV 8% vs.
0.0 ||| 4. ||| 4. ||| 331 4.
0.4344916343688965 ||| Wine ||| Chicken ||| Vin
0.5515190362930298 ||| 21 Cyclooxygenase is responsible for generation of prostaglandins. ||| The compound has a cryptosporidiostatic effect on Cryptosporidium parvum. ||| La cyclo-oxygénase est responsable de la synthèse des prostaglandines.
0.38546180725097656 ||| If a patient is hypersensitive to peanut or soya, CELSENTRI should not be used. ||| If you are allergic to peanut or soya, do not use this medicinal product. ||| CELSENTRI ne doit pas être utilisé chez les patients allergiques au soja ou à l’ arachide.
0.03619822859764099 |||  457 Injecting the solution Select the injection site. |||  408 Injecting the solution Select the injection site. ||| Injection de la solution Choisissez le site d’injection.
0.1107533872127533 ||| 86/ 125 10. ||| 92/ 125 9. ||| 90/ 129 10.
0.0 ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market. ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market. ||| Le titulaire de l’ AMM doit s’ assurer que le système de pharmacovigilance est mis en place et fonctionne avant que le produit soit mis sur la marché.
0.6639487743377686 ||| The benefits of Zavesca were maintained over three years of continuous treatment. ||| The HBM has gained substantial empirical support since its development in the 1950s. ||| Les bénéfices de Zavesca étaient maintenus pendant les trois ans de traitement continu.
2.919425226739769e-13 ||| Insulatard InnoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA) ||| Insulatard InnoLet 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA) ||| Insulatard InnoLet 100 UI/ml suspension injectable en stylo prérempli Insuline humaine (ADNr)
0.10470431298017502 ||| The other ingredients are microcrystalline cellulose (E460), lactose anhydrous, medium chain triglycerides, gelatin, croscarmellose sodium, sucrose, colloidal silicon dioxide, magnesium stearate (E572) butyl hydroxytoluene (E321), modified starch (maize), and sodium aluminium silicate (E554). ||| The other ingredients are: sodium starch glycollate (Type A), hypromellose, hypromellose 6cP, microcrystalline cellulose, lactose monohydrate, magnesium stearate, titanium dioxide (E171), macrogol 3000, glycerol triacetate and iron oxide red (E172). ||| Les autres composants sont la cellulose microcristalline (E460), le lactose anhydre, les triglycérides à chaînes moyennes, la gélatine, la croscarmellose sodique, le saccharose, la silice colloïdale, le stéarate de magnésium (E572), le butylhydroxytoluène (E321), l'amidon modifié (maïs), et le silicate d’aluminium sodique (E554).
0.3550805449485779 ||| This may be increased if necessary by your doctor until you are taking the amount you need. ||| Therefore, you should be careful until you are used to any effect the medication might have. ||| Cette dose peut être augmentée par votre médecin si nécessaire, jusqu’ à la dose dont vous avez besoin.
0.03709876909852028 ||| Advisory and consultancy services relating to the use of manure in agriculture, horticulture and forestry ||| Advisory and consultancy services relating to the use of fertilizers in agriculture, horticulture and forestry ||| Services de conseils et d'assistance en matière d'utilisation de fumier dans l'agriculture, l'horticulture et la sylviculture
0.09061898291110992 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of genotoxicity. ||| Non-clinical data reveal no special hazard for humans based on studies of repeated dose toxicity. ||| Les données non cliniques issues des études conventionnelles de génotoxicité n’ ont pas révélé de risque particulier pour l’ homme.
0.3088035583496094 ||| What is Aldurazyme used for? ||| What is Thalidomide Celgene used for? ||| Dans quel cas Aldurazyme est -il utilisé?
0.436279833316803 ||| On 1 January 2020, Ai again reported to the hospital's public health department and medical office the news of the admission of multiple patients by a clinic owner near the South China Seafood Market, hoping to attract attention. ||| On 16 March, the supermarket chain Samkaup announced that 27 grocery shops throughout Iceland would have special shopping times for vulnerable members of the public, including the elderly and those with chronic and underlying illnesses. ||| Le 1er janvier 2020, Ai signale à nouveau au service de santé publique et au cabinet médical de l'hôpital la nouvelle de l'admission de plusieurs patients par une clinique privée près du marché aux fruits de mer, dans l'espoir d'attirer l'attention.
0.4304176867008209 ||| 65 The following side effects are very common (> 1/ 10) with METALYSE: ||| The following uncommon (≥ 1/ 1,000 to ≤ 1/ 100) side effects are recognised for DaTSCAN: ||| Les effets secondaires suivants peuvent survenir fréquemment (> 1/100, < 1/10) après l'administration de METALYSE:
6.03563423198783e-13 ||| 29 1. ||| 29 1. ||| 32 1.
0.30268704891204834 ||| Hence an article 30 procedure (Directive 2001/ 83/ EC) for harmonisation of the SPC of lamotrigine across Europe has been initiated by the Marketing Authorisation Holder. ||| After finalisation of the procedure the Spanish Agency for Medicines and Health Products initiated a referral for arbitration to the CHMP under article 36.1 of Directive 2001/ 83/ EC. ||| Par conséquent, une procédure au titre de l’ article 30 (Directive 2001/ 83/ CE) visant à l’ harmonisation des RCP relatifs à la lamotrigine au sein de l’ Europe a été lancée par le TAMM.
0.42756593227386475 ||| Sealed radioactive substances for medical use ||| Nitrating liquids used as explosives ||| Substances radioactives scellées à usage médical
0.030017536133527756 ||| 4.8 Interactions with other medicinal products and other forms of interaction ||| 4.8 Interaction with other medicinal products and other forms of interaction ||| 4.8 Interactions médicamenteuses et autres formes d’ interaction
0.21255847811698914 ||| In the congenital heart disease study, monthly intramuscular doses of 15 mg/ kg achieved mean 30 day trough serum active substance concentrations of approximately 55 µg/ ml after the first injection and approximately 90 µg/ ml after the fourth injection. ||| Reproduction studies carried out with ganirelix at doses of 0.1 to 10 μ g/ kg/ day subcutaneously in the rat and 0.1 to 50 μ g/ kg/ day subcutaneously in the rabbit showed increased litter resorption in the highest dose groups. ||| Dans l'étude cardiopathie congénitale, des doses intramusculaires mensuelles de 15 mg/ kg ont permis d'obtenir des concentrations sériques résiduelles 30 jours plus tard de 55 µg/ ml après la première injection et d'environ 90 µg/ ml après la quatrième injection.
0.48447006940841675 ||| Complementing several already approved national measures, this scheme will support Italian businesses in continuing their operations in these difficult times and help preserve jobs. ||| Assistance is provided through partner organisations and can be adapted to local needs, so EU countries can set their own priorities. ||| Ce régime, qui vient s'ajouter à plusieurs mesures nationales déjà approuvées, aidera les entreprises italiennes à poursuivre leurs activités en ces temps difficiles et aidera à préserver les emplois.
0.6774132251739502 ||| Total Daily Dose (mg of base) ||| Twice Daily Dose (dose in mg) ||| dose/ jour (mg de base)
0.5674662590026855 ||| 2.71 0.39 ||| 1 9.84% ||| 0,63
0.10019885003566742 ||| Between November 2004 and June 2005, the MAH made oral explanations to the CHMP on cardiovascular and skin safety aspects for Dynastat on 18 January, 20 April and 25 May 2005. ||| Between November 2004 and June 2005, the MAH made oral explanations to the CHMP on cardiovascular and skin safety aspects for etoricoxib on 18 January and 15 February 2005. ||| Entre novembre 2004 et juin 2005, le titulaire l'Autorisation de Mise sur le Marché a fourni des explications orales au CHMP sur les aspects de sécurité cardiovasculaire et cutanée concernant Dynastat les 18 janvier, 20 avril et 25 mai 2005.
0.300390362739563 ||| General disorders and administration site conditions Very Common: ||| Vaginitis General disorders and administration site conditions Common: ||| 63 Troubles généraux et anomalies au site d’ administration Très fréquent:
0.47916319966316223 ||| Concentrate for solution for infusion 2 vials of 10 ml ||| 60 vials with powder for solution for injection 60 vials with solvent ||| Solution à diluer pour perfusion 2 flacons de 10 ml
0.5346431732177734 ||| - bleeding, loss of blood, increased tendency to bruise ||| - loss of weight, decrease in appetite, feeling tired, loss of taste ||| - saignement, pertes sanguines, tendance accrue aux echymoses (bleus)
0.2576115131378174 ||| In rats the incidence of pre-implantation loss was increased at a dose of 100 mg/ kg/ day, (10.4 times the human therapeutic exposure following a dose of 200 mg), which caused maternal toxicity. ||| No tumorigenic activity was observed in an oral carcinogenicity study in mice at doses of up to 250 mg/ kg/ day (12.5 to 50 times the human therapeutic dose range). ||| Chez le rat, une augmentation de l'incidence des pertes préimplantatoires, responsable d’ une toxicité maternelle, a été observée à la dose de 100 mg/ kg/ jour (10,4 fois l'exposition thérapeutique chez l'homme après administration d'une dose de 200 mg).
0.3283606171607971 ||| Saw blades for use with power tools ||| Electric motors for use with doors ||| Lames de scies pour outils électriques
0.4126109778881073 ||| Face shields for medical use ||| Protective visors for medical use ||| Écrans faciaux à usage médical
0.2923794686794281 ||| The incidence of adverse events was higher in patients with low weight (≤ 60 kg). ||| The overall incidence of vaginal bleeding was low (≤ 2.6% in all treatment groups). ||| Faible poids corporel: l’ incidence des effets indésirables était plus élevée chez les patients à faible poids corporel (≤ 60 kg).
0.44447147846221924 ||| Store gas cylinders indoors in well-ventilated rooms or outdoors in ventilated sheds where they are protected from rain and direct sunlight. ||| Do not store Norvir soft capsules in extreme heat or cold (such as in a car during hot or very cold weather, or in your freezer). ||| Conserver les bouteilles de gaz à l’ intérieur dans des pièces bien ventilées ou à l’ extérieur dans des abris ventilés où elles sont protégées de la pluie et du rayonnement direct du soleil.
1.7483556270599365 ||| There is a linear correlation between dose on the one hand and plasma concentration and AUC on the other. ||| The young and the old from the north or the south, the east or the west. ||| Il existe une corrélation linéaire entre d’ une part la dose et d’ autre part, la concentration plasmatique et l’ aire sous la courbe (AUC).
0.0 ||| None known. ||| None known. ||| Aucune connues.
0.2443995624780655 ||| Further treatment with clofarabine, generally at a lower dose, can be considered when patients are stabilised and organ function has returned to baseline. ||| It should be used with caution, possibly with a lower starting dose, in patients whose bodies may break Onsenal down slowly. ||| La poursuite du traitement par clofarabine (avec généralement administration d’ une dose plus faible) peut être envisagée lorsque l’ état des patients est stable et après retour aux valeurs normales des fonctions organiques.
0.16991204023361206 ||| 2/ 3 Other information about Tysabri: ||| 2/ 3 Other information about Caelyx: ||| Autres informations relatives à Tysabri:
0.12598523497581482 ||| You should normally use Humalog Mix50 within 15 minutes of a meal. ||| You should normally use Humalog within 15 minutes of a meal. ||| Vous utiliserez normalement Humalog Mix50 Pen dans les 15 minutes qui précèdent ou qui suivent le repas.
0.3140893578529358 ||| Subject to further funding being made available by the European Commission PHARE programme, it is planned to continue the initiative – PERF III – until December 2003 to coincide with the expected first wave of accession of new Member States. ||| Exceptionally, it will be possible to fully finance cohesion policy programmes related to COVID-19 through 100% EU funding during the accounting year starting on 1 July 2020 and ending on 30 June 2021. ||| Si un financement supplémentaire peut être obtenu grâce au programme PHARE de la Commission européenne, le plan est de poursuivre l'initiative (PERF III) jusqu'en décembre 2003 pour coïncider avec la première vague attendue d’ adhésion de nouveaux États membres.
1.137197494506836 ||| 3386 11 3437 46 2945 7 2972 35 3143 4 3190 12 ||| 1 3 4 4 34 33 34 13 36 43 12 10 227 - 6 2 10 14 30 32 54 24 10 32 214 441 ||| 3437 46 7 2972 35 4 3190 12
0.2595039904117584 ||| Starlix and older people Starlix can be used by people over 65 years of age. ||| Use in older people Emselex can be used by people older than 65. ||| Starlix chez les personnes âgées Starlix peut être utilisé chez les personnes âgées de plus de 65 ans.
0.1540820598602295 ||| Patients should receive calcium or vitamin D supplements if they are not getting enough from their diet. ||| Patients taking Bondenza should also take vitamin D and calcium supplements if they do not get enough from their diet. ||| Les patientes doivent prendre des suppléments en calcium ou en vitamine D si leurs apports alimentaires sont insuffisants.
0.2964094281196594 ||| Transmission of data by radiopaging ||| Transmission of data by teletypewriter ||| Transmission de données par radiomessagerie
0.3117120563983917 ||| The pharmacokinetic properties of NutropinAq have only been investigated in healthy adult males. ||| The pharmacokinetics of NovoMix 30 has not been investigated in children or adolescents. ||| Les propriétés pharmacocinétiques de NutropinAq ont été étudiées chez des adultes sains de sexe masculin.
0.8349257707595825 ||| Questions and Answers ||| Commonly Asked Questions ||| 641 QUESTIONS ET REPONSES
0.292653352022171 ||| If you take more Glustin 30 mg tablets than you should: ||| If you forget to take Glustin 45 mg tablets: ||| Si vous avez pris plus de comprimés de Glustin 30 mg que vous n’ auriez dû:
0.18837249279022217 ||| 13 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 25 PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING UNITS ||| 13 MENTIONS DEVANT FIGURER SUR LES PETITS RECIPIENTS
0.2506188750267029 ||| How to use Paxene 4. ||| How to use Caelyx 4. ||| Comment utiliser Paxene 4.
0.5849487781524658 ||| Glycine For a full list of excipients, see section 6.1. ||| For information on reconstitution of Xolair, see section 6.6. ||| Glycine Pour la liste complète des excipients, voir rubrique 6.1.
0.1464434266090393 ||| 6 IRUs ||| 2 IRUs ||| 6 DLI
0.17587286233901978 ||| lP ||| lp ||| Ce
0.2797117829322815 ||| Purevax RCP FeLV is a lyophilisate (freeze-dried pellet) and solvent that are made up into a suspension for injection. ||| Zevalin is a kit for the preparation of a ‘ radiolabelled’ infusion (drip into a vein) of the active substance ibritumomab tiuxetan. ||| Purevax RCP FeLV se présente sous la forme de lyophilisat et de solvant pour suspension injectable.
0.5528868436813354 ||| Impaired hepatic function No adjustment of dosage is necessary. ||| 2.4 Antimicrobial resistance development and justification of recommended dose ||| Insuffisance hépatique Aucune adaptation de la posologie n’ est nécessaire.
0.25519341230392456 ||| The active substance is oxybutynin. ||| The active substance is cinacalcet. ||| La substance active est l’ oxybutynine.
0.12454632669687271 ||| Taking Wilzin with food and drink: ||| Taking Xagrid with food and drink: ||| Aliments et boissons:
0.1011427789926529 ||| Clinical studies have shown that there are no clinically significant interactions between abacavir, lamivudine and zidovudine. ||| Clinical studies have shown that there are no clinically significant interactions between abacavir and lamivudine. ||| Aucune interaction cliniquement significative n’ a été observée entre l’ abacavir, la lamivudine et la zidovudine lors des études cliniques.
0.13911062479019165 ||| - if you are allergic (hypersensitive) to olanzapine or any of the other ingredients of ||| - if you know that you are allergic (hypersensitive) to bexarotene or to any of the other ||| - Si vous êtes allergique (hypersensible) à l’ olanzapine ou à l’ un des autres composants contenus
0.22243762016296387 ||| Rental of houses ||| Rental of warehouses ||| Location de maisons
0.5208394527435303 ||| You should avoid taking SIFROL together with antipsychotic medicines. ||| - not to add another antihistamine (even OTC preparations) but consult their physician. ||| Vous devez éviter de prendre SIFROL simultanément à des antipsychotiques.
0.3973228335380554 ||| Hemoglobin glutamer-200 (bovine) – 130 mg/ ml ||| medroxyprogesterone acetate (DMPA) 150 mg every 3 ||| Hémoglobine glutamer - 200 (bovine) - 130 mg/ ml
4.1087169473999485e-13 ||| Treatment with Enbrel may result in the formation of autoimmune antibodies (see section 4.8). ||| Treatment with Enbrel may result in the formation of autoimmune antibodies (see section 4.8). ||| Enbrel est susceptible d'entraîner la formation d'anticorps auto-immuns (voir section 4.8).
0.20881783962249756 ||| België/ Belgique/ Belgien Luxembourg/ Luxemburg SA Alcon-Couvreur NV + 32 (0)3 890 27 11 (België/ Belgique/ Belgien) ||| België/ Belgique/ Belgien/ Luxembourg/ Luxemburg Genzyme Belgium nv/ sa (Belgique/ Belgien), Tél/ Tel: + 32 2 714 17 11 ||| SA Alcon-Couvreur NV + 32 (0)3 890 27 11 (België/ Belgique/ Belgien)
0.5387723445892334 ||| Of the 36 subjects, 12 (33%) had a history of hypoglycaemia prior to beginning treatment. ||| At the end of 1997, the majority of retrievals (80 percent) related to electronic documents. ||| Parmi ces 36 patients, 12 (33%) avaient des antécédents d’ hypoglycémie antérieurs au traitement.
0.013997801579535007 ||| One vial contains 22.5 microgram of protein (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| One vial contains 7,5 microgram of protein (specific in vivo bioactivity equal to approximately 10 000 IU FSH / mg protein). ||| Un flacon contient 22,5 microgrammes de protéine (la bio-activité spécifique in vivo est environ égale à 10 000 UI de FSH/ mg de protéine).
0.0 ||| Both CYP2D6 and CYP1A2 catalyse the formation of the two major metabolites glucuronide conjugate of 4-hydroxy duloxetine and sulphate conjugate of 5-hydroxy,6-methoxy duloxetine. ||| Both CYP2D6 and CYP1A2 catalyse the formation of the two major metabolites glucuronide conjugate of 4-hydroxy duloxetine and sulphate conjugate of 5-hydroxy,6-methoxy duloxetine. ||| La duloxétine est largement métabolisée et les métabolites sont éliminés principalement dans l 'Le CYP2D6 et le CYP1A2, tous deux, sont responsables de la formation des deux principaux métabolites, le glucuroconjugué 4-hydroxyduloxétine et le sulfoconjugué 5-hydroxy,6- méthoxyduloxétine.
0.08121705055236816 ||| EVISTA should not be used in patients with severe renal impairment (see section 4.3). ||| EVISTA should not be used in patients with hepatic impairment (see section 4.3). ||| EVISTA ne doit pas être utilisé chez les patients ayant une insuffisance rénale sévère (voir rubrique 4.3).
0.4952819347381592 ||| Boxing gloves ||| Boxing rings ||| Gants de boxe
0.1310499757528305 ||| Each patch contains 8.4 mg of testosterone, releasing 300 micrograms of testosterone over 24 hours. ||| Each patch of 28 cm2 contains 8.4 mg testosterone and provides 300 micrograms of testosterone per 24 hours. ||| Chaque dispositif transdermique contient 8,4 mg de testostérone, libérant 300 microgrammes de testostérone par 24 heures.
0.30289122462272644 ||| In the pooled population pharmacokinetic analysis, there were no marked differences in the pharmacokinetics of rosiglitazone or glimepiride between males and females. ||| Population pharmacokinetic analyses in adult RA patients, showed that age, gender and ethnic origin did not affect the pharmacokinetics of tocilizumab. ||| 34 Sexe: l’ analyse des paramètres pharmacocinétiques sur l’ ensemble de la population ne montrait pas de différence notable des paramètres pharmacocinétiques de la rosiglitazone ou du glimépiride entre les hommes et les femmes.
0.3210952877998352 ||| Based on 3- and 5-year human data in the clinical trials, the incidence of cancer during treatment with lasofoxifene was not higher than for placebo. ||| In the post-orthopedic surgery pain studies, anemia was reported more frequently, although the frequency was similar to placebo. ||| Selon les données à 3 et 5 ans des essais cliniques chez l’ homme, l’ incidence de cancers durant le traitement par lasofoxifène n’ a pas été supérieure à celle observée sous placebo.
0.48477980494499207 ||| 7 tablets ||| 2 tablet ||| 7 comprimés
0.45833271741867065 ||| Luminous discharge lamps ||| Transportable guitar amplifiers ||| Lampes à décharge lumineuse
0.2017604112625122 ||| The excretion of tocilizumab in milk has not been studied in animals. ||| The excretion of 5-ALA or PPIX in milk has not been studied in animals. ||| L’ excrétion du tocilizumab dans le lait n’ a pas été étudié chez l’ animal.
0.26641497015953064 ||| Doses of 25 mg of Enbrel (based on dose-finding studies in patients with rheumatoid arthritis) or placebo were administered subcutaneously twice a week for 6 months in 138 patients. ||| Five randomised double-blind controlled studies have been conducted including scheduled upper gastrointestinal endoscopy in approximately 4500 patients free from initial ulceration (celecoxib doses from 50 mg-400 mg BID). ||| Des doses de 25 mg d’ Enbrel (déterminées lors des études de recherche de dose chez les patients atteints de polyarthrite rhumatoïde) ou de placebo ont été administrées par voie sous-cutanée deux fois par semaine pendant 6 mois chez 138 patients.
0.3385004997253418 ||| The lyophilised powder must be reconstituted and diluted before use. ||| The reconstituted solution should then be diluted in 500 ml Savene diluent. ||| La poudre lyophilisée doit être reconstituée et diluée avant utilisation.
0.3181535601615906 ||| Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom ||| Celgene Europe Limited Riverside House Riverside Walk Windsor Berkshire SL4 1NA United Kingdom ||| Titulaire de l’ Autorisation de mise sur le marché et fabricant Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW Royaume-Uni
0.43521296977996826 ||| During the treatment with Revlimid you have an increased risk of developing blood clots in the veins. ||| This increase in heart rate can cause the chest pain in people who suffer from angina. ||| Pendant le traitement par Revlimid, le risque de formation de caillots sanguins dans les veines est augmenté.
0.2661030888557434 ||| Lipodystrophy: combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump) (see section 4.4). ||| Trevaclyn is indicated for the treatment of dyslipidaemia, particularly in patients with combined mixed dyslipidaemia (characterised by elevated levels of LDL-cholesterol and triglycerides and low HDL-cholesterol) and in patients with primary hypercholesterolaemia (heterozygous familial and non-familial). ||| Les traitements par association d’ antirétroviraux ont été associés, chez les patients infectés par le VIH, à une redistribution de la masse grasse corporelle (lipodystrophie), incluant une perte du tissu adipeux sous-cutané périphérique et facial, une augmentation de la masse grasse intra- abdominale et viscérale, une hypertrophie mammaire et une accumulation de la masse grasse au niveau retro-cervicale (bosse de bison) – (voir rubrique 4.4).
0.0022076978348195553 ||| 386 • You may experience symptoms of neuropathy such as pain, burning, tingling, numbness and/or weakness. ||| 394 • You may experience symptoms of neuropathy such as pain, burning, tingling, numbness and/or weakness. ||| • Vous pouvez présenter des symptômes évocateurs d’une neuropathie, tels que douleurs, brûlures, picotements, engourdissement et/ou faiblesse musculaire.
0.064155712723732 ||| Like all medicines, Neoclarityn can cause side effects, although not everybody gets them. ||| Like all medicines, Olanzapine Mylan can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Neoclarityn peut provoquer des effets indésirables, mais ils ne surviennent pas systématiquement chez tout le monde.
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 6 6.6 Précautions particulières d’ élimination et manipulation
0.5437368750572205 ||| In two years, the risk in the placebo group was 85% and 69% in the Extavia group (Hazard Ratio = 0.57, 95% confidence interval (0.46, 0.71), p < 0.00001). ||| Odds Ratio (95% CI) = 0.53 (0.33 to 0.85), … P-value (stratified Cochran-Mantel-Haenszel test) = < 0.0084 ||| En 2 ans le risque dans le groupe placebo a été de 85% et de 69% dans le groupe Extavia (rapport de risques instantanés = 0,57, intervalle de confiance 95% (0,46, 0,71), p < 0,00001).
0.29248958826065063 ||| Rental of acoustic reproduction equipment ||| Rental of abrasive cleaning apparatus ||| Location de matériel de reproduction acoustique
0.2869528532028198 ||| The marketing authorisation holder is Pfizer Limited. ||| The marketing authorisation holder is Bayer Healthcare AG. ||| Le titulaire de l’ autorisation de mise sur le marché est Pfizer Limited.
0.05433182418346405 ||| - you should be observed closely for the development of a serious form of pneumonia called ||| - you should be observed closely for the development of a serious form of chest infection called ||| - vous devrez observer avec attention le développement d’une forme sévère de pneumonie appelée
0.07381832599639893 ||| Mixtard 30 NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Insulatard NovoLet 100 IU/ ml suspension for injection in a pre-filled pen. ||| Mixtard 30 NovoLet 100 UI/ ml suspension injectable en stylo prérempli
0.47879695892333984 ||| These medicines, including VIRACEPT, are called antiretroviral agents. ||| Antibacterials (often called antibiotics, active against bacterial infections), ||| Ces médicaments dont fait partie VIRACEPT sont appelés agents antirétroviraux.
0.08453978598117828 ||| Protaphane NovoLet 100 IU/ ml suspension for injection Insulin human (rDNA) SC use ||| Actrapid Penfill 100 IU/ ml solution for injection Insulin human (rDNA) SC use ||| Protaphane NovoLet 100 UI/ ml suspension injectable Insuline humaine (ADNr)
0.7291926145553589 ||| Habilitation in pharmacology, toxicology and pharmacy, University of Munich. ||| graduate qualifications in internal medicine (FRCP) and pharmaceutical medicine (FFPM). ||| Habilitation en pharmacologie, toxicologie et pharmacie, université de Munich.
0.3565337359905243 ||| The most common adverse reaction reported at a greater incidence in patients treated with the aprepitant regimen than with standard therapy in patients receiving moderately emetogenic chemotherapy was fatigue (2.5% versus 1.6%). ||| Radiographic progression at 12 months was significantly less in the Enbrel group than in the methotrexate group, while the combination was significantly better than either monotherapy at slowing radiographic progression (see figure below). ||| L’événement indésirable le plus fréquent, rapporté avec une incidence supérieure chez les patients traités par aprépitant comparés à ceux recevant un traitement standard dans le cadre d’une chimiothérapie moyennement émétisante, a été la fatigue (2,5% contre 1,6%).
0.48941007256507874 ||| Business management of models ||| Business management of sports people ||| Gestion des affaires des mannequins
0.23687586188316345 ||| (11.5, 23.0) ||| (11.6, 18.3) ||| (11,5 23,0)
0.2415561079978943 ||| On the first day of treatment the patient starts with Vimpat 50 mg tablets twice a day. ||| During the second week, the patient takes Vimpat 100 mg tablets twice a day. ||| Le premier jour du traitement, le patient commence par prendreVimpat comprimés à 50 mg deux fois par jour.
0.030884278938174248 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/ ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.eu.int/ ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne du médicament (EMEA) http://www.emea.europa.eu /
0.7083562612533569 ||| capsule every 48 hours ||| Every 48 hours ||| 48 heures
0.29112493991851807 ||| How to use MabThera 4. ||| How to use RoActemra 4. ||| Comment utiliser MabThera 4.
0.28399285674095154 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Neulasta. ||| - If you take a large overdose of Axura, contact your doctor or get medical advice, as you may ||| Si vous présentez une intolérance à certains sucres, contactez votre médecin avant de prendre Neulasta.
0.2892681360244751 ||| The relevance of the hepatocarcinogenic potential of micafungin for the human therapeutic use is not known. ||| The carcinogenic potential of darbepoetin alfa has not been evaluated in long-term animal studies. ||| La pertinence du potentiel hépatocarcinogène de la micafungine lors de l’ utilisation thérapeutique chez l’ homme n’ est pas connue.
0.0 ||| Table 6 ||| Table 6 ||| 23 Tableau 6
0.18156519532203674 ||| White, round, biconvex film-coated tablets marked “ PFIZER” on one side and “ RVT 20” on the other. ||| Blue rounded diamond-shaped tablets, marked “ PFIZER ” on one side and “ VGR 25 ” on the other. ||| Comprimés pelliculés biconvexes, ronds et blancs, avec l’ inscription « PFIZER » sur une face et « RVT 20 » sur l’ autre.
0.24164825677871704 ||| The concomitant use of aliskiren with ciclosporin, a highly potent P-gp inhibitor, and other potent P- gp inhibitors (quinidine, verapamil), is contraindicated (see section 4.5). ||| CHOP-like regimens are advised, but clinical experience is available only with CHVP (combination of cyclophosphamide, doxorubicin, teniposide and prednisolone). ||| L’ utilisation concomitante d’ aliskiren avec la ciclosporine, un inhibiteur hautement puissant de la gp- P, ainsi qu’ avec d’ autres inhibiteurs puissants de la gp-P (quinidine, vérapamil), est contre-indiquée (voir rubrique 4.5).
0.4378551244735718 ||| , Store in the original package in order to protect from light. ||| 6.4 Special precautions for storage Store in the original package, in order to protect from light. ||| 6.4 Précautions particulières de conservation Conserver dans le conditionnement original afin de protéger de la lumière.
0.23288500308990479 ||| ♦ Uncommon (these may occur with up to 1 in 100 doses of the vaccine): • Tingling or numbness of the hands or feet • Sleepiness • Dizziness • Diarrhoea, vomiting, stomach pain, feeling sick • Itching, rash • Generally feeling unwell • Sleeplessness ||| Very common side effects These may affect more than 1 in 10 people: • headache • feeling dizzy • feeling sleepy or drowsy • clumsiness and lack of co-ordination (ataxia) • double vision or blurred vision • feeling sick (nausea) or being sick (vomiting) • skin rash. ||| ♦ Peu fréquent (pouvant survenir jusqu’ à 1 dose de vaccin sur 100): • Picotements ou engourdissement des mains ou des pieds • Somnolence • Sensations vertigineuses • Diarrhées, vomissements, douleurs abdominales, nausées • Démangeaison, éruption cutanée • Malaise • Insomnie
0.13240905106067657 ||| • OJ C 243, 31.08.2001, p. ||| • OJ C 237, 02.10.2002, p. ||| 07.08.2001 JO C 243, 31.08.2001, p.
0.25133511424064636 ||| Therefore, clofarabine should be used with caution in patients with mild to moderate renal insufficiency (see sections 4.2 and 4.3). ||| Zavesca may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable (see sections 4.4 and 5.1). ||| Par conséquent, une attention particulière sera portée lors de l’ utilisation de la clofarabine chez des patients atteints d’ insuffisance rénale légère à modérée (voir rubriques 4.2 et 4.3).
0.34626758098602295 ||| BeneFIX is given by a slow infusion into a vein (usually up to 4 ml per minute). ||| The usual dose of Aloxi is 250 micrograms given as a rapid injection into a vein. ||| BeneFIX est administré par perfusion intraveineuse (dans une veine) à maximum 4 ml par minute.
0.1883147805929184 ||| What is the risk associated with Irbesartan BMS? ||| What is the risk associated with Rabigen SAG2? ||| Quel est le risque associé à l'utilisation d'Irbesartan BMS?
2.6495212274157964e-13 ||| a) the administration of the veterinary medicinal product to animals will interfere with the implementation of national programmes for the diagnosis, control and eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals. ||| a) the administration of the veterinary medicinal product to animals will interfere with the implementation of national programmes for the diagnosis, control and eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals. ||| a) l'administration du médicament vétérinaire à des animaux interférerait avec la mise en œ uvre de programmes nationaux pour le diagnostic, le contrôle et l'éradication de maladies animales ou entraînerait des difficultés à certifier l'absence de contamination des animaux vivants ou des aliments ou d'autres produits obtenus à partir des animaux traités;
0.08554371446371078 ||| 197 2. ||| 173 2. ||| 2.
0.8566387891769409 ||| Gold alloys ||| Iron alum ||| Alliages d'or
0.2369907945394516 ||| 60 A. ||| 60 C. ||| 65 A.
0.13049867749214172 ||| Fencing rails (Non-metallic -) ||| Fencing panels (Non-metallic -) ||| Planches de clôture non métalliques
0.3356049060821533 ||| Maintenance dose ||| 25 Maintenance dose ||| 84 Dose d’ entretien
0.3953889012336731 ||| Neurotoxicity, mainly peripheral neuropathy, appeared to be more frequent and severe with a 175 mg/ m2 3 hour infusion (85% neurotoxicity, 15% severe) than with a 135 mg/ m2 24 hour infusion (25% peripheral neuropathy, 3% severe) when paclitaxel was combined with cisplatin. ||| The most common site of spontaneous bleeding was the gastrointestinal tract (1.7% rate with prasugrel and 1.3% rate with clopidogrel); the most frequent site of provoked bleeding was the arterial puncture site (1.3% rate with prasugrel and 1.2% with clopidogrel). ||| La neurotoxicité, principalement neuropathie périphérique, semble être plus fréquente et sévère avec une perfusion de 175 mg/ m2 sur 3 heures (85% de neurotoxicité, 15% sévère) qu'avec une perfusion de 135 mg/ m2 sur 24 heures (25% de neuropathies périphériques, 3% sévère) de paclitaxel associé à cisplatine.
0.2881370484828949 ||| DaTSCAN 74 MBq/ ml solution for injection ||| Gadovist 1.0 mmol/ ml solution for injection ||| DaTSCAN 74 MBq/ ml, solution injectable.
0.4984893798828125 ||| 750 mg). ‘ Prolonged release ’ means that ranolazine is released slowly from the tablet over a few hours. ||| It takes some time (lagtime of 2-4 hours) before the active substance escapes from Nifedipine Pharmamatch retard tablets. ||| La libération prolongée signifie que la ranolazine est libérée lentement du comprimé en quelques heures.
0.3601182997226715 ||| Indinavir was rapidly eliminated with a half– life of 1.8 hours. ||| Elimination Meloxicam is eliminated with a half-life of 24 hours. ||| L'indinavir était éliminé rapidement avec une demi-vie plasmatique de 1,8 heure.
0.5567743182182312 ||| Medicated dentifrices ||| Ductility testers ||| Dentifrices médicamenteux
0.0 ||| In this study (baseline blood pressure 171/ 113 mmHg), an Imprida regimen of 5 mg/ 160 mg titrated to 10 mg/ 160 mg reduced sitting blood pressure by 36/ 29 mmHg as compared to 32/ 28 mmHg with a regimen of lisinopril/ hydrochlorothiazide 10 mg/ 12.5 mg titrated to 20 mg/ 12.5 mg. ||| In this study (baseline blood pressure 171/ 113 mmHg), an Imprida regimen of 5 mg/ 160 mg titrated to 10 mg/ 160 mg reduced sitting blood pressure by 36/ 29 mmHg as compared to 32/ 28 mmHg with a regimen of lisinopril/ hydrochlorothiazide 10 mg/ 12.5 mg titrated to 20 mg/ 12.5 mg. ||| 10 cette étude (pression artérielle initiale 171/ 113 mm Hg), un traitement par Imprida 5 mg/ 160 mg augmenté à 10 mg/ 160 mg a permis de réduire la pression artérielle en position assise de 36/ 29 mm Hg contre 32/ 28 mm Hg avec un traitement par lisinopril/ hydrochlorothiazide 10 mg/ 12,5 mg augmenté à 20 mg/ 12,5 mg.
0.7898508310317993 ||| Currency trading and exchange services ||| Mortgage lending and mortgage brokerage services ||| Services d'opérations de change de devises
0.427659809589386 ||| Spiked rollers [machines] for use in soil aeration ||| Fabrics for use in civil engineering (geotextiles) ||| Rouleaux à pointes pour l'aération du sol [machines]
0.22149845957756042 ||| If you are pregnant, or think you might be pregnant, or are planning to get pregnant, tell your doctor. ||| Tell your doctor if you are pregnant, think you may be pregnant, plan to become pregnant, or are breast-feeding. ||| Si vous êtes enceinte ou pensez l’ être ou si vous envisagez de débuter une grossesse, informez -en votre médecin.
0.04939800128340721 ||| Press release11 May 2020Brussels ||| Press release28 May 2020Brussels ||| Communiqué de presse11 mai 2020Bruxelles
4.124479078583543e-13 ||| What Insulin Human Winthrop Rapid looks like and contents of the pack Insulin Human Winthrop Rapid is a clear, colourless solution for injection, with no solid particles visible, and of a water-like consistency. ||| What Insulin Human Winthrop Rapid looks like and contents of the pack Insulin Human Winthrop Rapid is a clear, colourless solution for injection, with no solid particles visible, and of a water-like consistency. ||| Qu’ est -ce que Insulin Human Winthrop Rapid et contenu de l’ emballage extérieur Insulin Human Winthrop Rapid est une solution injectable claire, incolore, sans particules solides visibles et qui a la consistance de l’ eau.
0.2169264703989029 ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available and this summary will be updated as necessary. ||| Every year, the EMEA will review any new information that may become available and this summary will be updated as necessary. ||| Chaque année, l’ Agence européenne des médicaments (EMEA) examinera toute information nouvelle éventuellement disponible et, le cas échéant, procédera à la mise à jour du présent résumé.
0.31519365310668945 ||| An open-label extension of this study showed no further reductions in free and total testosterone concentrations over a period of 3 years in Mimpara-treated patients. ||| Following six months of Replagal treatment 12 of 28 male patients showed altered pharmacokinetics including an apparent increase in clearance. ||| Une étude d’ extension conduite en ouvert de ce précédent essai n’ a pas montré d’ autre diminution des concentrations de testostérone libre et totale, durant une période de 3 ans chez des patients traités par Mimpara.
0.0 ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/ ||| Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/ ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence Européenne des Médicaments (EMEA) http: / /www. emea. europa. eu/.
0.37391412258148193 ||| In such situations, appropriate monitoring of INR is desirable. ||| In all cases, INR should be monitored on a regular schedule. ||| Dans ces conditions, une surveillance de l’ INR est recommandée.
0.5133040547370911 ||| Dibotermin alfa was not detectable in serum. ||| Caspofungin is not dialysable. ||| La dibotermine alpha n'était pas détectable dans le sérum.
0.23266685009002686 ||| How is Cervarix used? ||| How is Foscan used? ||| Comment Cervarix est -il utilisé?
0.46408355236053467 ||| Cabinets for storing articles ||| Bandages for making casts ||| Meubles pour le rangement d'articles
0.01918698102235794 ||| EU/ 1/ 01/ 184/ 046 1 pack EU/ 1/ 01/ 184/ 058 4 pack ||| EU/ 1/ 01/ 184/ 072 1 pack EU/ 1/ 01/ 184/ 073 4 pack ||| ris EU/ 1/ 01/ 184/ 058 Boîte de 4
0.4940614104270935 ||| The amendment of the Communication will be published in the Official Journal of the European Union and on the Commission's competition website in the section on specific aid instruments . ||| Published by the European Commission in December 2001 in volume 9 of the 2001 edition of the Rules governing medicinal products in the European Union ||| La modification de la communication sera publiée au Journal officiel de l'Union européenne et sur le site web de la Commission consacré à la concurrence dans la section relative aux instruments d'aide spécifiques .
0.690245509147644 ||| 2 x (5 x 3 ml) pre-filled pens ||| 1 sterile matrix (7.5 x 10 cm) ||| 2 x 5 stylos
0.305414080619812 ||| Vistide is used in patients with acquired immunodeficiency syndrome (AIDS) who do not have kidney disease. ||| Ovitrelle should also not be used in patients with active thrombo-embolic (clotting) disorders. ||| Vistide est utilisé chez des patients atteints du syndrome d’ immunodéficience acquise (SIDA) ne présentant pas de maladie des reins.
0.45790785551071167 ||| s After withdrawal of the dose, any remaining solution must be discarded. ||| Any remaining suspension should be discarded 14 days after constitution. ||| Après prélèvement de la dose, toute solution restante doit être éliminée.
0.35048145055770874 ||| As normal physiological growth hormone production decreases with age, dose requirements may be reduced. ||| A number of substances affect glucose metabolism and may require dose adjustment of human insulin. ||| La sécrétion physiologique d’ hormone de croissance diminuant avec l’ âge, une réduction de la posologie est possible.
0.053388796746730804 ||| 2 (0.2) ||| 2 (0.4) ||| 3 (0,3) 2 (0,2)
0.0 ||| Pancreatitis ||| Pancreatitis ||| Pancréatites
0.44686222076416016 ||| Servo-controlled hydraulic pumps ||| Digital electro-hydraulic proportioning valves ||| Pompes hydrauliques servo-commandées
0.2639661729335785 ||| Patients with liver disease: ||| Patients with kidney disease: ||| Patients insuffisants hépatiques:
0.4956924319267273 ||| Cardiac disorders ||| Cushingoid disorders ||| Arrêt cardiaque
0.5485172271728516 ||| Zevalin should not be administered in the patients mentioned below as safety and efficacy has not been established: ||| Unless otherwise indicated by your doctor the recommended durations of use of [Invented name] are: - ||| Zevalin ne doit pas être administré chez les patients suivants, car son efficacité et sa tolérance n'ont pas été établies dans ces cas:
0.11591656506061554 ||| Studies in animals have shown reproductive toxicity (see section 5.3). ||| Animal studies have revealed minimal developmental toxicity (see section 5.3). ||| Des études menées chez l’ animal ont mis en évidence une toxicité sur la reproduction (voir rubrique 5.3).
0.0 ||| • if you are allergic (hypersensitive) to telmisartan or any other ingredients included in Micardis tablets (see section Further information for a list of other ingredients). • during the last six months of pregnancy (see section Pregnancy and breast-feeding). • if you are breast-feeding. • if you have severe liver problems such as cholestasis or biliary obstruction (problems with drainage of the bile from the liver and gall bladder) or any other severe liver disease. ||| • if you are allergic (hypersensitive) to telmisartan or any other ingredients included in Micardis tablets (see section Further information for a list of other ingredients). • during the last six months of pregnancy (see section Pregnancy and breast-feeding). • if you are breast-feeding. • if you have severe liver problems such as cholestasis or biliary obstruction (problems with drainage of the bile from the liver and gall bladder) or any other severe liver disease. ||| • Si vous êtes allergique (hypersensible) au telmisartan ou à l’ un des excipients contenus dans les comprimés de Micardis (voir la rubrique Informations complémentaires pour la liste des excipients). • Au cours des six derniers mois de la grossesse (voir rubrique Grossesse et Allaitement). • Si vous allaitez. • Si vous avez des troubles hépatiques sévères tels une choléstase ou une obstruction biliaire (un trouble lié au drainage de la bile au niveau du foie et de la vésicule biliaire) ou toute autre maladie sévère du foie.
0.055220380425453186 ||| 58 4.3 Contraindications ||| 62 4.3 Contraindications ||| 4.3 Contre-indications
0.12320536375045776 ||| reconstitution, each ml solution contains 2.5 mg porfimer sodium. ||| After reconstitution, each ml solution contains 2.5 mg porfimer sodium. ||| Après reconstitution, chaque millilitre de solution contient 2,5 mg de porfimère sodique.
0.2813616394996643 ||| 43 In patients treated with docetaxel in combination with cisplatin and 5-fluorouracil (TCF), febrile neutropenia and neutropenic infection occurred at lower rates when patients received prophylactic G-CSF. ||| Busilvex followed by cyclophosphamide (BuCy4) or melphalan (BuMel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients. ||| Chez les patients traités par docétaxel en association avec le cisplatine et le 5-fluorouracile (protocole TCF), l’ administration de G-CSF en prophylaxie permet de réduire la fréquence des neutropénies fébriles et des infections neutropéniques.
0.15436971187591553 ||| Nederland GlaxoSmithKline BV Tel: + 31 (0)30 6938100 nlinfo@gsk.com ||| Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com ||| Nederland GlaxoSmithKline BV Tel: + 31 (0)30 6938100 nlinfo@gsk. com
0.49881571531295776 ||| • Hold the syringe with the solvent vial upside down. ||| Turn the vial and syringe upside down. ||| • Retournez la seringue avec le flacon de solvant.
0.25556451082229614 ||| It is recommended to stop breast-feeding during treatment with Aldurazyme. ||| Breast-feeding must be stopped on initiation of treatment with posaconazole. ||| Il est recommandé d’ arrêter d’ allaiter pendant le traitement par Aldurazyme.
0.5661264657974243 ||| Fresh mulberries ||| Fresh noni fruit ||| Mûres fraîches
0.0 ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. ||| Dans chaque regroupement par fréquence, les effets indésirables sont présentés par ordre de gravité décroissant:
3.784038512220922e-13 ||| OUTER CARTON AND LABEL TEXT FOR BOTTLE PACK OUTER CARTON TEXT FOR BLISTER PACK ||| OUTER CARTON AND LABEL TEXT FOR BOTTLE PACK OUTER CARTON TEXT FOR BLISTER PACK ||| TEXTE DE L'EMBALLAGE EXTERIEUR ET DE L’ ETIQUETAGE DES FLACONS
0.32595494389533997 ||| In hypertensive patients with one or more additional risk factors for cardiovascular disease, doxazosin should not be used as a single agent for the first-line treatment of hypertension due to a possible increased risk for development of heart failure. ||| In patients with a high relapse rate before treatment has started, the risk of a severe relapse following discontinuation of Rebif in the event of pregnancy should be weighed against a possible increased risk of spontaneous abortion. ||| Chez les patients hypertendus présentant un ou plusieurs facteurs de risque cardiovasculaires supplémentaires, la doxazosine ne doit pas être utilisée seule comme traitement de première intention d’ une hypertension en raison de la possible augmentation du risque d’ apparition d’ une insuffisance cardiaque.
0.2878434658050537 ||| Cetrotide 0.25 mg is given daily, either in the morning or in the evening, starting on day 5 or 6 of ovarian stimulation, until the day of planned ovulation induction. ||| For optimal effect, Agopton should be taken once daily in the morning, except when used for H. pylori eradication when treatment should be twice a day, once in the morning and once in the evening. ||| Cetrotide 0,25 mg est administré une fois par jour, soit le matin, soit le soir.
0.8494340777397156 ||| We have committed to a new push for European democracy and we must all play our part to deliver." ||| To use all the power of our common spirit and the strength of our shared purpose. ||| Nous sommes résolus à donner une nouvelle impulsion en faveur de la démocratie européenne et nous devons tous jouer notre rôle dans cette entreprise.»
0.4038209319114685 ||| (d) Hold the pen with needle pointing up and tap the clear cartridge holder gently with your finger so any air bubbles collect near the top. ||| Mixing is best done by gently tilting the cartridge or pen (with the cartridge in it) back and forth at least 10 times. ||| (d) Tenir le stylo verticalement, l'aiguille dirigée vers le haut, et donner de petites tapes sur le côté du stylo pour que toutes les bulles présentes remontent à la surface.
0.692406415939331 ||| Lighterage services ||| authorisation Holder ||| Services d'aconage
0.002065707230940461 ||| Thiazides may decrease urinary calcium excretion and cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. ||| Thiazides may reduce urinary calcium excretion and cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. ||| 4 Les dérivés thiazidiques peuvent réduire l’ excrétion urinaire du calcium et entraîner une élévation légère et transitoire de la calcémie en l’ absence d’ anomalie connue du métabolisme du calcium.
0.47609129548072815 ||| Thus the trabectedin extraction ratio can be considered moderate. ||| A reticulocyte count should be considered as part of ||| Le rapport d’ extraction de la trabectédine peut donc être considéré comme modéré.
0.34251630306243896 ||| LIFE Study The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study was a randomised, triple-blind, active-controlled study in 9193 hypertensive patients aged 55 to 80 years with ECG- documented left ventricular hypertrophy. ||| 34 RENAAL-Study The Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan RENAAL study was a controlled clinical study conducted worldwide in 1513 Type 2 diabetic patients with proteinuria, with or without hypertension. ||| Etude LIFE L’ étude LIFE (Losartan Intervention For Endpoint reduction in hypertension) était une étude randomisée en triple aveugle, contrôlée contre comparateur actif, menée chez 9 193 patients hypertendus âgés de 55 à 80 ans et présentant une hypertrophie ventriculaire gauche électrocardiographique.
0.2561781406402588 ||| Settlement tanks, not of metal ||| Fireplace mantles, not of metal ||| Cuves de décantation non métalliques
0.5532757043838501 ||| * All Patients Treated Population (an intention-to-treat analysis). † Least squares means adjusted for prior antihyperglycaemic therapy status and baseline value. ‡ p < 0.001 compared to placebo or placebo + combination treatment. § HbA1c (%) at week 18. ||| MaxCmin2: any rise > 0.5 log at a specific visit; 200 copies/ml at week 4; 200 copies/ml at week 12; and a VL > 200 copies/ml at week 24. # ITT/e = Intent-to-treat/exposed † Data from clinical study report ‡ Data from MaxCmin1 publication ||| * Population Tous Patients Traités (analyse en Intention de Traiter) † Moyenne des moindres carrés ajustée en fonction du traitement antihyperglycémiant précédent et de la valeur initiale p < 0,001 comparé au placebo ou au placebo + traitement associé ‡
0.27523428201675415 ||| Following oral administration of a single dose of 10 mg adefovir dipivoxil to chronic hepatitis B patients, the median (range) peak serum concentration (Cmax) was achieved after 1.75 h (0.58-4.0 h). ||| The effective (peak to trough) half-life of lopinavir over a 12 hour dosing interval averaged 5 − 6 hours, and the apparent oral clearance (CL/ F) of lopinavir is 6 to 7 l/ h. ||| Après administration orale d’ une dose unique de 10 mg d’ adéfovir dipivoxil à des patients atteints d’ hépatite B chronique, la concentration plasmatique maximale (Cmax) a été atteinte après une durée médiane (extrêmes) de 1,75 h (0,58-4,0 h).
0.06988324224948883 ||| Musculoskeletal and connective tissue disorders ||| Musculoskeletal and connective tissue disorders: ||| Troubles musculo squelettiques, du tissu conjonctif et des os
0.24131442606449127 ||| Cases of antibody-mediated PRCA have been very rarely reported in chronic renal failure patients with erythropoietin administered by the subcutaneous route. ||| Treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care when response to usual laxative therapy has not been sufficient. ||| Des cas d’ érythroblastopénie (AEPA) véhiculée par les anticorps ont très rarement été signalés chez 158 les patients insuffisants rénaux chroniques recevant de l’ érythropoïétine par voie sous-cutanée.
0.7139366865158081 ||| You do not need to take another tablet if you were sick more than 1 hour after taking Viread. ||| It was a very lonely few weeks with only my host for company, but eventually I was allowed to come home. ||| Vous n’avez pas besoin de prendre un autre comprimé si vous avez vomi plus d’une heure après avoir pris Viread.
0.22743114829063416 ||| Within the system organ classes, adverse reactions are listed under headings of frequency (number of patients expected to experience the reaction), using the following categories: very common (≥ 1/ 10); common (≥ 1/ 100, < 1/ 10); uncommon (≥ 1/ 1,000, < 1/ 100); rare (≥ 1/ 10,000, < 1/ 1,000); very rare (< 1/ 10,000); not known (cannot be estimated form the available data). ||| b) The following adverse event listing is based on reports from clinical trials (table 1, adverse events and laboratory abnormalities) and from the post marketing surveillance (table 2, reporting rates based on spontaneous adverse drug reaction reports classified as very common ≥ 1/ 10, common ≥ 1/ 100 to < 1/ 10, uncommon ≥ 1/ 1,000 to < 1/ 100, rare ≥ 1/ 10,000 to < 1/ 1,000, very rare < 1/ 10,000) of Betaferon use. ||| Au sein des classes de systèmes d’ organes, les effets indésirables sont classés par ordre de fréquence (nombre attendu de patients qui présenteront l’ effet indésirable), en utilisant la classification suivante: très fréquents (≥ 1/ 10); fréquents (≥ 1/ 100, 1 < 1/ 10);, peu fréquents (≥ 1/ 1 000, < 1/ 100); rares (≥ 1/ 10 000, < 1/ 1 000); très rares (< 1/ 10 000); fréquence indeterminée (ne peut pas être estimée à partir des données disponibles).
0.3357618451118469 ||| 344 metres). ||| 321 meters). ||| 344 mètres).
0.7654930949211121 ||| Pulmonary arterial hypertension ||| Hypertensive crisis Hypertension ||| Hypertension artérielle pulmonaire.
0.31735387444496155 ||| Distribution The average binding of doripenem to plasma proteins was approximately 8.1% and is independent of plasma concentrations. ||| Total plasma concentration of pioglitazone is unchanged, but with an increased volume of distribution. ||| Distribution Le taux moyen de fixation du doripénème aux protéines plasmatiques est de 8,1% environ, et est indépendant de la concentration plasmatique.
0.33860015869140625 ||| Invasive procedure/ surgery An initial dose of 90 µg per kg body weight should be given immediately before the intervention. ||| Subcutaneous injection: a maximum volume of 1 ml at one injection site should generally not be exceeded. ||| Intervention chirurgicale/ procédure invasive Une dose initiale de 90 µg par kg de poids corporel sera administrée immédiatement avant l'intervention.
0.43511539697647095 ||| Reference should be made to current treatment guidelines. ||| Diagnosis should be made according to current guidelines. ||| Les recommandations en vigueur liées au traitement doivent être suivies.
0.47351089119911194 ||| transient increase in blood alkaline phosphatase, INR abnormal, prothrombin level abnormal ||| blood creatine phosphokinase increased, activated partial thromboplastin time ||| INR anormal taux de prothrombine anormal
0.8050071001052856 ||| Postmarketing ||| Study Start ||| Post-marketing
0.16439217329025269 ||| Patients with creatinine clearance < 50 ml/minute must not be treated with ViraferonPeg in combination with ribavirin (see section 4.3). ||| Data are not available for the use of ViraferonPeg in patients with creatinine clearance < 15 ml/minute (see section 5.2). ||| Les patients avec une clairance de la créatinine < 50 ml/ minute ne doivent pas être traités par ViraferonPeg en association avec la ribavirine (voir rubrique 4.3).
0.30857259035110474 ||| As a result, it inhibits the growth of tumour cells and eventually kills them. ||| This stops the production of DNA and thus slows down the growth and multiplication of tumour cells. ||| Il bloque ainsi la croissance des cellules tumorales et finit par les détruire.
0.5087994337081909 ||| Driving and using machines FOSAVANCE should not affect your ability to drive or operate machines. ||| NOTE • Bathing, showering and exercising should not affect how Neupro works. ||| Conduite de véhicules et utilisation de machines FOSAVANCE n’a pas en principe d’effet sur l’aptitude à conduire des véhicules ou à utiliser des machines.
0.5759700536727905 ||| NIMESULIDE 100 MG TABLETS, SOLUBLE TABLETS, EFFERVESCENT TABLETS, COATED TABLETS, CAPSULES, HARD CAPSULES, NIMESULIDE 50/ 100 MG GRANULES OR POWDER FOR ORAL SUSPENSION NIMESULIDE 1%, 2% OR 5% ORAL SUSPENSION ||| 20/ 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGE PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Dicural oral solution CARTON LABEL - 1 X 250 ML BOTTLE / 1 X 1000 ML BOTTLE / 6 X 1000 ML BOTTLE VIAL LABEL 250 ml bottle / 1000 ml bottle ||| NIMÉSULIDE COMPRIMÉS, COMPRIMÉS POUR SOLUTION BUVABLE, COMPRIMÉS EFFERVESCENTS, COMPRIMÉS ENROBÉS, CAPSULES, GÉLULES À 100 MG NIMÉSULIDE GRANULÉS OU POUDRE 50/ 100MG POUR SUSPENSION BUVABLE NMESULIDE 1%, 2% OU 5% SUSPENSION BUVABLE
0.22176402807235718 ||| Pharmaceutical preparations for the prevention of disorders of the respiratory system ||| Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders ||| Produits pharmaceutiques pour la prévention des troubles du système respiratoire
0.36872515082359314 ||| Take one sealed syringe blister and leave it to stand for a few minutes until it reaches room temperature prior to using it. ||| Keep the medicine in the box to protect it from light and allow it to reach room temperature for at least 30 minutes ||| Prenez une seringue emballée dans le blister et laissez-la reposer quelques minutes jusqu’à ce qu’elle atteigne la température ambiante avant de l’utiliser.
0.39555948972702026 ||| In addition to continuing the spirit of partnership between the national competent authorities and the EMEA, a sound financial basis for future EMEA operations must be found. ||| The EMEA with its network of national regulatory authorities is an excellent example how we operate and collaborate within the European Union. ||| Il faudra maintenir l’esprit de partenariat entre les autorités nationales compétentes et l’EMEA et rechercher, en outre, une base financière appropriée pour les futures activités de l’EMEA.
0.18932446837425232 ||| Take special care with Sebivo ||| Take special care with Rasilez ||| Faites attention avec Sebivo
0.08782310038805008 ||| If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 20-25°C ||| If not used immediately, the in-use storage time and conditions prior to use are the responsibility of the user and would normally not last longer than 4 hours below 25°C protected from light. ||| S’il n’est pas utilisé immédiatement, les conditions et la durée de conservation avant utilisation sont de la responsabilité de l’utilisateur et ne doivent normalement pas dépasser 24 h à 20-25°C.
0.36900609731674194 ||| Installations for street lighting ||| Lanterns for lighting ||| Installations d'éclairage de rues
0.2668525278568268 ||| If an anaphylactic reaction or other serious allergic reaction occurs, administration of Humira should be discontinued immediately and appropriate therapy initiated. ||| 49 If allergic or anaphylactic-type reactions occur, the administration should be discontinued immediately. ||| En cas de survenue d'une réaction anaphylactique ou d'une autre réaction allergique grave, l'administration d’ Humira doit être immédiatement interrompue et un traitement approprié mis en œ uvre.
0.4357072710990906 ||| A mild and transient hyperthermia very commonly occurs on the day of vaccination. ||| Peripheral neuropathy generally occurs following chronic use over a period of months. ||| Une hyperthermie légère et transitoire apparaît très communément le jour de la vaccination.
0.018546447157859802 ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at increased risk for severe and potentially fatal hepatic adverse reactions. ||| Patients with chronic hepatitis B or C treated with antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse reactions. ||| Les patients atteints d'une hépatite chronique B ou C et traités par une association d’ antirétroviraux présentent un risque accru de développer des événements indésirables hépatiques sévères, potentiellement fatals.
0.3367626368999481 ||| Neurotoxicity, mainly peripheral neuropathy, appeared to be more frequent and severe with a 175 mg/ m2 3 hour infusion (85% neurotoxicity, 15% severe) than with a 135 mg/ m2 24 hour infusion (25% peripheral neuropathy, 3% severe) when paclitaxel was combined with cisplatin. ||| Very rarely (less than 1 in 10000 patients) abnormal blood clottings (blood clots in blood vessels) have been seen to occur with similar medicines, so this could possibly occur with GONAL-f / hCG therapy or GONAL-f / lutropin alfa/ hCG therapy. ||| La neurotoxicité, principalement neuropathie périphérique, semble être plus fréquente et sévère avec une perfusion de 175 mg/ m2 sur 3 heures (85% de neurotoxicité, 15% sévère) qu'avec une perfusion de 135 mg/ m2 sur 24 heures (25% de neuropathies périphériques, 3% sévère) de paclitaxel associé à cisplatine.
0.02027994766831398 ||| Each tablet contains 70 mg alendronic acid as alendronate sodium trihydrate and 140 micrograms (5600 IU) colecalciferol (vitamin D3). ||| Each tablet contains 70 mg alendronic acid as alendronate sodium trihydrate, and 70 micrograms (2800 IU) colecalciferol (vitamin D3). ||| Chaque comprimé contient 70 mg d’ acide alendronique sous forme d’ alendronate monosodique trihydraté et 140 microgrammes (5600 UI) de colécalciférol (vitamine D3).
0.14092446863651276 ||| What Humalog 100 U/ml solution for injection in vial contains ||| What Humalog Mix50 100 U/ml suspension for injection in vial contains ||| Que contient Humalog 100 UI/ml, solution injectable en flacon
0.0826265811920166 ||| • The Trudexa syringe should NEVER be reused. ||| ris • The Trudexa syringe should NEVER be reused. ||| • Les seringues de Trudexa ne doivent JAMAIS être réutilisées.
0.19355711340904236 ||| Sprimeo 300 mg film-coated tablets ||| Vimpat 100 mg film-coated tablets ||| Sprimeo 300 mg comprimés pelliculés
0.22940289974212646 ||| - The other ingredients are m-cresol, glycerol, dibasic sodium phosphate 7 H2O, zinc oxide and ||| - The other ingredients are human albumin, sodium chloride, N-acetyltryptophan, caprylic acid, ||| - Les autres composants sont: le métacrésol, le glycérol, le phosphate disodique heptahydraté,
0.22746407985687256 ||| The expiry date refers to the last day of the month. ||| The expiry date refers to the last day of the month stated on the label. ||| La date d’ expiration fait référence au dernier jour du mois.
0.26780810952186584 ||| As renal excretion is a pathway of elimination, consideration should be given to decreasing the dosage of Siklos in patients with renal impairment. ||| However, accumulation of the glucuronide metabolite is to be expected; caution should therefore be exercised in treating patients with renal failure. ||| Comme l'excrétion rénale est une voie d'élimination, il faut envisager une diminution de la dose de Siklos chez les patients atteints d'insuffisance rénale.
0.4336702227592468 ||| Do not touch the needle or allow it to touch any surface. ||| Do not use too much force as the needle may loosen. ||| Ne touchez pas l’aiguille avec les doigts et évitez tout contact entre l’aiguille et une autre surface.
0.3220878541469574 ||| Elderly Hepatic clearance of vardenafil in healthy elderly volunteers (65 years and over) was reduced as compared to healthy younger volunteers (18 - 45 years). ||| Elderly patients (≥ 65 years) No dose adjustment is necessary since bioavailability, distribution and elimination were similar in elderly patients and younger subjects. ||| Sujets âgés Chez des volontaires sains âgés de 65 ans et plus, la clairance hépatique du vardénafil était diminuée par rapport à celle observée chez des volontaires sains plus jeunes (âgés de 18 - 45 ans).
0.683186411857605 ||| Withdraw the needle. ||| Release the plunger slowly. ||| Retirer l'aiguille.
0.27479150891304016 ||| When Glustin 15 mg tablets are taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines. ||| You might feel drowsy if Zalasta is taken in combination with these medicines,  if you are taking fluvoxamine (an antidepressant), or ciprofloxacin (an antibiotic), as it may be necessary to change your Zalasta dose. ||| Quand Glustin 15 mg, comprimé est pris en association avec d'autres médicaments utilisés pour traiter le diabète (tels que insuline, chlorpropamide, glibenclamide, gliclazide, tolbutamide), votre médecin vous indiquera si vous devez prendre une dose plus faible de vos médicaments.
0.14358192682266235 ||| Each tablet contains 50 mg vildagliptin.  The other ingredients are lactose anhydrous, microcrystalline cellulose, sodium starch glycolate (type A) and magnesium stearate. ||| The other ingredients are: lactose monohydrate, microcrystalline cellulose, povidone K30, sodium starch glycolate (Type A), iron oxide yellow (E172) and magnesium stearate. ||| Chaque comprimé contient 50 mg de vildagliptine.  Les autres composants sont le lactose anhydre, la cellulose microcristalline, le glycolate d’ amidon sodique (type A) et le stéarate de magnésium.
0.6504335999488831 ||| In addition, dose-related undesirable effects should be monitored after birth. ||| Consequently, newborns should be monitored carefully. ||| De plus, les effets indésirables dose-dépendants doivent être surveillés après la naissance.
0.23945513367652893 ||| Given that substantially lower antepartum exposures have been observed in a small study of HIV-infected pregnant patients and the limited data in this patient population, indinavir use is not recommended in HIV-infected pregnant patients (see section 5.2). ||| However, this raises no safety concern regarding target or special populations as hepatic impairment is contraindicated and the phase III clinical studies included a considerable number of elderly patients and patients with mild to moderate renal impairment. ||| 75 l’ utilisation de l’ indinavir n’ est pas recommandée chez la femme enceinte infectée par le VIH (voir rubrique 5.2).
0.2303452491760254 ||| - pain in the tummy (abdomen) caused by pancreatitis, inflammation of the gall bladder and/ or bile ||| • yellow skin or eyes, itching, or pain in the abdomen (tummy) caused by inflammation of the liver ||| - douleur du ventre (abdomen) due à une pancréatite, inflammation de la vésicule biliaire et/ ou des
0.21412314474582672 ||| Yeast extracts for pharmaceutical purposes ||| Stick liquorice for pharmaceutical purposes ||| Extraits de levure à usage pharmaceutique
0.4585880637168884 ||| Sterling silver table knives ||| Leather jewelry boxes ||| Couteaux de table en argent fin
0.37889838218688965 ||| A cardiovascular outcome study of pioglitazone has been performed in patients under 75 years with type 2 diabetes mellitus and pre-existing major macrovascular disease. ||| SOTI involved 1,649 postmenopausal women with established osteoporosis (low lumbar BMD and prevalent vertebral fracture) and a mean age of 70 years. ||| Une étude de morbi-mortalité cardiovasculaire avec la pioglitazone a été réalisée chez des patients diabétiques de type 2 de moins de 75 ans, avec une atteinte macrovasculaire majeure préexistante.
0.18942460417747498 ||| The exact way in which lacosamide works is still unclear, but it seems to reduce the activity of sodium channels (pores on the surface of nerve cells) that allow electrical impulses to be transmitted between nerve cells. ||| The exact way in which levetiracetam works is still unclear but it seems to interfere with a protein called the synaptic vesicle protein 2A, which is found in the space between nerves (synapses) and stops the release of chemical messengers between nerve cells. ||| La façon dont le lacosamide fonctionne demeure mal connue, mais il semble réduire l’ activité des canaux sodiques (pores situées sur la surface des cellules nerveuses) qui permettent la transmission des impulsions électriques entre cellules nerveuses.
0.13501612842082977 ||| Humalog Pen is used to treat diabetes. ||| Humalog is used to treat diabetes. ||| Humalog Pen est utilisé dans le traitement du diabète.
0.4726543724536896 ||| Decontamination showers ||| Commemorative shields ||| Douches de décontamination
0.2987680435180664 ||| 32 Neutropenia Caution should be exercised in patients with low leukocyte and/ or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of drug-induced bone marrow depression/ toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease. ||| Mimpara is used: • to treat secondary hyperparathyroidism in patients with kidney disease on dialysis. • to reduce high levels of calcium in the blood (hypercalcaemia) in patients with parathyroid cancer. • to reduce high levels of calcium in the blood (hypercalcaemia) in patients with primary hyperparathyroidism who still have high calcium levels after removal of the parathyroid gland or when removal of the gland is not possible. ||| Neutropénie La prudence s'impose chez les patients dont le nombre de leucocytes et/ ou de neutrophiles est faible quelle qu'en soit la cause, chez les patients recevant des médicaments connus pour induire des neutropénies, chez les patients ayant des antécédents de dépression médullaire ou de myélotoxicité médicamenteuse, chez les patients atteints de dépression médullaire qu'elle soit en relation avec une pathologie intercurrente, une radiothérapie ou une chimiothérapie et chez les patients atteints d'hyperéosinophilie ou de syndrome myéloprolifératif.
0.5367215871810913 ||| Hepatotoxicity: ||| Acute toxicity: ||| Hépatotoxicité:
0.4266273081302643 ||| 1 tablet contains 95 mg of mavacoxib. ||| for medicinal products containing 90 mg etoricoxib. ||| 1 comprimé contient 95mg de mavacoxib.
0.15687596797943115 ||| It is available as pink capsules (250 mg). ||| It is available as capsules (50 mg). ||| Il est disponible sous la forme de capsules de couleur rose (250 mg).
0.055295854806900024 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Aldurazyme to Genzyme Europe B. V. on 10 June 2003. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Cholestagel to Genzyme Europe B. V. on 10 March 2004. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Aldurazyme à Genzyme Europe B. V., le 10 juin 2003.
0.0660473182797432 ||| 30 Nervous system disorders ||| 28 Nervous system disorders ||| Troubles du système nerveux
0.4261833131313324 ||| Slowly draw back all the solution through the vial adapter into the syringe. ||| Transfer the solution back into the cartridge using the transfer set. ||| Aspirez lentement toute la solution dans la seringue.
0.7974790334701538 ||| With Next Generation EU we are providing an ambitious answer." ||| We will continue this through NextGenerationEU." ||| Grâce à Next Generation EU, nous apportons une réponse ambitieuse.»
0.2559814453125 ||| Studies in animals have shown reproductive toxicity including an increased incidence of foetal abnormalities and deaths (see section 5.3). ||| Other studies revealed changes in sperm parameters (motility and morphology) consistent with an observed reduction in fertility. ||| Des études chez l’ animal ont montré une toxicité sur les fonctions de reproduction, augmentation de l’ incidence des anomalies et des morts fœ tales (voir rubrique 5.3).
0.9426130056381226 ||| Promoting services for baseball game ||| Publishing services, except printing ||| Services de promotion de matchs de base-ball
0.30262815952301025 ||| the end of this leaflet (see section 6). ||| listed in section 6 of this leaflet. ||| dans Glivec mentionnés à la fin de cette notice (voir rubrique 6).
0.05113697052001953 ||| 8 • Anovulation A sequential treatment scheme is recommended starting with daily administration of 50 IU Fertavid. ||| 42 • Anovulation A sequential treatment scheme is recommended starting with daily administration of 50 IU Puregon. ||| 9 • Anovulation Un traitement séquentiel est recommandé, commençant par l'administration quotidienne de 50 UI de Fertavid.
0.6441100239753723 ||| No dosage tapering is needed on treatment discontinuation. ||| Suspension and emulsion to be mixed before administration ||| L’ arrêt du traitement ne nécessite pas de diminution progressive de la posologie.
0.5479480028152466 ||| NAME OF THE MEDICINAL PRODUCT AND ROUTES OF ADMINISTRATION ||| GROUNDS FOR AMENDMENT OF PRODUCT INFORMATION ||| DENOMINATION DU MEDICAMENT ET VOIE(S) D’ADMINISTRATION
0.7224428653717041 ||| 6 weeks. rod ||| 1 year survival,% ||| 6 semaines.
0.6236221194267273 ||| Limited data suggest that the abrupt discontinuation of Volibris is not associated with rebound worsening of PAH. ||| Randomisation was stratified by the intended use of ENF in the BR, previous use ||| Des données limitées suggèrent que l'interruption brutale de Volibris n'est pas associée à un effet rebond avec aggravation de l’ HTAP.
0.5467717051506042 ||| Volumetric measuring apparatus ||| Radar jamming apparatus ||| Appareils de mesure volumétrique
0.3577665090560913 ||| Fruit grinders (Electric -) ||| Copiers (Electrostatic -) ||| Broyeurs électriques pour fruits
0.15580764412879944 ||| How has Imprida been studied? ||| How has Dicural been studied? ||| Quelles études ont été menées sur Imprida?
0.3476351499557495 ||| The patients should be advised of the potential risk of multiple births before starting treatment. ||| Patients should be advised to immediately report any emergent skin condition to their physician. ||| 6 Les patientes devront être informées des risques éventuels de grossesse multiple avant le début du traitement.
0.41489487886428833 ||| Advisory and consultancy services relating to the procurement of goods for others ||| Information, advisory and consultancy services relating to legal matters ||| Services de conseil et consultation en matière d’approvisionnement de produits pour des tiers
0.28482407331466675 ||| What Tredaptive looks like and contents of the pack Each modified-release tablet is a capsule-shaped, white to off-white tablet, with “ 552” debossed on one side. ||| What Sebivo looks like and contents of the pack Sebivo film-coated tablets are white to slightly yellowish, oval, film-coated tablets with “ LDT” imprinted on one side. ||| Qu’ est -ce que Tredaptive et contenu de l’ emballage extérieur Le médicament est présenté sous forme de comprimé à libération modifiée ovale, blanc à blanc cassé, portant l’ inscription « 552 » gravée sur une face.
0.25099241733551025 ||| Pharmacokinetics in special populations ||| Pharmacokinetics in special clinical situations ||| Pharmacocinétique des populations particulières
0.20237413048744202 ||| What is Tarceva? ||| What is Fertavid? ||| Qu’ est -ce que Tarceva?
0.5553836822509766 ||| • You could also experience dizziness, sleeping problems, low blood pressure and flushing. ||| You may feel tired and pale. • Reduced white blood cell count. ||| • Des sensations vertigineuses, des troubles du sommeil, une diminution de la pression artérielle et une rougeur du visage sont également possibles.
0.362938791513443 ||| • fluid in the chest (pleural effusion) • breathing difficulties • a feeling of tightness in the throat • dry throat • chest discomfort. ||| 25 • discomfort in your stomach • indigestion • diarrhoea • feeling sick (nausea) • being sick (vomiting) • difficulty in swallowing. ||| • présence de liquide dans la cage thoracique (épanchement pleural) • difficultés respiratoires • sensation d’ oppression au niveau de la gorge • gorge sèche • gêne thoracique.
0.03828977793455124 ||| Treatment should be discontinued in case of severe leukopaenia (< 1,200/ mm3), severe neutropaenia (< 750/ mm3) or severe thrombocytopaenia (< 70,000/ mm3). ||| Treatment should be dis continued in case of severe leukopaenia (< 1,200/mm3), severe neutropaenia (< 750/mm3) or severe thrombocytopaenia (< 70,000/mm3). ||| Le traitement doit être interrompu en cas de leucopénie sévère (< 1 200/ mm3), de neutropénie sévère (< 750/ mm3) ou de thrombocytopénie sévère (< 70 000/ mm3).
0.29008960723876953 ||| No dose adjustment is necessary for either medicinal product when clarithromycin is administered in combination with amprenavir. ||| Caution is advised when combining lansoprazole with active substances, which are metabolised by this enzyme. ||| Aucun ajustement posologique de ces deux médicaments n’ est nécessaire en cas de co-administration.
3.899851633033108e-13 ||| Pregnancy and breast-feeding You must tell your doctor if you think that you are (or might become) pregnant. ||| Pregnancy and breast-feeding You must tell your doctor if you think that you are (or might become) pregnant. ||| 109 Grossesse et allaitement Vous devez informer votre médecin si vous êtes enceinte ou si vous pensez pouvoir être enceinte.
2.913565656098571e-13 ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| 175 Le capuchon de protection du stylo prérempli contient du caoutchouc naturel (un dérivé du latex) qui peut provoquer des réactions allergiques.
0.7483553886413574 ||| Spray method: ||| Security access: ||| Vaccination par nébulisation:
0.09558714181184769 ||| ra 4.8 Undesirable effects ||| au 4.8 Undesirable effects ||| é ris 4.8 Effets indésirables
0.25148868560791016 ||| 28 ||| 26 ||| 31
0.16681303083896637 ||| Very common ≥ 1/ 10 ||| Very Common ≥ 1/ 10 ||| Très fréquent ≥ 1/ 10
0.568415105342865 ||| have to be adjusted. ||| au needs to be considered. ||| car la dose devra peut-être être ajustée.
0.023328125476837158 ||| The marketing authorisation was renewed on 14 July 2004. ||| The marketing authorisation was renewed on 19 April 2007. ||| L’ autorisation de mise sur le marché a été renouvelée le 14 juillet 2004.
0.0 ||| You may be given other medicines (anti-emetics) to take before and/or after taking Temodal to prevent or control nausea and vomiting. ||| You may be given other medicines (anti-emetics) to take before and/or after taking Temodal to prevent or control nausea and vomiting. ||| Il peut vous prescrire d’autres traitements (anti-vomitifs) à prendre avant et/ou après avoir pris Temodal pour éviter ou contrôler les nausées et vomissements.
0.6880043745040894 ||| The liver is the primary site of action of the active form. ||| The recommended site of administration is the region of the deltoid. ||| Le foie est le principal site d’action de la forme active.
0.21551069617271423 ||| The following instructions explain how to inject IntronA yourself. ||| The following instructions explain how to inject ViraferonPeg yourself. ||| Les instructions suivantes expliquent comment vous injecter vous-même IntronA.
0.08842640370130539 ||| Actrapid NovoLet 100 IU/ ml solution for injection in a pre-filled pen Insulin human (rDNA) ||| Actrapid FlexPen 100 IU/ ml solution for injection in a pre-filled pen Insulin human (rDNA) ||| Actrapid NovoLet 100 UI/ ml solution injectable en stylo prérempli Insuline humaine (ADNr)
0.4195801019668579 ||| The aim of the MINE project will be to collect and validate information about the efficacy of medicines and then make it easily accessible to health care professionals and the public. ||| It is important to complete the process as quickly as possible to provide clarity and certainty to fishermen and women, to the aquaculture sector and national administrations alike. ||| L’ objectif du projet MINE consiste à rassembler et valider des informations sur l’ efficacité des médicaments et à les rendre aisément accessibles au public et aux professionnels de la santé.
0.8037596344947815 ||| Psychiatric Disorders: agitation ||| - Post-traumatic Stress Disorder ||| Affections psychiatriques: agitation
0.06971193104982376 ||| • 17.5.2002 ||| • 22.5.2002 ||| 17.5.2002
0.23498684167861938 ||| In patients previously un treated with chemotherapy, TMZ is administered orally at a dose of 200 mg/m2 once daily for the first 5 days followed by a 23 day treatment interruption (total of 28 days). ||| If Pelzont is missed for 7 or more consecutive days, therapy should be resumed at the 1000 mg/ 20 mg dose for 1 week, before advancing to the maintenance dose of 2000 mg/ 40 mg. ||| Chez les patients n’ ayant pas reçu de chimiothérapie au préalable, TMZ est administré par voie orale à la dose de 200 mg/ m2 une fois par jour pendant les 5 premiers jours du cycle puis le traitement devra être arrêté pendant les 23 jours suivants (total de 28 jours).
0.6048762798309326 ||| Patients with recurrent or progressive malignant glioma ||| experiencing an oral or vaginal yeast or fungal infection ||| Patients adultes atteints d’ un gliome malin en progression ou récidive
3.3744789731601776e-13 ||| Studies in animals have shown reproductive toxicity at high doses (see section 5.3). ||| Studies in animals have shown reproductive toxicity at high doses (see section 5.3). ||| Des études effectuées chez l'animal ont mis en évidence une toxicité sur la reproduction à doses élevées (voir rubrique 5.3).
0.0 ||| 6.5 Nature and contents of container ||| 6.5 Nature and contents of container ||| 20 6.5 Nature et contenu de l'emballage extérieur
0.0 ||| 8. ||| 8. ||| 14 8.
0.39201316237449646 ||| Neurotoxicity, mainly peripheral neuropathy, appeared to be more frequent and severe with a 175 mg/ m2 3 hour infusion (85% neurotoxicity, 15% severe) than with a 135 mg/ m2 24 hour infusion (25% peripheral neuropathy, 3% severe) when paclitaxel was combined with cisplatin. ||| o Incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria, o Manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor (see section 5.1), o Manifest glomerular non diabetic nephropathy as defined by macroproteinuria ≥ 3 g/ day (see section 5.1). ||| La neurotoxicité, principalement neuropathie périphérique, semble être plus fréquente et sévère avec une perfusion de 175 mg/ m2 sur 3 heures (85% de neurotoxicité, 15% sévère) qu'avec une perfusion de 135 mg/ m2 sur 24 heures (25% de neuropathies périphériques, 3% sévère) de paclitaxel associé à cisplatine.
0.3177492916584015 ||| Imatinib in combination with chemotherapy induction (see Table 5) resulted in a complete haematological response rate of 93% (147 out of 158 evaluable patients) and in a major cytogenetic response rate of 90% (19 out of 21 evaluable patients). ||| Successful response to voriconazole therapy was seen in 16 (6 complete, 10 partial responses) of 28 patients with S. apiospermum and in 2 (both partial responses) of 7 patients with S. prolificans infection. ||| L’ imatinib en association avec la chimiothérapie d’ induction (voir Tableau 5) a permis d’ obtenir un taux de réponse complète hématologique de 93% (147 sur 158 patients évaluables) et un taux de réponse cytogénique majeure de 90% (19 sur 71 21 patients évaluables).
0.07397349923849106 ||| The MAH must ensure that the system of pharmacovigilance, as described in version 2 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| The MAH must ensure that the system of pharmacovigilance as described in version 01 (dated 4 May 2006) presented in Module 1.8.1 of the Marketing Authorisation Application is in place and functioning before and whilst the product is on the market. ||| Le titulaire de l’ Autorisation de Mise sur le Marché (AMM) doit s’ assurer que le système de pharmacovigilance, tel que décrit dans la version 2 présentée dans le Module 1.8.1. de la demande d’ AMM, soit mis en place et fonctionnel avant et pendant la commercialisation du produit.
0.26768380403518677 ||| Haematological abnormalities Decreases in neutrophil and platelet counts have occurred following treatment with tocilizumab 8 mg/ kg in combination with MTX (see section 4.8). ||| Haematologic effects As with other nicotinic acid medicinal products, Pelzont (2000 mg/ 40 mg) was associated with small reductions in platelet count (see section 4.8). ||| Anomalies hématologiques Des diminutions du nombre de neutrophiles et de plaquettes sont survenues après un traitement par tocilizumab à la dose de 8 mg/ kg associé au MTX (voir rubrique 4.8).
0.38034409284591675 ||| If you stop using CEPROTIN ||| If you stop using BYETTA: ||| Si vous arrêtez d’ utiliser CEPROTIN
0.33905529975891113 ||| Verovš kova 57 SI-1526 Ljubljana Tel: + 386 (0)1 580 21 11 ||| Dunajska 22 SI-1000 Ljubljana Tel. + 386 01 3001070 ||| Verovš kova 57 SI-1526 Ljubljana Tel.: +386 1 580 21 11
0.01983783021569252 ||| 89 PACKAGE LEAFLET: ||| 97 PACKAGE LEAFLET: ||| 98 NOTICE:
0.6048872470855713 ||| No evidence supports these claims. ||| Other data sets have not confirmed this finding. ||| Aucune preuve n'étaye ces allégations.
0.3474498391151428 ||| - if you are breast feeding ||| - If you are breast-feeding. ||| - si vous allaitez
0.00031875085551291704 ||| During clinical trials with ADVATE in 145 paediatric and adult patients 6 diagnosed with severe to moderately severe haemophilia A (FVIII ≤ 2%), with previous exposure to factor VIII concentrates ≥ 150 days, one patient developed a low-titre inhibitor (2.4 BU in the modified Bethesda assay) after 26 exposure days to ADVATE. ||| During clinical trials with ADVATE in 145 paediatric and adult patients 12 diagnosed with severe to moderately severe haemophilia A (FVIII ≤ 2%), with previous exposure to factor VIII concentrates ≥ 150 days, one patient developed a low-titre inhibitor (2.4 BU in the modified Bethesda assay) after 26 exposure days to ADVATE. ||| Au cours des essais cliniques avec ADVATE, sur 145 patients 6 pédiatriques et adultes ayant fait l’ objet d’ un diagnostic d’ hémophilie A sévère à modérément sévère (FVIII ≤ 2%) et précédemment exposés à des concentrés de facteur VIII pendant au moins 150 jours, un patient a développé un inhibiteur de faible titre (2,4 UB selon le test Bethesda modifié) après 26 jours d’ exposition.
0.36287999153137207 ||| Rue de Stalle 73 B-1180 Brussels Belgium ||| Chaussée de Waterloo 1135 B- 1180 Brussels Belgium ||| Rue de Stalle 73 B-1180 Brussels Belgique
0.5119779109954834 ||| Avoid the use of other topical products on treated KS lesions. ||| Promote local guidelines on managing infections and using antibiotics. ||| Il convient d’ éviter l’ application de tout autre produit topique sur les lésions traitées.
0.38638871908187866 ||| blister (PVC/ alu) blister (PVC/ alu) perforated unit dose blister (PVC/ alu) ||| bottle (HDPE) bottle (HDPE) blister (alu) HDPE bottle blister (Alu) blister (alu/ PVC) ||| plaquette thermoformée avec perforations contenant des doses unitaires (PVC/ alu)
0.5245391130447388 ||| Manufacturer Roche Pharma AG Emil-Barrell-Str. ||| Manufacturer Janssen-Cilag SpA, Via C. ||| Fabricant Roche Pharma AG Emil-Barrell-Str.
0.2571238875389099 ||| Education and training in the field of electronic data processing ||| Education and training in the field of music and entertainment ||| Éducation et formation dans le domaine du traitement électronique de données
0.25281569361686707 ||| Children and adolescents As there has been no experience in children and adolescents, the use of febuxostat in such patients is not recommended. ||| Children and adolescents: because insufficient data are available, the use of Trizivir in children or adolescents is not recommended. ||| 2 Enfant et adolescent En l’ absence d’ expérience clinique chez l’ enfant et l’ adolescent, l’ utilisation de fébuxostat n’ est pas recommandée chez ces patients.
0.5490832328796387 ||| The total number of patients treated with ertapenem in clinical studies was 384. ||| Efficacy was based on 320 CP patients and 119 AP patients enrolled. ||| Au total 384 patients ont été traités par l’ ertapénème lors des études cliniques.
0.42733895778656006 ||| Any unused product should be discarded in accordance with local requirements. ||| Dispose of waste material in accordance with local requirements. ||| Tout produit non utilisé doit être éliminé conformément à la réglementation en vigueur.
0.02697935327887535 ||| 13 March 1997 Date of latest renewal: ||| 12 March 1999 Date of latest renewal: ||| 13 mars 1997 Date du dernier renouvellement de l’ autorisation:
0.3196353316307068 ||| The syringe can be removed from the refrigerator and left at room temperature for a single period of maximum 3 days (but not above 25°C). ||| If kept outside of the refrigerator, do not store above 25°C and discard any unused contents after 42 days (6 weeks). ||| Vous pouvez conserver le produit en dehors de ces conditions durant une période unique pouvant aller jusqu'à 3 jours à température ambiante (sans dépasser 25°C).
0.3722207546234131 ||| Genetic testing apparatus for medical purposes ||| Chromatographic supports for scientific laboratory use ||| Appareils de tests génétiques à usage médical
0.26708272099494934 ||| The effects of filgrastim on neutropenia due to bone marrow-infiltrating infection or malignancy have not been well established. ||| There was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys. ||| Les effets de filgrastim sur la neutropénie due à une infection ou à une affection maligne envahissant la moelle osseuse n’ ont pas été déterminés avec précision.
0.006656371057033539 ||| In patients with a creatinine clearance between 20 and 50 ml/ min, the initial daily dose of SIFROL should be administered in two divided doses, starting at 0.088 mg of base (0.125 mg of salt) twice a day (0.176 mg of base/ 0.25 mg of salt daily). ||| In patients with a creatinine clearance between 20 and 50 ml/ min, the initial daily dose of Oprymea should be administered in two divided doses, starting at 0.088 mg of base (0.125 mg of salt) twice a day (0.176 mg of base/ 0.25 mg of salt daily). ||| Si la clairance de la créatinine est comprise entre 20 et 50 ml/ min, la dose journalière initiale de SIFROL doit être de 0,176 mg de forme base (0,25 mg de forme sel), fractionnée en deux prises de 0,088 mg de forme base chacune (0,125 mg de forme sel).
0.4536823630332947 ||| Press the injection button completely in and discard the insulin. ||| Remove the intravenous cannula immediately following the injection. ||| Appuyez à fond sur le bouton d’ injection et éliminez l’ insuline.
0.4005495309829712 ||| Patients and caregivers have to receive appropriate training and instruction on the proper use of the Omnitrope cartridges and the pen from the physician or other suitable qualified health professionals. ||| You will receive appropriate training and instruction on the proper use of Omnitrope from your doctor or other suitably qualified health professional. ||| Les patients et les soignants doivent recevoir une formation appropriée et des instructions sur l’ utilisation correcte des cartouches d’ Omnitrope, et du stylo par le médecin ou autre professionnel de santé qualifié.
0.16334885358810425 ||| Electronic controllers ||| Electronic sensors ||| Contrôleurs électroniques
0.08789326250553131 ||| every 3 – 4 weeks to obtain IgG trough level of at least 4 – 6 g/l ||| every 2 – 4 weeks to obtain IgG minimum (trough) level of at least 4 – 6 g/l ||| toutes les 3 à 4 semaines afin d’obtenir un taux résiduel d’IgG d’au moins 4 à 6 g/l au minimum
0.8091000914573669 ||| 7, 10, 14, 20, 21, 30, 50, 60, 100x1, 100, 250 (PVC/ AL) 7 (PVC/ PE) 10, 14, 20, 21, 30, 50, 60, 100x1, 100, 250 (PVC) ||| 10 (1x10), 20 (2x10), 30 (3x10), 50 (5x10), 100 (10x10), 200 (20x10) and 500 (50x10) film-coated tablets; 14 (2x7), 28 (4x7), 56 (8x7), and 70 (10x7) film-coated tablets. ||| 21, 30, 50, 60, 100x1, 100, 250 (PVC/ AL) 7 (PVC/ PE) 10, 14, 20, 21, 30, 50, 60, 100x1, 100, 250 (PVC)  EMEA 2004
0.0 ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| La pioglitazone, principe actif d’ Actos, augmente la sensibilité 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.23418961465358734 ||| If an oral bisphosphonate or sodium fluoride is used concomitantly, this preparation should be administered at least three hours before the intake of Calcium Sandoz since gastrointestinal absorption of either oral bisphosphonate or sodium fluoride may be reduced. ||| Both colestyramine and activated powdered charcoal may influence the absorption of oestrogens and progestogens such that reliable contraception with oral contraceptives may not be guaranteed during the washout procedure with colestyramine or activated powdered charcoal. ||| En raison d’ une diminution de l’ absorption gastro-intestinale des bisphosphonates ou du fluorure de sodium, il est recommandé, lors de traitements concomitants, de respecter un délai d’ au moins trois heures avant de prendre du calcium.
0.4299737215042114 ||| The direct grant covers 90 % of the costs of the stockpile while the remaining 10 % are borne by the Member State. ||| Each Member State is allocated a share of the total Fund budget, based on the size of its fishing industry. ||| La subvention directe couvre 90 % des coûts de la réserve, les 10 % restants étant à la charge de l'État membre.
0.40417540073394775 ||| In postmarketing, serious allergic reactions including anaphylaxis have been reported very rarely following Humira administration. ||| - if you have ever suffered from a rare reaction to antipsychotic medicines called neuroleptic ||| Au cours de la surveillance post-marketing des réactions allergiques graves, incluant des réactions anaphylactiques ont été très rarement rapportées, après administration d'Humira.
0.6054095029830933 ||| Notice to applicants for marketing authorisations for veterinary medicinal products in the European Union catalogue n˚ CO-78-93-443-EN-C, also available in ES, DE, FR, IT ||| Good manufacturing practices for medicinal products catalogue n˚ CO-71-91-760-EN-C, also available in ES, DA, DE, GR, FR, NL, PT ||| Avis aux demandeurs d’autorisation de mise sur le marché de médicaments à usage vétérinaire dans l’Union Européenne catalogue nº CO-78-93-443-FR-C, disponible également en EN, ES, DE, IT
0.2686852514743805 ||| Compilation of statistics relating to advertising ||| Compilation of statistics relating to health care utilization ||| Compilation de statistiques en matière de publicité
0.20832577347755432 ||| Distribution: atazanavir was approximately 86% bound to human serum proteins over a concentration range of 100 to 10,000 ng/ ml. ||| The plasma protein binding of olanzapine was about 93% over the concentration range of about 7 to about 1000 ng/ ml. ||| 20 Distribution: la liaison d’ atazanavir aux protéines plasmatiques humaines était d’ environ 86% pour une concentration comprise entre 100 et 10.000 ng/ ml.
0.5330790281295776 ||| In total, the EU will support with €800 million our Western Balkan partners and Turkey to address the coronavirus. ||| The EU and its Member States are the lead donor of humanitarian and development aid in Somalia. ||| Au total, le soutien fourni par l'UE à ses partenaires dans les Balkans occidentaux et à la Turquie pour lutter contre le coronavirus se montera à 800 millions d'euros.
0.33676886558532715 ||| In this situation a reduced dose of atorvastatin should be considered. ||| A reduction of the nifedipine dose can be considered. ||| Dans ce cas, une réduction posologique de l’ atorvastatine doit être envisagée.
1.0211660861968994 ||| Posology Children and adolescents (birth through 15 years of age): ||| Median age in years (range) Gender: male/ female ||| Posologie Enfants et adolescents (de la naissance jusqu’ à l'âge de 15 ans):
0.2160254716873169 ||| Research and development services in the field of chemistry ||| Research and development services in the field of immunohistology ||| Services de recherche et de développement dans le domaine de la chimie
0.5344172120094299 ||| CARTON AND LABEL FOR BOTTLE ||| CARTON BOX AND BOTTLES ||| BOÎTE ET ÉTIQUETTE POUR FLACON
0.35659950971603394 ||| Clinical trials in adults Documentation of the safety and efficacy of Busilvex in combination with cyclophosphamide in the BuCy2 regimen prior to conventional allogeneic and/ or autologous HPCT derive from two clinical trials (OMC-BUS-4 and OMC-BUS-3). ||| Across all three doses of PROCOMVAX, there were no significant differences in the frequency of adverse experiences between PROCOMVAX and the monovalent vaccines Merck PRP- OMPC Vaccine and Merck Hepatitis B (Recombinant) Vaccine. ||| 10 Les données de tolérance et d’ efficacité du Busilvex en association avec le cyclophosphamide selon le protocole BuCy2, administrés avant autogreffe et/ ou allogreffe conventionnelle de CSH sont issues de deux études cliniques (OMC-BUS 4 et OMC-BUS 3).
0.2864965498447418 ||| What is SCINTIMUN? ||| What is DRAXXIN? ||| Qu’ est -ce que SCINTIMUN?
4.810877174063477e-13 ||| - atypical antipsychotic medications (such as clozapine, olanzapine), ||| - atypical antipsychotic medications (such as clozapine, olanzapine), ||| les produits antipsychotiques atypiques (tels que olanzapine et clozapine),
0.4609905481338501 ||| The mixture should be stirred and the entire contents given to the patient. ||| the entire contents of the correct size pipette should be used. ||| La préparation doit être mélangée, administrée au patient dans sa totalité et être immédiatement avalée.
0.3753771483898163 ||| The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only. ||| Transport of gas cylinders The gas cylinders should be transported with appropriate material in order to protect them from risks of shocks and falls. ||| Le nébulisateur doit être exempt de sédiments, corrosion et de traces de désinfectant, et idéalement, devrait être réservé pour la vaccination.
4.53713374379619e-13 ||| - If you have further questions, please ask your doctor or your pharmacist. ||| - If you have further questions, please ask your doctor or your pharmacist. ||| - Si vous avez d'autres questions, si vous avez un doute, demandez plus d’informations à votre
0.37830400466918945 ||| Next Generation EU of €750 billion as well as targeted reinforcements to the long-term EU budget for 2021-2027 will bring the total financial firepower of the EU budget to €1.85 trillion. ||| Since its introduction in mid-2019, the EIC Accelerator pilot has offered the option of direct equity investments, up to €15 million, in addition to the grant support, up to €2.5 million. ||| L'instrument Next Generation EU, doté d'une enveloppe de 750 milliards d'euros, ainsi que des renforcements ciblés du budget à long terme de l'Union pour la période 2021-2027 porteront à 1,85 billion d'euros la capacité financière totale du budget de l'Union.
0.4028121829032898 ||| CVMP received SPCs, a master reference dossier on residues and withdrawal periods, residue studies, efficacy data and periodic safety update reports, an expert statement on the efficacy including reference papers, pharmacokinetic data, antimicrobial resistance information and MIC/ resistance data. ||| 2.3 Pharmacovigilance and maintenance activities This includes activities related to pharmacovigilance information (adverse drug reaction reports (ADRs) and periodic safety update reports (PSURs)), follow-up measures, specific obligations, annual reassessments and renewal applications. ||| Le CVMP a reçu les RCP, un dossier de référence principal sur les résidus et les temps d’ attente, des études sur les résidus, des informations sur l’ efficacité et les rapports périodiques de sécurité actualisés, une déclaration d’ experts sur l’ efficacité comprenant des documents de référence, des données de pharmacocinétique, des informations sur la résistance aux antibiotiques et des données sur la CMI/ la résistance.
0.35567742586135864 ||| Given this outcome together with published data on the pharmacokinetics of sodium salicylate in calves and significant variation in individual pig concentrations post treatment2, the MAHs should justify that therapeutic concentrations are established and maintained following oral use of the drug through water medication and submit all available data that could substantiate the posology and dosage regimen of sodium salicylate when given orally to calves and pigs, together with a thorough discussion of the these data. ||| The aim of this study is to investigate: bortezomib PK after single and multiple dose treatment; the mechanisms behind the observed changes in the PK parameters after repeated dosing; any clinically plausible intrinsic factors that may explain and reduce variability; the relationship between body weight/ body surface area/ lean body weight) and PK parameters since dosing regimen is based on BSA; the concentration-proteasome inhibition relationship using PK/ PD-modelling; ||| Au vu de cette observation ainsi que des résultats publiés sur la pharmacocinétique du salicylate de sodium chez les veaux et les variations individuelles significatives des concentrations chez les porcs après le traitement2, les TAMM doivent justifier que les concentrations thérapeutiques sont établies et maintenues
0.34409573674201965 ||| The main medical purpose of washing hands is to cleanse the hands of pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals which can cause harm or diseases. ||| The hazard in a health care setting is exposure to blood, saliva, or other bodily fluids or aerosols that may carry infectious materials such as Hepatitis C, HIV, or other blood borne or bodily fluid pathogen. ||| Le principal objectif médical du lavage des mains est d’éliminer les agents pathogènes (bactéries, virus ou autres microorganismes susceptibles de provoquer des maladies) et les produits chimiques, pouvant être nocifs ou provoquer des maladies.
0.0 ||| 32 PACKAGE LEAFLET ||| 32 PACKAGE LEAFLET ||| 36 NOTICE
0.1666976511478424 ||| If an anaphylactic reaction or other serious allergic reaction occurs, administration of Humira should be discontinued immediately and appropriate therapy initiated. ||| If allergic or anaphylactic reactions occur, treatment should be discontinued immediately and appropriate therapy initiated. ||| En cas de survenue d'une réaction anaphylactique ou d'une autre réaction allergique grave, l'administration d’ Humira doit être immédiatement interrompue et un traitement approprié mis en œ uvre.
0.06644732505083084 ||| The active substance in Lantus, insulin glargine, is produced by a method known as ‘ recombinant technology’. ||| The active ingredient of Humalog, insulin lispro, is produced by a method known as ‘ recombinant DNA technology’. ||| Le principe actif chez Lantus, l’ insuline glargine, est produit par une méthode appelée la « technologie de recombinaison ».
0.5153020620346069 ||| Urine levels of interferon were below the detection limit following each of the three routes of administration. lp ||| Record date of transfer to room temperature and the end of the 9-month period on the outer carton. ||| tp Pour les trois voies d'administration, les concentrations urinaires d'interféron se situaient en dessous de la limite de détection. s Enfants et adolescents:
0.4639474153518677 ||| This appropriation covers the cost of checking of translations of product information by the member states. ||| This appropriation covers the cost of unemployment insurance for relevant staff. ||| Ce crédit couvre les frais de révision des traductions des informations sur les produits par les États membres.
0.004584546200931072 ||| 89 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 94 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 98 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.0 ||| 74 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 74 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 79 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.2931002378463745 ||| Amino acids and derivatives; ATC code: ||| Cephalosporins and related substances, ATC code: ||| Acides aminés et dérivés; Code ATC:
3.4405217932444165e-13 ||| 15 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 15 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 15 MENTIONS MINIMALES DE L’ EMBALLAGE PRIMAIRE
0.0822288990020752 ||| Your doctor will tell you exactly how many tablets of Xiliarx to take. ||| Your doctor will tell you exactly how many tablets of Galvus to take. ||| Votre médecin vous dira exactement combien de comprimés de Xiliarx vous devez prendre.
0.41666531562805176 ||| Very common side effects (likely to occur in more than 1 out of 10 persons): irregular menstrual periods and cessation of menstrual periods. ||| These are irregular menstrual periods or stopped menstrual periods (although stopped periods may be due to pregnancy). ||| Effets indésirables très fréquents (se produisent probablement chez plus de 1 personne sur 10): menstruations irrégulières et aménorrhée.
0.22582614421844482 ||| Radio-frequency receivers ||| Radio-frequency components ||| Récepteurs de radiofréquences
0.27395644783973694 ||| Co-administration of nimesulide and furosemide results in a decrease (of about 20%) of the AUC and cumulative excretion of furosemide, without affecting its renal clearance. ||| A small portion of gadofosveset dose was recovered in the faeces (4.7%, range 1.1 – 9.3%), indicating a minor role of biliary excretion in the disposition of gadofosveset. ||| L'administration concomitante de nimésulide et de furosémide entraîne une diminution (d'environ 20%) de la surface sous la courbe et de l'excrétion cumulée du furosémide, sans toutefois affecter sa clairance rénale.
0.5245376825332642 ||| Regular urinanalysis should be performed to monitor this event. ||| These samples are then sent for analysis at a specialised laboratory. ||| Des analyses d’ urines doivent être effectuées régulièrement afin de suivre cet évènement.
0.23224803805351257 ||| Pergoveris must be reconstituted with the solvent before use. ||| One vial of Raptiva should be reconstituted with the solvent before use. ||| Pergoveris doit, avant utilisation, être reconstitué avec le solvant.
0.48761075735092163 ||| N=114 Plasma HIV-1 RNA at ||| Plasma HIV-1 RNA at ||| N=114 plasmatique à la semaine 4
0.43184810876846313 ||| LeukoScan is an antibody fragment which is linked to a radioactive substance called technetium. ||| This enzyme normally breaks down a fatty waste product called glucocerebroside. ||| LeukoScan est un fragment d'anticorps qui est lié à une substance radioactive connue sous le nom de technétium.
0.03676094114780426 ||| Children and adolescents (< 18 years) STELARA is not recommended for use in children below age 18 due to a lack of data on safety and efficacy. ||| 2 Children and adolescents (< 18 years) Raptiva is not recommended for use in children below age 18 due to a lack of data on safety and efficacy. ||| Enfants et adolescents (< 18 ans) En l’ absence de données sur la tolérance et l’ efficacité, STELARA ne doit pas être utilisé chez les enfants de moins 18 ans.
0.3059602379798889 ||| You should not use Enbrel with medicines that contain the active ingredients anakinra or abatacept. ||| Do not take Viread if you are already taking other medicines containing tenofovir disoproxil fumarate. ||| Vous ne devez pas utiliser Enbrel avec des médicaments contenant les substances actives anakinra ou abatacept.
0.01982538215816021 ||| The Mutual Recognition Procedure started on 21 September 2006. ||| The Mutual Recognition Procedure started on 20 September 2007. ||| La procédure de reconnaissance mutuelle a débuté le 21 septembre 2006.
0.07634031027555466 ||| Genotype 2/3 ||| Genotype 1/4 ||| Génotype 2/ 3
0.3061041831970215 ||| The proposal represents an important step in fulfilling the Commission's commitment to use all economic policy tools at its disposal to support Member States' in protecting their citizens and mitigating the pandemic's severely negative socio-economic consequences. ||| Adopted in the heart of the COVID-19 pandemic, the strategy is a central element of the EU's recovery plan, crucial to preventing and building resilience to future outbreaks and providing immediate business and investment opportunities for restoring the EU's economy. ||| Cette proposition est une mesure importante que prend la Commission pour tenir son engagement: utiliser tous les instruments de politique économique dont elle dispose afin d'aider les États membres à protéger leurs citoyens et à atténuer les conséquences socio-économiques extrêmement négatives de la pandémie.
0.6446359753608704 ||| Muscle injury can sometimes cause dark urine. ||| Truvada may affect your kidneys. ||| Les lésions musculaires peuvent parfois provoquer l'émission d'urines foncées.
0.0993402749300003 ||| 39/ 45 ||| 39/ 44 ||| 40/ 46
0.33392080664634705 ||| A statistical study has found that countries that have tested more, relative to the number of deaths, have much lower case fatality rates, probably because these countries are better able to detect those with only mild or no symptoms. ||| Many countries are experiencing a severe shortage of test kits, and the authorities have not been able to test everybody who is at high risk, so the real number of cases is probably much higher than the official one. ||| Une étude statistique a découvert que les pays ayant réalisé le plus de tests, par rapport au nombre de décès, ont des taux de létalité beaucoup plus faibles, probablement parce que ces pays sont plus aptes à détecter les personnes ne présentant que des symptômes légers ou aucun symptôme.
0.8404573798179626 ||| Head of Unit Head of Sector for regulatory affairs ||| Head of Unit Personnel & support Accounts Total ||| Chef d’unité Chef du secteur Affaires réglementaires
0.3368678689002991 ||| Dating agency services ||| Entertainment agency services ||| Agences de rencontres
4.415340163800574e-13 ||| Caution is advised when Agenerase is used concomitantly with delavirdine (see section 4.5). ||| Caution is advised when Agenerase is used concomitantly with delavirdine (see section 4.5). ||| La prudence est conseillée en cas d’ utilisation concomitante d’’ Agenerase et de la delavirdine (voir rubrique 4.5).
0.4163243770599365 ||| Based on further in vitro results in human liver microsomes, therapeutic plasma concentrations of montelukast do not inhibit cytochromes P450 3A4, 2C9, 1A2, 2A6, 2C19, or 2D6. ||| In vitro enzymatic studies with human liver microsomes revealed that arsenic trioxide has no inhibitory activity on substrates of the major cytochrome P450 enzymes such as 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4/ 5, 4A9/ 11. ||| D'après d'autres résultats obtenus in vitro sur des microsomes hépatiques humains, les concentrations plasmatiques thérapeutiques du montelukast n'inhibent pas les cytochromes P450 3A4, 2C9, 1A2, 2A6, 2C19 ou 2D6.
0.35907524824142456 ||| 0.8 ml ||| 0.840 ml ||| 0,8 ml éd
0.536502480506897 ||| Overall, the safety and efficacy profiles for BID and TID dosing regimens were similar. ||| Response parameters as well as TTP remained significantly better for VELCADE independently of age. ||| Dans l’ ensemble, les profils de sécurité et d’ efficacité ont été similaires pour les schémas posologiques BID et TID.
0.24779513478279114 ||| medium dogs ||| Female dogs ||| chiens moyens
0.4616258144378662 ||| A dose dependent effect on TxB2 formation has been observed after high doses of celecoxib. ||| Robenacoxib tablets are therefore COX-1 sparing at recommended doses in dogs. ||| Un effet dose-dépendant sur la formation de TxB2 a été observé après des doses élevées de célécoxib.
0.26726508140563965 ||| In general, administration of somatropin to growth hormone deficient patients results in reduction in serum LDL and apolipoprotein B. ||| In addition to enhanced lipolysis, somatropin decreases the uptake of triglycerides into body fat stores. ||| En général, l'administration de somatropine chez les patients ayant un déficit en hormone de croissance entraîne une diminution des LDL et des apolipoprotéines B sériques.
0.3222980201244354 ||| Each prolonged-release capsule contains 1 mg of tacrolimus. ||| 1 dose of Silgard suspension for injection contains 0.5 ml. ||| Chaque gélule à libération prolongée contient 1 mg de tacrolimus.
0.048916518688201904 ||| WHAT HBVAXPRO 40 micrograms/ ml IS AND WHAT IT IS USED FOR ||| WHAT HBVAXPRO 5 micrograms/ 0.5 ml IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE HBVAXPRO 40 microgrammes/ml ET DANS QUEL CAS EST-IL UTILISÉ
0.23222976922988892 ||| Generally, acute and chronic infections (e. g. osteomyelitis and prostatitis, etc), where the causative organism is known to be sensitive to ciprofloxacin, should be treated for at least three days after the signs and symptoms of the infection have disappeared. ||| Taking antibiotics to fight mild bacterial infections, such as rhinosinusitis, sore throats, bronchitis or earaches, is often unnecessary [15-19] since, in most cases, your own immune system is able to deal with such mild infections. ||| En règle générale, les infections aiguës et chroniques (par exemple ostéomyélites et prostatites) dues à un germe de sensibilité connue à la ciprofloxacine doivent être traitées pendant au moins trois jours après la disparition des signes et des symptômes d’ infection.
0.40114718675613403 ||| Detailed instructions for self-administration are given at the end of this package leaflet. ||| Detailed instruction accompanying the cartridge and delivery system must be followed. ||| Les instructions détaillées pour une auto- administration sont données à la fin de cette notice.
0.3328337073326111 ||| Each pack provides 1 vial containing 3.5 ml or 5 ml solution for injection. ||| Solution for injection 14 x 2 ml glass vials Each vial contains one 0.5 ml dose. ||| Chaque boîte comprend 1 flacon contenant 3,5 ml ou 5 ml de solution injectable.
0.10331087559461594 ||| Technical project planning in the field of engineering ||| Technical project studies in the field of construction ||| Développement de projets techniques dans le domaine de l'ingénierie
0.21885675191879272 ||| The incidence of adverse events was higher in patients with low weight (≤ 60 kg). ||| The most pronounced increases were observed in patients of low body weight (< 30 kg). ||| Faible poids corporel: l’ incidence des effets indésirables était plus élevée chez les patients à faible poids corporel (≤ 60 kg).
0.18678462505340576 ||| Each tablet contains 4 mg of rosiglitazone (as maleate) and 1000 mg of metformin hydrochloride. ||| Each tablet contains 45 mg pioglitazone (as hydrochloride) and 4 mg glimepiride. ||| Chaque comprimé contient 4 mg de rosiglitazone (sous forme de maléate) et 1000 mg de chlorhydrate de metformine.
0.24723026156425476 ||| How to use Prometax 4. ||| How to use Hycamtin 4. ||| Comment utiliser Prometax 4.
0.0694977417588234 ||| Do not use Humalog BASAL after the expiry date which is stated on the label and the carton. ||| Do not use Humalog Mix25 Pen after the expiry date which is stated on the label and the carton. ||| Ne pas utiliser Humalog BASAL après la date de péremption mentionnée sur l’étiquette et la boîte.
0.06125792860984802 ||| If you have any further questions, ask your doctor or your pharmacist. ||| If you have further questions, ask your doctor or pharmacist. ||| Si vous avez d’autres questions, demandez plus d’informations à votre médecin ou à votre pharmacien.
0.010634594596922398 ||| The tablets must be swallowed whole with a sufficient amount of liquid. ||| The tablets should be swallowed whole with a sufficient amount of liquid. ||| Les comprimés doivent être avalés entiers avec une boisson en quantité suffisante.
0.10517248511314392 ||| It contains the active substance basiliximab. ||| It contains the active substance caspofungin. ||| Il contient le principe actif Simulec basiliximab.
0.12713631987571716 ||| In patients aged three to 17 years, the dose depends on body weight. ||| The dose for children aged six to 16 years depends on body weight. ||| Chez les patients âgés de 3 à 17 ans, la dose dépend du poids corporel.
0.2538437843322754 ||| Precision parting tools [parts of machines] ||| Linking mechanisms [parts of machines] ||| Outils à tronçonner de précision [pièces de machines]
0.29229211807250977 ||| Insuman Basal must never be injected intravenously. ||| Insulin Human Winthrop Basal must never be injected intravenously. ||| Insuman Basal ne doit jamais être injecté par voie intraveineuse.
0.05088573694229126 ||| PegIntron 80 micrograms powder and solvent for solution for injection peginterferon alfa-2b ||| ViraferonPeg 100 micrograms powder and solvent for solution for injection peginterferon alfa-2b ||| PegIntron 80 microgrammes poudre et solvant pour solution injectable peginterféron alfa-2b
0.5008724331855774 ||| Financing of purchases ||| Planning of journeys ||| Financement d'achats
0.6617542505264282 ||| Before you use Humalog Mix25 KwikPen 3. ||| Mixtard 30 Penfill and FlexPen: ||| Quelles sont les informations à connaître avant d'utiliser Humalog Mix25 KwikPen 3.
0.24787595868110657 ||| ► In insulin infusion pumps ► If FlexPen is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appears water clear and colourless. ||| Silapo must not be used if • The blister sealing is broken or the blister is damaged in any way. • The liquid is coloured or you can see particles floating in it. • Any liquid has leaked out of the pre-filled syringe or condensation is visible within the sealed blister. • It may have been accidentally frozen. ||| ► dans une pompe à perfusion d’insuline ► si votre FlexPen est tombé, a été endommagé ou a été écrasé car il y a un risque de fuite d’insuline ► s’il n’a pas été conservé correctement ou s’il a été congelé (voir 6 Comment conserver Levemir) ► si l’insuline n’apparaît pas limpide et incolore.
0.2038893699645996 ||| It is supplied in packs of 1 pre-filled pen and 5 needles for administration. ||| Pack of one pre-filled pen and 7 needles to be used with the pen for administration. ||| Il existe en boîte de 1 stylo prérempli et 5 aiguilles pour l’administration.
0.26155439019203186 ||| Tarceva dosing should be interrupted if changes in liver function are severe (see section 4.8). ||| However cardiac function should be monitored regularly in patients receiving Busilvex (see section 4.8). ||| L’ administration de Tarceva doit être interrompue en cas de modifications importantes de la fonction hépatique (voir rubrique 4.8).
0.0063065942376852036 ||| Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 7 days or disposed of. ||| Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 12 hours or disposed of. ||| Lorsque la seringue a été sortie du réfrigérateur et a atteint la température ambiante (jusqu’ à 25°C) elle doit être utilisée dans les 7 jours ou jetée.
0.2372346669435501 ||| Cultures of microorganisms for medical or veterinary use ||| Cultures of microorganisms for industrial purposes ||| Cultures de micro-organismes à usage médical ou vétérinaire
0.01539124920964241 ||| For the full list of all side effects reported with Zerene, see the Package Leaflet. ||| For the full list of all side effects reported with Kentera, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Zerene, voir la notice.
0.11731015145778656 ||| Before starting treatment, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, (up to five weeks ago) including medicines obtained without prescription. ||| Avant le début du traitement, si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez -en à votre médecin ou votre pharmacien.
0.4594687223434448 ||| Armrests for automobile seats ||| Upholstery for vehicle seats ||| Accoudoirs pour sièges d'automobiles
0.082723468542099 ||| Individuals with haemophilia B may develop antibodies (inhibitors) against factor IX. ||| Patients with haemophilia B may develop neutralising antibodies (inhibitors) to factor IX. ||| Les personnes atteintes d’ hémophilie B peuvent développer des anticorps (inhibiteurs) dirigés contre le facteur IX.
0.14745663106441498 ||| The active substance in VASOVIST, gadofosveset trisodium, contains gadolinium, a ‘ rare earth’ metal element. ||| The active substance in OptiMARK, gadoversetamide, contains gadolinium, a ‘ rare earth’ metal element. ||| Le principe actif de VASOVIST, le gadofosveset trisodique, contient du gadolinium, un « métal de terres rares » (lanthanide).
0.3794984817504883 ||| • When this treatment is finished, the infusion may go back to 0.25 mg/kg body weight, per hour. ||| After initiation of therapy, your doctor will maintain your haemoglobin level between 10 and 12 g/dL. ||| - Après l’ intervention, la perfusion sera ramenée à 0,25 mg/ kg/ h.
0.5495398640632629 ||| • Serious infections such as pneumonia (a chest infection) or infections of the skin. ||| These infections were due to bacteria, mycobacteria, fungi and viruses. ||| • infections graves telles qu’ une pneumonie (infection pulmonaire) ou des infections de la peau.
0.35675790905952454 ||| Liprolog KwikPen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin. ||| 6 Insulin lispro has been shown to be equipotent to human insulin on a molar basis but its effect is more rapid and of a shorter duration. ||| Après administration sous-cutanée, Liprolog KwikPen agit rapidement et possède une durée d'action (2 à 5 heures) plus courte que l'insuline rapide.
0.07737338542938232 ||| 11 ANNEX III ||| 9 ANNEX III ||| 11 ANNEXE III
0.038507767021656036 ||| Monoamine Oxidase Inhibitors (MAOIs): due to the risk of serotonin syndrome, DULOXETINE BOEHRINGER INGELHEIM should not be used in combination with nonselective irreversible monoamine oxidase inhibitors (MAOIs), or within at least 14 days of discontinuing treatment with an MAOI. ||| Monoamine oxidase inhibitors (MAOIs): due to the risk of serotonin syndrome, DULOXETINE BOEHRINGER INGELHEIM should not be used in combination with nonselective, irreversible monoamine oxidase inhibitors (MAOIs), or within at least 14 days of discontinuing treatment with an MAOI. ||| 54 Inhibiteurs de la monoamine oxydase (IMAO): en raison du risque de syndrome sérotoninergique, DULOXETINE BOEHRINGER INGELHEIM ne doit pas être associé avec des inhibiteurs de la monoamine oxydase (IMAO) non sélectifs irréversibles, ni prescrit dans les 14 jours suivant l'arrêt d’ un traitement par IMAO.
0.42136749625205994 ||| In addition to the European COVID-19 Data Platform launched today, the other actions focus on coordinating of funding, extending large EU-wide clinical trials, increasing support to innovative companies and supporting a pan-European Hackathon in the end of April to mobilise European innovators and the civil society. ||| In addition, the Commission also started a pledging marathon on 4 May, the Coronavirus Global Response , to lead global action for universal access to affordable coronavirus vaccination, treatment and testing, which was followed by the launch of a new campaign with the international advocacy organisation Global Citizen, "Global Goal: Unite For Our Future", culminating in a Global Pledging Summit on Saturday 27 June. ||| En plus de la plateforme européenne de données sur la COVID-19 lancée aujourd'hui, les autres actions portent plus particulièrement sur la coordination des financements, l'élargissement de grands essais cliniques à l'échelle de l'UE, l'augmentation de l'aide apportée aux entreprises innovantes et le soutien à un hackathon paneuropéen qui aura lieu à la fin du mois d'avril pour mobiliser les innovateurs européens et la société civile.
0.3799186050891876 ||| Parenteral drug products should be inspected visually for particulate matter and discoloration before administration. ||| Ventilatory support is mandatory for patients until adequate spontaneous respiration is restored following reversal of neuromuscular block. ||| Les substances médicamenteuses à usage parentéral doivent être visuellement vérifiées avant administration pour déceler la présence éventuelle de particules ou d'un changement de coloration.
0.1739300936460495 ||| - Rifampicin (used to treat bacterial infections) ||| - rifabutin (medicine against bacterial infections) ||| - de la rifampicine (utilisée pour traiter les infections bactériennes)
0.4272253215312958 ||| Statuettes of precious metal and their alloys ||| Trophies coated with precious metal alloys ||| Statuettes en métaux précieux et leur alliages
0.4994657337665558 ||| Normal images are characterised by two symmetrical crescent-shaped areas of equal intensity. ||| Abnormal images are either asymmetric or symmetric with unequal intensity and/ or loss of crescent. ||| Les images normales sont caractérisées par deux aires symétriques en forme de croissant d’égale intensité.
0.33786940574645996 ||| The study looked at the change in seizure rate between the start of the study and the 20-week period when the patients were taking their full dose. ||| The incidence of fever following co-administration of the two vaccines in the primary series was lower than that observed after the booster dose. ||| L’ étude portait sur l’ évolution de la fréquence des crises entre le début de l’ étude et la vingtième semaine de prise de la dose complète par les patients.
0.15990616381168365 ||| 36 B. ||| 13 B. ||| 42 B.
0.546453595161438 ||| Bone meal [fertilizer] ||| Smetana [sour cream] ||| Farine d'os [engrais]
0.5366870164871216 ||| Each pen contains 3 ml solution (300 Units) and they are available in packs of 1, 3, 4, 5, 6, 8, 9 and 10 pens. ||| Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges for OptiClik are available. ||| Disponible en boîtes de 1, 3, 4, 5, 6, 8, 9 et 10 stylos.
0.8528335094451904 ||| Frames for crochet ||| Pipette size to be ||| Cadres pour le crochet
0.1600731909275055 ||| For short term travelling, the solution can be kept out of the refrigerator at or below 25°C for a period up to seven days before use. ||| For short term travelling, the non-reconstituted product can be kept out of the refrigerator at or below 25°C for a period up to four weeks before use. ||| Pour des voyages de courte durée et avant utilisation, la solution peut être conservée en dehors du réfrigérateur à une température ne dépassant pas 25°C pendant une période ne dépassant pas 7 jours.
0.5245494842529297 ||| The following proposal has been sent to Member States for consultation of their views: ||| The Commission has swiftly approved requests received from all Member States. ||| La proposition suivante a été soumise aux États membres pour consultation:
3.818703708281801e-13 ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| é Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment
0.4066586494445801 ||| Presentation: ||| Distribution: ||| Conditionnement:
0.1094822809100151 ||| 22 Elderly No dosage adjustment is required based on age. ||| Elderly No dose adjustment is required based on age. ||| Sujets âgés Aucune adaptation posologique n'est nécessaire en fonction de l'âge.
0.36997368931770325 ||| Machine tools for removing waste material ||| Purification installations for waste material ||| Machines-outils pour l'évacuation des déchets
0.19801151752471924 ||| Dilute the total volume of the reconstituted Remicade solution dose to 250 ml with sodium chloride 9 mg/ ml (0.9%) solution for infusion. ||| The volume of Naglazyme is to be slowly added to the sodium chloride 9 mg/ ml (0.9%) solution for infusion. ||| Diluer le volume total de solution reconstituée de Remicade jusqu’ à 250 ml à l’ aide d’ une solution pour perfusion de chlorure de sodium à 9 mg/ ml (0,9%).
0.3914441764354706 ||| What are the consequences of the withdrawal for patients in clinical trials with Cerepro? ||| Points to consider on clinical investigation of medicinal products for the management of Crohn’s disease ||| Quelles sont les conséquences du retrait pour les patients participant à des essais cliniques portant sur Cerepro?
6.436114119955094e-13 ||| Always perform a safety test before using OptiSet. ||| Always perform a safety test before using OptiSet. ||| 328 Toujours réaliser un test de sécurité avant d’ utiliser OptiSet.
0.644116997718811 ||| Handrails of non-metallic materials for walkways ||| Mudguards for two-wheeled motor vehicles or bicycles ||| Mains courantes en matériaux non métalliques pour passages
0.4085381031036377 ||| Your baby ’ s doctor will decide how long your baby should be treated with INOmax. ||| Your child’ s doctor has prescribed this medicine to help treat your child’ s epilepsy. ||| Le médecin de votre enfant déterminera la durée du traitement par INOmax.
0.26626697182655334 ||| In controlled clinical trials, at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to placebo. ||| In a placebo-controlled study, cetirizine given at the high daily dose of 60 mg for seven days did not cause statistically significant prolongation of QT interval. ||| Lors des essais cliniques contrôlés à la dose recommandée de 5 mg par jour, il n’ y a pas eu d’ augmentation de l’ incidence de la somnolence par comparaison avec le placebo.
0.4626084864139557 ||| the product should be discontinued until the infection has cleared. ||| Treatment should not be restarted until the woman is completely mobilised. ||| REGRANEX, arrêter le traitement par REGRANEX jusqu'à ce que l'infection ait disparu.
0.2514324486255646 ||| For INTANZA no clinical data on exposed pregnancies are available. ||| For VELCADE no clinical data with regard to exposure during pregnancy are available. ||| Aucune donnée n'est disponible sur l'utilisation d'INTANZA chez la femme enceinte.
0.4414195120334625 ||| The CHMP normally takes up to 210 days to evaluate a new application. ||| The CPMP queried the safe use of the combination for more than 5 days. ||| Habituellement, l’ évaluation d’ une nouvelle demande par le CHMP nécessite 210 jours au plus.
0.018522407859563828 ||| electrolyte imbalance (including hypokalaemia and hyponatraemia, see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides ||| Electrolyte imbalance, including hypokalaemia and hyponatraemia (see section 4.4), hyperuricaemia, glycosuria, hyperglycaemia, increases in cholesterol and triglycerides ||| 50 glycosurie, hyperglycémie, augmentation du cholestérol et des triglycérides
0.45135021209716797 ||| IONSYS should be used with caution in patients with paralytic ileus. ||| Therapy with SINGULAIR in relation to other treatments for asthma. ||| IONSYS doit être utilisé avec précaution chez les patients présentant un iléus paralytique.
4.3620760215717924e-13 ||| MANUFACTURER’S BATCH NUMBER ||| MANUFACTURER’S BATCH NUMBER ||| NUMÉRO DU LOT DE FABRICATION
0.5068219304084778 ||| - A decrease of vitamin B12 absorption with decrease of serum levels has been observed in patients ||| - rises in the blood levels of liver enzymes (will show up in blood tests) ||| - Une diminution de l’ absorption de la vitamine B12 avec une réduction des taux sériques a été
0.38205718994140625 ||| Dextrins for industrial use ||| Scissors for household use ||| Dextrines à usage industriel
0.32262763381004333 ||| If darbepoetin alfa is given concomitantly with any of these drugs, blood levels of these drugs should be monitored and the dosage adjusted as the haemoglobin rises. ||| Difloxacin concentrations equal to or greater than the MICs for the relevant pathogens are achieved in all relevant tissues and maintained for as long as medication is continued. ||| Si la darbepoetin alfa est administrée en même temps que l’ un de ces produits, leurs taux 'e sanguins devront être surveillés et un ajustement de leur posologie devra être effectué en fonction de l’ augmentation du taux d’ hémoglobine. tn
9.124801608750843e-13 ||| Keep the vial in the outer carton. ||| Keep the vial in the outer carton. ||| Conserver le flacon dans sa boîte en carton.
0.42026254534721375 ||| This means that Oprymea is similar to a ‘ reference medicine’ already authorised in the European Union (EU) called Sifrol (also known as Mirapexin). ||| Rheumocam is a ‘ generic ’ which means that Rheumocam is similar to a ‘ reference veterinary medicine ’ already authorised in the EU (Metacam 1.5 mg/ ml oral suspension). ||| Cela signifie qu’ il est similaire à un « médicament de référence » déjà autorisé dans l’ Union européenne (UE), à savoir Sifrol (également connu sous la dénomination Mirapexin).
0.41476619243621826 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The Spanish "umbrella" scheme we approved today will support self-employed, SMEs and large companies affected by the coronavirus outbreak through a wide range of public support measures. ||| Maroš Šefčovič, Vice-President for Interinstitutional Relations and Foresight, said: "Simplification and burden reduction, especially for SMEs, is particularly needed in the aftermath of the COVID-19 pandemic. ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, a déclaré: «Le régime-cadre espagnol que nous avons autorisé aujourd'hui permettra d'aider les travailleurs indépendants, les PME et les grandes entreprises touchés par la flambée de coronavirus grâce à un large éventail de mesures publiques de soutien.
0.2875764071941376 ||| A pharmacodynamic interaction between clopidogrel and heparin is possible, leading to increased risk of bleeding. ||| The pharmacokinetic properties of doxazosin lead to a minor variation in plasma levels. ||| Une interaction pharmacodynamique entre le clopidogrel et l’héparine est possible, conduisant à une augmentation du risque de saignement.
0.2222597301006317 ||| If you have any further questions on the use of thismedicine, ask your doctor or pharmacist. ||| If you have any further questions on the use of (Invented name)®, ask your doctor or pharmacist. ||| Si vous avez d’ autres questions sur l’ utilisation de ce médicament, demandez plus d’ informations à votre médecin ou à votre pharmacien.
0.0 ||| common ||| common ||| rhinite
0.2725072503089905 ||| Velmetia must therefore not be used in women who are breast-feeding (see section 4.3). ||| The medicinal product must not be administered to breast feeding mothers (see section 4.3). ||| Velmetia ne doit donc pas être utilisé pendant l’ allaitement (voir rubrique 4.3).
0.25402623414993286 ||| How to store Comtan 6. ||| How to store Bondronat 6. ||| Comment conserver Comtan 6.
0.4786166548728943 ||| Electrical telegraph wires ||| Air conditioner hoses ||| Fils de télégraphes électriques
0.009838051162660122 ||| 16 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 15 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 17 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTERIEUR
0.6062588095664978 ||| Czech Republic: ||| Iceland Ireland: ||| République Tchèque:
0.3302443325519562 ||| *In pooled clinical trials, the incidence of headache was 30.3% with venlafaxine versus 31.3% with placebo. **Cases of suicidal ideation and suicidal behaviours have been reported during venlafaxine therapy or early after treatment discontinuation (see section 4.4). ||| 56 4 Cases of suicidal ideation and suicidal behaviours have been reported during duloxetine therapy or early after treatment discontinuation (see section 4.4) 5 Cases of aggression and anger have been reported particularly early in treatment of after treatment discontinuation. ||| 32 ** Des cas d’ idées suicidaires et de comportements suicidaires ont été rapportés pendant un traitement par la venlafaxine ou peu de temps après son arrêt (voir rubrique 4.4).
0.35843801498413086 ||| Metabolic enzyme inhibitors: co-administration of nelfinavir and a strong inhibitor of CYP3A, ketoconazole, resulted in a 35% increase in nelfinavir plasma AUC. ||| Olanzapine demonstrated a greater in vitro affinity for serotonin 5HT2 than dopamine D2 receptors and greater 5HT2 than D2 activity in vivo, models. ||| Inhibiteurs des enzymes métaboliques: l’administration conjointe de nelfinavir et d’un puissant inhibiteur du CYP3A, le kétoconazole, a entraîné une augmentation de 35% de l’aire sous la courbe du nelfinavir.
0.006959938444197178 ||| 65 The following side effects are very common (> 1/ 10) with METALYSE: ||| 59 The following side effects are very common (> 1/ 10) with METALYSE: ||| Les effets secondaires suivants peuvent survenir fréquemment (> 1/100, < 1/10) après l'administration de METALYSE:
0.7520544528961182 ||| Solvent for solution for injection. ||| Administer injection following instructions above. ||| Solvant pour solution à diluer injectable.
0.0 ||| Vascular disorders ||| Vascular disorders ||| Affections vasculaires Fréquent:
0.36090707778930664 ||| Furthermore, Denmark will ensure that the loan to the Fund will be fully dedicated to the reimbursement of cancelled package travel contracts due to the coronavirus outbreak. ||| In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission will finance part of the upfront costs faced by vaccines producers. ||| En outre, le Danemark veillera à ce que le prêt accordé au fonds soit entièrement consacré au remboursement des contrats de voyages à forfait annulés en raison de la pandémie de coronavirus.
0.4783352315425873 ||| This will not require any money from the national budgets and provide much needed liquidity to save lives, sustain companies and much more. ||| This will make it easier financially to get the medical equipment that doctors, nurses and patients desperately need. ||| Cette mesure ne mobilisera pas les budgets nationaux et fournira les liquidités fortement nécessaires pour sauver des vies, soutenir les entreprises et bien plus encore.
0.5641460418701172 ||| Ultrasonic diagnostic instruments for medical use ||| Specialisation courses for oncological doctors ||| Instruments de diagnostic à ultrasons à usage médical
0.36470648646354675 ||| This recurrence is usually more severe than on initial presentation, and may include life-threatening hypotension and death. ||| This condition is life-threatening and may have a fatal outcome. • increased skin sensitivity to sunlight or UV light. ||| Cette récidive est généralement plus sévère que l'épisode initial et peut entraîner une hypotension mettant en jeu le pronostic vital, voire le décès.
0.06868581473827362 ||| Unused solution should be discarded. ||| Any unused solution should be discarded. ||| Toute solution non utilisée doit être jetée.
0.07392314821481705 ||| ViraferonPeg 100 micrograms powder and solvent for solution for injection ||| PegIntron 100 micrograms powder and solvent for solution for injection ||| ViraferonPeg 100 microgrammes poudre et solvant pour solution injectable
0.21479864418506622 ||| Cutter bar knives [parts for machines] ||| Single point cutting tools [parts for machines] ||| Lames de barre de coupe [pièces de machines]
0.7270887494087219 ||| ut ra 3. ||| th au 13. ||| au 3.
0.3647536039352417 ||| Merck Sharp & Dohme (Italia) S. p. A. ||| Österreich Merck Sharp & Dohme G. m. b. H. ||| Merck Sharp & Dohme (Italia) S.p.A.
0.602149486541748 ||| Dose (IU/kg given 3x week) ||| Effective dose (Sv/ 1 GBq administered) ||| Dose (UI/ kg administrées 3x par semaine)
0.2927172780036926 ||| Obligations of health care professionals in relation to the prescribing of Volibris: o That patients should be capable of complying with the requirements for the safe use of Volibris. o The need to provide comprehensive advice and counselling to patients. o The need to provide patients with the appropriate information booklet(s) and patient reminder card. o Should consider monthly prescription of 30 day supply to ensure that patients and key test results are reviewed prior to further prescription. o That the safety database of Volibris is limited and physicians are encouraged to enrol patients in a post marketing surveillance study. o To report suspected adverse reactions and pregnancy. ||| The company that makes Zavesca will complete the following studies to address the product’ s effectiveness and safety in type 1 Gaucher disease:  a post-marketing plan to inform doctors on how to use Zavesca and to get patients to report information on the safety of the medicine;  a study to follow up patients already in clinical trials, to continue assessment of the medicine’ s safety and effectiveness and to find out more about the neurological aspects of the disease;  a study to look at the effectiveness and safety of Zavesca in patients who switch from ERT;  a further study of the natural history of the disease, together with the European Working Group for Gaucher Disease (EWGGD). ||| Obligations pour les professionnels de santé amenés à prescrire Volibris: o Les patients doivent être capables de suivre les conditions recommandées pour une utilisation sûre de Volibris. o La nécessité de fournir des informations et conseils compréhensibles par les patients. o La nécessité de fournir aux patients les livrets d’ informations appropriés et la carte aide mémoire destinée aux patients. o Une prescription de 30 jours devra être envisagée afin de s'assurer que les patients seront réexaminés et leurs principaux résultats d’ analyse contrôlés avant le renouvellement de la prescription. o Les données de pharmacovigilance du Volibris étant limitées, les médecins sont incités à inclure les patients dans une étude de surveillance post-commercialisation. o Les effets indésirables ainsi que les grossesses devront être rapportés.
0.6353819370269775 ||| Renal ||| Median ||| Rein
0.4179331064224243 ||| Shakers for spices ||| Fuels for lighters ||| Moulins à épices
0.2287125289440155 ||| In all clinical studies 38– 40% of patients were ≥ 60 years of age and 10– 12% of patients were ≥ 70 years of age. ||| The mean age of patients was 52.5 years, 13% were ≥ 65 years of age, and just 2% were ≥ 75 years of age. ||| Dans toutes les études cliniques, 38– 40% des patients avaient ≥ 60 ans et 10– 12% des patients avaient ≥ 70 ans.
0.0964343398809433 ||| Advisory services relating to product testing ||| Advisory services relating to planning applications ||| Services de conseils concernant les tests de produits
0.5525221824645996 ||| Electronic chips ||| Implant models ||| Puces électroniques
0.0 ||| - thrombocyte count ≥ 100 x 109/l ||| - thrombocyte count ≥ 100 x 109/l ||| 79 taux de plaquettes ≥ 100 x 109/ l,
0.6217434406280518 ||| Adoption placement ||| Adoption pending ||| Services d'adoption
0.3115677833557129 ||| For prevention of surgical site infections following surgery of the colon or rectum, the recommended dose of INVANZ is 1 g administered as a single intravenous dose 1 hour before surgery. ||| ed The safety and effectiveness of once every three weeks dosing of Nespo therapy in reducing the requirement for red blood cell transfusions in patients undergoing chemotherapy was assessed in a ||| 25 Pour la prévention des infections postopératoires en chirurgie du côlon ou du rectum, la dose recommandée d’ INVANZ est de 1 g en administration intraveineuse unique, dans l’ heure qui précède la chirurgie.
0.3061334788799286 ||| Similarly, there was no clinically significant pharmacokinetic interaction of Trazec with other oral antidiabetic agents such as metformin or glibenclamide. ||| For toremifene, flucloxacillin and fusidic acid displacement interactions could not be excluded (no clinically relevant capturing interactions are expected). ||| De même, on n’ a pas observé d’ interaction pharmacocinétique cliniquement significative entre Trazec et d'autres antidiabétiques oraux, tels que la metformine ou le glibenclamide.
0.37628939747810364 ||| Doxagamma 4 mg prolonged release tablets and associated names is unlikely to affect your blood pressure unless you suffer from hypertension. ||| Driving and using machines Doxastad 4 mg prolonged release tablets and associated names can cause drowsiness. ||| Il est peu probable que Doxagamma 4 mg, comprimé à libération prolongée et noms associés, affecte votre pression artérielle, sauf si vous souffrez d’ hypertension.
0.4001053273677826 ||| The clinical significance of these changes in clarithromycin plasma levels is not known. ||| However, the extent of labetalol bioavailability in terms of AUC did not change. ||| La signification clinique de ces variations de concentrations plasmatiques de clarithromycine n’ est pas connue.
0.27312877774238586 ||| Pandemic influenza vaccine (whole virion, inactivated, adjuvanted) ||| Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) ||| Daronrix, suspension injectable Vaccin grippal pandémique (virion entier, inactivé, avec adjuvant)
0.17852526903152466 ||| Patients who take ORENCIA are given a special alert card that explains this restriction, and instructs them to contact their doctor immediately if they develop an infection during a course of treatment with ORENCIA. ||| Patients who receive Soliris must be given a special card that explains the symptoms of certain types of infection, instructing them to seek medical care immediately if they experience them. ||| Les patients sous ORENCIA reçoivent une « carte d’ alerte médicale » leur expliquant cette contre-indication et leur indiquant de contacter immédiatement leur médecin en cas d’ apparition d’ une infection au cours du traitement par ORENCIA.
0.22897711396217346 ||| 1000 IU/ 0.5 ml ||| 180 IU/ ml ||| 1 000 UI / 0,5 ml
0.472369909286499 ||| The EU has done its utmost to use the tools at hand to protect lives whilst preserving the single market, and supporting Europe's economy. ||| This is the EU at its best: pooling resources, joining efforts, bringing tangible results to the everyday lives of people. ||| L'UE a fait tout ce qui est en son pouvoir pour protéger les vies tout en préservant le marché unique et en soutenant l'économie européenne.
0.29564517736434937 ||| TESAVEL has not been studied in patients with severe hepatic insufficiency. ||| NovoSeven has been studied in patients with haemophilia and in patients with factor VII deficiency. ||| TESAVEL n'a pas été étudié chez les patients ayant une insuffisance hépatique sévère.
0.4526929259300232 ||| Different dose recommendations have been approved by Member States with regards the starting dose, daily dose, dosing in the elderly and dosing during moderate renal and hepatic impairment. ||| The combination is indicated for the treatment of hypertension in all Member States where licensed, although it is noted that terms including essential hypertension, arterial hypertension and arterial essential hypertension are used. ||| Différentes recommandations posologiques ont été approuvées par les États membres en ce qui concerne la dose initiale, la dose journalière, l’ ajustement de la posologie chez les personnes âgées et les doses en cas d'insuffisance rénale et hépatique modérée.
0.28085607290267944 ||| If you take more TESAVEL than you should If you take more than the prescribed dosage of TESAVEL, contact your doctor immediately. ||| If you take more Revlimid than you should If you take more Revlimid than was prescribed, tell your doctor immediately. ||| 56 Si vous avez pris plus de TESAVEL que vous n’auriez dû Si vous avez pris une dose de TESAVEL plus forte que la dose prescrite, contactez immédiatement votre médecin.
0.0 ||| Tachycardia ||| Tachycardia ||| - Tachycardie
0.40965360403060913 ||| Poulvac FluFend H5N3 RG is a vaccine used in chickens and ducks to protect against avian influenza. ||| 7 Antiviral activity Cidofovir is active in vitro against HCMV, a member of the herpesviridae family. ||| Poulvac FluFend H5N3 RG est un vaccin utilisé chez la poule et le canard pour les protéger contre l'influenza aviaire.
0.22499534487724304 ||| 47 In case of severe vomiting associated with rivastigmine treatment, appropriate dose adjustments as recommended in section 4.2 must be made. ||| Reduction of pregabalin dose may be required in patients who have age related compromised renal function (see section 4.2 Table 1). ||| En cas de vomissements sévères associés à un traitement par la rivastigmine, les doses doivent être ajustées de manière appropriée, comme recommandé en rubrique 4.2.
0.3015627861022949 ||| Pipetting instruments for surgical use ||| Insulating vessels for laboratory use ||| Instruments de pipetage à usage chirurgical
0.00805421732366085 ||| 236 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 346 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 241 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2796595096588135 ||| How does Forcaltonin work? ||| How does Aldurazyme work? ||| Comment Forcaltonin fonctionne -t-il?
0.5443683862686157 ||| or Common: ||| common Common: ||| Fréquents:
0.3063815236091614 ||| The Commission is continuing to build on the experience gained by the European Cooperation Network on Elections and is facilitating the exchange of best practices on specific issues, such as adapting to the coronavirus pandemic or micro-targeting. ||| With the need to meet the Agency’ s obligations to provide more transparent veterinary pharmacovigilance reporting and communication to the outside world, as explicitly stated in the new Regulation, a considerable increase in data analysis with EudraVigilance and subsequent reporting is expected. ||| La Commission continue de s'appuyer sur l'expérience acquise par le Réseau européen de coopération en matière d'élections et facilite l'échange de bonnes pratiques sur des questions spécifiques, telles que l'adaptation à la pandémie de coronavirus ou le microciblage.
0.2996993064880371 ||| The most common adverse reactions in controlled adjunctive-therapy studies were somnolence, dizziness and anorexia. ||| Occasionally noted effects were diarrhoea, discolouration of the skin, cardiac arrhythmias and very rarely nystagmus. ||| 17 Les effets indésirables les plus fréquents observés dans les essais contrôlés du Zonegran administré en association ont été somnolence, vertiges et anorexie.
0.6274943351745605 ||| Protaphane contains the active substance insulin human (rDNA). ||| All foods contain a substance called 13Carbon (1% 13C). ||| Le principe actif de Protaphane est l’ insuline humaine (ADNr).
0.13535034656524658 ||| Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate. ||| Tablet core Croscarmellose sodium Microcrystalline cellulose Sodium laurilsulfate Hydroxypropylcellulose Lactose monohydrate Magnesium stearate ||| Lactose monohydraté Cellulose microcristalline Croscarmellose sodique Hypromellose Dioxyde de silicone Stéarate de magnésium.
0.4380719065666199 ||| Alternatively the flushing may be performed by infusion. ||| The injection should be performed with steady, continuous pressure. ||| Ce rinçage peut également être effectué au moyen d'une perfusion.
0.22341376543045044 ||| Speak with your doctor before you stop taking Truvada for any reason, particularly if you are experiencing any side effects or you have another illness. ||| If you have stopped taking Trizivir for any reason, particularly because you think you are having side effects or for other illness, it is important that you contact your doctor before restarting. ||| Contactez votre médecin avant d’arrêter de prendre Truvada pour quelque raison que ce soit, en particulier si vous souffrez d’effets indésirables ou d’une autre maladie.
0.21029424667358398 ||| 40/ 44 ||| 33/ 44 ||| 41/ 46
0.6800097227096558 ||| Transdermal Use ||| Sublingual Tablet ||| Voie transdermique
0.45420578122138977 ||| No special requirements ||| No special requirements. ||| Pas d'exigences particulières
0.38261938095092773 ||| Since amlodipine is slowly absorbed, gastric lavage can be useful in some cases. ||| Mineral oil may be used between Panretin gel applications in order to help prevent excessive dryness or itching. ||| L’ amlodipine étant absorbée lentement, un lavage gastrique peut être utile dans certains cas.
0.7059476375579834 ||| Dispose of in accordance with local regulations ||| Prolongation of the existing State aid rules ||| Elimination conformément à la réglementation en vigueur.
0.2819060683250427 ||| Production of the primary metabolite, ucb L057, is not supported by liver cytochrome P450 isoforms. ||| During celecoxib treatment, the mean plasma concentrations of the CYP2D6 substrate dextromethorphan were increased by 136%. ||| La production du métabolite principal, l'ucb L057, est indépendante des isoformes du cytochrome P450
0.351309597492218 ||| No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. ||| Incompatibilities No safety or efficacy information is available on the compatibility of this vaccine with any other vaccine. ||| Aucune information n’ est disponible concernant l’ innocuité et l’ efficacité de ce vaccin en cas d’ utilisation concomitante avec tout autre médicament vétérinaire.
0.5545880794525146 ||| The optimum regimen for safe administration of gemcitabine with therapeutic doses of radiation has not yet been determined in all tumour types. ||| Various fairly standardized abbreviations for vaccine names have developed, although the standardization is by no means centralized or global. ||| Le schéma optimal pour une administration sécurisée de la gemcitabine avec la radiothérapie à doses thérapeutiques n'a pas encore été déterminé dans tous les types de tumeurs.
0.37714895606040955 ||| Table 2. ||| Table 8. ||| 6 Table 2.
0.239698588848114 ||| - reduction in red blood cells (anaemia) ||| - reduction in white blood cells (granulocytopenia) ||| - diminution du nombre de globules rouges (anémie)
0.19676676392555237 ||| Dosage adjustment is necessary in patients with severe renal impairment and in patients that require haemodialysis (see section 4.2). ||| 42 Dosage adjustment in patients with reduced renal function or undergoing haemodialysis is necessary (see Section 4.2 Table 1). ||| Un ajustement posologique est nécessaire chez les patients présentant une insuffisance rénale sévère et chez les patients nécessitant une hémodialyse (voir rubrique 4.2).
0.06668514013290405 ||| What benefit has Janumet shown during the studies? ||| What benefit has Beromun shown during the studies? ||| Quel est le bénéfice démontré par Janumet au cours des études?
0.25882506370544434 ||| For patients requiring dental procedures, there are no data available to suggest whether discontinuation of bisphosphonate treatment reduces the risk of osteonecrosis of the jaw. ||| Care should be taken when transferring patients to Viani therapy, particularly if there is any reason to suppose that adrenal function is impaired from previous systemic steroid therapy. ||| Chez les patients nécessitant une intervention dentaire, aucune donnée ne permet de suggérer que l’ arrêt du traitement par bisphosphonates réduit le risque d’ ostéonécrose de la mâchoire.
0.0 ||| 6. ||| 6. ||| 15 6.
0.2173345983028412 ||| ► Keep out of the reach and sight of children. ||| • Keep your pen out of the reach and sight of children. ||| 25 ► Tenir hors de la portée et de la vue des enfants.
0.0 ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. ||| Si vous constatez des effets graves ou d’ autres effets non mentionnés dans cette notice, veuillez en informer votre vétérinaire.
0.11609146744012833 ||| Humalog may cause hypoglycaemia (low blood glucose). ||| Actrapid may cause hypoglycaemia (low blood sugar). ||| Humalog peut induire une hypoglycémie (faible glycémie).
0.33581510186195374 ||| In vitro studies have shown that degarelix is not a substrate for the human CYP450 system. ||| In vitro experiments have shown that tolcapone binds mainly to serum albumin. ||| Les études in vitro ont montré que dégarélix n’ est pas un substrat pour le CYP450 humain.
0.18327635526657104 ||| Always take Fuzeon exactly as your doctor has instructed you. ||| Always take LYRICA exactly as your doctor has instructed you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3120458722114563 ||| Take one 10 mg tablet once a day (white to off-white, centrally tapered oblong, biconvex, with a single breakline on both sides) for 7 days. ||| The patient should take one 5 mg film-coated tablet per day (white to off-white, oval-oblong) for 7 days. ||| Prendre un comprimé pelliculé de 10 mg une fois par jour (comprimé blanc à blanc cassé, de forme oblongue conique selon l’ axe central, biconvexe, avec une ligne de section unique sur les deux faces), pendant 7 jours.
0.5547850131988525 ||| Lactation did not influence duloxetine pharmacokinetics. ||| Telithromycin displays moderate non-linear pharmacokinetics. ||| L’ allaitement n’ a pas influencé pas la pharmacocinétique de la duloxétine.
0.39049333333969116 ||| Advisory services relating to surfacing projects ||| Training services relating to submarine diving ||| Services de conseils liés à des projets de revêtement
0.340872198343277 ||| Patients should remain at rest for 20 minutes after injection of Ceplene. ||| The scanning may take place 2-4 hours after injection of NeoSpect. ||| Les patients doivent rester au repos pendant 20 minutes après l’ injection de Ceplene.
0.20898427069187164 ||| 2.3 ||| 2.2 ||| 2.3.
0.46098941564559937 ||| HOW TO TAKE CARE OF YOUR INSULIN od ||| HOW TO TAKE YOUR DOSE pr ||| COMMENT ENTRETENIR VOTRE INHALATEUR D’INSULINE am
0.2734539210796356 ||| Irbesartan is an ‘ angiotensin II receptor antagonist’, which means that it blocks the action of a hormone in the body called angiotensin II. ||| Angiotensin I is converted into the hormone angiotensin II, which is a powerful vasoconstrictor (it narrows blood vessels). ||| L'irbésartan, est un « antagoniste des récepteurs de l'angiotensine-II », ce qui signifie qu'il bloque l'action d'une hormone dans l'organisme appelée angiotensine-II.
0.03206496685743332 ||| The adverse events are listed by system organ class and frequency using the following convention: very common (≥ 1/ 10), common (≥ 1/ 100 to < 1/ 10), uncommon (≥ 1/ 1,000 to < 1/ 100), rare (≥ 1/ 10,000 to < 1/ 1,000), very rare (< 1/ 10,000), not known (cannot be estimated from the available data). ||| Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥ 1/ 10); common (≥ 1/ 100 to < 1/ 10); uncommon (≥ 1/ 1,000 to < 1/ 100); rare (≥ 1/ 10,000 to < 1/ 1,000); very rare (< 1/ 10,000), not known (cannot be estimated from the available data). ||| (très fréquents (≥ 1/ 10), fréquents (≥ 1/ 100, < 1/ 10), peu fréquents (≥ 1/ 1 000, < 1/ 100), rares (≥ 1/ 10 000, < 1/ 1 000) et très rares (< 1/ 10 000), fréquence indéterminée (ne peut être estimée sur la base des données disponibles).
0.3506038784980774 ||| 135 Infections of the bones and joints Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation. ||| The assessment of the bathing water quality under the Bathing Water Directive makes use of the values of two microbiological parameters: Intestinal enterococci and Escherichia coli. ||| Infections ostéoarticulaires La ciprofloxacine doit être utilisée en association avec un autre antibiotique en fonction des résultats microbiologiques.
0.046803154051303864 ||| It must not be used by patients who have severe liver problems. ||| It should not be used in patients who have severe liver problems. ||| Il ne doit pas être administré aux patients atteints de graves troubles du foie.
0.34682124853134155 ||| r development of lymphomas or other malignancies in patients treated with a TNF-antagonist cannot be ||| surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced malignancies involving bone. ||| Il n'existe pas d'études chez des patients avec antécédents de tumeurs malignes ou chez des patients qui continuent leur traitement alors qu'ils développent une tumeur maligne sous Trudexa.
0.42911794781684875 ||| Dressers [furniture] ||| Gabardines [clothing] ||| Commodes [meubles]
0.39645999670028687 ||| Circovac Emulsion and suspension for emulsion for injection for pigs ||| Vial B Emulsion for emulsion for injection for Pandemrix ||| Circovac Emulsion et suspension pour émulsion injectable pour porcins.
0.4657222032546997 ||| When a pregnancy is planned or confirmed the switch to an alternative treatment should be initiated as soon as possible. ||| It is unclear whether it is possible to be reinfected with the virus after recovering from it the first time around. ||| Lorsqu’ une grossesse est prévue ou confirmée, un traitement de relais doit être instauré dès que possible.
0.6030293703079224 ||| Present ation a) Form b) Dose c) Number of Presentations ||| Commission a) Sent to Commission b) Date of regulation c) Official Journal ||| Présent ation a) Forme b) Dosage c) Nombre de Présentations
0.41763317584991455 ||| Instruments for monitoring traffic ||| Services for monitoring industrial processes ||| Instruments de surveillance du trafic
0.2411956787109375 ||| Therefore, the CHMP considered that the benefit risk for the indication Reduction in risk of cardiovascular morbidity and mortality (or risk of stroke_) in hypertensive patients with left ventricular hypertrophy is negative and this indication is not acceptable for the FDC. ||| very high Left Ventricular Hypertrophy The CHMP concluded that the indication for the initial therapy of hypertension with the fixed dose combination (FDC) does not have a positive benefit-risk ratio, and therefore is not acceptable. ||| Par conséquent, le CHMP a considéré que le rapport bénéfice/ risque pour l’ indication Réduction du risque de mortalité et de morbidité cardiovasculaires (ou du risque d’ accident cardiovasculaire) chez les patients hypertendus présentant une hypertrophie ventriculaire gauche est négatif et que cette indication n’ est pas acceptable pour les associations à doses fixes.
0.17189030349254608 ||| 14 Patients with renal impairment TRITAZIDE is contraindicated in severe renal impairment due to the hydrochlorothiazide component (creatinine clearance < 30 ml/ min) (see section 4.3). ||| Renal impairment: due to the hydrochlorothiazide component, Karvezide is not recommended for patients with severe renal dysfunction (creatinine clearance < 30 ml/ min). ||| 12 Patients ayant une insuffisance rénale TRITAZIDE est contre-indiqué en cas d’ insuffisance rénale sévère, en raison de son composant hydrochlorothiazide (clairance de la créatinine < 30 ml / min) (voir rubrique 4.3).
0.13738657534122467 ||| 6.6 Instructions for use, handling and disposal ||| 21 Instructions for use, handling and disposal ||| 6.6 Précautions particulières d’ élimination et manipulation
0.23419664800167084 ||| In postmarketing experience, fatal cardiac arrhythmias have been reported with the use of venlafaxine, especially in overdose. ||| In the postmarketing experience, there are reports of respiratory failure and coma in patients taking pregabalin and other CNS depressant medications. ||| Dans l’ expérience acquise depuis la commercialisation, des cas d’ arythmie cardiaque fatale ont été rapportés avec la venlafaxine, en particulier lors de surdosage.
0.3001546263694763 ||| The product contains the inactivated whole cells of Ornithobacterium rhinotracheale serotype A, strain B3263/ 91 mixed with an oil adjuvant. ||| Masivet is for the treatment of dogs with non-resectable mast cell tumours (Grade 2 or 3) with a confirmed mutated c-kit tyrosine kinase receptor. ||| Le produit contient la suspension de cellules entières inactivées de Ornithobacterium rhinotracheale de souche B3263/ 91 sérotype A, mélangée avec un adjuvant huileux.
0.4041494131088257 ||| Inhibitors have been observed in previously treated patients receiving factor VIII products, including ReFacto AF. ||| In addition, Aerius orodispersible tablets were well tolerated in a multiple dose trial. ||| Des inhibiteurs ont été observés chez les patients préalablement traités recevant des facteurs VIII, incluant ReFacto AF.
0.02222224697470665 ||| Therefore you should use Cetrotide 3 mg in repeated cycles only after a careful risk/ benefit evaluation by your doctor. ||| Therefore you should use Cetrotide 0.25 mg in repeated cycles only after a careful risk/ benefit evaluation by your doctor. ||| Par conséquent, vous ne devez utiliser Cetrotide 3 mg sur plusieurs cycles qu'après une évaluation attentive du rapport bénéfice/ risque par votre médecin.
0.5261411666870117 ||| On research and development, we will reinforce the European initiative to fund targeted research on the Coronavirus. ||| While we focus all our efforts on the post-COVID economic recovery, this calls for new impetus to enforcement. ||| En ce qui concerne la recherche et le développement, nous allons renforcer l'Initiative européenne afin de financer des recherches ciblées sur le coronavirus.
3.4842576957308524e-13 ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in the body. ||| A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and bind to a specific structure (called an antigen) that is found in the body. ||| Un anticorps monoclonal est un anticorps (un type de protéine) qui a été conçu pour reconnaître une structure spécifique présente dans l’ organisme (appelée antigène) et s’ y fixer.
0.39796608686447144 ||| Patients experiencing these side effects should not drive or use machines. ||| Ambulatory patients should be warned not to drive or use machines. ||| Les patients ressentant de tels effets indésirables ne devraient pas conduire ou utiliser des machines.
0.19766965508460999 ||| Cozaar is used • to treat patients with high blood pressure (hypertension) • to protect the kidney in hypertensive type 2 diabetic patients with laboratory evidence of impaired renal function and proteinuria ≥ 0.5 g per day (a condition in which urine contains an abnormal amount of protein). • to treat patients with chronic heart failure when therapy with specific medicines called angiotensin-converting-enzyme inhibitors (ACE inhibitors, medicine used to lower high blood pressure) is not considered suitable by your doctor. ||| Take special care with NeoRecormon: • if your anaemia does not improve with epoetin treatment • if you are low in certain B vitamins (folic acid or vitamin B12) • if you have very high levels of aluminium in your blood • if your blood platelet count is high • if you have chronic liver disease • if you have epilepsy • if you have developed anti-erythropoietin antibodies and pure red cell aplasia (reduced or stopped production of red blood cells) during prior exposure to any erythropoietic substance. ||| • pour traiter les patients ayant une pression artérielle élevée (hypertension), • pour préserver la fonction rénale des patients hypertendus diabétiques de type 2 insuffisants rénaux présentant une protéinurie ≥ 0,5g/ jour (présence d'une quantité anormale de protéines dans les urines) confirmée par des examens biologiques, • pour traiter les patients insuffisants cardiaques lorsque le médecin juge qu'un traitement par les inhibiteurs de l'enzyme de conversion de l'angiotensine (IEC, médicament antihypertenseurs) ne convient pas.
0.6005460023880005 ||| 10 bottles 56 x 1 tablets ||| Label bottle 10 and 30 ml ||| 56 x 1 tablets
0.38865533471107483 ||| These studies also established that seroconversion in response to vaccination against measles, mumps, and rubella paralleled protection from these diseases. ||| The twentieth century saw the introduction of several successful vaccines, including those against diphtheria, measles, mumps, and rubella. ||| Ces études ont également établi que la séroconversion induite par la vaccination contre la rougeole, les oreillons et la rubéole correspondait à la protection conférée contre ces maladies.
0.39746034145355225 ||| Elderly patients have slightly higher exposure than young patients. ||| Most older patients require the same dose as younger patients. ||| Les patients âgés ont une exposition légèrement supérieure à celle des patients jeunes.
0.12480578571557999 ||| - if you have a loss of liver function. ||| - if you have a loss of kidney function. ||| - Si vous avez une insuffisance hépatique.
0.03763371706008911 ||| Like all medicines, Starlix can cause side effects, although not everybody gets them. ||| Like all medicines, Zonegran can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Starlix est susceptible d’ avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.3086310625076294 ||| In all of the studies, the main measure of effectiveness was the number of patients who had undetectable levels of HIV-1 in their blood (viral loads) after 24 or 48 weeks of treatment. ||| Pharmacodynamic analysis demonstrated that this was a temporary effect; recovery of normal B-cells began within 6 months and median counts of B-cells were within normal range within 9 months after treatment. ||| Dans l’ ensemble des études, le principal critère d’ évaluation de l’ efficacité était le nombre de patients présentant des taux de VIH-1 dans le sang (charge virale) indétectables après 24 à 48 semaines de traitement.
0.018835339695215225 ||| WHAT BENEFIX IS AND WHAT IT IS USED FOR ||| WHAT IS BENEFIX AND WHAT IT IS USED FOR ||| QU’EST-CE QUE BENEFIX ET DANS QUEL CAS EST-IL UTILISE
0.32831907272338867 ||| The mean (%CV) tenofovir exposure increased from 2,185 ng• h/ ml (12%) in patients with normal renal function, to 3,064 ng• h/ ml (30%), 6,009 ng• h/ ml (42%) and 15,985 ng• h/ ml (45%) in patients with mild, moderate and severe renal impairment, respectively. ||| The immunogenicity of Gardasil was assessed in 8,915 (Gardasil n = 4,666; placebo n = 4,249) women 18 to 26 years of age and 3,400 female (Gardasil n = 1,471; placebo n = 583) and male (Gardasil n = 1,071; placebo n = 275) adolescents 9 to 17 years of age. ||| L’ exposition moyenne au ténofovir (% CV) a augmenté de 2 185 ng• h/ ml (12%) chez les patients ayant une fonction rénale normale à 3 064 ng• h/ ml (30%), 6 009 ng• h/ ml (42%) et 15 985 ng• h/ ml (45%) chez les patients présentant respectivement une insuffisance rénale légère, modérée et sévère.
0.2952645719051361 ||| The most common side effects (seen in more than 1 patient in 10) are conjunctival hyperaemia (increased blood supply to the eye, leading to redness of the eye) and growth of eyelashes. ||| The wheezing observed in the younger age group could be attributed to a number of diagnoses (viral infection, RSV bronchiolitis, or early symptoms of classic asthma). ||| Les effets indésirables les plus courants (observés chez plus d’ 1 patient sur 10) sont une hyperémie conjonctivale (augmentation de l’ irrigation sanguine de l’œ il entraînant une rougeur de l’œ il) et une pousse des cils.
0.4995036721229553 ||| Medical portable epilators ||| Electronic pocket translators ||| Épilateurs médicaux portables
0.38441646099090576 ||| Electrophysiology electrodes ||| Electrophysiology diagnostic catheters ||| Électrodes électrophysiologiques
0.6714332699775696 ||| Unit Sector for inspections Sector for document management and publishing Sector for conference services ||| Administration Unit ⋅ Sector for Personnel and support services ⋅ Sector for Accounting ||| d’unité du secteur Inspections du secteur Gestion et édition des documents du secteur Services de conférence
0.4690297842025757 ||| Pharmaceutical preparations for treating gastrointestinal disorders ||| Replacement therapy in primary immunodeficiency syndromes ||| Produits pharmaceutiques pour le traitement des troubles gastro-intestinaux
2.6354146729495875e-13 ||| Children 3 years of age and older and adolescents - 3 million IU/m2 3 times a week (every other day) injected subcutaneously (under the skin) in combination with ribavirin (Please also see ribavirin package leaflet). ||| Children 3 years of age and older and adolescents - 3 million IU/m2 3 times a week (every other day) injected subcutaneously (under the skin) in combination with ribavirin (Please also see ribavirin package leaflet). ||| Enfants âgés de 3 ans et plus et adolescents - 3 millions d’ UI/ m² 3 fois par semaine (un jour sur deux) injectés par voie sous-cutanée (sous la peau) en association avec la ribavirine (voir également la notice de la ribavirine).
0.29855653643608093 ||| Novo Nordisk A/ S Novo Allé, DK-2880 Bagsværd, Denmark ||| Marketing Authorisation Holder Novo Nordisk A/ S, Novo Allé, DK-2880 Bagsværd, Denmark ||| Novo Nordisk A/ S Novo Allé, DK 2880 Bagsvaerd, Danemark
0.40873369574546814 ||| Pharmacokinetic properties ||| Pharmacokinetic Parameter ||| 5.2 Propriétés pharmacocinétiques
0.2082708477973938 ||| The Committee decided that Carbaglu’ s benefits are greater than its risks for the treatment of hyperammonaemia due to NAGS deficiency. ||| Therefore, the CHMP decided that Valdoxan’ s benefits are greater than its risks for the treatment of major depressive episodes in adults. ||| Le comité a établi que les bénéfices de Carbaglu sont supérieurs aux risques qu’ il peut induire en ce qui concerne le traitement de l’ hyperammoniémie résultant d’ un déficit en NAGS.
0.219705730676651 ||| In a co-therapy study of patients treated with lithium or valproate for a minimum of 2 weeks, the addition of olanzapine 10 mg (co-therapy with lithium or valproate) resulted in a greater reduction in symptoms of mania than lithium or valproate monotherapy after 6 weeks. ||| In the treatment of NSCLC and the first-line treatment of ovarian cancer, the administration of paclitaxel as a 3 hour infusion in combination with cisplatin resulted in a greater incidence of severe neurotoxicity than both single-agent paclitaxel and cyclophosphamide followed by cisplatin. ||| 109 lithium ou le valproate depuis au moins deux semaines, l'introduction de 10 mg d'olanzapine (en association avec le lithium ou le valproate), a entraîné après 6 semaines, une réduction des symptômes maniaques supérieure à celle observée chez les patients traités par le lithium ou le valproate en monothérapie.
0.38705509901046753 ||| This fund would support the financial efforts undertaken by the healthcare sectors in all member states during the current crisis, as well as future investments in order to make healthcare systems more resilient and focused on those most in need. ||| State aid rules enable Member States to take swift and effective action to support citizens and companies, in particular SMEs, facing economic difficulties due to the coronavirus outbreak. ||| Ce fonds soutiendrait les efforts financiers consentis par les secteurs de la santé dans tous les États membres au cours de la crise actuelle ainsi que les investissements en matière de santé qui seront réalisés après la crise pour améliorer la résilience des systèmes de santé, tout en se concentrant sur les besoins les plus pressants.
0.3811836242675781 ||| The peak plasma concentration of perindoprilat is achieved within 3 to 4 hours. ||| After an oral dose of metformin, tmax is reached in 2.5 h. ||| Le pic de concentration plasmatique du périndoprilate est atteint en 3 à 4 heures.
0.23710325360298157 ||| 20 Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC, Cmax and t½ (1.6-fold, 1.4-fold and 1.2-fold respectively) with no statistically significant effects on the blood glucose levels. ||| Lopinavir / ritonavir (Kaletra): in an open-label, non-fasting pharmacokinetic study, the AUC, Cmax and Cmin of lopinavir were decreased by 38%, 28% and 52% respectively when amprenavir (750 mg twice daily) was given in combination with Kaletra (400 mg lopinavir + 100 mg ritonavir twice daily). ||| L’ administration concomitante de triméthoprime (160 mg deux fois par jour), un inhibiteur modéré du CYP2C8, et de répaglinide (dose unique de 0,25 mg) a entraîné une augmentation de l’ ASC, de la Cmax et du t1/ 2 du répaglinide (respectivement de 1,6 fois, 1,4 fois et 1,2 fois) sans effets statistiquement significatifs sur la glycémie.
0.42627644538879395 ||| Any patient developing significant liver function abnormalities during treatment must be monitored closely. ||| Pain intensity score improved during treatment in both groups indicating adequate pain management. ||| Tout patient développant des anomalies significatives de la fonction hépatique au cours du traitement doit être étroitement suivi.
0.0 ||| 6.3 Shelf life ||| 6.3 Shelf life ||| 152 6.3 Durée de conservation
0.0050830175168812275 ||| Selective COX-2 inhibitors reduce the formation of systemic (and therefore possibly endothelial) prostacyclin without affecting platelet thromboxane. ||| COX-2 selective inhibitors reduce the formation of systemic (and therefore possibly endothelial) prostacyclin without affecting platelet thromboxane. ||| Les inhibiteurs de la COX-2 réduisent la formation de prostacycline systémique (et par conséquent possiblement endothéliale) sans altérer le thromboxane plaquettaire.
0.037105411291122437 ||| Like all medicines, Cystadane can cause side effects, although not everybody gets them. ||| Like all medicines, Focetria can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Cystadane est susceptible d'avoir des effets indésirables, bien que tous n’y soient pas sujets.
0.39982885122299194 ||| Therefore, mixing of rapid acting insulin with Levemir should be avoided. ||| This effect may be enhanced if Advagraf is administered in association with alcohol. ||| Par conséquent, le mélange d’une insuline d’action rapide avec Levemir doit être évité.
0.17760220170021057 ||| The most commonly reported were tiredness, respiratory tract infections, throat discomfort, headache, stomach discomfort and pain, nausea, vomiting and diarrhoea. ||| The most commonly reported side effects are visual disturbances, fever, rash, nausea, vomiting, diarrhoea, headache, and swelling of the extremities. ||| Les réactions les plus fréquemment mentionnées ont été les suivantes: fatigue, infections des voies respiratoires, gêne au niveau de la gorge, maux de tête, douleur d’ estomac ou gêne gastrique, nausées, vomissements et diarrhée.
0.2767670750617981 ||| NutropinAq treatment should be started and supervised by a doctor experienced in the management of patients with growth disorders. ||| Radiolabelled LeukoScan treatment should only be handled and given by someone who is authorised to use radioactive medicines. ||| Le traitement par NutropinAq doit être instauré et supervisé par un médecin expérimenté dans la prise en charge de patients présentant des troubles de croissance.
0.9114504456520081 ||| Self-propelled loading vehicles ||| Dispersible/ Chewable Tablet ||| Véhicules de chargement automoteurs
0.14393508434295654 ||| Dibasic calcium phosphate, anhydrous Micro crystalline cellulose Colloidal silica, anhydrous Magnesium stearate Croscarmellose sodium ||| Maize starch Lactose Povidone Sodium starch glycolate Magnesium stearate Cellulose, microcrystalline Silica, colloidal anhydrous. ||| Hydrogénophosphate de calcium anhydre Cellulose microcristalline Silice colloïdale anhydre Stéarate de magnésium Croscarmellose sodique
0.6296933889389038 ||| All commercial cruises have been suspended until further notice. ||| These discussions are continuing but may be delayed. ||| Toutes les croisières commerciales ont été suspendues jusqu'à nouvel ordre.
0.2892611622810364 ||| Waterproof coatings [paints] ||| Textured coatings [paints] ||| Enduits imperméables [peintures]
0.1463792473077774 ||| Any material dislodged from the fusion site can cause ectopic ossification in the surrounding tissues with potential complications. ||| Any material dislodged from the non-union site can cause bone formation (ectopic ossification) in the surrounding tissues with potential complications. ||| Tout élément délogé du site de l’arthrodèse peut entraîner une ossification ectopique dans les tissus environnants avec des complications potentielles.
0.33459365367889404 ||| This Chapter sets out the activities of the Management Board and the Agency’ s partnership with national competent authorities. ||| This agreement reflects in a detailed manner the contributions of national competent authorities and the EMEA Secretariat to the functioning of the Agency. ||| Le présent chapitre décrit les activités du Conseil d’ administration et le partenariat de l’ Agence avec les autorités nationales compétentes.
0.39152055978775024 ||| Each dose (2 ml) of Porcilis Porcoli vaccine contains at least 100 SR803 each of the following components: the Escherichia coli LT toxoid and the Escherichia coli adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) and F6 (987P) in 941.4 mg liquid paraffin as adjuvant. ||| In preclinical studies, olanzapine exhibited a range of receptor affinities (Ki; < 100 nM) for serotonin 5 HT2A/ 2C, 5 HT3, 5 HT6; dopamine D1, D2, D3, D4, D5; cholinergic muscarinic receptors m1-m5; α 1 adrenergic; and histamine H1 receptors. ||| Chaque dose de 2 ml de vaccin Porcilis Porcoli contient au moins 100 SR801 de chacun des composants suivants: l’ anatoxine LT d’ Escherichia coli et les adhésines d’ E. coli F4ab (K88ab), F4ac (K88ac), F5 (K99) et F6 (987P) dans 941.4 mg de paraffine liquide en tant qu’ adjuvant.
3.533681051763604e-13 ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| Reversible effects consistent with elevated prolactin in rats included decreased weights of ovaries and uterus and morphologic changes in vaginal epithelium and in mammary gland. ||| 29 prolactinémie chez la rate comprenaient une diminution du poids des ovaires et de l’ utérus, des modifications morphologiques de l’ épithélium vaginal et de la glande mammaire.
0.16091538965702057 ||| Rebetol 200 mg hard capsules ||| Prometax 1.5 mg hard capsules ||| Rebetol 200 mg gélules
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Si votre médecin vous a dit que vous aviez une intolérance à certains sucres, contactez -le avant de prendre ce médicament.
0.4309905469417572 ||| In this study, abacavir increased the mean methadone systemic clearance by 22%. ||| Fondaparinux provided a significant reduction in the overall rate of VTE compared with placebo [3 ro ||| Dans cette étude, l’ abacavir a augmenté de 22% la valeur moyenne de la clairance systémique de la méthadone.
0.19133681058883667 ||| - The active substance is galsulfase. ||| - The active substance is tacrolimus. ||| - La substance active est la galsulfase.
0.43965935707092285 ||| Use the injection method as instructed by your health care professional. ||| Finish the course of treatment prescribed by your doctor. ||| Utilisez la technique d’ injection recommandée par votre professionnel de santé.
0.0 ||| The Aranesp (SureClick) pre-filled pen delivers the complete dose of each presentation. ||| The Aranesp (SureClick) pre-filled pen delivers the complete dose of each presentation. ||| 247 Le stylo prérempli Aranesp (SureClick) délivre la totalité de la dose contenue dans chaque présentation.
0.35999006032943726 ||| Europol has provided a recent assessment of new threats posed by criminal groups trying to take advantage of the pandemic. ||| The EU adapted its humanitarian response in light of the needs stemming from the coronavirus pandemic. ||| Europol a fourni une évaluation récente des nouvelle menaces que constituent les groupes criminels qui cherchent à tirer parti de la pandémie.
0.006260927766561508 ||| 13 Cardiovascular (CVS) adverse events, particularly arrhythmia, appeared to be correlated mostly with pre-existing CVS disease and prior therapy with cardiotoxic agents (see section 4.4). ||| 174 Cardiovascular (CVS) adverse events, particularly arrhythmia, appeared to be correlated mostly with pre-existing CVS disease and prior therapy with cardiotoxic agents (see section 4.4). ||| Les effets indésirables cardio-vasculaires (CV), notamment l'arythmie, semblent la plupart du temps être corrélés à une pathologie CV préexistante et à un traitement antérieur par des substances cardiotoxiques (voir rubrique 4.4).
4.0006217197526006e-13 ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| 52 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.12966732680797577 ||| 18 Do not store above 30°C. ||| 133 Do not store above 30 °C. ||| A conserver à une température ne dépassant pas 30°C.
0.39519283175468445 ||| Therefore, the dose of simvastatin should not exceed 10 mg daily in patients receiving concomitant medication with cyclosporine. ||| Therefore, for asepsis of the ampoule before use, ethanol 60% or isopropyl alcohol 70% is recommended. ||| Par conséquent, la posologie de simvastatine ne doit pas dépasser 10 mg/jour chez les patients dont le traitement comporte de la cicloporine.
0.2441003918647766 ||| 7 Filgrastim administration should be discontinued or its dosage should be reduced if the leukocyte counts rise to > 70 x109/ l. ||| Dose adjustments Filgrastim should be administered daily until the neutrophil count has reached and can be maintained at more than 1.5 x 109/ l. ||| L'administration de filgrastim doit être arrêtée ou la posologie diminuée si le nombre de leucocytes dépasse 70 x 109/ l.
0.33635959029197693 ||| However, as previous treatment with alkylating agents is widespread prior to Zevalin treatment, one does not know the exact role of Zevalin when these cancers occur after treatment with Zevalin, since radiation may potentially also cause these cancers. ||| As no data exist regarding the interchangeability of RotaTeq with another rotavirus vaccine, it is recommended that infants who receive RotaTeq for the first immunisation against rotavirus should receive this same vaccine for the subsequent doses. ||| Le recours aux agents alkylants étant fréquent avant un traitement par Zevalin, on ignore le rôle exact de Zevalin dans la survenue de ces cancers lorsqu’ils apparaissent après traitement par Zevalin, d’autant que les rayonnements peuvent aussi être éventuellement responsables de ces cancers.
0.4672829806804657 ||| Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded. ||| Authors are warning against reuses by non-professionals, pointing out that even the best scored methods can degrade the mask if not performed properly. ||| Malgré ces mesures, lorsque des médicaments préparés à partir de sang ou de plasma humain sont administrés, le risque de transmission d’infection ne peut être totalement exclu.
0.41100335121154785 ||| 0.— This appropriation covers the following categories of disabled persons, as part of a policy to assist the disabled: - relevant staff in active employment; - spouses of relevant staff in active employment, provided that they are not in gainful employment or receipt of income or pension deriving from an earlier occupation; - children in respect of whom the dependent child allowance is payable under the conditions set out in Article 2(2), (3), and (5) of Annex VII of the Staff Regulations; - children aged over 26 no longer eligible for the dependent child allowance referred to above, but in respect of whom tax is deductible under Regulation (EEC, Euratom, ECSC) No 260/ 68 laying down the conditions and procedure for applying the tax for the benefit of the European Communities; - orphans, who have lost both parents in receipt of an orphan’ s pension within the meaning of Article 21 of Annex VIII to the Staff Regulations. ||| The Temporary Framework, as amended on 3 April and 8 May 2020, provides for the following types of aid, which can be granted by Member States: (i) Direct grants, equity injections, selective tax advantages and advance payments; (ii) State guarantees for loans taken by companies; (iii) Subsidised public loans to companies, including subordinated loans; (iv) Safeguards for banks that channel State aid to the real economy; (v) Public short-term export credit insurance;(vi) Support for coronavirus related research and development (R&D); (vii) Support for the construction and upscaling of testing facilities; (viii) Support for the production of products relevant to tackle the coronavirus outbreak; (ix) Targeted support in the form of deferral of tax payments and/or suspensions of social security contributions; (x) Targeted support in the form of wage subsidies for employees; (xi) Targeted support in the form of equity and/or hybrid capital instruments. ||| 0.— Ce crédit couvre les catégories suivantes de personnes handicapées, dans le cadre d’ une politique visant à aider les personnes handicapées: - personnel concerné en activité; - conjoints des membres du personnel concernés en activité, pour autant qu’ ils n’ exercent pas une fonction rémunérée ni ne bénéficient d’ un revenu ou d’ une pension au titre d’ activités antérieures; - les enfants pour lesquels une allocation pour enfant à charge doit être versée conformément aux conditions exposées à l’ article 2, paragraphes 2, 3 et 5 de l’ annexe VII du statut du personnel; - les enfants de plus de 26 ans qui ne sont plus éligibles au bénéfice de l’ allocation pour enfant à charge à laquelle il est fait référence ci-dessus, mais ouvrant le droit à la déduction fiscale en vertu du règlement (CEE, Euratom, CECA) n° 260/ 68 du Conseil portant fixation des conditions et de la procédure d’ application de l’ impôt établi au profit des Communautés européennes; - les orphelins qui ont perdu leurs deux parents et bénéficient d’ une pension d’ orphelin au sens de l’ article 21 de l’ annexe VIII
0.2549974322319031 ||| At least 71% of the orally-administered dose is absorbed. ||| Less than 3% of an administered oral dose is recovered in urine. ||| Au moins 71% de la dose administrée par voie orale est absorbée.
0.0706055536866188 ||| Ask your doctor or pharmacist for advice before taking any medicine. ||| 71 Ask your doctor or pharmacist for advice before taking any medicine. ||| 77 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.23599214851856232 ||| Nespo is used to treat symptomatic anaemia that is associated with chronic renal failure (kidney failure) in adults and children. ||| Easotic is used to treat dogs that suffer from acute or recurrent episodes of ear infections (otitis externa). ||| Nespo est utilisé pour le traitement de l'anémie symptomatique liée à l'insuffisance rénale chronique (dysfonctionnement rénal) chez l'adulte et l'enfant.
0.4865032136440277 ||| any of the other ingredients of Betaferon. ||| information about some of the ingredients of Valtropin’). ||| humaine ou à l’un des autres composants contenus dans Betaferon.
0.4521803855895996 ||| These symptoms may suggest problems with your liver. ||| This disease can cause loss of vision. ||| Ces symptômes peuvent indiquer une atteinte de votre foie.
0.5194642543792725 ||| The safety of vardenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated until further information is available: ||| Therefore the safety and efficacy of this product when used with any other (either when used on the same day or at different times) has not been demonstrated ||| La tolérance du vardénafil n’ a pas été étudiée dans les sous-groupes de patients suivants et son utilisation chez ces patients est par conséquent contre-indiquée jusqu’ à ce que des informations complémentaires soient disponibles:
0.5911886692047119 ||| Corn flour [for food] ||| Shawls [from tricot only] ||| Farine de maïs alimentaire
0.32042813301086426 ||| The no-observable effect level for maternal toxicity in rats was 18 mg/ m2/ day and in rabbits was more than 12 mg/ m2/ day. ||| Acute toxicity The highest non-lethal single intravenous dose was 10 mg/ kg bodyweight in mice and 0.6 mg/ kg in rats. ||| Le taux d’ effets non observables de toxicité maternelle chez le rat était de 18 mg/ m²/ jour et de plus de 12 mg/ m²/ jour chez le lapin.
0.46198195219039917 ||| He was hospitalized on March 26 in grave condition and died two days later, becoming the second coronavirus patient to die in Uzbekistan. ||| The woman recovered and was discharged on 5 February after testing negative on two consecutive days. ||| Il est hospitalisé le 26 mars dans un état grave et succombe à la maladie deux jours plus tard.
0.4344409704208374 ||| Brackets for gas burners ||| Capillary tubes for blood ||| Appliques pour becs de gaz
0.29335305094718933 ||| CellCept 1 g/ 5 ml powder for oral suspension mycophenolate mofetil ||| Axura 10 mg/ g oral drops, solution Memantine hydrochloride ||| CellCept 1 g/ 5 ml poudre pour suspension buvable mycophénolate mofétil
0.1561909317970276 ||| Renal impairment Lenalidomide is substantially excreted by the kidney. ||| Renal insufficiency Daptomycin is eliminated primarily by the kidney. ||| Insuffisance rénale Le lénalidomide est essentiellement éliminé par les reins.
0.260507732629776 ||| What Bondenza 3 mg solution for injection in pre-filled syringes looks like and contents of the pack ||| Bonviva 3 mg solution for injection in pre-filled syringes is a clear colourless solution. ||| A quoi ressemble Bondenza 3 mg solution injectable en seringue pré-remplie et contenu de l’ emballage extérieur
0.4143074154853821 ||| Tap the syringe gently to bring the bubbles to the top. ||| Gently push the plunger until the air bubbles are gone. ||| Tapotez doucement la seringue pour faire monter les bulles.
0.06894215941429138 ||| Released for consultation November 2001 ||| Released for consultation May 2001 ||| diffusé pour consultation en novembre 2001
0.5510203838348389 ||| Additives (Chemical -) for plasticizing concrete ||| Action figures (Decorative -) of precious metal ||| Additifs chimiques pour plastifiant pour béton
0.11839679628610611 ||| What is Herceptin used for? ||| What is Betaferon used for? ||| Dans quel cas Herceptin est -il utilisé?
0.18311414122581482 ||| White, capsular-shaped, biconvex tablets debossed with “ Pfizer ” on one side and “ CHX 0.5” on the other side. ||| Blue, capsule-shaped, film-coated tablet, debossed on one side with “ GILEAD” and on the other side with “ 701”. ||| Comprimé pelliculé à 0,5 mg: comprimé blanc, biconvexe, en forme de capsule, gravé avec « Pfizer » sur une face et « CHX 0.5 » sur l’ autre face.
0.06885051727294922 ||| Renovascular hypertension: there is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system. ||| There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system. ||| Hypertension artérielle rénovasculaire: il existe un risque accru d'hypotension sévère et d'insuffisance rénale lorsque des patients présentant une sténose bilatérale de l'artère rénale ou une sténose artérielle rénale sur rein fonctionnel unique, reçoivent des médicaments qui agissent sur le système rénine- angiotensine-aldostérone.
0.4241984188556671 ||| Concrete pipes ||| Processed cereals ||| Tuyaux en béton
0.3568264842033386 ||| - if you suffer from moderate liver problems, ||| - if you are suffering from a serious infection, ||| - si vous souffrez de troubles hépatiques modérés,
0.35391533374786377 ||| The spray is flammable and should not be used next to a naked flame or any incandescent material. ||| If a capsule becomes damaged, contact of the powder contents with skin or mucous membrane must be avoided. ||| Le spray est inflammable et ne doit pas être utilisé à proximité d’ une flamme nue ou de matériaux incandescents.
0.63581782579422 ||| 1 pre-filled syringe of 0.5 ml solution for injection 4 pre-filled syringes of 0.5 ml solution for injection ||| Profender spot-on solution for small cats Profender spot-on solution for medium cats Profender spot-on solution for large cats ||| 1 seringue préremplie de 0,5 ml de solution injectable 4 seringues préremplies de 0,5 ml de solution injectable
0.4600524306297302 ||| Multilayer printed wiring boards ||| Window-mounted air conditioning units ||| Cartes de circuits imprimés multicouches
0.40149226784706116 ||| How to take Naglazyme 4. ||| How to use Ratiograstim 4. ||| Comment utiliser Naglazyme 4.
0.30582231283187866 ||| All samples were analysed for amoxicillin concentrations using an HPLC-UV method (HPLC-fluorescence for liver) with a claimed limit of quantification of 25 µg/ kg for all tissues. ||| These inhibitors are usually IgGs directed against the factor VIII procoagulant activity, which are quantified in Bethesda Units (BU) per ml of plasma using the modified Bethesda assay. ||| L’ analyse de la concentration d’ amoxicilline a été effectuée sur tous les échantillons à l’ aide d’ une méthode par CLHP-UV (CLHP- fluorescence pour le foie) avec une limite déclarée de quantification de 25 µg/ kg pour tous les tissus.
0.3609170913696289 ||| A reduction in body weight was seen in patients treated with BYETTA irrespective of the occurrence of nausea although the reduction was larger in the group with nausea (mean reduction 2.4kg versus 1.7kg) in the long term controlled studies of up to 52 weeks. ||| The safety profile of lamotrigine in children aged 1 month to 2 years was similar to that in older children except that clinically significant worsening of seizures (> =50%) was reported more often in children under 2 years of age (26%) as compared to older children (14%). ||| Les études contrôlées à long terme, jusqu’ à 52 semaines, ont cependant montré que la diminution était plus importante dans le groupe de patients présentant au moins un épisode de nausées (diminution moyenne de 2,4 kg versus 1,7 kg).
0.4049146771430969 ||| Within the European Commission the EMEA worked closely with the Pharmaceutical and cosmetics Unit of the Directorate-General for Enterprise, together with the services and scientific committees of the Directorate-General for Health and consumer protection. ||| Mr Pott joined the Secretariat of the European Parliament in 1989, serving on the secretariats of the Committee on Research, Technological Development and Energy, of the Committee on Budgets and latterly of the Parliament’s Bureau and Conference of Presidents. ||| Au sein de la Commission européenne, l’EMEA a travaillé en collaboration étroite avec l’unité des produits pharmaceutiques et cosmétiques de la direction générale des entreprises ainsi qu’avec les services et les comités scientifiques de la direction générale de la santé et de la protection des consommateurs.
0.33456099033355713 ||| not recommended if you have severe kidney disease or you are on dialysis. ||| ed is not recommended if you have breathing difficulties with congestive heart failure. ||| avez une maladie rénale grave ou si vous êtes sous dialyse, l’ utilisation de BYETTA n’ est pas recommandée;
0.3233693242073059 ||| Special care should be taken in women with signs and symptoms of active allergic conditions. ||| In case of severe allergic reactions, alternative haemostatic measures should be considered. ||| Des précautions particulières doivent être prises chez les femmes présentant des signes et des symptômes de prédispositions allergiques.
0.2668289840221405 ||| 36/ 39 For treatment of demodicosis, the product should be administered at monthly intervals until clinical signs resolve. ||| 2 If Zeffix is discontinued, patients should be periodically monitored for evidence of recurrent hepatitis (see section 4.4). ||| Pour le traitement de la démodécie, administrer le produit tous les mois jusqu’ à ce que les signes cliniques disparaissent.
0.4550575017929077 ||| Adult fleas are killed before they lay eggs for a minimum of 4 weeks after treatment. ||| Future layers and breeders should not be vaccinated before 3 weeks of age. ||| Les puces adultes sont tuées avant qu’ elles ne pondent des œ ufs pendant au minimum 4 semaines après traitement.
0.1472819447517395 ||| Dosage is individual and determined by the physician in accordance with the needs of the patient. ||| The dosage should be determined by the physician, according to the requirement of the patient. ||| La posologie dépend de chaque individu et est déterminée par le médecin en fonction des besoins du patient. e
0.5629433393478394 ||| Clothing for fishermen ||| Beverages for canines ||| Vêtements pour pêcheurs
0.4188362658023834 ||| The number of elderly patients in whom the pharmacokinetics were determined was limited (over 65 years, N=3). ||| Celvapan has been studied in adults, including the elderly (above 60 years of age). ||| Le nombre de patients âgés chez lesquels les caractéristiques pharmacocinétiques ont été évaluées est limité (plus de 65 ans, n = 3).
5.443272785635167e-13 ||| 3.2 ||| 3.2 ||| 3,0
0.37662452459335327 ||| The active substance in Viread, tenofovir disoproxil, is a ‘ prodrug ’ that is converted into tenofovir in the body. ||| When a solution of the radioactive substance sodium pertechnetate (99mTc) is added to the vial, 99mTc-depreotide is formed. ||| Le principe actif de Viread, le ténofovir disoproxil, est une prodrogue convertie en ténofovir dans l’ organisme.
0.7721920013427734 ||| Marketing Authorisation Holder Wyeth Europa Ltd. ||| Pfizer Ltd (as MA Holder logo) ||| Wyeth Europa Ltd.
0.37139177322387695 ||| The plasma methionine concentrations should be kept below 1000 µM. ||| The haemoglobin values should not exceed a value of 12 g/dL. ||| La concentration plasmatique de la méthionine doit être maintenue en dessous de 1000 µM.
0.0015818953979760408 ||| ris combination therapy using the Mann-Whitney U test c. p-value is from the pairwise comparison of Trudexa monotherapy and methotrexate monotherapy using the Mann-Whitney U test ||| tho combination therapy using the Mann-Whitney U test c. p-value is from the pairwise comparison of Trudexa monotherapy and methotrexate monotherapy using the Mann-Whitney U test ||| l'association Trudexa/ méthotrexate par le test U de Mann-Whitney c. valeur de p résulte de la monothérapie par Trudexa et de la monothérapie par méthotrexate par le test U de Mann-Whitney dic
0.5188065767288208 ||| Intramuscular injection (cattle, pigs). ||| Pigs: intramuscular injection. ||| Injection intramusculaire (bovins, porcs).
0.34496644139289856 ||| Your doctor will decide the most appropriate dose based on body surface area (height and weight). ||| Dosage The dose will be worked out by your doctor, based on your body weight and your condition. ||| Votre médecin décidera de la dose la plus appropriée en se basant sur la surface corporelle (taille et poids).
0.22568416595458984 ||| One pre-filled syringe of Ovitrelle (250 micrograms) is administered 24 to 48 hours after the last administration of an FSH- or hMG preparation, i. e. when optimal stimulation of follicular growth is achieved. ||| Then a single injection of a medicine used to induce final follicular maturation and containing up to 10 000 IU human chorionic gonadotrophin (hCG) is administered 24-48 hours after the last GONAL-f injection. ||| 1 seringue préremplie d’ Ovitrelle (250 microgrammes) est administrée 24 à 48 heures après la dernière administration de FSH ou d’ hMG, c’ est-à-dire lorsqu’ une croissance folliculaire adéquate est obtenue.
0.15079426765441895 ||| Stables (non-metallic -) [structures] ||| Water tanks (non-metallic -) [structures] ||| Étables non métallique [structures]
0.4419744610786438 ||| Loading dose of 200 mg (5 ml) once a day on the first day, then 100 mg (2.5 ml) once a day for 13 days. ||| Recommended dose for prevention 75 mg once daily 75 mg every second day, or 30 mg suspension once daily, or 30 mg capsules once daily ||| Dose de charge de 200 mg (5 ml) une fois par jour le premier jour, puis 100 mg (2,5 ml) une fois par jour pendant 13 jours.
3.9518938794134983e-13 ||| Absorption The maximum plasma concentration of the insulin is reached within 2-18 hours after subcutaneous administration. ||| Absorption The maximum plasma concentration of the insulin is reached within 2-18 hours after subcutaneous administration. ||| Absorption La concentration plasmatique maximale de l’ insuline est atteinte 2 à 18 heures après l’ administration
0.5957381129264832 ||| Retinal hemorrhage ||| Oedema peripheral ||| hémorragie rétinienne
0.683726966381073 ||| Haemophiliac patients ||| Aplastic anemia ||| Patients hémophiles
0.0 ||| See leaflet for further information. ||| See leaflet for further information. ||| Consulter la notice pour plus d'information.
0.022840484976768494 ||| Orodispersible tablet Round and pink, marked with "A" over "640" on one side and "10" on the other. ||| Orodispersible tablet Round and pink, marked with "A" over "643" on one side and "30" on the other. ||| Comprimé orodispersible Rond et rose, gravé "A" au dessus de "640" sur un coté et "10" sur l'autre côté.
0.17544472217559814 ||| Scientific research for medical purposes ||| Scientific investigations for medical purposes ||| Recherches scientifiques à des fins médicales
0.4787292182445526 ||| You may need to set an alarm clock to make sure you wake up to take the second dose. ||| When the red light starts to flash, you may start another dose at any time you need it. ||| Vous pouvez utiliser un réveil pour être sûr de vous réveiller pour prendre la seconde prise.
0.10055500268936157 ||| • 196 days • 477 days ||| • 210 days • 358 days ||| 196 jours 477 jours
0.4148632884025574 ||| Synthetic resins [semi-processed]for use in manufacture ||| Fused silica [semi-worked product], other than for building ||| Résines synthétiques semi-ouvrées pour procédés de fabrication
0.3513152003288269 ||| Reconstituted solutions should be visually inspected for particulate matter or discolouration. ||| Injection sites should be rotated within an anatomic region in order to avoid lipodystrophy. ||| Les solutions reconstituées seront examinées visuellement afin de rechercher la présence de particules ou une coloration anormale.
0.19354860484600067 ||| Prandin may also be used with metformin (another anti-diabetes medicine) in type 2 diabetes patients whose blood glucose levels are not satisfactorily controlled on metformin alone. ||| In patients with type 2 diabetes, NovoMix 50 can be given in monotherapy or in combination with metformin, when the blood glucose is inadequately controlled with metformin alone. ||| Prandin peut également être utilisé en association avec la metformine (autre médicament antidiabétique) chez les diabétiques de type 2 dont les niveaux de glucose dans le sang ne sont pas équilibrés de façon satisfaisante par la metformine seule.
0.4318641424179077 ||| In our efforts to mitigate the economic impacts of the COVID-19 pandemic, the Commission has today published guidelines to ensure EU passenger rights are applied in a coherent manner across the EU. ||| Europeans expect the EU and governments to act decisively to pave a way out of the crisis and build a more resilient Europe, MEPs said during a plenary debate on 16 April. ||| Dans le cadre de nos efforts destinés à atténuer les répercussions économiques de la pandémie de COVID-19, la Commission a publié aujourd'hui des orientations ayant pour objet de garantir l'application cohérente des droits des passagers de l'UE dans l'ensemble de l'Union.
0.18819710612297058 ||| Losartan/ HCTZ tablets must not be used in patients with severe renal impairment (i. e. creatinine clearance < 30 ml/ min) (see section 4.3). ||| Dose adjustment is needed for patients with cSSTI without bacteraemia whose creatinine clearance is < 30 ml/ min (see sections 4.2 and 5.2). ||| Les comprimés de losartan/ HCTZ ne doivent absolument pas être utilisés chez les patients atteints d'insuffisance rénale sévère (clairance de la créatinine < 30 ml/ mn) (voir rubrique 4.4).
0.01936950534582138 ||| Due to the relatively slow absorption of strontium, food and calcium intake should be avoided both before and after administration of PROTELOS. ||| Due to the relatively slow absorption of strontium, food and calcium intake should be avoided both before and after administration of OSSEOR. ||| En raison de l’ absorption relativement lente du strontium, la prise d’ aliments et de calcium doit être évitée avant et juste après l’ administration de PROTELOS.
0.0 ||| Pharmacotherapeutic group: antiepileptics, ATC code: ||| Pharmacotherapeutic group: antiepileptics, ATC code: ||| Classe pharmacothérapeutique: antiépileptique, Code ATC:
0.1637069284915924 ||| What is Viraferon used for? ||| What is Xyrem used for? ||| Dans quel cas Viraferon est -il utilisé? tn
0.012104395776987076 ||| EU/1/03/262/004 1 hard capsule EU/1/03/262/005 5 x 1 hard capsule ||| EU/1/03/262/007 1 hard capsule EU/1/03/262/008 5 x 1 hard capsule ||| EU/1/03/262/004 (1 gélule) EU/1/03/262/005 (5 x 1 gélule)
0.33397936820983887 ||| Nausea with or without vomiting is noted in approximately 10% of patients treated with calcitonin. ||| Patients receiving less than 70-100 mg carbidopa a day are more likely to experience nausea and vomiting. ||| Troubles gastro-intestinaux Très fréquent: des nausées, avec ou sans vomissements, sont observées chez environ 10% des patients traités par la calcitonine.
0.17789503931999207 ||| * In haemodialysis patients or in case of acute renal failure (creatinine clearance below 15 ml/ min or creatinine value above 60 mg/ l [530 μ mol/ l]), infusion of Refludan is to be avoided or stopped. ||| Due to limited clinical experience, Bonviva injection is not recommended for patients with a serum creatinine above 200 μ mol/ l (2.3 mg/ dl) or with a creatinine clearance below 30 ml/ min (see section 4.2 and section 5.2). ||| • Chez les patients hémodialysés ou en cas d'insuffisance rénale aiguë (clairance de la créatinine inférieure à 15 ml/ min ou créatininémie supérieure à 60 mg/ l [530 µmol/ l]), il est nécessaire d'éviter ou d'arrêter la perfusion de Refludan.
0.22851622104644775 ||| 2,167 ||| 4,604 ||| 2167
0.3000704050064087 ||| Vials containing Humalog Mix50 should be rotated in the palms of the hands before use to resuspend the insulin until it appears uniformly cloudy or milky. ||| The orodispersible tablets are taken by being placed on the tongue, where they disintegrate quickly in the saliva, or by mixing them in water before swallowing. ||| Faire rouler les flacons d'Humalog Mix50 entre les paumes des mains, avant utilisation, afin de bien mélanger la suspension d'insuline jusqu'à ce qu'elle prenne un aspect uniformément trouble ou laiteux.
0.2878434658050537 ||| Cetrotide 0.25 mg is given daily, either in the morning or in the evening, starting on day 5 or 6 of ovarian stimulation, until the day of planned ovulation induction. ||| For optimal effect, Agopton should be taken once daily in the morning, except when used for H. pylori eradication when treatment should be twice a day, once in the morning and once in the evening. ||| Cetrotide 0,25 mg est administré une fois par jour, soit le matin, soit le soir.
0.47384411096572876 ||| 58 Ελλάδα Καλορίζου Μ.-Σ.Κουρουπίδης ΟΕ Ηρώων Πολυτεχνείου 60 43100 Καρδίτσα Ελλάδα Τηλ: +3024410 41951 Email: info@vkk.gr ||| Κύπρος Astellas Pharmaceuticals AEBE 10ο χλµ Εθνικής Οδού, Αθηνών-Λαµίας GR-14451 Μεταµόρφωση Αττικής, Τηλ.: +30 210 2812640 ||| 59 Ελλάδα Καλορίζου Μ.-Σ.Κουρουπίδης ΟΕ Ηρώων Πολυτεχνείου 60 43100 Καρδίτσα Ελλάδα Τηλ: +3024410 41951 Email: info@vkk.gr
1.0634503364562988 ||| 46 Italia Merck Serono S. p. A. ||| ori 1 Carrat F, Bani-Sadr F, Pol S et al. ||| Suomi/ Finland Italia Merck Oy Merck Serono S. p. A.
0.3884214162826538 ||| Provision of aircraft financing ||| Provision of bowling alley facilities ||| Fourniture de financement d'aéronefs
0.2425617277622223 ||| PREZISTA 400 mg film-coated tablets darunavir ||| VFEND 50 mg film-coated tablets Voriconazole Oral use ||| PREZISTA 400 mg comprimés pelliculés darunavir
0.47579026222229004 ||| Physical-education services ||| Occupational psychology services ||| Services d'éducation physique
0.5713121891021729 ||| To date clinical data are available on hip surgery only. ||| Figures for 2020 concerning hostages are not available yet. ||| A ce jour les données cliniques ne concernent que la chirurgie de la hanche.
0.34318166971206665 ||| Patients received Enbrel 0.8 mg/ kg (up to 50 mg) or placebo once weekly for 12 weeks. ||| Patients were randomized to receive Nespo at 500 μ g once every three weeks or 2.25 μ g / kg once weekly. ||| Les patients recevaient soit Enbrel 0,8 mg/ kg (jusqu’ à 50 mg) soit le placebo une fois par semaine pendant 12 semaines.
0.4428584575653076 ||| Pfizer Consumer Healthcare BV Rivium Westlaan 142 NL-2909 LD Capelle a/ d IJsel Nederland ||| Novartis Consumer Health SA/ NV Medialaan, 30 Bus 5 - 1800 VILVOORDE Belgium Attn: ||| Pfizer Consumer Healthcare BV Rivium Westlaan 142 NL-2909 LD Capelle a/ d IJsel Pays-Bas
0.25890177488327026 ||| Each carton of VELCADE 3.5 mg powder for solution for injection contains a glass vial with a royal blue cap, in a transparent blister pack. ||| • The solvent for TAXOTERE 20 mg vial is a 7 ml clear glass vial with a transparent colourless flip-off cap. ||| Chaque boîte de VELCADE 3,5 mg poudre pour solution injectable contient un flacon en verre avec un capuchon bleu roi, dans une plaquette thermoformée transparente.
0.28452402353286743 ||| The medicine is given by slow intravenous injection (into a vein) over one minute. ||| This is given 3 times a week by injection into a vein (intravenous injection over 1-2 minutes). ||| Le médicament est administré en injection intraveineuse (dans une veine) lente pendant une minute.
0.17125938832759857 ||| 37.5 mg ||| 32.0 mg ||| 37,5 mg/ 2 ml
0.3484037518501282 ||| The linker chelate tiuxetan forms a stable complex with the radioisotopes yttrium-90 and indium-111 and only negligible degradation due to radiolysis is expected. ||| With respect to nevirapine resistance, all isolates that were sequenced carried at least one mutation associated with resistance, the most common single changes being K103N and Y181C. ||| Le ligand chélate de tiuxétan forme un complexe stable avec les deux radio-isotopes, yttrium-90 et indium-111, et seule une dégradation négligeable, due à la radiolyse, est attendue.
0.24666182696819305 ||| The pharmacokinetics of tenofovir in non-haemodialysis patients with creatinine clearance < 10 ml/ min and in patients with ESRD managed by peritoneal or other forms of dialysis have not been studied. ||| IntronA is indicated for the treatment of adult patients with chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV (see section 4.4). ||| La pharmacocinétique du ténofovir chez les patients non hémodialysés dont la clairance de la créatinine est < 10 ml/ min et chez les patients en IRT sous dialyse péritonéale ou autres types de dialyse n’ a pas été étudiée.
0.7641115784645081 ||| Rare • Myocardial infarct ||| Headache NOS Arachnoiditis Confusion ||| Rare • Infarctus du myocarde
0.8882008790969849 ||| For Intravenous Use. ||| Fully Supplemented Patients ||| Utilisation en injection intraveineuse
0.15044793486595154 ||| In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental ingestion, especially in the case of children, seek medical advice and show the package leaflet or the label to the physician. ||| En cas d'auto-injection accidentelle, prenez immédiatement conseil auprès de votre médecin en lui montrant la notice ou l’ étiquette.
0.6728708148002625 ||| Japanese drums (taiko) ||| Shochu (spirits) ||| Tambours japonais [taiko]
0.6914122700691223 ||| (< 1/ 10,000) ||| < 1/ 100) ic ||| isé (< 1/ 10.000)
0.2595660090446472 ||| Read all of this leaflet carefully before your child starts receiving this vaccine. ||| - Keep this leaflet until your child has finished the complete vaccination course. ||| Veuillez lire attentivement l'intégralité de cette notice avant que votre enfant ne reçoive ce vaccin.
0.3026575446128845 ||| This is why the Commission is coordinating action with Member States to ensure the continued flow of goods and functioning the internal market. ||| In addition, it is working on mobilising all available resources under the EU budget to support Member States in handling the outbreak. ||| C'est la raison pour laquelle la Commission coordonne des actions avec les États membres en vue de garantir la continuité du flux de marchandises et le fonctionnement du marché intérieur.
0.0013792095705866814 ||| 117 • The active substance is follitropin beta, a hormone known as follicle-stimulating hormone (FSH) in a strength of 50 IU in 0.5 ml aqueous solution per vial. • The other ingredients are sucrose, sodium citrate, L-methionine and polysorbate 20 in water for injections. ||| 255 • The active substance is follitropin beta, a hormone known as follicle-stimulating hormone (FSH) in a strength of 200 IU in 0.5 ml aqueous solution per vial. • The other ingredients are sucrose, sodium citrate, L-methionine and polysorbate 20 in water for injections. ||| • La substance active est la follitropine bêta, une hormone connue sous le nom d'Hormone Folliculo- Stimulante (FSH) à un dosage de 50 UI dans 0,5 ml de solution aqueuse par flacon. • Les autres composants sont le saccharose, le citrate de sodium, la L-méthionine et le polysorbate 20 dans de l’ eau pour préparations injectables.
0.5191423892974854 ||| : This can take the form of direct grants, tax advantages, repayable advances and no-loss guarantees. ||| Guarantees to cover losses may also be granted, either in addition to a direct grant, tax advantage or repayable advance, or as an independent aid measure. ||| Ces aides peuvent prendre la forme de subventions directes, d'avantages fiscaux, d'avances remboursables et de garanties de couverture de pertes.
0.3640126585960388 ||| Biotransformation: studies in humans and in vitro studies using human liver microsomes have demonstrated that efavirenz is principally metabolised by the cytochrome P450 system to hydroxylated metabolites with subsequent glucuronidation of these hydroxylated metabolites. ||| The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus. ||| Des études réalisées chez l’ homme et des études in vitro sur des microsomes hépatiques humains ont montré que l’ éfavirenz était principalement métabolisé par le système du cytochrome P450 en métabolites hydroxylés avec glucuronidation ultérieure de ces métabolites hydroxylés.
0.2936323881149292 ||| The effect of Lysodren on non-functional adrenal cortical carcinoma is not established. ||| Cytotoxic actions of erythropoietin on bone marrow cells could not be detected. ||| L’ efficacité de Lysodren sur le carcinome corticosurrénalien non fonctionnel n’ est pas établie.
0.040679968893527985 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Epivir. ||| If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking Revlimid. ||| Si vous avez été informé par votre médecin que vous aviez une intolérance à certains sucres, veuillez informer votre médecin avant de prendre Epivir.
0.2596132457256317 ||| A lower dose should be considered for patients with a history of hepatic impairment. ||| The slope is higher in patients with clinically significant hepatic impairment. ||| Utilisation chez les patients insuffisants hépatiques Une dose plus faible doit être envisagée chez les patients ayant des antécédents d’ insuffisance hépatique.
0.2646104097366333 ||| Patient monitoring on day 1 should include vital signs, including pulse, blood pressure and respiratory rate. ||| The patient should be monitored closely, including heart rate, heart rhythm and blood pressure. ||| La surveillance du patient le jour 1 doit inclure les signes vitaux, notamment le pouls, la tension artérielle et la fréquence respiratoire.
0.24019883573055267 ||| Ultrasonic diagnostic instruments for medical use ||| Ultrasonic probes for medical use ||| Instruments de diagnostic à ultrasons à usage médical
0.4796541929244995 ||| Hepatotoxicity: ||| Encephalopathy: ||| Hépatotoxicité:
0.4203455150127411 ||| We must continue to fund the development and equitable distribution of a vaccine, and we must commit to building back better from this crisis, guided by the SDGs." ||| It is therefore essential that we act decisively and collectively, to contain the spread of the virus and help patients, and to counter the economic fallout. ||| Nous devons continuer à financer la mise au point et la distribution équitable d'un vaccin et nous engager à sortir de cette crise en reconstruisant sur de meilleures bases, en nous appuyant sur les objectifs de développement durable.»
0.46178141236305237 ||| (vi) Support for coronavirus related research and development (R&D) to address the current health crisis in the form of direct grants, repayable advances or tax advantages. ||| The €7.5 billion are indicatively broken down for each partnership (vaccines, treatments, diagnostics), and within each partnership for Research Development and Deployment. ||| vi) soutien à la recherche et au développement en rapport avec le coronavirus (R & D) pour faire face à la crise sanitaire actuelle sous la forme de subventions directes, d'avances remboursables ou d'avantages fiscaux.
0.33008646965026855 ||| In patients with a creatinine clearance between 20 and 50 ml/ min, the initial daily dose of SIFROL should be administered in two divided doses, starting at 0.088 mg of base (0.125 mg of salt) twice a day (0.176 mg of base/ 0.25 mg of salt daily). ||| In order to correct your anaemia, your initial dose will be • 500 micrograms once every three weeks (6.75 micrograms of Aranesp per kilogram of your body weight), or • 2.25 micrograms (once weekly) of Aranesp per kilogram of your body weight. ||| Si la clairance de la créatinine est comprise entre 20 et 50 ml/ min, la dose journalière initiale de SIFROL doit être de 0,176 mg de forme base (0,25 mg de forme sel), fractionnée en deux prises de 0,088 mg de forme base chacune (0,125 mg de forme sel).
0.49075788259506226 ||| 16 mg ½ 1 ||| 20 mg 1 ||| 16 mg
0.5304750800132751 ||| On 21 March, Guaidó announced that he delivered medical kits to protect the health sector from the coronavirus pandemic. ||| Gamkrelidze wrote on his Facebook that he contracted the illness from a coworker, who has been tested positive for COVID-19 on Wednesday. ||| Juan Guaidó indique le 12 mars avoir contacté des pays alliés pour obtenir du matériel hospitalier avec l'aide d'agences internationales telle que l'Organisation panaméricaine de la santé.
0.3212098479270935 ||| As part of an ongoing worldwide pandemic, the first two patients with COVID-19 in Venezuela were confirmed on 13 March 2020; the first death was reported on 26 March. ||| As of 20 February 2020, the number of confirmed cases in South Korea was the third largest after China and the infections on the Diamond Princess. ||| Au cours de la pandémie de Covid-19, les deux premiers patients atteints de la nouvelle maladie de coronavirus ont été confirmés au Venezuela le 13 mars 2020.
0.46070438623428345 ||| 5 In a 2 year subcutaneous implantation study in rats, heterotopic bone formation was observed, as expected. ||| Carcinogenic potential was assessed in a 2-year rat study and a 6-month transgenic mouse study. ||| Selon une étude d’ une durée de 2 ans chez le rat portant sur l’ implantation sous-cutanée, une formation hétérotopique de tissu osseux a été observée comme prévu.
0.16588905453681946 ||| Bondenza can treat osteoporosis only as long as you keep taking it. ||| 42 Bonviva can treat osteoporosis only as long as you keep taking it. ||| Bondenza peut traiter votre ostéoporose et réduire votre risque de fracture seulement si vous continuez à prendre votre comprimé chaque mois.
0.38558459281921387 ||| The recommended daily dose of Tarceva is 150 mg taken at least one hour before or two hours after the ingestion of food. ||| Starlix is given within one to 30 minutes before breakfast, lunch and dinner and the dose is adjusted to give the best control. ||| La posologie quotidienne recommandée de Tarceva est de 150 mg à prendre au moins une heure avant ou deux heures après un repas.
0.15048745274543762 ||| Additives (Chemical -) for use in repairing asphalt ||| Additives (Chemical -) for use in drilling ||| Additifs chimiques destinés à la réparation de l'asphalte
0.0 ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market and for as long as the marketed product remains in use. ||| The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market and for as long as the marketed product remains in use. ||| Le titulaire de l’ AMM doit s’ assurer que le système de pharmacovigilance est en place et opérationnel avant que le produit soit mis sur le marché et pendant toute la durée d’ utilisation du produit.
0.3184395134449005 ||| However, response rates in this trial were shown to be dependent also on the dose of ribavirin administered in combination with PegIntron or interferon alfa-2b. ||| As Aerius oral solution contains the same concentration of desloratadine, no bioequivalence study was required and it is expected to be equivalent to the syrup and tablet. ||| Cependant, il a été montré que les taux de réponse dans cet essai étaient dépendants de la dose de ribavirine administrée en association avec PegIntron ou l’ interféron alfa-2b.
0.3752855062484741 ||| The dosage should therefore be reduced for patients with a creatinine clearance of < 50 ml/ minute. ||| At doses above 200 mg, the absorption was saturated probably due to poor solubility. ||| Chez les patients présentant une clairance de la créatinine inférieure à 50 ml/ min, la posologie doit donc être réduite.
0.2515201270580292 ||| Tel: +356 2540 2600 medinfo_mt@merck. com ||| Tel: +34 93 600 37 00 medicaldep@ferrergrupo. com ||| Tel: +356 2397 6000 medinfo_mt@merck.com
0.4150082468986511 ||| Disposable plastic bioreactors for cell culture ||| Throughflow operated centrifuges filters for medical use ||| Bioréacteurs en plastique jetables de laboratoire
0.43412625789642334 ||| By blocking TNF, adalimumab reduces the inflammation and other symptoms of the diseases. ||| It is also used to reduce infection with CSF and excretion of CSF virus into the environment. uth ||| En bloquant le TNF, l’ adalimumab réduit l’ inflammation et les autres symptômes de ces maladies.
0.3175593614578247 ||| It is recommended that Rapamune be used initially in combination with ciclosporin microemulsion and corticosteroids for 2 to 3 months. ||| If higher dosages than 500 mg morphine-equivalent are needed, a reassessment of opioid-therapy is recommended. ||| Il est recommandé d’ initier le traitement par Rapamune en association avec la ciclosporine microémulsion et les corticoïdes pendant 2 à 3 mois.
0.17705407738685608 ||| HOW TO TAKE EFEXOR ||| HOW TO TAKE EXFORGE ||| COMMENT PRENDRE EFEXOR
0.20047152042388916 ||| Skin and subcutaneous tissue disorders Very common: sweating, pruritus. ||| Skin and subcutaneous tissue disorders: not known: urticaria, pruritus, rash ||| Affections de la peau et du tissu sous-cutané Très fréquent: sueurs, prurit.
0.2831875681877136 ||| Raloxifene is metabolised primarily in the liver. ||| Erlotinib is primarily cleared by the liver. ||| Le raloxifène est principalement métabolisé par le foie.
0.0 ||| 6.1 List of excipients ||| 6.1 List of excipients ||| 79 6.1 Liste des excipients
0.16577200591564178 ||| Severe side effects affecting the brain and nervous system have been reported in patients taking Atriance, including somnolence, convulsions, and peripheral neuropathy causing numbness, unusual sensations, weakness and even paralysis. ||| Gastrointestinal reactions Symptoms such as early abdominal pain and tenderness, fever, diarrhea, with or without neutropenia, may be early manifestations of serious gastrointestinal toxicity and should be evaluated and treated promptly. ||| Des effets indésirables graves affectant le cerveau et le système nerveux ont été signalés chez certains patients traités par Atriance, dont notamment des cas de somnolence, de convulsions et de neuropathie périphérique pouvant entraîner des engourdissements, des sensations anormales, des faiblesse et même des paralysies.
0.2511158287525177 ||| If you stop taking NovoNorm ||| If you forget to take NovoNorm ||| Si vous arrêtez de prendre NovoNorm
0.24262294173240662 ||| HOW TO STORE INSULIN HUMAN WINTHROP COMB 50 ||| HOW TO USE INSULIN HUMAN WINTHROP RAPID ||| COMMENT CONSERVER INSULIN HUMAN WINTHROP COMB 50
0.3126283288002014 ||| Important information about some of the ingredients of ABILIFY If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Check with your doctor before using STELARA if you have: • Infections o You must tell your doctor if you have any kind of infection STELARA may make you less able to fight infections. ||| Information importante concernant certains composants de ABILIFY Si votre médecin vous a informé que vous êtes intolérant à certains sucres, contactez -le avant de prendre ce médicament.
0.0 ||| In patients taking cyclosporine, gemfibrozil, other fibrates (except fenofibrate) or lipid-lowering doses (≥ 1 g/ day) of niacin concomitantly with , the dose of should not exceed 10 mg/day. ||| In patients taking cyclosporine, gemfibrozil, other fibrates (except fenofibrate) or lipid-lowering doses (≥ 1 g/ day) of niacin concomitantly with , the dose of should not exceed 10 mg/day. ||| Chez les patients prenant, en association avec , de la ciclosporine, du gemfibrozil, d’autres fibrates (excepté le fénofibrate) ou de la niacine à doses hypolipémiantes (≥ 1 g/jour), la posologie de ne doit pas dépasser 10 mg/jour.
0.47616279125213623 ||| If difficulties arise isolating single muscles, injections should be performed using electromyographic guidance. ||| If possible multifocal electroretinography (performed according to ISCEV standards) should also be carried out. ||| En cas de difficulté pour isoler les muscles, les injections doivent être faites sous guidage électromyographique.
0.6013693809509277 ||| allow unused rural development funds to be reallocated to fight the effects of the COVID-19 crisis in rural areas, ||| €3.6 million to strengthen ongoing health and social protection to Palestine Refugees from Syria and hosting communities ||| Elles permettront également de libérer les fonds de développement rural liés à l'agriculture non utilisés pour lutter contre le COVID-19.
0.3571714758872986 ||| 3 Prophylaxis For long-term prophylaxis against bleeding in patients with severe haemophilia A, the usual doses are 20 to 40 IU of factor VIIIper kg body weight at intervals of 2 to 3 days. ||| Dosage recommendations – Liver transplantation Prophylaxis of transplant rejection - adults Oral therapy should commence at 0.10 - 0.20 mg/kg/day administered as two divided doses (e.g. morning and evening). ||| Prophylaxie Pour le traitement prophylactique à long terme des épisodes hémorragiques chez les patients atteints d’ hémophilie A sévère, les posologies habituelles sont de 20 à 40 UI de facteur VIII par kg de poids corporel à des intervalles de 2 à 3 jours.
0.07854712009429932 ||| WHAT GLUSTIN IS AND WHAT IT IS USED FOR ||| WHAT GLIVEC IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE GLUSTIN ET DANS QUELS CAS EST-IL UTILISE?
0.701768159866333 ||| Alendronate HEXAL and associated names (see Annex I) 10 mg tablets [See Annex I - To be completed nationally] ||| Antibiotic resistance - an increasing threat to human health - Design files - EN - [ZIP-3.71 MB] ||| Alendronat HEXAL et noms associés (voir Annexe I) comprimés 10 mg [Voir annexe I – A compléter au niveau national]
0.4037485122680664 ||| Uncommon: back pain, muscle spasms, myalgia ||| Uncommon: thrombophlebitis, hypertension, thrombosis ||| Peu fréquentes: maux de dos, spasmes musculaires, myalgie
0.33480823040008545 ||| 7.4 (6.4, 8.3) ||| 8.8 (6.4, 11.5) ||| 7,4 (6,4; 8,3)
0.4431210160255432 ||| The recommended starting dose in children is 40mg/ kg/ day. ||| All subsequent weekly doses are 250 mg/ m² each. ||| La dose initiale recommandée chez l'enfant est de 40 mg/ kg/ jour.
0.40322306752204895 ||| The pharmacodynamic profile of insulin aspart in children was similar to that seen in adults. ||| In children, the nature of the safety profile is similar to that seen in adults. ||| Le profil pharmacodynamique de l’ insuline asparte était similaire chez les enfants et les adultes.
0.037468694150447845 ||| EU/ 1/ 01/ 185/ 046 1 pack EU/ 1/ 01/ 185/ 058 4 pack ||| EU/ 1/ 01/ 185/ 045 1 pack EU/ 1/ 01/ 185/ 057 4 pack ||| EU/ 1/ 01/ 185/ 046 Boîte de 1 EU/ 1/ 01/ 185/ 058 Boîte de 4
0.29191064834594727 ||| Viracept has been studied in combination with other antiviral medicines in two main studies involving 605 patients aged 13 years or more, who were infected with HIV. ||| In type 2 diabetes (when the body is unable to use insulin effectively), Apidra has been studied in one study involving 878 adults. ||| Viracept a été étudié en association avec d’ autres médicaments antiviraux dans deux études principales ayant suivi 605 patients âgés de 13 ans ou plus, présentant une infection par le VIH.
3.937819579961921e-13 ||| There have been isolated reports of renal failure in neonates born to women taking nimesulide in late pregnancy. ||| There have been isolated reports of renal failure in neonates born to women taking nimesulide in late pregnancy. ||| Des rapports isolés ont fait état de cas d'insuffisance rénale chez des nouveau-nés dont les mères avaient pris du nimésulide lors des dernières étapes de leur grossesse.
0.27802979946136475 ||| However, in the presence of an inhibitor the doses required are variable and must be adjusted according to clinical response and monitoring of plasma factor VIII activity. ||| During the course of treatment, appropriate determination of plasma factor VIII levels is advised to guide the dose to be administered and the frequency of repeated injections. ||| Toutefois, en présence d’ un inhibiteur les doses nécessaires sont variables et doivent être ajustées en fonction de la réponse clinique du patient et du dosage de l’ activité plasmatique du facteur VIII.
0.3763290047645569 ||| Patients with creatinine clearance < 50 ml/minute must not be treated with ViraferonPeg in combination with ribavirin (see section 4.3). ||| The use of Angiotensin II Receptor Antagonists (AIIRAs) is not recommended during the first trimester of pregnancy (see section 4.4). ||| Les patients avec une clairance de la créatinine < 50 ml/ minute ne doivent pas être traités par ViraferonPeg en association avec la ribavirine (voir rubrique 4.3).
0.5043241381645203 ||| Handles for revolvers ||| Dividers for drawers ||| Crosses pour revolvers
0.07551585882902145 ||| 108 Using other medicines Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| 63 Using other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including any herbal products or medicines obtained without a prescription. ||| Prise d'autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez en à votre médecin ou à votre pharmacien.
0.22096148133277893 ||| Uncommon side effects (affects 1 to 10 users in 1000) are: • increased heart rate, • low blood pressure, • shortness of breath, • heartburn (painful or burning sensation just below the breast bone), • haemorrhoids (piles), • accidental loss or leakage of urine, • increased need to pass water, • weight increase. ||| Uncommon side effects (likely to affect 1 to 10 in every 1000 patients) • anger, aggression, thoughts of suicide, suicide attempt. • vomiting. • gall bladder inflammation, gallstones. • urinary stones. • pneumonia and urinary tract infections. • low blood potassium levels, convulsions/ seizures. ||| Les effets indésirables peu fréquents (observés chez au moins 1 patient sur 1000 et moins d’1 patient sur 100) sont: • accélération du rythme cardiaque, • tension artérielle basse, • acceleration de la respiration, • brûlures d’estomac (sensation de douleur ou de brûlure juste en-dessous du sternum), • hémorroïdes, • pertes d’urine accidentelles ou • fuites urinaires, • besoin accru d’uriner, • prise de poids.
0.0 ||| Marketing Authorisation Holder Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom ||| Marketing Authorisation Holder Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom ||| 93 Titulaire de l’ Autorisation de mise sur le marché Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB Royaume-Uni
0.21418173611164093 ||| Set the tip of the pen on the prepared injection site and press the needle into the skin by pushing the pen downward until the shield is totally depressed. ||| After all of the solution is injected, withdraw the needle slowly, applying gentle pressure with the alcohol swab on the skin where the needle was inserted. ||| Placez l’ extrémité du stylo sur le point d’ injection préparé et enfoncez l’ aiguille dans la peau en exerçant une pression verticale sur le stylo jusqu’ à ce que le cache soit totalement enfoncé.
0.08165919780731201 ||| WHAT ADROVANCE IS AND WHAT IT IS USED FOR ||| WHAT APROVEL IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE ADROVANCE ET DANS QUEL CAS EST-IL UTILISE
0.416889488697052 ||| It could choke you. ► If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death no ||| changing from your previous basal insulin to Lantus hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night) ||| Si elle n’ est pas traitée, l’ hypoglycémie sévère peut causer des lésions cérébrales (temporaires ► ou permanentes) et même la mort
0.41700416803359985 ||| Aftershave creams ||| Pre-shave creams ||| Crèmes après-rasage
0.2594684362411499 ||| The skeletal effects of FORSTEO depend upon the pattern of systemic exposure. ||| 6 The skeletal effects of parathyroid hormone depend upon the pattern of systemic exposure. ||| Les effets de FORSTEO sur le squelette dépendent du mode d'exposition systémique.
0.30628955364227295 ||| 74 Neutropenia Caution should be exercised in patients with low leukocyte and/ or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of drug-induced bone marrow depression/ toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease. ||| In subjects treated with approved doses of etanercept in clinical trials for up to 12 months, cumulative rates of anti-etanercept antibodies were approximately 6% of subjects with rheumatoid arthritis, 7.5% of subjects with psoriatic arthritis, 2% of subjects with ankylosing spondylitis, 7% of subjects with psoriasis, 9.7% of subjects with paediatric psoriasis, and 3% of subjects with juvenile idiopathic arthritis. ||| Neutropénie La prudence s'impose chez les patients dont le nombre de leucocytes et/ ou de neutrophiles est faible quelle qu'en soit la cause, chez les patients recevant des médicaments connus pour induire des neutropénies, chez les patients ayant des antécédents de dépression médullaire ou de myélotoxicité médicamenteuse, chez les patients atteints de dépression médullaire qu'elle soit en relation avec une pathologie intercurrente, une radiothérapie ou une chimiothérapie et chez les patients atteints d'hyperéosinophilie ou de syndrome myéloprolifératif.
0.011403173208236694 ||| 58 4.4 Special warnings and precautions for use ||| 56 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.3625286817550659 ||| Glass powder ||| Chocolate powder ||| Poudre de verre
0.3927074670791626 ||| 44 the open-label extension phase indicate that the reduction in rate of progression of structural damage is maintained for 60 months in a subset of patients. ||| 7 Continued treatment for up to 24 months in an open-label extension of this study resulted in a continued increase in BMD. ||| Les résultats de la phase d'extension en ouvert montrent que le ralentissement de la progression des dommages structuraux est est maintenu sur 60 mois pour une partie des patients.
0.2236555814743042 ||| Powder for suspension for injection ||| Powder for solution for injection ||| Poudre pour suspension injectable
0.2007695436477661 ||| au If you use more Nespo than you should ||| 61 If you use more Omnitrope than you should ||| Si vous avez utilisé plus de Nespo que vous n’auriez dû am
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 102 4.9 Surdosage
0.4405960142612457 ||| A patient who requires surgery while on Trudexa should be closely monitored for infections, and lon appropriate actions should be taken. ||| The patient should be placed on a standard cholesterol-lowering diet, and should continue on this diet during treatment with . ||| Un patient traité par Trudexa nécessitant une intervention chirurgicale doit être attentivement surveillé afin de dépister des infections et des actions appropriées doivent être dic
0.25105929374694824 ||| Female rats receiving duloxetine (45 mg/ kg/ day) before and during mating and early pregnancy had a decrease in maternal food consumption and body weight, oestrous cycle disruption, decreased live birth indices and progeny survival, and progeny growth retardation at systemic exposure levels estimated to be at the most at maximum clinical exposure (AUC). ||| The A/ Vietnam/ 1203/ 2004 vaccine afforded protection against homologous challenge as evidenced by full survivorship, reduced weight loss, a less pronounced and shorter increase in temperature, a less marked reduction in lymphocyte counts and in reduction of inflammation and necrosis in brain and olfactory bulb in the vaccinated cohorts as compared to control animals. ||| Chez des rates recevant la duloxétine (45mg/ kg/ jour), avant et pendant l’ accouplement et en début de gestation, une diminution de la consommation de nourriture et du poids corporel, une perturbation du cycle œ stral, une baisse du taux de naissances vivantes et de survie de la progéniture, et un retard de croissance chez les jeunes rats à des taux d’ exposition systémique (Aire Sous la Courbe
0.021587906405329704 ||| 21 Vardenafil causes mild and transient decreases in blood pressure which, in the majority of the cases, do not translate into clinical effects. ||| Vardenafil causes mild and transient decreases in blood pressure which, in the majority of the cases, do not translate into clinical effects. ||| Le vardénafil donne lieu à des baisses légères et transitoires de la pression artérielle qui, dans la majorité des cas, ne se traduit par aucun effet clinique.
0.39487671852111816 ||| Temperature limiters for central heating radiators [thermostatic valves] incorporating expansion rods ||| Valves (solenoid controls for automatically operating -) [parts of heating installations] ||| Limiteurs de température pour radiateurs de chauffage central, équipés de tiges de dilatation [robinets thermostatiques]
0.07924634218215942 ||| In these cases, GONAL-f is started approximately 2 weeks after the start of agonist treatment, both being continued until adequate follicular development is achieved. ||| In a commonly used protocol, GONAL-f is started approximately 2 weeks after the start of agonist treatment, both being continued until adequate follicular development is achieved. ||| Dans d’ autres cas, lorsqu’ une désensibilisation avec un agoniste de la GnRH est utilisée, GONAL-f est administré environ 2 semaines après le début du traitement par l’ agoniste, les deux traitements étant poursuivis jusqu’ à l’ obtention d’ une croissance folliculaire adéquate.
0.17082712054252625 ||| Chemicals for use in immuno-assay testing [other than medical or veterinary] ||| Chemicals for use in molecular separation processes [other than medical and veterinary] ||| Produits chimiques pour immunoessais autres qu'à usage médical ou vétérinaire
0.19858086109161377 ||| Do not use Kineret after the expiry date which is stated on the label and carton after EXP. ||| Do not use ATryn after the expiry date stated on the labelling after the letters EXP. ||| Ne pas utiliser Kineret après la date de péremption mentionnée sur l’ étiquette de la seringue et sur la boîte après {EXP}.
0.5642025470733643 ||| Abacavir and its metabolites are secreted into the milk of lactating rats. ||| Ceftriaxone penetrates the inflamed meninges of newborn, infants and children. ||| Chez la rate allaitante, l’ abacavir et ses métabolites sont sécrétés dans le lait maternel.
0.36526286602020264 ||| Before infusing insulin lispro, the manufacturers instructions should be studied to ascertain the suitability or otherwise for the particular pump. ||| Instructions for use and handling Humalog cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer. ||| Avant toute perfusion d’insuline lispro, consultez les instructions du fabricant afin de vous assurer que la pompe peut être utilisée.
0.2107289880514145 ||| How to store KOGENATE Bayer 1000 IU 6. ||| Before you use KOGENATE Bayer 1000 IU 3. ||| Comment conserver KOGENATE Bayer 1000 UI 6.
0.3418917655944824 ||| Combinations of oral blood glucose lowering drugs, ATC code: ||| Preparations inhibiting uric acid production, ATC code: ||| Associations d’ hypoglycémiants oraux, code ATC:
0.42492061853408813 ||| When ritonavir is co-administered an increase in clarithromycin concentrations may occur. ||| Cross-resistance across the fluoroquinolone class of antibiotics is common. ||| La co-administration de ritonavir peut majorer l'augmentation des concentrations de la clarithromycine.
0.2729068994522095 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| Upon complete dissolution of the powder, the vial should be vented with a needle to dissipate any foam that may be present. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
0.34446167945861816 ||| Cross resistance with other cephalosporins and other beta- lactam antibacterials can be observed. ||| Disease exacerbations or infusion related events may indicate the development of antibodies against natalizumab. ||| Une résistance croisée avec d’ autres céphalosporines et d’ autres béta-lactamines peut être observée.
0.34057140350341797 ||| Always put the dosing cup back onto the cap after use and cleaning. ||| Put the pen back into the refrigerator immediately after you have used it. ||| Toujours replacer le gobelet-doseur sur le bouchon après utilisation et rinçage.
0.17467078566551208 ||| However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines. ||| However, some people very rarely experience drowsiness, which may affect their ability to drive or use machines. ||| Toutefois, les patients doivent être informés que très rarement une somnolence peut survenir chez certaines personnes et peut affecter leur aptitude à conduire des véhicules ou à utiliser des machines.
0.388291597366333 ||| In addition, LYRICA is available in an HDPE bottle containing 200 capsules for the 75, 150 and 300 mg strengths. ||| In addition, TOVIAZ is also available in HDPE bottles containing 30 or 90 tablets. ||| LYRICA est également disponible en flacon PEHD contenant 200 gélules pour les dosages à 75, 150 et 300 mg.
0.36164426803588867 ||| Now you’ re ready to set the dose you need • Turn the cap in the direction of the arrow (picture F) to set the right dose. ||| If the dose you have dialled is too high, simply turn the dose knob backward (anticlockwise) until the correct dose is seen in the dose window. ||| Vous pouvez alors sélectionner la dose désirée Faites tourner le capuchon dans le sens de la flèche (figure F) pour sélectionner la dose • requise.
0.20125430822372437 ||| Keyboards for smartphones ||| Covers for smartphones ||| Claviers pour smartphones
0.005656557623296976 ||| 236 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 253 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 241 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.34752172231674194 ||| ARICLAIM is used in adults to treat a condition called diabetic neuropathic pain. ||| PROTELOS is a non-hormonal medicine used to treat osteoporosis in postmenopausal women. ||| ARICLAIM est un médicament destiné au traitement, par voie orale, d’ une affection appelée douleur neuropathique diabétique chez l’ adulte.
0.3215721547603607 ||| Moderate or severe hepatic impairment (see sections 4.2 and 5.2). ||| Severe renal impairment is contraindicated (see section 4.3.). ||| Insuffisance hépatique modérée ou sévère (voir rubriques 4.2 et 5.2).
0.03523315116763115 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Kineret on 8 March 2002. ||| The European Commission granted a marketing authorisation valid throughout the European Union for Zerene on 12 March 1999. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Kineret, le 8 mars 2002.
0.28863784670829773 ||| It should be noted that unfractionated heparin can be administered at doses necessary to maintain a patent central venous or arterial catheter (see sections 4.2 and 4.4). ||| It is important to follow the instructions to administer Rapamune oral solution at once when a plastic container is used for the dilution and/ or administration (see section 6.6). ||| Il faut noter que l’héparine non fractionnée peut être administrée à des doses nécessaires au maintien de la perméabilité d'un cathéter central artériel ou veineux (voir rubriques 4.2 et 4.4).
0.3672005534172058 ||| Sodium chloride and water for injections. ||| Sodium Chloride, Water for injections. ||| Chlorure de sodium et eau pour préparations injectables.
0.0 ||| Medicinal product subject to medical prescription. ||| Medicinal product subject to medical prescription. ||| Médicament soumis à prescription médicale
0.3652912378311157 ||| Constitutive activation of the PDGF receptor or the Abl protein tyrosine kinases as a consequence of fusion to diverse partner proteins or constitutive production of PDGF have been implicated in the pathogenesis of MDS/ MPD, HES/ CEL and DFSP. ||| In vitro the affinity binding of recombinant hLH to the LH/ CG receptor on Leydig tumour cells (MA-10) is between that for hCG and that of pituitary hLH, but within the same order of magnitude. ||| L’ activation constitutive du récepteur du PDGF ou des tyrosine kinases Abl, résultant de la fusion à différentes protéines partenaires ou de la production constitutive de PDGF, sont impliquées dans la pathogénèse des SMD/ SMP, des SHE/ LCE et du DFSP.
0.5657336115837097 ||| Rispolin 1 mg/ ml - 1 mg orale Lösung ||| Risperdal Risperdal 1 mg 1 mg/ ml, drank ||| Rispolin 1 mg/ ml 1 mg - orale Lösung
0.21153104305267334 ||| Other information about Pegasys: ||| Other information about Ziagen: ||| Autres informations relatives à Pegasys:
0.36091506481170654 ||| Therefore, steroid replacement may be necessary in these patients. ||| Therefore, breast-feeding is not recommended during treatment. ||| Par conséquent, un traitement substitutif en glucocorticoïdes peut s’ avérer nécessaire chez ces patients.
0.36831584572792053 ||| Early virological response by Week 12, defined as a 2 log viral load decrease or undetectable levels of HCV-RNA, has been shown to be predictive for sustained response. ||| The primary endpoint in the AP patients was overall confirmed haematological response (HR), defined as either a complete haematological response, no evidence of leukaemia or return to chronic phase. ||| 172 L’ obtention d’ une réponse virologique précoce à la 12ème semaine, définie comme une diminution de 2 log de la charge virale ou des niveaux indétectables de l’ ARN-VHC, s’ est révélée être prédictive d’ une réponse prolongée.
0.2759369909763336 ||| SINGULAIR is indicated in the treatment of asthma as add-on therapy in those 2 to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “ as-needed” short acting β -agonists provide inadequate clinical control of asthma. ||| These trials, involving 1308 patients with a history of an average of 23 years of partial-onset seizures, were designed to evaluate the efficacy and safety of lacosamide when administered concomitantly with 1-3 antiepileptic drugs in patients with uncontrolled partial-onset seizures with or without secondary generalisation. ||| SINGULAIR est indiqué en traitement additif chez les patients âgés de 2 à 5 ans présentant un asthme persistant léger à modéré insuffisamment contrôlé par corticothérapie inhalée et chez qui les bêta-2- mimétiques à action immédiate et de courte durée administrés « à la demande » n’ apportent pas un contrôle clinique suffisant de l’ asthme.
0.302569717168808 ||| Patients should be monitored closely for adverse reactions when entecavir is coadministered with such medicinal products. ||| Caution should be exercised if patients are required to take medicinal products that inhibit platelet function or anticoagulants. ||| Les patients devront être étroitement surveillés lorsque l'entecavir est administré avec de tels médicaments.
0.3119092583656311 ||| Somatropin and analogues, ATC Code: ||| Fluoroquinolones, ATC code: ||| Somatropine et analogues, Code ATC:
0.2280595898628235 ||| After reconstitution with the appropriate volume of solvent (water for injections), each vial contains octocog alfa 400 IU/ ml. ||| The volume of diluted sodium pertechnetate (99mTc) solution for injection, added to the vial must be 1 ml. ||| Après reconstitution avec le volume approprié de solvant (eau pour préparations injectables), chaque flacon contient 400 UI/ ml d’ octocog alfa.
0.5574078559875488 ||| Coronavirus: Commission offers financing to innovative ||| Coronavirus: An EU approach for efficient contact tracing ||| Coronavirus: la Commission propose un financement au
0.4880102574825287 ||| Several foods can naturally contain toxins, many of which are not produced by bacteria. ||| These medicines contain human antibodies, which are also present in your blood. ||| En contraste, divers aliments peuvent contenir naturellement des toxines qui ne sont pas produites par des bactéries et sont présentes naturellement dans les denrées alimentaires, parmi lesquelles :
0.05731556564569473 ||| These results suggest that some patients who have not responded by Week 4 benefit from continued maintenance therapy through Week 12. ||| These results suggest that some patients who have not responded by week 4 benefit from continued maintenance therapy through week 12. ||| Ces résultats suggèrent que certains patients n'ayant pas répondu à la semaine 4 bénéficient de la poursuite du traitement d'entretien jusqu'à la semaine 12.
0.06568300724029541 ||| 86 1. ||| 85 1. ||| 87 1.
0.22435566782951355 ||| Keep the vial in the outer carton in order to protect from light After reconstitution, protect from light and use immediately within 3 hours. ||| • Do not refrigerate or freeze. • Keep the vial in the outer carton until time of use in order to protect from light. ||| Après reconstitution, protéger le produit de la lumière et utiliser dans les 3 heures.
0.2980356812477112 ||| Distribution As systemic exposure is low with tacrolimus ointment, the high binding of tacrolimus (> 98.8%) to plasma proteins is considered not to be clinically relevant. ||| In general, susceptibility to atazanavir was retained (83% of isolates displayed < 2.5 fold change in EC50) among isolates resistant to no more than 2 protease inhibitors. ||| Distribution Compte tenu de la faible exposition systémique après application de tacrolimus pommade, il n'est pas considéré que la forte fixation du tacrolimus aux protéines plasmatiques (> 98,8%) ait une conséquence clinique.
0.1965254247188568 ||| 26 For any information about this medicinal product, please contact the representative in your country: ||| 26 For any information about this medicinal product, please contact the representative of Eli Lilly in your country: ||| 27 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’autorisation de mise sur le marché:
0.09987682104110718 ||| Do not use the cartridge if the solution contains particles or if the solution is not clear. ||| Do not use if the solution contains particles or if the solution is not clear. ||| Ne pas utiliser la cartouche si la solution contient des particules ou si la solution n’ est pas limpide.
0.4470358192920685 ||| - This anorectic agent should be used with caution in epileptic patients. ||| Ibaflin gel should only be used based on susceptibility testing. ||| Cet anorexigène doit être utilisé avec prudence chez les sujets épileptiques.
0.22840052843093872 ||| 35%*** ||| 12%** ||| 38%*** 35%***
0.24202832579612732 ||| Before you use Preotact 3. ||| Before you use Cetrotide 3. ||| Quelles sont les informations à connaître avant d'utiliser Preotact 3.
0.307539165019989 ||| Calls on the Commission to strengthen all components of crisis management and disaster response, and to further strengthen instruments such as RescEU to ensure a truly common, coordinated and effective response at EU level; believes that European disaster risk management, preparedness and prevention should be enhanced in addition to common equipment, materials and medicines stocks, in order to allow for their quick mobilisation to protect the lives and livelihoods of EU citizens; believes that the EU Civil Protection Mechanism should be strengthened in order to facilitate the joint repatriation of EU citizens; ||| Moreover, within InvestEU, the Commission is proposing to create a Strategic Investment Facility to increase Europe's resilience by building strategic autonomy in vital supply chains at the European level, while maintaining its openness to competition and trade in line with its rules.Thanks to provisioning of €15 billion from Next Generation EU, the new facility would provide an EU budget guarantee of €31.5 billion and could generate investments of up to €150 billion in strategic sectors and key value chains, including those crucial to the twin green and digital transitions. ||| 10. demande à la Commission de renforcer toutes les composantes de la gestion des crises et de la réaction aux catastrophes, et de renforcer davantage encore les instruments tels que RescEU afin de garantir une réaction véritablement commune, coordonnée et efficace au niveau de l'Union; estime qu'il convient d'améliorer la gestion, la préparation et la prévention des risques de catastrophes en Europe, et qu'il convient en outre de constituer des stocks communs d'équipements, de matériaux et de médicaments, afin de pouvoir les mobiliser rapidement pour protéger la vie et les moyens de subsistance des citoyens de l'Union; estime qu'il convient de renforcer le mécanisme européen de protection civile pour faciliter le rapatriement commun des citoyens de l'Union;
0.06826017796993256 ||| In the first study, the effectiveness of two different doses of Neupro was compared with that of placebo and in the second, it was compared with pramipexole (another dopamine agonist) and with placebo. ||| In the first study, the effectiveness of Neupro was compared with that of placebo (a dummy treatment) and in the second, it was compared with ropinirole (another dopamine agonist) and with placebo. ||| Dans la première étude, l’ efficacité de deux doses différentes de Neupro a été comparée à celle d’ un placebo et, dans la deuxième, elle a été comparée à celle du pramipexole (un autre agoniste de la dopamine) et d’ un placebo.
0.0 ||| 250 IU ||| 250 IU ||| Dosage 250 UI
0.769736647605896 ||| AsV is present in plasma only at relatively low levels. ||| 12/ 21 that reaches in lung are always higher than in plasma. ||| AsV est présent uniquement dans le plasma à des niveaux relativement faibles.
0.2876066565513611 ||| Croscarmellose sodium Magnesium stearate Maize starch Mannitol (E421) Povidone (E1201) ||| Povidone (K25) Meglumine Sodium hydroxide Sorbitol (E420) Magnesium stearate. ||| Croscarmellose sodique Stéarate de magnésium Amidon de maïs Mannitol (E421) Polyvidone (E1201)
0.22453926503658295 ||| 125 Č eská republika Novartis s. r. o. ||| Č eská republika Pfizer s. r. o. ||| Č eská republika Novartis s. r. o.
0.4517661929130554 ||| This appropriation is intended to cover expenditure on the Agency's obligations in respect of entertainment and representation. ||| This appropriation is intended to cover expenditure incurred by the Commission for administrative assistance given to the Agency, e. g. computerised payroll service. ||| Ce crédit est destiné à couvrir les dépenses afférentes aux obligations incombant à l'Agence en matière de réception et de représentation.
0.2576780915260315 ||| How does NeoSpect work? ||| How does BeneFIX work? ||| Comment NeoSpect fonctionne -t-il?
0.5849185585975647 ||| AIDS-KS patients with splenectomy: ||| * For HBeAg-positive patients: ||| Patients avec un SK-SIDA splénectomisés:
0.2929036617279053 ||| Appropriate measures should be taken and discontinuation of parecoxib therapy should be considered if there is clinical evidence of deterioration in the condition of specific clinical symptoms in these patients (see section 5.1). ||| Based on the clinical observations in this group of patients, there is no evidence to suggest that a change in topiramate dose and dosage schedules is needed if co- administered with stiripentol. ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une preuve clinique de détérioration symptomatique de l’ état de ces patients (voir rubrique 5.1 Propriétés pharmacodynamiques).
5.168437292729644e-13 ||| However, as clinical experience with olanzapine in patients with concomitant illness is limited, caution is advised when prescribing for patients with prostatic hypertrophy, or paralytic ileus and related conditions. ||| However, as clinical experience with olanzapine in patients with concomitant illness is limited, caution is advised when prescribing for patients with prostatic hypertrophy, or paralytic ileus and related conditions. ||| 19 l’ olanzapine étant limitée chez les patients ayant une pathologie associée, la prudence est recommandée lors de sa prescription chez des patients présentant des symptômes d’ hypertrophie prostatique, d’ iléus paralytique ou de toute autre pathologie en rapport avec le système cholinergique.
0.4743712246417999 ||| Hiring of surgical instruments ||| Medical and surgical dressings ||| Location d'instruments chirurgicaux
0.0 ||| Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. ||| Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. ||| 27 Au sein de chaque catégorie de fréquence, les effets indésirables sont présentés par ordre de gravité décroissante.
0.28663885593414307 ||| Dosing should be reduced to 150 mg Pradaxa daily in patients who received concomitantly dabigatran etexilate and amiodarone (see section 4.5). ||| 245 mg tenofovir disoproxil (as fumarate) may be administered every 7 days following completion of a haemodialysis session*. ||| La posologie de Pradaxa doit être réduite à 150 mg/ jour chez les patients traités à la fois par dabigatran etexilate et amiodarone (voir rubrique 4.5).
0.4781419336795807 ||| 32 (38) Very common: ||| 89 (86) Very common: ||| 32 (38) Très fréquent:
0.5100434422492981 ||| Promoting services for baseball game ||| Reservation services for concert tickets ||| Services de promotion de matchs de base-ball
0.15105436742305756 ||| • 12.7.2002 • 10.9.2002 ||| • 27.6.2002 • 19.8.2002 ||| 12.7.2002 10.9.2002
0.31337690353393555 ||| 45 18.9 2.9-76.2 ||| 37 49.0 13.3-145.7 ||| 45 18,9 2,9-76,2
0.10231877118349075 ||| Like all medicines, Xenical can cause side effects, although not everybody gets them. ||| Like all vaccines, Prevenar can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Xenical peut provoquer des effets indésirables, mais ils ne surviennent pas systématiquement chez tout le monde.
0.0504080206155777 ||| 673 Travel ||| 645 Travel ||| Voyages
0.5676544904708862 ||| "As soon as cases appeared in the UK on 31 January 2020, a public health information campaign, similar to the previous ""Catch it, Bin it, Kill it"" campaign, was launched in the UK, to advise people how to lessen the risk of spreading the virus." ||| He pointed out mistakes in the initial response to the crisis: "We could have acted earlier, we could have acted more decisively, we could have actually acted together", but added: "The European Union is the great hope that millions of Spaniards are looking to". ||| Dès l'apparition des premier cas au Royaume-Uni le 31 janvier, une campagne d'information sur la santé publique, similaire à la précédente campagne « Catch it, Bin it, Kill it », est lancée pour conseiller les gens sur la manière de réduire le risque de propager le virus.
0.2535889446735382 ||| Excipient: each hard capsule contains 114 mg of lactose monohydrate. ||| This medicinal product contains 50 mg of sorbitol per ml as excipient. ||| 114 mg de lactose monohydraté par gélule.
0.018153291195631027 ||| BOTTLE CARTON X 60 FILM-COATED TABLETS (150 mg) ||| BOTTLE CARTON X 30 FILM-COATED TABLETS (300 mg) ||| CONDITIONNEMENT EXTERIEUR (ETUI – FLACON X 60 COMPRIMES PELLICULES (150 mg))
0.5734239816665649 ||| HOW TO STORE IRBESARTAN HYDROCHLOROTHIAZIDE BMS ||| 65 PATIENT ALERT CARD TEXT FOR RHEUMATOID ARTHRITIS ||| COMMENT CONSERVER IRBESARTAN HYDROCHLOROTHIAZIDE BMS
0.35280126333236694 ||| (b) Pull dose knob out (in direction of the arrow) until a “ 0” appears in the dose window. ||| After the second “click” (or a count of 15) lift the pre-filled pen from the injection site. ||| (b) Tirer la bague de dosage (dans le sens de la flèche) jusqu'à ce que le chiffre "0" apparaisse dans la fenêtre de lecture.
0.27234798669815063 ||| 123 If you are a breast-feeding mother, you should stop breast-feeding during Trudexa treatment and for at least 5 months after the last Trudexa treatment. ||| If you are being treated with Remicade, you must avoid getting pregnant by using adequate contraception during your treatment and for at least 6 months after the last Remicade infusion. ||| Si vous allaitez, vous devriez arrêter l’allaitement pendant le traitement par Trudexa et pendant au moins 5 mois après l’arrêt du traitement.
0.4637906849384308 ||| Most of the side effects that occurred during studies were mild. ||| Other less common side effects have been reported and some of these were serious. ||| La plupart des effets indésirables qui sont survenus pendant les études de FABLYN ont été discrets.
0.40170860290527344 ||| In patients with moderately impaired hepatic function, the dose should be restricted to 15 mg daily. ||| Consideration must be given to pigs whose daily feed intake is reduced or restricted. ||| Chez les patients présentant une insuffisance hépatique modérée, la posologie ne devrait pas excéder 15 mg par jour.
0.28211379051208496 ||| The proportions of RISPERDAL and placebo-treated adult patients with schizophrenia meeting a weight gain criterion of ≥ 7% of body weight were compared in a pool of 6- to 8-week, placebo-controlled trials, revealing a statistically significantly greater incidence of weight gain for RISPERDAL (18%) compared to placebo (9%). ||| Based on Kaplan-Meier estimates, the probability of survival up to day 100 after randomization, was significantly higher for posaconazole recipients; this survival benefit was demonstrated when the analysis considered all causes of death (P= 0.0354) as well as IFI-related deaths (P = 0.0209). ||| Les pourcentages de patients adultes schizophrènes traités par RISPERDAL et placebo et atteignant le critère de prise de poids > 7% ont été comparés dans une analyse poolée d’ essais contrôlés versus placebo d’ une durée de 6 à 8 semaines, montrant une incidence significativement plus élevée de prise de poids dans le groupe RISPERDAL (18%) comparé au placebo (9%).
0.5192720890045166 ||| Patients with contraindications to radioactive tracer monitoring. ||| Preservatives against the deterioration of masonry ||| Patients présentant une contre-indication à l’ utilisation de marqueurs radioactifs.
0.26268601417541504 ||| Sodium chloride L-histidine Polysorbate 80 Sodium borate Water for injections ||| Trehalose dihydrate Sodium phosphate Polysorbate 20 Water for injections ||| Chlorure de sodium L-histidine Polysorbate 80 Borate de sodium Eau pour préparations injectables
0.2114056944847107 ||| They recommended that Eurican Herpes 205 should be given a marketing authorisation. ||| They recommended that Ibraxion should be given a marketing authorisation. ||| Il a également recommandé l’ octroi d’ une autorisation de mise sur le marché d’ Eurican Herpes 205.
0.30316340923309326 ||| Mild hepatic impairment did not notably affect the pharmacokinetics of cinacalcet. ||| Ethnic origin does not affect the pharmacokinetics of dabigatran in a clinically relevant manner. ||| Insuffisance hépatique: le profil pharmacocinétique du cinacalcet n’ a pas été particulièrement modifié chez les patients présentant une insuffisance hépatique légère.
0.7119377851486206 ||| Tyre analysis services ||| Ramen restaurant services ||| Services d'analyse de pneus
0.07535117119550705 ||| - monoamine axydase (MAO) inhibitors (used to treat depression), ||| - monoamine oxidase (MAO) inhibitors (used to treat depression), ||| - les inhibiteurs de la monoamine oxydase (IMAO) (utilisés pour traiter la dépression),
0.4391706585884094 ||| Cases for stamps [seals] ||| Commemorative stamps [seals] ||| Coffrets à timbres [cachets]
0.0 ||| If you forget to give yourself an injection, you should inject the next dose of Trudexa as soon as you remember. ||| If you forget to give yourself an injection, you should inject the next dose of Trudexa as soon as you remember. ||| Si vous oubliez de vous faire une injection, vous devrez vous injecter Trudexa dès que vous vous en souviendrez.
0.21475964784622192 ||| In carcinogenicity studies agomelatine induced an increase in the incidence of liver tumours in the rat and the mouse, at a dose at least 110-fold higher than the therapeutic dose. ||| No evidence of carcinogenicity was found in studies in mice and rats at the maximum tolerated dose, although the exposure to rivastigmine and its metabolites was lower than the human exposure. ||| Dans les études de cancérogénèse, l'agomélatine a induit une augmentation de l'incidence de tumeurs hépatiques chez le rat et la souris à des doses au moins 110 fois supérieures à la dose thérapeutique.
0.45235341787338257 ||| 0.90 (0.60, 1.35) ||| 1.09 (0.85 to 1.39) ||| 0,90 (0,60 - 1,35)
0.5239386558532715 ||| • Other possible effects ||| • Other possible side effects: ||| • Autres effets éventuels
0.4440344572067261 ||| 305 HOW TO SELF-INJECT VIRAFERONPEG? ||| INFORMATION ON HOW TO SELF-INJECT Valtropin ||| 323 COMMENT VOUS AUTO-INJECTER VIRAFERONPEG?
0.39736777544021606 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that TESAVEL’ s benefits are greater than its risks for the treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin and/ or a sulphonylurea, or a PPAR gamma agonist, when diet and exercise plus the other medicines do not provide adequate glycaemic control. ||| But soap and water is more effective than alcohol-based hand rubs for reducing H1N1 influenza A virus and Clostridium difficile spores from hands.Interventions to improve hand hygiene in healthcare settings can involve education for staff on hand washing, increasing the availability of alcohol-based hand rub, and written and verbal reminders to staff. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de TESAVEL sont supérieurs aux risques qu’ il comporte pour le traitement des patients souffrant de diabète de type 2 en vue d’ améliorer le contrôle de la glycémie, en association avec la metformine et/ ou un sulfamide hypoglycémiant, ou un agoniste des PPAR
0.8038649559020996 ||| Nervous system disorders Very rare (< 1/ 10,000) ||| Very common rash (all grades, 18%) ||| Affections du système nerveux Très rares (< 1/ 10 000)
0.06269682198762894 ||| 68 EMEA General Report 2000 ||| 47 EMEA General Report 2000 ||| 74 Rapport annuel EMEA 2000
0.03380517661571503 ||| Allow the vaccine to reach a temperature of 15°C-25°C and shake well before use. ||| e Allow the vaccine to reach a temperature of 15°C-25°C and shake well before use. ||| Laisser le vaccin atteindre une température de + 15 à + 25°C et agiter correctement avant l’ emploi.
0.18827110528945923 ||| HOW TO USE HUMALOG BASAL KWIKPEN ||| HOW TO USE LIPROLOG KWIKPEN ||| COMMENT UTILISER HUMALOG BASAL KWIKPEN
0.0021552671678364277 ||| Before first use, Insuman Comb 25 must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents. ||| Before first use, Insuman Comb 15 must be kept at room temperature for 1 to 2 hours and then resuspended to check the contents. ||| Avant la première utilisation, Insuman Comb 25 doit être conservé à température ambiante pendant 1 à 2 heures, puis remis en suspension pour en vérifier le contenu.
0.06322865933179855 ||| The full EPAR for INVANZ can be found here. ||| The full EPAR for TOVIAZ can be found here. ||| L’ EPAR complet est disponible à l’ adresse suivante: ici.
0.7308996915817261 ||| The sector will also contribute to the ongoing supervision and management of the site. ||| The company also plans to continue their compassionate use programme. ||| Le secteur contribuera également à la supervision et la gestion permanentes du site.
0.275967001914978 ||| The use of ciprofloxacin for specific severe infections other than those mentioned above has not been evaluated in clinical trials and the clinical experience is limited. ||| There is limited clinical experience with the effects of an acute overdose of Sonata, and overdose levels in humans have not been determined. ||| L’utilisation de la ciprofloxacine dans ces infections sévères spécifiques autres que les infections mentionnées plus haut n’a pas été évaluée lors des essais cliniques et l’expérience clinique dans ce domaine est limitée.
0.4455152153968811 ||| In very rare cases a fatal outcome has been reported. ||| Rare cases with fatal outcome were reported. ||| Dans de très rares cas, une évolution fatale a été rapportée.
0.21435976028442383 ||| (see sections 4.2 and 4.3) the potential risks and benefits of anagrelide therapy in a patient with impairment of renal function should be assessed before treatment is commenced. ||| The response to treatment and renal function should be closely monitored in all patients with some degree of renal insufficiency) (see also sections 4.4 and 5.2). ||| (cf rubriques 4.2 et 4.3) Les risques et bénéfices potentiels du traitement par anagrélide chez un patient insuffisant rénal doivent être évalués avant d’ entamer le traitement.
0.21932563185691833 ||| 5.1 Pharmacodynamic properties ||| 5.1 Pharmacodynamic properties: ||| 5.2 Propriétés pharmacodynamiques
0.5834637880325317 ||| This is important for the proper functioning of the test. ||| Safety of the product was satisfactorily demonstrated. ||| Ceci est important pour le bon fonctionnement du test.
0.6071760654449463 ||| Smoke projectiles for rockets ||| Fitted pushchair mosquito nets ||| Projectiles fumigènes pour roquettes
0.20185106992721558 ||| Patients treated with PegIntron and ribavirin combination therapy and zidovudine are at increased risk of developing anaemia and therefore the concomitant use of this combination with zidovudine is not recommended (see section 4.5). ||| The combination product lopinavir/ ritonavir should not be used with PREZISTA because co-administration causes large decreases in darunavir concentrations, which may in turn significantly decrease the darunavir therapeutic effect (see section 4.5). ||| Les patients traités par l’ association PegIntron et ribavirine et la zidovudine présentent un risque augmenté de développer une anémie; par conséquent, l’ administration concomitante de cette association avec la zidovudine n’ est pas recommandée (voir rubrique 4.5).
0.5039854049682617 ||| Adjunctive therapy WITH valproate (inhibitor of lamotrigine glucuronidation – see section 4.5): ||| Frequency of adverse reaction by treatment regimen Rosiglitazone monotherapy Rosiglitazone with sulphonylurea ||| Traitement en association AVEC le valproate (inhibiteur de la glucuronisation de la lamotrigine – voir rubrique 4.5):
0.34074482321739197 ||| Fabrics for industrial use ||| Fabric glues for industrial use ||| Tissus à usage industriel
0.4596930742263794 ||| 65.1% NA ||| 85.2% / ||| 46,0%
0.3209323585033417 ||| For patients with neovascularisation caused by pathologic myopia, after 12 months, 86% of the Visudyne-treated patients had a loss of less than 15 letters compared with 67% of the placebo-treated patients. ||| Three docetaxel patients (2%) discontinued the treatment due to fluid retention, whereas 15 doxorubicin patients (9%) discontinued due to cardiac toxicity (three cases of fatal congestive heart failure). ||| Pour les patients atteints de néovascularisation due à la myopie forte, après 12 mois de traitement, 86% des patients traités par Visudyne présentaient une perte de moins de 15 lettres, contre 67% des patients traités par le placebo.
0.37360525131225586 ||| Resistance to entecavir (when a virus becomes insensitive to the antiviral) has been seen in lamivudine-refractory patients. ||| The relationship between in vitro susceptibility of HIV to lamivudine and clinical response to lamivudine-containing therapy remains under investigation. ||| Une résistance à l’ entecavir (lorsque le virus devient insensible à l’ action de l’ antiviral) a été observée chez les patients réfractaires à la lamivudine.
0.12074343115091324 ||| AVENTIS PHARMA DEUTSCHLAND GMBH D-65926 Frankfurt am Main, Germany ||| SANOFI-AVENTIS DEUTSCHLAND GMBH 65926 Frankfurt am Main Germany ||| AVENTIS PHARMA DEUTSCHLAND GMBH D-65926 Frankfurt am Main, Allemagne
0.08713553845882416 ||| Together towards environmental and climate resilience ||| Together towards environmental and climate resilience; ||| Ensemble pour une résilience environnementale et climatique
0.24213775992393494 ||| Sitagliptin also reduces the amount of glucose made by the liver, by increasing insulin levels and decreasing the levels of the hormone glucagon. ||| By enhancing active incretin levels, sitagliptin increases insulin release and decreases glucagon levels in a glucose- dependent manner. ||| La sitagliptine réduit également la production de glucose par le foie, en augmentant le taux d’ insuline et en réduisant le taux de glucagon.
0.3166618347167969 ||| If you are unable to swallow the tablets, you can dissolve them in a glass of mineral water or apple juice: • Put the required number of tablet(s) in a sufficient quantity of liquid (approximately 50 ml for a 100 mg tablet and 200 ml for a 400 mg tablet) • Stir with a spoon until the tablets have dissolved completely • Immediately drink the whole content of the glass. ||| • Wash your hands thoroughly with soap and water before using your pen. • Clean the cartridge rubber seal with an alcohol swab or cotton ball saturated with alcohol. • Avoid touching the cartridge rubber seal at all times. • If you accidentally touch the cartridge rubber seal, clean it with an alcohol swab. • Do not use the same needle for more than one person. • Use needles only once. ||| Si vous avez des difficultés pour avaler les comprimés, vous pouvez les dissoudre dans un verre d’ eau minérale ou de jus de pomme: • Placez le nombre requis de comprimé(s) dans une quantité suffisante de liquide (environ 50 ml pour un comprimé à 100 mg et 200 ml pour un comprimé à 400 mg) • Remuez avec une cuillère jusqu’ à dissolution complète du comprimé • Buvez immédiatement la totalité du contenu du verre.
0.5576527118682861 ||| The following documents were adopted or released for consultation by the CPMP in 1998: ||| Details of the guidance documents expected to be released for consultation or finalised in 2003 are given in Annex 3. ||| Les documents suivants ont été adoptés ou transmis pour consultation par le CPMP en 1998:
0.4344671368598938 ||| Bleomycin is a cytostatic substance; this means that it stops the growth of cells. ||| This means that it blocks a specific type of opioid receptor called the ‘ mu-opioid receptor’. ||| Bleomycin est une substance cytostatique, ce qui signifie qu’ elle interrompt la croissance cellulaire.
0.42859208583831787 ||| You must take adequate contraceptive precautions during therapy and for at least three months after TAXOTERE is no longer administered to you. ||| However, if you do not take Tredaptive for 7 or more days in a row, talk to your doctor before restarting Tredaptive. ||| Vous devez prendre des mesures contraceptives adéquates pendant le traitement et les poursuivre au moins 3 mois après la fin de l'administration de TAXOTERE.
0.46949368715286255 ||| Polyurethane leather ||| Polyurethane adhesives ||| Cuir en polyuréthane
0.5473642945289612 ||| 10 ml single use vial. ||| Empty reaction vial (10 ml) ||| Flacon à usage unique 5 ml.
0.3543456196784973 ||| After two to four weeks of taking Rasilez HCT, the dose can be increased in patients whose blood pressure remains uncontrolled. ||| If subsequent monitoring shows that 85 dB is not surpassed for an eight-hour TWA, the employee is no longer required to wear hearing protection. ||| Après un traitement de deux à quatre semaines à base de Rasilez HCT, la dose peut être augmentée chez les patients dont la pression artérielle reste hors contrôle.
0.2595905065536499 ||| The cap is imprinted with the Boehringer Ingelheim company symbol, the body with “ R75”. ||| The Boehringer Ingelheim logo is printed on the cap and “ R75 ” on the body of the capsule. ||| La coiffe porte le logo imprimé de Boehringer Ingelheim, le corps est imprimé du code « R 75 ».
0.4199983775615692 ||| Elderly patients There is no evidence to suggest that dose adjustments are necessary in the patients over 65 years of age (see section 4.8). ||| Experience in patients aged 75 years and older is limited and caution should be exercised when treating this population (see also sections 5.1 and 5.2). ||| Il n'existe aucun élément suggérant que des ajustements de la posologie soient nécessaires chez les sujets âgés de plus de 65 ans (voir rubrique 4.8).
0.46524566411972046 ||| Rare • Myocardial infarct ||| Benign Prostatic hyperplasia: ||| Rare • Infarctus du myocarde
0.2215401530265808 ||| The blood level of this medicine can be increased or reduced. • caffeine (used as a stimulant), pentoxifylline (used to treat circulatory disorders in the limbs) and mexiletine (used to treat irregular heart beat). ||| It must also not be used in patients who are taking medicines that slow down the breakdown of Valdoxan in the body, such as fluvoxamine (another antidepressant) and ciprofloxacin (an antibiotic). ||| Le taux de ce médicament dans le sang peut augmenter ou diminuer. • caféine (utilisée comme stimulant), pentoxifylline (pour le traitement des troubles de la circulation dans les membres inférieurs) et mexilétine (pour le traitement de l’ arythmie).
0.29380056262016296 ||| The European Commission has approved a Polish aid scheme to support the Polish economy in the context of the coronavirus outbreak.The scheme was approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 . ||| The existing scheme, called "Fonds de solidarité" had initially been approved on 30 March 2020 under theState aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020 . ||| Le régime a été approuvé au titre de l' encadrement temporaire des mesures d'aide d'État adopté par la Commission le 19 mars 2020, tel que modifié le 3 avril 2020 .
0.8692508935928345 ||| The marketing authorisation holder is Janssen-Cilag International NV. ||| Around €488 million through Gavi, the Vaccine Alliance. ||| Le titulaire de l’ autorisation de mise sur le marché est Janssen-Cilag International NV.
0.44426459074020386 ||| Ventavis solution that you do not use in one inhalation session has to be thrown away. ||| You should not start breast-feeding until the IONSYS system has been removed for 24 hours. ||| La solution de Ventavis qui n’ a pas été utilisée au cours d’ une séance d’ inhalation doit être jetée.
0.3252301812171936 ||| p=0.029 ||| p = 0.029 ||| p= 0,029
0.32510584592819214 ||| Fulvestrant has been shown to cross the placenta after single intramuscular doses in rat and rabbit. ||| Montelukast has been shown to cross the placental barrier and is excreted in breast milk of animals. ||| Le fulvestrant traverse le placenta après une injection unique intramusculaire chez la rate et la lapine.
0.5306546688079834 ||| The EMEA developed and introduced a procedure for follow-up actions following testing. ||| This way, appropriate follow-up action can be taken everywhere in the EU. ||| L’ EMEA a développé et introduit une procédure pour les mesures de suivi consécutive aux tests.
0.4203184247016907 ||| Cases of proteinuria and rare cases of nephrotic syndrome have been reported. ||| Fatal cases of SJS, TEN and hypersensitivity reactions have been reported. ||| Des cas de protéinuries et de rares cas de syndrome néphrotique ont été rapportés.
0.045715175569057465 ||| Adopted March 2001 ||| Adopted March 2002 ||| Statut adopté en mars 2001
0.14517566561698914 ||| Patients with severe hepatic impairment ||| Use in patients with hepatic impairment ||| 2 Patients atteints d’ insuffisance hépatique sévère
0.22591632604599 ||| Concentrations of amiodarone, flecainide or propafenone may be increased when co-administered with Invirase/ ritonavir. ||| Cyclosporin, sirolimus (rapamycin) and tacrolimus: concentrations may be increased when co-administered with Kaletra. ||| Les concentrations d’ amiodarone, flécaïnide ou propafénone peuvent être augmentées en cas de co-administration avec Invirase/ ritonavir.
0.3206039369106293 ||| In terms of investments to reduce greenhouse gas emissions, through the Eastern Europe Energy Efficiency and Environment Partnership, the E5P Fund has provided more than €150 million in investment grants to 36 projects benefitting 8 million people. ||| Finally, the European and Developing Countries Clinical Trials Partnership (EDCTP) is funding three calls of up to €28 million from Horizon 2020 to support research on the coronavirus and strengthen research capacities in sub-Saharan Africa. ||| Pour ce qui est des investissements visant à réduire les émissions de gaz à effet de serre, dans le cadre du partenariat pour l'efficacité énergétique et l'environnement en Europe orientale, le Fonds E5P a fourni plus de 150 millions d'euros sous la forme de subventions à l'investissement à 36 projets bénéficiant à huit millions de personnes.
0.19983944296836853 ||| No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. ||| In cases of mild hepatic impairment no initial dosage adjustment is necessary at the recommended dose. ||| 13 Aucune adaptation posologique n’ est nécessaire chez les patients atteints d’ insuffisance hépatique légère à modérée.
0.13797461986541748 ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| 321 Pregnancy and breast -feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| 52 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.658502995967865 ||| Impaired renal function including cases of renal failure in patients at risk (see section 4.4) ||| The main safety concern discussed was visual field defects (VFD). ||| Affections du rein et des voies urinaires Altération de la fonction rénale incluant des cas isolés d’ insuffisance rénale aiguë chez des patients à risque (voir rubrique 4.4)
0.23888616263866425 ||| Usually, side effects are observed within the first week after treatment and are temporary in nature. ||| In dogs, these side effects occur usually within the first week of treatment and are generally transient (temporary). ||| Généralement, les effets indésirables se manifestent au cours de la première semaine suivant le traitement et sont de nature transitoire.
0.022158393636345863 ||| 343 PACKAGE LEAFLET: ||| 336 PACKAGE LEAFLET: ||| 366 NOTICE:
0.12698684632778168 ||| HOW TO USE HUMALOG MIX50 ||| HOW TO USE LIPROLOG MIX50 ||| COMMENT UTILISER HUMALOG MIX50
0.08386556804180145 ||| 5 µg; solvent: ||| 80 µg; solvent: ||| 5 µg
0.7015058398246765 ||| Fittings of metal for windows ||| Pans for panning for gold ||| Garnitures de fenêtres métalliques
0.3596404790878296 ||| Pre-fabricated houses of metal ||| Assembly of prefabricated houses ||| Maisons préfabriquées en métal
0.24144139885902405 ||| In addition, your doctor will stop Tasmar treatment if after 3 weeks you do not improve enough to justify the risks of continuing treatment. ||| If these results are abnormal, your doctor may decide to reduce your dose or stop treatment with Tracleer and to perform further tests to investigate the cause. ||| De plus, votre médecin arrêtera Tasmar si, au bout de 3 semaines, votre état ne s'est pas suffisamment amélioré pour justifier les risques de la poursuite du traitement.
0.2722901701927185 ||| 0.8%); Arthralgia (G3/ 4: ||| 4.3%); Diarrhoea (G3/ 4: ||| 0,8%); Arthralgie (G3/ 4:
0.33784615993499756 ||| The deterioration in Quality of Life was significantly less in Bondronat treated patients compared with placebo. ||| The negative predictive value for sustained response in patients treated with Pegasys in monotherapy was 98%. ||| La détérioration de la qualité de vie a été significativement inférieure chez les patientes traitées par Bondronat comparé aux patientes sous placebo.
0.492367148399353 ||| Mobile radio communications ||| Local mobile telephone systems ||| Communications par radio portable
0.48929712176322937 ||| Organisation of yacht races ||| Organisation of chess tournaments ||| Organisation de courses de yachts
0.2561722993850708 ||| 8 Oedema was reported in 6 – 9% of patients treated with pioglitazone over one year in controlled clinical trials. ||| Serious infections occurred in 6.3% of rheumatoid arthritis patients treated with Enbrel for up to 48 months. ||| Des œ dèmes ont été reportés chez 6 à 9% des patients ayant reçu la pioglitazone pendant plus d’ un an au cours d’ essais cliniques contrôlés.
0.09470434486865997 ||| 12 Preliminary data suggest that irbesartan may decrease Riprazo AUC and Cmax. ||| 12 Preliminary data suggest that irbesartan may decrease Tekturna AUC and Cmax. ||| Des données préliminaires suggèrent que l’ irbésartan peut réduire l’ ASC et la Cmax de Riprazo.
0.7252317667007446 ||| Clothing for fishermen ||| Jewelry for the head ||| Vêtements pour pêcheurs
0.5367705821990967 ||| Only use a single Neulasta pre-filled pen for each injection. ||| Always mix NovoRapid and long-acting insulin in the same sequence. ||| Pour chaque injection, n’utilisez qu’un seul stylo prérempli de Neulasta.
0.3646397590637207 ||| Prevention of gonadal function in bitches via long term blockade of gonadotrophin synthesis. ||| Reversal of neuromuscular blockade induced by rocuronium or vecuronium. ||| Blocage de la fonction ovarienne de la chienne par inhibition prolongée de la synthèse des gonadotrophines.
0.0 ||| 5.3 Preclinical safety data ||| 5.3 Preclinical safety data ||| 42 5.3 Données de sécurité précliniques
0.33855292201042175 ||| The biologic activity of the pegylated isomers is qualitatively similar, but weaker than free interferon alfa-2b. ||| This is predominantly via cytochrome P450 2C8 although other isoforms may be involved to a lesser degree. ||| L’ activité biologique des isomères pégylés est similaire qualitativement, mais plus faible que l’ interféron alfa-2b libre.
0.06581541895866394 ||| It is not known whether sapropterin or its metabolites are excreted in human breast milk. ||| It is unknown whether clofarabine or its metabolites are excreted in human breast milk. ||| On ignore si la saproptérine ou ses métabolites sont excrétés dans le lait maternel humain.
0.23841185867786407 ||| Chemical preparations for use in the repair of tyres ||| Chemicals for use in the printing of newspapers ||| Préparations chimiques destinées à la réparation des pneus
0.1590205729007721 ||| - if you have blood disorders, ||| - if you have heart problems, ||| - si vous avez des troubles du sang,
0.47204717993736267 ||| Massage divans ||| Nasal douches ||| Lits de massage
0.3851749002933502 ||| In patients with an allergic disposition the decision to use Gadovist must be made after particularly careful evaluation of the risk-benefit ratio. ||| 15 advice regarding possible effects of Zonegran on the foetus and the risk should be discussed with the patient in relation to the benefits before starting treatment. ||| Chez les patients présentant un terrain allergique, l’ utilisation de Gadovist nécessite une évaluation particulièrement prudente du rapport bénéfice/ risque.
0.35317450761795044 ||| Vertigo Deafness, hypoacusia, tinnitus, ear pain, ear pruritus ||| Hypotension, hypertension, syncope, flushing Peripheral ischaemia* ||| vertige surdité, hypo-acousie, acouphènes, douleur auriculaire, prurit auriculaire
0.15898051857948303 ||| Financial advisory services relating to assets management ||| Business advisory services relating to product manufacturing ||| Services de conseils financiers en matière de gestion du patrimoine
0.015530919656157494 ||| 38 Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com ||| Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998771 medinfo_ireland@merck. com ||| Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com
0.47283101081848145 ||| Xolair treatment should only be considered for patients with convincing IgE (immunoglobulin E) mediated asthma (see section 4.2). ||| Sustained Virologic Response (SVR) is defined as undetectable HCV-RNA at 24 weeks post-treatment (Table 10). ||| Le traitement par Xolair ne doit être envisagé que chez les patients présentant un asthme dont la dépendance aux IgE (immunoglobulines E) a été établie sur des critères probants (voir rubrique 4.2).
0.39719563722610474 ||| Ensure hands are dry to prevent the tablet from sticking to fingers. ||| Do not handle the tablets with wet hands as the tablets may break up. ||| S’ assurer d’ avoir les mains sèches pour éviter au comprimé de coller aux doigts.
5.23624438079906e-13 ||| Biotechnology Working Party ||| Biotechnology Working Party ||| Groupe de travail « biotechnologie »
0.5181708931922913 ||| If too much CellCept IV solution is given: ||| Effects when treatment with CellCept is stopped: ||| Si vous avez pris plus de CellCept que vous n’ auriez dû:
0.05947170406579971 ||| It is not known whether riluzole is excreted in human milk. ||| It is not known whether sirolimus is excreted in human milk. ||| Le passage du riluzole dans le lait maternel humain n'est pas connu.
0.048654764890670776 ||| This may stop your medicines from working properly, or may make any side effects worse. ||| This may stop the medicines from working properly, or may make any side effects worse. ||| Ceci peut empêcher vos médicaments d’ agir correctement ou en aggraver les effets indésirables.
0.03493480011820793 ||| If you are following a diabetic diet, you should continue with this while you are taking Actos 30mg tablets. ||| If you are following a diabetic diet, you should continue with this while you are taking Glustin 30 mg tablets. ||| Si vous suivez un régime alimentaire, vous devez continuer celui -ci alors que vous prenez Actos 30 mg comprimé.
0.39410868287086487 ||| There have been cases of cardiac failure reported from the market when pioglitazone was used in combination with insulin. or in patients with a history of cardiac failure. ||| Swine influenza was first proposed to be a disease related to human flu during the 1918 flu pandemic, when pigs became ill at the same time as humans. ||| Des cas d'insuffisance cardiaque ont été observés, après commercialisation, lorsque l’ insuline était associée à la pioglitazone, ou chez des patients ayant des antécédents d’ insuffisance cardiaque.
0.3848169445991516 ||| Graphite for industrial purposes ||| Broadforks for agricultural purposes ||| Graphite à usage industriel
0.3783511519432068 ||| There were no food restrictions in the studies that demonstrated the efficacy and safety of CELSENTRI (see section 5.1). ||| It is unknown if these cancer diagnoses were related to ISENTRESS use (see section 4.4). ||| Les études ayant démontré l’ efficacité et la tolérance du maraviroc n’ ont comporté aucune restriction alimentaire (voir rubrique 5.1).
0.22305238246917725 ||| The most common side effects (seen in more than 1 patient in 10) are conjunctival hyperaemia (increased blood supply to the eye, leading to redness of the eye) and growth of eyelashes. ||| Common side effects were (likely to occur in fewer than 1 out of 10 patients), headache, signs indicating malfunction of the pancreas (amylasemia), decreased levels of magnesium in the blood, and a transient increase in heart rate. ||| Les effets indésirables les plus courants (observés chez plus d’ 1 patient sur 10) sont une hyperémie conjonctivale (augmentation de l’ irrigation sanguine de l’œ il entraînant une rougeur de l’œ il) et une pousse des cils.
0.42254096269607544 ||| In women who could not ovulate, GONAL-f produced ovulation in 84% of women compared with 91% for the Comparator. ||| In anovulatory women, ovulation was seen in 91.9% of women treated with Ovitrelle. ||| Dans le cas des femmes anovulatoires, GONAL-f a déclenché une ovulation chez 84% d’ entre elles contre 91% pour le comparateur.
0.3736303448677063 ||| 805 In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. ||| In the long-term treatment of eczema, begin using as soon as you notice signs and symptoms (redness and itch). ||| Dans ces situations, vous courez le risque d'hypoglycémie sévère (et même de perte de connaissance) sans vous en apercevoir.
0.34080249071121216 ||| Caution must be exercised in the management and treatment of patients with compromised airways by limitation or careful monitoring of antihistamine and other sedative medication use. ||| The guidelines also include indications on the use of personal protective equipment such as face masks and on adequate protocols in case passengers present coronavirus symptoms. ||| La prudence s’ impose lors de la prise en charge et du traitement des patients ayant des troubles respiratoires: l’ utilisation d’ anti-histaminiques ou d’ autres sédatifs doit être limitée ou étroitement surveillée.
0.34554341435432434 ||| How to use NovoMix 70 4. ||| How to take MicardisPlus 4. ||| Comment utiliser NovoMix 70 4.
0.5292718410491943 ||| The first EMEA Internet web site was launched in September 1995. ||| The first EMEA workshop on gene therapy was held on 23 April 1998. ||| Le premier site Web de l’EMEA a été lancé en septembre 1995.
0.1310470998287201 ||| 12 Hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. ||| Hepatic impairment The recommended dosage in patients with mild hepatic impairment is 80 mg. ||| 13 Utilisation en cas d’ insuffisance hépatique Aucune adaptation posologique n’ est nécessaire chez les patients ayant une insuffisance hépatique légère.
0.25129690766334534 ||| ed One cartridge contains 18 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 1.2 ml. ||| One cartridge contains 10 mg (30 IU) of somatropin* * human growth hormone produced in Escherichia coli cells by recombinant DNA technology. ||| Une cartouche contient 18 millions d’ UI d’ interféron alfa-2b produit par une technique d’ ADN
0.254488468170166 ||| Furthermore CEPROTIN is used to prevent thrombosis in patients with severe congenital protein C deficiency if one or more of the following conditions are met: • surgery or invasive therapy is imminent • while initiating coumarin (anticoagulant medication, blood thinner) therapy • when coumarin therapy alone is not sufficient • when coumarin therapy is not feasible. ||| 30 • Initiation of Volibris is not recommended for patients with clinically significant anaemia. • Patients taking Volibris should have their haemoglobin and/ or haematocrit levels measured regularly. • If tests show a clinically significant decrease in haemoglobin or haematocrit, and other causes have been excluded, consider reducing the dose of Volibris, or stopping treatment. ||| De plus, CEPROTIN est utilisé dans la prévention de thrombose chez les patients atteints de déficit congenital sévère en protéine C lorsqu’ une ou plusieurs des conditions suivantes sont présentes: • Lors d'opération chirurgicale ou de traitement invasif imminent, • A l'instauration d’ un traitement par la coumarine (traitement anticoagulant, fluidifiant dusang), • Lorsque le traitement par la coumarine est insuffisant, • Lorsque le traitement par la coumarine est impossible.
0.6011536121368408 ||| Gastric lavage may also be of benefit. ||| This may be due to Avonex treatment. ||| Un lavage gastrique peut également avoir un effet bénéfique.
0.334678590297699 ||| Concomitant treatment with medicines displaying action on renal flow, e. g. diuretics or angiotensin converting enzyme (ACE) inhibitors, should be subject to clinical monitoring. ||| During Remicade treatment, other concomitant therapies, e. g., corticosteroids and immunosuppressants should be optimised. ||| Un traitement concommitant avec des médicaments agissant sur le débit rénal comme les diurétiques ou les inhibiteurs de l’ Enzyme de Conversion de l’ Angiotensine (IECA), devra faire l’ objet d’ une surveillance étroite.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.28210949897766113 ||| Co-administration of INVEGA once daily with carbamazepine 200 mg twice daily caused a decrease of approximately 37% in the mean steady-state Cmax and AUC of paliperidone. ||| Infusion of 100 mg fosaprepitant over 15 minutes with diltiazem 120 mg 3 times daily, resulted in a 1.5-fold increase of aprepitant AUC. ||| La co-administration d’ INVEGA une fois par jour avec de la carbamazépine administrée deux fois par jour à la dose de 200 mg a entraîné une diminution d'environ 37% de la Cmax et de l’ AUC moyennes de la palipéridone à l’ état d’ équilibre.
0.3348664939403534 ||| Do not chew the tablet. ||| Do not chew the tablet(s). ||| Ne mâchez pas le comprimé.
0.1792551875114441 ||| CYP2D6 inducers and inhibitors: in a population pharmacokinetic analysis, it has been shown that there was no significant effect on palonosetron clearance when co-administered with CYP2D6 inducers (dexamethasone and rifampicin) and inhibitors (including amiodarone, celecoxib, chlorpromazine, cimetidine, doxorubicin, fluoxetine, haloperidol, paroxetine, quinidine, ranitidine, ritonavir, sertraline or terbinafine). ||| However, the experience of the clinical use of entacapone with several medicinal products, including MAO-A inhibitors, tricyclic antidepressants, noradrenaline reuptake inhibitors such as desipramine, maprotiline and venlafaxine, and medicinal products that are metabolised by COMT (e. g. catechol-structured compounds: rimiterole, isoprenaline, adrenaline, noradrenaline, dopamine, dobutamine, alpha- methyldopa, apomorphine, and paroxetine) is still limited. ||| Inducteurs et inhibiteurs du CYP2D6: d’ après une analyse pharmacocinétique de population, il n’ a pas été observé d’ effet significatif sur la clairance du palonosétron en cas d'administration concomitante avec des inducteurs (dexaméthasone et rifampicine) et des inhibiteurs du CYP2D6 (incluant l'amiodarone, le célécoxib, la chlorpromazine, la cimétidine, la doxorubicine, la fluoxétine, l'halopéridol, la paroxétine, la quinidine, la ranitidine, le ritonavir, la sertraline ou la terbinafine).
0.009057484567165375 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Dafiro’ s benefits are greater than its risks for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Copalia’ s benefits are greater than its risks for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Dafiro sont supérieurs à ses risques pour le traitement de l’ hypertension artérielle essentielle chez les patients dont la pression artérielle n’ est contrôlée de manière adéquate ni par l’ amlodipine, ni par le valsartan en monothérapie.
0.22362086176872253 ||| Thalidomide is a poor substrate for cytochrome P450 isoenzymes and therefore clinically important interactions with medicinal products metabolized by this enzyme system are unlikely. ||| According to its metabolism, metabolic interactions with other medicinal products appear unlikely, although rivastigmine may inhibit the butyrylcholinesterase mediated metabolism of other substances. ||| Par conséquent, il est peu probable que des interactions avec des médicaments métabolisés par cette enzyme se produisent.
0.8829618096351624 ||| Artificial stones [precious or semi-precious] ||| Precious and semi-precious gems ||| Pierres artificielles [précieuses ou semi-précieuses]
0.05918920412659645 ||| Any unused product must be discarded after withdrawal of the dose. ||| Any unused product must be discarded after withdrawal of the dose. no ||| Après prélèvement de la dose, tout produit non util isé doit être éliminé.
0.5230934619903564 ||| An increase in the number of pre-submission meetings is anticipated to tackle regulatory and administrative questions aspects. ||| The Commission is proposing a gradual approach to lifting travel restriction, comprised of three phases. ||| Une augmentation du nombre de réunions de présoumission devrait permettre de mieux appréhender les questions réglementaires et administratives.
0.40506526827812195 ||| Abstral ||| Apparent ||| Rapinyl
0.30288174748420715 ||| Communicate: During the crisis, the EU has been stepping up its work to inform citizens about the risks and to enhance cooperation with other international actors to tackle disinformation. ||| The investments made in Ebola affected countries to strengthen national health care system's response capacity is paying off now, as these countries have enhanced resilience to cope with the crisis. ||| Communiquer: pendant la crise, l'UE a renforcé son travail pour informer les citoyens des risques et améliorer la coopération avec d'autres acteurs internationaux afin de lutter contre la désinformation.
0.5741605162620544 ||| Rapinyl ||| Urinary ||| Rapinyl Rapinyl3
0.5093663930892944 ||| Cardiovascular instruments ||| Cardiovascular ||| Instruments cardiovasculaires
0.44252800941467285 ||| For example, no single substitution or pair of substitutions was capable of engendering measurable (≥ four– fold) resistance to indinavir, and the level of resistance was dependent on the ways in which multiple substitutions were combined. ||| There is no cross-protection between serotypes (a vaccine for one serotype will not protect against any others) and in addition, two strains within a given serotype may have nucleotide sequences that differ by as much as 30% for a given gene. ||| Par exemple, en aucun cas, une seule substitution ni l'association de deux substitutions n’ ont été capables d’ induire une résistance mesurable (supérieure ou égale à 4 fois) à l’ indinavir, et le niveau de résistance était dépendant de la façon selon laquelle les substitutions multiples étaient combinées.
0.5605184435844421 ||| 35 PATIENT/ CARER REMINDER CARD ||| 46 REMINDER STICKERS TEXT ||| 37 CARTE DE RAPPEL PATIENT/ SOIGNANT
0.45092296600341797 ||| Chemical products for glazing leather ||| Metal moulds for forming cement products ||| Produits chimiques pour lustrer le cuir
0.36817002296447754 ||| A commonly used dose for superovulation involves the administration of 150-225 IU (0.24-0.36 ml) of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle. ||| This was followed by monotherapy TMZ (150 - 200 mg/m2) on Days 1 - 5 of every 28-day cycle for up to 6 cycles, starting 4 weeks after the end of RT. ||| La dose usuelle destinée à provoquer une superovulation comprend l’ administration de 150 à 225 UI (0,24 à 0,36 ml) de GONAL-f par jour, en commençant le 2ème ou 3ème jour du cycle de traitement.
0.465034157037735 ||| Combivir should not be taken with some other medicines. ||| You must not be given live vaccines while being treated with Kineret; ||| Combivir ne doit pas être associé à certains médicaments.
0.624504804611206 ||| 50 The doctor has a more complete list of side effects for M-M-RVAXPRO. ||| M-M-RVAXPRO is to be used on the basis of official recommendations. ||| Le médecin possède une liste plus complète des effets indésirables de M-M-RVAXPRO.
0.43068578839302063 ||| Beta-blocking agents may mask the symptoms of hypoglycaemia and delay recovery from no ||| β -blocking agents may mask the symptoms of hypoglycaemia. ||| Les agents bêta-bloquants peuvent masquer les symptômes d'hypoglycémie et retarder la récupération dic
0.010352482087910175 ||| 189 PACKAGE LEAFLET: ||| 198 PACKAGE LEAFLET: ||| 197 NOTICE:
0.0 ||| Do not store above 30°C ||| Do not store above 30°C ||| A conserver à une température ne dépassant pas 30ºC
0.3271420896053314 ||| Extreme hypercalcaemia may result in coma and death. ||| Overdose can lead to hypervitaminosis and hypercalcaemia. ||| Une hypercalcémie extrême peut conduire au coma et à la mort.
0.5053255558013916 ||| 156 Aylonos Str Sepolia GR-1044 Greece ||| Barbaras 53, GR-172 35 Dafni Greece ||| 156 Aylonos Str Sepolia GR-1044 Grèce
0.19805145263671875 ||| Tel: + 34 91 623 1732 ||| Tel: +39 0542 64 87 40 ||| Tel: + 36 1 328 5100
0.2742266356945038 ||| 13 Following intravenous and oral administration of 14C-labelled tacrolimus, most of the radioactivity was eliminated in the faeces. ||| Following intravenous administration, choriogonadotropin alfa is distributed to the extracellular fluid space with a distribution half-life of around 4.5 hours. ||| Excrétion Après administration intraveineuse et orale de tacrolimus marqué au 14C, la plupart de la radioactivité est éliminée dans les fèces.
0.500220775604248 ||| After the 12-week double-blind treatment period, all patients received Enbrel 0.8 mg/ kg (up to 50 mg) once weekly for additional 24 weeks. ||| Overall, 174 patients completed the full 16-month duration of the 2 studies combined (4 month double-blind and 12 month open-label continuation). ||| Après la période de traitement en double aveugle de 12 semaines, tous les patients recevaient Enbrel 0,8 mg/ kg (jusqu’ à 50 mg) une fois par semaine pendant 24 semaines supplémentaires.
0.18658456206321716 ||| Production of course material distributed at management courses ||| Production of course material distributed at professional lectures ||| Production de matériel pédagogique distribué lors de cours de gestion
0.2370176911354065 ||| 103 ||| 98 ||| 116
0.30238234996795654 ||| You cannot start another dose while the light is on. ||| The red light comes on when you start a dose. ||| Vous ne pouvez pas amorcer une nouvelle dose tant que la lumière est allumée.
0.33434006571769714 ||| 83 Side effects reported very rarely (in less than 1 patient in 10,000) ||| Very rare (occurring in less than 1 of 10,000 patients treated). ||| (chez moins de 1 patient sur 10 000)
0.26602715253829956 ||| How has CellCept been studied? ||| How has ReFacto AF been studied? ||| Quelles études ont été menées avec CellCept?
0.08556029200553894 ||| 55 (Notes information) ||| 38 (Notes information) ||| (Notes d’information)
0.03469251096248627 ||| EU/1/05/331/053 [84 transdermal patches] EU/1/05/331/055 [100 transdermal patches] ||| EU/1/05/331/036 [84 transdermal patches] EU/1/05/331/012 [100 transdermal patches] ||| EU/ 1/ 05/ 331/ 053 [84 dispositifs transdermiques] EU/ 1/ 05/ 331/ 055 [100 dispositifs transdermiques]
0.2296280562877655 ||| No compound-related tumours were observed in a 2-year rat study with prasugrel exposures ranging to greater than 75 times the recommended therapeutic exposures in humans (based on plasma exposures to the active and major circulating human metabolites). ||| The most frequent finding in the repeat-dose studies consisted of increased primary spongiosa in the metaphyses of long bones in growing animals at nearly all doses, a finding that reflected the compound’ s pharmacological antiresorptive activity. ||| Aucune tumeur attribuable au composant n'a été observée dans une étude de 2 ans chez le rat avec des expositions au prasugrel jusqu’ à des doses supérieures à 75 fois les expositions thérapeutiques recommandées chez l'homme (d'après les expositions plasmatiques au métabolite actif et aux principaux métabolites circulants).
0.15532928705215454 ||| • Wash your hands thoroughly • Set up the following items on a clean surface ||| • Wash your hands thoroughly • Set up the following items on a clean surface i dic ||| • Lavez vos mains soigneusement • Posez le matériel suivant sur une surface propre:
0.5731590390205383 ||| Provision of skill assessment courses ||| Provision of video recording studio facilities ||| Services de cours d'évaluation de compétences
0.30550670623779297 ||| Therefore this should be taken into consideration in patients affected with severe forms of phenylketonuria. ||| This would be particularly important in patients with a known history of zidovudine induced anaemia. ||| Par conséquent, il faut en tenir compte chez les patients atteints de formes sévères de phénylcétonurie
0.605462908744812 ||| In this study, abacavir increased the mean methadone systemic clearance by 22%. ||| Binding of A771726 is linear in the therapeutic concentration range. ||| Dans cette étude, l’ abacavir a augmenté de 22% la valeur moyenne de la clairance systémique de la méthadone.
0.6338949799537659 ||| Computerised data processing ||| Computerised business information retrieval ||| Traitement informatisé de données
2.5268432094979754e-13 ||| Frequencies are defined as: very common (> 1/ 10), common (> 1/ 100, ≤ 1/ 10), uncommon (> 1/ 1,000, ≤ 1/ 100), rare (≤ 1/ 1,000), not known (cannot be estimated from the available data). ||| Frequencies are defined as: very common (> 1/ 10), common (> 1/ 100, ≤ 1/ 10), uncommon (> 1/ 1,000, ≤ 1/ 100), rare (≤ 1/ 1,000), not known (cannot be estimated from the available data). ||| 62 Les effets indésirables Les effets indésirables, en dehors des cas isolés, sont repris ci-dessous: ils sont classés par organe et par ordre de fréquence en utilisant la convention suivante: très fréquent (> 1/ 10), fréquent (> 1/ 100, ≤ 1/ 10), peu fréquent (> 1/ 1 000, ≤ 1/ 100), rare ≤ 1/ 1 000), fréquence indéterminée (ne peut être estimée sur la base des données disponibles).
0.0023436779156327248 ||| 20 In pediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks. ||| 44 In pediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks. ||| Chez les enfants (de 4 à 16 ans), l’ efficacité du levetiracetam a été établie lors d’ une étude en double aveugle contrôlée versus placebo incluant 198 patients sur 14 semaines de traitement.
0.3436453342437744 ||| Today's EU pledge will economically empower women and youth, support social and economic development and the ambitious reforms of the civilian-led transitional Government, as well as strengthen stability and peace. ||| Our joint efforts will ensure that the EU and partners work together across the five objectives to better support the ecological and digital transformations, promote sustainable development and provide more decent job and economic opportunities, in particular for young people, and to promote gender equality. ||| Les promesses de dons faites aujourd'hui par l'UE permettront d'autonomiser les femmes et les jeunes sur le plan économique, de soutenir les réformes ambitieuses du gouvernement civil et de renforcer la stabilité et la paix.
0.10611794143915176 ||| E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00 rod ||| Nacional I E-28750 San Agustín de Guadalix – Madrid Tel: + 34-91 848 85 00 ||| isé Tel: + 34-91 848 85 00
0.05469822883605957 ||| Name and address of the manufacturer of the biological active substance ||| Name and address of the manufacturer of the biological active substance: ||| Nom et adresse du fabricant substance active d'origine biologique
0.012531500309705734 ||| London, 23 October 2007 EMEA/ 338591/ 2007 ||| London, 23 October 2007 EMEA/ 331678/ 2007 ||| Londres, le 23 octobre 2007 EMEA/ 331678/ 2007
0.17230087518692017 ||| Januvia is a medicine containing the active substance sitagliptin. ||| Adenuric is a medicine containing the active substance febuxostat. ||| Januvia est un médicament dont le principe actif est la sitagliptine.
0.2874145805835724 ||| From 1981 to 1983 Dr Abadie held a number of clinical and laboratory positions, before joining the pharmaceutical industry in 1983. ||| From 1965 to 1973, Mr Fairchild worked in a major pharmaceutical company setting up quality assurance systems and in production operations. ||| Expérience professionnelle: de 1981 à 1983, le Dr Abadie a occupé plusieurs postes cliniques et de laboratoire, avant de rejoindre l'industrie pharmaceutique en 1983.
0.054489411413669586 ||| 63 There have been reports of increased bleeding, including spontaneous skin haematomas and haemarthroses, in type A and B haemophiliac patients treated with protease inhibitors. ||| There have been reports of increased bleeding, including spontaneous skin haematomas and haemarthroses, in haemophiliac patients type A and B treated with PIs. ||| Des cas d’ augmentation des saignements comprenant des hématomes cutanés spontanés et des hémarthroses ont été signalés, chez les patients hémophiles de types A et B traités avec les inhibiteurs de protéase.
0.2939571142196655 ||| However, when CELSENTRI was given at the recommended dose in HIV infected patients in Phase 3 studies, postural hypotension was seen at a similar rate compared to placebo (approximately 0.5%). ||| Among these children, the following vaccine-related adverse reactions were observed in individuals following vaccination with M-M-RVAXPRO (excluding isolated reports with frequency < 0.2%). ||| Cependant, lorsque CELSENTRI a été administré à la dose recommandée chez des patients infectés par le VIH au cours des études de phase 3, l’ hypotension orthostatique a été observée à un taux similaire à celui observé sous placebo (approximativement 0,5%).
0.5936606526374817 ||| However, the potential for severe allergic reactions cannot be excluded. ||| Do not be alarmed by this list of possible side effects. ||| Il n'est cependant pas possible d'exclure la survenue éventuelle de réactions allergiques sévères.
0.31198054552078247 ||| If use of the oral solution is not possible, Sebivo film-coated tablets could be used as an alternative and dosing should be adjusted by increasing the time interval between doses, as detailed in Table 1. ||| In those patients where the same IV line is to be used to inject another medicinal product, the line must be adequately flushed prior to and after Dynastat injection with a solution of known compatibility. ||| Si l’ utilisation de la solution buvable n’ est pas possible, les comprimés pelliculés de Sebivo peuvent être utilisés comme alternative, en adaptant la posologie en espaçant l’ intervalle entre les prises, comme détaillé dans le tableau 1.
0.3700893521308899 ||| In an interaction study a comparable systemic exposure to sildenafil was observed for a single intake of 100 mg sildenafil alone and a single intake of 25 mg sildenafil co-administered with darunavir/ritonavir (400/100 mg b.i.d.). ||| * sum of active moieties of rifabutin (parent drug + 25-O-desacetyl metabolite) A dosage reduction of rifabutin by 75% of the usual dose of 300 mg/day [i.e. rifabutin 150 mg q.o.d. ||| Au cours d’une étude d’interaction, il a été observé une exposition systémique au sildénafil comparable après une prise unique de 100 mg de sildénafil administré seul et après une prise unique de 25 mg de sildénafil co-administré au darunavir/ritonavir (400/100 mg, 2 fois par jour).
0.2983689308166504 ||| The proposal represents an important step in fulfilling the Commission's commitment to use all economic policy tools at its disposal to support Member States' in protecting their citizens and mitigating the pandemic's severely negative socio-economic consequences. ||| This will allow all key players - Member States, health institutions and economic operators to give priority to the fight against the ongoing coronavirus pandemic, forming a key position in the timing of the lifting of confinement measures as Member States return to the road of recovery. ||| Cette proposition est une mesure importante que prend la Commission pour tenir son engagement: utiliser tous les instruments de politique économique dont elle dispose afin d'aider les États membres à protéger leurs citoyens et à atténuer les conséquences socio-économiques extrêmement négatives de la pandémie.
0.19268980622291565 ||| EU/ 1/ 97/ 046/ 016 14 tablets EU/ 1/ 97/ 046/ 017 28 tablets EU/ 1/ 97/ 046/ 034 30 tablets EU/ 1/ 97/ 046/ 018 56 tablets EU/ 1/ 97/ 046/ 019 56 x 1 tablets EU/ 1/ 97/ 046/ 031 84 tablets EU/ 1/ 97/ 046/ 037 90 tablets EU/ 1/ 97/ 046/ 020 98 tablets ||| EU/ 1/ 00/ 146/ 006 10 tablets EU/ 1/ 00/ 146/ 007 20 tablets EU/ 1/ 00/ 146/ 008 30 tablets EU/ 1/ 00/ 146/ 009 50 tablets EU/ 1/ 00/ 146/ 010 60 tablets EU/ 1/ 00/ 146/ 011 100 tablets EU/ 1/ 00/ 146/ 012 120 tablets EU/ 1/ 00/ 146/ 013 200 tablets ||| EU/ 1/ 97/ 046/ 016 14 comprimés EU/ 1/ 97/ 046/ 017 28 comprimés EU/ 1/ 97/ 046/ 034 30 comprimés EU/ 1/ 97/ 046/ 018 56 comprimés EU/ 1/ 97/ 046/ 019 56 x 1 comprimés EU/ 1/ 97/ 046/ 031 84 comprimés EU/ 1/ 97/ 046/ 037 90 comprimés EU/ 1/ 97/ 046/ 020 98 comprimés
0.30559301376342773 ||| There have been reports of aplastic anaemia and bone marrow depression in patients treated with CellCept, some of which have been fatal. ||| This may suggest a disease of the heart muscle (cardiomyopathy) which has been reported rarely in patients using Betaferon ||| Des cas isolés d’ anémie aplasique et d’ aplasie médullaire dont certains ont été d’ évolution fatale ont été rapportés chez des patients traités par CellCept.
0.2795112431049347 ||| For doses below 100 mg, one tablet should be dissolved in 100 ml of water and the volume of solution corresponding to the prescribed dose administered. ||| The prescribed number of tablets should be placed in a glass or cup with up to 120 ml of water and stirred until dissolved. ||| 3 Pour les doses inférieures à 100 mg, un comprimé doit être dissous dans 100 ml d’ eau et le volume de solution correspondant à la dose prescrite sera administré.
0.0996403843164444 ||| For more information on biosimilar medicines, see the question-and-answer document here. ||| For more information on generic medicines, see the question-and-answer document here. ||| Pour de plus amples d’ informations sur les médicaments biosimilaires, voir le document sous forme de questions-réponses ici.
0.3441244959831238 ||| Terminals for electronically processing credit card payments ||| Software for facilitating secure credit card transactions ||| Terminaux pour le traitement électronique des paiements par carte de crédit
0.049589112401008606 ||| If you are allergic (hypersensitive) to insulin or any of the other ingredients of Insuman Comb 25. ||| If you are allergic (hypersensitive) to insulin or any of the other ingredients of Insuman Basal. ||| si vous êtes allergique (hypersensible) à l'insuline ou à tout autre omposant contenu dans Insuman Comb 25.
0.2985150218009949 ||| Ultrasonic diagnostic apparatus for laboratory use ||| Ionization apparatus for scientific or laboratory use ||| Appareils de diagnostic à ultrasons pour laboratoires
0.07295357435941696 ||| Do not take a double dose to make up for a forgotten dose. ||| Do not take a double dose to make up for a forgotten individual dose. ||| N’injectez pas de dose double pour compenser la dose que vous avez oublié d’injecter.
0.5343490839004517 ||| Telzir does not require any other special storage conditions. ||| There are no special precautions for Locatim. ||| Telzir ne nécessite pas de précautions particulières de conservation.
0.006353061646223068 ||| If you use more KOGENATE Bayer 250 IU than you should: ||| If you use more KOGENATE Bayer 500 IU than you should: ||| Si vous avez pris plus de KOGENATE Bayer 250 UI que vous n'auriez dû:
0.25034406781196594 ||| For both types of injection, the maximum dose should not exceed 720 IU for every 1 kg of your body weight per week. ||| The maximum dose should not exceed 720 IU for every 1 kg of your body weight per week. ||| 277 Pour les deux modalités d'injection, la dose maximale à ne pas dépasser est de 720 UI par kg de poids corporel et par semaine.
0.2077960968017578 ||| Treatment with PREZISTA should be discontinued if such a condition develops. ||| Administration of ORENCIA should be discontinued if a patient develops a serious infection. ||| Le traitement par PREZISTA doit être arrêté en cas de survenue de tels effets.
0.3827195167541504 ||| Approximately 75% of patients who respond satisfactorily to treatment require a dose of ≤ 9.6 μ g/ day. ||| Approximately half of the patients who developed an ANC < 1 x 109/ l did so within 8 weeks after starting therapy. ||| Environ 75% des patients répondant de façon satisfaisante au traitement nécessitent une posologie ≤ 9,6 μ g/ jour.
0.5711452960968018 ||| Alopecia, pruritus*, skin dry*, rash* ||| flu-like symptoms, pyrexia2, chills2, sweating2 ||| Hépatomégalie, hyperbilirubinémie Alopécie, prurit*, peau sèche*, rash*
0.4582332372665405 ||| This will give the EU budget the necessary firepower to kick-start the economy and show solidarity among Member States. ||| EU State aid rules provide a toolbox for Member States to take swift and effective action. ||| Cela donnera au budget de l'Union la capacité de réaction nécessaire pour relancer l'économie et faire preuve de solidarité entre les États membres.
0.37859976291656494 ||| Based on the review of the data and the company’ s response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Advexin could not have been approved for the treatment of Li-Fraumeni cancer. ||| That much has been achieved in 1996 was indeed confirmed at the second audit of the European registration system chaired by Dr Martin Bangemann, and by the declarations made by representatives of consumers, pharmaceutical industry and other interest groups at that meeting. ||| Sur la base de l’ examen des données et des réponses du laboratoire à la liste de questions du CHMP, au moment du retrait, le CHMP avait des inquiétudes et pensait à ce stade qu’ Advexin ne pouvait pas être approuvé pour le traitement des patients atteints du cancer de Li-Fraumeni.
0.40010616183280945 ||| Since food does not affect absorption, Lisonorm may be taken irrespective of meals. ||| Disinfection is less effective than sterilization because it does not kill bacterial endospores. ||| La prise d’ aliments n’ affectant pas l’ absorption, Lisonorm peut être pris sans tenir compte des repas.
0.2901535630226135 ||| It is especially important that you tell your doctor or pharmacist if you are taking: ||| It is important that you tell your doctor, dentist and pharmacist, that you are taking Efient. ||| Il est particulièrement important d'informer votre médecin ou votre pharmacien si vous prenez:
0.5319229960441589 ||| Japanese style indoor sliding partitions (fusuma) ||| Horizontal venetian blinds [outdoor], of metal ||| Cloisons coulissantes d'intérieur de style japonais [fusuma]
0.385293185710907 ||| If no clinical benefits are observed after 3 months at optimal dose, treatment should be permanently discontinued. ||| While these complications may resolve when treatment is discontinued, complete resolution does not always occur. ||| En l’ absence de bénéfice clinique au bout de 3 mois à la dose optimale, le traitement doit être définitivement interrompu.
0.3461764454841614 ||| The vaccine is reconstituted by adding the contents of the syringe to the vial containing the Hib powder. ||| . Inject the entire content of the syringe into the vial containing the powder. ||| Le vaccin est reconstitué en ajoutant le contenu de la seringue au flacon contenant la poudre Hib.
5.02117119584311e-13 ||| About 9% of the dose is recovered in the faeces, primarily as metabolites. ||| About 9% of the dose is recovered in the faeces, primarily as metabolites. ||| Environ 9% de la dose est excrétée dans les selles, essentiellement sous forme de métabolites.
0.5391634702682495 ||| The product should be used with the accompanying solvent only. ||| To be used as two-components product with supplied device. ||| Il est recommandé de n’ utiliser le produit qu’ avec le solvant fourni.
0.30537107586860657 ||| In vitro and in vivo studies showed that maraviroc has a potential to increase QTc interval at supratherapeutic doses with no evidence of arrhythmia. ||| Ocular tissue distribution data in rabbits showed that timolol can be measured in aqueous humour up to 48 hours after administration of AZARGA. ||| Les études in vitro et in vivo ont montré que le maraviroc avait un potentiel pour augmenter l’ intervalle QT à des doses supra-thérapeutiques sans signes d’ arythmie.
0.48267167806625366 ||| Axura film-coated tablets are presented as pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20’ on one side and imprint ‘MEM’ on the other side. ||| Hard capsule (capsule) The capsule body is caramel opaque, printed with ‘ 250’ axially in black ink The capsule cap is light blue opaque printed ‘ M’ axially in black ink. ||| Les comprimés pelliculés d’Axura se présentent sous la forme de comprimés pelliculés rouge pâle à gris-rouge, de forme oblongue conique avec l’inscription « 20 » sur une face et « MEM » sur l’autre face.
0.39721569418907166 ||| This veterinary medicinal product does not require any special storage conditions. ||| This medicinal product does not require any special storing conditions prior to reconstitution. ||| Ce médicament vétérinaire ne requiert aucune condition de conservation particulière.
0.6865475177764893 ||| If you have not been previously treated with chemotherapy, your first dose of Temodal will be 200 mg/m2 once daily for the first 5 days. ||| For every 2 kg (4 lb) you lose from dieting alone, alli can help you lose 1 kg (2 lb) more. ||| Si vous n’ avez pas été traité préalablement par chimiothérapie, votre première dose de Temodal sera de 200 mg/ m2 une fois par jour pendant les 5 premiers jours.
0.1465362310409546 ||| Taking Irbesartan Krka with food and drink Irbesartan Krka can be taken with or without food. ||| Taking Irbesartan Winthrop with food and drink Irbesartan Winthrop can be taken with or without food. ||| Aliments et boissons Irbesartan Krka peut être pris au cours ou en dehors des repas.
0.28982704877853394 ||| Increases of approximately 10% in the QT interval of the ECG were observed in a study on healthy beagle dogs administered 8 mg/kg orally; however, such an increase is unlikely to be of clinical significance. ||| In this evaluation a considerable number of plant species have been tested and it has been possible to use a sensitivity distribution to calculate an HC5 of 150 µg/ kg (the HC5 is the hazardous concentration below which 95% of plant species will not be affected). ||| Des augmentations de l'intervalle QT de l'électrocardiogramme, d’ approximativement 10%, ont été observées lors d’ une étude faite sur des chiens sains de race « Beagle », après l’ administration orale de 8mg/ kg; cependant, il est improbable qu’ une telle augmentation soit significative cliniquement.
0.20920678973197937 ||| The following other side effects have been reported in very few patients treated with Tasigna: • confusion, disorientation • sensation of numbness or tingling in fingers and toes • increased sensitivity of the eyes or the skin to light • eye pain or redness, pain, swelling and itching of the eyelids • difficulty hearing, ear pain • joint stiffness, muscle weakness • unconsciousness • blood in urine • weight gain, tiredness, hair loss, muscle weakness, feeling cold If any of these affects you severely, tell your doctor. ||| If you develop any of these signs you should stop and talk to your doctor immediately: • shortness of breath, chest pains, or ankle swelling appear or if they get worse • yellowing of the skin and eyes (jaundice) – these are signs of liver problems • severe or continual stomach pain or your stools become black • an allergic reaction- which can include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue, or throat which may cause difficulty in breathing ||| Les autres effets indésirables suivants ont été rapportés chez très peu de patients traités par Tasigna: • confusion mentale, désorientation • sensation d’ engourdissement ou de picotements dans les doigts et les orteils • sensibilité accrue des yeux ou de la peau à la lumière • douleur ou rougeur oculaire, douleur, gonflement et démangeaisons au niveau des paupières • difficultés d’ audition, douleurs au niveau des oreilles • raideur articulaire, faiblesse musculaire • perte de connaissance
0.29644739627838135 ||| Important information about some of the ingredients of Aerius oral lyophilisate This product contains aspartame 1.75 mg/ dose. ||| Important information about some of the ingredients of NeoRecormon This medicine contains phenylalanine. ||| Informations importantes concernant certains composants d’ Aerius lyophilisat oral Ce produit contient 1,75 mg/ dose d’ aspartame.
0.03696458786725998 ||| 25 PACKAGE LEAFLET: ||| 27 PACKAGE LEAFLET: ||| 27 NOTICE:
0.38243603706359863 ||| Prandin can also be used for type 2 diabetes patients whose blood glucose levels are usually controlled well on diet, but are experiencing temporary loss of blood glucose control. ||| The patient ’ s blood levels of white blood cells, platelets and haemoglobin should be checked before treatment, to ensure that they are above set minimum levels. ||| Prandin peut également être utilisé chez les diabétiques de type 2 dont les niveaux de glycémie sont habituellement équilibrés par un régime alimentaire, mais qui sont sujets à un déséquilibre glycémique transitoire.
0.35026487708091736 ||| All swimming pools, museums, libraries and bars closed, as did any businesses requiring a proximity of less than 2 m (hairdressers, tattoo artists, etc.). ||| Restaurants and cafes were permitted to open, but operations were limited to between 6:00 and 18:00, while many other public locations such as gyms, nightclubs, museums and swimming pools were closed altogether. ||| Toutes les piscines, musées, bibliothèques et bars fermés, tout comme les commerces nécessitant une proximité inférieure à 2 m (coiffeurs, tatoueurs, etc.).
0.2613157033920288 ||| A food-effect study involving administration of ambrisentan to healthy volunteers under fasting conditions and with a high-fat meal indicated that the Cmax was decreased 12% while the AUC remained unchanged. ||| Administration of rimonabant to healthy subjects in the fasted state or with a high fat meal demonstrated that Cmax and AUC were increased 67% and 48% respectively, under fed conditions. ||| 24 Une étude de l'influence de l'alimentation portant sur l’ administration d’ ambrisentan chez des volontaires sains à jeun et après un repas riche en graisses a indiqué que la Cmax était diminuée de 12% tandis que l’ ASC demeurait identique.
0.2969895005226135 ||| Posology for Ph+ ALL The recommended dose of Glivec is 600 mg/ day for patients with Ph+ ALL. ||| Posology for HES/ CEL The recommended dose of Glivec is 100 mg/ day for patients with HES/ CEL. ||| Posologie dans les LAL Ph+ La posologie recommandée de Glivec est de 600 mg/ jour chez les patients atteints de LAL Ph+.
0.06871511042118073 ||| 49 Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214 ||| 83 Κύπρος Βαρνάβας Χατζηπαναγής Λτδ, 7 Ανδροκλέους CY-1060 Λευκωσία Τηλ: +357 22 755 214 ||| Κύπρος Βαρνάβας Χατζηπαναγής Λτδ 7 Ανδροκλέους CY-1060 Λευκωσία Tηλ: +357 22 755 214
0.11039648205041885 ||| Chemicals for use in the manufacture of smoke suppressed compositions ||| Chemicals for use in the manufacture of flame retardant coatings ||| Produits chimiques destinés à la fabrication de compositions antifumée
0.0793490931391716 ||| What benefit has Pruban shown during the studies? ||| What benefit has Tasmar shown during the studies? ||| Quel est le bénéfice démontré par Pruban au cours des études?
0.8952270746231079 ||| When combining controlled portions of ten trials (I-IX and CHARM) and ongoing open label lP ||| Two large clinical trials (WHI and HERS i.e. ||| En joignant les périodes contrôlées de dix essais (I-IX et CHARM) et les essais d'extension en ouvert dic
0.452556848526001 ||| Rispolin 1 mg/ ml - 1 mg orale Lösung ||| Rispolin 4 mg - 4 mg Filmtabletten ||| Rispolin 1 mg/ ml 1 mg - orale Lösung
0.09569351375102997 ||| Seat cushions for the seats of water vehicles ||| Seat cushions for the seats of aircraft ||| Coussins de sièges pour véhicules nautiques
0.22687065601348877 ||| Exposure in multiple myeloma patients is slightly higher based on Cmax and AUC values as compared to healthy male volunteers since the clearance/bioavailable fraction of a drug (CL/F) in multiple myeloma patients is lower (approximately 200 ml/min compared to 300 ml/min) than it is in healthy volunteers. ||| Analyses of nocturnal hypoglycaemia in patients with type 1 diabetes showed a significantly lower risk of minor nocturnal hypoglycaemia (able to self-treat and confirmed by capillary blood glucose less than 2.8 mmol/ L or 3.1 mmol/ L if expressed as plasma glucose) than with NPH insulin, whereas no difference was seen in type 2 diabetes. ||| L’ exposition, chez les patients atteints de myélomes multiples, est légèrement supérieure en termes de Cmax et d’ ASC par comparaison avec les volontaires sains de sexe masculin, le rapport clairance/ biodisponibilité des médicaments étant inférieur chez les patients atteints de myélomes multiples par rapport aux volontaires sains (environ 200 ml/ min contre 300 ml/ min).
0.26661035418510437 ||| Dukoral is a vaccine, which is available as a suspension in a vial. ||| Twinrix Paediatric is a vaccine, which is available as a suspension for injection. ||| Dukoral est un vaccin disponible sous la forme d’ une suspension contenue dans un flacon.
0.0 ||| Bottle pack: ||| Bottle pack: ||| Conditionnement flacon::
0.06687327474355698 ||| Woollen fabrics for use in the manufacture of jackets ||| Woollen fabrics for use in the manufacture of suits ||| Tissus en laine destinés à la confection de vestes
0.6108218431472778 ||| Box 501 183 25 Täby Sweden ||| Box 24 FIN-02231 Espoo Finland ||| Box 501 183 25 Täby Suède
0.3643099069595337 ||| Olanzapine is metabolized in the liver by conjugative and oxidative pathways. ||| During administration of micafungin, anaphylactoid reactions including shock may occur. ||| 61 L’ olanzapine est métabolisée dans le foie par conjugaison et oxydation.
0.11884012818336487 |||  134 the risk of increased toxicity, careful adjustments of doses are required for IntronA and for the concomitant chemotherapeutic agents (see section 4.5). ||| Because of the risk of increased toxicity, careful adjustments of doses are required for IntronA and for the concomitant chemotherapeutic agents (see section 4.5). ||| En raison du risque de potentialisation de toxicité, un ajustement précis des doses d’ IntronA et des agents chimiothérapeutiques associés est nécessaire (voir rubrique 4.5).
0.27831563353538513 ||| Ibandronic acid 2.5 mg administered daily, showed a statistically significant and medically relevant reduction in the incidence of new vertebral fractures. ||| Clinical end-point data indicate that lamivudine in combination with zidovudine, results in a significant reduction in the risk of disease progression and mortality. ||| L’ acide ibandronique, à la posologie de 2,5 mg par jour, a permis d’ obtenir une réduction statistiquement significative et cliniquement pertinente de l’ incidence de nouvelles fractures vertébrales.
0.43285202980041504 ||| Control groups included ferrets immunized with adjuvant alone, non-adjuvanted vaccine (15 micrograms HA) or phosphate buffered saline solution. ||| Do not mix Zometa reconstituted solution with calcium-containing or other divalent cation-containing solutions such as lactated Ringer’ s solution. ||| Les groupes contrôles ont inclus des furets immunisés avec l’ adjuvant seul, le vaccin non-adjuvanté (15 microgrammes de HA) ou une solution saline tamponnée de phosphate.
0.0 ||| If you are taking any of these medicines, tell your doctor immediately. ||| If you are taking any of these medicines, tell your doctor immediately. ||| 156 Prévenez immédiatement votre médecin si vous prenez l'un de ces médicaments.
0.330089807510376 ||| CELSENTRI was studied in two main studies involving a total of 1,076 patients with CCR5-tropic HIV infection. ||| The use of PegIntron alone in chronic hepatitis C has been studied in one study in 1,224 treatment- naïve adult patients. ||| CELSENTRI a été étudié dans le cadre de deux études principales comprenant 1 076 patients infectés par le VIH à tropisme CCR5.
0.36670950055122375 ||| It also encourages EU countries to set up mechanisms for recovering compensation payments from the offender. ||| Member States can also grant no-loss guarantees to provide incentives for companies to invest. ||| Elle encourage également les pays de l'UE à mettre en place des mécanismes permettant d'obtenir une indemnisation de la part de l'auteur de l'infraction.
0.348222017288208 ||| By blocking the receptors to which angiotensin II normally attaches, irbesartan stops the hormone having an effect, allowing the blood vessels to widen. ||| It blocks a receptor in the body, the muscarinic M3 receptor, and in the bladder, this causes the muscles which pushes urine out of the bladder to relax. ||| En bloquant les récepteurs auxquels l’ angiotensine se lie normalement, l’ irbésartan empêche l'hormone de faire effet, ce qui permet une augmentation du diamètre des vaisseaux sanguins.
0.369880735874176 ||| This means that it is injected through a short injection needle into the fatty tissue just under your skin. ||| Place a generous coating of gel over the whole surface of each lesion that you want to treat. ||| Cela signifie qu’il est injecté à l’aide d’une aiguille courte dans le tissu graisseux juste sous la peau.
0.039776332676410675 ||| Parenteral drug products should be inspected visually for particulate matter and discoloration before administration. ||| Parenteral medicinal products should be inspected visually for particulate matter and discolouration prior to administration. ||| Les substances médicamenteuses à usage parentéral doivent être visuellement vérifiées avant administration pour déceler la présence éventuelle de particules ou d'un changement de coloration.
0.03847889229655266 ||| Do not use Rebetol after the expiry date which is stated on the label. ||| Do not use NeoSpect after the expiry date which is stated on the label. ||| Ne pas utiliser Rebetol après la date de péremption mentionnée sur l’ étiquette.
7.503627710500615e-13 ||| This medicine does not require any special storage conditions. ||| This medicine does not require any special storage conditions. ||| Pas de précautions particulières de conservation.
0.300442636013031 ||| Rapilysin 10 U powder and solvent for solution for injection. ||| Diacomit 250 mg powder for oral suspension in sachets. ||| Rapilysin 10 U, poudre et solvant pour solution injectable.
0.06775227189064026 ||| Do not use Combivir after the expiry date which is stated on the container. ||| Do not use INVANZ after the expiry date which is stated on the container. ||| Ne pas utiliser Combivir après la date de péremption mentionnée sur la boîte.
4.063716052028765e-13 ||| Use of Tarceva in patients with severe hepatic impairment is not recommended (see section 5.2). ||| Use of Tarceva in patients with severe hepatic impairment is not recommended (see section 5.2). ||| L’ utilisation de Tarceva chez les patients ayant une insuffisance hépatique sévère n’ est pas recommandée (voir rubrique 5.2).
0.17662255465984344 ||| Other frequently observed signs or symptoms include nausea, vomiting, diarrhoea, abdominal pain and severe tiredness. ||| However, possible symptoms of overdose are expected to include nausea, vomiting, diarrhoea and severe bone marrow depression. ||| Les autres signes ou symptômes fréquemment observés sont les suivants: nausées, vomissements, diarrhée, douleurs abdominales et fatigue intense.
0.17400702834129333 ||| Via Palermo 26/ A 43100 Parma ||| Via Palermo, 26/ A 43100 Parma Italy ||| Via Palermo 26/ A 43100 Parma Italie
0.04436462000012398 ||| 27 June 2000 Date of latest renewal: ||| 18 June 1999 Date of latest renewal: ||| Date du dernier renouvellement de l’ autorisation:
0.5829029083251953 ||| If you forget to take a dose, do not worry. ||| If you need to dial back, that’s okay. ||| 67 Si vous oubliez de prendre votre comprimé de Micardis, n’ ayez pas d’ inquiétude.
0.42036736011505127 ||| Glucocerebroside is primarily derived from haematopoietic cell turnover. ||| - Pelvic inflammatory disease may be caused by fluoroquinolone resistant Neisseria ||| 5 Le glucocérébroside provient essentiellement de la dégradation des cellules hématopoïétiques.
0.1379692554473877 ||| 105 5. ||| 204 5. ||| 5.
0.4547308683395386 ||| 114 Lipids: increases in total cholesterol of 10 - 20% have been observed in some uninfected volunteers receiving efavirenz. ||| 62 humans; all showed activity that was at least 10-fold less than the activity of darunavir against wild type HIV. ||| Des augmentations du cholestérol total de 10 - 20% ont été observées chez certains volontaires non infectés recevant de l'éfavirenz.
0.2400822937488556 ||| The Rebif initiation package corresponds to the patient needs for the first month of treatment. ||| This package corresponds to the patient needs for the first month of therapy. ||| Le coffret d’ initiation Rebif correspond aux besoins du patient pour le premier mois de traitement.
0.3703722357749939 ||| 28 April 2003 CPMP/ 4060/ 03 ||| 7 November 2005 CHMP/ 408150/ 2005 ||| 28 avril 2003 CPMP/ 4060/ 03
0.2830865979194641 ||| In combination with metformin, a daily dose of 100 mg Xelevia reduced HbA1c by 0.70% (from 7.96 to 7.26%) after 24 weeks, compared to a fall of 0.08% in the patients adding placebo. ||| With metformin and with pioglitazone, the 100-mg daily dose was more effective than the 50 mg daily dose, with a reduction in HbA1c levels of between 0.8 and 1.0%. ||| En association avec la metformine, une dose quotidienne de 100 mg de Xelevia a permis d’ abaisser le taux de HbA1c de 0,70% (de 7,96 à 7,26%) après 24 semaines, contre seulement 0,08% chez les patients chez lesquels on a ajouté un placebo.
0.5265742540359497 ||| In cats infected by FIV, the mortality rate was low (5%) and was not changed by the treatment. ||| In Europe, 57% of the infected individuals were men and 72% of those died with COVID-19 were men. ||| Chez les chats infectés par le FIV, le taux de mortalité était faible (5%) et n’ a pas été influencé par le traitement.
0.9911817312240601 ||| - changes to blood tests. ||| function tests from time to time. ||| - modifications des résultats des examens sanguins.
3.7955830969535476e-13 ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY ||| SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY ||| PRÉCAUTIONS PARTICULIÈRES POUR L’ ÉLIMINATION DES MÉDICAMENTS VÉTÉRINAIRES NON UTILISÉS OU DES DECHETS DÉRIVÉS DE CES MÉDICAMENTS LE CAS ECHEANT
0.18875542283058167 ||| Inadequate dosage or discontinuation of treatment, especially in type 1 diabetes, may lead to uc ||| Inadequate dosage or discontinuation of treatment, especially in type 1 diabetes, may lead to hyperglycaemia. ||| Un dosage inadapté ou un arrêt du traitement, en particulier chez les diabétiques de type 1, peut conduire à une hyperglycémie et à une acidocétose diabétique.
0.008051510900259018 ||| Although animal studies have shown no teratogenic or embryotoxic effects, insufficient clinical data 5 are available on Sonata to assess its safety during pregnancy and breastfeeding. ||| Although animal studies have shown no teratogenic or embryotoxic effects, insufficient clinical data 5 are available on Zerene to assess its safety during pregnancy and breastfeeding. ||| Bien que les études animales n'aient mis en évidence aucun effet tératogène ou embryotoxique, les données cliniques disponibles sur Sonata sont insuffisantes pour évaluer l'innocuité de ce médicament au cours de la grossesse et de l'allaitement.
0.5587059259414673 ||| Organization of collections ||| Collection of credit sales ||| Organisation de collectes
0.3287733793258667 ||| By contrast, no effects suggesting prolongation of the QT-interval of the ECG were observed at similar doses in dogs or in isolated cardiac tissue. ||| However, a signal towards a higher rate of decreased appetite and/ or food intake was observed in the adefovir arm as compared to the placebo arm. ||| A l’opposé, aucun effet suggérant une prolongation de l’intervalle QT de l’ECG n’a été observé à des doses similaires chez le chien ou sur cœur isolé.
0.03311727195978165 ||| 145 Store in a refrigerator. ||| 95 Store in a refrigerator. ||| 156 A conserver au réfrigérateur.
0.3828473389148712 ||| 0.91% ||| 0.4%) ||| 0.91% 0.44%
0.06340152770280838 ||| 185 If you suffer from any of the following illnesses tell your doctor as soon as possible: ||| If you suffer from any of the following illnesses tell your doctor as soon as possible: ||| Si vous souffrez de l'une des maladies suivantes, veuillez en informer votre médecin le plus tôt possible:
0.2678315043449402 ||| 6 days ||| 6 weeks ||| 6 jours
0.08397707343101501 |||  24 (See ribavirin capsule SPC for dose of ribavirin capsules and dosage modification guidelines for combination therapy. ||| (See ribavirin capsule SPC for dose of ribavirin capsules and dosage modification guidelines for combination therapy. ||| (Se reporter au RCP de la ribavirine en gélule et aux Recommandations en matière de modification de la posologie pour le traitement combiné.
0.41427990794181824 ||| Owing to the greater sensitivity of this population, a lower starting dose should be considered when clinical factors warrant (see section 4.4). ||| As renal function decreases with age, this is the only factor to take into consideration (see renal impairment section). ||| En raison d'une sensibilité plus grande de cette population, une dose initiale plus faible doit être envisagée lorsque des raisons cliniques le justifient (voir rubrique 4.4).
0.5877521634101868 ||| Tatoiou Street Nea Erythrea 14671 Greece ||| Chiesi Hellas Aebe Anapafseos Avenue 30 Vrilissia 15235 Greece ||| Tatoiou Street, Nea Erythrea 14671 Greece
0.20172223448753357 ||| 250 mg 500 mg 750 mg 2 mg/ ml 2 mg/ ml 2 mg/ ml 2 mg/ ml ||| 2 mg/ ml 2 mg/ ml 2 mg/ ml 100 mg 250 mg 500 mg 750 mg 50 mg/ ml 100 mg/ ml 250 mg ||| 250 mg 500 mg 750 mg 2 mg/ ml
0.006478250492364168 ||| 27 The results of the tests for serum creatinine, serum ferritin and serum transaminases should be recorded and regularly assessed for trends. ||| 5 The results of the tests for serum creatinine, serum ferritin and serum transaminases should be recorded and regularly assessed for trends. ||| L’ évolution des résultats de la créatininémie, de la ferritinémie et des transaminases sériques doit être évaluée régulièrement.
0.7669914364814758 ||| 33 Haemophilus influenzae and Moraxella catarrhalis ||| - cSSTI without concurrent Staphylococcus aureus bacteraemia: ||| Haemophilus influenzae et Moraxella catarrhalis
0.21567358076572418 ||| If you are breast-feeding you must inform your doctor. ||| Also be sure to tell your doctor if you are breast-feeding. ||| Si vous allaitez, vous devez en informer votre médecin.
5.684286591770005e-13 ||| Many of these patients reported concurrent peripheral oedema. ||| Many of these patients reported concurrent peripheral oedema. ||| Parmi ces patients, plusieurs ont rapporté des œ dèmes périphériques concomitants.
0.16917917132377625 ||| Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate. ||| Tablet core Lactose monohydrate Microcrystalline cellulose Magnesium stearate Hydroxypropylcellulose 25 Croscarmellose sodium Silica, colloidal hydrated ||| Lactose monohydraté Cellulose microcristalline Croscarmellose sodique Hypromellose Dioxyde de silicone Stéarate de magnésium.
0.3880698084831238 ||| Remove the plastic packaging from the vial adapter and discard. ||| Remove the empty vial and the transfer needle. ||| Retirer l’emballage plastique de l’adaptateur et le jeter.
0.2769652009010315 ||| 52.4% NA ||| 46.0% NA ||| 52,4%
0.5311899781227112 ||| Please refer to the SPC of melphalan prior to commencing an ILP procedure. ||| Refer to the IL-2 SmPC for information on pregnancy and lactation with IL-2. ||| Se référer au résumé des caractéristiques du melphalan avant de mettre en œ uvre la technique d‘ ILP.
0.029835190623998642 ||| Hypersensitivity Current data suggest that, during the first year of therapy, IgG antibodies to imiglucerase are formed in approximately 15% of the treated patients. ||| Hypersensitivity Current data suggest that, during the first year of therapy, IgG antibodies to imigluceraseare formed in approximately 15% of the treated patients. ||| Hypersensibilité Les données actuelles suggèrent que des anticorps anti-imiglucérase de type IgG sont synthétisés au cours de la première année de traitement par Cerezyme chez 15% environ des patients traités.
0.0 ||| 4.7 Effects on ability to drive and use machines ||| 4.7 Effects on ability to drive and use machines ||| 5 4.7 Effets sur l’aptitude à conduire des véhicules et à utiliser des machines
0.39389538764953613 ||| Operational expenditure for 1998 amounts to ECU 14. 19 million, an increase of ECU 3.18 million over 1997, mainly because of the rise in number of meetings expected in 1998 and increase in the evaluation services provided by rapporteurs and co-rapporteurs. ||| A s a result of these expected increases in activities (an additional 50 percent of meetings and related activities for the EWP and 30 percent for the SWP) a corresponding increase in resources will be required to maintain current standards of support. ||| Les frais de fonctionnement s’élèvent à 14,19 millions d’écus pour 1998, soit une augmentation de 3,18 millions d’écus par rapport à 1997, essentiellement en raison de l’augmentation du nombre de réunions prévues en 1998 et de l’accroissement des services d’évaluation fournis par les rapporteurs et co-rapporteurs.
0.29202964901924133 ||| 5 ml suspension contains 1 g mycophenolate mofetil when reconstituted. ||| 10 LeukoScan is reconstituted with 0.5 ml isotonic sodium chloride injection. ||| 5 ml de suspension contiennent 1 g de mycophénolate mofétil après reconstitution.
0.29240289330482483 ||| When diluted in glucose 50 mg/ ml (5%) solution, filgrastim is compatible with glass and a variety of plastics including polyvinylchloride, polyolefin (a copolymer of polypropylene and polyethylene) and polypropylene. ||| Solutions of Herceptin for infusion are physically and chemically stable in polyvinylchloride, polyethylene or polypropylene bags containing 0.9% sodium chloride for 24 hours at temperatures not exceeding 30°C. ||| Après dilution dans une solution de glucose à 50 mg/ ml (5%), Zarzio est compatible avec le verre et diverses matières plastiques, y compris le chlorure de polyvinyle, la polyoléfine (un copolymère de polypropylène et de polyéthylène) et le polypropylène.
0.23885440826416016 ||| The active substance in Naxcel is ceftiofur, which belongs to a class of antibiotics called “ third generation cephalosporins”. ||| The active substance in EXULETT, dalbavancin, is an antibiotic that belongs to the group ‘ glycopeptides’. ||| Le principe actif de Naxcel est le ceftiofur, qui appartient à la famille des antibiotiques appelés « céphalosporines de troisième génération ».
0.8711472153663635 ||| HCV Genotype ||| EuroPharm database ||| Génotype VHC
0.39033204317092896 ||| Introduction Suramox 15% LA contains amoxicillin which is a beta lactam antibiotic belonging to the group of penicillins. ||| C02CA04 The generic name for the active substance in Doxastad 4 mg prolonged release tablets and associated names is doxazosin, which is a quinazoline derivative. ||| Introduction Suramox 15% LA contient de l’ amoxicilline, qui est une bêta-lactamine appartenant au groupe des pénicillines.
0.5198464393615723 ||| And it gives guidance on how to minimise any undue residual aid to the banks in line with EU rules. ||| What does the exemption of Member States from the need to comply with thematic concentration requirements entail? ||| Il donne également des orientations sur la manière de réduire au minimum toute aide résiduelle indue aux banques, conformément aux règles de l'UE.
0.493672251701355 ||| In particular, the support will not exceed €120 000 per company as provided by the Temporary Framework for companies active in the fishery and aquaculture sector. ||| 4.3 Safety of veterinary medicines A major distribution of activities in terms of fee earning capacity is expected for the Sector for the safety of veterinary medicines in 2000. ||| En particulier, le soutien accordé ne dépassera pas 120 000 euros par entreprise, comme le prévoit le cadre temporaire, pour les entreprises du secteur de la pêche et de l'aquaculture.
0.12439925223588943 ||| Why has Livensa been approved? ||| Why has Zonegran been approved? ||| Pourquoi Livensa a -t-il été approuvé?
0.4558812975883484 ||| Cyclosporin A (an inhibitor of ABCB1, ABCC1 [MRP-1], and CYP3A4) administered with oral topotecan increased topotecan AUC to approximately 2-2.5-fold of control. ||| Ambrisentan is glucuronidated via several UGT isoenzymes (UGT1A9S, UGT2B7S and UGT1A3S) to form ambrisentan glucuronide (13%). ||| La cyclosporine A (un inhibiteur de l’ ABCB1, ABCC1 [MRP-1], et le CYP3A4) administré avec le topotécan oral a augmenté d’ environ 2 à 2,5 fois l’ ASC du topotécan par rapport au contrôle.
0.022293437272310257 ||| The use of this veterinary medicinal product is only allowed under the particular conditions established by the European Community legislation on the control of Avian Influenza. ||| 5 The use of this veterinary medicinal product is only allowed under the particular conditions established by European Community legislation on the control of Avian Influenza. ||| L’ utilisation de ce médicament vétérinaire n’ est autorisée que sous certaines conditions définies par la législation communautaire européenne sur le contrôle de l’ influenza aviaire.
0.0 ||| 8. ||| 8. ||| 14 8.
0.36888861656188965 ||| Remove the needle cover by firmly pulling it straight off the syringe (see Diagram 2). ||| 320  While holding the vial in one hand, remove the plastic packaging from the vial adaptor (see Diagram 5). ||| Enlevez le capuchon de l’aiguille d’un mouvement ferme, dans l’axe de l’aiguille (voir Schéma 2).
0.3393620252609253 ||| If any of these conditions apply to you, please talk with your doctor before taking Efexor depot. ||| In case you administered more CEPROTIN than recommended, please inform your doctor as soon as possible. ||| Si vous êtes dans l’ une de cessituations, parlez -en à votre médecin avant de prendre Efexor depot.
0.0 ||| Under no circumstances should you attempt to inject yourself unless you have been trained to do so. ||| Under no circumstances should you attempt to inject yourself unless you have been trained to do so. ||| Vous ne devez en aucun cas procéder à une auto-injection sans avoir reçu au préalable une formation appropriée.
0.42692428827285767 ||| Ceftiofur 100 mg/ml ||| Doxyprex 100 mg/ g Premix ||| 100 mg/ ml.
0.04792259261012077 ||| The expiry date refers to the last day of that month. lo ||| The expiry date refers to the last day of that month. in ||| La date de péremption fait référence au dernier jour du mois.
0.02438681572675705 ||| neorecormon 20.000 IU ||| neorecormon 10.000 IU ||| neorecormon 20 000 UI
0.688685953617096 ||| - if you have ever had anaemia. ||| and are you having a fever now? ||| - si vous avez déjà eu une anémie.
0.37944841384887695 ||| No clinical data are available on the use of RotaTeq for post-exposure prophylaxis. ||| No clinical data are available on the interaction between IT chemotherapy and IT ziconotide. ||| L’ utilisation de Rotateq en prophylaxie après exposition au rotavirus n’ a pas été étudiée.
0.5756512880325317 ||| Unprocessed oats ||| Uncooked pizzas ||| Avoine brute
0.6662075519561768 ||| A contribution for the Agency is entered in the general budget of the European Union. ||| The country of the nominating Member State is given for information purposes only. ||| Une contribution destinée à l'Agence est inscrite au budget général de l'Union européenne.
0.13828936219215393 ||| 2 0 < 1 < 1 ||| 5 < 1 < 1 0 ||| 0 < 1 < 1
0.4957219064235687 ||| During the written procedure a request was received from France for a scientific assessment of new studies made available by the Marketing Authorisation Holder. ||| The emergency response part of the programme started and allows a gap analysis based on detailed surveys per country, dedicated ECDC staff will be available to help and advice. ||| Au cours de la procédure écrite, la France a formulé une demande d’évaluation scientifique des nouvelles études présentées par le titulaire de l’autorisation de mise sur le marché.
0.0 ||| 73 ||| 73 ||| 79
0.4906826913356781 ||| The low total body clearance and large volume of distribution resulted in a terminal elimination half-life in plasma of approximately 40 hours. ||| An almost constant release rate provides a relatively constant concentration of active substance in plasma, without major differences between maximal and minimal levels. ||| La faible clairance corporelle totale et l’ important volume de distribution se sont traduits par une demi-vie plasmatique d'élimination terminale de 40 heures environ.
0.2947950065135956 ||| Preclinical studies of tenofovir disoproxil fumarate conducted in rats, dogs and monkeys revealed effects on bone and a decrease in serum phosphate concentration. ||| In all studies in rats and dogs Aranesp produced marked increases in haemoglobin, haematocrits, red blood cell counts and reticulocytes, which correspond to the expected pharmacological effects. ||| Les études précliniques sur le fumarate de ténofovir disoproxil conduites chez le rat, le chien et le singe ont révélé des effets sur l’ os et une diminution de la concentration en phosphate sérique.
0.29271867871284485 ||| Additionally, nearly all patients received prophylactic treatment with antibiotics, according to clinical practice at each of the clinical trial sites 5 In two double-masked, randomised placebo-controlled studies, patients treated with NEVANAC had significantly less inflammation (aqueous cells and flare) from the early postoperative period through the end of treatment than those treated with placebo. ||| The frequencies of the following adverse events, which have been reported during clinical studies and/ or post-marketing use, are categorized based on an assessment of their incidence rates in large, long-term, placebo-controlled, clinical trials including HPS and 4S with 20,536 and 4,444 patients, respectively (see section 5.1). ||| Dans 2 études en double aveugle, randomisées, controlées versus placebo, les patients traités avec NEVANAC ont eu signicativement moins d’ inflammation (Tyndall protéique et cellulaire) que ceux traités avec le placebo du début de la période post-opératoire jusqu’ à la fin du traitement.
0.2244987040758133 ||| Results showed that in renal transplant patients early treated with pravastatin, there is a lower tendency in acute rejection and extra renal vascular complications. ||| In clinical studies, mild or moderate elevations of ALT and AST have been observed in patients receiving Remicade without progression to severe hepatic injury. ||| Les résultats ont démontré une tendance moindre au rejet aigu et aux complications rénales extravasculaires chez les greffés rénaux traités de manière précoce par pravastatine.
0.34500664472579956 ||| Similarly, there was no clinically significant pharmacokinetic interaction of Trazec with other oral antidiabetic agents such as metformin or glibenclamide. ||| Additionally, the relationship between the Pharmacokinetic and the Pharmacodynamic of orally administered norfloxacin in the treatment of complicated pyelonephritis was been established. ||| De même, on n’ a pas observé d’ interaction pharmacocinétique cliniquement significative entre Trazec et d'autres antidiabétiques oraux, tels que la metformine ou le glibenclamide.
0.29338783025741577 ||| Asthenia, flushing, hot flushes, condition aggravated, rigors, tongue discolouration, parosmia, thirst ||| Asthenia, face oedema, pain, condition aggravated, rigors, tooth disorder, taste perversion ||| Asthénie, bouffées vasomotrices, bouffées de chaleur, aggravation de l’ état, raideur, décoloration de la langue, parosmie, soif
0.3966834545135498 ||| Ultrasonic welding machines ||| Gamma radiation detectors ||| Machines à souder à ultrasons
0.3362202048301697 ||| If you are taking any of these medicines, your doctor may need to check the level of anticonvulsant medicine in your blood to ensure that it is not affected while taking SUSTIVA. ||| As this vial contains enough medication for several days of treatment, you need to make sure you only draw the amount of medication that was prescribed by your doctor. ||| Si vous prenez l'un de ces médicaments, votre médecin devra peut-être mesurer la concentration du médicament anticonvulsivant dans votre sang pour s’ assurer que celle -ci n’ est pas affectée par prise de SUSTIVA.
0.3405941426753998 ||| Your doctor has determined the exact dose of Firazyr and will tell you how often it should be used. ||| The doctor will carefully monitor you and decide what are the appropriate amounts of MabCampath to give during your whole treatment period. ||| Votre médecin a déterminé la dose exacte de Firazyr et vous indiquera à quelle fréquence vous devez en prendre.
0.6139122247695923 ||| Flushing, hot flushes Hypotension, hypertension, peripheral coldness ||| Uncommon Weight increase, increased appetite Uncommon Hypertension, flushing, hot flush, ||| Bouffées vasomotrices, bouffées de chaleur Hypotension, hypertension, sensation de froid aux extrémités
0.006310117430984974 ||| 415 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 422 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 418 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.20677438378334045 ||| • Replace the big outer needle cap and unscrew the needle. ||| • Replace the big outer needle cap and unscrew the needle • Dispose of it carefully. ||| • Replacez le grand capuchon externe de l’aiguille et dévissez l’aiguille.
0.4236339330673218 ||| How to store Thyrogen 6. ||| How to store Luminity 6. ||| Comment conserver Thyrogen 6.
0.2409370243549347 ||| Taking Mimpara with food and drink ||| Taking Kinzalmono with food and drink ||| Aliments et boissons
0.348055362701416 ||| Your doctor may continue to give you Thymanax when you are feeling better to prevent your depression from returning. ||| If a side effect is preventing you from taking Norvir as directed, tell your doctor straight away. ||| Votre médecin peut continuer à vous prescrire Thymanax même si vous vous sentez mieux, afin de prévenir une rechute.
0.4772002100944519 ||| Maintenance treatment of adult patients with schizophrenia sufficiently stabilised during acute treatment with oral olanzapine. ||| In adults: peripheral oedema; In paediatric patients: transient local skin reactions at the injection site ||| Traitement de maintien de la schizophrénie chez les patients adultes suffisamment stabilisés par olanzapine orale lors de la phase initiale du traitement.
0.2763161063194275 ||| In case of ingestion of a number of oral lyophilisates by a person, the advice of a doctor should be sought immediately. ||| 32 In case of signs of upper airway obstruction, the problem should be solved by a specialist before starting treatment with somatropin. ||| En cas d’ ingestion accidentelle par une personne de plusieurs lyophilisats oraux, le conseil d’ un médecin doit être pris immédiatement.
0.4753805994987488 ||| Rainwater purification installations ||| Underwater structural inspection services ||| Installations de purification d'eau de pluie
0.3568156957626343 ||| The reduction of bone loss helps to make bones less likely to break, and this is useful in preventing fractures in cancer patients with bone metastases. ||| It is important to treat with the right antibiotic, since these types of highly resistant bacteria can cause patients to be sicker and to have a worse outcome. ||| Cette réduction de la perte osseuse contribue à rendre les os moins fragiles, ce qui est utile pour éviter les fractures chez les patients cancéreux présentant des métastases osseuses.
0.17662502825260162 ||| Emulsion for injection. ||| Emulsion for injection ||| Emulsion pour injection.
0.0 ||| One vial contains 4 mg of zoledronic acid. ||| One vial contains 4 mg of zoledronic acid. ||| Chaque flacon contient 4 mg d’acide zolédronique.
0.2506047487258911 ||| If pregnancy occurs during treatment with Atriance, you must tell your doctor immediately. ||| When pregnancy is diagnosed, treatment with Lisonorm should be stopped immediately. ||| Si une grossesse survient pendant le traitement par Atriance, vous devez en informer votre médecin immédiatement.
0.8923617005348206 ||| Zarzio is available in strengths of 30 MU/ 0.5 ml and 48 MU/ 0.5 ml. ||| 500 μ g, 300 μ g, and 150 μ g should be considered. a ||| Zarzio est disponible aux doses de 30 MU/ 0,5 ml et 48 MU/ 0,5 ml.
0.00854447577148676 ||| Helixate NexGen 250 IU must not be mixed with other infusion solutions. ||| Helixate NexGen 1000 IU must not be mixed with other infusion solutions. ||| Helixate NexGen 250 UI ne doit pas être mélangé avec d’ autres solutions pour perfusion.
0.2111358791589737 ||| STATEMENT OF ACTIVE SUBSTANCE(S) ||| STATEMENT OF ACTIVE SUBSTANCE (S) ||| LISTE DES EXCIPIENTS
0.4362528920173645 ||| In case of persistence of HGD, further treatment courses (up to a maximum of three courses) may be given (separated by a minimum of 90 days) to increase the response rate. ||| Whereas regular meetings are expected to occupy one week per month, exceptional meetings (e.g. for pharmacovigilance) may have to be foreseen and would last 1-2 days each. ||| En cas de DHG résiduelle, d’ autres cures de traitement (trois au maximum) peuvent être administrées (séparées d’ au moins 90 jours entre chaque) pour augmenter le taux de réponse.
0.6052424907684326 ||| g) Supporting evidence-based hospital antibiotic guidelines for common infections and for surgical prophylaxis; ||| questionnaires for self-assessment and guidance for individuals (symptom checker functionality); ||| g) promouvoir les recommandations locales sur les antibiotiques qui s'appuient sur des données probantes pour les infections courantes et pour la prophylaxie chirurgicale;
0.4895398020744324 ||| On 3 February, the New Zealand Government announced that foreign travellers who left from China would be denied entry to New Zealand, with only New Zealand citizens and permanent residents and their family being allowed to enter. ||| EU citizens and citizens of Schengen Associated States and non-EU nationals legally residing in the EU, as well as their family members, should also be exempt from the travel restriction regardless of whether or not they are returning home, as was the case until now. ||| Le 3 février, le gouvernement de la Nouvelle-Zélande a annoncé que les voyageurs étrangers qui quittaient la Chine se verraient refuser l'entrée en Nouvelle-Zélande, seuls les citoyens et résidents permanents de la Nouvelle-Zélande et leur famille étant autorisés à y entrer.
0.08290684223175049 ||| Chemical products for the manufacture of toilet preparations ||| Chemical products for the manufacture of perfumery compositions ||| Produits chimiques pour la fabrication de produits de toilette
0.30643725395202637 ||| Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles. ||| Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines whereas other cell types can utilise salvage pathways, MPA has more potent cytostatic effects on lymphocytes than on other cells. ||| L'amprénavir se lie au site actif de la protéase du VIH-1 et prévient ainsi la transformation des précurseurs polyprotéiniques gag et gag-pol viraux, conduisant à la formation de particules virales immatures non- infectieuses.
0.48488059639930725 ||| On 16 March, the government announced that the total number of confirmed cases had risen to six, and that the patient identified on 11 March had made a recovery. ||| The Healthcare Department officials informed that ten patients were immediately cleared of the suspicion, while 55 patients were cleared after testing negative. ||| Le 16 mars, le gouvernement a annoncé que le nombre total de cas confirmés était passé à six et que le patient identifié le 11 mars s'était rétabli.
0.06261230260133743 ||| 4.1 Therapeutic Indications ||| 4.1 Therapeutic Indication ||| 4.1 Indications thérapeutiques
0.2565579414367676 ||| • if you are allergic (hypersensitive) to telmisartan or any other ingredients included in Kinzalmono tablets (see section Further information for a list of other ingredients). • during the last six months of pregnancy (see section Pregnancy and breast-feeding). • if you are breast-feeding. • if you have severe liver problems such as cholestasis or biliary obstruction (problems with drainage of the bile from the liver and gall bladder) or any other severe liver disease. ||| 249 If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated they can be very serious and cause headaches, nausea, vomiting, dehydration, unconsciousness, coma or even death (see A and B in section 4 “Possible Side Effects”). • Always keep spare syringes and a spare vial of Humalog Mix25, or a spare pen and cartridges, in case you lose your Pen or it gets damaged. • Always carry something to show you are diabetic. • Always carry sugar with you. ||| • Si vous êtes allergique (hypersensible) au telmisartan ou à l’ un des excipients contenus dans les comprimés de Kinzalmono (voir la rubrique Informations complémentaires pour la liste des excipients). • Au cours des six derniers mois de la grossesse (voir rubrique Grossesse et Allaitement) • Si vous allaitez • Si vous avez des troubles hépatiques sévères tels une choléstase ou une obstruction biliaire (un trouble lié au drainage de la bile au niveau de la vésicule biliaire) ou toute autre maladie sévère du foie.
0.3218674659729004 ||| The addition of the entire contents of the solvent vial to the contents of the Docetaxel Winthrop 20 mg vial ensures a premix concentration of 10 mg/ ml docetaxel. ||| Each single-dose vial of Docetaxel Winthrop 20 mg concentrate contains docetaxel which is a trihydrate corresponding to 20 mg of docetaxel (anhydrous). ||| L'ajout de la totalité du contenu du flacon de solvant au contenu du flacon de Docétaxel Winthrop 20 mg assure pour le prémélange une concentration de 10 mg/ ml en docétaxel.
0.27903157472610474 ||| 10 million IU/ ml uc rod ||| 18 million IU/ pen uc rod ||| 10 millions d’ UI/ ml e
0.353036493062973 ||| Animal reproduction studies have not been conducted with factor IX. ||| This dose adjustment has not been studied in HIV patients. ||| Aucune étude expérimentale de reproduction n’ a été conduite chez l’ animal.
0.5488435626029968 ||| PRILACTONE has been studied in the laboratory, as well as in three studies in dogs with heart valve diseases, which were treated in various veterinary practices or clinics across Europe (‘ clinical studies‘). ||| The image of the swans was revealed to have been taken in Burano, where swans are common, while footage of the dolphins was filmed at a port in Sardinia hundreds of miles away. ||| PRILACTONE a été étudié en laboratoire et lors de 3 études chez des chiens souffrant d’ insuffisance cardiaque, qui étaient traités dans divers cabinets et cliniques vétérinaires en Europe (« études cliniques »).
0.03587700426578522 ||| Careful monitoring of therapeutic and adverse effects is recommended when tacrolimus is concomitantly administered with indinavir/ ritonavir. ||| Careful monitoring of therapeutic and adverse effects is recommended when dexamethasone is concomitantly administered with indinavir/ ritonavir. ||| En cas d'administration concomitante de tacrolimus et d'indinavir/ ritonavir, une surveillance attentive des effets thérapeutiques et indésirables est recommandée.
0.23701725900173187 ||| Animal studies have shown reduced fertility and increased mortality in rat foetuses. ||| Studies with female rats revealed reduced fertility and enhanced embryonal mortality. ||| Les études animales ont montré une réduction de la fertilité et une augmentation de la mortalité fœ tale chez le rat.
0.0 ||| Mode of action ||| Mode of action ||| 104 Mode d' action
0.6416046023368835 ||| Bristol-Myers Squibb AEBE 102 Tatoiou and Kolokotroni Sreet 14671 Nea Erythrea Attikis ||| Coup Oe Kouparoussos & Sia Agias Varvaras 53 Dafni 17235 Greece ||| Bristol-Myers Squibb EPE 102 Tatoiou and Kolokotroni Sreet 14671 Nea Erythrea Attikis
0.41175758838653564 ||| The most commonly reported undesirable effects were nausea and vomiting, occurring in 31% Parareg and 19% placebo treated patients, and 27% Parareg and 15% placebo treated patients, respectively. ||| Nausea and fatigue were more often reported in female patients treated with SIFROL (20.8% and 10.5%, respectively) compared to males (6.7% and 7.3%, respectively). ||| Les effets indésirables (EI) les plus fréquemment rapportés ont été les nausées, survenues respectivement chez 31% des patients traités par Parareg et 19% des patients sous placebo, et les vomissements, survenus respectivement chez 27% des patients traités par Parareg et 15% des patients sous placebo.
0.41177475452423096 ||| In patients with mild to moderate hepatic impairment, the posology should not exceed 40 mg once daily (see section 4.4). ||| 131 other antipsychotics, it is recommended that blood pressure is measured periodically in patients over 65 years. ||| En cas d’ insuffisance hépatique légère à modérée, la posologie quotidienne ne doit pas excéder 40 mg en une prise par jour (voir rubrique 4.4).
0.6153943538665771 ||| Photographic restoration services ||| Satellite video conferencing services ||| Services de restauration photographique
0.5133978128433228 ||| Aluminium blister containing one 40 mg capsule. ||| capsule of Wilzin 50 mg three times daily. ||| Blister aluminium contenant une gélule de 40 mg.
0.09061028063297272 ||| Frequencies are defined as very common (≥ 1/ 10), common (≥ 1/ 100, < 1/ 10) or uncommon (≥ 1/ 1,000, < 1/ 100). ||| Frequencies are defined as common (≥ 1/ 100, < 1/ 10) or uncommon (≥ 1/ 1,000, < 1/ 100). ||| Les fréquences sont définies comme très fréquent (≥ 1/ 10), fréquent (≥ 1/ 100, < 1/ 10), peu fréquent (≥ 1/ 1 000, < 1/ 100).
0.20187637209892273 ||| INTANZA may be given at the same time as other vaccines. ||| Pandemrix should not be given at the same time as other vaccines. ||| INTANZA peut être administré en même temps que d'autres vaccins.
0.1093112975358963 ||| The studies of 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| The main measure of effectiveness 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.02920953370630741 ||| Rasilez should not be used by people who may be hypersensitive (allergic) to aliskiren or any of the other ingredients. ||| Sprimeo should not be used by people who may be hypersensitive (allergic) to aliskiren or any of the other ingredients. ||| Rasilez ne doit pas être utilisé chez les personnes pouvant présenter une hypersensibilité (allergie) à l’ aliskiren ou à l’ un des excipients.
0.26431697607040405 ||| Bridion is not recommended for use in children below two years of age because there is not enough information on its safety and effectiveness in this age group. ||| Because a benefit of Valdoxan has not been shown clearly in patients aged over 65 years, it should be used with caution in this age group. ||| L’ utilisation de Bridion n’ est pas recommandée chez les enfants âgés de moins de deux ans, en raison d’ un manque d’ information sur la sécurité et l’ efficacité pour ce groupe d’ âge.
0.2952613830566406 ||| Secondary progressive multiple sclerosis (SP-MS) Two controlled clinical trials with Extavia involving a total of 1,657 patients with secondary progressive multiple sclerosis (baseline EDSS 3 to 6.5, i. e. patients were able to walk) were performed. ||| Serious bleeding events during the 28-day study period In PROWESS, the incidence of serious bleeding events during the 28-day study period was 3.5% and 2.0% in drotrecogin alfa (activated)-treated and placebo-treated patients, respectively. ||| Sclérose en plaques secondairement progressive Deux essais cliniques contrôlés d’ Extavia dans les formes secondairement progressives de sclérose en plaques ont été menés sur un total de 1 657 patients, dont le score EDSS initial était compris entre 3 et 6,5 (patients capables de marcher).
0.3442387878894806 ||| For the following cycle, your doctor will prescribe follitropin alfa at a lower dose than that of the previous cycle. ||| For those patients on a fixed dose of oral risperidone for two weeks or more, the following conversion scheme should be considered. ||| Votre médecin vous prescrira pour le cycle suivant une dose de follitropine alfa inférieure à celle du cycle précédent.
0.47406888008117676 ||| Amlodipine/ Valsartan Over 1,400 hypertensive patients received Copalia once daily in two placebo-controlled trials. ||| In CURE, 823 (6.6%) patients received concomitant GPIIb/ IIIa receptor antagonist therapy. ||| Amlodipine/ valsartan Plus de 1 400 patients hypertendus ont reçu Copalia une fois par jour au cours de deux essais contrôlés contre placebo.
0.0 ||| Epilepsy ||| Epilepsy ||| Épilepsie
0.4573415517807007 ||| See section 5.1. ||| See section 6.6 ||| Voir rubrique 5.1
0.2905232608318329 ||| Concomitant treatment with other monoamine oxidase (MAO) inhibitors or pethidine (see section 4.5). ||| AZILECT should not be used with other monoamine oxidase inhibitors or pethidine (a painkiller). ||| En association à d'autres inhibiteurs de la monoamine oxydase (MAO) ou à la péthidine (voir rubrique 4.5).
0.018753353506326675 ||| 15 Docetaxel Winthrop 100 mg/ m² in combination with trastuzumab ||| 51 Docetaxel Winthrop 100 mg/ m² in combination with trastuzumab ||| 16 Docétaxel Winthrop 100 mg/ m² en association avec le trastuzumab
0.04727157950401306 ||| Non- steroidal antirheumatics or estrogens may reduce the antihypertensive effect of doxazosin. ||| Non-steroidal antirheumatics or estrogens may reduce the antihypertensive effect of doxazosin. ||| Les anti-inflammatoires non stéroïdiens ou les oestrogènes sont susceptibles de réduire les effets antihypertenseurs de la doxazosine.
0.220801442861557 ||| Use of tenofovir disoproxil fumarate should be avoided with concurrent or recent use of a nephrotoxic medicinal product (e. g. aminoglycosides, amphotericin B, foscarnet, ganciclovir, pentamidine, vancomycin, cidofovir or interleukin-2). ||| Therefore, caution should be used when erlotinib is combined with a potent CYP3A4 inhibitor, e.g. azole antifungals (i.e. ketoconazole, itraconazole, voriconazole), protease inhibitors, erythromycin or clarithromycin. ||| L’ utilisation du fumarate de ténofovir disoproxil doit être évitée en cas d’ utilisation actuelle ou récente d’ un médicament néphrotoxique (tels les aminosides, l’ amphotéricine B, le foscarnet, le ganciclovir, la pentamidine, la vancomycine, le cidofovir ou l’ interleukine-2).
0.024082131683826447 ||| Before every injection, dial 1 or 2 units and press the injection mechanism with the pen pointing up until a drop of Liprolog Mix25 comes out of the needle. ||| Before every injection, dial 1 or 2 units and press the injection mechanism with the pen pointing up until a drop of Liprolog comes out of the needle. ||| Avant chaque injection, choisissez 1 ou 2 unités et appuyez ensuite sur le mécanisme d’injection, le stylo pointant vers le haut, jusqu'à ce qu'une goutte de Liprolog Mix25 s'échappe de l'aiguille.
0.12441200017929077 ||| Possible side effects following the intravenous administration of Yttrium (90Y)-labelled a medicinal product prepared by radiolabelling with Yttriga, will be dependent on the specific medicinal product being used. ||| The toxicological properties of Yttrium (90Y)-labelled medicinal products prepared by radiolabelling with YTRACIS prior to administration, will be dependent on the nature of the medicinal product to be radiolabelled. ||| Les effets secondaires possibles dus à l'injection intraveineuse d'un médicament marqué à l'yttrium (90Y) préparés par radiomarquage avec de l’ Yttriga, dépendent spécifiquement du médicament utilisé.
0.5125992298126221 ||| Ziconotide did not induce bacterial gene mutation and was not ||| It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. ||| Le ziconotide n'a pas induit de mutation génétique bactérienne et ne s’ est pas avéré génotoxique.
0.0 ||| produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA ||| produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA ||| produit sur cellules de levure (Saccharomyces cerevisiae) par la technologie de l’ADN recombinant
0.3438311815261841 ||| 3.9 mg/ 24 h ||| 6.7 mg/ ml ||| 3,9 mg/ 24 h
0.42900562286376953 ||| The 3 ml cartridges are sealed in a disposable pen injector. ||| Keep the curtains drawn and use light bulbs of 60W or less. ||| Les cartouches de 3 ml sont scellées dans un stylo injecteur jetable.
0.08762262761592865 ||| 104 Any unused product or waste material should be disposed of in accordance with local requirements. ||| Disposal Any unused product or waste material should be disposed of in accordance with local requirements. ||| Tout produit non utilisé ou déchet doit être éliminé conformément à la réglementation en vigueur.
3.1735665527790613e-13 ||| Differences in sustained virological response (SVR) based on treatment duration, demographics and best responses to previous treatment are displayed in Table 12. ||| Differences in sustained virological response (SVR) based on treatment duration, demographics and best responses to previous treatment are displayed in Table 12. ||| Les différents taux de réponse virologique prolongée (RVP) en fonction de la durée de 50 traitement, des données démographiques et des meilleures réponses au traitement précédent sont présentées dans le Tableau 12.
0.41901177167892456 ||| affects more than 1 user in 10 affects 1 to less than 10 users in 100 affects 1 to less than 10 users in 1,000 affects 1 to less than 10 users in 10,000 affects less than 1 user in 10,000 frequency cannot be estimated from the available data ||| Affects more than 1 user in 10 Affects 1 to 10 users in 100 Affects 1 to 10 users in 1,000 Affects 1 to 10 users in 10,000 Frequency cannot be estimated from the available data ||| affectant plus de 1 patient sur 10 affectant 1 à 10 patients sur 100 affectant 1 à 10 patients sur 1000 affectant 1 à 10 patients sur 10000 affectant moins de 1 patient sur 10000 la fréquence ne peut pas être estimée à partir des données disponibles
0.5297359824180603 ||| Early breast cancer is defined as non-metastatic primary invasive carcinoma of the breast. ||| Sepsis is the most common cause of Multiple Organ Dysfunction Syndrome and may result in septic shock. ||| Un cancer du sein en situation adjuvante est défini comme un carcinome primitif du sein, infiltrant, non métastatique.
0.07804559171199799 ||| The Temporary Framework will be in place until the end of December 2020. ||| The amended Temporary Framework will be in place until the end of December 2020. ||| L'encadrement temporaire sera en place jusqu'à la fin du mois de décembre 2020.
0.0 ||| TEVA UK Ltd Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG UK ||| TEVA UK Ltd Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG UK ||| TEVA UK Ltd Brampton Road Hampden Park Eastbourne East Sussex BN22 9AG Royaume Uni
0.11886878311634064 ||| What is the risk associated with Netvax? ||| What is the risk associated with Fasturtec? ||| Quel est le risque associé à l'utilisation de Netvax?
0.07805705815553665 ||| What benefit has Lysodren shown during the studies? ||| What benefit has Quadrisol shown during the studies? ||| Quel est le bénéfice démontré par Lysodren au cours des études?
0.27162328362464905 ||| Study FVF3192g (PIER) was a randomised, double-masked, sham-controlled, two-year study designed to assess the safety and efficacy of Lucentis in patients with neovascular AMD (79% of the patients had minimally classic or occult AMD, 21% had a predominantly classic CNV component). ||| A phase III randomized, parallel-group, open-label, multicentre study comparing the safety and efficacy of Caelyx plus bortezomib combination therapy with bortezomib monotherapy in patients with multiple myeloma who have received at least 1 prior therapy and who did not progress while receiving anthracycline-based therapy, was conducted in 646 patients. ||| L'étude FVF3192g (PIER) est une étude randomisée de 2 ans, en double insu, contrôlée contre des injections simulées, destinée à évaluer la tolérance et l'efficacité de Lucentis chez des patients atteints de DMLA néovasculaire (79% des patients avaient une DMLA visible minoritaire ou occulte, 21% avaient une composante NVC à prédominance visible).
0.36193448305130005 ||| The pharmacokinetics of vardenafil in patients with severely impaired hepatic function (Child-Pugh C) has not been studied (see section 4.3). ||| The CDC has said that "the use, dosing, or duration of hydroxychloroquine for prophylaxis or treatment of SARS-CoV-2 infection" are not yet established. ||| Les caractéristiques pharmacocinétiques du vardénafil n'ont pas été étudiées chez les insuffisants hépatiques sévères (C dans la classification de Child-Pugh) (voir rubrique 4.3).
0.35562413930892944 ||| Vitamin D is excreted in faeces and urine. ||| Laronidase may be excreted in milk. ||| Elimination: la vitamine D3 est excrétée via les faeces et l’urine.
0.2070467472076416 ||| Particular caution should be exercised, and intensified blood glucose monitoring is advisable in patients in whom hypoglycaemic episodes might be of particular clinical relevance, such as in patients with significant stenoses of the coronary arteries or of the blood vessels supplying the brain (risk of cardiac or cerebral complications of hypoglycaemia) as well as in patients with proliferative retinopathy, particularly if not treated with photocoagulation (risk of transient amaurosis following hypoglycaemia). ||| Because there is a potential for worsening of the underlying disease, caution should be used when alendronate is given to patients with active upper gastrointestinal problems, such as dysphagia, oesophageal disease, gastritis, duodenitis, ulcers, or with a recent history (within the previous year) of major gastrointestinal disease such as peptic ulcer, or active gastrointestinal bleeding, or surgery of the upper gastrointestinal tract other than pyloroplasty (see section 4.3). ||| Il faut être particulièrement prudent et intensifier la surveillance de la glycémie chez les patients pour lesquels les épisodes hypoglycémiques risqueraient d'avoir des conséquences cliniques particulièrement graves, par exemple en cas de sténose serrée des artères coronaires ou carotidiennes (risque de complications cardiaques ou cérébrales de l'hypoglycémie), de même qu'en cas de rétinopathie proliférante, surtout si celle -ci n'est pas traitée par photocoagulation (risque d'amaurose transitoire après une hypoglycémie).
0.9166806936264038 ||| Why has ReFacto AF been approved? ||| The EU's Response to COVID-19 ||| Pourquoi ReFacto AF a -t-il été approuvé?
0.6008710265159607 ||| Do not rub the injection area. ||| The syringe will not empty. ||| Ne pas masser la zone d'injection.
0.31260135769844055 ||| Information on the safety of the vaccine when used during pregnancy and lactation is not available. ||| Therefore the use in this species is not recommended during pregnancy and lactation. ||| On ne dispose pas d’ information concernant l’ innocuité du vaccin lors de son utilisation au cours de la grossesse ou de l’ allaitement.
0.025457683950662613 ||| 42 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 43 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.0 ||| You may need urgent medical attention or hospitalisation. ||| You may need urgent medical attention or hospitalisation. ||| Vous pouvez avoir besoin d'une hospitalisation en urgence.
0.3363431990146637 ||| Kinzalkomb is taken by mouth once a day with liquid, with or without food. ||| Karvezide can be taken once daily, with or without food. ||| Kinzalkomb est administré par voie orale, une fois par jour, avec du liquide, pendant ou en dehors des repas.
0.413621187210083 ||| Studies in rats have shown that rotigotine and/ or its metabolite(s) is excreted in breast milk. ||| Four pharmacologically active hydroxyl metabolites have been identified, of which three occur in plasma of humans. ||| Les études chez le rat ont montré que la rotigotine et/ ou son/ ses métabolite(s) sont excrétés dans le lait maternel.
0.3306643068790436 ||| Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use. ||| These effects were observed at exposure levels in excess of the maximum human exposure indicating little relevance to clinical use. ||| Les effets observés chez l’ animal à des expositions largement supérieures à l’ exposition maximale chez l’ homme n’ ont que peu de signification clinique.
0.007388574071228504 ||| Bondenza injection is not recommended for use in patients who have a serum creatinine above 200 μ mol/ l (2.3 mg/ dl) or who have a creatinine clearance (measured or estimated) below 30 ml/ min, because of limited clinical data available from studies including such patients (see section 4.4 and section 5.2) ||| Bonviva injection is not recommended for use in patients who have a serum creatinine above 200 μ mol/ l (2.3 mg/ dl) or who have a creatinine clearance (measured or estimated) below 30 ml/ min, because of limited clinical data available from studies including such patients (see section 4.4 and section 5.2) ||| En raison de données limitées chez ces patientes lors des études cliniques, l’ utilisation de Bondenza IV n’ est pas recommandée chez les patientes présentant une créatinine sérique supérieure à 200 µmol/ l (2,3 mg/ dl) ou une clairance de la créatinine (mesurée ou estimée) inférieure à 30 ml/ min (voir rubrique 4.4 et rubrique 5.2).
0.298153817653656 ||| Glaxo Group Ltd Berkeley Avenue Greenford Middlesex UB6 0NN United Kingdom ||| The Wellcome Foundation Limited Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 0NN United Kingdom ||| Glaxo Group Ltd Berkeley Avenue Greenford Middlesex UB6 0NN Royaume Uni
0.26069942116737366 ||| Therefore, under conditions of compromised renal perfusion, administration of etoricoxib may cause a reduction in prostaglandin formation and, secondarily, in renal blood flow, and thereby impair renal function. ||| The anti-tumour effect of temsirolimus, therefore, may also in part stem from its ability to depress levels of HIF and VEGF in the tumour or tumour microenvironment, thereby impairing vessel development. ||| De ce fait, en cas de détérioration de la fonction rénale, l’ administration d’ étoricoxib peut entraîner une diminution de la synthèse des prostaglandines et secondairement du débit sanguin rénal, provoquant une insuffisance rénale.
0.0 ||| Absorption The absorption profile is due to the product being a mixture of insulin products with fast and protracted absorption respectively. ||| Absorption The absorption profile is due to the product being a mixture of insulin products with fast and protracted absorption respectively. ||| 89 Absorption Le profil d’ absorption est dû au fait qu’ il s’ agit d’ un mélange d’ insulines à absorption rapide et prolongée respectivement.
0.1930321753025055 ||| For use as excipient. ||| For use as excipient ||| Pour utilisation en tant qu’ excipient.
2.0302520515463884e-13 ||| In vivo studies with simvastatin, midazolam and cisapride have demonstrated a potent inhibition of intestinal CYP3A4 and a moderate inhibition of hepatic CYP3A4. ||| In vivo studies with simvastatin, midazolam and cisapride have demonstrated a potent inhibition of intestinal CYP3A4 and a moderate inhibition of hepatic CYP3A4. ||| isé avec la simvastatine, le midazolam et le cisapride ont montré une inhibition puissante du CYP3A4 intestinal et modérée du CYP3A4 hépatique.
0.3058878481388092 ||| Ischemic heart disease Under ischemic conditions, a deterioration of cardiac function and a decrease in coronary blood flow could theoretically arise from antagonism of bradykinin receptor type 2. ||| Heart failure Acute development or exacerbation of congestive heart failure, and/ or new onset of decreased left ventricular ejection fraction has been reported during bortezomib treatment. ||| Cardiopathie ischémique En cas de cardiopathie ischémique, une détérioration de la fonction cardiaque et une diminution du débit sanguin coronaire seraient théoriquement provoquées par l’ antagonisme du récepteur bradykinine de type 2.
0.39223384857177734 ||| The limited experience of the mutual recognition procedure does not make it possible to give valid estimates for the number of arbitrations which will arise once the procedure becomes systematic in 1998. ||| This change of the text is to ensure it doesn’ t suggest an immediate artificial abortion, which is not justified by the clinical experiences collected till now. ||| L’expérience limitée en ce qui concerne la procédure de reconnaissance mutuelle ne permet pas d’estimer avec certitude le nombre d’arbitrages lorsque la procédure deviendra systématique en 1988.
0.23274201154708862 ||| Power-operated sprayers for insecticides ||| Power-operated lubricant dispensers for machines ||| Pulvérisateurs électriques pour insecticides
0.007298337295651436 ||| If there is any indication of tendinitis (e. g. painful swelling) the administration of ciprofloxacin or other fluoroquinolones must immediately be discontinued, the affected extremity should not be strained and a physician must be consulted. ||| 9 If there is any indication of tendinitis (e. g. painful swelling) the administration of ciprofloxacin or other fluoroquinolones must immediately be discontinued, the affected extremity should not be strained and a physician must be consulted. ||| En cas de signe de tendinite (par exemple tuméfaction douloureuse), l’ administration de la ciprofloxacine ou de toute autre fluoroquinolone doit être immédiatement arrêtée, le membre atteint ne doit pas être soumis à des contraintes et un médecin doit être consulté.
0.41795405745506287 ||| Lamivudine is predominately cleared unchanged by renal excretion. ||| Weight is the most significant covariate affecting efalizumab clearance. ||| Elle est essentiellement éliminée par excrétion rénale sous forme inchangée.
0.33655834197998047 ||| Mean (% CV) multiple-dose pharmacokinetic parameters for Viraferon and ribavirin capsules when administered to children or adolescents with chronic hepatitis C ||| The mean (CV%) steady state pharmacokinetic parameters estimates of fondaparinux in patients with VTE receiving the fondaparinux proposed dose regimen once daily are: ||| Viraferon et de ribavirine en gélules chez les enfants ou adolescents présentant une hépatite C chronique e
0.39506134390830994 ||| Data from single-dose administrations of ADVATE in 53 paediatric patients less than 6 years of age were used to obtain this table. ||| Clinical trials involved the administration of 2029 doses of Ambirix to 1027 subjects from 1 year up to and including 15 years of age. ||| Les données obtenues sur la base d’ une administration d’ une dose unique d’ ADVATE chez 53 patients pédiatriques âgés de moins de 6 ans ont été utilisées pour obtenir le tableau suivant.
0.24768315255641937 ||| Dose adjustments of sildenafil may be required when co-administered with CYP3A4 inducers (see section 4.5). ||| The efficacy of contraceptive steroids may be reduced during co-treatment with dexamethasone (see section 4.5). ||| Des ajustements de la posologie du sildénafil peuvent être nécessaires lors de l’ administration concomitante avec des inducteurs du CYP3A4 (voir rubrique 4.5).
0.21350164711475372 ||| – The active substance is insulin aspart made by recombinant DNA technology in Saccharomyces cerevisiae (70% insulin aspart in a soluble fraction and 30% insulin aspart crystallised with protamine) – The other ingredients are glycerol, phenol, metacresol, zinc (as chloride), sodium chloride, disodium phosphate dihydrate, protamine sulphate, sodium hydroxide, hydrochloric acid and water for injections. ||| LeukoScan is a sterile, lyophilised formulation, containing 0.31 mg of sulesomab per vial and includes 0.22 mg stannous chloride dihydrate, 3.2 mg potassium sodium tartrate tetrahydrate, 7.4 mg sodium acetate trihydrate, 5.5 mg sodium chloride, glacial acetic acid (trace), hydrochloric acid (trace), 37.8 mg sucrose, nitrogen (vacuum). ||| La substance active est l’ insuline asparte produite par la technique de l’ ADN recombinant sur – Saccharomyces cerevisiae (70% d’ insuline asparte sous forme de fraction soluble et 30% d’ insuline asparte cristallisée avec de la protamine) Les autres composants sont le glycérol, le phénol, le métacrésol, le zinc (chlorure), le chlorure – de sodium, le phosphate disodique dihydraté, le sulfate de protamine, l’ hydroxyde de sodium, l’ acide chlorhydrique et l’ eau pour préparations injectables.
0.33389684557914734 ||| Advertising services relating to real property ||| Insurance services relating to holiday accommodation ||| Services publicitaires dans le domaine de l'immobilier
0.356711208820343 ||| During the 6 to 10 hour treatment period, showering or bathing should be avoided. ||| Avoid showering, bathing, or swimming for at least three hours after any application. ||| Durant les 6 à 10 heures de traitement, les bains et douches doivent être évités.
0.4593709707260132 ||| - if you have hepatitis and have been treated recently with medications that suppress the immune ||| - if you are taking a medicine which may cause low blood pressure when rising from a chair or ||| - si vous avez une hépatite et avez été récemment traité par des médicaments qui dépriment le
0.2664174437522888 ||| Ritonavir is a potent CYP3A inhibitor which inhibits the metabolism of lopinavir and therefore, increases plasma levels of lopinavir. ||| Itraconazole, is a potent CYP3A4 inhibitor and would be expected to increase the exposure of maraviroc. ||| Le ritonavir étant un inhibiteur puissant de l’ isoenzyme CYP3A, il inhibe donc le métabolisme du lopinavir et augmente ses concentrations plasmatiques.
0.5095090270042419 ||| Sealed radioactive substances for medical use ||| Mutual recognition of medicinal products for human use ||| Substances radioactives scellées à usage médical
0.3800332546234131 ||| This causes severe anaemia, symptoms of which would include unusual tiredness and a lack of energy. ||| This causes a wide range of symptoms, particularly difficulty breathing and difficulty walking. ||| Il en résulte des anémies sévères dont les symptômes peuvent inclure une fatigue inhabituelle et un manque d’énergie. e am
0.14151087403297424 ||| What is the risk associated with Netvax? ||| What is the risk associated with NovoRapid? ||| Quel est le risque associé à l'utilisation de Netvax?
0.2629050612449646 ||| These included looking at how the liver damage had evolved after 52 weeks of treatment using a liver biopsy (when a small sample of liver tissue is taken and examined under a microscope), as well as measuring other signs of the disease such as the levels of ALT or of hepatitis B viral DNA circulating in the blood. ||| The main measure of effectiveness was how far the patient could walk in six minutes (a way of measuring exercise capacity), but the study in class II disease also looked at the change in the resistance to blood flow in the lungs’ blood vessels (a marker of how narrow the blood vessels are). ||| L’ une d’ entre elles a consisté à évaluer l’ évolution des lésions hépatiques après 52 semaines de traitement, par biopsie du foie (prélèvement et examen au microscope d’ un petit échantillon de tissu hépatique); d’ autres mesures ont porté sur des signes de la maladie tels que les taux d’ ALAT ou d’ ADN du virus de l’ hépatite B circulant dans le sang.
0.22267097234725952 ||| What is Doribax used for? ||| What is Tysabri used for? ||| Dans quel cas Doribax est -il utilisé?
0.013748160563409328 ||| Insulin Human Winthrop Comb 25 contains 100 IU insulin per ml. ||| Insulin Human Winthrop Comb 15 contains 40 IU insulin per ml. ||| Insulin Human Winthrop Comb 25 contient 100 UI d'insuline par ml.
0.3834770917892456 ||| Important information about some of the ingredients of Gemzar Gemzar contains 3.5 mg (< 1 mmol) of sodium in each 200 mg vial and 17.5 mg (< 1 mmol) sodium in each 1000 mg vial. ||| This medicinal product contains less than 1 mmol sodium (23 mg) and less than 1 mmol of potassium (39 mg) per dose, i. e. essentially sodium- and potassium-free. ||| Informations importantes concernant certains composants de Gemzar Gemzar contient 3,5 mg (< 1 mmol) de sodium dans chaque flacon de 200 mg et 17,5 mg (< 1 mmol) de sodium dans chaque flacon de 1 000 mg.
0.42791998386383057 ||| Efficacy was demonstrated in controlled trials in patients treated for up to 29 weeks. ||| Analyses of data through 96 weeks of treatment demonstrated durability of antiviral activity. ||| Son efficacité a été démontrée au cours d’ études contrôlées chez des patients traités jusqu’ à 29 semaines.
0.00998245645314455 ||| Three tubes each containing 0.25 ml (30 mg selamectin). ||| Six tubes each containing 0.25 ml (30 mg selamectin). ||| 3 tubes contenant 0,25 ml de solution (30 mg de selamectine).
0.38276439905166626 ||| The type of respiratory support for individuals with COVID-19 related respiratory failure is being actively studied for people in hospital, with some evidence that intubation can be avoided with a high flow nasal cannula or bi-level positive airway pressure. ||| The reason for stage pooling is to become discriminative in terms of lung deposition and the measurement of particle size with an instrument such as an impactor is a way to obtain information on particle size of the aerosolized medication and the particle size distribution. ||| Le type d’assistance respiratoire pour les personnes souffrant de défaillance respiratoire liée à la COVID-19 est étudié activement pour les personnes hospitalisées. Certaines preuves indiquent que l’intubation peut être évitée en utilisant une canule nasale à haut débit ou une pression positive des voies respiratoires à double niveau.
0.3226967453956604 ||| No recommendation on dosage reduction is possible in patients with mild hepatic impairment due to the substantial variability of abacavir exposure. ||| Consumption of a diet low in fat will decrease the likelihood of experiencing adverse gastrointestinal reactions (see section 4.4). ||| Aucune recommandation de réduction de la posologie n’ est possible chez les patients ayant une insuffisance hépatique légère en raison de la grande variabilité de l’ imprégnation plasmatique en abacavir.
0.08145510405302048 ||| What benefit has Privigen shown during the studies? ||| What benefit has Gliolan shown during the studies? ||| Quel est le bénéfice démontré par Privigen au cours des études?
0.5284391641616821 ||| The European Union will do all in its power to ensure that all peoples of this world have access to a vaccine, irrespective of where they live." ||| We are at a time of temporary fragility and only a strong European Union can protect our common heritage and the economies of our Member States. ||| L'Union européenne fera tout ce qui est en son pouvoir pour que tous les citoyens, où qu'ils vivent dans le monde, aient accès à un vaccin.»
0.8500084280967712 ||| s Genotype 1: ||| s All Genotypes ||| Génotype 1:
1.0610175132751465 ||| 2 size, bear the marking “ CGPI 40”. ||| 5 “ +” indicates an ongoing response. ||| Gélule beige, taille 2, portant l’ inscription « CGPI 40 ».
0.39559000730514526 ||| Therefore, the use of Galvus is not recommended in these patients. ||| In some cases, their use with VIRACEPT is not usually recommended. ||| L’ utilisation de Galvus n’ est donc pas recommandée chez ces patients.
0.3159494996070862 ||| 21 Danmark Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Tlf: +45 46 77 11 11 info@nycomed. com ||| Slovenská republika Nycomed Langebjerg 1 DK-4000 Roskilde Dánsko Tel: +45 46 77 11 11 info@nycomed.com ||| Danmark Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Tlf: +45 46 77 11 11 info@nycomed. com
0.42299914360046387 ||| Other precautions: ||| Other precautions ||| 3 Autres précautions:
0.2785454988479614 ||| The most common side effects noted during the studies are local swellings and/ or other mild reactions (skin discolouration, small cysts) at the injection site. ||| In pigs transient local reactions at the injection site may occur after vaccination mainly in the form of a hard, warm and sometimes painful swelling (diameter up to 10 cm). ||| Les effets secondaires les plus fréquents observés au cours des études étaient des gonflements locaux et/ ou d'autres réactions légères (décoloration de la peau, petits kystes) au point d’ injection.
0.0 ||| 36 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 36 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 39 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.13689011335372925 ||| PegIntron 50 micrograms powder for injection SC ||| PegIntron 50 micrograms powder and solvent for injection SC ||| PegIntron 50 microgrammes poudre pour solution injectable S. C.
0.21017789840698242 ||| Shelf-life after first opening the immediate packaging: ||| 3 years Shelf-life after first opening the immediate packaging: ||| 2 ans Durée de conservation après première ouverture du conditionnement primaire:
0.25508058071136475 ||| Shoulder pads for sports use ||| Chest protectors for sports use ||| Protège-épaules pour le sport
0.2731647789478302 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Neulasta. ||| If you think that you notice any side effects after receiving an injection of SonoVue, tell the medical staff supervising your scan. ||| Si vous présentez une intolérance à certains sucres, contactez votre médecin avant de prendre Neulasta.
0.41283974051475525 ||| What Pelzont contains • The active substances are nicotinic acid and laropiprant. ||| Distribution Nicotinic acid Nicotinic acid is less than 20% bound to serum proteins. ||| Que contient Pelzont • Les substances actives sont l’ acide nicotinique et le laropiprant.
0.4409940838813782 ||| CYP2C19 poor metabolisers ||| CYP2C9 Poor Metabolizers: ||| Métaboliseurs lents du CYP2C19
0.8211306929588318 ||| Yarn singeing machines ||| Gospel choir singing ||| Machines à flamber les fils
0.2759862542152405 ||| Wipe the aluminium ring and the rubber stopper with an alcohol swab. ||| Clean the rubber stopper on the top of the powder vial with an alcohol swab. ||| Essuyez l’ anneau en aluminium et le bouchon en caoutchouc avec un tampon imbibé d’ alcool.
0.9702615141868591 ||| Swelling was very common. ||| They were hospitalized. ||| L’ apparition d’ oedèmes fut courante.
0.5069990754127502 ||| Ceftiofur 100 mg/ml ||| Ketoconazole 400 mg QD ||| 100 mg/ ml.
0.3644563555717468 ||| When diluted in glucose 50 mg/ ml (5%) solution, filgrastim is compatible with glass and a variety of plastics including polyvinylchloride, polyolefin (a copolymer of polypropylene and polyethylene) and polypropylene. ||| The chemical and physical stability of VISTIDE admixed with saline has been demonstrated in glass bottles, in infusion bags composed of either polyvinyl chloride (PVC) or ethylene/ propylene copolymer, and in PVC based vented I. V. administration sets. ||| Après dilution dans une solution de glucose à 50 mg/ ml (5%), Zarzio est compatible avec le verre et diverses matières plastiques, y compris le chlorure de polyvinyle, la polyoléfine (un copolymère de polypropylène et de polyéthylène) et le polypropylène.
0.3104512095451355 ||| Non-clinical data demonstrate that the solubility of dasatinib is pH-dependent. ||| These data indicate that elimination of micafungin is primarily non-renal. ||| Des données non cliniques montrent que la solubilité du dasatinib est pH-dépendante.
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Si votre médecin vous a dit que vous aviez une intolérance à certains sucres, contactez -le avant de prendre ce médicament.
0.23207223415374756 ||| A little bleeding may occur. ||| A small amount of bleeding may occur. ||| Un léger saignement peut apparaître.
0.2411767542362213 ||| Both pioglitazone and metformin have been shown to be present in the milk of lactating rats. ||| Both rosiglitazone and metformin have been detected in the milk of experimental animals. ||| Chez l'animal (rate), la pioglitazone ainsi que la metformine ont été détectées dans le lait.
0.39178556203842163 ||| These objectives may be summarised as the facilitation of communications within the European regulatory network, focusing on the communication tools, IT systems and logistical support required. ||| The sector actively contributes to the documentation and streamlining of financial procedures to ensure that system specifications are in line with user requirements. ||| Ces objectifs sont, en bref, la facilitation des communications au sein du réseau réglementaire européen, en mettant l'accent sur les outils de communication, les systèmes informatiques et l'assistance logistique requise.
0.9543989896774292 ||| a) Rilutek b) Riluzole c) Part B ||| b) tovafloxacin b) ||| a) Rilutek b) Riluzole c) Partie B
0.13720062375068665 ||| 45.9% 42.8% ||| 45.5% 46.6% ||| 45,9% 42,8%
0.5207363367080688 ||| As hospital prescribers your tasks related to improving antibiotic use include [31,42,43,52-54,56,70,71,90]: ||| Your tasks related to improving antibiotic use include [42,56,76,94,95]: ||| En tant que prescripteurs hospitaliers, vos tâches relatives à l'amélioration de l'utilisation d'antibiotiques consistent à [31,42,43,52-54,56,70,71,90] :
0.026507658883929253 ||| 5.6 Use during pregnancy and lactation ||| 4.6 Use during pregnancy and lactation ||| 5.6 Utilisation pendant la grossesse et l’ allaitement
0.7442724704742432 ||| Key messages for hospital prescribers ||| Key messages for junior doctors and students ||| Messages clés à l'intention des pharmaciens en hôpitaux
0.30094149708747864 ||| The kinetics of the main circulating metabolite were linear (plasma concentrations increased in proportion to dose) in the dose range of 50 to 150 mg of clopidogrel. ||| Both Cmax and AUC of buprenorphine increased with the increase in dose (in the range of 4-16 mg), although the increase was less than dose proportional. ||| Dans la gamme de posologie de 50 à 150 mg de clopidogrel, le principal métabolite circulant présente une pharmacocinétique linéaire (concentrations plasmatiques proportionnelles à la dose).
1.072429895401001 ||| 57 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTERS ||| 1 REVENUE FROM SERVICES RENDERED 10 REVENUE FROM SERVICES RENDERED 100 ||| 60 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.4531387984752655 ||| What Fareston contains ||| What Aloxi contains: ||| Que contient Fareston
0.19412967562675476 ||| For Nespo no clinical data on exposed pregnancies are available. ||| No clinical data on exposed pregnancies are available. ||| Aucune donnée clinique n’ est disponible chez la femme enceinte.
0.05650150775909424 ||| Among imatinib-resistant patients, the estimated rate of PFS was 88% (95% CI: ||| Among imatinib-intolerant patients, the estimated rate of PFS was 98% (95% CI: ||| Parmi les patients résistants à l'imatinib, le taux estimé de SSP était de 88% (IC 95%:
0.41555559635162354 ||| Malta Vivian Corporation Ltd. ||| Lietuva MediNet International Ltd. ||| Malte Vivian Corporation Ltd.
0.5505739450454712 ||| High density polyethylene (HDPE) bottles with child resistant closure (polypropylene). ||| Blister packs (polyamide/ aluminium/ polyvinyl chloride/ /aluminium) in a cardboard box. ||| Des flacons à comprimés en polyéthylène haute densité (PEHD) avec fermeture sécurité enfant.
0.3817819058895111 ||| Qualified medical doctor from the Medical School of the University of Dublin. ||| Qualified as a veterinary surgeon from the Royal Veterinary College, London University. ||| Docteur en médecine, diplômé de la faculté de médecine de l’université de Dublin.
0.33851921558380127 ||| blister (PVC/ PE/ PCTFE) blister (PVC/ PE/ PCTFE) blister (PVC/ PE/ PCTFE) bottle (HDPE) ||| Packaging bottle (HDPE) bottle (HDPE) bottle (HDPE) blister (Aclar/ PVC) blister (Aclar/ PVC) blister (Aclar/ PVC) ||| Plaquette thermoformée (PVC/ PE/ PCTFE) Plaquette thermoformée (PVC/ PE/ PCTFE) Plaquette thermoformée (PVC/ PE/ PCTFE) Flacon (HDPE)
0.07700260728597641 ||| Eye drops, solution; 0.35 ml x 30. ||| Eye drops, solution; 0.35 ml x 5. ||| Collyre en solution; 0,35 ml x 30.
0.1521517038345337 ||| EU/ 1/ 97/ 049/ 012 14 tablets EU/ 1/ 97/ 049/ 007 28 tablets EU/ 1/ 97/ 049/ 008 56 tablets EU/ 1/ 97/ 049/ 015 56 x 1 tablets EU/ 1/ 97/ 049/ 009 98 tablets ||| EU/ 1/ 06/ 376/ 011 14 tablets EU/ 1/ 06/ 376/ 012 28 tablets EU/ 1/ 06/ 376/ 013 56 tablets EU/ 1/ 06/ 376/ 014 56 x 1 tablets EU/ 1/ 06/ 376/ 015 98 tablets ||| EU/ 1/ 97/ 049/ 012 14 comprimés EU/ 1/ 97/ 049/ 007 28 comprimés EU/ 1/ 97/ 049/ 008 56 comprimés EU/ 1/ 97/ 049/ 015 56 x 1 comprimés EU/ 1/ 97/ 049/ 009 98 comprimés
0.28477489948272705 ||| Soliris administration should be interrupted in all patients experiencing severe infusion reactions and appropriate medical therapy administered. ||| Administration of Rotarix should be postponed in subjects suffering from acute severe febrile illness. ||| L’ administration de Soliris doit être interrompue chez tous les patients présentant des réactions sévères à la perfusion; ceux -ci doivent alors recevoir un traitement médical approprié.
0.40139850974082947 ||| Hanging folders ||| Postage stamps ||| Dossiers suspendus
0.4517671763896942 ||| Neupro is generally used as a long term treatment. ||| Osteoporosis-therapy is usually required for a long period. ||| On utilise généralement Neupro comme traitement à long terme.
0.06352250277996063 ||| IntronA 3 million IU/0.5 ml solution for injection or infusion Interferon alfa-2b ||| IntronA 18 million IU/3 ml solution for injection or infusion interferon alfa-2b ||| IntronA 3 millions d’UI/0,5 ml solution injectable ou pour perfusion Interféron alfa-2b
0.0647275522351265 ||| 16 5.3 Preclinical safety data ||| 11 5.3 Preclinical safety data ||| 5.3 Données de sécurité précliniques
0.3068696856498718 ||| Vimpat 200 mg 1 film-coated tablet contains 200 mg lacosamide. ||| Remeron 15 mg film-coated tablets contain 15 mg mirtazapine per film-coated tablet. ||| Vimpat 200 mg 1 comprimé pelliculé contient 200 mg de lacosamide.
0.1392105668783188 ||| 93 A hypo means your blood sugar level is too low. ||| is A hypo means your blood sugar level is too low. ||| Une hypoglycémie se produit lorsque le taux de sucre dans le sang est trop bas.
0.36044585704803467 ||| The workload arising from these priorities can be seen in the increase in meeting days forecast for 2002 and also in the significant rise in the number of reimbursed delegates expected in 2002, a significant number of which are experts for the evaluation of medicines for human use (see Section 5.3). ||| The ‘unusual event flexibility clause' was used a few times in the past, in order to take account of the exceptional expenditure related to the inflows of refugees in 2016 or for Italy in 2017, to take account of the exceptional expenditure related to earthquakes. ||| La charge de travail découlant de ces priorités se reflète dans l'augmentation du nombre de journées de réunion prévues pour 2002 et dans la hausse sensible du nombre de délégués remboursés prévu pour 2002, parmi lesquels se trouve un nombre significatif d’ experts pour l'évaluation des médicaments à usage humain (voir section 5.3).
0.186272531747818 ||| 53.4% N=82 12.7 ||| 59.1% N=124 16.2 ||| 53,4% N=82 12,7
0.7247138023376465 ||| 0.035-0.05 mg ||| 0.18 and 0.35 mg). ||| 0,035-0,05 mg
0.6790103316307068 ||| Ultramarine blue as pigment ||| A white homogenous paste ||| Bleu outremer [pigment]
0.32846471667289734 ||| The reduction of bone loss helps to make bones less likely to break, and this is useful in preventing fractures in cancer patients with bone metastases. ||| This can help the flow of blood to the heart to be maintained in patients with angina or who are having a heart attack and can improve the effectiveness of PCI. ||| Cette réduction de la perte osseuse contribue à rendre les os moins fragiles, ce qui est utile pour éviter les fractures chez les patients cancéreux présentant des métastases osseuses.
0.347450852394104 ||| Chemical products for drilling fluids ||| Oils for hydraulic suspensions ||| Produits chimiques pour fluides de forage
0.4354206919670105 ||| Control circuits ||| Writing instruments ||| Circuits de contrôle
0.2562616169452667 ||| Each patch is packed in a separate sachet. ||| Each transdermal patch is packed in a separate sachet. ||| 189 Chaque dispositif transdermique est emballé dans un sachet individuel.
0.47235846519470215 ||| Architectural services for the design of buildings ||| Planning and layout design services for cleanroom environments ||| Services d'architecture pour la conception de bâtiments
0.00823215488344431 ||| 60 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 12 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 62 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.1856791377067566 ||| - general feeling of tiredness, sleepiness, confusion, dizziness, weakness, bone pain, breast pain, ||| - Depression, difficulty in sleeping, mood swings, anxiety, tiredness, lethargy, irritability ||| - sensation générale de fatigue, somnolence, confusion, étourdissements, faiblesse, douleur
0.16421258449554443 ||| 687 Ísland Vistor hf. ||| 480 Ísland Vistor hf. ||| Vistor hf.
0.16825100779533386 ||| How does Cerenia work? ||| How does Kineret work? ||| Comment Cerenia fonctionne -t-il?
0.04960760474205017 ||| 175 9. ||| 165 9. ||| 185 9.
0.04504012316465378 ||| 9/ 19 ANNEX III ||| 7/ 19 ANNEX III ||| 9/ 19 ANNEXE III
0.38143378496170044 ||| 258 For ease of use the infusion vial stopper should be penetrated in the central ring. ||| 99 Instructions for injection For administration the use of a luer-lock syringe is required. ||| Pour faciliter l’utilisation, le bouchon du flacon de perfusion doit être transpercé au niveau de l’anneau central.
0.3735172748565674 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "AirBaltic plays a key role for the Latvian economy. ||| Executive Vice-President Margrethe Vestager, responsible for competition policy, said: "Air Canada and Transat are the two leading airlines operating a wide network of routes between Europe and Canada. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «AirBaltic joue un rôle essentiel dans l'économie lettone.
0.6651569604873657 ||| Lipid elevations: ||| Taste disturbances. ||| Hyperlipidémie:
0.5957316160202026 ||| The Committee recommended that Aivlosin should be given a marketing authorisation. ||| It was proposed to rationalise the authorised strengths of Lopid. ||| Le comité a recommandé l’ octroi de l’ autorisation de mise sur le marché pour Aivlosin.
0.017718903720378876 ||| 55 Insulin lispro Humulin R Hypoglycemic Activity ||| 86 Insulin lispro Humulin R Hypoglycemic Activity ||| Insuline lispro Umuline R
0.0 ||| 15. ||| 15. ||| 36 15.
0.019071612507104874 ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| Treatment with Abseamed may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| Le traitement par Binocrit peut être associé à un risque accru de formation post-opératoire de caillots sanguins (troubles vasculaires/ thrombotiques post-opératoires) si votre taux sanguin d’ hémoglobine (pigment rouge du sang) est trop élevé.
0.05892656743526459 ||| (see section 5.3). ||| (see section 5.1). ||| (voir rubrique 5.3).
0.3056585490703583 ||| After reconstitution, each ml solution for injection contains approximately 200 IU octocog alfa. * The potency (International Units) is determined using the chromogenic assay against an in-house standard that is referenced to the WHO standard. ||| Another moroctocog alfa product approved for use outside Europe has a different potency assigned using a manufacturing potency standard that has been calibrated to the WHO International Standard using a one-stage clotting assay; this product is identified by the tradename XYNTHA. ||| Chaque flacon contient nominalement 1000 UI * de facteur VIII (rDNA) de coagulation humain, octocog alfa * * Après reconstitution, chaque millilitre de solution pour injection contient approximativement 200 UI d’ octocog alfa. * Le titre (Unité Internationale) est déterminé par dosage chromogénique par rapport à un standard interne référencé au standard de l'OMS.
0.7541903257369995 ||| Intradermal use ||| Confusional state ||| Voie intradermique
0.02015664055943489 ||| 18 Gallstones and related biliary disorders were reported in about 2% of patients. ||| 7 Gallstones and related biliary disorders were reported in about 2% of patients. ||| Des calculs biliaires et des troubles biliaires ont été rapportés chez environ 2% des patients.
0.28566670417785645 ||| Most of these decreases were detected during the first 4 weeks of treatment and haemoglobin generally stabilised thereafter. ||| Generally, antibodies were first detected following 12 months of treatment and diminished after withdrawal of therapy. ||| Dans la majorité des cas, la diminution a été détectée au cours des 4 premières semaines de traitement et le taux d'hémoglobine s'est ensuite généralement stabilisé.
0.24794220924377441 ||| Rental of refrigerating apparatus ||| Rental of radio transmission apparatus ||| Location d'appareils de réfrigération
0.327316015958786 ||| Trizivir is used for the treatment of HIV infection in adults. ||| Xiliarx is used to treat patients with type 2 diabetes. ||| Trizivir est indiqué chez l’ adulte pour le traitement de l’ infection par le VIH.
0.6470978260040283 ||| Caution should be exercised in such situations. ||| Resistance was covered adequately in literature. ||| Une attention particulière doit être exercée dans de telles situations.
0.27891385555267334 ||| In some trials, the use of anticoagulants, acetylsalicylic acid, and non-steroidal anti-inflammatory drugs (NSAIDs) was allowed concurrently with SPRYCEL 3 if the platelet count was > 50,000/ mm. ||| 3 • The mode of action suggests that the effects of L-dopa, dopaminergic agonists, and anticholinergics may be enhanced by concomitant treatment with NMDA-antagonists such as memantine. ||| Les patients traités par des médicaments antiagrégants plaquettaires ou anticoagulants ont été exclus des études cliniques conduites avec SPRYCEL. Dans certaines études, l'utilisation concomitante de SPRYCEL et d'anticoagulants, acide acétylsalicylique, et anti-inflammatoires non stéroïdiens (AINS) était autorisée lorsque le taux de plaquettes était > 50 000/ mm3.
0.08475445955991745 ||| Your doctor will tell you how long you should continue to take EVISTA. ||| Your doctor will tell you how long you should continue to take OSSEOR. ||| Votre médecin vous dira combien de temps vous devez continuer à prendre EVISTA.
0.4061729609966278 ||| The powder is reconstituted in the water before it is injected by a health professional. ||| The appropriate dose can then be withdrawn with a sterile injection syringe and injected. ||| La poudre est reconstituée dans l’ eau avant son injection par un professionnel de santé.
0.31389182806015015 ||| In some clinical studies, Tritanrix HepB was used to reconstitute the lyophilised Hib vaccine (Hiberix); no interference in the immune response to any of the antigens was observed as compared to the responses observed following administration of the vaccines at separate sites (see section 6.2). ||| Measurement of serum FSH, LH and oestradiol during the study indicated some loss of suppression of ovarian hormonal activity in some women, although measurement of serum progesterone indicated that there was no hormonal evidence of ovulation in any of the 16 subjects. ||| Dans des études cliniques, Tritanrix HepB a été utilisé pour reconstituer le vaccin lyophilisé Hib (Hiberix); la réponse immunitaire à l'un ou l'autre des antigènes n'est pas différente de celle obtenue lors d'une administration séparée des deux vaccins (voir rubrique 6.2).
0.6074286699295044 ||| Very Rare ||| Common Rare ||| Très Rares
0.3300299644470215 ||| 25 mental status and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmia). ||| Nervous disorders: somnolence, rapid involuntary movements of the eyes (nystagmus), personality disorder, vertigo. ||| Les signes cliniques du SMN sont l'hyperthermie, la rigidité musculaire, l'altération des facultés mentales et des signes d’ instabilité neurovégétative (instabilité du pouls ou de la pression artérielle, tachycardie, hypersudation et troubles du rythme cardiaque).
0.6020609736442566 ||| Electronic chips ||| Machine tools ||| Puces électroniques
0.3185489773750305 ||| A total of 1,315 patients constituted the safety population in the three phase III studies with 24 months exposure to Lucentis and 440 patients were treated with the recommended dose of 0.5 mg. ||| However, in the second study, which involved 301 patients, it took an average of 15.3 hours for leakage to stop with TachoSil compared with 20.5 hours with standard techniques. ||| Au total, 1 315 patients ont constitué la population d’ évaluation de la tolérance dans les trois études de phase III avec 24 mois d'exposition à Lucentis et 440 patients ont été traités à la dose recommandée de 0,5 mg.
0.28663578629493713 ||| The mean elimination half-life after intravenous administration is approximately 2 hours. ||| Following intravenous administration, the elimination phase half-life averaged 15.1 hours. ||| Après administration intraveineuse la demi-vie d’ élimination moyenne est d’ environ 2 heures.
0.11856313049793243 ||| For children unable to take tablets, VIRACEPT oral powder may be administered (see Summary of Product Characteristics for VIRACEPT oral powder). ||| REYATAZ oral powder is available for patients who are unable to swallow capsules (see Summary of Product Characteristics for REYATAZ oral powder). ||| Pour les enfants incapables de prendre des comprimés, VIRACEPT peut être administré sous forme de poudre orale (voir le Résumé des Caractéristiques du Produit de VIRACEPT poudre orale).
0.27804112434387207 ||| Panretin gel can be expected to have local therapeutic effects only and it has no role in the prevention or treatment of visceral KS. ||| Although the product may be safely administered to dogs infected with adult heartworms, it has no therapeutic effect against adult Dirofilaria immitis. ||| Panretin gel n’ aurait que des effets thérapeutiques locaux et il ne joue pas de rôle dans la prévention ou le traitement des lésions viscérales du SK.
0.2589488625526428 ||| The Marketing Authorisation Holder commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance plan as agreed in version 5 of the Risk Management Plan (RMP) presented in Module 1.8.2. of the Marketing Authorisation and any subsequent updates of the RMP agreed by the CHMP. ||| Therefore, the CHMP has recommended to maintain the Marketing Authorisations for all medicinal products and to grant Marketing Authorisations for all applications referred to in Annex I of the Opinion in accordance with the amendments to the relevant sections of the Summary of Product Characteristics and Package Leaflet, set out in Annex III of the Opinion. ||| Le TAM s’ engage à réaliser les études et les activités de pharmacovigilance supplémentaires détaillées dans le Plan de Pharmacovigilance, décrites dans la version 5 du Plan de Gestion des Risques et présentées dans le Module 1.8.2 de l’ A. M. M., ainsi que les mises à jour successives approuvées par le CHMP.
0.314256489276886 ||| - If you have had a severe nervous or mental disorder. ||| - if you have had a serious heart or abdominal operation ||| très déprimé ou avez pensé ou tenté de vous suicider.
0.004127063788473606 ||| This is increased to 20 drops once a day (1x 10 mg) in the second week and to 30 drops once a day taken in the third week. ||| This is increased to 20 drops once a day (1x10 mg) in the second week and to 30 drops once a day taken in the third week. ||| Cette dose passe à 20 gouttes une fois par jour (1x 10 mg) au cours de la deuxième semaine et à 30 gouttes une fois par jour au cours de la troisième semaine.
0.25729942321777344 ||| • if you are allergic (hypersensitive) to telmisartan or any other ingredients included in Micardis tablets (see section Further information for a list of other ingredients). • during the last six months of pregnancy (see section Pregnancy and breast-feeding). • if you are breast-feeding. • if you have severe liver problems such as cholestasis or biliary obstruction (problems with the drainage of the bile from the liver and gall bladder) or any other severe liver disease. ||| If hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) is not treated they can be very serious and cause headaches, nausea, vomiting, dehydration, unconsciousness, coma or even death (see A and B in section 4 “Possible Side Effects”). • Always keep spare syringes and a spare vial of Liprolog Basal, or a spare pen and cartridges, in case you lose your pen or cartridges or they get damaged. • Always carry something to show you are diabetic. • Always carry sugar with you. ||| • Si vous êtes allergique (hypersensible) au telmisartan ou à l’ un des excipients contenus dans les comprimés de Micardis (voir la rubrique Informations complémentaires pour la liste des excipients). • Au cours des six derniers mois de la grossesse (voir rubrique Grossesse et Allaitement). • Si vous allaitez. • Si vous avez des troubles hépatiques sévères tels une choléstase ou une obstruction biliaire (un trouble lié au drainage de la bile au niveau du foie et de la vésicule biliaire) ou toute autre maladie sévère du foie.
0.1841689944267273 ||| Advisory services relating to the installation of fixings ||| Advisory services relating to the installation of lighting apparatus ||| Services de conseils liés à l'installation de fixations
0.23365838825702667 ||| All patients should be advised to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias (e. g. persistent fever, bruising, bleeding, pallor) while on Trudexa. ||| In 4% of the women treated with Fertavid in clinical studies, signs and symptoms related to ovarian hyperstimulation syndrome (e. g. feeling sick, weight gain and diarrhoea) have been reported. ||| Il doit être conseillé à tous les patients de demander immédiatement un avis médical s'ils ont des signes ou des symptômes suggérant des troubles sanguins (par ex: fièvre persistante, ecchymoses, saignements, pâleur) sous Trudexa.
0.49096858501434326 ||| Xagrid should not be taken while breast-feeding. ||| Cystadane should be taken orally (by mouth). ||| Xagrid ne doit pas être pris pendant l’ allaitement.
0.460845410823822 ||| The concentrate is a clear, colourless to light-yellow solution. ||| The powder has a white to off-white colour and comes in a glass vial. ||| La solution à diluer est une solution limpide, incolore ou jaune pâle.
0.0469231978058815 ||| It is recommended that HIV-infected women should not breast-feed under any circumstances in order to avoid transmission of HIV to the baby. ||| It is recommended that HIV-infected women do not breast-feed their infants under any circumstances in order to avoid transmission of HIV. ||| Il est recommandé dans tous les cas aux femmes infectées par le VIH de ne pas allaiter leurs enfants dans le but d'éviter la transmission du VIH au nourrisson.
0.6756131649017334 ||| 3 0 70 9 ||| 10 5 0 ||| 70 9
0.2962251901626587 ||| Ritonavir increases the serum levels of amprenavir (from fosamprenavir) as a result of CYP3A4 inhibition. ||| 31 appears to be greater for valdecoxib (the active metabolite of parecoxib) as compared to other COX-2 selective inhibitors. ||| Le ritonavir augmente les concentrations sériques de l’amprénavir (à partir du fosamprénavir) par inhibition du CYP 3A4.
3.578651589473958e-13 ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si l'un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.7776907086372375 ||| Subcutaneous use Resuspend according to instructions Read the package leaflet before use ||| Aranesp SureClick Pre-filled pen - Read package leaflet before use ENGLISH ||| Voie sous-cutanée Remettre en suspension conformément aux instructions de la notice Lire attentivement la notice avant utilisation
0.4755476713180542 ||| Business intermediary and advisory services in the field of selling products and rendering services ||| Administrative processing of purchase orders within the framework of services provided by mail-order companies ||| Services de médiation et de conseil dans le domaine de la vente de produits et de prestation de services
0.3113552927970886 ||| In the presence of the above signs, treatment with Cyanokit must not be delayed to obtain a plasma lactate concentration. ||| not recommended unless an assessment of the benefit/ risk to the patient justifies the use of voriconazole (see section 4.4). ||| En présence des signes mentionnés ci-dessus le traitement par Cyanokit ne doit pas attendre la détermination de la concentration plasmatique en lactate.
0.392752468585968 ||| Packs contain 1 or 5 vials each with 5 ml of solution. ||| Each pack contains 4 single dose vials and 8 alcohol swabs. ||| Les présentations disponibles contiennent 1 ou 5 flacons contenant chacun 5 ml de solution.
0.2906009554862976 ||| Protective nose masks for veterinary use ||| Protective visors for veterinary use ||| Masques de protection nasale à usage vétérinaire
0.5705323219299316 ||| o EU funding: EU continues providing immediate liquidity to businesses affected by the crisis through the Coronavirus Response Instrument Initiative, under shared management with Member States. ||| With this scheme, also other public institutions can grant support to the German economy and complement actions by the Kreditanstalt für Wiederaufbau. ||| o Financement de l'UE: l'UE continue de fournir des liquidités immédiates aux entreprises touchées par la crise, au moyen de l'initiative d'investissement en réaction au coronavirus, dans le cadre d'une gestion partagée avec les États membres.
0.32163339853286743 ||| 0.0* ||| 176* ||| 0,0*
0.31357884407043457 ||| The number of TachoSil sponges to be applied is governed by the size of the wound area. ||| The dose of Myocet will be calculated according to the surface area of your body. ||| Le nombre d’ éponges TachoSil à appliquer dépend de l’ importance de la surface lésée.
0.22626742720603943 ||| Do not take Efient ||| Do not take Revatio ||| Ne prenez jamais Efient
0.5352765321731567 ||| The population enrolled mainly consisted in children with mild to moderate hepatitis C. ||| For the sub-group of patients with platinum-sensitive disease the difference was greater: ||| La population sélectionnée comportait principalement des enfants et adolescents avec une hépatite C minime à modérée.
0.2610883116722107 ||| - antacids (used to treat heartburn or acid regurgitation) ||| - anticoagulant medicines (used to prevent or treat blood clotting), ||| - anti-acides (utilisés pour traiter les brûlures d’estomac ou les régurgitations acides)
0.38458672165870667 ||| The following proposal has been sent to Member States for consultation of their views: ||| Member States now have the possibility to comment on the Commission's draft proposal. ||| La proposition suivante a été soumise aux États membres pour consultation:
0.2031320333480835 ||| Concomitant use of vardenafil with potent CYP 3A4 inhibitors such as itraconazole and ketoconazole (oral form) should be avoided as very high plasma concentrations of vardenafil are reached if the medicinal products are combined (see sections 4.5 and 4.3). ||| Voriconazole: due to the potential for reduced voriconazole concentrations, co-administration of voriconazole and low dose ritonavir (100 mg twice daily) as contained in Kaletra should be avoided unless an assessment of the benefit/ risk to patient justifies the use of voriconazole. ||| L’ administration concomitante de vardénafil avec de puissants inhibiteurs du CYP3A4 tels que l’ itraconazole et le kétoconazole (forme orale) doit être évitée (voir rubrique 4.5), car des concentrations plasmatiques élevées de vardénafil sont obtenues si ces médicaments sont associés (voir rubriques 4.3 et 4.5).
0.5666834115982056 ||| Computerweg 10, 3542 DR Utrecht The Netherlands ||| Pfizer Oy, Tietokuja 4 00330 Helsinki Finland ||| Computerweg 10, 3542 DR Utrecht Pays-Bas
0.33782482147216797 ||| Patients exhibiting depression should be monitored closely during therapy and treated appropriately. ||| Physicians should evaluate patients for a history of drug abuse and follow such patients closely. ||| Les patients présentant une dépression doivent faire l'objet d'une surveillance particulière durant le traitement et être traités de façon appropriée.
0.013121731579303741 ||| If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| If you have further questions on the use of this product, ask your doctor or pharmacist. ||| Si vous avez d’ autres questions sur l’ utilisation de ce médicamentproduit, consultez demandez plus d’ informations à votre médecin ou à votre pharmacien.
0.3854067921638489 ||| Infanrix hexa, Powder and suspension for suspension for injection. ||| Equilis Prequenza, suspension for injection, for horses ||| Infanrix hexa, poudre et suspension pour suspension injectable
0.24328957498073578 ||| In another randomised phase III trial which compared IV topotecan to cyclophosphamide, Adriamycin (doxorubicin) and vincristine (CAV) in patients with relapsed, sensitive SCLC, the overall response rate was 24.3% for topotecan compared to 18.3% for the CAV group. ||| This randomised study in patients with metastatic colorectal cancer who had received initial combination treatment with oxaliplatin plus fluoropyrimidine for metastatic disease compared the combination of cetuximab and irinotecan (648 patients) with irinotecan alone (650 patients). ||| Dans un autre essai clinique de phase III randomisé comparant le topotécan IV au cyclophosphamide, adriamycine (doxorubicine) et vincristine (protocole CAV) chez les patients en rechute et sensibles à la première ligne de traitement, le taux de réponse global était de 24,3% dans le groupe topotécan comparé à 18,3% dans le groupe CAV.
0.16003456711769104 ||| It is not expected that performing the breath test during pregnancy and lactation has a damaging effect. ||| It is not expected that the test procedure may be harmful during pregnancy or lactation. ||| Rien ne laisse présager que l’utilisation de ce test durant la grossesse ou l’allaitement pourrait avoir un effet nocif.
0.2763862907886505 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Purevax RCP FeLV exceed the risks for the active immunisation of cats aged eight weeks or older against the diseases listed above, and recommended that Purevax RCP FeLV be given a marketing authorisation. ||| benefits of Purevax RCPCh FeLV exceed the risks for the active immunisation of cats aged eight weeks or older against the diseases listed above, and recommended that Purevax RCPCh FeLV be given a marketing authorisation. ||| Le comité des médicaments vétérinaires (CVMP) a considéré que les bénéfices de Purevax RCP FeLV sont supérieurs à ses risques dans l’ immunisation active des chats âgés de huit semaines ou plus contre les maladies énumérées ci-dessus et a recommandé l’ octroi d'une autorisation de mise sur le marché pour Purevax RCP FeLV.
0.4241645336151123 ||| In the second study, Viracept, in combination with zidovudine and lamivudine (other antiviral medicines) was compared with the combination of zidovudine and lamivudine in 297 treatment-naïve patients (who had not taken any antiviral medicines to treat HIV infection before). ||| Clinical experience Efficacy of PREZISTA co-administered with 100 mg ritonavir in treatment-naïve patients There are no data on the efficacy of darunavir co-administered with 100 mg ritonavir in treatment-naïve HIV-1 infected patients. ||| Dans la seconde étude, Viracept, en association avec la zidovudine et la lamivudine (autres médicaments antiviraux), a été comparé à l’ association de la zidovudine et de la lamivudine auprès de 297 patients naïfs de tout traitement (n’ ayant jamais été traités auparavant par des médicaments antiviraux pour leur infection par le VIH).
0.0 ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 20 4.5 Interactions avec d’ autres médicaments et autres formes d’ interactions
0.44698745012283325 ||| Window blinds made of wood [indoor] ||| Sun screens [outdoor], of metal ||| Stores en bois d'intérieur pour fenêtres
0.3032858371734619 ||| Serum folate levels may be depressed by hormonal contraceptive therapy. ||| Pioglitazone effects may be mediated by a reduction of insulin resistance. ||| Les concentrations sériques de folate peuvent être diminuées par un traitement contraceptif hormonal.
0.3819846510887146 ||| Filgrastim should be discontinued and appropriate treatment given in these cases. ||| Concomitant oral antidiabetic treatment may need to be adjusted. ||| Dans de telles circonstances, le filgrastim doit être arrêté et un traitement approprié doit être instauré.
0.0009445269242860377 ||| The non-confidential version of the decision will be made available under the case number SA.57076 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.57036 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.57076 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.3715219497680664 ||| Patients with high blood pressure and type 2 diabetes Treatment usually starts with 50 mg losartan (one tablet Cozaar 50 mg) once a day. ||| For patients with type 2 diabetes, the recommended starting dose of NovoMix 30 is 6 U at breakfast and 6 U at dinner (evening meal). ||| Patients hypertendus diabétiques de type 2 La dose habituelle d'initiation est 50 mg de losartan une fois par jour (1 comprimé de Cozaar 50 mg).
0.5963649749755859 ||| Vardenafil (saquinavir/ritonavir) ||| Saquinavir/ ritonavir/ Efavirenz CCR5 antagonist ||| Vardénafil (saquinavir/ritonavir)
0.5041167140007019 ||| Any other vaccines that are given at the same time as Menitorix will be injected separately at different parts of the body. ||| or The use of Protopy at the same time as other preparations to be used on the skin or while taking oral ||| Pour tout autre vaccin administré au même moment que Menitorix, des sites d’ injection séparés devront être utilisés.
0.37701743841171265 ||| Improvement of exercise duration was statistically significant compared to placebo for all three doses of ranolazine from 24 seconds at 500 mg twice daily to 46 seconds at 1500 mg twice daily, showing a dose-related response. ||| The data described below reflect exposure to SPRYCEL in 2,182 patients in clinical trials (starting dose 100 mg once daily, 140 mg once daily, 50 mg twice daily, or 70 mg twice daily). ||| Une amélioration de la durée de l'effort était statistiquement significative par rapport au placebo pour les trois doses de ranolazine (de 24 secondes avec la dose de 500 mg deux fois par jour jusqu'à 46 secondes avec la dose de 1500 mg deux fois par jour), prouvant l'existence d'une réponse dose-dépendante.
0.7586754560470581 ||| Treatment: ||| Development - ||| Traitement:
0.15400731563568115 ||| Rare side effects (may occur in fewer than 1 in 1,000 patients): ||| Rare side effects (affecting less than 1 in every 1,000 patients): ||| Les effets indésirables rares (pouvant survenir chez moins d’ 1 patient sur 1000):
0.18901675939559937 ||| Glivec 100 mg film-coated tablets Imatinib ||| SPRYCEL 100 mg film-coated tablets Dasatinib ||| Glivec 100 mg comprimés pelliculés Imatinib
0.6941670775413513 ||| Miticides for agricultural use ||| Unemployment insurance for staff ||| Acaricides à usage agricole
0.2061329185962677 ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com ||| Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@merck. com ||| Eesti Österreich Merck Sharp & Dohme OÜ Tel.: +372 6139 750 msdeesti@merck. com
0.33499789237976074 ||| See below in section ‘ Instructions for administration’ for further information about how to inject STELARA. ||| See section 3 “ How to use Fasturtec” and practical information on preparation and handling given below. ||| Voir ci-après rubrique « Instructions pour l’ administration » pour d’ autres informations sur comment injecter STELARA.
0.2762907147407532 ||| No studies on the effect of etoricoxib on the ability to drive or use machines have been performed. ||| No studies have been performed to assess the effect of QUADRAMET on reproduction. ||| Aucune étude sur l’ effet de l’ étoricoxib sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ a été réalisée.
0.8021730780601501 ||| Computer time sharing facilities (Provision of -) ||| • Sample preparation for (IRMS) ||| Location d'ordinateurs en temps partagé
0.5548162460327148 ||| The metabolism in horses has not been investigated. ||| children and adolescents has not yet been studied. ||| Le métabolisme chez les chevaux n’ a pas été étudié.
0.2812795639038086 ||| Once withdrawn from vial into the syringe, the suspension should be used immediately. ||| Once the powder has dissolved, draw the solution back into the syringe. ||| Une fois transferé du flacon dans la seringue, la suspension doit être utilisée immédiatement.
0.17686527967453003 ||| - If you are not eating enough, your blood sugar level may become too low (hypoglycaemia). ||| - If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia). ||| - Si vous ne vous nourrissez pas suffisamment, votre taux de sucre dans le sang risque de diminuer
5.021338162977673e-13 ||| 9 ||| 9 ||| 8
0.06277936697006226 ||| If you take more Imprida than you should If you have taken too many tablets of Imprida, or if someone else has taken your tablets, consult a doctor immediately. ||| If you take more Dafiro than you should If you have taken too many tablets of Dafiro, or if someone else has taken your tablets, consult a doctor immediately. ||| Si vous avez pris plus d’ Imprida que vous n’ auriez dû Si vous avez pris trop de comprimés d'Imprida, ou si quelqu’ un d’ autre que vous a pris vos comprimés, consultez un médecin immédiatement.
0.33161747455596924 ||| The patients should be carefully observed and given symptomatic and supportive treatment. ||| These are rare and an appropriate symptomatic treatment should be administered. ||| Les patients doivent être étroitement surveillés et un traitement symptomatique doit leur être administré.
0.4170699417591095 ||| For the different dosage regimens the following strengths are available: ||| The following are the recommended dose modifications for toxicity: ||| Pour les différents schémas posologiques, les dosages suivants sont disponibles:
0.3601818084716797 ||| 20 Pregnancy Valtropin should not be used during pregnancy unless clearly necessary. ||| Pregnancy During pregnancy, effective antiepileptic treatment must NOT be stopped. ||| Grossesse Valtropin ne doit pas être utilisé pendant la grossesse, à moins d’ une nécessité absolue.
0.2809428572654724 ||| The bioavailability of mecasermin after subcutaneous administration in healthy subjects has been reported to be approximately 100%. ||| In healthy subjects the absolute bioavailability of bosentan is approximately 50% and is not affected by food. ||| Une biodisponibilité d’ environ 100% a été rapportée pour la mécasermine après administration sous-cutanée chez des sujets sains.
0.0 ||| Gastrointestinal disorders ||| Gastrointestinal disorders ||| Troubles gastro-intestinaux Peu fréquent:
0.06658431887626648 ||| What Insulatard looks like and contents of the pack ||| What Inovelon looks like and contents of the pack ||| Qu’est-ce qu’Insulatard et contenu de l’emballage extérieur
0.42150819301605225 ||| Fresh mulberries ||| Natural rice flakes ||| Mûres fraîches
5.553072650148205e-13 ||| EXP (mm/ yyyy) Use immediately after reconstitution. ||| EXP (mm/ yyyy) Use immediately after reconstitution. ||| Utiliser immédiatement après reconstitution.
0.3875267505645752 ||| Ira Longini, et al., established a model to predict the outcome of the epidemic and suggested that SARS-CoV-2 could infect two-thirds of the global population. ||| In Pickar J. H. et al, the relationship between treatment duration and incidence of hyperplasia was also observed with the low dose of 0.3 mg CEE. ||| Ira Longini, et al., ont établi un modèle afin de prévoir l’issue de l’épidémie et ont conclu que le SARS-CoV-2 pourrait infecter deux tiers de la population mondiale.
0.4305788576602936 ||| You do not need to take another tablet if you are sick more than 1 hour after taking Hepsera. ||| It is best to take Remeron as a single dose before you go to bed. ||| Si vous vomissez plus d’une heure après avoir pris Hepsera, vous n’avez pas besoin de prendre un autre comprimé.
0.0 ||| In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. ||| In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products. ||| 25 En l’ absence d’ études de compatibilité, ce médicament ne doit pas être mélangé avec d’ autres médicaments.
0.17248886823654175 ||| Dyskinesia In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesia can occur during the initial titration of SIFROL. ||| 3 In advanced Parkinson’ s disease, in combination treatment with levodopa, dyskinesias can occur during the initial titration of Pramipexole Teva. ||| Dyskinésies A un stade avancé de la maladie de Parkinson, en association à la lévodopa, des dyskinésies peuvent apparaître lors de la phase initiale de traitement par SIFROL.
0.7508121132850647 ||| CVMP ||| CVMP General ||| BPF
0.3187998831272125 ||| The CHMP agreed that the indication should not be restricted to patients refractory to standard medication. ||| The CHMP concluded that conversion to monotherapy is not an indication but information on correct use of the product. ||| Le CHMP a approuvé le fait que l’ indication ne soit pas limitée aux patients réfractaires à une médication classique.
0.5359010696411133 ||| Gulleys of metal ||| Jardinieres of glass ||| Rigoles métalliques
0.5119116902351379 ||| You should take the multivitamin at bedtime, when you will not be taking alli, to help ensure that the vitamins are absorbed. ||| If you miss a meal, or your meal contains no fat, do not take a capsule. alli does not work unless there's some fat in the meal. ||| Prenez ce supplément au coucher, à distance de la prise de alli, pour aider à l’absorption des vitamines.
0.09353947639465332 ||| Aflunov was expected to provide protection against this strain, so that it could be used before or during a flu pandemic. ||| Prepandrix has been developed to provide protection against this strain, so that it can be used before or during a flu pandemic. ||| Aflunov devait fournir une protection contre cette souche afin qu’ il puisse être utilisé avant ou pendant une pandémie de grippe.
0.19465994834899902 ||| 23.4 ||| 19.4 ||| 23,4
0.14587441086769104 ||| WHAT INTRONA IS AND WHAT IT IS USED FOR ||| WHAT ORENCIA IS AND WHAT IT IS USED FOR ||| QU’EST-CE QUE INTRONA ET DANS QUEL CAS EST-IL UTILISE
0.28911349177360535 ||| In patients previously un treated with chemotherapy, TMZ is administered orally at a dose of 200 mg/m2 once daily for the first 5 days followed by a 23 day treatment interruption (total of 28 days). ||| Both treatment groups received Vitamin K antagonist therapy usually initiated within 72 hours after the first study drug administration and continued for 90 ± 7 days, with regular dose adjustments to achieve an INR of 2-3. ||| Chez les patients n’ ayant pas reçu de chimiothérapie au préalable, TMZ est administré par voie orale à la dose de 200 mg/ m2 une fois par jour pendant les 5 premiers jours du cycle puis le traitement devra être arrêté pendant les 23 jours suivants (total de 28 jours).
0.38498491048812866 ||| You will have to inject Ceplene and IL-2 twice a day by subcutaneous injection (in the layer of tissue just under the skin), according to the directions provided by your doctor. ||| After topical administration at a single site on the cat’ s neck at the base of the skull, metaflumizone is rapidly distributed throughout the surface of the skin. ||| Vous devrez vous injecter Ceplene et l’ IL-2 deux fois par jour par voie sous-cutanée (dans la couche de tissus juste sous la peau), conformément aux directives données par votre médecin.
0.19144102931022644 ||| 100 ml ||| 500 ml ||| 100 ml.
0.5131741762161255 ||| Clapperboards ||| Chairlifts ||| Claquettes
0.3970741033554077 ||| At clinical doses no effects on the suckling child are anticipated. ||| No effects on the suckling child are anticipated. ||| Aux doses utilisées en pratique clinique, aucun effet sur l’enfant allaité n’est attendu.
0.2745627462863922 ||| Single doses of antacid (magnesium hydroxide/ aluminium hydroxide) did not affect the bioavailability of sildenafil. ||| The oral solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed). ||| Il n'a pas été mis en évidence d'effet des anti-acides (hydroxyde de magnésium / hydroxyde d’ aluminium) en doses uniques sur la biodisponibilité du sildénafil.
0.2467740774154663 ||| Very common Common Uncommon Vascular disorders ||| Common Uncommon Vascular disorders ||| Très fréquent Fréquent Peu fréquent Troubles vasculaires
0.3493996560573578 ||| Dosage in the elderly: ||| 2 In the elderly: ||| Sujet âgé:
0.327306866645813 ||| 1 pen + 12 injection sets3 ||| 1 vial + 1 injection set2 ||| 1 stylo + 12 sets d’ injection3
0.21221834421157837 ||| CR No 2804/ 95 ||| CR No 2804/ 95. ||| RC No 2804/ 95
0.45781755447387695 ||| - pain in the tummy (abdomen) caused by pancreatitis, inflammation of the gall bladder and/ or bile ||| - cervical cancer (cancer of the cervix i. e. lower part of the uterus or womb), ||| - douleur du ventre (abdomen) due à une pancréatite, inflammation de la vésicule biliaire et/ ou des
0.5055145025253296 ||| Feather beds ||| Packaged meats ||| Lits de plume
0.2538505792617798 ||| The most common side effects (seen in more than 1 patient in 10) are conjunctival hyperaemia (increased blood supply to the eye, leading to redness of the eye) and growth of eyelashes. ||| Common side effects (occurring in less than 1 out of 10 patients) are bleeding from the stomach or the intestines and bleeding from the nose, and eye irritation due to keratitis. ||| Les effets indésirables les plus courants (observés chez plus d’ 1 patient sur 10) sont une hyperémie conjonctivale (augmentation de l’ irrigation sanguine de l’œ il entraînant une rougeur de l’œ il) et une pousse des cils.
0.4899996519088745 ||| Some types of microbes stay in the intestine, some produce a toxin that is absorbed into the bloodstream, and some can directly invade the deeper body tissues. ||| Typically, the brown pigmentation around the pupil spreads concentrically towards the periphery in affected eyes, but the entire iris or parts of it may be become more brownish. ||| Certains agents pathogènes restent dans l'intestin, d’autres produisent une toxine qui passe dans la circulation sanguine, et d’autres peuvent envahir directement les tissus les plus profonds de l’organisme.
0.7809288501739502 ||| Referrals started in 2002 ||| Ended positively in 2002* ||| favorable en 2002*
0.4537535011768341 ||| Collagen for industrial purposes ||| Polymers for industrial use ||| Collagène à usage industriel
0.19180341064929962 ||| Do not take Comtess – if you are allergic (hypersensitive) to entacapone or any of the other ingredients of Comtess; – if you have a tumour of the adrenal gland (known as pheochromocytoma; this may increase the risk of severe high blood pressure); – if you are taking certain antidepressants (ask your doctor or pharmacist whether your antidepressive medicine can be taken together with Comtess); – if you have liver disease; – if you have ever suffered from a rare reaction to antipsychotic medicines called neuroleptic malignant syndrome (NMS) and/ or a rare muscle disorder called non-traumatic rhabdomyolysis. ||| • If you are under 18. • If you are pregnant or breast-feeding. • If you are taking ciclosporin, used after organ transplants, for severe rheumatoid arthritis and some severe skin conditions. • If you are taking warfarin or other medicines used to thin the blood. • If you are allergic (hypersensitive) to orlistat or any of the ingredients of alli: see Chapter 6 for further information. • If you have cholestasis (condition where the flow of bile from the liver is blocked). • If you have problems absorbing food (chronic malabsorption syndrome) diagnosed by a doctor. ||| Ne prenez pas Comtess − si vous êtes allergique (hypersensible) à l’ entacapone ou à l’ un des autres composants contenus dans Comtess; − si vous avez une tumeur de la glande surrénale (connue sous le nom de phéochromocytome; (cela peut augmenter le risque d’ hypertension artérielle sévère); − si vous prenez certains antidépresseurs (contactez votre médecin ou votre pharmacien pour savoir si votre médicament antidépresseur est compatible avec Comtess); − si vous avez une maladie du foie; – si vous avez souffert d’ une réaction rare aux médicaments antipsychotiques appelée syndrome malin des neuroleptiques (SMN) et/ ou d’ un trouble musculaire rare appelé rhabdomyolyse non traumatique.
0.5638357996940613 ||| 50% soluble insulin aspart (rapid acting) and 50% protamine-crystallised insulin aspart (long acting), • NovoMix 70: ||| Overall response rate (complete response plus partial response) was 45% (XELOX plus bevacizumab) versus 47% (XELIRI plus bevacizumab). ||| 50% d’ insuline Asparte soluble (à action rapide) et 50% de cristaux de protamine d’ insuline Asparte (à action prolongée), • NovoMix 70:
0.23564480245113373 ||| Caution should be exercised when administering nucleoside analogues to any patient (particularly obese women) with hepatomegaly, hepatitis or other known risk factors for liver disease and hepatic steatosis (including certain medicinal products and alcohol). ||| Most of the patients who experienced CHF had metastatic breast cancer and had received previous treatment with anthracyclines, prior radiotherapy to the left chest wall or other risk factors for CHF, such as pre-existing coronary heart disease or concomitant cardiotoxic therapy. ||| L’ administration d’ analogues nucléosidiques se fera avec une prudence particulière chez tous les patients (notamment les femmes obèses) ayant une hépatomégalie, une hépatite ou tout autre facteur de risque connu d’ atteinte hépatique et de stéatose hépatique (y compris la prise de certains médicaments ou d’ alcool).
0.44731569290161133 ||| - Iscover 300 mg film-coated tablets ||| - Modified release film-coated tablets: ||| Iscover 300 mg, comprimés pelliculés
0.5254300832748413 ||| Microwave ovens for industrial purposes ||| Make-up mirrors for travel use ||| Fours à micro-ondes à usage industriel
0.01940084807574749 ||| 99 If you forget to take Agenerase If you forget to take a dose of Agenerase, take it as soon as you remember and then continue as before. ||| If you forget to take Agenerase If you forget to take a dose of Agenerase, take it as soon as you remember and then continue as before. ||| Si vous avez oublié de prendre Agenerase Si vous avez oublié de prendre une dose d'Agenerase, prenez-la dès que vous vous en apercevez, puis poursuivez le traitement comme auparavant.
0.2501230239868164 ||| Across a range of doses, higher AUC and Cmax levels have been reported in older subjects compared to younger subjects, reflecting the lower metabolism of melatonin in the elderly. ||| Increased plasma concentrations of paroxetine occur in elderly subjects, but the range of concentrations overlaps with that observed in younger subjects. ||| Pour différentes doses, une ASC plus importante et une Cmax plus élevée ont été rapportées chez des sujets plus âgés, comparé à des sujets plus jeunes, ce qui reflète le métabolisme plus faible de la mélatonine chez les personnes âgées:
0.30423128604888916 ||| In locally advanced head and neck cancers, it took longer for the disease to get worse when Erbitux was added to radiotherapy (24.4 months compared with 14.9 months). ||| In the other two studies, it took longer for the disease to get worse among patients with wild-type KRAS when Erbitux was added to their treatment. ||| Pour les cancers de la tête et du cou localement avancés, le délai avant aggravation du délai a été plus long lorsqu’ Erbitux était associé à la radiothérapie (24,4 mois par rapport à 14,9 mois).
0.8227273225784302 ||| Estrada de Alfragide, nº 67 ||| Avenida de Burgos, 91 ||| Estrada de Alfragide, n° 67 Alfrapark, Edifício D,
2.5227920880804833e-13 ||| The Commission has adopted a Temporary Framework to enable Member States to use the full flexibility foreseen under State aid rules to support the economy in the context of the coronavirus outbreak. ||| The Commission has adopted a Temporary Framework to enable Member States to use the full flexibility foreseen under State aid rules to support the economy in the context of the coronavirus outbreak. ||| La Commission a adopté un encadrement temporaire afin de permettre aux États membres de soutenir l'économie dans le contexte de la flambée de coronavirus en exploitant toute la flexibilité prévue par les règles en matière d'État.
0.41576048731803894 ||| Therefore, Pelzont should not be used during pregnancy unless clearly necessary. ||| Yondelis must not be used in children until further information is available. ||| Pelzont ne doit donc pas être utilisé pendant la grossesse à moins d'une nécessité absolue.
0.2708454728126526 ||| Macugen is not recommended during breast-feeding. ||| Sugammadex can be used during breast-feeding. ||| L’utilisation de Macugen n’est pas recommandée pendant l’allaitement.
0.2509320080280304 ||| In some patients with bilateral renal artery stenosis or stenosis of the artery to a solitary kidney, who have been treated with ACE inhibitors, increases in blood urea and serum creatinine, usually reversible 23  EMEA 2005 upon discontinuation of therapy, have been seen. ||| 11/ 25 Administration of Doxagamma 4 mg prolonged release tablets and associated names to patients with prostatic hyperplasia results in a significant improvement in urodynamics and symptoms as a result of a selective blockade of alpha-adrenoceptors located in the prostatic muscular stroma, capsule and bladder neck. ||| Des augmentations de l’ urée sanguine et de la créatinine sérique, généralement réversibles à l’ arrêt du traitement, ont été observées chez certains patients ayant une sténose bilatérale des artères rénales ou une sténose de l’ artère sur rein unique, traités par des IEC.
0.43525850772857666 ||| - if you have ever had anaemia. ||| - if you have had a recent stroke ||| - si vous avez déjà eu une anémie.
0.7636557817459106 ||| 5.3 Accounting ||| Clinical 6 ||| 5.3 Comptabilité
0.2008855640888214 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €110 million Lithuanian scheme we approved today will enable public guarantees on loans to support Lithuania's economy during the coronavirus outbreak. ||| Executive Vice President Margrethe Vestager, in charge of competition policy, said: Today, we approved a German scheme that will help companies affected by the coronavirus outbreak via direct grants, repayable advance or tax and payment advantages. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ce régime lituanien d'un montant de 110 millions d'euros que nous avons autorisé aujourd'hui permettra l'octroi de garanties publiques sur des prêts destinés à soutenir l'économie lituanienne durant la pandémie de coronavirus.
0.04911607503890991 ||| 80 Management of overdose There is no specific antidote for olanzapine. ||| Management of overdose There is no specific antidote for olanzapine. ||| Traitement du surdosage Il n’ y a pas d’ antidote spécifique de l’ olanzapine.
0.3416441082954407 ||| Neoclarityn tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. ||| Both dose regimens were effective and not statistically different from thyroid hormone withdrawal in stimulating radioiodine uptake for diagnostic imaging. ||| Neoclarityn comprimés administrés une fois par jour à la dose unique de 7,5 mg n’ a pas altéré la performance psychomotrice au cours des essais cliniques.
0.20175236463546753 ||| Following a single oral dose of cysteamine bitartrate equivalent to 1.05 g of cysteamine free base in healthy volunteers, the mean (± sd) values for the time to peak and peak plasma concentration are 1.4 (± 0.5) hours and 4.0 (± 1.0) µg/ ml, respectively. ||| For reversal of neutropenia The recommended starting dose of filgrastim is 0.1 MIU (1 μ g)/ kg/ day given daily by subcutaneous injection with titration up to a maximum of 0.4 MIU (4 μ g)/ kg/ day until a normal neutrophil count is reached and can be maintained (ANC > 2.0 x109/ l). ||| Après administration par voie orale chez le volontaire sain d'une dose unique de bitartrate de cystéamine équivalente à 1,05 g de cystéamine exprimée en base libre, les valeurs moyennes (± écart- type) correspondant au temps d’ apparition du pic plasmatique et à la concentration à ce pic sont respectivement de 1,4 (± 0,5) heures et de 4,0 (± 1,0) µg/ ml.
0.3004714250564575 ||| In the trial for the prevention of clinical fractures following a recent hip fracture, vitamin D levels were not routinely measured but the majority of patients received a loading dose of vitamin D prior to Aclasta administration (see section 4.2). ||| The CHMP acknowledges that the contraindication for subjects with a history of thymus dysfunction or thymectomy is based on a small number of observations made during post-marketing surveillance of yellow fever vaccines. ||| Dans l’ étude RFT, la majorité des patients a reçu une dose de charge en vitamine D avant l’ administration d’ Aclasta bien que le taux de vitamine D n’ ait pas été mesuré de façon systématique (voir rubrique 4.2).
0.2565196454524994 ||| 19/ 48 A. ||| 6/ 20 A. ||| 19/ 49 A.
0.24719227850437164 ||| 5 mg/ 1.5 ml ||| 1. 5 mg/ ml ||| 5 mg/ 1,5 ml
0.7193586826324463 ||| Containers of card for packaging ||| Containers for contact lenses ||| Récipients d'emballage en carton
0.39958423376083374 ||| Veterinarians should be aware that clinical signs of adverse reactions may continue when supportive therapy (such as gastro protectants) is discontinued. ||| Public health authorities may implement other forms of social distancing, such as school closings, when needing to control an epidemic. ||| Les vétérinaires doivent être informés que les signes cliniques sont susceptibles de continuer si le traitement de soutien est interrompu.
0.2887345254421234 ||| 2.7%) ||| 11.7%) ||| 2,7%).
0.10864522308111191 ||| 0. 25 ||| 0. 20 ||| 0,25
0.0026666296180337667 ||| 19 In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population. ||| 29 In clinical studies, subgroup analyses based on age and gender did not indicate any difference in safety and efficacy in insulin glargine-treated patients compared to the entire study population. ||| Dans les études cliniques, les analyses de sous-groupes (selon l'âge et le sexe) ne montrent aucune différence, en terme de tolérance ou d'efficacité, entre l'ensemble de la population étudiée et les différents sous-groupes de patients traités par l’ insuline glargine.
0.02353421226143837 ||| For the full list of all side effects reported with RotaTeq, see the Package Leaflet. ||| For the full list of all side effects reported with Retacrit, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de RotaTeq, voir la notice.
0.3449832499027252 ||| This dose should be continued for three weeks. ||| The treatment should last for 6 weeks. ||| Cette posologie doit être poursuivie pendant trois semaines.
0.6667156219482422 ||| Guaranteeing payment of medical expenses for travellers ||| Redirecting all Cohesion Policy funds to fight the emergency ||| Garantie de paiement de frais médicaux pour voyageurs
0.42694616317749023 ||| This medicine is not a cure for HIV infection. ||| The vaccine may not prevent hepatitis B in such patients. ||| Ce médicament ne permet pas de guérir de l’ infection par le VIH.
6.323422688248037e-13 ||| 16. ||| 16. ||| 19 16.
0.29785817861557007 ||| Escalation and maintenance doses should be adjusted according to clinical response (see section 5.2). ||| The initial and maintenance dosages should be conservative (see section 4.2). ||| Les augmentations posologiques et les posologies d’ entretien doivent être ajustées en fonction de la réponse clinique (voir rubrique 5.2).
0.022155601531267166 ||| 118 5.2 Pharmacokinetic properties ||| 111 5.2 Pharmacokinetic properties ||| 5.2 Propriétés pharmacocinétiques
0.3245137333869934 ||| Due to the unknown mechanism of deferiprone-induced neutropenia, patients must not take medicinal products known to be associated with neutropenia or those that can cause agranulocytosis (see section 4.5). ||| Due to the unavoidable presence of NO2 at high nitric oxide concentrations it is not clear whether these effects are caused by nitric oxide or NO2 since NO2 is a known genotoxic agent. ||| En raison du mécanisme inconnu de neutropénie induite par la défériprone, les patients ne doivent pas prendre d’ autres médicaments connus pour être associés avec une neutropénie, ni ceux susceptibles de provoquer une agranulocytose (voir rubrique 4.5).
0.3828182816505432 ||| The EMEA will continue to collect data on the costs of the centralised procedure and in particular the costs of services provided by national competent authorities for rapporteurships and inspections. ||| This would concern the electronic publication of the summary of product characteristics for products authorised after evaluation by the EMEA and also the mutual recognition procedure. ||| 1.4 Révision des redevances de l'EMEA L'EMEA continuera à collecter des données sur les coûts de la procédure centralisée et, notamment, ceux des services fournis par les autorités nationales compétentes pour les missions des rapporteurs et les inspections.
0.4173617362976074 ||| The marketing authorisation holder is Glaxo Group Ltd. ||| The marketing authorisation holder Alcon Laboratories (UK) Ltd. ||| Le titulaire de l’ autorisation de mise sur le marché est Glaxo Group Ltd.
0.11502358317375183 ||| Important information about some of the ingredients of Insulin Human Winthrop Comb 50 ||| Important information about some of the ingredients of Insulin Human Winthrop Basal ||| 788 Informations importantes concernant certains composants d’Insulin Human Winthrop Comb 50
0.3886984586715698 ||| 78 Pharmacokinetics in special patient groups ||| Pharmacokinetics in special patient groups Elderly: ||| Pharmacocinétique dans les populations particulières
0.09372076392173767 ||| Each hard capsule contains 200 mg of efavirenz. ||| Each hard capsule contains 100 mg of pregabalin. ||| Chaque gélule contient 200 mg d’ éfavirenz.
0.9885512590408325 ||| Elevated cholesterol levels Nervous system disorders Very common: ||| Decreased blood pressure Increased body temperature ||| Augmentation de la cholestérolémie 11 Affections du système nerveux Très fréquent:
0.025729242712259293 ||| Please also tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| However, please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Informez également votre médecin ou votre pharmacien si vous prenez ou avez récemment pris tout autre médicament, y compris des médicaments obtenus sans ordonnance.
0.291372150182724 ||| This indicates that active tubular secretion is an important part of the elimination of tenofovir. ||| The cleavage of these viral polyproteins is essential for the maturation of infectious virus. ||| Cette mesure montre que la sécrétion tubulaire active représente une part importante de l’ élimination du ténofovir.
0.40137621760368347 ||| Osteonecrosis of the jaw is generally associated with tooth extraction and/ or local infection (including osteomyelistis). ||| Stage 4 the patient is vasopressor dependent and oliguric or anuric; subsequently develops ischemic colitis and lactic acidosis. ||| L’ ostéonécrose de la mâchoire est généralement associée à une extraction dentaire et/ ou à une infection locale (y compris ostéomyélite).
2.608412742614746 ||| Pharmaceutical form Inhalation gas Inhalation gas ||| Sustiva Sustiva Sustiva Sustiva Sustiva Sustiva ||| Gaz d’ inhalation Gaz d’ inhalation
0.3917209208011627 ||| In the case of SARS-CoV-2, such research focuses on the S-spike protein that helps the virus intrude the ACE2 enzyme receptor. ||| In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs. ||| Dans le cas du SARS-CoV-2, ces recherches se concentrent sur la protéine S à spicule qui aide le virus à s’infiltrer dans le récepteur de l’enzyme ACE 2.
0.04230787605047226 ||| Dynepo 1,000 IU/ 0.5 ml injection Epoetin delta ||| Dynepo 5,000 IU/ 0.5 ml injection Epoetin delta ||| é ris Dynepo 1000 UI/ 0,5 ml Injectable Epoïétine delta
0.4679343104362488 ||| Pull the needle straight out of the skin. ||| Tilt your head back and look at the ceiling. ||| Retirez l’ aiguille de la peau.
0.3142407536506653 ||| • Continue to take Janumet as long as your doctor prescribes it so you can continue to help control your blood sugar. ||| Tell your doctor if you are on a controlled sodium diet as it could affect how you will be given your medicine. ||| • Continuez à prendre Janumet aussi longtemps que votre médecin vous l’a prescrit de manière à pouvoir maintenir le contrôle de votre glycémie.
0.1323586255311966 ||| The Reference Member State was the United Kingdom and the Concerned Member States were Belgium, Greece, Ireland, Poland and Spain. ||| The Reference Member State was France and the Concerned Member States were Belgium, the Czech Republic, Germany, Italy, Spain, and the United Kingdom. ||| L’ État membre de référence était le Royaume-Uni et les États membres concernés étaient la Belgique, l’ Espagne, la Grèce, l’ Irlande et la Pologne.
0.40475255250930786 ||| Chemical preparations for sanitary purposes ||| Diagnostic preparations for scientific purposes ||| Produits chimiques pour l'hygiène à usage médical
0.16100254654884338 ||| Posology for Ph+ ALL The recommended dose of Glivec is 600 mg/ day for patients with Ph+ ALL. ||| Posology for DFSP The recommended dose of Glivec is 800 mg/ day for patients with DFSP. ||| Posologie dans les LAL Ph+ La posologie recommandée de Glivec est de 600 mg/ jour chez les patients atteints de LAL Ph+.
0.3436504602432251 ||| - Phenytoin, carbamazepine or phenobarbital, treatments for epilepsy and other conditions ||| Other substances inducing hypotension like tricyclic antidepressants, antipsychotics, baclofene, amifostine: ||| - La phénytoïne, la carbamazépine ou le phénobarbital, des traitements pour l’ épilepsie et d’ autres
0.5291473269462585 ||| Preparing the injection: ||| E) Making the injection ||| Préparation de l’injection:
0.06633998453617096 ||| Use only according to the benefit/risk assessment by the responsible veterinarian. ||| Use only according to the risk/ benefit assessment of the responsible veterinarian. ||| L’ utilisation ne doit se faire qu’ après évaluation du rapport bénéfice/ risque par le vétérinaire.
0.5392233729362488 ||| Applications from designated orphan medicines represented 20% of the total number of applications. ||| Approximately half of the study population had at least two of the cardiovascular history entry criteria. ||| Les demandes de médicaments orphelins désignés ont représenté 20% du nombre total de demandes.
0.4851546883583069 ||| The terminal elimination half-life of irbesartan is 11 - 15 hours. ||| The terminal elimination half-life averaged 23.7 hours (range 12 - 33). ||| La demi-vie d’ élimination terminale de l'irbésartan est 11-15 heures.
0.2568822503089905 ||| Lacosamide should not be used during pregnancy unless clearly necessary (if the benefit to the mother clearly outweighs the potential risk to the foetus). ||| Pregnancy and breast-feeding Opgenra should not be used during pregnancy unless the benefits to the mother outweigh the risks to the unborn child. ||| Le lacosamide ne doit pas être utilisé au cours de la grossesse, sauf en cas de nécessité manifeste (c’ est-à-dire lorsque le bénéfice pour la mère prévaut clairement sur le risque potentiel pour le fœ tus).
0.25180116295814514 ||| Danmark Baxter A/S Gydevang 43 DK-3450 Allerød Tlf: +45 48 16 64 00 ||| 151 Danmark Abbott Laboratories A/S Emdrupvej 28C DK-2100 København Ø Tlf: + 45 39 77-00-00 ||| Danmark Baxter A/ S Gydevang 43 DK-3450 Allerød Tlf: +45 48 16 64 00
0.02697184309363365 ||| Combivir, taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level. ||| Kivexa, taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level. ||| Combivir, pris en association avec au moins un autre médicament antiviral, réduit la quantité de VIH dans le sang et le maintient à un niveau bas.
0.24209800362586975 ||| Thiazides, including hydrochlorothiazide, can cause fluid or electrolyte imbalance (hypokalaemia, hyponatraemia, and hypochloremic alkalosis). ||| Overdose with hydrochlorothiazide is associated with electrolyte depletion (hypokalaemia, hypochloremia, hyponatraemia) and dehydration resulting from excessive diuresis. ||| Les thiazidiques, dont l'hydrochlorothiazide, peuvent provoquer un déséquilibre hydroélectrolytique (hypokaliémie, hyponatrémie et alcalose hypochlorémique).
0.23085570335388184 ||| Efavirenz: when used in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in multiple protease inhibitor-experienced patients, increasing the dose of Kaletra 33.3% from 400/ 100 mg (3 capsules) twice daily to 533/ 133 mg (4 capsules) twice daily yielded similar lopinavir plasma concentrations as compared to historical data of Kaletra 400/ 100 mg (3 capsules) twice daily. ||| The study investigated the efficacy and safety of two different degarelix monthly dosing regimens with a starting dose of 240 mg (40 mg/ ml) followed by monthly doses subcutaneous administration of 160 mg (40 mg/ ml) or 80 mg (20 mg/ ml), in comparison to monthly intramuscular administration of 7.5 mg leuprorelin in patients with prostate cancer requiring androgen deprivation therapy. ||| Efavirenz: chez les patients multi-traités par des inhibiteurs de protéase et recevant Kaletra en association à l’ éfavirenz plus deux inhibiteurs nucléosidiques de la transcriptase inverse, une augmentation de 33,3% de la posologie de Kaletra, passant de 400/ 100 mg (3 capsules) 2 fois par jour à 533/ 133 mg (4 capsules) 2 fois par jour, a permis d’ obtenir des concentrations plasmatiques de lopinavir similaires à celles observées avec Kaletra administré à la posologie de 400/ 100 mg (3 capsules) 2 fois par jour (données historiques).
0.7661283612251282 ||| MRL status Annex II for Salmonidae1 ||| TSH decreased Arthralgia, Myalgia ||| Statut LMR Annexe II pour les salmonidés 1
0.4725136160850525 ||| Uncommon: acute renal failure ||| Uncommon: respiratory distress ||| Peu fréquents: insuffisance rénale aiguë
0.5373765826225281 ||| ACR Response in Placebo-Controlled Psoriatic Arthritis Studies (Percent of Patients) ||| CTC Grades 3/ 4 Haematological Laboratory Abnormalities in Clinical Studies ||| Réponse ACR des études contrôlées contre placebo, dans le rhumatisme psoriasique (pourcentage de patients) am
0.3379575312137604 ||| Discard any unused solution appropriately. ||| Discard any unused solution. ||| Toute solution non utilisée doit être éliminée de manière appropriée.
0.021214764565229416 ||| For the full list of all side effects reported with Sonata, see the Package Leaflet. ||| For the full list of all side effects reported with Avastin, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous Sonata, voir la notice.
0.31697970628738403 ||| In two randomised, double-blind, pivotal studies in patients with high risk stage II-IV breast cancer undergoing myelosuppressive chemotherapy consisting of doxorubicin and docetaxel, use of pegfilgrastim, as a single once per cycle dose, reduced the duration of neutropenia and the incidence of febrile neutropenia similarly to that observed with daily administrations of filgrastim (a median of 11 daily administrations). ||| In the toxicity studies, the plasma concentrations of lacosamide obtained were similar or only marginally higher than those observed in patients, which leaves low or non-existing margins to human exposure A safety pharmacology study with intravenous administration of lacosamide in anesthetized dogs showed transient increases in PR interval and QRS complex duration and decreases in blood pressure most likely due to a cardiodepressant action. ||| Dans deux études pivots randomisées, en double aveugle, chez des patientes atteintes d’ un cancer du sein à haut risque de stade II-IV, traitées par une chimiothérapie myélosuppressive associant doxorubicine et docétaxel, l’ administration de pegfilgrastim, à la posologie d’ une injection unique une fois par cycle, a entraîné la réduction de la durée de la neutropénie et de l’ incidence de la neutropénie fébrile de façon similaire à celle observée après administration quotidienne de filgrastim (avec une durée médiane d’ administration de 11 jours).
0.32935088872909546 ||| A case of peripheral neuropathy has been reported in a large adult male after receiving four sets of BOTOX injections, totalling 1800 U (for neck and back spasm, and severe pain) over an 11 week period. ||| A Canadian group reported that SARS-CoV-2 was detected in both mid-turbinate and throat swabs of patients who recovered and left the hospital 2 weeks earlier, which indicates that the newly identified virus could become a cyclical episode similar to influenza. ||| Un cas de neuropathie périphérique a été rapporté chez un homme adulte de forte corpulence, après quatre séries d'injections de BOTOX, représentant au total 1800 U (pour spasmes du cou et du dos et douleurs intenses) sur une période de 11 semaines.
0.1055660992860794 ||| au EU/ 1/ 99/ 128/ 003 ||| er EU/ 1/ 99/ 128/ 036 ||| us EU/ 1/ 99/ 128/ 003
0.0008789419662207365 ||| 162 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 172 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 174 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTERIEUR OU, EN L’ABSENCE D’EMBALLAGE EXTERIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.3644995093345642 ||| Somatropin induces hepatic LDL cholesterol receptors, and affects the profile of serum lipids and lipoproteins. ||| Mangafodipir can cause transient increases of bilirubin and liver transaminases and transient decreases in plasma zinc. ||| La somatropine est un inducteur des récepteurs hépatiques du LDL-cholestérol, et modifie le profil des lipides et des lipoprotéines sériques.
0.173383891582489 ||| Based on in vitro studies, palonosetron does not inhibit or induce cytochrome P450 isoenzyme at clinically relevant concentrations. ||| Results from in vitro and in vivo studies show that rosuvastatin is neither an inhibitor nor an inducer of cytochrome P450 isoenzymes. ||| Sur la base des études in vitro, le palonosétron n'est ni inducteur ni inhibiteur de l'isoenzyme du cytochrome P450 aux concentrations cliniques.
0.30826908349990845 ||| Insurance services relating to contingency planning ||| Financing services relating to maternity care ||| Services d'assurance concernant les plans de contingence
0.14714357256889343 ||| • 11.06.2001 • 07.09.2001 • 89 days ||| • 24.08.2001 • 21.11.2001 • 90 days ||| 25.05.2001 11.06.2001 07.09.2001 89 jours
0.11349467933177948 ||| 6.6 Special precautions for disposal ||| 6.6 Special precautions for disposal in ||| 6.6 Instructions pour l'utilisation, la manipulation et l' élimination
0.347189724445343 ||| 1 pre-filled syringe of 0.6 ml solution for injection 6 pre-filled syringes of 0.6 ml solution for injection ||| Solution for injection in a single use pre-filled syringe 1 pre-filled syringe 7 pre-filled syringes 28 pre-filled syringes ||| 1 seringue préremplie de 0,6 ml de solution injectable 6 seringues préremplies de 0,6 ml de solution injectable
0.3269883990287781 ||| Cases fitted with dissecting instruments [microscopy] ||| Insulated bottles [flasks] for laboratory use ||| Trousses de dissection garnies [microscopie]
0.4269590973854065 ||| Pressure controllers [regulators] for gas pipes ||| Water regulating valves [regulating accessories] ||| Pressostats pour canalisations de gaz [régulateurs]
0.398262083530426 ||| The company that makes Januvia has agreed that its scientific data can be used for TESAVEL. ||| The company that makes Inovelon will closely monitor the safety of the medicine. ||| La société qui fabrique Januvia a donné son accord pour que ses données scientifiques soient utilisées pour TESAVEL.
0.23866987228393555 ||| Important information about some of the ingredients of Effentora Each tablet of Effentora 100 micrograms contains 8 mg of sodium. ||| Important information about some of the ingredients of AMMONAPS One small spoon of AMMONAPS granules contains 118 mg of sodium. ||| Informations importantes concernant certains composants d’ Effentora Chaque comprimé d’ Effentora 100 microgrammes contient 8 mg de sodium.
0.6432211995124817 ||| Financial guarantee services ||| Credit risk insurance ||| Services de garanties financières
0.08281968533992767 ||| What Silgard looks like and contents of the pack ||| What Zerene looks like and contents of the pack ||| 70 Qu'est ce que Silgard et contenu de l’emballage extérieur
0.27897924184799194 ||| This may be due to an infection as a result of having low levels of white blood cells. • Chest pain or shortness of breath which may be accompanied with a fever. ||| In some cases you may need a blood transfusion. • Unusual bruising or bleeding, caused by a decrease in the number of clotting cells in the blood. ||| Ceci peut être dû à une infection résultant du nombre réduit de globules blancs. • Douleur dans la poitrine ou essoufflement, pouvant s’accompagner de fièvre.
0.2010153979063034 ||| If you have an allergic reaction, stop taking Januvia and call your doctor right away. ||| If you have an allergic reaction after taking Xolair, contact a doctor as soon as you can. ||| Si vous avez une réaction allergique, arrêtez de prendre Januvia et contactez immédiatement votre médecin.
0.21340888738632202 ||| The absolute bioavailability has not been determined. ||| The absolute bioavailability is not known. ||| La biodisponibilité absolue n'a pas été déterminée.
4.855570156017674e-13 ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse events. ||| Patients with chronic hepatitis B or C and treated with combination antiretroviral therapy are at an increased risk for severe and potentially fatal hepatic adverse events. ||| Les patients atteints d’une hépatite chronique B ou C et traités par association d'antirétroviraux présentent un risque accru de développer des évènements indésirables hépatiques sévères et potentiellement fatals.
0.35022473335266113 ||| The maximum recommended dose is 100 mg. ||| The minimum effective oral dose is approximately 0.6 mg. ||| La dose maximale recommandée est de 100 mg.
4.2073416690706356e-13 ||| Irbesartan BMS should not be given to children and adolescents (under 18 years). ||| Irbesartan BMS should not be given to children and adolescents (under 18 years). ||| Irbesartan BMS ne doit pas être donné aux enfants et adoslecents (de moins de 18 ans).
0.0 ||| Fold used patches and discard or return to the pharmacy. ||| Fold used patches and discard or return to the pharmacy. ||| 69 Plier les dispositifs utilisés et les jeter ou les rapporter à la pharmacie.
0.01655927486717701 ||| What Karvezide looks like and contents of the pack Karvezide 150 mg/ 12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side. ||| What Karvezide looks like and contents of the pack Karvezide 150 mg/ 12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side. ||| A quoi ressemble Karvezide et contenu de l'emballage extérieur Les comprimés pelliculés de Karvezide 150 mg/ 12,5 mg sont pêche, biconvexes, de forme ovale, avec un coeur gravé d'un coté et le numéro 2875 gravé sur l'autre coté.
0.39823946356773376 ||| From policies to strengthen health systems and the world economy to addressing the effects of lockdown and restrictions on travel, the digital hub includes a Country Policy Tracker, and aims to help countries learn from each other and to facilitate a co-ordinated global response to the coronavirus challenge. ||| Promoting international cooperation: Over the last two years, the Commission has stepped up bilateral, regional and multilateral dialogue, fostering a global culture of respect for privacy and convergence between different privacy systems to the benefit of citizens and businesses alike. ||| Entre politiques de renforcement des systèmes de santé et de l’économie mondiale et réponses aux effets du confinement et des restrictions de déplacement, la plateforme numérique inclut un outil Country Policy Tracker visant à aider les pays à apprendre les uns des autres et à faciliter une réponse mondiale coordonnée au défi que pose le coronavirus.
0.4381955862045288 ||| Patients are advised not to drive, operate complex machinery or engage in other potentially hazardous activities until it is known whether this medication affects their ability to perform these activities. ||| Behavior change programs that are usually focused on activities that help a person or a community to reflect upon their risk behaviors and change them to reduce their risk and vulnerability are known as interventions. ||| Il est donc conseillé aux patients de ne pas conduire, de ne pas utiliser de machines complexes ni d’entreprendre d'autres activités potentiellement dangereuses, avant d’avoir évalué l’impact éventuel de ce médicament sur leur capacité à effectuer ces activités.
0.25915905833244324 ||| Since limited data are available across all hepatic impairment groups and across all renal impairment groups, caution is advised in the use of TRISENOX in patients with hepatic and/ or renal impairment. ||| Renal and hepatic impairment Due to increased exposure in moderate renal and mild to moderate hepatic impairment, dosing recommendations to titrate according to individual tolerability should be closely followed (see section 5.2). ||| Les données disponibles chez les patients souffrant d’ insuffisance hépatique et d’ insuffisance rénale, quelque soit leur degré, étant limitées, il est recommandé d’ utiliser TRISENOX avec prudence chez ces patients.
0.5503726005554199 ||| Oral supplementation with vitamin D has no effect on strontium exposure. ||| IGF-1 has inhibitory effects on insulin secretion. ||| La supplémentation orale en vitamine D n’ a pas d’ effet sur l’ exposition au strontium.
0.6619575023651123 ||| Cyanokit is to be administered together with appropriate decontamination and supportive measures. ||| Phasing-out confinement requires accompanying measures, including: ||| Cyanokit doit être administré en association aux mesures de décontamination et de soutien appropriées.
0.0 ||| Information on the prescription status of this product may be found on the label/ outer package. ||| Information on the prescription status of this product may be found on the label/ outer package. ||| Pour toute information relative à la prescription de ce produit, veuillez consulter l’ étiquetage/ emballage extérieur.
0.30834296345710754 ||| Oral use Read the package leaflet before use. ||| Read the package leaflet and pen user manual before use. ||| Lire la notice avant utilisation.
0.3107835650444031 ||| Immunogenicity following concomitant administration In a double-blind, controlled clinical trial, 762 adults 50 years of age and older were randomized to receive a single dose of ZOSTAVAX administered either concomitantly (N=382) or nonconcomitantly (N=380) with inactivated split influenza vaccine. ||| Predictability of response and non-response – treatment-experienced patients In non-responder patients re-treated for 48 or 72 weeks, viral suppression at week 12 (undetectable HCV RNA defined as < 50 IU/ mL) has been shown to be predictive for sustained virological response. ||| Immunogénicité lors d'une administration concomitante Dans une étude clinique contrôlée en double aveugle, 762 adultes de 50 ans et plus ont été randomisés pour recevoir une dose de ZOSTAVAX administrée de façon concomitante (n= 382) ou non concomitante (n= 380) avec un vaccin grippal inactivé à virion fragmenté.
0.01702140085399151 ||| 88 Lactation: studies in rats have demonstrated that efavirenz is excreted in milk reaching concentrations much higher than those in maternal plasma. ||| Lactation: studies in rats have demonstrated that efavirenz is excreted in milk reaching concentrations much higher than those in maternal plasma. ||| Des études sur les rats ont montré que l'éfavirenz passait dans le lait maternel et y atteignait des concentrations bien supérieures à celles retrouvées dans le plasma maternel.
0.4160204827785492 ||| 153 Indications ||| 48 Investigations ||| Indications
0.47254303097724915 ||| Rare • Myocardial infarct ||| Oedema peripheral Pyrexia Pain ||| Rare • Infarctus du myocarde
0.5709704160690308 ||| Bill payment services provided through a website ||| Secretarial services provided by hotels ||| Services de paiement de factures via un site Web
2.7398363525860114e-13 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu ||| Une information détaillée sur le médicament est disponible sur le site de l’ Agence Européenne du médicament(EMEA): http: / /www. emea. europa. eu
0.4779740273952484 ||| HOW TO USE Fentanyl-ratiopharm ||| HOW TO STORE Filgrastim ratiopharm ||| COMMENT UTILISER FENTANYL-RATIOPHARM
0.42592933773994446 ||| Some of these articles said BGI Group from China sold genetic information of the Chinese people to the US, with the US then being able to deploy the virus specifically targeting the genome of Chinese individuals. ||| The company also presented evidence from the published scientific literature on patients treated in the United States of America (USA), where the medicine has been approved as a medical device for spine fusion since 2004. ||| Certains de ces articles affirment que le Beijing Genomics Institute a vendu des informations génétiques des habitants chinois aux États-Unis, ceux-ci étant alors en mesure de déployer le virus ciblant spécifiquement le génome d'individus chinois.
0.2747655510902405 ||| A higher rate of local reactions has been observed in children older than 24 months of age compared with infants (see section 4.8). ||| The incidence of symptoms observed in subjects over 60 years of age was lower as compared to the 18-60 years old population. ||| Un taux plus élevé de réactions locales a été observé chez les enfants de plus de 24 mois par rapport aux nourrissons (voir rubrique 4.8).
0.25202643871307373 ||| 79 Although there is elimination of radioactivity in urine after administration of radiolabelled etanercept to patients and volunteers, increased etanercept concentrations were not observed in patients with acute renal or hepatic failure. ||| In patients with impaired liver function, the metabolism of ramipril to ramiprilat was delayed due to diminished activity of hepatic esterases, and plasma ramipril levels in these patients were increased. ||| Bien que l’ on détecte de la radioactivité dans les urines après l’ administration d’ etanercept radiomarqué à des patients et à des volontaires sains, aucune augmentation des concentrations d’ etanercept n’ a été observée chez les patients présentant une insuffisance rénale ou hépatique aiguë.
0.3477754592895508 ||| This article covers revenue from programmes carried out jointly with other regulatory agencies (inside and outside the EU), pharmaceutical companies or other bodies authorised by the EMEA's Management Board. ||| Evaluations by the EMEA for centrally authorised medicines are recognised by the national authorities of central and eastern European countries through a simplified procedure at the request of the EU marketing authorisation holder. ||| 0.— Cet article est destiné à recevoir les revenus provenant de programmes menés conjointement avec d'autres agences de régulation (à l'intérieur comme à l'extérieur de l'UE), des sociétés pharmaceutiques ou d'autres organes agréés par le conseil d'administration de l'Agence.
0.5214999914169312 ||| Patients were randomized to receive either ViraferonPeg (100 or 150 µg /week based on weight) plus ribavirin (800-1,200 mg/day based on weight) or interferon alfa-2b (3 MIU TIW) plus ribavirin (800-1,200 mg/day based on weight). ||| Rebetol (800 mg) + peginterferon alfa-2b (1.5 micrograms/kg) Rebetol (1,000/1,200 mg) + peginterferon alfa-2b (1.5 to 0.5 microgram/kg) Rebetol (1,000/1,200 mg) + interferon alfa-2b (3 MIU) ||| Les patients étaient randomisés pour recevoir soit ViraferonPeg (100 ou 150 µg/ semaine, adapté en fonction du poids) en association avec de la ribavirine (800-1 200 mg/ jour, adaptée en fonction du poids) soit de l’ interféron alfa-2b (3 MUI trois fois par semaine) en association avec de la ribavirine (800-1 200 mg/ jour, adaptée en fonction du poids).
0.8873608112335205 ||| Remember to take your medicine. ||| pregnant because of how your medicine works. ||| N’ oubliez pas de prendre votre médicament.
0.45794057846069336 ||| Granules ||| Sulkies ||| granulés
0.08402407169342041 ||| 49 Member State ||| 48 Member State ||| 49 État membre
0.4686000347137451 ||| EMEA also made progress in improving transparency with the early publication of information on opinions adopted by our scientific committees. ||| Additional guidance for companies seeking scientific advice was developed in 2000 and made available on the EMEA web site. ||| L’ Agence a également amélioré la transparence de ses opérations par une publication plus précoce des avis de ses comités scientifiques.
0.5712950229644775 ||| Oral lyophilisate ||| agranulocytosis ||| lyophilisat oral
0.3601081371307373 ||| STRONGHOLD treatment was found to be effective after a single administration or repeated treatments at monthly intervals, depending on the type of infestation it was being used to treat or prevent. ||| Injection site reactions may be worse when injections are repeated in the same place on the body, or when the injection is given deeper than intended (for example, into a muscle). ||| Le traitement STRONGHOLD s’est avéré efficace après une seule administration ou après des traitements répétés à des intervalles d’un ou plusieurs mois, selon le type d’infestation que ce médicament devait traiter ou prévenir.
0.8292919397354126 ||| (Y) GBq/ vial ||| (w/ v) solution (ml) ||| (Y) GBq/ flacon
0.28159844875335693 ||| Although no studies have been conducted with Caelyx, doxorubicin hydrochloride, the pharmacologically active ingredient of Caelyx, is mutagenic and carcinogenic. ||| Folinic acid: a combination study with Xeloda and folinic acid indicated that folinic acid has no major effect on the pharmacokinetics of Xeloda and its metabolites. ||| Bien qu'aucune étude n'ait été conduite avec Caelyx, le chlorhydrate de doxorubicine, substance pharmacologiquement active de Caelyx, est mutagène et cancérogène.
0.6630822420120239 ||| The full EPAR for Myocet can be found here. ||| What information is still awaited for BeneFIX? ||| L’ EPAR complet pour Myocet est disponible ici.
0.6638746857643127 ||| The full EPAR for Intelence can be found here. ||| Proof of EU solidarity is easy to find. ||| L’ EPAR complet relatif à Intelence est disponible ici.
0.21598657965660095 ||| 40 mg/ day (1 dose) ||| 160 mg/ day (3 doses) ||| 40 mg/jour (3 prises)
0.21608245372772217 ||| Uncommon side effects are skin reactions at the injection site, such as redness, pain and swelling. ||| Local hypersensitivity reactions (redness, swelling and itching at the injection site) may occur during treatment with insulin. ||| Les effets indésirables peu fréquents sont des réactions cutanées au point d’ injection telles que rougeur, douleur et gonflement.
0.4128133952617645 ||| Taking these data into consideration, rufinamide should not be used during pregnancy unless clearly necessary and in women of childbearing age not using contraceptive measures. ||| Partner of patient information card should include the following information: • That Thelin is teratogenic and that women of child bearing age must use effective contraception ||| En prenant en considération ces données, le rufinamide ne doit pas être administré pendant la grossesse ainsi que chez les femmes en âge de procréer n’ utilisant pas de moyen de contraception à moins d'une nécessité absolue.
0.03799964487552643 ||| Prandin should be taken with caution. • If you are about to have major surgery or you have recently suffered a severe illness or infection. ||| NovoNorm should be taken with caution. • If you are about to have major surgery or you have recently suffered a severe illness or infection. ||| Prandin doit être pris avec prudence. • si vous allez subir une intervention chirurgicale importante ou si vous avez récemment souffert d’ une infection ou maladie grave.
0.006308258511126041 ||| 2 Elderly Dosing recommendations for elderly patients with normal renal function (≥ 80 ml/ min) are the same as for adults with normal renal function. ||| 42 Elderly Dosing recommendations for elderly patients with normal renal function (≥ 80 ml/ min) are the same as for adults with normal renal function. ||| Patient âgé Les recommandations posologiques chez les patients âgés ayant une fonction rénale normale (> 80ml/ min) sont identiques à celles des adultes avec fonction rénale normale.
0.2685432434082031 ||| If are prescribed for a patient receiving lithium therapy, lithium levels should be monitored closely. ||| In the event of hypocalcaemia, calcium gluconate infusions should be administered as clinically indicated. ||| Chez un patient traité par le lithium, l'administration de impose une surveillance étroite de la lithémie.
0.1445213258266449 ||| 297 5. ||| 285 2. ||| 5.
0.35330426692962646 ||| 30 million IU ||| 100000 IU ||| 30 millions
0.5528135895729065 ||| As a result of these changes the ratios of total- to HDL-C and LDL- to HDL-C are reduced. ||| The Cmin, Cmax and AUC0-24 were all significantly higher with the BID regimen compared with the TID regimen. ||| Il en résulte une diminution des rapports cholestérol total/HDL-cholestérol et LDL-cholestérol/HDL-cholestérol.
0.6803812384605408 ||| Straw ||| Chalk ||| Paille
0.3187580406665802 ||| If there is lasting irritation, a doctor should be consulted. ||| If such reactions occur, a physician must immediately be consulted. ||| Si l’irritation perdure, un médecin doit être consulté.
0.2682989835739136 ||| The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| If the solution appears cloudy, particles are observed or if there is evidence of damage to the syringe, or if the plastic clip is missing or not attached to the syringe, Macugen should not be used. ||| Examinez les cartouches régulièrement et ne pas les utiliser si la suspension présente des grumeaux ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.10863182693719864 ||| Manufacturer AstraZeneca UK Limited Silk Road Business Park Macclesfield Cheshire SK10 2NA United Kingdom ||| AstraZeneca UK Limited Silk Road Business Park Macclesfield Cheshire SK10 2NA United Kingdom ||| Nom du fabricant AstraZeneca UK Limited Silk Road Business Park Macclesfield Cheshire
0.2819388508796692 ||| The recommended dose of Avastin is 10 mg/ kg of body weight given once every 2 weeks or 15 mg/ kg of body weight given once every 3 weeks as an intravenous infusion. ||| Twice daily intravenous administration of 15 mg/ kg bodyweight, or 10 mg/ kg bodyweight three times daily (maximum of 1200 mg per day), then twice daily oral administration. ||| Avastin est recommandé à la posologie de 10 mg/ kg de poids corporel administré une fois toutes les 2 semaines ou à la posologie de 15 mg/ kg de poids corporel, administré une fois toutes les 3 semaines, en perfusion intraveineuse.
0.4099772870540619 ||| One patient experienced life-threatening dyspnoea and the others had no notable complications. ||| All of them had live birth pregnancies and no severe neonatal asphyxia was observed. ||| Les autres patients n'ont pas eu de complications notables.
3.818703708281801e-13 ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| é Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment
0.5927456021308899 ||| 2 151 000 ||| 12 170 0 ||| 151 000
0.18272539973258972 ||| 2/ 14 ||| 3/ 14 ||| 3/ 14
0.23596122860908508 ||| Portugal GlaxoSmithKline – Produtos Farmacêuticos, Lda Tel: + 351 21 412 95 00 FI.PT@gsk.com ||| Tel.: + 48 (0)22 576 9000 Portugal GlaxoSmithKline – Produtos Farmacêuticos, Lda. ||| Portugal GlaxoSmithKline – Produtos Farmacêuticos, Lda Tel: + 351 21 412 95 00 FI. PT@gsk. com
0.394377201795578 ||| AUC: ↓ 31% (↓ 8 to ↓ 47) Cmin: ↓ 40% A similar reduction in indinavir exposures was observed when indinavir 1.000 mg q8h was given with efavirenz 600 mg daily. ||| ORR was superior in patients with any 11q deletion (87% v 29%; p < 0.0001) or sole deletion 13q (91% v 62%; p=0.0087) treated with MabCampath compared to chlorambucil. ||| Cmin: ↓ 40% Une baisse similaire de l’ exposition à l’ indinavir a été observée lorsque 1000 mg d’ indinavir ont été administrés toutes les 8 heures avec 600 mg d’ efavirenz par jour.
0.2551310658454895 ||| The efficacy of venlafaxine immediate-release as a treatment for major depressive episodes was demonstrated in five randomised, double-blind, placebo-controlled, short-term trials ranging from 4 to 6 weeks duration, for doses up to 375 mg/ day. ||| Undesirable effects (moderate to severe) were reported from 467 patients treated with Zerit in combination with lamivudine and efavirenz in two randomised clinical trials and an ongoing long-term follow-up study (total follow-up: median 56 weeks ranging up to 119 weeks). ||| L’ efficacité de la venlafaxine à libération immédiate dans le traitement des épisodes dépressifs majeurs a été démontrée dans cinq études à court terme, de 4 à 6 semaines, contrôlées contre placebo, en double insu, randomisées, et à des posologies allant jusqu’ à 375 mg/ jour.
0.2399718314409256 ||| Hold the solvent vial, placed on a flat surface, with one hand and connect the tip of the syringe to the vial adapter by twisting the syringe on the vial adapter clockwise (Fig. ||| To prepare the IntronA solution insert the needle through the rubber top of the IntronA vial and gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands. ||| Tenir le flacon de solvant, positionné sur une surface plane, avec une main et assembler l’extrémité de la seringue à l’adaptateur en vissant la seringue sur l’adaptateur pour flacon dans le sens des aiguilles d’une montre (Fig.
0.5880094766616821 ||| Packs of 100 film-coated tablets are also available for hospital use. ||| In Salvador, local shops experienced shortages of masks and hand sanitizer. ||| Des boîtes de 100 comprimés sont également disponibles pour l’ usage hospitalier.
0.28878089785575867 ||| The effect of atorvastatin on fatal and non-fatal coronary heart disease was assessed in a randomized, double-blind, placebo-controlled study, the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA). ||| In an open-label study carried out by the Cancer and Leukaemia Group B and the Southwest Oncology Group, the safety and efficacy of nelarabine were evaluated in 39 adults with T-cell acute lymphoblastic leukaemia (T-ALL) or lymphoblastic lymphoma (T-LBL). ||| L'effet de l'atorvastatine sur les événements coronaires mortels et non mortels a été évalué dans une étude randomisée, en double-aveugle, contrôlée versus placebo, l'étude Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA).
0.6641955375671387 ||| The EU is currently importing 58% of its energy needs, mostly in the form of oil and gas. ||| Internet banking and shopping are also more popular, being used by 66% and 71% of internet users respectively. ||| L'UE importe actuellement 58 % de ses besoins énergétiques, principalement sous forme de pétrole et de gaz.
0.3538781404495239 ||| What is DaTSCAN? ||| What is NEVANAC? ||| Qu’ est -ce que DaTSCAN?
0.5176948308944702 ||| 73.9, 85.3) in the combined protocols at end of study. ||| 56, 95, per-protocol analysis) for the initial 6 months of follow-up. ||| 73,9 - 85,3) dans les protocoles combinés à fin d'étude.
0.07167720794677734 ||| Film-coated tablets 75 mg 3 presentations ||| Film-coated tablet 200 mg 4 presentations ||| Comprimés pelliculés 75 mg 3 Présentations
0.0821211189031601 ||| Keep the vial in the outer carton in order to protect from light ||| Keep the injection vial in the outer carton in order to protect from light ||| Conserver le flacon dans l'emballage extérieur à l’abri de la lumière.
0.2027634084224701 ||| - Liver transplantation ||| Liver transplantation: ||| - Transplantation hépatique
0.8376483917236328 ||| (N = 52) ||| t½ (h) ||| Topotecan oral (N = 52) 32,3
0.20552007853984833 ||| Adults The most frequently (seen in 1% of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, ||| Infusion reactions, allergic-like reactions and hypersensitivity Serious adverse reactions to Herceptin infusion that have been reported infrequently include dyspnoea, hypotension, wheezing, hypertension, bronchospasm, supraventricular tachyarrythmia, reduced oxygen saturation, anaphylaxis, respiratory distress, urticaria and angioedema (see 4.8). ||| Adultes Les effets indésirables les plus fréquemment rapportés (1% des patients) au cours des essais cliniques ont été: somnolence, prise de poids, éosinophilie, augmentation des taux de prolactine, de cholestérol, de la glycémie et de la triglycéridémie (voir rubrique 4.4), glucosurie, augmentation de l 'appétit, sensation vertigineuse, akathisie, parkinsonisme (voir rubrique 4.4), dyskinésie, hypotension orthostatique, effets anticholinergiques, élévations transitoires asymptomatiques des enzymes hépatiques (voir rubrique 4.4), rash, asthénie, fatigue et œ dème.
0.69852614402771 ||| Package sizes ||| Package size 28 capsules ||| Taille de l’ emballage
0.14585986733436584 ||| Vial containing the powder of your medicine ||| Vial containing the solution of your medicine ||| Flacon contenant le médicament en poudre
0.40531349182128906 ||| For intramuscular use after reconstitution with solvent. ||| For subcutaneous use after reconstitution. ||| Pour voie intramusculaire après reconstitution avec le solvant.
0.4460364580154419 ||| Corrugated polypropylene sheets [roofing material] ||| Polyethylene synthetic resin [unprocessed] for foam mouldings ||| Plaques ondulées en polypropylène [matériau de couverture]
0.29317304491996765 ||| This overfill ensures that after dilution with the entire contents of the accompanying solvent for Docetaxel Winthrop vial, there is a minimal extractable premix volume of 2 ml containing 10 mg/ ml docetaxel which corresponds to the labelled amount of 20 mg per vial. ||| • Withdraw 1.8 ml of the supplied diluent. • Inject the 1.8 ml of extracted diluent into the vial of TORISEL 25 mg/ ml concentrate, which contains 30 mg of temsirolimus (1.2 ml of concentrate). • Mix the diluent and the concentrate well by inversion of the vial. ||| Ce surremplissage permet d'assurer qu'après dilution avec la totalité du flacon de solvant accompagnant le flacon de Docétaxel Winthrop que le volume minimal extractible de prémélange de 2 ml contient 10 mg/ ml de docétaxel, ce qui correspond à la quantité indiquée de 20 mg par flacon.
0.20832881331443787 ||| Slicing machines (Electric -) for kitchen use ||| Kitchen machines (Electric -) for cooking ||| Machines à trancher électriques pour la cuisine
0.34265100955963135 ||| - pain in the joints ||| pain in the muscles and ||| - douleurs articulaires
0.34189969301223755 ||| The use of Rebetol and interferon alfa-2b in children and adolescents with existence of or history of severe psychiatric conditions is contraindicated (see section 4.3). ||| Ribavirin is embryotoxic or teratogenic, or both, at doses well below the recommended human dose in all animal species in which studies have been conducted. ||| L’ utilisation de Rebetol et de l’ interféron alfa-2b chez les enfants et adolescents présentant ou ayant des antécédents de troubles psychiatriques sévères est contre- indiquée (voir rubrique 4.3).
0.4559992849826813 ||| Do not use in pregnant or lactating dogs. ||| Must not be given to premature babies or neonates. ||| Ne pas administrer aux femelles gestantes ou allaitantes.
0.4042574167251587 ||| Suspension for injection in pre-filled syringe. ||| Preparing the syringe and needle for injection ||| Suspension injectable en seringue préremplie.
0.04017753154039383 ||| LEO Pharma A/S Industriparken 55 DK-2750 Ballerup Denmark ||| LEO Pharma A/ S Industriparken 55 DK-2750 Ballerup Denmark ||| LEO Pharma A/ S Industriparken 55 DK-2750 Ballerup Danemark
0.3018767833709717 ||| The proposed broadening of the scope of the Temporary Framework to aid in the form of recapitalisations complements the possibility of Member States to purchase existing shares of companies at market price or pari passu with private shareholders, which in principle falls outside the scope of EU State aid control. ||| (v) Prohibition of cross-subsidisation and acquisition ban: To ensure that beneficiaries do not unduly benefit from the recapitalisation aid by the State to the detriment of fair competition in the Single Market, they cannot use the aid to support economic activities of integrated companies that were in economic difficulties prior to 31 December 2019. ||| L'extension proposée du champ d'application de l'encadrement temporaire pour inclure les aides sous forme de recapitalisations s'ajoute à la possibilité pour les États membres de racheter les parts existantes des entreprises au prix du marché ou pari passu avec des actionnaires privés, ce qui, en principe, ne relève pas du champ d'application du contrôle des aides d'État de l'UE.
2.9838566513451514e-13 ||| Based on evidence for a primarily hepatic/ biliary elimination of photoactive substances, severity of phototoxic reactions and duration of the period of photosensitivity in patients with any grade of hepatic impairment may be increased. ||| Based on evidence for a primarily hepatic/ biliary elimination of photoactive substances, severity of phototoxic reactions and duration of the period of photosensitivity in patients with any grade of hepatic impairment may be increased. ||| 6 hépatique/ biliaire des substances photoactives, la sévérité des réactions de phototoxicité et la durée de la période de photosensibilité peuvent être augmentées chez les patients ayant une quelconque altération de la fonction hépatique.
0.823824405670166 ||| Hepatic failure: ||| Psoriasis Study 1 ||| Insuffisance hépatique:
0.25653111934661865 ||| Efficacy of Xolair treatment in combination with specific immunotherapy has not been established. ||| Concomitant use of Neulasta with any chemotherapy agent has not been evaluated in patients. ||| L’ efficacité du traitement par Xolair administré en association avec une immunothérapie spécifique n’ a pas été établie.
0.026097562164068222 ||| 673 Travel ||| 653 Travel ||| Voyages
0.47250938415527344 ||| Like all medicines, ZYPREXA VELOTAB can cause side effects, although not everybody gets them. ||| However, M-M-RVAXPRO may not always be able to prevent measles developing in these cases. ||| Comme tous les médicaments, ZYPREXA VELOTAB est susceptible d’ avoir des effets indésirables, bien que toutes les personnes n’ y soient pas sujettes.
0.16910870373249054 ||| As palonosetron may increase large bowel transit time, patients with a history of constipation or signs of subacute intestinal obstruction should be monitored following administration. ||| Since renal dysfunction may decrease the rate of elimination of dexrazoxane, patients with initial impaired renal function should be monitored for signs of haematological toxicity. ||| Comme le palonosétron peut augmenter le temps de transit colique, les patients ayant des antécédents de constipation ou des signes d'occlusion intestinale subaiguë doivent faire l'objet d'une surveillance après l'administration d'Aloxi.
0.3210514783859253 ||| The European Commission has also unlocked €1 billion from the European Fund for Strategic Investments, that will allow the European Investment Fund to issue guarantees to encourage banks and other lenders to provide up to €8 billion of liquidity in support to some 100,000 European businesses. ||| With provisioning in the EU budget of €5billion from the current financial framework in 2020 to ensure a fast start and an additional €26 billion from Next Generation EU, the Union budget will provide a guarantee of about €75billion to the European Investment Bank Group, which will ensure rapid delivery on the ground. ||| La Commission européenne a débloqué 1 milliard d'euros au titre du Fonds européen pour les investissements stratégiques (EFSI), qui servira de garantie au Fonds européen d'investissement (FEI), faisant partie du Groupe Banque européenne d'investissement.
0.07964591681957245 ||| - if you are allergic (hypersensitive) to tipranavir or any of the other ingredients of APTIVUS ||| - if you are allergic (hypersensitive) to fulvestrant or to any of the other ingredients of Faslodex ||| - si vous êtes allergique (hypersensible) au tipranavir ou à l'un des autres composants contenus
0.7190089225769043 ||| Diapered linen ||| Washing of linen ||| Linge ouvré
0.47855865955352783 ||| (angiooedema), severe allergic reaction (anaphylactic shock) which can be life -threatening (see Section 2: ||| - severe sometimes life-threatening reactions (Stevens-Johnson syndrome, toxic epidermal ||| muqueuses (œdème de Quincke), choc anaphylactique [brusque glonflement du visage et du cou avec des difficultés respiratoires] pouvant mettre la vie du patient en danger (voir rubrique 2:
0.4533267021179199 ||| Sodium starch glycollate, Povidone (K30), Magnesium stearate. ||| Hypromellose, Macrogol, Titanium dioxide. ||| Glycolate d’ amidon de sodium, Povidone (K30) Stéarate de magnésium
0.514372706413269 ||| Transmission of data by radiopaging ||| Transmission of information by electronic means ||| Transmission de données par radiomessagerie
0.259070485830307 ||| If you are over 65 years of age your doctor may monitor your health more closely. ||| As a routine precaution, if you are over 65 years your doctor may monitor your blood pressure. ||| Si vous avez plus de 65 ans, votre médecin pourra surveiller plus étroitement votre état de santé.
0.4431995153427124 ||| While these effects are generally reversible, in a few patients full resolution took up to three weeks. ||| In severe cases, these effects may interfere with certain daily activities, and may last for 4 weeks or longer before resolving completely. ||| Bien que ces effets soient généralement réversibles, chez certains patients il a fallu jusqu’ à trois semaines pour arriver à
0.3408440351486206 ||| During the concomitant phase, your doctor will start Temodal at a dose of 75 mg/m2 (usual dose). ||| At the beginning of your infusion you will receive Flebogammadif at a slow rate (0.01-0.02 ml/ kg/ min). ||| Durant la phase concomitante, votre médecin débutera Temodal à la dose de 75 mg/ m2 (dose usuelle).
0.33163395524024963 ||| If this is not possible the doses of SUTENT may need to be reduced to a minimum of 37.5 mg daily, based on careful monitoring of the tolerability. ||| Unless the applicant can show convincing data on satisfactory safety with the exposures obtained, it is recommended that a dose reduction of 50% is made. ||| Si cela n’ est pas possible, la dose de SUTENT pourra être diminuée jusqu’ à une dose minimale de 37,5 mg par jour, sous étroite surveillance de la tolérance.
0.2838188707828522 ||| Non-woven fabrics made substantially of paper ||| Non-woven fabrics of natural fibres ||| Étoffes non tissées essentiellement en papier
0.47997504472732544 ||| In addition, it is recommended to treat the environment with a suitable insecticide. ||| In such cases, it is recommended that a specialised haemophilia centre be contacted. ||| Il est de plus recommandé de traiter l’ environnement avec un insecticide approprié.
0.49181148409843445 ||| Photosensitivity reactions (see section 4.4) ||| See section 5.3 (reproductive toxicology) ||| Exacerbation des symptômes de myasthénie (voir rubrique 4.4)
0.28738218545913696 ||| 4 Any patient experiencing severe rash or a rash accompanied by constitutional symptoms such as fever, blistering, oral lesions, conjunctivitis, facial oedema, muscle or joint aches, or general malaise should discontinue the medicinal product and immediately seek medical evaluation. ||| All patients and parents/ caregivers should be advised that if the patient develops signs and symptoms suggestive of blood dyscrasias or infections (e. g. persistent fever, sore throat, bruising, bleeding, paleness) whilst on Enbrel, they should seek immediate medical advice. ||| En cas de survenue d'une éruption cutanée, sévère ou s'accompagnant de signes généraux (par exemple fièvre, phlyctènes, lésions buccales, conjonctivite, œ dème de la face, douleurs musculaires ou articulaires, malaise général), le patient doit interrompre le traitement et consulter immédiatement un médecin.
0.05176438018679619 ||| Use of hormonal contraceptives did not appear to affect the immune response to Silgard. ||| Use of hormonal contraceptives did not appear to affect the immune response to Gardasil. ||| L’ utilisation de contraceptifs hormonaux ne semble pas modifier la réponse immunitaire à Silgard.
0.29259374737739563 ||| Following oral administration of anagrelide in man, at least 70% is absorbed from the gastrointestinal tract. ||| Animal studies have shown that calcitonin is primarily metabolised via proteolysis in the kidney following parenteral administration. ||| Suite à l’ administration par voie orale d’ anagrélide chez l’ homme, au moins 70% est absorbé par les voies gastro-intestinales.
0.05984426289796829 ||| a) 01.01.95 b) 17.05.95 c) 107 days d) 30 days ||| a) 01.01.95 b) 12.07.95 c) 138 days d) 55 days ||| a) 01.01.95 b) 17.05.95 c) 107 jours d) 30 jours
0.012582482770085335 ||| Pre-treatment with other anti- inflammatory medicines may result in additional or increased adverse effects and accordingly a treatment-free period with such substances should be observed for at least 24 hours before the commencement of treatment with Onsior. ||| Pre-treatment with other anti- inflammatory medicines may result in additional or increased adverse effects and a treatment-free period with such substances should be observed for at least 24 hours before the commencement of treatment with Onsior. ||| En conséquence, une période d’ au moins 24 heures sans traitement devra être observée avant le début du traitement avec Onsior.
0.3982123136520386 ||| Both patients had recently returned from Iran. ||| The person had recently returned from China. ||| Les deux patients étaient récemment revenus d'Iran,.
0.0 ||| 405 11. ||| 405 11. ||| 11.
3.7346628610837596e-13 ||| - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, ||| - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, ||| Si l’un des effets indésirables devient grave ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin ou votre pharmacien.
0.0035888871643692255 ||| 32 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 33 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 34 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.0 ||| {MM/ YYYY} ||| {MM/ YYYY} ||| EXP {MM/ AAAA}
0.1305513083934784 ||| What is the risk associated with Circadin? ||| What is the risk associated with Synagis? ||| Quels sont les risques associés à Circadin?
0.7277746200561523 ||| - skin rash ||| - rash ||| - Eruption cutanée
0.9129778742790222 ||| Table 1 - Dosing for Combination Therapy ||| Article 3 - Rapporteurs and Co-Rapporteurs ||| Tableau 1 – Doses à utiliser en bithérapie
0.4354246258735657 ||| Hepatic transaminase elevations that occur with elevated bilirubin in patients receiving REYATAZ should be evaluated for alternative etiologies. ||| Donors who receive G-CSFs for PBPC mobilisation should be monitored until haematological indices return to normal. ||| Des élévations des transaminases hépatiques associées à des élévations de la bilirubine, chez les patients recevant REYATAZ, doivent faire l'objet d'une recherche d'autres étiologies.
0.3436068296432495 ||| Therefore, the use of Irbesartan Hydrochlorothiazide BMS is not recommended. ||| No specific information is available on the treatment of overdose with Irbesartan Hydrochlorothiazide BMS. ||| En conséquence, l'utilisation de Irbesartan Hydrochlorothiazide BMS n’ est pas recommandée.
0.5261590480804443 ||| Artificial milk based desserts ||| Cosmetic hair dressing preparations ||| Desserts à base de lait artificiel
3.079123598887651e-13 ||| Nespo did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| Nespo did not reveal any genotoxic potential nor did it have any effect on the proliferation of non- haematological cells in vitro or in vivo. ||| 377 L’ utilisation de Nespo n’ a pas permis de mettre en évidence une génotoxicité potentielle ni d’ effet sur la prolifération des cellules non hématologiques in vitro ou in vivo.
0.14351001381874084 ||| The maximum daily dose is 20 mg per day. ||| The recommended maintenance dose is 20 mg per day. ||| La dose maximale est de 20 mg par jour.
0.3014150857925415 ||| Xolair is given to you by a doctor or nurse as an injection just under the skin. ||| Ceftriaxone is normally given by a doctor or nurse It is given as an injection. ||| Xolair vous est administré par un médecin ou une infirmière sous forme d’ une injection juste au- dessous de la peau.
0.39012670516967773 ||| Complementing several already approved national measures, this scheme will support Italian businesses in continuing their operations in these difficult times and help preserve jobs. ||| Moreover, co-financing requirements will be abandoned, as Member States are already using all their means to fight the crisis. ||| Ce régime, qui vient s'ajouter à plusieurs mesures nationales déjà approuvées, aidera les entreprises italiennes à poursuivre leurs activités en ces temps difficiles et aidera à préserver les emplois.
0.3906906247138977 ||| This medicinal product is for single use only, any unused solution should be discarded. ||| Single use only, any unused solution should be disposed of.. ||| Ce médicament est à usage unique, toute solution non utilisée doit être éliminée.
0.0 ||| Primary prevention Reduction of cardiovascular morbidity in males with increased non-HDL cholesterol and at high risk for a first cardiovascular event, particularly when a statin is considered inappropriate or is not tolerated (see section 5.1). ||| Primary prevention Reduction of cardiovascular morbidity in males with increased non-HDL cholesterol and at high risk for a first cardiovascular event, particularly when a statin is considered inappropriate or is not tolerated (see section 5.1). ||| Prévention primaire Réduction de la morbidité cardiovasculaire chez les hommes présentant une élévation du cholestérol non- HDL et à haut risque d'un premier évènement cardiovasculaire, notamment lorsqu'une statine est considérée comme inadéquate ou mal tolérée (voir rubrique 5.1).
0.5480437278747559 ||| Firazyr 30 mg solution for injection pre-filled syringe Icatibant ||| Lopinavir/ ritonavir soft capsules or oral solution/ Efavirenz ||| Firazyr 30 mg solution injectable en seringue pré-remplie Icatibant
0.2773278057575226 ||| The powder and solvent are both contained in a two-chamber cartridge, Type I flint glass, separated by a bromobutyl rubber plunger. ||| The white powder and the clear and colourless solvent are both contained in a two-chamber glass cartridge assembled into a single use pre-filled pen. ||| La poudre et le solvant sont contenus dans une cartouche bicompartimentée, en verre de type I, séparés par un piston en caoutchouc bromobutyle.
0.03837425261735916 ||| Like all medicines, Copalia can cause side effects, although not everybody gets them. ||| Like all medicines, Avandia can cause side effects, but not everybody gets them. ||| Comme tous les médicaments, Copalia est susceptible d'avoir des effets indésirables, bien que tous n’ y soient pas sujets.
0.6830378770828247 ||| - Hepatic impairment. ||| visual impairment, diplopia ||| - Insuffisance hépatique.
0.3989707827568054 ||| Multi-packs containing 90, 98 or 280 tablets. ||| Each bottle contains 30, 120 or 240 tablets. ||| Boîtes de 90, 98 ou 280 comprimés en conditionnements multiples.
0.5950575470924377 ||| Chemical reagents for testing for chlorine ||| Effect on gastric acid secretion: ||| Réactifs chimiques pour l'analyse du chlore
0.43243980407714844 ||| Dompé Biotec S.p.A. ic ||| Österreich Astellas Pharma Ges.m.b.H. ||| Dompé Biotec S.p.A.
8.090126333605563e-13 ||| Solution for ||| Solution for ||| Solution injectable Voie sous-cutanée
0.14427657425403595 ||| OTHER SPECIAL WARNING(S), IF NECESSARY i na ||| OTHER SPECIAL WARNING(S), IF NECESSARY ro lp ||| AUTRE(S) MISE(S) EN GARDE SPECIALE(S) mé
6.360899220542171e-13 ||| Significance level at α =0.05. ||| Significance level at α =0.05. ||| Niveau de significativité à α =0.05.
0.13630488514900208 ||| 0.7%); Fever (G3/ 4: ||| 0.6%); Cough (G3/ 4: ||| 0,7%); Fièvre (G3/ 4:
0.25050318241119385 ||| The measure, with a total budget of €3 billion, aims at limiting the risk associated with issuing or restructuring loans to those companies that are most severely affected by the economic impact of the coronavirus outbreak, ensuring the continuation of activities. ||| To allow airlines to adjust their capacity in view of falling demand caused by the outbreak, and to protect the financial health of airlines as well as the environment, the Commission has made a proposal to introduce a temporary suspension of these slot usage rules. ||| La mesure, dotée d'un budget total de 3 milliards d'€, vise à limiter le risque associé à l'octroi ou à la restructuration de prêts pour les entreprises les plus durement touchées par l'impact économique de la pandémie de coronavirus, en assurant la poursuite de leurs activités.
0.1927265226840973 ||| An increased incidence of wavy ribs was observed in rats in association with reduced maternal body weight parameters, with a no-effect dose of 75 mg/kg (10-fold human exposure). ||| In pregnant rabbits, a maternal dose of 30 mg/ kg that produced slight toxicity in the mothers showed a statistically significant increase in the incidence of litter malformations. ||| Une incidence accrue de côtes ondulées a été observée chez le rat en association avec une diminution du poids corporel maternel, avec une dose sans effet de 75 mg/ kg (soit 10 fois l’ exposition chez l’ Homme).
0.1386958211660385 ||| Purevax RCP FeLV is a lyophilisate (freeze-dried pellet) and solvent that are made up into a suspension for injection. ||| Virbagen Omega is a lyophilisate (freeze dried pellet) and solvent that is made into a suspension for injection. ||| Purevax RCP FeLV se présente sous la forme de lyophilisat et de solvant pour suspension injectable.
0.4639076590538025 ||| Casement windows of metal ||| Street gutters of metal ||| Vasistas métalliques
0.14840932190418243 ||| Important information about some of the ingredients of Retacrit ||| Important information about some of the ingredients of Pergoveris ||| Informations importantes concernant certains composants de Retacrit
0.42512938380241394 ||| How Prepandrix is given 4. ||| How Infanrix Penta is given 4. ||| Comment est administré Prepandrix 4.
0.3689863085746765 ||| More information on the Temporary Framework and other action the Commission has taken to address the economic impact of the coronavirus pandemic can be found here . ||| In particular, the Temporary Framework Communication explains the main criteria that the Commission will follow in assessing these possible cooperation projects. ||| De plus amples informations sur l'encadrement temporaire et les autres mesures prises par la Commission pour faire face à l'impact économique de la pandémie de coronavirus sont disponibles ici .
0.21327120065689087 ||| Sadness, depressed mood; loss of interest in previously pleasurable activities; agitation; irritability; slowed, inhibited actions; poor concentration; anxiety; difficulty in sleeping (insomnia); thoughts or words about death or suicide. ||| For example, dysphoric or depressed mood; insomnia, irritability, frustration or anger; anxiety; difficulty concentrating; restlessness; decreased heart rate; increased appetite or weight gain have been reported in patients attempting to stop smoking. ||| Tristesse; humeur dépressive; perte d’intêret pour les activités que vous aimiez; agitation; irritabilité; activité ralentie, baisse de l’activité; difficultés de concentration; anxiété; troubles du sommeil (insomnies); idées suicidaires.
0.24560585618019104 ||| Patients who have problems with their liver (including hepatitis B or C infection) may be at an elevated risk of liver damage when taking Zerit. ||| A lower dose is recommended for patients with bone metastases (cancer that has spread to the bone) if they have mild to moderate problems with their kidneys. ||| Les patients qui souffrent de troubles du foie (notamment d’ une infection par le virus de l’ hépatite B ou C) peuvent présenter un risque élevé d’ atteinte hépatique en prenant Zerit.
0.42199015617370605 ||| No case of overdose has been reported that has led to acute clinical manifestations. ||| Cases of overdose (some with signs of systemic toxicity) have been reported. ||| 4.9 Surdosage 73 Aucun cas de surdosage ayant conduit à des manifestations cliniques aiguës n’ a été rapporté.
0.3653160333633423 ||| The Commission released today the European Innovation Scoreboard 2020 , which shows that Europe's innovation performance continues to improve across the EU, surpassingfor the second year the United States. ||| Today the Commission released the results of the 2020 Digital Economy and Society Index (DESI), which monitors Europe's overall digital performance and tracks the progress of EU countries with respect to their digital competitiveness. ||| La Commission a publié aujourd'hui le tableau de bord européen de l'innovation 2020 , qui montre que les performances de l'Europe en matière d'innovation continuent de s'améliorer dans l'ensemble de l'UE, dépassant celles des États-Unis pour la deuxième année consécutive.
0.16360370814800262 ||| Contact point Jonna SUNELL-HUET Direct telephone (44-20) 74 18 84 65 E-mail: certificate@emea.eudra.org ||| IQM adviser Marijke KORTEWEG Direct telephone (44-20) 74 18 85 56 E-mail: iqmanagement@emea.eu.int ||| Point de contact Jonna SUNELL-HUET Téléphone direct (44-20) 74 18 84 65 E-mail: certificate@emea.eudra.org
0.26397228240966797 ||| Concomitant treatment with inhibitors of the hepatic CYP 3A4 may result in a decrease of terfenadine metabolism. ||| Nitrofurantoin may impair quinolone efficacy if used concurrently in the treatment of urinary tract infections. ||| Un traitement concomitant par des inhibiteurs du CYP 3A4 hépatique peut se traduire par une diminution du métabolisme de la terfénadine.
0.4462955594062805 ||| The following adverse events have been reported after administration of Menitorix: ||| The following rare and very rare events have been reported with PegIntron: ||| Les effets indésirables suivants ont été rapportés après l’ administration de Menitorix:
0.2440585345029831 ||| Patients receiving immunosuppressive regimens involving combinations of medicinal products, including mycophenolate, are at increased risk of developing lymphomas and other malignancies, particularly of the skin (see section 4.4). ||| Infections and infestations As is well known for other potent immunosuppressive agents, patients receiving tacrolimus are frequently at increased risk for infections (viral, bacterial, fungal, protozoal). ||| Les patients recevant un traitement immunosuppresseur comportant plusieurs médicaments en association dont le mycophénolate, sont exposés à un risque accru de lymphome et d'autres tumeurs malignes, notamment cutanées (voir rubrique 4.4).
0.7736748456954956 ||| Gently push the tablet out. ||| Turn bottle upside down. ||| Pousser doucement sur le comprimé pour le faire sortir.
0.02025805041193962 ||| Herbal preparations containing St John’ s wort (Hypericum perforatum) must not be used while taking APTIVUS due to the risk of decreased plasma concentrations and reduced clinical effects of tipranavir (see section 4.5). ||| Herbal preparations containing St John’s wort (Hypericum perforatum) must not be used while taking PREZISTA due to the risk of decreased plasma concentrations and reduced clinical effects of darunavir (see section 4.5). ||| Les préparations phytothérapeutiques à base de millepertuis (Hypericum perforatum) ne doivent pas être utilisées pendant le traitement par APTIVUS, car elles risquent de réduire les concentrations plasmatiques et l'efficacité clinique du tipranavir (voir rubrique 4.5).
0.6142261028289795 ||| Empty gas cylinders will be collected by the supplier. ||| The baits are distributed by land or by air. ||| Les bouteilles de gaz vides seront collectées par le fournisseur.
0.621739387512207 ||| Study ACTG 364 48 weeks ||| Stratum Phase OL-LI 16 weeks ||| Etude ACTG 364 48 semaines
0.9858569502830505 ||| This is enough for 4 weeks’ usage. ||| It does this through 12 "actions". ||| Cette quantité est suffisante pour 4 semaines d’ utilisation.
0.17494015395641327 ||| ♦ Uncommon (These may occur with up to 1 in 100 doses of the vaccine): • crying • sleep disorder, sleepiness • constipation ||| Uncommon (These may occur in up to 1 in 100 doses of the vaccine) • sleepiness • cough • large swelling at the injected limb. ||| ♦ Peu fréquents (Ceux -ci peuvent survenir avec au maximum 1 dose de vaccin sur 100) • Pleurs • Troubles du sommeil, somnolence • Constipation
0.42331281304359436 ||| 8% (-1% to 17%) ||| 14.2% (10%; 19%) ||| (-1% à 17%)
0.8119868040084839 ||| 50/ 250 ||| 60 – 100 ||| 50/ 500
0.5642417073249817 ||| 10 Aclar / PVC / blisters with aluminium foil backing containing one clear blister of 11 x 0.5 mg and 14 x 1 mg film-coated tablets and a second clear blister of 28 x 1 mg film-coated tablets in secondary heat sealed card packaging. ||| Cartons contain 2, 4 or 12 vials of Enbrel with 2, 4 or 12 pre-filled solvent syringes, 2, 4 or 12 needles, 2, 4 or 12 vial adaptors and 4, 8 or 24 alcohol swabs. ||| Plaquettes thermoformées Aclar/ PVC avec feuille de protection en aluminium dans un étui thermoscellé, contenant une plaquette thermoformée transparente de 11 comprimés pelliculés à 0,5 mg et 14 comprimés pelliculés à 1 mg et une seconde plaquette thermoformée transparente contenant 28 comprimés pelliculés à 1 mg.
0.011713527143001556 ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/ ||| Detailed information on this medicinal product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/. ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu/
0.44170334935188293 ||| Computer software to enable the provision of information via communications networks ||| Promoting the goods and services of others via computer and communication networks ||| Logiciels de mise à disposition d'informations par le biais de réseaux de communications
0.06202946975827217 ||| There are no adequate data from the use of sirolimus in pregnant women. ||| There are no adequate data from the use of ropinirole in pregnant women. ||| Il n’ existe pas de données suffisamment pertinentes concernant l’ utilisation de sirolimus chez la femme enceinte.
0.3413064479827881 ||| The terminal half-life is higher than after intravenous administration, with an average of 13 - 28 hours. ||| The half-life of elimination was in the range of 4.5 hours to 13 hours, increasing with dose. ||| La demi-vie terminale est plus longue par voie sous-cutanée qu'après administration intraveineuse, avec une moyenne entre 13 et 28 heures.
0.29917141795158386 ||| Co-administration of APTIVUS with low dose ritonavir, with active substances that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/ or life-threatening events is contraindicated. ||| tho fertility and postnatal toxicity, were not performed with adalimumab due to the lack of appropriate models for an antibody with limited cross-reactivity to rodent TNF and the development of neutralizing antibodies in rodents. ||| La co-administration d'APTIVUS, avec le ritonavir à faible dose, et les substances actives dont la clairance est fortement dépendante du CYP3A, pour lesquelles une augmentation des concentrations plasmatiques peut entraîner des effets indésirables graves et/ ou pouvant mettre en jeu le pronostic vital, est contre-indiquée.
0.322631299495697 ||| The significance of these findings in humans is unknown. ||| The relevance of the findings to humans is likely limited. ||| La signification de ces données chez l’ homme est inconnue.
0.508033275604248 ||| Bedside lamps ||| Table top ovens ||| Lampes de chevet
1.0400385856628418 ||| Number and Strength of Tablets to be Administered Bodyweight ||| Frequently Asked Questions about Injecting Your Dose ||| Quantité et dosage des comprimés à administrer
0.40982985496520996 ||| The needle should be inserted into the skin. ||| You may want to hold the pen using the grip. ||| L'aiguille doit être introduite dans la peau.
0.268172949552536 ||| Considering the safety profile of Bonviva and the large number of patients currently enrolled in clinical and post marketing studies for the product as well as the ongoing post-marketing obligations and the continued reports of adverse events received by the MAH, the safety profile will continue to be monitored closely and updates should be provided regularly to the CHMP through 1-yearly PSURs. ||| The rise in number of reimbursed delegates in 2002 will come from an increased number of ad hoc meetings related to the evaluation of medicinal products for human use, increased use of experts in the designation process for orphan medicines and also from preparation and implementation of a number of special projects, in particular relating to the Agency’ s future role in the Community pharmaceuticals regulatory IT strategy. ||| Considérant le profil de sécurité de Bonviva et le grand nombre de patients actuellement inclus dans les études cliniques et études post-commercialisation ainsi que les obligations post-commercialisation en cours et les notifications continues d'événements indésirables reçues par le titulaire de l’ AMM, le profil de sécurité continuera à être étroitement surveillé et des mises à jour devront être fournies régulièrement au CHMP à partir des PSURs annuels.
0.15645462274551392 ||| Luveris should not be administered during pregnancy or lactation. ||| Pergoveris should not be used during pregnancy or lactation. ||| Luveris ne doit pas être administré au cours de la grossesse ou de l’ allaitement.
0.34291547536849976 ||| Various mobile apps have been implemented or proposed for voluntary use, and as of April 7, 2020, over a dozen expert groups were working on privacy-friendly solutions, such as using Bluetooth to log a user's proximity to other cellphones. ||| On 10 April 2020, Google and Apple, the companies that control the Android and iOS mobile platforms, announced an initiative for contact tracing, which they claimed would preserve privacy, based on a combination of Bluetooth Low Energy technology and privacy-preserving cryptography. ||| Diverses applications mobiles ont été lancées ou proposées sur la base du volontariat, et à compter du 7 avril 2020, plus d’une douzaine de groupes d’experts travaillaient sur des solutions respectueuses de la vie privée, comme l’utilisation du Bluetooth pour enregistrer la présence d’un utilisateur à proximité d’autres téléphones portables.
0.180454283952713 ||| In another study with intravenous administration of midazolam, EMEND was given as 125 mg on Day 1 and 80 mg/ day on Days 2 and 3, and 2 mg midazolam was given intravenously prior to the administration of the 3-day regimen of EMEND and on Days 4, 8, and 15. ||| Oral aprepitant increased the AUC of midazolam 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was co-administered on Days 1 and 5 of a regimen of oral aprepitant 125 mg on Day 1 and 80 mg/ day on Days 2 to 5. ||| Dans une autre étude avec administration intraveineuse de midazolam, EMEND a été administré à la posologie de 125 mg à J1 suivis de 80 mg/jour à J2 et J3, et 2 mg de midazolam ont été administrés par voie intraveineuse avant la mise en route du schéma posologique de 3 jours d’EMEND ainsi qu’à J4, J8 et J15.
0.2890437841415405 ||| Oxygenators for medical use ||| Sterilizers for medical use ||| Oxygénateurs à usage médical
0.4610695242881775 ||| Pharmacokinetic/ pharmacodynamic relationships The literature on busulfan suggests a therapeutic window between 900 and 1500 µMol. minute for AUC. ||| At approximately twice therapeutic concentrations, SUTENT has been shown to prolong the QTcF Inteval (Frederica’ s Correction). ||| Relation Pharmacocinétique/ Pharmacodynamique La littérature du busulfan suggère une fenêtre thérapeutique située entre 900 et 1500 µMol. minute pour l’ exposition plasmatique (AUC).
2.83052173279813e-13 ||| A commonly used dose for superovulation involves the administration of 150-225 IU (0.24-0.36 ml) of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle. ||| A commonly used dose for superovulation involves the administration of 150-225 IU (0.24-0.36 ml) of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle. ||| La dose usuelle destinée à provoquer une superovulation comprend l’ administration de 150 à 225 UI (0,24 à 0,36 ml) de GONAL-f par jour, en commençant le 2ème ou 3ème jour du cycle de traitement.
0.11204300820827484 ||| The usual dose of Irbesartan Hydrochlorothiazide BMS is one tablet a day. ||| The usual dose of Irbesartan Hydrochlorothiazide Winthrop is one or two tablets a day. ||| La posologie habituelle de Irbesartan Hydrochlorothiazide BMS est de un comprimé par jour.
0.34122732281684875 ||| Insulin Human Winthrop Rapid is supplied in pre-filled pens, SoloStar, containing 3 ml solution (300 IU). ||| Puregon 900 IU/ 1.08 ml solution for injection is designed for use in conjunction with the Puregon Pen. ||| Insulin Human Winthrop Rapid est fourni en stylo prérempli, SoloStar, contenant 3 ml de solution (300 UI).
0.3032502830028534 ||| Ariclaim should not be used in patients with certain types of liver disease or with severe kidney disease. ||| It must not be used in patients with advanced liver cancer or in women who are breast-feeding. ||| Ariclaim ne doit pas être prescrit aux patientes présentant certains types de maladies de foie, aux patientes présentant des troubles rénaux sévères 2/ 3 ainsi qu’ aux femmes enceintes ou allaitantes.
0.0 ||| Common ||| Common ||| Agitation
0.08261086046695709 ||| 250 6. ||| 750 6. ||| 6.
6.318898312582255e-13 ||| NAME OF THE MEDICINAL PRODUCT ||| NAME OF THE MEDICINAL PRODUCT ||| DÉNOMINATION DU MÉDICAMENT N
5.190971350682583e-13 ||| PHARMACOLOGICAL PROPERTIES ||| PHARMACOLOGICAL PROPERTIES ||| P ROPRIÉTÉS PHARMACOLOGIQUES
0.26356351375579834 ||| Set the tip of the pen on the prepared injection site and press the needle into the skin by pushing the pen downward until the shield is totally depressed. ||| If you are using the active shield, slide the shield onto the pen and push the 2 black lock knobs on the needle shield toward the tip. ||| Placez l’ extrémité du stylo sur le point d’ injection préparé et enfoncez l’ aiguille dans la peau en exerçant une pression verticale sur le stylo jusqu’ à ce que le cache soit totalement enfoncé.
0.2193264365196228 ||| Packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 orodispersible tablets. ||| Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 doses of oral lyophilisate. ||| Boîtes de 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 et 100 comprimés orodispersibles.
0.01715722493827343 ||| Haemoglobin levels dropped below 10 g/dl in up to 14% of adult patients and 7% of children and adolescents treated with Rebetol in combination with either peginterferon alfa-2b (adults only) or interferon alfa-2b. ||| Haemoglobin levels dropped below 10 g/ dl in up to 14% of adult patients and 7% of children and adolescents treated with Ribavirin in combination with either peginterferon alfa-2b (adults only) or interferon alfa-2b. ||| L’ hémoglobinémie a chuté en dessous de 10 g/ dl chez au plus 14% des patients adultes et 7% des enfants et adolescents traités par Rebetol en association avec peginterféron alfa-2b (seulement les adultes) ou interféron alfa-2b.
0.5638734102249146 ||| Keep them in the original package. ||| Keet the Penfill in the original package. ||| Conserver Penfill dans l’ emballage d’ origine.
0.28583115339279175 ||| The preferred injection site for using the Aranesp pre-filled pen is the front of the thigh. ||| Your doctor has prescribed the Nespo pre-filled pen for injection into the tissue just under the skin. ||| Le site d’ injection recommandé est le dessus de la cuisse.
0.19558793306350708 ||| However, rosiglitazone promoted differentiation and reversal of mutagenic changes in human colon cancer cells in vitro. ||| Azacitidine induces both gene mutations and chromosomal aberrations in bacterial and mammalian cell systems in vitro. ||| Toutefois, la rosiglitazone entraîne une différenciation et une inversion des modifications mutagènes des cellules cancéreuses de côlon humain in vitro.
0.6752665042877197 ||| 14 Elderly: ||| 8/ 24 Elderly: ||| Sujet âgé:
0.0 ||| ris combination therapy using the Mann-Whitney U test c. p-value is from the pairwise comparison of Trudexa monotherapy and methotrexate monotherapy using the Mann-Whitney U test ||| ris combination therapy using the Mann-Whitney U test c. p-value is from the pairwise comparison of Trudexa monotherapy and methotrexate monotherapy using the Mann-Whitney U test ||| l'association Trudexa/ méthotrexate par le test U de Mann-Whitney c. valeur de p résulte de la monothérapie par Trudexa et de la monothérapie par méthotrexate par le test U de Mann-Whitney dic
2.258160428396036e-13 ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| 53 L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.08351802825927734 ||| 92 6. ||| 82 6. ||| 97 6.
0.015505015850067139 ||| Marketing Authorisation Holder and Manufacturer Humalog Mix50 100 U/ml KwikPen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France, • Lilly Pharma Fertigung und Distribution GmbH & Co. ||| Marketing Authorisation Holder and Manufacturer Liprolog Basal 100 U/ml KwikPen, suspension for injection is made by: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France • Lilly Pharma Fertigung und Distribution GmbH & Co. ||| Titulaire de l'Autorisation de mise sur le marché et fabricant Humalog Mix50 100 UI/ml KwikPen, suspension injectable est fabriqué par: • Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim – France, • Lilly Pharma Fertigung und Distribution GmbH & Co.
0.2574706971645355 ||| Loxicom 5 mg/ ml solution for injection for dogs and cats. ||| Oxyglobin 130 mg/ ml solution for infusion for dogs. ||| Loxicom 5 mg/ ml solution injectable pour chiens et chats
0.0 ||| Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), asthenia, agitation or anxiety, nausea and/ or vomiting, tremor and headache are the most commonly reported reactions. ||| Dizziness, sensory disturbances (including paraesthesia), sleep disturbances (including insomnia and intense dreams), asthenia, agitation or anxiety, nausea and/ or vomiting, tremor and headache are the most commonly reported reactions. ||| rapportées sont les suivantes: sensations vertigineuses, troubles sensoriels (incluant paresthésie), troubles du sommeil (incluant insomnies et rêves intenses), asthénie, agitation ou anxiété, nausées et/ ou vomissement, tremblements et céphalées.
0.35240834951400757 ||| The possible risk of enhanced RSV infection in the season following the season in which the patients were treated with palivizumab has not been conclusively ruled out by studies performed aiming at this particular point. ||| Due to the high proportion of premature discontinuation (42% of patients discontinued randomised treatment by week 48), no definitive conclusion can be drawn regarding the equivalence between the treatment regimens at week 48. ||| Un risque possible de survenue d’ infections à VRS plus sévéres pendant la saison qui suit celle où les patients ont été traités par palivizumab, n’ a pas été écarté de façon concluante par les études réalisées pour évaluer ce point particulier.
0.4229579269886017 ||| Generally, improvement is seen within one week of starting treatment. ||| Generally, dose titration is recommended at the start of treatment. ||| Habituellement une amélioration est observée au cours de la première semaine de traitement.
0.4604143500328064 ||| Clinically significant interactions with CYP2C9 substrates or inhibitors are not anticipated. ||| Therefore, no CYP450-related drug interactions are to be expected. ||| Il n’ est pas attendu d’ interactions cliniquement significatives avec des substrats ou des inhibiteurs du CYP2C9.
0.377639502286911 ||| Ziconotide may cause confusion, somnolence and other neurological adverse reactions, therefore patients must be advised not to drive or operate machines if affected. ||| If you are a sensitive patient, you may find that the simultaneous use of alcohol or other nervous depressant agents may additionally affect your attention and ability to react. ||| Le ziconotide pouvant provoquer une confusion, une somnolence et d'autres réactions indésirables neurologiques, les patients doivent être avertis de ne pas conduire de véhicules ni d'utiliser des machines s’ ils présentent ces effets.
0.6396605968475342 ||| General Non-specific skin rashes have been described with epoetin alfa. ||| Three major classes of interferons have been identified: alpha, beta and gamma. i dic ||| Généralités Des rashes cutanés non spécifiques ont été décrits lors de l'utilisation d'époétine alfa.
0.1451396942138672 ||| ge EXP {MM/ YYYY} ||| r ge EXP {MM/ YYYY} ||| plu EXP
0.7224348783493042 ||| With the support of the European Parliament and Commission, the EMEA established the Committee for Orphan Medicinal Products early in 2000. ||| In 1999, the church created the Philadelphia Cultural Association (Association Culturelle Philadelphie) which sells many books, DVD and CD. ||| Avec l’ appui du Parlement européen et de la Commission, l’ EMEA a établi très tôt en 2000 son comité pour les médicaments orphelins.
0.0 ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| OTHER SPECIAL WARNING(S), IF NECESSARY ||| AUTRE(S) MISE EN GARDE(S) SPECIALE(S), SI NECESSAIRE
0.14890770614147186 ||| capsule shell: gelatin, titanium dioxide (E 171), sodium laurilsulfate, yellow iron oxide (E 172), indigo carmine (E 132). ||| Capsule shell: gelatin, titanium dioxide (E 171), sodium lauril sulfate, yellow iron oxide (E 172), red iron oxide (E 172) ||| - parois de la gélule: gélatine, dioxyde de titane (E171), lauryl sulfate de sodium, oxyde de
0.0630570724606514 ||| Irbesartan Hydrochlorothiazide BMS is contraindicated during breast-feeding. ||| Irbesartan Hydrochlorothiazide Winthrop is contraindicated during breast-feeding. ||| Irbesartan Hydrochlorothiazide BMS est contre-indiqué pendant l'allaitement.
0.2572430968284607 ||| In all of the studies, the main measure of effectiveness was the number of patients who had undetectable levels of HIV-1 in their blood (viral loads) after 24 or 48 weeks of treatment. ||| In all of the studies, the effectiveness was measured by looking at the number of patients who either had blood clots in the veins or in the lungs, or who died of any cause during the treatment period. ||| Dans l’ ensemble des études, le principal critère d’ évaluation de l’ efficacité était le nombre de patients présentant des taux de VIH-1 dans le sang (charge virale) indétectables après 24 à 48 semaines de traitement.
0.32362473011016846 ||| In CSF the peak concentrations of 18 mg/ l are achieved, after a 50– 100 mg/ kg intravenous dose, in about four hours. ||| In these studies, Keppra at doses of 1,000, 2,000 or 3,000 mg per day, was compared with placebo (a dummy treatment) over 12 to 14 weeks. ||| Dans le LCR, les concentrations maximales sont de 18 mg/l après l’administration intraveineuse de 50 à 100 mg/kg en quatre heures environ.
0.5515464544296265 ||| Other characteristics ||| Trial characteristics ||| Autres caractéristiques
0.476382851600647 ||| 1.4 mo ||| 2.4 3.0 ||| 1,4 mois
0.002329811453819275 ||| Insuman Comb 25 is supplied in pre-filled pens, OptiSet, containing 3 ml suspension, (300 IU). ||| Insuman Comb 15 is supplied in pre-filled pens, OptiSet, containing 3 ml suspension, (300 IU). ||| 721 Insuman Comb 25 est fourni en stylo prérempli, OptiSet, contenant 3 ml de suspension (300 UI).
0.5556027889251709 ||| Follow these instructions carefully to make sure you will benefit from FOSAVANCE. ||| Please follow these instructions, otherwise Zyrtec may not be fully effective. ||| Suivez ces instructions avec attention pour une efficacité optimale de FOSAVANCE.
0.3398558497428894 ||| However, due to the risk of haemorrhage, notably with NSAIDs with elimination half-lives > 12 hours, close observation for signs of bleeding is recommended (see section 4.4). ||| In clinical studies, delayed hypersensitivity reactions have been uncommon and have occurred after Remicade-free intervals of less than 1 year (see section 4.4 and 4.8: delayed hypersensitivity). ||| Cependant, en raison du risque hémorragique, une surveillance étroite des signes de saignement est recommandée, notamment avec les AINS à demi-vie d'élimination supérieure à 12 heures (voir rubrique 4.4).
0.1173897236585617 ||| België/Belgique/Belgien sanofi-aventis Belgium Tél/ Tel: +32 (0)2 710 54 00 ||| Luxembourg/ Luxemburg sanofi-aventis Belgium Tél/ Tel: +32 (0)2 710 54 00 (Belgique/ Belgien) ||| België/Belgique/ Belgien sanofi-aventis Belgium Tél/ Tel: +32 (0)2 710 54 00
0.011288084089756012 ||| 53 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| Les essais cliniques contrôlés n’ ont pas montré d’ effets bénéfiques significatifs attribuables à l’ administration des époétines lorsque le taux d’ hémoglobine dépassait le niveau nécessaire au contrôle des symptômes de l’ anémie et pour éviter une transfusion sanguine.
0.0 ||| 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 25 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 25 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR CARTON D'EMBALLAGE DE LA SERINGUE SANS PLAQUETTE THERMOFORMÉE
0.2917709946632385 ||| Caution should be exercised when pravastatin is administered to patients with a history of liver disease or heavy alcohol ingestion. ||| The veterinary medicinal product should be administered at monthly intervals when used as part of a treatment strategy for flea allergy dermatitis. ||| Il convient d'être prudent quand la pravastatine est administrée à des patients ayant un antécédent d'affection hépatique ou de consommation importante d’alcool.
0.24491623044013977 ||| Total Daily Dose (mg of base) ||| Total Daily Dose (mg of salt) ||| dose/ jour (mg de base)
0.6775457859039307 ||| • Dexrazoxane ||| • Deslorelin acetate ||| Dexrazoxane
0.5019366145133972 ||| 5 ml (2.5 mg) Neoclarityn oral solution once a day. ||| Refractory Invasive Fungal 400 mg (10 ml) twice a day. ||| 5 ml (2,5 mg) de Neoclarityn solution buvable une fois par jour.
0.23758341372013092 ||| 12 Allergic-type reactions, including anaphylaxis, skin rash, urticaria, angioedema, dyspnoea, hypotension, injection site reactions, erythaema and flushing, occurring on initial or subsequent treatment have been reported with Neulasta. ||| The ADRs that appeared to be dose-related included weight increased, headache, salivary hypersecretion, vomiting, dyskinesia, akathisia, dystonia, extrapyramidal disorder, hypertonia, and Parkinsonism. ||| Des réactions de type allergique, incluant anaphylaxie, rash cutané, urticaire, angio-œ dème, dyspnée, hypotension, réactions au site d’ injection, érythème et bouffées vaso-motrices apparaissant au cours de l’ administration initiale ou de la poursuite du traitement ont été rapportées avec Neulasta.
0.9556260108947754 ||| These symptoms are not really flu. ||| hearing things that are not real), confusion or suicide ||| Ces symptômes ne sont pas réellement dus à une grippe.
0.5496458411216736 ||| No relevant modification of pharmacokinetic parameters in patients with severe renal impairment has been observed (n=8, single dose of 25 mg), but caution should be exercised in patients with severe or moderate renal impairment as only limited clinical data are available in these patients (see section 4.2). ||| Moreover, CPC authorities also observed that consumers were not provided with clear and comprehensive information on all relevant aspects, such as the identity of the trader (on 58 websites), the geographical address of the trader's establishment (on 62 websites) or the trader's contact details (on 58 websites). ||| Aucune modification significative des paramètres pharmacocinétiques n’ a été observée chez les patients présentant une insuffisance rénale sévère (n=8, administration unique de 25 mg), mais l’ utilisation doit se faire avec prudence chez les patients présentant une insuffisance rénale modérée ou sévère en raison du peu de données cliniques disponibles chez ces patients (voir rubrique 4.2).
0.016431774944067 ||| Abseamed 1000 IU/ 0.5 ml solution for injection in a pre-filled syringe The syringes contain 0.5 ml (1000 IU) of solution. ||| Abseamed 3000 IU/ 0.3 ml solution for injection in a pre-filled syringe The syringes contain 0.3 ml (3000 IU) of solution. ||| Abseamed 1 000 UI/ 0,5 ml, solution injectable en seringue pré-remplie Les seringues contiennent 0,5 ml (1 000 UI) de solution.
0.3091036379337311 ||| The Lansoprazole dose should therefore be taken at least an hour prior or after. ||| Therefore lansoprazole should be taken at least 1 hour after taking these drugs. ||| La prise de lansoprazole doit donc avoir lieu au moins une heure avant ou une heure après la prise de sucralfate.
0.06595051288604736 ||| What Tasigna is and what it is used for 2. ||| What Gliolan is and what it is used for 2. ||| Qu'est -ce que Tasigna et dans quel cas est -il utilisé 2.
0.27906572818756104 ||| The CVMP prepared comments on the draft Codex Alimentarius guideline on residues at injection site, which served as the basis for the European Union’ s position on this issue at the meeting the Codex Committee on Residues of Veterinary Drugs in Food in September 1998. ||| EudraVigilance The main EudraVigilance related activity in 2002 was the implementation of the electronic transmission of individual case safety reports (ICSRs) as defined in the policy paper adopted by heads of national competent authorities in November 2001. ||| Le CVMP a préparé une contribution au projet de ligne directrice du Codex Alimentarius sur les résidus au point d’ injection qui ont servi de base à la ligne directrice de l’ Union européenne sur ce problème lors de la réunion du comité du codex sur les résidus de médicaments vétérinaires dans les aliments en septembre 1998.
0.11259724199771881 ||| Norge UCB Nordic A/ S Tel: +45 / 32 46 24 00 ||| Sverige UCB Nordic A/ S Tel: + 46 / (0) 40 29 49 00 ||| Tel: +45 / 32 46 24 00
0.021469488739967346 ||| EU/ 2/ 97/ 004/ 006 ||| EU/ 2/ 97/ 004/ 003 ||| EU/ 2/ 97/ 004/ 006 Metacam
0.0 ||| 15 ||| 15 ||| 60
0.5447518825531006 ||| Effentora was more effective than placebo in reducing pain in both studies. ||| In the study in men GONAL-f was effective in stimulating sperm production: ||| Effentora s’ est avéré plus efficace que le placebo pour la réduction de la douleur dans les deux études.
0.4610287547111511 ||| 64 The following table contains dosing guidelines for Kaletra 100/ 25 mg tablets based on BSA. ||| There is a separate Package Leaflet for Emtriva 10 mg/ ml oral solution. ||| Le tableau ci-dessous contient les recommandations posologiques pour Kaletra 100/ 25 mg comprimé, en fonction de la surface corporelle (SC)*.
0.05427993834018707 ||| 57 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTERS ||| 60 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER ||| 60 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.25089913606643677 ||| If you stop taking Preotact before finishing the treatment please inform you doctor. ||| If you stop using Valtropin Please ask your doctor for advice before stopping treatment. ||| Si vous arrêtez de prendre Preotact Si vous arrêtez de prendre Preotact avant d’ avoir fini votre traitement, veuillez en informer votre médecin.
0.08115014433860779 ||| The European Commission granted the initial marketing authorisation valid throughout the European Union, for Previcox to Merial on 13 September 2004. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Ibraxion to Merial on 9 March 2000. ||| La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne pour Previcox à Merial le 13 septembre 2004.
0.20401623845100403 ||| Effects of other medicinal products on voriconazole ||| 36 Effects of other drugs on lansoprazole ||| Effets des autres médicaments sur le voriconazole
0.30370479822158813 ||| At the end of the 90-minute procedure, the medicines are flushed out of the limb using a suitable fluid. ||| The veterinary medicinal product is then applied by activating the pump spray, from a distance of about 10 cm of the area to be treated. ||| Au terme de la procédure de 90 minutes, les médicaments sont chassés de la jambe par un fluide adéquat.
0.0 ||| 5 (1.1%) ||| 5 (1.1%) ||| Grade 3 n (%)
0.2362442910671234 ||| Post marketing Experience ||| Post marketing experience ||| Expérience après commercialisation:
0.3230980932712555 ||| Be sure to discuss this with your doctor. ||| Please discuss this with your doctor. ||| Assurez-vous d’en avoir parlé avec votre mé decin.
0.20712856948375702 ||| Symptoms almost always include fever or rash, but also very commonly include nausea, vomiting, diarrhoea, abdominal pain, dyspnoea (difficulty breathing), cough, lethargy, malaise, headache, signs of liver damage in the blood and myalgia (muscle pain). ||| Symptoms of hypercalcaemia may include anorexia, thirst, nausea, vomiting, constipation, abdominal pain, muscle weakness, fatigue, mental disturbances, polidipsia, polyuria, bone pain, nephrocalcinosis, renal calculi and in severe cases, cardiac arrhythmias. ||| Les symptômes presque toujours observés sont la fièvre ou une éruption cutanée, mais comprennent aussi très couramment nausées, vomissements, diarrhée, douleurs abdominales, dyspnée (difficulté à respirer), toux, léthargie, malaises, maux de tête, signes d’ atteintes hépatiques dans le sang et myalgies (douleurs musculaires).
0.29375091195106506 ||| Concomitant administration with the oral anti-diabetic agents metformin, glibenclamide and acarbose did not result in any clinically relevant pharmacokinetic interactions with rosiglitazone. ||| Population pharmacokinetic analysis indicated that oral antidiabetics, diuretics, insulin, phenobarbital, tiagabine and topiramate had no clinically significant effect on pregabalin clearance. ||| L’ administration concomitante d’ autres antidiabétiques oraux comme la metformine, le glibenclamide et l’ acarbose n’ entraîne pas d’ interactions pharmacocinétiques significatives avec la rosiglitazone.
0.6813889741897583 ||| Concentrate for Infusion ||| Solution for Injection ||| Concentré pour Infusion
0.41055989265441895 ||| Both valsartan and amlodipine are unlikely to be removed by haemodialysis. ||| All of these patients had also received drugs known as azathioprine or 6-mercaptopurine. ||| Il est peu probable que le valsartan et l'amlodipine puissent être éliminés par hémodialyse.
0.030436255037784576 ||| The effects of Optaflu were first tested in experimental models before being studied in humans. ||| The effects of Volibris were first tested in experimental models before being studied in humans. ||| Les effets d’ Optaflu ont d’ abord été testés sur des modèles expérimentaux avant d’ être étudiés chez les humains.
0.4450269341468811 ||| Replace the other trays in the refrigerator.  The dose tray should contain all the items needed for one dose. ||| ris If the washed chamber is not dry prior to taking your next dose, use your spare chamber. ||| Remettez les autres coffrets de traitement au réfrigérateur. • Le coffret de traitement doit contenir tous les éléments nécessaires pour une dose.
0.556874692440033 ||| Mutual recognition, which is the responsibility of national regulatory authorities, got off to a rather slower start but has established itself progressively since then. ||| The body of psychological research on pedestrian safety is currently much smaller than that in the epidemiological field, but is rapidly growing. ||| La procé- dure de reconnaissance mutuelle, sous la responsabilité des autorités nationales chargées de l’ enregistrement, s’ est progressivement établie malgré une mise en route plutôt lente.
7.378965602607146e-13 ||| 0 (0%) 0 (0%) ||| 0 (0%) 0 (0%) ||| 0 (0%) 0 (0%) 3 (0.6%)
0.3109860420227051 ||| The efficacy of ECALTA in neutropenic patients with candidaemia and in patients with deep tissue Candida infections or intra-abdominal abscess and peritonitis has not been established. ||| Renal artery stenosis No data are available on the use of Dafiro in patients with bilateral renal artery stenosis or stenosis to a solitary kidney. ||| L’ efficacité d’ ECALTA chez les patients neutropéniques avec une candidémie et chez les patients avec des candidoses profondes ou un abcès intra-abdominal ou une péritonite n’ a pas été établie.
0.6686179637908936 ||| Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom ||| ed Queenborough Kent ME11 5EL United Kingdom ||| Queenborough Kent ME11 5EL United Kingdom
0.3330056071281433 ||| It may be necessary to divide the total daily dose into 2 or 3 doses, distributed over the day, to achieve the best therapeutic effect. ||| Method of administration The total daily dose may be divided in two or three doses according to patient’ s convenience. ||| Il peut être nécessaire de diviser la dose quotidienne totale en 2 ou 3 prises réparties sur la journée, afin d'obtenir le meilleur effet thérapeutique.
0.33324170112609863 ||| Concurrent administration of medicinal products with cardiotoxicity or blood pressure lowering effects may increase the toxicity of Ceplene. ||| Blockage of CSF flow may result in increased free cytarabine concentrations in the CSF with increased risk of neurotoxicity. ||| Une administration simultanée de médicaments cardiotoxiques ou hypotenseurs peut augmenter la toxicité de Ceplene.
0.4139004945755005 ||| It is possible that the decreased bioavailability in this study was due to delayed transit of ribavirin or modified pH. ||| The factor that would influence the bioavailability the most would be if the granules were mixed with a vehicle of pH > 7. ||| Il est possible que la diminution de la biodisponibilité dans cette étude soit due à
0.8221931457519531 ||| Coronavirus global response: EU Humanitarian Air Bridge to Afghanistan and further support ||| Q A: Global EU response to the coronavirus pandemic ||| Réaction mondiale face au coronavirus: pont aérien humanitaire de l'UE vers l'Afghanistan et aide supplémentaire
0.5201809406280518 ||| Other medicines and Telzir Tell your doctor or pharmacist if you ’ re taking any other medicines, if you’ ve taken any recently, or if you start taking new ones – these include herbal medicines or other medicines you bought without a prescription. ||| TAKING OTHER MEDICINES …. []… “ Tell your doctor about any other medicines you are taking or took recently (in the last week) – even medicines you bought yourself without a prescription. ||| Prise d’autres médicaments avec Telzir Veuillez indiquer à votre médecin ou à votre pharmacien si vous prenez ou avez pris récemment d’autres médicaments, ou si vous envisagez de prendre de nouveaux médicaments – y compris les médicaments à base de plantes ou d'autres médicaments obtenus sans ordonnance.
0.5490516424179077 ||| Electrostatic precipitators ||| Resistance temperature detectors ||| Précipiteurs électrostatiques
0.45789480209350586 ||| Chemicals for use in aquariums [other than pharmaceuticals] ||| Edible essences for foodstuffs [other than etheric substances and essential oils] ||| Produits chimiques pour aquariums autres que produits pharmaceutiques
0.4509274959564209 ||| The increased risk gradually goes down after stopping the combined hormonal contraceptive. ||| These effects showed a tendency to regress after cessation of treatment. ||| 32 progressivement après l’ arrêt du contraceptif oestroprogestatif.
0.5745337605476379 ||| Following administration of Telzir, the half-life of amprenavir is 7.7 hours. ||| The median IgG half-life after administration of KIOVIG was 32.5 days. ||| Après administration de Telzir, la demi-vie d’ élimination plasmatique de l'amprénavir est de 7,7 heures.
0.22636640071868896 ||| Lowering the amount of angiotensin II allows the blood vessels to relax; this lowers blood pressure. ||| When the production of angiotensin II is lowered, the blood vessels relax and widen. ||| La réduction de la quantité d’ angiotensine II permet aux vaisseaux sanguins de se relâcher, ce qui abaisse la pression artérielle.
0.533944845199585 ||| Promoting services for baseball game ||| Arranging finance for television programs ||| Services de promotion de matchs de base-ball
0.15737566351890564 ||| How to use Protopy 4. ||| How to use Keppra 4. ||| Quelles sont les informations à connaître avant d'utiliser Protopy 3.
0.19480782747268677 ||| Week 3 (day 15-21): ||| Week 4 (day 22-28): ||| Semaine 3 (Jour 15 à 21):
0.39458638429641724 ||| Prevention of reflux oesophagitis Treatment of infections caused by the bacteria Helicobacter pylori when given in combination with antibiotic therapy ||| Taking other medicines Helicobacter Test INFAI is influenced by all medicines related to Helicobacter pylori or urease activity. ||| Traitement des infections in duites par les bactéries à Helicobacter pylori lorsqu’il est prescrit en association avec une antibiothérapie
0.3819981515407562 ||| Kinzalmono may increase the blood pressure lowering effect of other medicines used to treat high blood pressure. ||| A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. ||| Kinzalmono peut accentuer l’ effet de diminution de la pression artérielle d’ autres médicaments utilisés pour traiter l’ hypertension artérielle.
0.21707287430763245 ||| Mills [machines] ||| Hoppers [machines] ||| Moulins [machines]
0.12051674723625183 ||| Before use: store in a refrigerator (2°C - 8°C). ||| Before activation, store in a refrigerator (2°C - 8°C). ||| Avant utilisation: conserver au réfrigérateur (entre 2°C et 8°C).
0.21626512706279755 ||| Co-administration of rotigotine (3 mg/ 24 h) did not affect the pharmacodynamics and pharmacokinetics of oral contraceptives (0.03mg ethinylestradiol, 0.15mg levonorgestrel). ||| In an interaction study, celecoxib had no clinically relevant effects on the pharmacokinetics of oral contraceptives (1 mg norethistherone / 35 microg ethinylestradiol). ||| L’ administration concomitante de rotigotine (3 mg/ 24 h) n’ a pas affecté la pharmacodynamique et la pharmacocinétique des contraceptifs oraux (0,03 mg d’ éthinylestradiol, 0,15 mg de lévonorgestrel).
0.26763346791267395 ||| If necessary, apply a clean, dry cotton swab over the area and press gently for 1 or 2 minutes, or until the bleeding has stopped. ||| Keeping the vial in an upright position, vigorously swirl it (do not shake) for approximately 1 minute to evenly wet the powder. ||| Si nécessaire, appliquer un tampon de coton propre et sec sur la zone et appuyer délicatement pendant 1 ou 2 minutes, ou jusqu'à ce que le saignement cesse.
0.23144778609275818 ||| Clinical studies 201 and 202 indicate that the combination of IT ziconotide and IT morphine may effectively reduce pain and decrease systemic opioid use over a sustained period of time for patients whose pain was inadequately controlled with their maximum tolerated dose of IT ziconotide (median 8.7 μ g/ day, mean 25.7 μ g/ day – study 201) or with IT morphine (study 202) alone. ||| Oral anticoagulants In two clinical studies, one in normal volunteers and the other in hypercholesterolaemic patients, simvastatin 20-40 mg/ day modestly potentiated the effect of coumarin anticoagulants: the prothrombin time, reported as International Normalized Ratio (INR), increased from a baseline of 1.7 to 1.8 and from 2.6 to 3.4 in the volunteer and patient studies, respectively. ||| Les études cliniques 201 et 202 indiquent que l’ administration concomitante de ziconotide et de morphine par voie intrarachidienne peut efficacement réduire la douleur et diminuer l’ utilisation d’ opiacés par voie systémique pendant une période prolongée chez des patients chez qui l’ administration par voie intrarachidienne de la dose maximale tolérée de ziconotide (médiane 8,7 μ g/ jour, moyenne 25,7 μ g/ jour – étude 201) ou de morphine seule (étude 202) ne parvenait pas à contrôler la douleur de manière adéquate.
0.2429284006357193 ||| Since sorafenib is mainly eliminated via the hepatic route exposure might be increased in patients with severe hepatic impairment (see section 4.2 and 5.2). ||| Unbound darifenacin exposure was estimated to be 4.7-fold higher in subjects with moderate hepatic impairment than subjects with normal hepatic function (see section 4.2). ||| Le sorafénib étant essentiellement éliminé par voie hépatique, l’ exposition au sorafénib pourrait être augmentée chez les patients atteints d’ insuffisance hépatique sévère (Cf. rubriques 4.2 et 5.2).
0.18368378281593323 ||| 226.3 ||| 233.9 ||| 226,3
7.335794840503118e-13 ||| Solution for injection ||| Solution for injection ||| solution injectable
0.390899658203125 ||| In controlled clinical studies involving approximately 1400 patients, the following adverse reactions were reported in patients given Cholestagel. ||| Clinical trial data Based on clinical trial experience in more than 1,800 patients, the following undesirable effects have been observed. ||| Lors d’ études cliniques contrôlées impliquant environ 1400 patients, les effets indésirables suivants ont été rapportés chez des patients ayant reçu Cholestagel.
0.4088270664215088 ||| It is important that you carry on taking Olanzapine Mylan for as long as your doctor tells you. ||| - You will need to take Advagraf every day as long as you need immunosuppression to prevent ||| Il est important que vous preniez OLANZAPINE MYLAN aussi longtemps que votre médecin vous l’ aura indiqué.
0.45064276456832886 ||| 20, 30, 50, 100, 500; calendar blister: ||| 15, 30, 60, 90 Unit dose (blister): ||| 20, 30, 50, 100, 500; plaquette thermoformée avec impression des jours de la semaine:
3.29509640059622e-13 ||| Symptomatic postural hypotension may occur when levodopa is added to the treatment of patients already receiving antihypertensives. ||| Symptomatic postural hypotension may occur when levodopa is added to the treatment of patients already receiving antihypertensives. ||| 29 Antihypertenseurs: une hypotension orthostatique symptomatique peut se produire en cas d'addition de lévodopa au traitement de patients prenant déjà des antihypertenseurs.
3.351171879058257e-13 ||| If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. ||| If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. ||| Si vous êtes atteint de diabète de type 1 (diabète insulinodépendant), n’arrêtez pas votre insuline et continuez de prendre suffisamment d’hydrates de carbone.
0.46960002183914185 ||| Vice benches [furniture] ||| Envelopes [stationery] ||| Étaux-établis [meubles]
0.289961576461792 ||| ZYPREXA 20 mg coated tablets ||| CYSTAGON 150 mg hard capsules ||| ZYPREXA 20 mg comprimés enrobés.
0.16833269596099854 ||| Weakening of the blood-glucose-lowering effect and, thus raised blood glucose levels may occur when one of the following active substances is taken, for example: ||| Potentiation of the blood-glucose-lowering effect and, thus, in some instances hypoglycaemia may occur when one of the following active substances is taken, for example: ||| Une diminution de l’ effet hypoglycémiant et donc une élévation de la glycémie peuvent survenir en cas de prise de l’ un des principes actifs suivants, par exemple:
0.006502142176032066 ||| 112 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 72 For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. ||| 123 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l'autorisation de mise sur le marché:
0.31298428773880005 ||| Gadovist should not be used in case of severe discoloration, the occurrence of particulate matter or a defective container. ||| Special care must be taken to prevent any leakage of Osigraft due to irrigation, defective closure of surrounding tissue or inadequate haemostasis. ||| Gadovist ne doit pas être utilisé en cas de décoloration importante, de présence de particules ou d’ emballage défectueux.
0.23757286369800568 ||| Maintenance and repair of refrigerating apparatus ||| Maintenance and repair of dust extraction apparatus ||| Entretien et réparation d'appareils de réfrigération
0.15861168503761292 ||| Concomitant use of imatinib and medicinal products that induce CYP3A4 (e. g. dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital or Hypericum perforatum, also known as St. ||| CYP3A4 inducers (anticonvulsant agents [e. g. carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone], rifampicin, Hypericum perforatum) Co-administration may lead to reduced plasma concentrations of amlodipine. ||| L’ utilisation concomitante d’ imatinib et de médicaments inducteurs du CYP3A4 (par exemple: dexaméthasone, phénytoïne, carbamazépine, rifampicine, phénobarbital, ou Hypericum perforatum (millepertuis), peut réduire significativement l’ exposition systémique au Glivec et augmenter potentiellement le risque d’ échec thérapeutique.
0.9952167868614197 ||| Pigs (gilts and sows). ||| a) Bovine, porcine, poultry ||| Porcs (cochettes et truies)
0.332367479801178 ||| There have been reports of Graft versus Host Disease (GvHD) and fatalities in patients receiving G-CSF after allogeneic bone marrow transplantation (see section 5.1). ||| Treatment with FSH and LH followed by hCG can lead to a condition called ovarian hyperstimulation syndrome (OHSS) (see also section headed ‘Take Special Care with Luveris’). ||| Des cas de réaction du greffon contre l’ hôte (RGCH), avec dans certains cas une issue fatale, ont été observés chez des patients recevant le G-CSF après une greffe allogénique de moelle osseuse (voir rubrique 5.1).
5.904601894229922e-13 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| 501 Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224
0.28919288516044617 ||| Viracept has been studied in combination with other antiviral medicines in two main studies involving 605 patients aged 13 years or more, who were infected with HIV. ||| For the treatment of diabetic neuropathic pain, Ariclaim has been studied in two 12-week studies in 809 diabetic adults who had had pain every day for at least six months. ||| Viracept a été étudié en association avec d’ autres médicaments antiviraux dans deux études principales ayant suivi 605 patients âgés de 13 ans ou plus, présentant une infection par le VIH.
0.07375572621822357 ||| Animal studies have shown excretion of anidulafungin in breast milk. ||| Animal studies have shown excretion of brinzolamide in breast milk. ||| Les études chez l'animal ont montré une excrétion de l’ anidulafungine dans le lait maternel.
0.26982805132865906 ||| • Hypersensitivity to the active substance or to peanut or soya or any of the excipients • Urinary retention • Gastric retention • Uncontrolled narrow angle glaucoma • Myasthenia gravis • Severe hepatic impairment (Child Pugh C) • Concomitant use of potent CYP3A4 inhibitors in subjects with moderate to severe hepatic or renal impairment • Severe ulcerative colitis • Toxic megacolon. ||| InductOs is contraindicated for patients with: • Hypersensitivity to the active substance or to any of the excipients • Skeletal immaturity • Any active malignancy or patient undergoing treatment for a malignancy • An active infection at the operative site • Persistent compartment syndrome or neurovascular residua of compartment syndrome • Pathological fractures such as those observed in (but not limited to) Paget’ s disease or in metastatic bone ||| • Hypersensibilité à la substance active ou aux arachides ou au soja ou à l’ un des excipients • Rétention urinaire • Rétention gastrique • Glaucome à angle fermé non contrôlé • Myasthénie grave • Insuffisance hépatique sévère (Child-Pugh C) • Utilisation concomitante d’ inhibiteurs puissants du CYP3A4 chez les sujets souffrant d’ insuffisance hépatique ou rénale modérée à sévère • Rectocolite hémorragique grave • Mégacôlon toxique
0.3274052143096924 ||| Therefore, the recommended dose of docetaxel in those patients with elevated liver function test (LFTs) is 75 mg/ m2 and LFTs should be measured at baseline and before each cycle (see section 4.2). ||| The incidence of both ACUITY-scale and TIMI-scale bleeding events up to day 30 is presented in Table 9 for the overall (ITT) population and for patients that received aspirin and clopidogrel as per protocol. ||| En conséquence, la dose recommandée de docétaxel chez les patients ayant un bilan de la fonction hépatique élevé (BFH) est de 75 mg/ m2 et un bilan de la fonction hépatique (BFH) doit être fait en début de traitement et avant chaque cure (cf. paragraphe 4.2).
0.21594396233558655 ||| Efavirenz: when used in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in multiple protease inhibitor-experienced patients, increasing the dose of Kaletra 33.3% from 400/ 100 mg (3 capsules) twice daily to 533/ 133 mg (4 capsules) twice daily yielded similar lopinavir plasma concentrations as compared to historical data of Kaletra 400/ 100 mg (3 capsules) twice daily. ||| M98-957 is a randomised, open-label study evaluating Kaletra treatment at two dose levels (400/ 100 mg and 533/ 133 mg, both twice daily) plus efavirenz (600 mg once daily) and nucleoside reverse transcriptase inhibitors in 57 multiple protease inhibitor experienced, non-nucleoside reverse transcriptase inhibitor naïve patients. ||| Efavirenz: chez les patients multi-traités par des inhibiteurs de protéase et recevant Kaletra en association à l’ éfavirenz plus deux inhibiteurs nucléosidiques de la transcriptase inverse, une augmentation de 33,3% de la posologie de Kaletra, passant de 400/ 100 mg (3 capsules) 2 fois par jour à 533/ 133 mg (4 capsules) 2 fois par jour, a permis d’ obtenir des concentrations plasmatiques de lopinavir similaires à celles observées avec Kaletra administré à la posologie de 400/ 100 mg (3 capsules) 2 fois par jour (données historiques).
0.40172767639160156 ||| Special populations The influence of renal and hepatic impairment on exposure to porfimer sodium has not been evaluated (see sections 4.2, 4.3 and 4.4). ||| • Hypersensitivity to the active substance or to any of the excipients (see section 6.1) • Second and third trimester of pregnancy (see sections 4.4 and 4.6) ||| 12 L’ impact de l’ insuffisance rénale ou hépatique sur l’ exposition au porfimère sodique n'a pas été évalué (voir sections 4.2, 4.3 et 4.4).
0.2856820225715637 ||| ADRs reported in 2 of 9 late-onset patients treated with Myozyme for up to 1 year in 3 different studies included increased heart rate, hypertension, headache, peripheral coldness, paresthesia, flushing, infusion site pain, infusion site reaction, increased blood pressure and dizziness. ||| Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red na ||| Les EI rapportés chez 2 des 9 patients à forme tardive ayant reçu jusqu'à 1 an de traitement par Myozyme dans 3 études différentes, ont inclus: augmentation de la fréquence cardiaque, hypertension, céphalées, refroidissement des extrémités, paresthésie, bouffées vasomotrices, douleur au site de perfusion, réaction au site de perfusion, augmentation de la pression artérielle et vertiges.
0.37632861733436584 ||| The deterioration in Quality of Life was significantly less in Bondronat treated patients compared with placebo. ||| Discontinuation due to undesirable events was 7% for the patients treated with Zerit. ||| La détérioration de la qualité de vie a été significativement inférieure chez les patientes traitées par Bondronat comparé aux patientes sous placebo.
0.12213370203971863 ||| 60 tablets ||| 120 tablets ||| 60 comprimés
0.8630520105361938 ||| Chrome salts ||| medicines"). ||| Sels de chrome
0.39600062370300293 ||| The powder for solution for infusion is a white powder. ||| The powder for solution for injection contains: ||| La poudre pour solution pour perfusion est une poudre de couleur blanche.
0.27989643812179565 ||| When a person is given the vaccine, the immune system (the body’ s natural defences) will make antibodies against the measles, mumps, rubella, and varicella viruses. ||| When a person is given the vaccine, the immune system (the body’s natural defences) will make antibodies against the most commonly occurring types of rotavirus. ||| Lorsqu’ une personne reçoit ce vaccin, le système immunitaire (les défenses naturelles du corps) produit des anticorps contre les virus de la rougeole, des oreillons, de la rubéole et de la varicelle.
0.6944152116775513 ||| Very common Common Very common Common Very common Common ||| Very common Common Common Common Common Common Common Common ||| Très fréquent Fréquent Très fréquent Fréquent
0.22633591294288635 ||| Competact 15 mg/ 850 mg film-coated tablets. ||| Rasilez HCT 300 mg/ 12.5 mg film-coated tablets ||| Competact 15 mg/ 850 mg comprimés pelliculés.
0.2618919909000397 ||| What is Imprida? ||| What is Onsior? ||| Qu’ est -ce qu’ Imprida?
0.23725757002830505 ||| Each ml of solution contains 4 mg of temoporfin. ||| Each ml contains 100 mg of levetiracetam. ||| Chaque ml de solution contient 4 mg de témoporfine.
0.21614916622638702 ||| HOW TO STORE XELODA ||| HOW TO STORE HUMALOG ||| COMMENT CONSERVER XELODA
0.0027510393410921097 ||| 66 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 72 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.4205191731452942 ||| 88 Actrapid must be protected from excessive heat and sunlight. ||| NovoMix 30 Penfill must be protected from excessive heat and sunlight. ||| Actrapid doit être protégé de la chaleur excessive et de la lumière.
0.04243785887956619 ||| The Commission found that the Latvian scheme is in line with the conditions set out in the Temporary Framework. ||| The Commission found that Polish scheme is in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que le régime letton était conforme aux conditions énoncées dans l'encadrement temporaire.
0.4804840683937073 ||| Metal bleachers ||| Glass decanters ||| Gradins en métal
0.010823352262377739 ||| 163 Combination therapy ViraferonPeg 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| 25 Combination therapy ViraferonPeg 1.5 micrograms/kg/week in combination with ribavirin capsules. ||| Traitement combiné ViraferonPeg 1,5 microgrammes/ kg/ semaine avec des gélules de ribavirine.
4.0282770066672746e-13 ||| - you have not injected your insulin or not injected enough, or if it has become less effective, for ||| - you have not injected your insulin or not injected enough, or if it has become less effective, for ||| Par exemple, vous n’ avez pas ou pas assez injecté d’ insuline, ou si celle -ci est devenue moins efficace, du fait
0.3517322540283203 ||| There was a 2.5- to 3-fold increase in steady-state AUC as the dose was increased from 500 mg to 1000 mg twice daily. ||| After single dose administration in the dose range of 75 to 600 mg, a 2-fold increase in dose results in a ~2.3 and 2.6- fold increase in AUC and Cmax, respectively. ||| On observe une augmentation de facteur 2,5 à 3 de l'ASC à l'état d'équilibre avec une augmentation de la dose de 500 mg à 1000 mg deux fois par jour.
0.10832728445529938 ||| What RELISTOR looks like and contents of the pack ||| What SINGULAIR looks like and contents of the pack ||| Qu’ est -ce que RELISTOR et contenu de l’ emballage extérieur
0.2884994149208069 ||| It is recommended that Atripla be taken on an empty stomach since food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 4.8). ||| Moreover, switching from leflunomide to another DMARD without following the washout procedure (see section 4.4) may also increase the risk of serious adverse reactions even for a long time after the switching. ||| 2 Il est recommandé de prendre Atripla à jeun, car la prise concomitante de nourriture peut augmenter l’ exposition à l’ éfavirenz et peut entraîner une augmentation de la fréquence des effets indésirables (voir rubriques 4.4 et 4.8).
0.1368764340877533 ||| 55.9; 83.0) 70.8% (95% CI: ||| 55.9; 83.0) 12.4 (95% CI: ||| 55,9; 83,0) 70 ,8% (95% IC:
0.4048113226890564 ||| Olanzapine is metabolized in the liver by conjugative and oxidative pathways. ||| The oxidative metabolites are further metabolised by conjugation via glucuronidation. ||| 61 L’ olanzapine est métabolisée dans le foie par conjugaison et oxydation.
2.661927210774462e-13 ||| This can be caused if: • you take too much Humalog or other insulin; • you miss or delay meals or change your diet; • you exercise or work too hard just before or after a meal; • you have an infection or illness (especially diarrhoea or vomiting); • there is a change in your need for insulin; or • you have trouble with your kidneys or liver which gets worse. ||| This can be caused if: • you take too much Humalog or other insulin; • you miss or delay meals or change your diet; • you exercise or work too hard just before or after a meal; • you have an infection or illness (especially diarrhoea or vomiting); • there is a change in your need for insulin; or • you have trouble with your kidneys or liver which gets worse. ||| Hypoglycémie L’hypoglycémie (pas assez de sucre dans le sang) signifie qu'il n'y a pas suffisamment de sucre dans le sang et peut être provoquée par: • une dose trop élevée d'Humalog ou d'une autre insuline; • le fait que vous sautiez ou retardiez vos repas ou changiez de régime alimentaire; • des exercices ou des activités intenses juste avant ou après un repas; • une infection ou une maladie (en particulier des diarrhées ou vomissements); • un changement de vos besoins en insuline; • une insuffisance rénale ou hépatique en voie d'aggravation;
0.33743152022361755 ||| The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4. ||| (See Section 4.8 Undesirable Effects.) However, there is evidence to suggest that heterotopic ossification is not linked to sarcoma in humans. ||| Les effets d’un surdosage avec GONAL-f ne sont pas connus, néanmoins, chez la femme, un syndrome d’hyperstimulation ovarienne n’est pas exclu (se reporter à la rubrique 4).
0.43311864137649536 ||| Linearity/ non linearity The kinetics of ivabradine is linear over an oral dose range of 0.5 – 24 mg. ||| - on the level of endometrial hyperplasia, the trial on the 1 mg estradiol/ 0.1 mg NETA product ||| Linéarité/ non-linéarité La cinétique de l’ ivabradine est linéaire pour des doses orales comprises entre 0,5 et 24 mg.
0.3522307574748993 ||| Nephrolithiasis Fatigue Influenza-like illness Pyrexia ||| Asthenia Influenza-like illness Oedema peripheral Thirst Investigations: ||| Lithiase rénale Fatigue Syndrome pseudo-grippal Pyrexie
0.150350421667099 ||| What Zenapax looks like and contents of the pack ||| 30 What Noxafil looks like and contents of the pack ||| isé A quoi ressemble Zenapax et contenu de l’ emballage extérieur
0.0 ||| This will provide financial relief to beneficiaries. ||| This will provide financial relief to beneficiaries. ||| Cela reviendra à apporter une assistance financière aux bénéficiaires;
0.3457501232624054 ||| Clip clamps of metal ||| Cotter pins of metal ||| Pinces à clip en métal
0.23955237865447998 ||| Thermocouple wires ||| Thermocouple blocks ||| Fils de thermocouples
0.2755638360977173 ||| Do not use Fuzeon ||| Do not take Suboxone ||| N’ utilisez jamais Fuzeon
0.3909885287284851 ||| We are exchanging further with the World Organisation for Animal Health, so that they may benefit from the project's experience in the field, to extend its epidemio-surveillance activities to the presence of coronavirus in wildlife. ||| I am very pleased that today, together with the European Investment Bank, we are extending our support to BioNTech, which is yet another concrete step towards our goal of getting a vaccine and ensuring access to it for all." ||| L'UE poursuit ses échanges avec l'Organisation mondiale de la santé animale, de façon à ce que l'expérience acquise sur le terrain dans le cadre du projet puisse être exploitée pour étendre ces activités de surveillance épidémiologique à la présence du coronavirus au sein de la faune sauvage.
0.16709044575691223 ||| If you are taking any of these medicines, tell your doctor immediately. ||| Please tell your doctor if you are taking any of the following medicines. ||| 156 Prévenez immédiatement votre médecin si vous prenez l'un de ces médicaments.
0.3469858169555664 ||| You must use adequate contraception to prevent pregnancy during treatment and up to 4 months after receiving the last dose of Simulect. ||| For procedures with an inherent bleeding risk, discontinue Xigris for 2 hours prior to the start of the procedure. ||| Vous devez utiliser une contraception efficace pendant le traitement et jusqu’ à 4 mois après avoir reçu la dernière dose de Simulect.
0.3462461829185486 ||| If you switch from the mini-pill to EVRA • You may start EVRA any day after stopping the mini-pill • The first day after stopping the mini-pill, put on a patch • Use a non-hormonal contraceptive until Day 8, when you change your patch. ||| Do not repeat Section 2 for routine use, if you do, you will run out of BYETTA before 30 days of use. • You are now ready for your first dose of BYETTA. • Go to Section 3, Step 3, for instructions on how to inject your first routine dose. ||| Si vous passez d’une pilule minidosée à EVRA • Vous pouvez commencer EVRA n’importe quel jour en relais d’une pilule minidosée • Appliquez le patch dès le premier jour après avoir arrêté la pilule minidosée • Utilisez un contraceptif non hormonal jusqu’au Jour 8, lorsque vous changerez votre patch.
0.42830753326416016 ||| During maintenance treatment, corticosteroids may be tapered in accordance with clinical practice guidelines. ||| Check that antibiotic prescriptions follow antibiotic treatment protocols, based on evidence-based guidelines. ||| Pendant le traitement d'entretien, les corticoïdes pourront être progressivement diminués conformément aux recommandations de pratique clinique.
0.16345420479774475 ||| How has Avaglim been studied? ||| How has Netvax been studied? ||| Quelles études ont été menées avec Avaglim?
6.191115328735286e-13 ||| You should check with your doctor or pharmacist if you are not sure. ||| You should check with your doctor or pharmacist if you are not sure. ||| Il est impératif que vous vérifiez auprès de votre médecin ou de votre pharmacien en cas de doute.
6.267470266732578e-13 ||| 28 1. ||| 28 1. ||| 30 1.
0.33549636602401733 ||| - hepatotoxicity based on an increase in hepatic enzymes (e. g. aspartaminotransferase) and a ||| - Cyclosporin and tacrolimus (used for immune system suppression e. g. after transplants) ||| - hépatotoxicité caractérisée par une augmentation des enzymes hépatiques (par exemple
0.044470641762018204 ||| Insuman Rapid pre-filled pen, OptiSet, is not designed to allow any other insulin to be mixed in the cartridge. ||| Insuman Rapid pre-filled pen, SoloStar, is not designed to allow any other insulin to be mixed in the cartridge. ||| Insuman Rapid, stylo prérempli, OptiSet, n'est pas conçu pour permettre de mélanger une autre insuline dans la cartouche.
0.6317174434661865 ||| 13 (2.8) 8 (1.7) 5 (1.1) ||| (2.1) (1.8) (1.7) (2.1) ||| 13 (2,8) 4 (0,9)
0.34129804372787476 ||| Neutropenia (ANC < 1.5 x 109/ l) was reported in 2.4% patients receiving Kineret compared with 0.4% of placebo patients. ||| Severe (grade 3/ 4) neutropenia was reported in 4.2%, anaemia in 1.1% and thrombocytopenia in 1.7% of the patients. ||| Une neutropénie (PNN < 1,5 x 109/ l) a été observée chez 2,4% des patients traités par Kineret contre 0,4% des patients sous placebo.
0.03548671305179596 ||| When treating HIV infection, it is not always possible to tell whether some of the undesirable effects that occur are caused by Ziagen, by other medicines you are taking at the same time or by the HIV disease. ||| When treating HIV infection, it is not always possible to tell whether some of the unwanted effects are caused by Atripla or by other medicines that you are taking at the same time, or by the HIV disease itself. ||| Chez les patients infectés par le VIH, il n'est pas toujours possible de déterminer si les effets indésirables observés sont dus à Ziagen, ou à d'autres médicaments pris simultanément, ou à la maladie due au VIH.
0.8033251762390137 ||| Area (m) ||| Time (min) o ||| corporelle (m²)
0.3827381134033203 ||| Somatropin may induce a state of insulin resistance and in some patients hyperglycaemia. ||| Celecoxib may mask fever and other signs of inflammation. ||| La somatropine peut induire une insulino-résistance ainsi qu'une hyperglycémie chez certains patients.
0.5369068384170532 ||| Analogue circuits ||| Opotherapy preparations ||| Circuits analogiques
0.4146650433540344 ||| What ViraferonPeg is and what it is used for 2. ||| What M-M-RVAXPRO is and what it is used for 2. ||| Qu’ est -ce que ViraferonPeg et dans quel cas est -il utilisé 2.
0.3027524948120117 ||| The accumulation of bosentan in hepatocytes leading to cytolysis with potentially severe damage of the liver, or an immunological mechanism, are not excluded. ||| When there are spinal metastases at the cervico-dorsal level, an increased risk of spinal cord compression cannot be excluded. ||| Un mécanisme immuno- allergique ou la possibilité d’ une accumulation du bosentan dans les hépatocytes entraînant une cytolyse et un risque potentiel d’ atteinte hépatique sévère ne peuvent être écartés.
0.39446038007736206 ||| The data are limited but suggest that the pharmacokinetic profile in children and adolescents may be similar to that in adults. ||| The pharmacokinetic profile in patients less than 5 years old was similar to that of older and less severely affected patients. ||| Quoique limitées, les données suggèrent que le profil pharmacocinétique observé chez les enfants et les adolescents pourrait être similaire à celui des adultes.
0.30831947922706604 ||| In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not differ between the irbesartan/ hydrochlorothiazide and the placebo groups. ||| The findings observed in the 2-week and 13-week toxicity studies were consistent with those observed previously with aliskiren or hydrochlorothiazide monotherapies. ||| Lors des essais cliniques contrôlés versus placebo menés chez des patients hypertendus, l'incidence globale des événements indésirables n'a pas différé entre le groupe traité par irbésartan/ hydrochlorothiazide et le groupe recevant le placebo.
0.18530789017677307 ||| Jana Paw ł a II 29 PL-00- 867 Warszawa Tel.: + 48 (0) 22 653 68 00 ||| Al. jana Pawla II 29 PL-00- 867 Warszawa Tel.: + 48 (0) 22 653 68 00 ||| Jana Pawł a II 29 PL-00- 867 Warszawa Tel.: + 48 (0) 22 653 68 00
0.2834703326225281 ||| Macrolides inhibit bacterial protein biosynthesis by binding to the 50S ribosomal subunit and by preventing peptide chain elongation. ||| The non-genotoxic mechanism of pregabalin-induced tumour formation in mice involves platelet changes and associated endothelial cell proliferation. ||| Les macrolides inhibent la biosynthèse des protéines bactériennes en se fixant à l’ unité du ribosome 50S et en empêchant l’ élongation de la chaîne peptidique.
0.5997416973114014 ||| The primary areas of responsibility are inspection activities, document management and publishing, and conference services. ||| The aim is to improve diagnostics, preparedness, clinical management and treatment. ||| Les principaux domaines de responsabilité sont les activités d’inspection, la gestion et l’édition de documents et les services de conférence.
0.1122078001499176 ||| capsule shell: gelatin, titanium dioxide (E 171), sodium laurilsulfate, yellow iron oxide (E 172), indigo carmine (E 132). ||| - capsule shell: gelatin, titanium dioxide (E 171), sodium lauril sulfate, yellow iron oxide (E 172), ||| - parois de la gélule: gélatine, dioxyde de titane (E171), lauryl sulfate de sodium, oxyde de
0.03941274806857109 ||| The first injection (2ml) can be given from an age of 3 days, second injection (2 ml) 2-3 weeks later. ||| The first injection (2 ml) can be given from an age of 3 days, with the second injection (2 ml) 2-3 weeks later. ||| La première injection (2 ml) peut être réalisée à partir de l’ âge de 3 jours, suivie d’ une seconde injection (2 ml) 2-3 semaines plus tard.
0.5457935929298401 ||| Shelf life of the veterinary product as packaged for sale: ||| EXP Read the leaflet for the shelf life of the reconstituted product ||| Durée de conservation du médicament vétérinaire tel que conditionné pour la vente:
0.20457720756530762 ||| The volume of distribution at steady state (Vss) was approximately 18-19 litres. ||| The volume of distribution at steady state (Vdss) was approximately 120 l in humans. ||| Le volume de distribution à l’ état d’ équilibre (VD) a été d’ environ 18-19 litres.
0.0 ||| Ear and labyrinth disorders: ||| Ear and labyrinth disorders: ||| Troubles auditifs et labyrinthiques
0.4478107988834381 ||| Standard procedures for management of overdose may be indicated (i. e. gastric lavage, administration of activated charcoal). ||| 4 parenteral hydration, urine alkalinisation and dialysis should be promptly established, as indicated. ||| La prise en charge standard d 'surdosage peut être utilisée (lavage gastrique, un administration de charbon activé).
0.010018443688750267 ||| 34 No interaction studies have been performed with ADVATE. ||| 44 No interaction studies have been performed with ADVATE. ||| Aucune étude d’ interaction n’ a été réalisée avec ADVATE
0.36002472043037415 ||| The opinion should take into account the global safety profile of terfenadine in comparison with existing alternative non sedative anti-histamines (NSAHs) drugs available for the same indications in the European Union. ||| Whilst there is no controlled epidemiological data on the risk with Angiotensin II Receptor Antagonists (AIIRAs), similar risks may exist for this class of drugs. ||| L’ avis devrait prendre en compte le profil de sécurité global de la terfénadine en comparaison aux autres antihistaminiques non sédatifs (AHNS) existants, disponibles pour les mêmes indications dans l’ Union Européenne.
0.03058062121272087 ||| 247 6.5 Nature and contents of container ||| 191 6.5 Nature and contents of container ||| 6.5 Nature et contenu de l'emballage extérieur
0.09029419720172882 ||| Revasc is contraindicated in pregnancy (see section 4.3). ||| Arava is contraindicated in pregnancy (see section 4.3). ||| Revasc est contre- indiqué pendant la grossesse (voir rubrique 4.3).
0.404963880777359 ||| Supporting global efforts to combat export restrictions and ensure supply chains remain intact, notably for essential medical supplies and pharmaceuticals; ||| MEPs also voice their support for increasing EU production of key products such as medicines, pharmaceutical ingredients, medical devices, equipment and materials, to be better prepared for future global shocks. ||| soutenir les efforts déployés à l'échelle planétaire pour combattre les restrictions à l'exportation et préserver l'intégrité des chaînes d'approvisionnement, notamment celles des équipements médicaux et des produits pharmaceutiques essentiels;
0.0385441854596138 ||| Increased alkaline phosphatase ||| Increased alkaine phosphatase ||| Augmentation des phosphatases alcalines
0.1407049596309662 ||| The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolised via CYP3A4 (alprazolam, triazolam) should be considered when co- administering these agents with EMEND (125 mg/ 80 mg). ||| The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolised via CYP3A4 (alprazolam, triazolam) should be considered when co-administering these agents with a 3-day regimen of fosaprepitant followed by aprepitant. ||| Les effets potentiels des concentrations plasmatiques accrues du midazolam ou d’autres benzodiazépines métabolisées par le CYP3A4 (alprazolam, triazolam) doivent être envisagés en cas de co-administration de ces médicaments et d’ EMEND (125 mg/80 mg).
0.33527857065200806 ||| - The active substance is doxazosin (as the mesilate). ||| - The active substance is aliskiren (as hemifumarate) 150 mg. ||| - La substance active est la doxazosine (sous forme de mésilate).
0.15977829694747925 ||| 50 A. ||| 50 B. ||| 55 A.
0.3032558560371399 ||| Your doctor may adjust the dose to 2.5 mg based on your response to CIALIS. ||| The dose may be adjusted up to 120 mg a day based on your response to XERISTAR. ||| Votre médecin pourra adapter la dose à 2,5 mg en fonction des résultats obtenus avec CIALIS.
0.0 ||| Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses. ||| Standard measures to prevent infections resulting from the use of medicinal products prepared from human blood or plasma include selection of donors, screening of individual donations and plasma pools for specific markers of infection and the inclusion of effective manufacturing steps for the inactivation/removal of viruses. ||| Les mesures habituelles de prévention du risque de transmission d’agents infectieux par les médicaments préparés à partir de sang ou de plasma humain comprennent la sélection clinique des donneurs, la recherche des marqueurs spécifiques d’infection sur chaque don et sur les mélanges de plasma ainsi que la mise en oeuvre dans le procédé de fabrication d’étapes efficaces pour l’inactivation/élimination virale.
0.1299564391374588 ||| What Intrinsa is and what it is used for 2. ||| What Humalog is and what it is used for 2. ||| Qu’ est -ce qu’ Intrinsa et dans quel cas est -il utilisé 2.
0.4693749248981476 ||| Driving and using machines At the recommended dose, Neoclarityn is not expected to cause you to be drowsy or less alert. ||| Injecting Ceplene yourself Your doctor may decide that it would be more convenient for you to inject IL-2 and Ceplene yourself. ||| Conduite de véhicules et utilisation de machines A la dose recommandée, Neoclarityn ne rend généralement pas somnolent et ne diminue pas la vigilance.
0.2703520655632019 ||| Compared with biphasic human insulin, NovoMix 30 may have a more pronounced glucose lowering effect up to 6 hours after injection. ||| In healthy volunteers after intravenous administration, interferon beta-1a exhibits a sharp multi- exponential decline, with serum levels proportional to the dose. ||| 29 celui de l 'insuline humaine biphasique jusqu' 6 heures après l '
0.019869517534971237 ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. ||| La pioglitazone, principe actif d’ Actos, augmente la sensibilité 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.5140756368637085 ||| In most cases, these effects are mild and transient. ||| These effects are mild and temporary. ||| Dans la plupart des cas, ces effets sont bénins et transitoires.
0.8539255261421204 ||| Foam mattresses ||| Dia betes mellitus ||| Matelas en mousse
0.7407581210136414 ||| These energy savings, diversification and domestic production will help to build a more resilient European economy. ||| Together, Europe will arise more competitive, resilient and sovereign." ||| Ces économies d'énergie, la diversification et la production intérieure contribueront à renforcer la résilience de l'économie européenne.
0.0 ||| 6.6 Special precautions for disposal ||| 6.6 Special precautions for disposal ||| 6.6 Instructions pour l'utilisation, la manipulation et l' élimination
0.01740136370062828 ||| Actrapid FlexPen is designed to be used with NovoFine short cap needles of 8 mm or shorter in length. ||| Mixtard FlexPen is designed to be used with NovoFine short cap needles of 8 mm or shorter in length. ||| Actrapid FlexPen est conçu pour être utilisé avec les aiguilles NovoFine munies d’ une protection courte d’ une longueur maximale de 8 mm.
0.2759620249271393 ||| Developmental toxicity, including teratogenicity, was observed in rats and rabbits at dose levels of 150 mg/ kg and higher administered daily throughout organogenesis. ||| In the brain, microvacuolation has been observed in white matter tracts of rat, mouse and dog at doses of 30-50 mg/ kg/ day. ||| Une toxicité sur le développement du fœ tus, incluant une tératogénicité, a été observée chez le rat et le lapin aux doses de 150 mg/ kg et plus administrées quotidiennement tout au long de l’ organogenèse.
0.4919682741165161 ||| Certificates of a medicinal product ||| Certificates of a medicinal product 2000-2002 ||| Certificats d’un médicament
0.41846027970314026 ||| In addition, duration a pandemic, resources needed for an in-depth evaluation of Periodic Safety Update Reports in the format as defined in Volume 9a of the Rules Governing Medicinal Product in the European Union may not be adequate for a rapid identification of a new safety issue. ||| As a step in that direction, data on Total Official Support for Sustainable Development (TOSSD) will be collected for the first time in 2020, providing an overview of all officially-supported resources for the SDGs, beyond the flows captured in ODA. ||| De plus, durant une pandémie, les ressources nécessaires pour une évaluation approfondie des PSURs présentés comme défini dans le Volume 9a « Rules Governing Medicinal Product in the European Union » peuvent ne pas être appropriées pour une identification rapide de nouveaux signaux de tolérance.
0.01881295070052147 ||| Postural hypotension Postural hypotension was infrequently observed in the elderly in olanzapine clinical trials. ||| Postural hypotension Postural hypotension was infrequently observed in the elderly in oral olanzapine clinical trials. ||| 21 Hypotension orthostatique Une hypotension orthostatique a été rarement observée chez les sujets âgés lors des essais cliniques.
0.18175135552883148 ||| Brackets (Non-metallic -) for frames ||| Rollers (Non-metallic -) for sliding windows ||| Équerres non métalliques pour cadres
0.22254641354084015 ||| This is a special type of vaccine that is intended to protect against a strain of flu that may cause a future pandemic. ||| This is a special type of vaccine that can be developed to help with the management of a pandemic. ||| Il s’ agit d’ un type spécial de vaccin destiné à protéger contre une souche de grippe susceptible de provoquer une future pandémie.
0.4841577112674713 ||| Wood lacquers ||| Soft pretzels ||| Laques pour bois
0.3266694247722626 ||| Serum concentrations may be increased when co-administered with ritonavir resulting in the potential for increased incidence of adverse events. ||| Possible risk connected with the use of ephedrine in this group of animals can be reduced by appropriate management measures. ||| Les concentrations sériques peuvent être augmentées en cas d’administration concomitante avec le ritonavir, ce qui peut entraîner une incidence accrue des effets indésirables.
0.2051699310541153 ||| 49 Renal impairment: in patients with renal impairment or those undergoing haemodialysis, the pharmacokinetic parameters of irbesartan are not significantly altered. ||| 12 Renal impairment No dosage adjustment is required in patients with mild to moderate renal insufficiency, because Zerene pharmacokinetics is not altered in such patients. ||| Insuffisance rénale: les paramètres pharmacocinétiques de l'irbésartan ne sont pas significativement modifiés chez les insuffisants rénaux ou chez les patients soumis à une hémodialyse.
0.39352554082870483 ||| - excess fluid in the body (oedema); swelling of the arms and legs (peripheral oedema) ||| • have enlarged blood vessels in the gullet (oesophagus) (frequently caused by liver disease) ||| - excès de fluide dans le corps (œ dème), gonflement des bras et des jambes (œ dème périphérique)
0.3732966184616089 ||| One of the immediate economic consequences of the coronavirus pandemic is the sudden lack of liquidity affecting small and medium-sized businesses. ||| Given the economic impact of the coronavirus outbreak, the risk of insurers not being willing to issue this insurance has become higher. ||| L'une des conséquences économiques immédiates de la pandémie de coronavirus est le manque soudain de liquidités auquel font face les petites et moyennes entreprises.
0.33030545711517334 ||| Methotrexate doses were escalated from 7.5 mg/ week to a maximum of 20 mg/ week over the first 8 weeks of the trial and continued for up to 24 months. ||| Due to the sustained release from the injection site and the elimination half-life of about 40 hours (ranging from 12 to 70 hours), FSH levels remain increased for 24-48 hours. ||| Les doses de méthotrexate ont été augmentées de 7,5 mg/ semaine à 20 mg/ semaine maximum au cours des 8 premières semaines de l’ essai et maintenues jusqu’ à 24 mois.
0.25174546241760254 ||| High-density polyethylene (HDPE) bottles with child resistant screw cap (60 hard capsules per bottle), or ||| 100 hard capsule PVC/Aluminium blister pack (non-perforated) HDPE bottle containing 200 hard capsules. ||| Flacon en polyéthylène de haute densité avec bouchon de protection pour les enfants (60 gélules par flacon), ou
0.3519473075866699 ||| Safety evaluation of Tarceva is based on the data from 759 patients treated with at least one 150 mg dose of Tarceva monotherapy during Phase III NSCLC study BR.21, Phase II NSCLC study A248-1007, and three Phase II studies in populations other than NSCLC: ||| The consolidated analysis of Paediatric AIDS Clinical Trials Group (PACTG) protocols 245, 356, 366, 377, and 403 allowed for the evaluation of paediatric patients less than 3 months of age (n=17) enrolled in these PACTG studies. ||| L’évaluation de la tolérance de Tarceva est basée sur les données obtenues chez 759 patients ayant reçu au moins une dose de 150 mg de Tarceva en monothérapie lors des études suivantes: l’étude de phase III BR.21 dans le CBNPC, l’étude de phase II A248-1007 dans le CBNPC et trois études de phase II dans des populations traitées pour une autre pathologie que le CBNPC (248-101: cancer de l’ovaire; A248-1003: cancer de la tête et du cou, OSI2288g: cancer du sein métastatique) ainsi que
0.4111129641532898 ||| - if you have a history of autoimmune disease, or have had an organ transplant and are taking medicine that ||| - if you have had any lung disease in the past; are currently, or have been, an intravenous drug ||| - si vous avez une maladie auto-immune, ou avez eu une transplantation d’ organe et prenez un
0.3064979910850525 ||| - If you have recently got or are planning to get vaccinated, tell your doctor. ||| Please tell your doctor if you have recently received, or are receiving, radiotherapy. ||| Si vous avez récemment été vacciné ou si vous prévoyez de vous faire vacciner, informez votre
0.24899543821811676 ||| The efficacy of ECALTA in neutropenic patients with candidaemia and in patients with deep tissue Candida infections or intra-abdominal abscess and peritonitis has not been established. ||| Renal artery stenosis No data are available on the use of Sprimeo in patients with unilateral or bilateral renal artery stenosis, or stenosis to a solitary kidney. ||| L’ efficacité d’ ECALTA chez les patients neutropéniques avec une candidémie et chez les patients avec des candidoses profondes ou un abcès intra-abdominal ou une péritonite n’ a pas été établie.
0.3814711570739746 ||| Certain severe adverse drug reactions may be related to the rate of infusion. ||| Spontaneous serious adverse reactions of liver injury have been reported during the post marketing phase. ||| Certains effets indésirables graves peuvent être liés au débit de la perfusion.
0.40042853355407715 ||| Based on the draft OIP guideline, the Applicant initiated two parmacokinetic studies, both with a single dose administration of 800 µg salbutamol in healthy volunteers: studies 2007-59-DOS-5 (systemic safety study) and 2007-76-DOS-6 (pulmonary deposition study). ||| The EWP/ QWP joint group on pharmacokinetics, chaired by Professor José Guimarães Morais, met six times and continued its task on updating the existing note for guidance on bioavailability and bioequivalence, as well as on population pharmacokinetics (CPMP/ EWP/ QWP/ 1401/ 98). ||| Se fondant sur le projet de lignes directrices pour les PIO, le demandeur a lancé deux études pharmacocinétiques, toutes deux avec une administration d’ une dose unique de 800 µg de salbutamol chez des volontaires sains: études 2007-59- DOS-5 (étude de la sécurité systémique) et 2007-76-DOS-6 (étude du dépôt pulmonaire).
0.8235284090042114 ||| Kinzalkomb should not be used during the second and third trimester of pregnancy. ||| - 2nd and 3rd trimester of pregnancy (see sections 4.4 and 4.6) ||| Kinzalkomb est contre-indiqué au cours des 2ème et 3ème trimestres de la grossesse.
0.299730122089386 ||| ● Hold the barrel of the syringe with one hand and gently press the coloured needle protection device down on a flat surface until it covers the needle. ||| If no needle is available in the pack, use a needle not exceeding 25 mm in length to allow the needle guard to cover the needle completely. ||| • Prenez le corps de la seringue avec une main et faites remonter doucement le système de protection coloré en l’appuyant sur une surface plane jusqu’à ce qu’il recouvre l’aiguille.
0.040566518902778625 ||| Refludan should therefore not be administered to pregnant women or nursing mothers. ||| Refludan should not be administered to pregnant women or nursing mothers. ||| Par conséquent, Refludan ne doit pas être administré à la femme enceinte ou qui allaite.
0.49040448665618896 ||| No dosage adjustment is required in relation to age. ||| The period to onset of response cannot be assessed. ||| Aucune modification de posologie n’ est nécessaire chez les patientes âgées.
0.411050409078598 ||| The absolute risk increase for such events is unlikely to exceed 1% per year based on existing data (uncommon). ||| The frequency of these events is considered not known (cannot be estimated from the available data). ||| D’ après les données existantes, l’ augmentation du risque absolu pour de tels évènements ne devrait pas dépasser 1% par an (peu fréquent).
0.6313807964324951 ||| Press the injection button all the way in. ||| Drink the mixture all at once. ||| Pressez à fond le bouton d’injection.
0.3034657835960388 ||| When changing the route of administration the same dose must be used and the haemoglobin monitored every one or two weeks so that the appropriate dose adjustments can be made to keep the haemoglobin at the desired level. ||| Determine the number of vials to be reconstituted based on the individual patient’ s weight and remove the required vials from the refrigerator in order to allow them to reach room temperature (in approximately 30 minutes). ||| 185 Lorsque la voie d'administration est modifiée, il faut utiliser la même dose et contrôler le taux d'hémoglobine une fois par semaine ou toutes les deux semaines, de façon à adapter la dose pour maintenir le taux souhaité.
0.35018742084503174 ||| Subcutaneous injection into the abdominal wall ensures a faster absorption than from other injection sites. ||| NovoRapid has a shorter duration of action compared to soluble human insulin after subcutaneous injection. ||| Une injection par voie sous-cutanée dans la paroi abdominale assure une absorption plus rapide que dans les autres sites d’ injection.
0.22320321202278137 ||| In patients with chronic alcoholic liver disease, the AUC and peak plasma levels (Cmax) of loratadine were double while the pharmacokinetic profile of the active metabolite was not significantly changed from that in patients with normal liver function. ||| In an acute experimental study carried out in patients with mild to moderate renal impairment (creatinine clearance 30-80 ml/ min) versus healthy volunteers, peak plasma levels of nimesulide and its main metabolite were not higher than in healthy volunteers. ||| Chez des patients présentant une atteinte hépatique chronique d’ origine éthylique, l’ ASC et les pics de concentration plasmatiques (Cmax) de la loratadine observés ont été doublées alors que le profil pharmacocinétique du métabolite actif n’ était pas significativement modifié par rapport à celui des patients ayant une fonction hépatique normale.
0.38721442222595215 ||| ed How do I give my injection? ||| er How do I prepare my Nespo injection? ||| Comment me faire l'injection?
0.0 ||| The sixth and seventh 6-monthly safety update reports are expected in May 2008 and November 2008, respectively. ||| The sixth and seventh 6-monthly safety update reports are expected in May 2008 and November 2008, respectively. ||| Les sixième et septième rapports de sécurité actualisés semestriels sont attendus respectivement en mai 2008 et en novembre 2008.
0.3436797857284546 ||| The major symptom requiring intervention is respiratory depression, which could lead to respiratory arrest and death. ||| The most serious risk associated with CellCept is the possible development of cancer, particularly lymphoma and skin cancer. ||| Le principal symptôme nécessitant une intervention médicale est la dépression respiratoire, qui peut conduire à un arrêt respiratoire et à la mort.
0.23593387007713318 ||| After control of the disease the vaccine should be administered. • if your child has a bleeding problem or bruises easily • if your child has a tendency to seizures/ fits due to a fever, or if there is a history in the family of this As with all vaccines, Infanrix hexa may not completely protect all people who are vaccinated. ||| After control of the disease the vaccine should be administered • if your child has a bleeding problem or bruises easily • if your child has a tendency to seizures/ fits due to a fever, or if there is a history in the family of this ||| Une fois la maladie contrôlée, le vaccin pourra être administré • si votre enfant a des problèmes hémorragiques ou s’ il se fait des ecchymoses facilement • si votre enfant a une prédisposition ou des antécédents familiaux de convulsions fébriles Comme avec tous les vaccins, Infanrix hexa peut ne pas protéger complètement toutes les personnes vaccinées.
0.31185781955718994 ||| In a polyarticular juvenile idiopathic arthritis trial with Enbrel, 69 patients (aged 4 to 17 years) were administered 0.4 mg Enbrel/ kg twice weekly for three months. ||| EXJADE has been investigated in 411 adult (age ≥ 16 years) and 292 paediatric patients (aged 2 to < 16 years) with chronic iron overload due to blood transfusions. ||| Dans un essai d’ Enbrel dans l’ arthrite juvénile idiopathique polyarticulaire, 69 patients (âgés de 4 à 17 ans) ont reçu 0,4 mg d'Enbrel/ kg deux fois par semaine pendant trois mois.
0.16038188338279724 ||| If a further dose increase is necessary the daily dose should be increased by 0.54 mg base (0.75 mg salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day. ||| Maintenance treatment The individual dose should be in the range of 0.264 mg of base (0.375 mg of salt) to a maximum of 3.3 mg of base (4.5 mg of salt) per day. ||| 20 Si une posologie supérieure est nécessaire, la dose quotidienne peut être augmentée de 0,54 mg de forme base (0,75 mg de forme sel) par semaine, jusqu'à la dose maximale de 3,3 mg de forme base (4,5 mg de forme sel) par jour.
0.3619002103805542 ||| This is why the Commission is coordinating action with Member States to ensure the continued flow of goods and functioning the internal market. ||| A strong focus will be put on the transport and energy links, which are crucial for the economic development of the region and the EU alike. ||| C'est la raison pour laquelle la Commission coordonne des actions avec les États membres en vue de garantir la continuité du flux de marchandises et le fonctionnement du marché intérieur.
0.3608333170413971 ||| This article covers revenue from programmes carried out jointly with other regulatory agencies (inside and outside the EU), pharmaceutical companies or other bodies authorised by the EMEA's Management Board. ||| Evaluations by the EMEA for centrally authorised products may be recognised by the national authorities of central and eastern European countries through a simplified recognition procedure, at the request of the marketing authorisation holder. ||| 0.— Cet article est destiné à recevoir les revenus provenant de programmes menés conjointement avec d'autres agences de régulation (à l'intérieur comme à l'extérieur de l'UE), des sociétés pharmaceutiques ou d'autres organes agréés par le conseil d'administration de l'Agence.
0.3977324366569519 ||| - Infection of the lungs (pneumonia) acquired outside the hospital, except severe cases ||| - Infections caused by fungi of the Aspergillus family that have not improved during treatment ||| - Infection des poumons (pneumonie) contractée en dehors de l’ hôpital, à l’ exception des cas
0.0017713853158056736 ||| 112 For the purpose of ambulatory use, the patient may remove Abseamed from the refrigerator and store it not above 25°C for one single period of up to 3 days. ||| 126 For the purpose of ambulatory use, the patient may remove Abseamed from the refrigerator and store it not above 25°C for one single period of up to 3 days. ||| Pour l’ usage ambulatoire, le patient peut sortir Abseamed du réfrigérateur et le conserver à une température ne dépassant pas 25°C pour une seule période de 3 jours maximum.
0.28892236948013306 ||| ho enoxaparin was associated with a significant decrease (54% - 95% CI, 44%; 63%) in the rate of VTE evaluated up to day 11 after surgery, irrespective of the type of surgery performed. ||| An interim analysis showed there was a significant prolongation of the time to progression of disease in the 10 mg/ kg group as compared with the placebo group (hazard ratio, 2.55; p < 0.001). ||| 44% - 63%]) l'incidence des événements thrombo-emboliques veineux (ETV) par rapport à l’ énoxaparine dans les 11 jours suivant l’ intervention, et ce quel que soit le type d’ intervention.
0.22182241082191467 ||| Frequently, the reduction in renal calcium excretion is accompanied by a fall in serum phosphate levels (in approximately 20% of patients), which is asymptomatic not requiring treatment. ||| Frequently, decreased renal calcium excretion is accompanied by a fall in serum phosphate levels not requiring therapeutic measures. ||| Fréquemment, la réduction de l’ excrétion rénale du calcium est accompagnée d’ une baisse asymptomatique de la phosphatémie (chez environ 20% des patients), ne nécessitant pas de traitement.
0.2881556749343872 ||| Creatinine clearance should be ≥ 45 ml/ min. ||| - Creatinine clearance ≥ 30 ml/ min ||| La clairance de la créatinine doit être supérieure ou égale à 45 ml/ min.
0.22033661603927612 ||| Pumps for medical purposes ||| Oils for toilet purposes ||| Pompes à usage médical
0.43272802233695984 ||| Fresh bean sprouts ||| Fresh string beans ||| Germes de soja frais
0.3515649437904358 ||| The solvent for reconstitution is presented in 2 ml pre-filled syringes (Type I glass) with a rubber stopper. ||| The Humira pre-filled pen is a single-use grey- and plum-coloured pen which contains a glass syringe with Humira. ||| Le solvant pour reconstitution est présenté en seringue préremplie de 2 ml (verre type I) avec bouchon en caoutchouc.
0.509463906288147 ||| Transportation of household effects ||| Transport of farm products ||| Transport d'effets personnels
0.3969420790672302 ||| Engineering services for the design of machinery ||| Training in the development of software systems ||| Services d'ingénierie pour la conception de machines
0.7508974075317383 ||| Excipients ||| Palpitations ||| 78 Excipients
0.42326319217681885 ||| Peach film-coated tablet of biconvex, oblong shape with the marking ‘ 500’ on the one side and ‘ Xeloda’ on the other side. ||| Oval, biconvex, red-brown, scored and marked with ‘ Organon’ on one side-and a code on the other side (TZ/ 5). ||| Comprimé pelliculé de couleur pêche, biconvexe, oblong avec inscription « 500 » sur une face et « Xeloda » sur l’ autre face.
0.9459282159805298 ||| PEN LABEL (SoloStar) ||| Ritonavir dose (TWICE DAILY) ||| ETIQUETTE DU STYLO (SoloStar)
0.26535797119140625 ||| Docetaxel in combination with trastuzumab was studied for the treatment of patients with metastatic breast cancer whose tumors overexpress HER2, and who previously had not received chemotherapy for metastatic disease. ||| The use of Pegasys and ribavirin combination therapy in chronic hepatitis C patients who failed prior treatment has not been adequately studied in patients who discontinued prior therapy for hematological adverse events. ||| Le docétaxel en association avec le trastuzumab a été évalué chez des patientes présentant un cancer du sein métastatique avec surexpression tumorale de HER2, n’ ayant pas reçu de chimiothérapie pour leur maladie métastatique.
8.294105961932641e-13 ||| Hepatic impairment: ||| Hepatic impairment: ||| 11 Insuffisance hépatique:
0.39075329899787903 ||| Sterilization, if performed properly, is an effective way of preventing bacteria from spreading. ||| Even when antibiotics are used appropriately, antibiotic resistance sometimes develops as a natural adaptive reaction of bacteria. ||| La stérilisation, si elle est effectuée correctement, est un moyen efficace d'empêcher la propagation des bactéries.
0.22185376286506653 ||| If you do not prime before each injection, you may get too much or too little insulin. ||| • If you do not prime, you may get too much or too little insulin. ||| Si vous ne purgez pas avant chaque injection, vous risquez de vous injecter une dose trop importante ou trop faible d'insuline.
0.33941325545310974 ||| In adults, all three indications are treated by a 10 mg daily dose of cetirizine. ||| Of these 108 patients, 27 were treated with the recommended dosage of infliximab 5 mg/ kg. ||| Chez l’ adulte, les trois indications sont traitées par une dose quotidienne de 10 mg de cétirizine.
0.061331868171691895 ||| WHAT SILGARD IS AND WHAT IT IS USED FOR ||| WHAT STAMARIL IS AND WHAT IT IS USED FOR ||| QU'EST-CE QUE SILGARD ET DANS QUEL CAS EST-IL UTILISE
0.3432599902153015 ||| Intravenous 2 mg midazolam was given 1 hour after oral administration of a single dose of EMEND 125 mg. ||| The recommended starting dose is one to two tablets of Suboxone 2 mg/ 0.5 mg sublingual tablets. ||| Deuxmg de midazolam ont été administrés par voie intraveineuse 1 heure après une dose unique d’EMEND 125 mg par voie orale.
0.5233820080757141 ||| 31 Special populations ||| Special patient populations ||| Populations particulières
0.9150109887123108 ||| Adult respiratory distress syndrome ||| Upper 3.4 respiratory tract infection ||| syndrome de détresse respiratoire.
0.015169568359851837 ||| What Tredaptive looks like and contents of the pack Each modified-release tablet is a capsule-shaped, white to off-white tablet, with “ 552” debossed on one side. ||| What Trevaclyn looks like and contents of the pack Each modified-release tablet is a capsule-shaped, white to off-white tablet, with “ 552” debossed on one side. ||| Qu’ est -ce que Tredaptive et contenu de l’ emballage extérieur Le médicament est présenté sous forme de comprimé à libération modifiée ovale, blanc à blanc cassé, portant l’ inscription « 552 » gravée sur une face.
4.016102771522978e-13 ||| Single-dose administration of Puregon to rats induced no toxicologically significant effects. ||| Single-dose administration of Puregon to rats induced no toxicologically significant effects. ||| 34 L'administration d'une dose unique de Puregon chez le rat n'a induit aucun effet toxicologique significatif.
0.015874158591032028 ||| 75 Italia GlaxoSmithKline S.p.A. ||| 34 Italia GlaxoSmithKline S.p.A. ||| Italia GlaxoSmithKline S.p.A.
0.33317941427230835 ||| There is evidence that the concentration of macrolides is higher at the site of infection than in plasma, in particular in neutrophils, alveolar macrophages and alveolar epithelial cells. ||| In humans, consistent with passive transmission of lamivudine across the placenta, lamivudine concentrations in infant serum at birth were similar to those in maternal and cord serum at delivery. ||| On a pu constater que la concentration de macrolides est plus importante au siège de l’ infection que dans le plasma, tout particulièrement dans les neutrophiles, les macrophages alvéolaires et es cellules épithéliales alvéolaires.
0.07018120586872101 ||| Always take Telzir exactly as your doctor has told you. ||| Always take Tyverb exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3489818274974823 ||| There is no evidence from studies in rats and rabbits that filgrastim is teratogenic. ||| Studies in pregnant rats and rabbits showed that telbivudine crosses the placenta. ||| Des études chez le rat et le lapin n'ont pas mis en évidence d'effet tératogène du filgrastim.
0.1630408763885498 ||| Patients with renal or hepatic impairment: ||| Patients with impaired hepatic or renal function ||| Insuffisants rénaux ou hépatiques:
0.013896054588258266 ||| Isolated cases of sickle cell crises have been reported in patients with sickle cell disease (see section 4.4). ||| Isolated cases of sickle cells crises have been reported in patients with sickle cell disease (see section 4.4). ||| Des cas isolés de crises drépanocytaires ont été rapportés chez des patients atteints d’ anémie falciforme (voir rubrique 4.4).
0.0 ||| Name and address of the manufacturer of the biological active substance ||| Name and address of the manufacturer of the biological active substance ||| Nom et adresse du fabricant du(es) principe(s) actif(s) d'origine biologique
0.4646475911140442 ||| This will contribute to the stabilisation of the country by promoting a return to security and the presence of civil administration, public services and economic activities. ||| We will target key sectors for economic development, such as energy, transport and the environment in order to foster enhanced growth. ||| Cela contribuera à la stabilisation du pays en favorisant le retour à la sécurité et la présence de l'administration civile, des services publics et des activités économiques.
0.49741896986961365 ||| ► Keep out of the reach and sight of children. ||| [To be completed nationally] Keep out of the reach and sight of children. ||| 25 ► Tenir hors de la portée et de la vue des enfants.
0.14125415682792664 ||| Side effects are uncommon in patients treated with Circadin, but the most common side effects (seen in between 1 and 10 patients in 1,000) are irritability, nervousness, restlessness, insomnia, abnormal dreams, migraine, psychomotor hyperactivity (restlessness with increased activity), dizziness, somnolence (drowsiness), abdominal (tummy) pain, constipation, dry mouth, hyperbilirubinaemia (raised blood levels of bilirubin, a breakdown product of red blood cells, which can cause yellowing of the skin and eyes), hyperhidrosis (excessive sweating), asthenia (weakness) and increased weight. ||| Others visual disturbances may occur very rarely in patients who received higher doses than recommended. • Muscle and joint disorders - joint, muscle and bone pain, leg cramps and abnormal weakness of certain muscles (myasthenia). • Nerve disorders - numbness and tingling of your skin (which resolved in about 40 to 60% of patients), tiredness, dizziness, nervousness, depression, abnormal thoughts, insomnia, reduced mobility (hypokinesia), reduced sensory perception (hypaesthesia), gait disorders, altered taste and headache. ||| Les effets indésirables sont rares chez les patients traités par Circadin; les effets indésirables les plus fréquemment observés (chez 1 à 10 patients sur 1 000) sont l’ irritabilité, la nervosité, l’ agitation, l’ insomnie, les rêves anormaux, la migraine, l’ hyperactivité psychomotrice (agitation sans augmentation de l’ activité), les vertiges, la somnolence, les douleurs abdominales (au ventre), la constipation, la sécheresse buccale, l’ hyperbilirubinémie (augmentation des taux sanguins de bilirubine, produit de la décomposition des globules rouges qui peut provoquer un jaunissement de la peau et des yeux), l’ hyperhydrose (transpiration excessive), l’ asthénie (faiblesse) et une prise de poids.
0.22545528411865234 ||| - if you are taking ciclosporin (a medicine used in transplantation to prevent organ rejection or for ||| - ciclosporin (used to prevent the body rejecting a transplanted organ or for other conditions, such ||| - si vous prenez de la ciclosporine (un médicament utilisé en cas de greffe d’ organe pour prévenir
0.39718398451805115 ||| Hold the syringe slightly tilted with the vial facing downwards. ||| Hold the pen with the needle pointing upwards. ||| Tenez la seringue légèrement inclinée avec le flacon tourné vers le bas.
0.4139370322227478 ||| Broadcasting services ||| Tiling services ||| Services de diffusion
0.4894680976867676 ||| Dessert souffles ||| Salted tarts ||| Soufflés (desserts)
0.4772850275039673 ||| Surgery on the primary site of disease and/ or neck could be considered at anytime following completion of CRT. ||| In women transferring from sequential HRT regimens, treatment should start right after their withdrawal bleeding has ended. ||| La chirurgie du site primitif de la tumeur et/ ou du cou pouvait être envisagée à tout moment à l’ issue de la CRT.
0.32394760847091675 ||| The half-life of aprepitant is 25% lower in females as compared with males and its tmax occurs at approximately the same time. ||| Thelin was teratogenic at the lowest tested dose in rats, corresponding to exposures more than 30 times the human exposure. ||| La demi-vie de l’aprépitant a été inférieure de 25% chez les femmes comparée aux hommes, alors que le tmax survient approximativement au même moment.
0.0872211903333664 ||| The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Apidra cartridges, and as recommended in the information provided by the device manufacturer. ||| Insulin pen The cartridges are to be used in conjunction with an insulin pen such as OptiPen and other pens suitable for Optisulin cartridges, and as recommended in the information provided by the device manufacturer. ||| Les cartouches doivent être utilisées avec un stylo à insuline tel qu'OptiPen ou avec d’ autres stylos compatibles avec les cartouches Apidra, et conformément aux instructions du fabricant du dispositif.
0.3903960585594177 ||| Hirsutism was also very commonly reported. ||| Rhabdomyolysis has also been reported rarely. ||| 4 Des cas d’ hirsutisme ont également été très fréquemment rapportés.
0.2519719898700714 ||| The most likely signs of an overdose of Remeron (without other medicines or alcohol) are drowsiness, disorientation and increased heart rate. ||| The most frequent adverse reactions reported for loratadine in excess of placebo were somnolence, headache, increased appetite and insomnia. ||| Les effets les plus probables d’un surdosage de Remeron (quand il n’est pas associé à d’autres médicaments ni à l’alcool) sont une somnolence, une désorientation et une augmentation de la fréquence cardiaque.
0.44596219062805176 ||| To finance the proposed recovery measures, the Commission will borrow up to €750 billion on the financial markets on behalf of the Union, for recovery measures over the period 2021-2024. ||| The three pillars are expected to mobilise at least €150 billion of investments in the EU economy over the period 2021 - 2027. ||| Afin de financer les mesures de reprise proposées, la Commission empruntera jusqu'à 750 milliards € sur les marchés financiers au nom de l'Union, destinés à des mesures de reprise pour la période 2021-2024.
0.4429095983505249 ||| Slowly inject the reconstituted Myozyme directly into the 0.9% sodium chloride solution. ||| It is then further converted in the kidneys to 1,25 hydroxycholecalciferol. ||| Injecter lentement le Myozyme reconstitué directement dans la solution de chlorure de sodium à 0,9%.
0.08271728456020355 ||| This difference is not considered clinically relevant. ||| This difference is not clinically relevant. ||| Cette différence n’ est pas considérée comme cliniquement significative.
0.13070689141750336 ||| s ori Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/ ||| This leaflet was last approved in Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/ ||| au Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne du médicament (EMEA) http://www.emea.europa.eu/
0.30548739433288574 ||| 17 Your doctor will assess whether you should take Avamys with these medicines. ||| Your doctor should decide whether you can take YENTREVE with other medicines. ||| Votre médecin évaluera si vous pouvez prendre Avamys avec ces médicaments.
0.3726288080215454 ||| Congenital neutropenia The recommended starting dose is 1.2 MU/ kg/ day (12 μ g/ kg/ day) as a single dose or in divided doses. ||| Mean steady state clearance is 24 ml/ kg/ day (range 5-76 ml/ kg/ day) at 1 mg/ kg/ week subcutaneous. ||| Neutropénie congénitale La dose initiale recommandée est de 1,2 MU/ kg/ jour (12 µg/ kg/ jour) en dose unique ou en doses fractionnées.
0.40972888469696045 ||| The content must be clear and colourless. ||| The content must be clear and colourless after reconstitution. ||| Le contenu doit être limpide et incolore.
0.25143784284591675 ||| EMADINE is a medicine for the treatment of seasonal allergic conjunctivitis of the eye (allergic conditions of the eye). ||| OPATANOL is used for the treatment of signs and symptoms of seasonal allergic conjunctivitis. ||| EMADINE est utilisé pour traiter les conjonctivites allergiques saisonnières de l’œ il (situations allergiques de l’œ il).
0.023470712825655937 ||| The hard capsule is brown, opaque and imprinted with “ BMS” over a BMS code “ 1965” on one side and “ 20” on the other side. ||| The hard capsule is dark orange, opaque and imprinted with “ BMS” over a BMS code “ 1967” on one side and “ 40” on the other side. ||| La gélule est brune opaque et gravée “ BMS” sur un code BMS “ 1965” d’ un côté et “ 20” de l’ autre côté.
0.16372472047805786 ||| If you have or develop severe kidney or liver problems, the treatment will be stopped. ||| If severe kidney or liver problems develop, this treatment will be stopped. ||| Si vous avez ou développez des problèmes rénaux ou hépatiques sévères, ce traitement sera arrêté.
0.7843111753463745 ||| The current human resource projections of each Unit are as follows: ||| The Administration Unit comprises two operational sectors: ||| Les prévisions actuelles en ce qui concerne les ressources humaines pour chaque unité sont les suivantes:
0.4275171160697937 ||| No data are available in patients with severe hepatic impairment. ||| This is especially likely in patients with renal insufficiency. ||| 27 patients présentant une insuffisance hépatique sévère.
0.3098365068435669 ||| Patients in an autologous blood predonation programme have been reported to show a slightly higher frequency of thromboembolic events. ||| GPs take nasopharyngeal swabs from persons showing acute respiratory illness within 7 days of the onset of symptoms. ||| On a rapporté chez des patients inclus dans un programme de transfusions autologues une fréquence légèrement supérieure d’ accidents thrombo-emboliques.
0.36348849534988403 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking Neulasta. ||| If you forget an injection of NovoSeven If you forget an injection, or if you want to stop the treatment, get your doctor's advice. ||| Si vous présentez une intolérance à certains sucres, contactez votre médecin avant de prendre Neulasta.
0.8842213153839111 ||| Bismuth nitrite ||| R-methadone ||| Nitrite de bismuth
0.04922489821910858 ||| Focetria has been authorised under “ Exceptional Circumstances”. ||| 17 Focetria has been authorised under “ Exceptional Circumstances”. ||| Focetria a été autorisé « sous circonstances exceptionnelles ».
0.7047522068023682 ||| Arthrosis, tendon pain ||| infections or bladder stones ||| Arthrose, tendinites
0.5327874422073364 ||| Fishing tackle ||| Fishing tackle floats ||| Attirail de pêche
0.5174850225448608 ||| Use of alcohol is discouraged since it alters N95 mask microfibres' static charge which helps filtration. ||| By attaching to hsp90, efungumab blocks the protein’ s normal activities. ||| La consommation d'alcool est déconseillée car elle altère la charge statique des microfibres du masque N95 qui aide à la filtration.
0.268643319606781 ||| However, there is no evidence that lamotrigine affects the pharmacokinetics of other AEDs and data suggest that interactions between lamotrigine and medicinal products metabolised by cytochrome P450 enzymes are unlikely to occur. ||| 41 Hydrochlorothiazide: although equivocal evidence for a genotoxic or carcinogenic effect was found in some experimental models, the extensive human experience with hydrochlorothiazide has failed to show an association between its use and an increase in neoplasms. ||| 70 D’ autre part, la lamotrigine ne semble pas affecter la pharmacocinétique des autres AEs et les données suggèrent que les interactions entre la lamotrigine et les médicaments métabolisés par les enzymes du cytochrome P450 sont peu probables.
0.0 ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| Retacrit should also be used with caution in the presence of epilepsy and chronic liver failure. ||| 97 Retacrit doit également être utilisé avec prudence en présence d’ épilepsie et d’ insuffisance hépatique chronique.
0.28966984152793884 ||| Why has Telzir been approved? ||| Why has Pritor been approved? ||| Pourquoi Telzir a -t-il été approuvé?
0.3279998302459717 ||| There are no adequate data from the use of parecoxib sodium in pregnant women or during labour. ||| There are no data on the efficacy of Panretin gel applied less frequently than twice daily. ||| Il n’ y a pas de données suffisantes sur l’ utilisation du parécoxib sodium chez la femme enceinte ou pendant le travail.
0.23114687204360962 ||| Driving and using machines There are no reasons to suspect that DUKORAL will affect your ability to drive or handle machines ||| Driving and using machines The possible side effects associated with Viani are unlikely to affect your ability to drive or use machines. ||| Conduite de véhicules et utilisation de machines Il n’ y pas de raison de penser que DUKORAL puisse avoir un effet sur l’ aptitude à conduire des véhicules ou à utiliser des machines.
0.30112800002098083 ||| Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded. ||| The enzyme responsible for the metabolism of desloratadine has not been identified yet, and therefore, some interactions with other medicinal products can not be fully excluded. ||| Malgré cela la possibilité d’une transmission d’agents infectieux ne peut pas être totalement exclue lors de l’administration de médicaments préparés à partir de sang ou de plasma humain.
0.7671703696250916 ||| Other information about Fevaxyn Pentofel: ||| Interactions relevant to lamivudine ||| Autres informations relatives à Fevaxyn Pentofel:
0.20101787149906158 ||| When treating HIV infection, it is not always possible to tell whether some of the undesirable effects that occur are caused by Ziagen, by other medicines you are taking at the same time or by the HIV disease. ||| For many of the other adverse reactions reported, it is unclear whether they are related to Ziagen, to the wide range of medicinal products used in the management of HIV infection or as a result of the disease process. ||| Chez les patients infectés par le VIH, il n'est pas toujours possible de déterminer si les effets indésirables observés sont dus à Ziagen, ou à d'autres médicaments pris simultanément, ou à la maladie due au VIH.
0.4204062223434448 ||| In CURE, the major bleeding event rate for clopidogrel+ASA was dose-dependent on ASA (< 100mg: ||| The placebo-adjusted improvement in mean 6MWD at week 12 in patients in the 10 mg group in ARIES-1 was 51.4 m (95% CI: ||| CURE: la fréquence des saignements majeurs dans le groupe clopidogrel + AAS était dépendante de la dose d’AAS (< 100 mg:
0.42157262563705444 ||| - Nefazodone (saquinavir/ ritonavir) ||| Zalcitabine and/or Zidovudine (saquinavir/ritonavir) ||| - Néfazodone (saquinavir/ ritonavir)
0.11049677431583405 ||| One vial contains 150 mg of omalizumab. ||| Each vial delivers 75 mg of omalizumab. ||| Un flacon contient 150 mg d’ omalizumab.
0.010593101382255554 ||| 42 The results of AI455-099 and AI455-096 are presented in the table below: ||| 20 The results of AI455-099 and AI455-096 are presented in the table below: ||| 49 Les résultats de AI455-099 et AI455-096 sont présentés dans le tableau ci-dessous:
0.49065348505973816 ||| STORING VISUDYNE ||| STORING WILZIN ||| COMMENT CONSERVER VISUDYNE
0.48158201575279236 ||| ic ||| ICH ||| am
0.4438788890838623 ||| Abbott Biotechnology Deutschland GmbH Max-Planck-Ring 2 D – 65205 Wiesbaden Germany ||| ratiopharm Arzneimittel Vertriebs- GmbH Albert-Schweitzer- Gasse 3, 1140 WIEN, Austria ||| Abbott Biotechnology Deutschland GmbH Max-Planck-Ring 2 D-65205 Wiesbaden Germany
0.2470560073852539 ||| Clinical studies have shown that cetirizine at the recommended dosage has minor undesirable effects on the CNS, including somnolence, fatigue, dizziness and headache. ||| Based on the data from these studies, severe adverse events such as diarrhoea, rash and possibly increased activity of liver aminotransferases may occur above the recommended dose. ||| Des effets indésirables sans gravité sur le système nerveux central, incluant somnolence, fatigue, vertiges et céphalées ont été observés au cours des essais cliniques réalisés avec la cétirizine à la dose préconisée.
5.619606342766037e-13 ||| In the event of either being observed, discard the vaccine. ||| In the event of either being observed, discard the vaccine. ||| En cas de non-conformité, jetez le vaccin.
0.28874334692955017 ||| In the systemic circulation, tacrolimus binds strongly to erythrocytes resulting in an approximate 20:1 distribution ratio of whole blood/ plasma concentrations. ||| The time to reach average maximum plasma concentration and bioavailability are functions of systemic interconversion and enterohepatic cycling of raloxifene and its glucuronide metabolites. ||| Dans la circulation systémique, le tacrolimus est fortement lié aux érythrocytes, avec pour résultat un rapport de distribution des concentrations sang total/ plasma d’ environ 20 pour 1.
0.5973727703094482 ||| Packaging Vial (amber glass) Vial (amber glass) Vial (amber glass) Vial (amber glass) Vial (amber glass) ||| Packaging Pre-filled pen (glass) Pre-filled pen (glass) Pre-filled pen (glass) Pre-filled pen (glass) ||| Flacon (verre ambré) Flacon (verre ambré) Flacon (verre ambré) Flacon (verre ambré) Flacon (verre ambré)
0.3332955539226532 ||| The MAH shall agree the details of an education programme for surgeons with the National Competent Authorities and must implement such programme nationally to ensure that: ||| The Marketing Authorisation Holder shall agree the educational material with the national competent authorities in all the Member States prior to the launch of the product ||| Le titulaire de l’autorisation de mise sur le marché (TAMM) doit convenir des détails d'un programme de formation des chirurgiens avec les autorités nationales compétentes et mettre nationalement en place un tel programme pour s'assurer que:
0.46229976415634155 ||| Lubrication oils for industrial refrigeration apparatus ||| Electrical coffee pots incorporating percolators ||| Huiles lubrifiantes pour appareils frigorifiques industriels
0.1031234934926033 ||| WHAT EPIVIR IS AND WHAT IT IS USED FOR ||| WHAT TRIZIVIR IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QU’ EPIVIR ET DANS QUEL CAS EST-IL UTILISE
0.0 ||| Common ||| Common ||| Agitation
0.12451761215925217 ||| 45 9. ||| 46 9. ||| 9.
0.0 ||| 4.8 Undesirable effects ||| 4.8 Undesirable effects ||| 179 4.8 Effets indésirables
0.0 ||| 43 ||| 43 ||| 42
3.3627953394989307e-13 ||| During a randomised withdrawal period, significantly more patients re-randomised to placebo experienced disease relapse (loss of PASI 75 response) compared with patients re-randomised to Enbrel. ||| During a randomised withdrawal period, significantly more patients re-randomised to placebo experienced disease relapse (loss of PASI 75 response) compared with patients re-randomised to Enbrel. ||| 128 Pendant une période randomisée d’ arrêt, un nombre signifativement plus élevé de patients re- randomisés dans le groupe placebo a présenté une rechute (perte de la réponse au PASI 75) en comparaison aux patients re-randomisés dans le groupe Enbrel.
0.5004934668540955 ||| 5 mg tablet ||| 500 mg twice ||| Comprimé à 5 mg
0.7911037802696228 ||| CPMP meetings ||| CVMP working parties ||| Réunions du CPMP
0.29542461037635803 ||| Thyrogen in combination with diagnostic radioiodine whole body scintigraphy is contra-indicated in pregnancy, because of the consequent exposure of the foetus to a high dose of radioactive material. ||| d rimonabant in milk and/ or inhibition of the suckling reflex that is reported in the literature to be initiated in neonatal mice by endocannabinoid signalling via CB1 receptors. ||| Thyrogen en association avec une scintigraphie du corps entier est contre-indiqué pendant la grossesse en raison de l’ exposition du fœ tus à des doses élevées d’ iode radioactif.
0.05053521692752838 ||| 45 A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin. ||| ut ra A few patients who have experienced hypoglycaemic reactions after transfer from animal source insulin to human insulin have reported that early warning symptoms of hypoglycaemia were less pronounced or different from those experienced with their previous insulin. ||| Quelques patients ayant ressenti des réactions hypoglycémiques après transfert d’ une insuline animale ont rapporté que leurs signes précurseurs d’ hypoglycémie étaient moins prononcés ou différents de ceux provoqués par leur précédente insuline.
0.34669798612594604 ||| No safety concerns were raised. ||| No additional safety concern was identified. ||| Aucun problème de sécurité ne s’ est posé.
0.0023805606178939342 ||| 32 Results from a multiple-dose probe study assessing P450 substrates in chronic hepatitis C patients receiving once weekly ViraferonPeg (1.5 µg/kg) for 4 weeks demonstrated an increase in activity of CYP2D6 and CYP2C8/9. ||| 9 Results from a multiple-dose probe study assessing P450 substrates in chronic hepatitis C patients receiving once weekly ViraferonPeg (1.5 µg/kg) for 4 weeks demonstrated an increase in activity of CYP2D6 and CYP2C8/9. ||| Les résultats d’ une étude exploratoire évaluant des doses multiples de substrats du cytochrome P450 chez des patients atteints d’ hépatite C chronique ayant reçu ViraferonPeg (1,5 µg/ kg) une fois par semaine pendant 4 semaines ont démontré une augmentation de l’ activité du CYP2D6 et CYP2C8/ 9.
0.11195889115333557 ||| If you have an allergic reaction, stop taking Januvia and call your doctor right away. ||| If you have an allergic reaction, stop taking TESAVEL and call your doctor right away. ||| Si vous avez une réaction allergique, arrêtez de prendre Januvia et contacter immédiatement votre médecin.
0.0 ||| patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l) ct ||| patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l) ct ||| 33 métastatique recevant une chimiothérapie, lorsque les ASEs étaient administrés dans le but d’ atteindre des taux cibles d’ hémoglobine compris entre 12 et 14 g/ dl (7,5-8,7 mmol/ l)
0.9467684626579285 ||| WARNING: ||| CAUTION: ||| ATTENTION:
0.0 ||| Keep out of the reach and sight of children. ||| Keep out of the reach and sight of children. ||| Ne le laisser ni à la portée ni à la vue des enfants.
0.6534682512283325 ||| Undesirable effects in medical patients ||| Serious infections requiring hospitalisation ||| Effets indésirables chez des patients en milieu médical
0.42424076795578003 ||| These reforms can be expected to come into force at the same time as the European Union welcomes new Member States. ||| Arbitration referrals may be expected to be received by the EMEA during the next 12 months. ||| Ces réformes devraient entrer en vigueur au moment où l'Union européenne accueillera de nouveaux États membres.
0.533043384552002 ||| Taking Rapamune with food and drink Rapamune should be taken consistently, either with or without food. ||| Taking SUTENT with food and drink SUTENT can be taken with or without food; however do not take SUTENT with grapefruit juice. ||| Aliments et boissons Rapamune doit être pris soit toujours avec, soit toujours sans nourriture.
0.0007703881710767746 ||| During clinical trials with ADVATE in 145 paediatric and adult patients 6 diagnosed with severe to moderately severe haemophilia A (FVIII ≤ 2%), with previous exposure to factor VIII concentrates ≥ 150 days, one patient developed a low-titre inhibitor (2.4 BU in the modified Bethesda assay) after 26 exposure days to ADVATE. ||| During clinical trials with ADVATE in 145 paediatric and adult patients 2 diagnosed with severe to moderately severe haemophilia A (FVIII ≤ 2%), with previous exposure to factor VIII concentrates ≥ 150 days, one patient developed a low-titre inhibitor (2.4 BU in the modified Bethesda assay) after 26 exposure days to ADVATE. ||| Au cours des essais cliniques avec ADVATE, sur 145 patients 6 pédiatriques et adultes ayant fait l’ objet d’ un diagnostic d’ hémophilie A sévère à modérément sévère (FVIII ≤ 2%) et précédemment exposés à des concentrés de facteur VIII pendant au moins 150 jours, un patient a développé un inhibiteur de faible titre (2,4 UB selon le test Bethesda modifié) après 26 jours d’ exposition.
0.3903335630893707 ||| GlaxoSmithKline UK Limited Stockley Park West Uxbridge Middlesex UB11 1BT UK ||| Bristol Myers Squibb Pharma EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom ||| Stockley Park West Uxbridge Middlesex UB11 1BT UK
0.32845163345336914 ||| Each carton contains 6 foil blisters of 6 capsules (36 capsules). ||| 180 soft capsules (5 cartons of 6 foil blisters of 6 capsules) ||| Chaque étui contient 6 blisters de 6 capsules (36 capsules).
0.5355516672134399 ||| The pharmacokinetics of aprepitant is non-linear across the clinical dose range. ||| The pharmacokinetic profile is linear with low intra- and inter-subject variability. ||| La pharmacocinétique de l'aprépitant est non linéaire sur l'éventail des doses cliniques.
0.01883648708462715 ||| The Commission found that the Swedish aid scheme will compensate damages that are directly linked to the coronavirus outbreak. ||| The Commission found that the French aid scheme will compensate damages that are directly linked to the coronavirus outbreak. ||| La Commission a estimé que le régime d'aides suédois compenserait les dommages directement liés à la pandémie de coronavirus.
0.29447755217552185 ||| Commissioner for Transport Adina Vălean said: "At a time when international air transport - severely hit by the COVID-19 crisis - is slowly picking up, the signature of such a Horizontal Agreement provides hope for the future with more opportunities to develop long-haul services towards the Korean market. ||| Commissioner for International Partnerships Jutta Urpilainen said, "Building up immunisation systems is a fundamental part of the work the EU does with partner countries and Gavi to strengthen health systems, which will be more important than ever on our road to recovery from COVID-19. ||| La commissaire aux transports, Mme Adina Vălean, a déclaré à cette occasion: «Dans un contexte où le transport aérien international, gravement touché par la crise de la COVID-19, se redresse lentement, la signature d'un accord horizontal comme celui-là est porteuse d'espoir pour l'avenir en multipliant les possibilités de développer l'offre de vols long-courriers vers le marché coréen.
0.36752092838287354 ||| Speech by President von der Leyen at the European Parliament Plenary on the presentation of the programme of activities of the German Presidency of the Council of the EU ||| Remarks by President von der Leyen at the joint press conference with Angela Merkel, Federal Chancellor of Germany, on the beginning of the German Presidency of the Council of the EU ||| Discours de la Présidente von der Leyen à la plénière du Parlement européen sur la présentation du programme d'activités de la Présidence allemande du Conseil de l'UE
0.609738826751709 ||| 50 mg ||| 50 mg Spain ||| Placebo
5.078708178833657e-13 ||| Warning symptoms of hyperglycaemia ||| Warning symptoms of hyperglycaemia ||| Les symptômes annonciateurs d’ une hyperglycémie
0.07334604859352112 ||| To be taken into consideration by patients on a controlled sodium diet. ||| To be taken into consideration by patients on a controlled sodium diet, ||| A prendre en compte chez les patients effectuant un régime sans sel.
0.5016800761222839 ||| Via Provinciale Schito 131 I-80058 Torre Annunziata/ NA Italy ||| Via Dei Lavoratori, 54 I-20092 Cinisello Balsamo Milano Italy ||| Via Provinciale Schito 131 I-80058 Torre Annunziata/ NA Italie
0.4885644018650055 ||| Refrigerated dispensing units for beverages ||| Emergency servicing of apparatus for supplying electricity ||| Dispositifs de distribution de boissons réfrigérés
0.546206533908844 ||| headedness, swelling of the lips or skin rash during or after the infusion, then tell your doctor immediately. ||| Check for the appearance of red marks, swelling or blistering after one day. ||| respiration sifflante, des sensations vertigineuses ou des étourdissements importants, un gonflement des lèvres ou une éruption cutanée pendant ou après la perfusion, informez immédiatement votre médecin.
0.5364198684692383 ||| The longer study examined the use of Renagel in 192 patients, the majority of whom had taken Renagel in previous studies. ||| Because cladribine has been used for a number of years, the company presented data from the published literature. ||| L’ étude à plus long terme examinait l’ utilisation de Renagel chez 192 patients, la plupart d’ entre eux ayant déjà suivi un traitement par Renagel lors de précédentes études.
0.3786854147911072 ||| Elderly patients Safety and efficacy of Myocet have been assessed in 61 patients with metastatic breast cancer, age 65 and over. ||| Elderly population( > 65 years) Gemcitabine has been well tolerated in patients over the age of 65. ||| Personnes âgées La tolérance et l’ efficacité de Myocet ont été évaluées chez 61 patients, souffrant d’ un cancer du sein métastatique et âgées de 65 ans et plus.
0.4862379729747772 ||| Do not mix Optisulin with any other insulins or medicines. ||| Do not mix insulin in vials with insulin in cartridges. ||| Ne mélangez Optisulin à aucune autre insuline ou à aucun autre médicament.
0.5677562952041626 ||| Hepatic disease may delay elimination. ||| - neoplasm with increased bleeding risk ||| Son élimination peut être retardée en cas d’ insuffisance hépatique.
0.34108370542526245 ||| It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects. ||| Studies also demonstrate that the dissociation of binding to the insulin receptor of insulin lispro is equivalent to human insulin. ||| On pense généralement que c'est l'inhibition de l'ADN, de l'ARN et de la synthèse protéique qui est responsable du principal effet cytotoxique.
0.1301078051328659 ||| Other information about Rotarix: ||| Other information about Soliris: ||| Autres informations relatives à Rotarix:
0.1335107684135437 ||| 21 2. ||| 23 2. ||| 22 2.
0.0005462054978124797 ||| 102 apply to the administration of recombinant human erythropoietin to patients with cancer, treated with chemotherapy to achieve haemoglobin concentrations less than 13 g/dl, is unclear because few patients with these characteristics were included in the data reviewed. ||| 89 apply to the administration of recombinant human erythropoietin to patients with cancer, treated with chemotherapy to achieve haemoglobin concentrations less than 13 g/dl, is unclear because few patients with these characteristics were included in the data reviewed. ||| Il est difficile de savoir dans quelle mesure ces résultats peuvent s’ appliquer à l’ administration d’ une érythropoïétine humaine recombinante chez les patients cancéreux traités par chimiothérapie avec pour objectif un taux d’ hémoglobine inférieur à 13 g/ dl car les données passées en revue incluaient peu de patients réunissant ces caractéristiques.
0.6773339509963989 ||| The dose reductions can be temporary or permanent. ||| Extensions/modifications are expected to number 20. ||| Les réductions des doses peuvent être temporaires ou permanentes.
0.30871790647506714 ||| Neurotoxicity, mainly peripheral neuropathy, appeared to be more frequent and severe with a 175 mg/ m2 3 hour infusion (85% neurotoxicity, 15% severe) than with a 135 mg/ m2 24 hour infusion (25% peripheral neuropathy, 3% severe) when paclitaxel was combined with cisplatin. ||| Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical effects, were common (1/ 100 to < 1/ 10); reversible, mild to moderate elevations in lactate dehydrogenase, with no associated clinical effects, were very common (1/ 10) in patients receiving Neulasta following cytotoxic chemotherapy. ||| La neurotoxicité, principalement neuropathie périphérique, semble être plus fréquente et sévère avec une perfusion de 175 mg/ m2 sur 3 heures (85% de neurotoxicité, 15% sévère) qu'avec une perfusion de 135 mg/ m2 sur 24 heures (25% de neuropathies périphériques, 3% sévère) de paclitaxel associé à cisplatine.
0.4204486608505249 ||| Patients exhibiting depression should be monitored closely during therapy and treated appropriately. ||| Patients should be advised to promptly report febrile episodes. ||| Les patients présentant une dépression doivent faire l'objet d'une surveillance particulière durant le traitement et être traités de façon appropriée.
0.11293233931064606 ||| Jalra is a medicine containing the active substance vildagliptin. ||| Avandia is a medicine containing the active substance rosiglitazone. ||| Jalra est un médicament contenant le principe actif vildagliptine.
0.16044838726520538 ||| CYMBALTA 30 mg is available in packs of 7, 28 and 98 capsules. ||| YENTREVE 20 mg is available in blister packs of 28, 56 and 98 capsules. ||| CYMBALTA 30 mg est disponible en boîtes de 7, 28 et 98 gélules.
0.30293193459510803 ||| The solution for injection caused a gradual decrease in pain scores in cats and dogs after the operation. ||| Other types of reaction to the injection persist for about 30 days after injection in cattle and pigs. ||| La solution pour injection induisait une diminution progressive de la douleur chez les chats et les chiens, après une intervention chirurgicale.
0.13028497993946075 ||| Before using OptiSet, the Instructions for Use included in the Package Leaflet must be read carefully. ||| Before using OptiSet, the Instructions for Use included in the Package Leaflet must be read carefully (see section 6.6) ||| Les Instructions d’ Utilisation mentionnées dans la notice doivent être lues avec attention avant toute utilisation d’ OptiSet.
0.5073836445808411 ||| The plasma elimination half-life of zinc in healthy subjects is around 1 hour after a dose of 45 mg. ||| 15/ 17 of the animals may occur on the day of vaccination and/ or a transient swelling (max diameter: ||| La demi-vie d’ élimination plasmatique du zinc chez les sujets sains est d’ environ 1 heure après une dose de 45 mg.
0.44797539710998535 ||| België/ Belgique/ Belgien Novartis Pharma N. V. ||| 37 Belgique/ België/ Belgien Merck Sharp & Dohme B. V. ||| 44 België/ Belgique/ Belgien Novartis Pharma N. V.
0.27859926223754883 ||| Wall shelves [structures] of metal ||| Stalls [structures] of metal for horses ||| Étagères murales [structures] en métal
0.24167205393314362 ||| Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon. ||| Because emesis may occur in the presence of impaired consciousness, appropriate posture (left lateral recumbent position) and protection of the airway by intubation may be warranted. ||| Une incision et une irrigation rapides de la zone injectée peuvent s’ avérer nécessaires, notamment si les tissus mous ou le tendon d’ un doigt sont touchés
0.34521356225013733 ||| After first broaching of the vial, the product may be stored for 28 days. ||| The product (cartridges in-use in the pump) may be stored for a maximum of 2 weeks. ||| Après première ouverture, le flacon peut être stocké pendant 28 jours.
0.0 ||| 6.4 Special precautions for storage ||| 6.4 Special precautions for storage ||| 160 6.4 Précautions particulières de conservation
0.771458625793457 ||| Hepatomegaly Jaundice ||| Polypectomy snares ||| Hépatomégalie Ictère
0.40280503034591675 ||| During a randomised withdrawal period, significantly more patients re-randomised to placebo experienced disease relapse (loss of PASI 75 response) compared with patients re-randomised to Enbrel. ||| Patients with single lesions may continue on Extavia provided the necrosis is not too extensive, as some patients have experienced healing of injection site necrosis whilst on Extavia. ||| 128 Pendant une période randomisée d’ arrêt, un nombre signifativement plus élevé de patients re- randomisés dans le groupe placebo a présenté une rechute (perte de la réponse au PASI 75) en comparaison aux patients re-randomisés dans le groupe Enbrel.
0.2895612418651581 ||| In animals, sirolimus has a direct effect on T and B cell activation suppressing immune mediated reactions such as allograft rejection. ||| It is subject to first-pass hepatic and intestinal metabolism and the metabolites do not contribute to fentanyl’ s therapeutic effects. ||| Chez l’ animal, le sirolimus a un effet direct sur l’ activation des cellules T et B, inhibant les réactions à médiation immunitaire telles que le rejet d’ allogreffe.
2.258160428396036e-13 ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| 53 L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.16041292250156403 ||| Containers made of horn ||| Containers made of cane ||| Récipients en corne
0.2798161506652832 ||| Therefore the results of the study can not be extrapolated to the population intended for use and consequently, the protective anti-HBs level in the population intended for use is not known and neither whether the recommended dose in the core SPC could guarantee an appropriate antibody level to prevent hepatitis B in adults and hemodialysed patients as well as newborns of a hepatitis B virus carrier-mother. ||| The text agreed in the PhVWP of this warning doesn’ t encourage or propose the use of ACE inhibitors during the first trimester of the pregnancy on the contrary once the pregnancy is detected the prescriber has to stop the use of ACE inhibitors and to change if it is necessary for another anti- hypertensive agent as soon as possible. ||| Les résultats de l’ étude ne peuvent donc pas être extrapolés à la population visée pour l’ utilisation et par conséquent il est impossible de savoir quel est le taux d’ anticorps anti-HBs protecteur dans la population visée, ni si la dose recommandée dans le RCP de base pourrait garantir un taux d’ anticorps approprié pour prévenir l’ hépatite B chez les adultes et les patients dialysés, ainsi que chez les nouveau-nés de mères porteuses du virus de l’ hépatite B.
0.10460619628429413 ||| 0.8 1.5 ||| 0.8 1.0 ||| 0,3
0.38921451568603516 ||| Triglyceride and cholesterol testing is to be performed prior to initiating Kaletra therapy and at periodic intervals during therapy. ||| • Blood tests for liver function These will be done every month for the duration of treatment with Tracleer. ||| Les dosages des triglycérides et du cholestérol doivent être réalisés avant l’ initiation d’ un traitement par Kaletra et à des intervalles réguliers pendant le traitement.
0.3777053952217102 ||| During the second half of 1997, discussions started between EudraNet users about the improvement of the communication layer from ISDN to Frame Relay services provided by a single character (GlobalOne) within the framework of the TESTA (Trans-European Services for Telematics between Administrations) initiative, managed by DG III/IDA. ||| Two research collaborative projects were launched in sub-Saharan Africa in 2018, through the European and Developing Countries Clinical Trials Partnership from the Horizon 2020, to tackle the Ebola epidemic preparedness, in collaboration with the Africa CDC: ALERRT and PANDORA-ID-NET. ||| Pendant le second semestre 1997, des discussions ont démarré entre les utilisateurs d’EudraNet sur l’amélioration de la zone de communication entre l’ISDN et les services de « relais-cadre » fournis par un fournisseur unique (GlobalOne) dans le cadre de l’initiative TESTA émanant de la DG III/IDA.
0.7177872061729431 ||| Thinners for dyestuffs ||| Cuticle scissors ||| Diluants pour colorants
0.3718317151069641 ||| This funding will help in addressing immediate needs in the Central African Republic in the health, water and sanitation sectors as well as supporting the State budget with an early budget support payment. ||| It will focus on providing liquidity through public guarantees and loans to companies active in the agriculture, fishery and food processing sectors, as well as to companies in rural areas. ||| Ce financement permettra de répondre aux besoins immédiats constatés en République centrafricaine dans les secteurs de la santé, de l'eau et de l'assainissement, ainsi que de soutenir le budget de cet État par le versement d'un appui budgétaire anticipé.
0.16054822504520416 ||| Chemical preparations for use in the dairy industry ||| Enzyme preparations for use in the baking industry ||| Produits chimiques destinés à l’industrie des produits laitiers
0.43953990936279297 ||| The capsules are swallowed whole with liquid. ||| The capsules are provided in carton packs. ||| Les gélules doivent être avalées en entier avec du liquide.
0.5473865270614624 ||| (a) Quadrisol (b) Vedaprofen (c) Part B ||| a) Twinrix Adult b) Comb. vaccine c) Part A ||| a) Quadrisol b) Vedaprofen c) Partie B
0.44492897391319275 ||| 0.91% ||| 0.6%) ||| 0.91% 0.44%
0.32190221548080444 ||| All patients being treated with epoetin alfa should receive adequate iron supplementation (e. g. oral iron substitution of 200 mg Fe2+ daily) throughout the course of epoetin alfa treatment. ||| The results suggest that supplementing VIRAMUNE therapy with an additional 200 mg dose of VIRAMUNE following each dialysis treatment would help offset the effects of dialysis on nevirapine clearance. ||| Tous les patients traités par époétine alfa doivent recevoir un complément de fer adapté (par exemple, 200 mg/ jour de Fe2+ per os) pendant toute la durée du traitement par époétine alfa.
0.3860623836517334 ||| - The active substance is moroctocog alfa (recombinant coagulation factor VIII). ||| BeneFIX contains recombinant coagulation factor IX, (nonacog alfa). ||| - La substance active est le moroctocog alfa (facteur VIII de coagulation recombinant).
0.5189678072929382 ||| 352.9 ||| 0.0769 ||| 352,9
0.4770835041999817 ||| Firelighters for grills ||| Snow sledges for transportation ||| Allume-feux pour grills
0.2504170536994934 ||| Limited published data for exogenously-administered somatropin suggest absorption and elimination half-lives and time of maximum concentration tmax in Turner patients are similar to those observed in both normal and growth hormone deficient populations. ||| Pharmacodynamic effects Aclasta treatment rapidly reduced the rate of bone turnover from elevated post-menopausal levels with the nadir for resorption markers observed at 7 days, and for formation markers at 12 weeks. ||| Un petit nombre de données publiées concernant l’ administration exogène de somatropine suggèrent que les demi-vies d’ élimination et d’ absorption et le temps de concentration maximum tmax chez les patientes présentant un syndrome de Turner sont semblables à ceux observés à la fois chez les populations normales et chez les enfants ayant un déficit en hormone de croissance.
0.4389820992946625 ||| Water syringes for spraying plants ||| Washers for water taps ||| Seringues à eau pour vaporiser les plantes
0.0049567329697310925 ||| During long-term treatment, serum calcium levels should be followed and renal function should be monitored through measurement of serum creatinine. ||| During long-term treatment, serum calcium levels should be followed and renal function should be monitored through measurements of serum creatinine. ||| En cas de traitement de longue durée, il est justifié de contrôler la calcémie et la fonction rénale par dosage de la créatinine sérique.
0.426742285490036 ||| The number of discontinuations due to hypertension-related events was also not significantly different between lumiracoxib (37) and NSAIDs (52). ||| CV mortality, as well as overall mortality, was similar between the etoricoxib and diclofenac treatment groups. ||| Le nombre de sorties d’ étude pour événements liés à l’ hypertension n’ a pas non plus été significativement différent entre lumiracoxib (37) et AINS (52).
0.216537207365036 ||| România Boehringer Ingelheim RCV GmbH & Co KG Viena - Sucursala Bucuresti Tel: +4 021 330 99 63 ||| Magyarország Boehringer Ingelheim RCV GmbH & Co KG Magyarországi Fióktelepe Tel.: +36 1 299 8900 ||| România Boehringer Ingelheim Pharma Ges mbH Reprezentanţ a din România Tel: +4 021 330 99 63
3.3744293709107864e-13 ||| If you develop a new infection, or are about to have any major surgery, your doctor may wish to monitor your treatment with Enbrel.  Infections/ diabetes: ||| If you develop a new infection, or are about to have any major surgery, your doctor may wish to monitor your treatment with Enbrel.  Infections/ diabetes: ||| Si vous développez une n ouve lle infection, ou devez subir une intervention chirurgicale importante ou si vous développez une nouvelle infection par Enbrel.
0.004382228944450617 ||| Laboratory test findings In the pivotal three-year study with oral ibandronic acid 2.5 mg daily (MF 4411) there was no difference compared with placebo for laboratory abnormalities indicative of hepatic or renal dysfunction, impaired haematologic system, hypocalcaemia or hypophosphataemia. ||| Laboratory test findings In the pivotal three-year study with ibandronic acid 2.5 mg daily (MF 4411) there was no difference compared with placebo for laboratory abnormalities indicative of hepatic or renal dysfunction, an impaired haematologic system, hypocalcaemia or hypophosphataemia. ||| Effets biologiques Dans l’ étude pivot effectuée sur trois ans avec l’ acide ibandronique oral 2,5 mg une fois par jour (MF 4411), aucune différence n’ a été observée par rapport au placebo quant aux bilans biologiques pouvant évoquer une insuffisance hépatique ou rénale, un trouble hématologique, une hypocalcémie ou une hypophosphorémie.
0.133413165807724 ||| One pen contains 18 million IU of interferon alfa-2b in 1.2 ml of solution. ||| - One ml of solution contains 10 million IU of interferon alfa-2b ||| Un stylo contient 18 millions d’ UI d’ interféron alfa-2b dans 1,2 ml de solution.
0.33359062671661377 ||| Table 2 contains only the adverse reactions for which a causal relationship with medicinal product treatment could reasonably be established. ||| Why the comparison of all the individual stages is not more discriminative to detect differences between formulations that may have clinical relevance b. ||| 8 Le tableau 2 indique uniquement les effets indésirables pour lesquels une relation avec le médicament peut être raisonnablement établie.
0.5617737770080566 ||| Crystal [glassware] ||| Ferrotype plates [photography] ||| Cristaux [verrerie]
0.3673330843448639 ||| Time to Treatment Failure (months) (95% CI) Log Rank p-value* ||| Median progression free survival (months) (95% CI) Adjusted Hazard ratio ||| (IC 95%) Test du log-rank (p*)
0.3060981035232544 ||| No drug interaction study has been performed for the co-administration of VIRACEPT with benzodiazepines. ||| No interaction studies have been conducted with Rebetol and other medicinal products, except for interferon alfa-2b and antacids. ||| Aucune étude d’ interaction médicamenteuse n’ a été réalisée sur la co-administration de VIRACEPT avec les benzodiazepines.
0.2930545210838318 ||| ed One cartridge contains 18 million IU of recombinant interferon alfa-2b produced in E. coli by recombinant DNA technology, in 1.2 ml. ||| Virbagen Omega contains the active substance recombinant omega interferon of feline origin (from cats) at 5 MU/ vial or 10 MU/ vial. ||| Une cartouche contient 18 millions d’ UI d’ interféron alfa-2b produit par une technique d’ ADN
0.222833514213562 ||| Fuzeon is not recommended for use in children under six years of age. ||| Tamiflu is not to be used in children under the age of one year. ||| Fuzeon n’ est pas recommandé chez les enfants de moins de six ans.
0.24105075001716614 ||| Intra-cardiac impulse conduction delays were observed in dogs with a no-effect dose of 15 mg/ kg (7- fold human exposure based on Cmax). ||| In embryo-foetal development studies no undesirable effects were observed at doses up to 29-fold a human 10 mg/ kg dose based on AUC. ||| Des retards de la conduction intracardiaque ont été observés chez le chien avec une dose sans effet de 15 mg/ kg (7 fois l’ exposition chez l’ homme basée sur la Cmax).
0.14609035849571228 ||| Rare: flatulence, constipation, diarrhoea, nausea, vomiting, abdominal pain ||| Sialoadenitis, spasms, stomach irritation, nausea, vomiting, diarrhoea, constipation ||| Rare: flatulence, constipation, diarrhées, nausées, vomissements, douleurs abdominales
0.003204531967639923 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Ultratard been studied? ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Visudyne been studied? ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-mail: mail@emea. europa. eu http: / /www. emea. europa. eu ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées sur Ultratard?
0.528282642364502 ||| 30% (14-47) 26% (10-42) ||| 37 (19-50) 6.0 (0-33) ||| 30% (14-47)
0.6807504892349243 ||| Moreover, the management of post liver transplant hyperlipidaemia is poorly documented in literature. ||| In Bergamo, gastrology, internal medicine, neurology services have been repurposed. ||| En outre, la gestion de l’ hyperlipidémie post-transplantation hépatique est mal documentée.
0.21636971831321716 ||| 56 Table 2: ||| 53 Table 4: ||| Tableau 2:
0.038643039762973785 ||| - is of the Opinion that the benefit/ risk balance of medicinal products containing lumiracoxib in ||| - is of the Opinion that the benefit/ risk balance of medicinal products containing etoricoxib in the ||| - est d’ avis que le rapport bénéfice/ risque des médicaments contenant du lumiracoxib dans les
0.2077438086271286 ||| p=0.029 ||| p=0.0494 ||| p= 0,029
0.28682708740234375 ||| Clinical resistance Analysis of patients with virological rebound (confirmed increase of ≥ 1 log10 copies/ ml HBV DNA from nadir) in the pivotal study (NV-02B-007) at week 48 indicated that, among HBeAg-positive and HBeAg-negative patients, 5% (23/ 458) and 2% (5/ 222), of telbivudine recipients, respectively, had virological rebound with detectable HBV resistance mutations. ||| 22 Adverse events occurring more frequently (≥3%) in Tarceva 100 mg plus gemcitabine-treated patients than in the placebo plus gemcitabine group in the pivotal study PA.3, and in at least 10% of patients in the Tarceva 100 mg plus gemcitabine group, are summarised by National Cancer Institute-Common Toxicity Criteria (NCI-CTC) Grade in Table 2. ||| Résistance clinique L’ analyse des patients présentant un rebond virologique (augmentation confirmée de l’ ADN du VHB ≥ 1 log10 copies/ ml par rapport au nadir) dans l’ étude pivot (NV-02B-007) à la semaine 48 a montré que parmi les patients AgHBe positifs et AgHBe négatifs, respectivement 5% (23/ 458) et 2% (5/ 222) des patients traités par telbivudine ont présenté un rebond virologique associé à des mutations détectables de résistance du VHB.
0.3341468572616577 ||| Arranging and conducting of entertainment events ||| Arranging and conducting of television auctions ||| Conduite et organisation de manifestations de divertissement
0.14987081289291382 ||| Increasing use of short-acting bronchodilators to relieve symptoms indicates deterioration of control and patients should be reviewed by a physician. ||| Increasing use of short-acting bronchodilators to relieve asthma symptoms indicates deterioration of asthma control and patients should be reviewed by a physician. ||| Le patient sera informé qu'il doit ainsi avoir en permanence à sa disposition un médicament bronchodilatateur à action rapide et de courte durée destiné à être utilisé en cas de crise d'asthme.
0.9042483568191528 ||| ed is 1. ||| e ris SC ||| é ris 1.
0.5569511651992798 ||| Hepatotoxicity: ||| Lactic acidosis: ||| Hépatotoxicité:
0.4136163592338562 ||| Membership of the Committee is given in Annex 4. ||| Details of membership can be found in Annex 3. ||| Les membres du comité figurent à l'annexe 4.
4.550410612549904e-13 ||| The ampoule contents should be inspected for particulate matter and discolouration prior to administration. ||| The ampoule contents should be inspected for particulate matter and discolouration prior to administration. ||| Avant l’administration, il convient d’inspecter le contenu de l’ampoule pour s’assurer qu’aucune particule ni décoloration n’est présente.
3.799106211913039e-13 ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. ||| Ce médicament ne doit pas être mélangé avec d’ autres médicaments que ceux mentionnés en rubrique 6.6.
0.331420361995697 ||| 9 However, in clinical trials the related adverse events were numerically more frequent in the Xeomin group compared to the Botox group. ||| Tumours occurred earlier and in greater number in the group of mice administered the vehicle cream in comparison with the low UVR control group. ||| Cependant, dans le cadre des essais cliniques, les événements indésirables liés au médicament étaient plus nombreux dans le groupe sous Xeomin que dans le groupe sous Botox.
0.31419143080711365 ||| Rash with efavirenz: rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first two weeks of initiating therapy with efavirenz. ||| 116 Tendinitis and tendon rupture (especially Achilles tendon), sometimes bilateral, may occur with ciprofloxacin, as soon as the first 48 hours of treatment. ||| Les rashs sont généralement de type maculo-papuleux d’ intensité légère à modérée, apparaissant lors des deux premières semaines du traitement par l’ éfavirenz.
0.1520501971244812 ||| Rifampicin/ Tenofovir disoproxil fumarate (600 q. d. / 300 q. d.) ||| Indinavir/ Tenofovir disoproxil fumarate (800 q8h/ 300 q. d.) ||| 14 Rifampicine/ Fumarate de ténofovir disoproxil (600 q. d. / 300 q. d.)
0.7139869928359985 ||| Solutions for sterilising contact lenses ||| Nail skin treatment trimmers ||| Solutions stérilisantes pour lentilles de contact
0.3106526732444763 ||| No interactions are anticipated in humans, since systemic concentrations of bimatoprost are extremely low (less than 0.2 ng/ ml) following ocular dosing. ||| In monkeys, single oral doses up to 100 mg/ kg resulted in prostration and, at higher doses, semi-consciousness. ||| Aucune interaction n’ est attendue chez l'homme, car les concentrations systémiques de bimatoprost sont extrêmement faibles (moins de 0,2 ng/ ml) après administration par voie ophtalmique.
0.25514039397239685 ||| SonoVue should be administered immediately after drawing into the syringe by injection into a peripheral vein. ||| Your doctor has prescribed an Nespo pre-filled syringe for injection into the tissue just under the skin. ||| SonoVue doit être administré juste après aspiration dans la seringue, par injection dans une veine périphérique.
0.18212270736694336 ||| Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine. ||| Ask your doctor or pharmacist for advice before taking any medicine while you are pregnant or breast- feeding. ||| 52 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
0.694779634475708 ||| gonal-f 450 iu ||| rebif 44/ 0.5 ||| gonal-f 450 ui
0.0740211009979248 ||| For the full list of all side effects reported with LUMIGAN, see the Package Leaflet. ||| For the full list of side effects reported with HBVAXPRO, see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de LUMIGAN, voir la notice.
0.2051737904548645 ||| Elderly patients No dosage adjustment is necessary in elderly patients (see section 5.2). ||| Use in the elderly No dose adjustment is necessary for elderly patients (see section 5.2). ||| 2 Patients âgés Aucune adaptation posologique n’ est nécessaire chez les patients âgés (voir rubrique 5.2).
0.004713007248938084 ||| It provides contrast enhancement and facilitates visualization and helps with the characterization of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology. ||| It provides contrast enhancement and facilitates visualization and helps with characterization of focal lesions and abnormal structures in the CNS and liver in patients with known or highly suspected pathology. ||| Optimark renforce le contraste, facilite la visualisation et aide à la caractérisation des lésions focales et des structures anormales du SNC et du foie chez les patients qui présentent une pathologie connue ou fortement suspectée.
0.0 ||| These may be signs of a very serious condition called diabetic ketoacidosis. ||| These may be signs of a very serious condition called diabetic ketoacidosis. ||| Ces signes peuvent indiquer que vous souffrez d’un état très grave appelé acidocétose diabétique.
0.6571877002716064 ||| Casement windows of metal ||| Carton box of bottle ||| Vasistas métalliques
0.24211977422237396 ||| Portugal EF-Eisai Farmacêutica, Unipessoal Lda Tel: + 351 214 875 540 România Eisai Ltd. ||| Portugal EF-Eisai Farmacêutica, Unipessoal Lda Tel: +351 21 421 7399 ||| Portugal EF-Eisai Farmacêutica, Unipessoal Lda Tel: + 351 214 875 540
0.3585537374019623 ||| Other disorders affecting mineral metabolism (such as vitamin D deficiency and hypoparathyroidism) should also be effectively treated before starting ADROVANCE. ||| 2 Dosage adjustment Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirement. ||| De même, les autres troubles du métabolisme osseux (tels que les déficits en vitamine D et l’ hypoparathyroïdisme) doivent être efficacement corrigés avant de commencer le traitement par ADROVANCE.
0.3186846375465393 ||| Epithelial cell proliferation was assessed by Ki67 immunohistochemical staining in healthy subjects. ||| Haematopoetic growth factor has been used in patients with resistant myelosuppression. ||| Chez des sujets sains, la prolifération des cellules épithéliales a été évaluée par la coloration immunohistochimique de Ki67.
0.5502436757087708 ||| Retinoids: retinoid compounds are eliminated via alcohol dehydrogenase. ||| Protein C from human plasma purified by mouse monoclonal antibodies. ||| Les rétinoïdes sont éliminés par l'alcool-déshydrogénase.
0.35717225074768066 ||| The optimum daily dosage must be determined by careful titration of levodopa in each patient. ||| The required fentanyl dosage is adjusted individually and should be assessed regularly after each administration. ||| La dose quotidienne optimale doit être déterminée par ajustement prudent de la lévodopa chez chaque patient.
4.618876353439105e-13 ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. ||| This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6. ||| Ce médicament ne doit pas être mélangé avec d'autres médicaments, excepté à ceux mentionnés sous la rubrique 6.6.
0.3966018259525299 ||| Ultrasonic sensors ||| Polarizing microscopes ||| Capteurs à ultrasons
3.10198508589668e-13 ||| Sitagliptin is a substrate for human organic anion transporter-3 (hOAT-3), which may be involved in the renal elimination of sitagliptin. ||| Sitagliptin is a substrate for human organic anion transporter-3 (hOAT-3), which may be involved in the renal elimination of sitagliptin. ||| La sitagliptine est un substrat pour le système de transport des anions organiques humains 3 (hOAT-3), qui peut être impliqué dans son élimination rénale.
0.3204289674758911 ||| Pharmacotherapeutic group: other antiglaucoma preparations; ATC code: ||| Pharmacotherapeutic group: all other therapeutic products, ATC code: ||| Classe pharmacothérapeutique: autres préparations antiglaucomateuses; Code ATC:
0.36946365237236023 ||| The prevention of clinical signs of porcine colonic spirochaetosis (colitis) when the disease has been diagnosed in the herd. ||| The disease was usually preceded by the development of hyperkeratotic lesions on the scrotum, which was what the sweeps called soot warts. ||| Traitement des signes cliniques de l’ entéropathie proliférative porcine (iléite) Prévention des signes cliniques de la spirochétose du côlon (colite) du porc après diagnostic de la maladie dans l’ élevage.
0.3893793821334839 ||| In addition to the task of providing objective scientific opinions, members of each Committee shall ensure that there is appropriate co-ordination between the Agency and each national competent authority. ||| The Management Board will wish to ensure that suitable arrangements are put in place to ensure a smooth transition and that financial control functions carried out by the Commission are properly reported to the Board. ||| Outre la tâche de fournir des avis scientifiques objectifs, les membres de chaque comité veillent à ce qu’ il existe une coordination adéquate entre l'Agence et chaque autorité compétente nationale.
0.2584300935268402 ||| 38 Italia Meda Pharma S. p. A. ||| Italia Novartis Farma S. p. A. ||| Italie Meda Pharma S. p. A.
0.27119189500808716 ||| In combination with ritonavir, bioequivalence of Invirase hard capsules and film-coated tablets was demonstrated under fed conditions. ||| However, bioequivalence of Icandra with co-administered vildagliptin and metformin has been demonstrated (see section 5.2). ||| La bioéquivalence des gélules et des comprimés pelliculés d’Invirase, en association au ritonavir, a été démontrée en présence de nourriture.
0.4715043902397156 ||| This was a phase III randomised double-blind trial conducted to evaluate the efficacy and safety of Avastin in combination with interferon (IFN) alfa-2a (Roferon®) versus IFN alfa-2a alone as first-line treatment in mRCC. ||| When Menitorix was administered as a 3-dose primary vaccination course, a DTPa- HBV-IPV* vaccine (N=796) or a DTPa-IPV vaccine* (N=375) was administered concomitantly. ||| Il s’ agissait d’ une étude de phase III, randomisée, en double aveugle, qui évaluait l’ efficacité et la tolérance de Avastin en association à l’ interféron (IFN) alfa-2a (Roferon®) comparativement à l’ IFN alfa-2a seul, en traitement de première ligne du CRm.
0.5749796628952026 ||| serum calcium (mmol/ l) - [0.02 x albumin (g/ l)] + 0.8 ||| Cmax (mg/ l), and 0.24 and 0.95 for Cmin (mg/ l). du ||| en fonction de = calcémie (mmol/ l) - [0,02 x albumine (g/ l)] + 0,8
0.11173082888126373 ||| What benefit has Paxene shown during the studies? ||| What benefit has Tracleer shown during the studies? ||| Quels ont été les bénéfices démontrés par Paxene au cours des études?
0.004595393314957619 ||| 87 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 88 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 91 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR
0.32094842195510864 ||| Following the second vaccination swelling may persist for at least 35 days. ||| A priming response is maintained for up to six months after basic vaccination. ||| A la suite de la 2nde administration, l’ oedème peut persister pendant au moins 35 jours.
0.10870116949081421 ||| 57 5. ||| 77 5. ||| 5.
0.24771305918693542 ||| CoAprovel 300 mg/ 25 mg film-coated tablets. ||| Cozaar Comp 50 mg/ 12.5 mg mg film-coated tablets ||| CoAprovel 300 mg/ 25 mg comprimés pelliculés.
0.19225803017616272 ||| In addition benzalkonium chloride may cause eye irritation and is known to discolour soft contact lenses. ||| A preservative in LUMIGAN called benzalkonium chloride may cause eye irritation and can discolour soft contact lenses. ||| De plus le chlorure de benzalkonium peut conduire à une irritation oculaire et est connu pour teinter les lentilles de contact souples.
0.1825360655784607 ||| In advanced Parkinson’ s disease, Neupro was studied in a total of 842 patients in two studies. ||| In Parkinson’ s disease, Sifrol has been studied in five main studies involving 1,546 patients. ||| Au stade avancé de la maladie de Parkinson, Neupro a été étudié sur un total de 842 patients dans deux études.
0.20942753553390503 ||| After reconstitution with 20 ml of sodium chloride 9 mg/ ml (0.9%) solution for injection, each vial contains 25 mg/ ml of pemetrexed. ||| 1 vial of powder contains 5 mg (15 IU) somatropin (3.33 mg/ ml somatropin after reconstitution with 1.5 ml solvent). ||| Après reconstitution avec 20 ml de chlorure de sodium à 9 mg/ ml (0,9%) pour préparations injectables, chaque flacon contient 25 mg/ ml de pemetrexed.
0.21244479715824127 ||| How has Hepsera been studied? ||| How has Comtess been studied? ||| Quelles études ont été menées sur Hepsera?
0.37034517526626587 ||| Make sure you tell your doctor if you are taking any medicines which cause sleepiness as thalidomide may increase their effects. ||| Do not stop taking Seretide suddenly as this could make your asthma worse and could cause problems with the body’ s hormones. ||| Veillez à informer votre médecin si vous prenez des médicaments qui provoquent de la somnolence, car le thalidomide peut accroître leurs effets.
0.5017153024673462 ||| 2% 1% < 1% ||| 5% 1% 0% ||| 2% 1%
0.027756216004490852 ||| The clinical significance of this is unknown. ||| The clinical relevance of this is unknown. ||| La signification clinique de cette observation est inconnu.
0.6956437826156616 ||| What documentation did the Company present to support its application to the CVMP? ||| - To agree the details of an educational brochure with the MAH. ||| Quelle documentation a été présentée par le laboratoire à l'appui de sa demande au CVMP?
0.4048144817352295 ||| Talk to a doctor without taking Vivanza Medicine for the treatment of arrythmias, such as quinidine, procainamide, amiodarone or sotalol Ritonavir or indinavir, medicines for HIV. ||| clorazepate, diazepam, estazolam, flurazepam, triazolam or oral (taken by mouth) midazolam (used to help you sleep and/or relieve anxiety); ||| Médicaments pour le traitement des troubles du rythme cardiaque tels que la quinidine, la procainamide, l’ amiodarone ou le sotalol Le ritonavir ou l'indinavir, médicaments contre le HIV.
0.009398417547345161 ||| 22 PTH should be measured 1 to 4 weeks after initiation or dose adjustment of Mimpara. ||| 12 PTH should be measured 1 to 4 weeks after initiation or dose adjustment of Mimpara. ||| Le taux de PTH doit être mesuré 1 à 4 semaines après le début du traitement par Mimpara et après chaque adaptation posologique.
0.2626796364784241 ||| Children weighing > 40 kg and who are able to swallow capsules may receive prevention with a 75 mg capsule once daily for 10 days as an alternative to the recommended dose of Tamiflu suspension. ||| Following administration of 75 mg clopidogrel once daily for 10 days, 40 healthy subjects were switched to prasugrel 10 mg once daily with or without a loading dose of 60 mg. ||| Les enfants de plus de 40 kg et capables d’ avaler les gélules peuvent bénéficier d’ un traitement préventif, à raison d’ une gélule de 75 mg une fois par jour pendant 10 jours comme alternative à la posologie recommandée de Tamiflu suspension.
3.9726062066661183e-13 ||| Listed below are the most common medicines which may affect your insulin treatment. ||| Listed below are the most common medicines which may affect your insulin treatment. ||| Les principaux médicaments susceptibles de modifier votre traitement à l’insuline sont indiqués ci-dessous.
0.28402459621429443 ||| Most reports of hepatic failure involved patients with significant morbidities including pre-existing liver cirrhosis. ||| In clinical trials treatment-related tumour haemorrhage occurred in approximately 2% of patients with GIST. ||| Dans la plupart des cas, les patients présentaient des comorbidités significatives, dont une cirrhose hépatique et une défaillance multiviscérale.
0.0 ||| - If you have any further questions, ask your doctor or pharmacist. ||| - If you have any further questions, ask your doctor or pharmacist. ||| - Si vous avez d’ autres questions, si vous avez un doute, demandez plus d’ informations à votre
0.06717553734779358 ||| Adequate follicular development is usually achieved on average by the tenth day of treatment (range 5 to 20 days). ||| In general adequate follicular development is achieved on average by the tenth day of treatment (range 5 to 20 days). ||| La croissance folliculaire adéquate est généralement obtenue après en moyenne 10 jours (entre 5 et 20 jours) de traitement.
0.7112776041030884 ||| Primary education services ||| Religious education ||| Services d'enseignement primaire
0.11294019222259521 ||| WHAT FOSAVANCE IS AND WHAT IT IS USED FOR ||| WHAT EFFENTORA IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE FOSAVANCE ET DANS QUEL CAS EST-IL UTILISE
0.39701199531555176 ||| Aid will be granted in the form of direct grants to enhance and accelerate research and the production of products directly relevant to coronavirus. ||| Manage the increase in workload for activities relating to orphan drug designation and strengthen policies directed towards orphan medicinal products. ||| Les aides seront accordées sous la forme de subventions directes en vue d'intensifier et d'accélérer la recherche et la fabrication de produits ayant une utilité directe pour la lutte contre le coronavirus.
0.47180625796318054 ||| During treatment with TORISEL, vaccination may be less effective. ||| EMEND can affect other medicines both during and after treatment with EMEND. ||| Durant le traitement par TORISEL, la vaccination pourra être moins efficace.
0.24316148459911346 ||| CELSENTRI 300 mg film-coated tablets. ||| FABLYN 500 microgram film-coated tablets. ||| CELSENTRI 300 mg comprimés pelliculés.
0.255862295627594 ||| It is known that malignancies (lymphoma) secondary to the chronic use of immunosuppressive agents can occur and have been reported in patients in rare instances. ||| The efficacy of INOmax has been investigated in term and near-term newborns with hypoxic respiratory failure resulting from a variety of etiologies. ||| Il est connu que des néoplasies (lymphomes) secondaires à l’ utilisation chronique d’ agents immunosuppresseurs peuvent survenir et ont été rarement rapportées chez des patients.
0.4434501528739929 ||| Prandin 2 mg tablets Repaglinide ||| Viramune 200 mg tablets nevirapine ||| Prandin 2 mg, comprimés Répaglinide
0.39774924516677856 ||| In patients scheduled for major elective orthopaedic surgery the cause of anaemia should be established and treated, if possible, before the start of epoetin alfa treatment. ||| Two prospective, single arm, open-label, uncontrolled phase II studies were conducted in patients with haematological disease, the majority of whom had advanced disease. ||| Chez les patients devant bénéficier d’ une intervention chirurgicale orthopédique majeure programmée, la cause de l'anémie doit être établie et traitée, si possible avant l'instauration du traitement par époétine alfa.
0.34868305921554565 ||| Astellas Pharma S. A Paseo del Club Deportivo n°1, Bloque 14 28223 Pozuelo de Alarcón (Madrid) Spain ||| Avda. de los Reyes 1 Polígono Industrial La Mina 28770 Colmenar Viejo (Madrid) Spain ||| Paseo del Club Deportivo n° 1, Bloque 14 28223 Pozuelo de Alarcón (Madrid) Espagne
0.6256893277168274 ||| VFEND suspension should not be mixed with any other medication. ||| should prescribe another antibiotic in addition to [Invented name]. ||| VFEND suspension ne doit être mélangée à aucun autre médicament.
0.4931648373603821 ||| Pseudomonas aeruginosa* Pseudomonas fluorescens Serratia marcescens* Anaerobic micro-organisms Peptostreptococcus spp. ||| Pasteurella multocida, Actinobacillus pleuropneumoniae, Staphylococcus hyicus, E. coli, Haemophilus spp, ||| Pseudomonas aeruginosa* Pseudomonas fluorescens Serratia marcescens*
0.42777037620544434 ||| - if you experience angioedema (difficulties in breathing, or swallowing, or swelling of the face, ||| organs, for example, if you have noticed abnormal blood in your stools or urine, (except from menstrual bleeding). ||| - si vous êtes sujet à des angioedèmes (difficultés pour respirer, ou pour avaler, ou gonflement du
0.31726425886154175 ||| If necessary, the dosage of Eucreas may need to be adjusted during concomitant therapy and on its discontinuation. ||| Ideally, pregnancy testing, issuing a prescription and dispensing of isotretinoin should occur on the same day. ||| Si nécessaire, la posologie d’ Eucreas peut être adaptée au cours du traitement par l’ autre médicament et après son arrêt.
0.4173988699913025 ||| Voriconazole had no effect on the Cmax and AUCt of mycophenolic acid (1 g single dose). ||| Omeprazole 40 mg q. d. increased the AUC of lacosamide by 19%. ||| Le voriconazole n’ a eu aucun effet sur la Cmax et l’ ASCτ de l’ acide mycophénolique (dose unique de 1g).
0.5815632939338684 ||| Advising industrial enterprises in the conduct of their business ||| They encourage stockpiling responses in the supply chain. ||| Conseil en gestion d'affaires pour sociétés industrielles
0.36111128330230713 ||| 100 mg; salmon: ||| 15 mg; red: ||| 100 mg; saumon:
0.24533316493034363 ||| Nespo 60 micrograms solution for injection in a pre-filled pen. ||| Solution for injection in a single use pre-filled pen (0.6 ml). ||| 60 microgrammes, solution injectable en stylo prérempli.
0.17725327610969543 ||| Woven textiles (Non-metallic -) for stabilising the bottoms of watercourses ||| Woven fabrics (Non-metallic -) for the protection of dikes against erosion ||| Matières textiles tissées (non métalliques) pour la stabilisation des fonds de cours d'eau
0.4258089065551758 ||| Injecting it at the same time of day each week will help you not to forget to take it. ||| Taking Tasigna at the same time each day will help you remember when to take your capsules. ||| L’ injection réalisée régulièrement à la même heure le même jour de la semaine vous aidera à ne pas oublier de la prendre.
0.11857844889163971 ||| 197 2. ||| 147 2. ||| 2.
0.4760936200618744 ||| Lamivudine and VIRAMUNE can be co-administered without dose adjustments. ||| Heparin and Rapilysin are incompatible when combined in solution. ||| La lamivudine et VIRAMUNE peuvent être associés sans ajustement posologique.
0.5808027982711792 ||| - any signs of skin rash. ||| - Any evidence of activity of a tumour. ||| des signes d’ éruptions cutanées.
0.20154495537281036 ||| 45.1% ||| 47.3% ||| 45,1%
0.6346830129623413 ||| Bayley agreed if Tamina could defeat her friend Sasha Banks, which she did the following week to earn the title match at Money in the Bank. ||| Heavy Machinery then participated in the SmackDown Tag Team Championship Elimination Chamber match, where they were eliminated by Ziggler and Roode. ||| Bayley a accepté si Tamina pouvait vaincre son amie Sasha Banks, ce qu'elle a fait la semaine suivante pour gagner le match pour le titre à Money in the Bank .
0.08272450417280197 ||| What is the risk associated with Circadin? ||| What is the risk associated with Zactran? ||| Quels sont les risques associés à Circadin?
0.4468432068824768 ||| Hydroxycarbamide is excreted in human milk. ||| Ciprofloxacin is present in the bile in high concentrations. ||| L'hydroxycarbamide est excrété dans le lait humain.
0.0702599287033081 ||| In the long term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2% for aripiprazole-treated patients and 15.7% for placebo-treated patients. ||| In a long term 26-week placebo-controlled trial, the incidence of EPS was 19% for aripiprazole-treated patients and 13.1% for placebo-treated patients. ||| Dans l’ étude clinique contrôlée versus placebo long terme à 26 semaines de phase de maintenance, l’ incidence des symptômes extrapyramidaux était de 18,2% chez les patients traités par aripiprazole et de 15,7% chez les patients traités par le placebo.
0.013434283435344696 ||| Trocoxil 20 mg chewable tablets for dogs Mavacoxib ||| Trocoxil 6 mg chewable tablets for dogs Mavacoxib ||| Trocoxil 20 mg comprimés à croquer pour chiens Mavacoxib
0.33180707693099976 ||| The active ingredient of Regranex, becaplermin, is produced by a method known as ‘ recombinant DNA technology’. ||| Etanercept, the active ingredient in Enbrel, is a biologic medicine that is made from two human proteins. ||| Le principe actif de Regranex, la bécaplermine, est produit par un procédé connu sous le nom de « technologie de l’ ADN recombinant ».
0.0022259545512497425 ||| Each vial contains 200 μ g ziconotide (as ziconotide acetate). ||| Each vial contains 500 μ g ziconotide (as ziconotide acetate). ||| Flacon de 2 ml: chaque flacon contient 200 μ g de ziconotide (sous forme d'acétate).
0.3379018306732178 ||| 8 Co-administration of saquinavir and ritonavir has led to severe adverse events, mainly diabetic ketoacidosis and liver disorders, especially in patients with pre-existing liver disease. ||| Vaccines have been produced against several diseases caused by coronaviruses for animal use, including for infectious bronchitis virus in birds, canine coronavirus and feline coronavirus. ||| La co-administration de saquinavir et de ritonavir a entraîné des effets indésirables sévères, essentiellement une acidocétose diabétique et des troubles hépatiques, notamment chez les patients ayant une maladie hépatique préexistante.
0.3261035084724426 ||| In vascular surgery, 85% of the patients had no bleeding four minutes after treatment with Evicel (64 out of 75), compared with 39% of the patients treated with manual compression (28 out of 72). ||| Among all patients treated in clinical trials (including both those with severe neutropenia and those who did not develop severe neutropenia), 11% (4% of courses) developed fever and 26% (9% of courses) developed infection. ||| En chirurgie vasculaire, 85% des patients ne présentaient pas de saignements quatre minutes après le traitement par Evicel (64 patients sur 75), par comparaison à 39% des patients traités par une compression manuelle (28 patients sur 72).
0.006960444152355194 ||| 27/ 48 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 26/ 42 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 28/ 49 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2395067662000656 ||| After oral administration, erlotinib peak plasma levels are obtained in approximately 4 hours after oral dosing. ||| Olanzapine is well absorbed after oral administration, reaching peak plasma concentrations within 5 to 8 hours. ||| Après administration orale, le pic de concentration plasmatique est obtenu après environ 4 heures.
0.2717093825340271 ||| Although the available in vitro data suggest a low potential for promotion of tumour growth, the use of InductOs is contraindicated in patients with an active malignancy or in patients undergoing treatment for a malignancy (see also section 4.3). ||| There is limited clinical data on the safety of CIALIS in patients with severe hepatic impairment (Child-Pugh Class C); if prescribed, a careful individual benefit/ risk evaluation should be undertaken by the prescribing physician. ||| Bien que les données in vitro disponibles suggèrent un faible potentiel pour la promotion de croissance tumorale, l’utilisation d’InductOs est contre-indiquée chez les patients présentant une malignité active ou des patients subissant un traitement pour une tumeur maligne (voir aussi rubrique 4.3).
0.044142186641693115 ||| Keep out of the reach and sight of children. t ||| Keep out of the reach and sight of children. i ||| Tenir hors de la portée et de la vue des enfants.
0.0 ||| Gastrointestinal disorders ||| Gastrointestinal disorders ||| 57 Affections gastro-intestinales
0.3811262249946594 ||| Mosquito repellants for application to the skin ||| Carbolineum for the protection of plants ||| Répulsifs anti-moustiques à appliquer sur la peau
0.4221287965774536 ||| 95.1, 99.8) and 100.0% (95% CI: ||| 52.8 - 65.9) in AT arm versus 46.5% (95% CI: ||| 95,1 – 99,8) et de 100,0% (IC à 95%:
0.2814934253692627 ||| These results were confirmed during period II of the study where patients were randomized to continue losartan or placebo, after three weeks of treatment. ||| For patients who received only INVANZ, the following adverse reactions were reported during therapy plus follow-up for 14 days after treatment was stopped: ||| Ces résultats ont été confirmés au cours de la période II de l'étude pendant laquelle les patients ont été randomisés pour continuer à recevoir le losartan ou pour recevoir le placebo, après trois semaines de traitement.
0.28387436270713806 ||| Blast treatment of a surface (Services for the -) ||| Stabilisation of ground by cement injection (Services for the -) ||| Services de traitement de surfaces par jets d'air
0.973570704460144 ||| 31 August 2008 (draft protocol) ||| January 2002 (on-going) ||| 31 août 2008 (projet de protocole)
0.4569520056247711 ||| Treatment differences (BYETTA minus comparator) were -4.1 kg in the 26-week study and – 5.4 kg in the 52-week study. ||| In a pooled follow-up analysis of studies MM-009 and MM-010 (N = 704), the median TTP was 48.3 weeks (95% CI: ||| Les différences entre le traitement par BYETTA et les traitements comparateurs étaient de -4,1 kg dans l’ étude de 26 semaines et -5,4 kg dans l’ étude de 52 semaines.
0.5108522176742554 ||| • alli should not be taken for more than six months. • If you do not lose weight after taking alli for 12 weeks, see your doctor or pharmacist for advice. ||| you have had surgery within the last twelve hours before you receive Xigris, or you are bleeding from a previous surgery, or you might have surgery while you receive Xigris ||| • Vous ne devez pas prendre alli pendant plus de six mois. • Si vous n'avez pas perdu du poids après avoir pris alli pendant 12 semaines, demandez conseil à
0.4294317960739136 ||| The cancers occur some years (usually 20–30) after injection of Thorotrast. ||| Therapy should be continued until up to 72 hours after resolution of neutropaenia (ANC≥ 500). ||| Les cancers surviennent plusieurs années (généralement 20 à 30) après l'injection de Thorotrast.
0.4007747769355774 ||| The illness may also cause the lymph nodes and other organs such as liver and spleen to increase in size. ||| When it stimulates growth of cells in the long bones of the legs and spine, it causes an increase in height. ||| Cette maladie peut également entraîner une augmentation de la taille des ganglions lymphatiques et d'autres organes, comme le foie et la rate.
0.30979442596435547 ||| It is therefore recommended that no other vaccines should be administered within 14 days before or after vaccination with the product. ||| Therefore, administration of any of these products should be avoided within 1 month after a dose of ProQuad unless considered to be essential. ||| Il est par conséquent recommandé de ne pas administrer d’ autre vaccin pendant les 14 jours qui précèdent et qui suivent la vaccination.
0.46096885204315186 ||| The suppression of Helicobacter pylori might give false negative results. ||| Both might interfere with the Helicobacter pylori status. ||| L'éradication d'Helicobacter pylori pourrait donner des résultats faussement négatifs.
0.19325779378414154 ||| HOW TO STORE XELODA ||| HOW TO STORE SONOVUE ||| COMMENT CONSERVER XELODA
3.743169511329081e-13 ||| Both valsartan and amlodipine are unlikely to be removed by haemodialysis. ||| Both valsartan and amlodipine are unlikely to be removed by haemodialysis. ||| 8 Il est peu probable que le valsartan et l'amlodipine puissent être éliminés par hémodialyse.
0.6258012056350708 ||| A prior MCyR to imatinib was achieved in 28% and 29% of the patients in the dasatinib and imatinib arms, respectively. ||| Of these, 185 (98.9%) env genes carried specific substitutions in region of aa 36 - 45 of gp41. ||| Une RCyM à l'imatinib avait été obtenue antérieurement chez respectivement 28% et 29% des patients randomisés dans les bras dasatinib et imatinib.
0.26026421785354614 ||| The company also presented the results of a study looking at the effects of Retacrit injected subcutaneously in 261 cancer patients taking chemotherapy. ||| The company presented the results of one main study that compared the effects of EXULETT with those of linezolid (another antibiotic) in 873 adults. ||| La société a également présenté les résultats d’ une étude recherchant les effets de Retacrit injecté par voie sous-cutanée chez 261 patients atteints de cancer traités par chimiothérapie.
0.33257389068603516 ||| Atorvastatin (80 mg daily) did not alter the pharmacokinetics of prasugrel and its inhibition of platelet aggregation. ||| However, cyclosporine, a p-glycoprotein inhibitor, did not reduce the renal clearance of sitagliptin. ||| L'atorvastatine (80 mg par jour) n'a pas modifié la pharmacocinétique du prasugrel et son inhibition de l'agrégation plaquettaire.
1.1318418979644775 ||| Other information about Fevaxyn Pentofel: ||| Invented name Hepsera Hepsera ||| Autres informations relatives à Fevaxyn Pentofel:
0.2227073609828949 ||| The efficacy of CYMBALTA at the recommended dose of 60 mg once a day was demonstrated in three out of three randomized, double- blind, placebo-controlled, fixed dose acute studies in adult outpatients with major depressive disorder. ||| The safety and efficacy of 50mg Enbrel (two 25 mg SC injections) administered once weekly were evaluated in a double-blind, placebo-controlled study of 420 patients with active RA. ||| L’ efficacité de CYMBALTA à la posologie recommandée de 60 mg, une fois par jour, a été démontrée dans les trois études à court terme, randomisées, contrôlées en double insu versus placebo, utilisant des doses fixes de duloxétine chez des patients adultes non hospitalisés présentant un épisode dépressif majeur.
0.3089781403541565 ||| As it cannot be excluded that the change in Cmax is clinically significant, Temodal should be administered without food. ||| Since current safety and efficacy data are based upon administration with food, it is recommended that Xeloda be administered with food. ||| Comme on ne peut pas exclure que ce changement de la Cmax ait une signification clinique, Temodal doit être administré en dehors des repas.
0.2501377463340759 ||| How to store Lucentis 6. ||| How to take Siklos 4. ||| Comment conserver Lucentis 6.
0.4535311460494995 ||| 61% (50-71) ||| 70% (58/83) ||| 61%
0.19497385621070862 ||| These medicinal products are contraindicated for use with Invirase/ritonavir (see section 4.3). ||| Rifampicin is contraindicated in combination with Invirase/ ritonavir (see section 4.3). ||| Ces médicaments sont contre-indiqués avec Invirase/ritonavir (voir rubrique 4.3).
0.2914736568927765 ||| The transition regimen involves escalating the dose of lamotrigine to a maintenance stabilisation dose over six weeks (Table 3) after which other psychotropic medicinal products and/ or AEDs can be withdrawn, if clinically indicated (Table 4). ||| However, during the period of administration of filgrastim for PBPC mobilisation, it should be discontinued or its dose should be reduced if the leukocyte counts rise to > 70 x 109/ l. ||| Le schéma de transition implique une augmentation posologique de la lamotrigine jusqu’ à une posologie d’ entretien à stabilisation sur six semaines (Tableau 3) après lesquelles les autres médicaments psychotropes et/ ou AEs peuvent être arrêtés, si cela est indiqué cliniquement (Tableau 4).
0.5603823661804199 ||| -- ||| - ||| —
0.32994967699050903 ||| Velmetia combines two antihyperglycaemic agents with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: sitagliptin phosphate, a dipeptidyl peptidase 4 (DPP-4) inhibitor, and metformin hydrochloride, a member of the biguanide class. ||| Tolcapone’ s effect on levodopa pharmacokinetics is similar with all pharmaceutical formulations of levodopa/ benserazide and levodopa/ carbidopa; it is independent of levodopa dose, levodopa/ AADC-I (benserazide or carbidopa) ratio and the use of sustained-release formulations. ||| Velmetia associe deux agents antihyperglycémiants ayant des mécanismes d’ action complémentaires pour améliorer le contrôle glycémique chez les patients diabétiques de type 2: le phosphate de sitagliptine, un inhibiteur de la dipeptidylpeptidase 4 (DPP-4) et le chlorhydrate de metformine, un biguanide.
0.13063175976276398 ||| No dosage adjustment is necessary in patients with renal impairment. ||| No dose adjustment is necessary for patients with renal insufficiency. ||| Aucune adaptation de la posologie n’ est nécessaire chez les patients atteints d’ insuffisance rénale.
0.46543458104133606 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) considered that, in accordance with European Union requirements, Rheumocam has been shown to be bioequivalent to Metacam 1.5 mg/ ml oral suspension. ||| On 12 March 2020, Medicago, a biotechnology company in Quebec City, Quebec, reported development of a coronavirus-like particle under partial funding from the Canadian Institutes for Health Research. ||| Le comité des médicaments à usage vétérinaire (CVMP) a estimé que, conformément aux exigences de l’ Union européenne, il a été démontré que Rheumocam s’ est avéré bioéquivalent à Metacam 1,5 mg/ ml suspension orale.
0.8849378228187561 ||| Ethyl carbamate ||| Eurican Herpes 205 ||| Carbamate d’éthyle
0.2346986085176468 ||| As the likelihood of contamination of Bovilis BVD vaccine, and the subsequent probability of seroconversion by such contaminants is extremely low, the advantage of additional final product testing for extraneous agents (serological method) is considered to be negligible. ||| If there is evidence of worsening liver disease or persistent elevations of serum transaminases to greater than 5 times the upper limit of the normal range, the benefit of continued therapy with efavirenz needs to be weighed against the potential risks of significant liver toxicity. ||| La probabilité de contamination du vaccin Bovilis BVD et la probabilité subséquente de séroconversion par ces éventuels contaminants étant extrêmement faibles, l’ avantage que présente un test supplémentaire de dépistage d’ agents externes sur le produit fini (méthode sérologique) est considéré comme négligeable.
0.3102838397026062 ||| When used in combination with delavirdine, dose reduction of ritonavir may be considered. ||| The metabolism of tipranavir in the presence of low dose ritonavir is minimal. ||| En cas d’association avec la délavirdine, une réduction des doses de ritonavir peut être envisagée.
0.4009392261505127 ||| The frequency of undesirable effects listed in the table below is based on the following convention: ||| The adverse reactions reported below are classified according to frequency of occurrence as follows: ||| La fréquence des effets indésirables énumérés dans le tableau est fondée sur la convention suivante:
0.20022210478782654 ||| • 11.06.2001 • 07.09.2001 • 89 days ||| • 19.10.2000 • 15.01.2001 • 89 days ||| 25.05.2001 11.06.2001 07.09.2001 89 jours
0.1386539787054062 ||| Always take the outer carton of medicine with you, even if it is empty. ||| Always take the outer carton or the vial of medicine with you, even if it is empty. ||| Gardez toujours avec vous la boîte du médicament, même si elle est vide.
0.39701974391937256 ||| Dimethylacetamide Macrogol 400. ||| Pioglitazone / Metformin hydrochloride ||| Diméthylacétamide Macrogol 400.
0.2404090166091919 ||| Co-administration of 10 mg adefovir dipivoxil with other medicinal products that are eliminated by tubular secretion or alter tubular function may increase serum concentrations of either adefovir or the co-administered medicinal product (see section 4.4). ||| Because co-administration of bile acid sequestrants may reduce the bioavailability of acidic medicinal products such as nicotinic acid, it is recommended that Trevaclyn be administered > 1 hour before or > 4 hours after administration of a bile acid sequestrant. ||| L’ administration concomitante de 10 mg d’ adéfovir dipivoxil et d’ autres médicaments qui sont éliminés par sécrétion tubulaire ou qui modifient la fonction tubulaire est susceptible d’ entraîner une augmentation des concentrations sériques de l’ adéfovir ou du médicament co-administré (voir rubrique 4.4).
0.3070905804634094 ||| In clinical studies, administration of single doses of etoricoxib up to 500 mg and multiple doses up to 150 mg/ day for 21 days did not result in significant toxicity. ||| During the clinical development, there were a few reports of agomelatine overdose, taken alone (up to 450 mg) or in combination (up to 525 mg) with other psychotropic medicinal products. ||| Au cours des études cliniques, l’ administration de doses uniques d’ étoricoxib allant jusqu’ à 500 mg et de doses multiples allant jusqu’ à 150 mg par jour pendant 21 jours, n’ a pas entraîné de toxicité significative.
0.06729911267757416 ||| Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ: + 357 22 89 95 01 ||| Κύπρος GlaxoSmithKline (Cyprus) Ltd Τηλ: + 357 22 89 95 01 ||| 47 Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ: + 357 22 89 95 01
0.2599741220474243 ||| An average of only 0.3% of the IV dose was excreted in urine as inhibitors. ||| Only 2% of a riluzole dose was recovered unchanged in the urine. ||| En moyenne, seuls 0,3% de la dose IV ont été éliminés dans les urines sous forme d’inhibiteurs.
0.24695062637329102 ||| OSSEOR is used to treat osteoporosis (a disease that makes bones fragile) in postmenopausal women to reduce the risk of vertebral (spine) and hip fractures. ||| Rotarix is used in babies from six weeks of age as a vaccine to prevent gastroenteritis (diarrhoea and vomiting) caused by rotavirus infections. ||| OSSEOR est indiqué pour le traitement de l’ ostéoporose (maladie qui fragilise les os) chez la femme postménopausée afin de réduire le risque de fractures vertébrales et de la hanche.
0.0005167360650375485 ||| After reconstitution, each ml solution for injection contains approximately 100 IU octocog alfa. * The potency (International Units) is determined using the chromogenic assay against an in-house standard that is referenced to the WHO standard. ||| After reconstitution, each ml solution for injection contains approximately 50 IU octocog alfa. * The potency (International Units) is determined using the chromogenic assay against an in-house standard that is referenced to the WHO standard. ||| Chaque flacon contient nominalement 500 UI * de facteur VIII (rDNA) de coagulation humain, octocog alfa * * Après reconstitution, chaque millilitre de solution pour injection contient approximativement 100 UI d’ octocog alfa. * Le titre (Unité Internationale) est déterminé par dosage chromogénique par rapport à un standard interne référencé au standard de l'OMS.
0.39949584007263184 ||| The majority of patients did not interrupt natalizumab therapy during infections and recovery occurred with appropriate treatment. ||| When the treatment was instituted before any permanent brain damage, patients exhibited normal growth and psychomotor development. ||| La majorité des patients n’ a pas interrompu le traitement par natalizumab au cours des infections et leur guérison a été obtenue par un traitement approprié.
0.2146395444869995 ||| Skin and subcutaneous tissue disorders: macular rash, papular rash, pruruitis, urticaria, angioneurotic oedema. ||| Skin and subcutaneous tissue disorders Uncommon: contusion, exanthem, pruritus, rash, urticaria Rare: angioedema ||| 20 Affections de la peau et du tissu sous-cutané: rash maculaire, rash papulaire, prurit, urticaire, œ dème angioneurotique.
0.026073835790157318 ||| Non-clinical data reveal no special hazard to humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| ris Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| Les données de sécurité non cliniques issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, génotoxicité, cancérogénèse, et des fonctions de reproduction n'ont pas révélé de risque particulier pour l'homme.
0.005752498749643564 ||| Simulect is also available in vials with 10 mg basiliximab. ||| Simulect is also available in vials with 20 mg basiliximab. ||| Simulect est également disponible en flacon contenant 10 mg de basiliximab.
0.3030814826488495 ||| Immediately withdraw the needle and clean the skin with an alcohol swab using a circular motion. ||| Wipe the injection site with the enclosed alcohol pad, using a circular motion. ||| Retirez immédiatement l’ aiguille et frottez avec un coton imbibé d'alcool au point d'injection, en faisant des mouvements circulaires.
0.2712227702140808 ||| In pups of mice treated with an antibody analogue of efalizumab, a decrease in T-cell dependent immunity was observed up to at least 11 weeks of age. ||| Injections of human recombinant interferon alfa-2b for up to three months have shown no evidence of toxicity in mice, rats, and rabbits. ||| Chez des souriceaux traités avec un anticorps analogue de l'efalizumab, une baisse de l'immunité dépendante des cellules T a été observée jusqu'à un âge d'au moins 11 semaines.
0.11324137449264526 ||| - if you are allergic (hypersensitive) to sitagliptin or metformin or any of the other ingredients of ||| - If you are allergic (hypersensitive) to temsirolimus, to polysorbate 80 or any of the other ingredients ||| - si vous êtes allergique (hypersensible) à la sitagliptine ou à la metformine ou à l’un des autres
0.46713986992836 ||| − Haemophilia, as there have been reports of increased bleeding in patients with haemophilia who are taking this type of medicine (protease inhibitors). ||| Ovulation may restart Women who are infertile due to a condition affecting their ovaries (such as Polycystic Ovarian Syndrome), may start ovulating again when they start taking Avandia. ||| − Si vous êtes hémophile, car des cas d’augmentation des saignements ont été rapportés chez des patients hémophiles prenant ce type de médicament (inhibiteurs de la protéase).
0.24008366465568542 ||| Also contains: sodium chloride, water for injections, hydrochloric acid, sodium hydroxide. ||| 1 ml solvent ampoule contains sodium chloride, hydrochloric acid, sodium hydroxide and water for injections. ||| Contient également: chlorure de sodium, eau pour préparations injectables, acide chlorhydrique, hydroxyde de sodium.
0.0 ||| The efficacy of the 12.5 mg dose has not been investigated in clinical trials. ||| The efficacy of the 12.5 mg dose has not been investigated in clinical trials. ||| L’ efficacité de la dose de 12,5 mg n’ a pas été étudiée dans les essais cliniques
0.3131372928619385 ||| Salt, raw ||| Fruit, fresh ||| Sel brut
6.474418440607921e-13 ||| Eye disorders ||| Eye disorders ||| 19 Affections oculaires
0.20330733060836792 ||| In short-term studies (7 days), the incidence of endoscopically observed gastroduodenal ulcers or erosions in healthy young and elderly (≥ 65 years) subjects administered Dynastat (5-21%), although higher than placebo (5-12%), was statistically significantly lower than the incidence observed with NSAIDs (66-90%). ||| The pooled data from six placebo-controlled studies in mainly elderly patients (> 65 years of age) with dementia showed that CVAEs (serious and non- serious, combined) occurred in 3.3% (33/ 1009) of patients treated with risperidone and 1.2% (8/ 712) of patients treated with placebo. ||| Dans les études endoscopiques de courte durée (7 jours) chez le volontaire sain jeune et âgé (≥ 65 ans) l'incidence des ulcères gastro-duodénaux ou des érosions après administration de Dynastat (5-21%), bien que supérieure au placebo (5-12%), restait significativement inférieure à l’ incidence observée avec les AINS (66-90%).
0.391743540763855 ||| Alitretinoin was shown to have a weak potential to be a photo-irritant based on histidine and photoprotein binding. ||| Aripiprazole also exhibited moderate binding affinity for the serotonin reuptake site and no appreciable affinity for muscarinic receptors. ||| Il a été démontré que l’ alitrétinoïne avait un faible potentiel pour développer un effet photo-irritant sur la base de la liaison de l’ histidine et de la photoprotéine.
0.3761756420135498 ||| MEPs also asked the Commission to keep the culture and education committee updated about the number of participants currently on an exchange, their situation and the measures taken to support them. ||| In addition, focus groups of experts from the CVMP and interested parties will be convened to consider specific topics mutually agreed to by the Committee and interested parties. ||| Les députés ont également demandé à la Commission européenne de tenir la commission de la culture et de l'éducation informée du nombre de participants actuellement impliqués dans un programme d'échange, de leur situation et des mesures prises pour les soutenir.
0.0 ||| Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. ||| Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. ||| 27 Au sein de chaque catégorie de fréquence, les effets indésirables sont présentés par ordre de gravité décroissante.
0.0 ||| Your other hand will be free to move the plunger. ||| Your other hand will be free to move the plunger. ||| Votre autre main est libre pour faire bouger le piston.
0.16517402231693268 ||| - The other ingredients are: metacresol, sodium dihydrogen phosphate dihydrate, glycerol, sodium ||| - The other ingredients are polysorbate 20, sucrose, sodium dihydrogen phosphate monohydrate, ||| - Les autres composants sont: métacrésol, phosphate monosodique dihydrogéné dihydraté,
0.41058361530303955 ||| DO NOT use Aranesp: ||| DO NOT use Nespo: ||| NE PAS utiliser Aranesp:
0.06558786332607269 ||| 4.2 Posology and method of administration ||| 4.2 Posology and Method of administration ||| 28 4.2 Posologie et mode d' administration
0.2788298726081848 ||| By replacing the hormone, Circadin increases blood levels of melatonin, helping them to sleep. ||| Nateglinide, the active ingredient in Starlix, stimulates the pancreas to produce insulin more quickly. ||| En remplaçant cette hormone, Circadin augmente les taux de mélatonine dans le sang, ce qui favorise le sommeil.
0.3104091286659241 ||| It works by increasing urine output, reducing the amount of fluid in the blood and lowering the blood pressure. ||| It works by increasing the outflow of liquid, which lowers the pressure in the eye. ||| Il agit en augmentant la production d’ urine, ce qui diminue la quantité de liquide dans le sang et abaisse la pression artérielle.
0.2583390474319458 ||| Let the tops air-dry. ||| Let the skin air-dry. ||| Laisser sécher à l'air.
0.07880613207817078 ||| ed Rotate the injection sites to avoid discomfort at the site of injection. ||| Rotate the injection sites to avoid discomfort at the site of injection. ||| Alterner les sites d’ injection afin d’ éviter une gêne au point d’ injection.
4.56477303872882e-13 ||| It works by reducing the intensity of the allergic reaction. ||| It works by reducing the intensity of the allergic reaction. ||| Il agit en réduisant l’intensité de la réaction allergique.
0.011437750421464443 ||| Do not refill NovoMix 30 Penfill cartridges. ||| Do not refill NovoMix 70 Penfill cartridges. ||| Ne reremplissez pas les cartouches NovoMix 30 Penfill.
0.0 ||| 12 ||| 12 ||| 17 12
0.36579227447509766 ||| What is Herceptin? ||| What is Thyrogen? ||| Qu’ est -ce qu'Herceptin?
0.5203719139099121 ||| No interaction studies have been conducted in adults with sugammadex and other medicinal products. ||| These reactions were at non-wart sites which may have been in contact with imiquimod cream. ||| Aucune étude d’ interaction entre le sugammadex et d’ autres médicaments n’ a été réalisée chez l’ adulte.
0.449821412563324 ||| • your skin becoming fragile and easily blistered (especially areas that are frequently exposed to sunlight) • and/ or you have stomach or limb pain. ||| Tiredness, feeling faint, becoming easily breathless or if you look pale (since you might have less haemoglobin than normal which is very common). ||| • votre peau se fragilise ou cloque facilement (en particulier les zones fréquemment exposées au soleil) • et/ ou vous avez des douleurs au niveau de l’ estomac ou des membres.
0.13482001423835754 ||| Neupro 6 mg/24 h Each patch releases 6 mg of rotigotine per 24 hours. ||| Neupro 6 mg/ 24 h transdermal patch Each patch releases 6 mg of rotigotine per 24 hours. ||| Neupro 6 mg/ 24 h Chaque dispositif transdermique libère 6 mg de rotigotine par 24 heures.
0.4091726839542389 ||| This will contribute to the stabilisation of the country by promoting a return to security and the presence of civil administration, public services and economic activities. ||| The EU will also support for the energy efficiency of buildings, the development of renewable sources and the modernisation of the health sector. ||| Cela contribuera à la stabilisation du pays en favorisant le retour à la sécurité et la présence de l'administration civile, des services publics et des activités économiques.
0.4299284517765045 ||| Cytokine-Refractory Metastatic Renal Cell Carcinoma A phase 2 study of SUTENT was conducted in patients who were refractory to prior cytokine therapy with interleukin-2 or interferon-α. ||| Week 12 Virological Response (VR) and Sustained Virological Response (SVR) in Patients with Virological Response at Week 12 after Treatment with Pegasys and Ribavirin Combination Therapy in Nonresponders to Peginterferon alfa-2b plus Ribavirin. ||| Cancer du rein métastatique après échec d’ un traitement par cytokine Une étude de phase II a été conduite chez des patients après échec d’ un traitement préalable par cytokine à base d’ interleukine-2 ou d’ interféron-α.
0.10427732765674591 ||| You must tell your doctor if you are pregnant or intend to become pregnant. ||| You must tell your doctor if you are pregnant or think you are pregnant. ||| Si vous êtes enceinte ou si vous avez l’intention de le devenir, vous devez en informer votre médecin.
0.01006025169044733 ||| 18 In RA study III, improvement in physical function was maintained through Week 260 (60 months) of open-label treatment. ||| 99 In RA study III, improvement in physical function was maintained through Week 260 (60 months) of open-label treatment. ||| Dans l'étude III sur la PR, l'amélioration des capacités fonctionnelles était maintenue jusqu'à la semaine 260 (60 mois) du traitement en ouvert.
0.43344447016716003 ||| The EU has already delivered a coordinated and powerful collective response to cushion the economic blow of the coronavirus crisis. ||| Greece committed to be on the forefront of the fight to make the vaccine a global public good and accessible to all. ||| L'Union a déjà apporté une réponse collective coordonnée et forte pour amortir le choc économique de la crise liée au coronavirus.
0.0 ||| Mechanism of action: ||| Mechanism of action: ||| 18 Mécanisme d'action:
0.48742911219596863 ||| Tricyclic antidepressants (e.g. amitriptyline, imipramine) (saquinavir/ritonavir) ||| - atorvastatin, fluvastatin, lovastatin, rosuvastatin, simvastatin (cholesterol-lowering medicines) ||| Antidépresseurs tricycliques (comme l’amytriptyline, l’imipramine) (saquinavir/ritonavir)
0.3328778147697449 ||| In these patients, therapy should be started under medical supervision and the patients should be followed closely whenever the dose of and/or diuretic is adjusted. ||| In these patients, therapy should be initiated under close medical supervision with low doses, careful titration, and monitoring of renal function. ||| Chez ces patients, le traitement doit être débuté sous surveillance médicale et les patients doivent être suivis étroitement chaque fois que la dose de et/ ou de diurétique est ajustée.
0.3998594582080841 ||| Total clearance of ibandronic acid is low with average values in the range 84-160 ml/ min. ||| Total plasma tipranavir concentrations for these samples ranged from 9 to 82 µM. ||| La clairance totale de l’ acide ibandronique est faible, avec des valeurs moyennes comprises entre 84 et 160 ml/ min.
0.3604829013347626 ||| Adult studies ||| Adult patients ||| Etudes chez l' adulte
0.03379068523645401 ||| To help you remember to take ARICLAIM, you may find it easier to take it at the same times every day. ||| 84 To help you remember to take ARICLAIM, you may find it easier to take it at the same times every day. ||| Pour ne pas oublier de prendre ARICLAIM, il est conseillé de prendre votre traitement à heure fixe tous les jours.
0.3577914834022522 ||| Spandrel panels of metal ||| Fireplace mantles of metal ||| Panneaux d'allège métalliques
0.3289670944213867 ||| If well tolerated, the rate of administration may gradually be increased to a maximum of 0.1 ml/ kg/ min. ||| You should aim to lose weight at a gradual, steady pace of about 0.5 kg (1 lb) per week. ||| S’ il est bien toléré, le débit peut être accéléré progressivement jusqu’ à un maximum de 0,1 ml/ kg/ min.
0.2528332769870758 ||| During clinical trials with ADVATE in 145 paediatric and adult patients 6 diagnosed with severe to moderately severe haemophilia A (FVIII ≤ 2%), with previous exposure to factor VIII concentrates ≥ 150 days, one patient developed a low-titre inhibitor (2.4 BU in the modified Bethesda assay) after 26 exposure days to ADVATE. ||| In each of two randomised, placebo-controlled trials, PROWESS and ADDRESS (see section 5.1), 28- day and in-hospital mortality were higher in patients treated with drotrecogin alfa (activated) compared to placebo for the sub-population of patients with single organ dysfunction and recent surgery (n=98 in PROWESS and n=636 in ADDRESS). ||| Au cours des essais cliniques avec ADVATE, sur 145 patients 6 pédiatriques et adultes ayant fait l’ objet d’ un diagnostic d’ hémophilie A sévère à modérément sévère (FVIII ≤ 2%) et précédemment exposés à des concentrés de facteur VIII pendant au moins 150 jours, un patient a développé un inhibiteur de faible titre (2,4 UB selon le test Bethesda modifié) après 26 jours d’ exposition.
0.5046151876449585 ||| An early concern among Icelandic residents placed in home-based quarantine has been employees' rights to paid leave while being quarantined; it was announced on 5 March that the COVID-19 outbreak will likely result in changes to legislation within the next weeks. ||| The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease. ||| L'une des premières préoccupations des résidents islandais placés en quarantaine à domicile a été le droit des employés à un congé payé pendant leur mise en quarantaine; il a été annoncé le 5 mars que l'épidémie de Covid-19 entraînera probablement des modifications de la législation dans les prochaines semaines.
0.25855889916419983 ||| Do not use Insulin Human Winthrop Infusat after the expiry date which is stated on the carton and on the label of the vial. ||| Do not use Irbesartan Hydrochlorothiazide Winthrop after the expiry date which is stated on the carton and on the blister after EXP. ||| Ne pas utiliser Insulin Human Winthrop Infusat après la date de péremption mentionnée sur la boîte et l'étiquette du flacon.
6.162795967989965e-13 ||| haematuria, renal impairment, bladder and urethral symptoms ||| haematuria, renal impairment, bladder and urethral symptoms ||| Hématurie, insuffisance rénale, symptômes
0.2513704001903534 ||| In controlled clinical studies, the incidence of clinically important elevations in serum transaminases (ALT and/ or AST ≥ 3 X ULN, consecutive) was 1.0% for patients treated with Trevaclyn with or without a statin. ||| 4 In the pivotal studies, the negative predictive value for NeoSpect in association with CT for solitary pulmonary nodules (SPNs) was 90– 96% at a disease prevalence of 30-50%. ||| Dans les études cliniques contrôlées, l’ incidence d’ élévations cliniquement importantes des transaminases sériques (ALAT) et/ ou (ASAT) ≥ 3 x LSN consécutivement) a été de 1,0% chez les patients traités par Trevaclyn avec ou sans statine.
0.11915527284145355 ||| 22 March 2005 ||| 21 February 2005 ||| 22 mars 2005
0.4045594334602356 ||| Trays, not of metal [other than for domestic purposes] ||| Cages of non-metallic materials, other than for domestic use ||| Plateaux non métalliques autres qu'à usage domestique
0.28797703981399536 ||| How is EMSELEX used? ||| How is HBVAXPRO used? ||| Comment EMSELEX est -il utilisé?
0.38180625438690186 ||| Very common (≥ 1/ 10) and Common (≥ 1/ 100 to < 1/ 10). ||| Common (≥ 1/ 100, < 1/ 10) Very Rare (≤ 1/ 10 000) Immune system disorders: ||| Très fréquent (≥ 1/ 10) et Fréquent (≥ 1/ 100 et ≤ 1/ 10).
0.45406657457351685 ||| The potential clinical relevance of neutralizing antibody formation is not known. ||| Mechanisms responsible for the deviation from dose proportionality have not been identified. ||| La pertinence clinique de la présence d'anticorps neutralisants n'est pas connue.
0.31361839175224304 ||| In case a side effect repeatedly occurs or in case the dog stops eating for two consecutive days, stop the administration of Yarvitan to your dog and seek the advice of your veterinary surgeon as soon as possible. ||| However, in the unlikely event that an infant spits out or regurgitates most of the vaccine dose, a single replacement dose may be given at the same vaccination visit. ||| Si un effet secondaire survient de manière répétée ou si le chien s’ arrête de manger pendant deux jours consécutifs, arrêter d’ administrer Yarvitan à votre chien et demander conseil à votre vétérinaire le plus rapidement possible.
0.2924344539642334 ||| 8 plasma concentrations of 9-cis-retinoic acid in patients with KS applying Panretin gel never exceeded 0.638 ng/ ml (2.13 nMol). ||| Anaemia (haemoglobin < 9.4 g/ dl) was reported in 12% (23/ 194) of patients treated with Ribavirin in combination with peginterferon alfa-2b. ||| En revanche les concentrations plasmatiques de l’ acide 9-cis-rétinoïque chez les patients ayant un SK et appliquant Panretin gel n’ ont jamais dépassé 0,638 ng/ ml (2,13 nMol).
0.0 ||| 7, 10, 20, 30, 50, 100 ||| 7, 10, 20, 30, 50, 100 ||| 7, 10, 20, 30,
0.14663463830947876 ||| [85.7; 99.6] ||| [86.2;99.6] ||| [85,7; 99,6]
0.4567874073982239 ||| In clinical studies, 10-30 mg/ day doses of aripiprazole had no significant effect on the metabolism of substrates of CYP2D6 (dextromethorphan/ 3-methoxymorphinan ratio), 2C9 (warfarin), 2C19 (omeprazole), and 3A4 (dextromethorphan). ||| 126 Low concentrations of four metabolites have been reported, which were identified as: desethyleneciprofloxacin (M 1), sulphociprofloxacin (M 2), oxociprofloxacin (M 3) and formylciprofloxacin (M 4). ||| Dans les études cliniques, l'aripiprazole à des doses allant de 10 à 30 mg/ jour n'a pas eu d'effet significatif sur le métabolisme des substrats du CYP2D6 (rapport dextromethorphane/ 3-methoxymorphinane), du 2C9 (warfarine), du 2C19 (omeprazole) et du 3A4 (dextromethorphane).
0.2907451391220093 ||| One vial contains 1.3 mg (corresponding to 4 IU) of somatropin after reconstitution with 1 ml solvent. ||| One vial of powder contains 6 micrograms of follitropin alfa in order to deliver 5.5 micrograms, equivalent to 75 IU. ||| Un flacon contient 1,3 mg (correspondant à 4 UI) de somatropine après reconstitution avec 1 ml de solvant.
0.09298580884933472 ||| Transdermal Use ||| Transdermal use ||| Voie transdermique
0.42915430665016174 ||| The treatment with calcium and vitamin D must be discontinued. ||| Adequate intake of calcium and vitamin D is important in all patients. ||| Traitement de l’hypercalcémie: le traitement au calcium et à la vitamine D3 doit être arrêté.
0.42289862036705017 ||| Onsior 5 mg tablets for dogs Onsior 10 mg tablets for dogs Onsior 20 mg tablets for dogs Onsior 40 mg tablets for dogs ||| Ibaflin 30 mg tablets for dogs / Ibaflin 150 mg tablets for dogs / Ibaflin 300 mg tablets for dogs / Ibaflin 900 mg tablets for dogs ||| Onsior 5 mg comprimés pour chiens Onsior 10 mg comprimés pour chiens Onsior 20 mg comprimés pour chiens Onsior 40 mg comprimés pour chiens
0.12498952448368073 ||| HEXAVAC should be administered with caution to subjects with thrombocytopenia or a bleeding disorder since bleeding may occur following an intramuscular administration to these subjects. ||| This vaccine should be given with caution to individuals with thrombocytopaenia or any coagulation disorder because bleeding may occur following an intramuscular administration in these individuals. ||| HEXAVAC doit être administré avec précaution chez les sujets présentant une thrombocytopénie, ou un trouble de la coagulation en raison du risque de saignement qui peut survenir lors de l'administration intramusculaire du vaccin chez ces sujets.
0.3645654320716858 ||| - blistering of the skin, sometimes resulting in local wound infections ||| This puts the patient at risk of developing blood clots or bleeding problems. ||| - apparition de cloques sur la peau, provoquant parfois des infections de plaies locales
0.4863284230232239 ||| Eli Lilly Netherlands BV Grootslag 1-5 3991 RA Houten The Netherlands ||| Grootslag 1-5, 3991 RA Houten The Netherlands ||| Eli Lilly Netherlands BV Grootslag 1-5 3991 RA Houten Pays-Bas
0.3255468010902405 ||| Abseamed has no influence on the ability to drive and use machines. ||| Epoetin alfa HEXAL has no influence on the ability to drive and use machines. ||| Abseamed n’ a aucun effet sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.4516865015029907 ||| Packaging bags [sacks] of plastic for bulk transportation ||| Undercoats [paints] for use on wood ||| Sacs d'emballage en matières plastiques pour le transport en vrac
0.0 ||| Mode of action ||| Mode of action ||| 104 Mode d' action
0.364612340927124 ||| Based on simulation data, an alternating daily dosing regimen of 800 mg and 400 mg in patients with severe renal impairment can approximate the AUC (0-48h) in healthy subjects receiving 800 mg once daily. ||| Use in adolescents and adults (12 years of age and older) The appropriate dose and dosing frequency of Xolair is determined by baseline IgE (IU/ ml), measured before the start of treatment, and body weight (kg). ||| A partir de données de simulation, une dose de 800 mg/ jour en alternance 1 jour sur 2 avec une dose de 400 mg/ jour chez les insuffisants rénaux sévères correspond approximativement à l’ ASC (0-48 h) obtenue chez les sujets sains recevant une dose de 800 mg/ jour.
2.826901039643115e-13 ||| If a further dose increase is necessary the daily dose should be increased by 0.54 mg base (0.75 mg salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day. ||| If a further dose increase is necessary the daily dose should be increased by 0.54 mg base (0.75 mg salt) at weekly intervals up to a maximum dose of 3.3 mg of base (4.5 mg of salt) per day. ||| 2 Si une posologie supérieure est nécessaire, la dose quotidienne peut être augmentée de 0,54 mg de forme base (0,75 mg de forme sel) par semaine, jusqu’ à la dose maximale de 3,3 mg de forme base (4,5 mg de forme sel) par jour.
0.0 ||| vial (glass) ||| vial (glass) ||| Voie intraveineuse Flacon (verre)
0.4903983473777771 ||| Serum electrolytes should be monitored. ||| Spleen size should be evaluated regularly. ||| L’ ionogramme sanguin (taux d’ électrolytes) doit être contrôlé.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.4206188917160034 ||| Effects on fertility cannot be excluded. ||| Dose-related adverse events cannot be excluded. ||| Des effets sur la fertilité ne peuvent être exclus.
0.5131058096885681 ||| This measures the patients’ exercise capacity. ||| During therapy patient’ s weight should be monitored. ||| Cela permet de mesurer la tolérance à l'effort des patients.
0.3726407289505005 ||| The country is in the grip of an unprecedented humanitarian crisis that continues to be fueled by non-state armed groups targeting civilians. ||| The humanitarian situation in Syria remains dire, with the coronavirus pandemic further exacerbating the needs of the most vulnerable communities. ||| Ce pays est en proie à une crise humanitaire sans précédent, constamment attisée par des groupes armés non étatiques qui prennent les civils pour cible.
0.5173934102058411 ||| Talk to your doctor if you want to stop. ||| If you want to work, we support you. ||| Parlez -en à votre médecin si vous souhaitez interrompre le traitement.
0.5036078691482544 ||| The nozzle can then be released and the pump is ready for the following dose. ||| Then, the patch is fold back and the second part of the release liner is removed. ||| Le bec verseur peut alors être relâché et la pompe est prête à délivrer la dose suivante.
0.3620810806751251 ||| Fitted furniture ||| Fitted kitchen furniture ||| Meubles encastrables
0.10036030411720276 ||| Dosage adjustment in the elderly is not necessary. ||| Dose adjustment is not required in the elderly. ||| Aucune adaptation posologique n'est nécessaire chez le sujet âgé.
0.25015413761138916 ||| Such elevation in white blood cells is transient, typically seen 24 to 48 hours after administration and is consistent with the pharmacodynamic effects of Neulasta. ||| The pharmacokinetics of insulin lispro reflect a compound that is rapidly absorbed, and achieves peak blood levels 30 to 70 minutes following subcutaneous injection. ||| Une telle élévation de leucocytes est transitoire, spécifiquement observée 24 à 48 heures après l’ administration et conforme aux effets pharmacodynamiques de Neulasta.
0.22243717312812805 ||| 10 pre-filled syringes + 20 needles ||| 2 x 5 pre-filled syringes ||| 10 seringues préremplies + 20 aiguilles
0.3758295476436615 ||| Patients exhibiting depression should be monitored closely during therapy and treated appropriately. ||| Patients who develop these symptoms should be reassessed and their treatment regimens evaluated. ||| Les patients présentant une dépression doivent faire l'objet d'une surveillance particulière durant le traitement et être traités de façon appropriée.
4.676501156805624e-13 ||| (ii) State guarantees for loans taken by companies to ensure banks keep providing loans to the customers who need them. ||| (ii) State guarantees for loans taken by companies to ensure banks keep providing loans to the customers who need them. ||| ii) garanties publiques des États membres pour les prêts contractés par les entreprises, afin de garantir que les banques continuent d'accorder des prêts aux clients qui en ont besoin.
0.26342254877090454 ||| What is Firmagon used for? ||| What is Visudyne used for? ||| Dans quel cas Firmagon est -il utilisé?
0.531059980392456 ||| Belt bags and hip bags ||| Bed clothes and blankets ||| Sacs-ceintures et bananes
0.005469067022204399 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that TESAVEL’ s benefits are greater than its risks for the treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin and/ or a sulphonylurea, or a PPAR gamma agonist, when diet and exercise plus the other medicines do not provide adequate glycaemic control. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Januvia’ s benefits are greater than its risks for the treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin and/ or a sulphonylurea, or a PPAR gamma agonist, when diet and exercise plus the other medicines do not provide adequate glycaemic control. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de TESAVEL sont supérieurs aux risques qu’ il comporte pour le traitement des patients souffrant de diabète de type 2 en vue d’ améliorer le contrôle de la glycémie, en association avec la metformine et/ ou un sulfamide hypoglycémiant, ou un agoniste des PPAR
0.1261691153049469 ||| 143 Κύπρος sanofi-aventis Cyprus Ltd. ||| Κύπρος sanofi -aventis Cyprus Ltd. ||| Κύπρος sanofi-aventis Cyprus Ltd.
0.07189825922250748 ||| 5.8 ||| 8.5 ||| 5,8
0.7423301935195923 ||| • Clinical trials ||| Laboratory Tests: ||| • Essais cliniques:
0.3870469927787781 ||| How to take the Diacomit capsules These capsules should be swallowed whole with water. ||| How to take SPRYCEL The tablets must be swallowed whole, not crushed. ||| 62 Comment prendre les gélules de Diacomit Les gélules doivent être avalées entières avec de l’ eau au cours d’ un repas.
0.3306456208229065 ||| Follow-up and end of treatment A medically supervised pregnancy test should be repeated every 4 weeks, including 4 weeks after the end of treatment, except in the case of confirmed tubal sterilisation. ||| In 2-year controlled clinical trials in MS patients, an infusion-related event was defined as an adverse event occurring during the infusion or within 1 hour of the completion of the infusion. ||| Suivi et arrêt du traitement Un nouveau test de grossesse sous contrôle médical doit être effectué toutes les 4 semaines et jusqu’ à 4 semaines après l’ arrêt du traitement, sauf en cas de stérilisation tubaire confirmée.
0.20511701703071594 ||| - The active substance is palivizumab. ||| - The active substance is retapamulin. ||| - La substance active est le palivizumab.
0.5043900012969971 ||| Manufacturer Novartis Vaccines and Diagnostics S. r. l. - Loc. ||| Marketing Authorisation Holder Novartis Vaccines and Diagnostics S. r. l. - Via Fiorentina, 1 – Siena, Italy. ||| Fabricant Novartis Vaccines and Diagnostics S. r. l. - Loc.
0.44360506534576416 ||| Treatment should be initiated and monitored under specialist supervision. ||| 16 should be evaluated and treatment instituted when necessary. ||| Le traitement devrait être instauré et surveillé sous le contrôle d’ un médecin spécialiste.
0.5128457546234131 ||| Neutropenia, thrombocytopenia, lymphopenia, leukopenia ||| Neutropenia or lymphopenia (grade 3-4), thrombocytopenia (grade 3-4) ||| Neutropénie, thrombocytopénie, lymphopénie, leucopénie
0.2771921157836914 ||| Approximately 75% of the administered dose of meloxicam is eliminated via faeces and the remainder via urine. ||| Metabolites account for approximately 14% of the administered amprenavir dose in the urine, and approximately 75% in the faeces. ||| Près de 75% de la dose administrée se retrouvent dans les fèces, le reste étant excrété par voie urinaire.
0.2977830469608307 ||| The frequency of the side effects listed below is defined using the following convention: ||| The frequency of side effects is classified into the following categories: ||| La fréquence des effets indésirables listés ci-dessous est définie selon la convention suivante:
0.3697453737258911 ||| What Remicade looks like and contents of the pack Remicade is supplied as a glass vial containing a powder. ||| What RoActemra looks like and contents of the pack RoActemra is a concentrate for solution for infusion. ||| Qu’ est -ce que Remicade et contenu de l’ emballage Remicade est fourni sous la forme d’ un flacon de verre contenant une poudre.
0.3089666962623596 ||| Following oral administration of anagrelide in man, at least 70% is absorbed from the gastrointestinal tract. ||| After intravenous administration, gadobutrol is rapidly distributed in the extra cellular space. ||| Suite à l’ administration par voie orale d’ anagrélide chez l’ homme, au moins 70% est absorbé par les voies gastro-intestinales.
0.12823735177516937 ||| What is the risk associated with Rebif? ||| What is the risk associated with Efficib? ||| Quel est le risque associé à l’ utilisation de Rebif?
0.4872627258300781 ||| The following documents were adopted or released for consultation by the CPMP in 1998: ||| The following documents are intended to be finalised or released for consultation in 2002. ||| Les documents suivants ont été adoptés ou transmis pour consultation par le CPMP en 1998:
0.4383498430252075 ||| Concomitant use of other myelosuppressive medicinal products. ||| Current immunosuppressive therapy (including high doses of corticosteroids). ||| Utilisation concomitante d'autres médicaments myélosuppresseurs.
0.14382776618003845 ||| tho For psoriatic arthritis, Trudexa was compared to placebo in two studies including 413 patients. ||| For psoriatic arthritis, Humira was compared with placebo over 12 weeks in two studies including 413 patients. ||| lus Pour la polyarthrite psoriasique, Trudexa a été comparé à un placebo dans deux études menées chez 413 patients.
0.47918465733528137 ||| Transmission of messages, data and content via the Internet and other communications networks ||| Advertising by transmission of on-line publicity for third parties through electronic communications networks ||| Transmission de messages, de données et de contenus par Internet et d'autres réseaux de communication
0.36301136016845703 ||| In patients with normal renal function and no other complicating factors, neutropenia occurs rarely. ||| In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal. ||| Chez des patients ayant une fonction rénale normale et sans autre facteur de complication, la neutropénie survient rarement.
0.13367372751235962 ||| Before you use Preotact 3. ||| Before you use Fasturtec 3. ||| Quelles sont les informations à connaître avant d'utiliser Preotact 3.
0.0922919362783432 ||| ALIMTA 100 mg powder for concentrate for solution for infusion ||| CANCIDAS 70 mg powder for concentrate for solution for infusion ||| ALIMTA 100 mg poudre pour solution à diluer pour perfusion
0.25978052616119385 ||| The proportions of patients with HIV RNA < 50 copies/ ml in the REYATAZ + ritonavir arm and the lopinavir + ritonavir arm were 36% and 42%, respectively. ||| The proportions of patients with HIV RNA < 400 copies/ ml (< 50 copies/ ml) for REYATAZ + ritonavir were 43% (32%) and for ||| Le pourcentage de patients avec une charge virale VIH inférieure à 50 copies/ ml ritonavir était de 36% et de 42%, respectivement.
0.11514319479465485 ||| Like all medicines, Myfenax can have side effects, although not everybody gets them. ||| Like all medicines, Glustin 30 mg tablets can have side effects, although not everybody gets them. ||| Comme tous les médicaments, Myfenax est susceptible d'avoir des effets indésirables, bien que tous n’y soient pas sujets.
0.15724685788154602 ||| Investigations: decreased glucose tolerance, weight gain, weight loss, increased bilirubin, hormone level altered, lab test abnormal. ||| Decreased glucose tolerance, weigh gain, weight loss, increased bilirubin, hormone level altered, lab test abnormal ||| Investigations: diminution de la tolérance au glucose, prise et perte de poids, hyperbilirubinémie, perturbation des niveaux hormonaux, anomalie des tests biologiques.
0.4169262647628784 ||| 2/ How does the company justify the absence of adjustment for tests of multiplicity in the analysis of the EPC results? ||| What does the exemption of the requirement to review and update of ex-ante assessments and business plans entail? ||| 10 2/ Comment la société justifie -t-elle l’ absence d’ ajustement pour les tests d’ hétérogénéité dans l’ analyse des résultats d’ EPC?
0.8744274377822876 ||| Control group 62% group ||| 591 Special patient groups ||| Groupe pravastatine 83% Groupe contrôle 62%
0.007757396437227726 ||| Actraphane 10 NovoLet is a simple, compact pre-filled pen. ||| Actraphane 30 NovoLet is a simple, compact pre-filled pen. ||| Actraphane 10 NovoLet est un stylo prérempli simple et compact.
0.6115890145301819 ||| Fire extinguishing compositions ||| Initiating explosives ||| Compositions extinctrices
0.6430779695510864 ||| Do not rub the injection area. ||| Inject the mixture immediately. ||| Ne pas masser la zone d'injection.
0.08597354590892792 ||| To be supplied only on veterinary prescription. ||| To be supplied only on veterinary prescription. or ||| À usage vétérinaire - à ne délivrer que sur ordonnance vétérinaire.
0.9030965566635132 ||| The Marketing Authorisation Holder provided written explanations on 2 June 2008. ||| EU-UK Statement following the High Level Meeting on 15 June ||| Le titulaire de l’ autorisation de mise sur le marché a fourni des explications écrites le 2 juin 2008.
0.16372992098331451 ||| • 05.12.2001 ||| • 28.05.2001 ||| 17.09.2001 05.12.2001
0.2196166068315506 ||| How does Bondenza work? ||| How does Prialt work? ||| Comment Bondenza agit -il?
1.4543908070062395e-13 ||| Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. • if your child has previously had an allergic reaction to any vaccine against diphtheria, tetanus, pertussis (whooping cough) or hepatitis B diseases. • if your child experienced problems of the nervous system within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease. • if your child has a severe infection with a high temperature (over 38°C). ||| Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. • if your child has previously had an allergic reaction to any vaccine against diphtheria, tetanus, pertussis (whooping cough) or hepatitis B diseases. • if your child experienced problems of the nervous system within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease. • if your child has a severe infection with a high temperature (over 38°C). ||| Les signes de réaction allergique peuvent prendre la forme d’ une éruption cutanée avec démangeaisons, d'une difficulté respiratoire et d'un gonflement du visage ou de la langue. • si votre enfant a précédemment présenté une réaction allergique à un autre vaccin contre la diphtérie, le tétanos, la coqueluche ou l’ hépatite B. • si votre enfant a présenté des troubles neurologiques dans les 7 jours suivant une précédente vaccination par un vaccin contre la coqueluche. • si votre enfant a une infection sévère avec une forte fièvre (supérieure à 38°C).
0.011207452043890953 ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE AND ||| FABRICANT DE LA SUBSTANCE ACTIVE D'ORIGINE BIOLOGIQUE ET TITULAIRE DE L’AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.2282710075378418 ||| - Hypersensitivity to somatropin or to any of the excipients. ||| Hypersensitivity to travoprost, timolol, or to any of the excipients. ||| - Hypersensibilité à la somatropine ou à un des excipients.
0.19241462647914886 ||| Karvezide 150 mg/ 12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets. ||| Irbesartan BMS 75 mg film-coated tablets are supplied in blister packs of 14, 28, 56, 84 or 98 film- coated tablets. ||| Karvezide 150 mg/ 12,5 mg comprimés pelliculés sont fournis en conditionnements de 14, 28, 30, 56, 84, 90 ou 98 comprimés pelliculés présentés en plaquettes thermoformées.
0.34024298191070557 ||| The main side effect of Metalyse is bleeding, generally at the site of the injection. ||| Bridion is used to speed up the recovery from the muscle relaxant, usually at the end of the operation. ||| Les saignements, généralement au point d’ injection, constituent l’ effet indésirable principal associé à Métalyse.
0.43968677520751953 ||| 2 years After opening, the solution can be used up to the expiry date on the bottle. ||| Shelf life after dilution according to directions: the product should be used immediately. ||| 2 ans Après ouverture, la solution peut être utilisée jusqu'à la date d'expiration inscrite sur le flacon.
0.09047446399927139 ||| 54 1. ||| 56 1. ||| 60 1.
0.2812742590904236 ||| Although hypokalaemia may develop with the use of thiazide diuretics, concurrent therapy with irbesartan may reduce diuretic-induced hypokalaemia. ||| Although hypokalaemia may develop with the use of thiazide diuretics, concurrent therapy with ramipril may ||| L'hypokaliémie induite par les thiazidiques, peut être réduite par l'association de ces diurétiques à l'irbésartan.
4.53713374379619e-13 ||| - If you have further questions, please ask your doctor or your pharmacist. ||| - If you have further questions, please ask your doctor or your pharmacist. ||| - Si vous avez d'autres questions, si vous avez un doute, demandez plus d’informations à votre
0.5326671600341797 ||| Anaemia, thrombocytopenia Eosinophilia ||| - Nephrocalcinosis, nephrolithiasis ||| Anémie, thrombocytopénie Eosinophilie
0.3949054479598999 ||| Individual cases of interstitial lung disorders of unknown causal relationship to cetuximab have been reported. ||| Localized clusters of infections due to carbapenem-resistant organisms have been reported in the European Union. ||| De rares cas d’ atteinte interstitielle pulmonaire ont été rapportés, sans lien de causalité évident avec le cetuximab.
0.2524753510951996 ||| Truvada is not recommended for patients with severe renal impairment (creatinine clearance < 30 ml/ min) and in patients who require haemodialysis because appropriate dose reductions cannot be achieved with the combination tablet. ||| Effentora is not recommended for use in patients who have received monoamine oxidase (MAO) inhibitors within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics. ||| Truvada n’ est pas recommandé chez les patients présentant une insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) et chez les patients qui nécessitent une hémodialyse car les réductions des doses d’ emtricitabine et de ténofovir nécessaires chez ces patients ne peuvent être obtenues avec l’ association fixe.
0.20338580012321472 ||| Each 0.5 ml pre-filled syringe contains 30 micrograms (6 million IU) of interferon beta-1a. ||| After reconstitution, each millilitre contains 250 microgram (8 million IU) interferon beta-1b. − The other ingredients are ||| Chaque seringue préremplie de 0,5 ml contient 30 microgrammes (6 millions d’ UI) d’ interféron bêta- 1a.
0.2610319256782532 ||| If you are receiving dialysis treatment when you begin treatment with Silapo, your dialysis regimen may need to be adjusted to maintain urea, creatinine and potassium levels in the desired range. ||| In patients taking coumarin anticoagulants, prothrombin time should be determined before starting simvastatin and frequently enough during early therapy to ensure that no significant alteration of prothrombin time occurs. ||| Si vous êtes sous dialyse lorsque vous démarrez votre traitement par Silapo, votre régime de dialyse devra peut-être être ajusté pour maintenir les niveaux d'urée, de créatinine et de potassium dans l'intervalle souhaité.
0.14773692190647125 ||| Do not use Combivir after the expiry date which is stated on the container. ||| Do not use this medicine after the expiry date stated on the container. ||| Ne pas utiliser Combivir après la date de péremption mentionnée sur la boîte.
0.2821832597255707 ||| Ionising guns for the treatment of air ||| Ionization apparatus for the treatment of air ||| Pistolets ionisants pour traitement de l'air
0.43543821573257446 ||| Severe thrombocytopenias (< 50 x 109/ l) are observed in about 20% to 30% of all patients. ||| All clinically significant (≥ grade 3) bleeding events occurred at platelet counts < 30 x 109/ l. ||| Une thrombopénie sévère (< 50 x 109/ l) est observée chez environ 20 à 30% des patients.
0.31322264671325684 ||| Lactation Verteporfin and its diacid metabolic are excreted in human milk in low amounts. ||| Lamivudine is excreted in human milk at similar concentrations to those found in serum. ||| Allaitement La vertéporfine et son métabolite diacide sont excrétés en faible quantité dans le lait maternel humain.
0.13776463270187378 ||| 5 x 3 ml Humalog Mix50 cartridges for a 3 ml pen 2 x (5 x 3 ml) Humalog Mix50 cartridges for a 3 ml pen ||| 5 x 3 ml Liprolog cartridges for a 3 ml pen 2 x (5 x 3 ml) Liprolog cartridges for a 3 ml pen ||| Emballage multiple de 2 boîtes de 5 cartouches d'Humalog Mix50 3 ml pour un stylo de 3 ml.
0.45513826608657837 ||| Each cycle will be 8 injections (16 days), given in area 1 through to area 8 in turn. ||| Three separate 5-day treatments must be performed at day 0, day 14 and day 60. ||| Chacun comporte 8 injections (16 jours), effectuées successivement de la zone 1 à la zone 8.
0.27232223749160767 ||| Pharmacokinetic/ pharmacodynamic (PK/ PD) relationship PK/ PD relationship analysis has shown that heart rate decreases almost linearly with increasing ivabradine and S 18982 plasma concentrations for doses of up to 15-20 mg twice daily. ||| Treatment with vildagliptin 50-100 mg daily in patients with type 2 diabetes significantly improved markers of beta cell function including HOMA-  (Homeostasis Model Assessment–), proinsulin to insulin ratio and measures of beta cell responsiveness from the frequently-sampled meal tolerance test. ||| Relation pharmacocinétique/ pharmacodynamie (PK/ PD) L’ analyse de la relation PK/ PD a montré qu’ il existait une relation quasi-linéaire entre les concentrations plasmatiques d’ ivabradine et de S18982 et la baisse de la fréquence cardiaque, pour des doses allant jusqu’ à 15 à 20 mg deux fois par jour.
0.6371750235557556 ||| Taking Efficib with food and drink Take Efficib with meals to lower your chance of an upset stomach. ||| Taking TRITACE with food and alcohol • Drinking alcohol with TRITACE may make you feel dizzy or light-headed. ||| 57 Aliments et boissons La prise d'Efficib au cours du repas diminue le risque de troubles gastriques.
0.37355586886405945 ||| - if you have diabetic ketoacidosis (a complication of diabetes with rapid weight loss, nausea or ||| - If you have a special type of diabetic eye disease called macular oedema (swelling of the back ||| - si vous avez une acidocétose diabétique (une complication du diabète se manifestant par une
0.16167141497135162 ||| Ambrisentan did not have any clinically relevant effects on the pharmacokinetics or pharmacodynamics of warfarin. ||| BYETTA is not expected to have any clinically relevant effects on the pharmacokinetics of metformin or sulphonylureas. ||| L’ ambrisentan n’ a eu aucun effet cliniquement significatif sur la pharmacocinétique ou la pharmacodynamique de la warfarine.
0.7227667570114136 ||| MedDRA system organ class Skin and Subcutaneous Tissue Disorders ||| MedDRA system organ class Cardiac Disorders lp ||| Affections de la peau et du tissu sous-cutané am
0.0 ||| Product a) Brandname b) INN c) Part A/B ||| Product a) Brandname b) INN c) Part A/B ||| Produit a) Nom de marque b) DCI c) Partie A/B
0.25218045711517334 ||| It could infect the drops left in the bottle. • Gently press on the base of the bottle to release one drop of EMADINE at a time. • Don’t squeeze the bottle, it is designed so that just a gentle press on the bottom is needed (picture 2). • If you use drops in both eyes, repeat the steps for your other eye. • Put the bottle cap back on firmly immediately after use. ||| RISPERDAL Quicklet orodispersible tablets Only remove a tablet from the blister when it is time to take your medicine. • Peel open a blister to expose the tablet • Do not push the tablet through the foil because it may break • Remove the tablet from the blister with dry hands • Place the tablet on your tongue straight away • The tablet will begin disintegrating within seconds • It can then be swallowed with or without water. ||| Cela peut infecter le collyre. • Appuyez légèrement sur la base du flacon pour libérer une goutte d’ EMADINE à la fois. • Ne comprimez pas le flacon, il est conçu pour que seule une légère pression sur la base soit nécessaire (figure 2). • Si vous devez traiter les deux yeux, recommencez ces étapes pour l'autre œ il. • Bien refermer le flacon immédiatement après usage.
0.07683785259723663 ||| 7 6.5 Nature and composition of immediate packaging ||| 15 6.5 Nature and composition of immediate packaging ||| 6.5 Nature et composition du conditionnement primaire
0.0 ||| 128 9. ||| 128 9. ||| 138 9.
0.0455968901515007 ||| STOCRIN 50 mg tablets ||| STOCRIN 200 mg tablets ||| STOCRIN 50 mg
0.31329405307769775 ||| There is limited experience regarding concomitant administration of daptomycin with other medicinal products that may trigger myopathy. ||| Clinically significant hypotension has been observed postmarketing with concomitant use of risperidone and antihypertensive treatment. ||| On ne dispose que d’ une expérience limitée concernant l’ administration concomitante de daptomycine et d’ autres spécialités connues pour entraîner une atteinte musculaire.
0.5078264474868774 ||| Because FMD rarely infects humans, but spreads rapidly among animals, it is a much greater threat to the agriculture industry than to human health. ||| However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women. ||| Du fait que la fièvre aphteuse n’infecte l’homme que rarement, mais se diffuse rapidement parmi les animaux, elle constitue une menace beaucoup plus évidente pour l’économie agricole que pour la santé humaine.
0.4077339172363281 ||| - pain in the tummy (abdomen) caused by pancreatitis, inflammation of the gall bladder and/ or bile ||| - acute kidney failure, abnormal kidney function, vaginal secretion due to a fungal infection (vaginal ||| - douleur du ventre (abdomen) due à une pancréatite, inflammation de la vésicule biliaire et/ ou des
0.035391442477703094 ||| Lipodystrophy: combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump) (see section 4.4). ||| Lipodystrophy and metabolic abnormalities: combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump). ||| Les traitements par association d’ antirétroviraux ont été associés, chez les patients infectés par le VIH, à une redistribution de la masse grasse corporelle (lipodystrophie), incluant une perte du tissu adipeux sous-cutané périphérique et facial, une augmentation de la masse grasse intra- abdominale et viscérale, une hypertrophie mammaire et une accumulation de la masse grasse au niveau retro-cervicale (bosse de bison) – (voir rubrique 4.4).
0.505145788192749 ||| One cartridge in a pre-filled pen and 7 needles for administration. ||| Each pack also contains one transfer needle and one filter needle. ||| 1 cartouche en stylo prérempli et 7 aiguilles pour l’ administration.
0.17339201271533966 ||| HOW TO TAKE GLUSTIN ||| HOW TO TAKE STOCRIN ||| COMMENT PRENDRE GLUSTIN
0.5197340250015259 ||| Filgrastim should be discontinued and appropriate treatment given in these cases. ||| The {pharmaceutical form} may be taken without regard to mealtime. ||| Dans de telles circonstances, le filgrastim doit être arrêté et un traitement approprié doit être instauré.
0.0 ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. ||| L’ (auto-)injection accidentelle peut provoquer de fortes douleurs et un gonflement, notamment en cas d’ injection dans une articulation ou un doigt de la main, et, dans de rares cas, conduire à la perte de ce doigt si un examen médical n’ est pas effectué rapidement.
0.0 ||| Very common Common Uncommon ||| Very common Common Uncommon ||| Très fréquent Fréquent Peu fréquent
0.4395695924758911 ||| A dose adjustment may be needed for these medicines. ||| A higher dose may be needed in children. ||| Un ajustement de la posologie de ces médicaments peut être nécessaire.
0.4917985796928406 ||| Enbrel is administered by an injection under the skin (by subcutaneous injection). ||| The vaccine must be administered by subcutaneous route or by in ovo route. ||| Enbrel est administré par une injection sous la peau (par injection en sous-cutanée).
0.12010057270526886 ||| Common side effects (likely to occur in fewer than 1 in 10 patients): ||| Uncommon side effects (likely to occur in fewer than 1 in 100 patients): ||| Effets indésirables fréquents (pouvant apparaître chez moins de 1 patient sur 10)
0.2963821291923523 ||| The risk of these rare events may be higher with postoperative use of indwelling epidural catheters or the concomitant use of other medicinal products affecting haemostasis. ||| Due to the formation of neutralising antibodies pharmacodynamic effects of romiplostim in rats were often decreasing at prolonged duration of administration. ||| Le risque de ces événements rares peut être augmenté par l’utilisation postopératoire prolongée de cathéters périduraux ou par l’administration concomitante d’autres médicaments agissant sur l’hémostase.
0.04664592072367668 ||| 79 4.5 Interaction with other medicinal products and other forms of interaction ||| au 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interactions avec d'autres médicaments et autres formes d' interactions
0.3541237711906433 ||| Your doctor will tell you how many Ketek tablets to take, at what time and for how long. ||| Your doctor will tell you how much medicine to take and for how long. ||| Votre médecin vous indiquera le nombre de comprimés de Ketek à prendre, l’heure de la prise et la durée du traitement.
0.841385006904602 ||| Wait 1 to 3 minutes. ||| This takes about 1 hour. ||| Attendez 1 à 3 minutes.
0.5526594519615173 ||| The following organisms were tested and found to be susceptible to difloxacin in vitro: ||| The following organisms were found to be of intermediate susceptibility: ||| Les organismes suivants ont été testés et se sont révélés sensibles à la difloxacine in vitro:
0.5628550052642822 ||| Folding multimeters ||| Setting pliers ||| Multimètres pliants
0.1862916201353073 ||| HOW TO TAKE APTIVUS ||| HOW TO TAKE VIRACEPT ||| COMMENT PRENDRE APTIVUS
0.027096860110759735 ||| Concentrations of triazolam may be increased when co-administered with Invirase/ritonavir. ||| Concentrations of tadalafil may be increased when co-administered with Invirase/ritonavir. ||| Les concentrations de triazolam peuvent être augmentées en cas d’administration concomitante avec Invirase/ritonavir.
0.0 ||| 4. ||| 4. ||| 331 4.
0.13646626472473145 ||| Children should not take Aprovel Aprovel should not be given to children under 18 years of age. ||| Children should not take Karvea Karvea should not be given to children under 18 years of age. ||| Aprovel ne doit pas être administré aux enfants de moins de 18 ans.
0.46958744525909424 ||| POSSIBLE SIDE EFFECTS ||| UNDESIRABLE EFFECTS ||| QUELS SONT LES EFFETS INDÉSIRABLES ÉVENTUELS?
3.8033877262921845e-13 ||| Danmark GlaxoSmithKline Pharma A/ S Tlf: + 45 36 35 91 00 info@glaxosmithkline. dk ||| Danmark GlaxoSmithKline Pharma A/ S Tlf: + 45 36 35 91 00 info@glaxosmithkline. dk ||| Danmark GlaxoSmithKline Pharma A/ S Tlf: + 45 36 35 91 00 Info@glaxosmithkline. dk
0.417619526386261 ||| This will be checked by your doctor. ||| These can usually be treated by your doctor. ||| Cela sera 109 vérifié par votre médecin.
0.4216417670249939 ||| Production of sporting events for television ||| Organisation of entertainment activities for summer camps ||| Production d'événements sportifs pour la télévision
0.04601083695888519 ||| The Committee recommended that Intrinsa be given marketing authorisation. ||| The Committee recommended that Tasigna be given marketing authorisation. ||| Le comité a recommandé qu’ Intrinsa reçoive une autorisation de mise sur le marché.
0.46316397190093994 ||| Urease for medical purposes ||| Insulation for building purposes ||| Uréase à usage médical
0.2604195177555084 ||| Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to CART. ||| There have been rare spontaneous reports of death, sometimes associated with dysphagia, pneumonia, and/ or other significant debility, after treatment with botulinum toxin type A. ||| Des cas d’ ostéonécrose ont été rapportés, en particulier chez des patients présentant des facteurs de risque connus, un stade avancé de la maladie liée au VIH ou un traitement par association d’ antirétroviraux au long cours.
8.600973665923162e-13 ||| There is no specific antidote to RISPERDAL. ||| There is no specific antidote to RISPERDAL. ||| Il n’ existe pas d’ antidote spécifique à RISPERDAL.
5.15087159123212e-13 ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. ||| Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. ||| Dans chaque regroupement par fréquence, les effets indésirables sont présentés par ordre de gravité décroissant:
0.03901725262403488 ||| The referral procedure started on 20 September 2007. ||| The referral procedure started on 21 September 2006. ||| La procédure de saisine a débuté le 20 septembre 2007.
0.48948973417282104 ||| In 1987, he joined Coopers & Lybrand where he was a senior management consultant specialising in the management and financial control of large primarily IT-related projects. ||| In 2007 Sport England and David Lock Associates produced Active Design, which provided a set of design guidelines to help promote opportunities for sport and physical activity in the design and layout of new development. ||| En 1987, il a rejoint Coopers & Lybrand, où il a été conseiller-cadre en gestion spécialisé dans la gestion et le contrôle financier de grands projets, principalement informatiques.
0.43750953674316406 ||| As with other hepatitis B vaccines, the duration of the protective effect in healthy vaccinees is unknown at present. ||| As with any vaccine, a protective immune response may not be elicited in all vaccinees. ||| Comme avec les autres vaccins hépatite B, la durée de la protection chez les personnes saines vaccinées n'est pas connue à ce jour.
0.48075711727142334 ||| Shovels [hand tools] ||| Tool belts [holders] ||| Pelles [outils]
0.384530633687973 ||| Blast treatment of a surface (Services for the -) ||| Cleaning by water jetting (Services for -) ||| Services de traitement de surfaces par jets d'air
9.84825936078959e-13 ||| musculoskeletal pain* ||| musculoskeletal pain* ||| hypotension orthostatique*
0.2625997066497803 ||| 33 (6.1%) 250 (46.0%) ||| 184 (10.9%) 1508 (89.1%) ||| 250 (46.0%)
0.5414107441902161 ||| Cardiotoxicity. ||| Antidiabetic agent. ||| Cardiotoxicité:
0.23643776774406433 ||| ed 15. ||| ed 5. ||| 15.
0.20135557651519775 ||| If you forget to take Agopton ||| If you forget to take Omnitrope ||| 76 Si vous oubliez de prendre Agopton
0.04539031907916069 ||| 41 4.9 Overdose ||| 40 4.9 Overdose ||| 4.9 Surdosage
3.240640178078791e-13 ||| I IntronA (3 MIU 3 times a week) I/R IntronA (3 MIU 3 times a week) + ribavirin (1,000/1,200 mg/day) ||| I IntronA (3 MIU 3 times a week) I/R IntronA (3 MIU 3 times a week) + ribavirin (1,000/1,200 mg/day) ||| I/ R IntronA (3 MUI 3 fois par semaine) + ribavirine (1 000/ 1 200 mg/ jour)
0.46920377016067505 ||| Fluids for use in etching glass ||| Mineral spirits for use as paint thinner ||| Fluides destinés à la gravure du verre
0.03431427478790283 ||| As for all vaccines, if Prevenar is used in very premature babies, there is a risk of the babies experiencing apnoea (brief pauses in breathing). ||| As for all vaccines, if HBVAXPRO is used in very premature babies, there is a risk of the babies experiencing apnoea (brief pauses in breathing). ||| Comme pour tous les vaccins, si Prevenar est utilisé chez des grands prématurés, les bébés risquent de tomber en apnée (courtes pauses respiratoires).
0.2634519934654236 ||| Patients with renal impairment In patients with mild-to-moderate renal impairment (30-70 ml/ min creatinine clearance), strontium clearance decreases as creatinine clearance decreases (approximately 30% decrease over the creatinine clearance range 30 to 70 ml/ min) and thereby induces an increase in strontium plasma levels. ||| In mild to moderate renal impairment (creatinine clearance 30-80 ml/min) mean AUC was increased by 13% only, while a 4.5-fold increase in mean AUC was observed in severe renal impairment (creatinine clearance 5-30 ml/min). ||| Insuffisant rénal Chez les patientes atteintes d’ insuffisance rénale légère à modérée (clairance de la créatinine comprise entre 30 et 70 ml/ min), la clairance du strontium diminue comme celle de la créatinine (diminution d’ environ 30% lorsque la clairance de la créatinine est comprise entre 30 et 70 ml/ min), induisant ainsi une augmentation des taux plasmatiques de strontium.
0.486892431974411 ||| Factoring ||| Holder ||| Affacturage
0.0 ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| 162 L'insuline peut provoquer une rétention sodée et un œ dème, en particulier si l'équilibre métabolique auparavant médiocre se trouve amélioré par une insulinothérapie intensive.
0.5119253993034363 ||| Small amounts of air may be present in the needle and insulin reservoir during normal use. ||| The major sources of pollution are sewage and water draining from farms and farmland. ||| 652 Dans les conditions normales d’utilisation, de petites quantités Il y a des bulles d’air dans d’air peuvent être présentes dans l’aiguille et dans le réservoir le réservoir. d’insuline.
0.2068219929933548 ||| SUSTIVA must always be taken in combination with other anti-HIV medicines. ||| CELSENTRI must be taken in combination with other medicines used to treat HIV. ||| SUSTIVA doit toujours être associé à d’ autres médicaments anti-VIH.
0.34801673889160156 ||| Each tablet contains 76.50 mg of lactose monohydrate ||| Each dose of 71.4 microliter contains 100 micrograms parathyroid hormone. ||| Chaque comprimé contient 76,50 mg de lactose monohydraté.
0.4492895305156708 ||| This clearance was achieved in 69% (20/ 29) of the Fabrazyme treated patients, but in none of the placebo patients (p < 0.001). ||| The craving score, which was between 62.4 and 65.6 before treatment, was down to 29.8 with Suboxone (and 55.1 with placebo). ||| Cette élimination a été obtenue chez 69% (20/ 29) des patients traités par Fabrazyme, mais chez aucun des patients recevant le placebo (p < 0,001).
5.503250307715979e-13 ||| 1 ml ||| 1 ml ||| 1ml
0.43042874336242676 ||| Accidental exposure to freezing temperatures does not adversely affect the stability of Zarzio. ||| Exposure to ambient light after overdose carries an increased risk of photosensitivity reactions. ||| Une exposition accidentelle à la congélation n’ affecte pas la stabilité de Zarzio.
0.48079803586006165 ||| 3 Elderly patient: ||| Elderly patients use: ||| Patients âgés
7.445022246269084e-13 ||| Special care before injection ||| Special care before injection ||| 606 Précautions particulières avant l’injection
0.3481801152229309 ||| The daily dose is 0.09 g oral paste (5 mg trimetoprim + 25 mg sulfadiazin) per kg body weight. ||| 2.5-5 mg trimethoprim and 12.5-25 mg sulfamethoxasole per kg body weight per day for 3-5 days Chickens: ||| g de pâte orale (5 mg de triméthoprime + 25 mg de sulfadiazine) par kg de poids corporel.
0.34906312823295593 ||| This Referral procedure relates to a request for Arbritation concerning a type II variation for a new indication in the “ reduction of risk of cardiovascular events in patients with stable coronary artery disease”. ||| The Marketing Authorisation Holders submitted a type II variation subject to the MRP in July 2004 to extend the indication to include initial maintenance therapy with the fixed dose combination in patients with chronic persistent asthma. ||| La présente procédure de saisine est en relation avec une demande d’ arbitrage concernant une modification de type II pour une nouvelle indication « réduction du risque d’ accidents cardiovasculaires chez des patients souffrant d’ une maladie coronaire stable ».
0.38075125217437744 ||| Viread 245 mg film-coated tablets are supplied in bottles containing 30 tablets. ||| Unidose blister packs of 56 x 1 film-coated tablet for delivery in hospitals are also available. ||| Les comprimés pelliculés Viread 245 mg sont fournis en flacon de 30 comprimés.
0.14700067043304443 ||| How has Avandamet been studied? ||| How has Diacomit been studied? ||| Quelles études ont été menées sur Avandamet?
0.46222156286239624 ||| Drill bits for rotary power tools ||| Strip coiling machines for transformer coils ||| Forets pour outils électriques rotatifs
0.09159606695175171 ||| Check the label to make sure that your Mixtard 30 InnoLet contains the correct type of insulin. ||| Check the label to make sure that your Actraphane 20 NovoLet contains the correct type of insulin. ||| Contrôlez l’ étiquette pour vous assurer que votre Mixtard 30 InnoLet contient le type d’ insuline correct.
0.23666545748710632 ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF STAMARIL AND ASSOCIATED NAMES ||| OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF VIGABATRIN CONTAINING MEDICINAL PRODUCTS ||| RESUME GENERAL DE L’ EVALUATION SCIENTIFIQUE DE STAMARIL ET DES DENOMINATIONS ASSOCIEES
0.4723615348339081 ||| Ísland Vistor hf. ||| Ísland Icepharma hf. ||| 83 Ísland Vistor hf.
0.18574678897857666 ||| Sodium chloride, L-histidine, polysorbate 80, sodium borate, water for injections. ||| Glycine, sodium chloride, calcium chloride, histidine, polysorbate 80, sucrose. ||| Chlorure de sodium, L-histidine, polysorbate 80, borate de sodium, eau pour préparations injectables.
0.3718007802963257 ||| In the main study, Fabrazyme was compared with placebo (a dummy treatment) in 58 patients. ||| In the other study, Insuman Comb 25 was compared with semi-synthetic human insulin. ||| Dans l'étude principale, Fabrazyme a été comparé à un placebo (traitement fictif) chez 58 patients.
0.1703173816204071 ||| 160 mg metaflumizone ||| Metaflumizone 320 mg ||| 160 mg métaflumizone
0.07725316286087036 ||| 104 9. ||| 101 9. ||| 112 9.
0.26081404089927673 ||| Bows for musical instruments ||| Reeds for musical instruments ||| Archets pour instruments de musique
0.32865262031555176 ||| A desiccant unit containing black activated carbon and silica gel granules is included in the bottle. ||| The vial contents are added to a sodium chloride or glucose solution contained in a drip bag. ||| Le flacon contient également un agent dessiccant composé de charbon noir activé et de granules de gel de silice.
0.20264321565628052 ||| Such reactions may include photosensitivity, pseudotumor cerebri, pancreatitis, and anti-anabolic action which has led to increased BUN, azotaemia, acidosis, and hyperphosphataemia (see section 4.8). ||| Hypersensitivity reactions, including anaphylactic/ anaphylactoid reactions, angioedema, exfoliative dermatitis, and hypersensitivity vasculitis, have been associated with the administration of sirolimus (see section 4.8). ||| Ces effets peuvent être une photosensibilité, un syndrome d'hypertension intracrânienne bénigne, une pancréatite, un effet anti-anabolique pouvant entraîner une augmentation de l’ urée sanguine, une azotémie, une acidose et une hyperphosphatémie (voir rubrique 4.8).
0.20740064978599548 ||| Iscover belongs to a group of medicines called antiplatelet medicinal products. ||| Ebixa belongs to a group of medicines known as anti-dementia medicines. ||| Iscover appartient à une classe de médicaments appelés antiagrégants plaquettaires.
0.3867344260215759 ||| Mild induction of glucuronidation is also seen with 80 mg oral aprepitant given for 7 days. ||| Temoporfin is a low clearance substance with a terminal plasma half-life of 65 hours in patients. ||| Une induction légère de la glucuronidation est également constatée avec 80 mg d’ aprépitant administrés par voie orale pendant 7 jours.
0.3645544946193695 ||| HOW TO TAKE EVISTA ||| HOW TO TAKE REYATAZ ||| COMMENT PRENDRE EVISTA
0.5016286373138428 ||| In 2013, the European Commission issued a guidance document to assist EU countries in this process. ||| On this basis, the Commission approved the scheme under EU State aid rules. ||| En 2013, la Commission européenne a publié un document d'orientation pour aider les pays de l'UE dans ce processus.
0.7385743856430054 ||| 21 (81 %)* ||| 13 of 186 [7%]). ||| 33 (36 %)* 21 (81 %)*
0.6733261942863464 ||| Please read it carefully. ||| Dispose of it carefully. ||| Lisez -la attentivement.
0.001442005392163992 ||| Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCV-RNA polymerase chain reaction assay (PCR) (> 30 IU/ ml), a liver biopsy consistent with a histological diagnosis of chronic hepatitis with no other cause for the chronic hepatitis, and abnormal serum ALT. ||| Eligible patients for these trials had chronic hepatitis C confirmed by a positive HCV-RNA polymerase chain reaction assay (PCR) (> 30 IU/ml), a liver biopsy consistent with a histological diagnosis of chronic hepatitis with no other cause for the chronic hepatitis, and abnormal serum ALT. ||| Les patients éligibles pour ces études avaient une hépatite C chronique confirmée par un dosage positif « VHC-ARN polymerase chain reaction » (PCR) (> 30 UI/ ml), une biopsie hépatique cohérente avec un diagnostic histologique d’ hépatite chronique sans autre cause d’ hépatite chronique, et des ALT sériques anormales.
0.03570439666509628 ||| The Temporary Framework, as amended on 3 April 2020 and 8 May 2020 , provides for the following types of aid, which can be granted by Member States: ||| The Temporary Framework, as amended on 3 April and 8 May 2020, provides for the following types of aid, which can be granted by Member States: ||| L'encadrement temporaire, tel que modifié le 3 avril 2020 et le 8 mai 2020 , prévoit que les types d'aide ci-dessous peuvent être octroyés par les États membres:
0.24127420783042908 ||| Bottle: ||| Cattle: ||| Flacon:
0.0 ||| 9. ||| 9. ||| 137 9.
0.3223831057548523 ||| Fluoxetine should be discontinued in any patient entering a manic phase. ||| Parecoxib should be discontinued at the first sign of hypersensitivity. ||| Le traitement par la fluoxétine doit être interrompu chez tout patient présentant les premiers signes de manie ou d’ hypomanie.
0.18359501659870148 ||| It is used to treat patients with the following diseases, when they cannot tolerate other antifungal medicines (amphotericin B, itraconazole or fluconazole) or have not improved after at least 7 days of treatment with other antifungal medicines: • invasive aspergillosis (a type of fungal infection due to Aspergillus), • fusariosis (another type of fungal infection due to Fusarium), • chromoblastomycosis and mycetoma (long-term fungal infections of the skin or the tissue just below the skin, usually caused by fungal spores infecting wounds due to thorns or splinters), • coccidioidomycosis (fungal infection of the lungs caused by breathing in spores). ||| Remicade is used with methotrexate (a medicine that acts on the immune system), • Crohn’ s disease (a disease causing inflammation of the digestive tract), when the disease is severe or fistulising(with the formation of fistulae, abnormal passageways between the gut and other organs), • ulcerative colitis (a disease causing inflammation and ulcers in the lining of the gut), • ankylosing spondylitis (a disease causing inflammation and pain in the joints of the spine), • psoriatic arthritis (a disease causing red, scaly patches on the skin and inflammation of the joints), • psoriasis (a disease causing red, scaly patches on the skin). ||| Il est utilisé dans le traitement des patients atteints des maladies suivantes, lorsqu’ ils ne tolèrent pas d’ autres médicaments antifongiques (amphotéricine B, itraconazole ou fluconazole) ou lorsque leur état ne s’ est pas amélioré après au moins 7 jours de traitement par d’ autres médicaments antifongiques: • aspergillose invasive (type d’ infection fongique due à Aspergillus), • fusariose (autre type d’ infection fongique due à Fusarium), • chromoblastomycose et mycétome (infections fongiques à long terme de la peau ou des tissus situés juste en dessous de la peau, causées généralement par des spores fongiques infectant les plaies dues à des épines ou des échardes), • coccidioïdomycose (infection fongique des poumons causée par l’ inhalation de spores).
0.1977415382862091 ||| Studies done subsequently have suggested that it is feasible to administer gemcitabine at lower doses with concurrent radiotherapy with predictable toxicity, such as a phase II study in non-small cell lung cancer, where thoracic radiation doses of 66 Gy were applied concomitantly with an administration with gemcitabine (600 mg/m2, four times) and cisplatin (80 mg/m2 twice) during 6 weeks. ||| In an open-label, two-way crossover bioequivalence study of the pharmacokinetics of oral and intravenous TMZ in patients with primary CNS malignancies, Temodal 2.5 mg/ml powder for solution for infusion administered over 90 minutes was found to be bioequivalent for Cmax and AUC of TMZ and MTIC as compared to Temodal hard capsules, following administration of 150 mg/m2 dose. ||| Les études réalisées ultérieurement ont suggéré la faisabilité d'administrer la gemcitabine avec la radiothérapie à des doses plus faibles avec une toxicité prévisible, comme dans le cas d’une étude de phase II dans le cancer bronchique non à petites cellules, où les doses de radiothérapie thoracique de 66 Gy ont été administrées de façon concomitante avec la gemcitabine (600 mg/m2, quatre fois) et le cisplatine (80 mg/m2 deux fois) pendant 6 semaines.
0.12013393640518188 ||| Silgard is available in packs of 1, 10 or 20 pre-filled syringes. ||| Orgalutran is available in packs of 1 or 5 pre-filled syringes. ||| Silgard est disponible en boîtes de 1, 10 ou 20 seringues préremplies.
0.27895140647888184 ||| No studies on the effect of etoricoxib on the ability to drive or use machines have been performed. ||| No information is available on the effect of Kinzalkomb on the ability to drive or operate machinery. ||| Aucune étude sur l’ effet de l’ étoricoxib sur l’ aptitude à conduire des véhicules et à utiliser des machines n’ a été réalisée.
0.43431854248046875 ||| Chemical and physical in-use stability has been demonstrated for 3 hours at a temperature of 21 °C. ||| An increase in body temperature of up to 2°C may occur on the day of vaccination. ||| Il a été démontré que la stabilité chimique et physique à l’ usage est de 3 heures à une température de + 21 °C.
0.1939328908920288 ||| The reconstituted vaccine must not be used if any particulate matter is noted or if the appearance of the solvent or powder or of the reconstituted vaccine differs from that described above. ||| The reconstituted vaccine must not be used if any particulate matter is noted or if the appearance of the vaccine differs from that described above. ||| Le vaccin reconstitué ne doit pas être utilisé si une particule étrangère est présente ou si l'aspect du solvant, de la poudre ou du vaccin diffère de ce qui est décrit ci-dessus.
0.6497999429702759 ||| After reconstitution in the vial: ||| 2 years in the unopened vial. ||| 36 Après reconstitution dans le flacon:
0.31422674655914307 ||| In the long term 26-week maintenance phase of a placebo-controlled trial, the incidence of EPS was 18.2% for aripiprazole-treated patients and 15.7% for placebo-treated patients. ||| In the pivotal controlled trials, the rate of infection was 1.58per patient year in the Humira treated patients and 1.42 per patient year in the placebo and active control-treated patients. ||| Dans l’ étude clinique contrôlée versus placebo long terme à 26 semaines de phase de maintenance, l’ incidence des symptômes extrapyramidaux était de 18,2% chez les patients traités par aripiprazole et de 15,7% chez les patients traités par le placebo.
0.1276598870754242 ||| Rental of carpets ||| Rental of rugs ||| Location de tapis
0.01239154301583767 ||| PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen Peginterferon alfa-2b (conjugation of recombinant interferon alfa-2b with monomethoxy polyethylene glycol) ||| ViraferonPeg 150 micrograms powder and solvent for solution for injection in pre-filled pen Peginterferon alfa-2b (conjugation of recombinant interferon alfa-2b with monomethoxy polyethylene glycol) ||| PegIntron 120 microgrammes poudre et solvant pour solution injectable en stylo prérempli Peginterféron alfa -2b (conjugaison de l’interféron alfa-2b recombinant avec le monométhoxy polyéthylène glycol)
0.24851427972316742 ||| Capsule shell Gelatine Sodium laurilsulfate Yellow iron oxide (E172) Titanium dioxide (E171) Silicon dioxide (E551) ||| Gelatin Sodium Lauryl Sulfate Titanium Dioxide (E171) Indigo Carmine (E132) Red Iron oxide (E172) Yellow Iron Oxide (E172) Edible black ink. ||| Gélatine Laurylsulfate sodique Oxyde de fer jaune (E172) Dioxyde de titane (E171) Dioxyde de silicium (E551)
0.31914234161376953 ||| Therefore the results of the study can not be extrapolated to the population intended for use and consequently, the protective anti-HBs level in the population intended for use is not known and neither whether the recommended dose in the core SPC could guarantee an appropriate antibody level to prevent hepatitis B in adults and hemodialysed patients as well as newborns of a hepatitis B virus carrier-mother. ||| withdrawal periods for cattle and pigs are inadequate to ensure that foodstuffs obtained from the treated animals do not contain residues which might constitute a health hazard to the consumer; the CVMP recommends the suspension of the marketing authorisations for Suramox 15% LA or variations of that name as referred in Annex I, presented as injectable suspension for pigs and cattle. ||| Les résultats de l’ étude ne peuvent donc pas être extrapolés à la population visée pour l’ utilisation et par conséquent il est impossible de savoir quel est le taux d’ anticorps anti-HBs protecteur dans la population visée, ni si la dose recommandée dans le RCP de base pourrait garantir un taux d’ anticorps approprié pour prévenir l’ hépatite B chez les adultes et les patients dialysés, ainsi que chez les nouveau-nés de mères porteuses du virus de l’ hépatite B.
0.424781858921051 ||| If the solution is not to be used immediately, the syringe cap is to be carefully replaced. ||| However, do not scrub the area where the patch has been placed too hard. ||| Si la solution n’est pas utilisée immédiatement, l’embout de la seringue doit être soigneusement replacé.
0.546901285648346 ||| Irbesartan Hydrochlorothiazide BMS is contraindicated during breast-feeding. ||| A16AA05 Treatment of hyperammonaemia due to N-acetylglutamate ||| Irbesartan Hydrochlorothiazide BMS est contre-indiqué pendant l'allaitement.
0.41769224405288696 ||| What is the EU doing to protect workers affected by coronavirus? ||| What is the Commission doing to save jobs in the tourism sector? ||| Que fait l'UE pour protéger les travailleurs touchés par le coronavirus?
0.2317337691783905 ||| The medicine is used to help in the diagnosis of: • movement disorders such as those seen in Parkinson’ s disease and other related diseases, where a loss of striatal nerve cells in the brain leads to tremor (shaking), gait disturbance and stiffness of muscles. ||| by growth hormone deficiency (relative lack of growth hormone), Turner syndrome, or ‘ chronic renal insufficiency’ (a condition in which the kidneys gradually lose their ability to perform their normal functions, such as the removal of wastes and extra fluid from the body). ||| Le médicament est utilisé dans le diagnostic: • des troubles de coordination tels que ceux observés dans la maladie de Parkinson et d’ autres maladies liées, dans lesquelles une disparition des cellules nerveuses du striatum entraîne des tremblements, des troubles de la démarche et une raideur musculaire.
0.291278600692749 ||| From the bone tissue it is released very slowly back into the systemic circulation and eliminated via the kidney. ||| The blood is supplied with oxygen by a heart and lung machine and then pumped back into the artery in your affected limb. ||| Il est ensuite libéré très lentement du tissu osseux dans la circulation systémique et éliminé par voie rénale.
4.942462997030439e-13 ||| Mean VASPI score at end of initial titration in mm (SD) ||| Mean VASPI score at end of initial titration in mm (SD) ||| Score EVA moyen à la fin du titrage de doses initial, en mm (ET)
0.0 ||| Blood and lymphatic system disorders ||| Blood and lymphatic system disorders ||| Affections du système sanguin et lymphatique
0.3857642412185669 ||| Smoke projectiles for rockets ||| Motorized tailgates for trucks ||| Projectiles fumigènes pour roquettes
0.5412377119064331 ||| Storing LITAK 6. ||| Storing BEROMUN 6. ||| Comment conserver LITAK 6.
0.37645021080970764 ||| Bristol-Myers Squibb S. r. l., Contrada Fontana del Ceraso, 03012 Anagni (FR), Italy ||| Merck Serono S. p. A., Via delle Magnolie 15, I-70026 Modugno (Bari), Italy ||| Bristol-Myers Squibb S. r. l., Contrada Fontana del Ceraso, 03012 Anagni (FR), Italie
0.28301018476486206 ||| Transient elevations in CSF protein and white blood cells have also been observed in patients following DepoCyte administration and also been noted after intrathecal treatment with methotrexate or cytarabine. ||| After epileptic control has been achieved during adjunctive therapy, concomitant antiepileptic drugs (AEDs) may be withdrawn and patients continued on Lamictal monotherapy. ||| Des élévations transitoires de protéines et des leucocytes dans le LCR ont aussi été observées après une administration de DepoCyte et ont aussi été notées après un traitement par voie intrathécale de méthotrexate ou de cytarabine.
0.04445251077413559 ||| 146 B. ||| 153 B. ||| 168 B.
0.0636124312877655 ||| The Committee recommended that Humira be given marketing authorisation. ||| The Committee recommended that Zarzio be given marketing authorisation. ||| Le CHMP a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Humira.
0.019869517534971237 ||| 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel. ||| 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. ||| La pioglitazone, principe actif d’ Actos, augmente la sensibilité 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
0.2634545564651489 ||| The blood pressure lowering effect of Aprovel is evident within 1-2 weeks, with the maximal effect occurring by 4-6 weeks after start of therapy. ||| The antihypertensive effect persists constantly over 24 hours after dosing and includes the last 4 hours before the next dose as shown by ambulatory blood pressure measurements. ||| L'effet antihypertenseur de Aprovel se manifeste en une à deux semaines, l'effet maximal étant observé quatre à six semaines après le début du traitement.
0.32720646262168884 ||| Although not studied, voriconazole may increase the plasma concentrations of coumarins and therefore may cause an increase in prothrombin time. ||| As in dogs dexmedetomidine has a high clearance in cats and its elimination depends on the hepatic blood flow. ||| Bien que non étudié, le voriconazole est susceptible d’ augmenter les concentrations plasmatiques des coumarines et donc d’ augmenter le temps de prothrombine.
0.009906763210892677 ||| Kinzalkomb is not recommended in early pregnancy and may cause serious harm to your baby after 3 months of pregnancy (see section Pregnancy and breast-feeding). ||| Kinzalmono is not recommended in early pregnancy and may cause serious harm to your baby after 3 months of pregnancy (see section Pregnancy and breast-feeding). ||| Votre médecin vous recommandera normalement de prendre un autre médicament, puisque Kinzalkomb est déconseillé en début de grossesse et peut entraîner des problèmes de santé chez l’ enfant à naître si Kinzalkomb est pris après 3 mois de grossesse (voir rubrique « Grossesse et Allaitement »).
0.18384650349617004 ||| Shaver sockets (Electric -) ||| Stew-pots (Electric -) ||| Prises pour rasoirs électriques
0.10398992151021957 ||| Insuman Rapid must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of a water-like consistency. ||| It must only be used if the solution is clear, colourless, with no solid particles visible, and if it is of water-like consistency. ||| Insuman Rapid OptiSet ne doit être utilisé que si la solution est claire, incolore, sans particules solides visibles, et qu’ elle a la consistance de l'eau.
0.45479679107666016 ||| Schering Plough Europe Rue de Stalle 73 B-1180 Brussels Belgium ||| KG Binger Strasse 173 55216 Ingelheim am Rhein Germany ||| Rue de Stalle 73 B-1180 Brussels Belgique
0.012577811256051064 ||| Amlodipine/ Valsartan Over 1,400 hypertensive patients received Copalia once daily in two placebo-controlled trials. ||| Amlodipine/ Valsartan Over 1,400 hypertensive patients received Imprida once daily in two placebo-controlled trials. ||| Amlodipine/ valsartan Plus de 1 400 patients hypertendus ont reçu Copalia une fois par jour au cours de deux essais contrôlés contre placebo.
0.22328528761863708 ||| Children with Turner syndrome Inject 0.045 - 0.050 milligrams (mg) for each kilogramme of body weight once daily under the skin (subcutaneously). ||| Children with Turner syndrome The recommended dosage is 0.045 - 0.050 mg/ kg body weight per day, given as a subcutaneous injection. ||| Enfants atteints de syndrome de Turner Injecter 0,045 à 0,050 milligrammes (mg) par kilo de poids corporel une fois par jour sous la peau (par voie sous-cutanée).
0.3868890702724457 ||| Dextrins for industrial use ||| Diffusion furnaces for industrial use ||| Dextrines à usage industriel
0.2972142696380615 ||| If you have questions about how to inject, please ask your doctor, nurse, pharmacist for assistance. ||| However, you should tell your doctor or your pharmacist, or contact your nearest hospital emergency department for further advice. ||| Si vous avez des questions sur l’injection, demandez conseil à votre médecin, votre pharmacien ou à l'infirmier(ère).
0.6820588111877441 ||| This makes it suitable for use in a vaccine. ||| This product is specifically developed for dogs. ||| Cela la rend adaptée à l’ utilisation dans un vaccin.
3.034270968163555e-13 ||| Pegasys is presented as a solution for injection in a vial (1 ml) available in packs containing 1 or 4 single dose vials. ||| Pegasys is presented as a solution for injection in a vial (1 ml) available in packs containing 1 or 4 single dose vials. ||| Pegasys se présente sous la forme d'une solution injectable en flacon (1 ml) disponible en boîtes de 1 ou 4 flacons unidoses.
0.43036729097366333 ||| Strong recommendation to use the chromogenic substrate assay when monitoring patients. ||| Static perimetry is the preferred method for detecting vigabatrin associated visual field defect. ||| • La recommandation d’utiliser le dosage chromogénique lors du suivi des patients.
0.12229093164205551 ||| Benzalkonium chloride, mannitol, carbomer 974P, tyloxapol, edetate disodium, sodium chloride, hydrochloric acid/ sodium hydroxide (to adjust pH) purified water. ||| Contains: benzalkonium chloride 0.1 mg/ml, trometamol, sodium chloride, hypromellose, hydrochloric acid/sodium hydroxide (to adjust pH), purified water. ||| Chlorure de benzalkonium, mannitol, carbomère 974P, tyloxapol, édétate disodique, chlorure de sodium, acide chlorhydrique/ hydroxyde de sodium (ajustement du pH), eau purifiée.
0.48991185426712036 ||| National authorities will be able to adjust their aid schemes to reduce the risk of contamination. ||| If Member States need to modify their national operational programmes, the Commission will facilitate this work. ||| Les autorités nationales seront en mesure d'adapter leurs régimes d'aide afin de réduire le risque de contamination.
0.215409517288208 ||| Depression, emotional lability, insomnia Suicidal ideation, aggressive reaction, confusion, behaviour disorder, agitation, somnambulism, anxiety, nervousness, sleep ||| Depression, insomnia, anxiety, emotional lability Suicidal ideation, psychosis, aggressive behaviour, confusion, agitation, nervousness, sleep disorder, abnormal dreaming, abnormal crying, apathy, decreased libido ||| Hypertriglycéridémie§, hyperuricémie, augmentation de l’ appétit, Fréquent: § Affections psychiatriques Dépression, instabilité émotionnelle, insomnie Très fréquent:
0.3948180675506592 ||| In separate pharmacokinetic interaction studies, co-administration of ritonavir (potent CYP3A4 inhibitor) or saquinavir in combination with a booster dose of ritonavir or rifampicin (potent CYP34A inducer) did not result in clinically significant changes of the pharmacokinetics of enfuvirtide. ||| The separate pharmaceutical forms of efavirenz, emtricitabine and tenofovir disoproxil fumarate were used to determine the pharmacokinetics of efavirenz, emtricitabine and tenofovir disoproxil fumarate, administered separately in HIV infected patients. ||| Influence des médicaments associés sur le métabolisme de l'enfuvirtide: dans des études distinctes d'interactions pharmacocinétiques, l'administration concomitante de ritonavir (inhibiteur puissant du CYP3A4) ou de saquinavir en association à de faibles doses de ritonavir et de rifampicine (inducteur puissant du CYP3A4) n'a pas entraîné de modifications cliniquement significatives de la pharmacocinétique de l'enfuvirtide.
0.3023935854434967 ||| Caution should be used during concomitant administration because of the potential to reduce efficacy of Myfenax. ||| Appropriate treatment should be available for immediate use in the event of an anaphylactic reaction during administration of RoActemra. ||| La prudence est conseillée lors de l’ administration concomitante, car l’ efficacité de Myfenax pourrait être diminuée.
0.3137485980987549 ||| Combination antiretroviral therapy may also cause raised lactic acid and sugar in the blood, increased fats in the blood and resistance to insulin (insulin will not work as effectively). ||| It acts as an agonist on bone and partially on cholesterol metabolism (decrease in total and LDL-cholesterol), but not in the hypothalamus or in the uterine or breast tissues. ||| Les multithérapies antirétrovirales peuvent également entraîner une élévation de l’acide lactique et du sucre dans le sang, une augmentation du taux de graisses dans le sang (hyperlipidémie) et une résistance à l’insuline (l’insuline n’agit pas aussi efficacement qu’elle devrait).
0.058306582272052765 ||| This recurrence is usually more severe than on initial presentation, and may include life-threatening hypotension and death. ||| This recurrence is usually more severe than on initial presentation, and may include life- threatening hypotension and death. ||| Cette récidive est généralement plus sévère que l'épisode initial et peut entraîner une hypotension mettant en jeu le pronostic vital, voire le décès.
0.22549653053283691 ||| Both pioglitazone and metformin have been shown to be present in the milk of lactating rats. ||| Both rosiglitazone and glimepiride have been detected in the milk of experimental animals. ||| Chez l'animal (rate), la pioglitazone ainsi que la metformine ont été détectées dans le lait.
0.4788430333137512 ||| Selective inhibition of COX-2 by lumiracoxib provides anti-inflammatory and analgesic effects. ||| Coxibs display pain relief, anti-inflammatory and antipyretic properties. ||| L'inhibition sélective de la COX-2 par le lumiracoxib procure des effets anti-inflammatoires et antalgiques.
0.39014434814453125 ||| Hypoglycaemia, in general the most frequent undesirable effect of insulin therapy, may occur if the insulin dose is too high in relation to the insulin requirement. ||| The major treatment-related change was a reversible, mild to moderate anaemia, the severity of which was greater than that produced by either active substance alone. ||| Une hypoglycémie, en général l'effet indésirable le plus fréquent de toute insulinothérapie, peut survenir si les doses d'insuline sont supérieures aux besoins.
0.3139846920967102 ||| If you intend to have a high fat meal take the tablets at least 1 hour before or 2 hours after the meal. ||| If you have eaten a heavy meal, it will be necessary to fast for 6 hours before the test. ||| Si vous avez l’ intention d’ avoir un repas riche en graisses, prenez les comprimés au moins 1 heure avant ou 2 heures après le repas.
0.743803083896637 ||| S. A. ||| SP N.V. ||| S.A.
0.34546375274658203 ||| Each infusion will last 2 hours. − Busilvex will be administered every 6 hours during 4 consecutive days prior to transplant. ||| Subsequent maintenance Herceptin doses of 6 mg/ kg should then be given every 3 weeks, according to the previous schedule. ||| - Busilvex sera administré toutes les 6 heures pendant 4 jours consécutifs avant la greffe.
0.33549290895462036 ||| These are common and general principles aiming at ensuring that tracing apps can communicate with each other when required, so citizens can report a positive test or receive an alert, wherever they are in the EU and whatever app they are using. ||| For example, apps need to have a common approach to detecting proximity between devices, and they should allow individuals roaming in another Member State to be alerted with the relevant information in a language they understand. ||| Il s'agit de principes communs et généraux visant à faire en sorte que les applications de traçage puissent communiquer entre elles si nécessaire, de sorte que les citoyens puissent signaler avoir été dépistés positifs ou recevoir une alerte, quel que soit l'endroit où ils se trouvent dans l'UE et quelle que soit l'application qu'ils utilisent.
0.2819890081882477 ||| Medical patients who are at high risk for thromboembolic complications based on an individual risk assessment The recommended dose of fondaparinux is 2.5 mg once daily administered by subcutaneous injection. ||| Prophylaxis with adequate hydration and administration of uricostatics starting 48 hours prior to start of therapy is recommended for CLL patients to reduce the risk of tumour lysis syndrome. ||| Patients en milieu médical, à haut risque d’ évènements thrombo-emboliques selon une évaluation du risque individuel La posologie recommandée de fondaparinux est de 2,5 mg une fois par jour, administrée par injection sous-cutanée.
0.27405846118927 ||| Seventy-three percent of non-splenectomised patients receiving romiplostim were able to reduce the dose by more than 25% or discontinue concurrent ITP medical therapies by the end of the study compared to 50% of placebo treated patients (see section 4.5). ||| In both placebo-controlled, double-blind studies, patients already receiving ITP medical therapies at a constant dosing schedule were allowed to continue receiving these medical treatments throughout the study (corticosteroids, danazol and/ or azathioprine). ||| 73% des patients non-splénectomisés ayant reçu du romiplostim ont pu arrêter ou réduire la dose de plus de 25% de leurs traitements concomitants du PTI, par rapport à 50% des patients ayant reçu le placebo (voir rubrique 4.5).
0.08773291110992432 ||| Change the injection site if you notice the area is red or sore. ||| You may change the injection site if you notice the area is red or sore. ||| Vous pouvez changer de site d’injection si vous trouvez que le site d’injection est rouge ou douloureux.
0.5009273886680603 ||| Co-administration of diltiazem and REYATAZ/ ritonavir has not been studied. ||| - Interaction with Invirase/ritonavir not studied. ||| La co-administration du diltiazem et de REYATAZ / ritonavir n'a pas été étudiée.
0.13681095838546753 ||| The European Commission has approved a €700 million scheme to support the Polish economy in the context of the coronavirus outbreak. ||| The European Commission has approved an Italian aid scheme to support the economy in the context of the coronavirus outbreak. ||| La Commission européenne a autorisé un régime d'aides polonais d'un montant de 700 millions d'euros visant à soutenir l'économie polonaise dans le contexte de la pandémie de coronavirus.
0.3498137891292572 ||| The reconstituted solutions should be inspected visually for particulate matter and discolouration prior to administration, whenever the container permits. ||| Any unused dispersion remaining at the end of an examination or waste material must be discarded in accordance with local requirements. ||| Les solutions reconstituées seront examinées visuellement afin de rechercher la présence de particules ou d'une coloration anormale avant l'administration, si l'emballage extérieur le permet.
0.006370737683027983 ||| Do not use Insuman Comb 50 after the expiry date which is stated on the carton and on the label of the cartridge. ||| Do not use Insuman Comb 15 after the expiry date which is stated on the carton and on the label of the cartridge. ||| Ne pas utiliser Insuman Comb 50 après la date de péremption mentionnée sur la boîte et sur l’étiquette de la cartouche.
0.27249205112457275 ||| Riquent is a solution for injection that contains 50 mg/ ml of the active substance abetimus. ||| It is available as a solution for injection containing 12 mg methylnaltrexone bromide in 0.6 ml. ||| Riquent est une solution injectable qui contient 50 mg/ ml d’ abetimus, son principe actif.
4.643605378690241e-13 ||| You may need to read it again. ||| You may need to read it again. ||| - Conservez cette notice, vous pourriez avoir besoin de la relire.
0.18673965334892273 ||| 14 7. ||| 16 7. ||| 7.
0.32604312896728516 ||| How to take Exelon 4. ||| How to take Eucreas 4. ||| Comment prendre Exelon 4.
0.3549521565437317 ||| The physician should be consulted when using other medications in addition to Humalog KwikPen. ||| Your doctor may tell you to use Humalog KwikPen as well as a longer-acting insulin. ||| Le médecin doit être consulté en cas de prise simultanée d'autres médicaments avec Humalog KwikPen.
0.4351394474506378 ||| A total of 2192 patients were treated; for both groups, patients were treated for at least 5 days and up to 26 days (mean 7 days). ||| After 52 weeks all patients continued treatment for a total duration of more than 3 years (168 weeks with a median of 121 weeks). ||| Un total de 2192 patients a été traité; dans les deux groupes les pl patients ont été traités au moins 5 jours, et jusqu’ à 26 jours (en moyenne 7 jours).
0.3654886782169342 ||| The injection site should be varied with each dose to avoid discomfort. ||| Changing the site with each injection may help to prevent such skin changes. ||| Le site d’ injection doit être différent pour chaque dose, afin d’ éviter toute gène.
0.30251574516296387 ||| As with other anti-HIV medicines, patients taking Viread may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system). ||| Prevention of Venous Thromboembolic Events (VTE) in medical patients who are judged to be at high risk for VTE and who are immobilised due to acute illness such as cardiac insufficiency and/ or acute respiratory disorders, and/ or acute infectious or inflammatory disease. ||| Comme avec les autres médicaments anti-VIH, les patients traités par Viread peuvent présenter un risque de lipodystrophie (modifications de la distribution de la masse grasse corporelle), d’ ostéonécrose (mort du tissu osseux) ou de syndrome de restauration immunitaire (symptômes d’ infection dus à la restauration du système immunitaire).
0.0 ||| Oral lyophilisate ||| Oral lyophilisate ||| lyophilisat oral
0.30864179134368896 ||| In case of neutropenia, the physician should consider the use of growth factors in patient management. ||| As with other antipsychotics, patients should be advised of the potential for weight gain. ||| En cas de neutropénie, le médecin devra envisager l’ utilisation de facteurs de croissance.
0.25994381308555603 ||| Dr Jones joined the EMEA Management Board in 1995 and was elected chairman of the Board in 2001. ||| She joined the EMEA in November 1994 and was nominated acting head of sector in September 2001. ||| Le Dr Jones a rejoint le conseil d’ administration de l'EMEA en 1995, dont il a été élu président en 2001.
0.2626890540122986 ||| ra 4. ||| ge 4. ||| us 5.
0.4267697334289551 ||| In vitro studies have shown that degarelix is not a substrate for the human CYP450 system. ||| It is not known whether Cerezyme passes via the placenta to the developing foetus. ||| Les études in vitro ont montré que dégarélix n’ est pas un substrat pour le CYP450 humain.
0.09193795919418335 ||| Do not use Rapinyl after the expiry date which is stated on the carton after EXP. ||| Do not use MabThera after the expiry date which is stated on the carton after EXP. ||| Ne pas utiliser Rapinyl après la date de péremption mentionnée sur l’ étui en carton, après « EXP ».
1.4098787307739258 ||| Austria (8-00694) ||| ISBN 92-9155-034-5 ||| Autriche (8-00694)
0.22694218158721924 ||| ORENCIA is used in patients who have not had a sufficient response to other medicines for rheumatoid arthritis including at least one ‘ tumour necrosis factor (TNF) blocker’, or who cannot be given these medicines. ||| All three studies compared the effects of adding ORENCIA or placebo (a dummy treatment) to the other medicines that the patients were already taking for rheumatoid arthritis: these did not include a TNF blocker. ||| ORENCIA est utilisé chez les patients n’ ayant pas montré de réponse satisfaisante à d’ autres traitements contre la polyarthrite rhumatoïde, dont au moins un « inhibiteur du TNF (facteur de nécrose tumorale) », ou chez les patients qui ne sont pas en mesure de recevoir de tels traitements.
0.2841208875179291 ||| Symptoms almost always include fever or rash, but also very commonly include nausea, vomiting, diarrhoea, abdominal pain, dyspnoea (difficulty breathing), cough, lethargy, malaise, headache, signs of liver damage in the blood and myalgia (muscle pain). ||| diarrhoea, nausea inflammations or ulcers causing abdominal pain or diarrhoea, bleedings in the stomach, inflammations or ulcers in the mouth, collection of fluid in the belly, vomiting, abdominal pains, indigestion, constipation, flatulence, bloating, loose stools, stomach problems ||| Les symptômes presque toujours observés sont la fièvre ou une éruption cutanée, mais comprennent aussi très couramment nausées, vomissements, diarrhée, douleurs abdominales, dyspnée (difficulté à respirer), toux, léthargie, malaises, maux de tête, signes d’ atteintes hépatiques dans le sang et myalgies (douleurs musculaires).
0.6111729145050049 ||| deep, rapid breathing drowsiness nausea, vomiting and stomach pain ||| have a dry cough a cold and runny nose vomiting diarrhea ||| respiration profonde et rapide somnolence nausées, vomissements et douleur dans le ventre
0.2839204967021942 ||| In contrast to the experience in patients with breast cancer or ovarian cancer, myelosuppression appears to be the dose-limiting adverse event in patients with AIDS-KS (see section 4.8). ||| The safety profile seen in controlled-clinical studies in patients with post-myocardial infarction and/ or heart failure varies from the overall safety profile seen in hypertensive patients. ||| Contrairement à l’ expérience chez les patients avec cancer du sein ou de l’ ovaire, la myélosuppression semble être l’ effet indésirable dose- limitant chez les patients avec SK-SIDA (voir rubrique 4.8).
0.3339090347290039 ||| In clinical trials with Rebif, asymptomatic elevations of hepatic transaminases (particularly alanine aminotransferase (ALT)) were common and 1-3% of patients developed elevations of hepatic transaminases above 5 times the upper limit of normal (ULN). ||| The risk for increased exposure leading to adverse events in these different subgroups is higher in patients lacking CYP2D6 activity (poor metabolisers, PM) than subjects with CYP2D6 metabolising capacity (extensive metabolisers, EM) (see section 5.2). ||| Dans les essais cliniques avec Rebif, l’ augmentation asymptomatique des transaminases hépatiques (notamment l’ alanine-aminotransférase, ALAT) est fréquente et 1 à 3% des patients présentent une augmentation supérieure à 5 fois la limite supérieure de la normale (LSN).
0.24642695486545563 ||| Ciprofloxacin exerts a rapid bactericidal effect by inhibiting DNA-gyrase, resulting in inhibition of DNA synthesis. ||| Ciprofloxacin inhibits DNA-gyrase, resulting in inhibition of DNA synthesis. ||| La ciprofloxacine exerce un effet bactéricide rapide en inhibant l’ ADN gyrase, ce qui inhibe la synthèse de l’ ADN.
0.2717353403568268 ||| An increased incidence of wavy ribs was observed in rats in association with reduced maternal body weight parameters, with a no-effect dose of 75 mg/kg (10-fold human exposure). ||| A slight decrease in pup body weight was noted in the female fertility study in rats at 200 mg/ kg/ day (> 69-fold the clinical systemic exposure). ||| Une incidence accrue de côtes ondulées a été observée chez le rat en association avec une diminution du poids corporel maternel, avec une dose sans effet de 75 mg/ kg (soit 10 fois l’ exposition chez l’ Homme).
0.5151822566986084 ||| Blister foil of 10 tablets ||| 3 blisters of 10 tablets ||| Plaquette thermoformée de 10 comprimés
0.26584696769714355 ||| The scheme will be accessible to all companies in Czechia that are capable of carrying out relevant R&D projects in all sectors. ||| The scheme is open to all companies active in Wallonia that are capable of carrying out R D projects relevant to the coronavirus outbreak. ||| Ce régime sera accessible à toutes les entreprises en Tchéquie capables de mener des projets de R&D liés au coronavirus, dans tous les secteurs.
0.8457844257354736 ||| Common: accidental injury ||| 18 Common: vasodilatation ||| Fréquent: blessures accidentelles
0.29184797406196594 ||| Water syringes for spraying plants ||| Currying preparations for skins ||| Seringues à eau pour vaporiser les plantes
0.02415788546204567 ||| Hypersensitivity: hypersensitivity reactions, including angioneurotic oedema and anaphylactic reaction have been reported. ||| 9 Hypersensitivity: hypersensitivity reactions, including angioneurotic oedema and anaphylactic reaction have been reported. ||| Hypersensibilité: des réactions d’ hypersensibilité, incluant angioedème et réaction anaphylactique, ont été rapportées.
0.38823962211608887 ||| In patients with severe hepatic impairment, the data available are insufficient to establish recommendations. ||| Children There is insufficient clinical data available in children with renal impairment to be able to make any dosing recommendation. ||| Chez les patients atteints d'une insuffisance hépatique sévère, les données disponibles sont insuffisantes pour établir des recommandations.
0.5126568675041199 ||| Seroprotection rate* Seroconversion rate Seroconversion factor * anti-HA ≥ 1:40 ||| Seroprotection rate Seroconversion rate Seroconversion factor * measured by SRH assay ≥ 25 mm ** geometric mean ratios of SRH ||| Taux de séroprotection * Taux de séroconversion Facteur de séroconversion * antiHA ≥ 1:40
0.2039439082145691 ||| 26 13. ||| 26 16. ||| 13.
0.35881364345550537 ||| In women, safe and effective use of GONAL-f calls for monitoring of ovarian response with ultrasound, alone or preferably in combination with measurement of serum oestradiol levels, on a regular basis. ||| Use in adults Therapy must be initiated with the specified loading dose regimen of either intravenous or oral VFEND to achieve plasma concentrations on Day 1 that are close to steady state. ||| Chez les femmes, une utilisation bien tolérée et efficace de GONAL-f nécessite un suivi régulier de la réponse ovarienne par examen échographique seul ou, de préférence, en association avec le dosage des taux plasmatiques d’ estradiol.
0.04914252460002899 ||| This summary was last updated in 04-2007. ||| This summary was last updated in 10-2007. ||| Dernière mise à jour du présent résumé:
0.2993677258491516 ||| - protease inhibitors (used to treat HIV). ||| - ergotamine (used to treat migraine); ||| les inhibiteurs de protéase (utilisés pour traiter le VIH).
0.0 ||| Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. ||| Swelling of the face, lips or eyes or difficulty with breathing are more serious symptoms and require urgent medical attention. ||| Un oedème du visage, des lèvres, des yeux ou une difficulté respiratoire, sont des symptômes plus sévères, qui nécessitent une consultation médicale d’ urgence.
0.3971268832683563 ||| Gavi is one of the 12 global health initiatives that have committed to working better together in the Global Action Plan for Healthy Lives and Wellbeing for All, launched during the High Level Event at the United Nations General Assembly in September 2019. ||| The ‘Global Goal: Unite For Our Future' campaign launched by the Commission and the international advocacy organisation Global Citizen on 28 May will culminate in a global pledging summit and concert on Saturday 27 June. ||| Gavi est l'une des 12 initiatives mondiales en matière de santé qui se sont engagées à collaborer plus efficacement au sein du Plan d'action mondial pour des vies saines et le bien-être de tous, lancé en septembre 2019 à l'occasion de la réunion de haut niveau de l'Assemblée générale des Nations unies.
0.039890289306640625 ||| Keep the container in the outer carton in order to protect from light. ||| Keep the pen in the outer carton in order to protect from light. ||| Conserver le conditionnement primaire dans l'emballage extérieur à l’ abri de la lumière.
0.0 ||| 9. ||| 9. ||| 137 9.
0.5197689533233643 ||| Rental of containers for warehousing and storage ||| Container leasing for the shipping industry ||| Location de conteneurs de mise en entrepôt et d'entreposage
0.3571022152900696 ||| FABLYN contains lactose. ||| ISENTRESS contains lactose. ||| FABLYN contient du lactose.
0.45665961503982544 ||| n/ N (%) ||| N=110 n (%) ||| Lamivudine n/ N (%)
1.0804345699361173e-12 ||| Miscellaneous: ||| Miscellaneous: ||| Troubles divers:
0.28433674573898315 ||| Interface cables [electric] ||| Metallic cables [electric] ||| Câbles d'interface électriques
0.8233712315559387 ||| Matrices for setting presses ||| Requests for documents ||| Matrices pour le réglage de presses
0.45017752051353455 ||| Grease boxes [parts of machines] ||| Rental of slot machines [gaming machines] ||| Boîtes de graissage [machines]
0.24247466027736664 ||| In two 12-week double-blind endoscopy studies, the cumulative incidence of gastroduodenal ulceration was significantly lower in patients treated with etoricoxib 120 mg once daily than in patients treated with either naproxen 500 mg twice daily or ibuprofen 800 mg three times daily. ||| A 12-week phase III clinical study performed in patients with type 1 diabetes mellitus receiving insulin glargine as basal therapy indicate that the immediate postmeal administration of insulin glulisine provides efficacy that was comparable to immediate premeal insulin glulisine (0-15 minutes) or regular insulin (30-45 minutes). ||| Au cours de deux études endoscopiques en double aveugle d’ une durée de 12 semaines, l’ incidence cumulée des ulcères gastro-duodénaux a été significativement plus faible chez les patients traités par étoricoxib 120 mg une fois par jour, que chez les patients traités soit par naproxène 500 mg deux fois par jour, soit par ibuprofène 800 mg trois fois par jour.
0.35792773962020874 ||| The tablets are available in calendar packs (blisters) of 14, 28, 56, 84, 98, 100 or 112 tablets. ||| 77 Stalevo comes in six different pack sizes (10, 30, 100, 130, 175 or 250 tablets). ||| Les comprimés sont disponibles en boîte-calendrier (plaquettes thermoformées) de 14, 28, 56, 84, 98, 100 ou 112 comprimés.
0.5771547555923462 ||| Smoking of cheese ||| Brewing of beer ||| Fumage du fromage
0.6493186950683594 ||| Combivir is therefore contra- indicated in these patients (see section 4.4). |||  393 Other side effects not listed above may also occur in some patients. ||| L’ utilisation de Combivir est donc contre-indiquée chez ces patients (voir rubrique 4.4.).
0.23143920302391052 ||| If you are already being treated with rifabutin, your blood counts and some possible side effects to rifabutin will need to be monitored. • Some medicines used to treat or prevent fits, such as phenytoin, carbamazepine, phenobarbital, primidone. • Efavirenz, which is used to treat HIV infection. ||| It might be needed to lower the dose of Remeron, or when use of nefazodone is stopped, to increase the dose of Remeron again. • medicines for anxiety or insomnia such as benzodiazepines; medicines for schizophrenia such as olanzapine; medicines for allergies such as cetirizine; medicines for severe pain such as morphine. ||| Si vous êtes déjà traités avec la rifabutine, votre numération sanguine et certains effets indésirables liés à la rifabutine devront être surveillés. • Certains médicaments utilisés pour traiter ou prévenir les crises d’épilepsie, tels que la phénytoïne, la carbamazépine, le phénobarbital, la primidone. • Efavirenz, utilisé pour traiter l’infection induite par le VIH. • Les médicaments utilisés pour diminuer l’acidité de l’estomac tels que la cimétidine et la ranitidine ou l’oméprazole et les médicaments similaires appelés les inhibiteurs de pompe à protons.
0.5436575412750244 ||| What is the magnitude of solvency support needs? ||| Understanding the importance of calorie and fat targets ||| Quelle est l'ampleur des besoins de solvabilité?
0.36842936277389526 ||| Following administration of Telzir, the half-life of amprenavir is 7.7 hours. ||| Ritonavir significantly prolonged the half-life of Vivanza to 25.7 hours (see section 4.3). ||| Après administration de Telzir, la demi-vie d’ élimination plasmatique de l'amprénavir est de 7,7 heures.
0.66400146484375 ||| Blood charcoal ||| Alcohol free wine ||| Charbon de sang
0.3068283796310425 ||| The escape clause was introduced to allow for a coordinated and orderly temporary deviation from the normal requirements for all Member States in a situation of generalised crisis caused by a severe economic downturn for the euro area or the EU as a whole. ||| The exceptional or unusual circumstances refer to either a severe economic downturn for the euro area or the Union as a whole or an unusual event outside the control of the Member State with major unfavourable consequences for government finances in one or only few Member States. ||| La clause dérogatoire a été introduite pour permettre à tous les États membres, dans une situation de crise généralisée provoquée par une grave récession économique frappant la zone euro ou l'ensemble de l'UE, de s'écarter temporairement, de manière coordonnée et ordonnée, de leurs obligations ordinaires.
0.009162282571196556 ||| If you stop using Insulin Human Winthrop Infusat This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). ||| If you stop using Insulin Human Winthrop Basal This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). ||| Si vous arrêtez d’utiliser Insulin Human Winthrop Infusat Ceci peut entraîner une hyperglycémie sévère (taux très élevé de sucre dans le sang) et une acidocétose (formation d’acide dans le sang lorsque l’organisme dégrade les graisses au lieu du sucre).
0.2808782756328583 ||| Wilzin treatment should be initiated under the supervision of a physician experienced in the treatment of Wilson’ s disease (see section 4.4). ||| The benefit to the patient of treatment with Zavesca should be evaluated on a regular basis (see section 4.4). ||| Le traitement par Wilzin doit être instauré sous le contrôle d'un médecin expérimenté dans la prise en charge de la maladie de Wilson (voir rubrique 4.4).
0.32412660121917725 ||| The small amount of drug which was absorbed into the systemic circulation was promptly excreted by both urinary and faecal routes at a mean ratio of approximately 3 to 1. ||| At the initiation of each dose, an electrical current moves a pre-determined amount of fentanyl from the active substance-containing reservoir through the skin and into systemic circulation. ||| La faible quantité de principe actif retrouvé dans la circulation générale a été rapidement excrétée par voie rénale et digestive dans un rapport moyen d'environ 3 à 1.
0.28476017713546753 ||| No dosage adjustment of Irbesartan Hydrochlorothiazide Winthrop is necessary in patients with mild to moderate hepatic impairment (see section 4.3). ||| KOGENATE Bayer 250 IU is used for treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ||| Un ajustement de la posologie n’ est pas nécessaire chez les patients présentant une insuffisance hépatique légère à modérée (voir rubrique 4.3).
0.13881710171699524 ||| Phosphates for pharmaceutical purposes ||| Peptones for pharmaceutical purposes ||| Phosphates à usage pharmaceutique
5.80992177111328e-13 ||| INFORMATION IN BRAILLE ||| INFORMATION IN BRAILLE ||| 155 6 INFORMATIONS EN BRAILLE
0.5057500600814819 ||| - If you have heart failure. ||| - If yYou have high blood pressure. ||| - si vous avez une insuffisance cardiaque
0.039019256830215454 ||| Infanrix hexa should under no circumstances be administered intravascularly or intradermally. ||| Infanrix Penta should under no circumstances be administered intravascularly or intradermally. ||| Infanrix hexa ne doit en aucun cas être administré par voie intravasculaire ou intradermique.
0.07695893943309784 ||| What benefit has Advate shown during the studies? ||| What benefit has Actos shown during the studies? ||| Quel est le bénéfice démontré par Advate au cours des études?
0.24047993123531342 ||| Naglazyme 1 mg/ ml concentrate for solution for infusion Galsulfase ||| Tamiflu 12 mg/ml powder for oral suspension Oseltamivir ||| Naglazyme 1mg/ ml solution à diluer pour perfusion Galsulfase
0.28008854389190674 ||| Still, after 72 hours even in patients with severe renal impairment nearly the whole dose is recovered in the urine and in healthy populations up to 500 micromol/ kg doses were administered without safety issues. ||| This finding was not observed in repeat-dose studies in other species, including monkeys administered entecavir daily for 1 year at exposures ≥ 100 times those in humans. ||| En outre, chez les sujets sains, des doses allant jusqu’ à 500 micromoles/ kg ont été administrées sans que ne surviennent de problèmes de sécurité d’ emploi.
0.25179487466812134 ||| As the in vitro mutagenic activity of lamivudine could not be confirmed by in vivo tests, it is concluded that lamivudine should not represent a genotoxic hazard to patients undergoing treatment. ||| Although it has not been observed with Dynepo, since anaphylactoid reactions may occur with erythropoietin, it is recommended that the first dose be administered under medical supervision. ||| L’ activité mutagène in vitro de la lamivudine n’ ayant pas été confirmée par les tests in vivo, la lamivudine ne devrait pas entraîner de risque génotoxique chez les patients sous traitement.
0.4709170162677765 ||| The VWP considered the new submitted data along with the already submitted data and agreed that the safety and immunogenicity data are adequate and satisfactory to support the approval of Menitorix. ||| It worked well taken into account the adherence to the agreed timetable in general, the final approval dates and the positive outcome of all requested annual updates. ||| Après avoir examiné les nouvelles informations communiquées ainsi que les données déjà transmises, le VWP a décidé que les informations sur les questions de sécurité et d’ immunogénicité sont adéquates et suffisantes pour justifier l’ approbation de Menitorix.
0.5404043197631836 ||| Use in patients with renal impairment ||| Ensure treatment of infected persons ||| Utilisation chez les patients présentant une insuffisance rénale
0.16789157688617706 ||| Unopened cartridges Store in a refrigerator (2°C - 8°C). ||| Unopened vials: store in a refrigerator (2°C - 8°C). ||| Cartouches non ouvertes A conserver au réfrigérateur (2°C - 8°C).
0.3599866032600403 ||| This is increased to 20 drops once a day (1x 10 mg) in the second week and to 30 drops once a day taken in the third week. ||| 50 mg administered every 14 days for 3 doses (weeks 5, 7 and 9) followed by an additional dose of 50 mg at week 13. ||| Cette dose passe à 20 gouttes une fois par jour (1x 10 mg) au cours de la deuxième semaine et à 30 gouttes une fois par jour au cours de la troisième semaine.
0.019200081005692482 ||| • Tell your doctor if you have had kidney disease or if tests have shown problems with your kidneys. ||| • Tell your doctor if you have had kidney disease, or if tests have shown problems with your kidneys. ||| • Veuillez informer votre médecin si vous avez une maladie rénale ou si des examens ont montré que vous avez des problèmes rénaux.
0.3174712657928467 ||| Table decorations of paper ||| Table covers of plastic ||| Décorations de table en papier
0.38531893491744995 ||| Insulin glargine is very similar to human insulin with respect to insulin receptor binding kinetics. ||| Insulin glargine is a human insulin analogue designed to have a low solubility at neutral pH. ||| Fixation au récepteur de l'insuline: l'insuline glargine est tout à fait comparable à l'insuline humaine sur le plan de la cinétique de fixation au récepteur de l'insuline.
0.398663192987442 ||| 0 1 ||| (1) 0 ||| 1 1
0.43047887086868286 ||| Dose changes can be made in 500 mg twice daily increases or decreases every two to four weeks. ||| later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response. ||| Les augmentations et diminutions posologiques peuvent se faire par paliers de 500 mg deux fois par jour toutes les 2 à 4 semaines.
0.28847843408584595 ||| As with other haematopoietic growth factors, G-CSF has shown in vitro stimulating properties on human endothelial cells. ||| Neutrophils produced in response to filgrastim show normal or enhanced function as demonstrated by tests of chemotactic and phagocytic function. ||| Comme pour d’ autres facteurs de croissance hématopoïétiques, le G-CSF a montré in vitro des propriétés stimulantes des cellules endothéliales humaines.
0.16661113500595093 ||| 81 Ireland Roche Products (Ireland) Ltd. ||| ed Roche Products (Ireland) Ltd. ||| Ireland Roche Products (Ireland) Ltd.
0.0 ||| The advice of a hepatologist is recommended. ||| The advice of a hepatologist is recommended. ||| L'avis d'un hépatologue est recommandé.
0.0 ||| 4.4 Special warnings and precautions for use ||| 4.4 Special warnings and precautions for use ||| 3 4.4 Mises en garde spéciales et précautions d’ emploi
4.983313024384262e-13 ||| You should check with your doctor if you are not sure. ||| You should check with your doctor if you are not sure. ||| En cas d’incertitude, consultez votre médecin.
0.675688624382019 ||| Each bottle contains 60 tablets. ||| Each capsule contains: ||| Chaque flacon contient 60 comprimés.
0.7729014158248901 ||| Remove this filter Type: patient stories ||| Remove this filter Type: materiālu rīkkopa ||| Remove this filter Type: témoignages de patients
0.04396507143974304 ||| Demonstration of photographic equipment [for training purposes] ||| Demonstration of photographic equipment [for advertising purposes] ||| Démonstration d'équipements photographiques à des fins de formation
0.21836301684379578 ||| Other information about Ibaflin: ||| Other information about Xolair: ||| Autres informations relatives à Ibaflin:
0.08579982817173004 ||| Virological response is defined as absence of detectable HCV-RNA at Week 12. ||| Virological response is defined as absence of detectable HCV-RNA at Week 12 of treatment. ||| lus définie par un niveau indétectable d’ ARN-VHC à la 12ème semaine de traitement.
0.12086308002471924 ||| How has Yarvitan been studied? ||| How has Quintanrix been studied? ||| Quelles études ont été menées sur Yarvitan?
0.605010986328125 ||| Latvija H. ||| España Km. ||| 74 Latvija H.
0.16190481185913086 ||| - back pain ||| - abdominal pain ||| - Douleur dorsale
0.3721240758895874 ||| For carbamazepine, AUC12h was increased by 45%. ||| Ritonavir exposure (AUC12h) was decreased by 49%. ||| L’exposition à la carbamazépine (ASC12h) a été augmentée de 45%.
0.19298912584781647 ||| - At the request of the EMEA ||| At the request of the EMEA. ||| - A la demande de l’ EMEA
0.31056007742881775 ||| Paediatric patients Two clinical trials in 41 paediatric patients (4 to 15 years of age) were designed to characterise the safety, antiretroviral activity, and pharmacokinetics of indinavir in combination with stavudine and ||| In three paediatric studies, treatment-naïve (n=123) and treatment-experienced (n=46) paediatric patients aged 4 months to 18 years were treated with emtricitabine in combination with other antiretroviral agents. ||| Enfants et adolescents Deux essais cliniques portant sur 41 patients de pédiatrie (âgés de 4 à 15 ans) ont été conçus afin de mettre en évidence la sécurité d’ emploi, l’ activité antirétrovirale et la pharmacocinétique de l’ indinavir associé à la stavudine et à la lamivudine.
0.3016211986541748 ||| Nutritive agents for processing living cells [other than for medical use] ||| Chemicals for use in gluing [for industrial purposes] ||| Agents nutritifs pour le traitement de cellules vivantes autres qu'à usage médical
0.26734060049057007 ||| Solaria for medical purposes ||| Quinine for medical purposes ||| Solariums à usage médical
0.30032506585121155 ||| Ask your doctor or pharmacist before taking any medicine. ||| Taking other medicines Please tell your doctor or pharmacist ||| Demandez à votre médecin ou pharmacien avant de prendre ce médicament.
0.37482213973999023 ||| Chemical additives for mortars ||| Colorants for cellulosic materials ||| Additifs chimiques pour mortier
0.00019980399520136416 ||| 19 In a randomised, double-blind study in a total of 866 patients (864 females, 2 males) receiving chemotherapy that included cyclophosphamide 750-1500 mg/ m2; or cyclophosphamide 500- 1500 mg/ m2 and doxorubicin (< 60 mg/ m2) or epirubicin (< 100 mg/ m2), aprepitant in combination with an ondansetron/ dexamethasone regimen (see section 4.2) was compared with standard therapy (placebo plus ondansetron 8 mg orally (twice on Day 1, and every 12 hours on Days 2 and 3) plus dexamethasone 20 mg orally on Day 1). ||| 33 In a randomised, double-blind study in a total of 866 patients (864 females, 2 males) receiving chemotherapy that included cyclophosphamide 750-1500 mg/ m2; or cyclophosphamide 500- 1500 mg/ m2 and doxorubicin (< 60 mg/ m2) or epirubicin (< 100 mg/ m2), aprepitant in combination with an ondansetron/ dexamethasone regimen (see section 4.2) was compared with standard therapy (placebo plus ondansetron 8 mg orally (twice on Day 1, and every 12 hours on Days 2 and 3) plus dexamethasone 20 mg orally on Day 1). ||| Dans une étude randomisée, en double aveugle, réalisée sur un total de 866 patients (864 femmes, 2 hommes) recevant une chimiothérapie comprenant soit du cyclophosphamide 750-1500 mg/m2, soit du cyclophosphamide 500-1500 mg/m2 et de la doxorubicine (≤ 60 mg/m2) ou de l’épirubicine (≤ 100 mg/m2), l’aprépitant en association à un traitement ondansétron/dexaméthasone (voir rubrique 4.2) a été comparé à un traitement standard (placebo plus ondansétron 8 mg par voie orale (2 fois à J1 et toutes les 12 heures à J2 et J3) plus de la dexaméthasone 20 mg par voie orale à J1).
0.0 ||| 6.6 Special precautions for disposal and other handling ||| 6.6 Special precautions for disposal and other handling ||| 6 6.6 Précautions particulières d’ élimination et manipulation
0.2524677813053131 ||| 0.5 mg ||| 3.5 mg ||| 2,0 mg
0.18685282766819 ||| How to store Pradaxa 6. ||| How to store Fertavid 6. ||| Comment conserver Pradaxa 6.
0.3213726878166199 ||| Although patients with renal impairment were not studied with ZYPADHERA, it is recommended that a well-tolerated and effective dosage regimen using oral olanzapine is established in patients with renal impairment before treatment with ZYPADHERA is initiated (see section 4.2). ||| Prevention of Skeletal Events in Patients with Breast Cancer and Bone Metastases The safety profile of intravenous Bondronat in patients with breast cancer and bone metastases is derived from a controlled clinical trial in this indication and after the intravenous administration of Bondronat at the recommended dose. ||| Bien que ZYPADHERA n’ ait pas été étudié chez les patients atteints d’ insuffisance rénale, il est recommandé qu’ un schéma posologique bien toléré et efficace ait été établi avec l’ olanzapine orale avant d’ initier un traitement par ZYPADHERA (voir rubrique 4.2).
0.3998934030532837 ||| It was concluded that 160-320 mg of valsartan produced clinically relevant reductions in UAE in hypertensive patients with type 2 diabetes. ||| Three trials included 1,764 postmenopausal women who were treated with OPTRUMA and calcium or calcium supplemented placebo. ||| Il a été conclu que 160 à 320 mg de valsartan entraînaient des réductions cliniquement pertinentes de l’EUA chez les patients hypertendus diabétiques de type 2.
0.0 ||| Clear, colourless solution. ||| Clear, colourless solution. ||| Solution transparente, incolore.
0.6364405751228333 ||| Personnel, budget and facilities Frances NUTTALL Head of Sector Accounting Gerard O’ MALLEY ||| Michael ZOURIDAKIS Head of Sector David DRAKEFORD Deputy Head of Sector ||| Comptabilité Gerard O’ MALLEY Chef de secteur
0.06789414584636688 ||| London, 14 July 2008 EMEA/ CHMP/ 151554/ 2008 ||| London, 16 September 2008 EMEA/ CHMP/ 500252/ 2008 ||| Londres, le 14 juillet 2008 EMEA/ CHMP/ 151554/ 2008
0.051175959408283234 ||| 4/ 20 5.2 Pharmacokinetic particulars ||| 4/ 31 5.2 Pharmacokinetic particulars ||| 5.2 Caractéristiques pharmacocinétiques
0.36275848746299744 ||| Preparation of market reports and studies ||| Preparation of public opinion surveys ||| Préparation de rapports et d’études de marché
0.37740275263786316 ||| Ingelvac CircoFLEX suspension for injection for pigs ||| PROCOMVAX suspension for injection in vial. ||| Ingelvac CircoFLEX suspension injectable pour porcins
0.10268720984458923 ||| EXP {MM/ YYYY} ||| 55 EXP {MM/ YYYY} ||| 48 EXP {MM/AAAA}
0.36122798919677734 ||| Treatment with Enbrel may result in the formation of autoimmune antibodies (see section 4.8). ||| Mitotane can cause central nervous system undesirable effects at high concentrations (see section 4.8). ||| Enbrel est susceptible d'entraîner la formation d'anticorps auto-immuns (voir section 4.8).
0.009241114370524883 ||| In controlled clinical trials, maximum metformin plasma levels (Cmax) did not exceed 4 µg/ ml, even at maximum doses. ||| In controlled clinical trials, maximum metformin plasma levels (C max) did not exceed 4 µg/ml, even at maximum doses. ||| Dans des essais cliniques contrôlés, les concenrations plasmatiques maximales de metformine (Cmax) n'ont pas excédé 4 µg/ ml, même aux posologies maximales.
0.3797484040260315 ||| For instructions for use, see section 4.2 of the enclosed Summary of Product Characteristics. ||| in the Summary of Product Characteristics and relevant sections of the Package Leaflet of Protopic: ||| Pour le mode d’emploi, voir rubrique 4.2. du Résumé des Caractéristiques du Produit joint.
0.8034042119979858 ||| Lightly shake the bottle before dispensing. ||| Note the time upon drinking. ||| Agiter légèrement le flacon avant l’ emploi.
0.032931748777627945 ||| 725 Travel ||| 735 Travel ||| Voyages
0.0 ||| Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products. ||| Mild hypoglycaemic episodes will respond to oral administration of glucose or other sugar or saccharated products. ||| 53 Les épisodes d'hypoglycémie légère seront compensés par l'administration orale de glucose ou d'autres sucres ou d'autres produits sucrés.
0.36050328612327576 ||| Therefore, RISPERDAL should not be used during pregnancy unless clearly necessary. ||| SINGULAIR may be used during pregnancy only if it is considered to be clearly essential. ||| En conséquence, RISPERDAL ne doit pas être utilisé au cours de la grossesse sauf en cas de nécessité manifeste.
0.2431243658065796 ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| Persistent fever due to infection may occur following chemotherapy or medical conditions that lower the body’ s resistance to disease by lowering counts of certain white blood cells. ||| Le traitement par Binocrit peut être associé à un risque accru de formation post-opératoire de caillots sanguins (troubles vasculaires/ thrombotiques post-opératoires) si votre taux sanguin d’ hémoglobine (pigment rouge du sang) est trop élevé.
0.44283241033554077 ||| 16 medicinal products with Stalevo should be carefully observed for loss of therapeutic response. ||| results; other tests may therefore be necessary to confirm the presence of Helicobacter pylori. ||| Les patients prenant ces médicaments et Stalevo doivent être surveillés étroitement à la recherche d'une disparition de la réponse thérapeutique.
0.09455864876508713 ||| What is the risk associated with Oprymea? ||| What is the risk associated with Opgenra? ||| Quel est le risque associé à l’ utilisation d’ Oprymea?
0.5710367560386658 ||| In the largest study, 628 out of the 934 patients with ET treated with Xagrid (67.2%) had a complete response to treatment. ||| Data presented from controlled studies included 1357 patients, 766 who received Nespo and 591 no ||| Dans la plus grande étude, 628 patients sur 934 atteints de TE traités par Xagrid (67,2%) ont obtenu une réponse complète au traitement.
0.29312729835510254 ||| The exact mechanism of this interaction is not clear. ||| The mechanism for this increased risk is not known. ||| Le mécanisme exact de cette interaction n’ est pas clair.
3.9424813782530654e-13 ||| However, significant liver toxicity has not been observed in patients treated in clinical studies, either during administration of Agenerase or after discontinuation. ||| However, significant liver toxicity has not been observed in patients treated in clinical studies, either during administration of Agenerase or after discontinuation. ||| Toutefois, aucune hépatotoxicité significative n'a été observée chez les patients traités lors des essais cliniques, que ce soit lors de l'administration d’ Agenerase ou après son arrêt.
0.13399338722229004 ||| Symptoms of allergy include rash, hives, breathing difficulties, low blood pressure, tightness of chest, and shock. ||| Signs of such reactions include hives, rash, tightness of the chest, wheezing, drop in blood pressure and breathing difficulties. ||| Les symptômes d’ allergie comprennent démangeaisons, urticaire, difficulté respiratoire, hypotension, oppression thoracique et choc.
0.5568650960922241 ||| You should avoid taking SIFROL together with antipsychotic medicines. ||| - Pathological gambling, especially when taking high doses of SIFROL ||| Vous devez éviter de prendre SIFROL simultanément à des antipsychotiques.
0.5518272519111633 ||| The primary metabolite, 2'-deoxy-2', 2'-difluorouridine (dFdU), is not active and is found in plasma and urine. ||| The topotecan-O-glucuronide and N-desmethyl topotecan-O-glucuronide in the urine were less than 2.0%. ||| Le métabolite principal, le 2'-déoxy-2', 2'-difluorouridine (dFdU) retrouvé dans le plasma et l'urine est quant à lui inactif.
0.35743439197540283 ||| 24 Plasma levels of cinacalcet may be lower in smokers due to induction of CYP1A2-mediated metabolism. ||| 1-2 mg/ kg robenacoxib tablets produced a marked inhibition of COX-2 activity in cats and had no effect on COX-1 activity. ||| Le taux plasmatique du cinacalcet peut être diminué chez les fumeurs en raison d’ une induction du métabolisme médiée par le CYP1A2.
0.5302585959434509 ||| Nervous system: ||| Renal function: ||| Système nerveux:
0.20219194889068604 ||| 64 Pritor is available in blister packs containing 14, 28, 30, 56, 90, 98 or 280 tablets, or unit dose blister packs containing 28 x 1 tablets. ||| Exforge is available in packs containing 7, 14, 28, 30, 56, 90, 98 or 280 tablets and in multipacks comprising 4 cartons, each containing 70 tablets. ||| Pritor est disponible dans des plaquettes thermoformées par boîte de 14, 28, 30, 56, 90, 98 ou 280 comprimés ou dans des plaquettes thermoformées pour délivrance à l’ unité contenant 28 x 1 comprimés.
0.2956687808036804 ||| 102 An increased 3H-thymidine incorporation in the erythroid nucleated spleen cells has been found in vitro (mouse spleen cell culture) after incubation with epoetin alfa. ||| The binding affinity of 99mTc-depreotide to SSTR was shown in studies of pancreatic tumours in Lewis rats and in vitro in human tumour membranes. ||| Après incubation de cellules nucléées érythroïdes spléniques in vitro avec l’ époétine alfa (culture cellulaire de cellules spléniques de souris), il a été observé une augmentation de l'incorporation de la 3 H-thymidine.
0.36939501762390137 ||| Mugs made of ceramic materials ||| Armour made of common metals ||| Tasses [mugs] en céramique
0.45353272557258606 ||| The mean CD4 cell counts were increased by 63 ± 34.5 cells/ mm3 from baseline. ||| The patients ’ CD4 cell counts also rose from around 280 cells/ mm3 before treatment by an average of around 185 cells/ mm3. ||| La moyenne des taux de lymphocytes CD4 a augmenté de 63 ± 34,5 cellules/ mm3 par rapport aux valeurs de base.
0.9953852891921997 ||| (kg) 3.0 – 4.0 * 4. 1 – 8.0 8.1 – 1 2.0 12.1 – 24.0 24.1 – 30.0 30.1 – 60.0 ||| (mcg/ kg) 24 23 22.2 16.7 13 12.5 11.4 11.1 10 9.5 9.3 8.5 8.4 8.1 7.8 7.6 7.4 7.3 7 ||| chien (kg) 3.0 – 4.0* 4.1 – 8.0 8.1 – 12.0 12.1 – 24.0 24.1 – 30.0 30.1 – 60.0
0.4038662910461426 ||| It will also ensure adequate focus of these investments and reforms based on the green and digital transitions, to help create jobs and sustainable growth and make the Union more resilient. ||| This will allow for better access to digital infrastructure and services, better public services and administration for citizens, the extension of broadband infrastructures especially in regions and local areas, and a strengthened e-Governance. ||| Elle fera aussi en sorte que ces investissements et ces réformes soient suffisamment axés sur les transitions écologique et numérique afin de contribuer à la création d'emplois et à une croissance durable et de rendre l'Union plus résiliente.
0.2852841019630432 ||| Azomyr oral lyophilisate is indicated for adults and adolescents (12 years of age and older). ||| Azomyr 2.5 mg orodispersible tablet is indicated for adults and children (6 years of age and older). ||| Azomyr lyophilisat oral est indiqué chez l’ adulte et l’ adolescent (12 ans et plus).
0.3258182406425476 ||| The reduction of bone loss helps to make bones less likely to break, and this is useful in preventing fractures in cancer patients with bone metastases. ||| FOSAVANCE not only prevents the loss of bone but actually helps to rebuild bone you may have lost and reduces the risk of bones breaking in the spine and hip. ||| Cette réduction de la perte osseuse contribue à rendre les os moins fragiles, ce qui est utile pour éviter les fractures chez les patients cancéreux présentant des métastases osseuses.
0.3982605040073395 ||| The grounds for the referral were concerns regarding that there was not enough data showing that Sabumalin is equivalent to the reference medicine. ||| For the purpose of this table a cut off of 5% was used for inclusion of all events where the reporter considered a possible relationship to pemetrexed. ||| Les motifs de la saisine étaient des préoccupations concernant le fait qu’ il n’ y avait pas suffisamment de données montrant que Sabumalin est équivalent au médicament de référence.
0.29702603816986084 ||| Patients having other conditions leading to QT prolongation may also be at risk of these cardiac reactions to terfenadine. ||| Some selective COX- 2 inhibitors have been associated with an increased risk of skin reactions in patients with a history of any drug allergy. ||| Les patients qui présentent d'autres pathologies à l'origine d'un allongement de l'intervalle QT risquent également de développer ces effets secondaires cardiaques décrits avec la terfénadine.
0.30298781394958496 ||| Aldurazyme is used for enzyme replacement therapy in patients with a confirmed diagnosis of mucopolysaccharidosis I (MPS I; α -L-iduronidase deficiency) to treat the non-neurological symptoms of the disease (not connected with the brain or nerves). ||| Venous thromboembolism The combination of lenalidomide with dexamethasone is associated with an increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients with multiple myeloma (see sections 4.5 and 4.8). ||| Aldurazyme est indiqué en tant que traitement enzymatique substitutif chez les patients pour lesquels un diagnostic confirmé de mucopolysaccharidose de type I (MPS I, déficit en α -L-iduronidase) a été établi, afin de traiter les symptômes non neurologiques de la maladie (non connectés au cerveau ni aux nerfs).
7.559720536197412e-13 ||| The list of the product names concerned is given in Annex I. ||| The list of the product names concerned is given in Annex I. ||| La liste des dénominations concernées figure en annexe I.
0.43986499309539795 ||| Opgenra is contraindicated in children, adolescents and the skeletally immature (see section 4.3). ||| Overgrowth of non-susceptible organisms, including fungi (see section 4.4) ||| Opgenra est contre-indiqué chez les enfants, les adolescents et toutes personnes présentant une immaturité du squelette (voir rubrique 4.3).
0.33459487557411194 ||| What EVRA looks like and contents of the pack EVRA is a thin, beige, plastic transdermal patch. ||| What CANCIDAS looks like and contents of the pack CANCIDAS is a sterile, white to off-white, freeze-dried compact powder. ||| Qu’est-ce que EVRA et contenu de l’emballage extérieur EVRA est un mince dispositif transdermique en plastique beige.
0.11871030181646347 ||| Insulin requirements may be reduced in the presence of substances with hypoglycaemic activity, such as oral hypoglycaemics, salicylates (for example, acetylsalicylic acid), sulpha antibiotics, certain antidepressants (monoamine oxidase inhibitors), certain angiotensin converting enzyme inhibitors (captopril, enalapril), angiotensin II receptor blockers, beta-blockers, octreotide or alcohol. ||| The risk may increase in case of treatment combination with other medicinal products that may also provoke hyperkalaemia (salt substitutes containing potassium, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non steroidal anti- inflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim). ||| Les besoins en insuline peuvent diminuer en présence de substances à effet hypoglycémiant, telles que les hypoglycémiants oraux, les salicylés (par exemple, l'acide acétylsalicylique), les sulfamides antibactériens, certains antidépresseurs (inhibiteurs de la mono-amine oxydase), certains inhibiteurs de l'enzyme de conversion (captopril, enalapril), les antagonistes des récepteurs de l’ angiotensine II, les bêtabloquants, l'octréotide et l'alcool.
0.17212335765361786 ||| 20 July 2007 ||| 20 September 2007 ||| 20 juillet 2007
0.3882409930229187 ||| The vaccine strains vCP2242 and vCP1533 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/ equi-2/ Ohio/ 03 (American strain) and A/ equi-2/ Newmarket/ 2/ 93 (European strain), respectively. ||| The vaccine contains the inactivated ‘ surface antigen ’ from three different strains (types) of influenza (flu) virus as active substances (A/ Solomon Islands/ 3/ 2006, A/ Wisconsin/ 67/ 2005 and B/ Malaysia/ 2506/ 2004). ||| 3/ 17 Les souches vaccinales vCP2242 et vCP1533 sont des virus canarypox recombinés exprimant le gène de l’ hémagglutinine (HA) des souches virales de la grippe équine, respectivement A/ equi-2/ Ohio/ 03 (souche américaine) et A/ equi-2/ Newmarket/ 2/ 93 (souche européenne).
0.0 ||| 2 ||| 2 ||| 2 2001
0.4569559097290039 ||| EMEA/ CPMP/ 2811/ 03 5.3 Preclinical safety data ||| EMEA/ CHMP/ 123448/ 2006/ EN System Organ Class Adverse Event |||  EMEA 2003 EMEA/ CPMP/ 2811/ 03 calcifications massives observées avec la vitamine
0.3218817412853241 ||| Robotic mechanisms for working glass ||| Carbon brushes for electrical machines ||| Mécanismes robotisés pour le travail du verre
0.3098934590816498 ||| Adverse drug reactions observed in patients using Levemir are mainly dose-dependent and due to the pharmacologic effect of insulin. ||| In clinical studies, concurrent administration of abatacept and Enbrel resulted in increased incidences of serious adverse events. ||| Les effets indésirables observés chez les patients traités par Levemir sont le plus souvent dose- dépendants et sont dus à l’action pharmacologique de l’insuline.
0.36140865087509155 ||| The major metabolic product of folinic acid is 5-methyl-tetrahydrofolic acid (5-methyl-THF) which is predominantly produced in the liver and intestinal mucosa. ||| The most abundant metabolite is 8-hydroxy-ibafloxacin, which is also microbiologically active. lbafloxacin and 8-hydroxy-ibafloxacin act synergistically. ||| Le produit métabolique majeur de l’acide folinique est l’acide 5-méthyl-tétrahydrofolique (5-méthyl- THF) qui est principalement produit dans le foie et la muqueuse intestinale.
0.0015097481664270163 ||| 209 • A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different. ||| 205 • A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different. ||| Vous devrez étroitement surveiller les niveaux de sucre dans votre sang grâce à des tests fréquents de votre glycémie. • Quelques patients ayant présenté des hypoglycémies après passage d'une insuline animale à une insuline humaine ont rapporté que les symptômes précurseurs d'hypoglycémie étaient moins prononcés ou différents de ceux provoqués par une insuline animale.
0.12323445081710815 ||| WHAT EBIXA IS AND WHAT IT IS USED FOR ||| WHAT IS HEXAVAC AND WHAT IT IS USED FOR ||| QU’ EST-CE QU’ EBIXA ET DANS QUEL CAS EST-IL UTILISÉ
0.24589747190475464 ||| 1.7%) ||| 0.1%) ||| 1,7%)
0.21509544551372528 ||| In 1,715 hypertensive patients with type 2 diabetes, proteinuria ≥ 900 mg/ day and serum creatinine ranging from 1.0-3.0 mg/ dl, the long-term effects (mean 2.6 years) of Aprovel on the progression of renal disease and all-cause mortality were examined. ||| IRMA 2 was a placebo-controlled double blind morbidity study in 590 patients with type 2 diabetes, microalbuminuria (30-300 mg/ day) and normal renal function (serum creatinine ≤ 1.5 mg/ dl in males and < 1.1 mg/ dl in females). ||| Les effets à long terme (en moyenne 2,6 ans) de Aprovel sur la progression de l'atteinte rénale et sur la mortalité toute cause ont été étudiés chez 1.715 patients hypertendus diabétiques de type 2 ayant une protéinurie ≥ 900 mg/ jour et une créatininémie comprise entre 1,0 et 3,0 mg/ dl.
0.2989123463630676 ||| Due to a number of treatment withdrawals, the magnitude of the effect difference between infliximab and the methotrexate alone group cannot be defined. ||| In these studies, the clinical effect was closely related to the plasma concentration of A771726 and to the daily dose of leflunomide. ||| En raison d’ un certain nombre de sorties d’ étude, l’ importance de la différence des effets observés dans les groupes traités avec l’ infliximab par rapport au méthotrexate seul ne peut pas être définie.
0.20851147174835205 ||| The MAH must ensure that the system of pharmacovigilance, as described in version YM2007/ 00033/ 00 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market. ||| The MAH must ensure that the system of pharmacovigilance, as described in version 4 (14th April 2008) and included in the Type II variation (EMEA/ H/ C/ 250/ II/ 72) is in place and functioning before and whilst the product is on the market. ||| Le titulaire de l'AMM doit s'assurer que le système de pharmacovigilance, tel que décrit dans la version YM2007/ 00033/ 00 présentée dans le Module 1.8.1 du dossier de demande d'AMM, est en place et opérationnel avant et pendant la mise sur le marché de la spécialité.
0.009685808792710304 ||| Potent inducers of CYP3A (e. g., phenobarbital and carbamazepine) may reduce nelfinavir plasma concentrations. ||| Potent inducers of CYP3A (e.g., phenobarbital and carbamazepine) may reduce nelfinavir plasma concentrations. ||| Des inducteurs puissants du CYP3A (comme le phénobarbital et la carbamazépine) peuvent réduire les concentrations plasmatiques du nelfinavir.
0.005970509722828865 ||| 163 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 183 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 183 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.3875632882118225 ||| Immunoassays based on polypeptides for determining immunological profile, other than for medical use ||| Linkage compounds for scientific use in associating radiodiagnostic compounds with antibodies ||| Substances d'analyses immunologiques à base de polypeptides pour déterminer le profil immunologique autres qu'à usage médical
0.2281380444765091 ||| It was shown in a clinical study that concomitant use of ropinirole with ciprofloxacin, a moderate inhibitor of the CYP450 1A2 isozyme, results in an increase of Cmax and AUC of ropinirole by 60% and 84%, respectively. ||| Concomitant use of SUTENT with the CYP3A4 inducer, rifampin, resulted in a 23% and 46% reduction of the complex [sunitinib + primary metabolite] Cmax and AUC0-∞ values, respectively, after a single dose of SUTENT in healthy volunteers. ||| Un e ssai clinique a montré que l’utilisation concomitante de ropinirole et de ciprofloxacine, un inhibiteur modéré de l’isoenzyme 1A2 du CYP450, entraînait une augmentation de la Cmax et de l’AUC du ropinirole de 60% et 84%, respectivement.
0.25830912590026855 ||| Chemical preparations for use in the repair of tyres ||| Instruments for use in the preparation of artificial teeth ||| Préparations chimiques destinées à la réparation des pneus
0.1707131713628769 ||| Microcrystalline cellulose (E460) Pregelatinised starch (gluten free) Croscarmellose sodium Lactose monohydrate Magnesium stearate (E572) ||| Mannitol Microcrystalline cellulose Hyprolose (E 463) Red ferric oxide (E 172) Croscarmellose sodium Cherry flavour Aspartame (E 951) Magnesium stearate ||| Cellulose microcristalline (E460) Amidon prégélatinisé (sans gluten) Croscarmellose sodique Lactose monohydraté Stéarate de magnésium (E572)
0.5004575252532959 ||| In comparison to last year, e-Health indicators are not part of this year's index, as no new data are available. ||| For transparency purposes, last week's MFF communication shows these amounts both in current prices and in 2018 prices. ||| Contrairement à l'an dernier, les indicateurs relatifs à la santé en ligne ne font pas partie de l'indice de cette année, compte tenu de l'absence de nouvelles données disponibles.
0.07527633756399155 ||| For the full list of all side effects reported with Neupro, see the Package Leaflet. ||| For the full list of all the side effects reported with Protopic, please see the Package Leaflet. ||| Pour avoir le détail de tous les effets indésirables observés lors de l’ utilisation de Neupro, voir la notice.
0.6475610733032227 ||| But we have not stopped, because democracy cannot be suspended in the midst of such a dramatic crisis. ||| an intergenerational issue - we are robbing our descendants of the basis for a fulfilled life. ||| Mais nous n'avons pas arrêté, car la démocratie ne peut être suspendue au milieu d'une crise aussi dramatique.
0.07573505491018295 ||| Placebo Trudexa N=166 160/ 80 mg ||| Placebo Trudexa N=74 80/ 40 mg ||| Placebo Trudexa N = 166 160/ 80 mg
0.4200896620750427 ||| Remove child-resistant cap and push bottle adapter into neck of bottle. ||| Pull shield straight off needle to avoid damaging needle point. ||| Retirer le bouchon de sécurité enfant avant d’ introduire le bouchon adaptateur dans le goulot du flacon.
0.20779308676719666 ||| Provision of scientific information relating to chemicals ||| Provision of information relating to sports persons ||| Service d'information scientifique concernant les produits chimiques
0.7912817001342773 ||| > 600,000 IU/ ml ||| 500 IU and 1000 IU: ||| > 600.000 IU/ ml
0.09381701052188873 ||| Agenerase was originally authorised under ‘ Exceptional Circumstances’, because, for scientific reasons, limited information was available at the time of approval. ||| Betaferon was originally authorised under "Exceptional Circumstances", because, for scientific reasons, limited information was available at the time of approval. ||| Dans un premier temps, Agenerase a été autorisé dans des ‘ circonstances exceptionnelles’ en raison de données scientifiques limitées disponibles au moment de l’ approbation.
0.5643341541290283 ||| 179 (100) 28 (15.6) 7 (3.9) 11 (6.1) 2 (1.1) 0 1 (0.6) 1 (0.6) 0 0 3 (1.7) 1 (0.6) 0 0 2 (1.1) 0 0 0 ||| 6 (1.3) 4 (0.9) 5 (1.1) 3 (0.6) 17 (3.6) 21 (4.5) 14 (3.0) 19 (4.1) 8 (1.7) 13 (2.8) 5 (1.1) 7 (1.5) ||| 7 (3,9) 11 (6,1) 2 (1,1) 0 1 (0,6) 1 (0,6) 0 0 3 (1,7) 1 (0,6) 0 0 2 (1,1) 0 0 0
0.4054487943649292 ||| The Management Board will be concerned in 2000 and 2001 to build on progress in achieving a better understanding by EMEA and national competent authorities of the costs associated with the centralised procedure. ||| For this and depending on the nature of the programme, the Commission will work with each Member State to guarantee that every euro contributes to repair, recovery and resilience. ||| Le Conseil d’administration s’attachera en 2000 et 2001 à poursuivre les progrès réalisés pour améliorer la compréhension par l’EMEA et les autorités nationales compétentes des frais associés à la procédure centralisée.
0.07904885709285736 ||| Patients should be informed of the early signs of hypersensitivity reactions, which may include angioedema, burning and stinging at the injection site, chills, flushing, rash, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomitingand wheezing. ||| Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed infrequently in patients treated with factor IX containing products. ||| Les patients doivent être informés des signes précoces de réactions d’ hypersensibilité, tels que: œ dème de Quincke, brûlures et démangeaisons au point d’ injection, frissons, rougeurs, érythème, urticaire généralisée, céphalées, urticaire, hypotension, léthargie, nausées, agitation, tachycardie, oppression thoracique, fourmillements, vomissements et respiration sifflante.
0.1307957023382187 ||| hypersensitivity ||| Hypersensitivity ||| syndrome de
0.22655534744262695 ||| Following an oral dose of radioactive simvastatin to man, 13% of the radioactivity was excreted in the urine and 60% in the faeces within 96 hours. ||| The metabolites and unchanged amprenavir account for approximately 14% of the administered amprenavir dose in the urine, and approximately 75% in the faeces. ||| Après une dose orale de simvastatine radioactive chez l’homme, 13% de la radioactivité sont éliminés dans les urines et 60% dans les selles dans les 96 heures.
0.46746301651000977 ||| Body costume jewellery ||| Gold jewellery ||| Bijoux pour le corps
0.326460599899292 ||| rare: liver function abnormal ||| hepatitis, abnormal liver function ||| Rare: anomalie du fonctionnement du foie
0.5120620727539062 ||| - recommended follow up measures to further investigate the safety of celecoxib. ||| - Juvenile rat study to characterize the development and potential reversibility of testicular ||| - a recommandé des mesures de suivi afin d’ examiner plus avant la sécurité d’ emploi du
0.38127803802490234 ||| This may vary depending on whether you are M ||| This may vary depending on whether you are an adult or a ct ||| Cette posologie pourra varier selon que vous êtes un adulte ou un enfant.
0.3698423504829407 ||| When indicated, dose escalation should be performed with caution in these patients. ||| Therefore, clinical response to treatment should be closely monitored in these patients. ||| Lorsqu’ elle est indiquée, l’ augmentation posologique sera faite avec précaution chez ces patients.
0.3673279285430908 ||| Suspension or modification of therapy should be considered when drug-induced bone marrow depression is detected (see section 4.2). ||| For washout procedures and other recommended actions in case of desired or unintended pregnancy see section 4.6. ||| Une suspension ou une modification du traitement devra être envisagée chaque fois qu'une toxicité médullaire induite par le médicament est décelée (voir rubrique 4.2.).
0.17685329914093018 ||| If any of the above applies to you, tell your doctor or pharmacist before taking Pritor. ||| If any of these applies to you, tell your doctor or nurse before you are given Cubicin. ||| 58 Si vous êtes dans l’ un des cas ci-dessus, informez en votre médecin ou votre pharmacien avant de prendre Pritor.
0.0823502242565155 ||| Additional insulin inhaler, insulin release units and chamber packages are available. od ||| 62 Additional insulin inhaler, insulin release units and chamber packages are available. ||| Des conditionnements supplémentaires d’ inhalateur d’ insuline, de dispositifs de libération d’ insuline et de chambre sont disponibles. ic
0.5128889083862305 ||| The magnitude of weight gain and the proportion of adolescent patients who had clinically significant weight gain were greater with long-term exposure (at least 24 weeks) than with short-term exposure. ||| The mean half-life of elimination is 20-40 hours; longer half-lives, up to 65 hours, have occasionally been recorded and shorter half-lives have been seen in young men. ||| L’ amplitude de la prise de poids et la proportion des patients adolescents qui ont eu une augmentation du poids cliniquement significative ont été plus importantes lors d’ une exposition prolongée (au moins 24 semaines) que lors d’ une exposition de courte durée.
0.19939768314361572 ||| Provision of surveys [technical] ||| Provision of surveys [scientific] ||| Services d'études techniques
0.1204976737499237 ||| The marketing authorisation was renewed on 5 February 2003 and on 5 February 2008. ||| The marketing authorisation was renewed on 13 March 2002 and 13 March 2007. ||| L’ autorisation de mise sur le marché a été renouvelée le 5 février 2003 et le 5 février 2008.
0.3008396625518799 ||| Because ritonavir is highly protein bound it is unlikely that it will be significantly removed by haemodialysis or peritoneal dialysis. ||| Haemodialysis and peritoneal dialysis appear to have a limited effect on elimination of zidovudine, but enhance the elimination of the glucuronide metabolite. ||| Le ritonavir étant fortement lié aux protéines, il est improbable qu'il soit éliminé en quantité significative par hémodialyse ou dialyse péritonéale.
0.4105433225631714 ||| 100% ||| Total ||| 100% 100%
0.46470701694488525 ||| 2.5 mg / 12.5mg 5 mg/ 25mg ||| 1.25mg 2.5mg 5mg 10mg ||| Dosage 2.5 mg / 12.5mg 5 mg/ 25mg
0.2670662999153137 ||| In the phase III IMpact-RSV study in the premature and bronchopulmonary dysplasia paediatric populations, the proportions of patients in the placebo and palivizumab groups who received routine childhood vaccines, influenza vaccine, bronchodilators or corticosteroids were similar and no incremental increase in adverse reactions was observed among patients receiving these agents. ||| No medically important differences were observed during the prophylactic studies carried out in the premature and bronchopulmonary dysplasia paediatric populations in ADRs by body system or when evaluated in subgroups of children by clinical category, gender, age, gestational age, country, race/ ethnicity or quartile serum palivizumab concentration. ||| Au cours de l’ étude clinique de phase III IMpact-RSV chez les enfants prématurés atteints de dysplasie bronchopulmonaire, les proportions de patients dans les groupes placebo et palivizumab à qui ont été administrés les vaccins usuels de l’ enfance, le vaccin antigrippal, des bronchodilatateurs ou des corticostéroïdes ont été comparables et aucune augmentation des effets indésirables n’ a été observée parmi les patients recevant ces produits.
0.4120067059993744 ||| The EU's sanctions therefore provide for humanitarian exemptions and are fully in line with all obligations under international law. ||| Spain will ensure that the rules for cumulation of aid are respected across all measures under the Temporary Framework and granting authorities. ||| Et c'est pourquoi les sanctions de l'UE prévoient des exemptions humanitaires et respectent pleinement les obligations imposées par le droit international.
0.6934356689453125 ||| Conducting feasibility studies relative to mineral exploitation ||| Measures to ease impact of COVID-19 on aviation industry ||| Conduite d'études de faisabilité liées à l'exploitation des minéraux
0.5238251686096191 ||| From 1975 to 1990 Mrs Mendosa held a number of posts at the European Commission in Luxembourg, including the Conference Service, the Office for Official Publications and the Statistical Office. ||| Mr Parenti, an Italian national, is currently the Head of the Economic, Trade and Development section in the Delegation of the European Union to the United Nations. ||| Expérience professionnelle: de 1975 à 1990, Mme Mendosa a occupé plusieurs postes à la Commission européenne à Luxembourg, notamment au service des conférences, l'office des publications et l'office statistique.
0.3201770484447479 ||| Ferriprox is used to treat iron overload (an excess of iron in the body) in patients with thalassaemia major (an inherited disease where patients are unable to make enough haemoglobin, the protein found in red blood cells that carries oxygen around the body). ||| Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces (formerly known as non-insulin-dependent diabetes mellitus or maturity onset diabetes). ||| Ferriprox est indiqué pour le traitement de la surcharge en fer (excès de fer dans l’ organisme) chez les patients présentant une thalassémie majeure (maladie congénitale dans laquelle les patients ne fabriquent pas assez d’ hémoglobine, protéine présente dans les globules rouges qui transporte l’ oxygène dans l’ organisme).
0.35216742753982544 ||| Take the suspension exactly as your doctor has told you. ||| - Remove the patch after the period your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.4036911129951477 ||| Within the organ system classes, adverse reactions are listed under headings of frequency using the following categories: very common (≥1/10); common (≥1/100, < 1/10). ||| In a pre-defined subset of subjects (Cervarix = 8,130 versus control = 5,786), adverse events were followed for 30 days after each injection. ||| Au sein des systèmes d’ organes, les effets indésirables sont listés par type de fréquence en définissant les catégories suivantes: très fréquent ( 1/ 10); fréquent ( 1/ 100, < 1/ 10).
0.06387916952371597 ||| Kinzalkomb is not recommended for use in children below 18 years due to a lack of data on safety and efficacy. ||| RoActemra is not recommended for use in children below 18 years of age due to insufficient data on safety and efficacy. ||| Kinzalkomb ne doit pas être utilisé chez l’ enfant en dessous de 18 ans par manque de données concernant sa sécurité et son efficacité dans cette population.
0.2818395793437958 ||| Very Common (occurring in at least 1 in 10 patients treated) Common (occurring in at least 1 of 100 and less than 1 of 10 patients treated) Uncommon (occurring in at least 1of 1000 and less than 1 of 100 patients treated) Rare (occurring in at least 1 of 10,000 and less than 1 of 1000 patients treated) Not known (cannot be estimated from the available data) ||| Very common side effects (likely to occur in more than 1 in 10 patients) Common side effects (likely to occur in fewer than 1 in 10 patients) Uncommon side effects (likely to occur in fewer than 1 in 100 patients) Rare side effects (likely to occur in fewer than 1 in 1,000 patients) Very rare side effects (likely to occur in fewer than 1 in 10,000 patients). ||| Très fréquent (survenant chez au moins 1/ 10 patients traités) Fréquent (survenant chez au moins 1/ 100 patients traités et chez moins de 1/ 10) Peu fréquent (survenant chez au moins 1/ 1 000 patients traités et chez moins de 1/ 100) Rare (survenant chez au moins 1/ 10 000 patients traités et chez moins de 1/ 1 000) Inconnu (ne pouvant être estimé d’ après les données disponibles)
0.2314017117023468 ||| In patients previously un treated with chemotherapy, TMZ is administered orally at a dose of 200 mg/m2 once daily for the first 5 days followed by a 23 day treatment interruption (total of 28 days). ||| If Trevaclyn is missed for 7 or more consecutive days, therapy should be resumed at the 1000 mg/ 20 mg dose for 1 week, before advancing to the maintenance dose of 2000 mg/ 40 mg. ||| Chez les patients n’ ayant pas reçu de chimiothérapie au préalable, TMZ est administré par voie orale à la dose de 200 mg/ m2 une fois par jour pendant les 5 premiers jours du cycle puis le traitement devra être arrêté pendant les 23 jours suivants (total de 28 jours).
0.3887249529361725 ||| The best way to use Viraferon in this indication is in combination with ribavirin. rod ||| The dose of ribavirin to be used in combination with Pegasys is given in Table 1. ||| La meilleure façon d’ utiliser Viraferon dans cette indication est de l’ associer à la ribavirine.
0.006707611493766308 ||| 50 mg losartan potassium - 12.5 mg hydrochlorothiazide ||| 100 mg losartan potassium - 12.5 mg hydrochlorothiazide ||| COZAAR-COMP 50/ 12.5MG 50 mg losartan potassium - 12,5 mg hydrochlorothiazide
3.6763712733811627e-13 ||| Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer’ s dementia. ||| Treatment should be initiated and supervised by a physician experienced in the diagnosis and treatment of Alzheimer’ s dementia. ||| Le traitement doit être instauré et supervisé par un médecin ayant l’ expérience du diagnostic et du traitement des patients atteints de la maladie d’ Alzheimer.
0.383766233921051 ||| au If you use more Nespo than you should ||| 194 If you use more GONAL-f than you should ||| Si vous avez utilisé plus de Nespo que vous n’auriez dû am
0.11854393780231476 ||| 71% ||| 78% ||| 30%
0.2512781620025635 ||| Depending upon the results of these tests, your doctor may change the dose to be taken. ||| Depending on the results of these tests your doctor may advise you to change how often you take Sebivo. ||| En fonction des résultats de ces analyses, votre médecin peut modifier la dose à prendre.
0.3194269835948944 ||| EU/1/98/096/003 (5 hard capsules) EU/1/98/096/004 (20 hard capsules) ||| EU/1/06/348/001 pack of 1 tube EU/1/06/348/002 pack of 10 tubes ||| EU/ 1/ 98/ 096/ 003 (5 gélules) EU/ 1/ 98/ 096/ 004 (20 gélules)
0.0012861541472375393 ||| 49 primary endpoint were analysed, no effect in all cause mortality was observed, while a positive trend in the reduction in ESRD and a significant reduction in doubling of serum creatinine were observed. ||| 38 primary endpoint were analysed, no effect in all cause mortality was observed, while a positive trend in the reduction in ESRD and a significant reduction in doubling of serum creatinine were observed. ||| Lors de l'analyse individuelle des composants du critère principal, aucun effet sur la mortalité toute cause n'a été observé, alors qu'une tendance positive sur la réduction de l'IRT et une réduction significative du doublement de la créatininémie ont été observées.
0.009771858341991901 ||| As anaesthetic drugs may affect renal perfusion, the use of parenteral fluid therapy during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively. ||| As anaesthetics may affect renal perfusion, the use of parenteral fluid therapy during surgery should be considered to decrease potential renal complications when using NSAIDs peri-operatively. ||| Les produits anesthésiques pouvant affecter la perfusion rénale, un apport liquidien parentéral doit être envisagé pendant l’ opération afin de réduire de potentielles complications rénales lors de l’ utilisation d’ AINS en péri-opératoire.
0.3220646381378174 ||| Tell your doctor as soon as possible if you feel any deterioration in your condition while you are taking Targretin. ||| You must look out for certain symptoms while you are taking Avaglim, to reduce the risk of any problems. ||| Informez votre médecin le plus rapidement possible si vous ressentez une aggravation de votre état pendant que vous êtes sous Targretin.
0.22269019484519958 ||| 1.5 ml of oral suspension in a pre-filled oral applicator (type I glass) with a plunger stopper (rubber butyl) and a protective tip cap (rubber butyl) in pack sizes of 1, 5, 10 or 25. ||| 0.5 ml suspension for injection in pre-filled syringe (Type I glass) with a plunger rod (polypropylene) - pack size of 1 and 10 with or without needle, and multi pack of 5 packs of 10 pre-filled syringes without needle. ||| 20 1,5 ml de suspension buvable en applicateur pré-rempli pour administration orale (verre de type I) avec un bouchon-piston (gomme butyle) et un capuchon protecteur (gomme butyle) en boîte de 1, 5, 10 ou 25.
0.7535405158996582 ||| DILUTE BEFORE USE. ||| ho Syringe BEFORE USE ||| DILUER AVANT UTILISATION.
0.18421006202697754 ||| However, should very high dose cutaneous administration or accidental oral ingestion occur, attention should be paid to the effects seen with therapeutic doses of intravenous eflornithine (400 mg/ kg/ day or approximately 24 g/ day) used in the treatment of Trypanosoma brucei gambiense infection (African sleeping sickness): hair loss, facial swelling, seizures, hearing impairment, gastrointestinal disturbance, loss of appetite, headache, weakness, dizziness, anaemia, thrombocytopenia and leucopenia. ||| Adults The most frequently (seen in ≥ 1% of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic transaminases (see section 4.4), rash, asthenia, fatigue and oedema. ||| Cependant, en cas d'application cutanée de très forte dose ou d'ingestion accidentelle, on devra prêter attention à la survenue des mêmes effets que ceux observés lors de l'administration intraveineuse de doses thérapeutiques d'éflornithine (400 mg/ kg/ j soit environ 24 g/ j) dans le traitement des infections à trypanosoma brucei gambiense (maladie du sommeil): chute des cheveux, œ dème de la face, épilepsie, diminution de l'acuité auditive, troubles gastro-intestinaux, perte d'appétit, maux de tête, faiblesse, vertiges, anémie, thrombocytopénie et leucopénie.
0.6404681205749512 ||| rare: oedema, palpitation ||| Common: palpitations. ||| rares: oedème, palpitation Affections cardiaques
0.32782113552093506 ||| If your doctor advises you to stop treatment, follow your doctor’ s instructions concerning the gradual reduction of Inovelon in order to lower the risk of an increase in seizures. ||| As injections into the eye can cause a temporary increase in the pressure within the eye, the ophthalmologist will check for this after the injection and take corrective measures if needed. ||| Si votre médecin vous conseille d’ arrêter le traitement, suivez les recommandations de votre médecin en ce qui concerne la diminution progressive d’ Inovelon afin de diminuer le risque d’ augmentation des crises d’ épilepsie.
5.189409015352031e-13 ||| Insulins and analogues for injection, long-acting. ||| Insulins and analogues for injection, long-acting. ||| Antidiabétiques, Insulines et ses analogues injectables, d’ action lente.
0.565889298915863 ||| Do not use if the eardrum is perforated. ||| Use a plaster if you want to. ||| Ne pas administrer en cas de perforation de la membrane tympanique.
0.598795473575592 ||| Specula for otoscopes ||| Analogue to digital converters ||| Spéculums pour otoscopes
6.130566974210661e-13 ||| ra ||| ra ||| Ce
0.40272819995880127 ||| Instructions for injecting with the Aranesp pre-filled pen ||| Instructions for injecting Abseamed under the skin ||| Instructions pour l’ injection d’ Aranesp en stylo prérempli
0.5742214322090149 ||| Genes of seeds for agricultural production ||| 2.2 Determination of meat withdrawal periods for cattle ||| Gènes de semences pour la production agricole
0.21118269860744476 ||| - Lactose, anhydrous ||| - anhydrous lactose ||| - Lactose, anhydre
0.3633120059967041 ||| €6.5 million was also adopted to fund a Technical Cooperation Facility to ensure effective monitoring and evaluations of all the actions implemented under the North of Africa window of the EU Emergency Trust Fund of Africa. ||| 0 At the request of the European Commission the EMEA took over direct responsibility for managing the implementation and operation of the pharmaceutical aspects of the EU-Canada Mutual Recognition Agreement. ||| Un montant de 6,5 millions d'euros a également été prévu pour financer une facilité de coopération technique destinée à garantir l'effectivité du suivi et des évaluations de toutes les actions mises en œuvre au titre du volet «Afrique du Nord» du Fonds fiduciaire d'urgence de l'UE pour l'Afrique.
0.04630742967128754 ||| Efexor and associated names (see Annex I) 50 mg tablets ||| Efexor and associated names (see Annex I) 37.5 mg tablets ||| Efexor et noms associés (voir Annexe I) 50 mg comprimés
0.3993237614631653 ||| Notes: ||| * Notes: ||| Remarques:
0.2943812608718872 ||| The accumulation of bosentan in hepatocytes leading to cytolysis with potentially severe damage of the liver, or an immunological mechanism, are not excluded. ||| Animals showing a polyuria-polydipsia (excessive water intake and consequent excretion of a large volume of urine) should also not be treated with this product. ||| Un mécanisme immuno- allergique ou la possibilité d’ une accumulation du bosentan dans les hépatocytes entraînant une cytolyse et un risque potentiel d’ atteinte hépatique sévère ne peuvent être écartés.
0.3167860507965088 ||| You may have to take this treatment over a long period of time. • Your doctor will regularly monitor your condition to check that the treatment is having the desired effect. • Do not stop taking Galvus unless your doctor tells you to. ||| Although this complication is very rare, you should be aware that if you develop it, you would need to have regular blood transfusions, possibly lifelong, to treat your anaemia and the Silapo therapy would have to be discontinued. ||| Vous pouvez avoir à prendre ce médicament pendant une longue période. • Votre médecin surveillera régulièrement votre état de santé pour vérifier si le traitement a l’ effet désiré. • N’ arrêtez pas de prendre Galvus sauf si votre médecin vous dit de le faire.
0.29645806550979614 ||| HIV-1 isolates with decreased susceptibility to amprenavir have been selected during in vitro serial passage experiments Reduced susceptibility to amprenavir was associated with virus that had developed I50V or I84V or V32I+I47V or I54M mutations. ||| Resistance to emtricitabine or tenofovir has been seen in vitro and in some HIV-1 infected patients due to the development of an M184V or M184I substitution in RT with emtricitabine or a K65R substitution in RT with tenofovir. ||| Une sensibilité réduite à l’ amprenavir a été associée aux virus ayant développé les mutations I50V ou I84V ou V32I+I47V ou I54M.
0.34503090381622314 ||| What is GANFORT? ||| What is OPTISON? ||| Qu’ est -ce que GANFORT?
0.28309473395347595 ||| Administration of the product in accordance with the recommended monthly dosing schedule for a period of up to 6.5 months resulted in an improvement in lameness and quality of life in dogs with established osteoarthritis, as assessed by the dogs’ owners. ||| The company that makes Vectibix will supply the results of additional studies looking at the safety and effectiveness of the medicine in patients with colorectal cancer with and without mutated KRAS, as well as at the quality of life in patients receiving it. ||| L’ administration du produit conformément au schéma d’ administration mensuel recommandé pendant une période maximale de 6 mois et demi aboutissait à une réduction de la claudication et à une amélioration de la qualité de la vie, évaluées par les propriétaires de l’ animal, chez les chiens atteints d’ arthrose avérée.
0.3492920398712158 ||| Medicinal advice should be sought in the event of accidental ingestion, particularly by a child. ||| If pregnancy occurs during treatment the possibility of genetic counselling should be considered. ||| Un avis médical devra être sollicité en cas d’ ingestion accidentelle, en particulier par un enfant.
0.3631303012371063 ||| As the power sector has the highest share of renewables, we should increasingly use electricity where possible: for example for heat pumps in buildings, electric vehicles in transport or electric furnaces in certain industries. ||| And for those sectors where electrification is difficult, the strategy proposes steps to promote cleaner fuels, including sustainable biofuels and biogas, and renewable hydrogen. ||| Le secteur de l'électricité affichant la part la plus élevée d'énergies renouvelables, nous devrions privilégier l'utilisation de l'électricité partout où cela est possible: par exemple, pour les pompes à chaleur dans les bâtiments, les véhicules électriques dans les transports ou les fours électriques dans certaines industries.
3.783187955616607e-13 ||| In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. ||| In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. ||| En cas d’ auto-injection accidentelle, prenez immédiatement conseil auprès de votre médecin en lui montrant la notice ou l'étiquetage.
0.0 ||| See leaflet for further information. ||| See leaflet for further information. ||| Consulter la notice pour plus d'information.
9.253867203767863e-13 ||| Taking other medicines: ||| Taking other medicines: ||| 65 Prise d'autres médicaments
0.219217911362648 ||| These side effects may occur with certain frequencies, which are defined as follows: very common: affects more than 1 user in 10 common: affects 1 to 10 users in 100 uncommon: affects 1 to 10 users in 1,000 rare: affects 1 to 10 users in 10,000 very rare: affects less than 1 user in 10,000 not known: frequency cannot be estimated from the available data. ||| 64 very common: affects more than 1 user in 10 common: affects 1 to 10 users in 100 uncommon: affects 1 to 10 users in 1,000 rare: affects 1 to 10 users in 10,000 very rare: affects less than 1 user in 10,000 not known: frequency cannot be estimated from the available data. ||| Ces effets indésirables peuvent se produire à différentes fréquences, qui sont définies de la façon suivante: • très fréquent: touche plus d’1 patient sur 10 • fréquent: touche de 1 à 10 patients sur 100 • peu fréquent: touche de 1 à 10 patients sur 1000 • rare: touche de 1 à 10 patients sur 10 000 • très rare: touche moins de 1 patient sur 10 000 • fréquence indeterminée: qui ne peut être estimée sur la base des données disponibles.
0.4512932300567627 ||| Uncommon: mood or sleep disturbances ||| Uncommon: difficulty in walking ||| Peu fréquents: troubles de l’ humeur ou du sommeil
0.037784382700920105 ||| For the full list of all side effects reported with TRAVATAN, see the Package Leaflet. ||| For the full list of all side effects reported with ADROVANCE, see the Package Leaflet. ||| Pour une description complète des effets indésirables observés sous TRAVATAN, veuillez vous reporter à la notice.
0.08604744076728821 ||| WHAT CRIXIVAN IS AND WHAT IT IS USED FOR ||| WHAT NOXAFIL IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE CRIXIVAN ET DANS QUEL CAS EST-IL UTILISE
0.08855824172496796 ||| If you forget to use Insulin Human Winthrop Basal ||| If you forget to use Insulin Human Winthrop Infusat ||| Si vous oubliez d’utiliser Insulin Human Winthrop Basal
0.0 ||| 3. ||| 3. ||| 152 3.
5.456110823559568e-13 ||| Data with AVANDAMET is also consistent with this combined adverse reaction profile. ||| Data with AVANDAMET is also consistent with this combined adverse reaction profile. ||| Les données avec AVANDAMET sont cohérentes avec ce profil combiné d’ effets indésirables.
0.3150967061519623 ||| INVANZ is not recommended for use in children below 3 months of age due to a lack of data on safety and efficacy (see sections 4.4; 5.1 and section 5.2). ||| The safety and efficacy of Orgalutran have not been established in women weighing less than 50 kg or more than 90 kg (see also section 5.1 and 5.2). ||| INVANZ est déconseillé chez l’ enfant de moins de 3 mois en l'absence de donnée de sécurité d’ emploi et d’ efficacité (voir rubriques 4.4, 5.1 et 5.2).
0.236801877617836 ||| Viracept has been studied in combination with other antiviral medicines in two main studies involving 605 patients aged 13 years or more, who were infected with HIV. ||| The two main studies of Fuzeon included 1,013 patients aged 16 years or over who were infected with HIV and had taken, or were not responding to, other antiviral medicines. ||| Viracept a été étudié en association avec d’ autres médicaments antiviraux dans deux études principales ayant suivi 605 patients âgés de 13 ans ou plus, présentant une infection par le VIH.
0.4489003121852875 ||| is for oral administration once or twice daily and may be taken before or after meals. ||| The tablets are taken orally once daily shortly before or with the first main meal. ||| est destiné à une administration par voie orale, en une ou deux prises quotidiennes avant ou pendant les repas.
0.4075584411621094 ||| Anaphylactic reactions and hypersensitivity Anaphylactic and other hypersensitivity reactions have been reported in fewer than 1% of patients following the intravenous administration of proteins to patients. ||| Skin and subcutaneous tissue adverse reactions The majority of skin and subcutaneous adverse reactions were associated with the injection site. ||| Réactions anaphylactiques et hypersensibilité Des réactions anaphylactiques et d’ autres réactions d’ hypersensibilité ont été décrites chez moins de 1% des patients à la suite de l’ administration intraveineuse de protéines.
0.43953192234039307 ||| It is a suspension for injection that contains inactivated (killed) bluetongue serotype 8 viruses. ||| The Pw component is obtained by heat inactivation of phase I culture of Bordetella pertussis bacteria. ||| Il s’ agit d’ une suspension injectable qui contient les virus inactivés bluetongue, sérotype 8.
0.03797387704253197 ||| 32 PACKAGE LEAFLET ||| 22 PACKAGE LEAFLET ||| 36 NOTICE
0.14301583170890808 ||| Subsequent doses Topotecan should not be re-administered unless the neutrophil count is more than or equal to 1.5 x 109/ l, the platelet count is more than or equal to 100 x 109/ l, and the haemoglobin level is more than or equal to 9g/ dl (after transfusion if necessary). ||| Subsequent doses Topotecan should not be re-administered unless the neutrophil count is ≥ 1 x 109/ l, the platelet count is ≥ 100 x 109/ l, and the haemoglobin level is ≥ 9 g/ dl (after transfusion if necessary). ||| Posologie ultérieure Topotécan ne doit pas être réadministré si le nombre de polynucléaires neutrophiles est < à 1,5 x 109/ l, le nombre des plaquettes est < à 100 x 109/ l et le taux d’ hémoglobine est < à 9 g/ dl (après transfusion si nécessaire).
0.18426716327667236 ||| Rare side effects which may affect more than 1 person in a 10,000, are listed below ||| Rare side-effects which may affect less than 1 person in 1000 are listed below: ||| De rares effets indésirables pouvant affecter plus d' 1 patient sur 10 000 sont listés ci-dessous
0.671995997428894 ||| How to use Paxene 4. ||| The use of Atripla in ||| Comment utiliser Paxene 4.
0.2825202941894531 ||| This product contains amitraz, which can lead to adverse neurological effects in humans and especially in children. ||| This product contains human albumin and hence carries a potential risk for transmission of viral diseases. ||| Ce produit contient de l’ amitraz qui peut provoquer des effets secondaires neurologiques chez les humains et en particulier chez les enfants.
0.34523653984069824 ||| Financial management services provided via the Internet ||| Financial services provided over the Internet and telephone ||| Services de gestion financière fournis par le biais d'Internet
0.3291743993759155 ||| There are no apparent age -related effects on the pharmacokinetics of PegIntron. ||| Age, gender and WHO performance status had no effect on the pharmacokinetics of rituximab. ||| L’ âge n’ a pas d’ effet sur la pharmacocinétique de PegIntron.
0.22270715236663818 ||| Method and route of administration ||| Method and route of administration: ||| 41 Mode et voie d’ administration
0.4078001081943512 ||| • excess lactic acid in the blood (lactic acidosis, a serious side effect that can be fatal). ||| Common side effects • Bleeding inside your head. • An infection of the blood caused by bacteria (sepsis). ||| • excès d’acide lactique dans le sang (acidose lactique, un effet indésirable grave qui peut être fatal).
0.3308970630168915 ||| In patients who were revascularised with a thrombolytic, fondaparinux significantly reduced the incidence of death/ re-MI at Day 30 from 13.6% for the control group to 10.9% (hazard ratio 0.79, 95%CI, 0.68; 0.93, p = 0.003). ||| percutaneous transluminal coronary angioplasty) by 27% (p < 0.001)., The relative risk of stroke was also reduced by 32% (p = 0.032), and stroke or transient ischaemic attack (TIA) combined by 27% (p = 0.02). ||| Chez les patients revascularisés par thrombolyse, le fondaparinux a réduit significativement l'incidence de la mortalité/ récidives d’ IDM au 30ème jour de 13,6% dans le groupe contrôle à 10,9% (hazard ratio 0,79; IC 95%:
0.4273589849472046 ||| Your doctor will decide this. ||| Your doctor will check on this. ||| Votre médecin en décidera.
0.35514312982559204 ||| No hemolysis was found with the commercial formulation up to a fosaprepitant concentration of 1 mg/ ml in human whole blood and washed human erythrocytes. ||| In combination trials pioglitazone added to metformin resulted in mean weight increase over one year of 1.5 kg and added to a sulphonylurea of 2.8 kg. ||| Avec la formulation commerciale, aucune hémolyse n'a été trouvée dans le sang total et les globules rouges lavés chez l'Homme à des concentrations de fosaprépitant allant jusqu'à 1 mg/ ml.
0.31568050384521484 ||| Higher doses were associated with reductions in foetal body weights and/ or delayed ossification and in rabbits abortions were noted. ||| At high doses embryotoxicity was apparent and an increase in incomplete ossification and in skeletal anomalies was seen. ||| En administrant des doses plus fortes, on a pu observer une réduction du poids des fœ tus et/ ou un retard d’ ossification ainsi que des avortements chez les lapins.
0.21807584166526794 ||| 2 Avoid contact with eyes. ||| Avoid contact with eyes. ||| Eviter le contact avec les yeux.
0.4891197681427002 ||| Design and development of energy management software ||| Installation of security and safety equipment ||| Conception et développement de logiciels de gestion de l'énergie
0.01104145310819149 ||| 187 4.8 Undesirable effects ||| 188 4.8 Undesirable effects ||| 4.8 Effets indésirables
0.2300843596458435 ||| EMEA/ CPMP/ 0539/ 04 ||| In patients EMEA/ CPMP/ 0539/ 04 |||  EMEA 2004 EMEA/ CPMP/ 0539/ 04
0.3299265205860138 ||| The following side effects have been reported in patients taking Cholestagel: ||| The following side effects were reported as being related to Naglazyme: ||| Les effets indésirables suivants ont été observés chez les patients prenant Cholestagel:
0.5351855754852295 ||| Petroleum ether ||| Petroleum pitch ||| Éther de pétrole
0.3270532786846161 ||| Zonegran should be used with caution in patients being treated concomitantly with carbonic anhydrase inhibitors such as topiramate, as there are insufficient data to rule out a pharmacodynamic interaction (see Section 4.5). ||| The only safety concerns for human use derived from animal studies of salmeterol xinafoate and fluticasone propionate given separately were effects associated with exaggerated pharmacological actions. ||| Zonegran doit être administré avec prudence chez les patients traités de manière concomitante par des inhibiteurs de l’ anhydrase carbonique, par exemple le topiramate, car il n'existe pas de données suffisantes pour exclure la possibilité d'une interaction pharmacodynamique (voir rubrique 4.5).
0.0035955430939793587 ||| 152 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 162 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 162 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDEES
0.34237897396087646 ||| The intake of food reduces the bioavailability of lansoprazole: it is recommended to take lansoprazole before the meal. ||| Do not drink grapefruit juice while you are prescribed Rapinyl treatment as it may increase the side effects of Rapinyl. ||| La prise concomitante de nourriture diminue la biodisponibilité du lansoprazole: il est donc recommandé de prendre le médicament avant les repas.
0.27072447538375854 ||| Other common side effects are neuropathy (nerve disorders: numbness of hands and feet, and pins and needles), somnolence (sleepiness), arthralgia (joint pain), myalgia (muscle pain), and injection site reactions including erythema (redness), tenderness, skin discoloration, or swelling at the injection site. ||| Other common side effects are pseudofolliculitis barbae (ingrown hairs), alopecia (hair loss), stinging skin, burning skin, dry skin, pruritus (itching), erythema (redness), tingling skin, irritated skin, rash, and folliculitis (infected hair follicles). ||| Parmi les autres effets indésirables, on peut citer la neuropathie (troubles nerveux: engourdissement des mains et des pieds, et fourmillements), somnolence (endormissement), arthralgie (douleur articulaire), myalgie (douleur musculaire) et réactions au site d’ injection, notamment érythème (rougeur), sensibilité, peau décolorée ou œ dème au site d’ injection.
0.3650863766670227 ||| Furthermore, patients and caregivers should be aware of the fact that other behavioural symptoms of impulse control disorders and compulsions such as binge eating and compulsive shopping can occur. ||| Also, you should know that patients under 18 have an increased risk of side effects, such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when ||| Par ailleurs, les patients et les soignants doivent être prévenus des autres symptômes comportementaux des troubles du contrôle des impulsions et des actes impulsifs comme l’ augmentation de la prise de nourriture et les achats compulsifs qui peuvent survenir.
0.2221040278673172 ||| Film-coat: lactose monohydrate, hypromellose, triacetin, titanium dioxide (E171), iron oxide yellow (E172), talc. ||| Black ink containing: propylene glycol, black iron oxide (E172), polyvinyl acetate phthalate, polyethylene glycol 400, ammonium hydroxide ||| Pelliculage: lactose monohydraté, hypromellose, triacétine, dioxyde de titane (E171), oxyde de fer jaune (E172), talc.
0.1441246122121811 ||| 3.5 ml of concentrate for solution for infusion in a 5 ml vial (Type I glass) with a stopper (fluoro-resin coated butyl rubber), a one piece seal (aluminium) and flip-off cap. ||| 4 ml of solution in a 5 ml vial (type I glass) closed with a latex-free stopper (bromobutyl/ isoprene polymer) and a seal (lacquered plastic). ||| Même corrections 3,5 ml de solution à diluer pour perfusion dans un flacon de 5 ml (verre de type 1) fermé par un bouchon (de butylcaoutchouc recouvert de résine fluorée) recouvert d'un opercule (en aluminium) munie d'une capsule de type flip-off®.
0.0 ||| 9. ||| 9. ||| 137 9.
0.513201117515564 ||| Topotecan does not inhibit human P450 enzymes (see Section 5.2). ||| Elevations of hepatic transaminases (ALT/ AST; see section 4.4). ||| Topotécan n'inhibe pas chez l'homme les enzymes P450 (voir rubrique 5.2).
0.39969831705093384 ||| On the basis of the grounds for referral, the points considered by the CVMP were: ||| On the basis of the grounds for referral, the following questions were forwarded to the Marketing Authorisation Holders: ||| Sur la base des motifs de la saisine, les points suivants ont été examinés par le CVMP:
0.2291715145111084 ||| Based on an analysis of population pharmacokinetics in phase II trials, co-administration of dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, H2 receptor antagonists, or phenobarbital did not alter the clearance of TMZ. ||| Therefore, CYP3A inhibitors such as azol antifungals, HIV protease inhibitors, clarithromycin, telithromycin, verapamil, diltiazem, indinavir, ciprofloxacin, and grapefruit juice are not anticipated to have a significant effect on the pharmacokinetics of the active metabolite. ||| Selon une analyse pharmacocinétique de population lors des essais de phase II, l’ administration concomitante de dexaméthasone, de prochlorpérazine, de phénytoïne, de carbamazépine, d’ ondansétron, d’ antagonistes des récepteurs H2 ou de phénobarbital ne modifie pas la clairance du TMZ.
0.33860689401626587 ||| You should not use Cetrotide 0.25 mg if you are already pregnant, or suspect that you might be pregnant, or if you are breast-feeding. ||| Zonegran is not recommended for you. • are pregnant, planning to get pregnant or think that you may be pregnant, or are breastfeeding. ||| Ne pas utiliser Cetrotide 0,25 mg si vous êtes déjà enceinte ou si vous supposez que vous pouvez l’ être ou si vous allaitez..
0.24784357845783234 ||| - This anorectic agent should be used with caution in epileptic patients. ||| Angiox should be used with caution during beta brachytherapy procedures. ||| Cet anorexigène doit être utilisé avec prudence chez les sujets épileptiques.
0.33122527599334717 ||| Therefore, losartan should be used with caution in these patient groups. ||| Rimonabant should be used with caution in this population (see section 5.2). ||| Le losartan doit donc être utilisé avec prudence chez ces patients.
0.17858153581619263 ||| Tell your doctor before treatment if you have or have recently had any of the following, as your doctor will need to take account of these when prescribing your dose: • a head injury, because Rapinyl may cover up the extent of the injury • breathing problems or suffer from myasthenia gravis (a condition characterised by muscle weakness) • a slow heart rate or low blood pressure • liver or kidney disease, as this may require your doctor to more carefully adjust your dose • a brain tumour and/ or raised intracranial pressure (an increase of pressure in the brain which causes severe headache, a feeling of sickness and blurred vision) • mouth wounds or mucositis (swelling and redness of the inside of the mouth) ||| Your dose may need to be adjusted • You know of any factors which would favour you having a stroke, such as high blood pressure, cardiovascular disorder or blood vessel problems in the brain • You have Parkinson’ s disease or dementia • You are diabetic • You have epilepsy • You are a man and you have ever had a prolonged or painful erection If you experience this while taking RISPERDAL, contact your doctor straight away • You have problems controlling your body temperature or overheating • You have kidney problems • You have liver problems • You have an abnormally high level of the hormone prolactin in your blood or if you have a tumour, which is possibly dependent on prolactin. ||| Rapinyl pourrait masquer l’ étendue de la lésion; • vous souffrez de problèmes respiratoires ou de myasthénie grave (une pathologie caractérisée par une faiblesse musculaire); • votre rythme cardiaque est lent ou votre pression artérielle basse; • vous êtes atteint d’ une maladie hépatique ou rénale, qui pourrait exiger une adaptation posologique plus prudente; • vous êtes atteint d’ une tumeur cérébrale et/ ou d’ une hypertension intracrânienne (une augmentation de la pression à l’ intérieur du crâne, qui provoque des céphalées importantes, des sensations nauséeuses et une vision floue); • vous présentez une ulcération buccale ou une mucite (gonflement et rougeurs à l’ intérieur de la bouche).
0.7323646545410156 ||| — 1 4 18 ||| 2 12 19 16 -- ||| 18 18
0.5201519727706909 ||| Demonstration of photographic equipment [for training purposes] ||| Units [furniture] for the display of literature ||| Démonstration d'équipements photographiques à des fins de formation
0.10320673882961273 ||| Azarga contains two active substances, brinzolamide and timolol. ||| Imprida contains two active substances, amlodipine and valsartan. ||| Azarga contient deux principes actifs, le brinzolamide et le timolol.
0.42465487122535706 ||| More recent studies showed that effects on the embryo were due to maternal toxicity and not to direct effects of the substance on the developing embryo. ||| Single mutations may not result in clinical resistance, but multiple mutations generally result in clinical resistance to many or all active substances within the class. ||| Des études plus récentes ont montré que les effets sur l’ embryon étaient dus à une toxicité chez la mère et non à des effets directs de la substance sur l’ embryon en développement.
0.27074143290519714 ||| Peripheral sensory neuropathy, headache, dysgeusia, dizziness, peripheral motor neuropathy, ataxia, sensory disturbance, somnolence. ||| Common: dysgeusia, headache Uncommon: somnolence, motor dysfunction, amnesia, memory impairment, dizziness, paraesthesia ||| Fréquent: neuropathie sensitive périphérique, céphalées, dysgueusie, vertiges, neuropathie motrice périphérique, ataxie, troubles sensoriels, somnolence.
0.03380240872502327 ||| Careful monitoring of therapeutic and adverse effects is recommended when tacrolimus is concomitantly administered with indinavir/ ritonavir. ||| Careful monitoring of therapeutic and adverse effects is recommended when ketoconazole is concomitantly administered with indinavir/ ritonavir. ||| En cas d'administration concomitante de tacrolimus et d'indinavir/ ritonavir, une surveillance attentive des effets thérapeutiques et indésirables est recommandée.
0.39270469546318054 ||| These derogations allow operators to self-organise and implement market measures at their level to stabilise their sector and in the respect of the functioning of the internal market for a maximum period of 6 months. ||| We may need to return to the Management Board and the EU budgetary authority during the course of 2002 once we have a better understanding of the workload implications of some of these additional tasks. ||| Ces dérogations permettent aux opérateurs d'auto-organiser et de mettre en œuvre des mesures de marché à leur niveau pour stabiliser leur secteur et en ce qui concerne le fonctionnement du marché intérieur pendant une période maximale de 6 mois.
0.012723205611109734 ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/. ||| Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu/ ||| Des informations détaillées sur ce médicament vétérinaire sont disponibles sur le site web de l’ Agence européenne des médicaments (EMEA) http: / /www. emea. europa. eu
0.23871618509292603 ||| At 12 months, the incidence was 1.5% and did not increase following 3 years treatment. ||| The increase was observed at 12 months, and did not significantly increase through 3 years. ||| Au bout de 12 mois, l’ incidence était de 1,5% et n’ a pas augmenté pendant les 3 années de traitement.
0.35621052980422974 ||| Moist wipes impregnated with a cosmetic lotion ||| Tissues impregnated with cosmetic lotions ||| Lingettes imprégnées de lotion cosmétique
0.25976690649986267 ||| Each carton contains 1 bottle of 30 film-coated tablets. ||| 19 Cartons containing one bottle with 60 film-coated tablets. ||| Chaque emballage contient 1flacon de 30 comprimés pelliculés.
0.0 ||| A switch to a suitable alternative treatment should be carried out in advance of a planned pregnancy. ||| A switch to a suitable alternative treatment should be carried out in advance of a planned pregnancy. ||| Un changement pour un traitement alternatif adapté devra être effectué avant d’ envisager une grossesse.
0.5478413105010986 ||| Read and follow the instructions that accompany the infusion pump. ||| The same cleaning instructions apply to the syringe. ||| Lisez et suivez les instructions qui accompagnent la pompe.
0.25853830575942993 ||| In the primary efficacy studies of general populations, 81% of patients reported that CIALIS improved their erections as compared to 35% with placebo. ||| However, in the two studies that enrolled patients with SIOW the efficacy of retapamulin in infections due to MRSA was inadequate (75.7%). ||| Dans les études sur la population générale où l’ efficacité était le critère principal, 81% des patients ont rapporté que CIALIS améliorait leurs érections par comparaison à 35% sous placebo.
0.4243215024471283 ||| Diarrhoea, vomiting, nausea ||| Common: diarrhoea, vomiting ||| Diarrhée, vomissements, nausées
0.5048642754554749 ||| Financial management software ||| Sales account management ||| Logiciel de gestion financière
0.8163931965827942 ||| S. A. ||| Malta V.J. ||| S.A.
0.4019462764263153 ||| Sigma-Tau Industrie Farmaceutiche Riunite S. p. A. - Viale Shakespeare 47, 00144 Rome Italy ||| Janssen-Cilag Pharmaceuticals Aebe Eirinis Avenue 56, Pefki, 15121, Greece ||| Sigma-Tau Industrie Farmaceutiche Riunite S. p. A. - Viale Shakespeare 47, 00144 Rome, Italie
0.16206736862659454 ||| Rental of equipment for medical purposes ||| Rental of cooking equipment for industrial purposes ||| Location d'équipements à usage médical
0.640432596206665 ||| Coffee spoons ||| Ice cream scoops ||| Cuillères à café
0.5945578813552856 ||| Adults (1,500 mg/ m2) N=103 (%) ||| Cmax (mg/ l) - 0.50 (32%), na ||| Adultes (1 500 mg/ m2) N = 103 (%)
0.2913614809513092 ||| 3 While no increased risk was observed in extensive clinical trials with alendronate, there have been rare (post-marketing) reports of gastric and duodenal ulcers, some of which were severe and with complications (see section 4.8). ||| * Hypertension, vomiting and diarrhoea are included in Table 2 because they were reported more frequently in these studies, which were of 3-year duration, compared to Table 1, which includes adverse reactions from studies of 12-week duration. ||| Bien qu’ aucune augmentation du risque n’ ait été observée au cours de larges études cliniques avec l’ alendronate, de rares cas d’ ulcères gastriques et duodénaux ont été rapportés depuis la commercialisation dont certains cas étaient sévères et s’ accompagnaient de complications (voir rubrique 4.8).
0.013083366677165031 ||| 6 Immune reactivation syndrome: in HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic infections may arise (see section 4.4). ||| Immune Reactivation Syndrome: in HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic infections may arise (see section 4.4). ||| Chez les patients infectés par le VIH et présentant un déficit immunitaire sévère au moment de l’ instauration du traitement par une association d’ antirétroviraux, une réaction inflammatoire à des infections opportunistes asymptomatiques ou résiduelles peut se produire (cf 4.4).
0.5313374400138855 ||| If you r blood sugar level falls too much you may become unconscious. ||| - you r blood sugar levels are almost normal or are unstable, ||| Si votre glycémie diminue trop, vous risquez de perdre connaissance.
0.23148588836193085 ||| Following an oral dose of radioactive simvastatin to man, 13% of the radioactivity was excreted in the urine and 60% in the faeces within 96 hours. ||| Elimination After a single oral dose of 100 mg/ kg body weight, 9% of the dose is excreted unchanged in the urine and up to 60% in the faeces. ||| Après une dose orale de simvastatine radioactive chez l’homme, 13% de la radioactivité sont éliminés dans les urines et 60% dans les selles dans les 96 heures.
0.0129092987626791 ||| Patients with pre-existing liver dysfunction, including chronic active hepatitis, can have an increased frequency of liver function abnormalities during combination antiretroviral therapy and should be monitored according to standard practice. ||| Patients with pre-existing liver dysfunction, including chronic active hepatitis have an increased frequency of liver function abnormalities during combination antiretroviral therapy, and should be monitored according to standard practice. ||| Les patients ayant des troubles préexistants de la fonction hépatique, incluant une hépatite chronique active, peuvent présenter une fréquence accrue des anomalies de la fonction hépatique au cours d’ un traitement par association d’ antirétroviraux et devront faire l’ objet d’ une surveillance appropriée.
0.7568559050559998 ||| The adapter will snap over the vial cap. ||| What period will the waiver cover? ||| L’ adaptateur s’ enclenchera sur le bouchon du flacon.
0.2852683663368225 ||| However, in patients with mild to moderate renal impairment (creatinine clearance ≥ 30 ml/ min but < 60 ml/ min) this fixed dose combination should be administered with caution. ||| The cumulative dose at which cardiotoxicity would become a concern for these AIDS-KS patients (> 400 mg/ m2) would require more than 20 courses of Caelyx therapy over 40 to 60 weeks. ||| Cependant, chez les patients ayant une insuffisance rénale légère à modérée (clairance de la créatinine ≥ 30 ml/ min mais < 60 ml/ min), cette association à dose fixe doit être administrée avec précaution.
0.28591740131378174 ||| Hydrogen sulphide ||| Ammonium sulphide ||| Sulfure d'hydrogène
0.38968175649642944 ||| Substitutes for unprocessed and semi-processed rubber ||| Unprocessed and semi-processed gutta-percha ||| Substituts de caoutchouc non transformés et semi-transformés
0.3159363269805908 ||| There are reports of patients who have taken the recommended dose for more than 5 days of treatment (up to 64 days) with adverse events reported including bone marrow suppression, with or without infection, in some cases severe and prolonged and resulting in death. ||| A small number of animals may show temporary local reactions, in the form of a mild, local swelling at the injection site post vaccination (maximum 1 cm in diameter), that resolve by themselves within 1 to 2 days. ||| Chez des patients ayant pris la dose recommandée pendant plus de 5 jours de traitement (jusqu’ à 64 jours) les effets indésirables incluaient une aplasie médullaire, avec ou sans infection, dans certains cas sévère et prolongée, pouvant entraîner un décès.
0.6782116889953613 ||| On 14 June 2017, he was appointed Taoiseach in a 57–50 vote with 47 abstentions. ||| The proposal was adopted with 689 votes in favour, 6 against and one abstention. ||| Le 14 juin 2017, Leo Varadkar est élu Premier ministre par 57 voix pour, 50 voix contre et 45 abstentions.
0.4225667119026184 ||| The company that makes Silapo will provide information packs for healthcare workers in all Member States, including information on the safety of the medicine. ||| The EuroPharm is intended to be a European database of information relating to all medicinal products on the market in the European Union. ||| La société qui produit Silapo fournira des dossiers d’ information aux professionnels de santé dans tous les États membres, incluant des informations sur la sécurité d’ emploi du médicament.
0.7644615769386292 ||| There is a strong alliance out there to beat this virus, together." ||| We share a continent and we can only succeed together." ||| Il existe une alliance solide pour combattre ce virus ensemble.
0.010101499035954475 ||| 186 4.4 Special warnings and precautions for use ||| 185 4.4 Special warnings and precautions for use ||| 4.4 Mises en garde spéciales et précautions d’ emploi
0.43829965591430664 ||| The full effect was seen 24 to 48 hours after the first dose, and was maintained between weekly doses. ||| 16 The median first onset of effect is observed within seven days after injection. ||| L'effet maximal était observé 24 à 48 h après la première dose et était maintenu entre les injections hebdomadaires.
0.30010175704956055 ||| Rue De L'Etuve 52 B-1000 Brussels Belgium ||| Rue De La Pastorale 16/ 28 B-1080 Brussels Belgium ||| Rue De L'Etuve 52 B-1000 Brussels Belgique
0.14502400159835815 ||| Why has TOVIAZ been approved? ||| Why has SOMAVERT been approved? ||| Pourquoi TOVIAZ a -t-il été approuvé?
0.05862460285425186 ||| Adverse drug reactions occurring in ≥ 3% of patients, and more frequently in patients on Tracleer (125 and 250 mg twice daily), in placebo-controlled trials in pulmonary arterial hypertension ||| Adverse drug reactions occurring in ≥ 3% of patients, and more frequently in patients on Tracleer (125 mg twice daily), in the placebo-controlled trials in digital ulcers ||| Effets indésirables survenus chez plus de 3% des patients et plus fréquemment chez les patients sous Tracleer (posologie de 125 mg et 250 mg deux fois par jour) au cours des essais contrôlés contre placebo menés dans l’ hypertension artérielle pulmonaire.
0.30705389380455017 ||| The spray apparatus should be free from sediments, corrosion and traces of disinfectants and ideally should be used for vaccination purposes only. ||| The presence of disinfectant and/ or antiseptic in water and material used for the preparation of vaccine solution is not compatible with an effective vaccination. ||| Le nébulisateur doit être exempt de sédiments, corrosion et de traces de désinfectant, et idéalement, devrait être réservé pour la vaccination.
6.451714162913902e-13 ||| No treatment-related malformations were seen in the rat. ||| No treatment-related malformations were seen in the rat. ||| Aucune malformation liée au traitement n’a été observée chez le rat. m ica
3.442932245724395e-13 ||| The overall incidence of adverse events tended to decrease as the study progressed for all patients independent of age. ||| The overall incidence of adverse events tended to decrease as the study progressed for all patients independent of age. ||| Chez tous les patients, l’ incidence globale des effets indésirables a eu tendance à diminuer au fur et à mesure de l’ avancement de l’ étude,
0.6899317502975464 ||| 40% 28% ||| 22 - 28% ||| 28%
0.4373352825641632 ||| Prepared coffee and coffee-based beverages ||| Tea-based beverages with fruit flavoring ||| Café préparé et boissons à base de café
0.2600630521774292 ||| Other immunosuppression treatments for cytokine storm include the modulation of T cell-directed immune response; the blockade of IFN-γ, IL-1, and TNF; JAK inhibition; blinatumomab; suppressor of cytokine signaling 4; and HDAC inhibitors. ||| Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of0.1-0.2 nM). ||| D’autres traitements immunosuppresseurs pour les chocs cytokiniques incluent la modulation de la réponse immunitaire par les cellules T, le blocage des cytokines IFN-γ, IL-1 et TNF, l’inhibition des JAK, le blinatumomab, le suppresseur de signalement des cytokines 4 et les inhibiteurs d’HDAC.
1.0934895277023315 ||| Operation of the Committee on Orphan Medicinal Products............... 31 Applications for orphan designation............................................................... ..32 ||| 137 --------------------------------------------------------------------------------------------------------------------------- (Perforation to allow health care provider information to be detached) ||| Fonctionnement du comité des médicaments orphelins..................... 31 Demandes de désignation de médicaments orphelins................................. ..32
0.06852078437805176 ||| Keep out of the reach and sight of children. i dic ||| Keep out of the reach and sight of children. na ici ||| Tenir hors de la portée et de la vue des enfants. mé
1.013800697037548e-12 ||| r ge LOT: lon 14. ||| r ge LOT: lon 14. ||| LOT: …………………… en
0.4354661703109741 ||| Provision of information relating to mortgages ||| Provision of finance for the purchase of vehicles ||| Services d'informations en matière d'hypothèques
0.07142557948827744 ||| Eli Lilly Nederland BV, Grootslag 1 – 5, NL-3991 RA, Houten, The Netherlands ||| Eli Lilly Nederland BV, Grootslag 1-5, NL-3991 RA Houten, The Netherlands. ||| Eli Lilly Nederland BV, Grootslag 1 – 5, NL-3991 RA, Houten, Pays-Bas.
0.060610219836235046 ||| MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 381 BLISTERED PRE-FILLED SYRINGE LABEL ||| th au MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS UNBLISTERED PRE-FILLED SYRINGE LABEL ||| 406 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES ETIQUETAGE DE LA SERINGUE PREREMPLIE CONDITIONNEE SOUS PLAQUETTE THERMOFORMEE
0.011444165371358395 ||| Such reactions may especially be seen if the preparation is applied repeatedly, or administered to patients known to be hypersensitive to constituents of the product. ||| Such reactions may especially be seen, if the preparation is applied repeatedly, or administered to patients known to be hypersensitive to constituents of the product. ||| Ces réactions peuvent être observées surtout si la préparation est appliquée de façon répétée ou administrée à des patients dont l'hypersensibilité aux composants du produit est connue.
0.9038345813751221 ||| We also know that our greatest strength is the internal market. ||| We are far from sharing a common denominator with our British friends. ||| Nous le savons tous, notre force toute particulière, c'est le marché intérieur.
0.24496325850486755 ||| Other information about Enbrel: ||| Other information about Ceplene: ||| Autres informations relatives à Enbrel:
0.007140356115996838 ||| Co-administration of aliskiren with either valsartan (↓ 28%), metformin (↓ 28%), amlodipine (↑ 29%) or cimetidine (↑ 19%) resulted in between 20% and 30% change in Cmax or AUC of Sprimeo. ||| Co-administration of aliskiren with either valsartan (↓ 28%), metformin (↓ 28%), amlodipine (↑ 29%) or cimetidine (↑ 19%) resulted in between 20% and 30% change in Cmax or AUC of Riprazo. ||| L’ administration concomitante d’ aliskiren avec le valsartan (↓ 28%), la metformine (↓ 28%), l’ amlodipine (↑ 29%) ou la cimétidine (↑ 19%) a conduit à des modifications de la Cmax ou de l’ ASC (Aire Sous la Courbe) de Sprimeo entre 20% et 30%.
0.38348710536956787 ||| Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. ||| This deletion allows to differentiate vaccinated animals from infected animals allowing a better management of the disease. ||| La vaccination des animaux est utilisée à la fois pour prévenir certaines de leurs maladies infectieuses et pour prévenir la transmission de maladies aux humains.
0.3167073726654053 ||| If you experience sudden decrease or loss of vision, stop taking Tadalafil Lilly and contact your doctor immediately. ||| If you are suffering from angina (reduced blood flow to the heart muscle), please consult your doctor before using Firazyr. ||| En cas de diminution ou de perte soudaine de la vision, vous devez arrêter votre traitement par Tadalafil Lilly et contacter immédiatement votre médecin.
0.0656910240650177 ||| 464 C. ||| 772 C. ||| C.
0.27436044812202454 ||| The wording proposed by the MAH in the SPC was acceptable to the CHMP and the following wording was adopted: “ In patients with mild to moderate hepatic impairment without cholestasis the dose of valsartan should not exceed 80 mg (see section 4.4) .” ||| The MAH did not agree with the PhVWP/ CMD(h) agreed SPC wording for all antidepressants for Section 4.8, since suicidal ideation is not considered an adverse reaction in adult patients, but agreed to comply with the mandated class labelling. ||| La formulation proposée par le titulaire de l’ autorisation de mise sur le marché dans le RCP a été jugée acceptable par le CHMP et la formulation suivante a donc été adoptée: « Chez les patients souffrant d’ insuffisance hépatique légère à modérée, sans cholestase, la dose de valsartan ne doit pas dépasser 80 mg (voir section 4.4). ».
0.49740153551101685 ||| Propylene glycol methyl ether ||| - polyethylene glycol 3350 ||| Méthyl éther de propylène glycol.
0.3013068437576294 ||| Paediatric patients Vimpat is not recommended for use in children and adolescents below the age of 16 as there is no data on safety and efficacy in these age groups. ||| A French compassionate use program included children from 6 months of age because the diagnosis of Dravet’ s syndrome may be made with confidence at that age in some patients. ||| Utilisation chez l’ enfant Vimpat n’ est pas recommandé chez l’ enfant et l’ adolescent âgé de moins de 16 ans, car aucune donnée de tolérance et d’ efficacité n’ est disponible dans ces tranches d’ âge.
0.2554702162742615 ||| Rare side effects are experienced in less than 1 per 1,000 patients but in at least 1 per 10,000 patients. ||| Uncommon side effects (may occur in more than 1 in 1,000 patients but less that 1 in 100 patients) ||| Les effets indésirables rares sont observés chez moins de 1 patient sur 1 000, mais au moins 1 patient sur 10 000.
0.0 ||| 6. ||| 6. ||| 15 6.
0.09378889203071594 ||| au Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd am
0.37535595893859863 ||| In embryofoetal development studies, dasatinib likewise induced embryolethality with associated decreases in litter size in rats, as well as foetal skeletal alterations in both rats and rabbits. ||| There were no adverse effects observed in offspring from pregnant rats given pegfilgrastim subcutaneously, but in rabbits pegfilgrastim has been shown to cause embryo/ foetal toxicity (embryo al ||| Dans les études de développement embryo-foetal, dasatinib a également induit chez le rat une létalité embryonnaire associée à une diminution de la taille des portées, ainsi qu 'une altération du squelette fœ tal chez le rat et le lapin.
0.13030463457107544 ||| th Via San Martino 12 I-20122 Milan ||| Via San Martino 12 I-20122 Milan Italy ||| Via San Martino 12
0.414334774017334 ||| 100 IU (International Units) of the active substance insulin human. ||| - The active substance is lutropin alfa 75 IU (International Units). ||| Un ml d’Insulin Human Winthrop Comb 15 contient 100 UI (Unités Internationales) de la substance active insuline humaine.
0.0 ||| Metabolism and nutrition disorders Very common: ||| Metabolism and nutrition disorders Very common: ||| 91 Troubles du métabolisme et de la nutrition Très fréquent:
0.0 ||| Distribution No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed. ||| Distribution No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed. ||| 34 Distribution Aucune forte liaison aux protéines plasmatiques, à l’ exception d’ éventuels anticorps anti-insuline présents dans la circulation, n’ a été observée.
0.33269354701042175 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The Dutch guarantee scheme will help ensure that trade credit insurance remains available to all companies to secure their commercial exchanges. ||| Welcoming the toolbox, Commissioner for Internal Market Thierry Breton said: "Contact tracing apps to limit the spread of coronavirus can be useful, especially as part of Member States' exit strategies. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Le régime de garantie néerlandais contribuera à faire en sorte que toutes les entreprises puissent continuer à bénéficier de l'assurance-crédit afin de préserver leurs échanges commerciaux.
0.4012477993965149 ||| What Zalasta contains ||| What Pradaxa contains ||| Que contient ZALASTA
0.0494198240339756 ||| In case of accidental injection, seek prompt medical advice and show the Package Leaflet to the doctor. ||| If accidental injection happens, seek prompt medical advice and show the Package Leaflet to the doctor. ||| En cas d’ injection accidentelle, demander immédiatement conseil à un médecin et lui montrer la notice.
0.0015770324971526861 ||| 108 if you suffer from liver problems if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure). ||| 87 if you suffer from liver problems if you suffer from diabetes if you suffer from lupus erythematosus (also known as lupus or SLE) if you suffer from primary aldosteronism (a condition related to high production of the hormone aldosterone, which causes sodium retention and, in turn, an increase in blood pressure). ||| 116 Faites attention avec CoAprovel Prévenez votre médecin si une des situations suivantes se présentent: si vous souffrez de vomissements ou de diarrhées importantes si vous souffrez de problèmes rénaux, y compris si vous avez eu une transplantation rénale si vous souffrez de problèmes cardiaques si vous souffrez de problèmes hépatiques si vous souffrez d'un diabète si vous souffrez d'un lupus érythémateux (connu aussi sous le nom de lupus ou LED) si vous souffrez d’ hyperaldosteronisme primaire (une condition liée à une forte production de l’ hormone aldostérone, qui provoque une rétention du sodium et par conséquence une augmentation de la pression artérielle).
0.30357271432876587 ||| Dicural 50 mg Coated tablets for dogs ||| Clomicalm 20 mg tablets for dogs ||| Dicural 50 mg comprimés enrobés pour chiens
0.4559367895126343 ||| Pregnancy No clinical data are available on the use of Cholestagel in pregnant women. ||| Paediatric Population There are no data on the use of Bonviva in these age groups. ||| Grossesse Aucune donnée clinique n’ est disponible sur l’ emploi de Cholestagel chez la femme enceinte.
0.30136096477508545 ||| The transition regimen involves escalating the dose of lamotrigine to a maintenance stabilisation dose over six weeks (Table 3) after which other psychotropic medicinal products and/ or AEDs can be withdrawn, if clinically indicated (Table 4). ||| It considered the risk-benefit balance of terfenadine 6 mg/ ml oral suspension formulations acceptable and that the Marketing Authorisations should be maintained provided that the SPC is amended as stated in Annex I. ||| Le schéma de transition implique une augmentation posologique de la lamotrigine jusqu’ à une posologie d’ entretien à stabilisation sur six semaines (Tableau 3) après lesquelles les autres médicaments psychotropes et/ ou AEs peuvent être arrêtés, si cela est indiqué cliniquement (Tableau 4).
0.5042608976364136 ||| 7 Safety in patients with decompensated disease: ||| • Patients suffering from acute coronary syndrome: ||| Tolérance chez les patients atteints d’ une maladie décompensée:
0.2591380774974823 ||| Polyol for use in industry ||| Lipids for use in industry ||| Polyol destiné à l'industrie
0.2546505331993103 ||| These crystals can cause sudden, severe pain, redness, warmth and swelling in a joint (known as a gout attack). ||| The bacteria release a toxin (poison), which can cause muscle stiffness, painful muscle spasms, fits and even death. ||| Ces cristaux peuvent provoquer des douleurs intenses subites, une rougeur, une chaleur et un gonflement d’ une articulation (crise de goutte).
0.3499331772327423 ||| Construction of house extensions ||| Construction of sports arenas ||| Construction d'extensions de maison
0.22366899251937866 ||| You should not take FOSAVANCE if you are or think you may be pregnant, or if you are breast-feeding. ||| You should not use ADENURIC if you are breast feeding, or if you are planning to breastfeed. ||| Vous ne devez pas prendre FOSAVANCE si vous pensez être ou êtes enceinte, ou si vous allaitez.
0.37949132919311523 ||| • The M184V/ I mutation developed in 2/ 19 (10.5%) isolates analysed from patients in the efavirenz + emtricitabine + tenofovir disoproxil fumarate group and in 10/ 29 (34.5%) isolates analysed from the efavirenz + lamivudine/ zidovudine group (p-value < 0.05, Fisher’ s Exact test comparing the emtricitabine + tenofovir disoproxil fumarate group to the lamivudine/ zidovudine group among all subjects). • No virus analysed contained the K65R mutation. • Genotypic resistance to efavirenz, predominantly the K103N mutation, developed in virus from 13/ 19 (68%) patients in the efavirenz + emtricitabine + tenofovir disoproxil fumarate group and in virus from 21/ 29 (72%) patients in the efavirenz + lamivudine/ zidovudine group. ||| Study 0110 [WBC < 10 x 109/ l, platelets < 450 x 109/ l, myelocyte+metamyelocyte < 5% in blood, no blasts and promyelocytes in blood, basophils < 20%, no extramedullary involvement] and in studies 0102 and 0109 [ANC ≥ 1.5 x 109/ l, platelets ≥ 100 x 109/ l, no blood blasts, BM blasts < 5% and no extramedullary disease] NEL Same criteria as for CHR but ANC ≥ 1 x 109/ l and platelets ≥ 20 x 109/ l (0102 and 0109 only) RTC < 15% blasts BM and PB, < 30% blasts+promyelocytes in BM and PB, < 20% basophils in PB, no extramedullary disease other than spleen and liver (only for 0102 and 0109). ||| • La mutation M184V/ I est survenue pour 2 isolats sur 19 (10,5%) analysés, provenant de patients du groupe éfavirenz+emtricitabine+fumarate de ténofovir disoproxil, et pour 10 isolats sur 29 (34,5%) analysés provenant du groupe éfavirenz+lamivudine/ zidovudine (p < 0,05, test exact de Fisher comparant le groupe emtricitabine+fumarate de ténofovir disoproxil au groupe lamivudine/ zidovudine parmi tous les patients). • Aucun des virus analysés ne contenait la mutation K65R. • Une résistance génotypique à l’ éfavirenz, avec de façon prédominante la mutation K103N, s’ est développée pour les virus de 13 patients sur 19 (68%) du groupe
0.36617785692214966 ||| vial (glass) ||| syringe (glass) ||| Voie intraveineuse Flacon (verre)
0.36902210116386414 ||| To ensure the recovery is sustainable, even, inclusive and fair for all Member States, the Commission is proposing to create a new recovery instrument, Next Generation EU, embedded within a powerful, modern and revamped long-term EU budget. ||| The EU strategies for energy system integration and hydrogen, adopted today, will pave the way towards a more efficient and interconnected energy sector, driven by the twin goals of a cleaner planet and a stronger economy. ||| Pour faire en sorte que la reprise soit durable, homogène, inclusive et équitable pour tous les États membres, la Commission propose de créer un nouvel instrument pour la relance, Next Generation EU , qui s'inscrit dans un budget à long terme puissant, moderne et révisé pour l'Union.
0.7002389430999756 ||| - Eosinophilia ||| European Pharmacopoeia ||| - Eosinophilie
0.2542329728603363 ||| Myelosuppression was generally reversible and usually managed by withholding Tasigna temporarily or dose reduction (see section 4.2). ||| 61 reversible and usually managed by withholding dasatinib temporarily or by dose reduction (see sections 4.2 and 4.8). ||| En général, l’ aplasie médullaire a été réversible et elle a pu être traitée par une interruption temporaire du traitement par Tasigna ou en diminuant la posologie (voir rubrique 4.2).
0.48018747568130493 ||| Pneumatic controls for motors ||| Microorganisms for pond maintenance ||| Commandes pneumatiques pour moteurs
0.7353883981704712 ||| Hiring of flowers ||| Providing of education ||| Location de fleurs
0.3596898317337036 ||| There are currently limited data on the safety and efficacy of clofarabine when administered for more than 3 treatment cycles. ||| Animal studies of up to 13-week duration have been conducted with the combined substances in Eucreas. ||| Les données actuellement disponibles concernant la sécurité et l’ efficacité de la clofarabine administrée pendant plus de 3 cycles de traitement sont limitées.
0.45512986183166504 ||| Contains lactose monohydrate. ||| Contains, among others, Lactose monohydrate ||| Contient du lactose.
0.3026413917541504 ||| Lacosamide should not be used during pregnancy unless clearly necessary (if the benefit to the mother clearly outweighs the potential risk to the foetus). ||| Zonegran must not be used during pregnancy unless clearly necessary, in the opinion of the physician, and only if the potential benefit is considered to justify the risk to the foetus. ||| Le lacosamide ne doit pas être utilisé au cours de la grossesse, sauf en cas de nécessité manifeste (c’ est-à-dire lorsque le bénéfice pour la mère prévaut clairement sur le risque potentiel pour le fœ tus).
0.41159284114837646 ||| Distribution Darifenacin is a lipophilic base and is 98% bound to plasma proteins (primarily to alpha-1-acid- glycoprotein). ||| The strength indicates the quantity of the protein moiety of the methoxy polyethylene glycol-epoetin beta molecule without consideration of the glycosylation. ||| Distribution La darifénacine est lipophile et est à 98% liée aux protéines plasmatiques (principalement l’ alpha-1- acide-glycoprotéine).
0.0 ||| 6.6 Instructions for use and handling ||| 6.6 Instructions for use and handling ||| 6.6 Instructions pour l’ utilisation et l’ élimination
0.25511202216148376 ||| 1.6 ± 0.8 ||| 3.7 ± 2.6 ||| 1,6 ± 0,8
0.4104335606098175 ||| 31/ 64 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS Dicural 15 mg coated tablets Blister label ||| 17 PARTICULARS TO APPEAR ON OUTER PACKAGING Outer carton 1.0 ml vial ||| 32/ 67 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES Dicural 15 mg comprimés enrobés Etiquette de blister
0.14939521253108978 ||| How does Doribax work? ||| How does Livensa work? ||| Comment Doribax agit -il?
0.014814784750342369 ||| 79 PACKAGE LEAFLET: ||| 71 PACKAGE LEAFLET: ||| 83 NOTICE:
0.18053287267684937 ||| Headache Somnolence, dizziness, dysgeusia Tremor, coordination abnormal, dysarthria, hypertonia, restlessness, dysphoria, hypoaesthesia, hypogeusia, lethargy, libido increased, libido decreased ||| syncope, convulsion, lethargy, paraesthesia, hypoaesthesia, ageusia, dysgeusia, disturbance in attention, memory impairment, somnolence, sleep phase rhythm disturbance ||| Céphalées Somnolence, sensations vertigineuses, dysgueusie Tremblements, anomalie de la coordination, dysarthrie, hypertonie, agitation, dysphorie, hypoesthésie, hypogueusie, léthargie, augmentation de la libido, diminution de la libido
0.2820740044116974 ||| The observed incidence of hypoglycaemia in patients treated with Januvia was similar to placebo. ||| In clinical trials of aripiprazole, the incidence of QT prolongation was comparable to placebo. ||| Chez les patients traités par Januvia, l'incidence des hypoglycémies observées était similaire à celle observée sous placebo.
0.32586434483528137 ||| Raloxifene is metabolised primarily in the liver. ||| Telithromycin is widely distributed throughout the body. ||| Le raloxifène est principalement métabolisé par le foie.
0.3843863904476166 ||| 29.8% 36.4% ||| 29.5% 24.0% ||| 29,8% 36,4%
0.09883403033018112 ||| Marketing Authorisation Holder Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ United Kingdom ||| Marketing authorisation holder Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom. ||| Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ United Kingdom
0.4948170483112335 ||| If you need to inject a mixture, draw the other insulin into the injection syringe before Insulin Human Winthrop Basal. ||| In this case you must change the Insulin Release Unit (IRU) prior to your next inhalation. od ||| Si vous devez vous injecter un mélange, prélever d'abord l'autre insuline dans la seringue d’injection avant Insulin Human Winthrop Basal.
0.22982773184776306 ||| Advisory services relating to medical services ||| Consulting services relating to health care ||| Services de conseils concernant les services médicaux
0.44866982102394104 ||| Dilutional hyponatraemia may occur. ||| Potentiation of orthostatic hypotension may occur. ||| Une hyponatrémie de dilution peut survenir.
0.03352513164281845 ||| Aprovel belongs to a group of medicines known as angiotensin-II receptor antagonists. ||| Losartan belongs to a group of medicines known as angiotensin-II receptor antagonists. ||| Aprovel appartient à un groupe de médicaments connus sous le nom d’ antagonistes des récepteurs de l'angiotensine-II.
0.5756139755249023 ||| Urticaria, itching, rash ||| Bronchitis, cough, wheezing ||| Hépatite, ictère
0.4233774244785309 ||| Caution should be exercised in considering treatment of patients with increased risk for malignancy due to heavy smoking. ||| Bleeding risk should be taken into account when considering the risk benefit for individual patients. ||| Des précautions doivent être prises chez les patients présentant un risque accru de tumeurs du fait d’ un tabagisme important.
0.4270511865615845 ||| Interaction with zalcitabine is unlikely due to different routes of metabolism and excretion. ||| Vigabatrin has been effective in both simple and complex partial seizures and in the control of secondary generalization. ||| - Aucune étude d’interaction pharmacocinétique n’a été conduite.Une interaction avec la zalcitabine est peu probable car ce médicament a des voies de métabolisme et d’excrétion différentes.
0.1717037707567215 ||| Actraphane 30 vial 40 IU/ ml ||| Actrapid vial 100 IU/ ml ||| Actraphane 30 flacon 40 UI/ ml
0.3345523178577423 ||| A higher proportion of patients receiving the original rituximab/ MTX treatment also had no erosive progression over 56 weeks (Table 8). ||| The majority of experience including the pivotal phase III clinical trials with palivizumab has been gained with 5 injections during one season (see section 5.1). ||| Le pourcentage de patients sans progression radiographique après 56 semaines a été également significativement plus élevé dans le groupe de patients traités à l’ origine par rituximab/ MTX (Tableau8).
0.281814843416214 ||| Nervous system disorders Very rare: ||| er Nervous system disorders Common: ||| Affections du système nerveux
4.3546080370077123e-13 ||| Therefore the bleeding time should be monitored. • glibenclamide (used to treat diabetes). ||| Therefore the bleeding time should be monitored. • glibenclamide (used to treat diabetes). ||| Par conséquent, le temps de saignement doit être surveillé. • glibenclamide (pour le traitement du diabète).
0.24368919432163239 ||| 237 II. ||| 241 IV. ||| II.
3.682399166409639e-13 ||| Uncommon - Oedema Oedema may occur upon initiation of insulin therapy. ||| Uncommon - Oedema Oedema may occur upon initiation of insulin therapy. ||| Peu fréquent - Œ dème Un œ dème peut survenir au début de l 'insulinothérapie.
0.7994958162307739 ||| 32.4 (280/864) ||| (2,530-30,327) ||| 32,4 (280/ 864)
0.4407026767730713 ||| Finance services ||| Medical service ||| Services financiers
5.598767977010866e-13 ||| 47 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 47 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 47 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.07616491615772247 ||| Adults and adolescents (12 years of age and over): one dose of Azomyr oral lyophilisate placed in the mouth once a day for the relief of symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria (see section 5.1). ||| Children 6 to 11 years of age: one 2.5 mg Aerius orodispersible tablet placed in mouth once a day for the relief of symptoms associated with allergic rhinitis (including intermittent and persistent allergic rhinitis) and urticaria (see section 5.1). ||| Adultes et adolescents (12 ans et plus): une dose d’ Azomyr lyophilisat oral une fois par jour à laisser fondre dans la bouche pour le soulagement des symptômes associés à la rhinite allergique (incluant les rhinites allergiques intermittente et persistante) et à l’ urticaire (voir rubrique 5.1).
0.39309293031692505 ||| The mechanism of this interaction is unknown. ||| The safety of this combination has not been established. ||| Le mécanisme de cette interaction n’ est pas connu.
0.017896048724651337 ||| Liprolog Mix25 consists of 25% insulin lispro solution and 75% insulin lispro protamine suspension. ||| Liprolog Mix50 consists of 50% insulin lispro solution and 50% insulin lispro protamine suspension. ||| Liprolog Mix25 contient 25% d'insuline lispro en solution et 75% d'insuline lispro protamine en suspension.
0.44734734296798706 ||| Imiquimod has no direct antiviral activity. ||| Telbivudine was not active against HIV in vitro. ||| L'imiquimod n’a pas d'activité antivirale directe.
0.16003943979740143 ||| A diffuse hard or soft swelling (max. diameter 5 cm) may occur at the injection site, regressing within 2 days. ||| Swelling (max. diameter 5 cm) may occur at the injection site, either as a diffuse hard or soft swelling. ||| Un œ dème induré ou souple (diamètre maximum de 5 cm) peut survenir au point d’ injection, régressant dans les 2 jours.
0.5866299867630005 ||| On the same day, 215 Canadians (176 from the first plane, and 39 from a second plane chartered by the U.S. government) were evacuated from Wuhan to CFB Trenton to be quarantined for two weeks. ||| On 12 March, Taoiseach Leo Varadkar—speaking from Washington, D.C. where he was meeting U.S. President Donald Trump—announced the closure of all schools, colleges and childcare facilities across Ireland until at least 29 March. ||| Le même jour, 215 Canadiens (176 dans un premier avion et 39 dans un deuxième avion affrété par le gouvernement américain) ont été évacués de Wuhan vers la BFC Trenton afin d’être mis en quarantaine pendant deux semaines.
0.20083048939704895 ||| In a 6-month study of 599 patients with hypertension, type 2 diabetes mellitus and nephropathy, all of whom were receiving losartan 100 mg and optimised antihypertensive background therapy, addition of aliskiren 300 mg achieved a 20% reduction versus placebo in urinary albumin: creatinine ratio (UACR), i. e. from 58 mg/ mmol to 46 mg/ mmol. ||| A clinical trial in a single intensive care unit treating hyperglycaemia (blood glucose above 10 mmol/ l) in 204 diabetic and 1344 non-diabetic patients undergoing major surgery showed that normoglycaemia (blood glucose 4.4 – 6.1 mmol/ l) induced by intravenous Actrapid reduced mortality by 42% (8% versus 4.6%). ||| Dans une étude de 6 mois chez 599 patients hypertendus, diabétiques de type 2 et présentant une néphropathie, tous traités par 100 mg de losartan et un traitement antihypertenseur de fond optimisé, l’ ajout de 300 mg d’ aliskiren a permis une diminution de 20% versus placebo du rapport albumine/ créatinine urinaire (RAC urinaire), c'est-à-dire de 58 mg/ mmol à 46 mg/ mmol.
0.9867357015609741 ||| Rash, urticaria ||| Aquaria and vivaria ||| Rash, urticaire
0.3736150860786438 ||| If you receive prophylactic administration of protein C, higher trough levels may be warranted in situations of an increased risk of thrombosis (such as infection, trauma, or surgical intervention). ||| In hospitals, MRSA may be introduced in blood or other tissue in the body on several occasions during care, especially when performing invasive procedures such as surgery, injection, ventilation. ||| Si vous êtes traité en prophylaxie par la protéine C, des taux plus élevés peuvent être nécessaires dans les cas de risques importants de thromboses (tels qu’ infection, traumatisme ou intervention chirurgicale).
0.5442426204681396 ||| Computer programs and software for image processing used for mobile phones ||| Electronic and magnetic ID cards for use in connection with payment for services ||| Programmes et logiciels informatiques de traitement d'images pour téléphones portables
0.45022061467170715 ||| Viraferon is usually intended for subcutaneous use. ||| Cross-sensitivity to other hirudin products is possible. ||| Viraferon est habituellement destiné à la voie sous-cutanée.
0.6407860517501831 ||| Effects of other medicinal products on simvastatin ||| 12 Effect on gastric acid secretion: ||| Effets d’autres médicaments sur la simvastatine
0.37036603689193726 ||| Dosage Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will determine how much Apidra you will need. ||| NeoRecormon dosing The dose of NeoRecormon depends on your dise ase condition, the way the injection is given (under the skin) and your body weight. ||| Posologie En fonction de votre mode de vie et de vos analyses de taux de sucre dans votre sang (glucose) et de votre précédente utilisation d’insuline, votre médecin déterminera la dose d’Apidra nécessaire.
1.094367504119873 ||| ProMeris Duo Spot-on for Extra Large Dogs ||| ProMeris for Small Cats ProMeris for Large Cats ||| ProMeris Duo de grande taille ProMeris Duo de très grande taille
0.01838446967303753 ||| Its receipt, storage, use, transfer and disposal are subject to the regulations and/ or appropriate licenses of the local competent official organisations. ||| Its receipt, storage, use, transfer, and disposal are subject to the regulations and/ or appropriate licences of the local competent official organisations. ||| La réception, le stockage, l’ utilisation, le transfert et l’ élimination sont soumis aux réglementations en vigueur et/ ou aux autorisations appropriées des organismes officiels locaux compétents.
0.29207849502563477 ||| In accordance with current clinical practice, if pregabalin has to be discontinued it is recommended this should be done gradually over a minimum of 1 week independent of the indication (see section 4.8). ||| Since no preservative is present, it is recommended that the administration of the solution for infusion is to be started as soon as possible and within 3 hours of reconstitution and dilution. ||| Conformément aux pratiques cliniques actuelles, si le traitement par la prégabaline doit être interrompu, il est recommandé de le faire progressivement sur une période minimale d’ 1 semaine quelle que soit l'indication (voir 4.8).
0.28442129492759705 ||| Österreich Roche Austria GmbH Tel: +43 (0) 1 27739 ||| România Hospira UK Limited Tel: + 44 (0) 1926 820820 ||| Roche Austria GmbH Tel: +43 (0) 1 27739
0.011643964797258377 ||| 27/ 48 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 23/ 31 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 28/ 49 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.2703621983528137 ||| The use of AVANDAMET in combination with a sulphonylurea or insulin may be associated with increased risks of fluid retention and heart failure (see section 4.8). ||| In addition, dry mouth could have a damaging effect on teeth and mucous membranes of the mouth during long-term treatment with the combination of Rebetol and interferon alfa-2b. ||| L’ utilisation d’ AVANDAMET en association avec un sulfamide hypoglycémiant ou de l’ insuline peut être associée à une augmentation du risque de rétention hydrique et d’ insuffisance cardiaque (voir rubrique 4.8).
3.3890427898926323e-13 ||| Your doctor will normally advise you to stop taking Exforge as soon as you know you are pregnant. ||| Your doctor will normally advise you to stop taking Exforge as soon as you know you are pregnant. ||| 80 Votre médecin vous recommandera normalement d’ arrêter Exforge dès que vous savez que vous êtes enceinte.
0.28925347328186035 ||| Adverse reactions that have been reported including information on frequency are listed in the table below. ||| Adverse drug reactions are listed in the table below with information presented by system organ class and frequency. ||| Les effets indésirables rapportés, avec leur fréquence, sont cités dans le tableau ci-après.
0.0 ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE ||| PRECAUTIONS PARTICULIERES POUR L’ ELIMINATION DES MEDICAMENTS NON UTILISES OU DES DECHETS PROVENANT DE CES MEDICAMENTS S’ IL Y A LIEU
0.19644838571548462 ||| 73 16. ||| 57 16. ||| 16.
0.0 ||| The benefit- risk balance may be found in module 6 of this EPAR. ||| The benefit- risk balance may be found in module 6 of this EPAR. ||| Le rapport bénéfice/ risque est présenté au module 6 de cet EPAR.
0.19085922837257385 ||| What is the risk associated with Noxafil? ||| What is the risk associated with Virbagen Omega? ||| Quels est le risque associé à Noxafil?
0.1797141581773758 ||| What is TachoSil used for? ||| What is RotaTeq used for? ||| Dans quel cas TachoSil est -il utilisé?
0.01570119708776474 ||| Paediatric patients (below 18 years) Riprazo is not recommended for use in children and adolescents below age 18 due to a lack of data on safety and efficacy (see section 5.2). ||| Paediatric patients (below 18 years) Tekturna is not recommended for use in children and adolescents below age 18 due to a lack of data on safety and efficacy (see section 5.2). ||| Enfants et adolescents (moins de 18 ans) Riprazo ne doit pas être utilisé chez l’ enfant et les adolescents en dessous de 18 ans compte tenu de l’ absence de données concernant la sécurité et l’ efficacité (voir rubrique 5.2).
0.9373596906661987 ||| Concentrate for solution for infusion Concentrate for solution for infusion ||| For use as excipient For use as excipient ||| Solution à diluer pour perfusion Solution à diluer pour perfusion
0.4742884635925293 ||| The Commission is co-financing the delivery of more than 25 tonnes of personal protective equipment to China after the EU Civil Protection Mechanism was activated. ||| In its third year of co-operation with the Translation Centre in Luxembourg, the EMEA had 5 770 pages translated for a total of 220 documents. ||| La Commission cofinance la livraison de plus de 25 tonnes d'équipements de protection individuelle à la Chine après le déclenchement du mécanisme de protection civile de l'UE.
0.19618533551692963 ||| Abseamed is given by injection under the skin (subcutaneously). ||| Actrapid is for injection under the skin (subcutaneously). ||| Abseamed est administré par injection sous la peau (par voie sous-cutanée).
0.32144731283187866 ||| The solution is clear and colourless to light yellowish. ||| The solution will be clear or slightly opalescent and colourless. ||| La solution est transparente et incolore à légèrement jaunâtre.
0.39917704463005066 ||| Competact should be discontinued if any deterioration in cardiac status occurs. ||| Under no circumstance should this vaccine be administered by injection. ||| Competact doit être arrêté en cas de dégradation de l’ état cardiaque
0.0 ||| 4. ||| 4. ||| 331 4.
0.30131402611732483 ||| The studies looked at the levels of antibodies against O. rhinotracheale in the vaccinated breeders at four weeks after the second injection of the vaccine (22 weeks of age), and again at the end of the laying period (58 weeks of age). ||| In subjects aged 12-15 years at the time of primary vaccination, anti-HAV and anti-HBs antibodies have been shown to persist for at least 24 months following the initiation of a 0, 6 month schedule of Ambirix. ||| Les études examinaient les taux d’ anticorps dirigés contre O. rhinotracheale chez les poules pondeuses vaccinées quatre semaines après la seconde injection de vaccin (22 semaines d’ âge), puis de nouveau à la fin de la période de ponte (58 semaines d’ âge).
0.34645575284957886 ||| 166 In case of insufficient glucose control or a tendency to hyper- or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites and proper injection technique and all other relevant factors must be reviewed before dose adjustment is considered. ||| When an unusual cluster of illness is noted, infection control teams undertake an investigation to determine whether there is a true disease outbreak, a pseudo-outbreak (a result of contamination within the diagnostic testing process), or just random fluctuation in the frequency of illness. ||| Si l'équilibre glycémique n'est pas optimal ou si le patient a tendance à présenter des épisodes hyperglycémiques ou hypoglycémiques, il faut d'abord vérifier le respect par le patient du traitement prescrit, les sites et les techniques d'injection et l'ensemble des autres facteurs susceptibles d'augmenter la tendance à l'hyper- ou l'hypoglycémie, avant d'envisager l'ajustement de la dose d'insuline.
0.02602946013212204 ||| If this applies to you then your vaccination will usually be postponed until you are feeling better. ||| If this applies to you then your vaccination will be postponed until you are feeling better. ||| Le cas échéant, votre vaccination devra normalement être différée jusqu'à ce que votre état s'améliore.
0.04266563802957535 ||| Always take Rasilez exactly as your doctor has told you. ||| Always take Zonegran exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.2584388852119446 ||| For detailed recommendations on the reconstitution and administration of the medicinal product see section 6.6. ||| For instructions on reconstitution of the product before administration, see section 6.6. ||| Voir les recommandations détaillées sur la reconstitution et l’ administration du médicament dans la rubrique 6.6.
0.30388063192367554 ||| 8 Laronidase is a protein and is expected to be metabolically degraded through peptide hydrolysis. ||| Dexmedetomidine has a high clearance and its elimination depends on the hepatic blood flow. ||| La laronidase est une protéine pour laquelle est attendu un métabolisme par hydrolyse peptidique.
0.37772563099861145 ||| These data confirmed that the benefit of Xigris is limited to the more severely affected sepsis patients such as patients with multiple organ failure and shock. ||| Doctors must be aware that a very small number of patients using the medicine have developed cancer ng (skin cancer, lymphoma). ||| Ces données confirment que le bénéfice de Xigris est limité aux patients avec sepsis qui sont les plus gravement atteints, comme les patients avec plusieurs défaillances d'organes et un choc.
0.597590446472168 ||| [-12.8%; - P=0.0006 3.7%] P=0.11 ||| < 0.001 72.4% < 0.001 -61.8 ||| -8,2% [-12,8%; -3,7%]
0.3126203417778015 ||| Elevations in ALT values > 5 ULN were 4% (36/ 887) for sitaxentan 100 mg QD and 0.6% in the placebo group (1/ 155). ||| Xeloda was at least equivalent to IV 5-FU/ LV in disease-free survival in per protocol population (hazard ratio 0.92; 95% CI 0.80- 1.06). ||| L’ élévation du taux d’ ALAT > 5 LSN était de 4% (36/ 887) dans le groupe traité par sitaxentan 100 mg une fois/ jour et de 0,6% dans le groupe sous placebo (1/ 155).
0.2905120253562927 ||| The oral administration of difloxacin at up to 5 times the recommended dose rate for 30 days did not result in any adverse reactions. ||| Vardenafil dose should not exceed a maximum of 2.5 mg in a 72-hour period when given with a boosted protease inhibitor. ||| Chez les chiens, l’ administration orale de difloxacine jusqu’ à 5 fois la dose recommandée pendant 30 jours n’ a provoqué aucun effet indésirable.
0.4117380976676941 ||| Preparing the Enbrel dose for injection d. ||| Preparing the injection site and injecting the Enbrel solution h. ||| Préparation de la dose d’Enbrel pour l'injection d.
0.4170747697353363 ||| Patients who take Kivexa must be given the special alert card that summarises the key safety information about the medicine. ||| There is also an Alert Card included in the Kivexa pack, to remind you and medical staff about abacavir hypersensitivity. ||| Les patients qui prennent Kivexa doivent recevoir la carte de mise en garde spéciale qui résume les informations clés relatives à la sécurité du médicament.
0.4031636714935303 ||| Tighteners [hand-operated tools] ||| Weeding tools [hand operated] ||| Tendeurs [outillage manuel]
0.39660578966140747 ||| It is therefore recommended that no other vaccines should be administered on the same day or at different times. ||| It is advisable never to use several medicines at the same time without consulting your doctor first. ||| Par conséquent, il est recommandé de ne pas administrer d’ autres vaccins le même jour ou à des moments différents.
0.04236791655421257 ||| Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| However, please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Informez votre médecin si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance.
0.0 ||| 6. ||| 6. ||| 15 6.
0.002173706656321883 ||| 16 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 14 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING ||| 16 MENTIONS DEVANT FIGURER SUR L'EMBALLAGE PRIMAIRE OU, EN L'ABSENCE D'EMBALLAGE EXTERIEUR, SUR LE CONDITIONNEMENT PRIMAIRE
0.29701417684555054 ||| Periorbital oedema, dermatitis/ eczema/ rash Pruritus, face oedema, dry skin, erythema, alopecia, night sweats, photosensitivity reaction ||| pruritus, rash, alopecias, acne, sweating increased dermatitis, photosensitivity toxic epidermal necrolysis (Lyell’ s syndrome) ||| Douleur rénale, hématurie, insuffisance rénale aiguë, pollakiurie du tissu sous-cutané Oedème périorbitaire, dermatite/ eczéma/ rash Prurit, oedème de la face, peau sèche, erythème, alopécie, sueurs nocturnes, réaction de photosensibilité
0.14943918585777283 ||| In preclinical safety studies, doses producing exposure comparable to that in the clinical therapeutic range caused reduced red cell parameters (erythrocytes, haemoglobin, haematocrit), changes in renal haemodynamics (increased blood urea nitrogen and creatinine), as well as increased serum potassium in normotensive animals. ||| In non-clinical safety studies, high doses of valsartan (200 to 600 mg/ kg body weight) caused in rats a reduction of red blood cell parameters (erythrocytes, haemoglobin, haematocrit) and evidence of changes in renal haemodynamics (slightly raised plasma urea, and renal tubular hyperplasia and basophilia in males). ||| Dans les études précliniques de sécurité, des doses produisant une exposition comparable à celle observée dans la fourchette des doses utilisées en clinique ont induit une diminution des paramètres érythrocytaires (nombre d’ érythrocytes, hémoglobine et hématocrite), des modifications de l’ hémodynamique rénale (augmentation du taux d’ urée sanguine et de créatinémie) et une
0.5172523260116577 ||| 1 The number of person-days of interpretation needed for active spoken languages. ||| The usual language regime for most meetings permits 6 passive and 2 active languages. ||| 1 Nombre de jours d’interprétation/requis dans les langues actives.
0.45906519889831543 ||| Refraction anomalies may occur upon initiation of insulin therapy. ||| Hypersensitivity after previous administration of rotavirus vaccines. ||| Des anomalies de la réfraction peuvent survenir au début de l’ insulinothérapie.
0.3871802091598511 ||| 97 Pharmacotherapeutic group: gonadotrophins, ATC code: ||| Antimycotics for systemic use-triazole derivatives, ATC code: ||| Classe pharmacothérapeutique: gonadotrophines, code ATC:
0.07342945039272308 ||| Patients should be advised to take precautions in order to avoid hypoglycaemia whilst driving. ||| 11 Patients should be advised to take precautions to avoid hypoglycaemia whilst driving. ||| Les patients doivent être informés des précautions à prendre afin d’ éviter toute hypoglycémie pendant la conduite de véhicules.
0.6366281509399414 ||| Individuals should receive a single dose administered subcutaneously. ||| Patients received either ADROVANCE or alendronate only once a week. ||| Les sujets doivent recevoir une dose administrée par voie sous-cutanée.
0.27133989334106445 ||| Gastrointestinal events, mainly diarrhoea, have been observed in more than 80% of patients, either at the outset of treatment or intermittently during treatment (see section 4.8). ||| Very rarely, a partial or total rupture (in particular of the Achilles tendon) has been reported, especially in elderly patients who were previously treated systemically with glucocorticoids. ||| Des troubles gastro-intestinaux, principalement des diarrhées, ont été observés chez plus de 80% des patients au début du traitement ou de manière intermittente au cours du traitement (cf rubrique 4.8).
0.41919076442718506 ||| Serious infections (bacterial, viral, fungal) have been reported during treatment with alpha interferons including Pegasys. ||| Placebo-controlled trials in primary (idiopathic/ familial) PAH and PAH associated with connective tissue diseases ||| Des infections graves (bactériennes, virales, fongiques) ont été rapportées au cours de traitement avec des interférons alpha dont Pegasys.
0.37373533844947815 ||| In total, the Commission has adopted 43 decisions approving 53 national measures in relation to the coronavirus outbreak. ||| In a resolution adopted on Friday, Parliament welcomes the EU's fiscal measures and liquidity support to address the pandemic. ||| Au total, la Commission a adopté 43 décisions approuvant 53 mesures nationales relatives à la flambée de coronavirus.
0.3072044253349304 ||| Laboratory studies in rats and rabbits have not produced any evidence of a teratogenic, foetotoxic or maternotoxic effect. ||| Telmisartan showed no evidence of mutagenicity and relevant clastogenic activity in in vitro studies and no evidence of carcinogenicity in rats and mice. ||| Les études de laboratoire sur les rats et les lapins n'ont pas mis en évidence d'effets tératogènes, foetotoxiques ou maternotoxiques.
0.2784591317176819 ||| Clopidogrel Winthrop is used in adult patients to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries). ||| Fertavid can also be used to stimulate sperm production in men who have hypogonadotrophic hypogonadism (a rare hormone deficiency disease). ||| Clopidogrel Winthrop est utilisé chez l’ adulte pour prévenir les événements athérothrombotiques (problèmes dus à des caillots sanguins et au durcissement des artères).
0.0037856451235711575 ||| SOMAVERT 20 mg powder for solution for injection Pegvisomant Subcutaneous use ||| SOMAVERT 15 mg powder for solution for injection Pegvisomant Subcutaneous use ||| SOMAVERT 20 mg poudre pour solution injectable Pegvisomant Voie sous-cutanée
0.6605175137519836 ||| One pre-filled syringe contains either 500, 1,000, 2,000, ||| One cartridge contains either 10,000 IU, 20,000 IU or ||| Une seringue pré-remplie contient soit 500 UI, 1000 UI,
0.26830124855041504 ||| Chemical additives for use in the production of fuels ||| Chemical preparations for use in providing fire retarding properties ||| Additifs chimiques destinés à la production de carburants
0.5250312089920044 ||| Do not use this OptiSet. ||| Do not use this SoloStar. ||| Ne pas utiliser cet OptiSet.
0.26824140548706055 ||| However, ziconotide did not induce cell transformation in the in vitro Syrian hamster embryo (SHE) assay and did not increase cell proliferation (pre-neoplastic lesion formation) or apoptosis after subchronic intrathecal exposure in dogs. ||| No significant placental transfer of methoxy polyethylene glycol-epetin beta was observed in the rat, and studies in animals have not shown any harmful effect on pregnancy, embryofoetal development, parturition or postnatal development. ||| Cependant, le ziconotide n'a pas induit de transformation cellulaire dans l'étude in vitro effectuée chez l'embryon de hamster syrien (SHE, Syrian hamster embryo) et n'a pas augmenté la prolifération cellulaire (formation de lésions pré-néoplasiques) ou l'apoptose après administration intrarachidienne subchronique chez le chien.
0.478945255279541 ||| Epithelial cell proliferation was assessed by Ki67 immunohistochemical staining in healthy subjects. ||| VEGF165 is the VEGF isoform preferentially involved in pathological ocular neovascularisation. ||| Chez des sujets sains, la prolifération des cellules épithéliales a été évaluée par la coloration immunohistochimique de Ki67.
3.885780315137505e-13 ||| In a clinical trial with another TNF-antagonist worsening congestive heart failure and increased mortality due to congestive heart failure have been observed. ||| In a clinical trial with another TNF-antagonist worsening congestive heart failure and increased mortality due to congestive heart failure have been observed. ||| Dans un essai clinique mené avec un autre antagoniste du TNF, on a observé une aggravation de l'insuffisance cardiaque congestive et une augmentation de la mortalité par insuffisance cardiaque
0.4131515324115753 ||| • What should I do if I see an air bubble in the cartridge? ||| • Why should I use a new needle for each injection? ||| Que dois-je faire si je vois une bulle d'air dans la cartouche?
0.5765340924263 ||| Peel back the paper lid completely. ||| Swallow the tablet whole. ||| Retirer complètement le couvercle.
0.24043840169906616 ||| EU/ 1/ 99/ 125/ 001 28 orodispersible tablets EU/ 1/ 99/ 125/ 009 35 orodispersible tablets EU/ 1/ 99/ 125/ 005 56 orodispersible tablets EU/ 1/ 99/ 125/ 013 70 orodispersible tablets ||| EU/ 1/ 01/ 183/ 004 1 pre-filled syringe EU/ 1/ 01/ 183/ 005 10 pre-filled syringes EU/ 1/ 01/ 183/ 020 20 pre-filled syringes EU/ 1/ 01/ 183/ 021 50 pre-filled syringes ||| EU/ 1/ 99/ 125/ 001 28 comprimés orodispersibles EU/ 1/ 99/ 125/ 009 35 comprimés orodispersibles EU/ 1/ 99/ 125/ 005 56 comprimés orodispersibles EU/ 1/ 99/ 125/ 013 70 comprimés orodispersibles
0.4610898494720459 ||| 5 (0.9%) 5 (0.9%) ||| 1 (1.3%) 1 (1.3%) ||| 5 (0.9%)
0.4512239992618561 ||| You may need to stop taking alli. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, tell your doctor or pharmacist. ||| If you have any questions about travel, events, a major workstream, or coverage challenge, or anything else you may need help with, please don’t hesitate to notify and work with the CRT. ||| Il pourra être nécessaire d’arrêter de prendre alli. • Si l’un des effets indésirables s’aggrave ou si vous remarquez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.49437206983566284 ||| The Marketing Authorisation Holder commits to performing the study and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan. ||| Algorithm for Pregnancy Prevention Plan implementation This shall assist with patient categorisation, and determination of required pregnancy prevention and testing measures. ||| Le titulaire de l’ autorisation de mise sur le marche s´est engagé à réaliser l’ étude et les activités de pharmacovigilance décrites dans le plan de pharmacovigilance
0.0 ||| Not all pack sizes may be marketed. ||| Not all pack sizes may be marketed. ||| Toutes les présentations ne seront pas obligatoirement commercialisées.
0.35288092494010925 ||| Dispose of the syringes safely in a closed container. ||| - Always place the used syringes in the proper disposal unit. ||| Jetez les seringues en toute sécurité dans un contenant fermé.
0.49437522888183594 ||| Diarrhoea, vomiting, nausea ||| vomiting, a diarrhoea, constipation, ||| Diarrhée, vomissements, nausées
0.3387635350227356 ||| Dose The usual dose is 44 micrograms (12 million IU) given three times per week for adults and adolescents from 16 years of age. ||| Younger patients receive a lower dose (650 mg per square metre) given over one hour on five consecutive days, repeated every 21 days. ||| Posologie La dose habituelle est de 44 microgrammes (12 millions UI) administrée 3 fois par semaine chez l’ adulte et chez le patient de plus de 16 ans.
0.2824816107749939 ||| What is Herceptin? ||| What is Fendrix? ||| Qu’ est -ce qu'Herceptin?
0.27321135997772217 ||| Abrupt discontinuation of dopaminergic therapy can lead to the development of a neuroleptic malignant syndrome. ||| A disruption or early ending of treatment with somatropin may impair the success of growth hormone therapy. ||| Arrêt du traitement L’ arrêt brutal d’ un traitement dopaminergique peut entraîner un syndrome malin des neuroleptiques.
0.6790403127670288 ||| €15.7 million through the Global Fund to Fight AIDS, Tuberculosis and Malaria. ||| €2.7 billion will be put into the EU's Emergency Support Instrument ||| 15,7 millions d'euros au Fonds mondial de lutte contre le sida, la tuberculose et le paludisme.
0.054562292993068695 ||| Extavia contains 300 microgram (9.6 million IU) of recombinant interferon beta-1b per vial. ||| Betaferon contains 300 microgram (9.6 million IU) of recombinant interferon beta-1b per vial. ||| Un flacon d’ Extavia contient 300 microgrammes d’ interféron β -1b recombinant (9,6 millions d’ UI).
0.7128199338912964 ||| Synthetic lubricants ||| Pyrolytic graphite ||| Lubrifiants synthétiques
0.3029056489467621 ||| Usually only one dose is given For people with kidney problems, the dose does not need to be reduced, if hepatic function is normal. ||| Combivir tablets should not be used for children weighing less than 14 kg, since doses can not be appropriately adjusted for the weight of the child. ||| En cas d’ insuffisance rénale, la posologie ne doit pas être diminuée, si la fonction hépatique est normale.
0.024248458445072174 ||| 5% of patients receiving paroxetine (10-40mg daily) relapsed, versus 30% of patients on placebo. ||| 12% of patients receiving paroxetine (20-40mg daily) relapsed, versus 28% of patients on placebo. ||| 5% des patients recevant de la paroxétine (10-40 mg par jour) ont rechuté, contre 30% des patients sous placebo.
0.2306515872478485 ||| What is the risk associated with Viread? ||| What is the risk associated with PritorPlus? ||| Quels sont les risques associés à Viread?
0.4316898584365845 ||| Subcutaneous use NovoMix 30 Penfill cartridges are for use with Novo Nordisk insulin devices Read the package leaflet before use ||| The PSUR submission schedule for Olanzapine Mylan Film-coated tablets should follow the PSURs submission schedule for the reference medicinal product. ||| Voie sous-cutanée Les cartouches NovoMix 30 Penfill sont conçues pour être utilisées avec les systèmes d’ administration d’ insuline Novo Nordisk Lire la notice avant utilisation
3.355000196929303e-13 ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. ||| 100 En cas d'insuffisance rénale, les besoins en insuline peuvent être diminués en raison d'une réduction du métabolisme de l'insuline.
0.2563774883747101 ||| Hepatic impairment - Following a single, subcutaneous dose of fondaparinux in subjects with moderate hepatic impairment (Child-Pugh Category B), total (i. e., bound and unbound) Cmax and AUC were decreased by 22% and 39%, respectively, as compared to subjects with normal liver function. ||| In a multiple dose study with PREZISTA co-administered with ritonavir (600/100 mg) twice daily, it was demonstrated that the total plasma concentrations of darunavir in subjects with mild (Child-Pugh Class A, n=8) and moderate (Child-Pugh Class B, n=8) hepatic impairment were comparable with those in healthy subjects. ||| Insuffisance hépatique – Lors de l’ administration d’ une dose unique en sous-cutanée de fondaparinux chez des sujets ayant une insuffisance hépatique modérée (Child-Pugh B), la Cmax et l’ AUC des concentrations totales (i. e. liées et non liées) ont diminué respectivement de 22% et 39%, par rapport aux sujets ayant une fonction hépatique normale.
0.27280592918395996 ||| In patients with an allergy to animal insulin intradermal skin testing is recommended prior to a transfer to Insuman Comb 15, since they may experience immunological cross-reactions. ||| In patients undergoing major surgery or during anaesthesia with agents that produce hypotension , may block angiotensin II formation secondary to compensatory renin release. ||| 133 Chez les patients présentant une allergie à l'insuline d'origine animale, il est recommandé de procéder à des tests intradermiques avant de passer à Insuman Comb 15, en raison de la possibilité de réactions immunologiques croisées.
0.25536179542541504 ||| Telzir in combination with low dose ritonavir is indicated for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults, adolescents and children of 6 years and above in combination with other antiretroviral medicinal products. ||| Atripla is a treatment for Human Immunodeficiency Virus (HIV) infection in adults aged 18 and over who have previously been treated with other antiretroviral medicines and have their HIV-1 infection under control for at least three months. ||| Telzir associé à de faibles doses de ritonavir et à d’ autres antirétroviraux est indiqué dans le traitement des adultes, adolescents et enfants de 6 ans et plus, infectés par le Virus de l'Immunodéficience Humaine de Type 1 (VIH-1).
0.27044326066970825 ||| Bondronat 6 mg concentrate for solution for infusion ibandronic acid ||| Bondenza 3 mg solution for injection ibandronic acid ||| Bondronat 6 mg solution à diluer pour perfusion acide ibandronique
0.5250028371810913 ||| Back pain, myalgia ||| asthenopia, eye pain ||| Douleur du dos, myalgie
0.5623284578323364 ||| Artificial milk based desserts ||| Fruit-based snack food ||| Desserts à base de lait artificiel
0.2806137800216675 ||| What are the side effects of Quadrisol? ||| What are the side-effects of Neocolipor? ||| Quels sont les effets secondaires associés à Quadrisol?
0.29844096302986145 ||| The mean duration of follow-up was nearly two years. ||| The mean length of follow up was 4.8 years. ||| La durée moyenne du suivi a été de près de deux ans.
0.04510095715522766 ||| 10 pre-filled syringes + 10 separate needles ||| 20 pre-filled syringes + 20 separate needles ||| 10 seringues pré-remplies + 10 aiguilles individuelles
0.0 ||| Clinical studies have demonstrated that darbepoetin alfa had similar effectiveness when administered as a single injection either once every three weeks, once every two weeks, or weekly without any increase in total dose requirements. ||| Clinical studies have demonstrated that darbepoetin alfa had similar effectiveness when administered as a single injection either once every three weeks, once every two weeks, or weekly without any increase in total dose requirements. ||| Les études cliniques ont montré une même efficacité de la darbepoetin alfa qu’ elle soit administrée en m
0.0014436685014516115 ||| 243 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 242 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 255 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.035273030400276184 ||| Insulin Human Winthrop Comb 25 in cartridges for OptiClik has been developed for use with OptiClik only. ||| Insulin Human Winthrop Rapid in cartridges for OptiClik has been developed for use with OptiClik only. ||| Insulin Human Winthrop Comb 25 en cartouches pour OptiClik a été conçu pour être utilisé avec OptiClik uniquement.
0.4688015282154083 ||| Diagram 8. ||| Diagram J ||| Schéma 8.
0.1652047038078308 ||| 111 ||| 101 ||| 124
0.0009734076447784901 ||| It also enables Member States to combine all support measures granted under the Temporary Framework with existing possibilities to grant de minimis to a company of up to € 25,000 over three fiscal years for companies active in the primary agricultural sector, €30,000 over three fiscal years for companies active in the fishery and aquaculture sector and €200,000 over three fiscal years for companies active in all other sectors. ||| It also enables Member States to combine all support measures granted under the Temporary Framework with existing possibilities to grant de minimis to a company of up to €25,000 over three fiscal years for companies active in the primary agricultural sector, €30,000 over three fiscal years for companies active in the fishery and aquaculture sector and €200,000 over three fiscal years for companies active in all other sectors. ||| Il permet également aux États membres de combiner toutes les mesures de soutien accordées au titre de l'encadrement temporaire avec les possibilités existantes d'octroyer des aides de minimis plafonnées à 25 000 EUR par entreprise sur une période de trois ans pour les entreprises du secteur agricole primaire, à 30 000 EUR sur une période de trois ans pour les entreprises du secteur de la pêche et de l'aquaculture et à 200 000 EUR sur une période de trois ans pour les entreprises de tous les autres secteurs.
0.43058598041534424 ||| KOGENATE Bayer 500 IU must not be mixed with other infusion solutions. ||| Each TRISENOX ampoule must be used only once and does not contain any preservatives. ||| KOGENATE Bayer 500 UI ne doit pas être mélangé avec d’ autres solutions pour perfusion.
0.45075005292892456 ||| (atazanavir 300 mg QD with ritonavir 100 mg QD) ||| Ritonavir 100 mg bid (saquinavir 1000 mg bid) ||| par jour (300 mg d’ atazanavir une fois par jour associé à
0.565603494644165 ||| Under the Civil Protection Mechanism, the Commission has created a strategic rescEU medical stockpile and distribution mechanism with a budget of €380 million. ||| A universal and affordable Access to COVID-19 Tools (ACT-Accelerator) was the main objective of the 24 April call to action from global health partners. ||| Dans le cadre du mécanisme de protection civile, la Commission a créé une réserve stratégique rescEU de matériel médical et un mécanisme de distribution doté d'un budget de 380 millions €.
0.4433576762676239 ||| Interaction with saquinavir/ritonavir 1000/100 mg not studied. ||| Interaction study with Lopinavir/ ritonavir + rosuvastatin: ||| 1000/100 mg n’a pas été étudiée.
0.5397080183029175 ||| 6 tablets MIRAPEXIN 0.088 mg Total ||| ADROVANCE 70 mg 2800 IU ||| MIRAPEXIN 0,088 mg
0.27536389231681824 ||| The duration of treatment depends on the indication for treatment and the patient´s response. ||| The dose and frequency of administration should be adjusted for each patient depending on the clinical response. ||| La durée du traitement dépend de l’ indication traitée et de la réponse du patient.
0.18974821269512177 ||| Renal insufficiency No dose adjustment is required in patients with renal insufficiency and creatinine clearance above 15 ml/ min (see section 5.2). ||| 13 Patients with renal impairment No dosage adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/ min) (see section 5.2). ||| 2 Utilisation en cas d’ insuffisance rénale Aucune adaptation posologique n’ est nécessaire chez les patients avec une insuffisance rénale et une clairance de la créatinine supérieure à 15 ml/ min (voir rubrique 5.2).
0.28232425451278687 ||| Coated fabrics for use in the manufacture of rainwear ||| Powders in the nature of paint for use as coatings ||| Tissus enduits destinés à la fabrication de vêtements de pluie
0.5123292803764343 ||| Street lamps ||| Twin sets ||| Lampadaires
0.5435820817947388 ||| Gelatin Titanium dioxide (E 171) ||| and red iron oxide (E 172) ||| Gélatine Dioxyde de titane (E 171)
0.1074262261390686 ||| Pharmaceutical preparations for the treatment of kidney disorders ||| Pharmaceutical preparations for the treatment of inflammatory disorders ||| Produits pharmaceutiques pour le traitement des troubles rénaux
0.48023131489753723 ||| The bioavailability after per-oral dosing is about 76%. ||| Any increase in 13CO2 will be measured by isotopic analysis. ||| La biodisponibilité après un dosage oral est d’ environ 76%.
0.37735551595687866 ||| The study measured how long it took the children to develop an AIDS-related illness. ||| The study looked at the effectiveness of the medicine in preventing the progression of disability over three years. ||| L’ étude a évalué le délai avant que les enfants ne développent une maladie liée au SIDA.
0.19870144128799438 ||| Gastrointestinal tract: ||| Gastrointestinal studies: ||| 21 Voies digestives:
0.08021196722984314 ||| 105 5. ||| 106 5. ||| 5.
0.1274920552968979 ||| International Non-Proprietary Name (INN): cetirizine ||| International Non-Proprietary Name (INN): gemcitabine ||| Dénomination commune internationale (DCI): cétirizine
0.3813917636871338 ||| Communicate: During the crisis, the EU has been stepping up its work to inform citizens about the risks and to enhance cooperation with other international actors to tackle disinformation. ||| They also referred to the ongoing efforts at EU level to help Europe's societies and economies get back to a normal functioning and to sustainable growth. ||| Communiquer: pendant la crise, l'UE a renforcé son travail pour informer les citoyens des risques et améliorer la coopération avec d'autres acteurs internationaux afin de lutter contre la désinformation.
0.284422904253006 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The €40 million direct grant schemes will support Finnish companies active in primary agriculture and the fishery sector, and will help them continue their activities in these difficult times by covering part of the operating expenses such as salaries and rent. ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "This €5 billion French "umbrella" scheme will support research and development, and investments in testing and upscaling infrastructures and in the production of coronavirus relevant products, such as medicines, vaccines, and protective clothing. ||| Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Les 40 millions d'euros de ces régimes de subventions directes soutiendront les entreprises finlandaises du secteur agricole primaire et du secteur de la pêche et les aideront à poursuivre leurs activités en cette période difficile en couvrant une partie de leurs coûts d'exploitation, tels que les salaires et les loyers.
0.11175482720136642 ||| 4.2 Indications for use, specifying the target species Pr ||| 4.2 Indications for use, specifying the target species ||| Indications d'utilisation, spécifiant les espèces cibles éd
0.0748816728591919 ||| If psychiatric symptoms persist or worsen, or suicidal ideation is identified, it is recommended that treatment with IntronA be discontinued, and the patient followed, with psychiatric intervention as appropriate. ||| 24 symptoms persist or worsen, or suicidal ideation is identified, it is recommended that treatment with Viraferon be discontinued, and the patient followed, with psychiatric intervention as appropriate. ||| Si les symptômes psychiatriques persistent ou s’ aggravent, ou si des idées suicidaires sont identifiées, il est recommandé d’ interrompre le traitement par IntronA, et de suivre le patient, avec une prise en charge psychiatrique appropriée.
0.7682451009750366 ||| No tissue distribution data are available in humans. ||| Where ventilators from Germany provide a lifeline in Spain. ||| Aucune donnée de distribution tissulaire n’ est disponible chez l’ homme.
0.46082258224487305 ||| Sensation of warmth, pain, paraesthesia and rash at the site of application were also commonly observed. ||| The visual signs of incompatibility are e.g. precipitation, clouding, and discolouration. ||| Sensation de chaleur, douleur, paresthésie et éruption au site d’ application ont également été fréquemment observées.
0.2965286076068878 ||| These occurred at doses representing at least 25 times the exposure seen in humans receiving the clinical dose of 75 mg/ day and were a consequence of an effect on hepatic metabolising enzymes. ||| No interactions suceptible to have a noticeable impact have been observed between alcohol (at the blood level of 0.5 per mille corresponding to one glass of wine) and cetirizine used at the normal doses. ||| Celles-ci se sont produites à des doses représentant une exposition au moins 25 fois supérieure à celle observée chez l’homme recevant une dose thérapeutique de 75 mg/jour et ont été la conséquence de l’effet sur les enzymes du métabolisme hépatique.
0.2732011079788208 ||| Based on a retrospective analysis of plasma levels in patients who received lamotrigine both with and without gabapentin, gabapentin does not appear to change the apparent clearance of lamotrigine. ||| Evidence from clinical studies shows that lamivudine plus zidovudine delays the emergence of zidovudine resistant isolates in individuals with no prior antiretroviral therapy. ||| 61 Sur la base d’ analyse rétrospective des taux plasmatiques de patients ayant reçu de la lamotrigine à la fois avec et sans gabapentine, la gabapentine n’ a pas semblé modifier la clairance apparente de la lamotrigine.
0.3514823913574219 ||| Tell your doctor if you are being treated for either of these conditions or if you take other medicines to treat high blood pressure. ||| Take care if you are using any medicines that calme you down (have a sedative effect) or if you are drinking alcohol. ||| Informez également votre médecin si vous êtes traité pour l’ une de ces maladies ou si vous prenez d’ autres médicaments pour traiter l’ hypertension artérielle.
4.790005198040959e-13 ||| You must tell your doctor if you think that you are (or might become) pregnant. ||| You must tell your doctor if you think that you are (or might become) pregnant. ||| Vous devez informer votre médecin si vous êtes enceinte ou si vous pensez pouvoir être enceinte.
0.2991407811641693 ||| 4x1 film-coated tablets 30x1 film-coated tablets 100x1 film-coated tablets ||| 30 x 1 film-coated tablets 90 x 1 film-coated tablets ||| 4x1 comprimés pelliculés 30x1 comprimés pelliculés 100x1 comprimés pelliculés
0.40811026096343994 ||| 8 Immune system disorders Very rare: ||| Not known: § Immune system disorders ||| Atteintes du système immunitaire Très rare:
0.0 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/ ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/ ||| Des informations détaillées sur ce médicament sont disponibles sur le site Internet de l’ Agence européenne du médicament (EMEA) http: / /www. emea. europa. eu/
7.738670815271576e-13 ||| 5.1 Pharmacodynamic properties ||| 5.1 Pharmacodynamic properties ||| 5.2 Propriétés pharmacodynamiques
0.4736054539680481 ||| Safety and effectiveness in women have not been established because of the paucity of clinical data. ||| There are limited safety and no efficacy data available from the use of this combination. ||| La sécurité et l’ efficacité chez la femme n’ ont pas été établis en raison de données cliniques succinctes.
0.46211662888526917 ||| 5 days. ||| 24 hours. ||| 5 jours.
0.4686046242713928 ||| The dose may need to be adjusted for patients who experience side effects. ||| It should be noted that the adverse reactions may be intensified. ||| Il est possible de devoir ajuster la posologie en cas d’ apparition d’ effets secondaires.
0.5821159482002258 ||| Pregnancy testing ||| Environmental testing ||| Test de grossesse
0.37621259689331055 ||| Of those in clinical response at Week 4, 48% had been previously exposed to other anti-TNF therapy. ||| There were 45 different BCR-ABL mutations in 38% of patients enrolled in this trial. ||| Parmi les patients présentant une réponse clinique à la semaine 4, 48% avaient été préalablement exposés à un autre traitement anti-TNF.
0.4383152425289154 ||| Rare cases of hepatic dysfunction (including hepatitis) have been reported with vildagliptin. ||| Akathisia is more common in patients with bipolar disorder than in those with schizophrenia. ||| De rares cas de dysfonctionnement hépatique (incluant des hépatites) ont été observés avec la vildagliptine.
0.23814064264297485 ||| It could infect the drops left in the bottle. • Gently press on the base of the bottle to release one drop of EMADINE at a time. • Don’t squeeze the bottle, it is designed so that just a gentle press on the bottom is needed (picture 2). • If you use drops in both eyes, repeat the steps for your other eye. • Put the bottle cap back on firmly immediately after use. ||| Do not use the solution if it is discoloured, not clear, or contains particles. • Before attaching the needle, it is normal to see some small bubbles in the pre-filled pen window, near the top of the solution. • Place the pen back into the holder in the tray with the dosing button on the bottom. ||| Cela peut infecter le collyre. • Appuyez légèrement sur la base du flacon pour libérer une goutte d’ EMADINE à la fois. • Ne comprimez pas le flacon, il est conçu pour que seule une légère pression sur la base soit nécessaire (figure 2). • Si vous devez traiter les deux yeux, recommencez ces étapes pour l'autre œ il. • Bien refermer le flacon immédiatement après usage.
0.3310249447822571 ||| Siklos is supplied in blisters packed in cartons containing 30 tablets. ||| It is supplied in cartons containing 10 glass vials. ||| Siklos est présenté sous blisters emballés dans des boîtes en carton contenant 30 comprimés.
0.49935710430145264 ||| Optimal effect is obtained if the dose is administered in the evening. ||| A value of at least 90% should be obtained in a satisfactory preparation. ||| L’ effet est optimal si le traitement est administré le soir.
0.32469502091407776 ||| Avoid covering the KS lesions treated with gel with any bandage or material other than loose clothing. ||| Do not cover the treated area with bandages or other dressings after you have applied Aldara cream. ||| Evitez de couvrir les lésions SK traitées par le gel avec des pansements ou tissus autres que des vêtements lâches.
0.08178605139255524 ||| Mobilising the EU Budget ||| Mobilising the EU budget ||| Mobiliser le budget de l'UE
0.12492156773805618 ||| The European Commission granted a marketing authorisation valid throughout the European Union for Intelence to Janssen-Cilag International NV on 28 August 2008. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Equilis Prequenza to Intervet International BV on 8 July 2005. ||| Formatted La Commission européenne a délivré une autorisation de mise sur le marché valide dans toute l’ Union européenne à Janssen-Cilag International NV pour Intelence le 28 août 2008.
0.38079074025154114 ||| In the fasted state there was no significant difference in the extent of absorption, as measured by the area under the plasma concentration-time curve (AUC) and maximal peak concentration (Cmax), of each component. ||| The maximum plasma concentration (Cmax) and, to a smaller extent, the area under the plasma concentration-time curve (AUC), increase disproportionately with dose. ||| A jeun, l’ aire sous la courbe des concentrations plasmatiques (ASC) et les concentrations sériques maximales (Cmax) de chaque substance n'ont mis en évidence aucune différence significative en terme d'absorption.
0.6948479413986206 ||| This plan should address the following: ||| This request was based on the following reasons: ||| Ce plan doit couvrir les aspects suivants:
0.2909412086009979 ||| TEVA UK Ltd Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG UK ||| S-P Veterinary Ltd Breakspear Road South Harefield Uxbridge Middlesex, UB9 6LS United Kingdom ||| TEVA UK Ltd Brampton Road Hampden Park Eastbourne East Sussex BN22 9AG Royaume Uni
0.34620073437690735 ||| If the circulating avian influenza field virus has a different N component to the N6 included in the vaccine, it may be possible to differentiate between vaccinated and infected birds by using a diagnostic test to detect neuraminidase antibodies. ||| Conversely amprenavir retains activity against some isolates with resistance to other PIs and this retained activity would depend on the number and type of protease resistance mutations present in the isolates. ||| Si le virus sauvage circulant possède une neuraminidase différente de celle présente dans le vaccin (N6), il peut être possible de différencier les oiseaux vaccinés des oiseaux infectés en utilisant un test de diagnostic qui détecte les anticorps contre la neuraminidase.
0.04952471703290939 ||| Ireland GlaxoSmithKline (Ireland) Limited Stonemasons Way Rathfarnham Dublin 16 Ireland ||| GlaxoSmithKline (Ireland) Ltd Stonemasons Way Rathfarnham Dublin 16 Ireland ||| Irlande GlaxoSmithKline (Ireland) Limited (trading as:
4.052893545943015e-13 ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex). ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex). ||| Le capuchon de protection du stylo prérempli contient du caoutchouc naturel (un dérivé du latex).
0.0 ||| Combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump). ||| Combination antiretroviral therapy has been associated with redistribution of body fat (lipodystrophy) in HIV patients including the loss of peripheral and facial subcutaneous fat, increased intra-abdominal and visceral fat, breast hypertrophy and dorsocervical fat accumulation (buffalo hump). ||| 7 sous-cutané périphérique et facial, une augmentation de la masse grasse intra-abdominale et viscérale, une hypertrophie mammaire et une accumulation de la masse grasse au niveau rétro-cervical (bosse de bison).
0.20084607601165771 ||| What is the risk associated with Omnitrope? ||| What is the risk associated with Comtess? ||| Quel est le risque associé à l’ utilisation d’ Omnitrope?
0.17176325619220734 ||| Mixtard 10 Penfill 100 IU/ ml suspension for injection in a cartridge. ||| NovoMix 30 Penfill 100 U/ ml, suspension for injection in a cartridge. ||| Mixtard 10 Penfill 100 UI/ ml suspension injectable en cartouche
0.6409426331520081 ||| Palmitic acid ||| Mercuric oxide ||| Acide palmitique
0.7324950695037842 ||| Frequency of injections ||| Dosage and frequency ||| Fréquence d’injection
0.5548285841941833 ||| The company that makes Avamys has agreed that its scientific data can be used for Fluticasone Furoate GSK. ||| Richard Stallman began work on GNU Emacs in 1984 to produce a free software alternative to the proprietary Gosling Emacs. ||| La société qui fabrique Avamys a donné son accord pour que ses données scientifiques soient utilisées pour Fluticasone Furoate GSK.
0.36493223905563354 ||| Noxafil must not be administered with medicinal products that are substrates for CYP3A4 and are known to prolong the QTc interval (see sections 4.3 and 4.5). ||| Amoxicillin was previously evaluated by the CVMP together with other penicillins, in order to establish maximum residue limits (MRLs). ||| Noxafil ne doit pas être administré avec les médicaments qui sont des substrats du CYP3A4 et qui sont connus pour allonger l’ intervalle QTc (voir rubriques 4.3 et 4.5).
0.27321189641952515 ||| Severe side effects affecting the brain and nervous system have been reported in patients taking Atriance, including somnolence, convulsions, and peripheral neuropathy causing numbness, unusual sensations, weakness and even paralysis. ||| Nervous system symptoms: symptoms including, but not limited to, dizziness, insomnia, somnolence, impaired concentration and abnormal dreaming are frequently reported undesirable effects in patients receiving efavirenz 600 mg daily in clinical studies (see section 4.8). ||| Des effets indésirables graves affectant le cerveau et le système nerveux ont été signalés chez certains patients traités par Atriance, dont notamment des cas de somnolence, de convulsions et de neuropathie périphérique pouvant entraîner des engourdissements, des sensations anormales, des faiblesse et même des paralysies.
0.255727082490921 ||| What is Rebetol? ||| What is Preotact? ||| Qu’ est -ce que Rebetol?
0.4161722660064697 ||| If you receive only the vial, you will need to obtain alcohol swabs and an injection syringe. ||| Expel air, large bubbles, and any excess solution in order to obtain the required 1.2 ml dose. ||| Si vous disposez du flacon unique, vous aurez besoin de vous procurer des tampons alcoolisés et une seringue.
0.4547143876552582 ||| Do not open or chew the capsules. ||| How to take You should not chew or break the tablets. ||| N’ ouvrez pas ou ne mâchez pas les gélules.
0.28945639729499817 ||| If no improvement is observed within 10 weeks, treatment with fluoxetine should be reconsidered. ||| If treatment with INTEGRILIN is repeated, no diminished therapeutic response is expected. ||| En l’ absence d’ amélioration dans les 10 semaines, le traitement par fluoxétine devra être reconsidéré.
0.1768645942211151 ||| The other ingredients are microcrystalline cellulose (E460), lactose anhydrous, medium chain triglycerides, gelatin, croscarmellose sodium, sucrose, colloidal silicon dioxide, magnesium stearate (E572) butyl hydroxytoluene (E321), modified starch (maize), and sodium aluminium silicate (E554). ||| (tablet core) lactose monohydrate, maize starch, pregelatinised maize starch, crospovidone type A, magnesium stearate and (tablet coating) polyvinyl alcohol, titanium dioxide (E171), talc (E553b), lecithin (soya) (E322), xanthan gum (E415). ||| Les autres composants sont la cellulose microcristalline (E460), le lactose anhydre, les triglycérides à chaînes moyennes, la gélatine, la croscarmellose sodique, le saccharose, la silice colloïdale, le stéarate de magnésium (E572), le butylhydroxytoluène (E321), l'amidon modifié (maïs), et le silicate d’aluminium sodique (E554).
0.6062463521957397 ||| Attach the needle to the syringe by pushing firmly together. ||| Take the nozzle out and breathe out through your mouth. ||| Fixez ensemble l’ aiguille et la seringue en les poussant fermement.
0.37442466616630554 ||| Executive Vice-President Margrethe Vestager, in charge of competition policy, said: "The three measures, with an overall budget of around €900 million, will enable Hungary to support up to 5,000 companies of all sizes in addressing their immediate liquidity needs, alleviating their financial burden and helping them maintain jobs during and after the coronavirus outbreak. ||| Furthermore, in Sierra Leone, €34.7 million will be provided to address the economic consequences of the coronavirus through budget support to strengthen the macroeconomic resilience and stability and their national response plan (€25 million); cash transfers will allow to protect the income of the most vulnerable populations via the World Bank (€5.2 million) and support to the agriculture sector will boost food production (€4.5 million). ||| Mme Margrethe Vestager, vice-présidente exécutive chargée de la politique de concurrence, s'est exprimée en ces termes: «Ces trois mesures, dotées d'un budget global d'environ 900 millions d'euros, permettront à la Hongrie d'aider jusqu'à 5000 entreprises de toutes tailles à subvenir à leurs besoins immédiats en liquidités, à alléger leur charge financière et à maintenir l'emploi pendant et après la pandémie de coronavirus.
0.055513083934783936 ||| 1.230 ml (833 IU/ ml) ||| 0.270 ml (833 IU/ ml) ||| 1,230 ml (833 UI/ ml)
0.30127859115600586 ||| BLISTER OF 10 mg FILM-COATED TABLETS ||| BLISTER CARTON x 60 FILM-COATED TABLETS ||| Plaquette thermoformée de comprimés pelliculés dosés à 10 mg
0.3549686074256897 ||| Accordingly, high-risk patients, particularly young children and those receiving substantial immunosuppression should be monitored, using such procedures as echocardiography or ECG pre- and post-transplant (e. g. initially at three months and then at 9-12 months). ||| This study included acutely ill medical patients, aged ≥ 60 years, expected to require bed rest for at least four days, and hospitalized for congestive heart failure NYHA class III/ IV and/ or acute respiratory illness and/ or acute infectious or inflammatory disease. ||| Par conséquent, les patients à haut risque, notamment les jeunes enfants et les patients recevant une immunosuppression importante, doivent être surveillés par des méthodes telles que l’ échocardiographie ou ECG avant et après la transplantation (par exemple, le premier examen à 3 mois, puis à 9-12 mois).
0.8362693786621094 ||| Paresthesia, neuritis ||| Potassium cyanate ||| Paresthésie, névrite
0.15874984860420227 |||  457 Injecting the solution Select the injection site. ||| 285 Injecting the solution Select the injection site. ||| Injection de la solution Choisissez le site d’injection.
0.3215237259864807 ||| The CHMP was of the opinion that gemcitabine has shown activity as single agent in MBC but the lack of Phase III trials in this setting makes it difficult to give a specific recommendation about the precise place of gemcitabine in the treatment of advance breast cancer. ||| 14 Medical practice in the treatment of complicated UTI’ s with ciprofloxacin has developed and changed since the time of first licensing in 1987 and the proposed dosing is in line with current medical practice (5) and supported by the published literature. ||| Le CHMP était d’avis que la gemcitabine utilisée seule était active dans le cancer du sein métastatique mais le manque d’essais de Phase III dans ce contexte ne permet pas de formuler facilement une recommandation spécifique sur la place précise de la gemcitabine dans le traitement du cancer avancé du sein.
0.36817002296447754 ||| A commonly used dose for superovulation involves the administration of 150-225 IU (0.24-0.36 ml) of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle. ||| This was followed by monotherapy TMZ (150 - 200 mg/m2) on Days 1 - 5 of every 28-day cycle for up to 6 cycles, starting 4 weeks after the end of RT. ||| La dose usuelle destinée à provoquer une superovulation comprend l’ administration de 150 à 225 UI (0,24 à 0,36 ml) de GONAL-f par jour, en commençant le 2ème ou 3ème jour du cycle de traitement.
0.730086624622345 ||| Haemodialysis patients: ||| Oral -anticoagulants: ||| Patients hémodialysés:
0.1762598752975464 ||| 3/ 4 EU/ 1/ 01/ 185/ 058 ||| 3/ 4 EU/ 2/ 97/ 004/ 026 ||| EU/ 1/ 01/ 185/ 058
0.34870150685310364 ||| 7, 10, 20, 30, 50, 100 ||| 10, 14, 4, 10, 20, 28, 30, ||| 7, 10, 20, 30,
0.42963916063308716 ||| Waterproof coatings [paints] ||| Polyurethane finishes [paints] ||| Enduits imperméables [peintures]
0.011240096762776375 ||| The information given in this document and Annexes reflect only the CHMP Opinion dated 14 December 2006. ||| The information given in this document and Annexes reflect only the CHMP Opinion dated 8 December 2004. ||| Les informations fournies dans le présent document et dans les annexes reflètent uniquement l’ avis du CHMP en date du 14 décembre 2006.
0.13705961406230927 ||| Remote control receivers ||| Remote control transmitters ||| Récepteurs pour télécommandes
2.870407904420613e-13 ||| Osteonecrosis: cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to combination antiretroviral therapy (CART). ||| Osteonecrosis: cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long-term exposure to combination antiretroviral therapy (CART). ||| Des cas d’ ostéonécrose ont été rapportés, en particulier chez des patients présentant des facteurs de risque connus, un stade avancé de la maladie liée au VIH ou un traitement par association d’ antirétroviraux au long cours.
0.114400714635849 ||| Why has Tasigna been approved? ||| Why has Dicural been approved? ||| Pourquoi Tasigna a -t-il été approuvé?
0.3913533389568329 ||| SUSTIVA can reduce the amount of statins in your blood. ||| FORSTEO may cause an increase in the amount of calcium in your urine. ||| SUSTIVA peut réduire la quantité de statines dans votre sang.
0.5485233664512634 ||| Avoid stress in the birds around the time of vaccination. ||| No child must be left behind in the aftermath of the coronavirus crisis. ||| Eviter le stress chez les oiseaux avant, pendant et après la vaccination.
0.25187087059020996 ||| Patients with left ventricular outflow obstruction, e. g., aortic stenosis and idiopathic hypertrophic subaortic stenosis, can be sensitive to the action of vasodilators including Type 5 phosphodiesterase inhibitors. ||| Nplate is indicated for adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) splenectomised patients who are refractory to other treatments (e. g. corticosteroids, immunoglobulins). ||| Les patients présentant une obstruction à l’ éjection du ventricule gauche, par exemple sténose aortique, sténose sub-aortique hypertrophique idiopathique, peuvent être sensibles à l’ action de vasodilatateurs dont les inhibiteurs de la phosphodiestérase de type 5.
0.1424826979637146 ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Pradaxa’ s benefits are greater than its risks for primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Efient’ s benefits are greater than its risks, when co-administered with aspirin, for the prevention of atherothrombotic events in patients with acute coronary syndrome undergoing primary or delayed percutaneous coronary intervention. ||| Le comité des médicaments à usage humain (CHMP) a estimé que les bénéfices de Pradaxa sont supérieurs à ses risques pour la prévention primaire des événements thromboemboliques veineux chez les patients adultes ayant bénéficié d’ une chirurgie programmée pour prothèse totale de hanche ou de genou.
0.07175680994987488 ||| Cosmetics in the form of milks ||| Cosmetics in the form of gels ||| Cosmétiques sous forme de laits
0.2931004762649536 ||| If you are receiving dialysis treatment when you begin treatment with Silapo, your dialysis regimen may need to be adjusted to maintain urea, creatinine and potassium levels in the desired range. ||| If you have diarrhoea, your doctor may ask you to change your diet to reduce your lactose and carbohydrate intake, or not to take Zavesca together with food, or to temporarily reduce your dose. ||| Si vous êtes sous dialyse lorsque vous démarrez votre traitement par Silapo, votre régime de dialyse devra peut-être être ajusté pour maintenir les niveaux d'urée, de créatinine et de potassium dans l'intervalle souhaité.
0.4636099636554718 ||| Other medicines used for HIV infection: ||| Use in patients using other medicines: ||| Autres médicaments utilisés pour l’ infection par le VIH:
0.3081415295600891 ||| What Zerene contains ||| What Combivir contains ||| Que contient Zerene
0.2606288492679596 ||| The amino acid sequence of exenatide partially overlaps that of human GLP-1. ||| The amino acid sequence of the product is identical to that of endogenous human IGF-1. ||| La séquence d’ acides aminés de l’ exénatide correspond partiellement à celle du GLP-1 humain.
0.09559659659862518 ||| Paediatric population - Fondaparinux is not recommended for use in children below 17 years of age due to a lack of data on safety and efficacy ||| Paediatric population (< 18 years) Xiliarx is not recommended for use in children and adolescents due to a lack of data on safety and efficacy. ||| Pédiatrie - L’ utilisation du fondaparinux n’ est pas recommandée chez l’ enfant de moins de 17 ans, étant donné l’ insuffisance des données de tolérance et d’ efficacité.
0.3208332657814026 ||| Before therapy with Doribax is started, careful inquiry should be made concerning a previous history of hypersensitivity reactions to other active substances in this class or to beta-lactam antibiotics. ||| Although no specific information on pharmacodynamic interactions in the central nervous system is available, this should be borne in mind when co-prescribing medicinal products with central nervous system depressant action. ||| Avant de débuter un traitement par Doribax, un interrogatoire attentif doit rechercher des antécédents de réactions d’hypersensibilité à d’autres substances actives de cette classe ou à des antibiotiques de la famille des bêta-lactamines.
0.24486815929412842 ||| In patients with impaired renal function, adjustment of the ceftriaxone dose is not necessary if the hepatic function is normal. ||| Rimonabant is metabolised by the liver, thus caution is advised in patients with moderate hepatic impairment. ||| En cas de troubles de la fonction rénale, il n’est pas nécessaire d’adapter la posologie de la ceftriaxone si la fonction hépatique est normale.
0.1811392605304718 ||| 12 In the placebo-controlled phase, Extavia delayed the progression from the first clinical event to clinically definite multiple sclerosis (CDMS) in a statistically significant and clinically meaningful manner, corresponding to a risk reduction of 47% (Hazard Ratio = 0.53, 95% confidence interval (0.39, 0.73), p < 0.0001). ||| Retrospective analyses in subgroups showed that a treatment effect on disability progression is most likely in patients with active disease before treatment commences (Hazard Ratio 0.72, 95% confidence interval (0.59, 0.88), p=0.0011, corresponding to a 28% risk reduction due to Extavia in patients with relapses or pronounced EDSS progression, 8 million IU Extavia versus all placebo patients). ||| Lors de la phase versus placebo, Extavia a permis de retarder, de façon statistiquement significative et cliniquement confirmée, l’ évolution vers une sclérose en plaques cliniquement définie; ceci correspond à une réduction du risque de 47% (rapport de risques instantanés = 0,53, intervalle de confiance 95% (0,39, 0,73), p < 0,0001).
0.4619174599647522 ||| In a controlled clinical trial in patients with cardiac insufficiency the following adverse events were reported: ||| 4 The adverse reactions reported among 1788 adult patients in clinical studies are: ||| Les effets indésirables suivants ont été rapportés dans une étude clinique contrôlée menée chez des patients atteints d'insuffisance cardiaque:
0.17430785298347473 ||| 19 Using other medicines ||| 218 Using other medicines ||| Utilisation d'autres médicaments
0.23795297741889954 ||| In carcinogenicity studies agomelatine induced an increase in the incidence of liver tumours in the rat and the mouse, at a dose at least 110-fold higher than the therapeutic dose. ||| There was a low incidence of myopathy (defined as serum creatine kinase levels exceeding 10 times the upper limit of normal), that occurred in only 11 simvastatin-treated patients and six placebo-treated patients. ||| Dans les études de cancérogénèse, l'agomélatine a induit une augmentation de l'incidence de tumeurs hépatiques chez le rat et la souris à des doses au moins 110 fois supérieures à la dose thérapeutique.
0.5163521766662598 ||| The required dosage is determined using the following formula: ||| * Body surface area can be calculated with the following equation ||| La dose nécessaire est déterminée à l'aide de la formule suivante:
0.19175437092781067 ||| España GlaxoSmithKline, S.A. ||| 55 España GlaxoSmithKline, S. A. ||| Portugal España GlaxoSmithKline, Produtos Farmacêuticos, Lda.
3.8390105439219113e-13 ||| In another monotherapy study in mild to moderate Alzheimer’ s disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised. ||| In another monotherapy study in mild to moderate Alzheimer’ s disease a total of 470 patients (MMSE total scores at baseline of 11-23) were randomised. ||| Dans une autre étude en monothérapie de la maladie d’ Alzheimer au stade léger à modéré, un total de 470 patients (score total MMSE de 11 à 23 au début de l’ étude) ont été randomisés.
0.588593602180481 ||| You will take Temodal alone once daily for the first 5 days. ||| Every day for 4-7 days beginning immediately after you have received Caelyx: ||| Vous prendrez Temodal seul une fois par jour pendant les 5 premiers jours.
0.14067965745925903 ||| 37.1 ||| 35.5 ||| 37,1
0.34061193466186523 ||| Prescribers should exercise caution in considering the use of Humira in patients with pre-existing or recent-onset central nervous system demyelinating disorders. ||| Neurological disorders Physicians should be vigilant for symptoms potentially indicative of new-onset central demyelinating disorders. ||| La prudence est recommandée aux prescripteurs avant de traiter avec Humira chez des patients atteints d'une maladie démyélinisante du système nerveux central, préexistante ou de survenue récente.
0.0685420036315918 ||| Sucrose, hydrolysed gelatin, urea, sodium chloride, sorbitol, monosodium glutamate, sodium phosphate, sodium bicarbonate, potassium phosphate, potassium chloride, medium 199 with Hanks’ Salts, MEM, neomycin, phenol red, HCl, NaOH. ||| Powder Sucrose, hydrolysed gelatin, urea, sodium chloride, sorbitol, monosodium glutamate, sodium phosphate, sodium bicarbonate, potassium phosphate, potassium chloride, medium 199 with Hanks’ Salts, MEM, neomycin, phenol red, hydrochloric acid and sodium hydroxide. ||| Saccharose, gélatine hydrolysée, urée, chlorure de sodium, sorbitol, glutamate monosodique, phosphate de sodium, bicarbonate de sodium, phosphate de potassium, chlorure de potassium, milieu 199 avec sels de Hanks, MEM, néomycine, rouge de phénol, HCI, NaOH.
0.1231139525771141 ||| • If you are allergic (hypersensitive) to adalimumab or any of the other ingredients of Trudexa. ||| • If you a re allergic (hypersensitive) to adalimumab or any of the other ingredients of Trudexa. ||| • Si vous êtes allergique (hypersensible) à l’adalimumab ou à tout autre composant de Trudexa.
0.3076946437358856 ||| 10 pre-filled syringes + 20 needles ||| 5 pre-filled syringes with 0.8 ml ||| 10 seringues préremplies + 20 aiguilles
0.2923630475997925 ||| Particular caution should be exercised when administering Copalia to patients with mild to moderate hepatic impairment or biliary obstructive disorders. ||| A benefit-risk assessment should be done prior to the continuation of temsirolimus therapy in patients with severe or life-threatening reactions. ||| 16 surveillance particulière devra être instaurée chez les patients qui présentent une altération de la fonction hépatique légère à modérée ou des troubles dus à l'obstruction des voies biliaires.
0.12653252482414246 ||| - tablet core: lactose monohydrate, povidone, microcrystalline cellulose, crospovidone, purified ||| Tablet core: crospovidone, lactose monohydrate, magnesium stearate, cellulose microcrystalline and povidone. ||| - noyau du comprimé: lactose monohydraté, povidone, cellulose microcristalline, crospovidone,
0.24094155430793762 ||| • 28.3.2002 • 30.4.2002 ||| • 17.2.2002 • 18.4.2002 ||| 28.3.2002 30.4.2002
0.025740671902894974 ||| Bondronat tablets contain lactose and should not be administered to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. ||| The tablets contain lactose and should not be administered to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. ||| 15 ayant une galactosémie congénitale, un déficit en lactase ou un syndrome de malabsorption du glucose et du galactose.
0.4466855823993683 ||| The starting dose is provided by the 40 mg divisible tablet. ||| From day 19 you are injecting the full dose 1.0 ml. ||| La dose initiale est fournie par le comprimé sécable à 40 mg.
0.0 ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 15 4.5 Interactions avec d'autres médicaments et autres formes d' interaction
0.38523024320602417 ||| Each pen contains 3 ml solution (300 Units) and they are available in packs of 1, 3, 4, 5, 6, 8, 9 and 10 pens. ||| Packs of 1, 3, 4, 5, 6, 8, 9 and 10 pre-filled pens of 3 ml are available. ||| Disponible en boîtes de 1, 3, 4, 5, 6, 8, 9 et 10 stylos.
0.0016109441639855504 ||| Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i. e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial. ||| Insulin Human Winthrop Comb 50 must not be used if this cannot be achieved, i. e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial. ||| Insulin Human Winthrop Comb 15 ne doit pas être utilisé si tel n'est pas le cas, par exemple si la suspension reste claire ou si des agrégats, des particules ou des flocons apparaissent dans l'insuline ou restent collés à la paroi ou au fond du flacon.
0.433624267578125 ||| This effect is associated with increased plasma cholesterol concentrations. ||| The AUC of metabolites increased with decreased renal function. ||| Cet effet est associé à une augmentation des concentrations plasmatiques en cholestérol.
0.252150297164917 ||| Hepatic Disease: ||| 10 Hepatic Disease: ||| Insuffisants hépatiques:
0.3652353286743164 ||| Drill aligning instruments for use with machines ||| Leads for use with implantable cardiac stimulators ||| Instruments d'alignement de forage pour machines
3.5913844597876277e-13 ||| In the case of major surgical interventions in particular, a precise monitoring of the substitution therapy by means of coagulation analysis is indispensable. ||| In the case of major surgical interventions in particular, a precise monitoring of the substitution therapy by means of coagulation analysis is indispensable. ||| 174 chirurgicale majeure tout particulièrement, un contrôle minutieux du traitement substitutif est indispensable à l'aide des tests de coagulation.
0.21765032410621643 ||| Weight increased ||| Weight decrease ||| patients Augmentation du poids
0.026456620544195175 ||| Always take Ebixa exactly as your doctor has told you. ||| Always take Stalevo exactly as your doctor has told you. ||| Respectez toujours la posologie indiquée par votre médecin.
0.3135150074958801 ||| In general these reactions disappear within 3 weeks after the first vaccination. ||| Clinical improvement generally occurs within the first week after injection. ||| En règle générale, ces réactions disparaissent dans les 3 semaines qui suivent la première vaccination.
0.04700450599193573 ||| Adefovir can be removed by haemodialysis; the median haemodialysis clearance of adefovir is 104 ml/ min. ||| Tenofovir can be removed by haemodialysis; the median haemodialysis clearance of tenofovir is 134 ml/ min. ||| 8 L’ adéfovir peut être éliminé par hémodialyse; la vitesse médiane d’ élimination de l’ adéfovir par hémodialyse est de 104 ml/ min.
0.8622975945472717 ||| If you are unsure, or think you may have become pregnant, talk to your doctor. ||| There were times when I was not sure if I would survive. ||| En cas de doute, ou si vous pensez que vous pouvez être enceinte, parlez -en à votre médecin.
0.0479142852127552 ||| INFORMATION FOR THE USER Karvezide 150 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide ||| INFORMATION FOR THE USER CoAprovel 150 mg/ 12.5 mg film-coated tablets irbesartan/ hydrochlorothiazide ||| INFORMATION DE L'UTILISATEUR Karvezide 150 mg/ 12,5 mg comprimés pelliculés irbésartan/ hydrochlorothiazide
0.4142031967639923 ||| Serum electrolytes should be monitored in chronic renal failure patients. ||| Musculoskeletal pain is usually controlled with standard analgesics. ||| L’ ionogramme sanguin doit être contrôlé chez les insuffisants rénaux chroniques.
0.07034880667924881 ||| 13 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE ||| 41 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKING ||| 13 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.06921952962875366 ||| Less common are pain at the place of injection, flushing, low or high blood pressure, dry or teary eyes, redness of skin or skin disorder, psoriasis, hives, nail disorder, feeling unwell, feeling faint, poor coordination, confusion, increased or decreased sensitivity to touch, tense muscles, arthritis, bruising, loss of interest in activities including sex, sexual problem, unusual dreams, shaky hands, vertigo (spinning feeling), increased appetite, heartburn, intestinal gas (flatus), constipation, hemorrhoids, red or bleeding gums, redness or sores in mouth, change in taste, changes in hearing or ringing in ears, thirst, changed behaviour or aggressive behaviour (sometimes directed against others), feeling sleepy, cold sores, fungal or bacterial infections, irritation of prostate gland, increased need to pass urine, ear or respiratory infections, sinusitis, stuffy or runny nose, abnormal hair texture, sensitivity to sunlight, migraine headache, eye pain or infection, blurred vision, puffy face, puffy hands or feet, enlarged liver, problem affecting ovary or vagina, pain in breast, difficulty in speaking and swollen glands. ||| Commonly reported side effects (at least 1 in every 100 patients, but less than 1 in every 10 patients): thirst, dehydration, high blood pressure, migraines, swollen glands, flushing, menstrual problems, decreased sexual drive, vaginal problem, breast pain, pain in testicle, problems with thyroid gland, red gums, dry mouth, red or sore mouth or tongue, tooth ache or tooth disorder, herpes simplex (fever blisters), taste change, upset stomach, dyspepsia (heartburn), constipation, enlargement of liver (liver problems, sometimes severe), loose stools, bedwetting in children, inflammation of the sinuses, bronchitis, eye pain, problem with your tear ducts, conjunctivitis (“pink eye”), agitation, sleepiness, sleepwalking, problem with behaviour, nervousness, stuffy or runny nose, sneezing, rapid breathing, pale or reddened skin, bruising, fingers and toes very sensitive to cold, problem with skin or nails, psoriasis (new or worsened), increased sweating, increased need to pass urine, fine shaking movements, decreased sensitivity to touch, arthritis. ||| Les effets moins fréquents sont douleur au point d’ injection, bouffée de chaleur, pression sanguine élevée ou faible, œ il sec ou qui coule, rougeur ou trouble cutané, psoriasis, urticaire, lésion des ongles, sensation de mal-être, sensation de malaise, mauvaise coordination, confusion, sensibilité du toucher augmentée ou diminuée, tension musculaire, arthrite, ecchymoses, perte d’ intérêt pour les activités y compris le sexe, problèmes sexuels, rêves inhabituels, mains qui tremblent, vertige (sensation que ça tourne), augmentation de l’ appétit, brûlures d’ estomac, flatulence (gaz), constipation, hémorroïdes, rougeur ou saignement des gencives, rougeur ou aphtes dans la bouche, changement du goût, changements de l’ audition ou bourdonnement d’ oreille, soif, changement de comportement ou comportement agressif (parfois dirigé contre autrui), sensation de somnolence, boutons de fièvre, infections fongiques ou bactériennes, irritation de la prostate, envie plus fréquente d’ uriner, infections respiratoires ou de l’ oreille, sinusite, nez bouché ou qui coule, texture anormale des cheveux,
0.3091036379337311 ||| The Lansoprazole dose should therefore be taken at least an hour prior or after. ||| Therefore lansoprazole should be taken at least 1 hour after taking these drugs. ||| La prise de lansoprazole doit donc avoir lieu au moins une heure avant ou une heure après la prise de sucralfate.
0.0009820436825975776 ||| MIRCERA 30 micrograms/0.3 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta ||| MIRCERA 50 micrograms/0.3 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta ||| MIRCERA 30 microgrammes/ 0,3 ml, solution injectable en seringue préremplie méthoxy polyéthylène glycol-epoetin beta
0.2806568443775177 ||| The CVMP will continue its efforts to revise its position on injection site residues, taking account of recent progress made on the subject at Codex Alimentarius and will address the subject of reporting publicly how the concept of risk assessment is dealt with in the process of establishing MRLs in the European Union. ||| The current change in the European Regional Development Fund Regulation aims at ensuring a full alignment between the approach taken under the applicable EU State aid framework and the rules and conditions under which the ERDF may provide support to undertakings in the current crisis situation linked to the coronavirus outbreak. ||| Le CVMP poursuivra ses efforts afin de revoir sa position sur la présence de résidus au niveau du site d’injection en tenant compte des progrès récents réalisés à ce sujet par le Codex Alimentarius et examinera la question de l’information du public sur la manière de traiter le concept d’évaluation du risque dans le cadre de l’établissement des LMR dans l’Union européenne.
0.01985592022538185 ||| 104 6.4 Special precautions for storage ||| 116 6.4 Special precautions for storage ||| 6.4 Précautions particulières de conservation
0.5587618350982666 ||| Buttermilk ||| Currycombs ||| Babeurre
0.24162164330482483 ||| 25 vials ||| 10 vials ||| 25 flacons
0.7015992403030396 ||| How is Voraxaze expected to work? ||| How to prepare and administer Aclasta ||| Comment Voraxaze devait -il agir?
0.08114754408597946 ||| Rubber tracks for use with crawlers on agricultural machines ||| Rubber tracks for use with crawlers on construction machines ||| Chenilles en caoutchouc pour châssis à chenilles de machines agricoles
0.719468355178833 ||| Ammonium vanadate ||| A rifabutin dose ||| Vanadate d'ammonium
0.48729628324508667 ||| What Tasigna looks like and contents of the pack Tasigna is supplied as hard capsules. ||| What TRITACE looks like and contents of the pack Tablets, hard capsules [To be completed nationally] ||| Qu’ est -ce que Tasigna et contenu de l’ emballage extérieur Tasigna se présente sous forme de gélules.
0.31032508611679077 ||| Lamivudine is metabolised by both infected and uninfected cells to the triphosphate (TP) derivative which is the active form of the parent compound. ||| The orally applied 13C-urea is metabolised to carbon dioxide and ammonia or is integrated into the body’ s own urea cycle. ||| Dans les cellules infectées ou saines, la lamivudine est transformée en un métabolite triphosphate (TP), qui constitue la forme active de la molécule mère.
0.6526147127151489 ||| Together towards environmental and climate resilience ||| Together for resilient, fair and inclusive societies ||| Ensemble pour une résilience environnementale et climatique
0.0 ||| common ||| common ||| rhinite
0.3873292803764343 ||| 53% ||| 5.3% ||| 53% 76%
0.7970394492149353 ||| Summary of Product Characteristics section 4.2). ||| Efficacy Results from Phase III NeuroBloc Studies ||| Résumé des Caractéristiques du Produit, rubrique 4.2).
0.4254453182220459 ||| Connecting in an affected area may lead to entry restrictions later on, and if you've been in an affected area recently some countries won't even let you change planes. ||| Build in extra time for your connections, especially if transferring from an international flight to a domestic flight and especially if your itinerary involves a country that's seriously affected. ||| Une correspondance dans une zone touchée peut entraîner des restrictions d’entrée ultérieurement et, si vous avez récemment été dans une zone touchée, certains pays ne vous laisseront même pas changer d’avion.
0.3692348003387451 ||| Lamotrigine is rapidly and completely absorbed from the gut with no significant first-pass metabolism. ||| Aerius oral lyophilisate disperses instantly and water or other liquid is not needed. ||| La lamotrigine est rapidement et complètement absorbée au niveau gastro-intestinal avec un effet de premier passage hépatique négligeable.
0.07581088691949844 ||| Keep out of the reach and sight of children. i dic ||| Keep out of the reach and sight of children. al cin ||| Tenir hors de la portée et de la vue des enfants. mé
0.011350215412676334 ||| 10 A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| 16 A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| FABRICANTS DU PRINCIPE ACTIF D'ORIGINE BIOLOGIQUE ET TITULAIRE DE L’ AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.25281617045402527 ||| PRCA means that the body has stopped or reduced the production of red blood cells which causes severe anaemia. ||| Pure red cell aplasia, a condition where the body stopped or reduced the production of red blood cells, has been reported. ||| 499 production de globules rouges par votre organisme se traduisant par une anémie sévère.
0.4413835406303406 ||| The European Commission has adopted a second amendment to extend the scope of the State aid Temporary Framework adopted on 19 March 2020 to enable Member States to support the economy in the context of the coronavirus outbreak. ||| A Constituency Commission, convened in July 2016 under the provisions of the Electoral Act 1997 with Judge Robert Haughton as chair, made recommendations on changes to constituency boundaries after publication of initial population data from the 2016 census. ||| La Commission européenne a adopté une deuxième modification étendant le champ d'application de l' encadrement temporaire des aides d'État adopté le 19 mars 2020 pour permettre aux États membres de soutenir l'économie dans le contexte de la pandémie de coronavirus.
0.3676415681838989 ||| If you take more Zyrtec than you should If you think you have taken an overdose of Zyrtec please inform your doctor. ||| If you take more Seretide than you should It is important to take Seretide as your doctor recommended. ||| Si vous avez pris plus de Zyrtec que vous n’ auriez dû Contactez votre médecin si vous pensez que avez pris plus de comprimés de Zyrtec qu'il ne le fallait.
0.15544742345809937 ||| 80 B. ||| 100 B. ||| 88 B.
0.267916202545166 ||| There were no food restrictions in the studies that demonstrated the efficacy and safety of CELSENTRI (see section 5.1). ||| There are currently insufficient data to establish the safety and efficacy of clofarabine in adult patients (see section 5.2). ||| Les études ayant démontré l’ efficacité et la tolérance du maraviroc n’ ont comporté aucune restriction alimentaire (voir rubrique 5.1).
0.07791821658611298 ||| Like all medicines, QUADRAMET can have side effects, although not everybody gets them. ||| Like all medicines, LYRICA can have side effects, although not everyone gets them. ||| Comme tous les médicaments, QUADRAMET peut provoquer des effets indésirables, mais ils ne surviennent pas systématiquement chez tout le monde.
0.14507970213890076 ||| Abacavir and its metabolites are secreted into the milk of lactating rats. ||| Agomelatine or its metabolites are excreted in the milk of lactating rats. ||| Chez la rate allaitante, l’ abacavir et ses métabolites sont sécrétés dans le lait maternel.
0.39098986983299255 ||| • Disposal ||| 32 • Disposal ||| • Elimination
0.0 ||| Released for consultation ||| Released for consultation ||| Transmise pour consultation en mars 1997
0.3071088194847107 ||| Severe renal impairment (creatinine clearance < 30 ml/ min) (see section 4.4). ||| Moderate renal impairment (creatinine clearance 30-49 ml/ min): ||| Insuffisance rénale sévère (clairance de la créatinine < 30 ml/ min) (voir rubrique 4.4).
0.23384085297584534 ||| (31.5) ||| (30.3) ||| (31,5)
0.41008615493774414 ||| In view of this, the benefit-risk profile for the use of CASODEX is not considered favourable in this group of patients. ||| Dogs and cats: it was shown that strict compliance with the recommended posology is compulsory to achieve clinical benefit. ||| Sur la base de ces résultats, le rapport bénéfice/ risque d’ un traitement par CASODEX n’ est pas considéré comme favorable dans ce groupe de patients.
2.0385471468428035e-13 ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck. com ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck. com ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck.com
0.5910229682922363 ||| Elderly patients (≥ 65 years): ||| Children (weighing < 20 kg): ||| Sujets âgés (≥ 65 ans):
0.3172232210636139 ||| Treatment with nitisinone was also found to result in reduced risk for the development of hepatocellular carcinoma (2.3 to 3.7-fold) compared to historical data on treatment with dietary restriction alone. ||| In general, the adverse reaction profile of venlafaxine (in placebo-controlled clinical trials) in children and adolescents (ages 6 to 17) was similar to that seen for adults. ||| Il a été mis en évidence que le traitement par la nitisinone réduit le risque de survenue d’ un hépatome (risque 2,3 à 3,7 fois moindre) lorqu’ il est comparé aux données historiques avec régime alimentaire seul.
0.4220542907714844 ||| 4.1 Target species od ||| 4.1 Target species ||| Espèces cibles am
0.010637582279741764 ||| No dose recommendation can be given for co-administration of amprenavir with another protease inhibitor and efavirenz in children. ||| No dose recommendation can be given for the co-administration of amprenavir with another protease inhibitor and efavirenz in children. ||| Aucune recommandation posologique ne peut être faite en cas de co-administration d’ amprénavir avec un autre inhibiteur de protéase et l’ éfavirenz chez les enfants.
0.633824348449707 ||| • What should I do if I cannot completely push in the Dose Knob when priming the Pen? ||| You will push it in when you are ready to self-inject the ViraferonPeg. ||| • Que dois-je faire si je ne parviens pas à appuyer complètement sur le bouton d'injection au moment de la purge du stylo?
0.5689467191696167 ||| Geological estimations and research ||| Technical research projects and studies ||| Estimations et recherche géologiques
0.035975631326436996 ||| The exact way that Protopy works in atopic dermatitis is not yet fully understood. ||| The exact way that Protopic works in atopic dermatitis is not yet fully understood. ||| Le mode d’ action exact de Protopy sur la dermatite atopique n’ a pas encore été complètement élucidé.
0.4881478548049927 ||| There may also be bleeding, ulcers, swelling, and scarring. ||| These effects were pain, swelling, wound infection, and fever. ||| Il peut aussi survenir des hémorragies, ulcères, un gonflement et des cicatrices.
0.22985520958900452 ||| blister (PVC/ PCTFE/ Alu) ||| blister (PVC/ PE/ PVDC) ||| Plaquette (PVC/ PCTFE/ Alu)
0.2904110550880432 ||| However, daily doses of up to 180 mg of lansoprazole have been administered in trials without significant undesirable effects. ||| In addition, reports of accidental overdose with aripiprazole alone (up to 195 mg) in children have been received with no fatalities. ||| Cependant, des doses quotidiennes allant jusqu'à 180 mg de lansoprazole ont été administrées dans des essais cliniques sans générer d’ effets indésirables significatifs.
0.0027227194514125586 ||| 174 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 179 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 194 MENTIONS DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.38639870285987854 ||| Mentholated pipes ||| Penetrating oils ||| Pipes mentholées
0.2370053231716156 ||| Serious side effects (very rare: affects less than 1 user in 10,000) • Blood clots in arteries leading to heart attack or stroke • Blood clots in veins that can lead to blood clots in the lungs • Blood clots in liver predominantly in patients with liver disease or undergoing liver surgery. ||| Uncommon side effects (affects 1 to 10 users in 1,000): • sore or painful throat, collection of pus under the skin in the mouth • abnormal white cells in the blood, decrease in white cells in the blood, decrease in cells that help the blood to clot, decrease in red blood cells ||| Effets indésirables graves (très rares: surviennent chez moins de 1 utilisateur sur 10 000) • Thrombose artérielle conduisant à une crise cardiaque ou un accident vasculaire cérébral • Thrombose veineuse susceptible de conduire à des caillots sanguins dans les poumons • Thrombose hépatique principalement chez les patients présentant une maladie hépatique ou en cas de chirurgie hépatique.
0.11274032294750214 ||| CARTON CONTAINING 1 BOTTLE OF 5 OR 20 HARD CAPSULES OF TEMODAL 100 mg ||| LABEL FOR BOTTLES CONTAINING 5 OR 20 HARD CAPSULES OF TEMODAL 250 mg ||| ETUI CONTENANT 1 FLACON DE 5 OU 20 GELULES DE TEMODAL 100 mg
0.23829340934753418 ||| 4 Acute coronary syndrome As with other nicotinic acid medicinal products, caution should be used when Tredaptive is used in patients with unstable angina or in the acute phase of an MI, particularly when such patients are also receiving vasoactive medicinal products such as nitrates, calcium channel blockers, or adrenergic blocking agents. ||| However, as with other antipsychotics, caution should be exercised when olanzapine is prescribed with medicines known to increase QTc interval, especially in the elderly, in patients with congenital long QT syndrome, congestive heart failure, heart hypertrophy, hypokalaemia or hypomagnesaemia. ||| Syndrome coronarien aigu Comme avec les autres spécialités à base d’ acide nicotinique, la prudence s’ impose en cas d’ administration de Tredaptive chez des patients atteints d’ angor instable ou lors de la phase aiguë de l’ infarctus du myocarde, en particulier si ces patients reçoivent également des médicaments vaso-actifs tels que des dérivés nitrés, des inhibiteurs calciques ou des adrénolytiques.
0.05012357234954834 ||| Lamictal is not indicated for the acute treatment of manic or depressive episodes. ||| Lamictal is not indicated for the acute treatment of manic or depressive episodes”. ||| Lamictal n’ est pas indiqué dans le traitement aigu des épisodes maniaques ou dépressifs.
0.31329694390296936 ||| HOW TO STORE FLUTICASONE FUROATE GSK ||| HOW TO STORE AERIUS ORAL LYOPHILISATE ||| COMMENT CONSERVER FLUTICASONE FUROATE GSK
0.3079506754875183 ||| Because of the nature of the adverse events seen with combination of etanercept and anakinra therapy, similar toxicities may also result from the combination of anakinra and other TNFα -blocking agents. ||| Serious infections were seen in clinical studies with concurrent use of anakinra and another TNF-antagonist, etanercept, with no added clinical benefit compared to etanercept alone. ||| En raison de la nature des effets indésirables observés lors de l’ association thérapeutique de l’ anakinra et de l’ étanercept, des toxicités similaires peuvent résulter de l’ association entre l’ anakinra avec un autre agent anti-TNFα.
0.30234307050704956 ||| In clinical trials involving 813 patients, the average prolongation was around 3%, and 1.2% of patients developed Q-Tc intervals greater than 500 msec (prolongation of 100 msecs in 0.3%), but with no arrhythmic effects. ||| The first three studies showed that patients receiving Xolair had around half as many exacerbations of asthma over the first 28 or 52 weeks of treatment, with around 0.5 exacerbations per year in the Xolair group and around one per year in the placebo group. ||| Dans des études cliniques portant sur 813 patients, l 'allongement moyen était de 3%, et 1,2% d'entre eux ont présenté des intervalles QTc supérieurs à 500 msec (allongement de 100 msec dans 0,3% des cas) mais sans arythmie.
0.708027720451355 ||| We have made good progress on both fronts in 1997, as the Executive Director explains in his report. ||| In recent days many of you have quoted Jean Monnet on Europe being forged in crises. ||| Nous avons beaucoup progressé sur ces deux fronts en 1997, comme le directeur exécutif l’ explique dans son rapport.
0.08395186066627502 ||| Gadovist 1.0 mmol/ ml solution for injection in prefilled syringe Gadobutrol Intravenous use ||| Gadovist 1.0 mmol/ ml solution for injection in prefilled syringe Gadobutrol ||| Gadovist 1,0 mmol/ ml, solution injectable en seringue préremplie Gadobutrol Voie intraveineuse
0.20609182119369507 ||| HOW TO TAKE JANUMET ||| HOW TO TAKE MIMPARA ||| COMMENT PRENDRE JANUMET
0.4465405344963074 ||| Statues of common metal ||| Meshes of common metal ||| Statues en métaux communs
0.5507825613021851 ||| Global Citizen CEO and co-founder Hugh Evans said:"Global Goal: Unite for Our Future was launched in response to the COVID-19 pandemic, and we are proud to join the European Commission, and over 40 governments from around the world, to ensure COVID-19 tests, treatments and vaccines would be made available for everyone, everywhere. ||| Geoff Keighley, who had organized and hosted the E3 Coliseum, a live-streamed event over the course of E3 with interviews with developers and publishers, since E3 2017, said that he had decided not to participate this year nor be a part of E3, the first time in 25 years. ||| M. Hugh Evans, cofondateur et directeur général de Global Citizen, s'est exprimé en ces termes:«La campagne «Objectif mondial: unis pour notre avenir» a été lancée en réaction à la pandémie de COVID-19 et nous sommes fiers de nous associer avec la Commission européenne et plus de 40 gouvernements du monde entier pour faire en sorte que les tests de dépistage, les traitements et les vaccins contre la COVID-19 puissent être accessibles à tous et partout.
0.3480428457260132 ||| In clinical trials, the decrease in bodyweight with orlistat treatment was less in type II diabetic patients than in non-diabetic patients. ||| In a study conducted in elderly subjects with schizophrenia, the safety profile was similar to that seen in non-elderly subjects. ||| La perte de poids sous orlistat observée au cours des études cliniques, était inférieure chez les patients présentant un diabète de type 2 à celle observée chez les patients non diabétiques.
0.7539362907409668 ||| Hypothyroidism§, uc ||| Hypotension*, haematoma ||| Thrombocytopénie, lymphadénopathie Fréquent:
0.36900365352630615 ||| 16 medicinal products with Stalevo should be carefully observed for loss of therapeutic response. ||| More frequent therapeutic concentration monitoring is recommended until plasma levels of these products have been stabilised. ||| Les patients prenant ces médicaments et Stalevo doivent être surveillés étroitement à la recherche d'une disparition de la réponse thérapeutique.
0.31911975145339966 ||| In all of the studies, the main measure of effectiveness was the change in symptoms. ||| The main measure of effectiveness was based on the number of new bone complications. ||| Dans l’ ensemble de ces études, la principale mesure d’ efficacité a été l’ évolution des symptômes.
0.13193261623382568 ||| 115 Step 2. ||| 172 Step 2. ||| Etape 2.
0.1363694965839386 ||| 1 pre-filled syringe contains 6000 IU Epoetin zeta ||| 1 pre-filled syringe contains 1000 IU epoetin beta. ||| 1 seringue préremplie contient 6 000 UI d’ époétine zêta
0.42451125383377075 ||| If pregnancy is detected during therapy, Tekturna should be discontinued accordingly. ||| Ideally, pregnancy testing, issuing a prescription and dispensing should occur on the same day. ||| Par conséquent, si une grossesse est détectée pendant le traitement, Tekturna doit être interrompu.
0.11972509324550629 ||| 33 3. ||| 34 3. ||| 5,33
0.48509612679481506 ||| Do not handle this product if you know you are hypersensitive. ||| Do not try to inject yourself if you have not been trained. ro ||| En cas d’ hypersensibilité connue, ne pas manipuler le produit.
0.044171854853630066 ||| Pritor may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Pritor. ||| Kinzalmono may also be used in combination with diuretics ('water tablets') such as hydrochlorothiazide which has been shown to have an additive blood pressure lowering effect with Kinzalmono. ||| Pritor peut également être associé à des diurétiques comme l’ hydrochlorothiazide, une augmentation de l’ effet thérapeutique sur la pression artérielle ayant été mise en évidence en cas d’ association de ces deux médicaments.
0.41413748264312744 ||| Lesion conspicuity of hypo- and hypervascular lesions may be reduced if imaging is delayed more than 3 minutes due to the diffusion of the contrast agent into the interstitial spaces of both the liver parenchyma and lesion (e. g. metastasis) making the lesion isointense with the normal liver parenchyma. ||| 5 Fluorescence emission can be classified as intense (solid) red fluorescence (corresponds to vital, solid tumour tissue) and vague pink fluorescence (corresponds to infiltrating tumour cells), whereas normal brain tissue lacking enhanced PPIX levels reflects the violet-blue light and appears blue. ||| Si l’ acquisition des images est retardée de plus de 3 minutes, la visualisation des lésions hypovasculaires et hypervasculaires peut être diminuée, en raison de la diffusion du produit de contraste vers les espaces interstitiels tant du parenchyme hépatique que de la lésion (métastase, par ex.), mettant la lésion en isosignal avec le parenchyme hépatique sain environnant.
0.38124316930770874 ||| Instructions for preparation, see section 6.6. ||| For information on preparation of Lucentis, see section 6.6. ||| Instructions pour la manipulation: cf chapitre 6.6.
6.439281616602011e-13 ||| Never turn the dosage selector after injection button has been pulled out. ||| Never turn the dosage selector after injection button has been pulled out. ||| Ne jamais tourner le sélecteur de dose après avoir tiré le bouton d’ injection
0.0 ||| Recommended dose ||| Recommended dose ||| Posologie recommandée:
0.33063793182373047 ||| The wide variation in individual responses implies that the effects of CEPROTIN on coagulation parameters should be checked regularly. ||| Regardless of the route of dosing, pronounced pharmacodynamic changes are associated with the administration of Rebif. ||| La grande variation des réponses individuelles nécessite que les effets de CEPROTIN sur les paramètres de la coagulation soient vérifiés régulièrement.
0.16732501983642578 ||| The safety and efficacy of nelfinavir has not been established in patients with significant underlying liver disorders. ||| The safety and efficacy of the use of InductOs in patients with known autoimmune disease have not been established. ||| La tolérance et l'efficacité du nelfinavir n'ont pas été établies chez les patients présentant des troubles sous-jacents significatifs de la fonction hépatique.
0.1728832721710205 ||| Do not take Pelzont if • you are allergic (hypersensitive) to nicotinic acid, to laropiprant, or to any of the other ingredients of Pelzont (listed in section 6). • you currently have liver problems. • you have an ulcer in your stomach. • you have arterial bleeding. ||| • you are allergic (hypersensitive) to docetaxel or any of the other ingredients of Docetaxel Winthrop. • the number of white blood cells is too low. • you have a severe liver disease. • you are pregnant or breast feeding. ||| Ne prenez jamais Pelzont, si • vous êtes allergique (hypersensible) à l’ acide nicotinique, au laropiprant ou à l’ un des autres composants contenus dans Pelzont (indiqués en rubrique 6), • vous souffrez d’ un mauvais fonctionnement du foie, • vous avez un ulcère à l’ estomac, • vous présentez des saignements artériels.
0.2407940775156021 ||| Therefore, the use of Galvus is not recommended in these patients. ||| Therefore the use of Icandra is not recommended in this population. ||| L’ utilisation de Galvus n’ est donc pas recommandée chez ces patients.
0.34749674797058105 ||| Snow removal apparatus [machines] ||| Arc welding apparatus [electric machines] ||| Appareils de déneigement [machines]
0.23380929231643677 ||| Degree in law from the University of Genoa. ||| Degree in medicine and surgery from the University of Rome. ||| Licence en droit de l’université de Gènes.
0.3339973986148834 ||| When the receptors are blocked, histamine cannot have its effect, and this leads to a decrease in the symptoms of allergy. ||| When the enzyme is blocked, the virus does not reproduce normally, slowing down the spread of infection. ||| Lorsque les récepteurs sont bloqués, l’ histamine ne peut plus jouer son rôle habituel et les symptômes allergiques sont alors diminués.
0.13564440608024597 ||| Gender, race, elderly: ||| 47 Gender, race, elderly: ||| Sexe, population et âge:
0.0 ||| The trials compared the efficacy of Viraferon used alone or in combination with ribavirin. ||| The trials compared the efficacy of Viraferon used alone or in combination with ribavirin. ||| Les études comparaient l’ efficacité du Viraferon utilisé seul ou en association avec la am
0.0 ||| 66 10. ||| 66 10. ||| 10.
0.07060147821903229 ||| Film-coated tablet 50 mg: ||| 30 mg film-coated tablet: ||| 50 mg:
0.007327069994062185 ||| Please read the following instructions carefully before using your Actraphane 10 NovoLet. ||| Please read the following instructions carefully before using your Actraphane 20 NovoLet. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Actraphane 10 NovoLet.
0.4592077136039734 ||| The injection site should be dry before you inject. ||| The injection site is changed for each injection. ||| Veillez à ce que le site d’injection soit bien sec avant de faire la piqûre.
0.3982255458831787 ||| SUSTIVA must always be taken in combination with other anti-HIV medicines. ||| - Take your other HIV medicines used in combination with PREZISTA and ritonavir as ||| SUSTIVA doit toujours être associé à d’ autres médicaments anti-VIH.
0.5108276605606079 ||| 61.215 mg lactose monohydrate For a full list of excipients, see section 6.1. ||| - Tablet core: lactose monohydrate (See also end of section 2 – important information about some ||| Pour la liste complète des excipients, voir rubrique 6.1.
0.0016615395434200764 ||| 48 The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) ” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| 8 The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2) ” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.3162778913974762 ||| Ritonavir increases the serum levels of tipranavir as a result of CYP3A inhibition. ||| Co-administration of amprenavir with methadone leads to a decrease of methadone concentrations. ||| Le ritonavir augmente les concentrations sériques du tipranavir par inhibition du CYP3A.
0.23812514543533325 ||| They recommended that TRAVATAN be given marketing authorisation. ||| Hence they recommended that CHAMPIX be given marketing authorisation. ||| Il a recommandé que TRAVATAN reçoive une autorisation de mise sur le marché.
0.3392029404640198 ||| Two cases of constipation with faecal impaction requiring hospitalisation have been reported in association with palonosetron 750 micrograms. ||| The mean incidence of peripheral oedema evenly weighted across all doses was 5.1% with the amlodipine/ valsartan combination. ||| Deux cas de constipation avec fécalome nécessitant une hospitalisation ont été rapportés après l'administration de 750 microgrammes de palonosétron.
0.4953962564468384 ||| Gabapentin is removed from plasma by haemodialysis. ||| Tocilizumab normalises expression of these enzymes. ||| La gabapentine peut être éliminée du plasma par hémodialyse.
0.5471724271774292 ||| Each syringe should be used for a single injection only. ||| The vial is for a single examination only. ||| Chaque seringue doit être utilisée pour une seule injection uniquement.
0.32859814167022705 ||| Before initiation of growth hormone therapy, you should be observed for breathing problems during the night using a special monitor. ||| Before each injection, a local anaesthetic will be given to reduce or prevent any pain from the injection. ||| Avant le début du traitement, vous devez être suivi spécifiquement pour la recherche de problèmes respiratoires pendant la nuit.
0.3823719918727875 ||| Therefore no conclusions on the effect of enzyme replacement therapy on the neurological manifestations of the disease can be drawn. ||| From the interim analysis, the study hypothesis of an adverse effect on breast cancer risk has no support. ||| Par conséquent, aucune conclusion sur l’ effet d’ un traitement enzymatique de substitution sur les manifestations neurologiques de la maladie ne peut être tirée.
0.2088724970817566 ||| Particular caution should be exercised, and intensified blood glucose monitoring is advisable in patients in whom hypoglycaemic episodes might be of particular clinical relevance, such as in patients with significant stenoses of the coronary arteries or of the blood vessels supplying the brain (risk of cardiac or cerebral complications of hypoglycaemia) as well as in patients with proliferative retinopathy, particularly if not treated with photocoagulation (risk of transient amaurosis following hypoglycaemia). ||| Tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. ||| Il faut être particulièrement prudent et intensifier la surveillance de la glycémie chez les patients pour lesquels les épisodes hypoglycémiques risqueraient d'avoir des conséquences cliniques particulièrement graves, par exemple en cas de sténose serrée des artères coronaires ou carotidiennes (risque de complications cardiaques ou cérébrales de l'hypoglycémie), de même qu'en cas de rétinopathie proliférante, surtout si celle -ci n'est pas traitée par photocoagulation (risque d'amaurose transitoire après une hypoglycémie).
5.904601894229922e-13 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224 ||| 501 Lietuva UAB sanofi-aventis Lietuva Tel: +370 5 2755224
0.6085481643676758 ||| Dry throat ||| Dry screed ||| Gorge sèche
0.004604985471814871 ||| 19 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 18 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 20 MENTIONS DEVANT FIGURER À TITRE MINIMAL SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.15229052305221558 ||| The CHMP has recommended the granting of the Marketing Authorisation(s) for which the Summaries of Product Characteristics, labelling and package leaflet are set out in Annex III for Nifedipinr Pharmamatch Retard 30/ 60 mg and associated names (see Annex I). ||| the CHMP has recommended the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet remain as per the final versions achieved during the Coordination Group procedure as mentioned in Annex III for Bleomycin Pharmachemie and associated names (see Annex I). ||| le CHMP a recommandé l’ octroi des autorisations de mise sur le marché pour lesquelles les résumés des caractéristiques du produit, de l’ étiquetage et de la notice sont présentés à l’ annexe III pour Pharmamatch Retard 30/ 60 mg et les dénominations associées (voir annexe I).
0.3302770256996155 ||| 2.4 mg (120 KIU); 4.3 ml 0.6 mg/ ml (30 KIU/ ml) ||| 1.2 mg (60 KIU), 2.4 mg (120 KIU) and 4.8 mg (240 KIU). ||| 4,3 ml 0,6 mg/ ml (30 KUI/ ml)
0.23128649592399597 ||| Education advisory services relating to accountancy ||| Cultivation advisory services relating to agriculture ||| Services de conseils éducatifs en matière de comptabilité
0.39775240421295166 ||| On rare occasions, hyperaemia of the treated area has been observed. ||| In rare instances, these cases were associated with swelling of the entire limb. ||| Dans de rares cas, une hyperémie de la zone traitée a été observée.
0.4390840530395508 ||| Paroxetin AL 20 mg Filmtabletten ||| Paroxetin beta Filmtabletten ||| Paroxetin-Isis 20 mg
0.35131388902664185 ||| If you stop taking Preotact before finishing the treatment please inform you doctor. ||| If you are affected your doctor may suggest that you take STOCRIN at bedtime. ||| Si vous arrêtez de prendre Preotact Si vous arrêtez de prendre Preotact avant d’ avoir fini votre traitement, veuillez en informer votre médecin.
3.3606269351539597e-13 ||| Patients should be advised that current antiretroviral therapy does not cure HIV and has not been proven to prevent the transmission of HIV to others through blood or sexual contact. ||| Patients should be advised that current antiretroviral therapy does not cure HIV and has not been proven to prevent the transmission of HIV to others through blood or sexual contact. ||| Les patients devront être informés que les traitements antirétroviraux actuellement disponibles ne guérissent pas l'infection par le VIH et n’ ont pas démontré leur capacité à prévenir le risque de transmission du VIH à d’ autres personnes par voies sanguine ou sexuelle.
0.42866596579551697 ||| Auxiliary fluids for use with additives for fungicides ||| Clay for use as thixotropic agents for suspensions ||| Fluides auxiliaires utilisés avec des additifs pour les fongicides
0.20887067914009094 ||| What Velmetia looks like and contents of the pack ||| What Ribavirin Teva looks like and contents of the pack ||| Qu’est ce que Velmetia et contenu de l’emballage extérieur
0.3640512228012085 ||| The mean steady state volume of distribution (Vss) for sildenafil is 105 l, indicating distribution into the tissues. ||| The geometric mean apparent volume of distribution at steady state (Vdss) is approximately 66 l in humans. ||| Le volume de distribution moyen (Vss) à l’ état d’ équilibre du sildénafil est de 105 l, ce qui suggère une distribution tissulaire.
4.492025783460474e-13 ||| 4 ||| 4 ||| 68
0.5524466037750244 ||| As of 25 February, all 16 cases were recovered. ||| On 29 January, reports surged that masks were sold out. ||| Au 25 février, les 16 cas avaient été récupérés,,,,.
0.41091811656951904 ||| Asymptomatic or mildly symptomatic NYHA class I – II events were observed in 3.0% of patients in the Herceptin arm compared to 0.5% of patients in the observation arm. ||| The proportion of patients who discontinued treatment due to adverse events during the double-blind, controlled portion of Studies I− IX, CLASSIC I, GAIN and CHARM was 5.7% for patients taking ||| Les événements asymptomatiques ou modérément symptomatiques de classe I-II (NYHA) ont été observés chez 3,0% des patients du groupe Herceptin comparé à 0,5% des patients du groupe observationnel.
0.25942462682724 ||| Medicinal products which increase gastric pH may reduce the absorption of doxycycline, and should be taken at least 2 hours after doxycycline. ||| As ibuprofen may decrease the clearance of aminoglycosides, strict surveillance of their serum levels is recommended during co-administration with ibuprofen. ||| Les médicaments entraînant une augmentation du pH gastrique peuvent réduire l’ absorption de doxycycline et doivent également être pris 2 heures au moins après la prise de doxycycline.
0.050062134861946106 ||| Metacam 0.5 mg/ ml oral suspension for dogs ||| Flexicam 1.5 mg/ ml oral suspension for dogs ||| Metacam 0,5 mg/ ml suspension orale pour chiens
0.019241448491811752 ||| 80 Management of overdose There is no specific antidote for olanzapine. ||| 52 Management of overdose There is no specific antidote for olanzapine. ||| Traitement du surdosage Il n’ y a pas d’ antidote spécifique de l’ olanzapine.
0.3881479501724243 ||| Regarding the storage stability, the Applicant complemented the already submitted repriming study with comparative data from inverted storage and found that all investigated shots for the generic product comply with the specified delivered dose up to a storage period of 7 days. ||| Establishment of the withdrawal period following consideration of all residue studies for pigs and cattle available With the submission of the new residue study for cattle the MAH proposed a withdrawal period of 96 days based on the statistical method. ||| Concernant la stabilité de conservation, le demandeur a complété l’ étude de réamorçage déjà soumise avec des données comparatives de conservation en position retournée et a trouvé que toutes les pulvérisations étudiées pour le produit générique correspondaient à la dose délivrée spécifiée pour une durée de conservation allant jusqu’ à 7 jours.
0.36481261253356934 ||| Convulsions with or without fever, occurring within 3 days of vaccination. ||| *Reactions occurring during or within 24 hours of infusion. ||| Convulsions, avec ou sans fièvre, survenant dans les 3 jours après la vaccination.
0.4480711817741394 ||| Study features and results are presented in the table below. ||| Results at 48 weeks are presented in the table. ||| Les caractéristiques et les résultats de l’ étude sont présentés dans le tableau ci-dessous.
0.05265749990940094 ||| The Committee recommended that Thymanax be given marketing authorisation. ||| The Committee recommended that Myfenax be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Thymanax.
0.059939607977867126 ||| Do not use after the expiry date stated on the ampoule label. ||| Do not use after the expiry date stated on the ampoule. ||| Ne pas utiliser après la date de péremption figurant sur l'étiquette de l’ampoule.
0.48429951071739197 ||| Rectifier modules ||| Illumination regulators ||| Modules redresseurs
0.40598446130752563 ||| Dietetic sugar substitutes for medical use ||| Chemically activated cold compresses for medical use ||| Succédanés diététiques du sucre à usage médical
0.5012496113777161 ||| Hanging folders ||| Sounding leads ||| Dossiers suspendus
0.0 ||| Blood and lymphatic system disorders ||| Blood and lymphatic system disorders ||| Affections du système sanguin et lymphatique
2.7856138077632375e-13 ||| There have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy. ||| There have been rare reports of patients, including rheumatoid factor positive patients, who have developed other autoantibodies in conjunction with a lupus-like syndrome or rashes that are compatible with subacute cutaneous lupus or discoid lupus by clinical presentation and biopsy. ||| 66 Ont été rapportés, de rares cas de patients (y compris ceux ayant un facteur rhumatoïde positif), ayant développé d’ autres auto-anticorps associés à un syndrome lupique ou à des éruptions compatibles sur le plan clinique et après biopsie, avec un lupus cutané subaigu ou un lupus discoïde.
0.2646586298942566 ||| The proteinuria seen in clinical trials was not associated with renal dysfunction and rarely required permanent discontinuation of therapy. ||| Recovery could be slow and recurrences of the syndrome have been reported in some cases after discontinuation of corticosteroid therapy. ||| La protéinurie observée dans les essais cliniques n’ a pas été associée à un dysfonctionnement rénal et a rarement justifié un arrêt définitif du traitement.
0.28612038493156433 ||| It should not be used by women who are pregnant or breast-feeding, and in women with moderate or severe kidney or liver disease. ||| TESAVEL is not recommended for use in patients who have moderate or severe problems with their kidneys, or in patients aged less than 18 years. ||| Il ne devrait pas être utilisé par les femmes enceintes ou qui allaitent, ni par celles atteintes d’ affections rénales ou hépatiques modérées ou graves.
0.0 ||| System Organ Class ||| System Organ Class ||| Classes de sytèmes d’ organes
0.19640082120895386 ||| Pharmacodynamic effects Levetiracetam induces seizure protection in a broad range of animal models of partial and primary generalised seizures without having a pro-convulsant effect. ||| Pharmacodynamic effects Lacosamide protected against seizures in a broad range of animal models of partial and primary generalized seizures and delayed kindling development. ||| 59 Le lévétiracétam induit une protection contre les crises sur un grand nombre de modèles animaux de convulsions de type partielles et primaires généralisées sans avoir un effet proconvulsivant.
0.2581683397293091 ||| There is no relevant influence of renal function measured by creatinine clearance on trabectedin pharmacokinetics within the range of values (≥ 34.4 ml/ min) present in the patients included in the clinical studies. ||| The magnitude of this measurement artefact is proportional to the concentration of gadoversetamide in the blood, and in patients with normal renal clearance accurate values can be obtained approximately 90 minutes following injection. ||| Chez les patients inclus dans les études cliniques, la fonction rénale n’ a pas affecté les paramètres pharmacocinétiques du médicament, quand la clairance de la créatinine était ≥ 34,4 ml/ min.
0.0 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/. ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/. ||| Des information détaillées sur ce médicament sont disponibles sur le site internet de l’Agence Européenne du Médicament (EMEA): http://www.emea.europa.eu/.----------------------------------------- ------------------------------------------------------------------------------
0.21307969093322754 ||| Mannitol, hydrochloric acid, sodium hydroxide. ||| Sucrose, phosphoric acid, sodium hydroxide. ||| Mannitol, acide chlorhydrique, hydroxyde de sodium.
0.1495472639799118 ||| Other CNS effects including aggressive behaviour (sometimes directed against others), confusion and alterations of mental status have been observed with alpha interferons. ||| Other CNS effects including aggressive behaviour (sometimes directed against others), bipolar disorders, mania, confusion and alterations of mental status have been observed with alpha interferons. ||| D’ autres effets sur le SNC comprenant comportement agressif (parfois dirigé contre autrui), confusion et autres altérations de l’ état mental ont été observés avec l’ interféron alpha.
0.0 ||| Do not soak, wash or lubricate the pen as this may damage it. ||| Do not soak, wash or lubricate the pen as this may damage it. ||| 832 Ne pas faire tremper, ni laver ou lubrifier le stylo car cela risquerait de l’endommager.
0.4212362468242645 ||| The oral solution should be used in patients below three months of age. ||| The disease is usually diagnosed in infants between one and five years of age. ||| La solution buvable doit être utilisée chez des patients âgés de moins de trois mois.
1.194122552871704 ||| dizziness, headache ||| dizziness orthostatic dizziness ||| sensation vertigineuse, céphalée
0.35150134563446045 ||| Polymers for use in the analysis of biochemicals ||| Laboratory reagents for scientific use in analysing hydrocarbons ||| Polymères destinés à l'analyse de produits biochimiques
0.5706669092178345 ||| Dusting apparatus, non-electric ||| Beaters, non-electric ||| Dépoussiéreurs non électriques
0.029065009206533432 ||| 150 micrograms/0.5 ml ||| 80 micrograms/0.5 ml ||| 150 microgrammes/ 0,5 ml
0.20428058505058289 ||| As with other anticoagulants, the most common side effect of Xigris is bleeding. ||| As with other anticoagulants, bleeding is the most common adverse reaction. ||| Comme avec d’ autres anticoagulants, l’ effet secondaire le plus fréquemment associé à Xigris est celui de l’ hémorragie.
0.4721965491771698 ||| Bioremediation services ||| Biological cloning services ||| Services de bioremédiation
0.15166258811950684 ||| Dispose of your used Mixtard 40 NovoLet carefully without the needle attached. ||| Dispose of your used NovoRapid NovoLet carefully without the needle attached. ||| Eliminez votre Mixtard 40 NovoLet usagé prudemment, sans l’ aiguille attachée.
0.2672661542892456 ||| In patients who develop severe diarrhoea during or after use of cefuroxime axetil, the risk of life threatening pseudomembranous colitis should be taken into account. ||| Etoricoxib, as with other medicinal products inhibiting prostaglandin synthesis, may cause uterine inertia and premature closure of the ductus arteriosus during the last trimester. ||| Un risque de colite pseudomembraneuse potentiellement fatale doit être pris en compte en cas de survenue d’ une diarrhée sévère pendant ou au décours d’ un traitement par céfuroxime axétil.
0.007406134158372879 |||  346 If you are injecting IntronA yourself, please be sure that the dose that has been prescribed for you is clearly provided with the package of medicine you receive. |||  379 If you are injecting IntronA yourself, please be sure that the dose that has been prescribed for you is clearly provided with the package of medicine you receive. ||| Si vous vous injectez vous -même IntronA, assurez -vous que la dose qui vous a été prescrite est réellement indiquée sur l’ emballage du médicament que vous recevez.
0.10603918135166168 ||| Read the package leaflet before use. lp ||| Read the package leaflet before use. ro lp ||| Lire la notice avant utilisation.
0.023069463670253754 ||| Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate. ||| Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Hypromellose Silicon dioxide Magnesium stearate ||| Lactose monohydraté Cellulose microcristalline Croscarmellose sodique Hypromellose Dioxyde de silicone Stéarate de magnésium.
0.9466090798377991 ||| Steinaclox- Medichrom ||| Narrow-angle glaucoma ||| Steinaclox-Medichrom
0.3506259620189667 ||| Preparations for destroying mice ||| Preparations for fortifying plants ||| Produits pour détruire les souris
0.09074468910694122 ||| Clothing for protection against biological hazards ||| Footwear for protection against biological hazards ||| Vêtements de protection contre les risques biologiques
0.2986760139465332 ||| For children weighing at least 30 kg: the adult dosage of 150 mg twice daily should be taken. ||| For patients who can swallow tablets, the recommended dose is 25 mg once daily in patients > 20 to < 50 kg. ||| 2 Pour les enfants pesant au moins 30 kg: la posologie utilisée chez les adultes, de 150 mg deux fois par jour, devra être administrée.
0.023742102086544037 ||| As with other ACE inhibitors, Zestril may be less effective in lowering blood pressure in black patients than in non-blacks, possibly because of a higher prevalence of low-renin states in the black hypertensive population. ||| As with other ACE inhibitors, perindopril may be less effective in lowering blood pressure in black people than in non-blacks, possibly because of a higher prevalence of low-renin states in the black hypertensive population. ||| Comme avec les autres IEC, l'effet antihypertenseur de Zestril peut-être moins marqué chez les patients de population noire que chez les autres populations de patients; à cause d’ une prévalence accrue de patients à faible activité rénine dans la population noire hypertendue.
0.44434452056884766 ||| This difference is not considered clinically relevant. ||| The difference was not statistically significant: ||| Cette différence n’ est pas considérée comme cliniquement significative.
0.4070742130279541 ||| Turtleneck sweaters ||| Mock turtleneck sweaters ||| Pulls à col roulé
0.16652905941009521 ||| Any unused infusion solution should be disposed of. ||| Any unused injection or infusion solutions should be disposed of. ||| Toute solution injectable non utilisée doit être éliminée.
0.14844894409179688 ||| ORENCIA 250 mg powder for concentrate for solution for infusion Abatacept ||| ORENCIA 250 mg powder for concentrate for solution for infusion Abatacept Intravenous use ||| ORENCIA 250 mg, poudre pour solution à diluer pour perfusion Abatacept
0.4583981931209564 ||| National authorities will be able to adjust their aid schemes to reduce the risk of contamination. ||| The aim of the schemes is to help businesses cover immediate working capital or investment needs. ||| Les autorités nationales seront en mesure d'adapter leurs régimes d'aide afin de réduire le risque de contamination.
0.3315804600715637 ||| Tensioning heads being parts of machines ||| Cylinders being parts of machines ||| Têtes de tension en tant que parties de machines
0.45792466402053833 ||| Serum electrolytes should be monitored. ||| Renal function and serum potassium should be monitored. ||| L’ ionogramme sanguin (taux d’ électrolytes) doit être contrôlé.
0.31609880924224854 ||| - excess fluid in the body (oedema); swelling of the arms and legs (peripheral oedema) ||| - bleeding (including bleeding in the brain, gut wall and respiratory tract; haemorrhage) ||| - excès de fluide dans le corps (œ dème), gonflement des bras et des jambes (œ dème périphérique)
0.04242685064673424 ||| 68 This leaflet was last approved in {MM/ YYYY}. ||| 183 This leaflet was last approved in {MM/YYYY}. ||| La dernière date à laquelle cette notice a été approuvée est {MM/AAAA}.
0.6225892901420593 ||| Data in humans ||| Tip in liquid ||| Données obtenues chez l’homme
0.013842904940247536 ||| 140 150 IU/ kg 3x/ week or 450 IU/ kg once weekly ||| 20 150 IU/ kg 3x/ week or 450 IU/ kg once weekly ||| 140 150 UI/ kg 3 x/ semaine ou 450 UI/ kg 1 x/ semaine
0.5044264793395996 ||| Revlimid is taken in combination with dexamethasone. ||| 18 Zonisamide is a benzisoxazole derivative. ||| Revlimid est utilisé en association avec la dexaméthasone.
0.28078800439834595 ||| An increased incidence of altered renal microscopic morphology (collecting tubule basophilia) was observed in rats following chronic oral administration of sapropterin dihydrochloride at exposures at or slightly above the maximal recommended human dose. ||| Gastrointestinal pain and presence of excessive amount of gas in the stomach or bowels (flatulence), mostly mild increases in liver laboratory values (bilirubin, transaminases) which will return to normal values once treatment is over. ||| 8 Une augmentation de l'incidence des altérations morphologiques microscopiques rénales (basophilie des tubes collecteurs) a été observée chez le rat après administration orale chronique de dichlorhydrate de saproptérine à une dose légèrement supérieure ou égale à la dose maximale recommandée chez l’ homme.
0.5728750824928284 ||| Mediation and conclusion of commercial transactions for others ||| Conducting foreign exchange transactions for others ||| Conclusion de transactions commerciales pour le compte de tiers
0.014763899147510529 ||| The incidence of injection site reactions may be reduced by the use of an auto-injector. ||| The incidence of injection site reactions may be reduced by the use of an autoinjector. ||| L’ incidence des réactions au point d’ injection peut être réduite avec l’ utilisation d’ un autoinjecteur.
0.36008283495903015 ||| At present, there is insufficient clinical experience in these patients to provide dosing recommendations. ||| Currently, there are no data specific to this patient population and therefore specific dosage recommendations cannot be made. ||| A ce jour, l’ expérience clinique chez ces patients est trop limitée pour permettre des recommandations posologiques spécifiques.
0.7173489332199097 ||| Pale yellow clear liquid that may have a pink tint ||| or A white to slightly yellowish ointment. ||| Liquide clair, jaune pâle, pouvant avoir une teinte rosée
0.2798754572868347 ||| Always tell your doctor or pharmacist if you are taking any of these medicines that are often used for the relief of angina pectoris (or “ chest pain”). ||| Therefore, you should discuss the benefits of Silapo with your doctor, particularly if you are obese or have a history of blood clots/blood clotting disorders. ||| Prevenez toujours votre médecin ou votre pharmacien si vous prenez l’ un de ces médicaments qui sont souvent utilisés pour le soulagement des crises d’ angine de poitrine (ou angor).
0.3165946304798126 ||| If you stop taking ADENURIC Do not stop taking ADENURIC without the advice of your doctor even if you feel better. ||| If you stop taking LYRICA Do not stop taking LYRICA unless your doctor tells you to. ||| Si vous arrêtez de prendre ADENURIC N’ arrêtez pas de prendre ADENURIC sans l'avis de votre médecin, même si vous vous sentez mieux.
0.06383241713047028 ||| a) 01.01.95 b) 17.05.95 c) 107 days d) 30 days ||| a) 01.01.95 b) 22.11.95 c) 245 days d) 81 days ||| a) 01.01.95 b) 17.05.95 c) 107 jours d) 30 jours
0.652521014213562 ||| VIAL LABEL FOR THE SOLVENT ||| VIAL OF POWDER ||| ETIQUETTE DU FLACON DE SOLVANT
0.42741119861602783 ||| Real estate and property management services ||| Financial management of real estate projects ||| Gestion immobilière et de propriétés
0.24280838668346405 ||| Shaping machines [electric] ||| Metal welding machines [electric] ||| Machines à raboter électriques
0.6329197883605957 ||| Detergent compositions for cleaning golf clubs ||| Instructions f or alternate injection sites ||| Compositions détergentes pour nettoyer les clubs de golf
0.19837146997451782 ||| Due to both the potential risk of neonate hypoglycaemia related to metformin and the lack of human data with vildagliptin, Zomarist should not be used during lactation (see section 4.3). ||| Since increased concentrations of lovastatin and simvastatin may predispose patients to myopathies, including rhabdomyolysis, the combination of these medicinal products with ritonavir is contraindicated (see section 4.3). ||| En raison à la fois du risque potentiel d’ hypoglycémie chez le nouveau-né lié à la metformine et de l’ absence de données chez l’ Homme avec la vildagliptine, Zomarist ne doit pas être utilisé pendant l’ allaitement (voir rubrique 4.3).
0.1365007609128952 ||| The duration of treatment depends on the indication for treatment and the patient´s response. ||| The duration of treatment depends on the patient’ s condition and response to treatment. ||| La durée du traitement dépend de l’ indication traitée et de la réponse du patient.
0.539333701133728 ||| ADROVANCE reduces the risk of vertebral and hip fractures. ||| Elevated FSH blood levels are indicative of testicular damage. ||| ADROVANCE réduit le risque de fractures vertébrales et de la hanche.
3.330440307217075e-13 ||| Erythropoietin is a growth factor that primarily stimulates red cell production. ||| Erythropoietin is a growth factor that primarily stimulates red cell production. ||| L’ érythropoïétine est un facteur de croissance qui stimule essentiellement la production de globules rouges.
0.3946847915649414 ||| Vardenafil (10 mg) did not potentiate the increase in bleeding time caused by acetylsalicylic acid (2 x 81 mg). ||| Enbrel 25 mg was significantly superior to methotrexate for erosion scores at both 12 and 24 months. ||| Le vardénafil (10 mg) ne potentialise pas l'allongement du temps de saignement induit pas l'acide acétylsalicylique (2 x 81 mg).
0.3918534815311432 ||| Suicide-related behaviours (suicide attempt and suicidal thoughts), and hostility (predominantly aggression, oppositional behaviour and anger) were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared to those treated with placebo. ||| As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate behaviours (vocalisation and inappropriate defecation and/ or urination) and only in combination with behavioural modification techniques. ||| Des comportements de type suicidaire (tentatives de suicide et idées suicidaires) et de type hostile (principalement agressivité, comportement d’ opposition et colère) ont été plus fréquemment observés au cours des études cliniques chez les enfants et adolescents traités par antidépresseurs par rapport à ceux traités par placebo.
0.280055433511734 ||| Treatment with Binocrit may be associated with an increased risk of blood clotting after the surgery (postoperative thrombotic/ vascular disorders) if your levels of the red blood pigment are too high. ||| Take special care with Ferriprox − if you have a history of neutropenia, since one of the most serious side effects that may occur is a very low white blood cell (neutrophil) count. ||| Le traitement par Binocrit peut être associé à un risque accru de formation post-opératoire de caillots sanguins (troubles vasculaires/ thrombotiques post-opératoires) si votre taux sanguin d’ hémoglobine (pigment rouge du sang) est trop élevé.
0.3445572555065155 ||| Therefore at concentrations observed in the plasma (approximately 4% relative to parent ambrisentan), 4-hydroxymethyl ambrisentan is not expected to contribute to pharmacological activity of ambrisentan. ||| tho concomitant methotrexate, the incidence was 12.4%, compared to 0.6% when adalimumab was used as add-on to methotrexate. ||| Par conséquent, aux concentrations observées dans le plasma (environ 4% par rapport à l’ ambrisentan parent), le 4 hydroxyméthyl ambrisentan ne devrait pas contribuer à l’ activité pharmacologique de l’ ambrisentan.
0.2834484577178955 ||| The pharmacokinetics of ranolazine have been evaluated in patients with mild or moderate hepatic impairment. ||| The pharmacokinetics of abacavir in patients with end-stage renal disease is similar to patients with normal renal function. ||| Insuffisance hépatique: la pharmacocinétique de la ranolazine a été évaluée chez des patients atteints d’ insuffisance hépatique légère ou modérée.
0.4264480769634247 ||| 40 • If you experience severe muscle pain as it could be a sign of rhabdomyolysis (damage to the muscles, see section 4). ||| If you are a woman, this treatment increases your risk of developing ovarian hyperstimulation syndrome (OHSS) (see Section 4). ||| • si vous éprouvez de vives douleurs musculaires, car cela pourrait traduire une rhabdomyolyse (lésion des muscles, voir rubrique 4).
0.011093138717114925 ||| Lamictal and associated names (see Annex I) 200 mg tablets. ||| Lamictal and associated names (see Annex I) 25 mg tablets. ||| Lamictal et noms associés (voir Annexe 1) 200 mg comprimés.
0.02090979926288128 ||| The Committee for Medicinal products for Human Use (CHMP) decided that Humalog’ s benefits are greater than its risks for the treatment of diabetes mellitus. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Liprolog’ s benefits are greater than its risks for the treatment of diabetes mellitus. ||| Le comité des médicaments à usage humain (CHMP) a décidé que les bénéfices d’ Humalog sont supérieurs à ses risques dans le traitement du diabète sucré.
5.146837817049388e-13 ||| Centro Direzionale Colleoni Palazzo Andromeda Via Paracelso, 16 20041 Agrate Brianza (Mi) Italy ||| Centro Direzionale Colleoni Palazzo Andromeda Via Paracelso, 16 20041 Agrate Brianza (Mi) Italy ||| Centro Direzionale Colleoni Palazzo Andromeda Via Paracelso, 16 20041 Agrate Brianza (Mi)
0.9198863506317139 ||| Erlotinib N = 485 ||| INTELENCE + BR N=599 ||| Erlotinib N=485
0.19895698130130768 ||| Each hard capsule contains oseltamivir phosphate equivalent to 75 mg of oseltamivir. ||| Each tablet contains 80 mg of atorvastatin as atorvastatin calcium trihydrate. ||| Chaque gélule contient du phosphate d’ oseltamivir, correspondant à 75 mg d’ oseltamivir.
0.24726669490337372 ||| Filtering materials [mineral substances] ||| Filtering materials [chemical preparations] ||| Matières filtrantes [substances minérales]
3.321283677769349e-13 ||| In man, an activity in both partial and generalised epilepsy conditions (epileptiform discharge/ photoparoxysmal response) has confirmed the broad spectrum pharmacological profile of levetiracetam. ||| In man, an activity in both partial and generalised epilepsy conditions (epileptiform discharge/ photoparoxysmal response) has confirmed the broad spectrum pharmacological profile of levetiracetam. ||| Chez l’ homme, une activité dans les épilepsies partielles et généralisées (décharge épileptiforme / réponse photoparoxystique), a confirmé le large spectre du profil pharmacologique.
0.5181277990341187 ||| - the coordination of the scientific evaluation of the quality, safety and efficacy of medicinal products ||| - the coordination of the supervision, under practical conditions of use, of medicinal products ||| - coordonner l'évaluation scientifique de la qualité, de la sécurité et de l'efficacité des médicaments à
0.5579373836517334 ||| Do not add water to bottles of VIRACEPT powder. ||| Do not remove the blue cap from the BAXJECT II device. ||| Ne pas ajouter d’eau dans les flacons de VIRACEPT poudre.
0.7004951238632202 ||| - The active substance is 0.5 mg varenicline and 1 mg varenicline respectively ||| contains 10 mg loratadine >  contains 1 mg loratadine > ||| - La substance active est la varénicline à 0,5 mg et 1 mg respectivement.
0.06127151846885681 ||| 103 HYPERGLYCAEMIA AND HYPOGLYCAEMIA ||| 553 HYPERGLYCAEMIA AND HYPOGLYCAEMIA ||| 106 HYPERGLYCEMIE ET HYPOGLYCEMIE
0.4044308662414551 ||| Plotting papers [graph paper as finished products] ||| Paperboard boxes [for industrial packaging] ||| Papier millimétré [papier graphique en tant que produit fini]
3.688553640041753e-13 ||| Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy (see section 4.2) ||| Symptoms suggestive of neuroleptic malignant syndrome have been reported with abrupt withdrawal of dopaminergic therapy (see section 4.2) ||| Des symptômes évocateurs d’ un syndrome malin des neuroleptiques ont été rapportés lors de l’ arrêt brutal d’ autres traitements dopaminergiques (voir rubrique 4.2.).
0.520082414150238 ||| Surgical resection was allowed following chemotherapy, before or after radiotherapy. ||| Following chemotherapy, patients should receive chemoradiotherapy. ||| Une chirurgie était autorisée après la chimiothérapie, avant ou après la radiothérapie.
0.23869353532791138 ||| Ritonavir is a potent CYP3A inhibitor which inhibits the metabolism of lopinavir and therefore, increases plasma levels of lopinavir. ||| Ritonavir is a potent inhibitor of CYP3A4 and therefore will affect drugs metabolised by this enzyme. ||| Le ritonavir étant un inhibiteur puissant de l’ isoenzyme CYP3A, il inhibe donc le métabolisme du lopinavir et augmente ses concentrations plasmatiques.
0.25204768776893616 ||| Keep this Patient Alert Card with you. − If you have any further questions, please ask your doctor or pharmacist. − This medicine has been prescribed for you. ||| If you stop taking {PRODUCT NAME} 40 mg If you have any further questions on the use of this product, ask your doctor or pharmacist. ||| - Si vous avez d’autres questions, demandez plus d’informations à votre médecin ou pharmacien.
0.34922128915786743 ||| - reduction in red blood cells (anaemia) ||| improves (increase in red blood cells). ||| - diminution du nombre de globules rouges (anémie)
0.18840201199054718 ||| Electronic storage of digital video files ||| Electronic storage of digital images ||| Stockage électronique de fichiers vidéo numériques
0.0 ||| [To be completed nationally] ||| [To be completed nationally] ||| [A compléter au niveau natonal]
0.0 ||| The IM injection is to be given slowly and deeply into the muscle and the IV bolus injection may be given rapidly and directly into a vein or into an existing IV line. ||| The IM injection is to be given slowly and deeply into the muscle and the IV bolus injection may be given rapidly and directly into a vein or into an existing IV line. ||| L’ injection IM doit être faite lentement et profondément dans le muscle et l’ injection en bolus peut être donnée rapidement et directement dans la veine ou dans la tubulure d’ une perfusion.
2.8245266368853716e-13 ||| If lansoprazole is used in combination with antibiotics for eradication therapy of H.pylori, then the instructions for the use of these antibiotics should also be followed. ||| If lansoprazole is used in combination with antibiotics for eradication therapy of H.pylori, then the instructions for the use of these antibiotics should also be followed. ||| Si le lansoprazole est utilisé en association avec des antibiotiques pour le traitement d’éradication de H. pylori, les conditions d’utilisation de ces antibiotiques doivent également être suivies.
0.4287634491920471 ||| Keppra 100 mg/ ml ||| Neupro 4 mg/24 h ||| Keppra 100 mg per ml
0.5593703389167786 ||| Since the beginning, the Commission provided for flexible working arrangements (teleworking) for colleagues reflecting the specific needs. ||| New staff on arrival receive an extensive, individual briefing about their employment conditions. ||| Depuis le début, la Commission a prévu des formules souples de travail (télétravail).
0.08954135328531265 ||| If you accidentally take too many Viread tablets, contact your doctor or nearest emergency department for advice. ||| If you accidentally take too many Emtriva hard capsules, contact your doctor or nearest emergency department for advice. ||| Si vous avez pris accidentellement trop de comprimés de Viread, contactez votre médecin ou le plus proche service d’urgences pour demander conseil.
0.5291754007339478 ||| Latent diabetes mellitus may become manifest during thiazide therapy. ||| Vasculitis, possibly associated with transient renal involvement ||| Un diabète sucré latent peut se révéler à l'occasion d’ un traitement par thiazidique.
0.6053638458251953 ||| This appropriation is intended to cover maintenance costs for premises, lifts, central heating, air-conditioning equipment, etc.; the expenditure occasioned by regular cleaning operations, the purchase of maintenance, washing, laundry and dry-cleaning products, etc. and by repainting, repairs and supplies. ||| All types of PPE must be selected based upon the hazard to the worker, properly fitted as applicable (e.g., respirators), consistently and properly worn, regularly inspected, maintained, and replaced, as necessary, and properly removed, cleaned, and stored or disposed of to avoid contamination. ||| Ce crédit est destiné à couvrir les frais de nettoyage et d'entretien des locaux, des ascenseurs, du chauffage central, des équipements de conditionnement d'air, etc., les frais résultant de certains nettoyages périodiques, de l'achat de produits d'entretien, de lavage, de blanchissage, de nettoyage à sec, etc., ainsi que des remises en peinture, des réparations et des fournitures.
0.2506072521209717 ||| Adverse reactions to orlistat are largely gastrointestinal in nature and related to the pharmacologic effect of the medicinal product on preventing the absorption of ingested fat. ||| The occurrence of dysphagia is attributable to the spread of the pharmacological effect of Xeomin as the result of the neurotoxin spread into the oesophageal musculature. ||| Les effets indésirables de l’ orlistat sont essentiellement d’ ordre gastro-intestinal et liés à l' effet
0.633903443813324 ||| Calcium chloride Human albumin Mannitol Sodium acetate Water for injections ||| Ethanol 8 Propylene glycol 9 Benzyl alcohol 10 Arginine 11 ||| Chlorure de calcium Albumine humaine Mannitol Acétate de sodium Eau pour préparations injectables
0.03958659991621971 ||| 385 11. ||| 355 11. ||| 11.
0.08311536908149719 ||| 81 Ireland Roche Products (Ireland) Ltd. ||| Ireland Roche Products (Ireland) Ltd. ||| Ireland Roche Products (Ireland) Ltd.
0.49830299615859985 ||| This means that Oprymea is similar to a ‘ reference medicine’ already authorised in the European Union (EU) called Sifrol (also known as Mirapexin). ||| Vildagliptin on its own was approved by the EU in September 2007 under the name Galvus, and metformin has been available in the EU since 1959. ||| Cela signifie qu’ il est similaire à un « médicament de référence » déjà autorisé dans l’ Union européenne (UE), à savoir Sifrol (également connu sous la dénomination Mirapexin).
0.5443323254585266 ||| Side effects are reversible. ||| The symptoms were completely reversible. ||| Ces effets sont réversibles.
0.0636368915438652 ||| Insulin requirements usually fall in the first trimester and subsequently increase during the second and third trimesters. ||| Insulin requirements may decrease during the first trimester and generally increase during the second and third trimesters. ||| 102 Les besoins en insuline chutent habituellement au cours du premier trimestre puis augmentent au cours des deuxième et troisième trimestres.
0.37523728609085083 ||| Stored in a refrigerator (2ºC-8°C) until used. ||| Solutions may be stored at 15°C-30°C or refrigerated. ||| A conserver au réfrigérateur (entre 2 °C et 8 °C) jusqu’ à son utilisation.
0.29450690746307373 ||| A total of 1,315 patients constituted the safety population in the three phase III studies with 24 months exposure to Lucentis and 440 patients were treated with the recommended dose of 0.5 mg. ||| The other two studies involved a total of 1,159 patients with later stage disease, where AZILECT was added to the patients’ existing treatment including levodopa. ||| Au total, 1 315 patients ont constitué la population d’ évaluation de la tolérance dans les trois études de phase III avec 24 mois d'exposition à Lucentis et 440 patients ont été traités à la dose recommandée de 0,5 mg.
0.25536268949508667 ||| GlaxoSmithKline Pharma GmbH Albert Schweitzer Gasse 6 A-1140 Wien Austria ||| GlaxoSmithKline Pharma A/ S, Nykær 68 DK-2605 Brøndby Denmark ||| Albert Schweitzer Gasse 6 A-1140 Wien Austria
0.2962600588798523 ||| Diabetes, abnormal heart rhythm, inflammation of pancreas, inflammation and degeneration of muscle tissue and peripheral nerves, kidney problems and seizures. ||| Pyoderma, superficial and deep, wounds, abscesses, acute uncomplicated urinary tract infections and upper respiratory tract infections. ||| Diabètes, rythme du coeur anormal, inflammation du pancréas, inflammation et dégénération du tissu musculaire et des nerfs périphériques, problèmes et défaillance du rein.
0.26386404037475586 ||| In the event of an overdose the patient should be monitored and appropriate supportive treatment should be given, if considered necessary. ||| If necessary and depending on the clinical response, treatment can be continued until the response is considered to be adequate. ||| En cas de surdosage, une surveillance du patient s’ impose et, si besoin, des traitements symptomatiques appropriés seront administrés.
0.03623614087700844 ||| After 2 years of treatment, 92.8% of patients receiving 3 mg injections and 84.7% of patient receiving 2.5 mg oral therapy had increased or maintained lumbar spine BMD (p=0.001). ||| After 2 years of treatment, 85.6% of patients receiving 3 mg injections and 77.0% of patient receiving 2.5 mg oral therapy had increased or maintained total hip BMD (p=0.004). ||| A deux ans, la DMO lombaire a augmenté ou s’ est maintenue chez 92,8% des patientes sous Bondenza IV 3 mg tous les 3 mois versus 84,7% des patientes sous acide ibandronique oral 2,5 mg une fois par jour (p= 0,001).
0.43482130765914917 ||| The administration of Keppra to patients with renal impairment may require dose adjustment. ||| Breast-feeding women may require adjustments in insulin dose and diet. tn ||| L’ administration de Keppra chez le patient insuffisant rénal peut nécessiter une adaptation de la dose.
0.42452389001846313 ||| Before you use NEVANAC 3. ||| Before you use PROCOMVAX 3. ||| Quelles sont les informations à connaître avant d'utiliser NEVANAC 3.
0.2603338360786438 ||| In patients with rheumatoid arthritis celecoxib had no statistically significant effect on the pharmacokinetics (plasma or renal clearance) of methotrexate (in rheumatologic doses). ||| Leukemia In the docetaxel, doxorubicin and cyclophosphamide (TAC) treated patients, the risk of delayed myelodysplasia or myeloid leukemia requires haematological follow-up. ||| Chez les patients souffrant de polyarthrite rhumatoïde, le célécoxib n’ a pas d’ effet statistiquement significatif sur les paramètres pharmacocinétiques (clairance plasmatique ou rénale) du méthotrexate (aux doses utilisées en rhumatologie).
0.42543649673461914 ||| Decreased sperm count has been associated with the use of Rapamune and usually resolves after discontinuation. ||| Abrupt withdrawal of Exforge has not been associated with a rapid increase in blood pressure. ||| Une diminution du nombre de spermatozoïdes, généralement réversible après arrêt du traitement, a été associée à l’ utilisation de Rapamune.
0.32096654176712036 ||| Plasminogen activator inhibitor 1 (PAI-1) activity can be reduced to around zero, but rapidly normalises within two hours showing a rebound phenomenon. ||| As with other plasminogen activators a rebound phenomenon then occurs during which fibrinogen levels reach a maximum within 9 days and remain elevated for up to 18 days. ||| L'activité de l'inhibiteur 1 de l'activateur du plasminogène (IAP-1) peut être réduite à zéro, mais se normalise rapidement en moins de deux heures, reflétant un effet rebond.
0.20770259201526642 ||| BEFORE YOU USE INSUMAN COMB 50 ||| BEFORE YOU USE HUMALOG MIX50 ||| QUELLES SONT LES INFORMATIONS A CONNAITRE AVANT D'UTILISER INSUMAN COMB 50
0.20090678334236145 ||| - Loss of appetite, nausea, diarrhoea, abdominal pain, vomiting, weight loss ||| - diarrhoea, nausea, vomiting, heartburn, abdominal pain, inflammation of the stomach, flatulence ||| - Perte d'appétit, nausées, diarrhées, douleur abdominale, vomissements, perte de poids;
0.4482308030128479 ||| CellCept 500 mg powder for concentrate for solution for infusion is used to prevent your body rejecting a transplanted kidney or liver. ||| VASOVIST is an injectable contrast medium for making a diagnostic image of the body's blood vessels in the abdomen or limb clearer. ||| CellCept 500 mg poudre pour solution à diluer pour perfusion est utilisé pour prévenir le rejet, par votre organisme, du rein ou du foie qui vous a été greffé.
0.007882260717451572 ||| 177 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 182 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 199 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.13190540671348572 ||| Dose adjustments of concomitant medicinal products may be required when Mimpara is administered with individually titrated, narrow therapeutic index substances that are predominantly metabolised by CYP2D6 (e. g., flecainide, propafenone, metoprolol given in heart failure, desipramine, nortriptyline, clomipramine) (see section 4.4). ||| Caution is advised if YENTREVE is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol). ||| Médicaments métabolisés par l’ isoenzyme 2D6 du cytochrome P450 (CYP2D6): le cinacalcet étant un inhibiteur puissant du CYP2D6, des adaptations posologiques des traitements concomitants peuvent être nécessaires notamment si Mimpara est administré avec des médicaments métabolisés par le CYP2D6 présentant un indice thérapeutique étroit et nécessitant une adaptation posologique individuelle (ex. flécaïnide, propafenone, metoprolol indiqué dans l’ insuffisance cardiaque, desipramine, nortriptyline, clomipramine) (voir rubrique 4.4).
0.3999831974506378 ||| Quintanrix is available in the following pack sizes: ||| The medicinal product is available in three pack sizes: ||| Quintanrix est disponible dans les conditionnements suivants:
0.5942391157150269 ||| He joined the EMEA in 1995 as Principal Scientific Administrator and from 1996 to 1998 he was Head of Sector for new chemical substances. ||| He has proved himself as an excellent manager as Deputy Director-General of the Medical Product Agency in Sweden. ||| Il a rejoint l'EMEA en 1995 en tant qu'administrateur scientifique principal et, de 1996 à 1998, comme chef du secteur des nouvelles substances cliniques.
0.0 ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interaction with other medicinal products and other forms of interaction ||| 15 4.5 Interactions avec d'autres médicaments et autres formes d' interaction
0.1845172643661499 ||| The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Nobivac Bb exceed the risks of its use. ||| The Committee for Medicinal Products for Human Use (CHMP) decided that Aldurazyme gives effective control of the symptoms of MPS I. ||| Le comité des médicaments à usage vétérinaire (CVMP) a conclu que les bénéfices de Nobivac Bb sont supérieurs aux risques associés à son utilisation.
0.46480417251586914 ||| Take the number of capsules or tablets as instructed by your doctor. ||| Wear a medical mask and follow the instructions of authorities and doctors. ||| Prenez le nombre de gélules ou de comprimés prescrits par votre médecin.
0.2545250356197357 ||| About half of the patients taking Zeffix had an improvement in liver damage assessed in a biopsy, compared with about a quarter of the patients who took placebo. ||| In the first study, viral loads fell by an average of 98% in the patients taking Fuzeon, compared with 83% in the patients not taking Fuzeon. ||| Environ la moitié des patients prenant Zeffix présentaient une amélioration de l’ atteinte du foie évaluée par une biopsie, contre un quart environ des patients qui prenaient le placebo.
0.2557191550731659 ||| It has been noted that neuromuscular blocking agents, narcotic analgesics, and various contrast media can induce the release of endogenous histamine; therefore in patients undergoing diagnostic or surgical procedures, the additive effect of Ceplene treatment should be considered prior to the procedure (see section 4.4). ||| Additionally, the CHMP concluded that Protopic should not be used in immunocompromised adults or children and that Protopic should not be applied to lesions that are considered to be potentially malignant or pre-malignant and that lymphadenopathy present at initiation of therapy should be investigated and kept under review. ||| Il a été constaté que les agents bloquants neuromusculaires, les analgésiques narcotiques et divers produits de contraste peuvent induire la libération d’ histamine endogène; par conséquent, chez les patients soumis à des procédures diagnostiques ou chirurgicales, l’ effet additionnel du traitement par Ceplene doit être pris en compte avant la procédure (voir rubrique 4.4).
0.18527072668075562 ||| Rental of carpets ||| Rental of uniforms ||| Location de tapis
0.0 ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia. ||| If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia. ||| Si vous n'êtes pas familiarisé avec les symptômes annonciateurs d'hypoglycémie, évitez les situations - comme de conduire un véhicule - qui pourraient constituer un risque pour vous -même ou des tiers du fait de l'hypoglycémie.
0.3991459608078003 ||| This resulted in a greater reduction of plasma cortisol as compared with fluticasone propionate alone. ||| Itraconazole concentrations are expected to increase in the same manner as ketoconazole. ||| La réduction du cortisol plasmatique était plus importante que celle observée après l’ administration de propionate de fluticasone seul.
0.30990803241729736 ||| In female hypertensive patients the plasma levels of losartan were up to twice as high as in male hypertensive patients, while the plasma levels of the active metabolite did not differ between men and women. ||| Rotigotine did not influence male fertility in rats, but clearly reduced female fertility in rats and mice, because of the effects on prolactin levels which are particularly significant in rodents. ||| Chez des femmes hypertendues, les concentrations plasmatiques du losartan ont été jusqu’ à deux fois plus élevées que chez des hommes hypertendus, alors que celles du métabolite actif n’ ont pas été différentes entre les hommes et les femmes.
4.068095144603434e-13 ||| What is the time to allow before the animal can be slaughtered and the meat used for human consumption (withdrawal period)? ||| What is the time to allow before the animal can be slaughtered and the meat used for human consumption (withdrawal period)? ||| Combien de temps faut -il attendre avant que l’ animal puisse être abattu et que la viande puisse être utilisée pour la consommation humaine (temps d’ attente)?
0.019051581621170044 ||| In patients taking medicinal products where the pharmacokinetic interaction with lamotrigine is currently not known (see section 4.5), the dose escalation as recommended for lamotrigine with concurrent valproate, should be used. ||| In patients taking medicinal products where the pharmacokinetic interaction with lamotrigine is currently not known (see section 4.5), the treatment regimen as recommended for lamotrigine with concurrent valproate, should be used. ||| Chez les patients prenant des médicaments dont l’ interaction pharmacocinétique avec la lamotrigine n’ est pas connue actuellement (voir rubrique 4.5), la posologie recommandée de Lamictal en cas d’ association au valproate doit être appliquée.
0.3609365224838257 ||| Therefore the Commission proposes to use a range of instruments to support investment and reforms in the Member States, focusing on where the crisis impact and resilience needs are greatest: ||| This means that resources will also be reoriented to assist countries in Asia and the Pacific (€1.22 billion) to address the crisis and its impact, targeting specifically the action on most vulnerable countries and population groups. ||| La Commission propose par conséquent de recourir à un ensemble d'instruments pour soutenir les investissements et les réformes dans les États membres, en mettant l'accent là où les répercussions de la crise se font le plus sentir et où les besoins en termes de résilience sont les plus pressants:
0.40981295704841614 ||| In paediatric patients AUC values were dose proportional over the dose range of 0.5-4 mg/kg. ||| The highest blood concentrations measured in 2 paediatric patients aged 8 months to 14 years were 2.0 ng/ml. ||| Chez les enfants, les valeurs de l’ ASC ont été proportionnelles à la dose pour des doses allant de 0,5 à 4 mg/ kg.
0.22996266186237335 ||| Chemical preparations for use in the dairy industry ||| Catalysts for use in the oil processing industry ||| Produits chimiques destinés à l’industrie des produits laitiers
0.07594797015190125 ||| What benefit has Kaletra shown during the studies? ||| What benefit has Keppra shown during the studies? ||| Quel est le bénéfice démontré par Kaletra au cours des études?
0.3055638372898102 ||| In the second active-controlled trial the rate of serious adverse events after 2 years of treatment was similar among the three treatment groups (Enbrell 16%, methotrexate 15% and Enbrel in combination with methotrexate 17%). ||| In this trial, the combination of PegIntron (1.5 micrograms/kg/week) and ribavirin was significantly more effective than the combination of interferon alfa-2b and ribavirin (Table 5), particularly in patients infected with Genotype 1 (Table 6). ||| Dans le second essai contrôlé versus traitement actif, le taux d’ événements indésirables graves après 2 ans de traitement était similaire parmi les trois groupes de traitement (Enbrel 16%, méthotrexate 15% et Enbrel associé au méthotrexate 17%).
0.07089906930923462 ||| 289 1. ||| 488 1. ||| 1.
0.45459097623825073 ||| - blistering of the skin, sometimes resulting in local wound infections ||| The limbs affected by the disease may be painfully deformed. ||| - apparition de cloques sur la peau, provoquant parfois des infections de plaies locales
0.43244048953056335 ||| Holographic plates ||| Pyrotechnic charges ||| Plaques holographiques
0.35891255736351013 ||| Today's guidelines call on Member States, in coordination with the Commission, to designate ports around EU shores for fast-track crew changes, with adequate facilities for seafarers to undertake medical checks, quarantine if required by the country in question, and transport connections onward to their home country. ||| The Communication on the implementation of green lanes adopted by the European Commission on 23 March 2020 is intended to ensure continuous flow of goods in a cooperative manner across the EU to ensure all freight, including but not limited to essential goods such as food and medical supplies, gets to its destination quickly, without any delays. ||| Les lignes directrices publiées aujourd'hui invitent les États membres, en coordination avec la Commission, à désigner des ports situés le long des côtes européennes où des changements rapides d'équipage peuvent être effectués et qui sont dotés d'installations adéquates permettant de soumettre les gens de mer à des contrôles médicaux, de les placer en quarantaine si le pays en question le requiert, et de leur proposer des liaisons de transport vers leur pays d'origine.
0.3284226953983307 ||| During the controlled portions of pivotal Humira trials at least 12 weeks in duration in patients with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’ s disease and psoriasis, malignancies, other than lymphoma and non-melanoma skin cancer, were observed at a rate (95% confidence interval) of 5.9 (3.5, 9.9) per 1,000 patient-years among 3,853 Humira treated patients versus a rate of 4.3 (1.8, 10.4) per 1,000 patient-years among 2,183 control patients (median duration of treatment was 5.5 months for Humira and 3.9 months for control-treated patients). ||| In the controlled and non-controlled portions of psoriasis clinical studies, the rate of infection was 1.24 per patient-year of follow-up in ustekinumab-treated patients, and the incidence of serious infections was 0.01 per patient-year of follow-up in ustekinumab-treated patients (24 serious infections in 2,251 patient-years of follow-up) and serious infections reported included cellulitis, diverticulitis, osteomyelitis, viral infections, gastroenteritis, pneumonia, and urinary tract infections. ||| Pendant les périodes contrôlées des essais cliniques pivots avec Humira d’ une durée d’ au moins 12 semaines chez des patients souffrant de polyarthrite rhumatoïde modérément à sévèrement active, de rhumatisme psoriasique, de spondylarthrite ankylosante, de la maladie de Crohn et de psoriasis, un taux (intervalle de confiance 95%) de cancers autres que lymphomes ou cancers de la peau non mélanomes, de 5,9 (3,5 - 9,9) pour 1000 patient-années parmi les 3853 patients traités par Humira, a été observé versus un taux de 4,3 (1,8 - 10,4) pour 1000 patient-années parmi les 2183 patients du groupe contrôle (la durée moyenne du traitement était de 5,5 mois pour les patients traités par Humira et de 3,9 mois pour les patients du groupe contrôle).
0.4147370457649231 ||| 20 exposure levels were lower than those with the recommended clinical dose in humans. ||| These levels are substantially above the recommended maximal clinical dose. ||| Les niveaux d’exposition étaient plus bas que ceux observés à la dose recommandée chez l’homme.
0.0 ||| The most frequently reported adverse reactions related to VIRAMUNE therapy, across all clinical trials, were rash, allergic reactions, hepatitis, abnormal liver function tests, nausea, vomiting, diarrhoea, abdominal pain, fatigue, fever, headache and myalgia. ||| The most frequently reported adverse reactions related to VIRAMUNE therapy, across all clinical trials, were rash, allergic reactions, hepatitis, abnormal liver function tests, nausea, vomiting, diarrhoea, abdominal pain, fatigue, fever, headache and myalgia. ||| Au cours des essais cliniques, les effets indésirables le plus souvent décrits et imputés à VIRAMUNE ont été des cas d'éruption cutanée, de réactions allergiques, d’ hépatites, des tests de la fonction hépatiques anormaux, de nausées, de vomissements, de diarrhées, de douleurs abdominales, d'asthénie, de fièvre, de céphalées, et de myalgies.
0.3236697316169739 ||| Tell your doctor immediately if you are pregnant or intend to become pregnant. ||| Tell your doctor at once if you are or plan to become pregnant in the near future. ||| Informez votre médecin immédiatement si vous êtes enceinte ou si vous prévoyez de l’ être.
0.41949740052223206 ||| If you stop taking ZYPREXA VELOTAB Do not stop taking your tablets just because you feel better. ||| If you forget to take OLANZAPINE NEOPHARMA Take your tablets as soon as you remember. ||| Si vous arrêtez de prendre ZYPREXA N’ arrêtez pas de prendre vos comprimés simplement parce que vous vous sentez mieux.
0.3699846863746643 ||| What Valtropin contains ||| What Tamiflu contains ||| Que contient Valtropin
0.19163039326667786 ||| Construction of house extensions ||| Custom construction of buildings ||| Construction d'extensions de maison
0.4260057806968689 ||| This document sets out a programme for 2002 that will make demands on the staff of the EMEA and also colleagues in the national agencies with whom we work. ||| Its members selected through this call should have high expertise in implementing EU law and be able to represent the interests shared by different stakeholder organisations in their field. ||| Ce document définit un programme pour 2002 qui exigera beaucoup du personnel de l'EMEA, mais également des collègues des agences nationales avec qui nous travaillons.
0.20960858464241028 ||| 8 Co-administration of saquinavir and ritonavir has led to severe adverse events, mainly diabetic ketoacidosis and liver disorders, especially in patients with pre-existing liver disease. ||| Toremifene treatment has been associated with changes in liver enzyme levels (increases of transaminases) and in very rare occasions with more severe liver function abnormalities (jaundice). ||| La co-administration de saquinavir et de ritonavir a entraîné des effets indésirables sévères, essentiellement une acidocétose diabétique et des troubles hépatiques, notamment chez les patients ayant une maladie hépatique préexistante.
0.14567533135414124 ||| Do not start or stop taking any medicines, including those bought without a prescription, natural and herbal remedies, before checking with your doctor or pharmacist. ||| Do not start or stop taking any medicines, including those bought without a prescription and herbal remedies, before checking with your doctor. ||| Ne commencez ou n’ arrêtez aucun médicament, y compris ceux disponibles sans ordonnance ainsi que les remèdes naturels et à base de plantes, avant d’ en avoir vérifié la compatibilité auprès de votre médecin ou de votre pharmacien.
0.0032052560709416866 ||| Keep your Humalog Mix25 Pen in use at room temperature (below 30°C) for up to 28 days. ||| Keep your Humalog Mix50 Pen in use at room temperature (below 30°C) for up to 28 days. ||| Conservez Humalog Mix 25 Pen en cours d’utilisation à température ambiante (inférieure à 30°C) pendant 28 jours maximum.
0.8068901300430298 ||| Climbers' harness ||| - Swollen glands ||| Baudriers d'escalade
0.4282195270061493 ||| Tandemact 30 mg/ 2 mg tablets ||| Clomicalm 80 mg ½ tablet 1 tablet ||| Tandemact 30 mg/ 2 mg, comprimés
0.2746274173259735 ||| The solvent pre-filled syringe provided should be used for reconstitution only and then disposed of in accordance with local requirements. ||| Any used or unused transdermal patches should be disposed of in accordance with local requirements or returned to the pharmacy. ||| La seringue préremplie de solvant fournie ne doit être utilisée que pour la reconstitution; elle doit ensuite être éliminée conformément à la réglementation en vigueur.
0.5414352416992188 ||| For the purpose of ambulatory use, Nespo may be removed from storage once for a maximum single in ||| - to complete a primary immunisation course or as a booster dose in subjects who have previously ||| Pour l’ usage ambulatoire, Nespo peut être sorti de ces conditions de conservation une seule fois, éd
0.42877858877182007 ||| Patients should remain at rest for 20 minutes after injection of Ceplene. ||| need to stop taking Janumet for a couple of days before and after the procedure ||| Les patients doivent rester au repos pendant 20 minutes après l’ injection de Ceplene.
0.33119267225265503 ||| Please consult your doctor, even if these statements were applicable to you at any time in the past. ||| Tell your doctor, even when any of the above-mentioned circumstances had happened to you in the past. ||| Veuillez consulter votre médecin si l’ un des cas ci-dessus vous concerne, ou vous a concerné dans le passé.
0.0 ||| 4.9 Overdose ||| 4.9 Overdose ||| 132 4.9 Surdosage
0.44092100858688354 ||| Commission President Ursula von der Leyen and Commissioner for Innovation, Research, Culture, Education and Youth, Mariya Gabriel, discussed with the CureVac management via videoconference. ||| The committee will debate on Friday at 10:00 with Innovation, Research, Culture, Education and Youth Commissioner Mariya Gabriel and Internal Market Commissioner Thierry Breton on the way forward for Parliament's proposals. ||| Mme Ursula von der Leyen, présidente de la Commission, et Mme Mariya Gabriel, commissaire chargée de l'innovation, de la recherche, de la culture, de l'éducation et de la jeunesse, se sont entretenues par vidéoconférence avec la direction de CureVac.
0.027588974684476852 ||| 38 5.3 Preclinical safety data ||| 39 5.3 Preclinical safety data ||| 5.3 Données de sécurité précliniques
0.49086466431617737 ||| Paget’ s disease of the bone It is normal that old bone is removed and is replaced with new bone material. ||| Osteoporosis happens when not enough new bone grows to replace the bone that is naturally broken down. ||| Maladie de Paget Il est normal que le tissu osseux ancien se résorbe et soit remplacé par de l’ os nouveau.
0.393382728099823 ||| Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i. e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial. ||| 15 For patients with difficulty swallowing; studies and clinical practice suggest that the capsules may be opened and the granules mixed with a small amount of water, apple/tomato juice or sprinkled onto a small amount of soft food (e.g. yoghurt, apple puree) to ease administration. ||| Insulin Human Winthrop Comb 15 ne doit pas être utilisé si tel n'est pas le cas, par exemple si la suspension reste claire ou si des agrégats, des particules ou des flocons apparaissent dans l'insuline ou restent collés à la paroi ou au fond du flacon.
0.43663740158081055 ||| 188 Via Ilderbrando Vivanti 00144 Rome Italy ||| Via Luigi Einaudi 11 00012 Guidonia Montecelio/ Rome Italy ||| 188 Via Ilderbrando Vivanti 00144 Rome Italie
0.4304735064506531 ||| Portable buildings (Non-metallic -) incorporating toilet facilities ||| Double glazing panels (Metal -) incorporating insulating glass ||| Constructions transportables non métalliques équipées d'installations de toilettes
0.30224376916885376 ||| Hepatic and renal impairment Specific studies have not been conducted in patients with hepatic and renal impairment (see section 4.2). ||| There are limited data in patients with moderate hepatic impairment and no data in patients with severe hepatic impairment (see sections 4.4 and 5.2). ||| Insuffisance hépatique ou rénale Aucune étude spécifique n’ a été réalisée chez des patients présentant une insuffisance hépatique ou rénale (voir rubrique 4.2).
0.03428906202316284 ||| Interferon monotherapy, including PegIntron, is indicated mainly in case of intolerance or contraindication to ribavirin. ||| Interferon monotherapy, including ViraferonPeg, is indicated mainly in case of intolerance or contraindication to ribavirin. ||| L’ interféron en monothérapie, dont PegIntron, est indiqué principalement en cas d’ intolérance ou de contre-indication à la ribavirine.
0.27678126096725464 ||| Patients with renal impairment must be closely monitored for toxicities when treated with nelarabine. ||| Patients with renal impairment may be more sensitive to the blood pressure lowering effects of Ceplene. ||| Les patients insuffisants rénaux doivent être étroitement surveillés afin de détecter d'éventuelles toxicités sous traitement par nélarabine.
0.45139724016189575 ||| Mastic for sealing joints ||| Grafting mastic for trees ||| Mastic pour joints d'étanchéité
0.35307788848876953 ||| All of these principles should also apply to third country nationals if they are essential to ensuring that cargo moves freely within and into the EU. ||| If Member States want to provide subordinated debt in amounts exceeding the thresholds, all conditions for recapitalisation measures set out above will apply. ||| Tous ces principes devraient également s'appliquer aux ressortissants de pays tiers, s'ils sont essentiels pour assurer le libre flux des marchandises entrant dans l'UE et circulant sur son territoire.
0.5906569957733154 ||| Local reactions at injection site can also occur. ||| Systemic exposure increases with increasing treatment areas. ||| Des réactions locales au site d’ injection peuvent également survenir.
0.3259771764278412 ||| Considering the margins of exposure in relation to the expected exposure in the human use, these findings do not change the benefit-risk of Tamiflu in its adopted therapeutic indications. ||| Taking the benefit of the treatment into account and the relatively low level of adverse effects, as it appears from PMS studies, the risk/ benefit balance is considered favourable. ||| Toutefois, au regard de l'amplitude de l'exposition chez ces rongeurs par rapport à l'exposition attendue en usage clinique, ces données ne modifient pas le rapport bénéfice/ risque de Tamiflu dans les indications approuvées.
0.3741161823272705 ||| No specific information is available on the treatment of overdose with Karvezide. ||| There is also no information on using Atripla with other anti-HIV medicines. ||| Aucune information spécifique n’ est disponible sur le traitement en cas de surdosage par Karvezide.
0.4409670829772949 ||| Cements for affixing floor tiles ||| Refining towers for distillation ||| Ciments de fixation pour dalles de sol
0.44670629501342773 ||| When ritonavir is co-administered an increase in clarithromycin concentrations may occur. ||| - Moxifloxacin has been shown to prolong the QTc interval on the electrocardiogram in some ||| La co-administration de ritonavir peut majorer l'augmentation des concentrations de la clarithromycine.
0.4866812527179718 ||| This finding is compatible with the short half-life of melatonin in humans. ||| Compared to symptom control alone, Hycamtin prolonged survival by 12 weeks. ||| Cette observation est compatible avec la demi-vie brève de la mélatonine chez l’ homme.
0.5818204283714294 ||| E216 and methyl parahydroxybenzoate: ||| Phenothiazines and alpha-2-agonists: ||| E216 et parahydroxybenzoate de méthyle:
0.4290245771408081 ||| Training services relating to the therapy of primary cause analysis by hypnosis ||| Clinical investigation of medicinal products for the treatment of cardiac failure (revision) ||| Services de formation en matière de thérapie de l'analyse des causes premières par hypnose
0.46671417355537415 ||| To stimulate active immunity in chickens and ducks against avian influenza virus, H5 subtype. ||| Tylvalosin has activity against the following mycoplasma species found in chickens: ||| Le vaccin induit une réponse immunitaire chez les poules et les canards contre le virus de l’ influenza aviaire, sous-type H5.
0.4755491614341736 ||| As of 8 March, US military has suspended all travels to and from South Korea for all military personnel and their family over the concern of the virus. ||| More than 3.9 million individuals have accessed healthcare thanks to EU support in response to the Syrian crisis in refugee hosting countries. ||| Les États-Unis cessent tous les voyages militaires depuis et vers la Corée du Sud le 8 mars.
0.6821110248565674 ||| Taking Wilzin with food and drink: ||| Taking other medicines with VFEND: ||| Aliments et boissons:
0.006704587489366531 ||| anti-HA antibody Seroprotection rate* † Seroconversion rate† Seroconversion factor† * anti-HA ≥ 1:40 ||| anti-HA antibody Seroprotection rate*† Seroconversion rate† Seroconversion factor† * anti-HA ≥ 1:40 ||| Anticorps anti-HA Taux de séroprotection *† Taux de séroconversion † Facteur de séroconversion † * anti-HA ≥ 1:40
0.542630672454834 ||| - Bleeding under the skin ||| bleeding inside the skull; ||| 50 Saignement sous la peau
0.12224460393190384 ||| If you suddenly stop taking Olanzapine Teva, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur. ||| If you suddenly stop taking OLANZAPINE NEOPHARMA, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur. ||| Si vous arrêtez brutalement de prendre Olanzapine, des symptômes tels que sueurs, incapacité à dormir, tremblement, anxiété ou des nausées et des vomissements peuvent survenir.
0.354007363319397 ||| España Gilead Sciences, S. L. ||| Italia Gilead Sciences S. r. l. ||| España Gilead Sciences, S.L.
0.39390304684638977 ||| The mechanism of interaction could possibly be due to an initial inhibition and subsequent induction of transport proteins. ||| These events may occur as part of an infusion-related reaction or with a delayed onset. ||| Le mécanisme probable de l’ interaction pourrait être imputé à une inhibition initiale suivie d’ une induction ultérieure du transport de protéines.
0.3849228024482727 ||| Computer programmes relating to financial matters ||| Computerised financial services relating to foreign currency dealings ||| Programmes informatiques liés aux données financières
0.08153307437896729 ||| The full EPAR for Orfadin can be found here. ||| The full EPAR for Riprazo can be found here. ||| L’ EPAR complet est disponible: ici
0.41362130641937256 ||| SPECIAL STORAGE CONDITIONS ||| SPECIAL STORAGE PRECAUTIONS ||| PRECAUTIONS PARTICULIERES DE CONSERVATION
0.5497722029685974 ||| See section 6.6 for preparation instructions. ||| See Section 4.4 for further details. ||| Voir la rubrique 6.6 pour les instructions de préparation.
0.31138500571250916 ||| Sterilisation autoclaves for medical use ||| Separation instruments for medical use ||| Autoclaves de stérilisation à usage médical
0.022491294890642166 ||| 514 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| 489 For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| 528 Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l'autorisation de mise sur le marché:
0.42231541872024536 ||| Cases of worsening congestive heart failure have also been reported in patients receiving Trudexa. ||| Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping Truvada. ||| Des cas d'aggravation d'insuffisance cardiaque ont aussi été rapportés chez des patients
0.48073238134384155 ||| Soil conditioning preparations for regulating the growth of horticultural products ||| Spiked tires to assist the traction of vehicles in icy conditions ||| Préparations pour l'amendement des sols destinées à réguler la croissance de produits horticoles
5.356572390508019e-13 ||| Oral ||| Oral ||| Orale
0.3818536400794983 ||| The optimal therapeutic management of patients with YMDD variant HBV has not yet been established (see section 4.4). ||| Clinical trials have demonstrated that RILUTEK extends survival for patients with ALS (see section 5.1). ||| La prise en charge optimale des patients avec variant YMDD du VHB n'a pas encore été établie (voir section 4.4).
0.13700515031814575 ||| What is Refludan used for? ||| What is Nexavar used for? ||| Dans quels cas Refludan est -il utilisé?
0.11190705001354218 ||| 29/ 41 ||| 29/ 61 ||| 30/ 43
0.6767207384109497 ||| Therefore, concomitant administration of these combinations should be avoided (see section 4.5). ||| Consequently, this co-administration is not recommended. ||| Par conséquent, l’administration concomitante de ces associations doit être évitée (voir rubrique 4.5).
0.704362154006958 ||| Treatment response* at week 48 (pooled studies RESIST-1 and RESIST-2 in treatment- experienced patients) ||| * Results from study C04-002 refer to pre- versus post-treatment comparisons. ||| 20 Réponse au traitement* à 48 semaines (résultats compilés des essais RESIST-1 et RESIST-2 chez les patients pré-traités)
0.20052391290664673 ||| If you notice any symptoms of infection, please tell your doctor at once. ||| - Tell your doctor immediately if you notice any symptoms of infections. ||| Si vous remarquez des symptômes d’ infection, veuillez en informer votre médecin immédiatement.
0.0 ||| Further dose adjustments should be done based on the clinical response and the occurrence of undesirable effects. ||| Further dose adjustments should be done based on the clinical response and the occurrence of undesirable effects. ||| Les adaptations de doses doivent être réalisées en fonction de la réponse clinique et La survenue d’ effets indésirables.
0.21489590406417847 ||| HOW TO USE SILAPO ||| HOW TO USE LEUKOSCAN ||| COMMENT UTILISER SILAPO
0.5399280786514282 ||| Abdominal discomfort; Flatulence ||| Mouth ulceration Oral discomfort ||| Gêne abdominale; Flatulences
0.44462618231773376 ||| Anchorage plates of metal ||| Hand railings of metal ||| Plaques d'ancrage en métal
0.44353026151657104 ||| For example, we need more uniformity in the application of the rules across the Union: this is important for citizens and for businesses, especially SMEs. ||| In response, the first priority is to save lives and to meet the needs of our health care systems and professionals who are working miracles every day right across our Union. ||| Par exemple, nous avons besoin d'une plus grande uniformité dans l'application des règles sur tout le territoire de l'Union: c'est important pour les citoyens et pour les entreprises, notamment les PME.
0.539790153503418 ||| Provision of funds for hire purchase and for leasing ||| Negotiation for the collection of cheques and bills of payment ||| Fourniture de fonds pour la location-vente et la location
0.2990526854991913 ||| However, if it is time for your next dose, skip the missed dose and take only a single dose as usual. ||| If a dose is missed the patient should not take an additional dose, but take the usual prescribed next dose. ||| Cependant, s’ il est l’ heure de la prise suivante, sautez la prise oubliée et ne prenez qu’ une seule dose comme d’ habitude.
0.0 ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. ||| Si votre médecin vous a dit que vous aviez une intolérance à certains sucres, contactez -le avant de prendre ce médicament.
5.011776041917437e-13 ||| Store in the original carton. ||| Store in the original carton. ||| A conserver dans l’ emballage extérieur d’ origine.
0.19028179347515106 ||| If you accidentally miss a daily dose, just take the next dose as normal. ||| If you accidentally miss a dose, then simply take your normal dose when the next one is due. ||| Si vous oubliez de prendre Aprovel Si par inadvertance vous oubliez un jour de prendre votre médicament, prenez la dose suivante comme d'habitude.
0.25164636969566345 ||| diarrhoea, abdominal pain, stomatitis and mouth ulceration, nausea ||| disorders dysphagia diarrhoea, dry mouth, vomiting, colitis ||| isé Oedème pulmonaire, œ dème pharyngé, Rare épanchement pleural, pleurésie.
0.7112917900085449 ||| Pancreatitis, Intestinal angioedema ||| Retroperitoneal Gastrointestinal and ||| Pancréatite, angio-œ dème intestinal
0.3566080331802368 ||| Common side effects likely to affect less than 1 in 10, but more than 1 in 100 people:  Changes in different laboratory parameters, including increase in liver enzymes, renal parameters such as creatinine, potassium, blood sugar, blood lipids, cholesterol, phosphates, magnesium, calcium and uric acid  Kidney problems with increased levels of urea  Disorders of the digestive system such as constipation, indigestion, flatulence, belching, inflammation of the mouth, oesophagus, stomach, intestine, liver or pancreas and gastrointestinal bleeding  Convulsions, increased tension in the muscles, shaking and muscle weakness, joint pain  Sleeplessness dizziness and headache, tingling or numbness, change of the sense of taste, loss of appetite, weight loss 47  Inflammation and infections of the respiratory and gastrointestinal tract, sore throat, inflammation of the sinuses, runny and itchy nose  Skin cancer or non cancerous growth of the skin and fungal infections of the skin and vagina  Changes in blood pressure, faster heart beat, dilation of blood vessels  Fluid retention in the body, fever, discomfort, lethargy and weakness  Inflammation of the liver, yellowing of the skin and whites of the eyes ||| Common side effects (> 1% - 10%) reported with Keppra are: • nervous system disorders: dizziness (sensation of unsteadiness), convulsion, headache, hyperkinesia (hyperactivity), ataxia (impaired coordinated movements), tremor (involuntary trembling), amnesia (loss of memory), balance disorder (equilibrium disorder), disturbance in attention (loss of cocentration), memory impairment (forgetfulness); • psychiatric disorders: agitation, depression, emotional instability/ mood swings, hostility or aggression, insomnia, nervousness or irritability, personality disorders (behavioral problems), thinking abnormal (slow thinking, unable to concentrate); • digestive disorders: abdominal pain, nausea, dyspepsia (indigestion), diarrhoea, vomiting; • nutrition disorders: anorexia (loss of appetite), weight increase; • ear and labyrinth disorders: vertigo (sensation of rotation); • eye disorders: diplopia (double vision), vision blurred; • musculoskeletal and connective tissue disorders: myalgia (muscle pain); • injury: accidental injury; • infections: infection, nasopharyngitis; • respiratory disorders: cough (increase of pre-existing cough); • skin disorders: rash; eczema, pruritus; • blood disorders: decreased number of blood platelets. ||| 48 Effets indésirables courants susceptibles d’affecter moins de 1 patient sur 10 mais plus de 1 patient sur 100: • anomalies des tests de laboratoire, comprenant augmentation des enzymes hépatiques, paramètres rénaux tels que créatinine, potassium, sucre, graisses, cholestérol, phosphates, magnésium, calcium et acide urique; • troubles rénaux avec augmentation des taux d’urée; • troubles du système digestif tels que constipation, troubles de la digestion, flatulences, éructations, aphtes, inflammation de l’œsophage, de l’estomac, de l’intestin, du foie ou du pancréas et saignements gastro-intestinaux; • convulsions, spasmes musculaires, tremblements et faiblesse musculaire, douleurs articulaires; • troubles du sommeil, vertiges et maux de tête, picotement ou engourdissement, perte du goût, perte d’appétit, perte de poids; • inflammation et infections des voies respiratoires et gastro-intestinales, maux de gorge, sinusite, écoulements et démangeaisons nasales; • carcinome cutané ou croissance bénigne des cellules de la peau, infection fongique cutanée et vaginale; • variation de la pression artérielle, accélération du rythme cardiaque et dilatation des vaisseaux sanguins; • oedèmes corporels, fièvre, malaise, douleur, somnolence et faiblesse; • inflammation du foie, jaunissement de la peau et du blanc des yeux.
0.4315152168273926 ||| Heart failure: ||| Breast cancer: ||| 53 Insuffisance cardiaque:
0.6473090648651123 ||| Leather furniture ||| Lawn furniture ||| Meubles en cuir
0.41295838356018066 ||| Latex gloves for medical use ||| Shock wave apparatus for medical use ||| Gants en latex à usage médical
0.13802294433116913 ||| Non-clinical data reveal no special hazard for humans based on conventional studies of genotoxicity. ||| Non-clinical data revealed no special hazard for humans based on conventional studies of repeated dose toxicity. ||| Les données non cliniques issues des études conventionnelles de génotoxicité n’ ont pas révélé de risque particulier pour l’ homme.
0.6261603832244873 ||| Pyrexia Injection site phlebitis ||| Constipation Vomiting Pancreatitis2 ||| Pyrexie Phlébite au point d' injection
0.24988524615764618 ||| 5 1 In this placebo-controlled 24-week study of sitagliptin 100 mg once daily in combination with metformin, the incidence of adverse reactions considered as drug-related in patients treated with sitagliptin/ metformin compared to treatment with placebo/ metformin was 9.3% and 10.1%, respectively. ||| In a study involving healthy volunteers (N=12), when a 60 mg controlled-release morphine capsule was administered 2 hours prior to a 600 mg gabapentin capsule, mean gabapentin AUC increased by 44% compared to gabapentin administered without morphine. ||| 1 Dans cette étude de 24 semaines, versus placebo, menée avec 100 mg de sitagliptine, une fois par jour, en association avec la metformine, l'incidence des effets indésirables considérés comme imputables au médicament a été respectivement de 9,3% et 10,1% chez les patients traités par sitagliptine + metformine et chez les patients traités par placebo + metformine.
0.2847974896430969 ||| Since these neurotransmitters are involved in schizophrenia, olanzapine helps to normalise the activity of the brain, reducing the symptoms of the disease. ||| As such, natalizumab may act to suppress inflammatory activity present at the disease site, and inhibit further recruitment of immune cells into inflamed tissues. ||| Comme ces neurotransmetteurs interviennent dans la schizophrénie, l’ olanzapine aide à normaliser l’ activité cérébrale, diminuant ainsi les symptômes de la maladie.
0.24848705530166626 ||| There was no change in the kinetics of imatinib on repeated dosing, and accumulation was 1.5– 2.5-fold at steady state when dosed once daily. ||| If unexplained reductions in serum bicarbonate levels to less than 20 mmol/ l occur, the dose should be reduced by 50% on the next cycle. ||| Lors d’ administrations répétées en prise quotidienne unique, la cinétique de l'imatinib n’ est pas modifiée, mais son accumulation, à l’ état d'équilibre, est augmentée d’ un facteur de 1,5 à 2,5.
0.11739303171634674 ||| The clinical relevance of these findings is unknown. ||| The clinical relevance of these findings is not established. ||| La pertinence clinique de ces observations est inconnue.
0.4186744689941406 ||| It is recommended that Rapamune be taken consistently either with or without food. ||| It is important that all doses of Kaletra are taken with food. ||| Il est recommandé de prendre Rapamune soit toujours avec, soit toujours sans nourriture.
0.19361752271652222 ||| The overall rate of thrombotic events in patients treated with Arixtra was significantly less than in patients treated with placebo or enoxaparin (for patients undergoing leg surgery), and was similar to that seen with enoxaparin (treatment of DVT), dalteparin or unfractionated heparin. ||| When administered as a 3 hour infusion for the first-line chemotherapy of ovarian cancer, neurotoxicity, arthralgia/ mayalgia, and hypersensitivity were reported as more frequent and severe by patients treated with paclitaxel followed by cisplatin than patients treated with cyclophosphamide followed by cisplatin. ||| Le taux global d’ événements thrombotiques chez les patients sous Arixtra s’ est révélé significativement inférieur à celui observé chez les patients sous placebo ou sous énoxaparine (en cas de chirurgie d'un membre inférieur) et similaire au taux observé chez les patients sous énoxaparine (traitement des TVP), daltéparine ou héparine non fractionnée.
0.3322177529335022 ||| Ornaments made of stone ||| Ornaments made of stone for aquaria ||| Décorations en pierre
0.4559912085533142 ||| These soft capsules are oblong, opaque, off white to cream in colour and marked with the code GX CC2. ||| White to yellow powder in an orange to greyish-orange opaque capsule, marked “ NVR SI”. ||| Ces capsules molles sont de forme allongée, opaques, de couleur blanc cassé à crème, et sont marquées du code GX CC2.
0.12813863158226013 ||| Respiratory, thoracic and mediastinal disorders Very common: ||| 5 Respiratory, thoracic and mediastinal disorders: ||| Affections respiratoires, thoraciques et médiastinales Très fréquent:
0.29009732604026794 ||| Chemical compositions for retarding the setting of concrete ||| Compositions for accelerating the setting of concrete ||| Compositions chimiques pour retarder la prise du béton
0.6474518775939941 ||| Reduction of the mean fasting blood 1 glucose ||| - Worsening of existing high blood pressure ||| Réduction de la glycémie à jeun 1 moyenne
0.35656219720840454 ||| Humira 40 mg solution for injection in single-use vial (type I glass), fitted with rubber stoppers, aluminium crimps and flip-off seals. ||| The pack contains: • ViraferonPeg pre-filled pen • one disposable injection needle • two cleansing swabs, and • dosing tray b. ||| Humira 40 mg solution injectable en flacon à usage unique (verre de type I) muni d’ un bouchon (caoutchouc) avec un sertissage en aluminium et scellé par une capsule de type flip-off.
0.4056912362575531 ||| About 9% of the dose is recovered in the faeces, primarily as metabolites. ||| Small amounts (0.5-2%) of additional metabolites were found in the urine. ||| Environ 9% de la dose est excrétée dans les selles, essentiellement sous forme de métabolites.
0.0 ||| 10 ||| 10 ||| 10 11
4.5133940530274475e-13 ||| Pigs: ||| Pigs: ||| Porcins:
0.430105984210968 ||| This effect of age is not clinically significant and does not warrant a dose adjustment. ||| The mechanism of this interaction is not clear, but may be the result of transporter inhibition. ||| Cet effet lié à l'âge n'est pas cliniquement significatif et ne justifie pas d’ ajustement posologique.
0.20395813882350922 ||| FABLYN-treated and placebo-treated groups had similar incidences of endometrial hyperplasia and endometrial cancer (see section 5.1). ||| There was no difference between FABLYN- and placebo-treated women in the incidences of endometrial carcinoma and endometrial hyperplasia. ||| L’ incidence d’ hyperplasie endométriale et de cancer de l’ endomètre était comparable dans les groupes ayant reçu FABLYN ou le placebo (voir rubrique 5.1)
0.4807334542274475 ||| What ADROVANCE is and what it is used for Before you take ADROVANCE How to take ADROVANCE Possible side effects How to store ADROVANCE Further information ||| What Aldara cream is and what it is used for Before you use Aldara cream How to use Aldara cream Possible side effects How to store Aldara cream Further information ||| Qu’ est -ce que ADROVANCE et dans quel cas est -il utilisé Quelles sont les informations à connaître avant de prendre ADROVANCE Comment prendre ADROVANCE Quels sont les effets indésirables éventuels Comment conserver ADROVANCE Informations supplémentaires
0.8444704413414001 ||| 60 mg film-coated tablets 90 mg film-coated tablets 120 mg film-coated tablets [See Annex I - To be completed nationally] ||| I Applications received (non-orphan medicines) I Applications received (orphan medicines) ||| 60 mg comprimés pelliculés 90 mg comprimés pelliculés 120 mg comprimés pelliculés [Voir Annexe I – A compléter au niveau national]
0.0 ||| For animal treatment only. ||| For animal treatment only. ||| Usage vétérinaire.
0.047854356467723846 ||| As an aid in the treatment of separation related disorders manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques. ||| As an aid in the treatment of separation-related disorders in dogs manifested by destruction and inappropriate elimination (defaecation and urination) and only in combination with behavioural modification techniques. ||| Aide au traitement de l’ anxiété de séparation se manifestant par des destructions et des troubles de l’ élimination (défécation et miction) et seulement en association avec une thérapie de comportement.
0.0 ||| Meta-analysis of overall survival data produced a hazard ratio point estimate of 1.08 in favour of controls (95% CI: ||| Meta-analysis of overall survival data produced a hazard ratio point estimate of 1.08 in favour of controls (95% CI: ||| Une méta-analyse des données de survie globale a estimé le risque relatif à 1,08 en ic
0.6429866552352905 ||| Advertising, promotional and public relations services ||| Education, entertainment and sport services ||| Services publicitaires, promotionnels et relations publiques
0.07359093427658081 ||| 61 10. ||| 71 10. ||| 10.
0.2976894974708557 ||| 1 Injection site reactions including pain, inflammation and very rare cases of abscess or cellulitis that may require surgical intervention have been reported. ||| In very rare cases following administration of Profender transient alopecia, pruritus and/ or inflammation were observed at the application site. ||| 1 Des réactions au site d'injection incluant douleur, inflammation et, dans de très rares cas, abcès ou cellulite pouvant nécessiter une intervention chirurgicale ont également été rapportées.
0.16725388169288635 ||| 72 ||| 82 ||| 73
0.35131460428237915 ||| Insulin Human Winthrop Rapid is used to reduce high blood sugar in patients with diabetes mellitus. ||| Insulin Human Winthrop was effective for both type 1 and type 2 diabetes. ||| Insulin Human Winthrop Rapid est utilisé pour diminuer le taux de sucre dans le sang en cas de diabète sucré.
0.31853222846984863 ||| The tissue cross-reactivity of eculizumab was evaluated by assessing binding to a panel of 38 human tissues. ||| Data on tissue distribution and elimination were obtained in studies with radioactively labeled tenecteplase in rats. ||| La réactivité croisée tissulaire de l’ eculizumab a été évaluée en examinant la liaison sur un panel de 38 tissus humains.
0.01982542686164379 ||| If you are injecting ViraferonPeg yourself, please be sure that the dose that has been prescribed for you is clearly provided on the package of medicine you receive. ||| If you are injecting PegIntron yourself, please be sure that the dose that has been prescribed for you is clearly provided on the package of medicine you receive. ||| Si vous injectez ViraferonPeg vous -même, assurez -vous que la dose qui vous a été prescrite est réellement indiquée sur l’ emballage du médicament que vous recevez.
0.27928102016448975 ||| In clinical studies 2.1% of patients treated with 600 mg of efavirenz discontinued therapy because of nervous system symptoms. ||| In a clinical study with Valtropin, 3% of children with growth hormone deficiency developed such antibodies. ||| Au cours des études cliniques, 2,1% des patients traités par 600 mg d’ éfavirenz ont interrompu leur traitement en raison de symptômes neurologiques.
0.2029774934053421 ||| If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist. i dic ||| If you have any further questions on Silgard after reading this leaflet, please ask your doctor or pharmacist. ||| Si vous remarquez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin ou votre pharmacien.
0.2639085650444031 ||| The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’ s overall risks (see section 4.3 and 4.4). ||| Before therapy is initiated with AVAGLIM appropriate clinical evaluation should be made to assess the patient’ s risk of developing hypoglycaemia (see section 4.4). ||| La décision de prescrire un inhibiteur sélectif de la COX-2 doit être basée sur l’ évaluation du risque global spécifique à chaque patient (voir rubriques 4.3 et 4.4).
0.07584664225578308 ||| ► In insulin infusion pumps ► If FlexPen is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn ’ t been stored correctly or if it has been frozen (see 6 How to store Levemir) ► If the insulin does not appears water clear and colourless. ||| ► If the cartridge or the device containing the cartridge is dropped, damaged or crushed, there is a risk of leakage of insulin ► If it hasn’ t been stored correctly or if it has been frozen (see 6 How to store NovoRapid) ► If the insulin does not appear clear and colourless. ||| ► dans une pompe à perfusion d’insuline ► si votre FlexPen est tombé, a été endommagé ou a été écrasé car il y a un risque de fuite d’insuline ► s’il n’a pas été conservé correctement ou s’il a été congelé (voir 6 Comment conserver Levemir) ► si l’insuline n’apparaît pas limpide et incolore.
0.2938172221183777 ||| Masters Degree in European and international law from University of Paris II and various post-graduate diplomas in public health, pharmaceutical legislation and European Community Studies. ||| Doctor of Sciences in physical sciences and qualification in management of research, PhD and MSc in physical organic chemistry, Degree in Biochemistry, from the University of Montpellier. ||| Maîtrise en droit européen et international de l’université de Paris II et divers certificats d’études supérieures en santé publique, législation pharmaceutique et études des Communautés européennes.
0.8190128803253174 ||| Interactions with food and drink ||| Transparency and relations with interested parties ||| Interactions avec la prise de nourriture et de boisson
0.0 ||| - diarrhoea, constipation, nausea, vomiting, abdominal pain ||| - diarrhoea, constipation, nausea, vomiting, abdominal pain ||| supérieures, sinusite, toux majorée, essoufflement diarrhées, constipation, nausées, vomissements, douleurs abdominales
0.5311799049377441 ||| - You should remain in an upright (sitting or standing) position while taking Bondronat tablets ||| ORACEA should be swallowed whilst in an upright sitting or standing posture. ||| - Vous devez rester dans une position verticale (assis ou debout) pendant que vous prenez les
0.5956926345825195 ||| In December 1998, the group reported on its activities to the Management Board and to the European Commission. ||| The Commission also has contacts with the European Parliament and with other stakeholders. ||| En décembre 1998, le groupe a fait part de ses activités au Conseil d’ administration et à la Commission européenne.
6.968593454018124e-13 ||| The following information is intended for medical or healthcare professionals only: ||| The following information is intended for medical or healthcare professionals only: ||| Information destinée exclusivement aux professionnels de la santé.
0.3592311143875122 ||| NutropinAq therapy should be discontinued if pregnancy occurs. ||| If pregnancy occurs, FORSTEO should be discontinued. ||| Le traitement par NutropinAq doit être interrompu en cas de grossesse.
0.4676249027252197 ||| The Summary of Product Characteristics of ritonavir must therefore be consulted prior to initiation of therapy with APTIVUS (especially as regards the contraindications, warnings and undesirable effects sections). ||| Guidance on the pharmacodynamic section of the summary of product characteristics for antibacterial medicinal products Points to consider on Biostatistical/methodological issues arising from CPMP discussion on licensing applications: ||| Le Résumé des Caractéristiques du Produit du ritonavir doit donc être consulté avant l’ instauration d’ un traitement par APTIVUS (en particulier en ce qui concerne les rubriques contre-indications, mises en garde et effets indésirables).
0.3642771542072296 ||| Satisfactory specificity and sensitivity have been demonstrated in clinical studies where breath was analysed using isotope ratio mass spectrometry (IRMS). ||| Therapeutic indications Optimark is indicated for use with magnetic resonance imaging (MRI) of the central nervous system (CNS) and liver. ||| Une spécificité et une sensibilité satisfaisantes ont été démontrées dans les études cliniques entreprises dans le cadre desquelles l’ air expiré a été analysé en utilisant la spectrométrie de masse.
0.2842106819152832 ||| You will have to inject Ceplene and IL-2 twice a day by subcutaneous injection (in the layer of tissue just under the skin), according to the directions provided by your doctor. ||| The total weekly dose that you receive should not normally exceed 200 IU/kg and should be given by injection into a vein or a tube that goes into a vein. ||| Vous devrez vous injecter Ceplene et l’ IL-2 deux fois par jour par voie sous-cutanée (dans la couche de tissus juste sous la peau), conformément aux directives données par votre médecin.
0.4224283993244171 ||| - Hypersensitivity and allergic reactions have been reported for fluoroquinolones including ||| Hypersensitivity reactions including anaphylaxis There have also been reports of: ||| - Des réactions d’ hypersensibilité et allergiques ont été rapportées dès la première prise avec les
0.340554803609848 ||| Rebetol oral solution is used in combination with interferon alfa-2b for injection. ||| Thyroid dysfunction during treatment with Ribavirin and interferon alfa-2b has been observed. ||| Rebetol solution buvable est utilisé en association avec l’ interféron alfa-2b, solution injectable.
0.2552611827850342 ||| Elastomeric sheeting for protecting surfaces in areas used for shot-peening ||| Elastomers for bonding to surfaces in areas for shot-peening ||| Feuilles élastomères pour la protection des surfaces de zones destinées au grenaillage
0.4353386163711548 ||| Fittings of metal for windows ||| Doors and windows of metal ||| Garnitures de fenêtres métalliques
0.6382712125778198 ||| Kaletra should not be given to these patients (see section 4.3). ||| au prescribing to this age group (see section 4.1). ||| Kaletra ne doit pas être administré à ces patients (voir rubrique 4.3).
0.0 ||| 82 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 82 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 90 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.4082271456718445 ||| In a population of patients with refractory SCLC (those not responding to first line therapy), the response rate to topotecan was 4.0%. ||| Of the animals receiving adjuvanted vaccine, 87% and 96% were protected against the lethal homologous or heterologous challenge, respectively. ||| Dans une population de patients réfractaires (ceux ne répondant pas à la première ligne de traitement), le taux de réponse au topotécan était de 4,0%.
0.6111865043640137 ||| Push button ||| Push button scale ||| Bouton-poussoir
0.48892146348953247 ||| Consideration should be given to official/ national guidance on the appropriate use of antifungal agents. ||| Any additional instructions from the respective equipment manufacturer must also be strictly adhered to. ||| Il convient de tenir compte des recommandations officielles/ nationales concernant l’ utilisation appropriée des antifongiques.
0.3328351378440857 ||| Chapter 3 – Medicinal products for veterinary use ||| 31 3 Medicinal products for veterinary use ||| Chapitre 3 – Médicaments à usage vétérinaire 6
0.4620668888092041 ||| Interactive transmission of video over digital networks ||| Transmission of video data via the Internet ||| Transmission interactive de vidéos sur des réseaux numériques
0.803551197052002 ||| Tea caddies ||| Animal teeth ||| Boîtes à thé
3.546650549201419e-13 ||| The scale on the cartridge shows about how many units you have left. • Do not mix any other insulin in your disposable pen. ||| The scale on the cartridge shows about how many units you have left. • Do not mix any other insulin in your disposable pen. ||| L'échelle qui figure sur la cartouche indique le nombre d'unités libérées. • Ne mélangez aucune autre insuline dans votre stylo jetable.
0.7017925977706909 ||| Rigid bronchoscopes ||| Expanded graphites ||| Bronchoscopes rigides
0.3628048300743103 ||| Amitriptyline does not affect the pharmacokinetics of risperidone or the active antipsychotic fraction. ||| d acetylsalicylic acid or piroxicam treatment, nor the pharmacokinetics of digoxin at steady state. ||| L’ amitryptiline ne modifie pas la pharmacocinétique de la rispéridone ou de la fraction antipsychotique active.
0.39940688014030457 ||| Upper gastrointestinal haemorrhage, Mouth ulceration, Gastritis, Abdominal distension, Gastroesophageal reflux disease, Oral pain, Dysphagia, Rectal haemorrhage, Abdominal pain lower ||| Nausea Vomiting Diarrhoea Abdominal pain and dyspepsia Gastric and duodenal ulcers Gastrointestinal haemorrhage Pancreatitis Some cases of severe vomiting were associated with ||| Hémorragie gastro-intestinale haute, Ulcération buccale, Gastrite, Distension abdominale, reflux gastro-oesophagien, Douleur buccale, Dysphagie, Rectorragie, Douleur abdominale basse
0.3249339461326599 ||| Patients should be monitored with respect to this. ||| Patients should be closely monitored throughout this period. ||| Les patients doivent être suivis en conséquence.
0.18433699011802673 ||| INFORMATION FOR THE USER Irbesartan BMS 150 mg tablets irbesartan ||| INFORMATION FOR THE USER Irbesartan BMS 75 mg film-coated tablets irbesartan ||| INFORMATION DE L'UTILISATEUR Irbesartan BMS 150 mg comprimés irbésartan
0.7201467156410217 ||| Filgrastim ratiopharm 48 MIU/ 0.8 ml: ||| Insulin aspart∗....................................... ..100 U/ ml ||| Filgrastim ratiopharm 48 MUI/ 0,8 ml:
0.2690838575363159 ||| 5/ 17 PROHIBITION OF SALE, SUPPLY AND/ OR USE ||| PROHIBITION OF SALE, SUPPLY AND/OR USE ||| INTERDICTION DE VENTE, DE DÉLIVRANCE ET/ OU D' UTILISATION
0.2052149474620819 ||| No clinical studies have been performed in children and adolescents 75 years of age. ||| No clinical data have been generated in subjects below 18 years of age. ||| Aucune étude n’ a été réalisée chez les enfants et adolescents de moins de 18 ans ou chez les patients de plus de 75 ans.
0.2492230087518692 ||| Sebivo is indicated for the treatment of chronic hepatitis B in adult patients with compensated liver disease and evidence of viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/ or fibrosis. ||| Controlled studies of haemodynamic effects and exercise tolerance in patients with heart failure class II-IV have demonstrated that amlodipine does not lead to clinical deterioration regarding exercise tolerance, left ventricular ejection fraction and clinical symptomatology. ||| Sebivo est indiqué dans le traitement de l’ hépatite B chronique chez les patients adultes atteints d’ une maladie hépatique compensée avec mise en évidence d’ une réplication virale, d’ une élévation persistante des taux sériques d’ alanine aminotransférase (ALAT) et d’ une inflammation hépatique active et/ ou une fibrose histologiquement prouvées.
3.598636146018297e-13 ||| In the event of suspected overdose, appropriate supportive medical care should be provided e. g. by eliminating the gastric contents, clinical supervision and, if necessary, the institution of symptomatic treatment. ||| In the event of suspected overdose, appropriate supportive medical care should be provided e. g. by eliminating the gastric contents, clinical supervision and, if necessary, the institution of symptomatic treatment. ||| En cas d’ éventuel surdosage, une prise en charge médicale adaptée est nécessaire, par exemple évacuation du contenu gastrique, surveillance clinique et, si nécessaire, un traitement symptomatique.
0.0 ||| Merck Sharp & Dohme (Italia) S. p. A. ||| Merck Sharp & Dohme (Italia) S. p. A. ||| Merck Sharp & Dohme (Italia) S.p.A.
0.008510918356478214 ||| Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41% and AUC by about 51%, suggesting that charcoal may be effective in the treatment of overdose. ||| 52 Activated charcoal (50 g), administered one hour after aripiprazole, decreased aripiprazole Cmax by about 41% and AUC by about 51%, suggesting that charcoal may be effective in the treatment of overdose. ||| L’ administration de 50 g de charbon activé, une heure après l'administration d’ aripiprazole, a diminué la Cmax de l'aripiprazole d’ environ 41% et l'ASC d’ environ 51%, ce qui suggère que le charbon peut être efficace pour le traitement du surdosage.
0.3587254285812378 ||| Diarrhea (G3/ 4: ||| Stomatitis (G3/ 4: ||| 2,9%); Vomissements (G3/ 4:
0.26896950602531433 ||| Polyurethane foam for insulating purposes ||| Polystyrene panels for insulating purposes ||| Mousse de polyuréthane à des fins d'isolation
0.046305254101753235 ||| The European Medicines Agency (EMEA) has completed a referral procedure following a disagreement among Member States of the European Union regarding the authorisation of the medicine Sabumalin. ||| The European Medicines Agency (EMEA) has completed an arbitration procedure following a disagreement among Member States of the European Union regarding the authorisation of the medicine Implanon. ||| L’ Agence européenne des médicaments (EMEA) a achevé une procédure de saisine lancée suite à un désaccord parmi les États membres de l’ Union européenne concernant l’ autorisation du médicament Sabumalin.
0.03748675435781479 ||| Like all medicines, Mixtard can cause side effects, although not everybody gets them. ||| Like all medicines, Firazyr can cause side effects, although not everybody gets them. ||| Comme tous les médicaments, Mixtard peut provoquerdes effets indésirables, mais ils ne surviennent pas systématiquement chez tout le monde.
0.542984127998352 ||| "During this time in Canada, ""community quarantine"" was used to reduce transmission of the disease with moderate success." ||| "It overlapped with the simultaneously used term of Verwaltungswissenschaft (or ""administrative science"") and was a university course included in official trainings." ||| Lors de l'épidémie de SRAS de 2003 au Canada, la quarantaine communautaire a été utilisée pour réduire la transmission de la maladie avec un succès modéré.
0.33240288496017456 ||| The study Data Safety Monitoring Board stopped the ZDV/ 3TC/ ABC arm at this time based on the higher proportion of patients with virologic failure. ||| During maintenance treatment, the incidence of grade 3/ 4 cardiac disorders was comparable between patients treated with MabThera and observation. ||| Le Comité de Suivi des Données de Tolérance de l'étude (DSMB) a dès lors décidé d'arrêter le bras ZDV/ 3TC/ ABC en raison du nombre plus élevé de sujets en échec virologique.
0.01695612259209156 ||| 72 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| 2 Adjustment of dosage may also be necessary if patients change physical activity or their usual diet. ||| Un ajustement de la posologie peut également être nécessaire si le patient modifie son activité physique ou son régime alimentaire.
0.45630747079849243 ||| The replacement enzyme helps to break down the Gb3 and stops it building up (accumulating) in the cells. ||| By attaching to the channels, rufinamide prevents them switching from an inactive state to an active state. ||| L’ enzyme de substitution permet d’ éliminer le Gb3 et empêche son accumulation à l’ intérieur des cellules.
0.3429367244243622 ||| Treatment of patients with G6PD-deficiency with sulfonylurea agents can lead to haemolytic anaemia. ||| Thiazide diuretic- associated azotaemia may occur in patients with impaired renal function. ||| 36 Le traitement des patients atteints d’ un déficit en G6PD par des sulfamides hypoglycémiants peut provoquer une anémie hémolytique.
0.25443699955940247 ||| X-ray laminographic inspection apparatus, other than for medical use ||| Diagnostic ultrasound apparatus, other than for medical use ||| Appareils d'inspection à rayons X avec tomographie, autres qu'à usage médical
0.0663224309682846 ||| EU/ 1/ 08/ 469/ 016 30 tablets: ||| EU/ 1/ 08/ 469/ 021 30 tablets: ||| EU/ 1/ 08/ 469/ 016 30 Comprimés:
0.2929798364639282 ||| • Attach the syringe with the vial adapter or transfer needle to the powder vial. ||| If using a vial adapter, tip the syringe to remove it from the vial. ||| • Attachez la seringue avec l’ adaptateur pour flacon ou l’ aiguille de transfert au flacon de poudre.
0.46430373191833496 ||| Protective coatings for metals [paints] ||| Protective shrouds for vehicles [shaped] ||| Enduits protecteurs pour métaux [peintures]
0.32496166229248047 ||| A €55 billion top-up of the current cohesion policy programmes between now and 2022 under the new REACT-EU initiative to be allocated based on the severity of the socio-economic impacts of the crisis, including the level of youth unemployment and the relative prosperity of Member States. ||| "The EU and ECB together have mobilised hundreds of billions of euros in financial support to underpin state finances and the economy, which is only possible due to the credit worthiness of the European Union and the large-scale leverage it has when acting together," explained Karas. ||| un complément de 55 milliards d'euros pour les programmes actuels de la politique de cohésion entre aujourd'hui et 2022 au titre de la nouvelle initiative REACT-EU qui sera réparti en fonction de la gravité des effets socio-économiques de la crise, notamment le taux de chômage des jeunes et la prospérité relative des États membres;
0.5725858807563782 ||| These findings showed reversibility over a follow-up period of 18 months. ||| Similar findings were found based on a 18-months landmark analysis. ||| Ces observations ont montré une réversibilité sur une période de suivi de 18 mois.
0.17188529670238495 ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that Baraclude had shown that it was as or more effective than the current treatment for hepatitis B virus infections. ||| The Committee for Medicinal Products for Human Use (CHMP) concluded that Evista had shown its effectiveness in preventing and treating osteoporosis, and had no effects on the breast or womb. ||| Le comité des médicaments à usage humain (CHMP) a conclu que Baraclude est aussi ou plus efficace que le traitement actuel des infections chroniques par le virus de l'hépatite B.
3.6388069207110574e-13 ||| When the 0, 1 and 6 month schedule is followed, ≥ 96% of vaccinees have seroprotective levels of antibody 7 months after the first dose. ||| When the 0, 1 and 6 month schedule is followed, ≥ 96% of vaccinees have seroprotective levels of antibody 7 months after the first dose. ||| Avec le schéma 0-1-6 mois, le taux de séroconversion est ≥ 96%, 7 mois après la première dose.
0.11856146901845932 ||| 49 9. ||| 47 9. ||| 52 9.
0.36499571800231934 ||| The active substance in Azopt, brinzolamide, is a carbonic anhydrase inhibitor. ||| A preservative in DuoTrav (benzalkonium chloride) can affect soft lenses. ||| Le principe actif d’ Azopt, le brinzolamide, est un inhibiteur de l’ anhydrase carbonique.
0.4268835783004761 ||| The clinical significance of the pharmacokinetic interaction is unknown. ||| No time-dependency of the Pharmacokinetics was observed. ||| La pertinence clinique de l’ interaction pharmacocinétique n’ est pas connue.
0.3519909977912903 ||| Erythropoietin is a growth factor that primarily stimulates red cell production. ||| In a lower degree bleomycin also affects the RNA and protein synthesis. ||| 168 L'érythropoïétine est un facteur de croissance qui stimule essentiellement la production des érythrocytes.
0.03238171339035034 ||| The calculation of the required dosage of factor VIII is based on the empirical finding that 1 International Unit (IU) factor VIII per kg body weight raises the plasma factor VIII activity by 1.5% to 2.5% of normal activity. ||| The calculation of the required dosage of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 1.1% of normal activity. ||| 20 Le calcul de la dose nécessaire en facteur VIII se base sur le résultat empirique qu’ 1 Unité Internationale (UI) de facteur VIII par kg de poids corporel augmente l’ activité en facteur VIII plasmatique de 1,5% à 2,5%.
1.2096045017242432 ||| EXP.: ro lp ||| Picture F ro lP ||| EXP.: éd
0.6125075221061707 ||| Television and radio programme preparation and production ||| Interactive television and radio broadcasting ||| Préparation et production de programmes radiophoniques et télévisés
0.6003149747848511 ||| 17 Volibris tablets contain lactose monohydrate. ||| • Iodine salts and/ or levothyroxine. ||| Chaque comprimé contient du lactose monohydraté.
0.1630634367465973 ||| How to use Liprolog Mix50 KwikPen 4. ||| Before you use Liprolog Mix50 KwikPen 3. ||| Comment utiliser Liprolog Mix50 KwikPen 4.
0.46759289503097534 ||| The cartridge in use must not be stored in a refrigerator. ||| You should always store the pen in a refrigerator. ||| Les cartouches en cours d’ utilisation ne doivent pas être conservées au réfrigérateur.
0.17689773440361023 ||| What is Azomyr used for? ||| How is Azomyr used? ||| Dans quel cas Azomyr est -il utilisé?
0.09649357199668884 ||| lo EU/ 1/ 01/ 184/ 007 ||| r EU/ 1/ 01/ 184/ 005 ||| n EU/ 1/ 01/ 184/ 007
0.5656225681304932 ||| Kerosene ||| Canoes ||| Kérosène
0.46790260076522827 ||| In 2013, the European Commission issued a guidance document to assist EU countries in this process. ||| The European Commission has today published a draft legal agreement for the future EU-UK partnership. ||| En 2013, la Commission européenne a publié un document d'orientation pour aider les pays de l'UE dans ce processus.
0.4884618818759918 ||| Around a quarter of the patients in this study also had a reduction in tumour size. ||| 13 In another case of a large overdose, the patient also survived and recovered. ||| Près d’ un quart des patients de cette étude ont également présenté une réduction de la taille de la tumeur.
0.2250985950231552 ||| The duration of treatment is dependent on clinical response. ||| The duration of treatment depends upon the type of infection. ||| La durée du traitement dépend de la réponse clinique.
0.23703357577323914 ||| If you are taking any of these medicines, your doctor may need to check the level of anticonvulsant medicine in your blood to ensure that it is not affected while taking Atripla. ||| If you suffer from liver disease and your doctor decides to use unboosted Agenerase capsules (that is without ritonavir), the dose of Agenerase may need to be adjusted. ||| Si vous prenez l’ un de ces médicaments, votre médecin devra peut-être mesurer la concentration du médicament anticonvulsivant dans votre sang pour s’ assurer que celle -ci
0.47270306944847107 ||| This concerns the vast majority of tracing apps that were already - or are about to be - launched in the EU. ||| A total of 171 cases have been confirmed, a majority of which can be traced to ski areas in the Alps. ||| Cela concerne la vaste majorité des applications de traçage déjà lancées dans l'UE ou sur le point de l'être.
0.028098486363887787 ||| SP Labo N.V., Industriepark 30, B- 2220 Heist-op-den-Berg, Belgium ||| SP Labo N. V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgium ||| SP Labo N. V., Industriepark 30, B-2220 Heist-op-den-Berg, Belgique
0.28427746891975403 ||| It is unlikely that atosiban is involved in cytochrome P450 mediated drug-drug interactions as in vitro investigations have shown that atosiban is not a substrate for the cytochrome P450 system, and does not inhibit the drug metabolising cytochrome P450 enzymes. ||| The binding affinities of the major circulating metabolites of lasofoxifene were at least 31-fold and 18-fold less than those of lasofoxifene for the estrogen receptor alpha and the estrogen receptor beta, respectively, indicating that these metabolites are unlikely to contribute to the pharmacologic activity of lasofoxifene. ||| Il est peu probable qu'atosiban soit impliqué dans des interactions médicamenteuses faisant intervenir le cytochrome P450 puisque des études in vitro ont démontré qu'atosiban n'est pas un substrat pour le système du cytochrome P450, et n'inhibe pas l'action des enzymes du cytochrome P450 participants au métabolisme des médicaments.
0.2994309961795807 ||| The incidence of dry cough was significantly lower in patients treated with telmisartan than in those given angiotensin converting enzyme inhibitors in clinical trials directly comparing the two antihypertensive treatments. ||| Among co-infected patients, 3% of those treated with efavirenz-containing regimens and 2% in the control arm discontinued from the study because of liver or biliary system disorders. ||| 27 Au cours des essais cliniques comparant le telmisartan à des inhibiteurs de l’ enzyme de conversion, l’ incidence de la toux sèche a été significativement plus faible dans les groupes de patients traités par le telmisartan que dans les groupes de patients traités par les inhibiteurs de l’ enzyme de conversion.
0.253520131111145 ||| Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. ||| Because toxic effects can occur at any time during therapy (although they are most likely within 5 days of administration), patients receiving DepoCyte therapy should be monitored continuously for the development of neurotoxicity. ||| En conséquence, il est recommandé d'observer un arrêt de ces traitements d'au moins 24 heures avant de débuter le traitement.
0.5150513052940369 ||| I would like to thank Member States for their efforts during this process. ||| I am working on the following measures to support Member States in their efforts: ||| Je souhaite remercier les États membres pour leurs efforts au cours de ce processus.
0.4973323345184326 ||| Despite these measures, when medicines prepared from human blood or plasma are administered, the possibility of passing on infection cannot be totally excluded. ||| Various forms of isolation exist, in some of which contact procedures are modified, and others in which the patient is kept away from all others. ||| Malgré ces mesures, lorsque des médicaments préparés à partir de sang ou de plasma humain sont administrés, le risque de transmission d’infection ne peut être totalement exclu.
0.09198002517223358 ||| If you are injecting LITAK by yourself, you will be instructed how to prepare and to give the injection. ||| If you are injecting this medicine yourself, you will be instructed how to prepare and give the injection. ||| Si vous vous injectez LITAK vous -même, vous recevrez des indications sur la manière de préparer et d'administrer l'injection.
0.7176554203033447 ||| The following additional safety results were observed in the study: ||| The following studies are the most important. ||| 38 Dans cette études, les autres résultats de sécurité suivants ont été observés:
0.7293635606765747 ||| 0/ 40, without zidovudine: ||| 4 (0.1%), placebo: ||| 0/ 40; sans zidovudine:
3.9256575420920647e-13 ||| Adefovir is excreted renally, by a combination of glomerular filtration and active tubular secretion. ||| Adefovir is excreted renally, by a combination of glomerular filtration and active tubular secretion. ||| L’ adéfovir est éliminé par voie rénale, à la fois par filtration glomérulaire et par sécrétion tubulaire active.
0.2590080499649048 ||| 6 FURTHER INFORMATION ||| FURTHER INFORMATION ||| INFORMATIONS SUPPLEMENTAIRES
0.2118491679430008 ||| HOW TO USE KENTERA ||| HOW TO USE MIRCERA ||| COMMENT UTILISER KENTERA
0.32083937525749207 ||| A UN Crisis Management Team was activated as a result, allowing coordination of the entire United Nations response, which the WHO states will allow them to "focus on the health response while the other agencies can bring their expertise to bear on the wider social, economic and developmental implications of the outbreak". ||| Enforcing EU-level criminal law provisions and information exchange: Judicial and police cooperation, on the basis of EU instruments and institutional arrangements, is essential to ensure the proper exchange of information.The private sector can also play a role in fighting money laundering and terrorist financing. ||| Une équipe de gestion de crise de l’ONU a donc été activée, permettant de coordonner l’ensemble de la réponse des Nations Unies, ce qui d’après l’OMS leur permettra de « se concentrer sur la réponse sanitaire tandis que les autres agences pourront apporter leur expertise pour gérer les implications sociales, économiques et de développement plus larges de l’épidémie ».
0.3431175947189331 ||| Settlement tanks, not of metal ||| Modular silos, not of metal ||| Cuves de décantation non métalliques
0.0098464610055089 ||| The following events have been mentioned: insomnia, headache, nausea, diarrhoea, flu syndrome, nervousness, depression, pain, sweating, and dizziness. ||| The following events have been mentioned: insomnia, headache, nausea, diarrhoea, flu syndrome, nervousness, depression, pain, sweating and dizziness. ||| Les événements suivants ont été rapportés: insomnie, céphalées, nausées, diarrhée, syndrome grippal, nervosité, dépression, douleurs, sudation, et étourdissements.
0.010228995233774185 ||| One cartridge contains 1.5 ml corresponding to 10 mg Somatropin* (30 IU). ||| One cartridge contains 1.5 ml corresponding to 5 mg Somatropin* (15 IU). ||| Une cartouche contient 1,5 ml correspondant à 10 mg de somatropine* (30 UI).
0.21905583143234253 ||| 160 In the controlled portions of clinical trials of TNF-antagonists, more cases of lymphoma have been observed among patients receiving a TNF-antagonist compared with control patients. ||| Although no clinical trials have been performed evaluating Enbrel therapy in patients with multiple sclerosis, clinical trials of other TNF antagonists in patients with multiple sclerosis have shown increases in disease activity. ||| Dans les phases contrôlées des essais cliniques avec des anti-TNF, il a été observé plus de cas de lymphomes parmi les patients ayant reçu un anti-TNF que chez les patients contrôle.
0.30146005749702454 ||| 14 x 1 mg film-coated tablets and 1 clear blister of 28 x CHAMPIX 1 mg film-coated tablets in card packaging. ||| 21 film-coated tablets of 12.5 mg and 7 film-coated tablets of 50 mg losartan potassium. ||| plaquette thermoformée transparente de 11 comprimés pelliculés de CHAMPIX 0,5 mg et 14 comprimés pelliculés de CHAMPIX 1 mg et 1 plaquette thermoformée transparente de 28 comprimés pelliculés de CHAMPIX 1 mg dans un étui.
0.14509770274162292 ||| 40 10. ||| 50 10. ||| 42 10.
0.17062094807624817 ||| The AUC and Cmin of amprenavir were increased by 64% and 508% respectively and the Cmax decreased by 30% when ritonavir (100 mg twice daily) was coadministered with amprenavir (600 mg twice daily) compared to values achieved after 1200 mg twice daily doses of amprenavir. ||| Rifabutin: compared to rifabutin administered alone (300 mg once daily), plasma rifabutin AUC (0- 48) was unchanged and Cmax was decreased 14% following co-administration of reduced doses of rifabutin (150 mg every other day) with fosamprenavir 700 mg twice daily with ritonavir 100 mg twice daily. ||| L’ ASC et la Cmin d’ amprénavir ont été augmentées respectivement de 64% et 508% et la Cmax diminuée de 30% lorsque le ritonavir (100 mg deux fois par jour) a été co-administré avec l'amprénavir (600 mg deux fois par jour) par rapport aux valeurs obtenues après administration de doses d'amprénavir de 1200 mg deux fois par jour.
0.305782675743103 ||| Each tablet of Karvezide 300 mg/ 12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide. ||| - Each Icandra 50 mg/850 mg film-coated tablet contains 50 mg vildagliptin and 850 mg ||| Chaque comprimé de Karvezide 300 mg/ 12,5 mg contient 300 mg d'irbésartan et 12,5 mg d'hydrochlorothiazide.
0.2529586851596832 ||| Because arsenic trioxide can affect the heart, patients receiving TRISENOX should be closely monitored, and should have electrocardiograms before and during treatment. ||| In order to ensure effective erythropoiesis, iron status should be evaluated for all patients prior to and during treatment and supplementary iron therapy may be necessary. ||| Etant donné que le trioxyde d'arsenic peut affecter le cœ ur, il importe que les patients recevant TRISENOX fassent l'objet d'un suivi, et soient soumis à des électrocardiogrammes avant et pendant le traitement.
0.22812490165233612 ||| Kinzalmono 80 mg tablets telmisartan ||| Pritor 80 mg tablets telmisartan ||| Kinzalmono 80 mg comprimés telmisartan
1.0399276925698864e-12 ||| Italia Ipsen SpA Via A. ||| Italia Ipsen SpA Via A. ||| Ipsen SpA 190 Bath Road Via A.
0.5492479801177979 ||| Cozaar Comp 50 mg/ 12.5 mg, Cozaar Comp 100 mg/ 12.5 mg and Cozaar Comp 100 mg/ 25 mg: ||| Tritace 2.5 Comb 2.5 mg/12.5 mg tabletki, Tritace 5 Comb 5 mg/25 mg tabletki ||| Cozaar Comp 50 mg/ 12,5 mg, Cozaar Comp 100 mg/ 12,5 mg et Cozaar Comp 100 mg/ 25 mg:
0.30609676241874695 ||| Patients exhibiting depression should be monitored closely during therapy and treated appropriately. ||| Care should be taken with patients with a history of psychiatric illness and patients should be advised accordingly. ||| Les patients présentant une dépression doivent faire l'objet d'une surveillance particulière durant le traitement et être traités de façon appropriée.
0.0904562845826149 ||| WHAT CRIXIVAN IS AND WHAT IT IS USED FOR ||| WHAT OPTISULIN IS AND WHAT IT IS USED FOR ||| QU’ EST-CE QUE CRIXIVAN ET DANS QUEL CAS EST-IL UTILISE
0.34294527769088745 ||| 23 If you have severe renal insufficiency you should take alternating daily doses of 800 mg (two tablets of 400 mg) and 400 mg (one tablet of 400 mg), starting with the 800 mg dose. ||| The required number of tablets should be placed in the appropriate volume of beverage (approximately 50 ml for a 100 mg tablet, and 200 ml for a 400 mg tablet) and stirred with a spoon. ||| En cas d’insuffisance rénale sévère, prendre en alternance 1 jour sur 2 une prise quotidienne de 800 mg (2 comprimés de 400 mg) et de 400 mg (un comprimé de 400 mg) en commençant par la dose tp de 800 mg.
0.9072306156158447 ||| Capsule core: ||| Strengths: ||| Contenu de la gélule:
0.37646484375 ||| Due to reduced travel and closures of heavy industry, there has been a decrease in air pollution and carbon emissions. ||| The pandemic has already led to extension of some contracts, potentially with a negative impact on wellbeing of seafarers. ||| En raison de la diminution des voyages et des fermetures dans l’industrie lourde, il y a eu une diminution de la pollution atmosphérique et des émissions de carbone.
0.4592823088169098 ||| ZYPREXA VELOTAB 5 mg, 10 mg, 15 mg and 20 mg are available in cartons containing 28, 35, 56 or 70 tablets. ||| Each RISPERDAL film-coated tablet contains either 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg or 6 mg of risperidone. ||| ZYPREXA VELOTAB 5 mg, 10 mg, 15 mg ou 20 mg sont disponibles en boîtes de 28, 35, 56 ou 70 comprimés.
0.6542264223098755 ||| Hydrogen cyanide ||| Calcium fortified candy ||| Cyanure d'hydrogène
0.3203180730342865 ||| If an individual patient should require dosages outside the recommended regimen, appropriate doses of beta-agonist and/ or corticosteroid should be prescribed. ||| 59 To eliminate these side effects, your child’ s doctor may have to change the dose of concomitant medicines, or the dosage of Diacomit. ||| Si les dosages disponibles de cette association fixe ne répondent pas aux nécessités pour ajuster les posologies en fonction de l’ état du patient, bêta-2 agonistes et/ ou corticoïdes devront être prescrits individuellement.
0.4153933525085449 ||| The cellular events induced by the active substance take place within the collagen matrix. ||| The resulting increased calcium influx induces insulin secretion from the β -cell. ||| Les événements cellulaires déclenchés par le principe actif s’ effectuent alors dans la matrice collagène.
0.27794742584228516 ||| Take special care with Ventavis: ||| 25 Take special care with Galvus: ||| Faites attention avec Ventavis:
0.7491073608398438 ||| Resolution has been observed at 56 days post-injection. ||| 6 months after the last (re-)vaccination. ||| Ces réactions disparaissent 56 jours après l’ injection.
0.22829174995422363 ||| 71 ||| 70 ||| 81
0.3304833173751831 ||| Previous projects to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). ||| For instance, the Middle East respiratory syndrome coronavirus (MERS-CoV) originated from camels and the Severe Acute Respiratory Syndrome (SARS) originated from civet cats. ||| Les projets de vaccins (dont vaccin nasal) ont aussi concerné des coronavirus humains, dont le coronavirus du syndrome respiratoire aigu sévère (SRAS) et le syndrome respiratoire du Moyen-Orient (MERS).
0.18442317843437195 ||| indications for oral and intravenous formulations in children and adolescents: • Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa. • Complicated urinary tract infections and pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative intent) ||| • Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa • Complicated urinary tract infections and pyelonephritis • Inhalation anthrax (post-exposure prophylaxis and curative treatment) ||| suivantes, pour les formulations orales et intraveineuses, chez les enfants et adolescents: • Infections broncho-pulmonaires de la mucoviscidose causées par Pseudomonas aeruginosa • Infections urinaires compliquées et pyélonéphrite • Charbon pulmonaire (prophylaxie post-exposition et traitement curatif)
0.4473542273044586 ||| - if you have a history of autoimmune disease, or have had an organ transplant and are taking medicine that ||| - if you have a severe infection or are seriously dehydrated (have lost a lot of water from your ||| - si vous avez une maladie auto-immune, ou avez eu une transplantation d’ organe et prenez un
0.35722148418426514 ||| Universal precautions refer to the practice, in medicine, of avoiding contact with patients' bodily fluids, by means of the wearing of nonporous articles such as medical gloves, goggles, and face shields. ||| For those who are collecting respiratory specimens from, caring for, or transporting COVID-19 patients without any aerosol-generating procedures, WHO recommends a surgical mask, goggles, or face shield, gown, and gloves. ||| Les précautions universelles désignent la pratique, en médecine, consistant à éviter tout contact avec les fluides corporels des patients, par le port d'articles non poreux tels que des gants médicaux, des lunettes de protection et des écrans faciaux.
0.526236891746521 ||| Atripla, your doctor may need to adjust your dose of the calcium channel blocker. ||| Your doctor has given you Neupopeg to encourage your bone marrow (part of the bone which makes al ||| Lorsque vous commencez votre traitement par Atripla, votre médecin devra peut-être changer votre dose d’ inhibiteur de canal calcique.
0.4389961361885071 ||| au Novo Allé DK-2880 Bagsværd Denmark ||| tho DK-2880 Bagsværd Denmark ||| us DK-2880 Bagsværd Danemark
0.3650282919406891 ||| Oesophagitis Blood creatinine increased Proteinuria Renal tubulopathy (acquired Fanconi’ s syndrome), glycosuria Acute renal failure 1 P P ||| Adverse Reaction intestinal perforation reactivation of hepatitis B demyelinating disorders (e. g. optic neuritis, Guillian-Barré syndrome) ||| Augmentation de la créatininémie Protéinurie Tubulopathie rénale (syndrome de Fanconi acquis), glycosurie Insuffisance rénale aiguë1
0.2620224356651306 ||| However, patients treated with chemotherapy and/ or radiotherapy are at higher risk of developing secondary tumours some of which may express KGF receptors, and theoretically, be stimulated by KGF receptor ligands. ||| As with other gadolinium containing contrast media, in rare cases allergy-like reactions (hypersensitivity and anaphylaxis) may occur, including severe reactions (shock) that may need immediate medical intervention. ||| Cependant, les patients traités par chimiothérapie et/ ou radiothérapie ont un risque plus élevé de développer des cancers secondaires dont certains peuvent exprimer les récepteurs au KGF et, théoriquement, être stimulés par les ligands du récepteur au KGF.
0.45850545167922974 ||| Depreotide ||| Repaglinide ||| Dépréotide
0.27810537815093994 ||| INFORMATION FOR THE USER Karvea 75 mg film-coated tablets irbesartan ||| INFORMATION FOR THE USER Aprovel 75 mg tablets irbesartan ||| INFORMATION DE L'UTILISATEUR Karvea 75 mg comprimés pelliculés irbésartan
0.323251873254776 ||| What benefit has Helixate NexGen shown during the studies? ||| What benefit has Filgrastim ratiopharm shown during the studies? ||| Quel est le bénéfice démontré par Helixate NexGen au cours des études?
0.5115930438041687 ||| Busts of stone ||| Figurines of stone ||| Bustes en pierre
6.021393236452233e-13 ||| 11. ||| 11. ||| 35 11.
0.408760130405426 ||| Manufacturer SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - France ||| Marketing Authorisation Holder SANOFI PHARMA BRISTOL-MYERS SQUIBB SNC 174 avenue de France F-75013 Paris - France ||| 96 Fabricant SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - France
0.13870665431022644 ||| Important information about some of the ingredients of Gadovist This medicinal product contains less than 1 mmol sodium (23 mg) per dose (based on the average amount given to a 70 kg person), i. e. essentially ‘ sodium-free’. ||| Safety and efficacy have not been studied in this age group.  Sodium This medicinal product contains less than 1 mmol sodium (23 mg) per dose of up to 17 ml, i. e. essentially ‘ sodium- free’. ||| Informations importantes concernant certains composants de Gadovist Ce médicament contient moins de 1 mmol de sodium (23 mg) par dose (calculé pour une dose moyenne administrée à une personne de 70 kg): il est donc essentiellement « sans sel ».
0.7744865417480469 ||| Patients with rare hereditary problems of fructose intolerance should not take this medicine. ||| do you have any other diseases chronic medical problems like diabetes? ||| Les patients ayant une intolérance héréditaire au fructose ne doivent pas prendre ce médicament.
0.6955019235610962 ||| lupus-like reactions. ||| Major depressive episodes. ||| réactions type lupus.
0.26005205512046814 ||| - if you have severe liver problems. ||| - if you have serious liver disease ||| - si vous avez des maladies graves du foie.
0.04864038527011871 ||| 172 ANNEX III ||| 154 ANNEX III ||| 193 ANNEXE III
0.1680517941713333 ||| Do not blow into the mouthpiece. ic ||| Do not blow into the mouthpiece. pr ||| Ne soufflez pas dans l’embout buccal. m
0.3576357960700989 ||| Invented name Atriance ||| Invented name Macugen ||| Nom de fantaisie Atriance
0.5496818423271179 ||| Unmanned transportation conveyors ||| Staged and segmented conveyors ||| Transporteurs automatiques
0.6154017448425293 ||| At present, there is insufficient clinical experience in these patients to provide dosing recommendations. ||| Ensure that all information and advice you receive has been backed by reputable doctors and scientists. ||| A ce jour, l’ expérience clinique chez ces patients est trop limitée pour permettre des recommandations posologiques spécifiques.
0.2676681876182556 ||| Advisory services relating to the care of pet animals ||| Advice relating to the breeding of animals ||| Services de conseils concernant le soin des animaux domestiques
0.014899179339408875 ||| 4 4.5 Interaction with other medicinal products and other forms of interaction ||| 14 4.5 Interaction with other medicinal products and other forms of interaction ||| 4.5 Interactions avec d’ autres médicaments et autres formes d’ interaction
0.29760438203811646 ||| Cardiomegaly, ventricular hypertrophy, atrial hypertrophy*, tachycardia, tachycardia paroxysmal*, mitral valve incompetence*, tricuspid valve incompetence* ||| Oedema peripheral Ventricular fibrillation, ventricular arrhythmia, syncope, supraventricular arrhythmia, supraventricular tachycardia, tachycardia, bradycardia ||| Cardiomégalie, hypertrophie ventriculaire, hypertrophie auriculaire*, tachycardie, tachycardie paroxystique*, insuffisance mitrale*, insuffisance tricuspidienne*
0.3465399742126465 ||| Once a day dosing of CIALIS may be useful to men who anticipate having sexual activity two or more times per week. ||| Use in adult men In general, the recommended dose is 10 mg taken prior to anticipated sexual activity and with or without food. ||| La prise quotidienne de CIALIS peut être appropriée chez les hommes qui envisagent d'avoir des rapports sexuels au moins deux fois par semaine.
0.8327076435089111 ||| Increased CPK, myalgia ||| Late neutropenia2, transient increase ||| Augmentation des CPK, myalgies
0.15225574374198914 ||| 275 6. ||| 720 6. ||| 6.
0.30438828468322754 ||| In the absence of pharmacokinetic interaction studies, alli is not recommended to be used by patients receiving acarbose. ||| There is no pharmacological reason to expect that commonly prescribed medications used in the treatment of asthma will interact with omalizumab. ||| En l'absence d'études d'interactions pharmacocinétiques, l'administration simultanée de alli et d'acarbose n'est pas recommandée.
0.3072090744972229 ||| - Hot flush ||| - hot flushes ||| - Bouffées de chaleur
0.6164348721504211 ||| Cardiac disorders Common: heart failure ||| Allergy: increased allergic symptoms ||| Troubles cardiaques Fréquent:
0.16107970476150513 ||| Consultancy services relating to insurance ||| Consultancy services relating to cosmetics ||| Services de conseillers en matière d'assurance
0.5360537767410278 ||| Aromatic hydrocarbons ||| Hydrocarbons ||| Hydrocarbures aromatiques
0.36444589495658875 ||| Concomitant treatment with inhibitors of the hepatic CYP 3A4 may result in a decrease of terfenadine metabolism. ||| Concomitant use of losartan and ACE-inhibitors has shown to impair renal function. ||| Un traitement concomitant par des inhibiteurs du CYP 3A4 hépatique peut se traduire par une diminution du métabolisme de la terfénadine.
0.45092058181762695 ||| No dose adjustment is necessary in the elderly. ||| Elderly No dose adjustment is necessary. ||| Aucune adaptation posologique n’ est nécessaire chez les patients âgés.
0.31512463092803955 ||| Physical storage of electronically stored digital data, photographs, audio and image files ||| Electronic transmission of images, photographs, graphic images and illustrations over a global computer network ||| Stockage physique de fichiers audio et d'images, de photos et de données numériques stockés électroniquement
0.299489825963974 ||| Clinical Trial data The Princess study was designed to determine whether early acute treatment with cerivastatin after a myocardial infarction would reduce the incidence of cardiovascular morbidity and mortality. ||| Maintenance treatment in severe active Crohn’ s disease The efficacy of repeated infusions with infliximab was studied in a 1-year clinical study (ACCENT I). ||| Résultats des études cliniques L’étude PRINCESS était conçue pour déterminer si un traitement aigu précoce par la cérivastatine après un infarctus du myocarde réduisait l’incidence de la morbidité et de la mortalité cardiovasculaire.
0.6984676122665405 ||| Potent ||| Ovine ||| Puissant
0.0 ||| 36 ||| 36 ||| 6.
0.10969659686088562 ||| 99 BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom ||| 123 Marketing Authorisation Holder BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH - United Kingdom ||| BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH Royaume-Uni
0.45054057240486145 ||| NeoRecormon contains the active ingredient epoetin beta. ||| NeoRecormon is almost sodium-free. ||| Le principe actif de NeoRecormon est l’ epoetin bêta.
0.0 ||| Rare: ||| Rare: ||| Peu fréquent:
0.5036680698394775 ||| Aprovel 150 mg tablets. ||| Avelox 400 400 mg ||| Aprovel 150 mg comprimés.
0.02868972346186638 ||| For the treatment and prevention of porcine respiratory disease caused by Pasteurella multocida and Bordetella bronchiseptica, susceptible to doxycycline, when the disease has been diagnosed in the herd. ||| “ For the treatment and prevention of porcine respiratory disease caused by Pasteurella multocida and Bordetella bronchiseptica, susceptible to doxycycline, when the disease has been diagnosed in the herd. “ ||| Prévention et traitement de la maladie respiratoire porcine causée par Pasteurella multocida et Bordetella bronchiseptica, sensibles à la doxycycline, lorsque la maladie a été diagnostiquée dans le troupeau.
0.5023386478424072 ||| Only a solution that is clear and colourless should be injected. ||| The resulting solution should be clear, without particles. ||| Seule une solution limpide et incolore peut être injectée.
0.3816570043563843 ||| Genotoxic and carcinogenic potential are not expected. ||| No carcinogenic potential was detected. ||| Aucun potentiel carcinogène et génotoxique n’ est attendu.
0.11347559839487076 ||| If you take more SUTENT than you should If you have accidentally taken too many capsules, talk to your doctor straight away. ||| If you take more Trazec than you should If you have accidentally taken too many tablets, talk to a doctor straight away. ||| Si vous avez accidentellement pris trop de gélules, avertissez -en immédiatement votre médecin.
0.5275985598564148 ||| The European Commission has approved an approximately €322 million (HRK 2.450 million) Croatian scheme for loan guarantees and subsidised loans to micro companies and small and medium-sized enterprises (SMEs) affected by the coronavirus outbreak. ||| On April 26, the Mexican Council of Businessmen (CMN) and IDB Invest announce a US$12 billion plan to provide credit to 30,000 micro-, small-, and medium-sized industries. ||| La Commission européenne a autorisé un régime croate de garanties de prêts et de prêts bonifiés d'un montant d'environ 322 millions d'euros (2 450 millions de HRK) pour les micro et petites et moyennes entreprises (PME) touchées par la pandémie de coronavirus.
0.15600857138633728 ||| Do not use Viraferon if you notice changes in the appearance of Viraferon. ||| Do not use IntronA if you notice changes in the appearance of IntronA. ||| tor Ne pas utiliser, si vous remarquez un changement dans l’apparence de Viraferon.
0.0 ||| Each hard capsule contains 140 mg temozolomide. ||| Each hard capsule contains 140 mg temozolomide. ||| Chaque gélule contient 140 mg de témozolomide.
0.22155901789665222 ||| 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 200 film-coated tablets ||| 28 film-coated tablets 30 film-coated tablets 50x1 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets 14 film-coated tablets 7 film-coated tablets ||| 20 comprimés pelliculés 30 comprimés pelliculés 50 comprimés pelliculés 60 comprimés pelliculés 100 comprimés pelliculés 200 comprimés pelliculés
0.31467247009277344 ||| 5.11 Special precautions to be taken by the person administering the product to animals ||| What are the special precautions to be taken by the person administering Masivet? ||| 5.11 Précautions particulières à prendre par la personne qui administre le produit aux animaux
0.33449995517730713 ||| The report presents the accomplishments of the agency against last years approved plan and provides good evidence that the standards of service to stakeholders (patients, healthcare professionals, the European Institutions, member states and the pharmaceutical industry) have been maintained at a high level and improved in some important respects. ||| Since the beginning of the outbreak and thanks to the Trust Fund's flexibility, the EU and contributing countries have been able to provide personal protective equipment, hygiene kits, infection prevention trainings, health education and awareness campaigns, and essential protection services to women facing gender based violence. ||| Ce rapport présente les réalisations de l’ Agence dans le cadre du plan approuvé l'années dernière et apporte des arguments montrant que le service rendu aux différentes parties (patients, professionnels de la santé, institutions européennes, États membres et industrie pharmaceutiques) a été maintenu à un niveau élevé et a même été amélioré en ce qui concerne certains aspects importants.
0.3046428859233856 ||| Genetic testing apparatus for medical purposes ||| Diagnostic testing materials for medical use ||| Appareils de tests génétiques à usage médical
0.48648104071617126 ||| Renal impairment No dosage adjustment of Exforge is required for patients with mild to moderate renal impairment (GFR > 30 ml/ min/ 1.73 m2). ||| BSA (m2) X 50 mg/ m2 = Daily Maintenance Dose The daily maintenance dose should not exceed 70 mg regardless of the patient's calculated dose. ||| Altération de la fonction rénale Aucun ajustement posologique d'Exforge n'est nécessaire lors d'une altération faible à modérée de la fonction rénale (DFG > 30 ml/ min/ 1,73 m²).
0.275200217962265 ||| There is no known specific antidote. ||| Treatment No specific antidote is known. ||| Il n’ y a pas d’ antidote spécifique connu.
0.3718551993370056 ||| An order signed by the Ministry of Education as a preventative measure aims to prevent the spread of respiratory diseases in connection with the WHO coronavirus pandemic. ||| Because of the current epidemiological situation of avian influenza and the consequent threat to both human and animal health, the Committee recommended the granting of a Marketing Authorisation. ||| Une ordonnance signée par le ministère de l’Éducation en tant que mesure de prévention vise à éviter la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.
0.4958297610282898 ||| Varenicline exhibits linear kinetics when given as single (0.1 to 3 mg) or repeated 1 to 3 mg/ day) doses. ||| At lower doses (10 mg/ m2 – 20 mg/ m2) Caelyx displayed linear pharmacokinetics. ||| 9 Linéarité/ non-linéarité: la varénicline présente une cinétique linéaire en cas d'administration de doses uniques (0,1 à 3 mg) ou répétées (1 à 3 mg par jour).
0.022804126143455505 ||| For patients with a severe infection, initiate effective antibiotic treatment as soon as possible [31,74]. ||| For patients with severe infections, initiate effective antibiotic treatment as soon as possible [31,74]. ||| Pour les patients présentant une infection sévère, instaurez dès que possible un traitement antibiotique efficace [31,74].
0.6813889741897583 ||| Concentrate for Infusion ||| Solution for Injection ||| Concentré pour Infusion
0.09378889203071594 ||| au Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark ||| Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd am
0.26731136441230774 ||| In reproductive toxicity studies in rats, where dibotermin alfa was administered intravenously to maximize systemic exposure, increased fetal weight and increased fetal ossification was observed and a treatment related effect could not be ruled out. ||| There is no evidence of a teratogenic effect, but animal studies indicated some hazardous potential of telmisartan to the postnatal development of the offspring such as lower body weight, delayed eye opening, and higher mortality. ||| Dans les études de toxicité de la reproduction chez le rat, où la dibotermine alpha a été administrée par voie intraveineuse pour maximiser l’exposition générale, une augmentation du poids fœtal et de l’ossification fœtale a été observée et un lien avec le traitement ne peut être exclu.
0.40280064940452576 ||| Kinzalmono is available in blister packs containing 14, 28, 56 or 98 tablets, or unit dose blister packs containing 28 x 1 tablets. ||| ise blister packs containing 70 x 1 tablets, and in white plastic bottles containing 28, 98 and 500 tablets. ||| Kinzalmono est disponible dans des plaquettes thermoformées par boîte de 14, 28, 56 ou 98 comprimés ou dans des plaquettes thermoformées pour délivrance à l’ unité contenant 28 x 1 comprimés.
0.13855260610580444 ||| 1 pre-filled syringe contains 6000 IU Epoetin zeta ||| 1 pre-filled syringe contains 6000 IU epoetin beta. ||| 1 seringue préremplie contient 6 000 UI d’ époétine zêta
0.21618467569351196 ||| Why has Kivexa been approved? ||| Why has Mimpara been approved? ||| Pourquoi Kivexa a -t-il été approuvé?
0.0 ||| - if your child has any bleeding problems. ||| - if your child has any bleeding problems. ||| - lorsque votre enfant présente des problèmes de coagulation, quels qu’ils soient.
0.37055158615112305 ||| Beverage refrigerators for use in automobiles ||| Automatic timers for use with beverage makers ||| Réfrigérateurs de boissons pour voitures automobiles
0.03170737996697426 ||| ZYPREXA 20 mg coated tablets ||| ZYPREXA 5 mg coated tablets ||| ZYPREXA 20 mg comprimés enrobés.
0.46606189012527466 ||| Ripened cheeses ||| Boiled sweets ||| Fromages affinés
0.23455318808555603 ||| Patients being treated with entacapone in association with levodopa and presenting with somnolence and/ or sudden sleep onset episodes must be instructed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e. g. operating machines) until such recurrent episodes have resolved (see also section 4.4). ||| In more severe or persistent cases of diarrhoea, or cases leading to dehydration, particularly in groups of patients with aggravating risk factors (concomitant medications, symptoms or diseases or other predisposing conditions including advanced age), Tarceva therapy should be interrupted and appropriate measures should be taken to intensively rehydrate the patients intravenously. ||| Les patients traités par l’ entacapone en association avec la lévodopa, et présentant une somnolence et/ ou des accès de sommeil d’ apparition soudaine doivent être informés qu’ ils ne doivent pas conduire de véhicules ni exercer une activité où une altération de leur vigilance pourrait les exposer eux -même ou d’ autres personnes à un risque d’ accident grave ou de décès (par exemple, l’ utilisation de machines) jusqu’ à la disparition de ces effets (voir rubrique 4.4).
0.5720027685165405 ||| Electronic transmission of messages and data ||| Data transmission and data broadcasting ||| Transmission électronique de message et de données
0.3903657793998718 ||| Both the lansoprazole 15 and 30 mg dose are effective and the dosing recommendations proposed by the MAH are acceptable. ||| The fondaparinux dose (10 mg) in the interaction studies was higher than the dose recommended for the present indications. ||| Les doses de 15 et 30 mg de lansoprazole sont toutes deux efficaces et les recommandations posologiques proposées par le TAMM sont acceptables.
0.6412864923477173 ||| Metal venetian blinds [external] ||| Mandarins [fruit, fresh] ||| Stores vénitiens d'extérieurs en métal
0.40969932079315186 ||| Audio transmitter units ||| Audio time delay units ||| Transmetteurs audio
0.19712059199810028 ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. eu. int http: / /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged survival was studied, and compared to historical records (report of patient survival with diet only as published in medical journals). ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 86 13 E-mail: mail@emea. eu. int http: / /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended. ||| (44-20) 74 18 84 00 Fax (44-20) 74 18 84 16 E-mail: mail@emea. eu. int http: / /www. emea. eu. int ©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Quelles études ont été menées sur Orfadin?
0.02517709508538246 ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see also sections 4.3 and 4.4). ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see section 4.3 and 4.4). ||| Les nouveau-nés de mère traitée par un inhibiteur des récepteurs de l’ angiotensine II doivent être surveillés sur le plan tensionnel (voir rubriques 4.3 et 4.4).
0.2711513638496399 ||| 19 May 2006 du ||| 19 May 2006 ro ||| 19 Mai 2006 'e tn
0.22660155594348907 ||| Elderly patients No dosage adjustment is necessary in elderly patients (see section 5.2). ||| Elderly No dose adjustment is required in the elderly (see section 5.2). ||| 2 Patients âgés Aucune adaptation posologique n’ est nécessaire chez les patients âgés (voir rubrique 5.2).
0.33701133728027344 ||| Your doctor will review the medicines you are currently taking to make sure you are not taking something that can’t be taken with the Tyverb. ||| Tell your doctor if you are taking these medicines, or if you notice that Stalevo does not work as well when you take them. ||| Votre médecin vérifiera les médicaments que vous prenez actuellement afin de s'assurer que vous ne prenez pas de substance incompatible avec Tyverb.
0.039777662605047226 ||| Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr. ||| Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Aerius oral solution. ||| Concernant la durée du traitement, votre médecin déterminera le type de rhinite allergique dont vous souffrez et déterminera la durée pendant laquelle vous devrez prendre Azomyr.
0.36649301648139954 ||| 12 PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR SINGLE BOTTLE 2.5 ml + CARTON FOR 3x2.5 ml BOTTLES ||| 29/ 64 PARTICULARS TO APPEAR ON THE OUTER PACKAGE Dicural 150 mg Coated tablets CARTON OF 10 TABLETS / 20 TABLETS / 100 TABLETS ||| 12 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR ETUI POUR FLACON UNIQUE 2,5 ml + ETUI CONTENANT 3 FLACONS DE 2,5 ml
0.009910188615322113 ||| 69 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 145 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING ||| 70 MENTIONS DEVANT FIGURER SUR LE CONDITIONNEMENT PRIMAIRE
0.262604296207428 ||| The most common side effects with Comtess (seen in between 1 and 10 patients in 100) are dyskinesia (uncontrollable movements), nausea (feeling sick) and harmless urine discoloration. ||| The most common side effects in adults taking Telzir (seen in more than 1 patient in 10) are diarrhoea and increases in the levels of triglycerides (a type of fat) in the blood. ||| Les effets indésirables les plus courants (observés chez 1 à 10 patients sur 100) sont la dyskinésie (mouvements incontrôlables), les nausées (mal au cœ ur) et une décoloration sans danger des urines.
0.9447143077850342 ||| He urged the relocation of the K-2 Air Force Base used with Daegu International Airport. ||| Grand Princess is a Grand-class cruise ship owned by Princess Cruises. ||| Il appelle à la relocalisation de la base aérienne K-2 utilisée avec l'aéroport international de Daegu.
0.20343397557735443 ||| 0.94 ||| 0.41 ||| 0,94
0.19874754548072815 ||| Where symptoms have occurred, they have included nausea, vomiting and diarrhoea, hypertension or hallucinations. ||| Adverse drug reactions such as nausea, vomiting, diarrhoea and sweating were reported. ||| Lorsque des symptômes ont été observés il s’ agissait de: nausées, vomissements et diarrhée, hypertension ou hallucinations.
0.2803764343261719 ||| The mutational profiles were similar to those described for PI-experienced adults treated with fosamprenavir / ritonavir. ||| comparison showed that the pharmacokinetics of darbepoetin alfa were similar for paediatric and adult patients with CRF. ||| Les profils de mutations étaient similaires à ceux décrits chez les patients adultes préalablement traités par IP et recevant l'association fosamprénavir/ ritonavir.
0.34968066215515137 ||| 1 ml (025 mg/ ml) ||| 1 ml (100 mg/ ml) Powder 100 mg ||| 1 ml (0,25 mg/ ml)
0.18202127516269684 ||| Dosage Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will: ||| Based on your life-style and the results of your blood sugar (glucose) tests, your doctor will ||| En fonction de votre mode de vie et de vos analyses de taux de sucre dans votre sang (glycémie) et de votre précédente utilisation d'insuline, votre médecin:
0.5055701732635498 ||| Please read the following instructions carefully before using your Mixtard 30 FlexPen. ||| Single Test Powder for oral solution Please read enclosed instructions for use. ||| Veuillez lire attentivement les instructions ci-dessous avant d’ utiliser votre Mixtard 30 FlexPen.
0.39097148180007935 ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/. There are also links to other websites about rare diseases and treatments. ||| Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/. ------------------------------------------------------------------------------------------------------------------------- The following information is intended for medical or healthcare professionals only: ||| Il existe aussi des liens à d’ autres sites concernant les maladies rares et les médicaments orphelins.
0.2837951183319092 ||| 53 Controlled clinical trials have not shown significant benefits attributable to the administration of epoetins when haemoglobin concentration is increased beyond the level necessary to control symptoms of anaemia and to avoid blood transfusion. ||| The CHMP considered it acceptable to remove this contraindication, as the primary route of elimination of valsartan is via biliary route and renal clearance accounts for less than 30% of plasma clearance. ||| Les essais cliniques contrôlés n’ ont pas montré d’ effets bénéfiques significatifs attribuables à l’ administration des époétines lorsque le taux d’ hémoglobine dépassait le niveau nécessaire au contrôle des symptômes de l’ anémie et pour éviter une transfusion sanguine.
0.2747465670108795 ||| Lasofoxifene was not teratogenic in rats up to a dose of 10mg/ kg (approximately 53 times the AUC in humans) or rabbits up to a dose of 3 mg/ kg (below the level of systemic exposure in humans). ||| Emedastine was found to increase the QT interval in dogs; the NOEL corresponds to levels 23-fold higher than those found in patients (7 ng/ ml as compared with 0.3 ng/ ml, i. e., the limit of detection for emedastine). ||| 17 Le lasofoxifène n’ a pas été tératogène chez le rat jusqu’ à une dose de 10mg/ kg (environ 53 fois l’ ASC chez l’ homme) ou le lapin jusqu’ à une dose de 3 mg/ kg (en dessous du niveau d’ exposition systémique chez l’ homme).
0.2955644130706787 ||| - If you have a history of liver problems. ||| - You have a serious liver problem. ||| - Si vous avez des antécédents de problèmes de foie.
0.2578197717666626 ||| Each hard capsule contains 200 mg of efavirenz. ||| Each 80 mg hard capsule contains 80 mg of aprepitant. ||| Chaque gélule contient 200 mg d’ éfavirenz.
0.4524005651473999 ||| Inflatable boats ||| Inflatable toys ||| Bateaux gonflables
0.4291486144065857 ||| Provision of finance for sales ||| Provision of translation services ||| Services de financement pour ventes
0.38538432121276855 ||| Most of these decreases were detected during the first 4 weeks of treatment and haemoglobin generally stabilised thereafter. ||| After the peak, plasma concentrations slowly decrease over the remainder of the 24-hour period of application. ||| Dans la majorité des cas, la diminution a été détectée au cours des 4 premières semaines de traitement et le taux d'hémoglobine s'est ensuite généralement stabilisé.
0.0 ||| Dosage and duration of treatment ||| Dosage and duration of treatment ||| COMMENT PRENDRE TEMODAL 198 Posologie et durée de traitement
0.36250075697898865 ||| Skin and subcutaneous tissue disorders Uncommon: sweating ||| Infections and infestations Uncommon: upper respiratory tract infection ||| Troubles cutanés et sous-cutanés Peu fréquent: sudation
0.30311012268066406 ||| - Blood and lymphatic system disorders ||| Sinusitis Blood and lymphatic system disorders ||| - Troubles hématologiques et lymphatiques:
0.7507833242416382 ||| 1,25 mg 2,5 mg 5 mg ||| 1,200 mg 1,400 mg ||| 2,5 mg 5 mg
2.1404606602784537e-13 ||| A single dose pre-filled syringe delivers 1.65 mg pegaptanib sodium, corresponding to 0.3 mg of the free acid form of the oligonucleotide, in a nominal volume of 90 microlitres. ||| A single dose pre-filled syringe delivers 1.65 mg pegaptanib sodium, corresponding to 0.3 mg of the free acid form of the oligonucleotide, in a nominal volume of 90 microlitres. ||| Une seringue pré-remplie unidose délivre 1,65 mg de pegaptanib sodium, correspondant à 0,3 mg de l’ oligonucléotide sous forme acide libre, dans un volume nominal de 90 microlitres.
0.44772952795028687 ||| Discard the vial if particulate matter or discoloration is observed. ||| 83 effect (decreased tissue perfusion due to increased blood viscosity). ||| Eliminer le flacon si des particules ou une décoloration sont observées.
0.5435277223587036 ||| Photographic restoration services ||| Cheque authorization services ||| Services de restauration photographique
0.45763006806373596 ||| A higher rate of discontinuation due to hypertension was seen (2.3% versus 0.7%) and this was statistically significant. ||| A relative risk reduction of 61% was observed after 2 years (p=0.0006). ||| En ce qui concerne l’ arrêt de traitement pour cause d’ hypertension artérielle, une incidence plus élevée, statistiquement significative, a également été observé (2,3% contre 0,7%).
0.07370434701442719 ||| 6.8 ||| 8.9 ||| 9,3
0.2923682630062103 ||| EMEA/ CHMP/ 411086/ 2008 ||| EMEA/ CVMP/ 345752/ 2008-EN 2. ||| EMEA/ CHMP/ 411073/ 2008
0.3423146605491638 ||| Nimesulide is extensively metabolised in the liver following multiple pathways, including cytochrome P450 (CYP) 2C9 isoenzymes. ||| Sildenafil metabolism is principally mediated by the cytochrome P450 (CYP) isoforms 3A4 (major route) and 2C9 (minor route). ||| Le nimésulide subit un métabolisme hépatique intensif par de nombreuses voies, dont celle des isoenzymes 2C9 du système du cytochrome P450 (CYP).
0.23259998857975006 ||| Avoid contact with skin or eyes. ||| Avoid direct contact with skin, eyes or mouth. ||| Eviter le contact avec les yeux et la peau.
0.4661320447921753 ||| The incidence of PPE was similar in both lapatinib plus capecitabine and capecitabine alone treatment arms. ||| Spontaneous abortion has been reported with both buprenorphine and buprenorphine-naloxone. ||| L'incidence de l’ érythro-dysesthésie palmo-plantaire était similaire entre les bras lapatinib + capécitabine et capécitabine seule.
0.3093147873878479 ||| Caution should be exercised when pravastatin is administered to patients with a history of liver disease or heavy alcohol ingestion. ||| Novem is used in cattle for acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs. ||| Il convient d'être prudent quand la pravastatine est administrée à des patients ayant un antécédent d'affection hépatique ou de consommation importante d’alcool.
0.5233592987060547 ||| The vials contain 0.5 ml of solution (0.70 ml including overfill) to facilitate the dose extraction of a single 0.5 ml dose. ||| ge Taking three separate 1 mg unit dose blisters delivers more insulin to your lungs than a single 3 mg unit dose blister does. ||| Les flacons contiennent 0,5 ml de solution (0,70 ml surremplissage compris) pour faciliter le prélèvement d’ une dose unique de 0,5 ml.
1.1140171901277696e-12 ||| Distribution Plasma protein binding is negligible. ||| Distribution Plasma protein binding is negligible. ||| Distribution La fixation aux protéines plasmatiques est négligeable.
3.7758132124393606e-13 ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| The letter from the company notifying the EMEA of the withdrawal of the application is available here. ||| La lettre de la société, notifiant à l’ EMEA le retrait de la demande, est disponible ici.
0.22957147657871246 ||| How does MabCampath work? ||| How does Kinzalkomb work? ||| Comment MabCampath agit -il?
0.5080283880233765 ||| Planning services relating to life assurance ||| Forensic advice relating to damage assessment ||| Services de planification en matière d'assurance-vie
0.4714190363883972 ||| - abdominal pain, diarrhoea, being sick ||| fatigue, fever asthenia, feeling drunk ||| douleurs abdominales, diarrhée, vomissements
0.42754000425338745 ||| Study 2 (P02080) was a randomized, single centre study that enrolled 95 previously untreated adult patients with chronic hepatitis C rod ||| One large, open-label, multicentre, international randomised phase III study has been conducted in patients with newly diagnosed Ph+ CML. ||| tp (P02080), étude randomisée, monocentrique a inclus 95 patients adultes naïfs avec une hépatite C chronique co-infectés par le VIH.
0.42804768681526184 ||| Rubber sealant for caulking and adhesive purposes ||| Sorting of waste and recyclable material ||| Produits d'étanchéité en caoutchouc pour calfatage et collage
0.9434451460838318 ||| Shuttering (Non-metallic -) ||| Strength / Active substance (INN) ||| Coffrages non métalliques
0.3439003825187683 ||| These substances are included in Fendrix to accelerate, improve and prolong the protective effect of the vaccine. ||| Continuous efforts are being made to improve the immunogenicity of the HepB component of Hexavac. ||| Ces substances sont ajoutées à Fendrix pour accélérer, augmenter et prolonger l’ effet protecteur du vaccin.
0.2131481021642685 ||| Electricity measuring instruments ||| Optical measuring components ||| Instruments de mesure de l'électricité
0.22037199139595032 ||| How to store Oprymea 6. ||| How to store Lisonorm 6. ||| Comment conserver Oprymea 6.
0.07721143215894699 ||| 47 4.3 Contraindications ||| 37 4.3 Contraindications ||| 4.3 Contre-indications
9.845273468006566e-13 ||| General disorders and administration site conditions: ||| General disorders and administration site conditions: ||| Troubles généraux et accidents liés au site d’ administration:
0.6622501611709595 ||| GANFORT contains two active substances: bimatoprost (0.3 mg/ ml) and timolol (5 mg/ ml). ||| Baseline therapy included ACE inhibitors (93%), diuretics (86%), digoxin (67%) and beta blockers (36%). ||| GANFORT contient deux principes actifs: le bimatoprost (0,3 mg/ ml) et le timolol (5 mg/ ml).
0.016497492790222168 ||| There is limited experience on the use of the product in sick and debilitated animals, thus the product should only be used based on a risk-benefit assessment for these animals. ||| There is limited experience on the use of the product in sick and debilitated animals, thus the product should only be used based on a benefit-risk assessment for these animals. ||| Compte tenu de l’ expérience limitée quant à l’ utilisation du produit chez les animaux malades ou affaiblis, le produit ne devra être administré chez ces animaux qu’ après évaluation du rapport bénéfice-risque.
0.3762773871421814 ||| 18 to < 23 ≥ 23 ||| to < 22 ≥ 22 ||| 18 à < 23 ≥ 23
1.2747503519058228 ||| capsule every 48 hours ||| Number of continent days per week ||| 48 heures
0.1713680922985077 ||| - The active substance is daptomycin. ||| - The active substance is nifedipine. ||| - La substance active est la daptomycine.
0.2983299195766449 ||| Profiling machines ||| Sizing machines ||| Machines à profiler
0.10056775063276291 ||| The following terms and frequencies are applied: very common (≥ 1/ 10), common (≥ 1/ 100 to < 1/ 10), uncommon (≥ 1/ 1000 to < 1/ 100), rare (≥ 1/ 10,000 to < 1/ 1000), very rare (< 1/ 10,000), and not known (cannot be estimated from the available clinical trial data). ||| The following convention has been used for the classification of the adverse reactions: very common (1/ 10), common (1/ 100 to < 1/ 10), uncommon (1/ 1,000 to < 1/ 100), rare (1/ 10,000 to < 1/ 1,000) very rare (< 1/ 10,000), not known (cannot be estimated from the available data). ||| Les termes et fréquences suivants sont utilisés: très fréquent (> 1/ 10), fréquent (> 1/ 100 à 1/ 1000 à 1/ 10000 à < 1/ 1000), et très rare (< 1/ 10000), et inconnu (ne peut être estimée à partir des données disponibles des essais cliniques).
0.5402387380599976 ||| Massage divans ||| Ball gowns ||| Lits de massage
0.0012397821992635727 ||| The non-confidential version of the decision will be made available under the case number SA.56986 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56877 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56986 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.010540442541241646 ||| 157 Table 10 Rates of Response to retreatment in prior treatment failures ||| 111 Table 10 Rates of Response to retreatment in prior treatment failures ||| 165 Tableau 10 Taux de réponse virologique prolongée (RVP) lors d’ un retraitement après échecs à un précédent traitement
0.5965018272399902 ||| 64.1 mg 21.4 mg ||| 0.064 ml 0.63 ml ||| 64,1 mg 21,4 mg
0.6028170585632324 ||| For the full list of all side effects reported with Flebogammadif, see the Package Leaflet. ||| Kaplan-Meier estimates of 18-month survival for each study are shown below. ||| Pour la liste complète des effets secondaires observés sous Flebogammadif, veuillez vous reporter à la notice.
0.2196485698223114 ||| 0.5 mg 1.5 mg ||| 100 mg 0.5 mg ||| 0,5 mg/ ml 1,5 mg/ ml
0.01584763079881668 ||| As the company had supplied the additional information requested, the "Exceptional Circumstances" ended on 17 April 2007. ||| As the company had supplied the additional information requested, the "Exceptional Circumstances" ended on 18 May 2001. ||| La société ayant fourni les informations complémentaires demandées, les « circonstances exceptionnelles » ont pris fin le 17 avril 2007.
0.15832482278347015 ||| Important information about some of the ingredients of Insuman Comb 15 ||| Important information about some of the ingredients of Insuman Basal ||| Informations importantes concernant certains composants d’Insuman Comb 15
0.30638188123703003 ||| Slowly inject the diluent, aiming the stream of liquid at the glass wall of the vial in order to avoid production uc ||| Inject the solvent SLOWLY, aiming the stream of liquid at the glass wall of the vial. ||| Injectez lentement le diluant, en dirigeant le jet de liquide vers la paroi en verre du flacon afin d’éviter la production de bulles d’air.
0.05174406245350838 ||| Use only according to the benefit/risk assessment by the responsible veterinarian. ||| Use only accordingly to the benefit/ risk assessment by the responsible veterinarian. ||| L’ utilisation ne doit se faire qu’ après évaluation du rapport bénéfice/ risque par le vétérinaire.
0.0 ||| 10. ||| 10. ||| 285 10.
0.38090139627456665 ||| After buccal administration of Effentora, fentanyl undergoes initial rapid distribution that represents an equilibration of fentanyl between plasma and the highly perfused tissues (brain, heart and lungs). ||| A few days later, a hormone such as hCG (human Chorionic Gonadotropin) is given to trigger ovulation, and the eggs are then harvested and used in techniques such as in-vitro fertilisation. ||| Après administration buccale d’ Effentora, le fentanyl subit une distribution initiale rapide qui représente une équilibration du fentanyl entre le plasma et les tissus fortement vascularisés (cerveau, cœ ur et poumons).
0.31097787618637085 ||| In the study comparing NEVANAC with ketorolac, around 65% of both groups of patients showed no or few signs of inflammation. ||| In addition, a successful response was seen in 1 of 3 patients with infections caused by more than one organism including Scedosporium spp. ||| Dans l’ étude comparant NEVANAC au kétorolac, environ 65% des deux groupes de patients n’ ont présenté que peu de signes d’ inflammation, si ce n’ est aucun.
0.29004502296447754 ||| Any inflammatory symptoms should be evaluated and treatment instituted when necessary (see section 4.8). ||| If super infection occurs, appropriate measures should be taken (see section 4.8). ||| Tout symptôme inflammatoire doit être évalué et un traitement doit être instauré si nécessaire (voir rubrique 4.8).
0.2929799556732178 ||| Ammonaps is used with other treatments and a special diet for the long-term management of patients with urea cycle disorders where there is lack of one or more of the following enzymes: carbamyl phosphate synthetase, ornithine transcarbamylase, or argininosuccinate synthetase. ||| Diuretics and other antihypertensive agents: other antihypertensive agents may increase the hypotensive effects of irbesartan; however Karvea has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics. ||| Ammonaps est utilisé en association avec d’ autres traitements ainsi qu’ avec un régime alimentaire spécial dans le cadre d’ une prise en charge à long terme de patients atteints de désordres du cycle de l’ urée et présentant un déficit d’ une ou plusieurs des enzymes suivantes: carbamyl phosphate synthétase, ornithine transcarbamylase ou argininosuccinate synthétase.
0.09814450889825821 ||| Keep the container tightly closed. ||| Keep the bottle tightly closed. ||| Bien fermer le flacon.
0.39349132776260376 ||| The time frame for dose escalation of 2 to 4 weeks appears appropriate based on individual variability. ||| The dosage interval when steady state has been reached varies from two to four weeks. ||| L’ intervalle de temps fixé pour augmenter la dose, de 2 à 4 semaines en fonction de variabilités individuelles, semble approprié.
0.49575698375701904 ||| Inhibitors have been observed in previously treated patients receiving factor VIII products, including ReFacto AF. ||| • That hypersensitivity reactions, although uncommon, have been reported with Volibris. ||| Des inhibiteurs ont été observés chez les patients préalablement traités recevant des facteurs VIII, incluant ReFacto AF.
0.06487327814102173 ||| 100 film-coated tablets ||| 24 film-coated tablets ||| 100 comprimés pelliculés
0.370944082736969 ||| In parallel, today's Action Plan encourages the European Banking Authority (EBA) to make full use of its new powers to tackle money laundering and terrorist financing. ||| To make money available for fighting the crisis, the Commission is proposing to mobilise quickly cash reserves from the European Structural and Investment Funds (ESIF) - the EU's cohesion money. ||| Parallèlement, le plan d'action présenté aujourd'hui encourage l'Autorité bancaire européenne (ABE) à faire pleinement usage de ses nouvelles compétences pour combattre le blanchiment de capitaux et le financement du terrorisme.
0.6100925207138062 ||| Absorption Not applicable ||| 103 Absorption ||| Absorption Non applicable
0.29681655764579773 ||| It can be used in patients with liver cirrhosis (scarring) and in patients also infected with human immunodeficiency virus (HIV). ||| It is used to treat adults infected with human immunodeficiency virus-1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). ||| Il peut être utilisé chez les patients atteints de cirrhose hépatique (formation de cicatrices) ainsi que chez les patients également atteints par le virus de l’ immunodéficience humaine (VIH).
0.469363272190094 ||| Hypertension : may be used in monotherapy or in combination with other classes of antihypertensive therapy. ||| It may be used in patients on dialysis (a blood clearance technique) or not on dialysis. ||| Hypertension artérielle: peut être utilisé en monothérapie ou en association avec d’ autres médicaments antihypertenseurs.
0.32768046855926514 ||| As with any injection procedure, vasovagal syncope can infrequently occur following administration of Twinrix Adult to adults and adolescents. ||| 36 When compared with soluble human insulin, if hypoglycaemia occurs after an injection with rapid acting analogues, it may occur earlier. ||| Comme pour toute injection, une syncope vaso-vagale peut rarement survenir après administration de Twinrix Adulte chez l’ adulte et l’ adolescent.
0.08129633963108063 ||| 22 bubbles must be removed from the cartridge before injection (see instruction for using pen). ||| Air bubbles must be removed from the cartridge before injection (see instructions for using the pen). ||| Les bulles d’ air doivent être éliminées de la cartouche avant l’ injection (voir les instructions d’ utilisation du stylo).
0.22429297864437103 ||| Following administration of single SC doses of 0.1-0.75 mg/ kg, plasma concentrations of desirudin increased rapidly to maximum levels (Cmax) between 1 and 3 h. ||| The volume of distribution at steady-state (Vss) determined after intravenous administration at 1 - 2 mg/kg ranged from approximately 4.4 to 7.0 L/kg. ||| Après des doses uniques en SC de 0,1- 0,75 mg/ kg, les concentrations plasmatiques de désirudine augmentent rapidement, les concentrations plasmatiques maximales (Cmax) étant atteintes en 1 à 3 h.
0.3992765247821808 ||| You should also tell your doctor if you develop lymphoma or other cancers while you are taking Remicade. ||| If you do not respond to glucagon treatment, you will have to be treated in a hospital. ||| Vous devez également prévenir votre médecin si vous développez un lymphome ou d’ autres cancers lors du traitement par Remicade.
0.1541239619255066 ||| Dose interval adjustments are recommended for patients with creatinine clearance 30-49 ml/ min (see section 4.2). ||| Dose interval adjustments are recommended for patients with creatinine clearance between 30 and 49 ml/ min. ||| Il est recommandé d’ adapter l’ intervalle entre les administrations chez les patients présentant une clairance de la créatinine de 30 à 49 ml/ min (voir rubrique 4.2).
0.024545082822442055 ||| In addition, an updated RMP should be submitted: • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA ||| In addition, an updated RMP should be submitted: • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimization Activities • Within 60 days of an important (pharmacovigilance or risk minimisation) milestone being reached • At the request of the EMEA. ||| En outre, un PGR mis à jour devra être soumis: • Lors de la réception de nouvelles informations pouvant avoir un impact sur les Spécifications Sécurité, le Plan de Pharmacovigilance ou les activités liées à la minimisation des risques • Dans les 60 jours suivant le passage d’ une étape importante (pharmacovigilance ou minimisation des risques) • A la demande de l’ EMEA.
0.24787406623363495 ||| Aclasta 5 mg solution for infusion Zoledronic acid ||| Bonviva 3 mg solution for injection ibandronic acid ||| Aclasta 5 mg solution pour perfusion Acide zolédronique
0.43245744705200195 ||| Nevertheless, respiratory dysfunction and failure are the major threat to the patients and the major cause of death. ||| The crisis we face because of Coronavirus has both a very significant human dimension, and a potentially major economic impact. ||| Néanmoins, un dysfonctionnement et une insuffisance respiratoires constituent la principale menace pour les patients, et la principale cause de décès.
0.0 ||| 2. ||| 2. ||| 456 2.
0.34540826082229614 ||| Rocket launching platforms of metal ||| Rocket launching platforms, not of metal ||| Rampes de lancement de fusées métalliques
0.016349269077181816 ||| 68 PACKAGE LEAFLET: ||| 66 PACKAGE LEAFLET: ||| 76 NOTICE:
0.09691684693098068 ||| These measures will help to protect the environment. ||| These measures will help to protect the environment ||| Prenez les mesures qui peuvent concourir à la protection de l’ environnement.
0.5733186602592468 ||| In clinical trials mean total and LDL cholesterol declined by 15-31%. ||| Systemic exposure was 6- to 11-fold higher based on AUC(0-24). ||| Dans des essais cliniques, le taux moyen de cholestérol total et de LDL cholestérol a diminué de 15 à 31%.
0.005913705565035343 ||| Karvezide 150 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide ||| Karvezide 300 mg/ 12.5 mg tablets irbesartan/ hydrochlorothiazide ||| Karvezide 150 mg/ 12,5 mg comprimés irbésartan/ hydrochlorothiazide
0.26169121265411377 ||| Patients with severe organ impairment should be carefully monitored for adverse events. ||| Special care is required when treating patients with any risk factors for seizures. ||| En cas d’ atteinte organique sévère, les patients doivent être surveillés attentivement afin de détecter les événements indésirables.
3.343378362791888e-13 ||| • er Allergic reactions, including anaphylactic reaction, angioedema, skin rash and urticaria. ng • Convulsions. lo ||| • er Allergic reactions, including anaphylactic reaction, angioedema, skin rash and urticaria. ng • Convulsions. lo ||| pl • Réactions allergiques, y compris réactions anaphylactiques, oedème de Quinck, rash cutané et urticaire. st • Convulsions. 'e
0.29698458313941956 ||| When Pradaxa was coadministered with pantoprazole, a decrease in the dabigatran area under the plasma concentration - time curve of approximately 30% was observed. ||| However, the bioavailability of ciprofloxacin was decreased by approximately 50% when co-administered with Renagel in a single dose study. ||| Une diminution d’ environ 30% de l’ aire sous la courbe des concentrations plasmatiques de dabigatran en fonction du temps a été observée après administration concomitante de Pradaxa et de pantoprazole.
0.15476524829864502 ||| 123 of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| Because of individual variability, titration to optimal therapeutic doses is expected for individual patients. ||| En raison des variabilités individuelles, la recherche de la dose thérapeutique optimale doit être effectuée pour chaque patient.
0.06574694812297821 ||| What benefit has Xeloda shown during the studies? ||| What benefit has Faslodex shown during the studies? ||| Quel est le bénéfice démontré par Xeloda au cours des études?
0.3743836581707001 ||| Partial recovery of vision was observed in some patients. ||| No increase in mortality from heart failure was observed. ||| Une récupération partielle de la vision a été observée chez certains patients.
0.352603018283844 ||| After 30 minutes, any pieces of the tablet remaining can be swallowed with a glass of water. ||| The powder should be mixed in a glass of water and should be taken immediately after mixing during a meal. ||| Après 30 minutes, tous les morceaux de comprimés restants peuvent être avalés avec un verre d’ eau.
0.4241024851799011 ||| 14 In an additional study limited to patients with severe SUI, all responses with duloxetine were achieved within 2 weeks. ||| Overall, in studies in type 1 and type 2 diabetes, Exubera gave similar blood glucose control to that ||| 14 Dans une étude complémentaire limitée aux patientes atteintes d 'incontinence urinaire d’ effort sévère, toutes les réponses avec la duloxétine ont été obtenues dans les 2 semaines.
0.002301344648003578 ||| s Viraferon 5 million IU/ ml powder and solvent for solution for injection interferon alfa-2b ||| s Viraferon 10 million IU/ ml powder and solvent for solution for injection interferon alfa-2b ||| isé Viraferon 5 millions UI/ ml poudre et solvant pour solution injectable interféron alfa-2b
0.4387173652648926 ||| 95 / 100 (95) ||| 114 / 119 (96) ||| 95/ 100 (95) 8.0
0.427931010723114 ||| Mugs made of ceramic materials ||| Building materials consisting of glass ||| Tasses [mugs] en céramique
0.8125817179679871 ||| Injury, poisoning and procedural complications Common: ||| Rare: seizures, seizures associated with fever ||| Lésions, intoxications et complications liées aux procédures Fréquent:
0.2956715226173401 ||| Olanzapine also demonstrated comparable efficacy results to haloperidol in terms of the proportion of patients in symptomatic remission from mania and depression at 6 and 12 weeks. ||| Efficacy In patients with osteoarthritis, lumiracoxib doses up to 200 mg once daily provided significant improvements in pain, stiffness, function, and patient assessments of disease status. ||| L'olanzapine a également montré des résultats d'efficacité comparables à l'halopéridol en terme de proportion de patients en rémission des symptômes maniaques et dépressifs à 6 et 12 semaines.
0.003032337874174118 ||| 168 As with any insulin therapy, lipodystrophy may occur at the injection site and delay local insulin absorption. ||| 140 As with any insulin therapy, lipodystrophy may occur at the injection site and delay local insulin absorption. ||| Comme avec toute insulinothérapie, une lipodystrophie peut survenir au site d'injection, ce qui peut retarder la résorption locale de l'insuline.
0.14495772123336792 ||| If you take more Tasmar than you should: ||| If you take more Wilzin than you should: ||| 52 Si vous avez pris plus de Tasmar que vous n’ auriez dû:
0.7449274063110352 ||| Management Board................................................................................. .7 EMEA management challenges............................................................ .11 Financial control.................................................................................... .13 ||| Operation of the Committee for Proprietary Medicinal Products...... ..25 Performance indicators.................................................................................... .25 Centralised procedures.................................................................................... .26 ||| Conseil d’ administration........................................................................ 7 Défis de gestion de l’ EMEA............................................................... .11 Contrôle financier.............................................................................. ..14
0.40971946716308594 ||| The effects of filgrastim on neutropenia due to bone marrow-infiltrating infection or malignancy have not been well established. ||| Do not use in intact bitches, as the efficacy has only been established in ovariohysterectomised bitches. ||| Les effets de filgrastim sur la neutropénie due à une infection ou à une affection maligne envahissant la moelle osseuse n’ ont pas été déterminés avec précision.
0.4043898284435272 ||| - No dose adjustment required. ||| No dosage adjustment is recommended. ||| - Aucune adaptation posologique n’ est requise.
0.0 ||| 15. ||| 15. ||| 36 15.
0.3520495295524597 ||| Gastrointestinal ||| Gastrointestinal Common ||| Bronchospasme Dyspnée
0.284105122089386 ||| Steady-state concentrations after prolonged dosing are similar to concentrations seen at 4 to 5 weeks. ||| Steady-state plasma levels are reached after 7 to 8 days of consecutive daily dosing. ||| Les concentrations plasmatiques à l’ équilibre après une administration prolongée sont similaires aux concentrations observées après 4 ou 5 semaines.
0.4056186079978943 ||| It is strongly recommended to avoid the use of AZOPT when breast-feeding. ||| It is strongly recommended to vaccinate all pigs in the herd. ||| Il est fortement recommandé d’ éviter d’ utiliser AZOPT pendant l’ allaitement.
0.5372384786605835 ||| Porcine ||| Carbide ||| —
0.2665664255619049 ||| The pharmacokinetics of duloxetine and its metabolites have not been studied in patients with mild or severe hepatic insufficiency. ||| The pharmacokinetics of parathyroid hormone in patients with severe renal impairment (creatinine clearance of less than 30 ml/min) has not been investigated. ||| La pharmacocinétique de la duloxétine et de ses métabolites n'a pas été étudiée chez les patients présentant une insuffisance hépatique légère ou sévère.
0.22834274172782898 ||| allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or shortness of breath. ||| of Olanzapine Mylan An allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or shortness of breath. ||| Une réaction allergique peut prendre la forme d’ une éruption cutanée, de démangeaisons, de gonflement du visage ou des lèvres ou de difficultés à respirer.
0.07068666815757751 ||| 68 EMEA General Report 2000 ||| 43 EMEA General Report 2000 ||| 74 Rapport annuel EMEA 2000
0.21897229552268982 ||| Developmental toxicity observed in rats (embryolethality, decreased foetal body weight and ossification delays and visceral changes, including delayed testicular descent) occurred mainly at a maternally toxic dosage. ||| Reproductive toxicity studies showed a slight treatment-related increased incidence of fetal rib malformations (absent, hypoplastic and wavy ribs) in the offspring of rats at systemic exposure levels more than 29 times the human exposure levels. ||| Les anomalies au niveau du développement observées chez les rats (embryolétalité, diminution du poids fœtal, retard d’ossification et altérations viscérales dont un retard de descente des testicules) se sont produites principalement à des doses materno-toxiques.
0.260830819606781 ||| 72/ 94 PACKAGE LEAFLET: ||| 15/ 21 PACKAGE LEAFLET ||| 67/ 89 NOTICE:
0.3955703675746918 ||| Haemolysis has been reported in patients receiving Fasturtec. ||| Angioedema has occurred during treatment with Rasilez. ||| Des cas d’ hémolyse ont été rapportés chez des patients traités par Fasturtec.
0.08170349150896072 ||| The Committee recommended that Adenuric be given marketing authorisation. ||| The Committee recommended that Azomyr be given marketing authorisation. ||| Le comité a recommandé l’ octroi d’ une autorisation de mise sur le marché pour Adenuric.
1.0472235058289758e-12 ||| OUTER CARTON ||| OUTER CARTON ||| COFFRET
0.39539551734924316 ||| Protopic ointment should not be applied under occlusion (see section 4.4). ||| with renal insufficiency not yet undergoing dialysis (See section 4.4). ||| Ne pas appliquer sous pansement occlusif (voir rubrique 4.4).
0.28848835825920105 ||| Media for use in offset lithographic printing ||| Gum arabic for use in lithographic printing processes ||| Supports pour l'impression lithographique offset
0.5569122433662415 ||| Double sided adhesive tapes [other than for stationery, household or medical use] ||| Red algae gelatine glue, for stationery or household purposes [funori] ||| Rubans adhésifs double face autres que pour la papeterie, le ménage ou la médecine
0.2764210104942322 ||| In healthy subjects and diabetic patients, insulin serum concentrations indicated a slower and much more prolonged absorption and showed a lack of a peak after subcutaneous injection of insulin glargine in comparison to human NPH insulin. ||| In clinical studies, for patients treated with pegvisomant (n=160), the majority of adverse reactions to pegvisomant were of mild to moderate intensity, of limited duration and did not require discontinuation of treatment. ||| Chez des sujets sains comme chez des diabétiques, l'analyse des concentrations sériques d'insuline a montré que la résorption de l'insuline glargine était plus lente et beaucoup plus prolongée que celle de l'insuline NPH humaine et qu'il n'y avait pas de pic après injection sous-cutanée d’ insuline glargine.
0.3771302402019501 ||| Subcutaneous absorption at the 90 mg dose is comparable when injected into abdomen, thigh or arm. ||| Subcutaneous injection in the neck or intramuscular injection in the breast of one dose of 0.25 ml. ||| A la dose de 90 mg, l'absorption sous-cutanée est comparable, que l’ injection soit faite dans l’ abdomen, la cuisse ou le bras.
0.05247386172413826 ||| Biograstim 48 MIU/ 0.8 ml solution for injection or infusion ||| Tevagrastim 48 MIU/ 0.8 ml solution for injection or infusion ||| Biograstim 48 MUI/ 0,8 ml solution injectable ou pour perfusion
4.614575865521942e-13 ||| Name and address of the manufacturers of the biological active substance ||| Name and address of the manufacturers of the biological active substance ||| Nom et adresse du fabricant de la substance active d'origine biologique
0.41894328594207764 ||| Immunomedics GmbH Otto-Röhm-Straße 69 D-64293 Darmstadt Germany Telephone: +49-6151- 66 715 66 Fax: +49-6151-66 715 77 ||| Addmedica 84 rue d'Amsterdam 75009 Paris France Phone: +33 1 72 69 01 86 Fax: +33 1 73 72 94 13 E-mail: contact@addmedica. com ||| 69 D-64293 Darmstadt Allemagne Telephone: +49-6151- 66 715 66 Fax: +49-6151-66 715 77
0.3287152349948883 ||| VIAL TEXT Fertavid 200 IU/ 0.5 ml ||| VIAL TEXT FOR PAXENE 100 mg/16.7 ml ||| TEXTE DU FLACON Fertavid 200 UI/ 0,5 ml
0.32881683111190796 ||| Azomyr syrup is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). ||| The 2.5 mg strength is also used to treat patients with unstable angina (a type of chest pain that ro ||| Azomyr sirop est aussi utilisé pour soulager les symptômes associés à l'urticaire (atteinte cutanée provoquée par une allergie).
0.344759464263916 ||| 30 ml Type 1 glass vial with an elastomeric stopper and aluminium seal with flip-off cap. ||| 7 ml clear glass Type I vial with a green flip-off cap. ||| Flacon de verre de type I de 30 ml avec bouchon en élastomère et muni d'une bague en aluminium avec capsule flip-off.
0.4787744879722595 ||| In addition, the following side effects were observed in these patients: ||| However, the following efficacy and safety issues were addressed: ||| Par ailleurs, les effets indésirables suivants ont été constatés chez ces patients:
5.189597124428957e-13 ||| Should this happen to you, seek immediate advice from your doctor. ||| Should this happen to you, seek immediate advice from your doctor. ||| Si cela vous arrivait, consultez immédiatement votre médecin.
0.6872189044952393 ||| 83.1 [< 0.0;99.7] ||| (0.015, 0.147) < 0.0001 ||| 83,1 [< 0,0; 99,7]
0.3301934003829956 ||| Individual cases of interstitial lung disorders of unknown causal relationship to cetuximab have been reported. ||| Data on a large number of exposed pregnancies do not indicate a teratogenic effect of fluoxetine. ||| De rares cas d’ atteinte interstitielle pulmonaire ont été rapportés, sans lien de causalité évident avec le cetuximab.
3.029997043199617e-13 ||| G-CSF can promote growth of myeloid cells, including malignant cells, in vitro and similar effects may be seen on some non-myeloid cells in vitro. ||| G-CSF can promote growth of myeloid cells, including malignant cells, in vitro and similar effects may be seen on some non-myeloid cells in vitro. ||| s des cellules malignes, in vitro et des effets similaires ont pu être observés sur certaines cellules non
0.3547229468822479 ||| Serious adverse reactions including infusion reactions, hypersensitivity, allergic-like reactions and pulmonary events have been observed in patients receiving Herceptin therapy. ||| Diagnosis of cancer, chemotherapy, radiotherapy, corticosteroids and poor oral hygiene are also deemed as risk factors (see section 4.4). ||| Des réactions indésirables graves incluant des réactions liées à la perfusion, hypersensibilité, réactions de type allergique et manifestations pulmonaires ont été observées chez les patients traités par Herceptin.
0.4956910014152527 ||| However, precautionary measures have to be followed in order to avoid direct or indirect contact between vaccinated chickens and turkeys. ||| Furthermore, patients and caregivers should be aware of the fact that behavioural changes can occur. ||| Toutefois, des mesures de précaution doivent être prises afin d’ éviter tout contact direct ou indirect entre les poussins vaccinés et les dindes.
0.2120419591665268 ||| If you are already being treated with rifabutin, your blood counts and some possible side effects to rifabutin will need to be monitored. • Some medicines used to treat or prevent fits, such as phenytoin, carbamazepine, phenobarbital, primidone. • Efavirenz, which is used to treat HIV infection. ||| The following medicines may increase the buprenorphine blood concentrations, so concomitant use of these medicines together with Suboxone should be closely monitored and could require in some cases a dose reduction by your doctor: • anti-retrovirals (ritonavir, nelfinavir, indinavir) • ketoconazole • itraconazole ||| Si vous êtes déjà traités avec la rifabutine, votre numération sanguine et certains effets indésirables liés à la rifabutine devront être surveillés. • Certains médicaments utilisés pour traiter ou prévenir les crises d’épilepsie, tels que la phénytoïne, la carbamazépine, le phénobarbital, la primidone. • Efavirenz, utilisé pour traiter l’infection induite par le VIH. • Les médicaments utilisés pour diminuer l’acidité de l’estomac tels que la cimétidine et la ranitidine ou l’oméprazole et les médicaments similaires appelés les inhibiteurs de pompe à protons.
0.599026083946228 ||| State aid: Coronavirus: €201 million Danish loan ||| State aid: Coronavirus: Slovak employment aid scheme ||| Aides d'État: coronavirus: prêt danois de 201 millions €
0.5519617199897766 ||| 300 (10 x 30) ampoules with 2 ml. ||| 90 ampoules with 2 ml. ||| 300 (10 x 30) ampoules de 2 ml.
0.28071868419647217 ||| The AUC and Cmax of amprenavir were decreased by 18% and 35% respectively, whilst the Cmin (C12h) was comparable, when a single 1400 mg dose of fosamprenavir was co-administered with a single 30 ml ||| When administered with irinotecan, whose active metabolite SN-38 is further metabolised by the UGT1A1 pathway, there was a 67 - 120% increase in the AUC of SN-38 and a 26 - 42% increase in the AUC of irinotecan. ||| En cas de co-administration d’ une dose unique de 1400 mg de fosamprénavir avec une dose unique de 30 ml de suspension d’ anti-acide (équivalent à 3,6 g d’ hydroxyde d’ aluminium et 1,8 g d’ hydroxyde de magnésium), l’ ASC et la Cmax de l’ amprénavir sont diminuées respectivement de 18% et 35%, alors que la Cmin (C12h) est comparable.
0.0 ||| Store in the original package in order to protect from moisture. ||| Store in the original package in order to protect from moisture. ||| A conserver à une température ne dépassant pas +25 ºC A conserver dans l’ emballage extérieur d'origine à l'abri de l' humidité
0.8520806431770325 ||| LPV/r N=163 ||| ALT/ AST > 3xULN ||| LPV/r n=163 76%
0.6450814008712769 ||| An immediate use is recommended. ||| Supportive management is recommended. ||| Une utilisation immédiate est recommandée.
0.2972450852394104 ||| Do not shake or vigorously agitate the vial. ||| Do not shake the vial vigorously. ||| Ne pas secouer ni agiter vigoureusement le flacon.
0.1355251669883728 ||| 0.0020 ||| 0.0010 ||| 0,0020
0.24976111948490143 ||| Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lansoprazole is initiated or ended. ||| 27 Voriconazole should be administered with caution in patients with concomitant medication that is known to prolong QT interval. ||| Il est recommandé de contrôler les concentrations plasmatiques de tacrolimus lors de l’ instauration ou de l’ arrêt d’ un traitement par le lansoprazole.
0.05347577482461929 ||| EU/ 1/ 05/ 323/ 010 – pack of 1 EU/ 1/ 05/ 323/ 011 – pack of 10 EU/ 1/ 05/ 323/ 013 – pack of 20 ||| EU/ 1/ 06/ 341/ 005 – pack of 1 EU/ 1/ 06/ 341/ 006 – pack of 10 EU/ 1/ 06/ 341/ 007 – pack of 20 ||| EU/ 1/ 05/ 323/ 010 - boîte de 1 EU/ 1/ 05/ 323/ 011 - boîte de 10 EU/ 1/ 05/ 323/ 013 - boîte de 20
0.055347226560115814 ||| 39 ANNEX II ||| 40 ANNEX II ||| 39 ANNEXE II
3.9667249519814707e-13 ||| Name and address of the manufacturer(s) of the biological active substance ||| Name and address of the manufacturer(s) of the biological active substance ||| Nom et adresse du (des) fabricant(s) de la (des) substance (s) d'origine biologique
0.3859871029853821 ||| Thermostat controllers ||| Thermostat wires ||| Contrôleurs thermostatiques
0.17733478546142578 ||| The treatment with Protopic should only be initiated by physicians with experience in the diagnosis and treatment of atopic dermatitis. ||| Treatment with INCRELEX should be supervised by doctors who have experience in the diagnosis and treatment of patients with growth disorders. ||| Le traitement par Protopic ne doit être initié que par un médecin expérimenté dans le domaine du diagnostic et du traitement de la dermatite atopique.
0.5542112588882446 ||| If blood appears, do not inject Ceplene because the needle has entered a blood vessel. ||| If you take INTELENCE on an empty stomach, only half the amount of INTELENCE is absorbed. ||| Si du sang apparaît dans la seringue, n’ injectez pas Ceplene, car l’ aiguille est entrée dans un vaisseau sanguin.
0.0 ||| Risk Management Plan ||| Risk Management Plan ||| Plan de gestion du risque
0.15516158938407898 ||| How to store Thyrogen 6. ||| How to store Glustin 6. ||| Comment conserver Thyrogen 6.
0.5893427729606628 ||| Determination of activated partial thromboplastin time (aPTT) is a conventional in vitro assay method for biological activity of factor VIII. ||| or prothrombin time (PT)/ International Normalised Ratio (INR) tests in plasma nor bleeding time or fibrinolytic activity. ||| Le temps de céphaline activée (TCA) est un moyen classique de mesure de l'activité biologique du facteur VIII in vitro.
1.042711853981018 ||| Treatment should be initiated and monitored under specialist supervision. ||| and carefully monitored and assessed, ||| Le traitement devrait être instauré et surveillé sous le contrôle d’ un médecin spécialiste.
0.019264142960309982 ||| The recommended dose of robenacoxib is 1 mg/ kg body weight with a range 1-2.4 mg/ kg. ||| The recommended dose of robenacoxib is 1 mg/ kg body weight with a range 1-2 mg/ kg. ||| La dose recommandée de robenacoxib est de 1 mg/ kg de poids corporel, pouvant varier de 1 à 2,4 mg/ kg.
0.42596501111984253 ||| Electric musical instruments ||| Japanese traditional musical instruments ||| Instruments de musique électriques
0.20016807317733765 ||| 10 ml empty reaction vial (type I glass) with a rubber stopper (teflon-lined bromobutyl) ||| 0.5 ml in single-dose vial (type I glass) with stopper (halo-butyl rubber). ||| Flacon de réaction de 10 ml, vide, (en verre de type I), muni d'un bouchon en caoutchouc (bromobutylé recouvert de Téflon).
0.42031189799308777 ||| - if you suffer from liver problems, because there is limited information on the use of Inovelon in ||| - if you suffer from severe mental disorders, then the use of Ribavarin Teva in combination with ||| - si vous avez des problèmes de foie, car les informations concernant l’ emploi d’ Inovelon dans ce
0.5570777058601379 ||| ADMINISTRATION EVERY 4 WEEKS. ||| ADMINISTRATION EVERY 4 WEEKS SEE TABLE 2 ||| ADMINISTRATION TOUTES LES 4 SEMAINES.
0.061334267258644104 ||| Replagal has no or negligible influence on the ability to drive and use machines. ||| Caelyx has no or negligible influence on the ability to drive and use machines. ||| Replagal n’ a aucun effet ou qu’ un effet négligeable sur l’ aptitude à conduire des véhicules et à utiliser des machines.
0.5858265161514282 ||| {number} al ||| {number} in ic ||| {numéro} e
0.0 ||| Store and transport refrigerated (2°C - 8°C). ||| Store and transport refrigerated (2°C - 8°C). ||| Conserver et transporter réfrigéré (2°C - 8°C).
0.008354466408491135 ||| 284 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 272 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 305 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.2752472758293152 ||| Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment. ||| Pharmacokinetic parameters for bivalirudin in patients with normal and impaired renal function. ||| Les données pharmacocinétiques sont limitées chez les patientes atteintes d'insuffisance rénale légère ou modérée.
0.38747483491897583 ||| Isolated cases of ulceration of the cornea have been observed. ||| In both cases, the reduction of oocysts excretion has been demonstrated. ||| Des cas isolés d’ulcération de la cornée ont été observés.
0.29167959094047546 ||| The amount of salbutamol impacted on stages comprising throat/ 0/ 1/ 2 are non respirable (i. e. > 4.7 µm) and will correspond to larger particles deposited on the oropharynx (throat stage) and upper airway (stages 0/ 1/ 2). ||| b) The Applicant indeed considered that it is the amount of respirable particles < 4.7 µm that will ultimately determine bronchodilator efficacy, particularly for stages 3/ 4/ 5 (i. e. particle size 1.1-4.7 µm) which correspond to bronchial deposition where the airway smooth muscle beta-2 adrenoceptors are located. ||| Les quantités de salbutamol projetées au niveau des étages gorge/ 0/ 1/ 2 ne sont pas respirables (c’ est-à-dire > 4,7 µ) et correspondront à des particules plus grandes déposées sur l’ oropharynx (étage gorge) et dans les voies aériennes supérieures (étages 0/ 1/ 2).
1.0850012294866263e-12 ||| Invented name ||| Invented name ||| Nom inventé
0.25790321826934814 ||| The study of the “ Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2 )” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria. ||| Hypertension and type 2 diabetes with renal disease The “ Irbesartan Diabetic Nephropathy Trial (IDNT) ” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria. ||| 53 L'étude "Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2 Diabetes Mellitus (IRMA 2)" montre qu'irbésartan 300 mg retarde la progression vers une protéinurie avérée chez des patients ayant une microalbuminurie.
0.12036214768886566 ||| EXULETT is a powder that is made up into a solution for infusion (drip into a vein). ||| Angiox is a white powder that is made up into a solution for injection or infusion (drip into a vein). ||| EXULETT est une poudre destinée à être reconstituée en une solution pour perfusion (goutte-à-goutte dans une veine).
0.2666504383087158 ||| 36 ||| 39 ||| 6.
0.2513829469680786 ||| Controlled studies with ACE inhibitors have not been done in humans, but in a 26  EMEA 2005 limited number of cases with first trimester exposure there do not appear to have been any malformations consistent with human foetotoxicity as described below. ||| Controlled studies with ACE inhibitors have not been done in humans, but a limited number of cases with first trimester exposure have not appeared to manifest malformations consistent with human fetotoxicity as described below. ||| Des études contrôlées avec des IEC n’ ont pas été réalisées chez l’ homme; sur un nombre limité de cas exposés durant le premier trimestre, il n’ est pas apparu de malformations conséquentes avec foetotoxicité humaine comme décrit ci-après.
0.3127483129501343 ||| S-P Veterinary Shire Park Welwyn Garden City Hertfordshire AL7 1TW United Kingdom ||| Fisher Clinical Services UK Ltd Langhurstwood Road Horsham West Sussex RH12 4QD UK ||| S-P Veterinary Shire Park Welwyn Garden City Hertfordshire AL7 1TW Royaume-Uni
0.3484438359737396 ||| - Numbness, tingling, pain and/ or burning sensation in the arms and/ or legs ||| - difficulty in breathing with or without swelling of the face, lips, tongue and/ or throat. ||| - Engourdissement, fourmillements, douleur et/ ou sensation de brûlure dans les bras et/ ou les
0.060989949852228165 ||| Wheel cylinders for vehicles ||| Engine cylinders for vehicles ||| Cylindres de roues pour véhicules
4.1164787507527723e-13 ||| Zyrtec and associated names (see Annex I) 1 mg/ ml oral solution ||| Zyrtec and associated names (see Annex I) 1 mg/ ml oral solution ||| Zyrtec et noms associés (voir Annexe 1) 1 mg/ ml, solution buvable [Voir Annexe 1 – A compléter au niveau national]
0.1533583253622055 ||| A connection between visceral lipomatosis and PIs and lipoatrophy and nucleoside reverse transcriptase inhibitors (NRTIs) has been hypothesised. ||| A connection between visceral lipomatosis and PIs and lipoatrophy and Nucleoside Reverse Transcriptase Inhibitors (NRTIs) has been hypothesised. ||| L’ hypothèse d’ une relation entre lipomatose viscérale et inhibiteurs de protéase d’ une part, et lipoatrophie et inhibiteurs nucléosidiques de la transcriptase inverse d’ autre part, a été émise.
0.0901804193854332 ||| Excipient: each hard capsule contains 28.5 mg of lactose monohydrate. ||| Excipients: each tablet contains 94.5 mg of lactose monohydrate. ||| 28,5 mg de lactose monohydraté par gélule.
0.710763692855835 ||| (3) Serology sample collection across all age groups. ||| Posology adjustments for special populations: ||| (3) Prélèvement d’échantillons sérologiques dans toutes les tranches d’âge.
0.4821241796016693 ||| España Alcon Cusí, S.A. + 34 93 497 7000 ||| 33 (0) 4 92 08 73 00 Malta VIRBAC S. A. ||| España Alcon Cusí, S. A. + 34 93 497 7000
0.31475603580474854 ||| If these symptoms occur, contact your doctor. ||| If these symptoms occur, they should inform the physician. ||| Si ces symptômes surviennent, prévenez votre médecin.
0.4502530097961426 ||| Syringe is now ready for needle or infusion tubing attachment. ||| In insulin infusion pumps If the protective cap is loose or missing. ||| La seringue est à présent prête à être fixée sur une aiguille ou une tubulure de cathéter.
0.06655974686145782 ||| In case of accidental self-injection, seek medical advice immediately and show the package insert or the label to the physician. ||| In case of accidental self injection, seek medical advice immediately and show the package insert or the label to the physician. ||| En cas d’ injection accidentelle à l’ homme, consulter un médecin immédiatement et lui montrer la notice ou l’ étiquette.
0.29823237657546997 ||| Zometa treatment in TIH patients who also have severe renal impairment should be considered only after evaluating the risks and benefits of treatment. ||| Milder forms may not cause any muscle symptoms, and the diagnosis is based on abnormal blood tests in the context of other problems. ||| Le traitement par Zometa des patients ayant une hypercalcémie induite par des tumeurs et présentant également une atteinte rénale sévère devront être envisagée uniquement après l’ évaluation des risques et des bénéfices de ce traitement.
0.1805168092250824 ||| As with any anti-hypertensive agent, excessive blood pressure decrease in patients with ischemic cardiopathy or ischemic cardiovascular disease could result in a myocardial infarction or stroke. ||| Similar considerations may apply to patients with ischemic heart or cerebrovascular disease in whom an excessive fall in blood pressure could result in a myocardial infarction or cerebrovascular accident. ||| Comme avec n’ importe quel agent antihypertenseur, une baisse brutale de la pression artérielle chez des patients porteurs d’ une cardiopathie ischémique ou d’ une maladie cardiovasculaire ischémique pourrait entraîner un infarctus du myocarde ou un accident vasculaire cérébral.
0.2241729497909546 ||| The active substance of Siklos, i. e. hydroxycarbamide, is a substance which inhibits growth and proliferation of some cells, such as blood cells; these effects lead to a reduction of circulating red, white and coagulation blood cells (myelosuppressive effect). ||| Other effects of this type of medicine Sebivo belongs to a class of medicines (a nucleoside analogue) that can cause an excess of lactic acid in the blood (lactic acidosis) and enlargement of the liver (hepatomegaly) with fatty liver (steatosis). ||| Le principe actif de Siklos, l’ hydroxycarbamide, est une substance qui inhibe la croissance et la prolifération de certaines cellules, comme les cellules du sang; ces effets provoquent une réduction du nombre de globules rouges, des globules blancs et des plaquettes en circulation dans le sang (myelosuppression).
7.545965805336174e-13 ||| - somatropin (growth hormone), ||| - somatropin (growth hormone), ||| - la somatropine (hormone de croissance),
0.4943237900733948 ||| Computer software for assisting in the design of sports equipment ||| Services for the production of entertainment in the form of film ||| Logiciels d'aide à la conception d'équipements de sport
0.0 ||| 60 10. ||| 60 10. ||| 10.
3.996249674492053e-13 ||| Distribution and elimination In man, the disposition of tacrolimus after intravenous infusion may be described as biphasic. ||| Distribution and elimination In man, the disposition of tacrolimus after intravenous infusion may be described as biphasic. ||| 46 Distribution et élimination Chez l’ homme, la cinétique du tacrolimus après perfusion intraveineuse peut être décrite par un modèle bicompartimental.
2.150929309880159e-13 ||| Standard haematological tests and blood chemistries (complete blood count and differential, platelet count, electrolytes, liver enzymes, serum protein, serum bilirubin and serum creatinine) are to be conducted in all patients prior to and periodically during systemic treatment with IntronA. ||| Standard haematological tests and blood chemistries (complete blood count and differential, platelet count, electrolytes, liver enzymes, serum protein, serum bilirubin and serum creatinine) are to be conducted in all patients prior to and periodically during systemic treatment with IntronA. ||| 170 Des tests hématologiques et biochimiques standards sanguins (numération formule sanguine, plaquettes, électrolytes, enzymes hépatiques, protéines sériques, bilirubine sérique et créatinine sérique) doivent être réalisés chez tous les patients avant et périodiquement durant tout traitement systémique par IntronA.
0.32719430327415466 ||| Rebif 22 micrograms is a solution for injection in a pre-filled syringe with a fixed needle for self-administration. ||| For multiple vial entry, an aspirating needle or multi-dose syringe is recommended to avoid excessive broaching of the stopper. ||| Rebif 22 microgrammes se présente sous la forme d’une solution injectable en seringue préremplie avec une aiguille fixe permettant l’auto-administration.
0.4266507625579834 ||| Media for use in offset lithographic printing ||| Inks for use in silk screen printing ||| Supports pour l'impression lithographique offset
0.2608329653739929 ||| The following adverse drug reactions were reported in patients in the SPRYCEL clinical trials at a frequency of < 5%: ||| Adverse reactions attributed to Herceptin in > 1% and < 10% of patients in the two pivotal clinical trials were the following: ||| Les effets indésirables suivants ont été rapportés chez les patients des études cliniques SPRYCELà une fréquence < 5%:
0.24615377187728882 ||| When applied topically, systemic overdosage with imiquimod cream is unlikely due to minimal percutaneous absorption. ||| The dosage of sodium oxybate therefore does not require adjustment when given concomitantly with proton pump inhibitors. ||| L’absorption percutanée étant minime, un surdosage systémique est peu probable après application locale de la crème imiquimod.
0.0678977519273758 ||| 10 SCIENTIFIC CONCLUSIONS ||| 4 SCIENTIFIC CONCLUSIONS ||| 10 CONCLUSIONS SCIENTIFIQUES
0.3312857151031494 ||| Signs of nausea including excessive salivation and lethargy might remain after treatment. ||| Rare side effects in patients taking CIALIS include fainting, migraine and swelling of the face. ||| Les signes de nausées incluant salivation excessive et léthargie peuvent persister après le traitement.
0.0 ||| Clear, colourless solution. ||| Clear, colourless solution. ||| Solution transparente, incolore.
0.34638500213623047 ||| While you are being treated with Kivexa, your doctor will monitor you closely for any signs that you may be developing lactic acidosis. ||| It is currently unclear whether Aclasta causes this irregular heart rhythm but you should report it to your doctor if you experience such symptoms after you have received Aclasta. ||| Votre médecin assurera un suivi régulier des signes liés au risque de développement d’ une acidose lactique, ceci tout au long de votre traitement par Kivexa.
0.23228824138641357 ||| Ferriprox is used to treat iron overload (an excess of iron in the body) in patients with thalassaemia major (an inherited disease where patients are unable to make enough haemoglobin, the protein found in red blood cells that carries oxygen around the body). ||| In patients with Alzheimer’ s dementia or dementia due to Parkinson’ s disease, certain nerve cells die in the brain, resulting in low levels of the neurotransmitter acetylcholine (a chemical that allows nerve cells to communicate with each other). ||| Ferriprox est indiqué pour le traitement de la surcharge en fer (excès de fer dans l’ organisme) chez les patients présentant une thalassémie majeure (maladie congénitale dans laquelle les patients ne fabriquent pas assez d’ hémoglobine, protéine présente dans les globules rouges qui transporte l’ oxygène dans l’ organisme).
3.897837456447173e-13 ||| Olanzapine is indicated for the treatment of moderate to severe manic episode. ||| Olanzapine is indicated for the treatment of moderate to severe manic episode. ||| L'olanzapine est indiquée dans le traitement des épisodes maniaques modérés à sévères.
0.545211136341095 ||| Hydrocortisone acetate 1% ct ||| au Sodium chloride Polysorbate 80 ||| d’ hydrocortisone 1% deux fois par jour (N=207)
0.5640352368354797 ||| Boxing gloves ||| Processed herbs ||| Gants de boxe
0.2951660752296448 ||| Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents. ||| Desirudin should be used with care in patients receiving anticoagulants, and/ or platelet inhibitors, and/ or non-steroidal anti-inflammatory medicinal products. ||| Ne pas administrer conjointement avec des anti-inflammatoires glucocorticostéroïdes ou non stéroïdiens, ni avec des anticoagulants.
0.7956596612930298 ||| 252 Turning the dose selector will not inject insulin. ||| ed Inject the insulin • Inject the insulin under the skin. ||| Tourner le sélecteur de dose n’ entraînera pas d’ injection de l’ insuline.
0.22877871990203857 ||| Co-administration of APTIVUS and low dose ritonavir with single dose methadone was demonstrated to decrease methadone pharmacokinetic parameters (AUC0-24h ratio of 0.47 with 90% CI [0.44; 0.51] and Cmax ratio of 0.45 with 90% CI [0.41; 0.49]), in a study conducted in fasted healthy subjects. ||| Among patients with candidaemia, favourable response rates at the end of IV study therapy were comparable for caspofungin (72% [66/ 92]) and amphotericin B (63% [59/ 94]) in the primary efficacy analysis (MITT analysis) [% difference 10.0 (95.0% CI -4.5, 24.5)]. ||| Une diminution des paramètres pharmacocinétiques de la méthadone (ASC0-24h ratio de 0,47, IC90 [0,44; 0,51] et Cmax ratio de 0,45, IC90 [0,41; 0,49]) a été mise en évidence lors de la co-administration à jeun d’ APTIVUS, associé au ritonavir à faible dose, et d’ une dose unique de méthadone au cours d’ une étude chez des volontaires sains.
0.5070450901985168 ||| Fingerboards for stringed musical instruments ||| Instruction manuals for music synthesizers ||| Touches pour instruments de musique à cordes
0.43354350328445435 ||| However some trends were apparent for patients in exploratory subgroup analyses. ||| Similar response rates were seen in the patients taking the comparator medicines. ||| Cependant, certaines tendances étaient visibles dans les analyses exploratoires de sous-groupes.
0.5171651244163513 ||| Alternatively, any other suitably-validated method may be used, carried out by any objectively qualified laboratory. ||| These can be circumvented by alternative manufacturing methods, but this required R D infrastructure and a suitably skilled workforce. ||| Alternativement, toute autre méthode adéquatement validée pourra être utilisée et réalisée par tout laboratoire objectivement qualifié.
0.4074144959449768 ||| Optimark should be used in these patients with caution. ||| This combination should be used with caution. ||| Optimark doit donc être utilisé avec précaution chez ces patients.
0.22610078752040863 ||| EU/ 1/ 06/ 364/ 006 – 2 tablets EU/ 1/ 06/ 364/ 007 – 4 tablets EU/ 1/ 06/ 364/ 008 – 12 tablets EU/ 1/ 06/ 364/ 009 – 40 tablets ||| EU/ 2/ 07/ 079/ 001 10 ml EU/ 2/ 07/ 079/ 002 50 ml EU/ 2/ 07/ 079/ 003 100 ml EU/ 2/ 07/ 079/ 004 250 ml ||| EU/ 1/ 06/ 364/ 006 – 2 comprimés EU/ 1/ 06/ 364/ 007 – 4 comprimés EU/ 1/ 06/ 364/ 008 – 12 comprimés EU/ 1/ 06/ 364/ 009 – 40 comprimés
0.4549104869365692 ||| Novaris Healthcare A/ S, Lyngbyvej 172 DK-2100 København Ø, Denmark ||| Pfizer Luxembourg SARL, branch office Dubravska cesta 2, 841 04 Bratislava, Slovak Republic ||| Novaris Healthcare A/ S, Lyngbyvej 172 DK-2100 København Ø, Danemark
0.2328239381313324 ||| The most common adverse reaction reported at a greater incidence in patients treated with the aprepitant regimen than with standard therapy in patients receiving moderately emetogenic chemotherapy was fatigue (2.5% versus 1.6%). ||| Adverse reactions considered as drug-related by the investigator were reported in approximately 17% of patients treated with the aprepitant regimen compared with approximately 13% of patients treated with standard therapy in patients receiving highly emetogenic chemotherapy. ||| L’événement indésirable le plus fréquent, rapporté avec une incidence supérieure chez les patients traités par aprépitant comparés à ceux recevant un traitement standard dans le cadre d’une chimiothérapie moyennement émétisante, a été la fatigue (2,5% contre 1,6%).
0.3264000415802002 ||| In addition, the Commission has made available up to €8 billion in financing for 100,000 small businesses hit by the crisis, with the European Investment Fund. ||| This means that the total amount in funding for coronavirus research, mobilised from Horizon 2020 and the industry through IMI, could reach almost €140 million. ||| En outre, la Commission et le Fonds européen d'investissement ont mis à disposition jusqu'à 8 milliards d'euros pour financer 100 000 petites entreprises touchées par la crise..
0.31775128841400146 ||| Although no clinical information is available, it is likely that, as in animals, elimination of alendronate via the kidney will be reduced in patients with impaired renal function. ||| However, due to the lack of interaction studies with other NSAIDs it is presently unclear whether there is an increased risk of gastrointestinal bleeding with all NSAIDs. ||| Bien qu'aucune donnée clinique ne soit disponible, il est vraisemblable que, comme chez l'animal, l'élimination d'alendronate par le rein soit diminuée chez les patientes ayant une insuffisance rénale.
0.3484553098678589 ||| However, the CHMP concluded that this is unlikely to lead to a difference in the rate of protection against infection with S. pneumoniae following a booster injection, when Prevenar is used as part of a routine immunisation programme in which most infants are vaccinated. ||| In relation to suicidality, the CHMP concluded that the current warning of the product information already informs doctors and parents to monitor patients carefully for the appearance of suicidal behaviour, self-harm or hostility, particularly at the beginning of treatment. ||| Cependant, le CHMP a conclu que ceci a peu de chances d’ entraîner une différence dans le taux de protection contre l’ infection à S. pneumonia après un rappel, lorsque Prevenar est utilisé dans le cadre d’ un programme d’ immunisation de routine au cours duquel la plupart des nourrissons sont vaccinés.
6.452000392287438e-13 ||| Pharmacokinetic properties ||| Pharmacokinetic properties ||| 5.2 Propriétés pharmacocinétiques
0.09210182726383209 ||| Irbesartan Winthrop is also used to treat renal (kidney) disease in patients with hypertension and type 2 diabetes (non-insulin-dependent diabetes). ||| Karvea is also used to treat renal (kidney) disease in patients with hypertension and type 2 diabetes (non-insulin-dependent diabetes). ||| Irbesartan Winthrop est également utilisé dans le traitement de l’ atteinte rénale (rein) des patients souffrant d’ hypertension et de diabète de type 2 (diabète non insulino dépendant).
0.4502870440483093 ||| AUC: ↓ 77% Cmax: ↓ 61% Efavirenz: ||| AUC: ↑ 44% Cmax: ↑ 38% Voriconazole: ||| ASC: ↓ 77% Cmax: ↓ 61% Efavirenz:
0.5257991552352905 ||| Onset of immunity has been demonstrated 2 weeks after primary vaccination course. ||| Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching. ||| La mise en place de l’ immunité a été démontrée 2 semaines après la primo-vaccination.
0.3444889187812805 ||| Withdrawal of risperidone may be needed • fever, severe muscle stiffness, sweating or a lowered level of consciousness (a disorder called “ neuroleptic malignant syndrome). ||| e • bleeding (for example from an operation site, an existing stomach ulcer, nosebleed, gums) • anaemia (a reduction in the number of red blood cells). ||| L’ arrêt de la rispéridone peut être nécessaire. • de la fièvre, une raideur musculaire importante, de la transpiration ou une diminution du niveau de conscience (un trouble appelé « syndrome malin des neuroleptiques).
0.3948012590408325 ||| However, health professionals complained that they were ill-equipped to face the crisis, due to inadequate stocks of protective equipment. ||| However, the response from commercial suppliers was disappointing and expensive and did not meet the Agency’s needs in complying with the financial regulations. ||| Néanmoins des professionnels de santé se plaignent d’une information ressentie comme insuffisante, de l'absence de stratégie de dépistage et du manque de matériels,,.
0.753229022026062 ||| 10.4% 1.0% 0.6% 0.2% ||| 0.22 0.21 0.004 0.006 ||| 10,4% 1,0% 0,6% 0,2%
0.21814671158790588 ||| The most common side effects with Ebixa (seen in between 1 and 10 patients in 100) are headache, somnolence (sleepiness), hypertension (high blood pressure), constipation and dizziness. ||| Very common effects – likely to affect more than 1 in 10 people The most common side effects are weight loss, tremor, diarrhoea, flatulence (wind), abdominal (stomach) pain. ||| Les effets indésirables les plus courants (observés chez 1 à 10 patients sur 100) sont les céphalées, la somnolence (endormissement), l’ hypertension (tension artérielle élevée), la constipation et les vertiges.
0.0 ||| The fraction of carbon dioxide gas, identified by its characteristic retention time, is introduced into mass spectrometer. ||| The fraction of carbon dioxide gas, identified by its characteristic retention time, is introduced into mass spectrometer. ||| L'air dépourvu de CO2 (gaz de référence) nécessaire à l'étalonnage et à la mesure est produit au moyen d'un absorbeur de CO2 intégré à l'analyseur.
0.2796382009983063 ||| After reconstitution with the appropriate volume of solvent (water for injections), each vial contains octocog alfa 400 IU/ ml. ||| The product contains approximately 175 IU/ ml antithrombin alfa when reconstituted with 10 ml of Sterile Water for Injection (WFI). ||| Après reconstitution avec le volume approprié de solvant (eau pour préparations injectables), chaque flacon contient 400 UI/ ml d’ octocog alfa.
0.39031273126602173 ||| For section 4.6, the CHMP discussed the wording, moving the mention of galactorrhea to section 4.8 and adopting the following harmonised wording: ||| The CHMP included under this session the warning about primary hyperaldosteronism, therefore adopted the following harmonised wording: ||| Pour la section 4.6, le CHMP a discuté de la formulation, déplaçant la mention de galactorrhée à la section 4.8 et adoptant la formulation harmonisée suivante:
0.2004997581243515 ||| Then, insert the needle into the vial, push the plunger to expel the air, turn the vial upside down and gently draw up all the solvent. ||| Attach the needle for reconstitution to the syringe, with the syringe in one hand, pick up the open ampoule, insert the needle and draw up all of the solvent. ||| Puis, introduisez l'aiguille dans le flacon, poussez sur le piston de façon à expulser l'air, retournez le flacon la tête en bas et aspirez doucement tout le solvant.
0.0 ||| IMMUNOLOGICAL PROPERTIES ||| IMMUNOLOGICAL PROPERTIES ||| PROPRIETES PHARMACOLOGIQUES
0.41689348220825195 ||| EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. ||| The European Commission is also monitoring and supporting Member States on the implementation of EU rules for specific group of victims, such as victims of child sexual abuse and exploitation . ||| Les États membres de l'Union européenne ont mis au point, avec le soutien de la Commission européenne, une boîte à outils commune au niveau de l'UE en vue de l'utilisation d'applications mobiles de traçage des contacts et d'alerte pour lutter contre la pandémie de coronavirus.
0.3072136640548706 ||| In fertility studies, gemcitabine caused reversible hypospermatogenesis in male mice. ||| In reproduction studies in animals, temsirolimus caused embryo/ foetotoxicity ||| Dans les études de fertilité, la gemcitabine a provoqué une hypospermatogénèse réversible chez les souris mâles.
0.3363240361213684 ||| Generalised hypersensitivity reactions are potentially life threatening (anaphylactic reactions). ||| Generalised hypersensitivity reactions are potentially life- threatening. ||| Les réactions d’hypersensibilité généralisée peuvent menacer le pronostic vital (réactions anaphylactiques).
0.03664075583219528 ||| 143 5.2 Pharmacokinetic properties ||| 199 5.2 Pharmacokinetic properties ||| 5.2 Propriétés pharmacocinétiques
0.28982874751091003 ||| Confirmatory clinical trials in treatment-naïve patients All clinical trials recruited interferon-naïve patients with chronic hepatitis C confirmed by detectable levels of serum HCV RNA, elevated levels of ALT (with the exception of study NR16071) and a liver biopsy consistent with chronic hepatitis. ||| Tracleer has been evaluated in an open-label non-controlled study in 19 paediatric patients with pulmonary arterial hypertension (AC-052-356, BREATHE-3: primary pulmonary hypertension 10 patients, and pulmonary arterial hypertension related to congenital heart diseases 9 patients). ||| Résumé des essais cliniques chez les patients naïfs Dans tous les essais cliniques, les patients inclus n’avaient jamais été traités par interféron et présentaient une hépatite chronique C confirmée par des taux sériques d’ARN du VHC détectables, des taux d’ALAT élevés (à l’exception de l’étude NR16071) et une biopsie hépatique compatible avec une hépatite chronique.
0.0 ||| It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| Si l’ un des effets indésirables devient grave, ou si vous remarquez un effet indésirable non mentionné dans cette notice, parlez -en à votre médecin ou votre pharmacien.
0.5663522481918335 ||| Medicinal preparations and substances ||| Other ventilation modes and strategies ||| Substances et préparations médicinales
0.34319719672203064 ||| How much to take Adults The recommended dose is one 700 mg Telzir tablet twice daily with 100 mg ritonavir twice daily. ||| How much Sebivo to take The usual dose of Sebivo is one 600 mg tablet once a day. ||| Quelle quantité prendre Adultes La dose recommandée est de un comprimé de Telzir de 700 mg deux fois par jour avec 100 mg de ritonavir deux fois par jour.
0.5877984762191772 ||| Box of 10 vials ||| Package size 8 vials ||| Boite de 10 flacons
0.5337897539138794 ||| 28 hard capsules 56 hard capsules 112 hard capsules ||| 5 hard capsules in sachets 20 hard capsules in sachets ||| 28 gélules 56 gélules 112 gélules
0.32611793279647827 ||| Take your dose at around the same time every day. ||| Try to take your daily dose at about the same time each day. ||| Prenez votre traitement tous les jours au même moment de la journée.
0.2848321199417114 ||| The dosage should therefore be reduced for patients with a creatinine clearance of < 50 ml/ minute. ||| If you have kidney disease the infusion dose may be reduced to 1.0 microgram/ kg/ minute. ||| Chez les patients présentant une clairance de la créatinine inférieure à 50 ml/ min, la posologie doit donc être réduite.
0.6222765445709229 ||| The use of RotaTeq should be in accordance with official recommendations. ||| the use of data would have to be limited to COVID-19 purposes; ||| Rotateq doit être utilisé selon les recommandations officielles.
0.048241134732961655 ||| The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, red and yellow ferric oxides. ||| The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188. ||| Les autres composants sont cellulose microcristalline, croscarmellose sodique, lactose monohydraté, stéarate de magnésium, silice colloïdale hydratée, amidon de maïs prégélatinisé, oxyde de fer rouge et oxyde de fer jaune.
0.4657341241836548 ||| Interpretation ||| Investigations ||| Interprétation
0.25724345445632935 ||| In the Phase II study in imatinib-resistant and intolerant CML patients in chronic and accelerated phase, the change from baseline in mean time-averaged QTcF interval at steady state was 6 and 8 msec, respectively. ||| For patients with CCyR and reduction in Bcr-Abl transcripts of at least 3 logarithms at 12 months, the probability of remaining free from progression to accelerated phase/ blast crisis was 100% at 60 months. ||| Dans l’ étude de phase II menée chez les patients atteints de LMC en phase chronique et en phase accélérée résistants ou intolérants à l’ imatinib, la variation moyennée de l’ intervalle QTcF dans des conditions standard a été de 6 ms et 8 ms respectivement par rapport aux valeurs initiales.
0.30768030881881714 ||| If you forget to use Betaferon: ||| If you forget to use piroxicam: ||| Si vous oubliez d’utiliser Betaferon:
0.5933495163917542 ||| Coronavirus: EU funding for the transport of medical goods, medical teams and patients ||| €4 million to support essential water and sanitation services and hygiene kits in refugee camps and for vulnerable host communities ||| Coronavirus: financement de l'UE pour le transport de produits médicaux, d'équipes médicales et de patients
0.2902544140815735 ||| This will protect the liquidity needs of French companies and will help them carry on their commercial activities in these difficult times. ||| This will enable these companies to have access to liquidity to continue their activities in these difficult times. ||| Ce régime aidera les entreprises françaises à couvrir leurs besoins de liquidité et à poursuivre leurs activités commerciales en ces temps difficiles.
0.5723798274993896 ||| • Look at the expiry date on the syringe. ||| Check the appearance of Aranesp through the inspection window. ||| • Vérifiez la date de péremption sur la seringue.
0.4636821746826172 ||| If the symptoms are not relieved within 4 weeks with a daily dose of 30 mg, further examinations are recommended. ||| Blood tests can be used, but these require two blood samples taken two weeks apart and the results have little immediate value. ||| Si les symptômes ne sont pas soulagés dans les 4 semaines avec une posologie quotidienne de 30 mg, d’autres examens sont recommandés.
0.28842973709106445 ||| It contains no antibacterial preservative. ||| It has no anti-bacterial effects. ||| Elle ne contient aucun conservateur antibactérien.
5.738983507169726e-13 ||| Temodal is first used together with radiotherapy ||| Temodal is first used together with radiotherapy ||| Temodal est tout d’ abord utilisé en
0.22357025742530823 ||| Administration of tenofovir disoproxil fumarate with a high fat meal enhanced the oral bioavailability, with an increase in tenofovir AUC by approximately 40% and Cmax by approximately 14%. ||| The bioavailability of ribavirin 600 mg was decreased by co-administration with an antacid containing magnesium, aluminium and simethicone; AUCtf decreased 14%. ||| L’ administration de fumarate de ténofovir disoproxil avec un repas riche en graisse augmente la biodisponibilité orale, avec une augmentation de l’ ASC du ténofovir d’ environ 40% et de la Cmax d’ environ 14%.
0.0 ||| 27 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 27 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 29 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.38777241110801697 ||| Pharmacotherapeutic group: inactivated bacterial vaccine. ||| Pharmacotherapeutic group: antithrombotic agents. ||| Groupe pharmacothérapeutique: vaccin bactérien inactivé.
0.023300230503082275 ||| - if you are taking a sulphonylurea, a diabetes medicine, together with Velmetia, as you may ||| - if you are taking a sulphonylurea, a diabetes medicine, together with Janumet, as you may ||| - si vous prenez un sulfamide hypoglycémiant, médicament antidiabétique, en même temps que
0.0895041674375534 ||| 24/ 42 ||| 23/ 42 ||| 23/ 42
0.6587826013565063 ||| (< 50 HIV-1 RNA copies/ml). ||| o (CSF) virus minimum 32 µg ||| (ARN du VIH-1 < 50 copies/ml).
0.4975089430809021 ||| Petrol injection instruments ||| Industrial oil for batteries ||| Instruments d'injection d'essence
0.0 ||| Each tablet contains 80 mg telmisartan and 25 mg hydrochlorothiazide. ||| Each tablet contains 80 mg telmisartan and 25 mg hydrochlorothiazide. ||| Un comprimé contient 80 mg de telmisartan et 25 mg d’ hydrochlorothiazide
0.3268139362335205 ||| In the trial for the prevention of clinical fractures following a recent hip fracture, vitamin D levels were not routinely measured but the majority of patients received a loading dose of vitamin D prior to Aclasta administration (see section 4.2). ||| Among these 232 patients, 158 had also undergone a scan using a standard scintigraphy technique (when the patient receives a specially prepared injection of their own white blood cells radiolabelled with a suitable radioactive marker). ||| Dans l’ étude RFT, la majorité des patients a reçu une dose de charge en vitamine D avant l’ administration d’ Aclasta bien que le taux de vitamine D n’ ait pas été mesuré de façon systématique (voir rubrique 4.2).
0.19773730635643005 ||| Safety and efficacy of concurrent use with Tetanus-Serum from Intervet has been demonstrated. ||| Safety and efficacy of concurrent use with Tetanus-Serum from Intervet (see section 4.9) has been demonstrated. ||| L’ innocuité et l’ efficacité de l’ utilisation concomitante avec le sérum tétanique d’ Intervet ont été démontrées.
0.2691030204296112 ||| It is unknown whether recombinant human parathyroid hormone is excreted in the milk of lactating animals. ||| Lactation It is not known whether infliximab is excreted in human milk or absorbed systemically after ingestion. ||| Aucune information n’ est disponible sur l’ excrétion de l’ hormone parathyroïde recombinante dans le lait des animaux.
0.13084760308265686 ||| 21 for monotherapy should be reduced in patients with moderate or severe renal impairment (see sections 4.2 and 4.4). ||| No dose adjustment is necessary in patients with mild to moderate hepatic impairment (see sections 4.4 and 5.2). ||| La dose de PegIntron en monothérapie doit être réduite chez les patients avec une insuffisance rénale modérée ou sévère (voir rubriques 4.2 et 4.4).
0.003147580660879612 ||| 45 More significant obtundation and coma, including cases of encephalopathy, have been observed in some patients, usually elderly, treated at higher doses. ||| 25 More significant obtundation and coma, including cases of encephalopathy, have been observed in some patients, usually elderly, treated at higher doses. ||| Des états plus significatifs de confusion et de coma, comprenant des cas d’ encéphalopathie, ont été observés chez certains patients, généralement âgés, traités à des doses élevées.
0.032177019864320755 ||| 302 Adult patients with chronic renal failure ||| 218 Adult patients with chronic renal failure ||| Adultes insuffisants rénaux chroniques
0.3922443985939026 ||| Multi-packs containing 90, 98 or 280 tablets. ||| Blister boxes contain 14, 28, or 84 tablets. ||| Boîtes de 90, 98 ou 280 comprimés en conditionnements multiples.
0.060070525854825974 ||| Irbesartan Hydrochlorothiazide BMS is taken by mouth, with or without food. ||| Irbesartan Hydrochlorothiazide Winthrop is taken by mouth, with or without food. ||| Irbesartan Hydrochlorothiazide BMS est administré par voie orale, au cours ou en dehors des repas.
0.419861376285553 ||| Commercial monitors ||| Commercial vehicles ||| Moniteurs commerciaux
0.45974233746528625 ||| Contents: ||| Pack contents: ||| Contenu:
0.559698760509491 ||| PritorPlus 80 mg/ 12.5 mg tablets ||| Triatec Plus 5 mg/25 mg δισκία ||| PritorPlus 80 mg/ 12,5 mg comprimés
0.22273971140384674 ||| How does TRAVATAN work? ||| How is TRAVATAN used? ||| Comment TRAVATAN fonctionne -t-il?
0.2938137650489807 ||| Finally intravenous calcium folinate can be administered for the prevention and treatment of folate deficiency when it cannot be prevented or corrected by the administration of folic acid by the oral route. ||| Each dose of Posaconazole SP should be administered with a meal, or with a nutritional supplement in patients who cannot tolerate food to enhance the oral absorption and to ensure adequate exposure. ||| Le folinate de calcium peut enfin être administré par voie intraveineuse à des fins de prévention et de traitement d’ une carence en folate quand celle -ci ne peut être ni évitée ni corrigée par l’ administration d’ acide folique par voie orale.
0.25475043058395386 ||| In two clinical studies performed in healthy adult subjects, cyclosporin A (one 4 mg/ kg dose or two 3 mg/ kg doses 12 hours apart) increased the AUC of caspofungin by approximately 35%. ||| In both species the product is administered intramuscularly at a dose rate of 15 mg amoxicillin/ kg bw (equivalent to 1 ml of Suramox 15% LA/ 10 kg bw) twice at 48 hours interval. ||| Dans deux études cliniques réalisées chez des sujets adultes sains, la ciclosporine A (à la dose unique de 4 mg/ kg ou lors de l’ administration de deux doses de 3 mg/ kg séparées par un intervalle de
0.4170413613319397 ||| How long to take Sebivo Do not change your dose or stop taking Sebivo without talking to your doctor. ||| 18 If you stop taking Comtess Do not stop taking Comtess unless your doctor tells you to. ||| Ne modifiez pas votre dose, et n’ arrêtez pas la prise de Sebivo sans en parler avec votre médecin.
0.22266939282417297 ||| Pregnancy and breast feeding Tell your doctor if you are pregnant or planning to become pregnant. ||| Pregnancy and breast-feeding Tell your doctor immediately if you are pregnant. ||| Grossesse et allaitement Prévenez votre médecin si vous êtes enceinte ou envisagez de le devenir.
0.03439388424158096 ||| Econor 0.5% mg Econor 0.5% premix/ kg feed = Dosage required (mg/ kg) x 200 x bodyweight (kg)/ Daily feed intake (kg). ||| Econor 10% mg Econor 10% premix/ kg feed = Dosage required (mg/ kg) x 10 x bodyweight (kg)/ Daily feed intake (kg). ||| Econor 0,5% mg d’ Econor 0 ,5% Prémélange médicamenteux/ kg d’ aliment = dose requise (mg/ kg) x 200 x poids vif (kg)/ quantité de nourriture ingérée par jour (kg).
0.23398056626319885 ||| HOW TO USE SAVENE ||| HOW TO USE IVEMEND ||| COMMENT UTILISER SAVENE
0.25584712624549866 ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck. com ||| Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 dkmail@msd.dk ||| Eesti Merck Sharp & Dohme OÜ Tel.: +372 613 9750 msdeesti@merck.com
0.2914888858795166 ||| If any of the following events occur in temporal relation to receipt of Tritanrix HepB, the decision to give subsequent doses of vaccine containing the pertussis component should be carefully considered. ||| Therefore, Efient can be administered without regard to food; however, the administration of prasugrel loading dose in the fasted state may provide most rapid onset of action (see section 4.2). ||| Si l'une des réactions décrites ci-dessous apparaît après l’ administration de Tritanrix HepB, la décision d'administrer les doses suivantes du vaccin contenant la valence coquelucheuse doit être soigneusement évaluée:
0.12037856131792068 ||| How will these resources be distributed among Member States? ||| How will this money be distributed among Member States? ||| Comment ces ressources seront-elles réparties entre les États membres?
0.002291683806106448 ||| 145 Following transfer from an animal insulin to human insulin, dosage reduction may be required in particular in patients who ||| 135 Following transfer from an animal insulin to human insulin, dosage reduction may be required in particular in patients who ||| 146 Après passage d'une insuline animale à une insuline humaine, une réduction de la posologie peut être nécessaire, en particulier chez les patients:
0.6319414377212524 ||| Gardening tools (Electric -) ||| Ice-skating events (Organising of -) ||| Outils électriques de jardinage
0.32574063539505005 ||| 20 In pediatric patients (4 to 16 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 198 patients and had a treatment duration of 14 weeks. ||| Long-term treatment Two double-blind studies of long-term management of atopic dermatitis were undertaken in 713 children and adolescents (2-17 years) and 251 infants (3-23 months). was evaluated as foundation therapy. ||| Chez les enfants (de 4 à 16 ans), l’ efficacité du levetiracetam a été établie lors d’ une étude en double aveugle contrôlée versus placebo incluant 198 patients sur 14 semaines de traitement.
0.33245331048965454 ||| Women must not be pregnant during treatment with Busilvex and up to 6 months after treatment. ||| Women of childbearing potential must use effective contraception during and up to 6 months after treatment. ||| Les femmes ne doivent pas être enceintes pendant et jusqu’ à 6 mois après le traitement avec Busilvex.
2.632952720866416e-13 ||| In all studies, the main measure of effectiveness was the reduction in diastolic blood pressure (the blood pressure measured between two heartbeats). ||| In all studies, the main measure of effectiveness was the reduction in diastolic blood pressure (the blood pressure measured between two heartbeats). ||| Dans toutes les études, la mesure principale d’ efficacité était la réduction de la pression artérielle diastolique (la tension artérielle mesurée entre deux battements du cœ ur).
0.09691832959651947 ||| The full EPAR for Baraclude can be found here. ||| The full EPAR for Cystadane can be found here. ||| L’ EPAR complet pour Baraclude est disponible à l’ adresse suivante: ici.
0.03011026605963707 ||| The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. ||| The prevalence of acquired resistance may vary geographically and with time for selected species, and local information on resistance is desirable, particularly when treating severe infections. ||| 56 La prévalence de la résistance acquise peut varier en fonction de la géographie et du temps pour certaines espèces; il est donc utile de disposer d’informations sur la prévalence de la résistance locale, surtout pour le traitement d’infections sévères.
0.27349406480789185 ||| Oral TMZ has been studied in paediatric patients (age 3-18 years) with recurrent brainstem glioma or recurrent high grade astrocytoma, in a regimen administered daily for 5 days every 28 days. ||| Using the FVIIa assay, the pharmacokinetic properties of rFVIIa were studied in 12 paediatric (2 - 12 years) and 5 adult patients in non bleeding state. ||| TMZ oral a été étudié chez les enfants (3-18 ans) atteints d’ un gliome du tronc cérébral en récidive ou d’ un astrocytome de haut Grade en récidive, administré quotidiennement pendant 5 jours tous les 28 jours.
0.4176844358444214 ||| 6000 IU/ 0.6 ml ||| 30000 IU/0.75 ml ||| 6 000 UI /
0.8632676601409912 ||| your doctor. ||| Tell your doctor ||| médecin.
0.4266146123409271 ||| For continuous protection, re-vaccination is recommended after 2 years. ||| Seroprotection is generally obtained within 2 to 3 weeks. ||| Pour obtenir une protection continue, une revaccination est recommandée après 2 ans.
0.005957859568297863 ||| Gastrointestinal: colitis including cytomegalovirus colitis, (≥ 1/ 100 to < 1/ 10), pancreatitis (≥ 1/ 100 to < 1/ 10) and intestinal villous atrophy. ||| Gastrointestinal: colitis including cytomegalovirus colitis, (≥ 1/ 100 to < 1/ 10), pancreatitis, (≥ 1/ 100 to < 1/ 10) and intestinal villous atrophy. ||| Appareil digestif: colite y compris colite à cytomégalovirus (≥ 1/ 100 à < 1/ 10), pancréatite (≥ 1/ 100 à < 1/ 10) et cas isolés d'atrophie villositaire intestinale.
0.42251476645469666 ||| anthracycline-containing chemotherapy. ||| Coumarin-derivative anticoagulation. ||| d'anthracycline.
0.32833874225616455 ||| It is used in combination with dexamethasone (an anti-inflammatory medicine) to treat adult patients with multiple myeloma whose disease has been treated at least once in the past. ||| His brother-in-law suggested that he take ciprofloxacin, a fluoroquinolone antibiotic which is one of the most frequently used antibiotics for urinary tract infections. ||| Il est indiqué, en association avec la dexaméthasone (anti-inflammatoire), pour le traitement du myélome multiple chez les patients adultes ayant déjà reçu au moins un traitement antérieur.
0.1949971318244934 ||| How does Neulasta work? ||| How does Xarelto work? ||| Comment Neulasta agit -il?
0.2114119976758957 ||| * In haemodialysis patients or in case of acute renal failure (creatinine clearance below 15 ml/ min or creatinine value above 60 mg/ l [530 μ mol/ l]), infusion of Refludan is to be avoided or stopped. ||| However, in patients with liver iron concentration < 7 mg Fe/ g dw treated with EXJADE (5 and 10 mg/ kg) or deferoxamine (20 to 35 mg/ kg), non-inferiority was not established due to imbalance in the dosing of the two chelators. ||| • Chez les patients hémodialysés ou en cas d'insuffisance rénale aiguë (clairance de la créatinine inférieure à 15 ml/ min ou créatininémie supérieure à 60 mg/ l [530 µmol/ l]), il est nécessaire d'éviter ou d'arrêter la perfusion de Refludan.
0.5748392343521118 ||| As of 3 April, there have been no cases in the British territory. ||| As of 6 April 2020, the details had not yet been released. ||| Au 17 mars, aucun cas n'avait été signalé sur le territoire américain.
0.3334216773509979 ||| 7 tablets ||| 3 tablets ||| 7 comprimés
0.2516214847564697 ||| 44 Xolair may indirectly reduce the efficacy of medicinal products for the treatment of helminthic or other parasitic infections (see section 4.4). ||| The recommended anti-infective prophylaxis treatment appears to be effective in reducing the risk of PCP and herpes infections (see section 4.4). ||| Xolair peut réduire indirectement l’ efficacité des médicaments utilisés dans le traitement des infestations helminthiques ou d’ autres infestations parasitaires (voir rubrique 4.4).
0.0 ||| A single subcutaneous injection. ||| A single subcutaneous injection. ||| Injection unique par voie sous-cutanée.
0.0709696114063263 ||| 5 mL twice daily (one 5-mL measuring spoonful twice daily) ||| 10 mL twice daily (two 5-mL measuring spoonfuls twice daily) ||| 5 ml 2 fois/jour (1 cuillère-mesure de 5 ml 2 fois/jour)
0.13646796345710754 ||| Ophthalmologic preparations ||| Ophthalmological instruments ||| Préparations ophtalmiques
0.3464032709598541 ||| Remove any air in the infusion set tubing by drawing back on the syringe. ||| Turn the bottle upside down while holding the oral syringe in place. ||| Retirez tout l’air éventuellement présent dans la tubulure du nécessaire à perfusion en tirant sur le piston de la seringue.
0.4392244815826416 ||| Since doxazosin is strongly bound to proteins dialysis is not indicated. ||| Unchanged etravirine in faeces is likely to be unabsorbed drug. ||| La doxazosine se liant fortement aux protéines, la dialyse n’ est pas indiquée.
0.0157031062990427 ||| 50 IU/kg 3 times per week by the intravenous route. ||| 50 IU/ kg 3 times per week by the intravenous route. ||| 50 UI/ kg 3 fois par semaine, par voie intraveineuse.
0.2051185667514801 ||| The second study showed that Xyrem continued to prevent cataplexy attacks after long-term treatment: there was no change over 2 weeks in the number of attacks in the patients continuing to take Xyrem, compared to an increase of 21.0 in those switching to placebo. ||| The proportion of patients who discontinued treatment due to adverse events was the same in both the Enbrel and placebo treatment groups; in the first active-controlled trial, the dropout rate was significantly higher for methotrexate (10%) than for Enbrel (5%). ||| La seconde étude a montré que Xyrem continuait à empêcher l’ apparition d’ attaques de cataplexie après un traitement au long cours: aucun changement sur 2 semaines dans le nombre d’ attaques n’ a été observé chez les patients poursuivant leur traitement par Xyrem, tandis qu’ on a observé une augmentation de 21,0 chez les patients dont le traitement a été substitué par un placebo.
0.6054409742355347 ||| Corporate funds management ||| Personal equity plan management ||| Gestion de fonds de sociétés
0.2210412323474884 ||| 22 March 2005 ||| 3 February 2005 ||| 22 mars 2005
0.3740132451057434 ||| Skin and subcutaneous tissue disorders Very common: sweating, pruritus. ||| Disorders of kidney, urinary system and genitals very common: common: ||| Affections de la peau et du tissu sous-cutané Très fréquent: sueurs, prurit.
6.952236095841835e-13 ||| See also section 4.4. ||| See also section 4.4. ||| Voir également paragraphe 4.4.
0.2775178551673889 ||| Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated. ||| Mimpara is used in adults and elderly patients: • to treat secondary hyperparathyroidism, a condition in which the parathyroid glands in the neck produce too much parathyroid hormone (PTH). ‘ Secondary ’ means that the hyperparathyroidism is caused by another condition. ||| Traitement de l’ hypercalcémie chez les patients présentant: • un cancer de la parathyroïde • une hyperparathyroïdie primaire, chez qui la parathyroïdectomie serait indiquée sur la base des taux de calcium sérique (définis par les recommandations thérapeutiques en vigueur) mais chez qui la parathyroïdectomie est contre-indiquée ou n’ est pas cliniquement appropriée
0.6023429036140442 ||| Advertisement boards of card ||| Compilation of mailing lists ||| Panneaux de publicité en carton
0.2765163779258728 ||| Broadcasting of motion pictures by satellite ||| Broadcasting of motion picture films via the Internet ||| Diffusion de films cinématographiques par satellite
0.23706045746803284 ||| ► If you wish to become pregnant, discuss this with your doctor first. ||| If you are concerned about having children, you should discuss this with your doctor before treatment. ||| Si vous envisagez une grossesse, parlez-en d’abord à votre médecin.
0.14243736863136292 ||| No dosage adjustment for needed for either product ||| No dosage adjustment needed for either product ||| Aucun ajustement posologique nécessaire pour
0.0049048857763409615 ||| 73 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 72 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ||| 81 MENTIONS MINIMALES DEVANT FIGURER SUR LES PLAQUETTES THERMOFORMEES OU LES FILMS THERMOSOUDES
0.6136431694030762 ||| 98.8% ||| +8.8% ||| 98,8%
0.29070228338241577 ||| Patients should be informed of the most frequent adverse reactions associated with interferon beta administration, including symptoms of the flu-like syndrome (see section 4.8). ||| Patients taking medicinal products known to affect blood pressure or cardiac function should be closely monitored during treatment with clofarabine (see sections 4.4 and 4.8). ||| Les patients doivent être informés des effets indésirables les plus fréquents associés à l’ administration d’ interféron bêta, y compris un syndrome pseudo-grippal (voir rubrique 4.8).
0.09814450889825821 ||| Keep the container tightly closed. ||| Keep the bottle tightly closed. ||| Bien fermer le flacon.
6.201308997560995e-13 ||| 60 A. ||| 60 A. ||| 65 A.
0.8767966032028198 ||| P > 0.05‡ ||| < 2000 /mm3 ||| p > 0,05‡
0.34465470910072327 ||| High-density polyethylene bottles with rubber stopper and aluminium cap ||| Translucent twin-wall sheets made of polycarbonates ||| Flacon polyéthylène haute densité avec bouchon caoutchouc et capsule aluminium
0.34932374954223633 ||| Take an infusion bag of adequate size of sterile sodium chloride 9 mg/ ml (0.9%) solution. ||| A box with two (2) polyolefin infusion bags (125 ml), each within an overwrap. ||| Prendre une poche à perfusion de solution stérile de chlorure de sodium 9 mg/ ml (0,9%) de taille appropriée.
0.46775299310684204 ||| The reorientation process ensures that funds will be drawn from programmes that cannot be implemented as planned due to the pandemic. ||| Furthermore, under the scheme, investment projects will be completed within six months after the date of granting the aid. ||| Le processus de réorientation garantit que les fonds proviendront de programmes qui ne peuvent pas être mis en œuvre comme prévu en raison de la pandémie.
0.37332141399383545 ||| Immunogenicity: ||| 52 Immunogenicity ||| Immunogénicité:
0.3727688491344452 ||| EVISTA should not be used in patients with severe renal impairment (see section 4.3). ||| In the event of these patients developing renal insufficiency, see above Renal function. ||| EVISTA ne doit pas être utilisé chez les patients ayant une insuffisance rénale sévère (voir rubrique 4.3).
2.6153206119858274e-13 ||| When followed by a 2.0 microgram/ kg/ min continuous infusion, this regimen produces a > 80% inhibition of ADP-induced ex vivo platelet aggregation, at physiologic calcium concentrations, in more than 80% of patients. ||| When followed by a 2.0 microgram/ kg/ min continuous infusion, this regimen produces a > 80% inhibition of ADP-induced ex vivo platelet aggregation, at physiologic calcium concentrations, in more than 80% of patients. ||| 10 entraîne chez plus de 80% des patients une inhibition > 80% de l’ agrégation plaquettaire ex vivo induite par l’ ADP, pour des concentrations physiologiques en calcium.
0.49932557344436646 ||| Alarm systems for trucks ||| Cleaning agents for the hands ||| Systèmes d'alarme pour camions
0.0 ||| 4. ||| 4. ||| 331 4.
0.27112239599227905 ||| Each pack provides 1 vial containing 3.5 ml or 5 ml solution for injection. ||| Two vials, each containing 2.5 g of powder for solution for infusion. ||| Chaque boîte comprend 1 flacon contenant 3,5 ml ou 5 ml de solution injectable.
0.29459473490715027 ||| INTANZA is a suspension for injection in a pre-filled syringe of 0.1 ml with a Micro-Injection System in packs of 1, 10 or 20. ||| 14 The Micro-Injection System for intradermal injection consists of a pre-filled syringe with a micro- needle (1.5 mm) and a needle shielding system. ||| INTANZA est une suspension injectable en seringue préremplie de 0,1 ml avec un Système de Micro- Injection en boîte de 1, 10 ou 20.
0.23722779750823975 ||| Caution must also be exercised and reduced doses should be considered if ritonavir is used concurrently with atorvastatin, which is metabolised to a lesser extent by CYP3A. ||| Caution is advised when bisphosphonates are administered with aminoglycosides, since both agents may have an additive effect, resulting in a lower serum calcium level for longer periods than required. ||| Lorsque Norvir est administré avec l’ atorvastatine, qui est métabolisée à un degré moindre par le CYP3A, la prudence est également recommandée et des réductions posologiques doivent être envisagées.
0.31146296858787537 ||| 23 reduced the incidence of acute otitis media from 26.5% (53/ 200) in the placebo group to 16% (29/ 183) in the oseltamivir treated children (p = 0.013). ||| In patients with baseline haemoglobin ≤ 10 g/ dl (n=899), the hazard ratio point estimate for survival was 0.98 (95% CI 0.68 to 1.40). ||| L'oseltamivir a réduit l'incidence d'otite moyenne aiguë de 26,5% (53/ 200) dans le groupe placebo à 16% (29/ 183) dans le groupe des enfants traités par l'oseltamivir (p = 0,013).
0.28167662024497986 ||| If any of these applies to you, tell your doctor before you take Sebivo. ||| If any of them apply to you, talk to your doctor before you take the medicine: ||| Si une de ces situations s’ applique à vous, informez -en votre médecin avant de prendre Sebivo.
0.2750979959964752 ||| Rats treated with near-life time daily injections had dose-dependent exaggerated bone formation and increased incidence of osteosarcoma most probably due to an epigenetic mechanism. ||| Peripheral blood lymphocytes further showed no significant decrease in number or in proliferative responses to in vitro mitogenic stimulation when compared with untreated patients’ cells. ||| Des rats traités pendant presque toute leur durée de vie par des injections quotidiennes ont présenté une augmentation excessive dose-dépendante de la formation osseuse et une augmentation de l’ incidence des cas d'ostéosarcome, dû vraisemblablement à un mécanisme épigénétique.
4.978082833104192e-13 ||| DATE OF REVISION OF THE TEXT ||| DATE OF REVISION OF THE TEXT ||| DATE DE MISE A JOUR DU TEXTE 10.
0.6850763559341431 ||| Sheets of reclaimed cellulose for wrapping ||| 5 Platelets, bleeding and clotting ||| Feuilles de cellulose régénérée pour l'emballage
0.014995865523815155 ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available and this summary will be updated as necessary. ||| Every year, the European Medicines Agency (EMEA) will review any new information that may become available, and this summary will be updated as necessary. ||| Chaque année, l’ Agence européenne des médicaments (EMEA) examinera toute information nouvelle éventuellement disponible et, le cas échéant, procédera à la mise à jour du présent résumé.
0.21383804082870483 ||| If use cannot be avoided, these animals require careful monitoring and fluid therapy. ||| If use cannot be avoided, these cats require careful monitoring. ||| L’ utilisation dans de telles conditions, si elle ne peut être évitée, nécessite une surveillance étroite et une fluidothérapie.
0.07958661019802094 ||| Training services relating to the therapy of primary cause analysis by hypnosis ||| Training services relating to the science of primary cause analysis by hypnosis ||| Services de formation en matière de thérapie de l'analyse des causes premières par hypnose
0.035325050354003906 ||| Treatment with Binocrit must be started under the supervision of a doctor who has experience in the management of patients with the conditions that the medicine is used for. ||| Treatment with Abseamed must be started under the supervision of a doctor who has experience in the management of patients with the conditions that the medicine is used for. ||| Le traitement par Binocrit doit être démarré sous la surveillance d’ un médecin ayant l’ expérience de la prise en charge de patients dans le cadre des indications ci-dessus.
0.3968781530857086 ||| Pipetting instruments for surgical use ||| Angostura bark for medical purposes ||| Instruments de pipetage à usage chirurgical
0.19734083116054535 ||| Metal panels for walls ||| Aluminium supports for panels ||| Panneaux muraux en métal
0.03833211958408356 ||| 594 Travel ||| 484 Travel ||| 636 Voyages
0.11038877815008163 ||| 72/ 94 PACKAGE LEAFLET: ||| 34/ 44 PACKAGE LEAFLET: ||| 67/ 89 NOTICE:
0.05685851350426674 ||| What benefit has Lysodren shown during the studies? ||| What benefit has Cetrotide shown during the studies? ||| Quel est le bénéfice démontré par Lysodren au cours des études?
0.08554187417030334 ||| 28 film-coated tablets 84 film-coated tablets ||| 30 film-coated tablets 100 film-coated tablets ||| 84 comprimés pelliculés.
0.16206227242946625 ||| This leaflet was last approved in Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/. ||| This leaflet was last approved in Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http: / /www. emea. europa. eu/ __________________________________________________________________________________ ||| Des informations détaillées sur ce médicament sont disponibles sur le site internet de l’Agence européenne du médicament (EMEA): http://www.emea.europa.eu/.. --------------------------------------------------------------------------------------------------------------------------- ---
0.5017300248146057 ||| The treatment will be discontinued when white cells in your blood reach a certain number. ||| They are usually mild or moderate and only affect the area of skin the patch has been on. ||| Le traitement sera arrêté lorsque les globules blancs de votre sang auront atteint un certain nombre.
0.0266883447766304 ||| Do not use Insulin Human Winthrop Comb 50 after the expiry date which is stated on the carton and on the label of the vial. ||| Do not use Insulin Human Winthrop Comb 25 after the expiry date which is stated on the carton and on the label of the cartridge. ||| Ne pas utiliser Insulin Human Winthrop Comb 50 après la date de péremption mentionnée sur la boîte et l'étiquette du flacon.
0.36007916927337646 ||| The mean concentration of toremifene at steady- state is 0.9 (range 0.6 - 1.3) µg/ ml at the recommended dose of 60 mg per day. ||| 16/ 21 b. w. / day this dose corresponds to 250 mg of doxycycline per kg of feed which gives a rate of incorporation of 2.5 kg/ Ton.. ||| La concentration moyenne en torémifène à l'état d'équilibre est de 0,9 µg/ ml (0,6 à 1,3 µg/ ml) après administration de la dose de 60 mg / jour.
0.0 ||| MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE ||| FABRICANTS DE LA SUBSTANCE ACTIVE D’ORIGINE BIOLOGIQUE ET TITULAIRE DE L’AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBÉRATION DES LOTS
0.0 ||| Common Common Common ||| Common Common Common ||| Fréquent Fréquent Fréquent Très fréquent
0.05060809850692749 ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Ovitrelle to Serono Europe Limited on 2 February 2001. ||| The European Commission granted a marketing authorisation valid throughout the European Union, for Cetrotide to Serono Europe Limited on 13 April 1999. ||| La Commission européenne a délivré une autorisation de mise sur le marché valable dans toute l’ Union européenne à Serono Europe Limited pour Ovitrelle, le 2 février 2001.
0.3340725302696228 ||| An intravenous dose of up to 0.4mg/ kg/ day for 14 days to female rats produced no effects on fertility. ||| Nicotinic acid induced reproduction toxic effects in rats when dosed at 1000 mg/ kg/ day during days 5-16 of gestation. ||| Des doses par voie intraveineuse allant jusqu’ à 0,4mg/ kg/ jour pendant 14 jours chez des rats femelles n’ ont pas eu d’ effet sur la fertilité.
7.428239880841181e-13 ||| 0.3 ml (3333 IU/ ml) ||| 0.3 ml (3333 IU/ ml) ||| 0,3 ml (3333 UI/ ml)
0.46674031019210815 ||| 110.7). ||| 1.0%). ||| 110,7).
0.3970741033554077 ||| At clinical doses no effects on the suckling child are anticipated. ||| No effects on the suckling child are anticipated. ||| Aux doses utilisées en pratique clinique, aucun effet sur l’enfant allaité n’est attendu.
0.04701308161020279 ||| The studies measured the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled. ||| The studies measured the level of fasting blood sugar or a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled. ||| Ces études ont mesuré le taux sanguin d’ une substance spécifique appelée hémoglobine glycosylée (HbA1c), qui fournit une indication du niveau de la régulation glycémique.
0.35912024974823 ||| In addition, rosiglitazone inhibited ovarian oestradiol and progesterone synthesis and lowered plasma levels of these hormones resulting in effects on oestrus/ menstrual cycles and fertility (see section 4.4). ||| COX-2 is also involved in ovulation, implantation and closure of the ductus arteriosus, regulation of renal function, and central nervous system functions (fever induction, pain perception and cognitive function). ||| Ceci entraîne des effets sur les cycles menstruels et la fertilité (voir rubrique 4.4).
0.3416908383369446 ||| 68 Treatment of duodenal or stomach ulcer in patients requiring continued NSAID treatment: one 30 mg oro-dispersible tablet every day for 4 weeks. ||| Daily oral treatment with ibandronic acid 2.5 mg tablets resulted in progressive increases in BMD at vertebral and nonvertebral sites of the skeleton. ||| Traitement des ulcères duodénal ou gastrique chez les patients nécessitant un traitement par AINS en continu: une gélule de 30 mg tous les jours pendant 4 semaines.
0.517241895198822 ||| - if you develop symptoms associated with a cold or other respiratory infection (such as cough, ||| - if you have ever had depression or develop symptoms associated with depression(e. g. feelings ||| - si vous développez des signes comme ceux d’un rhume ou d’une autre affection respiratoire,
0.02651086635887623 ||| Humalog Pen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin. ||| Liprolog Pen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin. ||| Après administration sous-cutanée, Humalog Pen agit rapidement et possède une durée d'action (2 à 5 heures) plus courte que l'insuline rapide.
0.018631605431437492 ||| STOCRIN 50 mg film-coated tablets efavirenz ||| STOCRIN 600 mg film-coated tablets efavirenz ||| STOCRIN 50 mg, comprimés pelliculés éfavirenz
0.13322177529335022 ||| Absorption Following oral administration of a 100-mg dose to healthy subjects, sitagliptin was rapidly absorbed, with peak plasma concentrations (median Tmax) occurring 1 to 4 hours post-dose, mean plasma AUC of sitagliptin was 8.52 μ M• hr, Cmax was 950 nM. ||| 26 Absorption Following oral administration of a 600 mg single dose of telbivudine to healthy subjects (n = 42), the peak plasma concentration (Cmax) of telbivudine was 3.2 ± 1.1 μ g/ ml (mean ± SD) and occurred at median 3.0 hours post dose. ||| Absorption Après administration orale de 100 mg chez des sujets sains, la sitagliptine est rapidement absorbée avec un pic de concentrations plasmatiques (Tmax médian) atteint entre 1 et 4 heures après la dose, l’ ASC plasmatique moyenne de la sitagliptine étant de 8,52 µM x h, la Cmax de 950 nM.
0.38987547159194946 ||| [85.7; 99.6] ||| [91.2, 96.6]† ||| [85,7; 99,6]
0.6487323045730591 ||| Rhenium ||| Xenon ||| Rhénium
0.3342917561531067 ||| The intake of food reduces the bioavailability of lansoprazole: it is recommended to take lansoprazole before the meal. ||| When initiating voriconazole in patients already receiving omeprazole, it is recommended that the omeprazole dose be halved. ||| La prise concomitante de nourriture diminue la biodisponibilité du lansoprazole: il est donc recommandé de prendre le médicament avant les repas.
0.45804136991500854 ||| Median time to recovery from severe neutropenia was estimated as 22 days in both treatment groups. ||| Patients taking either of two doses of Zerit also had similar survival rates over 22 weeks. ||| 14 médian de récupération d’ une neutropénie sévère a été estimé à 22 jours dans les deux groupes traités.
9.538506052717e-13 ||| In addition, an updated RMP should be submitted ||| In addition, an updated RMP should be submitted ||| De plus, un PGR actualisé doit être soumis
0.24468295276165009 ||| Clinical studies ||| Clinical experience ||| Études cliniques
0.700660228729248 ||| 604 Special care before injection |||  Application by dripping ||| Précautions particulières avant l’injection
1.176511287689209 ||| Ireland na ||| Dublin Ireland ||| Ir eland
0.4708344340324402 ||| Myocardial infarction (see section 4.4), Tachycardia, Palpitations, ||| Iritis, uveitis, hypotony of the eye (see Section 4.4) ||| Infarctus du myocarde (voir rubrique 4.4), tachycardie, palpitations
3.5499305318237306e-13 ||| Overall experience with IVF indicates that in general the treatment success rate remains stable during the first four attempts and gradually declines thereafter. ||| Overall experience with IVF indicates that in general the treatment success rate remains stable during the first four attempts and gradually declines thereafter. ||| L'expérience pratique en FIV a montré que le taux de succès du traitement reste le même pendant les quatre premières tentatives et diminue progressivement par la suite.
0.400726318359375 ||| The CVMP recommended the refusal of the granting of the Marketing Authorisation and the suspension of the Marketing Authorisation for Equimectin where appropriate. ||| The CHMP agreed on the following proposal for conditions of the renewal of the Marketing Authorisation previously presented by the RMS: ||| Le CVMP a recommandé de refuser l’ octroi de l’ autorisation de mise sur le marché ainsi que de suspendre l’ autorisation de mise sur le marché pour Équimectine, si nécessaire.
0.2898979187011719 ||| Based on a pharmacokinetic study, the dose of valsartan should not exceed 80 mg in these patients and should be used with caution. ||| 2 Based on limited data in patients with liver metastases, it is recommended that the initial dose of Myocet is reduced in accordance with the following table ||| D’ après une étude de pharmacocinétique, la dose de valsartan ne doit pas dépasser 80 mg chez ces patients et doit être administrée avec précaution.
0.14581146836280823 ||| Organisation of dancing competitions ||| Organisation of dancing displays ||| Organisation de concours de danse
0.027082674205303192 ||| It is essential you read the information on this reaction under “ Take special care with Kivexa” in section 2 of this leaflet. ||| It is essential you read the information on this reaction under “ Take special care with Ziagen” in section 2 of this leaflet. ||| Il est essentiel que vous lisiez les informations sur cette réaction figurant à la section "Faites attention avec Kivexa" de la rubrique 2 de cette notice.
0.04525816813111305 ||| PegIntron is recommended for use in fertile women only when they are using effective contraception during the treatment. ||| ViraferonPeg is recommended for use in fertile women only when they are using effective contraception during the treatment. ||| L’ utilisation de PegIntron chez des femmes en âge de procréer est recommandée seulement si elles utilisent une contraception efficace pendant le traitement.
0.47580182552337646 ||| You should swallow the tablets with a glass of water. ||| If you wish you may take a glass of water with it. ||| Vous devez avaler votre comprimé avec un verre d'eau.
0.0 ||| This leaflet was last approved in ||| This leaflet was last approved in ||| La date à laquelle cette notice a été approuvée est
0.3172590136528015 ||| Remote transmission of audio signals by means of telecommunications ||| Electronic communication services for transmission by means of cables ||| Transmission de signaux audio à distance par le biais de télécommunications
0.6673950552940369 ||| MM/ YYYY ||| MM/ JJJJ ||| MM/AAAA
0.4481096863746643 ||| These side effects occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. ||| This is because in rare instances such reactions have been reported to develop into severe cases, even with the possibility of death. ||| Ils sont dans la plupart des cas transitoires et disparaissent à la suite de l'arrêt du traitement, mais ils peuvent être sévères ou fatals dans de très rares cas.
0.019626202061772346 ||| In cancer patients receiving chemotherapy, the 2-3 week delay between erythropoietin administration and the appearance of erythropoietin-induced red cells should be taken into account when assessing if Retacrit therapy is appropriate (patient at risk of being transfused). ||| In cancer patients receiving chemotherapy, the 2-3 week delay between erythropoietin administration and the appearance of erythropoietin-induced red cells should be taken into account when assessing if Silapo therapy is appropriate (patient at risk of being transfused). ||| Chez les patients recevant une chimiothérapie, le délai de 2-3 semaines entre l’ administration d’ érythropoïétine et l’ apparition de globules rouges induits par l'érythropoïétine doit être pris en compte lors de l'évaluation de l’ adéquation du traitement par Retacrit (patient à risque d’ être transfusé).
0.43622076511383057 ||| Because of the length of the withdrawal period, in some countries broilers are treated rarely. ||| India has suspended all tourist visas, as a majority of the confirmed cases were linked to other countries. ||| Du fait de la durée du temps d’ attente, les poulets de chair sont rarement traités dans certains pays.
0.07126909494400024 ||| Patients with hepatic insufficiency Velmetia should not be used in patients with hepatic impairment (see sections 4.3 and 5.2). ||| Patients with hepatic impairment Glubrava should not be used in patients with hepatic impairment (see sections 4.3 and 4.4). ||| Patients insuffisants hépatiques Velmetia ne doit pas être utilisé chez les patients présentant une insuffisance hépatique (voir rubriques 4.3 et 5.2).
0.5322698950767517 ||| - Ventricular extrasystoles ||| -Radiographic vertebral fractures ||| - Extrasystoles ventriculaires
1.0676305759599325e-12 ||| Risk Management Plan ||| Risk Management Plan ||| Plan de gestion du risque
0.2862916886806488 ||| Shelf-life after first opening the immediate packaging: ||| Shelf life after first opening the container: ||| 2 ans Durée de conservation après première ouverture du conditionnement primaire:
0.5412638783454895 ||| Post-authorisation activities continue at a reasonable pace in accordance with the increase in number of centrally approved ||| ⋅ to maximise the proactive dialogue with applicants in the pre -evaluation phase to ensure full efficiency of the centralised procedures - once initiated ||| Les activités après autorisation se poursuivent à un rythme raisonnable, parallèlement à
0.3852652609348297 ||| 15 OTHER INFORMATION ||| OTHER INFORMATION ||| INFORMATIONS SUPPLÉMENTAIRES
0.29282522201538086 ||| 20 March 2006 ||| 06 March 2008 ||| 20 mars 2006.
0.3934670686721802 ||| From day 8 to day 14, you should take one light blue CHAMPIX 1 mg film-coated tablet twice daily, once in the morning and once in the evening, at about the same time each day. ||| EXJADE must be taken once daily on an empty stomach at least 30 minutes before food, preferably at the same time each day (see sections 4.5 and 5.2). ||| Du Jour 8 au Jour 14, vous devrez prendre un comprimé pelliculé bleu clair de CHAMPIX 1 mg deux fois par jour, une fois le matin et une fois le soir, à peu près à la même heure chaque jour.
0.3586086630821228 ||| Co-administration of ISENTRESS with medicinal products that are known to be potent UGT1A1 inhibitors (e. g., atazanavir) may increase plasma levels of raltegravir. ||| 3 Caution should be used when co-administering ISENTRESS with strong inducers of uridine diphosphate glucuronosyltransferase (UGT) 1A1 (e. g., rifampicin). ||| La co-administration d'ISENTRESS avec des médicaments connus pour être des inhibiteurs puissants de l'UGT1A1 (tels que l'atazanavir) peut augmenter les concentrations plasmatiques du raltégravir.
0.4526829719543457 ||| 34.8 15.2 ||| 44.7 11.3 ||| 34,8
0.5458619594573975 ||| Dermatological pharmaceutical substances ||| Effervescent analgesic pharmaceutical preparations ||| Substances pharmaceutiques dermatologiques
0.51446533203125 ||| The dose is 1 MU/ kg bodyweight. ||| You should use 16400 IU* per kg bodyweight. ||| La dose est de 1 MU/ kg de poids vif.
0.30523401498794556 ||| Nausea with or without vomiting is noted in approximately 10% of patients treated with calcitonin. ||| Irritation at or around the injection site has been reported occasionally in patients treated with salmon calcitonin. ||| Troubles gastro-intestinaux Très fréquent: des nausées, avec ou sans vomissements, sont observées chez environ 10% des patients traités par la calcitonine.
0.43392840027809143 ||| - metformin, in patients (particularly overweight patients) with insufficient glycaemic ||| - in patients with hypo- or agammaglobulinaemia with or without IgA deficiency, ||| - la metformine, chez les patients en particulier en surpoids, lorsqu’ une dose maximale tolérée
0.08165176212787628 ||| Be aware that the desired effect is not achieved if you stop taking Prandin. ||| Be aware that the desired effect is not achieved if you stop taking NovoNorm. ||| Si vous arrêtez de prendre Prandin, vous n’ obtiendrez pas l’ effet attendu du médicament.
0.0 ||| Premedication with antihistamines and/ or glucocorticoids may be considered.  Patients taking beta-blockers It should be noted that patients using beta-blockers do not necessarily respond to the beta-agonists usually used for the treatment of hypersensitivity reactions.  Patients with cardiovascular disease In this group of patients hypersensitivity reactions may be severe. ||| Premedication with antihistamines and/ or glucocorticoids may be considered.  Patients taking beta-blockers It should be noted that patients using beta-blockers do not necessarily respond to the beta-agonists usually used for the treatment of hypersensitivity reactions.  Patients with cardiovascular disease In this group of patients hypersensitivity reactions may be severe. ||| 3  Patients sous bêtabloquants Il est à noter que les patients sous bêtabloquants peuvent ne pas répondre aux bêta-agonistes habituellement utilisés pour le traitement des réactions d’ hypersensibilité.  Patients atteints de maladies cardiovasculaires Chez ces patients, les réactions d'hypersensibilité peuvent être sévères.
0.24674192070960999 ||| There have been reports of prolonged visual adverse events, including blurred vision, optic neuritis and papilloedema (see Section 4.8). ||| Spontaneous cases of serious liver injuries, increased liver enzymes, hyperbilirubinaemia have been reported during the post marketing phase (see section 4.4). ||| Des cas d’ événements indésirables visuels prolongés ont été rapportés, incluant une vision trouble, une névrite optique et un œ dème papillaire (voir rubrique 4.8).
0.14575336873531342 ||| Impact drills [machines or parts of machines] ||| Crimping tools [machines or parts of machines] ||| Perceuses à percussion [machines ou parties de machines]
0.41477566957473755 ||| The final opinion was converted into a Decision by the European Commission on 3 April 2006. ||| The proposed transaction was notified to the Commission on 15 April 2020. ||| L’ avis définitif est devenu décision de la Commission européenne en date du le 3 avril 20.
0.03188922256231308 ||| DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION du ||| DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION Me ||| DATE DE PREMIÈRE AUTORISATION/ DE RENOUVELLEMENT DE L’ AUTORISATION
0.6073164939880371 ||| Distribution: efavirenz is highly bound (> 99%) to human plasma proteins, predominantly albumin. ||| Stiripentol binds extensively to circulating plasma proteins (about 99%). ||| L’ éfavirenz est fortement lié aux protéines plasmatiques humaines (> 99%), principalement à l’ albumine.
0.4376208782196045 ||| Cases of acute renal failure have been reported in patients receiving IVIg therapy. ||| There are limited data on salvage therapy on patients who have failed therapy with Kaletra. ||| Des cas d’insuffisances rénales aiguës ont été rapportés chez des patients suivant une thérapie à base d’IgIV.
0.21672323346138 ||| Gently push the plunger until the air is injected into the vial. ||| Slowly pull the plunger until all the liquid is in the syringe. ||| Pousser délicatement le piston jusqu’à ce que de l’air soit injecté dans le flacon.
0.43394753336906433 ||| From 1978 to 1983 Dr Papaluca worked in the Third Internal Medicine Department of the University of Rome on research projects in the area of clinical immunology and cellular immunology. ||| In 1992, he became Professor of Clinical Pharmacology and Therapeutics and Director of the Masters/ Diploma course on European Registration of Medicinal Products (UAB). ||| De 1978 à 1983, le Dr Papaluca a travaillé au troisième département de médecine interne de l’université de Rome, en tant que responsable des projets de recherche dans le domaine de l’immunologie clinique et cellulaire.
0.455291211605072 ||| Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| - if you are taking other medicines, including those you can obtain without a prescription. ||| Informez votre médecin si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance.
0.1556055247783661 ||| How is Combivir used? ||| How is Puregon used? ||| Comment Combivir est -il utilisé?
0.42839306592941284 ||| OPTISON should only be administered by doctors experienced in the field of diagnostic ultrasound imaging. ||| Currently, virology samples for influenza surveillance are accompanied by a standard request form. ||| OPTISON ne devra être administré que par des médecins expérimentés dans les techniques d’ imagerie échographique.
0.364838182926178 ||| Defrosters for vehicles ||| Thrusters for vehicles ||| Dégivreurs pour véhicules
0.46712297201156616 ||| Tritace has been authorised in the EU since 1989, first in France and then in the following countries: ||| Dopharma also described the history of the product since 1987, the year of its first authorisation in the Netherlands. ||| Tritace a été autorisé dans l’ UE en 1989, d’ abord en France, puis dans les pays suivants:
0.38979947566986084 ||| Insulatard may be used alone or mixed with fast-acting insulin. ||| Injections of fast-acting insulin were also used at mealtimes. ||| Insulatard peut être utilisé seul ou mélangé avec une insuline d’ action rapide.
0.11636044085025787 ||| Design and creation of homepages and Internet pages ||| Design and construction of homepages and websites ||| Conception et création de pages d'accueil et de pages Internet
5.017631817851032e-13 ||| ACR 20 ||| ACR 20 ||| ACR 20 dic
0.11690537631511688 ||| OPTISON should only be administered by doctors experienced in the field of diagnostic ultrasound imaging. ||| Gadovist should only be administered by physicians experienced in the field of clinical MRI practice. ||| OPTISON ne devra être administré que par des médecins expérimentés dans les techniques d’ imagerie échographique.
0.7322081327438354 ||| 2000 IU/ 1.0 ml ||| IV/ SC 0.4 ml ||| 2 000 UI / 1,0 ml
0.22464610636234283 ||| Liquid paraffin: ||| Liquid paraffin. ||| Paraffine liquide:
0.011659376323223114 ||| 284 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 268 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 305 MENTIONS DEVANT FIGURER SUR L’EMBALLAGE EXTÉRIEUR
0.8933703899383545 ||| N=157 41%* 48%* ||| 40%*** 17% 20%*** 48%*** 18% NAd ||| N = 157 41%* 48%*
0.3049350380897522 ||| In postmarketing, serious allergic reactions including anaphylaxis have been reported very rarely following Humira administration. ||| Zidovudine resistance emerged as more frequent after 30-60 weeks, especially in patients receiving double combination therapy. ||| Au cours de la surveillance post-marketing des réactions allergiques graves, incluant des réactions anaphylactiques ont été très rarement rapportées, après administration d'Humira.
0.04293840378522873 ||| 12 Not all pack sizes may be marketed. ||| 33 Not all pack sizes may be marketed. ||| Certaines tailles de conditionnement peuvent ne pas être commercialisées
0.7950695157051086 ||| Fosamprenavir is converted in man to amprenavir. ||| For men taking Thalidomide Celgene Thalidomide passes into semen. ||| Chez l’ homme, le fosamprénavir est métabolisé en amprénavir.
0.31140273809432983 ||| Caution should be used when initiating treatment with lumiracoxib in patients with dehydration. ||| Caution should be exercised when treating patients with myasthenia gravis. ||| Des précautions devront être prises lors de l’ initiation du traitement par le lumiracoxib chez des patients présentant une déshydratation.
0.16945528984069824 ||| Don’t put in any more drops until it’s time for your next regular dose. ||| Do not put in any more drops until it is time for your next regular dose. ||| Ne mettez pas d’ autres gouttes jusqu’ à ce que le moment soit venu de prendre la goutte suivante.
0.5325915813446045 ||| - Lactose, anhydrous ||| - Theophylline, caffeine ||| - Lactose, anhydre
0.9899914860725403 ||| HAQ = Health Assessment Questionnaire; greater values indicate less disability. ||| or Global Evaluation § lower values = greater improvement ||| HAQ = Health Assessment Questionnaire; plus les valeurs sont élevées moins l’ invalidité est importante.
0.6428105235099792 ||| Of the 62 new cases, 58 were in Abidjan and 4 in Adiaké. ||| 24 of the 27 suspected cases in Khyber Pakhtunkwa were also cleared that day. ||| Sur les 62 nouveaux cas, 58 étaient à Abidjan et quatre à Adiaké.
0.16785094141960144 ||| Chemical products for the manufacture of binders ||| Chemical products for the preparation of enamels ||| Produits chimiques pour la fabrication de liants
0.40546339750289917 ||| Turkeys: ||| Hens: ||| Dindes:
0.30895915627479553 ||| To ensure that the needle is in the vein, check for blood return by pulling back very slightly on the plunger of the syringe. ||| Each foil has a perforation down the middle to allow the blisters to be separated into a daily dose of 5 tablets. ||| Afin de vérifier que l’aiguille est dans la veine, aspirer très doucement en tirant sur le piston de la seringue.
0.37259653210639954 ||| blister (PVC/ alu) non perforated ||| blister (PVC/ Aluminium) ||| plaquette thermoformée non- prédécoupée (PVC/ alu)
0.6454606056213379 ||| Do not open the blister until ready to administer. ||| Do not attempt to dial past this point. ||| Ne pas ouvrir la plaquette thermoformée avant administration.
0.746877908706665 ||| Emery paper ||| Yellow amber ||| Papier émeri
0.02419138513505459 ||| 76 ANNEX II ||| 77 ANNEX II ||| 83 ANNEXE II
0.21516153216362 ||| It is not known whether VZV is secreted in human milk. ||| It is not known whether it is excreted in human milk. ||| On ne sait pas si le VVZ est excrété dans le lait maternel.
0.2629413902759552 ||| Very rare cases of allergic reactions to GONAL-f have occurred causing redness of the skin, rash, swelling, hives and difficulty in breathing. ||| Reactions during the infusion have occurred uncommonly with VFEND (including flushing, fever, sweating, increased heart rate and shortness of breath). ||| 203 Quelques rares cas de réactions allergiques à GONAL-f sont survenus, provoquant au niveau de la peau, rougeur, éruption, gonflement, urticaire, ainsi qu'une gêne respiratoire.
0.660856306552887 ||| Gravel paper for bird cages ||| Quebracho bark for industrial use ||| Papier sablé pour cages d'oiseaux
0.1856415718793869 ||| Humidifiers [for household purposes] ||| Water ionizers [for household purposes] ||| Humidificateurs à usage domestique
0.40368151664733887 ||| Japanese style low tables (zataku) ||| Japanese sleeping robes (nemaki) ||| Tables basses de style japonais (zataku)
0.4289396405220032 ||| peripheral edema, palpitation and chest pain. ||| myocardial infarction, severe arrhythmic disorders. ||| Oedèmes Cardiovasculaire périphériques, palpitation et douleur thoracique.
0.2011803239583969 ||| -- ||| --- ||| —
0.2643788754940033 ||| It is recommended that patients who have pre-existing cardiac abnormalities have electrocardiograms taken prior to and during the course of treatment. ||| If patients are re-treated after a prolonged period, they must be closely monitored for signs and symptoms of delayed hypersensitivity. ||| Il est recommandé que les patients ayant des anomalies cardiaques préexistantes aient des électrocardiogrammes avant et pendant le traitement.
0.2723233699798584 ||| Causes of a hypo ||| 77 Causes of a hypo ||| Causes de l’hypoglycémie
0.3781006634235382 ||| Oseltamivir is effective only against illness caused by influenza viruses. ||| Zidovudine concentrations are increased in patients with advanced renal failure. ||| L'oseltamivir n'est efficace que dans les infections dues aux virus de la grippe.
0.21396157145500183 ||| 42 {PRODUCT NAME} is contraindicated in patients: − with hypersensitivity to the active substance or to any of the excipients of this medication − with active liver disease or unexplained persistent elevations of serum transaminases exceeding 3 times the upper limit of normal − with myopathy − during pregnancy − while breast-feeding − in women of child-bearing potential not using appropriate contraceptive measures. ||| HYCAMTIN is contraindicated in patients who − have a history of severe hypersensitivity to the active substance or to any of the excipients − are breast feeding (see section 4.6) − already have severe bone marrow depression prior to starting first course, as evidenced by baseline neutrophils < 1.5 x 109/ l and/ or a platelet count of < 100 x 109/ l. ||| {PRODUCT NAME} est contre indiqué chez les patients présentant: − une hypersensibilité à la substance active ou à l’ un des excipients de ce médicament, − une affection hépatique évolutive ou une augmentation persistante et inexpliquée des transaminases sériques dépassant 3 fois la limite supérieure de la normale − une myopathie, − en cas de grossesse, − au cours de l’ allaitement, − chez les femmes en âge de procréer ne prenant pas de mesures de contraception adéquates.
0.08931396901607513 ||| - If you are pregnant. ||| - if you are pregnant. ||| - Si vous êtes enceinte
0.6339626312255859 ||| 42 Laboratory test abnormalities: ||| Eye disorders During monotherapy clinical trials: ||| Anomalies dans les tests biologiques:
0.4054104685783386 ||| In combination with insulin, the current insulin dose can be continued upon initiation of pioglitazone therapy. ||| For conversion to , treatment should begin with the initial oral dose recommended for primary immunosuppression. ||| 15 En association à l’ insuline, la dose d’ insuline peut être maintenue lors de l’ initiation du traitement par pioglitazone.
0.3374159336090088 ||| A transient diffuse swelling may occur at the vaccination site in 50% of the animals, which persists for about 14 days. ||| For pigs of 40-50 kg, it was possible to derive a withdrawal period of 35 days based on injection site residues. ||| Un œ dème diffus transitoire peut survenir au point d’ injection chez 50% des animaux et persister pendant environ 14 jours.
0.33638375997543335 ||| Method of administration Cubicin is given by intravenous infusion (see section 6.6) and administered over a 30 minute period. ||| When NovoMix 30 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection. ||| Mode d’ administration Cubicin s’ administre en perfusion intraveineuse (voir rubrique 6.6) d’ une durée de 30 minutes.
0.11989323794841766 ||| You can set the dose in steps of 2 units, from a minimum of 2 units to a maximum of 40 units. ||| The dose can be set in steps of 1 unit, from a minimum of 1 unit to a maximum of 80 units. ||| Vous pouvez sélectionner la dose par intervalles de 2 unités, d’ un minimum de 2 unités à un maximum de 40 unités.
0.41822347044944763 ||| Upon reconstitution the product should be used immediately. ||| This product should only be administered intravenously. ||| La solution doit être utilisée immédiatement après sa reconstitution.
0.4734167158603668 ||| INSTRUCTIONS ON USE ||| USER INSTRUCTIONS ||| INSTRUCTIONS POUR UTILISATION
0.021602146327495575 ||| 28 film-coated tablets Component of a multipack comprising 3 packs, each containing 28 tablets. ||| 60 film-coated tablets Component of a multipack comprising 3 packs, each containing 60 tablets. ||| 28 comprimés pelliculés Composant d’ un conditionnement multiple comprenant 3 boîtes, contenant chacune 28 comprimés.
0.4445990324020386 ||| A renal impairment study after oral dosing of olopatadine has been performed in patients with severe renal impairment. ||| Tissue sealing in lung surgery was investigated in two controlled trials in patients undergoing lung surgery. ||| Une étude de l'altération rénale après administration orale d'olopatadine a été réalisée chez des patients ayant une insuffisance rénale sévère.
0.8890137672424316 ||| Shire Pharmaceutical Contracts Ltd Hampshire International Business Park ||| ed Abbott Bioresearch Center 100 Research Drive Worcester ||| u Hampshire International Business Park Chineham, Basingstoke
0.4387606382369995 ||| A gentle massage of the site - while still maintaining pressure - helps disperse the Puregon solution and relieve any discomfort. ||| This ensures that you get an accurate dose by: • ensuring that pen and needle work properly • removing air bubbles ||| - aidera la solution de Puregon à se disperser et fera disparaître toute sensation désagréable.
0.2725445330142975 ||| Plasma levels of certain anti- epileptic drugs, such as phenytoin and carbamazepine, may be increased by co-administration with Clomicalm. ||| Do not use epinephrine, dopamine, or other sympathomimetic agents with beta- agonist activity since beta stimulation may worsen hypotension. ||| Les niveaux plasmatiques de certains produits anti-épileptiques, tels que la phénytoïne et la carbamazépine, peuvent être augmentés par l’ administration conjointe de Clomicalm.
0.4198891520500183 ||| 20, 50, 100 ||| 20, 50, ||| 20, 100
0.41502445936203003 ||| A confirmed haematological response was achieved in 71.5% of patients (Table 4). ||| Thirty-one percent (31%) of patients in studies were documented as having palpable splenomegaly. ||| 17 réponse hématologique confirmée a été obtenue chez 71,5% des patients (Tableau 4).
0.2769988775253296 ||| Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom ||| Aesica Queenborough Ltd Queenborough Kent ME11 5EL United Kingdom ||| Queenborough Kent ME11 5EL United Kingdom
0.3419569134712219 ||| The efficacy and safety of MabThera in alleviating the symptoms and signs of rheumatoid arthritis was demonstrated in three randomized, controlled, double-blind, multicenter studies. ||| In two single-dose trials, Azomyr oral lyophilisate was well tolerated as documented by clinical laboratory findings, physical examinations, vital signs, and ECG interval data. ||| L’ efficacité et la tolérance de MabThera dans la réduction des signes et symptômes de la polyarthrite rhumatoïde ont été démontrées dans trois études multicentriques, randomisées, contrôlées et en double insu.
0.006581529509276152 ||| Each 0.4 ml pre-filled syringe contains 40 micrograms darbepoetin alfa (100 micrograms/ ml). ||| Each 0.4 ml pre-filled syringe contains 10 micrograms darbepoetin alfa (25 micrograms/ ml). ||| Chaque seringue préremplie de 0,4 ml contient 40 microgrammes de darbepoetin alfa (100 microgrammes/ ml).
3.9170706608859795e-13 ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: ||| Pour toute information complémentaire concernant ce médicament, veuillez prendre contact avec le représentant local du titulaire de l’ Autorisation de Mise sur le Marché.
0.44461631774902344 ||| There is a proportional increase in Cmax and AUC from 20 mg to 60 mg, the range of single-dose administrations tested. ||| There is little to no accumulation in AUC and Cmax and evidence of slight accumulation in C12 hr. ||| Une augmentation de la Cmax et de l’ Aire Sous la Courbe (ASC) proportionnelle à la dose a été observée pour des doses uniques allant de 20 à 60 mg.
0.35235923528671265 ||| Spray crystallized maltose for industrial use ||| Gasket sealer compound for automotive use ||| Maltose cristallisé par atomisation à usage industriel
1.0100562572479248 ||| Management Board................................................................................. .7 EMEA management challenges............................................................ .11 Financial control.................................................................................... .13 ||| Goals and objectives for veterinary medicines.................................... .28 Veterinary marketing authorisation procedures................................. ..30 Safety of veterinary medicines............................................................... 32 Information technology........................................................................ ..33 ||| Conseil d’ administration........................................................................ 7 Défis de gestion de l’ EMEA............................................................... .11 Contrôle financier.............................................................................. ..14
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist. ||| Si vous ressentez un des effets mentionnés comme grave, ou si vous présentez des effets indésirables non mentionnés dans cette notice, veuillez en informer votre médecin, votre infirmière ou votre pharmacien.
0.014431413263082504 ||| Preclinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential. ||| Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential. ||| Les données précliniques (études conventionnelles de sécurité, toxicité par administration réitérée, génotoxicité, potentiel cancérogène) n’ ont pas mis en évidence de danger particulier pour l’ homme.
0.0 ||| 10. ||| 10. ||| 285 10.
0.02137049287557602 ||| Actraphane vials are for use with insulin syringes with the corresponding unit scale. ||| Protaphane vials are for use with insulin syringes with the corresponding unit scale. ||| Les flacons d‘ Actraphane doivent être utilisés avec des seringues à insuline portant une graduation adéquate.
0.1771671622991562 ||| How to store Silapo 6. ||| How to store Protopy 6. ||| Comment conserver Silapo 6.
0.271219938993454 ||| Since dasatinib is associated with severe myelosuppression (see section 4.4), patients who ingested more than the recommended dose should be closely monitored for myelosuppression and appropriate supportive treatment given. ||| As this could result in raised plasma levels of sitaxentan sodium, patients in need of the combination should be closely monitored for adverse events related to sitaxentan sodium (see section 4.5). ||| Compte tenu que dasatinib est associé à des myélosuppressions sévères (voir rubrique 4.4), les patients ayant absorbé une dose plus importante que la dose recommandée doivent être étroitement surveillés pour la myélosuppression et un traitement symptomatique approprié doit être donné.
0.36145031452178955 ||| If you develop a new infection, or are about to have any major surgery, your doctor may wish to monitor your treatment with Enbrel.  Infections/ diabetes: ||| • If you have an infection, including long-term or localized infection (for example, leg ulcer) consult your doctor before starting Humira. ||| Si vous développez une n ouve lle infection, ou devez subir une intervention chirurgicale importante ou si vous développez une nouvelle infection par Enbrel.
0.019310109317302704 ||| If you receive prophylactic administration of protein C, higher trough levels may be warranted in situations of an increased risk of thrombosis (such as infection, trauma, or surgical intervention). ||| In patients receiving prophylactic administration of protein C, higher trough levels may be warranted in situations of an increased risk of thrombosis (such as infection, trauma, or surgical intervention). ||| Si vous êtes traité en prophylaxie par la protéine C, des taux plus élevés peuvent être nécessaires dans les cas de risques importants de thromboses (tels qu’ infection, traumatisme ou intervention chirurgicale).
6.005931429270417e-13 ||| - If you have any further questions, ask your doctor. ||| - If you have any further questions, ask your doctor. ||| - Si vous avez toute autre question, si vous avez un doute, demandez plus d'informations à votre
0.8088157176971436 ||| Quarantine requirements are a matter for every individual EU Member State. ||| Member State to one or more other Member States identified by the applicant. ||| Les exigences en matière de quarantaine sont du ressort de chaque État membre de l'UE.
0.2389579713344574 ||| It is available in a vial, a cartridge (PenFill) or in a prefilled pen (NovoLet, FlexPen or InnoLet). ||| Protaphane is supplied in vials, cartridges (Penfill), or pre-filled pens (InnoLet, NovoLet and FlexPen). ||| Elle est fournie en flacon, en cartouche (PenFill) ou en stylo prérempli (NovoLet, FlexPen ou InnoLet).
0.45565328001976013 ||| Naïve patients also received nucleoside reverse transcriptase inhibitors. ||| Rivastigmine transdermal patches were not phototoxic. ||| Les patients naïfs ont également reçu des inhibiteurs nucléosidiques de la transcriptase inverse.
0.3695752024650574 ||| Diarrhoea, including severe diarrhoea requiring hospitalization, has been reported during treatment with oral topotecan. ||| Diarrhoea has occurred in approximately 50% of patients on Tarceva and moderate or severe diarrhoea should be treated with e.g. loperamide. ||| Des diarrhées, incluant des diarrhées sévères nécessitant une hospitalisation, ont été rapportées au cours d’ un traitement par topotécan oral.
0.0 ||| 4.7 Effects on ability to drive and use machines ||| 4.7 Effects on ability to drive and use machines ||| é 4.7 Effets sur l'aptitude à conduire des véhicules et à utiliser des machines
0.73231041431427 ||| - fever, ||| sepsis, + ||| - fiévre
0.356589138507843 ||| From the data provided by the MAHs the CHMP concluded that efficacy has not been demonstrated in children and adolescents with major depressive disorder as included in the trials. ||| In summary, the CHMP agreed that there is at this time no firm evidence of an association between Implanon exposure and an increased risk of breast cancer in young women. ||| À partir des données fournies par les TAMM, le CHMP a conclu que l’ efficacité n’ a pas été démontrée chez les enfants et les adolescents présentant un épisode dépressif majeur, comme indiqué dans les essais.
0.07519911974668503 ||| SOMAVERT is a powder and solvent that are mixed together to make up a solution for injection. ||| Advate is a powder and solvent that are mixed together to make a solution for injection. ||| SOMAVERT se présente sous la forme d’ une poudre et d’ un solvant à mélanger afin de préparer une solution injectable.
0.37053182721138 ||| • 17.09.2001 • 05.12.2001 ||| • 15.09.98 • 19.07.00 ||| 17.09.2001 05.12.2001
0.43780356645584106 ||| Somatropin and analogues, ATC Code: ||| Androgens, testosterone, ATC code: ||| Somatropine et analogues, Code ATC:
0.4678228795528412 ||| Over long term treatment up to 3 years, a small and gradual decrease in mean platelet counts within the normal range was observed. ||| Time to onset was rapid (as early as week 2) and the magnitude of response continued to improve with duration of treatment. ||| Lors du traitement au long cours jusqu’ à 3 ans a été observée une légère baisse progressive des numérations plaquettaires moyennes à l’ intérieur des limites de la normale.
0.6900702118873596 ||| MARKETING AUTHORISATION HOLDER See Annex A ||| V. GETTING TOURISM BACK ON TRACK ||| TITULAIRE DE L'AUTORISATION DE MISE SUR LE MARCHE Voir Annexe A
0.24323514103889465 ||| Cushions adapted for use in vehicles ||| Backrests adapted for use in vehicles ||| Coussins conçus pour les véhicules
0.13604605197906494 ||| Omeprazole 40 mg qd (saquinavir/ ritonavir 1000/ 100 mg bid) ||| Didanosine 400 mg single dose (saquinavir/ ritonavir 1600/ 100 mg qd) ||| (saquinavir/ ritonavir 1000/ 100 mg deux fois par jour)
0.48111093044281006 ||| If you get dizzy, you should avoid driving or operating machines after taking Pelzont. ||| 34 If you stop using EVRA You may get irregular, little or no bleeding. ||| Si c’ est votre cas, il est déconseillé de conduire ou d’ utiliser des machines après avoir pris Pelzont.
0.3369606137275696 ||| Once daily administration (abacavir 600 mg): the benefit of abacavir as a once daily regimen is mainly based on a study performed in combination with efavirenz and lamivudine, in antiretroviral- naïve adult patients (see section 5.1). ||| Results from clinical trials performed with once-daily tacrolimus Advagraf Liver transplantation The efficacy and safety of Advagraf and Prograf, both in combination with corticosteroids, was compared in 471 de novo liver transplant recipients. ||| Le bénéfice de l’ abacavir administré en une prise par jour est principalement basé sur une étude réalisée en association avec l'efavirenz et la lamivudine, chez des patients adultes n'ayant jamais reçu d'antirétroviraux (voir rubrique 5.1.).
0.16640880703926086 ||| From a microbiological point of view, the product should be used immediately. ||| From a microbiological point of view, the product should be used immediately after reconstitution. ||| D’ un point de vue microbiologique, le produit devrait être utilisé immédiatement.
1.168554510967701e-12 ||| General disorders and administration site conditions ||| General disorders and administration site conditions ||| Troubles généraux et anomalies au site d’ administration Affections psychiatriques
0.579625129699707 ||| In addition to 33 core data elements, product information (SPC, PIL, labels) will be included in the database for a subset of centrally authorised products. ||| information for each product, together with the English- language version of the summary of product characteristics (SPCs). ||| En plus de 33 principaux éléments de données, des informations sur les produits (RCP, notice, étiquetage) seront incluses dans la base de données dans un sous-ensemble de produits autorisés via la procédure centralisée.
0.4989859461784363 ||| Allergic reactions: ||| Serious allergic reactions ||| Réactions allergiques:
0.6748830080032349 ||| Laser scribing ||| Glass polishing ||| Traçage par laser
0.6635439395904541 ||| Hepatobiliary disorders ||| Homogenous catalysts ||| alvéolaire pulmonaire
0.05595748871564865 ||| 137 LYRICA 200 mg capsules are light orange hard capsules, with “Pfizer” marked on the cap and “PGN 200” on the body. ||| LYRICA 25 mg capsules are white hard capsules, with “Pfizer” marked on the cap and “PGN 25” on the body. ||| - LYRICA 200 mg se présente sous forme de gélules de couleur orange clair, portant les
0.27917081117630005 ||| No dose adjustment is needed for warfarin and similar oral anticoagulant agents when bosentan is initiated but intensified monitoring of INR is recommended, especially during bosentan initiation and the up-titration period. ||| Patients starting on Cholestagel already taking ciclosporin should have their blood concentrations monitored prior to combination therapy and frequently monitored immediately starting co-therapy with the ciclosporin dose adjusted accordingly. ||| Aucune adaptation de la posologie de la warfarine ou d’ autres anticoagulants oraux n’ est nécessaire lors de l’ initiation du traitement par bosentan, mais une surveillance accrue de l’ INR est recommandée, en particulier pendant les périodes d’ initiation et d’ augmentation de posologie.
0.0019562197849154472 ||| Quixidar is available in pack sizes of 2, 7, 10 and 20 pre-filled syringes with a blue automatic safety system. ||| Quixidar is available in pack sizes of 2, 7, 10 and 20 pre-filled syringes with a yellow automatic safety system. ||| Quixidar est disponible en boîte de 2, 7, 10 et 20 seringues pré-remplies bleues avec système de sécurité automatique.
0.12719321250915527 ||| As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine. ||| Appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic reaction following the administration of the vaccine. ||| Comme pour tout vaccin injectable, il est recommandé de disposer d’ un traitement médical approprié et de surveiller le sujet dans l’ éventualité, rare, d’ une réaction anaphylactique suite à l’ administration du vaccin.
0.9382635354995728 ||| 22880 Wedel Germany ||| 28108 Alcobendas ||| 22880 Wedel Allemagne
0.5573920607566833 ||| 8 I welcome these positive developments and am grateful for their support, particularly as we prepare for the review of the European system in the year 2001. ||| This year, celebrations take on an added significance as we thank those working for the benefit of all during this extraordinary period. ||| 10 de ces développements positifs et le climat de confiance ainsi renforcé, ce qui revêt une importance particulière dans le cadre de la préparation de la révision du système européen en l’ 2001. an
0.06061289831995964 ||| 27 ANNEX III ||| 29 ANNEX III ||| 31 ANNEXE III
0.36048561334609985 ||| The suspension should be given using the Metacam measuring syringe provided in the package. ||| The screw cap on the 1 litre bottle can be used as a measuring device. ||| La suspension doit être dosée au moyen de la seringue-doseuse Metacam fournie dans le conditionnement.
0.43055492639541626 ||| All of the studies lasted six months and compared the effects of Prometax with those of placebo (a dummy treatment). ||| The results obtained with Paxene are closely similar to those of published paclitaxel Phase III trials. ||| Toutes les études ont duré six mois et ont comparé les effets de Prometax à ceux d’ un placebo (traitement fictif).
0.4821302890777588 ||| Cutting of precious stones ||| Mining for precious stones ||| Taille de pierres précieuses
0.2635616064071655 ||| In the pivotal placebo-controlled studies with ORACEA in rosacea, 269 patients were treated with ORACEA 40 mg once daily and 268 patients were treated with placebo for 16 weeks. ||| In the double blind placebo controlled studies 529 patients were treated with rasagiline 1 mg/ day for 212 patient years and 539 patients received placebo for 213 patient years. ||| Lors d’ études pivot contrôlées contre placebo sur ORACEA dans le traitement de la rosacée, 269 et 268 patients ont été respectivement traités pendant 16 semaines, soit par 40 mg d'ORACEA par jour soit par le placebo.
0.3801390528678894 ||| Fasturtec should not be used during pregnancy or in breast- feeding women. ||| Women of childbearing potential: pregnancy should be avoided in women treated with efavirenz. ||| Fasturtec ne doit pas être utilisé pendant la grossesse ou chez les femmes allaitant.
0.1491401493549347 ||| The recommended dose of Avastin is 10 mg/ kg of body weight given once every 2 weeks as an intravenous infusion. ||| Replagal is administered at a dose of 0.2 mg/ kg body weight every other week by intravenous infusion over 40 minutes. ||| Avastin est recommandé à la posologie de 10 mg/ kg de poids corporel, administré une fois toutes les 2 semaines, en perfusion intraveineuse.
0.608540415763855 ||| Tulathromycin may cause sensitisation by skin contact. ||| Atripla may affect your kidneys. ||| La tulathromycine peut provoquer des irritations cutanées.
0.12368378043174744 ||| A symptom complex has been reported which may include one or more of the following: fever, vasculitis, myalgia, arthralgia/arthritis, a positive antinuclear antibodies (ANA), elevated red blood cell sedimentation rate (ESR), eosinophilia and leucocytosis, rash, photosensitivity or other dermatological manifestations may occur. ||| A syndrome has been reported that may include one or more of the following symptoms: fever, vasculitis, myalgia, arthralgia/ arthritis, positive ANA, elevated ESR value, eosinophilia and leucocytosis, rash, photosensitivity or other dermatological manifestations. ||| Des cas associant un ou plusieurs des symptômes suivants: fièvre, vascularite, myalgies, arthralgies/arthrite, présence d’anticorps anti-nucléaires, augmentation de la vitesse de sédimentation, éosinophilie et leucocytose, éruption cutanée, photosensibilisation ou autres manifestations cutanées ont été rapportés.
0.45169925689697266 ||| Patients with a recent history of pulmonary infiltrates or er pneumonia may be at higher risk. ng ||| Cytokine storm can be a complication in the later stages of severe COVID-19. ||| Les risques peuvent être majorés chez les patients ayant des antécédents récents d’ infiltration pulmonaire ou de pneumonie. 'e
0.25209707021713257 ||| 135 Infections of the bones and joints Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation. ||| Due to the lack of clinical experience in multiple sclerosis patients, the use of Extavia together with immunomodulators other than corticosteroids or ACTH is not recommended. ||| Infections ostéoarticulaires La ciprofloxacine doit être utilisée en association avec un autre antibiotique en fonction des résultats microbiologiques.
0.10068696737289429 ||| OUTER CARTON TEXT Puregon 75 IU 5 vials ||| OUTER CARTON TEXT Puregon 100 IU 10 ampoules ||| TEXTE DE L'ETUI Puregon 75 UI 5 flacons
0.05878426879644394 ||| The addition of the entire contents of the solvent vial to the contents of the Docetaxel Winthrop 20 mg vial ensures a premix concentration of 10 mg/ ml docetaxel. ||| The addition of the entire contents of the solvent vial to the contents of the Docetaxel Winthrop 20 mg concentrate for solution for infusion vial ensures a premix concentration of 10 mg/ ml docetaxel. ||| L'ajout de la totalité du contenu du flacon de solvant au contenu du flacon de Docétaxel Winthrop 20 mg assure pour le prémélange une concentration de 10 mg/ ml en docétaxel.
0.019621852785348892 ||| ed Viraferon 30 million IU solution for injection multidose pen interferon alfa-2b ||| s Viraferon 30 million IU solution for injection multidose pen interferon alfa-2b ||| isé Viraferon 30 millions UI solution injectable stylo multidose interféron alfa-2b Voie sous-cutanée
0.32542309165000916 ||| 29 One retrospective European study evaluating the use of G-CSF after allogeneic bone marrow transplantation in patients with acute leukaemias suggested an increase in the risk of GvHD, treatment related mortality (TRM) and mortality when G-CSF was administered. ||| The incidence of Non-CABG-related TIMI major bleeding, including life-threatening and fatal, as well as TIMI minor bleeding, was statistically significantly higher in subjects treated with prasugrel compared to clopidogrel in the UA/ NSTEMI and All ACS populations. ||| Une étude rétrospective européenne évaluant l’ utilisation de G-CSF à la suite d’ une greffe de moelle osseuse allogénique chez des patients atteints de leucémie aiguë a indiqué un risque accru de RGCH, de mortalité associée au traitement (MAT), ainsi que de mortalité, lorsque le G-CSF était administré.
0.34160614013671875 ||| Higher exposure to lansoprazole in comparison to adults has been seen in infants below the age of 2-3 months with doses of both 1.0 mg/kg and 0.5 mg/kg body weight given as a single dose. ||| However, limited published data suggest that the safety profile in adolescents from 12 to 16 years of age receiving Betaferon 8.0 million IU subcutaneously every other day is similar to that seen in adults. ||| Une plus forte exposition au lansoprazole comparée aux adultes a été vu chez des enfants de moins de 2-3 mois avec des doses à la fois de 1,0 mg/kg et 0,5 mg/kg de poids corporel données en dose unique.
0.2509717643260956 ||| There was no discernible difference in the rate of serious thrombotic cardiovascular events between patients receiving etoricoxib ≥ 60 mg, placebo, or non-naproxen NSAIDs. ||| Immunogenicity data for subcutaneous use of Epoetin alfa HEXAL in patients at risk for antibody-induced PRCA, i. e. patients with renal anaemia, are not sufficient. ||| Aucune différence notable n’ a été observée dans l’ incidence des événements cardiovasculaires thrombotiques graves, entre les patients recevant soit l’ étoricoxib à une posologie ≥ 60 mg, soit le placebo, soit des AINS autres que le naproxène.
0.016340797767043114 ||| ViraferonPeg is a well characterized polyethylene glycol-modified (“pegylated”) derivative of interferon alfa-2b and is predominantly composed of monopegylated species. ||| PegIntron is a well characterized polyethylene glycol-modified (“pegylated”) derivative of interferon alfa-2b and is predominantly composed of monopegylated species. ||| ViraferonPeg est un dérivé (pégylé) d’ interféron alfa-2b conjugué avec un polyéthylène glycol modifié bien caractérisé et est principalement composé d’ éléments monopégylés.
0.2422739714384079 ||| In clinical trials, cases of colitis (including intestinal and rectal bleeding, sometimes fatal, intestinal perforation, intestinal necrosis and typhlitis) have been reported uncommonly in patients treated with pemetrexed. ||| Upper gastrointestinal complications [perforations, ulcers or bleedings (PUBs)], some of them resulting in fatal outcome, have occurred in patients treated with parecoxib. ||| Dans des essais cliniques, des cas de colite (incluant saignement intestinal et rectal, parfois fatal, perforation intestinale, nécrose intestinale et colite neutropénique) ont été peu fréquemment rapportés chez des patients traités par pemetrexed.
0.4102739691734314 ||| Zevalin could affect the ability to drive and to use machines, as dizziness has been reported as a common side effect. ||| However, hepatic metabolism represents the major route of drug clearance and liver function may therefore be expected to influence this process. ||| Zevalin pourrait affecter l'aptitude à conduire des véhicules et à utiliser des machines, car des cas de sensations vertigineuses ont été signalés à titre d’ effet indésirable fréquent.
2.4365844628407296e-13 ||| Conversely, based on the experience with the use of other medicinal products that blunt the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e. g. heparin sodium) may lead to increases in serum potassium. ||| Conversely, based on the experience with the use of other medicinal products that blunt the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e. g. heparin sodium) may lead to increases in serum potassium. ||| A l'inverse, en se fondant sur l'expérience acquise avec les autres médicaments intervenant sur le système rénine-angiotensine, l'administration concomitante de Irbesartan Hydrochlorothiazide BMS avec des diurétiques d’ épargne potassique, une supplémentation en potassium, des sels de régime contenant du potassium ou d’ autres médicaments qui peuvent augmenter les taux de potassium plasmatique (par exemple héparine sodique) peut donner lieu à une élévation de la kaliémie.
0.6209796667098999 ||| Toy Christmas trees ||| Musical Christmas tree ornaments ||| Sapins de Noël [jouets]
0.3891179859638214 ||| Pericardial effusion and pericarditis were reported as an adverse event in 8% (10/ 132) of patients. ||| Dose reduction for rash and diarrhoea was needed in 6% and 1% of patients, respectively. ||| L’ épanchement péricardique et la péricardite ont été rapportés chez 8% (10/ 132) des patients.
0.16139155626296997 ||| Boxes (packaging -) in collapsible form [wood] ||| Boxes (packaging -) in made-up form [metal] ||| Boîtes d'emballage pliables en bois
0.479938268661499 ||| Portable nebulisers for medical purposes ||| Percussion hammers for diagnostic purposes ||| Nébuliseurs portatifs à usage médical
0.2669030725955963 ||| Ear and labyrinth disorders: common: vertigo ||| Ear and labyrinth disorders: tinnitus. ||| Affections de l’ oreille et du labyrinthe:
0.3755122423171997 ||| The once weekly dose of romiplostim should be increased by increments of 1 μ g/ kg until the patient achieves a platelet count ≥ 50 x 109/ l. ||| 2 If cytopenia is unrelated to leukaemia, stop treatment until ANC ≥ 1.0 x 109/ l and platelets ≥ 20 x 109/ l and resume at the original starting dose. ||| La dose hebdomadaire de romiplostim doit être augmentée par paliers de 1 µg/ kg jusqu’ à ce que le patient atteigne un taux de plaquettes ≥ 50 x 109/ l.
0.20602697134017944 ||| However, caution should be exercised when these medicinal products are used concomitantly with Stalevo (see sections 4.3 and 4.4). ||| Therefore, special caution should be exercised when atorvastatin is used in combination with such medicinal agents (see section 4.4). ||| La prudence s'impose cependant en cas d'utilisation concomitante de ces médicaments et de Stalevo (voir également les rubriques 4.3 et 4.4).
0.38777339458465576 ||| The doctor who prescribes Ytracis must ensure that the risks linked to the radioactive exposure are lower than the risks from the disease itself. ||| Patient-time is the sum of individual units of time that the patient in the study has been exposed to AVONEX before experiencing the adverse reaction. ||| Le médecin prescripteur d’ Ytracis doit s’ assurer que les risques liés à l’ exposition aux radiations sont moins importants que ceux liés à la maladie proprement dite.
0.5202593803405762 ||| Parque Empresarial La Moraleja 28108 Alcobendas (Madrid) ||| Comadran 37 Barbera Del Valles 08210 Barcelona Spain ||| Av. de Europa 20-B Parque Empresarial La MOral useeja 28108 Alcobendas (Madrid)
0.1058453693985939 ||| 38 7. ||| 39 7. ||| 41 7.
0.3999618887901306 ||| Escalation and maintenance doses should be adjusted according to clinical response (see section 5.2). ||| Do not exceed the recommended dosage and the duration of treatment (see 4.2). ||| Les augmentations posologiques et les posologies d’ entretien doivent être ajustées en fonction de la réponse clinique (voir rubrique 5.2).
0.20806623995304108 ||| Each vial contains gemcitabine hydrochloride equivalent to 1000 mg gemcitabine ||| 1 coated tablet contains cefuroxime axetil equivalent to 125 mg cefuroxime ||| Chaque flacon contient du chlorhydrate de gemcitabine correspondant à 1 000 mg de gemcitabine.
0.4955459237098694 ||| p value ||| value a ||| Valeur p
0.3988388776779175 ||| Pigs Vaccine against atrophic rhinitis ||| Piglets Passive immunisation against neonatal ||| Vaccine against atrophic rhinitis
0.17728209495544434 ||| Follow carefully all instructions given by your doctor or nurse. ||| Follow carefully all instructions given to you by your doctor. ||| Respectez scrupuleusement les instructions de votre médecin ou de votre infirmière.
0.39349400997161865 ||| Atopic dermatitis (eczema) is rarely observed in patients aged 65 and over. ||| Diarrhoea is reported more commonly in paediatric patients aged 2 to 5 years than in older patients. ||| Sujets âgés La dermatite atopique (eczéma) est rarement observée chez les patients âgés de 65 ans et plus.
0.31197410821914673 ||| week 1 ||| Day 1 ||| Semaine 1
0.056028224527835846 ||| Wyeth Europa Ltd Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH United Kingdom ||| Wyeth Europa Limited Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH United Kingdom Tel: ||| Wyeth Europa Ltd Huntercombe Lane South Taplow, Maidenhead Berkshire SL6 0PH Royaume Uni
0.28119298815727234 ||| Since the objections and the issues related entirely to pharmaceutical quality matters without any impact on the SPC, it was not considered necessary to amend the latest SPC as proposed on day 90 of the Mutual recognition Procedure. ||| Quality issues No significant issues relating to quality were identified and the pharmaceutical particulars of the SPC were harmonised, except the sections, which need to be introduced nationally by the Member States when implementing the harmonised SPC. ||| Étant donné que les objections et les questions ne concernaient que des problèmes de qualité pharmaceutique n’ ayant aucun impact sur le RCP, il n’ a pas semblé nécessaire d’ amender le dernier RCP proposé le 90ème jour de la procédure de reconnaissance mutuelle.
0.22017616033554077 ||| Insulin Human Winthrop Comb 25 in cartridges for OptiClik has been developed for use with OptiClik only. ||| Insuman Rapid in cartridges for OptiClik has been developed for use with OptiClik only. ||| Insulin Human Winthrop Comb 25 en cartouches pour OptiClik a été conçu pour être utilisé avec OptiClik uniquement.
0.4404677450656891 ||| For oral use. ||| For oral use ||| Administration par voie orale.
0.22784310579299927 ||| Adjustment of the dose is required in patients with creatinine clearance < 50 ml/ min, including those with end-stage renal disease (ESRD) on haemodialysis. ||| Use in patients with renal impairment In patients with moderate to severe renal dysfunction (creatinine clearance < 50 ml/ min), accumulation of the intravenous vehicle, SBECD, occurs. ||| Une adaptation de la posologie est nécessaire chez les patients ayant une clairance de la créatinine < 50 ml/ min, y compris chez les patients au stade d’ insuffisance rénale terminale (IRT) hémodialysés.
0.4327888488769531 ||| 22 If you are taking any of the following medicines, please be sure to discuss this with your doctor or pharmacist before using Ceplene. ||| To find out more about these medicines, please ask your doctor or read the Package Leaflet that comes with these medicines. ||| Si vous prenez l’ un des médicaments suivants, parlez -en avec votre médecin ou votre pharmacien avant d’ utiliser Ceplene.
2.8213667296536626e-13 ||| (iii) Safeguards for banks that channel State aid to the real economy that such aid is considered as direct aid to the banks' customers, not to the banks themselves, and gives guidance on how to ensure minimal distortion of competition between banks. ||| (iii) Safeguards for banks that channel State aid to the real economy that such aid is considered as direct aid to the banks' customers, not to the banks themselves, and gives guidance on how to ensure minimal distortion of competition between banks. ||| iv) garde-fous pour les banques qui acheminent les aides d'État vers l'économie réelle: ce type d'aide est considéré comme une aide directe aux clients des banques, non aux banques elles-mêmes, des orientations ayant été fournies sur la manière de limiter au minimum les distorsions de concurrence entre banques;
0.1887374222278595 ||| Retacrit 3000 IU ||| Retacrit 40000 IU ||| Retacrit 3 000 UI
2.342618942260742 ||| Vimpat 50 mg film-coated tablets Vimpat 100 mg film-coated tablets Vimpat 150 mg film-coated tablets Vimpat 200 mg film-coated tablets ||| Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist ||| Vimpat 50 mg comprimés pelliculés, Vimpat 100 mg comprimés pelliculés, Vimpat 150 mg comprimés pelliculés, Vimpat 200 mg comprimés pelliculés
0.1577056348323822 ||| How has Zactran been studied? ||| How has Zalasta been studied? ||| Quelles études ont été menées avec Zactran?
0.5034798383712769 ||| Forensic accounting services ||| Trustee advisory services ||| Services de comptabilité judiciaire
0.26918303966522217 ||| 35 The antihypertensive effect of Cozaar was established in a clinical study involving 177 hypertensive pediatric patients 6 to 16 years of age with a body weight > 20 kg and a glomerular filration rate > 30 ml/ min/ 1.73 m2. ||| Osteoporosis in men with increased risk of fracture The efficacy of alendronate 10 mg once daily in men (31-87 years, mean age 63 years, n=241) with osteoporosis was evaluated in a two-year study. ||| Hypertension en pédiatrie L’ effet antihypertenseur de Cozaar a été établi dans une étude clinique menée chez 177 patients pédiatriques hypertendus âgés de 6 à 16 ans, pesant plus de 20 kg et ayant un débit de filtration glomérulaire supérieur à 30 ml/ mn/ 1,73 m2.
0.321085125207901 ||| Caution is advised when SonoVue is administered to patients with clinically significant pulmonary disease, including severe chronic obstructive pulmonary disease. ||| (Invented name)® should be offered to a child or young person with moderate to severe major depressive disorder only in combination with psychological therapy. ||| Une attention particulière sera apportée lors de l'administration de SonoVue chez les patients porteurs de maladie pulmonaire cliniquement significative, notamment bronchopneumopathie chronique obstructive sévère.
0.4406108260154724 ||| The significance of these data in pregnant women is not known; therefore the use of AMMONAPS is contra-indicated during pregnancy (see section 4.3). ||| However the company challenged this view and proposed a contraindication through out pregnancy, based on data from the ramipril pregnancy register. ||| La signification de ces données pour la femme enceinte n'est pas connue; par conséquent, l'utilisation d’ AMMONAPS est contre-indiquée pendant la grossesse (voir rubrique 4.3).
0.31993046402931213 ||| Vectibix has not been tested in pregnant women. ||| INVANZ has not been studied in pregnant women. ||| Vectibix n'a pas été étudié chez la femme enceinte.
0.07782210409641266 ||| Neoplasms benign, malignant and unspecified (including cysts and polyps) ||| Neoplasms benign, malignant and unspecified (incl cysts and polyps) ||| Tumeurs bénignes et malignes et non précisées (y compris kystes et polypes)
0.1873946189880371 ||| The referral procedure started on 26 June 2003. ||| The arbitration procedure started on 27 April 2006. ||| La procédure de saisine a débuté le 26 juin 2003.
0.4065213203430176 ||| Prevention of Venous Thromboembolic Events (VTE) in patients undergoing abdominal surgery who are judged to be at high risk of thromboembolic complications, such as patients undergoing abdominal cancer surgery (see section 5.1). ||| Non-Coronary Artery Bypass Graft (CABG) related bleeding In TRITON, the frequency of patients experiencing a non-CABG related bleeding event is shown in Table 1. ||| Prévention des évènements thrombo-emboliques veineux en chirurgie abdominale chez les patients jugés à haut risque de complications thrombo-emboliques, tels que les patients soumis à une chirurgie abdominale pour cancer (voir rubrique 5.1).
0.3786389231681824 ||| Afterwards, many other Asian countries started to confirm cases, with some of the most affected countries being South Korea, Turkey and Iran. ||| As of 30 April, cases have been reported in all Asian countries except for North Korea and Turkmenistan, both of which have suspected cases. ||| Par la suite, de nombreux autres pays asiatiques ont commencé à confirmer des cas, certains des pays les plus touchés étant la Corée du Sud, la Malaisie et l'Iran.
0.00792638212442398 ||| 124 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 128 PARTICULARS TO APPEAR ON THE OUTER PACKAGING ||| 135 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTERIEUR
0.23166033625602722 ||| Appropriate measures should be taken and discontinuation of parecoxib therapy should be considered if there is clinical evidence of deterioration in the condition of specific clinical symptoms in these patients (see section 5.1). ||| Patients should be monitored for haematologic response/ toxicity and renal toxicities (see section 4.4); a delay in starting the next cycle or a dose reduction as described below may be necessary. ||| Des mesures appropriées seront prises et l’ arrêt du traitement par le parécoxib doit être envisagé s’ il existe une preuve clinique de détérioration symptomatique de l’ état de ces patients (voir rubrique 5.1 Propriétés pharmacodynamiques).
0.37436339259147644 ||| No genotoxicity has been observed following testing of memantine in standard assays. ||| In one single genotoxicity study (Ames test), no mutagenic effect has been observed. ||| 15 Aucune génotoxicité n’ a été observée suite aux études standards de la mémantine.
0.4885733723640442 ||| London, 20 March 2007 Doc. ||| London, 1 June 2006 Doc. Ref. ||| Londres, le 20 mars 2007 Doc.
0.24611634016036987 ||| Aranesp 10 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 15 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 20 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 30 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 40 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 50 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 60 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 80 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 100 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 130 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 150 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 300 micrograms solution for injection in a pre-filled pen (SureClick) Aranesp 500 micrograms solution for injection in a pre-filled pen (SureClick) darbepoetin alfa ||| Aranesp 10 micrograms solution for injection in a pre-filled syringe Aranesp 15 micrograms solution for injection in a pre-filled syringe Aranesp 20 micrograms solution for injection in a pre-filled syringe Aranesp 30 micrograms solution for injection in a pre-filled syringe Aranesp 40 micrograms solution for injection in a pre-filled syringe Aranesp 50 micrograms solution for injection in a pre-filled syringe Aranesp 60 micrograms solution for injection in a pre-filled syringe Aranesp 80 micrograms solution for injection in a pre-filled syringe Aranesp 100 micrograms solution for injection in a pre-filled syringe Aranesp 130 micrograms solution for injection in a pre-filled syringe Aranesp 150 micrograms solution for injection in a pre-filled syringe Aranesp 300 micrograms solution for injection in a pre-filled syringe Aranesp 500 micrograms solution for injection in a pre-filled syringe darbepoetin alfa ||| Aranesp 10 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 15 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 20 microgrammes solution injectable en stylo prérempli(SureClick) Aranesp 30 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 40 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 50 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 60 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 80 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 100 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 130 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 150 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 300 microgrammes solution injectable en stylo prérempli (SureClick) Aranesp 500 microgrammes solution injectable en stylo prérempli (SureClick) Darbepoetin alfa
0.111384816467762 ||| Uncommon: diarrhoea ||| Uncommon: diarrhoea. ||| Peu fréquent: diarrhée
0.3184710741043091 ||| This complements the tools available to Member States as set out in the Commission's guidelines to ensure a strong EU-wide approach to foreign investment screening in a time of public health crisis and related economic vulnerability. ||| When State aid rules are applicable, Member States can design ample aid measures to support specific companies or sectors suffering from the consequences of the coronavirus outbreak in line with the existing EU State aid framework. ||| Ces mesures de recapitalisation complètent la panoplie d'instruments à la disposition des États membres figurant dans les orientations de la Commission afin de garantir l'application d'une approche résolue, à l'échelle de l'UE, en matière de filtrage des investissements étrangers, dans le contexte de la crise de santé publique actuelle et de la vulnérabilité économique que celle-ci entraîne.
0.3284226953983307 ||| During the controlled portions of pivotal Humira trials at least 12 weeks in duration in patients with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’ s disease and psoriasis, malignancies, other than lymphoma and non-melanoma skin cancer, were observed at a rate (95% confidence interval) of 5.9 (3.5, 9.9) per 1,000 patient-years among 3,853 Humira treated patients versus a rate of 4.3 (1.8, 10.4) per 1,000 patient-years among 2,183 control patients (median duration of treatment was 5.5 months for Humira and 3.9 months for control-treated patients). ||| In the controlled and non-controlled portions of psoriasis clinical studies, the rate of infection was 1.24 per patient-year of follow-up in ustekinumab-treated patients, and the incidence of serious infections was 0.01 per patient-year of follow-up in ustekinumab-treated patients (24 serious infections in 2,251 patient-years of follow-up) and serious infections reported included cellulitis, diverticulitis, osteomyelitis, viral infections, gastroenteritis, pneumonia, and urinary tract infections. ||| Pendant les périodes contrôlées des essais cliniques pivots avec Humira d’ une durée d’ au moins 12 semaines chez des patients souffrant de polyarthrite rhumatoïde modérément à sévèrement active, de rhumatisme psoriasique, de spondylarthrite ankylosante, de la maladie de Crohn et de psoriasis, un taux (intervalle de confiance 95%) de cancers autres que lymphomes ou cancers de la peau non mélanomes, de 5,9 (3,5 - 9,9) pour 1000 patient-années parmi les 3853 patients traités par Humira, a été observé versus un taux de 4,3 (1,8 - 10,4) pour 1000 patient-années parmi les 2183 patients du groupe contrôle (la durée moyenne du traitement était de 5,5 mois pour les patients traités par Humira et de 3,9 mois pour les patients du groupe contrôle).
0.14162948727607727 ||| Patients not responding to the initial 75 mg/ day dose may benefit from dose increases up to a maximum dose of 225 mg/ day. ||| However, in individual patients not responding to the initial 75 mg/ day, increases up to a maximum dose of 225 mg/ day may be considered. ||| Les patients ne répondant pas à la posologie initiale de 75 mg/ jour peuvent bénéficier d’ une augmentation de posologie jusqu’ à une posologie maximale de 225 mg/ jour.
0.3637278974056244 ||| The data supporting this application, as interpreted according with the CHMP guidance, did not support authorization of regular daily doses in excess of 160 µg in the treatment populations, and this was considered to be of serious public health concern. ||| The approved aid does not address any damage caused to the company by the coronavirus outbreak and has not been approved in the context of the recent crisis, but is required to address the longer term difficulties faced by Đuro Đaković, which predate the current situation. ||| Les données qui corroborent cette demande, interprétées sur la base des recommandations du CHMP, n’ étaient pas favorables à l’ autorisation de doses régulières de plus de 160 µg/ jour dans le traitement des populations et il a été considéré qu’ il s’ agissait d’ un problème de santé publique majeur.
0.45936012268066406 ||| may need to treat you with other medicines and interrupt your Tarceva treatment; ||| - if you are given anaesthetics during your treatment with ECALTA. ||| votre médecin peut alors décider de vous traiter par d’autres médicaments et d’interrompre votre traitement par Tarceva;
0.05472216755151749 ||| The Concerned Member States have not been able to reach an agreement in respect of the Mutual Recognition of the Marketing Authorisation granted by the Reference Member State. ||| These Member States were not been able to reach an agreement in respect of the Mutual Recognition of the Marketing Authorisation granted by the Reference Member State. ||| Les États membres concernés ne sont pas parvenus à un accord concernant la reconnaissance mutuelle de l’ autorisation de mise sur le marché par l’ État membre de référence.
0.7322098612785339 ||| i) Special precautions for use in animals ||| Inconsistent recommendations on usage in children ||| i) Précautions particulières d’ emploi chez l’ animal
0.39718398451805115 ||| Hold the syringe slightly tilted with the vial facing downwards. ||| Hold the pen with the needle pointing upwards. ||| Tenez la seringue légèrement inclinée avec le flacon tourné vers le bas.
0.3428843021392822 ||| Grafts for surgical use ||| Goniometers for surgical use ||| Greffes à usage chirurgical
0.5253746509552002 ||| concomitant RT n=288* ||| of Menitorix* N=123 ||| TMZ + RT concomitante n=288*
0.21763500571250916 ||| Hepatic insufficiency The pharmacokinetics of daptomycin is not altered in subjects with moderate hepatic insufficiency (Child-Pugh B classification of hepatic insufficiency) compared with healthy volunteers matched for gender, age and weight following a single 4 mg/ kg dose. ||| Hepatic impairment The effect of impaired hepatic function on the pharmacokinetics of vildagliptin was studied in patients with mild, moderate and severe hepatic impairment based on the Child-Pugh scores (ranging from 6 for mild to 12 for severe) in comparison with healthy subjects. ||| Insuffisance hépatique La pharmacocinétique de la daptomycine n’ est pas différente chez les sujets présentant une insuffisance hépatique modérée (score Child-Pugh B de l’ insuffisance hépatique) de celle des volontaires sains présentant les mêmes caractéristiques de sexe, d’ âge et de poids après administration d’ une dose unique de 4 mg/ kg.
0.19731405377388 ||| Precision parting tools [parts of machines] ||| Adaptors for tool bits [parts of machines] ||| Outils à tronçonner de précision [pièces de machines]
0.0012102201581001282 ||| The non-confidential version of the decision will be made available under the case number SA.56690 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| The non-confidential version of the decision will be made available under the case number SA.56840 in the State aid register on the Commission's competition website once any confidentiality issues have been resolved. ||| La version non confidentielle de la décision sera publiée sous le numéro SA.56690 dans le registre des aides d'État figurant sur le site web de la Commission consacré à la concurrence , dès que les éventuels problèmes de confidentialité auront été résolus.
0.30904120206832886 ||| EU/1/98/096/003 (5 hard capsules) EU/1/98/096/004 (20 hard capsules) ||| EU/1/99/127/002 1 vial of powder EU/1/99/127/003 6 vials of powder ||| EU/ 1/ 98/ 096/ 003 (5 gélules) EU/ 1/ 98/ 096/ 004 (20 gélules)
0.2266876995563507 ||| The appropriate volume of required dose is removed from the vial and further diluted to 100 ml with sodium chloride 9 mg/ ml (0.9%) solution for injection (see section 6.6.). ||| Filgrastim should be diluted in 20 ml of glucose 50 mg/ ml (5%) solution for infusion (see section 6.6 for instructions on dilution). ||| Le volume approprié pour la dose requise est prélevé dans le flacon puis est ensuite dilué dans 100 ml de solution de chlorure de sodium à 9 mg/ ml (0,9%) pour préparations injectables (voir rubrique 6.6).
0.25927653908729553 ||| As palonosetron may increase large bowel transit time, patients with a history of constipation or signs of subacute intestinal obstruction should be monitored following administration. ||| Calcitonin markedly reduces bone turnover in conditions with an increased rate of bone resorption such as Paget ‘ s disease and acute bone loss due to sudden immobilisation. ||| Comme le palonosétron peut augmenter le temps de transit colique, les patients ayant des antécédents de constipation ou des signes d'occlusion intestinale subaiguë doivent faire l'objet d'une surveillance après l'administration d'Aloxi.
0.3263353109359741 ||| Therefore, it is recommended that if nitisinone treatment is initiated with food, this should be maintained on a routine basis. ||| Should treatment with any of these agents be required, it is recommended that therapy with Tasigna be interrupted if possible (see section 4.5). ||| De ce fait, si le traitement par la nitisinone est instauré avec l’ alimentation, il est recommandé de le poursuivre dans les mêmes conditions.
0.026596708223223686 ||| Retacrit 20000 IU/ 0.5ml solution for injection in pre-filled syringe Epoetin zeta ||| Retacrit 10000 IU/ 1.0ml solution for injection in pre-filled syringe Epoetin zeta ||| Retacrit 20 000 UI/ 0,5 ml solution injectable en seringue préremplie Époétine zêta
0.2300843745470047 ||| Thalidomide may also potentially aggravate existing neuropathy and should therefore not be used in patients with clinical signs or symptoms of peripheral neuropathy unless the clinical benefits outweigh the risks. ||| In patients with current suicidal ideations and/ or with a history of suicidal ideation and depressive disorder rimonabant should not be used unless the benefits of treatment are considered to outweigh these risks in an individual patient. ||| Il ne doit donc pas être administré à des patients présentant des signes ou des symptômes cliniques de neuropathie périphérique à moins que les bénéfices cliniques ne soient supérieurs aux risques.
0.3493329882621765 ||| Fasturtec should not be used during pregnancy or in breast- feeding women. ||| Pregnancy and breast-feeding ADROVANCE is only intended for use in postmenopausal women. ||| Fasturtec ne doit pas être utilisé pendant la grossesse ou chez les femmes allaitant.
0.3218432664871216 ||| Just take your next dose at the usual time. ||| Take your next dose the next day at the usual time. ||| Il suffit de prendre la dose suivante à l'heure habituelle.
0.02174852229654789 ||| In postmarketing, serious allergic reactions including anaphylaxis have been reported very rarely following Humira administration. ||| In postmarketing, serious allergic reactions including anaphylaxis have been reported very rarely following Trudexa administration. ||| Au cours de la surveillance post-marketing des réactions allergiques graves, incluant des réactions anaphylactiques ont été très rarement rapportées, après administration d'Humira.
0.077176034450531 ||| 55 Common: ||| 53 Common: ||| Fréquents:
0.4768514037132263 ||| ProQuad is a vaccine against measles, mumps, rubella, and varicella (chickenpox). ||| Bronchial infections caused by Escherichia coli, Salmonella spp. and Pasteurella spp. ||| ProQuad est un vaccin contre la rougeole, les oreillons, la rubéole et la varicelle.
0.29523929953575134 ||| If you stop using Extavia Talk to your doctor if you stop or wish to stop treatment. ||| If you stop taking Activelle If you want to stop taking Activelle, talk to your doctor first. ||| Si vous arrêtez d’utiliser Extavia Si vous avez arrêté ou souhaitez arrêter le traitement, parlez-en à votre médecin.
0.2693038582801819 ||| Numerical control apparatus ||| Programmable control apparatus ||| Appareils à commande numérique
0.3621640205383301 ||| 22 The recommended starting dose of tadalafil is one 10 mg tablet before sexual activity. ||| The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. ||| La dose recommandée de tadalafil est d’ un comprimé à 10 mg à prendre avant l’ activité sexuelle.
0.042568329721689224 ||| 0.6 ml (1000 µg/ ml) ||| 0.4 ml (200 µg/ ml) ||| 0,6 ml (1000 µg/ ml)
0.20977568626403809 ||| Through 48 weeks of therapy, the proportion of patients with HIV RNA < 400 copies/ ml was 84% for antiretroviral naïve patients and 75% for antiretroviral experienced patients and the mean increase from baseline in CD4 cell count were 404 cells/ mm3 and 284 cells/ mm3 respectively. ||| At 48 weeks, approximately 75% of the patients treated with nelfinavir 750 mg TID plus zidovudine and lamivudine remained below the level of detection of the assay (< 400 copies/ml); mean increase in CD4 cell counts was 198 cells/mm3 at 48 weeks in this group. ||| Au cours des 48 semaines de traitement, la proportion de patients avec une charge virale < 400 copies/ ml était de 84% pour les patients naïfs d’ antirétroviraux et 75% pour les patients prétraités et les augmentations moyennes des taux de CD4 par rapport à la valeur initiale étaient respectivement de 404 cellules/ mm3 et de 284 cellules/ mm3.
0.0 ||| Pharmacovigilance Working Party ||| Pharmacovigilance Working Party ||| Groupe de travail “pharmacovigilance”
0.2699309289455414 ||| This must be considered during concomitant therapy with medicinal products metabolised by this route, such as the xanthine derivatives ||| This must be considered during concomitant therapy with medicinal products metabolised by this route, such as the xanthine derivatives theophylline or aminophylline. ||| Il faut envisager cet effet lors d’ un traitement concomitant avec des médicaments métabolisés par cette voie, tels les dérivés des xanthines
0.772620439529419 ||| Mineral supplements ATC code: ||| Ultrasound contrast media ATC code: ||| Code ATC:
0.12406796962022781 ||| 38 3. ||| 36 3. ||| 3.
0.6648126840591431 ||| We also call to the rest of the countries of Latin America to join this effort as well. ||| There are a number of ways for you to join the EAAD social media movement in 2019. ||| Nous appelons également les autres pays d'Amérique latine à s'unir à cet effort.
0.6294878721237183 ||| Sodium chloride and water for injections. ||| amount of itraconazole in your blood. ||| Chlorure de sodium et eau pour préparations injectables.
0.023543838411569595 ||| One multidose vial of powder contains: follitropin alfa 1200 IU/ 2 ml. ||| One multidose vial of powder contains: follitropin alfa 600 IU/ ml. ||| Un flacon multidose de poudre contient: follitropine alfa 1.200 UI/ 2 ml.
0.5648488402366638 ||| Press the knob. ||| 3) Prime the pen. ||| Appuyer sur le bouton.
0.01965503767132759 ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| Α MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| FABRICANT DE LA SUBSTANCE ACTIVE D'ORIGINE BIOLOGIQUE ET TITULAIRE DE L’AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.08316630125045776 ||| • 210 days • 224 days ||| • 199 days • 202 days ||| 210 jours 224 jours
0.4532310962677002 ||| Efficacy of Xolair treatment in combination with specific immunotherapy has not been established. ||| The re are no studies to demonstrate beneficial effects on survival of treatment with Tracleer. ||| L’ efficacité du traitement par Xolair administré en association avec une immunothérapie spécifique n’ a pas été établie.
0.04283297061920166 ||| 1000/ 1200 mg 48 weeks ||| 1000/ 1200 mg 24 weeks ||| 1000/1200 mg 48 semaines 92% (47/51)
0.711181640625 ||| Insert the needle into your skin. ||| Take this medicine on an empty stomach. ||| Insérez l’ aiguille dans votre peau.
0.0 ||| 6.4 Special precautions for storage ||| 6.4 Special precautions for storage ||| 160 6.4 Précautions particulières de conservation
0.18699505925178528 ||| When Micardis is used in patients with impaired renal function, periodic monitoring of potassium and creatinine serum levels is recommended. ||| In patients with impaired renal function, calcium salts should be taken under medical supervision with monitoring of calcium and phosphate serum levels. ||| En cas d’ administration de Micardis à des patients atteints d’ insuffisance rénale, une surveillance régulière de la kaliémie et du taux de créatinine sérique est recommandée.
0.3583119809627533 ||| A higher proportion of patients receiving the original rituximab/ MTX treatment also had no erosive progression over 56 weeks (Table 8). ||| Similarly, no differences were noted between the groups in the pivotal study with Bondenza 3 mg injection every 3 months (BM 16550). ||| Le pourcentage de patients sans progression radiographique après 56 semaines a été également significativement plus élevé dans le groupe de patients traités à l’ origine par rituximab/ MTX (Tableau8).
0.46837660670280457 ||| Also on the same day, the first patient had recovered from COVID-19 in Karachi and was discharged from the hospital. ||| He sought medical attention because of serious illness and died shortly after arriving at the Húsavík health clinic. ||| Le même jour également, le premier patient s'était rétabli du COVID-19 à Karachi et a quitté l'hôpital.
0.42055824398994446 ||| The usual dose for adults with psoriasis is an initial dose of 80 mg, followed by 40 mg given every other week starting one week after the initial dose. ||| Treatment can be given as a once daily dose or alternatively the daily dose may be split into two administrations – one in the morning and one in the evening. ||| La posologie habituelle chez l’adulte atteint de psoriasis est une dose initiale de 80 mg, suivie de 40 mg administrés une semaine sur deux après la dose initiale.
0.02120322361588478 ||| Valsartan does not exhibit any partial agonist activity at the AT 1 receptor and has much (about 20,000 fold) greater affinity for the AT 1 receptor than for the AT 2 receptor. ||| Valsartan does not exhibit any partial agonist activity at the AT1 receptor and has much (about 20,000-fold) greater affinity for the AT1 receptor than for the AT2 receptor. ||| Aucune activité agoniste partielle sur le récepteur AT1 n’a été mise en évidence pour le valsartan dont l’affinité pour le récepteur AT 1 est beaucoup plus forte (environ 20 000 fois) que pour le récepteur AT 2.
0.0 ||| Using other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Using other medicines Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. ||| Utilisation d’autres médicaments Si vous prenez ou avez pris récemment un autre médicament, y compris un médicament obtenu sans ordonnance, parlez-en à votre médecin.
0.020509010180830956 ||| At the menopause, the ovaries stop producing the female hormone, oestrogen, which helps to keep a woman’ s skeleton healthy. ||| At the menopause, the ovaries stop producing the female hormone, oestrogen, which helps to keep a woman ’ s skeleton healthy. ||| Après la ménopause, les ovaires arrêtent leur production d'hormones féminines, les estrogènes qui aident les femmes à conserver leur squelette sain.
0.10022948682308197 ||| GONAL-f 300 IU/ 0.50 ml (22 micrograms/ 0.50 ml) powder and solvent for solution for injection Follitropin alfa ||| GONAL-f 300 IU/ 0.50 ml (22 micrograms/ 0.50 ml) powder and solvent for solution for injection. ||| GONAL-f 300 UI/ 0,50 ml (22 microgrammes/ 0,50 ml) poudre et solvant pour solution injectable follitropine alfa
0.39926210045814514 ||| Archery bowstrings ||| Rear wheel sprockets ||| Cordes d'arc de tir
0.7244132161140442 ||| Bill payment services provided through a website ||| Data communication services accessible by access code ||| Services de paiement de factures via un site Web
0.30570608377456665 ||| In two clinical studies performed in healthy adult subjects, cyclosporin A (one 4 mg/ kg dose or two 3 mg/ kg doses 12 hours apart) increased the AUC of caspofungin by approximately 35%. ||| In the event a patient does still not respond when treated with the maximum dose of hydroxycarbamide (35 mg/ kg b. w. / day) over three to six months, permanent discontinuation of Siklos should be considered. ||| Dans deux études cliniques réalisées chez des sujets adultes sains, la ciclosporine A (à la dose unique de 4 mg/ kg ou lors de l’ administration de deux doses de 3 mg/ kg séparées par un intervalle de
0.3743627965450287 ||| Glass vial (Type 1) closed with a disc (bromobutyl/ polyisoprene rubber) and a protective tamper-proof plastic cap containing 10 ml of solution. ||| The solvent container is a neutral, colourless glass type 1 vial with a bromobutyl rubber stopper or a neutral, colourless glass type 1 ampoule. ||| Flacon en verre (type 1) obturé par un disque (caoutchouc bromobutyl/ polyisoprène) et un opercule de sécurité en plastique contenant 10 ml de solution.
0.1837952733039856 ||| HOW TO STORE REVASC ||| HOW TO STORE PREPANDRIX ||| COMMENT CONSERVER REVASC
0.0 ||| The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. ||| The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. ||| 7 incrétines font partie d'un système endogène impliqué dans la régulation physiologique de l'homéostasie du glucose.
0.27374160289764404 ||| Dexmedetomidine also induces a number of other α 2-adrenoceptor mediated effects, which include piloerection, depression of motor and secretory functions of the gastrointestinal tract, diuresis and hyperglycaemia. ||| In repeat-dose toxicity studies, daily oral administration of capecitabine to cynomolgus monkeys and mice produced toxic effects on the gastrointestinal, lymphoid and haemopoietic systems, typical for fluoropyrimidines. ||| La dexmédétomidine induit également un certain nombre d'autres effets associés aux récepteurs α 2-adrénergiques notamment: pilo-érection, dépression des fonctions motrices et sécrétoires du tractus gastro-intestinal, diurèse et hyperglycémie.
0.3315754234790802 ||| The CHMP was also concerned that the levels of MULTAQ could be altered in patients taking some other medicines, including medicines used to treat the heart. ||| The additional studies showed that protection against hepatitis B from PROCOMVAX was adequate in infants who had and who had not received hepatitis B vaccination in the past. ||| Le CHMP avait également des inquiétudes sur le maintien des niveaux de MULTAQ chez les patients prenant d'autres médicaments, notamment des médicaments pour le cœ ur.
0.3336741328239441 ||| This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. ||| These actions are effective methods to lower the risk of infection as well as prevent the spread of the virus. ||| Ceci améliorera votre système immunitaire et diminuera le risque de développer des maladies liées à l’infection par le VIH.
0.30124449729919434 ||| Table 5 includes adverse reactions reported during clinical trials for recurrent or progressive malignant glioma and following the marketing of Temodal. ||| The adverse event profile reported in the ACS program is consistent with the adverse drug reactions identified for VTE prophylaxis. ||| Le Tableau 5 comprend les effets indésirables rapportés lors des essais cliniques dans le cadre de gliome malin en progression ou récidive et suite à la mise sur le marché de Temodal.
0.45851993560791016 ||| 28.6%). ||| 9.9%); ||| 28,6%).
0.4103650748729706 ||| The number of elderly patients in whom the pharmacokinetics were determined was limited (over 65 years, N=3). ||| Only a small number of elderly patients (≥ 65 years, n=23/ 872; 2.6%) provided pharmacokinetic data. ||| Le nombre de patients âgés chez lesquels les caractéristiques pharmacocinétiques ont été évaluées est limité (plus de 65 ans, n = 3).
0.6142630577087402 ||| The injections can then be given by a doctor, trained nurse or other health care professional. ||| Staff are also offered the possibility to ask questions by email or phone to a dedicated helpdesk 24/7. ||| Les injections de Silapo peuvent être effectuées par un médecin, une infirmière ou un autre professionnel de santé.
0.15955553948879242 ||| Atripla is an antiviral medicine. ||| Stocrin is an antiviral medicine. ||| Atripla est un médicament antiviral.
0.39029765129089355 ||| Riquent is a solution for injection that contains 50 mg/ ml of the active substance abetimus. ||| Nobilis OR Inac is an emulsion (a mixture of oil- and water-based liquids) for injection. ||| Riquent est une solution injectable qui contient 50 mg/ ml d’ abetimus, son principe actif.
0.31005847454071045 ||| Thromboembolic events, including pulmonary embolism ||| Thromboembolic and other vascular disorders ||| Évènements thrombo-emboliques y
0.39934873580932617 ||| Formal interaction studies between Thyrogen and other medicinal products have not been performed. ||| However, pharmacodynamic interactions with these drugs have not been assessed. ||| Il n'a pas été mené d'études d'interaction entre Thyrogen et d'autres médicaments.
0.15150503814220428 ||| Microcrystalline cellulose (E460) Pregelatinised starch (gluten free) Croscarmellose sodium Lactose monohydrate Magnesium stearate (E572) ||| Lactose monohydrate Cellulose, microcrystalline (E460) Sodium starch glycolate Type A Sodium laurilsulfate Magnesium stearate (E470 b) ||| Cellulose microcristalline (E460) Amidon prégélatinisé (sans gluten) Croscarmellose sodique Lactose monohydraté Stéarate de magnésium (E572)
0.5443594455718994 ||| The arbitration procedure started on 15 November 2007 with the adoption of a list of questions. ||| The procedure for evaluation of the new data started on 15 April 2008. ||| La procédure d’ arbitrage a démarré le 15 novembre 2007 avec l’ adoption d’ une liste de questions.
0.7349392771720886 ||| Industrial ovens ||| Linen clothing ||| Fours industriels
0.3982282280921936 ||| 20 In two clinical studies (study B2222 and an intergroup study S0033) the daily dose of Glivec was escalated to 800 mg in patients progressing at the lower daily doses of 400 mg or 600 mg. ||| Similar remission rates were observed for the 160/ 80 mg and 80/ 40 mg induction regimens by Week 8 and adverse events were more frequently noted in the 160/ 80 mg group. ||| Dans les deux études cliniques (étude B2222 et étude intergroupe S0033), la dose quotidienne de Glivec a été augmentée à 800 mg chez les patients qui progressaient aux plus faibles doses de 400 mg ou 600 mg par jour.
0.8521338701248169 ||| EXP After first opening, use within 30 days. ||| First episode: stop 5-FU only, at all subsequent cycles. ||| EXP Utiliser dans les 30 jours après ouverture initiale.
0.31459861993789673 ||| Therefore, administration of YENTREVE to children and adolescents is not recommended. ||| Therefore, administration of XERISTAR to children and adolescents is not recommended (see section 4.4). ||| Par conséquent, l'administration de YENTREVE est déconseillée chez les enfants et les adolescentes.
0.002017255872488022 ||| 3 Before travelling between different time zones, the patient should be advised to consult the doctor, since this may mean that the patient has to take insulin and meals at different times. ||| 3 Before travelling between different time zones, the patient should be advised to consult the physician, since this may mean that the patient has to take insulin and meals at different times. ||| au Il est conseillé aux patients prévoyant d’ effectuer un voyage lors duquel ils subiront un décalage horaire de consulter leur médecin, car ils pourront avoir besoin de prendre leur insuline et leurs repas à des heures différentes des heures habituelles.
0.44188734889030457 ||| These transaminase increases were likely to be related to the skeletal muscle effects. ||| These changes were mainly attributed to age-related changes in renal function. ||| Cette augmentation des transaminases était probablement liée à des effets sur le muscle squelettique.
0.0 ||| Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ: + 357 22 89 95 01 ||| Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ: + 357 22 89 95 01 ||| 47 Κύπρος GlaxoSmithKline Cyprus Ltd Τηλ: + 357 22 89 95 01
0.7403353452682495 ||| For subcutaneous administration only. ||| Consolidation in several respects. ||| Réservé uniquement à l’ administration par voie sous-cutanée.
0.6808463335037231 ||| - Joint pain ||| • Stomach pain ||| - Douleurs articulaires
0.3107783794403076 ||| MPA is metabolised principally by glucuronyl transferase to form the phenolic glucuronide of MPA (MPAG), which is not pharmacologically active. ||| It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors. ||| Le MPA est transformé principalement par la glucuronyl transférase en glucuronide phénolique du MPA (MPAG), lequel n'est pas pharmacologiquement actif.
0.5006780624389648 ||| Blade sharpening [stropping] machines ||| Treating [stamping] of metal ||| Machines pour le repassage des lames
0.21718865633010864 ||| Each vial contains gemcitabine hydrochloride equivalent to 1000 mg gemcitabine ||| Each vial contains doripenem monohydrate equivalent to 500 mg doripenem ||| Chaque flacon contient du chlorhydrate de gemcitabine correspondant à 1 000 mg de gemcitabine.
0.16942650079727173 ||| The combination of Pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin. ||| This combination is also indicated in relapse patients and patients who have not responded previously to interferon alpha (pegylated or nonpegylated) and ribavirin combination therapy or interferon alpha monotherapy. ||| L’ association de Pegasys et de la ribavirine est indiquée chez les patients naïfs et les patients en échec à un précédent traitement par interféron alpha (pégylé ou non pégylé) seul ou en association avec la ribavirine.
0.056789886206388474 ||| In clinical trials there was no age-related difference with regard to efficacy or safety profiles of alendronate. ||| In clinical studies there was no age-related difference in the efficacy or safety profiles of alendronate. ||| Les études cliniques n’ ont révélé aucune différence liée à l’ âge eu égard aux profils d’ efficacité et de sécurité d’ emploi de l’ alendronate.
0.26895731687545776 ||| Thus, patients who develop fatigue, somnolence, or confusion during treatment must be cautioned to avoid driving or operating machinery. ||| Patients should be instructed that if they experience sedation or dizziness they should avoid potentially hazardous tasks such as driving or operating machinery. ||| Ainsi, les patients qui présentent fatigue, somnolence ou confusion pendant le traitement doivent être avertis de ne pas conduire de véhicules ou utiliser des machines.
0.9120680093765259 ||| EMEA guidance documents in 2003 ||| Parallel distribution notifications 1998-2000 ||| Documents d’ orientation de l’ EMEA 2003
0.3454081118106842 ||| Special caution is necessary when you are treated with a ß-blocker concomitantly, • if you have problems with your heart valves or heart muscle, • if you suffer from coronary heart disease (caused by a reduced blood flow in the blood vessels of the heart) or from cerebrovascular disease (caused by a reduced blood circulation in the brain), • if you suffer from primary hyperaldosteronism (a syndrome associated with increased secretion of the hormone aldosterone by the adrenal gland, caused by an abnormality within the gland). ||| 39 Take special care with Emselex: • if you have autonomic neuropathy - your doctor will have told you if you have this. • if you have heartburn and belching. • if you have difficulties in passing urine and a weak stream of urine. • if you have severe constipation (less than or equal to 2 bowel movements per week). • if you have an obstructive gastrointestinal disorder - your doctor will have told you if you have this. • if you are receiving treatment for narrow-angle glaucoma. • if you have liver problems. • if you have kidney problems. ||| Une attention particulière est nécessaire lorsque vous êtes traités simultanément par des bêtabloquants, • Si vous avez un problème de valves cardiaques ou du muscle cardiaque, • Si vous souffrez d'une maladie coronaire (causée par une réduction de la circulation sanguine dans les vaisseaux cardiaques), ou d'une maladie cérébro-vasculaire (causée par une réduction de la circulation sanguine dans le cerveau) • Si vous avez un hyperaldostéronisme primaire (un syndrome associé à une augmentation de la sécrétion d'aldostérone suite à une anomalie des glandes surrénales),
0.20908205211162567 ||| Electric wine coolers for household purposes ||| Electric food dehydrators for household purposes ||| Refroidisseur de vin à usage domestique
0.3025151491165161 ||| Dafiro 5 mg/ 160 mg film-coated tablets amlodipine/ valsartan ||| Stalevo 200 mg/ 50 mg/ 200 mg film-coated tablets levodopa/ carbidopa/ entacapone ||| Dafiro 5 mg/ 160 mg comprimés pelliculés amlodipine/ valsartan
0.48625874519348145 ||| Fire extinguishing apparatus for automobiles ||| Armour-piercing incendiary projectiles ||| Extincteurs pour véhicules automobiles
0.24497082829475403 ||| White to off-white, oval tablet, debossed with “ T125” on one side and “ 100” on the other side. ||| Bonviva tablets are white to off white, of oblong shape and marked “BNVA” on one side, and “150” on the other side. ||| Comprimé ovale, blanc à blanc cassé, portant les inscriptions « T125 » gravée sur une face et « 100 » gravée sur l’ autre face.
0.29835981130599976 ||| Laser sensors ||| Solar modules ||| Capteurs laser
0.3045172691345215 ||| Except for zidovudine, which interferes with the activity of stavudine, Zerit may be taken with many of the other medicines commonly used in patients with HIV infection. ||| If you take zidovudine or stavudine as a treatment for HIV or AIDS, it is possible that ribavirin will affect the way these medicines work. ||| Hormis la zidovudine, qui interagit avec la stavudine, Zerit peut être associé à de nombreux autres médicaments utilisés par les patients infectés par le VIH.
0.002921285107731819 ||| EU/ 1/ 97/ 030/ 122 (3 cartridges of 3 ml) EU/ 1/ 97/ 030/ 123 (4 cartridges of 3 ml) EU/ 1/ 97/ 030/ 124 (5 cartridges of 3 ml) EU/ 1/ 97/ 030/ 125 (6 cartridges of 3 ml) EU/ 1/ 97/ 030/ 126 (9 cartridges of 3 ml) EU/ 1/ 97/ 030/ 127 (10 cartridges of 3 ml) ||| EU/ 1/ 97/ 030/ 116 (3 cartridges of 3 ml) EU/ 1/ 97/ 030/ 117 (4 cartridges of 3 ml) EU/ 1/ 97/ 030/ 118 (5 cartridges of 3 ml) EU/ 1/ 97/ 030/ 119 (6 cartridges of 3 ml) EU/ 1/ 97/ 030/ 120 (9 cartridges of 3 ml) EU/ 1/ 97/ 030/ 121 (10 cartridges of 3 ml) ||| EU/ 1/ 97/ 030/ 122 (3 cartouches de 3 ml) EU/ 1/ 97/ 030/ 123 (4 cartouches de 3 ml) EU/ 1/ 97/ 030/ 124 (5 cartouches de 3 ml) EU/ 1/ 97/ 030/ 125 (6 cartouches de 3 ml) EU/ 1/ 97/ 030/ 126 (9 cartouches de 3 ml) EU/ 1/ 97/ 030/ 127 (10 cartouches de 3 ml)
0.1478460133075714 ||| The European Commission has approved two Portuguese State aid schemes to support the Portuguese economy in the context of the coronavirus outbreak. ||| The European Commission has approved two Croatian schemes to support the Croatian economy in the context of the coronavirus outbreak. ||| La Commission européenne a autorisé deux régimes d'aides d'État portugais visant à soutenir l'économie portugaise dans le contexte de la pandémie de COVID-19.
0.27786168456077576 ||| 10 months. ||| 26 months. ||| 10 mois.
0.42843782901763916 ||| - if you have a history of pancreatitis, have uncontrolled lipid (blood fats) elevations (high blood ||| • pain and swelling at injection site • high number of platelets (blood cells necessary for blood clotting) du ||| - si vous avez des antécédents de pancréatite, d’ augmentations incontrôlées en lipides dans le sang
0.38404494524002075 ||| Urinary antispasmodic, ATC code: ||| Interleukin inhibitors, ATC code: ||| Classe pharmacothérapeutique: antispasmodiques urinaires, code ATC:
0.19602365791797638 ||| How to store Ciprofloxacin Kabi 6. ||| Before you use Ciprofloxacin Kabi 3. ||| Comment conserver Ciprofloxacine Kabi 6.
0.004874702077358961 ||| Treatment should be maintained in the case of stable disease, i. e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated. ||| Treatment should be maintained in the case of stable disease, i.e. static, partial or complete tumour response, provided that the product is sufficiently well tolerated. ||| Le traitement doit être maintenu dans le cas d’ une maladie stable, c’ est-à-dire lorsque la réponse tumorale est statique, partielle ou complète, sous réserve que le produit soit suffisamment bien toléré.
0.28821784257888794 ||| If any of these apply to you, your doctor may need to monitor you more closely while you are on this medicine. ||| If you have any of these conditions, please talk to your doctor as he/ she may want to adjust your dose or monitor you for a while. ||| Dans ce cas, votre médecin vous surveillera plus étroitement pendant que vous utilisez ce médicament.
0.40452224016189575 ||| Once completed, the database will be a further source of authoritative information about medicines for patients, healthcare professionals and regulators. ||| This appropriation is intended to cover preliminary legal costs and the services of lawyers or other experts called in to advise the Agency. ||| Une fois achevée, la base de données constituera une source supplémentaire de renseignements faisant autorité à l’ intention des patients, des professionnels de la santé et des responsables de la réglementation.
0.3235536813735962 ||| During clinical trials, the following side effects were reported with the use of IDflu. ||| The following side effects were reported in patients with CTCL who were treated with the recommended initial dose of capsules. ||| Au cours des études cliniques, les effets indésirables suivants ont été rapportés avec IDflu.
0.17935509979724884 ||| Special precautions for use in animals ke ||| Special precautions for use in animals ||| Précautions particulières d’ emploi chez les animaux r
0.0 ||| 48 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 48 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 48 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.08497411012649536 ||| What Rebetol is and what it is used for 2. ||| What Panretin is and what it is used for 2. ||| Qu’ est -ce que Rebetol et dans quel cas est -il utilisé 2.
0.0 ||| DATE OF REVISION OF THE TEXT a in ic ||| DATE OF REVISION OF THE TEXT a in ic ||| DATE DE MISE À JOUR DU TEXTE
0.7485473155975342 ||| The reconstituted product is a white to slightly yellowish suspension with strawberry odour. ||| White, opaque and imprinted with blue ink. ||| Le produit reconstitué est une suspension de couleur blanche à légèrement jaunâtre ayant un arôme fraise.
0.41986584663391113 ||| Assistance and consultancy relating to business management and organisation ||| Consultancy and information services relating to information technology architecture and infrastructure ||| Services d'assistance et de conseillers en organisation et gestion des affaires commerciales
0.10204896330833435 ||| Before the first use store your Liprolog Basal Pen in a refrigerator (2°C – 8°C). ||| Before the first use store your Humalog Mix25 Pen in a refrigerator (2°C – 8°C). ||| Avant la première utilisation, conservez Liprolog BASAL Pen au réfrigérateur, à une température comprise entre 2°C et 8°C.
0.1890757977962494 ||| In schizophrenia, Zyprexa tablets have been studied in about 3,000 adults, in which their effectiveness was compared with that of placebo (a dummy treatment) or haloperidol (another antipsychotic medicine). ||| For advanced ovarian cancer, Caelyx has been compared with topotecan (another anticancer medicine) in one study involving 474 women who had received platinum-based chemotherapy in the past. ||| Leur efficacité a été comparée soit à celle d’ un placebo (traitement factice), soit à celle de l’ halopéridol (un autre neuroleptique).
0.4590388238430023 ||| Medical information services provided via the Internet ||| Financial information provided by electronic means ||| Services d'informations médicales fournis par le biais d'Internet
0.025482211261987686 ||| 480 PACKAGE LEAFLET: ||| 330 PACKAGE LEAFLET: ||| 512 NOTICE:
0.27351075410842896 ||| Atorvastatin (80 mg daily) did not alter the pharmacokinetics of prasugrel and its inhibition of platelet aggregation. ||| 22 The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges. ||| L'atorvastatine (80 mg par jour) n'a pas modifié la pharmacocinétique du prasugrel et son inhibition de l'agrégation plaquettaire.
0.0011590035865083337 ||| 49 Metformin Non-clinical data for metformin reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| 66 Metformin Non-clinical data for metformin reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. ||| Metformine Les données non cliniques, basées sur des études conventionnelles portant sur la sécurité pharmacologique, la toxicité après des doses répétées, la génotoxicité, le pouvoir cancérigène, et la toxicité sur la reproduction, ne révèlent aucun risque particulier pour l'homme.
0.42995476722717285 ||| Frequency ||| Frequency and ||| Fréquent:
0.14436179399490356 ||| Glivec 100 mg film-coated tablets Imatinib ||| Starlix 60 mg film-coated tablets Nateglinide ||| Glivec 100 mg comprimés pelliculés Imatinib
0.029369276016950607 ||| 3 ml of solution (corresponding to 18 MIU) in a vial (type I glass), with a stopper (halobutyl rubber) in a flip- off seal (aluminium) with a bonnet (polypropylene). ||| 24 mg of powder (corresponding to 10 MIU) in a vial (type I glass), with a stopper (butyl rubber) in a flip-off seal (aluminium) with a bonnet (polypropylene) t ||| 3 ml de solution (correspondant à 18 MUI) dans un flacon (verre de type I), avec un bouchon (caoutchouc en halobutyle) serti d'une bague d'inviolabilité (aluminium) entourée d’ une protection (polypropylène).
0.8226326704025269 ||| Lekkerkerker, respectively. ||| Lekkerkerker and Dr. ||| Lekkerkerker, respectivement.
0.38975435495376587 ||| uncommon: ||| ed Uncommon: ||| Peu fréquents:
0.16092874109745026 ||| • 17.5.2002 ||| • 19.3.2002 ||| 17.5.2002
0.08376465737819672 ||| They recommended that Regranex be given marketing authorisation. ||| They recommended that Inovelon be given marketing authorisation. ||| Il a recommandé que Regranex reçoive une autorisation de mise sur le marché.
0.0017179944552481174 ||| 78 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 77 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS ||| 84 MENTIONS MINIMALES DEVANT FIGURER SUR LES PETITS CONDITIONNEMENTS PRIMAIRES
0.5762014389038086 ||| Electric coffee urns ||| Expresso coffee machines ||| Cafetières électriques
0.23873946070671082 ||| In patients with severe hepatic impairment (Child Pugh C), the dose of Tygacil should be reduced to 25 mg every 12 hours following the 100 mg loading dose. ||| Use in patients with a low heart rate Ivabradine must not be initiated in patients with a pre-treatment resting heart rate below 60 beats per minute (see section 4.3). ||| Chez les patients avec une insuffisance hépatique sévère (score Child Pugh C), la dose de Tygacil doit être réduite à 25 mg toutes les 12 heures après une dose de charge de 100 mg.
0.5507289171218872 ||| All swimming pools, museums, libraries and bars closed, as did any businesses requiring a proximity of less than 2 m (hairdressers, tattoo artists, etc.). ||| Performances across Europe have been cancelled, festivals, conferences and exhibitions postponed, cinemas, theatres and museums closed, television and film productions put on hold, so many artists cannot earn a living. ||| Toutes les piscines, musées, bibliothèques et bars fermés, tout comme les commerces nécessitant une proximité inférieure à 2 m (coiffeurs, tatoueurs, etc.).
0.3635726869106293 ||| Greece notified to the Commission under the Temporary Framework a scheme to provide a one-off payment of €800 per self-employed person, including self-employed managers of companies that employ less than 20 employees in sectors severely affected by the coronavirus outbreak. ||| During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 million British workers applied for a universal credit scheme.Almost half a million companies in Germany have sent their workers on a government-subsidized short-time working schemes known as Kurzarbeit. ||| La Grèce a notifié à la Commission, en vertu de l' encadrement temporaire , un régime prévoyant un versement unique de 800 euros à chaque travailleur indépendant, y compris aux gérants indépendants d'entreprises employant moins de 20 salariés dans les secteurs durement touchés par la pandémie de coronavirus.
0.39837878942489624 ||| Therefore the Commission proposes to use a range of instruments to support investment and reforms in the Member States, focusing on where the crisis impact and resilience needs are greatest: ||| Today, we are presenting concrete actions to Member States to proactively prevent shortages and ensure that our hospitals have the essential medicines needed to save lives. ||| La Commission propose par conséquent de recourir à un ensemble d'instruments pour soutenir les investissements et les réformes dans les États membres, en mettant l'accent là où les répercussions de la crise se font le plus sentir et où les besoins en termes de résilience sont les plus pressants:
2.4731651730898474e-13 ||| Safeguards are in place to avoid undue distortions of competition in the Single Market: conditions on the necessity, appropriateness and size of intervention; conditions on the State's entry in the capital of companies and remuneration; conditions regarding the exit of the State from the capital of the companies concerned; conditions regarding governance including dividend ban and remuneration caps for senior management; prohibition of cross-subsidisation and acquisition ban and additional measures to limit competition distortions; transparency and reporting requirements. ||| Safeguards are in place to avoid undue distortions of competition in the Single Market: conditions on the necessity, appropriateness and size of intervention; conditions on the State's entry in the capital of companies and remuneration; conditions regarding the exit of the State from the capital of the companies concerned; conditions regarding governance including dividend ban and remuneration caps for senior management; prohibition of cross-subsidisation and acquisition ban and additional measures to limit competition distortions; transparency and reporting requirements. ||| Des garanties sont prévues pour éviter toute distorsion indue de la concurrence sur le marché unique: conditions relatives à la nécessité, au caractère approprié et à la taille de l'intervention; conditions relatives à l'entrée de l'État dans le capital des entreprises et à la rémunération; conditions relatives à la sortie de l'État du capital des entreprises concernées; conditions relatives à la gouvernance, y compris l'interdiction de verser des dividendes et les plafonds de rémunération pour l'encadrement supérieur; interdiction des subventions croisées et des acquisitions, et mesures supplémentaires visant à limiter les distorsions de concurrence; obligations de déclaration et de transparence.
0.04303670674562454 ||| 65 LABELLING ||| 55 LABELLING ||| 68 ETIQUETAGE
3.097887072735228e-13 ||| Concomitant treatment with medicines displaying action on renal flow, e. g. diuretics or angiotensin converting enzyme (ACE) inhibitors, should be subject to clinical monitoring. ||| Concomitant treatment with medicines displaying action on renal flow, e. g. diuretics or angiotensin converting enzyme (ACE) inhibitors, should be subject to clinical monitoring. ||| Un traitement concommitant avec des médicaments agissant sur le débit rénal comme les diurétiques ou les inhibiteurs de l’ Enzyme de Conversion de l’ Angiotensine (IECA), devra faire l’ objet d’ une surveillance étroite.
0.36909162998199463 ||| You should not take DULOXETINE BOEHRINGER INGELHEIM if you are taking, or have recently taken within the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI). ||| If a decision to initiate antidepressant pharmacological therapy is taken, the gradual discontinuation of DULOXETINE BOEHRINGER INGELHEIM is recommended (see Section 4.2). ||| Inhibiteurs de la monoamine oxydase (IMAO): vous ne devez pas prendre DULOXETINE BOEHRINGER INGELHEIM en association avec un IMAO ou dans les 14 jours suivant l’ arrêt d'un IMAO.
0.49516916275024414 ||| Only use TRAVATAN for dropping in your eyes. ||| Do not use BYETTA after your meal. ||| Utilisez TRAVATAN seulement en gouttes dans les yeux.
0.6929465532302856 ||| Headache Dizziness ||| Dysgeusia Headache ||| Céphalées Vertiges
0.015917588025331497 ||| Do not use ABILIFY if you are allergic (hypersensitive) to aripiprazole or any of the other ingredients of ABILIFY. ||| Do not take ABILIFY if you are allergic (hypersensitive) to aripiprazole or any of the other ingredients of ABILIFY. ||| N'utilisez jamais ABILIFY si vous êtes allergique (hypersensible) à l'aripiprazole ou à l'un des autres composants contenus dans ABILIFY.
0.3628948926925659 ||| The mean steady state volume of distribution (Vss) for sildenafil is 105 l, indicating distribution into the tissues. ||| The maximum tolerated dose (MTD) of Beromun for ILP is 4 mg, which is 10 times the systemic MTD. ||| Le volume de distribution moyen (Vss) à l’ état d’ équilibre du sildénafil est de 105 l, ce qui suggère une distribution tissulaire.
0.48626893758773804 ||| Infanrix hexa, Powder and suspension for suspension for injection. ||| Powder and suspension for suspension for injection Vial: powder Pre-filled syringe: suspension ||| Infanrix hexa, poudre et suspension pour suspension injectable
0.8731582760810852 ||| Clear, colourless solution. ||| Clear colourless solution ||| Solution transparente, incolore.
0.21536321938037872 ||| You and your partner must each use an effective contraceptive during the time you are taking the treatment and for 7 months after stopping treatment. ||| If you are a male patient, you and your partner must each use an effective contraceptive during the time you are taking ribavirin and for 7 months after stopping treatment. ||| Vous et votre partenaire devez chacun utiliser une méthode de contraception efficace durant toute la durée de votre traitement et pendant les 7 mois suivant son arrêt.
0.08882738649845123 ||| -49.6 (-69.0; -30.3) -49.8(-63.1; -36.6) -58.3 (-85.7; -30.9) 6.7 (-10.6; 23.9) -40.5 (-64.1; -16.8) ||| -51.6 (-57.9; -45.3) -50.5 (-57.5; -43.4) -59.5 (-72.9; -46.1) 6.7 8-12.5; 25.8) 38.2 (-50.2; -26.1) ||| -49,6 (-69;-30,3) -49,8(-63,1;-36,6) -58,3 (-85,7;-30,9) 6,7 (-10,6;23,9) -40,5 (-64,1;-16,8)
0.473246693611145 ||| What Olanzapine Neopharma contains ||| What Tritanrix HepB contains ||| Que contient Olanzapine Neopharma
0.3199864625930786 ||| If required, Ratiograstim may be diluted in glucose 50 mg/ ml (5%) solution for infusion. ||| Caution must be exercised in handling Temodal 2.5 mg/ml powder for solution for infusion. ||| Si nécessaire, Ratiograstim peut être dilué dans une solution de glucose à 50 mg/ ml (5%).
0.30783432722091675 ||| For patients receiving haemodialysis, the pregabalin daily dose should be adjusted based on renal function. ||| Patients with this medical history should have serum triglycerides monitored when taking lasofoxifene. ||| Pour les patients hémodialysés, la dose journalière de prégabaline doit être adaptée en tenant compte de la fonction rénale.
0.674797534942627 ||| Statuettes made of ivory ||| Kitchen utensils of silicon ||| Statuettes en ivoire
0.3054024577140808 ||| Connect the plunger rod by screwing it clockwise into the syringe. ||| Unwrap the 30 gauge needle and connect it to the syringe. ||| Fixer le piston en le vissant sur la seringue dans le sens des aiguilles d'une montre.
0.0 ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. ||| - Si l’ un des effets indésirables devient grave ou si vous remarquez un effet indésirable non
0.18737487494945526 ||| Oral use Read the package leaflet before use ||| Dilute before use Read the package leaflet before use ||| Voie orale Lire attentivement la notice avant utilisation
0.26523271203041077 ||| • If you have problems with your kidneys, your doctor may advise you to take Truvada less frequently. ||| Your doctor may prescribe you a different dose if you have problems with your kidneys. ||| • Si vous avez des problèmes de rein, votre médecin peut vous conseiller de prendre Truvada moins fréquemment.
0.5552894473075867 ||| Packaging bottle (HDPE) bottle (HDPE) bottle (HDPE) ||| Packaging Bottle (HDPE) Bottle (HDPE) ||| Conditionnement Flacon (PEHD) Flacon (PEHD) Flacon (PEHD)
0.5090126991271973 ||| Use only as directed by your doctor. ||| Refer to them before using your medicine. ||| Suivre les indications de votre médecin.
0.022427329793572426 ||| 8 Oedema was reported in 6 – 9% of patients treated with pioglitazone over one year in controlled clinical trials. ||| Oedema was reported in 6 – 9% of patients treated with pioglitazone over one year in controlled clinical trials. ||| Des œ dèmes ont été reportés chez 6 à 9% des patients ayant reçu la pioglitazone pendant plus d’ un an au cours d’ essais cliniques contrôlés.
0.2905997633934021 ||| When IONSYS is applied without activating the current, the average absorption rate of fentanyl over 24 hours was 2.3 micrograms fentanyl/ hour, indicating minimal passive delivery. ||| Following intravenous administration to healthy adults, the volume of distribution (Vdss) of nevirapine was 1.21 ± 0.09 l/ kg, suggesting that nevirapine is widely distributed in humans. ||| Lorsque IONSYS est appliqué sans activer le courant, le taux moyen d’ absorption de fentanyl sur 24 heures est de 2,3 microgrammes de fentanyl par heure, ce qui indique une délivrance passive minimale.
0.29653245210647583 ||| 11 “Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas”. ||| Panretin gel is indicated for the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’ s sarcoma (KS) when: ||| «La gemcitabine est indiquée pour le traitement des patients atteints d’adénocarcinomes du pancréas localement avancés ou métastatiques.»
0.25183287262916565 ||| 22 No incompatibilities between Herceptin and polyvinylchloride, polyethylene or polypropylene bags have been observed. ||| No incompatibilities between MabThera and polyvinyl chloride or polyethylene bags or infusion sets have been observed. ||| Il n’a été noté aucune incompatibilité entre Herceptin et les poches à perfusion en chlorure de polyvinyle, en polyéthylène ou en polypropylène.
0.342376708984375 ||| The antibodies will help to fight the bacteria, preventing mastitis occurring or reducing the severity of its symptoms. ||| PROTELOS works by reducing bone breakdown and stimulating rebuilding of bone and therefore reduces the risk of fracture. ||| Ces anticorps aideront la vache à lutter contre les bactéries et empêcheront l’ apparition de la mammite ou réduiront la gravité de ses symptômes.
0.009983220137655735 ||| In the subset of patients with genotype 1 infection and low viral load (< 600,000 IU/ml) who become HCV-RN A negative at treatment week 4 and remain HCV-RNA negative at week 24, the treatment could either be stopped after this 24 week treatment course or pursued for an additional 24 weeks (i.e. overall 48 weeks treatment duration). ||| In the subset of patients with genotype 1 infection and low viral load (< 600,000 IU/ml) who become HCV-RNA negative at treatment week 4 and remain HCV-RNA negative at week 24, the treatment could either be stopped after this 24 week treatment course or pursued for an additional 24 weeks (i.e. overall 48 weeks treatment duration). ||| Dans le sous-groupe de patients de génotype 1 avec une faible charge virale (< 600 000 UI/ ml) ayant un taux d’ ARN-VHC indétectable à la 4ème semaine de traitement et restant indétectable à la 24ème semaine, le traitement peut soit être arrêté après ces 24 semaines de traitement soit être poursuivi 24 semaines supplémentaires (soit une durée totale de traitement de 48 semaines).
0.0 ||| Outer Carton ||| Outer Carton ||| Boîte en carton
0.4994626045227051 ||| INOmax treatment should be supervised by a doctor who has experience in neonatal (newborn) intensive care. ||| treatment may only be initiated by a specialist in epileptology, neurology or paediatric neurology. ||| Le traitement par INOmax doit être supervisé par un médecin ayant l’ expérience des soins intensifs en néonatologie (chez les nouveau-nés).
0.40695565938949585 ||| Resin impregnated tapes for fabrication aerospace components ||| Laminated building glass incorporating fine electrical conductors ||| Bandes imprégnées de résine pour la fabrication de composants aérospatiaux
0.0 ||| 9. ||| 9. ||| 137 9.
0.011327503249049187 ||| - if you have autoimmune hepatitis or any other problem with your immune system; if you are ||| - If you have autoimmune hepatitis or any other problem with your immune system; if you are ||| - si vous avez une hépatite auto-immune ou tout autre problème avec votre système immunitaire;
0.01316535472869873 ||| Eesti Österreich GlaxoSmithKline Eesti OÜ Tel: + 372 6676 900 estonia@gsk.com ||| Eesti Österreich GlaxoSmithKline Eesti OÜ Tel: +372 667 6900 estonia@gsk. com ||| Eesti GlaxoSmithKline Eesti OÜ Tel: + 372 6676 900 estonia@gsk.com
0.046936944127082825 ||| an assessment of the individual patient's overall risks. ||| on an assessment of the individual patient's overall risks. ||| doit être basée sur l’ évaluation de l’ ensemble des risques spécifiques à chaque patient.
0.13270047307014465 ||| In dogs, Onsior tablets are used for the treatment of pain and inflammation associated with chronic osteoarthritis (a long-term disease causing pain in the joints). ||| In cats, Onsior tablets are used for the treatment of acute pain and inflammation associated with musculoskeletal disorders (problems with the muscles and bones). ||| Chez le chien, Onsior comprimés est utilisé pour le traitement de la douleur et de l’ inflammation associée à l’ arthrose chronique (une maladie à long terme qui provoque une douleur des articulations).
0.5131759643554688 ||| Swallow Nexavar tablets with a glass of water, either without food or with a low-fat or moderate fat meal. ||| If soap and water are not available, then use a gt;60% alcohol-based hand sanitizer. ||| 26 Avaler les comprimés de Nexavar avec un verre d’ eau, soit en dehors des repas soit au cours d’ un repas pauvre ou modérément riche en graisses.
0.43182820081710815 ||| The concomitant use of ivabradine with these medicinal products is not recommended (see section 4.4). ||| No dosage adjustment of CHAMPIX or co-administered medicinal products listed below is recommended. ||| L’ utilisation concomitante de l’ ivabradine avec ces médicaments n’ est pas recommandée (voir rubrique 4.4).
0.37988847494125366 ||| Concurrent administration of probenicid may affect renal excretion of the conjugation product of sodium phenylbutyrate. ||| The degree of cross-resistance between ciprofloxacin and other fluoroquinolones that results is variable. ||| L'administration concomitante de probénécide peut affecter l'excrétion rénale du produit de conjugaison du phénylbutyrate de sodium.
0.0 ||| 6. ||| 6. ||| 15 6.
0.3849652409553528 ||| Polyethylene oxide 200K Sodium chloride Povidone (K29-32) Stearic acid Butyl hydroxytoluene (E321) Ferric Oxide (Yellow) (E172) (3, 12 mg tablet only) Polyethylene Oxide 7000K Ferric Oxide (Red) (E172) Hydroxyethyl Cellulose Polyethylene glycol 3350 Cellulose acetate Iron oxide (Black) (E172) (1.5, 9 mg tablet only) ||| 375 mg tablet: polyethylene glycol, polysorbate 80, Blue #2/ Indigo Carmine Aluminium Lake (E132) 500 mg tablet: polyethylene glycol, polysorbate 80, Yellow #6/ Sunset Yellow FCF Aluminium Lake (E110) 750 mg tablet: glycerol triacetate, lactose monohydrate, Blue #1/ Brilliant Blue FCF Aluminium Lake (E133) and Yellow #5/ Tartrazine Aluminium Lake (E102) ||| Oxyde de polyéthylène 200K Chlorure de sodium Povidone (K29-32) Acide stéarique Butylhydroxytoluène (E321) Oxyde ferrique (jaune) (E172 )(comprimés à 3, et 12 mg uniquement) Oxyde de polyéthylène 7000K Oxyde ferrique (rouge) (E172) Hydroxyéthylcellulose Polyéthylène glycol 3350 Acétate de cellulose Oxyde de fer (noir) (E172) (1,5, 9 mg comprimé uniquement)
0.2883126139640808 ||| Always swallow the capsules or tablets whole with plenty of water. ||| Swallow the tablets whole, with some water or another drink. ||| Avalez toujours les gélules ou les comprimés en entier avec un grand verre d'eau.
0.2379136085510254 ||| Before starting to use Fentanyl-ratiopharm you should inform your doctor if you suffer from any of the below disorders, because the risk of side effects is higher and/ or your doctor may need to prescribe a lower dose of fentanyl. ||| If you experience sudden worsening in breathing in the first weeks after starting treatment with Tracleer or changing to a higher dose of Tracleer, contact your doctor immediately as there might be a need to change your treatment. ||| 93 Avant de commencer à utiliser Fentanyl-ratiopharm, vous devez avertir votre médecin si vous souffrez de l’ un des troubles énumérés ci-dessous, parce que dans ces cas le risque d’ effets indésirables est plus élevé et/ ou parce que votre médecin peut devoir vous prescrire une dose plus faible de fentanyl.
0.5101954936981201 ||| Rental of apparatus and installations in the field of medical technology ||| Arranging and conducting of seminars in the field of oncology ||| Location d'appareils et d'installations dans le domaine de la technologie médicale
0.3475533425807953 ||| Altargo has been studied in five main studies involving over 3,000 patients aged from 9 months upwards. ||| Three main studies of Ambirix were carried out in a total of 615 children from one year of age. ||| Altargo a été étudié dans le cadre de cinq études principales portant sur un total de plus de 3 000 patients âgés de 9 mois et plus.
0.3297567665576935 ||| Abbott Laboratories Ltd Queenborough Kent ME11 5EL United Kingdom ||| Aesica Queenborough Limited Queenborough Kent ME11 5EL United Kingdom ||| Queenborough Kent ME11 5EL United Kingdom
0.6557804942131042 ||| HYPERSENSITIVITY REACTION ||| EFFICACY ASPECTS ||| REACTION D’ HYPERSENSIBILITE
0.06108873337507248 ||| The most common side effect with Trevaclyn (seen in more than 1 patient in 10) is flushing. ||| The most common side effect with Stocrin (seen in more than 1 patient in 10) is rash. ||| L’ effet indésirable les plus couramment observé sous Trevaclyn (chez plus d’ un patient sur 10) est un rougissement.
0.7066655158996582 ||| Chromium plating compositions ||| Pigments in liquid form ||| Compositions pour le chromage
0.4993072748184204 ||| Notably, 22% of patients reported a complete cytogenetic response (CCyR) in the dasatinib arm while only 8% achieved a CCyR in the imatinib arm. ||| Three patients presented a complete haematological response (CHR) and one patient experienced a partial haematological response (PHR). ||| Notamment, 22% des patients ont atteint une Réponse Cytogénétique Complète (RCyC) dans le bras dasatinib contre seulement 8% dans le bras imatinib.
0.28109103441238403 ||| Cleaning of building interiors ||| Cleaning of exterior wall surfaces ||| Nettoyage d'intérieurs de bâtiments
0.0 ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES ||| CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SURE ET EFFICACE DU MEDICAMENT A ADRESSER AUX ETATS MEMBRES CONDITIONS OU RESTRICTIONS EN VUE D’ UNE UTILISATION SURE ET EFFICACE DU MEDICAMENT A ADRESSER AUX ETATS MEMBRES
0.2561076879501343 ||| How does Prometax work? ||| How does Purevax RC work? ||| Comment Prometax agit -il?
0.366426944732666 ||| It can be used to treat impetigo (a skin infection causing crusting scabs), and small infected lacerations (cuts), abrasions (grazes) and wounds that have been sutured (stitched). ||| Wounds that are especially prone to infection are burns, fractures, deep wounds or wounds contaminated with soil, dust, horse manure/dung or wood splinters. ||| Il peut être utilisé pour traiter l’ impétigo (une infection de la peau responsable de l’ apparition de croûtes), ainsi que les petites entailles infectées (coupures), les écorchures (égratignures) et les plaies suturées (plaies recousues).
0.49227598309516907 ||| Depending upon the results of these tests, your doctor may change the dose to be taken. ||| The lowest effective dose in relation to the treatment objective should be used in both men and women. ||| En fonction des résultats de ces analyses, votre médecin peut modifier la dose à prendre.
0.5163711309432983 ||| Robotic vacuum cleaners ||| Stick-type vacuum cleaners ||| Aspirateurs robotisés
0.019705679267644882 ||| HOW TO TAKE {PRODUCT NAME} 40 mg ||| HOW TO TAKE {PRODUCT NAME} 10 mg ||| COMMENT PRENDRE {NOM DU PRODUIT} 40 mg
0.06546107679605484 ||| When driving vehicles or operating machines it should be taken into account that occasionally dizziness or weariness may occur. ||| When driving vehicles or operating machines, it should be taken into account that dizziness or weariness may occur during treatment. ||| En cas de conduite de véhicule ou d'utilisation de machines, la survenue occasionnelle d'étourdissements ou de lassitude doit être prise en considération.
0.5628830790519714 ||| N (%) ||| 1c (%) ||| (0,4)
0.17969997227191925 ||| If you forget to take Xagrid: ||| If you forget to take Keppra: ||| Si vous oubliez de prendre Xagrid:
0.5075215697288513 ||| The woman may switch any day from the minipill (from an implant on the day of its removal, from an injectable when the next injection would be due), but a back-up barrier method of birth control must be used during the first 7 days. ||| In one example, when an Italian hospital urgently required a ventilator valve, and the supplier was unable to deliver in the timescale required, a local startup reverse-engineered and printed the required 100 valves overnight. ||| La femme peut remplacer à tout moment la pilule microdosée (ou l’ implant le jour de son retrait, ou la méthode injectable au moment de la prochaine injection) mais elle doit associer une méthode de contraception mécanique pendant les 7 premiers jours.
0.600351870059967 ||| Dilitazem 120 mg QD (Indinavir/ ritonavir 800/ 100 BID) ||| Mean (±SEM) Serum Uric Acid Level (mg/ dL) Placebo ||| INHIBITEURS CALCIQUES Dilitazem 120 mg, une
0.7877144813537598 ||| Urethral probes ||| Remergon SolTab ||| Sondes urétrales
0.04553070664405823 ||| 7 This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i. e. essentially “ sodium- free”. ||| This medicinal product contains less than 1 mmol sodium (23 mg) per ml, i. e. essentially ‘ sodium- free’. ||| Ce médicament contient moins de 1 mmol de sodium (23 mg) par dose, c'est-à-dire qu’ il est essentiellement « sans sodium ».
0.2740609049797058 ||| Reconcile 16 mg tablet ||| Prandin 2 mg tablets ||| Comprimé Reconcile 16 mg
0.17848899960517883 ||| 8.5 mg/ ml orbifloxacin, 0.9 mg/ ml mometasone furoate (as monohydrate) and 0.9 mg/ ml posaconazole. ||| Orbifloxacin 8.5 mg/ ml Mometasone furoate (as monohydrate) 0.9 mg/ ml Posaconazole 0.9 mg/ ml ||| 8,5 mg d’ orbifloxacine, 0,9 mg de furoate de mométasone (sous forme de monohydrate) et 0,9 mg de posaconazole.
0.1273220032453537 ||| Business advisory and information services ||| Financial information and advisory services ||| Services d'informations et de conseils commerciaux
0.03059244528412819 ||| Blood and the lymphatic system disorders anaemia granulocytopaenia ||| Blood and the lymphatic system disorders Anaemia granulocytopaenia ||| Affections hématologiques et du système lymphatique anémie granulocytopénie
0.3547230362892151 ||| Serious adverse reactions including infusion reactions, hypersensitivity, allergic-like reactions and pulmonary events have been observed in patients receiving Herceptin therapy. ||| Diagnosis of cancer, chemotherapy, radiotherapy, corticosteroids and poor oral hygiene are also deemed as risk factors (see section 4.4). ||| Des réactions indésirables graves incluant des réactions liées à la perfusion, hypersensibilité, réactions de type allergique et manifestations pulmonaires ont été observées chez les patients traités par Herceptin.
0.40787258744239807 ||| Following single dose administration, Cmax was 1.70 µg/ ml with a Tmax of 6 hours. ||| After a 40 micrograms/ kg bw intramuscular dose the Cmax is 17 ng/ ml. ||| Après administration d’ une dose unique, le Cmax est de 1,70 µg/ ml avec un Tmax de 6 heures.
0.10140646994113922 ||| Tell your doctor at once if any of these apply to you. ||| Tell your doctor if any of these apply to you. ||| Indiquez à votre médecin si vous prenez un de ces médicaments.
0.48728421330451965 ||| If you are taking Lamictal for epilepsy To stop taking Lamictal, it is important that your dose is reduced gradually, over about 2 weeks. ||| 18 If you forget to take the Comtan tablet with your levodopa dose, you should continue the treatment by taking the next Comtan tablet with your next levodopa dose. ||| Si vous prenez Lamictal pour une épilepsie Pour arrêter de prendre Lamictal, il est important que votre dose soit réduite progressivement, sur environ 2 semaines.
0.34706348180770874 ||| Elixirs for relieving chills ||| Elixirs for relieving asthma ||| Élixirs pour soulager les frissons
0.0 ||| Surgery ||| Surgery ||| Chirurgie am
0.3753748834133148 ||| Twinrix Adult contains small amounts of inactivated hepatitis A viruses and the ‘ surface antigen ’ (proteins from the surface) of the hepatitis B virus. ||| All papillomaviruses have a shell or ‘ capsid’, which is made up of proteins called ‘ L1 proteins’. ||| Twinrix Adulte contient de petites quantités de virus inactivés de l’ hépatite A et de l’ « antigène de surface » (protéines de la surface) du virus de l’ hépatite B.
0.2468859702348709 ||| Tablet coating: hydroxypropyl methylcellulose hydroxypropyl cellulose titanium dioxide (E171) polyethylene glycol 400 indigo carmine aluminium lake (E132) red iron oxide (E172) ||| isostearic acid benzyl alcohol cetyl alcohol stearyl alcohol white soft paraffin polysorbate 60 sorbitan stearate glycerol methyl hydroxybenzoate (E218) propyl hydroxybenzoate (E216) xanthan gum purified water. ||| Enrobage des comprimés: méthylhydroxypropylcellulose hydroxypropylcellulose dioxyde de titane (E 171) polyéthylèneglycol 400 laque d'indigotine (E 132) oxyde de fer rouge (E 172)
0.12448664754629135 ||| The use of Galvus in children and adolescents is not recommended. ||| The use of Tekturna in children and adolescents is not recommended. ||| L'utilisation de Galvus chez l'enfant et les adolescents n’ est pas recommandée.
0.4392625689506531 ||| You should not use Neupro if you are pregnant, as the effects of rotigotine on pregnancy and the unborn baby are not known. ||| - if you are male and wish to father a child, as Arava can cause birth defects in new born infants. ||| Neupro ne devrait pas être utilisé pendant la grossesse, les effets de la rotigotine sur la grossesse et l’ enfant à naître n’ étant pas connus.
0.06333640962839127 ||| EU/ 1/ 06/ 343/ 003 EU/ 1/ 06/ 343/ 006 ||| th EU/ 1/ 06/ 344/ 003 EU/ 1/ 06/ 344/ 004 ||| EU/ 1/ 06/ 343/ 003 Blisters:
0.5307716727256775 ||| (VIAL LABEL) ||| LABEL (DILUENT VIAL) ||| (ETIQUETTE DU FLACON)
0.17368966341018677 ||| Ranibizumab is a humanised monoclonal antibody fragment produced in Escherichia coli cells by recombinant DNA technology. ||| Efalizumab is a recombinant humanized monoclonal antibody produced in genetically engineered Chinese Hamster Ovary (CHO) cells. ||| Le ranibizumab est un fragment d'anticorps monoclonal humanisé produit dans des cellules d'Escherichia coli par la technologie de l'ADN recombinant.
0.21138939261436462 ||| 42 Women of childbearing potential should be advised to avoid becoming pregnant while receiving treatment with SUTENT. ||| Women who might get pregnant are advised to use effective contraception during treatment with SUTENT. ||| Il est conseillé aux femmes en âge de procréer d’ éviter d’ être enceintes au cours du traitement par SUTENT.
0.23874357342720032 ||| Adjuvants, other than for medical or veterinary purposes ||| Stem cells, other than for medical or veterinary purposes ||| Adjuvants autres qu'à usage médical ou vétérinaire
0.5364120006561279 ||| Injection site pain ||| Injection site reactions ||| Douleur au site d’ injection
0.10057392716407776 ||| España Pfizer S. A. ||| España Pfizer S.A. ||| 38 España Pfizer S. A.
0.24056267738342285 ||| Rifabutin AUC*: ↑ 54% Rifabutin Cmin*: ↑ 99% (*Relative to rifabutin 300 mg QD alone. ||| Indinavir AUC: ↓ 20% Indinavir Cmin: ↑ 29% (Relative to Indinavir 800 mg TID alone) ||| Rifabutine ASC*: ↑ 54% Rifabutine Cmin*: ↑ 99% (*Par rapport à la rifabutine 300 mg seule, une fois/ jour.
0.33725693821907043 ||| In tumours, activation of KRAS by EGFR contributes to EGFR-mediated increased proliferation, survival and the production of pro-angiogenic factors. ||| Long- term administration results in pituitary desensitisation to the effects of GnRH resulting in a suppression of LH and FSH secretion by the pituitary. ||| Au sein des tumeurs, l’ activation du gène KRAS par l’ EGFR contribue à l’ augmentation de la prolifération, de la survie et de la production des facteurs angiogéniques favorisée par l’ EGFR.
0.373851478099823 ||| The daily dosage is administered in equally divided doses 3 times a day. ||| The medicine was given with the drinking water at a dosage of 25 for three consecutive days. ||| Fractionner la dose journalière totale en trois prises égales.
0.25982749462127686 ||| If it isn’ t in perfect condition when you get the vial, return the vial to your supplier ► If it hasn’ t been stored correctly or if it has been frozen (see 6 How to store NovoRapid) ► If the insulin does not appear clear and colourless. ||| Do not use Arixtra: • after the expiry date stated on the label and carton • if you notice any particles in the solution, or if the solution is discoloured • if you notice that the syringe is damaged • if you have opened a syringe and you do not use it straightaway. ||| Si elle n’ est pas en parfait état quand vous achetez votre flacon, ramenez le flacon à votre pharmacien ► s’ il n’ a pas été conservé correctement ou s’ il a été congelé (voir 6 Comment conserver NovoRapid) ► si la solution d’ insuline n’ est pas limpide et incolore.
0.09937185049057007 ||| Ropinirole is mainly metabolised by the isoform CYP1A2 of cytochrome P450. ||| Ropinirole is principally metabolised by the cytochrome P450 isoenzyme CYP1A2. ||| Métabolisme Le ropinirole est principalement métabolisé par l’ isoenzyme CYP1A2 du cytochrome P450.
0.03623399883508682 ||| Adopted in March 1998 ||| Adopted in April 1998 ||| Adopté en mars 1998
0.515629231929779 ||| Sauces for frozen fish ||| Frozen cooked fish ||| Sauces pour poisson surgelé
0.3362434208393097 ||| • if you are allergic to emedastine or any of the other ingredients. ||| - if you are allergic to other medicines, foods and dyes. ||| • si vous êtes allergique à l’émédastine ou à l’un des autres composants.
0.0 ||| ORACEA ||| ORACEA ||| ORACEA ORACEA2
0.24004781246185303 ||| BYETTA reduced HbA1c and body weight in patients treated for 30 weeks in three placebo-controlled studies, whether the BYETTA was added to metformin, a sulphonylurea or a combination of both. ||| In studies with a maximal duration of three years, rosiglitazone given once or twice daily in dual oral therapy with metformin produced a sustained improvement in glycaemic control (FPG and HbA1c). ||| Les trois études contrôlées versus placebo ont montré que BYETTA diminuait l’ HbA1c et le poids chez les patients traités pendant 30 semaines, en association avec la metformine, un sulfamide hypoglycémiant ou une association des deux.
0.45468294620513916 ||| The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic. ||| Research assessing the contribution of cues to action in predicting health-related behaviors is limited. ||| L’évaluation rapide des risques répertorie également les mesures de santé publique permettant d’atténuer l’impact de la pandémie.
0.31899040937423706 ||| Paper sheets [stationery] ||| Stencils [stationery] ||| Feuilles [papeterie]
0.7494628429412842 ||| The full EPAR for Truvada is available here. ||| A Global Citizen press release are available online. ||| L’ EPAR complet est disponible à l’ adresse suivante; ici.
0.10968931019306183 ||| Use only the pre-filled syringe of solvent provided in the box for reconstitution. ||| Use only the pre-filled syringe provided in the box for reconstitution. ||| Utiliser uniquement la seringue pré-remplie de solvant fournie dans la boîte pour reconstitution.
0.0503995418548584 ||| Because the number of patients with hereditary tyrosinemia type 1 is low, the disease is rare, and Orfadin was designated an ‘ orphan medicine’ (a medicine used in rare diseases) on 29 December 2000. ||| Because the number of patients with Lennox-Gastaut syndrome is low, the disease is rare, and Inovelon was designated an ‘ orphan medicine’ (a medicine used in rare diseases) on 20 October 2004. ||| Étant donné que le nombre de patients atteints de tyrosinémie de type 1 est faible, la maladie est rare, et Orfadin a reçu la désignation de « médicament orphelin » (médicament utilisé dans les maladies rares), le 29 décembre 2000.
0.19220715761184692 ||| 59 (13.4%) ||| 29 (5.3%) ||| 81 (18.4%)
0.5273685455322266 ||| Holders for cosmetics ||| Speakers for record players ||| Supports pour cosmétiques
0.0690324455499649 ||| Milk or antacids should be given to bind Bondenza, and any adverse reactions treated symptomatically. ||| Milk or antacids should be given to bind Bonviva, and any adverse reactions treated symptomatically. ||| Du lait ou des antiacides doivent être administrés pour chélater Bondenza et les effets indésirables doivent faire l’ objet d’ un traitement symptomatique.
0.7305899858474731 ||| Glass vial ||| Kitchen linen ||| Flacons (de verre)
0.44460660219192505 ||| The three recommended injection sites for Enbrel using a pre-filled syringe include: ||| The three areas of the body recommended for injection of RELISTOR are: ||| Les trois sites d’injection recommandés pour Enbrel dans le cas de l’utilisation d’une seringue pré-remplie sont:
3.355142769514985e-13 ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| The needle cover of the pre-filled pen contains dry natural rubber (a derivative of latex), which may cause allergic reactions. ||| 175 Le capuchon de protection du stylo prérempli contient du caoutchouc naturel (un dérivé du latex) qui peut provoquer des réactions allergiques.
0.2108718901872635 ||| Suicidal ideation, aggressive reaction, confusion, behaviour disorder, agitation, somnambulism, anxiety, nervousness, sleep disorder, abnormal dreaming, apathy lon ||| abnormal dreams, insomnia confusion, hallucination, libido disorder abnormal behaviour, delusion, hypersexuality, increased eating, paranoia, pathological gambling ||| Idée suicidaire, réaction agressive, confusion, troubles du Fréquent: comportement, agitation, somnambulisme, anxiété, nervosité, 206 trouble du sommeil, rêves inhabituels, apathie Affections du système nerveux§ Céphalée, étourdissements Très fréquent:
0.4391999840736389 ||| The dose may need to be adjusted in patients who have problems with their kidneys or certain side effects. ||| This is of benefit in reducing effects on nearby muscles when small muscle groups are being injected. ||| Il peut être nécessaire d’ ajuster la dose chez des patients ayant des problèmes de reins ou présentant certains effets indésirables.
0.28379496932029724 ||| This especially holds true when taking potent CYP3A4 inhibitors (see sections 4.2, 4.5 and 5.1). ||| Such combinations should be avoided in known CYP2C9 poor metabolisers (see sections 4.2 and 5.2). ||| Il en va particulièrement de même lors de la prise d’ inhibiteurs puissants du CYP3A4 (voir rubriques 4.2, 4.5 et 5.1).
0.25340187549591064 ||| In another 12-week trial, the incidence of EPS was 26.6% for patients treated with aripiprazole and 17.6% for those treated with lithium. ||| Major bleeding during the initial treatment period was observed in 1.1% of fondaparinux patients, compared to 1.2% with enoxaparin. ||| Dans une autre étude clinique à 12 semaines, l’ incidence des symptômes extrapyramidaux était de 26,6% chez les patients traités par aripiprazole et 17,6% chez les patients traités par lithium.
0.5559954643249512 ||| A total of 573 patients were randomised to receive either TMZ + RT (n=287) or RT alone (n=286). ||| Patients were in WHO functional class II (N = 15 patients, 79%) or class III (N = 4 patients, 21%) at baseline. ||| Un total de 573 patients ont été randomisés pour recevoir soit, TMZ + RT (n=287) soit RT seule (n=286).
0.19975689053535461 ||| This is a tumour that arises from blood vessels in the skin or internal organs and typically appears as flat or raised, purple to dark brown patches on the skin. • advanced breast cancer when certain other treatments (standard anthracycline-containing therapy) have been tried but have not worked or when the patient is unsuitable for these treatments. • advanced ovarian cancer or remaining tumour (> 1 cm) after initial surgery, in combination with cisplatin as first-line treatment. ||| It should also not be used in the following groups: • patients who have developed pure red cell aplasia (reduced or stopped red blood cell production) following treatment with any erythropoietin; • patients with hypertension (high blood pressure) that is not controlled; • patients about to undergo surgery who have severe cardiovascular (heart and blood vessel) problems including a recent heart attack or stroke; • patients who cannot receive medicines for the prevention of blood clots. ||| Le sarcome de Kaposi est une tumeur provenant des vaisseaux sanguins cutanés ou d’ autres organes, qui se traduit par l’ apparition de taches plates ou en relief violettes à brun foncé sur la peau. • le cancer du sein avancé après échec d’ autres traitements (traitements classiques contenant des anthracyclines) ou lorsque le patient ne relève pas de ces traitements. • le cancer de l’ ovaire avancé ou résiduel (> 1 cm) après chirurgie initiale, en association avec le cisplatine en traitement de première intention. • le cancer de l’ ovaire avancé après échec d’ autres traitements (traitement par des associations contenant du platine mais pas de taxanes) en seconde intention. • le cancer bronchique non à petites cellules si une chirurgie potentiellement curative et/ ou une radiothérapie ne sont pas possibles, en association avec le cisplatine.
0.32298409938812256 ||| Consultancy services relating to insurance ||| Consultancy relating to tax accounting ||| Services de conseillers en matière d'assurance
0.14445394277572632 ||| Dyspnoea, coughing Sinusitis, bronchitis, epistaxis, rhinitis, respiratory disorder, nasal congestion, rhinorrhea, nonproductive cough ||| Uncommon: dysponea, asthma, respiratory disorder, pharyngolaryngeal pain, cough, dysphonia, nasal congestion, throat irritation ||| Dyspnée, toux Sinusite, bronchite, épistaxis, rhinite, trouble respiratoire, congestion nasale, rhinorrhée, toux non productive
0.0 ||| Eye disorders ||| Eye disorders ||| 19 Affections oculaires
0.0 ||| Cardiac disorders: ||| Cardiac disorders: ||| Effets cardiaques:
0.4341069459915161 ||| Viracept has been studied in combination with other antiviral medicines in two main studies involving 605 patients aged 13 years or more, who were infected with HIV. ||| By 13 March, more than forty countries and territories had reported deaths, on every continent except Antarctica.Several measures are commonly used to quantify mortality. ||| Viracept a été étudié en association avec d’ autres médicaments antiviraux dans deux études principales ayant suivi 605 patients âgés de 13 ans ou plus, présentant une infection par le VIH.
0.0 ||| No data are available for cardiac or hepatic transplant patients with severe chronic renal impairment. ||| No data are available for cardiac or hepatic transplant patients with severe chronic renal impairment. ||| Aucune donnée n’ est disponible concernant les patients transplantés cardiaques ou hépatiques souffrant d’ insuffisance rénale chronique sévère.
0.43672603368759155 ||| ADROVANCE reduces the risk of vertebral and hip fractures. ||| Inhibition results in the regression of prostatic tumours. ||| ADROVANCE réduit le risque de fractures vertébrales et de la hanche.
0.31195777654647827 ||| Dosing of APTIVUS, co-administered with low dose ritonavir, with antacids should be separated by at least a two hours time interval. ||| Therefore, this specific regimen with concomitant administration with high-dose cytarabine (2 g/ m2 per day) by continuous infusion over 24 hours is not recommended. ||| La co-administration d’ APTIVUS, associé au ritonavir à faible dose, avec les antiacides doit être séparée par un intervalle d’ au moins deux heures.
0.011979144997894764 ||| Co-administration may result in competitive inhibition of the metabolism of these active substances thus increasing their plasma levels and leading to serious and / or life-threatening adverse reactions such as cardiac arrhythmia (e. g. amiodarone, astemizole, bepridil, cisapride, pimozide, quinidine, terfenadine) or peripheral vasospasm or ischaemia (e. g. ergotamine, dihydroergotamine). ||| Co-administration may result in competitive inhibition of the metabolism of these active substances thus increasing their plasma level and leading to serious and / or life-threatening adverse reactions such as cardiac arrhythmia (e. g. amiodarone, astemizole, bepridil, cisapride, pimozide, quinidine, terfenadine) or peripheral vasospasm or ischaemia (e. g. ergotamine, dihydroergotamine) (see section 4.3). ||| Leur administration concomitante peut entraîner une inhibition compétitive du métabolisme de ces substances actives, induisant ainsi une augmentation de leur concentration plasmatique et un risque de survenue d'effets indésirables graves et/ ou pouvant mettre en jeu le pronostic vital comme: arythmie cardiaque (ex: amiodarone, astémizole, bépridil, cisapride, pimozide, quinidine, terfénadine) ou vasoconstriction périphérique ou ischémie (ex: ergotamine, dihydroergotamine).
3.000439523573317e-13 ||| In case of severe or persistent undesirable effects, the dose of Rebif may be temporarily lowered or interrupted, at the discretion of the physician. ||| In case of severe or persistent undesirable effects, the dose of Rebif may be temporarily lowered or interrupted, at the discretion of the physician. ||| 41 la dose de Rebif peut être temporairement diminuée ou les injections interrompues, selon l’ avis du médecin.
0.19550065696239471 ||| Characteristics in patients The pharmacokinetics of sitagliptin were generally similar in healthy subjects and in patients with type 2 diabetes. ||| Hepatic impairment The pharmacokinetics of Pegasys were similar between healthy subjects and patients with hepatitis B or C. ||| 37 Populations particulières La pharmacocinétique de la sitagliptine est généralement similaire chez les sujets sains et chez les diabétiques de type 2.
0.12115199863910675 ||| 7 Hungary ||| 7 Denmark ||| 7 Hongrie
0.30049604177474976 ||| Therefore, AVANDAMET should not be used during pregnancy. ||| You should not use TESAVEL during pregnancy. ||| Par conséquent, AVANDAMET ne doit pas être utilisé pendant la grossesse.
0.6948479413986206 ||| This plan should address the following: ||| This request was based on the following reasons: ||| Ce plan doit couvrir les aspects suivants:
0.4692729115486145 ||| Make sure to tell your doctor if you are taking any of the following medicines, as a dose adjustment of Procoralan or monitoring should be required: ||| 191 You should make sure you fully understand and remember the following: • how many capsules you need to take every dosing day. ||| Indiquez à votre médecin si vous prenez l’ un des médicaments suivants qui peuvent nécessiter un ajustement de la dose de Procoralan ou une surveillance particulière:
0.2272455394268036 ||| If CRIXIVAN with ritonavir is coadministered with parenteral midazolam, it should be done in an intensive care unit with close clinical monitoring in case of respiratory depression and/ or prolonged sedation. ||| In patients who do not maintain a sustained serological response, consideration should be given to retreatment with either lamivudine or an alternative antiviral agent for resumption of clinical control of HBV. ||| Si CRIXIVAN associé au ritonavir est co- administré avec du midazolam par voie parentérale, cela doit être réalisé dans une unité de soins intensifs avec une surveillance clinique étroite en cas de dépression respiratoire et/ ou de sédation prolongée.
0.1355362832546234 ||| 22 1. ||| 23 1. ||| 23 1.
0.5536038279533386 ||| The no-effect dose for these findings was 1.3 times the human dose. ||| For the 10 individual HPV types, statistical significance was only reached for HPV 31. ||| La dose seuil pour l’ apparition de ces évènements a été de 1,3 fois la dose utilisée chez l’ homme.
0.3427138328552246 ||| Starlix works by stimulating the pancreas to produce insulin more quickly. ||| Galvus works by making the pancreas produce more insulin and less glucagon. ||| Starlix agit en stimulant le pancréas afin qu'il produise plus rapidement de l'insuline.
9.454451110890716e-13 ||| Cardiac disorders ||| Cardiac disorders ||| Arrêt cardiaque
0.2419164478778839 ||| The effects of filgrastim on neutropenia due to bone marrow-infiltrating infection or malignancy have not been well established. ||| Simvastatin therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants. ||| Les effets de filgrastim sur la neutropénie due à une infection ou à une affection maligne envahissant la moelle osseuse n’ ont pas été déterminés avec précision.
0.3957783579826355 ||| In patients exhibiting ≥ 2+ proteinuria, intravenous hydration should be performed and the test repeated. ||| and if abnormal WBC counts re-occur during the following cycle a permanent IL-2 reduction is recommended. ||| Chez les patients ayant une protéinurie ≥ 2+, une hydratation intraveineuse doit être entreprise et l’ examen devra être répété.
0.7812153697013855 ||| Peg Intron. ||| Bilirubin – Indirect ||| PegIntron.
0.07847018539905548 ||| Each Olanzapine Teva 10 mg film-coated tablet contains 10 mg of the active substance. ||| Each Olanzapine Teva 5 mg orodispersible tablet contains 5 mg of the active substance. ||| Chaque comprimé pelliculé d’ Olanzapine Teva 10 mg contient 10 mg de substance active.
0.003868330270051956 ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, 59 France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F-69007 Lyon, 52 France ||| Sanofi Pasteur MSD SNC, 8 rue Jonas Salk, F- 69007 Lyon, France
0.010456092655658722 ||| AZARGA 10 mg/ml + 5 mg/ml eye drops, suspension Brinzolamide/Timolol ||| AZARGA 10 mg/ ml + 5 mg/ml eye drops, suspension Brinzolamide/Timolol ||| AZARGA 10 mg/ml + 5 mg/ml collyre en suspension Brinzolamide/Timolol
0.2702200412750244 ||| Powder and solvent for emulsion for injection ||| Powder for emulsion for injection: ||| Poudre et solvant pour émulsion injectable
0.20866860449314117 ||| EXP After first opening, use within 30 days. ||| EXP Use within 6 months after first opening. ||| EXP Utiliser dans les 30 jours après ouverture initiale.
0.2992182970046997 ||| Non-electric wires of common metal ||| Cables of metal, non-electric ||| Fils métalliques non électriques
0.24030795693397522 ||| MERIAL 29 Avenue Tony Garnier 69007 Lyon France ||| MERIAL 29 avenue Tony Garnier 69007 Lyon, France ||| MERIAL 29 avenue Tony Garnier 69007 LYON, FRANCE
0.2543003261089325 ||| Swallow the tablets with plenty of fluid. ||| Swallow the tablet whole and with plenty of water. ||| Avalez les comprimés avec une grande quantité de boisson.
0.3580286502838135 ||| The studies in children showed that Ziagen, in combination with other antiviral medicines, reduced viral loads to a similar extent to other combinations after 24 weeks. ||| The results of the study comparing IONSYS with morphine were insufficient to determine whether the two medicines were of similar effectiveness in relieving pain or not. ||| Les études chez l’ enfant ont démontré que Ziagen, en association à d’ autres médicaments antiviraux, conduit à une réduction de la charge virale similaire à celle provoquée par d’ autres associations après 24 semaines.
0.2260957956314087 ||| Broadcasting of motion pictures by satellite ||| Broadcasting of motion pictures by television ||| Diffusion de films cinématographiques par satellite
0.24396121501922607 ||| Glitter for cosmetic purposes ||| Rubber for dental purposes ||| Paillettes à usage cosmétique
0.31714296340942383 ||| 7 After removing Actraphane vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use. ||| Because of the viscosity of the reconstituted product care must be taken to WITHDRAW ALL OF THE PRODUCT from the vial before expelling any air or excess solution from the syringe in order to obtain the 0.6 ml. ||| Après avoir sorti un flacon d’ Actraphane du réfrigérateur, il est recommandé d’ attendre que le flacon arrive à température ambiante (ne dépassant pas 25°C) avant de remettre l’ insuline en suspension, comme indiqué dans les instructions concernant la première utilisation.
0.1373697817325592 ||| This medicinal product must not be mixed with other medicinal products or diluents except those mentioned in section 6.6. ||| This medicinal product must not be mixed with other medicinal products except for the supplied solvent mentioned in section 6.6. ||| Ce médicament ne doit pas être mélangé avec d’ autres médicaments ou diluants à l’ exception de ceux mentionnés à la rubrique 6.6.
0.3562402129173279 ||| The ECDC is in continuous contact with the European Commission, the public health authorities in the EU Member States, China and other countries and the World Health Organization for the assessment of this outbreak. ||| The EU and its Member States will continue to engage with and within the United Nations and the Council of Europe to promote EU victims' rights in partner countries and to exchange best practices. ||| L'ECDC est en contact permanent avec la Commission européenne, les autorités sanitaires des États membres de l'UE, de Chine et d'autres pays ainsi qu'avec l'Organisation mondiale de la santé pour l'évaluation de cette épidémie.
0.5674020051956177 ||| Do try to take the tablets at around the same time every day. c. ||| If you are scheduled to inject this product every day, and lp ||| Essayez de prendre les comprimés à peu près à la même heure chaque jour. c.
0.43864548206329346 ||| Imprida 5 mg/ 80 mg film-coated tablets ||| 15 mg/ ml film-coated ||| Imprida 5 mg/ 80 mg comprimés pelliculés
0.0 ||| 20 mg ||| 20 mg ||| 20 mg tablets
0.4499014616012573 ||| The plasma concentrations of bosentan were also decreased by 29%. ||| The Cmax of digoxin increased by less than 5%. ||| Les concentrations plasmatiques du bosentan sont également diminuées de 29%.
0.3164379298686981 ||| Ranitidine (taken 1 hour before Ketek) and antacid containing aluminium and magnesium hydroxide has no clinically relevant influence on telithromycin pharmacokinetics. ||| The Applicant provided these pharmacokinetic results for amlodipine and lisinopril along with semi-logarithmic mean plasma concentration-time curves. ||| 6 La ranitidine (prise 1 heure avant la télithromycine) et les anti-acides contenant des hydroxydes d’ aluminium et de magnésium ne présentent pas d’ interaction pharmacocinétique, cliniquement significative, avec la télithromycine.
0.0 ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| Insulin may cause sodium retention and oedema, particularly if previously poor metabolic control is improved by intensified insulin therapy. ||| 162 L'insuline peut provoquer une rétention sodée et un œ dème, en particulier si l'équilibre métabolique auparavant médiocre se trouve amélioré par une insulinothérapie intensive.
0.2539563477039337 ||| Effect and safety studies (with a total of 1,317 patients treated with doxazosin) have only been performed in patients with a baseline of ≥ 12 on the International Prostate Symptom Score and a maximum urinary flow of < 15 ml/ sec. ||| The primary efficacy endpoint in all four studies was the proportion of patients in each treatment group who achieved the PASI 75 (i. e. at least a 75% improvement in the Psoriasis Area and Severity Index score from baseline) at 12 weeks. ||| Les études sur les effets et la sécurité d’ emploi du produit (chez un total de 1 317 patients traités par la doxazosine) ont porté exclusivement sur des patients présentant un score (International Prostate Symptom Score) initial ≥ 12 et un débit urinaire maximal de < 15 mL/ s.
0.5763112902641296 ||| These findings showed reversibility over a follow-up period of 18 months. ||| Furthermore, there was a prolongation of the relapse-free interval. ||| Ces observations ont montré une réversibilité sur une période de suivi de 18 mois.
0.04207172244787216 ||| Forced diuresis, dialysis, haemoperfusion, and exchange transfusion are unlikely to be of benefit. ||| Forced diuresis, dialysis, hemoperfusion and exchange transfusion are unlikely to be of benefit. ||| Les techniques de diurèse forcée, de dialyse, d’ hémoperfusion et d’ exsanguino-transfusion sont probablement sans bénéfice pour le patient.
0.14901494979858398 ||| What ARICLAIM is and what it is used for 2. ||| What ABILIFY is and what it is used for 2. ||| Qu’ est -ce que ARICLAIM et dans quel cas est -il utilisé 2.
0.0 ||| Reduced susceptibility to amprenavir was associated with virus that had developed I50V or I84V or V32I+I47V or I54M mutations. ||| Reduced susceptibility to amprenavir was associated with virus that had developed I50V or I84V or V32I+I47V or I54M mutations. ||| Une sensibilité réduite à l’ amprénavir était associée à un virus ayant développé des mutations I50V ou I84V ou V32I+I47V ou I54M.
0.5850152373313904 ||| Coronavirus: Commission offers financing to innovative ||| Coronavirus: EU funding for the transport of essential goods ||| Coronavirus: la Commission propose un financement au
0.9137329459190369 ||| Missed dose: ||| Omit dose* ||| Dose oubliée:
0.249108225107193 ||| • Attach the syringe with the vial adapter or transfer needle to the powder vial. ||| • If using a vial adpater, unscrew the vial adapter with the empty vial. ||| • Attachez la seringue avec l’ adaptateur pour flacon ou l’ aiguille de transfert au flacon de poudre.
0.4072583317756653 ||| Higher doses of ritonavir have been shown to be associated with an increased incidence of adverse events. ||| There are also animal data suggesting an increased susceptibility to airway infection upon exposure to low levels of NO2. ||| Il a été observé que des doses plus élevées étaient associées à une incidence accrue d’ événements indésirables.
0.42543789744377136 ||| More frequent monitoring of hepatic function was recommended in all instances. ||| Closer monitoring of TSH levels is therefore recommended in patients receiving both medicinal products. ||| Une surveillance plus fréquente de la fonction hépatique a été recommandée dans tous les cas.
0.31242072582244873 ||| CYMBALTA 60 mg once daily demonstrated a statistically significant superiority compared to placebo (p=0.004) on the primary outcome measure, the prevention of depressive relapse, as measured by time to relapse. ||| Absorption is variable and the mean oral bioavailability of tacrolimus (investigated with the Prograf formulation) is in the range of 20% - 25% (individual range in adult patients 6% - 43%). ||| CYMBALTA, à la dose de 60 mg une fois par jour, a démontré une supériorité statistiquement significative versus placebo sur le critère primaire d’ évaluation qui était la prévention des rechutes, mesurée par le délai de rechute (p=0,004).
0.11711287498474121 ||| • Cardboard box containing 270 x 1 PVC/Aluminium perforated unit dose blisters (9 pouches) in ||| ra • Cardboard box containing 180 x 1 PVC/ Aluminium perforated unit dose blisters (6 pouches) ||| Boîte en carton de 270 x 1 dose sous plaquette thermoformée prédécoupée en PVC/ Aluminium (9 sachets) et 6 Dispositifs de Libération d’ Insuline (DLI) de rechange
0.0 ||| Table 2: ||| Table 2: ||| 63 Tableau 2:
0.28069740533828735 ||| MabCampath has been examined in four main studies involving a total of 446 patients with CLL. ||| Safety of Volibris has been evaluated in clinical trials of more than 483 patients with PAH (see section 5.1). ||| MabCampath a fait l’ objet de quatre études principales portant sur 446 patients atteints de LLC.
1.467111587524414 ||| Injecting a Dose ||| Dose of Dose of ||| Injection de la dose
0.0 ||| Do not store above 25 °C. ||| Do not store above 25 °C. ||| Plaquettes thermoformées: à conserver à une température ne dépassant pas +25 °C.
0.7043150663375854 ||| Break the top of the ampoule of solvent. ||| - drooping of the upper eyelid ||| Cassez le haut de l’ampoule de solvant.
0.2366401106119156 ||| Since sodium oxybate is metabolised by GHB dehydrogenase there is a potential risk of an interaction with drugs that stimulate or inhibit this enzyme (e. g. valproate, phenytoin or ethosuximide). ||| 4 Caution is advised when leflunomide is given together with drugs, other than NSAIDs, metabolised by CYP2C9 such as phenytoin, warfarin, phenprocoumon and tolbutamide. ||| L’ oxybate de sodium étant métabolisé par la gamma hydroxybutyrate déshydrogénase, il y a donc un risque potentiel d’ interaction avec les médicaments stimulants ou inhibiteurs de cette enzyme (par exemple valproate, phénytoïne ou éthosuximide).
0.7061452269554138 ||| Most of these were not serious and could be managed without treatment. ||| Yet the challenges we faced before this crisis have not gone away. ||| La plupart n’étaient pas graves et n’ont pas nécessité de traitement spécifique.
0.25601449608802795 ||| As the likelihood of contamination of Bovilis BVD vaccine, and the subsequent probability of seroconversion by such contaminants is extremely low, the advantage of additional final product testing for extraneous agents (serological method) is considered to be negligible. ||| More recently, formulations that use benzalkonium chloride have been shown to have persistent and cumulative antimicrobial activity after application, unlike alcohol, which has been shown to decrease in efficacy after repeated use, probably due to progressive adverse skin reactions. ||| La probabilité de contamination du vaccin Bovilis BVD et la probabilité subséquente de séroconversion par ces éventuels contaminants étant extrêmement faibles, l’ avantage que présente un test supplémentaire de dépistage d’ agents externes sur le produit fini (méthode sérologique) est considéré comme négligeable.
0.3647317588329315 ||| Following oral administration, the plasma concentration of unchanged lacosamide increases rapidly and reaches Cmax about 0.5 to 4 hours post-dose. ||| Food delays the time to reach the peak concentration from 6 to 10 hours and it marginally decreases the extent of absorption (approximately 11%). ||| Après une administration orale, la concentration plasmatique du lacosamide sous forme inchangée augmente rapidement et la Cmax est atteinte environ 0,5 à 4 heures après l’ administration.
0.13949447870254517 ||| Why has Daronrix been approved? ||| Why has Quintanrix been approved? ||| Pourquoi Daronrix a -t-il été approuvé?
0.0029927873983979225 ||| 35 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 36 PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND THE IMMEDIATE PACKAGING ||| 38 MENTIONS DEVANT FIGURER SUR L’ EMBALLAGE EXTÉRIEUR ET SUR LE CONDITIONNEMENT PRIMAIRE
0.33558911085128784 ||| Under these conditions the applicant is exempted from submitting further preclinical or clinical data on efficacy of the proposed product, and can claim the same indications for use and the same precautionary warnings to ensure safe use for the product as for the reference product Tribrissen Oral Paste. ||| The Fifth Anti-Money Laundering Directive clarifies the type of enhanced vigilance to be applied, which includes obtaining additional information on the customer and on the beneficial owner or obtaining the approval of senior management for establishing a business relationship. ||| Dans ces conditions, le demandeur est dispensé de soumettre d’ autres données précliniques ou cliniques concernant l’ efficacité du produit proposé et peut revendiquer les mêmes indications pour
0.3736094832420349 ||| However, the transmission of SARS-CoV was considered to occur when the patients are severely ill, while most transmission did not happen at the early phase. ||| The more common side effects of ADARTREL can happen when some patients first start their therapy and/ or when the dose is increased. ||| Cependant, il était considéré que le SARS-CoV était transmis par les patients gravement malades, avec une très faible probabilité de transmission dans la première phase.
0.5964969396591187 ||| 22 October 2004 ||| 22.10.97 ||| 22 Octobre 2004
0.045221421867609024 ||| Which measures are being taken to ensure the safe use of Cubicin? ||| Which measures are being taken to ensure the safe use of Valtropin? ||| Quelles sont les mesures prises pour assurer la sécurité d'emploi de Cubicin?
0.02267937734723091 ||| Polska Alcon Polska Sp. z o. o. + 48 22 820 3450 ||| Polska Alcon Polska Sp. z o.o. + 48 22 820 3450 ||| Polska Alcon Polska Sp. z o.o. + 48 22 820 3450
0.0 ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE ||| FABRICANT DE LA SUBSTANCE ACTIVE D'ORIGINE BIOLOGIQUE ET TITULAIRE DE L’AUTORISATION DE FABRICATION RESPONSABLE DE LA LIBERATION DES LOTS
0.38189423084259033 ||| With the help of the European Commission, the EMEA now has in place a mechanism that should allow it face the future with greater certainty. ||| The EMEA expects to be able to make a contribution to the European Commission during 2002 with regard to future changes in the structure of fees. ||| Grâce à l’ aide de la Commission européenne, l’ d’ mécanisme lui permettant de faire face à l’
0.49276256561279297 ||| Management and compilation of computerised databases ||| Publication and editing of printed matter ||| Gestion et compilation de bases de données informatiques
0.026801209896802902 ||| 14 tablets 28 tablets 28 x 1 tablets 56 tablets 98 tablets ||| 14 tablets 28 tablets 56 tablets 56 x 1 tablets 98 tablets ||| 14 comprimés 28 comprimés 28 x 1 comprimés 56 comprimés 98 comprimés
0.015721339732408524 ||| The Commission found that the Italian measure is in line with the conditions set out in the Temporary Framework. ||| The Commission found that the French measure is in line with the conditions set out in the Temporary Framework. ||| La Commission a estimé que la mesure prise par l'Italie était conforme aux conditions énoncées dans l'encadrement temporaire.
4.2762381092728563e-13 ||| Cardiac failure should be adequately controlled before beginning therapy with timolol. ||| Cardiac failure should be adequately controlled before beginning therapy with timolol. ||| L'insuffisance cardiaque doit être convenablement contrôlée avant de débuter un traitement par le timolol.
0.0 ||| 9. ||| 9. ||| 137 9.
0.4113767743110657 ||| Hepatocellular changes should be monitored frequently if this combination is prescribed. ||| Method of administration This vaccine should be administered intramuscularly. ||| - Les modifications hépato- cellulaires doivent être surveillées fréquemment si cette association est prescrite.
0.4038087725639343 ||| These patients should be followed closely. ||| This should be checked routinely. ||| Ces patients doivent être étroitement surveillés.
0.23281288146972656 ||| In the case of severe renal insufficiency, Azomyr should be used with caution (see section 5.2). ||| In the event of polycythaemia, Nespo should be temporarily withheld (see section 4.2). ||| Azomyr doit être utilisé avec précaution en cas d’ insuffisance rénale sévère (voir rubrique 5.2).
0.31076276302337646 ||| CYSTAGON is a medicine that reacts with cystine to decrease its level within the cells. ||| STOCRIN taken in combination with other antiretroviral medicines reduces the amount of the virus in the blood. ||| CYSTAGON est un médicament qui réagit avec la cystine pour abaisser sa concentration dans les cellules.
0.4844779968261719 ||| Luxembourg/Luxemburg Rue de Stalle 73 B-1180 Bruxelles/Brüssel Belgique/Belgien Tél/Tel: + 32-(0)2 370 92 11 ||| Luxembourg/Luxemburg Rue de Stalle 73 B-1180 Bruxelles/Brüssel Belgique/Belgien ||| Luxembourg/ Luxemburg Rue de Stalle 73 B-1180 Bruxelles/ Brüssel Belgique/ Belgien Tél/ Tel: + 32-(0)2 370 92 11
0.14457693696022034 ||| Novo Nordisk A/ S Hallas Allé DK-4400 Kalundborg Denmark ||| Novo Nordisk A/ S Brennum Park DK-3400 Hillerød Denmark ||| Novo Nordisk A/ S Hallas Allé DK-4400 Kalundborg Danemark
0.314264178276062 ||| Polyurethane foam for insulating purposes ||| Polyurethane foam sheeting for use as building insulation ||| Mousse de polyuréthane à des fins d'isolation
0.0724879801273346 ||| 97 Pharmacotherapeutic group: gonadotrophins, ATC code: ||| Pharmacotherapeutic group: gonadotrophins; ATC code: ||| Classe pharmacothérapeutique: gonadotrophines, code ATC:
0.8135435581207275 ||| Cured sausages ||| Sweet and sour sauce ||| Saucisses séchées
0.21735958755016327 ||| Serious hypersensitivity reactions (anaphylaxis and angioedema) have been reported in patients receiving celecoxib (see section 4.8). ||| Immune system disorders Allergic and anaphylactoid reactions have been observed in patients receiving tacrolimus (see section 4.4). ||| De graves réactions d’ hypersensibilité (anaphylaxie et œ dème de Quincke) ont été rapportées chez les patients recevant du célécoxib (voir rubrique 4.8).
0.4426848292350769 ||| This appropriation is intended to cover the purchase of books, documents and other non-periodic publications and the updating of existing volumes required by Agency departments. ||| This appropriation is intended to cover the cost of running restaurants, cafeterias and canteens, including maintenance facilities. ||| Ce crédit est destiné à couvrir les acquisitions d'ouvrages, de documents et d'autres publications non périodiques ainsi que des mises à jour de volumes existants nécessaires aux services de l'Agence.
0.08578495681285858 ||| th EU/ 1/ 99/ 128/ 034 ||| u EU/ 1/ 99/ 128/ 035 ||| EU/ 1/ 99/ 128/ 034
0.16583630442619324 ||| - Enterobacteriaceae: ≤ 0.5 µg/ ml for susceptible, > 1 µg/ ml for resistant; ||| - N. meningitides: ≤ 0.03 µg/ ml for susceptible, > 0.06 µg/ ml for resistant; ||| Enterobacteriaceæ: sensibilité, ≤ 0,5 µg/ ml; résistance, > 1 µg/ ml;
0.5629290342330933 ||| Let the tops air-dry. ||| Allow to air-dry completely. ||| Laisser sécher à l'air.
3.7539120575046103e-13 ||| In controlled studies, a higher proportion of patients treated with pregabalin reported blurred vision than did patients treated with placebo which resolved in a majority of cases with continued dosing. ||| In controlled studies, a higher proportion of patients treated with pregabalin reported blurred vision than did patients treated with placebo which resolved in a majority of cases with continued dosing. ||| 53 Dans les essais cliniques contrôlés, une proportion plus importante de patients traités par la prégabaline que de patients sous placebo a signalé une vision trouble qui a disparu dans la majorité des cas malgré la poursuite du traitement.
2.9896739381016224e-13 ||| Olanzapine also demonstrated comparable efficacy results to haloperidol in terms of the proportion of patients in symptomatic remission from mania and depression at 6 and 12 weeks. ||| Olanzapine also demonstrated comparable efficacy results to haloperidol in terms of the proportion of patients in symptomatic remission from mania and depression at 6 and 12 weeks. ||| L'olanzapine a également montré des résultats d'efficacité comparables à l'halopéridol en terme de proportion de patients en rémission des symptômes maniaques et dépressifs à 6 et 12 semaines.
0.547444224357605 ||| Suspended ceilings of metal ||| Corn kernels being toasted ||| Faux plafonds métalliques
0.15368551015853882 ||| Hypersensitivity to zonisamide, to any of the excipients or to sulphonamides. ||| Hypersensitivity to cefuroxime, other cephalosporins or to any of the excipients. ||| Hypersensibilité au zonisamide, à l’ un des excipients ou aux sulfamides.
0.3881340026855469 ||| Loading dose of 200 mg (5 ml) once a day on the first day, then 100 mg (2.5 ml) once a day for 13 days. ||| This can be taken either as 1 x 150 mg tablet twice a day approximately 12 hours apart or 300 mg once a day (2 x 150 mg tablet or 1 x 300 mg tablet). ||| Dose de charge de 200 mg (5 ml) une fois par jour le premier jour, puis 100 mg (2,5 ml) une fois par jour pendant 13 jours.
0.43116849660873413 ||| Filgrastim Hexal can also be used in people who are about to donate blood stem cells for transplant, to help release these cells from the bone marrow. ||| For the treatment of large numbers of pigs, Aivlosin was mixed into pig food by an authorised feed mill using the “ premix for medicated feeding stuff”. ||| Filgrastim Hexal peut également être utilisé chez les personnes qui sont sur le point de donner des cellules souches de sang en vue d’ une transplantation, pour aider la moelle osseuse à produire ces cellules.
0.021853838115930557 ||| 33 6.6 Special precautions for disposal ||| 36 6.6 Special precautions for disposal ||| 6.6 Précautions particulières d’ élimination
0.28943145275115967 ||| Boehringer Ingelheim RCV GmbH & Co KG Tel: +43 1 80 105-0 ||| Danmark Boehringer Ingelheim Danmark A/ S Tlf: +45 39 15 88 49 ||| Österreich Boehringer Ingelheim Austria GmbH Tel: +43 1 80 105-0
0.19272860884666443 ||| 4 Gastrointestinal disorders: ||| 7 Gastrointestinal disorders ||| 4 Très fréquent: céphalées
0.21914058923721313 ||| How to use Prometax 4. ||| How to use Erbitux 4. ||| Comment utiliser Prometax 4.
0.13154980540275574 ||| The most common side effects with Imprida (seen in between 1 and 10 patients in 100) are headache, nasopharyngitis (inflammation of the nose and throat), influenza (flu), various types of oedema (swelling), fatigue (tiredness), flushing (reddening), asthenia (weakness) and hot flushes. ||| The most common side effects of Competact (seen in between 1 and 10 patients in 100) are anaemia (low red blood cells), visual disturbance, weight increase, arthralgia (joint pain), headache, haematuria (blood in the urine), erectile dysfunction (problems getting an erection). ||| Les effets indésirables les plus couramment observés sous Imprida (chez entre 1 et 10 patients sur 100) sont les céphalées (maux de tête), la rhinopharyngite (inflammation du nez et de la gorge), la grippe, divers types d’œ dèmes (gonflements), la fatigue (épuisement), les bouffées vasomotrices (rougeurs), l’ asthénie (faiblesse) et les bouffées de chaleur.
0.06467297673225403 ||| 109 10. ||| 107 10. ||| 119 10.
0.4801282584667206 ||| Ultrasonic cleaning instruments for veterinary use ||| Face masks for surgical use for anti bacterial protection ||| Instruments de nettoyage ultrasoniques à usage vétérinaire
0.2616824507713318 ||| ori ||| OB ||| tor
0.008061744272708893 ||| 3 the absence of a clear aetiology for the lymphadenopathy or in the presence of acute infectious mononucleosis, discontinuation of Protopy should be considered. ||| 3 the absence of a clear aetiology for the lymphadenopathy or in the presence of acute infectious mononucleosis, discontinuation of Protopic should be considered. ||| En l'absence d'étiologie précise, ou en cas de mononucléose infectieuse aiguë, l'arrêt de Protopy devra être envisagé.
6.82268369404937e-13 ||| Interaction via effects on transport proteins cannot be excluded. ||| Interaction via effects on transport proteins cannot be excluded. ||| Une interaction via des effets sur les protéines de transport ne peut être exclue.
0.00990832969546318 ||| 60 The occurrence of anaemia (haemoglobin < 10 g/ dl) has been observed in up to 15% of chronic hepatitis C patients in clinical trials on the combined treatment of Pegasys with ribavirin. ||| The occurrence of anaemia (haemoglobin < 10 g/ dl) has been observed in up to 15% of chronic hepatitis C patients in clinical trials on the combined treatment of Pegasys with ribavirin. ||| La survenue d’une anémie (hémoglobine < 10 g/dl) a été observée à un pourcentage pouvant aller jusqu'à 15% des patients atteints d’hépatite chronique C et traités par Pegasys associé à la ribavirine dans les études cliniques.
0.6332922577857971 ||| The most frequently occurring adverse reactions with a higher incidence in the Axura group than in the placebo group were dizziness (6.3% vs 5.6%, respectively), headache (5.2% vs 3.9%), constipation (4.6% vs 2.6%), somnolence (3.4% vs 2.2%) and hypertension (4.1% vs 2.8%). ||| pancreatitis (0.7% vs 0.2%), haematemesis (0.2% vs 0%), stomatitis (0.2% vs 0.2%), constipation (0.3% vs 0.5%), abdominal distension (0.7% vs 1.0%), dry mouth (0.2% vs 0%), retching (0.2% vs 0%) ||| Les effets indésirables les plus fréquents avec une incidence supérieure dans le groupe Axura par rapport au groupe placebo ont été: sensations vertigineuses (6,3% vs 5,6%, respectivement), céphalée (5,2% vs 3,9%), constipation (4,6% vs 2,6%), somnolence (3,4% vs 2,2%) et hypertension (4,1% vs 2,8%).
0.5291048288345337 ||| Serious haemorrhage, haemorrhage of operative wound, vasculitis, hypotension ||| Degree of haemorrhage/ Type of surgical procedure Haemorrhage ||| Hémorragie grave, hémorragie d’une plaie opératoire, vascularite, hypotension
0.41381722688674927 ||| The study compared the effects of three doses of Zonegran with those of placebo (a dummy treatment). ||| In the other study, three different dosing schedules of subcutaneous Dynepo were compared. ||| L’ étude a comparé les effets de trois doses de Zonegran avec ceux du placebo (traitement fictif).
0.0 ||| General Disorders and Administration Site Conditions ||| General Disorders and Administration Site Conditions ||| Troubles généraux et anomalies au site d’ administration
0.30387991666793823 ||| Infants whose mothers have taken AIIRAs should be closely observed for hypotension (see also sections 4.3 and 4.4). ||| Physicians should consider using alternatives when a patient is taking VIRACEPT (see sections 4.3 and 4.5). ||| Les nouveau-nés de mère traitée par un inhibiteur des récepteurs de l’ angiotensine II doivent être surveillés sur le plan tensionnel (voir rubriques 4.3 et 4.4).
0.3997027277946472 ||| Efficacy of Xolair treatment in combination with specific immunotherapy has not been established. ||| The relationship of these substitutions to in vivo effectiveness of enfuvirtide has not been established. ||| L’ efficacité du traitement par Xolair administré en association avec une immunothérapie spécifique n’ a pas été établie.
0.05164314806461334 ||| Adopted in September 1997 ||| Adopted in April 1997 ||| Adoptée en septembre 1997
0.4278736710548401 ||| If grade 3 sensory neuropathy develops, treatment should be withheld until resolution to grade 1 or 2 followed by a dose reduction for all subsequent courses of Abraxane is recommended (see section 4.2). ||| The sample size of the KLIM/ PD/ 11/ USA study may be considered too small to draw any definite conclusion regarding endometrial safety of E2 0,5 mg, even for 2 year- treatment. ||| En cas d’ apparition d’ une neuropathie sensitive de grade 3, le traitement sera suspendu jusqu’ à ce que la neuropathie recouvre un grade 1 ou 2, et il est recommandé de réduire la dose pour toutes les cures suivantes d’ Abraxane (voir la section 4.2).
0.12263139337301254 ||| Ziconotide should not be used during pregnancy unless clearly necessary. ||| Porfimer sodium should not be used during pregnancy, unless clearly necessary. ||| Le ziconotide ne doit pas être utilisé pendant la grossesse sauf en cas de nécessité absolue.
0.7091742753982544 ||| Tomato juice for cooking ||| Rice meal for forage ||| Jus de tomates pour la cuisine
0.07700681686401367 ||| 4 pens of 3 ml. ||| 3 pens of 3 ml. ||| 4 stylos de 3 ml.
0.7887364625930786 ||| Fireplace inserts in the nature of stoves ||| the muscle pains with the hay fever ||| Inserts de cheminée sous forme de poêles
0.25272509455680847 ||| Cryostats, other than for laboratory use ||| Electrolyte solutions, other than for medical use ||| Cryostats autres que pour laboratoires
0.5704746246337891 ||| Careful risk-to-benefit evaluation should be done for these subjects (see section 4.3). ||| Subsequent failures should be handled on case- by-case basis. ||| Une évaluation soigneuse du rapport bénéfice-risque doit être faite pour ces sujets (voir rubrique 4.3).
0.6200544834136963 ||| Deputy Chief Public Health Officer—Health Protection and Chronic Disease Prevention Branch ||| Assistant Deputy Minister—Infectious Disease and Emergency Preparedness ||| Député-chef de la santé publique - Protection de la santé publique et la section de prévention des maladies chroniques
0.12953901290893555 ||| These findings are not considered clinically significant. ||| These data are not considered clinically significant. ||| Ces données ne sont pas considérées comme cliniquement significatives.
0.21054977178573608 ||| Mirapexin must be given less frequently in patients who have problems with their kidneys. ||| Atripla is not recommended for patients who have moderate or severe problems with their kidneys. ||| La fréquence d’ administration de Mirapexin doit être réduite chez les patients atteints d’ insuffisance rénale.
0.09000378102064133 ||| Nonclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction. ||| Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity potential, and toxicity to reproduction, local tolerance or compatibility with blood. ||| Les données non cliniques issues des études conventionnelles de pharmacologie de sécurité, toxicologie en administration répétée, génotoxicité, cancérogénèse, et toxicité sur les fonctions de reproduction, n’ont pas révélé de risque particulier pour l’homme.
0.34223246574401855 ||| The results indicate that a somewhat higher plasma concentration can be expected with OPATANOL in this population. ||| Plasma concentrations of abacavir are expected to be variable and substantially increased in these patients (see section 4.3). ||| Les résultats indiquent que, dans cette population, une concentration plasmatique un peu plus élevée peut être attendue avec OPATANOL.
0.037296753376722336 ||| EU/ 1/ 96/ 008/ 034 ||| EU/ 2/ 97/ 004/ 031 ||| 3 EU/ 1/ 96/ 008/ 034 Puregon
0.3761196732521057 ||| In contrast, patients adding placebo had smaller changes in HbA1c levels, with a rise of 0.23% from a starting level of 8.30%. ||| Decreased values of albumin caused a reduced clearance (CL/ f); and higher levels of WBC led to a reduction of CL/ f. ||| En revanche, les patients chez lesquels le placebo a été ajouté ont connu des fluctuations moins importantes du taux de HbA1c, celui -ci augmentant de 0,23% pour un taux initial de 8,30%.
0.19697719812393188 ||| Mildly anaemic patients (haematocrit of 33 - 39%) requiring predeposit of ≥ 4 units of blood should be treated with Binocrit at a dose of 600 IU/ kg body weight 2 times weekly for 3 weeks prior to surgery. ||| Patients who experience severe neutropenia (neutrophil count < 0.50 x 109/ l for a week or longer) or severe sensory neuropathy during Abraxane therapy should have the dose reduced to 220 mg/ m2 for subsequent courses. ||| Les patients légèrement anémiques (hématocrite de 33-39%) nécessitant un prélèvement préalable de ≥ 4 unités sanguines doivent être traités par Binocrit à la dose de 600 UI/ kg de masse corporelle 2 fois par semaine pendant 3 semaines avant l’ intervention chirurgicale.
0.12181489169597626 ||| Safety alarms [other than for vehicles] ||| Security alarm systems [other than for vehicles] ||| Alarmes de sécurité [autres que pour véhicules]
0.2977989912033081 ||| Perlite for use in horticulture ||| Gases for use in horticulture ||| Perlite destinée à l'horticulture
0.3558768033981323 ||| This included diuretics, cardiac glycosides, beta- blockers and/ or angiotensin-converting enzyme inhibitors. ||| Direct acting antivirals, nucleosides and nucleotides (excl. reverse transcriptase inhibitors), ATC code: ||| Celui -ci comportait des diurétiques, des digitaliques, des bêta-bloquants et/ ou des inhibiteurs de l’ enzyme de conversion de l’ angiotensine.
0.3683100938796997 ||| It is recommended to implement the standard sentence “ Use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies ” in section 4.5 of the relevant SPCs. ||| The company has qualified both foreseeable impurities according ICH Q3B Guideline, which is in line with the current regulatory provisions for drug products for long-term use. ||| Il est recommandé d’ inclure la phrase standard suivante « L’ utilisation du médicament doit être basée sur un test de sensibilité et tenir compte des politiques officielles et locales de lutte contre les microbes » dans le chapitre 4.5 des RCP pertinents.
0.2476920187473297 ||| Pregnancy and breast-feeding There are insufficient data concerning the use of Cervarix during pregnancy. ||| 17 Pregnancy and breast-feeding The safety of OPTISON for use during human pregnancy has not been fully established. ||| Grossesse et allaitement Les données concernant l’utilisation de Cervarix pendant la grossesse sont insuffisantes.
0.23976930975914001 ||| However, subgroup analysis did not identify an increased magnitude of PR prolongation in patients with concomitant administration of carbamazepine or lamotrigine in clinical trials. ||| In an exploratory analysis, the extent of Avastin benefit on overall survival was less pronounced in the subgroup of patients who did not have adenocarcinoma histology. ||| Toutefois, les analyses de sous- groupes au cours des essais cliniques n’ ont pas identifié d’ augmentation de l’ importance de l’ allongement de PR chez les patients en cas d’ administration concomitante de carbamazépine ou lamotrigine.
0.2373001128435135 ||| Rifabutin AUC*: ↑ 54% Rifabutin Cmin*: ↑ 99% (*Relative to rifabutin 300 mg QD alone. ||| Indinavir AUC: ↑ 53% Indinavir Cmin ↑ 298% (Relative to Indinavir 800 mg TID alone) ||| Rifabutine ASC*: ↑ 54% Rifabutine Cmin*: ↑ 99% (*Par rapport à la rifabutine 300 mg seule, une fois/ jour.
0.0 ||| The potential risk for humans is unknown. ||| The potential risk for humans is unknown. ||| Le risque demeure inconnu pour l’ être humain.
0.4949999153614044 ||| Since doxazosin is strongly bound to proteins dialysis is not indicated. ||| This leads to a release of insulin by exocytosis. ||| La doxazosine se liant fortement aux protéines, la dialyse n’ est pas indiquée.
0.6491827368736267 ||| The cartridges should be examined frequently and should not be used if clumps of material are present or if solid white particles stick to the bottom or wall of the cartridge, giving it a frosted appearance. ||| It uses the dark palette of greens and browns, typical of Van Gogh's early work, with touches of green and red in the painting indicating that winter has passed and spring has begun. ||| Examinez les cartouches régulièrement et ne pas les utiliser si la suspension présente des grumeaux ou si des particules blanches restent collées au fond de la cartouche ou sur les parois, lui donnant un aspect givré.
0.3930843472480774 ||| Propellers for boats ||| Mudguards for trucks ||| Hélices pour bateaux
0.19889521598815918 ||| 60 mg pink, round, bevelled-edge tablets with “ STARLIX” marked on one side and “ 60” on the other. ||| Starlix 120 mg film-coated tablets are yellow, ovaloid tablets with “ STARLIX” marked on one side and “ 120” on the other. ||| Comprimés de 60 mg, ronds, roses, à bords biseautés, portant les inscriptions « STARLIX » sur une face et « 60 » sur l'autre.
0.4725117087364197 ||| The increased digoxin levels may lessen over time (see section 4.5). ||| because of higher rate of febrile reactions (see section 4.8). ||| L’augmentation de la digoxinémie peut s’atténuer au cours du temps (voir rubrique 4.5).
0.25755196809768677 ||| Medicinal product subject to medical prescription. t uc ||| Medicinal product subject to medical prescription a in ic ||| CONDITIONS DE PRESCRIPTION ET DE DELIVRANCE s Médicament soumis à prescription médicale. n' e
0.3103567957878113 ||| It is recommended that Xigris be infused with an infusion pump to accurately control the infusion rate. ||| To prepare the area of skin where RELISTOR is to be injected, wipe the injection site with an alcohol swab. ||| Il est recommandé d’ administrer Xigris avec une pompe à perfusion pour contrôler de façon précise le débit de perfusion.
0.22643031179904938 ||| Losartan is not recommended in children with glomerular filtration rate < 30ml/ min/ 1.73 m2as no data are available (see section 4.2). ||| No dose adjustment is necessary in TIH patients with serum creatinine < 400 µmol/ l or < 4.5 mg/ dl (see section 4.4). ||| Le losartan n’ est pas recommandé chez l’ enfant présentant un taux de filtration glomérulaire inférieur à 30 ml/ min/ 1,73 m2, aucune donnée n’ étant disponible (voir section 4.2).
0.04902992025017738 ||| Ask your doctor or pharmacist for advice before taking any medicine. ||| Ask your doctor or hospital pharmacist for advice before taking any medicine. ||| 77 Demandez conseil à votre médecin ou à votre pharmacien avant de prendre tout médicament.
